PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Broekhuizen, K; van Poppel, MNM; Koppes, LL; Kindt, I; Brug, J; van Mechelen, W				Broekhuizen, Karen; van Poppel, Mireille N. M.; Koppes, Lando L.; Kindt, Iris; Brug, Johannes; van Mechelen, Willem			Can Multiple Lifestyle Behaviours Be Improved in People with Familial Hypercholesterolemia? Results of a Parallel Randomised Controlled Trial	PLOS ONE			English	Article							INTERVENTIONS TARGETING ADULTS; CARDIOVASCULAR-DISEASE RISK; CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; SMOKING-CESSATION; MEDICATION ADHERENCE; SHORT QUESTIONNAIRE; RELATIVE VALIDITY; EFFICACY; PREVENTION	Objective: To evaluate the efficacy of an individualised tailored lifestyle intervention on physical activity, dietary intake, smoking and compliance to statin therapy in people with Familial Hypercholesterolemia (FH). Methods: Adults with FH (n = 340) were randomly assigned to a usual care control group or an intervention group. The intervention consisted of web-based tailored lifestyle advice and face-to-face counselling. Physical activity, fat, fruit and vegetable intake, smoking and compliance to statin therapy were self-reported at baseline and after 12 months. Regression analyses were conducted to examine between-group differences. Intervention reach, dose and fidelity were assessed. Results: In both groups, non-significant improvements in all lifestyle behaviours were found. Post-hoc analyses showed a significant decrease in saturated fat intake among women in the intervention group (beta = -1.03; CI -1.98/-0.03). In the intervention group, 95% received a log on account, of which 49% logged on and completed one module. Nearly all participants received face-to-face counselling and on average, 4.2 telephone booster calls. Intervention fidelity was low. Conclusions: Individually tailored feedback is not superior to no intervention regarding changes in multiple lifestyle behaviours in people with FH. A higher received dose of computer-tailored interventions should be achieved by uplifting the website and reducing the burden of screening questionnaires. Counsellor training should be more extensive.	[Broekhuizen, Karen; van Poppel, Mireille N. M.; van Mechelen, Willem] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Koppes, Lando L.] TNO, Div Work & Employment, Hoofddorp, Netherlands; [Kindt, Iris] Fdn Identificat Persons Inherited Hypercholestero, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands Organization Applied Science Research	van Poppel, MNM (corresponding author), Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	mnm.vanpoppel@vumc.nl	van Mechelen, Willem/C-8463-2013; Van Poppel, Mireille/AAL-8228-2020; Brug, Johannes/A-8242-2018	Van Poppel, Mireille/0000-0001-5694-4324; Brug, Johannes/0000-0002-1904-7349; van Mechelen, Willem/0000-0001-7136-6382	ZonMw (Netherlands Organisation for Health, Research and Development); Netherlands Organization of Scientific Research	ZonMw (Netherlands Organisation for Health, Research and Development)(Netherlands Organization for Health Research and Development); Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO))	This project was financed by ZonMw (Netherlands Organisation for Health, Research and Development). The publication of the manuscript was funded by The Netherlands Organization of Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, BMJ, V303, P893; Austin MA, 2004, AM J EPIDEMIOL, V160, P421, DOI 10.1093/aje/kwh237; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Blokstra A, 2012, EUR J CARDIOVASC NUR, V11, P97, DOI 10.1016/j.ejcnurse.2010.10.005; Bogers RP, 2004, AM J EPIDEMIOL, V159, P900, DOI 10.1093/aje/kwh123; Britt E, 2004, PATIENT EDUC COUNS, V53, P147, DOI 10.1016/S0738-3991(03)00141-1; Broekhuizen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-348; Broekhuizen Karen, 2012, BMC Res Notes, V5, P181, DOI 10.1186/1756-0500-5-181; Broekhuizen K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-69; Brouwer W, 2011, J MED INTERNET RES, V13, P23, DOI 10.2196/jmir.1639; Campbell MK, 2009, ANN BEHAV MED, V38, P71, DOI 10.1007/s12160-009-9140-5; Carey M, 2006, IRISH J MED SCI, V175, P30, DOI 10.1007/BF03167964; Civeira F, 2004, ATHEROSCLEROSIS, V173, P55, DOI 10.1016/j.atherosclerosis.2003.11.010; Civljak M, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007078.pub3, 10.1002/14651858.CD007078.pub5]; De Vet E, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-13; de Vries H, 2006, CANCER EPIDEM BIOMAR, V15, P1360, DOI 10.1158/1055-9965.EPI-05-0877; Foundation for the Identification of Persons with Inherited Hypercholesterolemia, 2010, ANN REP 2009; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Haynes RB, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub2; Heckman CJ, 2010, TOB CONTROL, V19, P410, DOI 10.1136/tc.2009.033175; Hegele RA, 2002, ATHEROSCLEROSIS SUPP, V2, P5, DOI 10.1016/S1567-5688(01)00013-7; Hettema J, 2005, ANNU REV CLIN PSYCHO, V1, P91, DOI 10.1146/annurev.clinpsy.1.102803.143833; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Issa J S, 1996, Arq Bras Cardiol, V66, P339; Julius RJ, 2009, J PSYCHIATR PRACT, V15, P34, DOI 10.1097/01.pra.0000344917.43780.77; Kasper D., 2008, HARRISONS PRINCIPLES; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kostalova B, 2011, NORM GEZOND BEWEGEN; Kotseva K, 2009, EUR J CARDIOV PREV R, V16, P121, DOI 10.1097/HJR.0b013e3283294b1d; Krebs P, 2010, PREV MED, V51, P214, DOI 10.1016/j.ypmed.2010.06.004; Kripalani S, 2007, ARCH INTERN MED, V167, P540, DOI 10.1001/archinte.167.6.540; Kroeze W, 2006, ANN BEHAV MED, V31, P205, DOI 10.1207/s15324796abm3103_2; Kromhout D, 2002, CIRCULATION, V105, P893, DOI 10.1161/hc0702.103728; Levensky ER, 2007, AM J NURS, V107, P50, DOI 10.1097/01.NAJ.0000292202.06571.24; Lustria MLA, 2009, PATIENT EDUC COUNS, V74, P156, DOI 10.1016/j.pec.2008.08.023; Moyers T., 2007, REVISED GLOBAL SCALE; Mudde AN., 2000, MEETINSTRUMENTEN OND; Neville LM, 2009, HEALTH PROMOT J AUST, V20, P48, DOI 10.1071/HE09048; Neville LM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-30; Nigg CR, 2002, HEALTH EDUC RES, V17, P670, DOI 10.1093/her/17.5.670; Noar SM, 2007, PSYCHOL BULL, V133, P673, DOI 10.1037/0033-2909.133.4.673; Oenema A, 2008, ANN BEHAV MED, V35, P125, DOI 10.1007/s12160-008-9023-1; Panz V R, 2005, Cardiovasc J S Afr, V16, P112; Prochaska JO, 2008, PREV MED, V46, P226, DOI 10.1016/j.ypmed.2007.11.007; Prochaska JJ, 2004, HEALTH PSYCHOL, V23, P314, DOI 10.1037/0278-6133.23.3.314; Prochaska JJ, 2008, PREV MED, V46, P181, DOI 10.1016/j.ypmed.2008.02.001; Rubak S, 2005, BRIT J GEN PRACT, V55, P305; Rubin DB., 2004, MULTIPLE IMPUTATION; Schulz KF, 2011, INT J SURG, V9, P672, DOI 10.1016/j.ijsu.2011.09.004; Shafiq N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001918.pub2; Shahab L, 2009, ADDICTION, V104, P1792, DOI 10.1111/j.1360-0443.2009.02710.x; STEPHENSON BJ, 1993, JAMA-J AM MED ASSOC, V269, P2779, DOI 10.1001/jama.269.21.2779; Sweet SN, 2010, INT J ENV RES PUB HE, V7, P1720, DOI 10.3390/ijerph7041720; Treurniet HF, 2005, PUBLIC HEALTH, V119, P159, DOI 10.1016/j.puhe.2004.05.018; van Assema P, 2001, J HUM NUTR DIET, V14, P377, DOI 10.1046/j.1365-277X.2001.00310.x; Van Assema Patricia, 2002, Nutrition and Health (Bicester), V16, P85; van Keulen HM, 2011, ANN BEHAV MED, V41, P104, DOI 10.1007/s12160-010-9231-3; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; Voedingscentrum, 2011, RICHTL VOEDS; Warren JM, 2010, EUR J CARDIOV PREV R, V17, P127, DOI 10.1097/HJR.0b013e32832ed875; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; Yuan G, 2006, CAN MED ASSOC J, V174, P1124, DOI 10.1503/cmaj.051313; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zantinge E, 2009, VOLKSGEZONDHEID TOEK	65	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50032	10.1371/journal.pone.0050032	http://dx.doi.org/10.1371/journal.pone.0050032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251355	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200023
J	Dong, Z; Di, H; Dai, W; Liang, JY; Pan, MY; Zhang, MJ; Zhou, ZB; Li, Z; Liu, RZ; Yu, SY				Dong, Zhao; Di, Hai; Dai, Wei; Liang, Jingyao; Pan, Meiyan; Zhang, Mingjie; Zhou, Zhibin; Li, Zheng; Liu, Ruozhuo; Yu, Shengyuan			Application of ICHD-II Criteria in a Headache Clinic of China	PLOS ONE			English	Article							CLUSTER HEADACHE; UNITED-STATES; PREVALENCE; MIGRAINE; CLASSIFICATION; DISORDERS; FREQUENCY; FEATURES; PROFILE; BURDEN	Background: China has the huge map and the largest population in the world. Previous studies on the prevalence and classification of headaches were conducted based on the general population, however, similar studies among the Chinese outpatient population are scarce. This study aimed to analyze the characteristics of 1843 headache patients enrolled in a North China headache clinic of the General Hospital for Chinese People's Liberation Army from October 2011 to May 2012, with the International Classification of Headache Disorders, 2nd Edition (ICHD-II). Methods and Results: Personal interviews were carried out and a detailed questionnaire was used to collect medical records including age, sex and headache characteristics. Patients came from 28 regions of China with the median age of 40.9 (9-80) years and the female/male ratio of 1.67/1. The primary headaches (78.4%) were classified as the following: migraine (39.1%), tension-type headache (32.5%), trigeminal autonomic cephalalgias (5.3%) and other primary headache (1.5%). Among the rest patients, 12.9% were secondary headaches, 5.9% were cranial neuralgias and 2.5% were unspecified or not elsewhere classified. Fourteen point nine percent (275/1843) were given an additional diagnosis of chronic daily headache, including medication-overuse headache (MOH, 49.5%), chronic tension-type headache (CTTH, 32.7%) and chronic migraine (CM, 13.5%). The visual analogue scale (VAS) score of TTH with MOH was significantly higher than that of CTTH (6.8 +/- 2.0 vs 5.6 +/- 2.0, P<0.001). The similar result was also observed in VAS score between migraine with MOH and CM (8.0 +/- 1.5 vs 7.0 +/- 1.5, P = 0.004). The peak age at onset of TTH for male and female were both in the 3rd decade of life. However, the age distribution at onset of migraine shows an obvious sex difference, i.e. the 2nd decade for females and the 1st decade for males. Conclusions/Significance: This study revealed the characteristics of the headache clinic outpatients in a tertiary hospital of North China that migraine is the most common diagnosis. Furthermore, most headaches in this patient population can be classified using ICHD-II criteria.	[Dong, Zhao; Di, Hai; Dai, Wei; Liang, Jingyao; Pan, Meiyan; Zhang, Mingjie; Zhou, Zhibin; Li, Zheng; Liu, Ruozhuo; Yu, Shengyuan] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Int Headache Ctr, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Yu, SY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Int Headache Ctr, Beijing, Peoples R China.	yusy1963@126.com	Dai, Wei/AFV-9133-2022	Dai, Wei/0000-0002-7015-2531; Zhang, Mingjie/0000-0002-3519-1746	National Science Foundation Committee (NSFC) in China [30970417, 81171058]	National Science Foundation Committee (NSFC) in China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the National Science Foundation Committee (NSFC) in China (no. 30970417 and no. 81171058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakravarty A, 2003, CEPHALALGIA, V23, P348, DOI 10.1046/j.1468-2982.2003.00514.x; Couch JR, 2011, CURR TREAT OPTION NE, V13, P41, DOI 10.1007/s11940-010-0104-7; De Diego EV, 2005, CEPHALALGIA, V25, P184, DOI 10.1111/j.1468-2982.2004.00820.x; Dermitzakis EV, 2010, J HEADACHE PAIN, V11, P123, DOI 10.1007/s10194-009-0178-3; Felicio AC, 2006, ARQ NEURO-PSIQUIAT, V64, P41, DOI 10.1590/S0004-282X2006000100009; Friedman BW, 2007, ANN EMERG MED, V49, P409, DOI 10.1016/j.annemergmed.2006.11.004; Gesztelyi G, 2004, EUR J NEUROL, V11, P389, DOI 10.1111/j.1468-1331.2004.00800.x; Goldstein JN, 2006, CEPHALALGIA, V26, P684, DOI 10.1111/j.1468-2982.2006.01093.x; Guerrero AL, 2011, HEADACHE, V51, P226, DOI 10.1111/j.1526-4610.2010.01828.x; Imai N, 2011, CEPHALALGIA, V31, P628, DOI 10.1177/0333102410391486; Lin KH, 2004, CEPHALALGIA, V24, P631, DOI 10.1111/j.1468-2982.2003.00721.x; Lu SR, 2001, CEPHALALGIA, V21, P980, DOI 10.1046/j.1468-2982.2001.00294.x; Murtaza M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005827; Okumura Toshikatsu, 2010, Asia Pac Fam Med, V9, P10, DOI 10.1186/1447-056X-9-10; Ondo WG, 2004, CEPHALALGIA, V24, P60, DOI 10.1111/j.1468-2982.2004.00641.x; Relja Giuliano, 2005, J Headache Pain, V6, P298; Sakai F, 1997, CEPHALALGIA, V17, P15, DOI 10.1046/j.1468-2982.1997.1701015.x; Scher AI, 2003, PAIN, V106, P81, DOI 10.1016/S0304-3959(03)00293-8; Silberstein SD, 2000, CURR OPIN NEUROL, V13, P277, DOI 10.1097/00019052-200006000-00008; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Victor TW, 2010, CEPHALALGIA, V30, P1065, DOI 10.1177/0333102409355601; Wang SJ, 2008, HEADACHE, V48, P1356, DOI 10.1111/j.1526-4610.2008.01088.x; Wang YF, 2011, J HEADACHE PAIN, V12, P561, DOI 10.1007/s10194-011-0360-2; Yu SY, 2012, HEADACHE, V52, P582, DOI 10.1111/j.1526-4610.2011.02061.x	24	30	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50898	10.1371/journal.pone.0050898	http://dx.doi.org/10.1371/journal.pone.0050898			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239993	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800029
J	Suess, T; Remschmidt, C; Schink, SB; Schweiger, B; Heider, A; Milde, J; Nitsche, A; Schroeder, K; Doellinger, J; Braun, C; Haas, W; Krause, G; Buchholz, U				Suess, Thorsten; Remschmidt, Cornelius; Schink, Susanne B.; Schweiger, Brunhilde; Heider, Alla; Milde, Jeanette; Nitsche, Andreas; Schroeder, Kati; Doellinger, Joerg; Braun, Christian; Haas, Walter; Krause, Gerard; Buchholz, Udo			Comparison of Shedding Characteristics of Seasonal Influenza Virus (Sub)Types and Influenza A(H1N1)pdm09; Germany, 2007-2011	PLOS ONE			English	Article							NEURAMINIDASE INHIBITOR OSELTAMIVIR; RANDOMIZED CONTROLLED-TRIAL; H1N1 PANDEMIC INFLUENZA; HOUSEHOLD TRANSMISSION; CLINICAL ILLNESS; HAND HYGIENE; A VIRUS; INFECTIONS; A/H1N1; DURATION	Background: Influenza viral shedding studies provide fundamental information for preventive strategies and modelling exercises. We conducted a prospective household study to investigate viral shedding in seasonal and pandemic influenza between 2007 and 2011 in Berlin and Munich, Germany. Methods: Study physicians recruited index patients and their household members. Serial nasal specimens were obtained from all household members over at least eight days and tested quantitatively by qRT-PCR for the influenza virus (sub) type of the index patient. A subset of samples was also tested by viral culture. Symptoms were recorded daily. Results: We recruited 122 index patients and 320 household contacts, of which 67 became secondary household cases. Among all 189 influenza cases, 12 were infected with seasonal/prepandemic influenza A(H1N1), 19 with A(H3N2), 60 with influenza B, and 98 with A(H1N1)pdm09. Nine (14%) of 65 non-vaccinated secondary cases were asymptomatic/subclinical (0 (0%) of 21 children, 9 (21%) of 44 adults; p = 0.03). Viral load among patients with influenza-like illness (ILI) peaked on illness days 1, 2 or 3 for all (sub) types and declined steadily until days 7-9. Clinical symptom scores roughly paralleled viral shedding dynamics. On the first day prior to symptom onset 30% (12/40) of specimens were positive. Viral load in 6 asymptomatic/subclinical patients was similar to that in ILI-patients. Duration of infectiousness as measured by viral culture lasted approximately until illness days 4-6. Viral load did not seem to be influenced by antiviral therapy, age or vaccination status. Conclusion: Asymptomatic/subclinical infections occur infrequently, but may be associated with substantial amounts of viral shedding. Presymptomatic shedding may arise in one third of cases, and shedding characteristics appear to be independent of (seasonal or pandemic) (sub) type, age, antiviral therapy or vaccination; however the power to find moderate differences was limited.	[Suess, Thorsten; Remschmidt, Cornelius; Schink, Susanne B.; Braun, Christian; Haas, Walter; Krause, Gerard; Buchholz, Udo] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Schweiger, Brunhilde; Heider, Alla; Milde, Jeanette] Robert Koch Inst, Natl Reference Ctr Influenza, Berlin, Germany; [Nitsche, Andreas; Schroeder, Kati; Doellinger, Joerg] Robert Koch Inst, Ctr Biol Secur, Div Highly Pathogen Viruses ZBS1, Berlin, Germany	Robert Koch Institute; Robert Koch Institute; Robert Koch Institute	Buchholz, U (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.	BuchholzU@rki.de	Schink, Susanne Barbara/F-7758-2015; Schink, Susanne Barbara/A-2669-2017	Schink, Susanne Barbara/0000-0001-7542-9416; Doellinger, Joerg/0000-0001-8309-082X; Suess, Thorsten/0000-0002-0498-7426; Krause, Gerard/0000-0003-3328-8808; Nitsche, Andreas/0000-0001-8185-3176	ministry of health; ministry for education and science	ministry of health; ministry for education and science	The study was funded by the ministry of health (www.bmg.bund.de) and the ministry for education and science (www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	an der Heiden M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008356; Bhattarai A, 2011, CLIN INFECT DIS, V52, pS102, DOI 10.1093/cid/ciq026; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Chan MCW, 2009, J CLIN VIROL, V45, P208, DOI 10.1016/j.jcv.2009.06.011; Cheng CKY, 2009, DIAGN MICR INFEC DIS, V65, P35, DOI 10.1016/j.diagmicrobio.2009.05.003; COUCH RB, 1971, J INFECT DIS, V124, P473, DOI 10.1093/infdis/124.5.473; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; Donnelly CA, 2011, CLIN INFECT DIS, V52, pS123, DOI 10.1093/cid/ciq028; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Gu Y, 2011, EMERG INFECT DIS, V17, P1737, DOI 10.3201/eid1709.101411; Hayden FG, 2000, ANTIVIR THER, V5, P205; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Ito Y, 1999, J MED VIROL, V58, P420, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;420::AID-JMV16&gt;3.0.CO;2-T; KHAKPOUR M, 1969, BRIT MED J, V4, P208, DOI 10.1136/bmj.4.5677.208; Killingley B, 2010, HEALTH TECHNOL ASSES, V14, P237, DOI 10.3310/hta14460-04; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Li CC, 2010, EMERG INFECT DIS, V16, P1265, DOI 10.3201/eid1608.091918; Liao CM, 2010, EPIDEMIOL INFECT, V138, P825, DOI 10.1017/S0950268809991178; Loeb M, 2012, J INFECT DIS; Mori I, 1997, CLIN INFECT DIS, V24, P736; Ng S, 2010, CLIN INFECT DIS, V50, P707, DOI 10.1086/650458; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Schulze M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009966; Suess T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-26; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; Suryaprasad A, 2011, CLIN INFECT DIS, V52, pS109, DOI 10.1093/cid/ciq014; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022534; Viboud C, 2004, BRIT J GEN PRACT, V54, P684	36	77	78	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51653	10.1371/journal.pone.0051653	http://dx.doi.org/10.1371/journal.pone.0051653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240050	Green Published, gold			2022-12-27	WOS:000312290800086
J	Corcoran, C; Rani, S; O'Brien, K; O'Neill, A; Prencipe, M; Sheikh, R; Webb, G; McDermott, R; Watson, W; Crown, J; O'Driscoll, L				Corcoran, Claire; Rani, Sweta; O'Brien, Keith; O'Neill, Amanda; Prencipe, Maria; Sheikh, Rizwan; Webb, Glenn; McDermott, Ray; Watson, William; Crown, John; O'Driscoll, Lorraine			Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes	PLOS ONE			English	Article							CELL-LINES; INTERCELLULAR COMMUNICATION; DOXORUBICIN; EXPRESSION; CARCINOMA; INVASION; PROTEIN; RNA; ESTABLISHMENT; MICROVESICLES	Background: Hormone-refractory prostate cancer remains hindered by inevitable progression of resistance to first-line treatment with docetaxel. Recent studies suggest that phenotypic changes associated with cancer may be transferred from cell-to-cell via microvesicles/exosomes. Here we aimed to investigate phenotypic changes associated with docetaxel-resistance in order to help determine the complexity of this problem and to assess the relevance of secreted exosomes in prostate cancer. Methodology/Principal Findings: Docetaxel-resistant variants of DU145 and 22Rv1 were established and characterised in terms of cross-resistance, morphology, proliferation, motility, invasion, anoikis, colony formation, exosomes secretion their and functional relevance. Preliminary analysis of exosomes from relevant serum specimens was also performed. Acquired docetaxel-resistance conferred cross-resistance to doxorubicin and induced alterations in motility, invasion, proliferation and anchorage-independent growth. Exosomes expelled from DU145 and 22Rv1 docetaxel-resistant variants (DU145RD and 22Rv1RD) conferred docetaxel-resistance to DU145, 22Rv1 and LNCap cells, which may be partly due to exosomal MDR-1/P-gp transfer. Exosomes from prostate cancer patients' sera induced increased cell proliferation and invasion, compared to exosomes from age-matched controls. Furthermore, exosomes from sera of patients undergoing a course of docetaxel treatment compared to matched exosomes from the same patients prior to commencing docetaxel treatment, when applied to both DU145 and 22Rv1 cells, showed a correlation between cellular response to docetaxel and patients' response to treatment with docetaxel. Conclusions/Significance: Our studies indicate the complex and multifaceted nature of docetaxel-resistance in prostate cancer. Furthermore, our in vitro observations and preliminary clinical studies indicate that exosomes may play an important role in prostate cancer, in cell-cell communication, and thus may offer potential as vehicles containing predictive biomarkers and new therapeutic targets.	[Corcoran, Claire; Rani, Sweta; O'Brien, Keith; Sheikh, Rizwan; O'Driscoll, Lorraine] Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Dublin, Ireland; [Corcoran, Claire; Rani, Sweta; O'Brien, Keith; Sheikh, Rizwan; O'Driscoll, Lorraine] Trinity Coll Dublin, Trinity Biomed Sci Inst, Dublin, Ireland; [O'Neill, Amanda; Prencipe, Maria; Watson, William] Univ Coll Dublin, UCD Sch Med & Med Sci, Dublin 2, Ireland; [Webb, Glenn] All Ireland Cooperat Oncol Res Grp ICORG, Dublin, Ireland; [McDermott, Ray; Crown, John] ICORG, Dublin, Ireland; [McDermott, Ray] Adelaide & Meath Hosp, Natl Childrens Hosp AMNCH, Dublin, Ireland; [Crown, John] Mol Therapeut Canc Ireland MTCI, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; University College Dublin; All-Ireland Cooperative Oncology Research Group; All-Ireland Cooperative Oncology Research Group; Trinity College Dublin	O'Driscoll, L (corresponding author), Trinity Coll Dublin, Sch Pharm & Pharmaceut Sci, Dublin, Ireland.	lodrisc@tcd.ie	Crown, John/AAL-3367-2020; Webb, Glenn/AAW-7228-2021	Crown, John/0000-0002-3125-7613; O'Driscoll, Lorraine/0000-0002-9860-8262; McDermott, Ray/0000-0002-8952-4315; Rani, Sweta/0000-0003-0937-0094; Prencipe, Maria/0000-0002-8864-1560	Science Foundation Ireland of Strategic Research Cluster, Molecular Therapeutics for Cancer Ireland [08/SRC/B1410]; Trinity College Dublin	Science Foundation Ireland of Strategic Research Cluster, Molecular Therapeutics for Cancer Ireland(Science Foundation Ireland); Trinity College Dublin	This research was supported by Science Foundation Ireland's funding of Strategic Research Cluster, Molecular Therapeutics for Cancer Ireland (08/SRC/B1410) to JC, WW, LOD; funding, to LOD, to support KOB as a Marie Keating Foundation Scholarship at Trinity College Dublin; and infrastructure and core facility support through Ireland's HEA's Programme for Research in Third Level Institutes (PRTLI) Cycle 5 to LOD among other TCD PIs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Andre F, 2004, ANN ONCOL, V15, P141, DOI 10.1093/annonc/mdh918; BASHIR I, 1994, INT J CANCER, V57, P719, DOI 10.1002/ijc.2910570519; Bhangal G, 2000, UROL ONCOL, V5, P118, DOI 10.1016/S1078-1439(99)00055-1; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Ciravolo V, 2012, J CELL PHYSIOL, V227, P658, DOI 10.1002/jcp.22773; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; David-Beabes GL, 2000, INT J ONCOL, V17, P1077; Fernandez-Llama P, 2010, KIDNEY INT, V77, P736, DOI 10.1038/ki.2009.550; Gabai VL, 2005, ONCOGENE, V24, P3328, DOI 10.1038/sj.onc.1208495; Germano S, 2012, INT J CANCER, V130, P1991, DOI 10.1002/ijc.26200; Guescini M, 2010, J NEURAL TRANSM, V117, P1, DOI 10.1007/s00702-009-0288-8; Guo BQ, 2004, BREAST CANCER RES TR, V85, P31, DOI 10.1023/B:BREA.0000021046.29834.12; Guo XX, 2008, ANTICANCER RES, V28, P9; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Kharaziha P, 2012, BBA-REV CANCER, V1826, P103, DOI 10.1016/j.bbcan.2012.03.006; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Liu B, 2001, J SURG RES, V99, P179, DOI 10.1006/jsre.2001.6126; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; O'Driscoll L, 2002, ANTICANCER RES, V22, P3117; O'Neill AJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-126; Rani S, 2011, METHODS MOL BIOL, V784, P181, DOI 10.1007/978-1-61779-289-2_13; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Shibata T, 2010, ONCOGENE, V29, P4671, DOI 10.1038/onc.2010.217; Shtanko O, 2011, J VIROL, V85, P3631, DOI 10.1128/JVI.01984-10; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Takeda M, 2007, PROSTATE, V67, P955, DOI 10.1002/pros.20581; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yu DH, 1998, ONCOGENE, V16, P2087, DOI 10.1038/sj.onc.1201729; Zhang F, 2011, ASIAN PAC J CANCER P, V12, P239	36	306	319	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50999	10.1371/journal.pone.0050999	http://dx.doi.org/10.1371/journal.pone.0050999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251413	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900031
J	Ables, GP; Perrone, CE; Orentreich, D; Orentreich, N				Ables, Gene P.; Perrone, Carmen E.; Orentreich, David; Orentreich, Norman			Methionine-Restricted C57BL/6J Mice Are Resistant to Diet-Induced Obesity and Insulin Resistance but Have Low Bone Density	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; ACTIVATED RECEPTOR-GAMMA; FATTY-ACID OXIDATION; HEPATIC STEATOSIS; PPAR-GAMMA; LIFE-SPAN; ENERGY-EXPENDITURE; GENE-EXPRESSION; MOUSE MODEL; LIVER	Dietary methionine restriction (MR) extends lifespan, an effect associated with reduction of body weight gain, and improvement of insulin sensitivity in mice and rats as a result of metabolic adaptations in liver, adipose tissue and skeletal muscle. To test whether MR confers resistance to adiposity and insulin resistance, C57BL/6J mice were fed a high fat diet (HFD) containing either 0.86% methionine (control fed; CF) or 0.12% methionine (methionine-restricted; MR). MR mice on HFD had lower body weight gain despite increased food intake and absorption efficiency compared to their CF counterparts. MR mice on HFD were more glucose tolerant and insulin sensitive with reduced accumulation of hepatic triglycerides. In plasma, MR mice on HFD had higher levels of adiponectin and FGF21 while leptin and IGF-1 levels were reduced. Hepatic gene expression showed the downregulation of Scd1 while Pparg, Atgl, Cd36, Jak2 and Fgf21 were upregulated in MR mice on HFD. Restriction of growth rate in MR mice on HFD was also associated with lower bone mass and increased plasma levels of the collagen degradation marker C-terminal telopeptide of type 1 collagen (CTX-1). It is concluded that MR mice on HFD are metabolically healthy compared to CF mice on HFD but have decreased bone mass. These effects could be associated with the observed increase in FGF21 levels.	[Ables, Gene P.; Perrone, Carmen E.; Orentreich, David; Orentreich, Norman] Orentreich Fdn Adv Sci, Cold Spring On Hudson, NY 10516 USA		Ables, GP (corresponding author), Orentreich Fdn Adv Sci, Cold Spring On Hudson, NY 10516 USA.	gables@orentreich.org			Orentreich Foundation for the Advancement of Science	Orentreich Foundation for the Advancement of Science	Funding provided by the Orentreich Foundation for the Advancement of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit SC, 2004, RECENT PROG HORM RES, V59, P267, DOI 10.1210/rp.59.1.267; Berthiaume M, 2009, INT J OBESITY, V33, P601, DOI 10.1038/ijo.2009.33; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Elshorbagy AK, 2011, J LIPID RES, V52, P104, DOI 10.1194/jlr.M010215; Fiorentino L, 2010, HEPATOLOGY, V51, P103, DOI 10.1002/hep.23250; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hasek BE, 2010, AM J PHYSIOL-REG I, V299, pR728, DOI 10.1152/ajpregu.00837.2009; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Kadowaki Takashi, 2007, Novartis Found Symp, V286, P164; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kamon Junji, 2003, Nihon Yakurigaku Zasshi, V122, P294; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748; Maddatu TP, 2012, NUCLEIC ACIDS RES, V40, pD887, DOI 10.1093/nar/gkr1061; Malloy VL, 2006, AGING CELL, V5, P305, DOI 10.1111/j.1474-9726.2006.00220.x; Menghini R, 2012, DIABETES, V61, P454, DOI 10.2337/db11-0613; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Nan YM, 2011, SCAND J GASTROENTERO, V46, P358, DOI 10.3109/00365521.2010.525717; Nan YM, 2009, SCAND J GASTROENTERO, V44, P358, DOI 10.1080/00365520802530861; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; ORENTREICH N, 1993, J NUTR, V123, P269; Pallier PN, 2009, BRAIN RES BULL, V78, P347, DOI 10.1016/j.brainresbull.2008.10.007; Perrone CE, 2008, J LIPID RES, V49, P12, DOI 10.1194/jlr.M700194-JLR200; Perrone CE, 2010, METABOLISM, V59, P1000, DOI 10.1016/j.metabol.2009.10.023; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Plaisance EP, 2011, J CLIN ENDOCR METAB, V96, pE836, DOI 10.1210/jc.2010-2493; Plaisance EP, 2010, AM J PHYSIOL-REG I, V299, pR740, DOI 10.1152/ajpregu.00838.2009; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Rosen CJ, 2010, CELL, V142, P198, DOI 10.1016/j.cell.2010.07.001; Sjogren K, 2001, J NUTR, V131, P2963, DOI 10.1093/jn/131.11.2963; Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051; Sun XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014605; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017057; Yoshinari O, 2011, BRIT J NUTR, V106, P995, DOI 10.1017/S0007114511001279; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zhang YL, 2006, J BIOL CHEM, V281, P37603, DOI 10.1074/jbc.M604709200; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3	51	151	159	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51357	10.1371/journal.pone.0051357	http://dx.doi.org/10.1371/journal.pone.0051357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236485	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100105
J	Chafai, M; Corbani, M; Guillon, G; Desarmenien, MG				Chafai, Magda; Corbani, Maithe; Guillon, Gilles; Desarmenien, Michel G.			Vasopressin Inhibits LTP in the CA2 Mouse Hippocampal Area	PLOS ONE			English	Article							V-1B RECEPTOR ANTAGONIST; LONG-TERM POTENTIATION; RAT-BRAIN; 1B RECEPTOR; PERFORANT PATH; AVP ANTAGONIST; BINDING-SITES; DENTATE GYRUS; KNOCKOUT MICE; V1B RECEPTOR	Growing evidence points to vasopressin (AVP) as a social behavior regulator modulating various memory processes and involved in pathologies such as mood disorders, anxiety and depression. Accordingly, AVP antagonists are actually envisaged as putative treatments. However, the underlying mechanisms are poorly characterized, in particular the influence of AVP on cellular or synaptic activities in limbic brain areas involved in social behavior. In the present study, we investigated AVP action on the synapse between the entorhinal cortex and CA2 hippocampal pyramidal neurons, by using both field potential and whole-cell recordings in mice brain acute slices. Short application (1 min) of AVP transiently reduced the synaptic response, only following induction of long-term potentiation (LTP) by high frequency stimulation (HFS) of afferent fibers. The basal synaptic response, measured in the absence of HFS, was not affected. The Schaffer collateral-CA1 synapse was not affected by AVP, even after LTP, while the Schaffer collateral-CA2 synapse was inhibited. Although investigated only recently, this CA2 hippocampal area appears to have a distinctive circuitry and a peculiar role in controlling episodic memory. Accordingly, AVP action on LTP-increased synaptic responses in this limbic structure may contribute to the role of this neuropeptide in controlling memory and social behavior.	[Chafai, Magda; Corbani, Maithe; Guillon, Gilles; Desarmenien, Michel G.] CNRS, Inst Genom Fonctionnelle, UMR 5203, Montpellier, France; [Chafai, Magda; Corbani, Maithe; Guillon, Gilles; Desarmenien, Michel G.] INSERM, U661, Montpellier, France; [Chafai, Magda; Corbani, Maithe; Guillon, Gilles; Desarmenien, Michel G.] Univ Montpellier I, UMR 5203, Montpellier, France; [Chafai, Magda; Corbani, Maithe; Guillon, Gilles; Desarmenien, Michel G.] Univ Montpellier 2, UMR 5203, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Desarmenien, MG (corresponding author), CNRS, Inst Genom Fonctionnelle, UMR 5203, Montpellier, France.	michel.desarmenien@igf.cnrs.fr			CNRS; INSERM; Agence Nationale de la Recherche [ANR-09-MNPS-031-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by CNRS, INSERM and Agence Nationale de la Recherche (ANR-09-MNPS-031-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005; BARBERIS C, 1993, ANN NY ACAD SCI, V689, P475, DOI 10.1111/j.1749-6632.1993.tb55573.x; Bartesaghi R, 2004, HIPPOCAMPUS, V14, P948, DOI 10.1002/hipo.20011; Benes FM, 1998, BIOL PSYCHIAT, V44, P88, DOI 10.1016/S0006-3223(98)00138-3; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Caldwell HK, 2008, PROG BRAIN RES, V170, P65, DOI 10.1016/S0079-6123(08)00406-8; CHEN C, 1993, HIPPOCAMPUS, V3, P193, DOI 10.1002/hipo.450030211; Chevaleyre V, 2000, J NEUROSCI, V20, P5813, DOI 10.1523/JNEUROSCI.20-15-05813.2000; Chevaleyre V, 2010, NEURON, V66, P560, DOI 10.1016/j.neuron.2010.04.013; Corbani M, 2011, J MED CHEM, V54, P2864, DOI 10.1021/jm1016208; DeVito LM, 2009, J NEUROSCI, V29, P2676, DOI 10.1523/JNEUROSCI.5488-08.2009; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Dubrovsky B, 2003, BRAIN RES BULL, V59, P467, DOI 10.1016/S0361-9230(02)00961-9; Egashira N, 2004, NEUROSCI LETT, V356, P195, DOI 10.1016/j.neulet.2003.11.050; Frank E, 2008, EUR J PHARMACOL, V583, P226, DOI 10.1016/j.ejphar.2007.11.063; Griebel G, 2002, P NATL ACAD SCI USA, V99, P6370, DOI 10.1073/pnas.092012099; HAMANN M, 1988, BRAIN RES, V442, P287, DOI 10.1016/0006-8993(88)91514-4; Hernando F, 2001, ENDOCRINOLOGY, V142, P1659, DOI 10.1210/en.142.4.1659; Holmes A, 2003, TRENDS PHARMACOL SCI, V24, P580, DOI 10.1016/j.tips.2003.09.011; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; JOHNSON AE, 1993, BRAIN RES, V622, P9, DOI 10.1016/0006-8993(93)90795-O; Kombian SB, 1997, NEURON, V19, P903, DOI 10.1016/S0896-6273(00)80971-X; Mercer A, 2010, HIPPOCAMPUS; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; OSTROWSKI NL, 1994, ENDOCRINOLOGY, V135, P1511, DOI 10.1210/en.135.4.1511; Piskorowski RA, 2012, CELL MOL LIFE SCI, V69, P75, DOI 10.1007/s00018-011-0769-4; Raggenbass M, 2008, EUR J PHARMACOL, V583, P243, DOI 10.1016/j.ejphar.2007.11.074; Rood BD, 2011, J COMP NEUROL, V519, P2434, DOI 10.1002/cne.22635; Sakurai E, 1998, JPN J PHARMACOL, V77, P103, DOI 10.1254/jjp.77.103; Serradeil-Le Gal C, 2002, J PHARMACOL EXP THER, V300, P1122; SLOVITER RS, 1983, BRAIN RES BULL, V10, P675, DOI 10.1016/0361-9230(83)90037-0; Surget A, 2008, EUR J PHARMACOL, V583, P340, DOI 10.1016/j.ejphar.2007.11.065; TIBERIIS BE, 1983, NEUROPEPTIDES, V4, P65, DOI 10.1016/0143-4179(83)90010-0; Tobin V, 2006, EUR J NEUROSCI, V24, P400, DOI 10.1111/j.1460-9568.2006.04935.x; Vaccari C, 1998, ENDOCRINOLOGY, V139, P5015, DOI 10.1210/en.139.12.5015; Van Wimersma Greidanus TB, 1980, ACTA PSYCHIAT BELG, V80, P721; Wersinger SR, 2007, GENES BRAIN BEHAV, V6, P540, DOI 10.1111/j.1601-183X.2006.00281.x; Wersinger SR, 2002, MOL PSYCHIATR, V7, P975, DOI 10.1038/sj.mp.4001195; Young WS, 2006, NEUROSCIENCE, V143, P1031, DOI 10.1016/j.neuroscience.2006.08.040; Zwier JM, 2010, J BIOMOL SCREEN, V15, P1248, DOI 10.1177/1087057110384611	42	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e49708	10.1371/journal.pone.0049708	http://dx.doi.org/10.1371/journal.pone.0049708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236353	Green Submitted, gold, Green Published			2022-12-27	WOS:000312064100005
J	Medina-Roldan, E; Bardgett, RD				Medina-Roldan, Eduardo; Bardgett, Richard D.			Inter-Specific Competition, but Not Different Soil Microbial Communities, Affects N Chemical Forms Uptake by Competing Graminoids of Upland Grasslands	PLOS ONE			English	Article							ORGANIC NITROGEN RELEVANCE; INORGANIC CARBON UPTAKE; EXTRACTION METHOD; PLANT UPTAKE; NICHE COMPLEMENTARITY; NARDUS-STRICTA; AMINO-ACIDS; ECOSYSTEM; DIVERSITY; ISOTOPES	Evidence that plants differ in their ability to take up both organic (ON) and inorganic (IN) forms of nitrogen (N) has increased ecologists' interest on resource-based plant competition. However, whether plant uptake of IN and ON responds to differences in soil microbial community composition and/or functioning has not yet been explored, despite soil microbes playing a key role in N cycling. Here, we report results from a competition experiment testing the hypothesis that soil microbial communities differing in metabolic activity as a result of long-term differences to grazing exposure could modify N uptake of Eriophorum vaginatum L. and Nardus stricta L. These graminoids co-occur on nutrient-poor, mountain grasslands where E. vaginatum decreases and N. stricta increases in response to long-term grazing. We inoculated sterilised soil with soil microbial communities from continuously grazed and ungrazed grasslands and planted soils with both E. vaginatum and N. stricta, and then tracked uptake of isotopically labelled NH4+ (IN) and glycine (ON) into plant tissues. The metabolically different microbial communities had no effect on N uptake by either of the graminoids, which might suggest functional equivalence of soil microbes in their impacts on plant N uptake. Consistent with its dominance in soils with greater concentrations of ON relative to IN in the soluble N pool, Eriophorum vaginatum took up more glycine than N. stricta. Nardus stricta reduced the glycine proportion taken up by E. vaginatum, thus increasing niche overlap in N usage between these species. Local abundances of these species in mountain grasslands are principally controlled by grazing and soil moisture, although our results suggest that changes in the relative availability of ON to IN can also play a role. Our results also suggest that coexistence of these species in mountain grasslands is likely based on non-equilibrium mechanisms such as disturbance and/or soil heterogeneity.	[Medina-Roldan, Eduardo; Bardgett, Richard D.] Univ Lancaster, Soil & Ecosyst Ecol Lab, Lancaster Environm Ctr, Lancaster, England	Lancaster University	Medina-Roldan, E (corresponding author), Xian Jiaotong Liverpool Univ, Dept Environm Sci, Suzhou Ind Pk, Suzhou, Peoples R China.	educamero@googlemail.com			National Council of Science and Technology in Mexico, CONACYT; Natural Environment Research Council [ceh010010] Funding Source: researchfish	National Council of Science and Technology in Mexico, CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by the National Council of Science and Technology in Mexico, CONACYT (www.conacyt.gob.mx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUARGHUB SM, 1988, NEW PHYTOL, V108, P433, DOI 10.1111/j.1469-8137.1988.tb04184.x; [Anonymous], 2010, R LANG ENV STAT COMP; Ashton IW, 2008, OECOLOGIA, V156, P625, DOI 10.1007/s00442-008-1006-1; Ashton IW, 2010, ECOLOGY, V91, P3252, DOI 10.1890/09-1849.1; Bardgett RD, 1997, SOIL BIOL BIOCHEM, V29, P1285, DOI 10.1016/S0038-0717(97)00019-9; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; CHAPIN FS, 1993, NATURE, V361, P150, DOI 10.1038/361150a0; Dunn RM, 2006, PLANT SOIL, V289, P321, DOI 10.1007/s11104-006-9142-z; EDGELL MCR, 1971, J ECOL, V59, P189, DOI 10.2307/2258461; Farrell M, 2011, SOIL BIOL BIOCHEM, V43, P835, DOI 10.1016/j.soilbio.2010.12.022; FISHER TR, 1979, LIMNOL OCEANOGR, V24, P593, DOI 10.4319/lo.1979.24.3.0593; Frank DA, 2003, OECOLOGIA, V137, P603, DOI 10.1007/s00442-003-1385-2; GRANT SA, 1985, J APPL ECOL, V22, P739, DOI 10.2307/2403226; Griffiths BS, 2001, SOIL BIOL BIOCHEM, V33, P1713, DOI 10.1016/S0038-0717(01)00094-3; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Harrison KA, 2008, SOIL BIOL BIOCHEM, V40, P228, DOI 10.1016/j.soilbio.2007.08.004; Harrison KA, 2007, ECOLOGY, V88, P989, DOI 10.1890/06-1018; Hartley SE, 1999, J ECOL, V87, P330, DOI 10.1046/j.1365-2745.1999.00353.x; HAVILL DC, 1974, NEW PHYTOL, V73, P1221, DOI 10.1111/j.1469-8137.1974.tb02151.x; Hill PW, 2011, NAT CLIM CHANGE, V1, P50, DOI [10.1038/nclimate1060, 10.1038/NCLIMATE1060]; Jones DL, 2005, SOIL BIOL BIOCHEM, V37, P413, DOI 10.1016/j.soilbio.2004.08.008; Kahmen A, 2006, ECOLOGY, V87, P1244, DOI 10.1890/0012-9658(2006)87[1244:NCFNAE]2.0.CO;2; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Lipson DA, 1999, ECOLOGY, V80, P1623; MCKANE RB, 1990, ECOLOGY, V71, P1126, DOI 10.2307/1937380; McKane RB, 2002, NATURE, V415, P68, DOI 10.1038/415068a; Medina-Roldan E, 2012, OECOLOGIA, V170, P159, DOI 10.1007/s00442-012-2287-y; Medina-Roldan E, 2012, AGR ECOSYST ENVIRON, V149, P118, DOI 10.1016/j.agee.2011.12.012; Medina-Roldan E, 2011, PLANT SOIL, V344, P377, DOI 10.1007/s11104-011-0756-4; Miller AE, 2007, ECOLOGY, V88, P1832, DOI 10.1890/06-0946.1; Nasholm T, 2009, SOIL BIOL BIOCHEM, V41, P1588, DOI 10.1016/j.soilbio.2009.05.001; Nasholm T, 2000, ECOLOGY, V81, P1155, DOI 10.1890/0012-9658(2000)081[1155:UOONIT]2.0.CO;2; Paungfoo-Lonhienne C, 2008, P NATL ACAD SCI USA, V105, P4524, DOI 10.1073/pnas.0712078105; Rasmussen J, 2009, SOIL BIOL BIOCHEM, V41, P1586, DOI 10.1016/j.soilbio.2009.03.006; RATCLIFFE DA, 1959, J ECOL, V47, P371, DOI 10.2307/2257373; Ritchie ME, 1998, ECOLOGY, V79, P165, DOI 10.1890/0012-9658(1998)079[0165:HEOPAN]2.0.CO;2; Rodwell, 1992, BRIT PLANT COMMUNITI, V3; SALONIUS PO, 1967, PLANT SOIL, V27, P239, DOI 10.1007/BF01373392; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Sorensen LI, 2008, SOIL BIOL BIOCHEM, V40, P2891, DOI 10.1016/j.soilbio.2008.08.009; SPARLING GP, 1990, SOIL BIOL BIOCHEM, V22, P301, DOI 10.1016/0038-0717(90)90104-8; Streeter TC, 2000, RAPID COMMUN MASS SP, V14, P1351, DOI 10.1002/1097-0231(20000815)14:15<1351::AID-RCM23>3.3.CO;2-0; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Weigelt A, 2005, OECOLOGIA, V142, P627, DOI 10.1007/s00442-004-1765-2; WEIN RW, 1973, J ECOL, V61, P601, DOI 10.2307/2259047; WELCH D, 1986, J APPL ECOL, V23, P1047, DOI 10.2307/2403954; Wertz S, 2007, ENVIRON MICROBIOL, V9, P2211, DOI 10.1111/j.1462-2920.2007.01335.x; Wertz S, 2006, ENVIRON MICROBIOL, V8, P2162, DOI 10.1111/j.1462-2920.2006.01098.x	51	4	4	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51193	10.1371/journal.pone.0051193	http://dx.doi.org/10.1371/journal.pone.0051193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236451	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100079
J	Peng, P; Lian, JF; Huang, RS; Xu, LM; Huang, Y; Ba, YN; Yang, X; Huang, XY; Dong, CZ; Zhang, LN; Ye, M; Zhou, JQ; Duan, SW				Peng, Ping; Lian, Jiangfang; Huang, R. Stephanie; Xu, Limin; Huang, Yi; Ba, Yanna; Yang, Xi; Huang, Xiaoyan; Dong, Changzhen; Zhang, Lina; Ye, Meng; Zhou, Jianqing; Duan, Shiwei			Meta-Analyses of KIF6 Trp719Arg in Coronary Heart Disease and Statin Therapeutic Effect	PLOS ONE			English	Article							KINESIN-LIKE PROTEIN-6; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; POLYMORPHISM; ASSOCIATION; RISK; GENE; POPULATION; VARIANTS; BIAS	Aims: The goal of our study is to assess the contribution of KIF6 Trp719Arg to both the risk of CHD and the efficacy of statin therapy in CHD patients. Methods and Results: Meta-analysis of 8 prospective studies among 77,400 Caucasians provides evidence that 719Arg increases the risk of CHD (P<0.001, HR = 1.27, 95% CI = 1.15-1.41). However, another meta-analysis of 7 case-control studies among 65,200 individuals fails to find a significant relationship between Trp719Arg and the risk of CHD (P = 0.642, OR = 1.02, 95% CI = 0.95-1.08). This suggests that the contribution of Trp719Arg to CHD varies in different ethnic groups. Additional meta-analysis also shows that statin therapy only benefit the vascular patients carry 719Arg allele (P, 0.001, relative ratio (RR) = 0.60, 95% CI = 0.54-0.67). To examine the role of this genetic variant in CHD risk in Han Chinese, we have conducted a case-control study with 289 CHD cases, 193 non-CHD controls, and 329 unrelated healthy volunteers as healthy controls. On post hoc analysis, significant allele frequency difference of 719Arg is observed between female CHD cases and female total controls under the dominant model (P = 0.04, chi(2) = 4.228, df = 1, odd ratio (OR) = 1.979, 95% confidence interval (CI) = 1.023-3.828). Similar trends are observed for post hoc analysis between female CHD cases and female healthy controls (dominant model: P = 0.04, chi(2) = 4.231, df = 1, OR = 2.015, 95% CI = 1.024-3.964). Non-genetic CHD risk factors are not controlled in these analyses. Conclusions: Our meta-analysis demonstrates the role of Trp719Arg of KIF6 gene in the risk of CHD in Caucasians. The meta-analysis also suggests the role of this variant in statin therapeutic response in vascular diseases. Our case-control study suggests that Trp719Arg of KIF6 gene is associated with CHD in female Han Chinese through a post hoc analysis.	[Peng, Ping; Lian, Jiangfang; Ba, Yanna; Yang, Xi; Huang, Xiaoyan; Zhou, Jianqing] Ningbo Univ, Lihuili Hosp, Ningbo Med Ctr, Ningbo 315211, Zhejiang, Peoples R China; [Peng, Ping; Xu, Limin; Huang, Yi; Ba, Yanna; Dong, Changzhen; Zhang, Lina; Ye, Meng; Duan, Shiwei] Ningbo Univ, Affiliated Hosp, Sch Med, Ningbo 315211, Zhejiang, Peoples R China; [Huang, R. Stephanie] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Ningbo University; Ningbo University; University of Chicago	Peng, P (corresponding author), Ningbo Univ, Lihuili Hosp, Ningbo Med Ctr, Ningbo 315211, Zhejiang, Peoples R China.	hjmpin@163.com; duanshiwei@nbu.edu.cn	Duan, Shiwei/AAA-4782-2022; Duan, Shiwei/J-9633-2012	Duan, Shiwei/0000-0001-7682-2877; Huang, R. Stephanie/0000-0002-9862-0368; Huang, Yi/0000-0003-3598-9747	National Natural Science Foundation of China [31100919, 30772155]; K.C. Wong Magna Fund in Ningbo University; Zhejiang Provincial Program for the Cultivation of High level Innovative Health Talents; Natural Science Foundation of Zhejiang Province [Y206608]; Youth and Doctor Foundation of Ningbo [2005A610016]; Zhejiang Provincial Natural Science Foundation [Y2100240]; Ningbo Natural Science Foundation [2009A610142]; K.C. Wong Education Foundation, Hong Kong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); K.C. Wong Magna Fund in Ningbo University; Zhejiang Provincial Program for the Cultivation of High level Innovative Health Talents; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Youth and Doctor Foundation of Ningbo; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Ningbo Natural Science Foundation; K.C. Wong Education Foundation, Hong Kong	The research was supported by grants from: National Natural Science Foundation of China (31100919 and 30772155), K.C. Wong Magna Fund in Ningbo University, Zhejiang Provincial Program for the Cultivation of High level Innovative Health Talents, Natural Science Foundation of Zhejiang Province (Y206608), Youth and Doctor Foundation of Ningbo (2005A610016), Zhejiang Provincial Natural Science Foundation (No. Y2100240), and Ningbo Natural Science Foundation (No. 2009A610142). The authors gratefully acknowledge the support of K.C. Wong Education Foundation, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao H, 2012, ATHEROSCLEROSIS, V220, P456, DOI 10.1016/j.atherosclerosis.2011.11.037; [Anonymous], 1979, Circulation, V59, P607; Assimes TL, 2010, J AM COLL CARDIOL, V56, P1552, DOI 10.1016/j.jacc.2010.06.022; Bare LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013081; Bhanushali AA, 2011, GENET TEST MOL BIOMA, V15, P883, DOI 10.1089/gtmb.2011.0079; Butterworth AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002260; Cheng YM, 2011, CARDIOLOGY, V119, P90, DOI 10.1159/000330412; Clarke R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001177; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Higgs ZCJ, 2005, LANCET, V366, P1407, DOI 10.1016/S0140-6736(05)66878-X; Hopewell JC, 2011, J AM COLL CARDIOL, V57, P2000, DOI 10.1016/j.jacc.2011.02.015; Iakoubova O, 2008, J AM COLL CARDIOL, V51, P2195, DOI 10.1016/j.jacc.2008.02.061; Iakoubova OA, 2008, J AM COLL CARDIOL, V51, P449, DOI 10.1016/j.jacc.2007.10.017; Iakoubova OA, 2008, J AM COLL CARDIOL, V51, P435, DOI 10.1016/j.jacc.2007.05.057; Iakoubova OA, 2010, EUR J CARDIOV PREV R, V17, P455, DOI 10.1097/HJR.0b013e328336a0dd; Li YH, 2011, HUM GENET, V129, P17, DOI 10.1007/s00439-010-0892-6; Li YH, 2010, AM J CARDIOL, V106, P994, DOI 10.1016/j.amjcard.2010.05.033; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031406, 10.1371/journal.pone.0048083]; Luke MM, 2007, ARTERIOSCL THROM VAS, V27, P2030, DOI 10.1161/ATVBAHA.107.141291; Luke MM, 2009, CEREBROVASC DIS, V28, P499, DOI 10.1159/000236914; Nolan DK, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-12; Peden JF, 2011, HUM MOL GENET, V20, pR198, DOI 10.1093/hmg/ddr384; Ridker PM, 2011, CIRC-CARDIOVASC GENE, V4, P312, DOI 10.1161/CIRCGENETICS.110.959353; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Shiffman D, 2010, AM J CARDIOL, V105, P1300, DOI 10.1016/j.amjcard.2009.12.049; Stewart AFR, 2009, J AM COLL CARDIOL, V53, P1471, DOI 10.1016/j.jacc.2008.12.051; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Wang AZ, 2011, ANN HUM GENET, V75, P475, DOI 10.1111/j.1469-1809.2011.00646.x; Wang LY, 2011, STROKE, V42, P588, DOI 10.1161/STROKEAHA.110.596841; Williams P, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-42; Xu S-kY Wen-shen, 2011, MOL CARDIOLOGY CHINA, V11, P5; Yu J, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-200; Zhou JQ, 2012, THROMB RES, V130, P602, DOI 10.1016/j.thromres.2012.05.023	37	23	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50126	10.1371/journal.pone.0050126	http://dx.doi.org/10.1371/journal.pone.0050126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236363	gold, Green Submitted, Green Published			2022-12-27	WOS:000312064100012
J	Shao, LL; Zhang, L; Hou, Y; Yu, S; Liu, XG; Huang, XY; Sun, YX; Tian, T; He, N; Ma, DX; Peng, J; Hou, M				Shao, Lin-lin; Zhang, Lei; Hou, Yu; Yu, Shuang; Liu, Xin-guang; Huang, Xiao-yang; Sun, Yuan-xin; Tian, Tian; He, Na; Ma, Dao-xin; Peng, Jun; Hou, Ming			Th22 Cells as Well as Th17 Cells Expand Differentially in Patients with Early-Stage and Late-Stage Myelodysplastic Syndrome	PLOS ONE			English	Article							REGULATORY T-CELLS; INTERLEUKIN 22; SYNDROME MDS; EXPRESSION; RESPONSES; T(H)17; INFLAMMATION; APOPTOSIS; CYTOKINES; PROTEINS	Background: Immunological mechanisms are increasingly recognized in the progression of myelodysplastic syndrome (MDS). Early-stage MDS (E-MDS) is characterized by autoimmune-mediated myelosuppression whereas late-stage MDS (L-MDS) involves immune evasion, giving dysplastic cells growth potential to progress into acute myeloid leukemia. T-helper (Th) 22 is involved in the pathogenesis of inflammatory autoimmunity and tumorigenesis. The roles of Th22 cells in the pathophysiology of E-MDS and L-MDS remain unsettled. Design and Methods: We studied 37 MDS patients (E-MDS, n = 17; L-MDS, n = 20) and 20 healthy controls to characterize their peripheral blood (PB), as well as 25 MDS patients and 10 healthy controls to characterize their bone marrow(BM). The expression of Interleukin-22 (IL-22), IL-17 or interferon gamma (IFN-gamma) was examined in E-MDS, L-MDS patients and controls by flow cytometry. The mRNA expression levels of RAR-related orphan receptor C (RORC), IL-6, tumor necrosis factor alpha (TNF-alpha) and IL-23 in peripheral blood mononuclear cells (PBMCs) were determined by real-time quantitative polymerase chain reaction. The levels of IL-22 and IL-17 both in PB and BM plasma were examined by enzyme-linked immunosorbent assay. Results: In E-MDS, peripheral Th17 cells were significantly elevated and correlated with peripheral Th22 cells compared with healthy controls and L-MDS. Significantly higher levels of peripheral Th22 expansion, mRNA expression of IL-6, TNF-alpha and lower level of RORC mRNA expression were observed in L-MDS compared with E-MDS. No statistical difference was found in IL-23 mRNA expression or plasma IL-22, IL-17 levels among E-MDS, L-MDS and controls. Conclusions: Our data demonstrated that L-MDS cohort had increased frequencies of peripheral Th22 cells and higher mRNA expression levels of IL-6 and TNF-alpha, indicating that Th22 cells along with Th17 cells or not are involved in the dynamic immune responses of MDS.	[Shao, Lin-lin; Yu, Shuang; Liu, Xin-guang; Sun, Yuan-xin; Tian, Tian; He, Na; Ma, Dao-xin; Peng, Jun; Hou, Ming] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Zhang, Lei] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Orthoped, Jinan 250100, Peoples R China; [Hou, Yu] Shandong Univ, Coll Med, Jinan 250100, Peoples R China; [Huang, Xiao-yang] Shandong Univ, Qilu Hosp, Dept Pediat, Jinan 250100, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong University	Ma, DX (corresponding author), Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China.	daoxinma@sdu.edu.cn		Liu, Xin Guang/0000-0001-9033-9099	Tai Shan Scholar Foundation; National Natural Science Foundation of China [81070407, 81170515, 81070396, 81270578]; 973 Program [2009CB521904, 2011CB503906]; National Natural Science Foundation of China for Innovative Research Group [81021001]; National Public Health Grand Research Foundation [201202017]; Public Health Ministry of China; National Key Vocational School About Clinical Speciality for Blood Disorders; Clinical Medicine Center Foundation of Shandong Province; Leading Medical Professionals Foundation of Shandong Province; Outstanding Young Scientist Research Award Foundation of Shandong Province [BS2009SW014]	Tai Shan Scholar Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); National Public Health Grand Research Foundation; Public Health Ministry of China; National Key Vocational School About Clinical Speciality for Blood Disorders; Clinical Medicine Center Foundation of Shandong Province; Leading Medical Professionals Foundation of Shandong Province; Outstanding Young Scientist Research Award Foundation of Shandong Province	This work was supported by grants from Tai Shan Scholar Foundation, National Natural Science Foundation of China (No. 81070407, No. 81170515, No. 81070396, No. 81270578), 973 Program (No. 2009CB521904, No. 2011CB503906), State Program of National Natural Science Foundation of China for Innovative Research Group 2011-2013 (No. 81021001), National Public Health Grand Research Foundation (No. 201202017), Key Clinical Research Project of Public Health Ministry of China 2010-2012, National Key Vocational School About Clinical Speciality for Blood Disorders, Clinical Medicine Center Foundation of Shandong Province, Leading Medical Professionals Foundation of Shandong Province, and Outstanding Young Scientist Research Award Foundation of Shandong Province (No. BS2009SW014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2011, BRIT J HAEMATOL, V153, P568, DOI 10.1111/j.1365-2141.2011.08683.x; Alexandrakis M, 1998, HAEMATOLOGIA, V29, P13; Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071; Bard JD, 2008, LEUKEMIA, V22, P1595, DOI 10.1038/leu.2008.129; Bouchliou I, 2011, CLIN IMMUNOL, V139, P350, DOI 10.1016/j.clim.2011.03.001; Chamuleau MED, 2009, HAEMATOL-HEMATOL J, V94, P496, DOI 10.3324/haematol.13612; Cheng F, 2009, ANN RHEUM DIS, V68, P604, DOI 10.1136/ard.2008.097089; Cheson BD, 2000, BLOOD, V96, P3671; Chizzolini C, 2010, EUROPEAN J IMMUNOLOG, V40, P2450; Dhiman R, 2009, J IMMUNOL, V183, P6639, DOI 10.4049/jimmunol.0902587; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Epling-Burnette PK, 2007, BLOOD, V109, P4816, DOI 10.1182/blood-2006-07-035519; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Fozza C, 2009, EXP HEMATOL, V37, P947, DOI 10.1016/j.exphem.2009.04.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kiladjian JJ, 2006, LEUKEMIA, V20, P463, DOI 10.1038/sj.leu.2404080; Kitagawa M, 1997, LEUKEMIA, V11, P2049, DOI 10.1038/sj.leu.2400844; Kochenderfer JN, 2002, BLOOD, V100, P3639, DOI 10.1182/blood-2002-01-0155; Kondo A, 2010, BLOOD, V116, P1124, DOI 10.1182/blood-2009-12-255125; Kordasti SY, 2007, BLOOD, V110, P847, DOI 10.1182/blood-2007-01-067546; Kordasti SY, 2009, BRIT J HAEMATOL, V145, P64, DOI 10.1111/j.1365-2141.2009.07593.x; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kotsianidis I, 2009, LEUKEMIA, V23, P510, DOI 10.1038/leu.2008.333; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Molldrem JJ, 1998, BRIT J HAEMATOL, V102, P1314, DOI 10.1046/j.1365-2141.1998.00920.x; Pardanani A, 2012, LEUKEMIA, V26, P693, DOI 10.1038/leu.2011.251; Parker JE, 2000, BLOOD, V96, P3932, DOI 10.1182/blood.V96.12.3932.h8003932_3932_3938; Prabhala RH, 2010, BLOOD, V115, P5385, DOI 10.1182/blood-2009-10-246660; Schnyder B, 2010, CYTOKINE, V50, P220, DOI 10.1016/j.cyto.2010.02.003; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Ye ZJ, 2012, AM J RESP CRIT CARE, V185, P660, DOI 10.1164/rccm.201107-1198OC; Zhang L, 2011, J CLIN IMMUNOL, V31, P606, DOI 10.1007/s10875-011-9540-8; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou L, 2011, CANCER RES, V71, P955, DOI 10.1158/0008-5472.CAN-10-2933; Zhuang Y, 2012, CANC IMMUNOL IMMUNOT	43	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51339	10.1371/journal.pone.0051339	http://dx.doi.org/10.1371/journal.pone.0051339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236476	gold, Green Published, Green Submitted			2022-12-27	WOS:000312064100098
J	Spuler, M; Rosenstiel, W; Bogdan, M				Spueler, Martin; Rosenstiel, Wolfgang; Bogdan, Martin			Online Adaptation of a c-VEP Brain-Computer Interface(BCI) Based on Error-Related Potentials and Unsupervised Learning	PLOS ONE			English	Article								The goal of a Brain-Computer Interface (BCI) is to control a computer by pure brain activity. Recently, BCIs based on code-modulated visual evoked potentials (c-VEPs) have shown great potential to establish high-performance communication. In this paper we present a c-VEP BCI that uses online adaptation of the classifier to reduce calibration time and increase performance. We compare two different approaches for online adaptation of the system: an unsupervised method and a method that uses the detection of error-related potentials. Both approaches were tested in an online study, in which an average accuracy of 96% was achieved with adaptation based on error-related potentials. This accuracy corresponds to an average information transfer rate of 144 bit/min, which is the highest bitrate reported so far for a non-invasive BCI. In a free-spelling mode, the subjects were able to write with an average of 21.3 error-free letters per minute, which shows the feasibility of the BCI system in a normal-use scenario. In addition we show that a calibration of the BCI system solely based on the detection of error-related potentials is possible, without knowing the true class labels.	[Spueler, Martin; Rosenstiel, Wolfgang; Bogdan, Martin] Univ Tubingen, Wilhelm Schickard Inst Comp Sci, Tubingen, Germany; [Bogdan, Martin] Univ Leipzig, Leipzig, Germany	Eberhard Karls University of Tubingen; Leipzig University	Spuler, M (corresponding author), Univ Tubingen, Wilhelm Schickard Inst Comp Sci, Tubingen, Germany.	spueler@informatik.uni-tuebingen.de			ERC [227632]; German Federal Ministry of Education and Research (BMBF) [UTu 01 GQ 0831]	ERC(European Research Council (ERC)European Commission); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was partly funded by the ERC (Grant 227632, BCCI) and the German Federal Ministry of Education and Research (BMBF, BFNT F*T, Grant UTu 01 GQ 0831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bin GY, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025015; Bin GY, 2009, IEEE COMPUT INTELL M, V4, P22, DOI 10.1109/MCI.2009.934562; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Blankertz B, 2002, LECT NOTES COMPUT SC, V2415, P1137; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Dal Seno B, 2010, IEEE T NEUR SYS REH, V18, P20, DOI 10.1109/TNSRE.2009.2032642; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Ferrez PW, 2008, IEEE T BIO-MED ENG, V55, P923, DOI 10.1109/TBME.2007.908083; Golomb S. W., 1982, SHIFT REGISTER SEQUE; Kelly SP, 2005, IEEE T NEUR SYS REH, V13, P172, DOI 10.1109/TNSRE.2005.847369; Llera A, 2011, NEURAL NETWORKS, V24, P1120, DOI 10.1016/j.neunet.2011.05.006; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Schlogl A, 2007, CLIN NEUROPHYSIOL, V118, P98, DOI 10.1016/j.clinph.2006.09.003; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Spuler M, 2012, CLIN NEUROPHYSIOL, V123, P1328, DOI 10.1016/j.clinph.2011.11.082; Spuler M, 2012, P 20 EUR S ART NEUR, P103, DOI [10.13140/2.1.2186.7526, DOI 10.13140/2.1.2186.7526]; SUTTER EE, 1992, J MICROCOMPUT APPL, V15, P31, DOI 10.1016/0745-7138(92)90045-7; Sutter EE, 1984, P IEEE S BIOS, P85; Urbina MH, 2007, P 3 C COMM GAZ INT C, P65; Vidaurre C, 2011, NEURAL COMPUT, V23, P791, DOI 10.1162/NECO_a_00089; Volosyak I, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036020; Wilson JA, 2010, IEEE T BIO-MED ENG, V57, P1785, DOI 10.1109/TBME.2010.2047259; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Zhang D, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016010	24	119	120	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51077	10.1371/journal.pone.0051077	http://dx.doi.org/10.1371/journal.pone.0051077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236433	Green Submitted, gold, Green Published			2022-12-27	WOS:000312064100062
J	Gifford, JL; Ishida, H; Vogel, HJ				Gifford, Jessica L.; Ishida, Hiroaki; Vogel, Hans J.			Structural Characterization of the Interaction of Human Lactoferrin with Calmodulin	PLOS ONE			English	Article							LIGHT-CHAIN KINASE; NF-KAPPA-B; NEUTROPHIL LACTOFERRIN; PROTEIN-KINASE; BINDING DOMAIN; PROTEOLYTIC FRAGMENTS; NUCLEAR-LOCALIZATION; CROSS-SATURATION; GENE DELIVERY; ACTIVATION	Lactoferrin (Lf) is an 80 kDa, iron (Fe3+)-binding immunoregulatory glycoprotein secreted into most exocrine fluids, found in high concentrations in colostrum and milk, and released from neutrophil secondary granules at sites of infection and inflammation. In a number of cell types, Lf is internalized through receptor-mediated endocytosis and targeted to the nucleus where it has been demonstrated to act as a transcriptional trans-activator. Here we characterize human Lf's interaction with calmodulin (CaM), a ubiquitous, 17 kDa regulatory calcium (Ca2+)-binding protein localized in the cytoplasm and nucleus of activated cells. Due to the size of this intermolecular complex (similar to 100 kDa), TROSY-based NMR techniques were employed to structurally characterize Ca2+-CaM when bound to intact apo-Lf. Both CaM's backbone amides and the epsilon-methyl group of key methionine residues were used as probes in chemical shift perturbation and cross-saturation experiments to define the binding interface of apo-Lf on Ca2+-CaM. Unlike the collapsed conformation through which Ca2+-CaM binds the CaM-binding domains of its classical targets, Ca2+-CaM assumes an extended structure when bound to apo-Lf. Apo-Lf appears to interact predominantly with the C-terminal lobe of Ca2+-CaM, enabling the N-terminal lobe to potentially bind another target. Our use of intact apo-Lf has made possible the identification of a secondary interaction interface, removed from CaM's primary binding domain. Secondary interfaces play a key role in the target's response to CaM binding, highlighting the importance of studying intact complexes. This solution-based approach can be applied to study other regulatory calcium-binding EF-hand proteins in intact intermolecular complexes. Citation: Gifford JL, Ishida H, Vogel HJ (2012) Structural Characterization of the Interaction of Human Lactoferrin with Calmodulin. PLoS ONE 7(12): e51026. doi:10.1371/journal.pone.0051026	[Gifford, Jessica L.; Ishida, Hiroaki; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Biochem Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Biochem Res Grp, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca			Canadian Institute of Health Research; National Science and Engineering Research Council; Alberta Ingenuity Fund as well as a Killam Fellowship; Alberta Heritage Foundation for Medical Research Scientist	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity Fund as well as a Killam Fellowship; Alberta Heritage Foundation for Medical Research Scientist(Alberta Heritage Foundation for Medical Research)	This work is supported by an operating grant from the Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). JLG was the recipient of postgraduate scholarships from the National Science and Engineering Research Council and Alberta Ingenuity Fund as well as a Killam Fellowship. HJV is an Alberta Heritage Foundation for Medical Research Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SJ, 2009, BIOCHEMISTRY-US, V48, P7575, DOI 10.1021/bi900769j; Actor JK, 2009, CURR PHARM DESIGN, V15, P1956, DOI 10.2174/138161209788453202; ANDERSSON A, 1983, BIOCHEMISTRY-US, V22, P2309, DOI 10.1021/bi00279a001; Andre I, 2002, ANAL BIOCHEM, V305, P195, DOI 10.1006/abio.2002.5661; Ashida K, 2004, BIOMETALS, V17, P311, DOI 10.1023/B:BIOM.0000027710.13543.3f; Baker HM, 2012, BIOCHEM CELL BIOL, V90, P320, DOI [10.1139/O11-071, 10.1139/o11-071]; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BAYNES RD, 1986, SCAND J HAEMATOL, V36, P79; Bertini I, 2007, J AM CHEM SOC, V129, P12786, DOI 10.1021/ja0726613; Britigan BE, 2001, J IMMUNOL, V167, P2921, DOI 10.4049/jimmunol.167.5.2921; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; DAVIDSON LA, 1987, ACTA PAEDIATR SCAND, V76, P733, DOI 10.1111/j.1651-2227.1987.tb10557.x; de Diego I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000552; De la Rosa G, 2008, J IMMUNOL, V180, P6868, DOI 10.4049/jimmunol.180.10.6868; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DELILLO A, 1992, FEBS LETT, V298, P195, DOI 10.1016/0014-5793(92)80055-L; Dhennin-Duthille I, 2000, J CELL BIOCHEM, V79, P583, DOI 10.1002/1097-4644(20001215)79:4<583::AID-JCB70>3.0.CO;2-9; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Edwards RA, 1998, BIOCHEM J, V331, P149, DOI 10.1042/bj3310149; Elass E, 2002, INFECT IMMUN, V70, P1860, DOI 10.1128/IAI.70.4.1860-1866.2002; ElassRochard E, 1995, BIOCHEM J, V312, P839, DOI 10.1042/bj3120839; Elfinger M, 2007, BIOMATERIALS, V28, P3448, DOI 10.1016/j.biomaterials.2007.04.011; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; ERICKSONVIITANEN S, 1987, METHOD ENZYMOL, V139, P455; Fischer R, 2006, BIOCHEM CELL BIOL, V84, P303, DOI 10.1139/O06-058; Florian P, 2012, BIOCHEM CELL BIOL, V90, P449, DOI [10.1139/O11-090, 10.1139/o11-090]; Gardner KH, 1997, BIOCHEMISTRY-US, V36, P1389, DOI 10.1021/bi9624806; GARRE C, 1992, J CELL PHYSIOL, V153, P477, DOI 10.1002/jcp.1041530306; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gifford JL, 2012, J BIOL CHEM, V287, P26513, DOI 10.1074/jbc.M112.373373; Gifford JL, 2011, J BIOMOL NMR, V50, P71, DOI 10.1007/s10858-011-9495-3; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hanover JA, 2007, J BIOL CHEM, V282, P33743, DOI 10.1074/jbc.M705875200; Haversen L, 2002, CELL IMMUNOL, V220, P83, DOI 10.1016/S0008-8749(03)00006-6; HE JL, 1995, NATURE, V373, P721, DOI 10.1038/373721a0; He SH, 2003, BIOCHEM PHARMACOL, V65, P1007, DOI 10.1016/S0006-2952(02)01651-9; Hellermann GR, 1997, J BIOL CHEM, V272, P12030, DOI 10.1074/jbc.272.18.12030; Huang H, 2012, J AM CHEM SOC, V134, P3864, DOI 10.1021/ja2111306; Huang RQ, 2008, BIOMATERIALS, V29, P238, DOI 10.1016/j.biomaterials.2007.09.024; IKURA M, 1991, BIOCHEMISTRY-US, V30, P9216, DOI 10.1021/bi00102a013; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Ishida H, 2009, J BIOL CHEM, V284, P28292, DOI 10.1074/jbc.M109.025080; Jain NU, 2004, J MOL BIOL, V343, P1379, DOI 10.1016/j.jmb.2004.08.103; Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015; Jiang RL, 2011, J CELL PHYSIOL, V226, P3022, DOI 10.1002/jcp.22650; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kim CW, 2012, FEBS LETT, V586, P229, DOI 10.1016/j.febslet.2011.12.011; Koster S, 2011, J BIOL CHEM, V286, P40954, DOI 10.1074/jbc.M111.286906; Kranz JK, 2002, J BIOL CHEM, V277, P16351, DOI 10.1074/jbc.C200139200; Kurokawa H, 2001, J MOL BIOL, V312, P59, DOI 10.1006/jmbi.2001.4822; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, pR23; Legrand D, 1997, BIOCHEM J, V327, P841, DOI 10.1042/bj3270841; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Legrand D, 2006, BIOCHEM CELL BIOL, V84, P282, DOI 10.1139/O06-045; Legrand D, 2010, BIOMETALS, V23, P365, DOI 10.1007/s10534-010-9297-1; Liao BR, 1999, P NATL ACAD SCI USA, V96, P6217, DOI 10.1073/pnas.96.11.6217; Liao YL, 2012, BIOCHEM CELL BIOL, V90, P476, DOI [10.1139/o11-075, 10.1139/O11-075]; Liu JO, 2009, IMMUNOL REV, V228, P184, DOI 10.1111/j.1600-065X.2008.00756.x; Liu ZH, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00038; Lopez V, 2008, BIOCH J; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; Mariller C, 2012, BIOCHEM CELL BIOL, V90, P307, DOI [10.1139/O11-070, 10.1139/o11-070]; Medvedeva MV, 1996, BIOCHEM J, V315, P1021, DOI 10.1042/bj3151021; Nagulapalli M, 2012, STRUCTURE, V20, P522, DOI 10.1016/j.str.2012.01.021; Oh SM, 2007, J IMMUNOL, V179, P5686, DOI 10.4049/jimmunol.179.9.5686; Oh SM, 2004, ONCOGENE, V23, P8282, DOI 10.1038/sj.onc.1208021; Oh SM, 2001, J BIOL CHEM, V276, P42575, DOI 10.1074/jbc.M107724200; Penco S, 2001, BIOTECHNOL APPL BIOC, V34, P151, DOI 10.1042/BA20010038; Puddu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022504; Puddu P, 2009, BIOCHIMIE, V91, P11, DOI 10.1016/j.biochi.2008.05.005; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; Rainaldi M, 2007, J BIOL CHEM, V282, P6031, DOI 10.1074/jbc.M608970200; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Rodriguez-Castaneda F, 2010, EMBO J, V29, P680, DOI 10.1038/emboj.2009.373; Sabatucci A, 2007, J MOL BIOL, V371, P1038, DOI 10.1016/j.jmb.2007.05.089; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Senkovich O, 2007, J MOL BIOL, V370, P701, DOI 10.1016/j.jmb.2007.04.075; Shi QY, 2008, BIOPHYS CHEM, V138, P138, DOI 10.1016/j.bpc.2008.09.012; Shimada I, 2005, METHOD ENZYMOL, V394, P483, DOI 10.1016/S0076-6879(05)94020-2; Shuman CF, 2006, J MOL BIOL, V358, P870, DOI 10.1016/j.jmb.2006.02.017; Siebert PD, 1997, P NATL ACAD SCI USA, V94, P2198, DOI 10.1073/pnas.94.6.2198; Son KN, 2002, BIOCHEM BIOPH RES CO, V290, P236, DOI 10.1006/bbrc.2001.6181; Spadaro M, 2008, FASEB J, V22, P2747, DOI 10.1096/fj.07-098038; SU ZH, 1994, J BIOL CHEM, V269, P16761; Suzuki YA, 2005, CELL MOL LIFE SCI, V62, P2560, DOI 10.1007/s00018-005-5371-1; Suzuki YA, 2008, BIOCHEMISTRY-US, V47, P10915, DOI 10.1021/bi8012164; Sweitzer TD, 1996, P NATL ACAD SCI USA, V93, P14574, DOI 10.1073/pnas.93.25.14574; Takahashi H, 2006, J BIOMOL NMR, V34, P167, DOI 10.1007/s10858-006-0008-8; TEUWISSEN B, 1974, EUR J BIOCHEM, V42, P411, DOI 10.1111/j.1432-1033.1974.tb03354.x; Torok K, 1998, BIOCHEMISTRY-US, V37, P6188, DOI 10.1021/bi972773e; Turner JH, 2005, J BIOL CHEM, V280, P30741, DOI 10.1074/jbc.M501696200; Van Lierop JE, 2002, J BIOL CHEM, V277, P6550, DOI 10.1074/jbc.M111404200; Vogel HJ, 2012, BIOCHEM CELL BIOL, V90, P233, DOI [10.1139/O2012-016, 10.1139/o2012-016]; VOGEL HJ, 1983, FEBS LETT, V157, P241, DOI 10.1016/0014-5793(83)80554-7; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; WALSH M, 1977, J BIOL CHEM, V252, P7440; WARD PP, 1992, BIO-TECHNOL, V10, P784, DOI 10.1038/nbt0792-784; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yamniuk AP, 2007, PLANT SIGNAL BEHAV, V2, P354, DOI 10.4161/psb.2.5.4155; Yamniuk AP, 2009, MOL IMMUNOL, V46, P2395, DOI 10.1016/j.molimm.2009.04.024; Yamniuk AP, 2009, BIOPHYS J, V96, P1495, DOI 10.1016/j.bpj.2008.10.060; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap KL, 2003, J MOL BIOL, V328, P193, DOI 10.1016/S0022-2836(03)00271-7; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; Yuan T, 2001, BIOPOLYMERS, V58, P50, DOI 10.1002/1097-0282(200101)58:1<50::AID-BIP60>3.0.CO;2-S; ZHANG MJ, 1994, J BIOL CHEM, V269, P15546	108	16	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51026	10.1371/journal.pone.0051026	http://dx.doi.org/10.1371/journal.pone.0051026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236421	Green Published, gold, Green Submitted			2022-12-27	WOS:000312589700027
J	Said, RS; Nada, AS; El-Demerdash, E				Said, Riham S.; Nada, Ahmed S.; El-Demerdash, Ebtehal			Sodium Selenite Improves Folliculogenesis in Radiation-Induced Ovarian Failure: A Mechanistic Approach	PLOS ONE			English	Article							GRANULOSA-CELLS; IN-VITRO; GLUTATHIONE-PEROXIDASE; FERTILITY PRESERVATION; ANTIOXIDANT DEFENSE; INDUCED APOPTOSIS; FOLLICULAR-FLUID; RATS; TISSUES; DAMAGE	Radiotherapy is a major factor contributing to female infertility by inducing premature ovarian failure (POF). Therefore, the need for an effective radioprotective agent is evident. The present study investigated the mechanism of potential radioprotective effect of sodium selenite on radiation-induced ovarian failure and whether sodium selenite can stimulate invivo follicular development in experimental rats. Immature female Sprague-Dawely rats were either exposed to gammaradiation (3.2 Gy, LD20), once and/or treated with sodium selenite (0.5 mg/kg), once daily for one week before irradiation. Follicular and oocyte development, apoptotic markers, proliferation marker as well as oxidative stress markers were assessed 24-h after irradiation. In addition, fertility assessment was performed after female rats became completely mature at two months of age. Sodium selenite significantly enhanced follicular development as compared to the irradiated group. Sodium selenite significantly reversed the oxidative stress effects of radiation that was evidenced by increasing in lipid peroxide level and decreasing in glutathione level, and glutathione peroxidase (GPx) activity. Assessment of apoptosis and cell proliferation markers revealed that caspase 3 and cytochrome c expressions markedly-increased, whereas, PCNA expression markedly-decreased in the irradiated group; in contrast, sodium selenite treatment prevented these alterations. Histopathological examination further confirmed the radioprotective efficacy of sodium selenite and its in-vivo effect on ovarian follicles' maturation. In conclusion, sodium selenite showed a radioprotective effect and improved folliculogenesis through increasing ovarian granulosa cells proliferation, estradiol and FSH secretion, and GPx activity, whilst decreasing lipid peroxidation and oxidative stress, leading to inhibition of the apoptosis pathway through decreasing the expressions of caspase 3 and cytochrome c. Citation: Said RS, Nada AS, El-Demerdash E (2012) Sodium Selenite Improves Folliculogenesis in Radiation-Induced Ovarian Failure: A Mechanistic Approach. PLoS ONE 7(12): e50928. doi:10.1371/journal.pone.0050928	[El-Demerdash, Ebtehal] Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [Said, Riham S.; Nada, Ahmed S.] Atom Energy Author, Natl Ctr Radiat Res & Technol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Egyptian Atomic Energy Authority (EAEA); National Center for Radiation Research & Technology	El-Demerdash, E (corresponding author), Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	ebtehal_dm@yahoo.com	El-Demerdash, Ebtehal/ABE-6729-2020; Said, Riham/AAR-1943-2021					Abedelahi A, 2008, J ASSIST REPROD GEN, V25, P483, DOI 10.1007/s10815-008-9252-z; Abedelahi A, 2010, HUM REPROD, V25, P977, DOI 10.1093/humrep/deq002; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Amsterdam A, 1997, ENDOCR REV, V18, P435, DOI 10.1210/er.18.4.435; Andersen CY, 2012, FUTURE ONCOL, V8, P595, DOI [10.2217/fon.12.47, 10.2217/FON.12.47]; ATAYA KM, 1985, CANCER RES, V45, P3651; Barrington JW, 1996, BRIT J OBSTET GYNAEC, V103, P130, DOI 10.1111/j.1471-0528.1996.tb09663.x; Basini G, 2000, DOMEST ANIM ENDOCRIN, V18, P1, DOI 10.1016/S0739-7240(99)00059-4; Bath LE, 1999, BRIT J OBSTET GYNAEC, V106, P1265, DOI 10.1111/j.1471-0528.1999.tb08180.x; Bedaiwy MA, 2004, FERTIL STERIL, V82, P593, DOI 10.1016/j.fertnstert.2004.02.121; Beltran-Garcia MJ, 2000, CONTRACEPTION, V61, P99, DOI 10.1016/S0010-7824(00)00085-8; Borek C, 2004, J NUTR, V134, p3207S, DOI 10.1093/jn/134.11.3207S; BRAW RH, 1980, J REPROD FERTIL, V59, P267, DOI 10.1530/jrf.0.0590267; Britt KL, 2000, ENDOCRINOLOGY, V141, P2614, DOI 10.1210/en.141.7.2614; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Cadet J, 2004, J ENVIRON PATHOL TOX, V23, P33, DOI 10.1615/JEnvPathToxOncol.v23.i1.30; Cassano E, 1999, CELL PHYSIOL BIOCHEM, V9, P106, DOI 10.1159/000016307; CEKAN E, 1985, ACTA RADIOL ONCOL, V24, P267, DOI 10.3109/02841868509134399; Chattopadhyay S, 2003, TOXICOL SCI, V75, P412, DOI 10.1093/toxsci/kfg194; CLEMENS JA, 1977, ACTA ENDOCRINOL-COP, V85, P18; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; COULAM CB, 1982, FERTIL STERIL, V38, P645; DAMEWOOD MD, 1986, FERTIL STERIL, V45, P443; DJUJIC IS, 1992, BIOL TRACE ELEM RES, V33, P197, DOI 10.1007/BF02784023; Pontual MLD, 2007, J APPL ORAL SCI, V15, P162, DOI 10.1590/S1678-77572007000300003; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; England K, 2005, REDOX REP, V10, P237, DOI 10.1179/135100005X70224; Esterbauer H, 1996, PATHOL BIOL, V44, P25; Feinendegen LE, 2002, HUM EXP TOXICOL, V21, P85, DOI 10.1191/0960327102ht216oa; Fraunholz I, 2008, STRAHLENTHER ONKOL, V184, P411, DOI 10.1007/s00066-008-1867-6; Gopee NV, 2004, TOXICOL SCI, V78, P204, DOI 10.1093/toxsci/kfh072; Imam SZ, 2000, BRAIN RES, V855, P186, DOI 10.1016/S0006-8993(99)02249-0; Jancar N, 2007, J ASSIST REPROD GEN, V24, P91, DOI 10.1007/s10815-006-9103-8; Kamat JP, 2000, J ETHNOPHARMACOL, V71, P425, DOI 10.1016/S0378-8741(00)00176-8; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Lee Young-Keun, 1998, Arhiv za Higijenu Rada i Toksikologiju, V49, P147; MANDL AM, 1959, PROC R SOC SER B-BIO, V150, P53, DOI 10.1098/rspb.1959.0007; Markstrom E, 2002, REPRODUCTION, V123, P23, DOI 10.1530/rep.0.1230023; Mutlu-Turkoglu U, 2000, LIFE SCI, V66, P1905, DOI 10.1016/S0024-3205(00)00516-6; Navarro J, 1997, FREE RADICAL BIO MED, V22, P1203, DOI 10.1016/S0891-5849(96)00554-0; Naziroglu M, 2004, TOXICOLOGY, V195, P221, DOI 10.1016/j.tox.2003.10.012; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; Ognjanovic BI, 2008, PHYSIOL RES, V57, P403, DOI 10.33549/physiolres.931197; OKTAY K, 1995, BIOL REPROD, V53, P295, DOI 10.1095/biolreprod53.2.295; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; PASZKOWSKI T, 1995, CLIN CHIM ACTA, V236, P173, DOI 10.1016/0009-8981(95)98130-9; Patil S R, 1998, Indian J Physiol Pharmacol, V42, P503; RABINOVICI J, 1990, ENDOCR REV, V11, P532, DOI 10.1210/edrv-11-4-532; Schueller P, 2004, ANTICANCER RES, V24, P2913; Shinomiya N, 2001, J CELL MOL MED, V5, P240, DOI 10.1111/j.1582-4934.2001.tb00158.x; Skillern A, 2008, SEX DEV, V2, P228, DOI 10.1159/000152039; Sonmezer M, 2008, CURR OPIN ENDOCRINOL, V15, P514, DOI 10.1097/MED.0b013e32831a46fc; Tian JQ, 2010, INT J RADIAT ONCOL, V78, P230, DOI 10.1016/j.ijrobp.2010.03.006; Tsunoda M, 2000, ARCH ENVIRON CON TOX, V39, P32, DOI 10.1007/s002440010076; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; VIJAYAN E, 1978, NEUROENDOCRINOLOGY, V25, P150, DOI 10.1159/000122737; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WEISS JF, 1992, ADV SPACE RES-SERIES, V12, P223, DOI 10.1016/0273-1177(92)90112-B; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yacobi K, 2004, ENDOCRINOLOGY, V145, P1943, DOI 10.1210/en.2003-1395; Yoon SO, 2001, FASEB J, V15, P111, DOI 10.1096/fj.01-0398fje; Zeng HW, 2002, J NUTR, V132, P674, DOI 10.1093/jn/132.4.674; Zhang JY, 2006, BIOTECHNOL BIOENG, V95, P1188, DOI 10.1002/bit.21081	64	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50928	10.1371/journal.pone.0050928	http://dx.doi.org/10.1371/journal.pone.0050928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236409	Green Submitted, Green Published, gold			2022-12-27	WOS:000312589700022
J	Schabrun, SM; Ridding, MC; Galea, MP; Hodges, PW; Chipchase, LS				Schabrun, Siobhan M.; Ridding, Michael C.; Galea, Mary P.; Hodges, Paul W.; Chipchase, Lucinda S.			Primary Sensory and Motor Cortex Excitability Are Co-Modulated in Response to Peripheral Electrical Nerve Stimulation	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SOMATOSENSORY EVOKED-POTENTIALS; SYSTEM AMPLIFICATION; FUNCTIONAL-ROLE; INPUT; PLASTICITY; HUMANS; MUSCLE; TENS; PAIN	Peripheral electrical stimulation (PES) is a common clinical technique known to induce changes in corticomotor excitability; PES applied to induce a tetanic motor contraction increases, and PES at sub-motor threshold (sensory) intensities decreases, corticomotor excitability. Understanding of the mechanisms underlying these opposite changes in corticomotor excitability remains elusive. Modulation of primary sensory cortex (S1) excitability could underlie altered corticomotor excitability with PES. Here we examined whether changes in primary sensory (S1) and motor (M1) cortex excitability follow the same time-course when PES is applied using identical stimulus parameters. Corticomotor excitability was measured using transcranial magnetic stimulation (TMS) and sensory cortex excitability using somatosensory evoked potentials (SEPs) before and after 30 min of PES to right abductor pollicis brevis (APB). Two PES paradigms were tested in separate sessions; PES sufficient to induce a tetanic motor contraction (30-50 Hz; strong motor intensity) and PES at sub motor-threshold intensity (100 Hz). PES applied to induce strong activation of APB increased the size of the N-20-P-25 component, thought to reflect sensory processing at cortical level, and increased corticomotor excitability. PES at sensory intensity decreased the size of the P25-N33 component and reduced corticomotor excitability. A positive correlation was observed between the changes in amplitude of the cortical SEP components and corticomotor excitability following sensory and motor PES. Sensory PES also increased the sub-cortical P-14-N-20 SEP component. These findings provide evidence that PES results in co-modulation of S1 and M1 excitability, possibly due to cortico-cortical projections between S1 and M1. This mechanism may underpin changes in corticomotor excitability in response to afferent input generated by PES.	[Schabrun, Siobhan M.; Hodges, Paul W.; Chipchase, Lucinda S.] Univ Queensland, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Brisbane, Qld, Australia; [Schabrun, Siobhan M.; Hodges, Paul W.; Chipchase, Lucinda S.] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Ridding, Michael C.] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Inst, Adelaide, SA 5005, Australia; [Galea, Mary P.] Univ Melbourne, Rehabil Sci Res Ctr, Melbourne, Vic 3010, Australia	University of Queensland; University of Queensland; Robinson Research Institute; University of Adelaide; University of Melbourne	Schabrun, SM (corresponding author), Univ Queensland, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Brisbane, Qld, Australia.	s.schabrun@uq.edu.au	Galea, Mary/F-4242-2010; Schabrun, Siobhan/F-6925-2010; Hodges, Paul W/B-6578-2008	Galea, Mary/0000-0003-0045-7978; Hodges, Paul W/0000-0002-1206-9107; Chipchase, Lucy/0000-0003-0228-3326; Schabrun, Siobhan/0000-0002-9083-3107	Clinical Research Fellowship; National Health and Medical Research Council of Australia	Clinical Research Fellowship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	SM Schabrun is supported by a Clinical Research Fellowship, MC Ridding by a Senior Research Fellowship and PW Hodges by a Senior Principal Research Fellowship from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANUMA H, 1984, J NEUROPHYSIOL, V52, P212, DOI 10.1152/jn.1984.52.2.212; ASANUMA H, 1980, EXP BRAIN RES, V38, P349; Brosseau L., 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004377; Chipchase LS, 2011, CLIN NEUROPHYSIOL, V122, P456, DOI 10.1016/j.clinph.2010.07.025; Chipchase L, 2012, CLIN NEUROPHYSIOL, V123, P1698, DOI 10.1016/j.clinph.2012.05.003; Chipchase LS, 2011, ARCH PHYS MED REHAB, V92, P1423, DOI 10.1016/j.apmr.2011.01.011; DARIANSMITH C, 1990, J COMP NEUROL, V299, P47, DOI 10.1002/cne.902990104; Dowswell T, 2009, COCHRANE DATABASE SY; EISEN A, 1982, NEUROLOGY, V32, P359, DOI 10.1212/WNL.32.4.359; Embrey DG, 2010, ARCH PHYS MED REHAB, V91, P687, DOI 10.1016/j.apmr.2009.12.024; Everaert DG, 2010, NEUROREHAB NEURAL RE, V24, P168, DOI 10.1177/1545968309349939; Fernandez-del-Olmo M, 2008, CLIN NEUROPHYSIOL, V119, P1834, DOI 10.1016/j.clinph.2008.04.002; GOLDING JF, 1986, J NEUROL NEUROSUR PS, V49, P1397, DOI 10.1136/jnnp.49.12.1397; Kaelin-Lang A, 2002, J PHYSIOL-LONDON, V540, P623, DOI 10.1113/jphysiol.2001.012801; KANEKO T, 1994, J COMP NEUROL, V345, P161, DOI 10.1002/cne.903450202; KANEKO T, 1994, J COMP NEUROL, V345, P172, DOI 10.1002/cne.903450203; Keel JC, 2001, BIOL PSYCHIAT, V49, p167S; MACEFIELD G, 1991, ELECTROEN CLIN NEURO, V78, P150, DOI 10.1016/0013-4694(91)90115-K; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; NARDONE A, 1989, ELECTROEN CLIN NEURO, V74, P24, DOI 10.1016/0168-5597(89)90048-8; Perez M, 2002, PFLUG ARCH EUR J PHY, V443, P866, DOI 10.1007/s00424-001-0769-6; Popovic MR, 2011, NEUROREHAB NEURAL RE, V25, P433, DOI 10.1177/1545968310392924; Powell J, 1999, STROKE, V30, P1384, DOI 10.1161/01.STR.30.7.1384; Ridding MC, 2000, EXP BRAIN RES, V131, P135, DOI 10.1007/s002219900269; ROCHESTER L, 1995, PARAPLEGIA, V33, P514, DOI 10.1038/sc.1995.112; Rossi A, 1998, NEUROSCI LETT, V248, P155, DOI 10.1016/S0304-3940(98)00354-1; Rossi S, 2003, CLIN NEUROPHYSIOL, V114, P1351, DOI 10.1016/S1388-2457(03)00073-7; SAKAMOTO T, 1987, BRAIN RES, V413, P360, DOI 10.1016/0006-8993(87)91029-8; SAKAMOTO T, 1989, BRAIN RES, V503, P258, DOI 10.1016/0006-8993(89)91672-7; Schabrun SM, 2007, EXP BRAIN RES, V183, P41, DOI 10.1007/s00221-007-1019-8; Seki K, 2012, J NEUROSCI, V32, P890, DOI 10.1523/JNEUROSCI.4958-11.2012; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Sujith OK, 2008, EUR J NEUROL, V15, P437, DOI 10.1111/j.1468-1331.2008.02127.x; Tinazzi M, 2005, EXP BRAIN RES, V161, P457, DOI 10.1007/s00221-004-2091-y; TYNER FS, 1987, J CLIN NEUROPHYSIOL, V4, P397; URASAKI E, 1988, ELECTROEN CLIN NEURO, V71, P400, DOI 10.1016/0168-5597(88)90043-3; Urasaki E, 1998, J NEUROL, V245, P143, DOI 10.1007/s004150050194; Zanette G, 2004, CLIN NEUROPHYSIOL, V115, P1264, DOI 10.1016/j.clinph.2003.12.033; Ziemann U, 1998, J NEUROSCI, V18, P1115	39	69	71	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51298	10.1371/journal.pone.0051298	http://dx.doi.org/10.1371/journal.pone.0051298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227260	gold, Green Published			2022-12-27	WOS:000312588200119
J	Spellicy, CJ; Northrup, H; Fletcher, JM; Cirino, PT; Dennis, M; Morrison, AC; Martinez, CA; Au, KS				Spellicy, Catherine J.; Northrup, Hope; Fletcher, Jack M.; Cirino, Paul T.; Dennis, Maureen; Morrison, Alanna C.; Martinez, Carla A.; Au, Kit Sing			Folate Metabolism Gene 5,10-Methylenetetrahydrofolate Reductase (MTHFR) Is Associated with ADHD in Myelomeningocele Patients	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; NEURAL-TUBE DEFECTS; SPINA-BIFIDA; FOLIC-ACID; CHILDHOOD LEUKEMIA; ATTENTION; CHILDREN; POLYMORPHISMS; VITAMIN-B-12; PREVALENCE	The objective of this study was to examine the relation between the 5, 10-methylenetetrahydrofolate reductase (MTHFR) gene and behaviors related to attention-deficit/hyperactivity disorder (ADHD) in individuals with myelomeningocele. The rationale for the study was twofold: folate metabolizing genes, (e.g. MTHFR), are important not only in the etiology of neural tube defects but are also critical to cognitive function; and individuals with myelomeningocele have an elevated incidence of ADHD. Here, we tested 478 individuals with myelomeningocele for attention-deficit hyperactivity disorder behavior using the Swanson Nolan Achenbach Pelham-IV ADHD rating scale. Myelomeningocele participants in this group for whom DNAs were available were genotyped for seven single nucleotide polymorphisms (SNPs) in the MTHFR gene. The SNPs were evaluated for an association with manifestation of the ADHD phenotype in children with myelomeningocele. The data show that 28.7% of myelomeningocele participants exhibit rating scale elevations consistent with ADHD; of these 70.1% had scores consistent with the predominantly inattentive subtype. In addition, we also show a positive association between the SNP rs4846049 in the 39-untranslated region of the MTHFR gene and the attention-deficit hyperactivity disorder phenotype in myelomeningocele participants. These results lend further support to the finding that behavior related to ADHD is more prevalent in patients with myelomeningocele than in the general population. These data also indicate the potential importance of the MTHFR gene in the etiology of the ADHD phenotype.	[Spellicy, Catherine J.; Northrup, Hope; Au, Kit Sing] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Univ Texas Med Sch Houston, Houston, TX USA; [Northrup, Hope] Shriners Hosp Children, Houston, TX USA; [Fletcher, Jack M.; Cirino, Paul T.] Univ Houston, Dept Psychol, Houston, TX USA; [Cirino, Paul T.] Univ Houston, TIMES, Houston, TX USA; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Dennis, Maureen] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Div Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX USA; [Martinez, Carla A.] Texas Tech Univ Hlth Sci Ctr, Dept Obstet & Gynecol, El Paso, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston; University of Houston System; University of Houston; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Texas Tech University System; Texas Tech University Health Science Center	Au, KS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Univ Texas Med Sch Houston, Houston, TX USA.	Kit-Sing.Au@uth.tmc.edu	fletcher, jack/Q-5975-2019; Fletcher, Jack/AAX-2931-2020	Cirino, Paul T./0000-0002-9587-0388; Morrison, Alanna/0000-0001-6381-4296; Au, Kit Sing/0000-0002-2694-5833	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [P01-HD35946]; Shriners Hospital for Children [8580]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD035946] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Shriners Hospital for Children; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Grant sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) P01-HD35946 (HN, JMF, PTC, DM, ACM, KSA); Shriners Hospital for Children #8580 (KSA, HN). The content is solely the responsibility of the authors and does not necessarily represent the official views of Shriners Hospital for Children, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agiopian A, 2011, AM J MED GENET A, V9999, P1; Ammerman RT, 1998, J CLIN PSYCHOL MED S, V5, P449, DOI 10.1023/A:1026211028595; Brookes K, 2006, MOL PSYCHIATR, V11, P934, DOI 10.1038/sj.mp.4001869; Burmeister R, 2005, CHILD NEUROPSYCHOL, V11, P265, DOI 10.1080/092970490911324; Bussing R, 2008, ASSESSMENT, V15, P317, DOI 10.1177/1073191107313888; Canfield MA, 2009, PAEDIATR PERINAT EP, V23, P41, DOI 10.1111/j.1365-3016.2008.00975.x; CDC, 2010, VIT HLTH STAT 10; Chen BH, 2008, BIRTH DEFECTS RES A, V82, P547, DOI 10.1002/bdra.20466; Crider KS, 2011, NUTRIENTS, V3, P370, DOI 10.3390/nu3030370; Davidson CM, 2008, REPROD SCI, V15, P51, DOI 10.1177/1933719107309590; de Lau LML, 2009, J NEUROL NEUROSUR PS, V80, P149, DOI 10.1136/jnnp.2008.149286; de Lau LML, 2007, AM J CLIN NUTR, V86, P728, DOI 10.1093/ajcn/86.3.728; Dennis M, 2006, J INT NEUROPSYCH SOC, V12, P285, DOI 10.1017/S1355617706060371; Dennis M, 2005, NEUROPSYCHOLOGIA, V43, P976, DOI 10.1016/j.neuropsychologia.2004.08.012; Dennis M, 2008, J INT NEUROPSYCH SOC, V14, P673, DOI 10.1017/S1355617708080983; Dennis M, 2010, DEV DISABIL RES REV, V16, P31, DOI 10.1002/ddrr.89; Elia J, 2012, NAT GENET, V44, P78, DOI 10.1038/ng.1013; Ergul E, 2012, GENET TEST MOL BIOMA, V16, P67, DOI 10.1089/gtmb.2011.0062; GIRALT J, 1992, INT J RADIAT ONCOL, V24, P49, DOI 10.1016/0360-3016(92)91020-N; Gokcen C, 2011, INT J MED SCI, V8, P523, DOI 10.7150/ijms.8.523; Greene NDE, 2009, HUM MOL GENET, V18, pR113, DOI 10.1093/hmg/ddp347; Harris MJ, 2009, BIRTH DEFECTS RES A, V85, P331, DOI 10.1002/bdra.20552; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Koturbash I, 2013, MOL CARCINOGEN, V52, P318, DOI 10.1002/mc.21861; Krull KR, 2008, J PEDIATR-US, V152, P101, DOI 10.1016/j.jpeds.2007.05.047; Kuznetsova AY, 2008, J COMPUT NEUROSCI, V24, P314, DOI 10.1007/s10827-007-0057-3; Lakhan SE, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-2; MALOUF R, 2008, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD004514; MARIA BL, 1993, CAN J NEUROL SCI, V20, P199; Martinez D, 2009, AM J OBSTET GYNECOL, V201, pel; Moretti P, 2008, J AUTISM DEV DISORD, V38, P1170, DOI 10.1007/s10803-007-0492-z; MORGAN DJR, 1995, POSTGRAD MED J, V71, P17, DOI 10.1136/pgmj.71.831.17; Morris MS, 2001, AM J CLIN NUTR, V73, P927; NINDS NIH, 2007, SPIN BIF FACT SHEET; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sen A, 2009, INDIAN PEDIATR, V46, P849; Swartwout MAD, 2008, NEUROPSYCHOLOGY, V22, P765, DOI 10.1037/a0013373; Tangney CC, 2009, NEUROLOGY, V72, P361, DOI 10.1212/01.wnl.0000341272.48617.b0; Trembath D, 1999, TERATOLOGY, V59, P331, DOI 10.1002/(SICI)1096-9926(199905)59:5<331::AID-TERA4>3.0.CO;2-L; van der Linden IJM, 2006, P NUTR SOC, V65, P204, DOI 10.1079/PNS2006495; vanderPut NMJ, 1997, QJM-MON J ASSOC PHYS, V90, P111, DOI 10.1093/qjmed/90.2.111; WALD N, 1991, LANCET, V338, P131; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Wu C, 2012, NUTR METAB CARDIOVAS, V28; Zhao R, 2001, J NEUROCHEM, V78, P788, DOI 10.1046/j.1471-4159.2001.00471.x	46	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51330	10.1371/journal.pone.0051330	http://dx.doi.org/10.1371/journal.pone.0051330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227261	gold, Green Published			2022-12-27	WOS:000312588200120
J	Zhong, SF; Monakhov, M; Mok, HP; Tong, T; Lai, PS; Chew, SH; Ebstein, RP				Zhong, Songfa; Monakhov, Mikhail; Mok, Helen P.; Tong, Terry; Lai, Poh San; Chew, Soo Hong; Ebstein, Richard P.			U-Shaped Relation between Plasma Oxytocin Levels and Behavior in the Trust Game	PLOS ONE			English	Article							SOCIAL-BEHAVIOR; VASOPRESSIN; HUMANS; RISK; RECIPROCITY; DISORDER; AVERSION; HORMESIS; RELEASE; BINDING	Trust underpins much of social and economic exchanges across human societies. In experimental economics, the Trust Game has served as the workhorse for the study of trust in a controlled incentivized setting. Recent evidence using intranasal drug administration, aka 'sniffing', suggests that oxytocin (OT) can function as a social hormone facilitating trust and other affiliative behaviors. Here we hypothesized that baseline plasma OT is a biomarker that partially predicts the degree of trust and trustworthiness observed in the trust game. Using a large sample of 1,158 participants, we observed a significant U-shaped relationship between plasma OT with the level of trust, and marginally with the level of trustworthiness, especially among males. Specifically, subjects with more extreme levels of plasma OT were more likely to be trusting as well as trustworthy than those with moderate levels of plasma OT. Our results contribute to a deeper understanding of the biological basis of human trust and underscore the usefulness of peripheral plasma OT measures in characterizing human social behavior.	[Ebstein, Richard P.] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Zhong, Songfa; Monakhov, Mikhail; Chew, Soo Hong] Natl Univ Singapore, Dept Econ, Singapore 117548, Singapore; [Mok, Helen P.; Tong, Terry] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 117595, Singapore; [Lai, Poh San] Natl Univ Singapore, Dept Paediat, Singapore 117548, Singapore; [Chew, Soo Hong] Natl Univ Singapore, Dept Finance, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Ebstein, RP (corresponding author), Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore.	rpebstein@gmail.com	Zhong, Songfa Z/I-4718-2016; Mikhail, Monakhov/J-5899-2016	Mikhail, Monakhov/0000-0003-0285-2293; Chew, Soo Hong/0000-0003-1245-0909; Ebstein, Richard/0000-0002-3626-541X	Ministry of Education at Singapore; AXA research foundation; Templeton foundation	Ministry of Education at Singapore(Ministry of Education, Singapore); AXA research foundation(AXA Research Fund); Templeton foundation	This study has been financial supports from Ministry of Education at Singapore (http://www.moe.gov.sg/; Tier 2: Biological Economics and Decision Making), AXA research foundation (http://www.axa-research.org/; Biology of Decision Making under Risk) and the Templeton foundation (http://www.templeton.org/; Genes, God and Generosity). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JA, 2008, EXPT EC, P1; Aimone JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017725; Andari E, 2010, P NATL ACAD SCI USA, V107, P4389, DOI 10.1073/pnas.0910249107; [Anonymous], OXYTOCIN ELISA KIT I; Apicella CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011153; Backstrom T, 2011, NEUROSCIENCE, V191, P46, DOI 10.1016/j.neuroscience.2011.03.061; Bales KL, 2004, DEV PSYCHOBIOL, V44, P123, DOI 10.1002/dev.10165; Bartz J, 2010, SOC COGN AFFECT NEUR; Bartz JA, 2011, TRENDS COGNITIVE SCI; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bick J, 2010, DEV PSYCHOBIOL, V52, P100, DOI 10.1002/dev.20411; Biederman J, 2004, INT J NEUROPSYCHOPH, V7, P77, DOI 10.1017/S1461145703003973; Boccia MM, 1998, NEUROBIOL LEARN MEM, V69, P136, DOI 10.1006/nlme.1997.3817; Bohnet I, 2008, AM ECON REV, V98, P294, DOI 10.1257/aer.98.1.294; BURBACH JPH, 1983, EUR J PHARMACOL, V94, P125, DOI 10.1016/0014-2999(83)90449-1; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P453, DOI 10.1080/10408440802004007; Camerer C, 2003, BEHAV GAME THEORY EX, Vxv; Carter CS, 2007, ANN NY ACAD SCI, V1098, P312, DOI 10.1196/annals.1384.006; Carter CS, 2008, PROG BRAIN RES, V170, P331, DOI 10.1016/S0079-6123(08)00427-5; Carter CS, 2006, BEHAV BRAIN RES; Coleman James S., 1988, AM J SOCIOL, V94, P95, DOI DOI 10.1086/228943; Conlisk J, 2011, J EC BEHAV ORG; Cox JC, 2004, GAME ECON BEHAV, V46, P260, DOI 10.1016/S0899-8256(03)00119-2; Croson R, 1999, AM ECON REV, V89, P386, DOI 10.1257/aer.89.2.386; Danalache BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013643; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; De Dreu CKW, 2011, PSYCHONEUROENDOCRINO; Domes G, 2006, BIOL PSYCHIAT; Ebstein RP, 2012, HORM BEHAV, V61, P359, DOI 10.1016/j.yhbeh.2011.12.014; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Feldman R, 2007, PSYCHOL SCI, V18, P965, DOI 10.1111/j.1467-9280.2007.02010.x; Gambetta D, 1988, TRUST MAKING BREAKIN, P217; Gneezy U, 1997, Q J ECON, V112, P631, DOI 10.1162/003355397555217; Gordon I, 2010, BIOL PSYCHIAT, V68, P377, DOI 10.1016/j.biopsych.2010.02.005; Green LA, 2001, BIOL PSYCHIAT, V50, P609, DOI 10.1016/S0006-3223(01)01139-8; Guastella AJ, 2009, BIOL PSYCHIAT; Holt-Lunstad J, 2011, PSYCHONEUROENDOCRINO; Houser D, 2010, J ECON BEHAV ORGAN, V74, P72, DOI 10.1016/j.jebo.2010.01.002; Kastin AJ, 2008, CRIT REV TOXICOL, V38, P629, DOI 10.1080/10408440802026372; Kelemenova S, 2010, PSYCHIAT GENET, V20, P137, DOI 10.1097/YPG.0b013e32833a1eb3; Keri S, 2011, PHYSIOL BEHAV, V102, P221, DOI 10.1016/j.physbeh.2010.11.011; Kok BE, 2010, BIOL PSYCHOL, V85, P432, DOI 10.1016/j.biopsycho.2010.09.005; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lee AG, 2011, BIOL LETTERS, V7, P584, DOI 10.1098/rsbl.2011.0107; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; LUHMANN Niklas, 1979, TRUST POWER; Michopoulos V, 2011, HORM BEHAV, V59, P528, DOI 10.1016/j.yhbeh.2011.02.002; Misztal BA, 1996, TRUST MODERN SOC SEA; Momose K, 1998, PEPTIDES, V19, P1739, DOI 10.1016/S0196-9781(98)00131-4; Opacka-Juffry J, 2011, STRESS; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Razzoli M, 2003, HORM BEHAV, V43, P549, DOI 10.1016/S0018-506X(03)00064-3; Smeltzer MD, 2006, NEUROSCI LETT, V394, P146, DOI 10.1016/j.neulet.2005.10.019; Stanton SJ, 2011, PSYCHOL SCI, V22, P447, DOI 10.1177/0956797611401752; Szeto A, 2011, PSYCHOSOMATIC MED; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Uhl-Bronner S, 2005, NEUROSCIENCE, V135, P147, DOI 10.1016/j.neuroscience.2005.05.025; Van Ijzendoorn MH, 2011, PSYCHONEUROENDOCRINO; Wayner MJ, 2001, PEPTIDES, V22, P1403, DOI 10.1016/S0196-9781(01)00475-2; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Zak PJ, 2001, ECON J, V111, P295, DOI 10.1111/1468-0297.00609	63	53	54	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51095	10.1371/journal.pone.0051095	http://dx.doi.org/10.1371/journal.pone.0051095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227239	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200099
J	Kanzaki, S; Fujioka, M; Yasuda, A; Shibata, S; Nakamura, M; Okano, HJ; Ogawa, K; Okano, H				Kanzaki, Sho; Fujioka, Masato; Yasuda, Akimasa; Shibata, Shinsuke; Nakamura, Masaya; Okano, Hirotaka James; Ogawa, Kaoru; Okano, Hideyuki			Novel In Vivo Imaging Analysis of an Inner Ear Drug Delivery System in Mice: Comparison of Inner Ear Drug Concentrations over Time after Transtympanic and Systemic Injections	PLOS ONE			English	Article							DEXAMETHASONE PHARMACOKINETICS	Objective: Systemic steroid injections are used to treat idiopathic sudden-onset sensorineural hearing loss (ISSHL) and some inner ear disorders. Recent studies show that transtympanic (TT) steroid injections are effective for treating ISSHL. As in vivo monitoring of drug delivery dynamics for inner ear is lacking, its time course and dispersion of drugs is unknown. Here, we used a new in vivo imaging system to monitor drug delivery in live mice and to compare drug concentrations over time after TT and systemic injections. Methods: Luciferin delivered into the inner ears of GFAP-Luc transgenic mice reacted with luciferase in GFAP-expressing cells in the cochlear spiral ganglion, resulting in photon bioluminescence. We used the Xenogen IVISH imaging system to measure how long photons continued to be emitted in the inner ear after TT or systemic injections of luciferin, and then compared the associated drug dynamics. Results: The response to TT and IP injections differed significantly. Photons were detected five minutes after TT injection, peaking at,20 minutes. By contrast, photons were first detected 30 minutes after i.p. injection. TT and i.p. drug delivery time differed considerably. With TT injections, photons were detected earlier than with IP injections. Photon bioluminescence also disappeared sooner. Delivery time varied with TT injections. Conclusions: We speculate that the drug might enter the Eustachian tube from the middle ear. We conclude that inner-ear drug concentration can be maintained longer if the two injection routes are combined. As the size of luciferin differs from that of therapeutics like dexamethasone, combining drugs with luciferin may advance our understanding of in vivo drug delivery dynamics in the inner ear.	[Kanzaki, Sho; Fujioka, Masato; Ogawa, Kaoru] Keio Univ, Dept Otolaryngol Head & Neck Surg, Shinjuku Ku, Tokyo, Japan; [Yasuda, Akimasa; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthoped, Shinjuku Ku, Tokyo, Japan; [Shibata, Shinsuke; Okano, Hirotaka James; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan	Keio University; Keio University; Keio University	Kanzaki, S (corresponding author), Keio Univ, Dept Otolaryngol Head & Neck Surg, Shinjuku Ku, Tokyo, Japan.	skan@a7.keio.jp	Okano, Hideyuki/I-7584-2019; Nakamura, Masaya/K-4111-2013; Kanzaki, Sho/B-3100-2014; Shibata, Shinsuke/AAM-6620-2020	Kanzaki, Sho/0000-0001-9056-0850; Fujioka, Masato/0000-0002-5317-0885; Okano, Hirotaka James/0000-0003-4611-7098	Ministry of Health, Labor and Welfare [KO 2011]; Ministry of Education, Culture, Sports, Science and Technology [KO 2012]	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Health, Labor and Welfare (KO 2011) and by a grant from the Ministry of Education, Culture, Sports, Science and Technology (KO 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandrasekhar SS, 2000, OTOLARYNG HEAD NECK, V122, P521, DOI 10.1016/S0194-5998(00)70094-5; Hahn H, 2006, HEARING RES, V212, P236, DOI 10.1016/j.heares.2005.12.001; Iizuka T, 2008, HUM GENE THER, V19, P384, DOI 10.1089/hum.2007.167; Kanzaki S, 2012, AURIS NASUS LARYNX, V39, P208, DOI 10.1016/j.anl.2011.04.006; Liu HJ, 2006, ORL-J OTO-RHIN-LARYN, V68, P93, DOI 10.1159/000091210; Parnes LS, 1999, LARYNGOSCOPE, V109, P1, DOI 10.1097/00005537-199907001-00001; Rauch SD, 2011, JAMA-J AM MED ASSOC, V305, P2071, DOI 10.1001/jama.2011.679; Silverstein H, 1997, AM J OTOL, V18, P586; Thorne M, 1999, LARYNGOSCOPE, V109, P1661, DOI 10.1097/00005537-199910000-00021; Zhu LY, 2004, NEUROSCI LETT, V367, P210, DOI 10.1016/j.neulet.2004.06.020	10	18	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48480	10.1371/journal.pone.0048480	http://dx.doi.org/10.1371/journal.pone.0048480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251331	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200005
J	Weierstall, R; Huth, S; Knecht, J; Nandi, C; Elbert, T				Weierstall, Roland; Huth, Sina; Knecht, Jasmin; Nandi, Corina; Elbert, Thomas			Appetitive Aggression as a Resilience Factor against Trauma Disorders: Appetitive Aggression and PTSD in German World War II Veterans	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; VIETNAM VETERANS; US VETERANS; EXPOSURE; VIOLENCE; CHECKLIST; CLINICIAN; SAMPLE; MODEL; SCALE	Background: Repeated exposure to traumatic stressors such as combat results in chronic symptoms of PTSD. However, previous findings suggest that former soldiers who report combat-related aggression to be appetitive are more resilient to develop PTSD. Appetitive Aggression should therefore prevent widespread mental suffering in perpetrators of severe atrocities even after decades. Methods and Findings: To test the long-term relationship between trauma-related illness and attraction to aggression, we surveyed a sample of 51 German male World-War II veterans (age: M = 86.7, SD = 2.8). War-related appetitive aggression was assessed with the Appetitive Aggression Scale (AAS). Current- and lifetime PTSD symptoms were assessed with the PSS-I. In a linear regression analysis accounting for 31% of the variance we found that veterans that score higher on the AAS show lower PSS-I symptom severity scores across their whole post-war lifetime (beta = -.31, p = .014). The effect size and power were sufficient (f(2) = 0.51, (1-beta) = .99). The same was true for current PTSD (beta = -.27, p = .030). Conclusions: Appetitive Aggression appears to be a resilience factor for negative long-term effects of combat experiences in perpetrators of violence. This result has practical relevance for preventing trauma-related mental suffering in Peace Corps and for designing adequate homecoming reception for veterans.	[Weierstall, Roland; Huth, Sina; Knecht, Jasmin; Nandi, Corina; Elbert, Thomas] Univ Konstanz, Dept Psychol, Constance, Germany	University of Konstanz	Weierstall, R (corresponding author), Univ Konstanz, Dept Psychol, Constance, Germany.	roland.weierstall@uni-konstanz.de	Elbert, Thomas/C-8556-2009	Elbert, Thomas/0000-0003-1332-4939	German Research Council (DFG)	German Research Council (DFG)(German Research Foundation (DFG))	The support of the German Research Council (DFG) is gratefully acknowledged. http://www.dfg.de/en/index.jsp The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Arendt H., 1963, EICHMANN JERUSALEM B; Bichescu Dana, 2005, Clin Pract Epidemiol Ment Health, V1, P17, DOI 10.1186/1745-0179-1-17; Boscarino JA, 2006, COMPR PSYCHIAT, V47, P503, DOI 10.1016/j.comppsych.2006.02.006; BRESLAU N, 1987, J NERV MENT DIS, V175, P255, DOI 10.1097/00005053-198705000-00001; BULLMAN TA, 1994, J NERV MENT DIS, V182, P604, DOI 10.1097/00005053-199411000-00002; Buss D. M., 2004, EVOLUTIONARY PSYCHOL; Castro CA, 1994, INTERVENTION TRAUMA, P301; Catani C, 2009, J TRAUMA STRESS, V22, P163, DOI 10.1002/jts.20415; Daly M., 1988, HOMICIDE; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Duntley JD, 2005, PLAUSIBILTIY ADAPTAT, V1; Elbert T, 2002, NATURE, V419, P883, DOI 10.1038/419883a; Elbert T, 2010, EUR ARCH PSY CLIN N, V260, pS100, DOI 10.1007/s00406-010-0144-8; ENGDAHL BE, 1991, J NERV MENT DIS, V179, P181, DOI 10.1097/00005053-199104000-00001; Engen Robert, 2008, CANADIAN MILITARY J, V9, P120; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferguson CJ, 2012, AGGRESS VIOLENT BEH, V17, P220, DOI 10.1016/j.avb.2012.02.007; Ferguson CJ, 2010, REV GEN PSYCHOL, V14, P68, DOI 10.1037/a0018941; Ferguson CJ, 2009, AGGRESS VIOLENT BEH, V14, P286, DOI 10.1016/j.avb.2009.03.005; Foa EB, 2000, J TRAUMA STRESS, V13, P181, DOI 10.1023/A:1007781909213; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FONTANA A, 1994, J NERV MENT DIS, V182, P677, DOI 10.1097/00005053-199412000-00001; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Friedmann MJ, 1994, PSYCHIAT CLIN N AM, V17, P13; Grossman David, 2009, KILLING PSYCHOL COST; Haney C, 1998, AM PSYCHOL, V53, P709, DOI 10.1037/0003-066X.53.7.709; Hannig N, 2006, WAS GILT DENN UNSERL; Hawley PH, 2003, MERRILL PALMER QUART, V49, P239, DOI 10.1353/mpq.2003.0012; HERRMANN N, 1994, AM J GERIAT PSYCHIAT, V2, P324, DOI 10.1097/00019442-199402040-00007; Holmes Richard, 1985, ACTS WAR BEHAV MEN B; Hunt N, 2001, AGING MENT HEALTH, V5, P183, DOI 10.1080/13607860120038393; KAUP BA, 1994, AM J GERIAT PSYCHIAT, V2, P239, DOI 10.1097/00019442-199400230-00008; Kolassa IT, 2010, PSYCHOL TRAUMA-US, V2, P169, DOI 10.1037/a0019362; Linne G, 2000, ENZYKLOPADISCHE BIBL, V3; Macnair R. M., 2002, PERPETRATION INDUCED; Maercker A, 2008, NERVENARZT, V79, P577, DOI 10.1007/s00115-008-2467-5; Mantell DM, 1972, FAMILIE AGGRESSION; Neitzel S, 2011, SOLDIERS PROTOCOLS F; Nell V, 2006, BEHAV BRAIN SCI, V29, P211, DOI 10.1017/S0140525X06009058; Neuner F, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-34; Nolting HP, 2004, PSYCHOL POLITISCHER; Op den Velde W, 1993, PTSD DUTCH RESISTANC; Peters UH., 2007, LEXIKON PSYCHIAT PSY; Prigerson HG, 2001, J NERV MENT DIS, V189, P99, DOI 10.1097/00005053-200102000-00005; Rauch SAM, 2009, J TRAUMA STRESS, V22, P60, DOI 10.1002/jts.20380; Schauer M., 2003, EUROPEAN SOC TRAUMAT, V10, P5; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Smith P., 2007, AGGRESSION ADAPTATIO, P65; Sommerville D., 2008, COMPLETE ILLUSTRATED; Thompson WW, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-19; Vitiello B, 1997, J AM ACAD CHILD PSY, V36, P307, DOI 10.1097/00004583-199703000-00008; Weierstall R, 2012, INTERVENTIONEN BEI G; Weierstall R, 2012, BMC PSYCHIA IN PRESS; Weierstall R, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.8430; Wrangham Richard, 1996, DEMONIC MALES APES O	59	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50891	10.1371/journal.pone.0050891	http://dx.doi.org/10.1371/journal.pone.0050891			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251398	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200044
J	Che-Castaldo, JP; Neel, MC				Che-Castaldo, Judy P.; Neel, Maile C.			Testing Surrogacy Assumptions: Can Threatened and Endangered Plants Be Grouped by Biological Similarity and Abundances?	PLOS ONE			English	Article							REGRESSION TREES; SPECIES RICHNESS; LIFE-HISTORY; CONSERVATION; EXTINCTION; BIRDS; BIODIVERSITY; CLASSIFICATION; COMPLEMENTARITY; INDICATORS	There is renewed interest in implementing surrogate species approaches in conservation planning due to the large number of species in need of management but limited resources and data. One type of surrogate approach involves selection of one or a few species to represent a larger group of species requiring similar management actions, so that protection and persistence of the selected species would result in conservation of the group of species. However, among the criticisms of surrogate approaches is the need to test underlying assumptions, which remain rarely examined. In this study, we tested one of the fundamental assumptions underlying use of surrogate species in recovery planning: that there exist groups of threatened and endangered species that are sufficiently similar to warrant similar management or recovery criteria. Using a comprehensive database of all plant species listed under the U.S. Endangered Species Act and tree-based random forest analysis, we found no evidence of species groups based on a set of distributional and biological traits or by abundances and patterns of decline. Our results suggested that application of surrogate approaches for endangered species recovery would be unjustified. Thus, conservation planning focused on individual species and their patterns of decline will likely be required to recover listed species.	[Che-Castaldo, Judy P.; Neel, Maile C.] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; [Neel, Maile C.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Che-Castaldo, JP (corresponding author), Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA.	jchecastaldo@sesync.org			Strategic Environmental Research and Development Program of the US Department of Defense [SI-1475]	Strategic Environmental Research and Development Program of the US Department of Defense	Funding was provided by the Strategic Environmental Research and Development Program of the US Department of Defense (http://www.serdp.org/), project number SI-1475. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Bevill RL, 1999, CONSERV BIOL, V13, P493, DOI 10.1046/j.1523-1739.1999.97369.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brooks T, 2001, OSTRICH, P3; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Caro T, 2005, CONSERV BIOL, V19, P1821, DOI 10.1111/j.1523-1739.2005.00251.x; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; Chase MK, 2000, CONSERV BIOL, V14, P474, DOI 10.1046/j.1523-1739.2000.98312.x; Crone EE, 2011, ECOL LETT, V14, P1, DOI 10.1111/j.1461-0248.2010.01540.x; Cushman SA, 2010, CONSERV BIOL, V24, P830, DOI 10.1111/j.1523-1739.2009.01396.x; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Elphick CS, 2001, CONSERV BIOL, V15, P1285, DOI 10.1046/j.1523-1739.2001.00356.x; Faith D. P., 1996, Biodiversity Letters, V3, P18, DOI 10.2307/2999706; Favreau JM, 2006, BIODIVERS CONSERV, V15, P3949, DOI 10.1007/s10531-005-2631-1; Fenneman N.M., 1946, PHYSIOGRAPHIC DIVISI; Flather CH, 2011, TRENDS ECOL EVOL, V26, P307, DOI 10.1016/j.tree.2011.03.001; Fleishman E, 2001, ECOL APPL, V11, P1489, DOI 10.1890/1051-0761(2001)011[1489:EVOAMF]2.0.CO;2; GASTON KJ, 1995, PHILOS T R SOC B, V347, P205, DOI 10.1098/rstb.1995.0022; Gladstone W, 2002, BIOL CONSERV, V104, P211, DOI 10.1016/S0006-3207(01)00167-7; Inhaber H., 1976, ENV INDICES; Kesler DC, 2007, BIOL CONSERV, V136, P520, DOI 10.1016/j.biocon.2006.12.023; Lambeck RJ, 1997, CONSERV BIOL, V11, P849, DOI 10.1046/j.1523-1739.1997.96319.x; LANDRES PB, 1988, CONSERV BIOL, V2, P316, DOI 10.1111/j.1523-1739.1988.tb00195.x; Leidner AK, 2011, CONSERV BIOL, V25, P716, DOI 10.1111/j.1523-1739.2011.01689.x; Lewandowski AS, 2010, CONSERV BIOL, V24, P1367, DOI 10.1111/j.1523-1739.2010.01513.x; Lindenmayer DB, 2011, ECOSYSTEMS, V14, P47, DOI 10.1007/s10021-010-9394-6; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; Murphy DD, 2011, CONSERV BIOL, V25, P873, DOI 10.1111/j.1523-1739.2011.01711.x; Murray BR, 2002, AUSTRAL ECOL, V27, P291, DOI 10.1046/j.1442-9993.2002.01181.x; Murray BR, 2002, EVOL ECOL RES, V4, P937; Neel MC, 2012, BIOSCIENCE, V62, P646, DOI 10.1525/bio.2012.62.7.7; Neel MC, CONSERVATIO IN PRESS; Neel MC, 2008, CONSERVATION BIOL EV, P283; Niemi GJ, 2004, ANNU REV ECOL EVOL S, V35, P89, DOI 10.1146/annurev.ecolsys.35.112202.130132; Noon Barry R., 2008, P51; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Noss RF., 1997, SCI CONSERVATION PLA; Pearman PB, 2011, BIOL CONSERV, V144, P866, DOI 10.1016/j.biocon.2010.11.020; R Development Core Team, 2012, LANG ENV STAT COMP; Reed RN, 2002, CONSERV BIOL, V16, P451, DOI 10.1046/j.1523-1739.2002.02283.x; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; SAETERSDAL M, 1993, BIOL CONSERV, V65, P121, DOI 10.1016/0006-3207(93)90441-3; SCHEMSKE DW, 1994, ECOLOGY, V75, P584, DOI 10.2307/1941718; Scott TA, 2000, ENVIRON MANAGE, V26, pS37; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; Sodhi NS, 2008, DIVERS DISTRIB, V14, P1, DOI 10.1111/j.1472-4642.2007.00398.x; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Tear TH, 2005, BIOSCIENCE, V55, P835, DOI 10.1641/0006-3568(2005)055[0835:HMIETR]2.0.CO;2; TEAR TH, 1993, SCIENCE, V262, P976, DOI 10.1126/science.262.5136.976; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; U. S. Fish & Wildlife Service, 2012, DRAFT GUID SEL SPEC; Vamosi JC, 2005, DIVERS DISTRIB, V11, P25, DOI 10.1111/j.1366-9516.2005.00119.x; Virolainen KM, 2000, P ROY SOC B-BIOL SCI, V267, P1143, DOI 10.1098/rspb.2000.1120; Wiens JA, 2008, BIOSCIENCE, V58, P241, DOI 10.1641/B580310; WILCOX B. A., 1984, NATL PARKS CONSERVAT, P18, DOI DOI 10.13140/2.1.4879.2322; Williams PH, 2000, ANIM CONSERV, V3, P249, DOI 10.1111/j.1469-1795.2000.tb00110.x; Zeigler SL, CONSERVATION B UNPUB	65	7	7	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51659	10.1371/journal.pone.0051659	http://dx.doi.org/10.1371/journal.pone.0051659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240051	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800087
J	Dong, YY; Wang, JX; Fu, HH; Zhou, GQ; Shi, MM; Gao, HC				Dong, Yangyang; Wang, Jixuan; Fu, Huihui; Zhou, Guangqi; Shi, Miaomiao; Gao, Haichun			A Crp-Dependent Two-Component System Regulates Nitrate and Nitrite Respiration in Shewanella oneidensis	PLOS ONE			English	Article							REDUCTASE OPERON EXPRESSION; ESCHERICHIA-COLI K-12; ANAEROBIC RESPIRATION; FNR PROTEIN; NARX; PROMOTERS; TRANSPORT; NRFA; IDENTIFICATION; REASSESSMENT	We have previously illustrated the nitrate/nitrite respiratory pathway of Shewanella oneidensis, which is renowned for its remarkable versatility in respiration. Here we investigated the systems regulating the pathway with a reliable approach which enables characterization of mutants impaired in nitrate/nitrite respiration by guaranteeing biomass. The S. oneidensis genome encodes an Escherichia coli NarQ/NarX homolog SO3981 and two E. coli NarP/NarL homologs SO1860 and SO3982. Results of physiological characterization and mutational analyses demonstrated that S. oneidensis possesses a single two-component system (TCS) for regulation of nitrate/nitrite respiration, consisting of the sensor kinase SO3981(NarQ) and the response regulator SO3982(NarP). The TCS directly controls the transcription of nap and nrfA (genes encoding nitrate and nitrite reductases, respectively) but regulates the former less tightly than the latter. Additionally, phosphorylation at residue 57 of SO3982 is essential for its DNA-binding capacity. At the global control level, Crp is found to regulate expression of narQP as well as nap and nrfA. In contrast to NarP-NarQ, Crp is more essential for nap rather than nrfA.	[Gao, Haichun] Zhejiang Univ, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Gao, HC (corresponding author), Zhejiang Univ, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	haichung@zju.edu.cn	Gao, Haichun/AFU-4588-2022; Gao, Haichun/A-2160-2014	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563	Major State Basic Research Development Program (973 Program) [2010CB833803]; National Natural Science Foundation of China [30870032]; Natural Science Foundation of Zhejiang province [R3110096]; Major Program of Science and Technology Department of Zhejiang [2009C12061]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province); Major Program of Science and Technology Department of Zhejiang	This research was supported by Major State Basic Research Development Program (973 Program: 2010CB833803), National Natural Science Foundation of China (30870032), Natural Science Foundation of Zhejiang province (R3110096), and Major Program of Science and Technology Department of Zhejiang (2009C12061) to HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraquet C, 2009, MOL MICROBIOL, V73, P278, DOI 10.1111/j.1365-2958.2009.06770.x; Binnenkade L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023440; Browning DF, 2004, MOL MICROBIOL, V53, P203, DOI 10.1111/j.1365-2958.2004.04104.x; Browning DF, 2002, MOL MICROBIOL, V43, P687, DOI 10.1046/j.1365-2958.2002.02776.x; Charania MA, 2009, J BACTERIOL, V191, P4298, DOI 10.1128/JB.01829-08; Chen Y, 2011, ISME J, V5, P843, DOI 10.1038/ismej.2010.182; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Crack J, 2004, J BIOL CHEM, V279, P9278, DOI 10.1074/jbc.M309878200; Cruz-Garcia C, 2007, J BACTERIOL, V189, P656, DOI 10.1128/JB.01194-06; Cruz-Garcia C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-64; Darwin AJ, 1998, J BACTERIOL, V180, P4192, DOI 10.1128/JB.180.16.4192-4198.1998; DARWIN AJ, 1995, J BACTERIOL, V177, P3865, DOI 10.1128/jb.177.13.3865-3869.1995; Elias DA, 2008, ARCH MICROBIOL, V189, P313, DOI 10.1007/s00203-007-0321-y; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao HC, 2009, ISME J, V3, P966, DOI 10.1038/ismej.2009.40; Gao HC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002983; Gon S, 2002, J BACTERIOL, V184, P1262, DOI 10.1128/JB.184.5.1262-1269.2002; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Gralnick JA, 2005, MOL MICROBIOL, V56, P1347, DOI 10.1111/j.1365-2958.2005.04628.x; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Jepson BJN, 2006, BIOCHEM SOC T, V34, P122, DOI 10.1042/BST0340122; Lamberg KE, 2000, MOL MICROBIOL, V38, P817, DOI 10.1046/j.1365-2958.2000.02172.x; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Liang YL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015295, 10.1371/journal.pone.0012860]; Maier TM, 2003, J BASIC MICROB, V43, P312, DOI 10.1002/jobm.200390034; Maier TM, 2001, J BACTERIOL, V183, P4918, DOI 10.1128/JB.183.16.4918-4926.2001; Melville SB, 1996, P NATL ACAD SCI USA, V93, P1226, DOI 10.1073/pnas.93.3.1226; Miller JH., 1972, EXPT MOL GENETICS; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Noriega CE, 2010, MOL MICROBIOL, V75, P394, DOI 10.1111/j.1365-2958.2009.06987.x; RABIN RS, 1992, P NATL ACAD SCI USA, V89, P8419, DOI 10.1073/pnas.89.18.8419; Rowe JL, 2005, J BACTERIOL, V187, P6317, DOI 10.1128/JB.187.18.6317-6323.2005; Saffarini DA, 2003, J BACTERIOL, V185, P3668, DOI 10.1128/JB.185.12.3668-3671.2003; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Simon J, 2001, EUR J BIOCHEM, V268, P5776, DOI 10.1046/j.0014-2956.2001.02520.x; Simpson PJL, 2010, MICROBIOL-SGM, V156, P302, DOI 10.1099/mic.0.034421-0; Stewart V, 2003, J BACTERIOL, V185, P5862, DOI 10.1128/JB.185.19.5862-5870.2003; Stewart V, 2003, BIOCHEM SOC T, V31, P1; Stewart V, 2009, J BACTERIOL, V191, P996, DOI 10.1128/JB.00873-08; TRAGESER M, 1990, MOL MICROBIOL, V4, P21, DOI 10.1111/j.1365-2958.1990.tb02011.x; TuAnh NH, 2010, P NATL ACAD SCI USA, V107, P21140, DOI 10.1073/pnas.1013081107; Wang HN, 2000, J BACTERIOL, V182, P5813, DOI 10.1128/JB.182.20.5813-5822.2000; Wu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021479; Yuan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023701	46	11	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51643	10.1371/journal.pone.0051643	http://dx.doi.org/10.1371/journal.pone.0051643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240049	gold, Green Published, Green Submitted			2022-12-27	WOS:000312290800085
J	Domaica, CI; Fuertes, MB; Uriarte, I; Girart, MV; Sardanons, J; Comas, DI; Di Giovanni, D; Gaillard, MI; Bezrodnik, L; Zwirner, NW				Ines Domaica, Carolina; Beatriz Fuertes, Mercedes; Uriarte, Ignacio; Victoria Girart, Maria; Sardanons, Jessica; Ileana Comas, Dorina; Di Giovanni, Daniela; Isabel Gaillard, Maria; Bezrodnik, Liliana; Walter Zwirner, Norberto			Human Natural Killer Cell Maturation Defect Supports In Vivo CD56(bright) to CD56(dim) Lineage Development	PLOS ONE			English	Article							HUMAN NK CELLS; DENDRITIC CELLS; ADAPTIVE IMMUNITY; L-SELECTIN; DIFFERENTIATION; SUBSET; DEFICIENCY; ACTIVATION; EXPRESSION; INNATE	Two populations of human natural killer (NK) cells can be identified in peripheral blood. The majority are CD3(-)CD56(dim) cells while the minority exhibits a CD3(-)CD56(bright) phenotype. In vitro evidence indicates that CD56(bright) cells are precursors of CD56(dim) cells, but in vivo evidence is lacking. Here, we studied NK cells from a patient that suffered from a melanoma and opportunistic fungal infection during childhood. The patient exhibited a stable phenotype characterized by a reduction in the frequency of peripheral blood CD3(-)CD56(dim) NK cells, accompanied by an overt increase in the frequency and absolute number of CD3(-)CD56(bright) cells. These NK cells exhibited similar expression of perforin, CD57 and CD158, the major activating receptors CD16, NKp46, NKG2D, DNAM-1, and 2B4, as well as the inhibitory receptor CD94/NKG2A, on both CD56(bright) and CD56(dim) NK cells as healthy controls. Also, both NK cell subpopulations produced IFN-gamma upon stimulation with cytokines, and CD3(-)CD56(dim) NK cells degranulated in response to cytokines or K562 cells. However, upon stimulation with cytokines, a substantial fraction of CD56(dim) cells failed to up-regulate CD57 and CD158, showed a reduction in the percentage of CD16(+) cells, and CD56(bright) cells did not down-regulate CD62L, suggesting that CD56(dim) cells could not acquire a terminally differentiated phenotype and that CD56(bright) cells exhibit a maturation defect that might result in a potential altered migration pattern. These observations, support the notion that NK cells of this patient display a maturation/activation defect that precludes the generation of mature NK cells at a normal rate accompanied by CD56(dim) NK cells that cannot completely acquire a terminally differentiated phenotype. Thus, our results provide evidence that support the concept that in vivo CD56(bright) NK cells differentiate into CD56(dim) NK cells, and contribute to further understand human NK cell ontogeny.	[Ines Domaica, Carolina; Beatriz Fuertes, Mercedes; Victoria Girart, Maria; Walter Zwirner, Norberto] Consejo Nacl Invest Cient & Tecn CONICET, Lab Fisiopatol Inmunidad Innata, Inst Biol & Med Expt IBYME, Buenos Aires, DF, Argentina; [Beatriz Fuertes, Mercedes] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, RA-1428 Buenos Aires, DF, Argentina; [Uriarte, Ignacio; Sardanons, Jessica; Ileana Comas, Dorina; Di Giovanni, Daniela; Isabel Gaillard, Maria; Bezrodnik, Liliana] Hosp Ninos Dr Ricardo Gutierrez, Unidad Inmunol, Buenos Aires, DF, Argentina; [Walter Zwirner, Norberto] Univ Buenos Aires, Fac Med, Dept Microbiol Parasitol & Inmunol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; University of Buenos Aires	Zwirner, NW (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Lab Fisiopatol Inmunidad Innata, Inst Biol & Med Expt IBYME, Buenos Aires, DF, Argentina.	nzwirner@ibyme.conicet.gov.ar	Zwirner, Norberto/AAI-8961-2020; Comas, David/D-5382-2014	Comas, David/0000-0002-5075-0956; Domaica, Carolina Ines/0000-0001-9596-4889; Fuertes, Mercedes Beatriz/0000-0002-2734-1468; Zwirner, Norberto/0000-0001-7098-359X	National Agency for Promotion of Science and Technology from Argentina (ANPCYT); University of Buenos Aires (UBA); Bunge & Born Foundation	National Agency for Promotion of Science and Technology from Argentina (ANPCYT); University of Buenos Aires (UBA)(University of Buenos Aires); Bunge & Born Foundation	This work was supported by grants from the National Agency for Promotion of Science and Technology from Argentina (ANPCYT) and the University of Buenos Aires (UBA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C.I.D. was a postdoctoral fellow of CONICET and currently holds a postdoctoral fellowship of the Bunge & Born Foundation. M. B. F., L. B. and N.W.Z. are members of the Researcher Career of CONICET.	Allan DSJ, 2010, EUR J IMMUNOL, V40, P2289, DOI 10.1002/eji.200939910; Barcelos W, 2008, SCAND J IMMUNOL, V68, P92, DOI 10.1111/j.1365-3083.2008.02116.x; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; Beziat V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011966; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Chan A, 2007, J IMMUNOL, V179, P89, DOI 10.4049/jimmunol.179.1.89; De Maria A, 2011, P NATL ACAD SCI USA, V108, P728, DOI 10.1073/pnas.1012356108; Dulphy N, 2008, J IMMUNOL, V181, P2227, DOI 10.4049/jimmunol.181.3.2227; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Frey M, 1998, J IMMUNOL, V161, P400; Gineau L, 2012, J CLIN INVEST, V122, P821, DOI 10.1172/JCI61014; Hughes CR, 2012, J CLIN INVEST, V122, P814, DOI 10.1172/JCI60224; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Li ZQ, 2005, J IMMUNOL, V174, P5187, DOI 10.4049/jimmunol.174.9.5187; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Moldovan I, 1999, IMMUNOL LETT, V68, P125, DOI 10.1016/S0165-2478(99)00041-3; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Orange JS, 2006, CURR OPIN ALLERGY CL, V6, P399, DOI 10.1097/ACI.0b013e3280106b65; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Strowig T, 2008, J IMMUNOL, V180, P7785, DOI 10.4049/jimmunol.180.12.7785; Sun JC, 2011, J IMMUNOL, V186, P1891, DOI 10.4049/jimmunol.1003035; Villa-Forte A, 2008, ARTHRITIS RHEUM-US, V58, P2579, DOI 10.1002/art.23675; Vitale C, 2005, MOL IMMUNOL, V42, P405, DOI 10.1016/j.molimm.2004.07.019; Vitale M, 2004, EUR J IMMUNOL, V34, P1715, DOI 10.1002/eji.200425100; Warren HS, 1996, J IMMUNOL, V156, P3254; Zimmer J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001033; Zwirner NW, 2010, BIOFACTORS, V36, P274, DOI 10.1002/biof.107	35	19	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51677	10.1371/journal.pone.0051677	http://dx.doi.org/10.1371/journal.pone.0051677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240056	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800092
J	Robles, VM; Marechal, JD; Bahloul, A; Sari, MA; Mahy, JP; Golinelli-Pimpaneau, B				Munoz Robles, Victor; Marechal, Jean-Didier; Bahloul, Amel; Sari, Marie-Agnes; Mahy, Jean-Pierre; Golinelli-Pimpaneau, Beatrice			Crystal Structure of Two Anti-Porphyrin Antibodies with Peroxidase Activity	PLOS ONE			English	Article							OBTAINING ARTIFICIAL HEMOPROTEINS; X-RAY STRUCTURES; CATALYTIC ANTIBODIES; 3-DIMENSIONAL STRUCTURES; IRON PORPHYRINS; PEPTIDE-EPITOPE; METAL-ION; COMPLEXES; AFFINITY; HEMOABZYMES	We report the crystal structures at 2.05 and 2.45 angstrom resolution of two antibodies, 13G10 and 14H7, directed against an iron(III)-alpha alpha alpha beta-carboxyphenylporphyrin, which display some peroxidase activity. Although these two antibodies differ by only one amino acid in their variable lambda-light chain and display 86% sequence identity in their variable heavy chain, their complementary determining regions (CDR) CDRH1 and CDRH3 adopt very different conformations. The presence of Met or Leu residues at positions preceding residue H101 in CDRH3 in 13G10 and 14H7, respectively, yields to shallow combining sites pockets with different shapes that are mainly hydrophobic. The hapten and other carboxyphenyl-derivatized iron(III)-porphyrins have been modeled in the active sites of both antibodies using protein ligand docking with the program GOLD. The hapten is maintained in the antibody pockets of 13G10 and 14H7 by a strong network of hydrogen bonds with two or three carboxylates of the carboxyphenyl substituents of the porphyrin, respectively, as well as numerous stacking and van der Waals interactions with the very hydrophobic CDRH3. However, no amino acid residue was found to chelate the iron. Modeling also allows us to rationalize the recognition of alternative porphyrinic cofactors by the 13G10 and 14H7 antibodies and the effect of imidazole binding on the peroxidase activity of the 13G10/porphyrin complexes. Citation: Munoz Robles V, Marechal J-D, Bahloul A, Sari M-A, Mahy J-P, et al. (2012) Crystal Structure of Two Anti-Porphyrin Antibodies with Peroxidase Activity. PLoS ONE 7(12): e51128. doi:10.1371/journal.pone.0051128	[Munoz Robles, Victor; Marechal, Jean-Didier] Univ Autonoma Barcelona, Dept Quim, E-08193 Barcelona, Spain; [Bahloul, Amel; Golinelli-Pimpaneau, Beatrice] Ctr Rech Gif, CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France; [Sari, Marie-Agnes] Univ Paris 05, CNRS, Lab Chim & Biochim Pharmacol & Toxicol, Paris, France; [Mahy, Jean-Pierre] Univ Paris 11, CNRS, Inst Chim Mol & Mat Orsay, Lab Chim Biorgan & Bioinorgan, F-91405 Orsay, France	Autonomous University of Barcelona; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Golinelli-Pimpaneau, B (corresponding author), Coll France, CNRS, Lab Chim Proc Biol, F-75231 Paris, France.	beatrice.golinelli@college-de-france.fr	Maréchal, Jean-Didier P/A-8936-2012; Golinelli, Beatrice/ABB-8347-2021; Muñoz Robles, Victor/K-3004-2012; Mahy, Jean-Pierre/AAQ-3621-2020	Maréchal, Jean-Didier P/0000-0002-8344-9043; Golinelli, Beatrice/0000-0001-8248-4704; Mahy, Jean-Pierre/0000-0001-6502-7923; BAHLOUL, Amel/0000-0001-7042-4616	Centre National de la Recherche Scientifique (Programme Physique et Chimie du Vivant); Spanish "Ministerio de Ciencia e Innovacion" [CTQ2008-06866-C02-01]; Generalitat de Catalunya [2009SGR68]	Centre National de la Recherche Scientifique (Programme Physique et Chimie du Vivant); Spanish "Ministerio de Ciencia e Innovacion"(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	Financial support was provided to B.G.-P. and J.-P.M. by the Centre National de la Recherche Scientifique (Programme Physique et Chimie du Vivant) and to J.-D.M. and V. M. by the Spanish "Ministerio de Ciencia e Innovacion" through projects CTQ2008-06866-C02-01 and consolider- ingenio 2010 and by the Generalitat de Catalunya through project 2009SGR68. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BRITTON D, 1972, ACTA CRYSTALL A-CRYS, V28, P296, DOI 10.1107/S0567739472000786; Chang S, 2005, MOL IMMUNOL, V42, P1293, DOI 10.1016/j.molimm.2004.12.008; Charbonnier JB, 1997, BIOCHIMIE, V79, P653, DOI 10.1016/S0300-9084(97)83498-0; COCHRAN AG, 1990, SCIENCE, V249, P781, DOI 10.1126/science.2389144; COCHRAN AG, 1990, J AM CHEM SOC, V112, P9414, DOI 10.1021/ja00181a065; Corneillie TM, 2003, J AM CHEM SOC, V125, P15039, DOI 10.1021/ja037236y; CYGLER M, 1991, SCIENCE, V253, P442, DOI 10.1126/science.1713710; De Lauzon S, 1998, EUR J BIOCHEM, V257, P121, DOI 10.1046/j.1432-1327.1998.2570121.x; de Lauzon S, 1999, FEBS LETT, V443, P229, DOI 10.1016/S0014-5793(98)01703-7; de Lauzon S, 2002, EUR J BIOCHEM, V269, P470, DOI 10.1046/j.0014-2956.2001.02670.x; Debler EW, 2007, J MOL BIOL, V368, P1392, DOI 10.1016/j.jmb.2007.02.081; DEMONTELLANO PRO, 1992, ANNU REV PHARMACOL, V32, P89, DOI 10.1146/annurev.pharmtox.32.1.89; Dokurno P, 1998, J MOL BIOL, V284, P713, DOI 10.1006/jmbi.1998.2209; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Eigenbrot C, 2003, J MOL BIOL, V331, P433, DOI 10.1016/S0022-2836(03)00735-6; EISEN HN, 1985, ANNU REV IMMUNOL, V3, P337, DOI 10.1146/annurev.iy.03.040185.002005; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; FENG Y, 1995, ANN NY ACAD SCI, V750, P271, DOI 10.1111/j.1749-6632.1995.tb19964.x; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; Ganesh K, 2011, FASEB J, V25, P1123, DOI 10.1096/fj.11-0402ufm; Golinelli-Pimpaneau B, 2000, P NATL ACAD SCI USA, V97, P9892, DOI 10.1073/pnas.97.18.9892; Golinelli-Pimpaneau B, 2005, ACTA CRYSTALLOGR D, V61, P472, DOI 10.1107/S0907444905003331; Golinelli-Pimpaneau B, 2002, J IMMUNOL METHODS, V269, P157, DOI 10.1016/S0022-1759(02)00240-5; Golinelli-Pimpaneau B, 2000, CURR OPIN STRUC BIOL, V10, P697, DOI 10.1016/S0959-440X(00)00157-3; Golinelli-Pimpaneau B, 2006, J BIOL CHEM, V281, P23969, DOI 10.1074/jbc.M602184200; Goswami RK, 2009, BIOORG MED CHEM LETT, V19, P3821, DOI 10.1016/j.bmcl.2009.04.041; Guddat LW, 2000, J MOL BIOL, V302, P853, DOI 10.1006/jmbi.2000.4083; GUDDAT LW, 1994, J MOL BIOL, V236, P247, DOI 10.1006/jmbi.1994.1133; Hamdane D, 2009, ACTA CRYSTALLOGR D, V65, P388, DOI 10.1107/S0907444909003382; Harada A, 1997, INORG CHEM, V36, P6099, DOI 10.1021/ic9610849; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Hart-Davis J, 1998, J AM CHEM SOC, V120, P12524, DOI 10.1021/ja981805y; HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI [10.1063/1.448975, 10.1063/1.448800, 10.1063/1.448799]; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; Hosomi N, 2005, J BIOSCI BIOENG, V99, P222, DOI 10.1263/jbb.99.222; HsiehWilson LC, 1996, P NATL ACAD SCI USA, V93, P5363, DOI 10.1073/pnas.93.11.5363; JONES ST, 1991, BIO-TECHNOL, V9, P579; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabat EA, 1991, SEQUENCES PROTEINS I; KawamuraKonishi Y, 1996, J BIOCHEM-TOKYO, V119, P857; Khan T, 2012, J IMMUNOL, V188, P1819, DOI 10.4049/jimmunol.1102701; Kohda K, 1997, FEBS LETT, V407, P280, DOI 10.1016/S0014-5793(97)00338-4; Larsen NA, 2002, ACTA CRYSTALLOGR D, V58, P2055, DOI 10.1107/S0907444902017420; Larsen NA, 2004, BIOCHEMISTRY-US, V43, P8067, DOI 10.1021/bi049495l; Le KHD, 2010, J MOL BIOL, V400, P518, DOI 10.1016/j.jmb.2010.05.035; Le Minoux D, 2012, MOL IMMUNOL, V50, P160, DOI 10.1016/j.molimm.2012.01.004; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee JE, 2008, J MOL BIOL, V375, P202, DOI 10.1016/j.jmb.2007.10.017; LOVE RA, 1993, BIOCHEMISTRY-US, V32, P10950, DOI 10.1021/bi00092a004; Mahy JP, 2009, BIOCHIMIE, V91, P1321, DOI 10.1016/j.biochi.2009.03.002; Mahy JP, 1998, APPL BIOCHEM BIOTECH, V75, P103, DOI 10.1007/BF02787712; Mansuy D., 1994, CYTOCHROME P450 MODE, P99; Marnett Lawrence J., 1995, P49; MILLETT F, 1995, J BIOENERG BIOMEMBR, V27, P341, DOI 10.1007/BF02110103; MIZUTANI R, 1995, J MOL BIOL, V254, P208, DOI 10.1006/jmbi.1995.0612; Monnet C, 2002, J MOL BIOL, V315, P699, DOI 10.1006/jmbi.2001.5284; Robles VM, 2011, FARADAY DISCUSS, V148, P137, DOI 10.1039/c004578k; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nimri S, 1999, J AM CHEM SOC, V121, P8978, DOI 10.1021/ja990314q; Nogi T, 2008, PROTEIN SCI, V17, P2120, DOI 10.1110/ps.038299.108; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quilez R, 1996, FEBS LETT, V395, P73, DOI 10.1016/0014-5793(96)01006-X; Ricoux R, 2004, EUR J BIOCHEM, V271, P1277, DOI 10.1111/j.1432-1033.2004.04032.x; Ricoux R, 2002, J PROTEIN CHEM, V21, P473, DOI 10.1023/A:1021351120772; Ricoux R, 2002, J IMMUNOL METHODS, V269, P39, DOI 10.1016/S0022-1759(02)00223-5; Ricoux R, 2008, BIOCONJUGATE CHEM, V19, P899, DOI 10.1021/bc700435a; Rietjens IMCM, 1996, J BIOL INORG CHEM, V1, P372, DOI 10.1007/s007750050068; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Romesberg FE, 1998, BIOCHEMISTRY-US, V37, P14404, DOI 10.1021/bi981578c; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAVITSKY AP, 1994, APPL BIOCHEM BIOTECH, V47, P317, DOI 10.1007/BF02787943; SCHAEFER WH, 1985, BIOCHEMISTRY-US, V24, P3254, DOI 10.1021/bi00334a027; Seebeck B, 2008, PROTEINS, V71, P1237, DOI 10.1002/prot.21818; Shinde S, 2012, J BIOL INORG CHEM, V17, P557, DOI 10.1007/s00775-012-0876-1; Smith LJ, 2010, PROTEINS, V78, P2349, DOI 10.1002/prot.22747; Stevenson JD, 2000, NAT PROD REP, V17, P535, DOI 10.1039/b006389o; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Sundaramoorthy M, 1995, STRUCTURE, V3, P1367, DOI 10.1016/S0969-2126(01)00274-X; TAKAGI M, 1995, FEBS LETT, V375, P273, DOI 10.1016/0014-5793(95)01224-3; Tanaka F, 2002, J IMMUNOL METHODS, V269, P67, DOI 10.1016/S0022-1759(02)00225-9; Thayer MM, 1999, J MOL BIOL, V291, P329, DOI 10.1006/jmbi.1999.2960; WAGNER J, 1995, SCIENCE, V270, P1797, DOI 10.1126/science.270.5243.1797; Wentworth P, 2001, CELL BIOCHEM BIOPHYS, V35, P63, DOI 10.1385/CBB:35:1:63; Xu Y, 2004, BIOORGAN MED CHEM, V12, P5247, DOI 10.1016/j.bmc.2004.03.077; Yin J, 2004, J AM CHEM SOC, V126, P3006, DOI 10.1021/ja039198o; Yin J, 2003, P NATL ACAD SCI USA, V100, P856, DOI 10.1073/pnas.0235873100; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Yin J, 2001, BIOCHEMISTRY-US, V40, P10764, DOI 10.1021/bi010536c; Yuhasz SC, 1995, MOL IMMUNOL, V32, P1143, DOI 10.1016/0161-5890(95)00063-1; Zahnd C, 2004, J BIOL CHEM, V279, P18870, DOI 10.1074/jbc.M309169200	99	9	9	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51128	10.1371/journal.pone.0051128	http://dx.doi.org/10.1371/journal.pone.0051128			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240001	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800037
J	Traby, L; Kollars, M; Eischer, L; Eichinger, S; Kyrle, PA				Traby, Ludwig; Kollars, Marietta; Eischer, Lisbeth; Eichinger, Sabine; Kyrle, Paul A.			Prediction of Recurrent Venous Thromboembolism by Clot Lysis Time: A Prospective Cohort Study	PLOS ONE			English	Article							RISK; THROMBOSIS; HYPOFIBRINOLYSIS	Venous thromboembolism (VTE) is a chronic disease, which tends to recur. Whether an abnormal fibrinolytic system is associated with an increased risk of VTE is unclear. We assessed the relationship between fibrinolytic capacity (reflected by clot lysis time [CLT]) and risk of recurrent VTE. We followed 704 patients (378 women; mean age 48 yrs) with a first unprovoked VTE for an average of 46 months after anticoagulation withdrawal. Patients with natural coagulation inhibitor deficiency, lupus anticoagulant, cancer, homozygosity for factor V Leiden or prothrombin mutation, or requirement for indefinite anticoagulation were excluded. Study endpoint was symptomatic recurrent VTE. For measurement of CLT, a tissue factor-induced clot was lysed by adding tissue-type plasminogen activator. Time between clot formation and lysis was determined by measuring the turbidity. 135 (19%) patients had recurrent VTE. For each increase in CLT of 10 minutes, the crude relative risk (RR) of recurrence was 1.13 (95% CI 1.02-1.25; p = 0.02) and was 1.08 (95% CI 0.98-1.20; p = 0.13) after adjustment for age and sex. For women only, the adjusted RR was 1.14 (95% CI, 0.91-1.42, p = 0.22) for each increase in CLT of 10 minutes. CLT values in the 4th quartile of the female patient population, as compared to values in the 1st quartile, conferred a risk of recurrence of 3.28 (95% CI, 1.07-10.05; p = 0.04). No association between CLT and recurrence risk was found in men. Hypofibrinolysis as assessed by CLT confers a moderate increase in the risk of recurrent VTE. A weak association between CLT and risk of recurrence was found in women only.	[Traby, Ludwig; Kollars, Marietta; Eischer, Lisbeth; Eichinger, Sabine; Kyrle, Paul A.] Med Univ Vienna, Dept Med 1, Vienna, Austria; [Eichinger, Sabine; Kyrle, Paul A.] Karl Landsteiner Inst Clin Thrombosis Res, Vienna, Austria	Medical University of Vienna	Kyrle, PA (corresponding author), Med Univ Vienna, Dept Med 1, Vienna, Austria.	paul.kyrle@meduniwien.ac.at	Traby, Ludwig/ABC-2338-2020	Traby, Ludwig/0000-0003-2861-5771	Osterreichische Nationalbank; Medizinisch-Wissenschaftlicher Fonds des Burgermeisters der Bundeshauptstadt Wien	Osterreichische Nationalbank; Medizinisch-Wissenschaftlicher Fonds des Burgermeisters der Bundeshauptstadt Wien(Austrian Science Fund (FWF))	This work was supported by grants of the Osterreichische Nationalbank and the Medizinisch-Wissenschaftlicher Fonds des Burgermeisters der Bundeshauptstadt Wien. Both institutions are non-commercial and do not have a potential competing interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; Crowther MA, 2001, THROMB HAEMOSTASIS, V85, P390; Eichinger S, 2004, BLOOD, V103, P3773, DOI 10.1182/blood-2003-10-3422; Eichinger S, 2008, CLIN CHEM, V54, P2042, DOI 10.1373/clinchem.2008.112243; Kalbfleisch J. D., 1980, WILEY SERIES PROBABI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; KORNINGER C, 1984, THROMB HAEMOSTASIS, V52, P127; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; Kyrle PA, 2010, LANCET, V376, P2032, DOI 10.1016/S0140-6736(10)60962-2; Meltzer ME, 2010, J THROMB HAEMOST, V8, P605, DOI 10.1111/j.1538-7836.2009.03715.x; Meltzer ME, 2010, BLOOD, V116, P113, DOI 10.1182/blood-2010-02-267740; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Schulman S, 1996, THROMB HAEMOSTASIS, V75, P607	14	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51447	10.1371/journal.pone.0051447	http://dx.doi.org/10.1371/journal.pone.0051447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240024	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800060
J	Papatheodorou, I; Ziehm, M; Wieser, D; Alic, N; Partridge, L; Thornton, JM				Papatheodorou, Irene; Ziehm, Matthias; Wieser, Daniela; Alic, Nazif; Partridge, Linda; Thornton, Janet M.			Using Answer Set Programming to Integrate RNA Expression with Signalling Pathway Information to Infer How Mutations Affect Ageing	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; INSULIN-RECEPTOR; REGULATORY NETWORKS; GROWTH; GENE; NORMALIZATION; MODULATORS; LONGEVITY; APOPTOSIS; SUMMARIES	A challenge of systems biology is to integrate incomplete knowledge on pathways with existing experimental data sets and relate these to measured phenotypes. Research on ageing often generates such incomplete data, creating difficulties in integrating RNA expression with information about biological processes and the phenotypes of ageing, including longevity. Here, we develop a logic-based method that employs Answer Set Programming, and use it to infer signalling effects of genetic perturbations, based on a model of the insulin signalling pathway. We apply our method to RNA expression data from Drosophila mutants in the insulin pathway that alter lifespan, in a foxo dependent fashion. We use this information to deduce how the pathway influences lifespan in the mutant animals. We also develop a method for inferring the largest common sub-paths within each of our signalling predictions. Our comparisons reveal consistent homeostatic mechanisms across both long-and short-lived mutants. The transcriptional changes observed in each mutation usually provide negative feedback to signalling predicted for that mutation. We also identify an S6K-mediated feedback in two long-lived mutants that suggests a crosstalk between these pathways in mutants of the insulin pathway, in vivo. By formulating the problem as a logic-based theory in a qualitative fashion, we are able to use the efficient search facilities of Answer Set Programming, allowing us to explore larger pathways, combine molecular changes with pathways and phenotype and infer effects on signalling in in vivo, whole-organism, mutants, where direct signalling stimulation assays are difficult to perform. Our methods are available in the web-service NetEffects: http://www.ebi.ac.uk/thornton-srv/software/NetEffects.	[Papatheodorou, Irene; Ziehm, Matthias; Wieser, Daniela; Thornton, Janet M.] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Papatheodorou, Irene; Alic, Nazif; Partridge, Linda] UCL, Inst Healthy Ageing, London, England; [Papatheodorou, Irene; Alic, Nazif; Partridge, Linda] UCL, Dept Genet Evolut & Environm, London, England; [Partridge, Linda] Max Planck Inst Biol Ageing, Cologne, Germany	European Molecular Biology Laboratory (EMBL); University of London; University College London; University of London; University College London; Max Planck Society	Papatheodorou, I (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England.	irenep@ebi.ac.uk	Partridge, Linda/E-7342-2015; Partridge, Linda/A-5501-2010; Alic, Nazif/B-4665-2009	Alic, Nazif/0000-0003-0356-6600; Thornton, Janet/0000-0003-0824-4096; Papatheodorou, Irene/0000-0001-7270-5470; Ziehm, Matthias/0000-0001-7074-4054; Partridge, Linda/0000-0001-9615-0094	EMBL-EBI, Wellcome Trust	EMBL-EBI, Wellcome Trust(Wellcome Trust)	This work was funded by EMBL-EBI (http://www.ebi.ac.uk/), Wellcome Trust Strategic Award (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.36; Alic N, 2011, AGING CELL, V10, P137, DOI 10.1111/j.1474-9726.2010.00653.x; Babur O, 2010, NUCLEIC ACIDS RES, V38, P5648, DOI 10.1093/nar/gkq287; BARAL C., 2003, KNOWLEDGE REPRESENTA; Bjedov I, 2011, BIOCHEM SOC T, V39, P460, DOI 10.1042/BST0390460; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Calzone L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000702; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Domingos P., 2006, P AAAI 06 21 NAT C A, P2; Dupont J, 2003, CELL CYCLE, V2, P270, DOI 10.4161/cc.2.4.408; Dworschak S, 2008, CONSTRAINTS, V13, P21, DOI 10.1007/s10601-007-9031-y; Fayruzov T, 2011, INT J DATA MIN BIOIN, V5, P209, DOI 10.1504/IJDMB.2011.039178; Fayruzov T, 2009, IEEE INT C BIOINFORM, P99, DOI 10.1109/BIBM.2009.9; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gebser M., 2010, 2010 Proceedings of 22nd International Conference on Tools with Artificial Intelligence (ICTAI 2010), P383, DOI 10.1109/ICTAI.2010.62; Gebser M, 2011, AI COMMUN, V24, P107, DOI 10.3233/AIC-2011-0491; Guziolowski C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-244; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Kockel L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000990; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Naldi A, 2009, BIOSYSTEMS, V97, P134, DOI 10.1016/j.biosystems.2009.04.008; Nielsen MD, 2008, AGING CELL, V7, P688, DOI 10.1111/j.1474-9726.2008.00420.x; Pezze PD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002469; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Saez-Rodriguez J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.87; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Slack C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000881; Smith G, 2010, BALLET REV, V38, P5; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Videla S, 2012, CMBS 10 COMP METH SY, V7605, P342, DOI [10.1007/978-3-642-33636-2_20, DOI 10.1007/978-3-642-33636-2_20]; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Werz C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000596; Wieser D, 2011, PHILOS T R SOC B, V366, P51, DOI 10.1098/rstb.2010.0286; Wittwer F, 2005, DEV CELL, V8, P817, DOI 10.1016/j.devcel.2005.04.002	52	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50881	10.1371/journal.pone.0050881	http://dx.doi.org/10.1371/journal.pone.0050881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251396	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900024
J	Acosta, C; McMullan, S; Djouhri, L; Gao, LL; Watkins, R; Berry, C; Dempsey, K; Lawson, SN				Acosta, Cristian; McMullan, Simon; Djouhri, Laiche; Gao, Linlin; Watkins, Roger; Berry, Carol; Dempsey, Katherine; Lawson, Sally N.			HCN1 and HCN2 in Rat DRG Neurons: Levels in Nociceptors and Non-Nociceptors, NT3-Dependence and Influence of CFA-Induced Skin Inflammation on HCN2 and NT3 Expression	PLOS ONE			English	Article							ROOT GANGLION NEURONS; ACTIVATED PACEMAKER CHANNELS; PRIMARY AFFERENT NEURONS; PRIMARY SENSORY NEURONS; NUCLEOTIDE-GATED CHANNELS; MESSENGER-RNA EXPRESSION; MUSCLE-SPINDLE AFFERENTS; ACTION-POTENTIAL SHAPE; C-FIBER NOCICEPTORS; GUINEA-PIG	I-h, which influences neuronal excitability, has recently been measured in vivo in sensory neuron subtypes in dorsal root ganglia (DRGs). However, expression levels of HCN (hyperpolarization-activated cyclic nucleotide-gated) channel proteins that underlie I-h were unknown. We therefore examined immunostaining of the most abundant isoforms in DRGs, HCN1 and HCN2 in these neuron subtypes. This immunostaining was cytoplasmic and membrane-associated (ring). Ring-staining for both isoforms was in neurofilament-rich A-fiber neurons, but not in small neurofilament-poor C-fiber neurons, although some C-neurons showed cytoplasmic HCN2 staining. We recorded intracellularly from DRG neurons in vivo, determined their sensory properties (nociceptive or low-threshold-mechanoreceptive, LTM) and conduction velocities (CVs). We then injected fluorescent dye enabling subsequent immunostaining. For each dye-injected neuron, ring- and cytoplasmic-immunointensities were determined relative to maximum ring-immunointensity. Both HCN1- and HCN2-ring-immuno-intensities were positively correlated with CV in both nociceptors and LTMs; they were high in A beta-nociceptors and A alpha/beta-LTMs. High HCN1 and HCN2 levels in A alpha/beta-neurons may, via I-h, influence normal non-painful (e. g. touch and proprioceptive) sensations as well as nociception and pain. HCN2-, not HCN1-, ring-intensities were higher in muscle spindle afferents (MSAs) than in all other neurons. The previously reported very high I-h in MSAs may relate to their very high HCN2. In normal C-nociceptors, low HCN1 and HCN2 were consistent with their low/undetectable I-h. In some C-LTMs HCN2-intensities were higher than in C-nociceptors. Together, HCN1 and HCN2 expressions reflect previously reported I-h magnitudes and properties in neuronal subgroups, suggesting these isoforms underlie I-h in DRG neurons. Expression of both isoforms was NT3-dependent in cultured DRG neurons. HCN2-immunostaining in small neurons increased 1 day after cutaneous inflammation (CFA-induced) and recovered by 4 days. This could contribute to acute inflammatory pain. HCN2-immunostaining in large neurons decreased 4 days after CFA, when NT3 was decreased in the DRG. Thus HCN2-expression control differs between large and small neurons.	[Acosta, Cristian; Gao, Linlin; Watkins, Roger; Berry, Carol; Dempsey, Katherine; Lawson, Sally N.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [McMullan, Simon] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Djouhri, Laiche] King Faisal Univ, Dept Biomed Sci, Fac Med, Al Hasa, Saudi Arabia; [Gao, Linlin] Huazhong Univ Sci & Technol, Dept Physiol, Tongji Med Sch, Wuhan 430074, Peoples R China	University of Bristol; Macquarie University; King Faisal University; Huazhong University of Science & Technology	Lawson, SN (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	Sally.Lawson@bristol.ac.uk		McMullan, Simon/0000-0002-9854-1029; Acosta, Cristian/0000-0001-9333-5843	Wellcome Trust UK [WT82508MA]; China Scholarship Council; University of Bristol; MRC [G0700420] Funding Source: UKRI; Medical Research Council [G0700420] Funding Source: researchfish	Wellcome Trust UK(Wellcome Trust); China Scholarship Council(China Scholarship Council); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust UK (WT82508MA). LG was supported by Overseas Research Scholarship, China Scholarship Council and a postgraduate scholarship from The University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta C, 2008, J NEUROSCI RES, V86, P1077, DOI 10.1002/jnr.21565; Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Amaya F, 2004, EUR J NEUROSCI, V20, P2303, DOI 10.1111/j.1460-9568.2004.03701.x; Barrow AJ, 2009, J NEUROSCI, V29, P5841, DOI 10.1523/JNEUROSCI.5746-08.2009; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Chaplan SR, 2003, J NEUROSCI, V23, P1169, DOI 10.1523/JNEUROSCI.23-04-01169.2003; Cho HJ, 2009, NEUROSCIENCE, V162, P453, DOI 10.1016/j.neuroscience.2009.04.063; Cote MP, 2011, J NEUROTRAUM, V28, P299, DOI 10.1089/neu.2010.1594; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Dekker JP, 2006, J GEN PHYSIOL, V128, P561, DOI 10.1085/jgp.200609599; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Djouhri L, 2004, BRAIN RES REV, V46, P131, DOI 10.1016/j.brainresrev.2004.07.015; Djouhri L, 1998, J PHYSIOL-LONDON, V513, P857, DOI 10.1111/j.1469-7793.1998.857ba.x; Djouhri L, 1999, J PHYSIOL-LONDON, V520, P565, DOI 10.1111/j.1469-7793.1999.t01-1-00565.x; Djouhri L, 2001, NEUROSCIENCE, V108, P479, DOI 10.1016/S0306-4522(01)00423-7; Djouhri L, 2012, PAIN; Doan TN, 2004, J NEUROSCI, V24, P3335, DOI 10.1523/JNEUROSCI.5156-03.2004; Emery E.C., 2012, TRENDS PHARM SCI; Emery EC, 2011, SCIENCE, V333, P1462, DOI 10.1126/science.1206243; Fang X, 2005, J NEUROSCI, V25, P4868, DOI 10.1523/JNEUROSCI.0249-05.2005; Fang X, 2002, J NEUROSCI, V22, P7425; Fang X, 2006, J NEUROSCI, V26, P7281, DOI 10.1523/JNEUROSCI.1072-06.2006; Franz O, 2000, EUR J NEUROSCI, V12, P2685, DOI 10.1046/j.1460-9568.2000.00151.x; Gao LL, 2012, J PHYSIOL-LONDON, V590, P4691, DOI 10.1113/jphysiol.2012.238485; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Han W, 2002, CIRC RES, V91, P790, DOI 10.1161/01.RES.0000039534.18114.D9; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hogan QH, 2008, BRAIN RES, V1207, P102, DOI 10.1016/j.brainres.2008.02.066; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Jenkins SM, 2002, P NATL ACAD SCI USA, V99, P2303, DOI 10.1073/pnas.042601799; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Kouranova EV, 2008, NEUROSCIENCE, V153, P1008, DOI 10.1016/j.neuroscience.2008.03.032; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; Lawson SN, 2002, EXP PHYSIOL, V87, P239, DOI 10.1113/eph8702350; LAWSON SN, 1984, J COMP NEUROL, V228, P263, DOI 10.1002/cne.902280211; Lawson SN, 1997, J PHYSIOL-LONDON, V505, P177, DOI 10.1111/j.1469-7793.1997.00177.x; Li HY, 2011, MOL VIS, V17, P3314; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; McMahon Stephen B, 2004, Novartis Found Symp, V261, P68; Michels G, 2008, CARDIOVASC RES, V78, P466, DOI 10.1093/cvr/cvn032; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Morris NP, 2004, BRAIN RES, V1006, P74, DOI 10.1016/j.brainres.2004.01.062; Noam Y, 2010, J BIOL CHEM, V285, P14724, DOI 10.1074/jbc.M109.070391; Oakley RA, 1997, J NEUROSCI, V17, P4262; Pannese E, 2002, INT REV CYTOL, V220, P1; Parekh A, 2010, J PHYSIOL-LONDON, V588, P4131, DOI 10.1113/jphysiol.2010.196386; PERL ER, 1968, J PHYSIOL-LONDON, V197, P593, DOI 10.1113/jphysiol.1968.sp008576; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; SCROGGS RS, 1994, J NEUROPHYSIOL, V71, P271, DOI 10.1152/jn.1994.71.1.271; Simeone TA, 2005, J PHYSIOL-LONDON, V568, P371, DOI 10.1113/jphysiol.2005.093161; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Tu HY, 2004, J NEUROSCI RES, V76, P713, DOI 10.1002/jnr.20109; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Vetter I, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-22; Villiere V, 1996, J NEUROPHYSIOL, V76, P1924, DOI 10.1152/jn.1996.76.3.1924; Watanabe M, 2000, NEUROSCI LETT, V282, P61, DOI 10.1016/S0304-3940(00)00842-9; Weng X, 2012, PAIN; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; Zhou XF, 1998, NEUROSCIENCE, V86, P1155, DOI 10.1016/S0306-4522(98)00076-1	64	55	57	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50442	10.1371/journal.pone.0050442	http://dx.doi.org/10.1371/journal.pone.0050442			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236374	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100017
J	Chaudhuri, N; Jary, H; Lea, S; Khan, N; Piddock, KC; Dockrell, DH; Donaldson, K; Duffin, R; Singh, D; Parker, LC; Sabroe, I				Chaudhuri, Nazia; Jary, Hannah; Lea, Simon; Khan, Naimat; Piddock, Katie C.; Dockrell, David H.; Donaldson, Ken; Duffin, Rodger; Singh, Dave; Parker, Lisa C.; Sabroe, Ian			Diesel Exhaust Particle Exposure In Vitro Alters Monocyte Differentiation and Function	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BRONCHIAL EPITHELIAL-CELLS; PARTICULATE AIR-POLLUTION; ALVEOLAR MACROPHAGES; INFLAMMATORY RESPONSES; CIGARETTE-SMOKE; HEALTHY HUMANS; LIPOPOLYSACCHARIDE; CHEMICALS; RELEASE	Air pollution by diesel exhaust particles is associated with elevated mortality and increased hospital admissions in individuals with respiratory diseases such as asthma and chronic obstructive pulmonary disease. During active inflammation monocytes are recruited to the airways and can replace resident alveolar macrophages. We therefore investigated whether chronic fourteen day exposure to low concentrations of diesel exhaust particles can alter the phenotype and function of monocytes from healthy individuals and those with chronic obstructive pulmonary disease. Monocytes were purified from the blood of healthy individuals and people with a diagnosis of chronic obstructive pulmonary disease. Monocyte-derived macrophages were generated in the presence or absence of diesel exhaust particles and their phenotypes studied through investigation of their lifespan, cytokine generation in response to Toll like receptor agonists and heat killed bacteria, and expression of surface markers. Chronic fourteen day exposure of monocyte-derived macrophages to concentrations of diesel exhaust particles >10 mu g/ml caused mitochondrial and lysosomal dysfunction, and a gradual loss of cells over time both in healthy and chronic obstructive pulmonary disease individuals. Chronic exposure to lower concentrations of diesel exhaust particles impaired CXCL8 cytokine responses to lipopolysaccharide and heat killed E. coli, and this phenotype was associated with a reduction in CD14 and CD11b expression. Chronic diesel exhaust particle exposure may therefore alter both numbers and function of lung macrophages differentiating from locally recruited monocytes in the lungs of healthy people and patients with chronic obstructive pulmonary disease.	[Chaudhuri, Nazia; Jary, Hannah; Piddock, Katie C.; Dockrell, David H.; Parker, Lisa C.; Sabroe, Ian] Univ Sheffield, Sch Med & Biomed Sci, Acad Unit Resp Med, Sheffield, S Yorkshire, England; [Lea, Simon; Khan, Naimat; Singh, Dave] Univ Hosp S Manchester NHS Trust, Educ & Res Ctr, Manchester, Lancs, England; [Donaldson, Ken; Duffin, Rodger] Univ Edinburgh, Queens Med Inst, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland	University of Sheffield; Wythenshawe Hospital NHS Foundation Trust; University of Edinburgh	Sabroe, I (corresponding author), Univ Sheffield, Sch Med & Biomed Sci, Acad Unit Resp Med, Sheffield, S Yorkshire, England.	i.sabroe@sheffield.ac.uk	Sabroe, Ian/AAE-5858-2019; Singh, Dave/AAH-4342-2020; Lea, Simon/U-3590-2019; Sabroe, Ian/I-5981-2013; Chaudhuri, Nazia/J-4517-2019	Singh, Dave/0000-0001-8918-7075; Sabroe, Ian/0000-0001-9750-8975; Chaudhuri, Nazia/0000-0003-3325-6996; Duffin, Rodger/0000-0002-3425-9745; Dockrell, David/0000-0002-2718-4861	Sheffield Hospital Charitable trust [7887]; MRC [G0901697] Funding Source: UKRI; Medical Research Council [G0901697] Funding Source: researchfish	Sheffield Hospital Charitable trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is supported by the Sheffield Hospital Charitable trust 7887. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2000, BIOCHEM BIOPH RES CO, V268, P172, DOI 10.1006/bbrc.2000.2089; Atkinson RW, 1999, EUR RESPIR J, V13, P257, DOI 10.1183/09031936.99.13225799; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Becker S, 2002, TOXICOL IN VITRO, V16, P209, DOI 10.1016/S0887-2333(02)00015-2; Behndig AF, 2006, EUR RESPIR J, V27, P359, DOI 10.1183/09031936.06.00136904; Chaudhuri N, 2010, AM J PHYSIOL-LUNG C, V299, pL263, DOI 10.1152/ajplung.00297.2009; Ciccone G, 1998, OCCUP ENVIRON MED, V55, P771, DOI 10.1136/oem.55.11.771; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Goto Y, 2004, AM J RESP CRIT CARE, V170, P891, DOI 10.1164/rccm.200402-235OC; HASLETT C, 1985, AM J PATHOL, V119, P101; Hiura TS, 1999, J IMMUNOL, V163, P5582; Hiura TS, 2000, J IMMUNOL, V165, P2703, DOI 10.4049/jimmunol.165.5.2703; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Ishii H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-87; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; Li N, 2002, J IMMUNOL, V169, P4531, DOI 10.4049/jimmunol.169.8.4531; MacRedmond RE, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-84; Maus UA, 2006, AM J RESP CELL MOL, V35, P227, DOI 10.1165/rcmb.2005-0241OC; Mazzarella G, 2007, RESP MED, V101, P1155, DOI 10.1016/j.rmed.2006.11.011; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Morris GE, 2006, FASEB J, V20, P2153, DOI 10.1096/fj.06-5910fje; Nordenhall C, 2001, EUR RESPIR J, V17, P909, DOI 10.1183/09031936.01.17509090; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Rusznak C, 2000, AM J RESP CELL MOL, V23, P530, DOI 10.1165/ajrcmb.23.4.3959; Saito Y, 2002, EXP LUNG RES, V28, P201, DOI 10.1080/019021402753570509; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; Sapey E, 2009, J CLIN IMMUNOL, V29, P508, DOI 10.1007/s10875-009-9286-8; SCHWARTZ J, 1993, AM REV RESPIR DIS, V147, P826, DOI 10.1164/ajrccm/147.4.826; Stenfors N, 2004, EUR RESPIR J, V23, P82, DOI 10.1183/09031936.03.00004603; Takizawa H, 2004, CURR OPIN ALLERGY CL, V4, P355, DOI 10.1097/00130832-200410000-00005; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; Webster SJ, 2010, J IMMUNOL, V185, P2968, DOI 10.4049/jimmunol.1000805; Yang HM, 2001, ENVIRON HEALTH PERSP, V109, P515, DOI 10.2307/3454711; Yin XJJ, 2007, J TOXICOL ENV HEAL A, V70, P820, DOI 10.1080/15287390701209766	36	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51107	10.1371/journal.pone.0051107	http://dx.doi.org/10.1371/journal.pone.0051107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236439	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000312064100068
J	Cossarizza, A; Bertoncelli, L; Nemes, E; Lugli, E; Pinti, M; Nasi, M; De Biasi, S; Gibellini, L; Montagna, JP; Vecchia, M; Manzini, L; Meschiari, M; Borghi, V; Guaraldi, G; Mussini, C				Cossarizza, Andrea; Bertoncelli, Linda; Nemes, Elisa; Lugli, Enrico; Pinti, Marcello; Nasi, Milena; De Biasi, Sara; Gibellini, Lara; Montagna, Jonas P.; Vecchia, Marco; Manzini, Lisa; Meschiari, Marianna; Borghi, Vanni; Guaraldi, Giovanni; Mussini, Cristina			T Cell Activation but Not Polyfunctionality after Primary HIV Infection Predicts Control of Viral Load and Length of the Time without Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; PERIPHERAL-BLOOD; GASTROINTESTINAL-TRACT; TREATMENT INTERRUPTION; FUNCTIONAL PROFILE; TYPE-1 INFECTION; LYMPHOCYTES; RESPONSES	Objective: Immune changes occurring after primary HIV infection (PHI) have a pivotal relevance. Our objective was to characterize the polyfunctionality of immune response triggered by PHI, and to characterize immune activation and regulatory T cells, correlating such features to disease progression. Patients and Methods: We followed 11 patients experiencing PHI for 4 years. By polychromatic flow cytometry, we studied every month, for the first 6 months, T lymphocyte polyfunctionality after cell stimulation with peptides derived from HIV-1 gag and nef. Tregs were identified by flow cytometry, and T cell activation studied by CD38 and HLA-DR expression. Results: An increase of anti-gag and anti-nef CD8+ specific T cells was observed 3 months after PHI; however, truly polyfunctional T cells, also able to produce IL-2, were never found. No gross changes in Tregs were present. T lymphocyte activation was maximal 1 and 2 months after PHI, and significantly decreased in the following period. The level of activation two months after PHI was strictly correlated to the plasma viral load 1 year after infection, and significantly influenced the length of period without therapy. Indeed, 80% of patients with less than the median value of activated CD8+ (15.5%) or CD4+ (0.9%) T cells remained free of therapy for >46 months, while all patients over the median value had to start treatment within 26 months. Conclusions: T cell activation after PHI, more than T cell polyfunctionality or Tregs, is a predictive marker for the control of viral load and for the time required to start treatment. Citation: Cossarizza A, Bertoncelli L, Nemes E, Lugli E, Pinti M, et al. (2012) T Cell Activation but Not Polyfunctionality after Primary HIV Infection Predicts Control of Viral Load and Length of the Time without Therapy. PLoS ONE 7(12): e50728. doi:10.1371/journal.pone.0050728	[Cossarizza, Andrea; Bertoncelli, Linda; Nemes, Elisa; Lugli, Enrico; Nasi, Milena; De Biasi, Sara; Gibellini, Lara; Montagna, Jonas P.; Vecchia, Marco; Manzini, Lisa; Meschiari, Marianna; Mussini, Cristina] Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci, Modena, Italy; [Pinti, Marcello] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Borghi, Vanni; Guaraldi, Giovanni; Mussini, Cristina] Azienda Osped Univ Policlin Modena, Infect Dis Clin, Modena, Italy; [Guaraldi, Giovanni] Univ Modena & Reggio Emilia, Dept Med & Surg Sci Mother Child & Adult, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia	Cossarizza, A (corresponding author), Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci, Modena, Italy.	andrea.cossarizza@unimore.it	Nasi, Milena/J-4425-2016; Meschiari, Marianna/AAC-1916-2022; Guaraldi, Giovanni/J-9467-2018; Pinti, Marcello/C-9351-2015; De Biasi, Sara/AAB-7520-2019; Mussini, Cristina/K-8672-2016; Lugli, Enrico/AAB-7933-2019	Nasi, Milena/0000-0003-3079-8001; Meschiari, Marianna/0000-0002-1254-9995; Pinti, Marcello/0000-0001-9118-1262; De Biasi, Sara/0000-0002-3217-9821; Mussini, Cristina/0000-0002-6615-4198; Lugli, Enrico/0000-0002-1964-7678; Cossarizza, Andrea/0000-0002-5381-1558; Gray, Clive/0000-0002-9293-901X; Vecchia, Marco/0000-0002-6660-2448; Guaraldi, Giovanni/0000-0002-5724-3914	"Programma Nazionale di Ricerca sull'AIDS - Istituto Superiore di Sanita'', Rome, Italy [40H71]	"Programma Nazionale di Ricerca sull'AIDS - Istituto Superiore di Sanita'', Rome, Italy	This study was partially supported by "Programma Nazionale di Ricerca sull'AIDS 2009-2010 - Istituto Superiore di Sanita'', Rome, Italy (grant 40H71 to AC). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Al-Harthi L, 2007, CLIN IMMUNOL, V125, P299, DOI 10.1016/j.clim.2007.08.011; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Barbieri D, 1998, NEUROCHEM INT, V32, P493, DOI 10.1016/S0197-0186(97)00129-0; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Bignami F, 2012, BLOOD, V119, P6259, DOI 10.1182/blood-2011-09-379503; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bosinger SE, 2011, CURR OPIN HIV AIDS, V6, P411, DOI 10.1097/COH.0b013e3283499cf6; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Chase AJ, 2008, J VIROL, V82, P8307, DOI 10.1128/JVI.00520-08; Cossarizza A, 2004, JAIDS-J ACQ IMM DEF, V35, P213, DOI 10.1097/00126334-200403010-00001; Cossarizza A, 1999, EXP CELL RES, V247, P304, DOI 10.1006/excr.1999.4387; COSSARIZZA A, 1995, AIDS, V9, P547, DOI 10.1097/00002030-199506000-00003; Cossarizza A, 1997, AIDS, V11, P19, DOI 10.1097/00002030-199701000-00004; COSSARIZZA A, 1995, J INFECT DIS, V172, P105, DOI 10.1093/infdis/172.1.105; Cossarizza A, 2000, AIDS, V14, P345, DOI 10.1097/00002030-200003100-00007; Cossarizza A, 2011, MITOCHONDRION, V11, P750, DOI 10.1016/j.mito.2011.06.005; Daucher M, 2008, J VIROL, V82, P4102, DOI 10.1128/JVI.02212-07; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Lugli E, 2007, CYTOM PART A, V71A, P334, DOI 10.1002/cyto.a.20387; Maenetje P, 2010, J IMMUNOL, V184, P4926, DOI 10.4049/jimmunol.0903771; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Moreno-Fernandez ME, 2012, J VIROL, V86, P10262, DOI 10.1128/JVI.00993-12; Nemes E, 2006, AIDS, V20, P2021, DOI 10.1097/01.aids.0000247575.41622.b1; Nemes E, 2011, AIDS, V25, P1443, DOI 10.1097/QAD.0b013e328347b5e2; Nemes E, 2010, AIDS, V24, P947, DOI 10.1097/QAD.0b013e328337b144; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Ortiz AM, 2011, J CLIN INVEST, V121, P4433, DOI 10.1172/JCI46023; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Pinti M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.47; Presicce P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028118; Rehr M, 2008, J VIROL, V82, P3391, DOI 10.1128/JVI.02383-07; Rizzardi GP, 2002, J CLIN INVEST, V109, P681, DOI 10.1172/JCI200214522; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Tran TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003305; Turk G, 2008, J VIROL, V82, P2853, DOI 10.1128/JVI.02260-07; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	48	19	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50728	10.1371/journal.pone.0050728	http://dx.doi.org/10.1371/journal.pone.0050728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236388	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100030
J	Estopinal, CB; van Dijk, JH; Sitali, S; Stewart, H; Davidson, MA; Spurrier, J; Vermund, SH				Estopinal, Christopher B.; van Dijk, Janneke H.; Sitali, Stanley; Stewart, Hannah; Davidson, Mario A.; Spurrier, John; Vermund, Sten H.			Availability of Volunteer-Led Home-Based Care System and Baseline Factors as Predictors of Clinical Outcomes in HIV-Infected Patients in Rural Zambia	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-1-INFECTED PATIENTS; ADHERENCE; MORTALITY; SUPPORT	Background: We assessed the impact of home-based care (HBC) for HIV+ patients, comparing outcomes between two groups of Zambians receiving antiretroviral therapy (ART) who lived in villages with and without HBC teams. Methods: We conducted a retrospective cohort study using medical charts from Macha Mission Hospital, a hospital providing HIV care in Zambia's rural Southern Province. Date of birth, date of ART initiation, place of residence, sex, body mass index (BMI), CD4+ cell count, and hemoglobin (Hgb) were abstracted. Logistic regression was used to test our hypothesis that HBC was associated with treatment outcomes. Results: Of 655 patients, 523 (80%) were eligible and included in the study. There were 428 patients (82%) with favorable outcomes (alive and on ART) and 95 patients (18%) with unfavorable outcomes (died, lost to follow-up, or stopped treatment). A minority of the 523 eligible patients (n = 84, 16%) lived in villages with HBC available. Living in a village with HBC was not significantly associated with treatment outcomes; 80% of patients in a village with HBC had favorable outcomes, compared to 82% of patients in a village without HBC (P = 0.6 by chi(2)). In bivariable analysis, lower BMI (P < 0.001), low CD4+ cell count (P = 0.02), low Hgb concentration (P = 0.02), and older age at ART initiation (P = 0.047) were associated with unfavorable outcomes. In multivariable analysis, low BMI remained associated with unfavorable outcomes (P, 0.001). Conclusions: We did not find that living in a village with HBC available was associated with improved treatment outcomes. We speculate that the ART clinic's rigorous treatment preparation before ART initiation and continuous adherence counseling during ART create a motivated group of patients whose outcomes did not improve with additional HBC support. An alternative explanation is that the quality of the HBC program is suboptimal.	[Estopinal, Christopher B.; Davidson, Mario A.; Vermund, Sten H.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [van Dijk, Janneke H.; Stewart, Hannah] Macha Res Trust, Macha, Zambia; [Sitali, Stanley; Spurrier, John] Macha Mission Hosp, Macha, Zambia	Vanderbilt University	Estopinal, CB (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	chris.estopinal@vanderbilt.edu	Vermund, Sten/AAD-3592-2020; Davidson, Mario/AAX-1102-2021	Vermund, Sten/0000-0001-7289-8698; 	Vanderbilt University Emphasis program; Vanderbilt-Meharry Framework Program for Global Health (Fogarty International Center, NIH) [R25TW007766]; FOGARTY INTERNATIONAL CENTER [R25TW007766] Funding Source: NIH RePORTER	Vanderbilt University Emphasis program; Vanderbilt-Meharry Framework Program for Global Health (Fogarty International Center, NIH); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Vanderbilt University Emphasis program and the Vanderbilt-Meharry Framework Program for Global Health (Fogarty International Center, NIH grant #R25TW007766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu AW, 2010, GLOB HLTH ACTION, V3; Berrien VM, 2004, AIDS PATIENT CARE ST, V18, P355, DOI 10.1089/1087291041444078; Bhattacharyya K, 2001, COMMUNITY HLTH WORKE; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Carlucci JG, 2008, JAIDS-J ACQ IMM DEF, V47, P615, DOI 10.1097/QAI.0b013e318165dc25; CSO/Macro, 2009, ZAMB DEM HLTH SURV 2; Denny CC, 2008, JAMA-J AM MED ASSOC, V300, P2048, DOI 10.1001/jama.2008.556; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Gordis L, 2004, EPIDEMIOLOGY, P226; Gostin LO, 2010, JAMA-J AM MED ASSOC, V304, P789, DOI 10.1001/jama.2010.1164; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Heimburger DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010687; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Johnson BA, 2004, J NATL MED ASSOC, V96, P496; Kabore I, 2010, AIDS PATIENT CARE ST, V24, P581, DOI 10.1089/apc.2009.0307; Lehmann U, 2007, COMMUNITY HLTH WORKE, P41; Miles MS, 2003, NURS RES, V52, P350, DOI 10.1097/00006199-200311000-00002; Ndaba-Mbata R D, 2000, Int Nurs Rev, V47, P218, DOI 10.1046/j.1466-7657.2000.00023.x; Olang'o CO, 2010, HEALTH POLICY, V97, P232, DOI 10.1016/j.healthpol.2010.05.004; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tuboi SH, 2005, JAIDS-J ACQ IMM DEF, V40, P324, DOI 10.1097/01.qai.0000182627.28595.01; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNDP, 2010, UN DEV PROGR HUM DEP; United Nations Development Programme (UNDP), 2010, HUM DEV REP 2010 20; Vermund SH, 2012, AIDS, V26, P1303, DOI 10.1097/QAD.0b013e3283552185; Williams AB, 2006, JAIDS-J ACQ IMM DEF, V42, P314, DOI 10.1097/01.qai.0000221681.60187.88; World Health Organization, 2006, ANT THER HIV INF AD; Wouters E, 2008, AIDS, V22, P2545, DOI 10.1097/QAD.0b013e32831c5562; Wube M, 2010, J PAIN SYMPTOM MANAG, V40, P6, DOI 10.1016/j.jpainsymman.2010.04.003; Young T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005417.pub2; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010	31	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e49564	10.1371/journal.pone.0049564	http://dx.doi.org/10.1371/journal.pone.0049564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	050OT	23236351	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100004
J	Jourdain, P; Boss, D; Rappaz, B; Moratal, C; Hernandez, MC; Depeursinge, C; Magistretti, PJ; Marquet, P				Jourdain, Pascal; Boss, Daniel; Rappaz, Benjamin; Moratal, Corinne; Hernandez, Maria-Clemencia; Depeursinge, Christian; Magistretti, Pierre Julius; Marquet, Pierre			Simultaneous Optical Recording in Multiple Cells by Digital Holographic Microscopy of Chloride Current Associated to Activation of the Ligand-Gated Chloride Channel GABA(A) Receptor	PLOS ONE			English	Article							K-CL COTRANSPORTER; PHASE MICROSCOPY; LIVING CELLS; ACID; EXPRESSION; CONTRAST; GLYCINE; NEURONS; BRAIN; NKCC1	Chloride channels represent a group of targets for major clinical indications. However, molecular screening for chloride channel modulators has proven to be difficult and time-consuming as approaches essentially rely on the use of fluorescent dyes or invasive patch-clamp techniques which do not lend themselves to the screening of large sets of compounds. To address this problem, we have developed a non-invasive optical method, based on digital holographic microcopy (DHM), allowing monitoring of ion channel activity without using any electrode or fluorescent dye. To illustrate this approach, GABA(A) mediated chloride currents have been monitored with DHM. Practically, we show that DHM can non-invasively provide the quantitative determination of transmembrane chloride fluxes mediated by the activation of chloride channels associated with GABA(A) receptors. Indeed through an original algorithm, chloride currents elicited by application of appropriate agonists of the GABA(A) receptor can be derived from the quantitative phase signal recorded with DHM. Finally, chloride currents can be determined and pharmacologically characterized non-invasively simultaneously on a large cellular sampling by DHM.	[Jourdain, Pascal; Boss, Daniel; Rappaz, Benjamin; Moratal, Corinne; Magistretti, Pierre Julius; Marquet, Pierre] Ecole Polytech Fed Lausanne, Brain & Mind Inst, Lausanne, Switzerland; [Hernandez, Maria-Clemencia] Hoffmann La Roche AG, Basel, Switzerland; [Depeursinge, Christian] Ecole Polytech Fed Lausanne, Inst Appl Opt, Lausanne, Switzerland; [Magistretti, Pierre Julius; Marquet, Pierre] Univ Lausanne Hosp, Ctr Psychiat, Dept Neurosci, Prilly, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Roche Holding; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Jourdain, P (corresponding author), Ecole Polytech Fed Lausanne, Brain & Mind Inst, Lausanne, Switzerland.	pascal.jourdain@epfl.ch; pierre.marquet@chuv.ch	Rappaz, Benjamin/C-1881-2014	Rappaz, Benjamin/0000-0002-8744-600X; Magistretti, Pierre Julius/0000-0002-6678-320X	CTI/KTI [9389.1]; Swiss National Science Foundation (SNSF) [CR3213_132993]	CTI/KTI; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This research has been funded by the CTI/KTI project (http://www.kti.admin.ch/index.html?lang=en) #9389.1 and by the Swiss National Science Foundation (SNSF; http://www.snf.ch/E/Pages/default.aspx) grant no CR3213_132993. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARER R, 1953, NATURE, V172, P1097, DOI 10.1038/1721097a0; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Bowery NG, 2006, BRIT J PHARMACOL, V147, pS109, DOI 10.1038/sj.bjp.0706443; Carl D, 2004, APPL OPTICS, V43, P6536, DOI 10.1364/AO.43.006536; Colomb T, 2006, J OPT SOC AM A, V23, P3177, DOI 10.1364/JOSAA.23.003177; Cuche E, 1999, APPL OPTICS, V38, P6994, DOI 10.1364/AO.38.006994; Curl CL, 2004, CLIN EXP PHARMACOL P, V31, P896, DOI 10.1111/j.1440-1681.2004.04100.x; Depeursinge C, 2007, P ANN INT IEEE EMBS, P6244; Duran C, 2010, ANNU REV PHYSIOL, V72, P95, DOI 10.1146/annurev-physiol-021909-135811; FAHLKE C, 1995, NEURON, V15, P463, DOI 10.1016/0896-6273(95)90050-0; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; HAMILTON BJ, 1993, NEUROSCI LETT, V153, P206, DOI 10.1016/0304-3940(93)90323-D; Helix N, 2003, J MEMBRANE BIOL, V196, P83, DOI 10.1007/s00232-003-0627-x; Isenring P, 1998, J BIOL CHEM, V273, P11295, DOI 10.1074/jbc.273.18.11295; Jourdain P, 2011, J NEUROSCI, V31, P11846, DOI 10.1523/JNEUROSCI.0286-11.2011; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Loscher W, 2012, NEUROPHARMACOLOGY; Macaulay N, 2004, NEUROSCIENCE, V129, P1031, DOI 10.1016/j.neuroscience.2004.06.045; Maksay G, 2001, NEUROSCI LETT, V311, P169, DOI 10.1016/S0304-3940(01)02163-2; MALHERBE P, 1990, J NEUROSCI, V10, P2330; Marquet P, 2005, OPT LETT, V30, P468, DOI 10.1364/OL.30.000468; Pavillon N, 2010, J BIOPHOTONICS, V3, P432, DOI 10.1002/jbio.201000018; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Popescu G, 2006, OPT LETT, V31, P775, DOI 10.1364/OL.31.000775; Rappaz B, 2005, OPT EXPRESS, V13, P9361, DOI 10.1364/OPEX.13.009361; Rappaz B, 2008, CYTOM PART A, V73A, P895, DOI 10.1002/cyto.a.20605; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; VERKMAN AS, 1990, AM J PHYSIOL, V259, pC375, DOI 10.1152/ajpcell.1990.259.3.C375; Wong CGT, 2003, ANN NEUROL, V54, pS3, DOI 10.1002/ana.10696	31	23	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51041	10.1371/journal.pone.0051041	http://dx.doi.org/10.1371/journal.pone.0051041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236427	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100057
J	McNally, B; Willette, M; Ye, F; Partida-Sanchez, S; Flano, E				McNally, Beth; Willette, Meredith; Ye, Fang; Partida-Sanchez, Santiago; Flano, Emilio			Intranasal Administration of dsRNA Analog Poly(I:C) Induces Interferon-alpha Receptor-Dependent Accumulation of Antigen Experienced T Cells in the Airways	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; VACCINE PROTECTS; VIRUS REPLICATION; MICE; RECOGNITION; RESPONSES; IMMUNITY; DIFFERENTIATION; ACTIVATION	Polyriboinosinic-polyribocytoidylic acid (pIC), a synthetic dsRNA, acts as an adjuvant that boosts immune responses and protection. Intranasal (IN) administration of pIC has recently been used to adjuvant influenza virus vaccines; however, the effects of IN pIC administration on pulmonary T cell responses remain unclear. Here we show that a single IN administered dose of dsRNA into mice induced local Th1 chemokine production in the lungs and airways, and generated a biphasic and sustained migration of T lymphocytes to the airways. Furthermore, IN pIC-induced chemokine production and T cell recruitment to the airways were interferon-alpha receptor (IFNAR) signaling dependent. The effect of dsRNA on T cell recruitment to the airways was also dependent on the presence of high molecular weight (HMW) pIC, as a low molecular weight (LMW) pIC preparation known to only interact with TLR3 did not elicit the same effect on T cell migration to the airways, suggesting that the observed effects were dependent upon dsRNA recognition by multiple pattern recognition receptors (PPRs). IN pIC was additionally capable of stimulating low levels of T cell proliferation in the draining lymph nodes approximately 4-6 days after treatment that preceded a small population of de-novo T cells found in the airways by day 10. Taken together, these results demonstrate that the adjuvant effect of IN pIC that results in enhanced T cell proliferation and sustained T cell recruitment to the airways requires multiple PRRs and IFNAR signaling.	[McNally, Beth; Willette, Meredith; Ye, Fang; Flano, Emilio] Res Inst Nationwide Childrens Hosp, Ctr Vaccines & Immun, Columbus, OH 43205 USA; [Partida-Sanchez, Santiago] Res Inst Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Columbus, OH USA; [Partida-Sanchez, Santiago; Flano, Emilio] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Flano, E (corresponding author), Res Inst Nationwide Childrens Hosp, Ctr Vaccines & Immun, Columbus, OH 43205 USA.	Emilio.flano@nationwidechildrens.org	Flano, Emilio/E-3066-2011; Partida-Sanchez, Santiago/B-7523-2008	Partida-Sanchez, Santiago/0000-0003-2996-9440	NIH [AI082962, AI059603]; Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI059603, U01AI082962, R01AI059603, R01AI092117] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grants AI082962 and AI059603 and by The Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini C, 2001, AM J PATHOL, V158, P1703, DOI 10.1016/S0002-9440(10)64126-0; Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Atmar RL, 2007, VACCINE, V25, P5367, DOI 10.1016/j.vaccine.2007.05.002; Avraamides G, 2007, J INTERF CYTOK RES, V27, P291, DOI 10.1089/jir.2006.0107; Avril T, 2009, J IMMUNOTHER, V32, P353, DOI 10.1097/CJI.0b013e31819d29bf; Barnard Dale L., 2006, Antiviral Chemistry & Chemotherapy, V17, P275; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Durand V, 2006, VACCINE, V24, pS22, DOI 10.1016/j.vaccine.2005.01.115; Shen EX, 2007, CELL MOL IMMUNOL, V4, P113; Flano E, 2009, CURR PROTOC CELL BIO; Guerrero-Plata A, 2005, J VIROL, V79, P10190, DOI 10.1128/JVI.79.16.10190-10199.2005; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Ichinohe T, 2007, MICROBES INFECT, V9, P1333, DOI 10.1016/j.micinf.2007.06.007; Ichinohe T, 2010, J MED VIROL, V82, P1754, DOI 10.1002/jmv.21824; Ichinohe T, 2009, VACCINE, V27, P6276, DOI 10.1016/j.vaccine.2009.04.074; Isogawa M, 2005, J VIROL, V79, P7269, DOI 10.1128/JVI.79.11.7269-7272.2005; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khan IA, 2000, IMMUNITY, V12, P483, DOI 10.1016/S1074-7613(00)80200-9; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Lau YF, 2009, VACCINE, V27, P1354, DOI 10.1016/j.vaccine.2008.12.048; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Ngoi SM, 2008, J IMMUNOL, V181, P7670, DOI 10.4049/jimmunol.181.11.7670; Salaun B, 2009, VACCINE, V27, P1841, DOI 10.1016/j.vaccine.2009.01.044; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Starkhammar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032110; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Tough DF, 2012, IMMUNOL CELL BIOL; Wareing MD, 2003, VACCINE, V21, P3097, DOI 10.1016/S0264-410X(03)00262-7; Wiesel M, 2012, EUR J IMMUNOL, V42, P320, DOI 10.1002/eji.201142091; Wiesel M, 2011, J IMMUNOL, V186, P754, DOI 10.4049/jimmunol.1003166; Wong JP, 2009, VACCINE, V27, P3481, DOI 10.1016/j.vaccine.2009.01.048	42	20	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51351	10.1371/journal.pone.0051351	http://dx.doi.org/10.1371/journal.pone.0051351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236482	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100103
J	Qiu, MT; Hu, JW; Ding, XX; Yang, X; Zhang, Z; Yin, R; Xu, L				Qiu, Man-Tang; Hu, Jing-Wen; Ding, Xiang-Xiang; Yang, Xin; Zhang, Zhi; Yin, Rong; Xu, Lin			Hsa-miR-499 rs3746444 Polymorphism Contributes to Cancer Risk: A Meta-Analysis of 12 Studies	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GENETIC-VARIANTS; PRE-MICRORNAS; HEPATOCELLULAR-CARCINOMA; CHINESE POPULATION; CLINICAL-TRIALS; ASSOCIATION; SUSCEPTIBILITY	Background: Single nucleotide polymorphisms (SNPs) occurred in pre-microRNAs or targets of microRNAs (miRs) may contribute to cancer risks. Since 2007, many studies have investigated the association between common SNPs located on hsa-miR-499 (rs3746444) and cancer risks; however, the results were inconclusive. Methodology/Principal Findings: We conducted a meta-analysis of 12 studies that included 5765 cases and 7076 controls to identify the strength of association. Odds ratio (OR) and 95% confidence intervals (95% CI) were used to assess the strength of association. Overall, individuals with the variant AG (OR = 1.215, 95% CI: 1.027, 1.437; P-heterogeneity <0.01) and AG/GG (OR = 1.227, 95% CI: 1.046, 1.439; P-heterogeneity <0.01) genotypes were associated with a significantly increased risk of cancer than those with wild AA genotype. Sub-group analysis revealed that the variant AG (OR = 1.411, 95% CI: 1.142, 1.745; P-heterogeneity = 0.01) and AG/GG (OR = 1.413, 95% CI: 1.163, 1.717, P-heterogeneity = 0.01) genotypes still showed an increased risk of cancer in Asians; however, a trend of reduced risk of cancer was observed in Caucasians (AG vs. AA: OR = 0.948, 955 CI: 0.851, 1.057, P-heterogeneity = 0.12; AG/GG vs. AA: OR = 0.959, 95% CI: 0.865, 1.064; P-heterogeneity = 0.19). Meta-regression showed that ethnicity (p = 0.048) and sample size (p = 0.02) but not cancer types (p = 0.89) or source of control (p = 0.97) were the sources of heterogeneity. Conclusions: These meta-analysis results suggest that hsa-miR-499 polymorphism rs3746444 is associated with a significantly increased risk of cancer, especially in Asian populations.	[Qiu, Man-Tang; Hu, Jing-Wen; Yang, Xin; Zhang, Zhi; Yin, Rong; Xu, Lin] Nanjing Med Univ, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China; [Qiu, Man-Tang; Hu, Jing-Wen; Yang, Xin] Nanjing Med Univ, Clin Coll 4, Nanjing, Jiangsu, Peoples R China; [Ding, Xiang-Xiang] Nanjing Med Univ, Clin Coll 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Yin, R (corresponding author), Nanjing Med Univ, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Dept Thorac Surg, Nanjing, Jiangsu, Peoples R China.	yinhero001@126.com; xulin83cn@gmail.com	Qiu, Mantang/L-8937-2019		National Natural Science Foundation of China [81201830]; Natural Science Foundation of Jiangsu Province, China [BK2010589, BK2011857]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (81201830) and Natural Science Foundation of Jiangsu Province (BK2010589, BK2011857), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, ASIAN PAC J CANCER P, V12, P3107; Alshatwi AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030049; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aumiller V, 2008, BBA-GENE REGUL MECH, V1779, P692, DOI 10.1016/j.bbagrm.2008.04.008; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Catucci I, 2010, HUM MUTAT, V31, pE1052, DOI 10.1002/humu.21141; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Chu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039777; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gao LB, 2011, BREAST CANCER RES TR, V125, P571, DOI 10.1007/s10549-010-0993-x; Gong J., 2012, ONCOGENE; Guo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030585; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li DD, 2011, HUM IMMUNOL, V72, P598, DOI 10.1016/j.humimm.2011.03.004; Lian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031615; Liu XQ, 2011, CARCINOGENESIS, V32, P1798, DOI 10.1093/carcin/bgr213; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Mittal RD, 2011, DNA CELL BIOL, V30, P401, DOI 10.1089/dna.2010.1159; Mocellin S, 2009, MINI-REV MED CHEM, V9, P70, DOI 10.2174/138955709787001802; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Wang F, 2012, MOL BIOL REP, V39, P269, DOI 10.1007/s11033-011-0735-0; Wang J, 2012, MOL BIOL REP, V39, P4571, DOI 10.1007/s11033-011-1247-7; WHITEHEAD A, 1991, STAT MED, V10, P1665, DOI 10.1002/sim.4780101105; Xiang Y, 2012, MOL BIOL REP, V39, P7019, DOI 10.1007/s11033-012-1532-0; Yang B, 2011, MOL BIOL REP, V38, P4913, DOI 10.1007/s11033-010-0633-x; Zhang JL, 2011, MOL BIOL REP, V38, P1463, DOI 10.1007/s11033-010-0252-6; Zhou B, 2011, MOL CARCINOGEN, V50, P499, DOI 10.1002/mc.20740; Zhou J, 2012, DNA CELL BIOL, V31, P524, DOI 10.1089/dna.2011.1340	35	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50887	10.1371/journal.pone.0050887	http://dx.doi.org/10.1371/journal.pone.0050887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236400	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100038
J	Sargeant, DP; Gryk, MR; Maciejewski, MW; Thapar, V; Kundeti, V; Rajasekaran, S; Romero, P; Dunker, K; Li, SC; Kaneko, T; Schiller, MR				Sargeant, David P.; Gryk, Michael R.; Maciejewski, Mark W.; Thapar, Vishal; Kundeti, Vamsi; Rajasekaran, Sanguthevar; Romero, Pedro; Dunker, Keith; Li, Shun-Cheng; Kaneko, Tomonori; Schiller, Martin R.			Secondary Structure, a Missing Component of Sequence-Based Minimotif Definitions	PLOS ONE			English	Article							POLYPROLINE-II HELICES; RAMAN OPTICAL-ACTIVITY; PROLINE-RICH PEPTIDES; PROTEIN DATA-BANK; RESIDUAL STRUCTURE; SH3 DOMAIN; DENATURED-STATE; CRYSTAL-STRUCTURE; LINEAR MOTIFS; ALPHA-HELIX	Minimotifs are short contiguous segments of proteins that have a known biological function. The hundreds of thousands of minimotifs discovered thus far are an important part of the theoretical understanding of the specificity of protein-protein interactions, posttranslational modifications, and signal transduction that occur in cells. However, a longstanding problem is that the different abstractions of the sequence definitions do not accurately capture the specificity, despite decades of effort by many labs. We present evidence that structure is an essential component of minimotif specificity, yet is not used in minimotif definitions. Our analysis of several known minimotifs as case studies, analysis of occurrences of minimotifs in structured and disordered regions of proteins, and review of the literature support a new model for minimotif definitions that includes sequence, structure, and function.	[Sargeant, David P.; Schiller, Martin R.] Univ Nevada Las Vegas, Sch Life Sci, Las Vegas, NV 89119 USA; [Gryk, Michael R.; Maciejewski, Mark W.] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT USA; [Thapar, Vishal; Kundeti, Vamsi; Rajasekaran, Sanguthevar] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT USA; [Romero, Pedro; Dunker, Keith] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Li, Shun-Cheng; Kaneko, Tomonori] Univ Western Ontario, Dept Biochem, London, ON, Canada	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Connecticut; University of Connecticut; Indiana University System; Indiana University Bloomington; Western University (University of Western Ontario)	Schiller, MR (corresponding author), Univ Nevada Las Vegas, Sch Life Sci, Las Vegas, NV 89119 USA.	Martin.Schiller@unlv.edu	Romero, Pedro R/D-4110-2018	Romero, Pedro R/0000-0002-6995-5193; Kaneko, Tomonori/0000-0001-5448-9639; Schiller, Martin R/0000-0003-1671-6823	National Institutes of Health [GM079689, LM010101]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079689] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by National Institutes of Health grants GM079689 and LM010101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasland R, 2002, FEBS LETT, V513, P141, DOI 10.1016/S0014-5793(01)03295-1; Adler MJ, 2011, CURR TOP MICROBIOL, V348, P1, DOI 10.1007/82_2010_91; ADZHUBEI AA, 1994, PROTEIN SCI, V3, P2395, DOI 10.1002/pro.5560031223; ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; Alix Alain J. P., 2001, Journal de la Societe de Biologie, V195, P181; AUNE KC, 1967, J BIOL CHEM, V242, P4486; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bienkiewicz EA, 2000, J MOL BIOL, V297, P119, DOI 10.1006/jmbi.2000.3545; Bourguet E, 2003, BIOORG MED CHEM LETT, V13, P1561, DOI 10.1016/S0960-894X(03)00181-1; Bowler BE, 2007, MOL BIOSYST, V3, P88, DOI 10.1039/b611895j; BRAKCH N, 1993, BIOCHEMISTRY-US, V32, P4925, DOI 10.1021/bi00069a029; BRAKCH N, 1993, EUR J BIOCHEM, V216, P39, DOI 10.1111/j.1432-1033.1993.tb18114.x; Bustos DM, 2006, PROTEINS, V63, P35, DOI 10.1002/prot.20888; CALLAHAN JF, 1992, J MED CHEM, V35, P3970, DOI 10.1021/jm00099a027; Ceol A, 2007, NUCLEIC ACIDS RES, V35, pD557, DOI 10.1093/nar/gkl961; Cesareni G, 2002, FEBS LETT, V513, P38, DOI 10.1016/S0014-5793(01)03307-5; Chica C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006052; Chou KC, 2000, ANAL BIOCHEM, V286, P1, DOI 10.1006/abio.2000.4757; Chugh J, 2008, BIOPHYS CHEM, V137, P13, DOI 10.1016/j.bpc.2008.06.005; Cobos ES, 2004, J MOL BIOL, V342, P355, DOI 10.1016/j.jmb.2004.06.078; Cortajarena AL, 2008, J MOL BIOL, V382, P203, DOI 10.1016/j.jmb.2008.07.005; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Creighton CJ, 2006, BIOORG MED CHEM LETT, V16, P3971, DOI 10.1016/j.bmcl.2006.05.020; Crisma M, 2002, BIOPOLYMERS, V64, P236, DOI 10.1002/bip.10178; Dalgarno DC, 1997, BIOPOLYMERS, V43, P383; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; DeLano WL, 2004, ABSTR PAP AM CHEM S, V228, pU313; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dunker A K, 1998, Pac Symp Biocomput, P473; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Edwards RJ, 2012, MOL BIOSYST, V8, P282, DOI 10.1039/c1mb05212h; Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Finnegan ML, 2010, J MOL BIOL, V403, P495, DOI 10.1016/j.jmb.2010.09.004; Fisher MJ, 1997, J MED CHEM, V40, P2085, DOI 10.1021/jm9701076; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gmeiner WH, 2001, CELL BIOCHEM BIOPHYS, V35, P115, DOI 10.1385/CBB:35:2:115; Hagarman A, 2011, CHEM-EUR J, V17, P6789, DOI 10.1002/chem.201100016; Harkiolaki M, 2009, STRUCTURE, V17, P809, DOI 10.1016/j.str.2009.03.017; Higo J, 2001, PROTEIN SCI, V10, P1160, DOI 10.1110/ps.44901; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; HOOG SS, 1995, J MED CHEM, V38, P3246, DOI 10.1021/jm00017a008; Hugo W, 2010, BIOINFORMATICS, V26, P1036, DOI 10.1093/bioinformatics/btq065; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; JOHNSON WC, 1993, BIOCHEMISTRY-US, V32, P268, DOI 10.1021/bi00052a034; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karvounis G, 2004, J CHEM PHYS, V121, P4925, DOI 10.1063/1.1780152; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; Kolano C, 2006, NATURE, V444, P469, DOI 10.1038/nature05352; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KOSHLAND DE, 1958, FED PROC, V17, P1145; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lazarus Robert A., 1993, Current Opinion in Biotechnology, V4, P438, DOI 10.1016/0958-1669(93)90009-L; Lewitzky M, 2004, J BIOL CHEM, V279, P28724, DOI 10.1074/jbc.M402745200; Li H, 2008, J BIOL CHEM, V283, P27165, DOI 10.1074/jbc.M803892200; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu Q, 2003, MOL CELL, V11, P471, DOI 10.1016/S1097-2765(03)00046-7; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; MATTHEWS CR, 1975, BIOCHEMISTRY-US, V14, P4532, DOI 10.1021/bi00691a031; MAYO KH, 1991, BIOCHEMISTRY-US, V30, P8251, DOI 10.1021/bi00247a022; McCarney ER, 2005, CRIT REV BIOCHEM MOL, V40, P181, DOI 10.1080/10409230591008143; Mi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045589; Mi T, 2012, NUCLEIC ACIDS RES, V40, pD252, DOI 10.1093/nar/gkr1189; MONSALVE RI, 1990, FEBS LETT, V263, P209, DOI 10.1016/0014-5793(90)81375-X; Mooney C, 2012, J MOL BIOL, V415, P193, DOI 10.1016/j.jmb.2011.10.025; Moroy G, 2009, PROTEINS, V76, P461, DOI 10.1002/prot.22361; Morton CJ, 1996, STRUCTURE, V4, P705, DOI 10.1016/S0969-2126(96)00076-7; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neira JL, 1999, J MOL BIOL, V285, P627, DOI 10.1006/jmbi.1998.2365; NEWLANDER KA, 1993, J MED CHEM, V36, P2321, DOI 10.1021/jm00068a008; Newman RA, 2008, PROTEINS, V71, P1792, DOI 10.1002/prot.21861; Nguyen JT, 1998, SCIENCE, V282, P2088, DOI 10.1126/science.282.5396.2088; Nioche P, 2002, J MOL BIOL, V315, P1167, DOI 10.1006/jmbi.2001.5299; O'Shea J Conor, 2002, Expert Opin Pharmacother, V3, P1199; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Paz A, 2008, BIOPHYS J, V95, P1928, DOI 10.1529/biophysj.107.126995; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Petsalaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000335; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; Podust LM, 2001, J BIOL CHEM, V276, P505, DOI 10.1074/jbc.M005594200; Prlic A, 2012, BIOINFORMATICS, V28, P2693, DOI 10.1093/bioinformatics/bts494; Rajasekaran S, 2010, ALGORITHMS COMPUTATI, P261; Rajasekaran S, 2011, PROTEINS, V79, P153, DOI 10.1002/prot.22868; Rajasekaran S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012276; Rajasekaran S, 2009, NUCLEIC ACIDS RES, V37, pD185, DOI 10.1093/nar/gkn865; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Ren S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S26; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2; Skelton NJ, 2001, BIOCHEMISTRY-US, V40, P8487, DOI 10.1021/bi0103866; Smith LJ, 1996, FOLD DES, V1, pR95, DOI 10.1016/S1359-0278(96)00046-6; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; STANFIELD RL, 1995, CURR OPIN STRUC BIOL, V5, P103, DOI 10.1016/0959-440X(95)80015-S; Stein A, 2011, NUCLEIC ACIDS RES, V39, pD718, DOI 10.1093/nar/gkq962; Tompa P, 2003, J MOL STRUC-THEOCHEM, V666, P361, DOI 10.1016/j.theochem.2003.08.047; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Vanhee P, 2011, NUCLEIC ACIDS RES, V39, pD435, DOI 10.1093/nar/gkq972; Vanhee P, 2010, NUCLEIC ACIDS RES, V38, pD545, DOI 10.1093/nar/gkp893; Via A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-351; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Vyas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-328; Vyas J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-360; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Willighagen E, 2007, NATURE PRECEEDINGS; Wilson G, 1996, BIOCHEMISTRY-US, V35, P12518, DOI 10.1021/bi961314v; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; Yamada T, 1996, FEBS LETT, V387, P11, DOI 10.1016/0014-5793(96)00409-7; Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816; Yoon MK, 2009, PROTEIN SCI, V18, P337, DOI 10.1002/pro.34; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zhu F, 2008, PROTEINS, V70, P823, DOI 10.1002/prot.21593; Zor T, 2002, J BIOL CHEM, V277, P42241, DOI 10.1074/jbc.M207361200	123	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e49957	10.1371/journal.pone.0049957	http://dx.doi.org/10.1371/journal.pone.0049957			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236358	gold, Green Published, Green Submitted			2022-12-27	WOS:000312064100009
J	Liu, PW; Chen, MF; Tsai, APY; Lee, TJF				Liu, Po-Wen; Chen, Mei-Fang; Tsai, Andy Po-Yi; Lee, Tony J. F.			STAT1 Mediates Oroxylin A Inhibition of iNOS and Pro-Inflammatory Cytokines Expression in Microglial BV-2 Cells	PLOS ONE			English	Article							NITRIC-OXIDE-SYNTHASE; FACTOR-KAPPA-B; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); ACTIVATED MACROPHAGES; MEMORY IMPAIRMENT; GENE-EXPRESSION; UP-REGULATION; LIPOPOLYSACCHARIDE; MECHANISMS; DISEASE	Microglia-mediated inflammation is implicated in pathogenesis of neurodegenerative diseases. Oroxylin A, a flavonoid isolated from Scutellariae baicalensis, has been shown to ameliorate microglia activation-mediated neurodegeneration in vivo. The molecular mechanism underlying the inhibitory effects of oroxylin A on microglia activation, however, remains unknown. In the present study, effects of oroxylin A co-treated with lipopolysaccharide (LPS, 100 ng/ml) on LPS-induced activation of cultured microglial BV-2 cells were examined. Nitric oxide (NO) production was determined by Greiss method. Expression of inducible nitric oxide synthase (iNOS), interleukin (IL)-1 beta and IL-6 was assessed using real-time RT-PCR or Western blot analysis. Furthermore, activation of the nuclear factor kappa B (NF kappa B) and the signal transducer and activator of transcription 1 (STAT1) was examined by Western blot analysis and transcription factor DNA-binding activity assay. Our results indicated that oroxylin A (10-100 mu M) in a concentration-dependent manner inhibited LPS-induced NO production via blocking iNOS expression at both mRNA and protein levels without affecting the degradation rate of iNOS mRNA. Moreover, oroxylin A significantly attenuated LPS-induced late expression (20 hours after LPS challenge) of IL-1 beta and IL-6. Furthermore, oroxylin A significantly suppressed LPS-induced JAK2-mediated STAT1 phosphorylation without affecting LPS-induced NF kappa B-p65 nuclear translocation or NF kappa B-p65 DNA-binding activity. This is consistent with the finding that AG490, a specific JAK2 inhibitor, significantly inhibited LPS-induced STAT1 phosphorylation with almost completely diminished iNOS expression. These results suggest that oroxylin A, via suppressing STAT1 phosphorylation, inhibits LPS-induced expression of pro-inflammatory genes in BV-2 microglial cells. Citation: Liu P-W, Chen M-F, Tsai AP-Y, Lee TJF (2012) STAT1 Mediates Oroxylin A Inhibition of iNOS and Pro-Inflammatory Cytokines Expression in Microglial BV-2 Cells. PLoS ONE 7(12): e50363. doi:10.1371/journal.pone.0050363	[Liu, Po-Wen; Tsai, Andy Po-Yi; Lee, Tony J. F.] Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan; [Lee, Tony J. F.] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Chen, Mei-Fang; Lee, Tony J. F.] Tzu Chi Univ, Coll Life Sci, Ctr Vasc Med, Hualien, Taiwan; [Chen, Mei-Fang] Buddhist Tzu Chi Gen Hosp, Dept Res, Hualien, Taiwan; [Chen, Mei-Fang] Tzu Chi Coll Technol, Hualien, Taiwan; [Lee, Tony J. F.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Tzu Chi University; Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University of Science & Technology; Southern Illinois University System; Southern Illinois University	Lee, TJF (corresponding author), Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan.	tlee@mail.tcu.edu.tw	Tsai, Andy/AAP-2963-2021; TSAI, ANDY/AAT-2711-2021	Tsai, Andy/0000-0001-6400-544X; 	Tzu Chi University [TCIRP 95005-01, TCIRP 95005-02, TCIRP 98005-01, TCIRP 98005-02, TCRPP99006]; National Science Council of Taiwan [NSC-95-2320-B-320-013-MY2, NSC-96-2320-B-320-005-MY3, NSC-99-2320-B-320-008, NSC-99-2120-M-259001, NSC 100-2320-B-320-007-MY2]; Tzu Chi Foundation	Tzu Chi University; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Tzu Chi Foundation	This study was supported by Tzu Chi University (Grants TCIRP 95005-01, TCIRP 95005-02, TCIRP 98005-01, TCIRP 98005-02, and TCRPP99006), National Science Council of Taiwan (NSC-95-2320-B-320-013-MY2, NSC-96-2320-B-320-005-MY3, NSC-99-2320-B-320-008, NSC-99-2120-M-259001, and NSC 100-2320-B-320-007-MY2), and Tzu Chi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Beck KF, 1996, FEBS LETT, V394, P263, DOI 10.1016/0014-5793(96)00966-0; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Chang LC, 2008, BIOCHEM PHARMACOL, V76, P507, DOI 10.1016/j.bcp.2008.06.002; Chen YC, 2000, BIOCHEM PHARMACOL, V59, P1445, DOI 10.1016/S0006-2952(00)00255-0; Combs CK, 2000, J NEUROSCI, V20, P558, DOI 10.1523/JNEUROSCI.20-02-00558.2000; Gao HM, 2003, FASEB J, V17, P1957, DOI 10.1096/fj.03-0203fje; Ghosh CC, 2010, J IMMUNOL, V185, P3685, DOI 10.4049/jimmunol.0902230; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Hammermann R, 2000, MOL PHARMACOL, V58, P1294, DOI 10.1124/mol.58.6.1294; Ichikawa T, 2009, J ETHNOPHARMACOL, V125, P145, DOI 10.1016/j.jep.2009.05.032; Jacobs AT, 2001, J BIOL CHEM, V276, P47950, DOI 10.1074/jbc.M106639200; Kim DH, 2008, NEUROPHARMACOLOGY, V55, P639, DOI 10.1016/j.neuropharm.2008.05.019; Kim DH, 2006, PHARMACOL BIOCHEM BE, V85, P658, DOI 10.1016/j.pbb.2006.10.025; Kim HP, 2004, J PHARMACOL SCI, V96, P229, DOI 10.1254/jphs.CRJ04003X; Lahti A, 2003, MOL PHARMACOL, V64, P308, DOI 10.1124/mol.64.2.308; Liberatore GT, 1999, NAT MED, V5, P1403; Mander P, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-20; Mizuno T, 2004, NEUROPHARMACOLOGY, V46, P404, DOI 10.1016/j.neuropharm.2003.09.009; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Okugawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC399, DOI 10.1152/ajpcell.00026.2003; Pautz A, 2009, J BIOL CHEM, V284, P2755, DOI 10.1074/jbc.M809314200; Pearson VL, 1999, GLIA, V25, P311, DOI 10.1002/(SICI)1098-1136(19990215)25:4<311::AID-GLIA1>3.3.CO;2-5; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Pham TAN, 2012, BIOORG MED CHEM LETT, V22, P2534, DOI 10.1016/j.bmcl.2012.01.135; Possel H, 2000, GLIA, V32, P51, DOI 10.1002/1098-1136(200010)32:1<51::AID-GLIA50>3.0.CO;2-4; Prele CM, 2008, J IMMUNOL, V181, P8018, DOI 10.4049/jimmunol.181.11.8018; Salonen T, 2006, BRIT J PHARMACOL, V147, P790, DOI 10.1038/sj.bjp.0706672; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Sareila O, 2008, J PHARMACOL EXP THER, V324, P858, DOI 10.1124/jpet.107.129114; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Takeuchi H, 2006, NEUROBIOL DIS, V22, P33, DOI 10.1016/j.nbd.2005.09.014; Tedeschi E, 2004, MOL PHARMACOL, V65, P111, DOI 10.1124/mol.65.1.111; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Wang MJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-99; Won JS, 2004, FREE RADICAL BIO MED, V37, P1834, DOI 10.1016/j.freeradbiomed.2004.08.017	40	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50363	10.1371/journal.pone.0050363	http://dx.doi.org/10.1371/journal.pone.0050363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236370	gold, Green Submitted, Green Published			2022-12-27	WOS:000312589700012
J	Helfer, JL; White, ER; Christie, BR				Helfer, Jennifer L.; White, Emily R.; Christie, Brian R.			Enhanced Deficits in Long-Term Potentiation in the Adult Dentate Gyrus with 2nd Trimester Ethanol Consumption	PLOS ONE			English	Article							PRENATAL PROTEIN-MALNUTRITION; FETAL ALCOHOL SYNDROME; DECARBOXYLASE IMMUNOREACTIVE CELLS; BINDING-SITE DENSITY; BRAIN GROWTH SPURT; HIPPOCAMPAL-FORMATION; POSTNATAL EXPOSURE; RAT HIPPOCAMPUS; EARLY UNDERNUTRITION; SYNAPTIC PLASTICITY	Ethanol exposure during pregnancy can cause structural and functional changes in the brain that can impair cognitive capacity. The hippocampal formation, an area of the brain strongly linked with learning and memory, is particularly vulnerable to the teratogenic effects of ethanol. In the present experiments we sought to determine if the functional effects of developmental ethanol exposure could be linked to ethanol exposure during any single trimester-equivalent. Ethanol exposure during the 1st or 3rd trimester-equivalent produced only minor changes in synaptic plasticity in adult offspring. In contrast, ethanol exposure during the 2nd trimester equivalent resulted in a pronounced decrease in long-term potentiation, indicating that the timing of exposure influences the severity of the deficit. Together, the results from these experiments demonstrate long-lasting alterations in synaptic plasticity as the result of developmental ethanol exposure and dependent on the timing of exposure. Furthermore, these results allude to neural circuit malfunction within the hippocampal formation, perhaps relating to the learning and memory deficits observed in individuals with fetal alcohol spectrum disorders.	[Helfer, Jennifer L.; White, Emily R.; Christie, Brian R.] Univ Victoria, Div Med Sci, Victoria, BC, Canada; [Helfer, Jennifer L.; Christie, Brian R.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [White, Emily R.; Christie, Brian R.] Univ Victoria, Grad Program Neurosci, Victoria, BC, Canada; [Christie, Brian R.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Christie, Brian R.] Univ British Columbia, Grad Program Neurosci, Vancouver, BC V5Z 1M9, Canada; [Christie, Brian R.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of Victoria; University of Victoria; University of Victoria; University of British Columbia; University of British Columbia; University of British Columbia	Christie, BR (corresponding author), Univ Victoria, Div Med Sci, Victoria, BC, Canada.	brain64@uvic.ca	Christie, Brian Ross/AAF-3766-2019	Christie, Brian Ross/0000-0002-6830-0160; Helfer, Jennifer/0000-0002-3769-0602	Candian Institute for Health Research (CIHR)	Candian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding for this work was supplied by the Candian Institute for Health Research (CIHR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; Altman J., 1975, HIPPOCAMPUS STRUCTUR, P95, DOI [10.1007/978-1-4684-2976-3_5, DOI 10.1007/978-1-4684-2976-3_5]; ANGEVINE JB, 1965, EXP NEUROL, VS, P1; AUSTIN KB, 1986, DEV BRAIN RES, V29, P267, DOI 10.1016/0165-3806(86)90102-1; BARNES DE, 1981, DEV BRAIN RES, V1, P333, DOI 10.1016/0165-3806(81)90071-7; BAYER SA, 1975, EXP NEUROL, V48, P167, DOI 10.1016/0014-4886(75)90231-9; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; Bellinger FP, 1999, SYNAPSE, V31, P51, DOI 10.1002/(SICI)1098-2396(199901)31:1<51::AID-SYN7>3.0.CO;2-O; Bronzino JD, 1997, EXP NEUROL, V148, P317, DOI 10.1006/exnr.1997.6653; Byrnes ML, 2004, NEUROTOXICOL TERATOL, V26, P543, DOI 10.1016/j.ntt.2004.04.005; Ceranik K, 1999, EUR J NEUROSCI, V11, P4278, DOI 10.1046/j.1460-9568.1999.00860.x; Christie BR, 2005, EUR J NEUROSCI, V21, P1719, DOI 10.1111/j.1460-9568.2005.04004.x; CLARREN SK, 1978, J PEDIATR-US, V92, P64, DOI 10.1016/S0022-3476(78)80072-9; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Costa ET, 2000, J BIOL CHEM, V275, P38268, DOI 10.1074/jbc.M004136200; CRAIN B, 1973, BRAIN RES, V63, P195, DOI 10.1016/0006-8993(73)90088-7; Datta S, 2000, J SLEEP RES, V9, P71, DOI 10.1046/j.1365-2869.2000.00179.x; de Rooij SR, 2010, P NATL ACAD SCI USA, V107, P16881, DOI 10.1073/pnas.1009459107; DEBASSIO WA, 1994, BRAIN RES BULL, V35, P57, DOI 10.1016/0361-9230(94)90216-X; Debassio WA, 1996, BRAIN RES BULL, V41, P379, DOI 10.1016/S0361-9230(96)00214-6; DiazGranados JL, 1997, ALCOHOL CLIN EXP RES, V21, P874, DOI 10.1097/00000374-199708000-00016; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; DREOSTI IE, 1993, ANN NY ACAD SCI, V678, P193; Ethen M, 2009, MATERN CHILD HLTH J, V13, P274, DOI 10.1007/s10995-008-0328-2; Fisher H, 1997, ALCOHOL, V14, P199, DOI 10.1016/S0741-8329(97)83140-0; FISHER SE, 1988, ALCOHOL CLIN EXP RES, V12, P417, DOI 10.1111/j.1530-0277.1988.tb00219.x; Gloria L, 1997, AM J GASTROENTEROL, V92, P485; Goodlett CR, 1998, NEUROTOXICOL TERATOL, V20, P285, DOI 10.1016/S0892-0362(97)00102-5; Goodlett CR, 1997, NEUROTOXICOL TERATOL, V19, P435, DOI 10.1016/S0892-0362(97)00062-7; GREEN PHR, 1983, CLIN GASTROENTEROL, V12, P563; Guerri C, 2009, ALCOHOL ALCOHOLISM, V44, P108, DOI 10.1093/alcalc/agn105; HALL JL, 1994, PSYCHOBIOLOGY, V22, P181; Helfer JL, 2009, BRAIN RES, V1294, P1, DOI 10.1016/j.brainres.2009.07.090; Helfer JL, 2009, J COMP NEUROL, V514, P259, DOI 10.1002/cne.22018; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; JORDAN TC, 1983, BEHAV NEUROSCI, V97, P319, DOI 10.1037/0735-7044.97.2.319; JORDAN TC, 1982, RES EXP MED, V180, P201, DOI 10.1007/BF01852291; KOTCH LE, 1992, INT J DEV NEUROSCI, V10, P273, DOI 10.1016/0736-5748(92)90016-S; KOTKOSKIE LA, 1988, ALCOHOL CLIN EXP RES, V12, P831, DOI 10.1111/j.1530-0277.1988.tb01355.x; Krahl SE, 1999, ALCOHOL, V17, P125, DOI 10.1016/S0741-8329(98)00043-3; Kuhn HG, 2011, EUR J NEUROSCI, V33, P1115, DOI 10.1111/j.1460-9568.2011.07610.x; Kumada T, 2006, J NEUROSCI, V26, P742, DOI 10.1523/JNEUROSCI.4478-05.2006; Maier SE, 1996, PHARMACOL BIOCHEM BE, V55, P521, DOI 10.1016/S0091-3057(96)00282-1; Maier SE, 2001, ALCOHOL RES HEALTH, V25, P168; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; MCGIVERN RF, 1993, ALCOHOL CLIN EXP RES, V17, P1215, DOI 10.1111/j.1530-0277.1993.tb05232.x; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; MIDDAUGH LD, 1991, ALCOHOL CLIN EXP RES, V15, P919, DOI 10.1111/j.1530-0277.1991.tb05189.x; MILLER MW, 1995, ALCOHOL CLIN EXP RES, V19, P1359, DOI 10.1111/j.1530-0277.1995.tb01625.x; MILLER MW, 1993, ALCOHOL CLIN EXP RES, V17, P304, DOI 10.1111/j.1530-0277.1993.tb00768.x; MILLER MW, 1986, SCIENCE, V233, P1308, DOI 10.1126/science.3749878; Miller MW, 1995, ALCOHOL CLIN EXP RES, V19, P1500, DOI 10.1111/j.1530-0277.1995.tb01014.x; Morgane PJ, 2002, NEUROSCI BIOBEHAV R, V26, P471, DOI 10.1016/S0149-7634(02)00012-X; Nixon K, 2004, ALCOHOL CLIN EXP RES, V28, P105, DOI 10.1097/01.ALC.0000106311.88523.7B; Palmer AA, 2008, BRAIN RES, V1237, P62, DOI 10.1016/j.brainres.2008.07.089; RAO GA, 1987, HEPATOLOGY, V7, P416, DOI 10.1002/hep.1840070248; Richardson DP, 2002, EUR J NEUROSCI, V16, P1593, DOI 10.1046/j.1460-9568.2002.02214.x; River C, 2012, SPRAGUE DAWLEY RATS; Rosoklija G, 2000, ARCH GEN PSYCHIAT, V57, P349, DOI 10.1001/archpsyc.57.4.349; Rotta LN, 2003, NEUROCHEM RES, V28, P1181, DOI 10.1023/A:1024272227219; Rubert G, 2006, J NEUROSCI RES, V84, P483, DOI 10.1002/jnr.20963; SAVAGE DD, 1992, ALCOHOL, V9, P37, DOI 10.1016/0741-8329(92)90007-W; SAVAGE DD, 1991, ALCOHOL, V8, P193, DOI 10.1016/0741-8329(91)90806-8; SCHENKER S, 1990, J LAB CLIN MED, V116, P106; SERESS L, 1977, ANAT EMBRYOL, V151, P335, DOI 10.1007/BF00318935; Seress L, 2007, PROG BRAIN RES, V163, P23; Shultz PL, 1999, BEHAV PHARMACOL, V10, P379, DOI 10.1097/00008877-199907000-00005; Sliwowska JH, 2008, PSYCHONEUROENDOCRINO, V33, P1111, DOI 10.1016/j.psyneuen.2008.05.001; SMART JL, 1990, UPSALA J MED SCI, P21; SORIANO E, 1989, J COMP NEUROL, V281, P603, DOI 10.1002/cne.902810409; SORIANO E, 1989, J COMP NEUROL, V281, P586, DOI 10.1002/cne.902810408; Stratton K., 1996, FETAL ALCOHOL SYNDRO; STREISSGUTH AP, 1994, DRUG ALCOHOL DEPEN, V36, P89, DOI 10.1016/0376-8716(94)90090-6; Sulik KK, 2005, EXP BIOL MED, V230, P366, DOI 10.1177/15353702-0323006-04; SUPER H, 1994, J COMP NEUROL, V344, P101, DOI 10.1002/cne.903440108; Sutherland RJ, 1997, HIPPOCAMPUS, V7, P232, DOI 10.1002/(SICI)1098-1063(1997)7:2<232::AID-HIPO9>3.0.CO;2-O; SWARTZWELDER HS, 1988, ALCOHOL, V5, P121, DOI 10.1016/0741-8329(88)90008-0; TAN SE, 1990, ALCOHOL, V7, P507, DOI 10.1016/0741-8329(90)90040-J; Tateno M, 2004, ALCOHOL CLIN EXP RES, V28, p134S, DOI 10.1097/01.ALC.0000133538.40841.36; Titterness AK, 2012, HIPPOCAMPUS, V22, P69, DOI 10.1002/hipo.20849; TONKISS J, 1990, BEHAV BRAIN RES, V40, P95, DOI 10.1016/0166-4328(90)90002-V; TONKISS J, 1990, PHYSIOL BEHAV, V48, P73, DOI 10.1016/0031-9384(90)90263-4; Tran TD, 2003, NEUROTOXICOL TERATOL, V25, P519, DOI 10.1016/S0892-0362(03)00074-6; Varaschin RK, 2010, J PHARMACOL EXP THER, V334, P191, DOI 10.1124/jpet.109.165027; WEST JR, 1984, CIBA F SYMP, V105, P8; Young CL, 2008, NEUROBIOL DIS, V31, P355, DOI 10.1016/j.nbd.2008.05.009	87	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51344	10.1371/journal.pone.0051344	http://dx.doi.org/10.1371/journal.pone.0051344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227262	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200121
J	Kajitani, N; Hisaoka-Nakashima, K; Morioka, N; Okada-Tsuchioka, M; Kaneko, M; Kasai, M; Shibasaki, C; Nakata, Y; Takebayashi, M				Kajitani, Naoto; Hisaoka-Nakashima, Kazue; Morioka, Norimitsu; Okada-Tsuchioka, Mami; Kaneko, Masahiro; Kasai, Miho; Shibasaki, Chiyo; Nakata, Yoshihiro; Takebayashi, Minoru			Antidepressant Acts on Astrocytes Leading to an Increase in the Expression of Neurotrophic/Growth Factors: Differential Regulation of FGF-2 by Noradrenaline	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; CULTURED RAT ASTROCYTES; HIPPOCAMPAL-NEURONS; MAJOR DEPRESSION; MESSENGER-RNA; GLIAL-CELLS; TRANSCRIPTIONAL REGULATION; KINASE ACTIVATION; ASTROGLIAL CELLS; BRAIN	Recently, multiple neurotrophic/growth factors have been proposed to play an important role in the therapeutic action of antidepressants. In this study, we prepared astrocyte-and neuron-enriched cultures from the neonatal rat cortex, and examined the changes in neurotrophic/growth factor expression by antidepressant treatment using real-time PCR. Treatment with amitriptyline (a tricyclic antidepressant) significantly increased the expression of fibroblast growth factor-2 (FGF-2), brain-derived neurotrophic factor, vascular endothelial growth factor and glial cell line-derived neurotrophic factor mRNA with a different time course in astrocyte cultures, but not in neuron-enriched cultures. Only the expression of FGF-2 was higher in astrocyte cultures than in neuron-enriched cultures. We focused on the FGF-2 production in astrocytes. Several different classes of antidepressants, but not non-antidepressants, also induced FGF-2 mRNA expression. Noradrenaline (NA) is known to induce FGF-2 expression in astrocyte cultures, as with antidepressants. Therefore, we also assessed the mechanism of NA-induced FGF-2 expression, in comparison to amitriptyline. NA increased the FGF-2 mRNA expression via alpha 1 and beta-adrenergic receptors; however, the amitriptyline-induced FGF-2 mRNA expression was not mediated via these adrenergic receptors. Furthermore, the amitriptyline-induced FGF-2 mRNA expression was completely blocked by cycloheximide (an inhibitor of protein synthesis), while the NA-induced FGF-2 mRNA was not. These data suggest that the regulation of FGF-2 mRNA expression by amitriptyline was distinct from that by NA. Taken together, antidepressant-stimulated astrocytes may therefore be important mediators that produce several neurotrophic/growth factors, especially FGF-2, through a monoamine-independent and a de novo protein synthesis-dependent mechanism.	[Kajitani, Naoto; Okada-Tsuchioka, Mami; Shibasaki, Chiyo; Takebayashi, Minoru] Natl Hosp Org NHO Kure Med Ctr, Div Psychiat & Neurosci, Inst Clin Res, Kure, Hiroshima, Japan; [Kajitani, Naoto; Okada-Tsuchioka, Mami; Shibasaki, Chiyo; Takebayashi, Minoru] Chugoku Canc Ctr, Kure, Hiroshima, Japan; [Kajitani, Naoto; Hisaoka-Nakashima, Kazue; Morioka, Norimitsu; Kaneko, Masahiro; Kasai, Miho; Nakata, Yoshihiro] Hiroshima Univ, Dept Pharmacol, Grad Sch Biomed Sci, Hiroshima, Japan; [Shibasaki, Chiyo; Takebayashi, Minoru] Natl Hosp Org NHO Kure Med Ctr, Dept Psychiat, Kure, Hiroshima, Japan	Hiroshima University	Takebayashi, M (corresponding author), Natl Hosp Org NHO Kure Med Ctr, Div Psychiat & Neurosci, Inst Clin Res, Kure, Hiroshima, Japan.	mtakebayashi@kure-nh.go.jp	Morioka, Norimitsu/J-3165-2019	Morioka, Norimitsu/0000-0001-9148-4167; Kajitani, Naoto/0000-0001-7245-9206	JSPS KAKENHI [23591686, 23790297, 24006852]; Pharmacological Research Foundation, Tokyo; SENSHIN Medical Research Foundation, Osaka; Grants-in-Aid for Scientific Research [12J06852] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Pharmacological Research Foundation, Tokyo(Pharmacological Research Foundation, Tokyo); SENSHIN Medical Research Foundation, Osaka; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grant Number 23591686, 23790297, 24006852 and by the Pharmacological Research Foundation, Tokyo and by a grant from SENSHIN Medical Research Foundation, Osaka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, PSYCHOPHARMACOLOGY, V216, P75, DOI 10.1007/s00213-011-2190-y; Audigier S, 2008, RNA, V14, P1852, DOI 10.1261/rna.790608; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bachis A, 2008, NEUROPHARMACOLOGY, V55, P1114, DOI 10.1016/j.neuropharm.2008.07.014; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; BAUMANN P, 1984, PSYCHOPHARMACOLOGY, V84, P489, DOI 10.1007/BF00431455; Biesiada E, 1996, J BIOL CHEM, V271, P18576, DOI 10.1074/jbc.271.31.18576; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Chen FH, 2010, HIPPOCAMPUS, V20, P1376, DOI 10.1002/hipo.20718; Chen MJ, 2007, CELL SIGNAL, V19, P114, DOI 10.1016/j.cellsig.2006.05.028; CHEN Y, 1995, BRAIN RES BULL, V38, P153, DOI 10.1016/0361-9230(95)00082-P; Czeh B., 2012, EUR NEUROPSYCHOPHARM; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Elsayed M, 2012, BIOL PSYCHIAT, V72, P258, DOI 10.1016/j.biopsych.2012.03.003; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; Fuchikami M, 2009, INT J NEUROPSYCHOPH, V12, P73, DOI 10.1017/S1461145708008997; FURUKAWA S, 1987, BIOCHEM BIOPH RES CO, V147, P1048, DOI 10.1016/S0006-291X(87)80176-6; GLOTZBACH RK, 1982, PSYCHOPHARMACOLOGY, V78, P25, DOI 10.1007/BF00470582; Hisaoka K, 2007, J PHARMACOL EXP THER, V321, P148, DOI 10.1124/jpet.106.116558; Hisaoka K, 2011, J BIOL CHEM, V286, P21118, DOI 10.1074/jbc.M111.224683; Iwata M, 2011, HIPPOCAMPUS, V21, P877, DOI 10.1002/hipo.20803; Jarosik J, 2011, RESTOR NEUROL NEUROS, V29, P153, DOI 10.3233/RNN-2011-0588; Juric DM, 2006, BRAIN RES, V1108, P54, DOI 10.1016/j.brainres.2006.06.008; Kim Y, 2011, PROG NEURO-PSYCHOPH, V35, P1026, DOI 10.1016/j.pnpbp.2011.02.012; Krzan M, 2001, J NEUROSCI RES, V64, P261, DOI 10.1002/jnr.1074; Li AJ, 2002, EUR J NEUROSCI, V16, P1313, DOI 10.1046/j.1460-9568.2002.02193.x; Liu Q, 2009, EUR NEUROPSYCHOPHARM, V19, P796, DOI 10.1016/j.euroneuro.2009.06.010; Luo XY, 2009, J NEUROCHEM, V108, P952, DOI 10.1111/j.1471-4159.2008.05845.x; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Malberg JE, 2004, J PSYCHIATR NEUROSCI, V29, P196; Mallei A, 2002, MOL PHARMACOL, V61, P1017, DOI 10.1124/mol.61.5.1017; Mercier G, 2004, J MOL NEUROSCI, V24, P207, DOI 10.1385/JMN:24:2:207; MIYAKE K, 1990, J PHARM SCI, V79, P288, DOI 10.1002/jps.2600790403; Moffett J, 1998, MOL BIOL CELL, V9, P2269, DOI 10.1091/mbc.9.8.2269; Morishima T, 2008, NEUROSCI RES, V61, P18, DOI 10.1016/j.neures.2008.01.005; Mudo G, 2009, J NEURAL TRANSM, V116, P995, DOI 10.1007/s00702-009-0207-z; Nelson AD, 2006, MOL CELL NEUROSCI, V33, P29, DOI 10.1016/j.mcn.2006.06.003; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Numakawa T, 2002, J BIOL CHEM, V277, P6520, DOI 10.1074/jbc.M109139200; O'Donnell JM, 2011, GOODMAN GILMANS PHAR, V12th, P397; Ongur D, 1998, P NATL ACAD SCI USA, V95, P13290; Overstreet DH, 2010, PHARMACOL BIOCHEM BE, V94, P553, DOI 10.1016/j.pbb.2009.11.010; Pav M, 2008, PHYSIOL RES, V57, P151, DOI 10.33549/physiolres.930990; PROUTY RW, 1990, J FORENSIC SCI, V35, P243; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Riva MA, 1996, MOL PHARMACOL, V49, P699; Sergent-Tanguy S, 2006, J NEUROSCI RES, V83, P1515, DOI 10.1002/jnr.20846; Seth P, 2008, J BIOSCIENCES, V33, P405, DOI 10.1007/s12038-008-0060-5; Shinozaki Y, 2005, GLIA, V49, P288, DOI 10.1002/glia.20118; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Slezak M, 2003, TRENDS NEUROSCI, V26, P531, DOI 10.1016/j.tins.2003.08.005; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Sugimoto T, 2011, NEUROSCIENCE, V185, P1, DOI 10.1016/j.neuroscience.2011.04.024; Takebayashi M, 2009, RECENT DEV DEPRESSIO, P125; Tsuchioka M, 2008, J NEUROCHEM, V106, P244, DOI 10.1111/j.1471-4159.2008.05357.x; Turner CA, 2008, BRAIN RES, V1224, P63, DOI 10.1016/j.brainres.2008.05.088; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; Warner-Schmidt JL, 2007, P NATL ACAD SCI USA, V104, P4647, DOI 10.1073/pnas.0610282104; Yan M, 2011, NEUROCHEM INT, V58, P549, DOI 10.1016/j.neuint.2011.01.013; Zhang XB, 2008, PROG NEURO-PSYCHOPH, V32, P886, DOI 10.1016/j.pnpbp.2008.01.004	63	65	67	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51197	10.1371/journal.pone.0051197	http://dx.doi.org/10.1371/journal.pone.0051197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227251	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200110
J	Morano, M; Colella, D; Rutigliano, I; Fiore, P; Pettoello-Mantovani, M; Campanozzi, A				Morano, Milena; Colella, Dario; Rutigliano, Irene; Fiore, Pietro; Pettoello-Mantovani, Massimo; Campanozzi, Angelo			Changes in Actual and Perceived Physical Abilities in Clinically Obese Children: A 9-Month Multi-Component Intervention Study	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; MOTOR-PERFORMANCE; SELF-PERCEPTION; BODY-IMAGE; OVERWEIGHT; ADOLESCENTS; HEALTH; EXERCISE; FITNESS	Objectives: (1) To examine relationships among changes in physical activity, physical fitness and some psychosocial determinants of activity behavior in a clinical sample of obese children involved in a multi-component program; (2) to investigate the causal relationship over time between physical activity and one of its strongest correlates (i.e. perceived physical ability). Methods: Self-reported physical activity and health-related fitness tests were administered before and after a 9-month intervention in 24 boys and 20 girls aged 8 to 11 years. Individuals' perceptions of strength, speed and agility were assessed using the Perceived Physical Ability Scale, while body image was measured using Collins' Child Figure Drawings. Results: Findings showed that body mass index, physical activity, performances on throwing and weight-bearing tasks, perceived physical ability and body image significantly improved after treatment among obese children. Gender differences were found in the correlational analyses, showing a link between actual and perceived physical abilities in boys, but not in girls. For the specific measurement interval of this study, perception of physical ability was an antecedent and not a potential consequence of physical activity. Conclusions: Results indicate that a multi-component activity program not based merely on a dose-effect approach enhances adherence of the participants and has the potential to increase the lifelong exercise skills of obese children. Rather than focusing entirely on diet and weight loss, findings support the inclusion of interventions directed toward improving perceived physical ability that is predictive of subsequent physical activity.	[Morano, Milena; Colella, Dario] Univ Foggia, Dept Biomed Sci Motor Act & Sport Sci, Foggia, Italy; [Fiore, Pietro] Univ Foggia, Dept Med Sci, Phys Med & Rehabil Unit, Foggia, Italy; Univ Foggia, Phys Med & Rehabil Unit, Foggia, Italy	University of Foggia; University of Foggia; University of Foggia	Morano, M (corresponding author), Univ Foggia, Dept Biomed Sci Motor Act & Sport Sci, Foggia, Italy.	milenamorano@gmail.com	Rutigliano, Irene/AAB-3458-2021; Campanozzi, Angelo/AAR-6227-2020; Morano, Milena/GNH-4072-2022; MANTOVANI, Massimo PETTOELLO/AAC-1990-2019	Campanozzi, Angelo/0000-0002-3489-2524; Morano, Milena/0000-0003-2574-6055; MANTOVANI, Massimo PETTOELLO/0000-0002-0688-1131; Rutigliano, Irene/0000-0003-3217-5393; FIORE, PIETRO/0000-0001-5621-2393	Italian Ministry of Education, University and Research [2009PMTYTP]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This study was funded by the Italian Ministry of Education, University and Research in the framework of the Projects of Relevant National Interest (PRIN 2009), according to the Italian Ministerial Decree No. 404/Recognised of 14 July 2011 (2009PMTYTP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, YOUTH PHYS ACTIVITY; [Anonymous], 2007, FITNESSGRAM ACTIVITY; Atlantis E, 2006, INT J OBESITY, V30, P1027, DOI 10.1038/sj.ijo.0803286; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Barnett LM, 2011, MED SCI SPORT EXER, V43, P898, DOI 10.1249/MSS.0b013e3181fdfadd; Barnett LM, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-40; Bortoli L, 1997, PERCEPT MOTOR SKILL, V85, P187, DOI 10.2466/pms.1997.85.1.187; BROOK CGD, 1971, ARCH DIS CHILD, V46, P182, DOI 10.1136/adc.46.246.182; Chen LJ, 2010, WOMEN STUD INT FORUM, V33, P234, DOI 10.1016/j.wsif.2010.01.003; Cliff DP, 2010, OBES REV, V11, P516, DOI 10.1111/j.1467-789X.2009.00625.x; Cohen J., 2003, APPL MULTIPLE REGRES; Colella D, 2009, PERCEPT MOTOR SKILL, V108, P209, DOI 10.2466/PMS.108.1.209-218; COLLINS ME, 1991, INT J EAT DISORDER, V10, P199, DOI 10.1002/1098-108X(199103)10:2&lt;199::AID-EAT2260100209&gt;3.0.CO;2-D; *COMM EXP SPORTS R, 1993, HDB EUR TESTS PHYS F; Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011; Crocker PRE, 2000, J SPORT SCI, V18, P383, DOI 10.1080/02640410050074313; CURETON KJ, 1995, MED SCI SPORT EXER, V27, P445; Deforche B, 2004, PATIENT EDUC COUNS, V55, P407, DOI 10.1016/j.pec.2003.07.012; Fulton JE, 2004, SPORTS MED, V34, P581, DOI 10.2165/00007256-200434090-00003; Goldfield GS, 2007, J PEDIATR PSYCHOL, V32, P783, DOI 10.1093/jpepsy/jsm017; Harter S, 1985, MANUAL SELF PERCEPTI; Hopkins W.G., 2002, SCALE MAGNITUDES EFF; Kamath CC, 2008, J CLIN ENDOCR METAB, V93, P4606, DOI 10.1210/jc.2006-2411; Kessler R. C., 1981, LINEAR PANEL ANAL MO; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P174, DOI 10.1123/pes.9.2.174; Kuczmarski Robert J, 2002, Vital Health Stat 11, P1; Martin KA, 2004, BODY IMAGE HDB THEOR, P414; Moller NC, 2007, SCAND J MED SCI SPOR, V17, P331, DOI 10.1111/j.1600-0838.2006.00583.x; Morano M, 2011, SCAND J MED SCI SPOR, V21, P465, DOI 10.1111/j.1600-0838.2009.01068.x; Morrow JR., 2005, MEASUREMENT EVOLUTIO, V3rd, P416; Norton K, 1996, ANTHROPOMETRICA, V1, P25; O'Dea JA, 2005, HEALTH EDUC, V105, P11, DOI 10.1108/09654280510572277; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Reilly JJ, 2005, BEST PRACT RES CL EN, V19, P327, DOI 10.1016/j.beem.2005.04.002; Rowland T.W., 2005, CHILDRENS EXERCISE P; Siri W., 1961, TECHNIQUES MEASURING, P223; Spinelli A., 2009, 0924 ISTISAN; Stodden DF, 2008, QUEST, V60, P290, DOI 10.1080/00336297.2008.10483582; Sung RYT, 2005, EUR J CLIN NUTR, V59, P101, DOI 10.1038/sj.ejcn.1602044; Tanaka C., 2006, BODY IMAGE NEW RES, P243; Taris T. W., 2000, PRIMER LONGITUDINAL; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Watts K, 2005, SPORTS MED, V35, P375, DOI 10.2165/00007256-200535050-00002	44	16	16	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50782	10.1371/journal.pone.0050782	http://dx.doi.org/10.1371/journal.pone.0050782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23239985	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200068
J	Yahata, K; Treeck, M; Culleton, R; Gilberger, TW; Kaneko, O				Yahata, Kazuhide; Treeck, Moritz; Culleton, Richard; Gilberger, Tim-Wolf; Kaneko, Osamu			Time-Lapse Imaging of Red Blood Cell Invasion by the Rodent Malaria Parasite Plasmodium yoelii	PLOS ONE			English	Article							MEMBRANE ANTIGEN 1; FALCIPARUM MEROZOITES; MOVING JUNCTION; PROTEIN; TRANSFECTION; ERYTHROCYTE; TRANSFORMATION; TOXOPLASMA; MATURATION; VIRULENCE	In order to propagate within the mammalian host, malaria parasites must invade red blood cells (RBCs). This process offers a window of opportunity in which to target the parasite with drugs or vaccines. However, most of the studies relating to RBC invasion have analyzed the molecular interactions of parasite proteins with host cells under static conditions, and the dynamics of these interactions remain largely unstudied. Time-lapse imaging of RBC invasion is a powerful technique to investigate cell invasion and has been reported for Plasmodium knowlesi and Plasmodium falciparum. However, experimental modification of genetic loci is laborious and time consuming for these species. We have established a system of time-lapse imaging for the rodent malaria parasite Plasmodium yoelii, for which modification of genetic loci is quicker and simpler. We compared the kinetics of RBC invasion by P. yoelii with that of P. falciparum and found that the overall kinetics during invasion were similar, with some exceptions. The most striking of these differences is that, following egress from the RBC, the shape of P. yoelii merozoites gradually changes from flat elongated ovals to spherical bodies, a process taking about 60 sec. During this period merozoites were able to attach to and deform the RBC membrane, but were not able to reorient and invade. We propose that this morphological change of P. yoelii merozoites may be related to the secretion or activation of invasion-related proteins. Thus the P. yoelii merozoite appears to be an excellent model to analyze the molecular dynamics of RBC invasion, particularly during the morphological transition phase, which could serve as an expanded window that cannot be observed in P. falciparum.	[Yahata, Kazuhide; Culleton, Richard; Kaneko, Osamu] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 852, Japan; [Yahata, Kazuhide; Culleton, Richard; Kaneko, Osamu] Nagasaki Univ, Global COE Program, Nagasaki 852, Japan; [Treeck, Moritz; Gilberger, Tim-Wolf] Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, Hamburg, Germany; [Treeck, Moritz] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Culleton, Richard] Nagasaki Univ, Inst Trop Med NEKKEN, Malaria Unit, Nagasaki 852, Japan; [Gilberger, Tim-Wolf] McMaster Univ, MG DeGroote Inst Infect Dis Res, Dept Pathol & Mol Med, Hamilton, ON, Canada	Nagasaki University; Nagasaki University; Bernhard Nocht Institut fur Tropenmedizin; Stanford University; Nagasaki University; McMaster University	Yahata, K (corresponding author), Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 852, Japan.	kyahata@nagasaki-u.ac.jp; okaneko@nagasaki-u.ac.jp	Treeck, Moritz/O-6662-2017; Treeck, Moritz/X-8007-2019; Treeck, Moritz/Q-9078-2019; Culleton, Richard/H-8327-2014	Treeck, Moritz/0000-0002-9727-6657; Treeck, Moritz/0000-0002-9727-6657; Culleton, Richard/0000-0001-8808-5771; Gilberger, Tim-Wolf/0000-0002-7965-8272	Japan Society for the Promotion of Science (JSPS)-German Research Foundation (DFG) Joint Research Program [09035811-000063]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22790397, 24590509, 22390079]	Japan Society for the Promotion of Science (JSPS)-German Research Foundation (DFG) Joint Research Program; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This project was supported by a Japan Society for the Promotion of Science (JSPS)-German Research Foundation (DFG) Joint Research Program 09035811-000063 (OK). This work was also supported in part by Grants-in-Aids for Scientific Research 22790397 (KY), 24590509 (KY) and 22390079 (OK), and the Global COE Program, Nagasaki University, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; BANNISTER LH, 1995, ANN TROP MED PARASIT, V89, P105, DOI 10.1080/00034983.1995.11812940; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Blackman MJ, 1998, J BIOL CHEM, V273, P23398, DOI 10.1074/jbc.273.36.23398; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Child MA, 2010, MOL MICROBIOL, V78, P187, DOI 10.1111/j.1365-2958.2010.07324.x; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Glushakova S, 2005, CURR BIOL, V15, P1645, DOI 10.1016/j.cub.2005.07.067; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Jongco AM, 2006, MOL BIOCHEM PARASIT, V146, P242, DOI 10.1016/j.molbiopara.2006.01.001; Kaneko O, 2002, MOL BIOCHEM PARASIT, V121, P275, DOI 10.1016/S0166-6851(02)00042-7; Kendric RK, 1978, RODENT MALARIA, P85; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Leykauf K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000941; Li J, 2011, P NATL ACAD SCI USA, V108, pE374, DOI 10.1073/pnas.1102261108; Liu J, 2010, BLOOD, V115, P2021, DOI 10.1182/blood-2009-08-241182; Mota MM, 2001, MOL BIOCHEM PARASIT, V113, P271, DOI 10.1016/S0166-6851(01)00228-6; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Otsuki H, 2009, P NATL ACAD SCI USA, V106, P7167, DOI 10.1073/pnas.0811313106; PETERSON MG, 1989, MOL CELL BIOL, V9, P3151, DOI 10.1128/MCB.9.7.3151; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Spence PJ, 2011, NAT PROTOC, V6, P553, DOI 10.1038/nprot.2011.313; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; VANDIJK MR, 1995, SCIENCE, V268, P1358, DOI 10.1126/science.7761856; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; YOELI M, 1975, ANN TROP MED PARASIT, V69, P173, DOI 10.1080/00034983.1975.11686998; YOELI M, 1974, SCIENCE, V184, P572, DOI 10.1126/science.184.4136.572	34	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50780	10.1371/journal.pone.0050780	http://dx.doi.org/10.1371/journal.pone.0050780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227208	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200067
J	Kamath, PL; Getz, WM				Kamath, Pauline L.; Getz, Wayne M.			Unraveling the Effects of Selection and Demography on Immune Gene Variation in Free-Ranging Plains Zebra (Equus quagga) Populations	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; FREQUENCY-DEPENDENT SELECTION; DNA-SEQUENCES; PHYLOGENETIC ANALYSIS; ARTHROPOD PARASITES; MICROSATELLITE LOCI; MAXIMUM-LIKELIHOOD; STATISTICAL-METHOD; NATURAL-SELECTION; MHC	Demography, migration and natural selection are predominant processes affecting the distribution of genetic variation among natural populations. Many studies use neutral genetic markers to make inferences about population history. However, the investigation of functional coding loci, which directly reflect fitness, is critical to our understanding of species' ecology and evolution. Immune genes, such as those of the Major Histocompatibility Complex (MHC), play an important role in pathogen recognition and provide a potent model system for studying selection. We contrasted diversity patterns of neutral data with MHC loci, ELA-DRA and -DQA, in two southern African plains zebra (Equus quagga) populations: Etosha National Park, Namibia, and Kruger National Park, South Africa. Results from neutrality tests, along with observations of elevated diversity and low differentiation across populations, supported previous genus-level evidence for balancing selection at these loci. Despite being low, MHC divergence across populations was significant and may be attributed to drift effects typical of geographically separated populations experiencing little to no gene flow, or alternatively to shifting allele frequency distributions driven by spatially variable and fluctuating pathogen communities. At the DRA, zebra exhibited geographic differentiation concordant with microsatellites and reduced levels of diversity in Etosha due to highly skewed allele frequencies that could not be explained by demography, suggestive of spatially heterogeneous selection and local adaptation. This study highlights the complexity in which selection affects immune gene diversity and warrants the need for further research on the ecological mechanisms shaping patterns of adaptive variation among natural populations. Citation: Kamath PL, Getz WM (2012) Unraveling the Effects of Selection and Demography on Immune Gene Variation in Free-Ranging Plains Zebra (Equus quagga) Populations. PLoS ONE 7(12): e50971. doi:10.1371/journal.pone.0050971	[Kamath, Pauline L.; Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Getz, Wayne M.] Univ KwaZulu Natal, Sch Math Sci, Durban, South Africa	University of California System; University of California Berkeley; University of Kwazulu Natal	Kamath, PL (corresponding author), US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT 59717 USA.	pkamath@usgs.gov	Kamath, Pauline/H-1358-2013; Getz, Wayne/I-4521-2013	Kamath, Pauline/0000-0002-6458-4514; Getz, Wayne/0000-0001-8784-9354	National Institutes of Health Ecology and Evolution of Infectious Disease Grant [GM083863]; National Science Foundation Doctoral Dissertation Improvement Grant [MCINS-20091291]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER	National Institutes of Health Ecology and Evolution of Infectious Disease Grant; National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a National Institutes of Health Ecology and Evolution of Infectious Disease Grant (GM083863) to WMG and a National Science Foundation Doctoral Dissertation Improvement Grant (MCINS-20091291) to PLK. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2008, MOL ECOL, V17, P2652, DOI 10.1111/j.1365-294X.2008.03791.x; [Anonymous], 2014, TRACER V1 6; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Avise J, 2004, MOL MARKERS NATURAL; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1111/j.1365-294X.1996.tb00329.x; BODMER WF, 1972, NATURE, V237, P139, DOI 10.1038/237139a0; Bos DH, 2007, HEREDITAS, V144, P228, DOI 10.1111/j.2007.0018-0661.01994.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Crawford NG, MOL ECOLOGY RESOURCE, V10, P556; Cutrera AP, 2006, J MAMMAL, V87, P706, DOI 10.1644/05-MAMM-A-383R1.1; De Vos V., 1990, SALISBURY MED B S, V678, P19; Dixon CJ, 2010, MOL ECOL RESOUR, V10, P335, DOI 10.1111/j.1755-0998.2009.02749.x; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Drummond A.J, 2010, GENEIOUS, V5, P3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ebedes H., 1976, MADOQUA, V10, P99; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Ejsmond MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-332; Ekblom R, 2007, MOL ECOL, V16, P1439, DOI 10.1111/j.1365-294X.2007.03281.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frantz AC, 2003, MOL ECOL, V12, P1649, DOI 10.1046/j.1365-294X.2003.01848.x; Fraser DG, 1998, IMMUNOGENETICS, V47, P487, DOI 10.1007/s002510050387; Fu YX, 1997, GENETICS, V147, P915; Garrigan D, 2003, EVOLUTION, V57, P1707; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hansen H, 2008, MOL ECOL RESOUR, V8, P282, DOI 10.1111/j.1471-8286.2007.01992.x; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Harrigan RJ, 2008, MOL ECOL RESOUR, V8, P1239, DOI 10.1111/j.1755-0998.2008.02241.x; Hedrick P, 1998, GENETICS EVOLUTION S, P205; Hedrick PW, 1999, GENETICS, V152, P1701; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; HEDRICK PW, 1987, BIOL J LINN SOC, V31, P311, DOI 10.1111/j.1095-8312.1987.tb01996.x; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HOLM S, 1979, SCAND J STAT, V6, P65; HORAK IG, 1992, ONDERSTEPOORT J VET, V59, P253; HORAK IG, 1984, ONDERSTEPOORT J VET, V51, P145; HUDSON RR, 1992, GENETICS, V132, P583; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Janova E, 2009, IMMUNOGENETICS, V61, P513, DOI 10.1007/s00251-009-0380-0; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kamath PL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-128; KLEIN J, 1986, NATURAL HIST MAJOR H; Kloch A, 2010, MOL ECOL, V19, P255, DOI 10.1111/j.1365-294X.2009.04476.x; KRECEK RC, 1987, J WILDLIFE DIS, V23, P404, DOI 10.7589/0090-3558-23.3.404; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Landry C, 2001, MOL ECOL, V10, P2525, DOI 10.1046/j.1365-294X.2001.01383.x; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; LEWONTIN RC, 1973, GENETICS, V74, P175; LINDEQUE PM, 1994, ONDERSTEPOORT J VET, V61, P71; Loiseau C, 2009, MOL ECOL, V18, P1331, DOI 10.1111/j.1365-294X.2009.04105.x; Lorenzen ED, 2008, MOL ECOL, V17, P2812, DOI 10.1111/j.1365-294X.2008.03781.x; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; LYNCH M, 1990, MOL BIOL EVOL, V7, P478; Matocq MD, 2007, MOL PHYLOGENET EVOL, V42, P637, DOI 10.1016/j.ympev.2006.08.011; Matthee S, 2004, J PARASITOL, V90, P1263, DOI 10.1645/GE-3353; Meyer D, 2001, ANN HUM GENET, V65, P1, DOI 10.1046/j.1469-1809.2001.6510001.x; Miller HC, 2010, MOL ECOL, V19, P3894, DOI 10.1111/j.1365-294X.2010.04771.x; Miller KM, 2001, GENETICA, V111, P237, DOI 10.1023/A:1013716020351; Mona S, 2008, MOL ECOL, V17, P4053, DOI 10.1111/j.1365-294X.2008.03892.x; NEI M, 1981, GENETICS, V97, P145; Nei M., 1987, pi; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Oliver MK, 2009, MOL ECOL, V18, P80, DOI 10.1111/j.1365-294X.2008.04015.x; Owen-Smith N, 2005, J ANIM ECOL, V74, P762, DOI 10.1111/j.1365-2656.2005.00973.x; Paetkau D, 1997, GENETICS, V147, P1943; Pajewski NM, 2011, GENES IMMUN, V12, P457, DOI 10.1038/gene.2011.15; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PIENAAR UDV, 1967, FED PROC, V26, P1496; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Prychitko TM, 1997, MOL PHYLOGENET EVOL, V8, P193, DOI 10.1006/mpev.1997.0420; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Schierup MH, 2000, GENET RES, V76, P51, DOI 10.1017/S0016672300004535; SLADE RW, 1992, GENETICS, V132, P861; SLATKIN M, 1994, GENET RES, V64, P71, DOI 10.1017/S0016672300032560; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; TAKAHATA N, 1990, P NATL ACAD SCI USA, V87, P2419, DOI 10.1073/pnas.87.7.2419; TAKAHATA N, 1990, GENETICS, V124, P967; Turner WC, 2010, J WILDLIFE DIS, V46, P1108, DOI 10.7589/0090-3558-46.4.1108; van Tienderen PH, 2002, TRENDS ECOL EVOL, V17, P577, DOI 10.1016/S0169-5347(02)02624-1; Vranova M, 2011, INFECT GENET EVOL, V11, P1136, DOI 10.1016/j.meegid.2011.04.010; WATTERSON GA, 1978, GENETICS, V88, P405; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wickliffe J.K., 2003, OCCAS PAP MUS TEXAS, V219, P1; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu L, 2005, MOL PHYLOGENET EVOL, V35, P483, DOI 10.1016/j.ympev.2005.01.017; YUHKI N, 1990, P NATL ACAD SCI USA, V87, P836, DOI 10.1073/pnas.87.2.836	112	11	11	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50971	10.1371/journal.pone.0050971	http://dx.doi.org/10.1371/journal.pone.0050971			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251409	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386800024
J	Lambertucci, AC; Lambertucci, RH; Hirabara, SM; Curi, R; Moriscot, AS; Alba-Loureiro, TC; Guimaraes-Ferreira, L; Levada-Pires, AC; Vasconcelos, DAA; Sellitti, DF; Pithon-Curi, TC				Lambertucci, Adriana C.; Lambertucci, Rafael H.; Hirabara, Sandro M.; Curi, Rui; Moriscot, Anselmo S.; Alba-Loureiro, Tatiana C.; Guimaraes-Ferreira, Lucas; Levada-Pires, Adriana C.; Vasconcelos, Diogo A. A.; Sellitti, Donald F.; Pithon-Curi, Tania C.			Glutamine Supplementation Stimulates Protein-Synthetic and Inhibits Protein-Degradative Signaling Pathways in Skeletal Muscle of Diabetic Rats	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; INSULIN-RESISTANCE; AMINO-ACIDS; UBIQUITIN LIGASES; LEUCINE; ATROPHY; METABOLISM; ACTIVATION; EXPRESSION; ATROGIN-1	In this study, we investigated the effect of glutamine (Gln) supplementation on the signaling pathways regulating protein synthesis and protein degradation in the skeletal muscle of rats with streptozotocin (STZ)-induced diabetes. The expression levels of key regulatory proteins in the synthetic pathways (Akt, mTOR, GSK3 and 4E-BP1) and the degradation pathways (MuRF-1 and MAFbx) were determined using real-time PCR and Western blotting in four groups of male Wistar rats; 1) control, non-supplemented with glutamine; 2) control, supplemented with glutamine; 3) diabetic, non-supplemented with glutamine; and 4) diabetic, supplemented with glutamine. Diabetes was induced by the intravenous injection of 65 mg/kg bw STZ in citrate buffer (pH 4.2); the non-diabetic controls received only citrate buffer. After 48 hours, diabetes was confirmed in the STZ-treated animals by the determination of blood glucose levels above 200 mg/dL. Starting on that day, a solution of 1 g/kg bw Gln in phosphate buffered saline (PBS) was administered daily via gavage for 15 days to groups 2 and 4. Groups 1 and 3 received only PBS for the same duration. The rats were euthanized, and the soleus muscles were removed and homogenized in extraction buffer for the subsequent measurement of protein and mRNA levels. The results demonstrated a significant decrease in the muscle Gln content in the diabetic rats, and this level increased toward the control value in the diabetic rats receiving Gln. In addition, the diabetic rats exhibited a reduced mRNA expression of regulatory proteins in the protein synthesis pathway and increased expression of those associated with protein degradation. A reduction in the skeletal muscle mass in the diabetic rats was observed and was alleviated partially with Gln supplementation. The data suggest that glutamine supplementation is potentially useful for slowing the progression of muscle atrophy in patients with diabetes.	[Lambertucci, Adriana C.; Lambertucci, Rafael H.; Hirabara, Sandro M.; Levada-Pires, Adriana C.; Pithon-Curi, Tania C.] Univ Cruzeiro Sul, Postgrad Program Human Movement Sci, Inst Phys Act Sci & Sports, Sao Paulo, Brazil; [Lambertucci, Rafael H.; Curi, Rui; Alba-Loureiro, Tatiana C.; Vasconcelos, Diogo A. A.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Moriscot, Anselmo S.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell Biol & Dev, Sao Paulo, Brazil; [Guimaraes-Ferreira, Lucas] Univ Fed Espirito Santo, Ctr Phys Educ & Sports, Vitoria, ES, Brazil; [Sellitti, Donald F.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA	Universidade Cruzeiro do Sul; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Espirito Santo; Uniformed Services University of the Health Sciences - USA	Pithon-Curi, TC (corresponding author), Univ Cruzeiro Sul, Postgrad Program Human Movement Sci, Inst Phys Act Sci & Sports, Sao Paulo, Brazil.	tcuri@icb.usp.br	Lambertucci, Rafael H/C-6975-2012; Curi, Rui/C-9351-2012; Moriscot, Anselmo S./C-4506-2012; Hirabara, Sandro Massao/C-4014-2012; Loureiro, Tatiana C Alba/U-9436-2018; Loureiro, Tatiana/C-6712-2012; Pithon-Curi, Tania Cristina/AAB-9436-2021; Pires, Adriana Cristina Levada/AAC-9783-2021; Guimarães-Ferreira, Lucas/B-1137-2011	Lambertucci, Rafael H/0000-0001-8532-2639; Moriscot, Anselmo S./0000-0003-3098-4613; Hirabara, Sandro Massao/0000-0002-7392-0444; Guimarães-Ferreira, Lucas/0000-0002-2970-7355; PITHON-CURI, TANIA CRISTINA/0000-0002-9714-9105	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptista IL, 2010, MUSCLE NERVE, V41, P800, DOI 10.1002/mus.21578; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Curi R, 2005, J CELL PHYSIOL, V204, P392, DOI 10.1002/jcp.20339; Curi R, 2007, FRONT BIOSCI-LANDMRK, V12, P344, DOI 10.2741/2068; Dokken BB, 2005, AM J PHYSIOL-ENDOC M, V288, pE1188, DOI 10.1152/ajpendo.00547.2004; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HIGUCHI R, 1992, BIO-TECHNOL, V10, P413, DOI 10.1038/nbt0492-413; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Kimball Scot R, 2004, Nutr Metab (Lond), V1, P3, DOI 10.1186/1743-7075-1-3; Lagranha CJ, 2004, MED SCI SPORT EXER, V36, P210, DOI 10.1249/01.MSS.0000113490.98089.B1; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Medeiros C, 2011, J CELL PHYSIOL, V226, P666, DOI 10.1002/jcp.22387; Newsholme P, 2011, FRONT BIOSCI-LANDMRK, V16, P315, DOI 10.2741/3690; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; O'Neill ED, 2010, AGE, V32, P209, DOI 10.1007/s11357-009-9125-0; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Peters SJ, 2011, ONCOL REP, V26, P247, DOI 10.3892/or.2011.1269; Pithon-Curi TC, 2003, AM J PHYSIOL-CELL PH, V284, pC1355, DOI 10.1152/ajpcell.00224.2002; Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Semiz S, 2002, MOL CELL BIOCHEM, V231, P23, DOI 10.1023/A:1014437019586; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sugita H, 2005, AM J PHYSIOL-ENDOC M, V288, pE585, DOI 10.1152/ajpendo.00321.2004; Vary TC, 2007, J NUTR, V137, P2074, DOI 10.1093/jn/137.9.2074; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; WINDMUELLER HG, 1974, J BIOL CHEM, V249, P5070; Wolfe RR, 2002, J NUTR, V132, p3219S, DOI 10.1093/jn/131.10.3219S; Wu M, 2010, J CELL PHYSL, V226, P29; Xi PB, 2011, FRONT BIOSCI-LANDMRK, V16, P578, DOI 10.2741/3707	40	33	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50390	10.1371/journal.pone.0050390	http://dx.doi.org/10.1371/journal.pone.0050390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239980	Green Published, gold			2022-12-27	WOS:000312290800018
J	Leal, MDC; Pincini, A; Tornillo, G; Fiorito, E; Bisaro, B; Di Luca, E; Turco, E; Defilippi, P; Cabodi, S				Leal, Maria del Pilar Camacho; Pincini, Alessandra; Tornillo, Giusy; Fiorito, Elisa; Bisaro, Brigitte; Di Luca, Elisa; Turco, Emilia; Defilippi, Paola; Cabodi, Sara			p130Cas Over-Expression Impairs Mammary Branching Morphogenesis in Response to Estrogen and EGF	PLOS ONE			English	Article							RECEPTOR-ALPHA; BREAST-CANCER; CELL-DEATH; GLAND; ACTIVATION; SRC; GROWTH; AMPHIREGULIN; ASSOCIATION; MAINTENANCE	p130Cas adaptor protein regulates basic processes such as cell cycle control, survival and migration. p130Cas over-expression has been related to mammary gland transformation, however the in vivo consequences of p130Cas over-expression during mammary gland morphogenesis are not known. In ex vivo mammary explants from MMTV-p130Cas transgenic mice, we show that p130Cas impairs the functional interplay between Epidermal Growth Factor Receptor (EGFR) and Estrogen Receptor (ER) during mammary gland development. Indeed, we demonstrate that p130Cas over-expression upon the concomitant stimulation with EGF and estrogen (E2) severely impairs mammary morphogenesis giving rise to enlarged multicellular spherical structures with altered architecture and absence of the central lumen. These filled acinar structures are characterized by increased cell survival and proliferation and by a strong activation of Erk1/2 MAPKs and Akt. Interestingly, antagonizing the ER activity is sufficient to re-establish branching morphogenesis and normal Erk1/2 MAPK activity. Overall, these results indicate that high levels of p130Cas expression profoundly affect mammary morphogenesis by altering epithelial architecture, survival and unbalancing Erk1/2 MAPKs activation in response to growth factors and hormones. These results suggest that alteration of morphogenetic pathways due to p130Cas over-expression might prime mammary epithelium to tumorigenesis.	[Leal, Maria del Pilar Camacho; Pincini, Alessandra; Tornillo, Giusy; Fiorito, Elisa; Bisaro, Brigitte; Di Luca, Elisa; Turco, Emilia; Defilippi, Paola; Cabodi, Sara] Univ Turin, Dept Genet Biol & Biochem, MBC, Turin, Italy; [Fiorito, Elisa] Nordic EMBL Partnership, Ctr Mol Med Norway NCMM, Oslo, Norway	University of Turin	Cabodi, S (corresponding author), Univ Turin, Dept Genet Biol & Biochem, MBC, Turin, Italy.	sara.cabodi@unito.it	Tornillo, Giusy/AAZ-8165-2020; DEFILIPPI, Paola/L-2232-2014; De Luca, Elisa/L-2491-2017	Tornillo, Giusy/0000-0002-3934-3567; Migliaccio, Antimo/0000-0002-4197-2055; De Luca, Elisa/0000-0001-9849-0703; Cabodi, Sara/0000-0003-1248-6549; Defilippi, Paola/0000-0001-6427-4906	Associazione Italiana Ricerca sul Cancro (AIRC) [IG2008, IG2011]; Fondazione Ricerca Italiana sul cancro (FIRC) fellowships; Progetto Sanita Finalizzata; Piattaforma per la ricerca su cellule staminali (PiSTEM); Ministero Italiano Universita e Ricerca (FIRB Giovani)	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Ricerca Italiana sul cancro (FIRC) fellowships(Fondazione AIRC per la ricerca sul cancro); Progetto Sanita Finalizzata; Piattaforma per la ricerca su cellule staminali (PiSTEM); Ministero Italiano Universita e Ricerca (FIRB Giovani)	This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC) (Grant IG2008 and IG2011), Ministero Italiano Universita e Ricerca (FIRB Giovani 2008), Piattaforma per la ricerca su cellule staminali (PiSTEM), Progetto Sanita Finalizzata. G. Tornillo and B. Bisaro are supported by Fondazione Ricerca Italiana sul cancro (FIRC) fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2006, CANCER LETT, V238, P1, DOI 10.1016/j.canlet.2005.06.018; Auricchio F, 2008, STEROIDS, V73, P880, DOI 10.1016/j.steroids.2008.01.023; Blatchford DR, 1999, J CELL PHYSIOL, V181, P304, DOI 10.1002/(SICI)1097-4652(199911)181:2<304::AID-JCP12>3.0.CO;2-5; Boonyaratanakornkit V, STEROIDS, V76, P877; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cabodi S, 2010, FASEB J, V24, P3796, DOI 10.1096/fj.10-157347; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Cowell LN, 2006, ONCOGENE, V25, P7597, DOI 10.1038/sj.onc.1209747; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168; Guo XM, 2005, J BIOL CHEM, V280, P19704, DOI 10.1074/jbc.M501244200; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Hynes NE, COLD SPRING HARB PER, V2; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; LaMarca HL, 2008, ENDOCRINOLOGY, V149, P4317, DOI 10.1210/en.2008-0450; Lee YR, 2005, BIOCHEM BIOPH RES CO, V336, P1221, DOI 10.1016/j.bbrc.2005.08.256; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Marino M, 2006, STEROIDS, V71, P298, DOI 10.1016/j.steroids.2005.09.011; Migliaccio A, 2010, MOL CELL ENDOCRINOL, V327, P19, DOI 10.1016/j.mce.2010.06.014; Murray P, 2000, J CELL BIOL, V150, P1215, DOI 10.1083/jcb.150.5.1215; Nelson CM, 2005, SEMIN CANCER BIOL, V15, P342, DOI 10.1016/j.semcancer.2005.05.001; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Razandi M, 2004, MOL ENDOCRINOL, V18, P2854, DOI 10.1210/me.2004-0115; Reginato MJ, 2006, J MAMMARY GLAND BIOL, V11, P205, DOI 10.1007/s10911-006-9030-4; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Sebastian J, 1998, CELL GROWTH DIFFER, V9, P777; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Tian J, 2012, J CLIN INVEST, V122, P192, DOI 10.1172/JCI42204; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Tornillo G, 2011, EUR J CELL BIOL, V90, P237, DOI 10.1016/j.ejcb.2010.09.002; van der Flier S, 2000, JNCI-J NATL CANCER I, V92, P120, DOI 10.1093/jnci/92.2.120; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439	47	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49817	10.1371/journal.pone.0049817	http://dx.doi.org/10.1371/journal.pone.0049817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239970	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000312290800008
J	Mansiaux, Y; Carrat, F				Mansiaux, Yohann; Carrat, Fabrice			Contribution of Genome-Wide Association Studies to Scientific Research: A Bibliometric Survey of the Citation Impacts of GWAS and Candidate Gene Studies Published during the Same Period and in the Same Journals	PLOS ONE			English	Article							POPULATIONS; RISKS	In genetic epidemiology, genome-wide association studies (GWAS) are used to rapidly scan a large set of genetic variants and thus to identify associations with a particular trait or disease. The GWAS philosophy is different to that of conventional candidate-gene-based approaches, which directly test the effects of genetic variants of potentially contributory genes in an association study. One controversial question is whether GWAS provide relevant scientific outcomes by comparison with candidate-gene studies. We thus performed a bibliometric study using two citation metrics to assess whether the GWAS have contributed a capital gain in knowledge discovery by comparison with candidate-gene approaches. We selected GWAS published between 2005 and 2009 and matched them with candidate-gene studies on the same topic and published in the same period of time. We observed that the GWAS papers have received, on average, 30 +/- 55 citations more than the candidate gene papers, 1 year after their publication date, and 39 +/- 58 citations more 2 years after their publication date. The GWAS papers were, on average, 2.8 +/- 2.4 and 2.9 +/- 2.4 times more cited than expected, 1 and 2 years after their publication date; whereas the candidate gene papers were 1.5 +/- 1.2 and 1.5 +/- 1.4 times more cited than expected. While the evaluation of the contribution to scientific research through citation metrics may be challenged, it cannot be denied that GWAS are great hypothesis generators, and are a powerful complement to candidate gene studies.	[Mansiaux, Yohann; Carrat, Fabrice] Univ Paris 06, UMR S 707, Paris, France; [Carrat, Fabrice] St Antoine Hosp, Publ Hlth Unit, Paris, France; [Mansiaux, Yohann; Carrat, Fabrice] Inserm U707, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mansiaux, Y (corresponding author), Univ Paris 06, UMR S 707, Paris, France.	mansiaux@u707.jussieu.fr	Carrat, Fabrice/AAU-8480-2020	Carrat, Fabrice/0000-0002-8672-7918	Ministry of Higher Education and Research of France	Ministry of Higher Education and Research of France	This work was supported by the Ministry of Higher Education and Research of France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Hindorff LA, 2009, CATALOG PUBLISHED GE; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Marques FZ, 2011, HYPERTENSION, V58, P1093, DOI 10.1161/HYPERTENSIONAHA.111.180729; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Rappaport SM, 2011, J EXPO SCI ENV EPID, V21, P5, DOI 10.1038/jes.2010.50; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Tang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023691; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yap IKS, 2010, J PROTEOME RES, V9, P6647, DOI 10.1021/pr100798r	11	9	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51408	10.1371/journal.pone.0051408	http://dx.doi.org/10.1371/journal.pone.0051408			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240019	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800055
J	Rosowski, EE; Saeij, JPJ				Rosowski, Emily E.; Saeij, Jeroen P. J.			Toxoplasma gondii Clonal Strains All Inhibit STAT1 Transcriptional Activity but Polymorphic Effectors Differentially Modulate IFN gamma Induced Gene Expression and STAT1 Phosphorylation	PLOS ONE			English	Article							INTERFERON-GAMMA; MURINE MACROPHAGES; NITRIC-OXIDE; ANTIGEN PRESENTATION; CELL-LINE; INFECTION; MECHANISMS; RESPONSES; ALPHA; MICE	Host defense against the parasite Toxoplasma gondii requires the cytokine interferon-gamma (IFN gamma). However, Toxoplasma inhibits the host cell transcriptional response to IFN gamma, which is thought to allow the parasite to establish a chronic infection. It is not known whether all strains of Toxoplasma block IFN gamma-responsive transcription equally and whether this inhibition occurs solely through the modulation of STAT1 activity or whether other transcription factors are involved. We find that strains from three North American/European clonal lineages of Toxoplasma, types I, II, and III, can differentially modulate specific aspects of IFN gamma signaling through the polymorphic effector proteins ROP16 and GRA15. STAT1 tyrosine phosphorylation is activated in the absence of IFN gamma by the Toxoplasma kinase ROP16, but this ROP16-activated STAT1 is not transcriptionally active. Many genes induced by STAT1 can also be controlled by other transcription factors and therefore using these genes as specific readouts to determine Toxoplasma inhibition of STAT1 activity might be inappropriate. Indeed, GRA15 and ROP16 modulate the expression of subsets of IFN gamma responsive genes through activation of the NF-kappa B/IRF1 and STAT3/6 transcription factors, respectively. However, using a stable STAT1-specific reporter cell line we show that strains from the type I, II, and III clonal lineages equally inhibit STAT1 transcriptional activity. Furthermore, all three of the clonal lineages significantly inhibit global IFN gamma induced gene expression.	[Rosowski, Emily E.; Saeij, Jeroen P. J.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Saeij, JPJ (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	jsaeij@mit.edu	Rosowski, Emily E./U-9654-2019	Rosowski, Emily E./0000-0002-6761-1098; Saeij, Jeroen/0000-0003-0289-7109	National Institutes of Health [R01-AI080621]; American Heart Association [0835099N]; pre-doctoral grant in the Biological Sciences [5-T32- GM007287-33]; Cleo and Paul Schimmel Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); pre-doctoral grant in the Biological Sciences; Cleo and Paul Schimmel Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J. Saeij was supported by National Institutes of Health R01-AI080621 and by a Scientist Development Grant from the American Heart Association (0835099N). E. Rosowski was supported by a pre-doctoral grant in the Biological Sciences (5-T32- GM007287-33) and the Cleo and Paul Schimmel Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baus D, 2009, LEUKEMIA, V23, P1885, DOI 10.1038/leu.2009.103; Boyle JP, 2007, EXP PARASITOL, V116, P302, DOI 10.1016/j.exppara.2007.01.010; Costa-Pereira AP, 2002, P NATL ACAD SCI USA, V99, P8043, DOI 10.1073/pnas.122236099; Hebbar PB, 2008, J BIOL CHEM, V283, P4595, DOI 10.1074/jbc.M709121200; Hebenstreit D, 2003, J IMMUNOL, V171, P5901, DOI 10.4049/jimmunol.171.11.5901; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Jensen KDC, 2011, CELL HOST MICROBE, V9, P472, DOI 10.1016/j.chom.2011.04.015; Khan IA, 1997, P NATL ACAD SCI USA, V94, P13955, DOI 10.1073/pnas.94.25.13955; Kim SK, 2007, J IMMUNOL, V178, P5154, DOI 10.4049/jimmunol.178.8.5154; Kim SK, 2007, INFECT IMMUN, V75, P1626, DOI 10.1128/IAI.01862-06; Koshy AA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002825; Lang C, 2006, MICROBES INFECT, V8, P1994, DOI 10.1016/j.micinf.2006.02.031; Leng J, 2009, J IMMUNOL, V182, P489, DOI 10.4049/jimmunol.182.1.489; Lieberman LA, 2004, J IMMUNOL, V172, P457, DOI 10.4049/jimmunol.172.1.457; Liesenfeld O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020568; Luder CGK, 1998, CLIN EXP IMMUNOL, V112, P308; Luder CGK, 2003, J NEUROIMMUNOL, V134, P12, DOI 10.1016/S0165-5728(02)00320-X; Luder CGK, 2001, EUR J IMMUNOL, V31, P1475, DOI 10.1002/1521-4141(200105)31:5&lt;1475::AID-IMMU1475&gt;3.0.CO;2-C; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Melo MB, 2011, TRENDS PARASITOL, V27, P487, DOI 10.1016/j.pt.2011.08.001; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Ohmori Y, 1997, J IMMUNOL, V159, P5474; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Robinson CM, 2006, CYTOKINE, V35, P53, DOI 10.1016/j.cyto.2006.07.007; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Rozenfeld C, 2005, AM J PATHOL, V167, P1021, DOI 10.1016/S0002-9440(10)61191-1; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Seabra SJ, 2002, EXP PARASITOL, V100, P62, DOI 10.1006/expr.2001.4675; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Wang YX, 2011, BIOCHEM BIOPH RES CO, V410, P549, DOI 10.1016/j.bbrc.2011.06.022; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Yang TH, 1996, MICROBIOL IMMUNOL, V40, P443, DOI 10.1111/j.1348-0421.1996.tb01091.x; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Zimmermann S, 2006, J IMMUNOL, V176, P1840, DOI 10.4049/jimmunol.176.3.1840	44	52	54	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51448	10.1371/journal.pone.0051448	http://dx.doi.org/10.1371/journal.pone.0051448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240025	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800061
J	Ajelli, M; Merler, S				Ajelli, Marco; Merler, Stefano			Transmission Potential and Design of Adequate Control Measures for Marburg Hemorrhagic Fever	PLOS ONE			English	Article							VIRUS-DISEASE; NONHUMAN-PRIMATES; INFLUENZA; OUTBREAK; EBOLA; STRATEGIES; EPIDEMIC; ANGOLA	Marburg hemorrhagic fever is rare yet among the most severe diseases affecting humans, with case fatality ratio even higher than 80%. By analyzing the largest documented Marburg hemorrhagic fever epidemic, which occurred in Angola in 2005 and caused 329 deaths, and data on viral load over time in non-human primates, we make an assessment of transmissibility and severity of the disease. We also give insight into the control of new Marburg hemorrhagic fever epidemics to inform appropriate health responses. We estimated the distribution of the generation time to have mean 9 days (95%CI: 8.2-10 days) and standard deviation 5.4 days (95%CI: 3.9-8.6 days), and the basic reproduction number to be R-0 = 1.59 (95%CI: 1.53-1.66). Model simulations suggest that a timely isolation of cases, starting no later than 2-3 days after symptoms onset, is sufficient to contain an outbreak. Our analysis reveals that Marburg hemorrhagic fever is characterized by a relatively small reproduction number and by a relatively long generation time. Such factors, along with the extremely high severity and fatality, support the rare occurrence of large epidemics in human populations. Our results also support the effectiveness of social distancing measures - case isolation in particular - to contain or at least to mitigate an emerging outbreak. This work represents an advance in the knowledge required to manage a potential Marburg hemorrhagic fever epidemic.	[Ajelli, Marco; Merler, Stefano] Bruno Kessler Fdn, Trento, Italy	Fondazione Bruno Kessler	Ajelli, M (corresponding author), Bruno Kessler Fdn, Trento, Italy.	ajelli@fbk.eu	Ajelli, Marco/AAX-1113-2020; merler, stefano/I-3557-2017	Ajelli, Marco/0000-0003-1753-4749; merler, stefano/0000-0002-5117-0611	European Union FP7 EPIWORK project [231807]	European Union FP7 EPIWORK project	The authors thank the European Union FP7 EPIWORK project (contract no. 231807) for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajelli M, 2011, EPIDEMIOL INFECT, V139, P68, DOI 10.1017/S0950268810001317; ANDERSON R M, 1991; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Bausch DG, 2006, NEW ENGL J MED, V355, P909, DOI 10.1056/NEJMoa051465; Bausch DG, 2003, EMERG INFECT DIS, V9, P1531, DOI 10.3201/eid0912.030355; Bettencourt L.M., 2009, MATH STAT ESTIMATION, P143; Boelle PY, 2009, EUROSURVEILLANCE, V14, P10; Borchert M, 2002, TROP MED INT HEALTH, V7, P902, DOI 10.1046/j.1365-3156.2002.00945.x; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006; Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34; Daddario-DiCaprio KM, 2006, LANCET, V367, P1399, DOI 10.1016/S0140-6736(06)68546-2; degli Atti MLC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001790; Embassy of Angola, 2011, PROV UIG; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Fujita N., 2009, Morbidity and Mortality Weekly Report, V58, P1377; GEAR JSS, 1975, BRIT MED J, V4, P489, DOI 10.1136/bmj.4.5995.489; Geisbert TW, 2010, REV MED VIROL, V20, P344, DOI 10.1002/rmv.661; Geisbert TW, 2010, J VIROL, V84, P10386, DOI 10.1128/JVI.00594-10; Grolla A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001183; Jeffs B, 2007, J INFECT DIS, V196, pS154, DOI 10.1086/520548; Johnson ED, 1996, ARCH VIROL, P101; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kolokol'tsov AA, 2001, B EXP BIOL MED+, V132, P686, DOI 10.1023/A:1012540614713; Ligon B Lee, 2005, Semin Pediatr Infect Dis, V16, P219, DOI 10.1053/j.spid.2005.05.001; MARTINI GA, 1973, POSTGRAD MED J, V49, P542, DOI 10.1136/pgmj.49.574.542; Merler S, 2008, J THEOR BIOL, V254, P499, DOI 10.1016/j.jtbi.2008.06.004; Merler S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002205; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Merler S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-117; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Nishiura H, 2009, EUROSURVEILLANCE, V14; Rizzo C, 2011, VACCINE, V29, pB27, DOI 10.1016/j.vaccine.2011.02.049; SMITH DH, 1982, LANCET, V1, P816; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Timen A, 2009, EMERG INFECT DIS, V15, P1171, DOI [10.3201/eid1508.090015, 10.3201/eid1508.090051]; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2006, J VIROL, V80, P6497, DOI 10.1128/JVI.00069-06; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; U.S. Census Bureau, 2012, INT DAT BAS; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; World Health Organization, 2008, MARB HAEM FEV ANG; World Health Organization, 2008, MARB HAEM FEV; World Health Organization, 2008, GLOB AL RESP MARB HA	47	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50948	10.1371/journal.pone.0050948	http://dx.doi.org/10.1371/journal.pone.0050948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251407	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900028
J	Huang, CT; Hwang, IS				Huang, Chien-Ting; Hwang, Ing-Shiou			Eye-Hand Synergy and Intermittent Behaviors during Target-Directed Tracking with Visual and Non-visual Information	PLOS ONE			English	Article							MOTOR-UNIT RECRUITMENT; OCULO-MANUAL TRACKING; SMOOTH-PURSUIT; COORDINATION CONTROL; SUPERIOR-COLLICULUS; COMPONENT SUBMOVEMENTS; SENSORY FEEDBACK; FORCE PRODUCTION; ELDERLY ADULTS; MOVEMENTS	Visual feedback and non-visual information play different roles in tracking of an external target. This study explored the respective roles of the visual and non-visual information in eleven healthy volunteers who coupled the manual cursor to a rhythmically moving target of 0.5 Hz under three sensorimotor conditions: eye-alone tracking (EA), eye-hand tracking with visual feedback of manual outputs (EH tracking), and the same tracking without such feedback (EHM tracking). Tracking error, kinematic variables, and movement intermittency (saccade and speed pulse) were contrasted among tracking conditions. The results showed that EHM tracking exhibited larger pursuit gain, less tracking error, and less movement intermittency for the ocular plant than EA tracking. With the vision of manual cursor, EH tracking achieved superior tracking congruency of the ocular and manual effectors with smaller movement intermittency than EHM tracking, except that the rate precision of manual action was similar for both types of tracking. The present study demonstrated that visibility of manual consequences altered mutual relationships between movement intermittency and tracking error. The speed pulse metrics of manual output were linked to ocular tracking error, and saccade events were time-locked to the positional error of manual tracking during EH tracking. In conclusion, peripheral non-visual information is critical to smooth pursuit characteristics and rate control of rhythmic manual tracking. Visual information adds to eye-hand synchrony, underlying improved amplitude control and elaborate error interpretation during oculo-manual tracking.	[Huang, Chien-Ting; Hwang, Ing-Shiou] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan 70101, Taiwan; [Hwang, Ing-Shiou] Natl Cheng Kung Univ, Coll Med, Dept Phys Therapy, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University	Hwang, IS (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan 70101, Taiwan.	ishwang@mail.ncku.edu.tw			National Science Council, ROC [NSC 100-2314-B-006-005-MY3]	National Science Council, ROC(Ministry of Science and Technology, Taiwan)	This research was supported in part by a grant from the National Science Council, ROC. (http://web1.nsc.gov.tw/mp.aspx?mp=7), under Grant No. NSC 100-2314-B-006-005-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ABRAMS RA, 1993, J MOTOR BEHAV, V25, P288, DOI 10.1080/00222895.1993.9941650; Ausborn J, 2007, J NEUROSCI, V27, P9319, DOI 10.1523/JNEUROSCI.0907-07.2007; BALOH RW, 1988, AVIAT SPACE ENVIR MD, V59, P121; Balslev D, 2007, J COGNITIVE NEUROSCI, V19, P1535, DOI 10.1162/jocn.2007.19.9.1535; Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Basso MA, 2000, J NEUROPHYSIOL, V84, P892, DOI 10.1152/jn.2000.84.2.892; Bergeron A, 2002, J NEUROPHYSIOL, V88, P1726, DOI 10.1152/jn.2002.88.4.1726; CLAMANN HP, 1993, PHYS THER, V73, P830, DOI 10.1093/ptj/73.12.830; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; de Brouwer S, 2002, J NEUROPHYSIOL, V87, P1772, DOI 10.1152/jn.00621.2001; de Xivry JJO, 2007, J PHYSIOL-LONDON, V584, P11, DOI 10.1113/jphysiol.2007.139881; ECKMILLER R, 1987, PHYSIOL REV, V67, P797, DOI 10.1152/physrev.1987.67.3.797; Fried PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027204; GAUTHIER GM, 1988, EXP BRAIN RES, V73, P127, DOI 10.1007/BF00279667; Gowen E, 2006, HUM MOVEMENT SCI, V25, P568, DOI 10.1016/j.humov.2006.06.005; Gritsenko V, 2009, J NEUROPHYSIOL, V102, P914, DOI 10.1152/jn.91324.2008; Hafed ZM, 2008, J NEUROSCI, V28, P8124, DOI 10.1523/JNEUROSCI.1317-08.2008; Hocherman S, 2000, PERCEPT MOTOR SKILL, V90, P1235, DOI 10.2466/PMS.90.3.1235-1248; Inoue K, 1998, J NEUROPHYSIOL, V79, P117, DOI 10.1152/jn.1998.79.1.117; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Keller EL, 1996, J NEUROPHYSIOL, V76, P3573, DOI 10.1152/jn.1996.76.5.3573; Khan MA, 2000, J MOTOR BEHAV, V32, P227, DOI 10.1080/00222890009601374; KOKEN PW, 1992, EXP BRAIN RES, V88, P657; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Krauzlis RJ, 2005, NEUROSCIENTIST, V11, P124, DOI 10.1177/1073858404271196; Krauzlis RJ, 2000, NEUROREPORT, V11, P1045, DOI 10.1097/00001756-200004070-00029; Lencer R, 2008, BRAIN COGNITION, V68, P219, DOI 10.1016/j.bandc.2008.08.013; Levy-Tzedek S, 2011, J NEUROPHYSIOL, V106, P2120, DOI 10.1152/jn.00266.2011; MacDonald PA, 2003, CEREB CORTEX, V13, P962, DOI 10.1093/cercor/13.9.962; MATHER JA, 1981, EXP BRAIN RES, V43, P406; McGibbon CA, 2001, J NEUROSCI METH, V106, P171, DOI 10.1016/S0165-0270(01)00346-6; Miall RC, 2000, EXP BRAIN RES, V135, P22, DOI 10.1007/s002210000491; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; MIALL RC, 1988, BEHAV BRAIN RES, V27, P1, DOI 10.1016/0166-4328(88)90104-0; MILNER TE, 1992, NEUROSCIENCE, V49, P487, DOI 10.1016/0306-4522(92)90113-G; NAVAS F, 1968, BIOPHYS J, V8, P252, DOI 10.1016/S0006-3495(68)86488-4; NEWSOME WT, 1985, J NEUROSCI, V5, P825; Nitschke MF, 2005, PROG BRAIN RES, V148, P151, DOI 10.1016/S0079-6123(04)48013-3; Obhi SS, 2009, COGNITION, V110, P65, DOI 10.1016/j.cognition.2008.10.009; Park S, 1999, PERCEPT MOTOR SKILL, V88, P631, DOI 10.2466/PMS.88.2.631-647; Pasalar S, 2005, EXP BRAIN RES, V163, P214, DOI 10.1007/s00221-004-2169-6; Poston B, 2009, BRAIN COGNITION, V69, P30, DOI 10.1016/j.bandc.2008.05.002; Prsa M, 2009, J NEUROSCI, V29, P250, DOI 10.1523/JNEUROSCI.4791-08.2009; Roerdink M, 2005, HUM MOVEMENT SCI, V24, P379, DOI 10.1016/j.humov.2005.06.007; Roitman AV, 2004, J NEUROPHYSIOL, V91, P901, DOI 10.1152/jn.00261.2003; Romero DH, 2003, HUM MOVEMENT SCI, V22, P207, DOI 10.1016/S0167-9457(02)00160-4; Rottach KG, 1996, VISION RES, V36, P2189, DOI 10.1016/0042-6989(95)00302-9; Sailer U, 2005, BEHAV BRAIN RES, V160, P72, DOI 10.1016/j.bbr.2004.11.020; Selen LPJ, 2006, J NEUROPHYSIOL, V96, P2750, DOI 10.1152/jn.00552.2006; Slifkin AB, 2000, J MOTOR BEHAV, V32, P141, DOI 10.1080/00222890009601366; Tansey KE, 1996, J NEUROPHYSIOL, V75, P26, DOI 10.1152/jn.1996.75.1.26; Thura D, 2008, BEHAV BRAIN RES, V186, P148, DOI 10.1016/j.bbr.2007.07.035; VALLBO AB, 1993, J PHYSIOL-LONDON, V469, P673, DOI 10.1113/jphysiol.1993.sp019837; Vercher JL, 1996, J NEUROPHYSIOL, V76, P1133, DOI 10.1152/jn.1996.76.2.1133; VERCHER JL, 1988, EXP BRAIN RES, V73, P155, DOI 10.1007/BF00279669; VERCHER JL, 1995, EXP BRAIN RES, V103, P311; Vercher JL, 2003, PROG BRAIN RES, V142, P203; Vercher JL, 1997, BIOL CYBERN, V77, P267, DOI 10.1007/s004220050387; Wisleder D, 2007, EXP BRAIN RES, V176, P132, DOI 10.1007/s00221-006-0603-7; Yoshitake Y, 2004, J APPL PHYSIOL, V97, P2090, DOI 10.1152/japplphysiol.00560.2004	61	11	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51417	10.1371/journal.pone.0051417	http://dx.doi.org/10.1371/journal.pone.0051417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	050OT	23236498	gold, Green Submitted, Green Published			2022-12-27	WOS:000312064100117
J	Jaerve, A; Kruse, F; Malik, K; Hartung, HP; Muller, HW				Jaerve, Anne; Kruse, Fabian; Malik, Katharina; Hartung, Hans-Peter; Mueller, Hans Werner			Age-Dependent Modulation of Cortical Transcriptomes in Spinal Cord Injury and Repair	PLOS ONE			English	Article							CORTICOSPINAL MOTOR-NEURONS; NEUROTROPHIC FACTOR CNTF; NEURITE OUTGROWTH; AXON REGENERATION; NERVOUS-SYSTEM; DM-GRASP; COMPLEMENT; PROTEIN; BRAIN; GENE	Both injury and aging of the central nervous system reportedly produce profound changes in gene expression. Therefore, aging may interfere with the success of therapeutic interventions which were tailored for young patients. Using genome-scale transcriptional profiling, we identified distinct age-dependent expression profiles in rat sensorimotor cortex during acute, subacute and chronic phases of spinal cord injury (SCI). Aging affects the cortical transcriptomes triggered by transection of the corticospinal tract as there was only a small overlap between the significantly lesion-regulated genes in both age groups. Over-representation analysis of the lesion-regulated genes revealed that, in addition to biological processes in common, such as lipid metabolism, others, such as activation of complement cascade, were specific for aged animals. When a recently developed treatment to suppress fibrotic scarring (anti-scarring treatment AST) was applied to the injured spinal cord of aged (22 months) and young (2 months) rats, we found that the cortical gene expression in old rats was modulated to resemble regeneration-associated profiles of young animals including the up-regulation of known repair promoting growth and transcription factors at 35 dpo. In combination with recent immunohistochemical findings demonstrating regenerative axon growth upon AST in aged animals, the present investigation on the level of gene expression strongly supports the feasibility of a successful AST therapy in elderly patients.	[Jaerve, Anne; Kruse, Fabian; Malik, Katharina; Hartung, Hans-Peter; Mueller, Hans Werner] Univ Dusseldorf, Fac Med, Dept Neurol, Mol Neurobiol Lab, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Muller, HW (corresponding author), Univ Dusseldorf, Fac Med, Dept Neurol, Mol Neurobiol Lab, D-40225 Dusseldorf, Germany.	hanswerner.mueller@uni-duesseldorf.de		Jarve, Anne/0000-0003-2096-0706	German Research Council Deutsche Forschungsgemeinschaft DFG [SFB 590/TPC2]; German Research Council Deutsche Forschungsgemeinschaft DFG (Research Training Group) [1033]; Aging Research Foundation, Dusseldorf, Germany	German Research Council Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); German Research Council Deutsche Forschungsgemeinschaft DFG (Research Training Group); Aging Research Foundation, Dusseldorf, Germany	This work was supported by the German Research Council Deutsche Forschungsgemeinschaft DFG (SFB 590/TPC2 and Research Training Group 1033) and by the Aging Research Foundation, Dusseldorf, Germany. The authors declare: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023764; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; Blackmore MG, 2012, P NATL ACAD SCI USA, V109, P7517, DOI 10.1073/pnas.1120684109; Bloch J, 2011, J COMP NEUROL, V519, P775, DOI 10.1002/cne.22547; Brauer AU, 2003, NAT NEUROSCI, V6, P572, DOI 10.1038/nn1052; BURNS FR, 1991, NEURON, V7, P209, DOI 10.1016/0896-6273(91)90259-3; Carmichael ST, 2003, CURR OPIN NEUROL, V16, P699, DOI 10.1097/00019052-200312000-00009; Chrast R, 2004, NEUROCHEM INT, V45, P353, DOI 10.1016/j.neuint.2003.069.011; Cox S, 2004, BRAIN RES, V1010, P55, DOI 10.1016/j.brainres.2004.02.068; DALE SM, 1995, EXP NEUROL, V135, P67, DOI 10.1006/exnr.1995.1066; Dauth S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-74; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; DeBernardo AP, 1996, J CELL BIOL, V133, P657, DOI 10.1083/jcb.133.3.657; Dutta R, 2007, BRAIN, V130, P2566, DOI 10.1093/brain/awm206; Galvan MD, 2008, J NEUROSCI, V28, P13876, DOI 10.1523/JNEUROSCI.2823-08.2008; Gillis J, 2010, NAT PROTOC, V5, P1148, DOI 10.1038/nprot.2010.78; Hao HP, 2007, J NEUROSCI RES, V85, P2196, DOI 10.1002/jnr.21357; He YD, 2011, ACTA NEUROCHIR SUPPL, V111, P133, DOI 10.1007/978-3-7091-0693-8_22; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 1999, SCIENCE, V285, P595, DOI 10.1126/science.285.5427.595; Jaerve A, 2011, EXP NEUROL, V231, P284, DOI 10.1016/j.expneurol.2011.07.002; Junger H, 1998, NEUROREPORT, V9, P3749, DOI 10.1097/00001756-199811160-00033; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; Kriebel M, 2012, INT J BIOCH IN PRESS; Kruse F., 2008, NEURAL DEGENERATION, P61; Kruse F, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00026; Laub F, 2005, MOL CELL BIOL, V25, P5699, DOI 10.1128/MCB.25.13.5699-5711.2005; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Lee S, 2005, HUM MOL GENET, V14, P627, DOI 10.1093/hmg/ddi059; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Liu XJ, 2009, MOL CELL NEUROSCI, V41, P51, DOI 10.1016/j.mcn.2009.01.009; Marszalek JR, 2004, J BIOL CHEM, V279, P23882, DOI 10.1074/jbc.M313460200; Martin-Villalba A, 1998, MOL BRAIN RES, V62, P158, DOI 10.1016/S0169-328X(98)00239-3; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; National Spinal Cord Injury Statistical Center, FACTS FIG GLANC; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; PASINETTI GM, 1992, EXP NEUROL, V118, P117, DOI 10.1016/0014-4886(92)90028-O; Petcu EB, 2008, GERONTOLOGY, V54, P6, DOI 10.1159/000112845; Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Rossner MJ, 2006, J NEUROSCI, V26, P9956, DOI 10.1523/JNEUROSCI.0468-06.2006; Schiwy N, 2009, EUR J NEUROSCI, V30, P1544, DOI 10.1111/j.1460-9568.2009.06929.x; Schraufstatter IU, 2009, J IMMUNOL, V182, P3827, DOI 10.4049/jimmunol.0803055; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; Shimokawara T, 2002, NEUROPATHOLOGY, V22, P261, DOI 10.1046/j.1440-1789.2002.00463.x; Singhrao SK, 2000, AM J PATHOL, V157, P905, DOI 10.1016/S0002-9440(10)64604-4; Tsai MJ, 2007, J NEUROSCI RES, V85, P2950, DOI 10.1002/jnr.21395; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Zahn JM, 2007, CURR OPIN BIOTECH, V18, P355, DOI 10.1016/j.copbio.2007.07.004	51	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e49812	10.1371/journal.pone.0049812	http://dx.doi.org/10.1371/journal.pone.0049812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236355	gold, Green Published, Green Submitted			2022-12-27	WOS:000312064100007
J	Forel, JM; Chiche, L; Thomas, G; Mancini, J; Farnarier, C; Cognet, C; Guervilly, C; Daumas, A; Vely, F; Xeridat, F; Vivier, E; Papazian, L				Forel, Jean-Marie; Chiche, Laurent; Thomas, Guillemette; Mancini, Julien; Farnarier, Catherine; Cognet, Celine; Guervilly, Christophe; Daumas, Aurelie; Vely, Frederic; Xeridat, Francois; Vivier, Eric; Papazian, Laurent			Phenotype and Functions of Natural Killer Cells in Critically-Ill Septic Patients	PLOS ONE			English	Article							HUMAN NK CELLS; INFLAMMATORY RESPONSE; IN-VITRO; GAMMA PRODUCTION; IFN-GAMMA; SEPSIS; CYTOKINE; LYMPHOCYTES; INNATE; INTERFERON	Rationale: Natural killer cells, as a major source of interferon-gamma, contribute to the amplification of the inflammatory response as well as to mortality during severe sepsis in animal models. Objective: We studied the phenotype and functions of circulating NK cells in critically-ill septic patients. Methods: Blood samples were taken <48 hours after admission from 42 ICU patients with severe sepsis (n = 15) or septic shock (n = 14) (Sepsis group), non-septic SIRS (n = 13) (SIRS group), as well as 21 healthy controls. The immuno-phenotype and functions of NK cells were studied by flow cytometry. Results: The absolute number of peripheral blood CD3-CD56(+) NK cells was similarly reduced in all groups of ICU patients, but with a normal percentage of NK cells. When NK cell cytotoxicity was evaluated with degranulation assays (CD107 expression), no difference was observed between Sepsis patients and healthy controls. Under antibody-dependent cell cytotoxicity (ADCC) conditions, SIRS patients exhibited increased CD107 surface expression on NK cells (62.9[61.3-70]%) compared to healthy controls (43.5[32.1-53.1]%) or Sepsis patients (49.2[37.3-62.9]%) (p = 0.002). Compared to healthy (10.2[6.3-13.1]%), reduced interferon-gamma production by NK cells (K562 stimulation) was observed in Sepsis group (6.2[2.2-9.9]%, p<0.01), and especially in patients with septic shock. Conversely, SIRS patients exhibited increased interferon-gamma production (42.9[30.1-54.7]%) compared to Sepsis patients (18.4[11.7-35.7]%, p<0.01) or healthy controls (26.8[19.3-44.9]%, p = 0.09) in ADCC condition. Conclusions: Extensive monitoring of the NK-cell phenotype and function in critically-ill septic patients revealed early decreased NK-cell function with impaired interferon-gamma production. These results may aid future NK-based immuno-interventions.	[Forel, Jean-Marie; Chiche, Laurent; Thomas, Guillemette; Guervilly, Christophe; Daumas, Aurelie; Xeridat, Francois; Papazian, Laurent] Hop Nord Marseille, APHM, Marseille, France; [Forel, Jean-Marie; Papazian, Laurent] Aix Marseille Univ, Fac Med, URMITE UMR CNRS 7278, Marseille, France; [Chiche, Laurent; Thomas, Guillemette; Vivier, Eric] Aix Marseille Univ, Ctr Immunol Marseille Luminy, INSERM U, CNRS UMR7280, Marseille, France; [Chiche, Laurent; Thomas, Guillemette; Farnarier, Catherine; Cognet, Celine; Vely, Frederic; Vivier, Eric] Hop Conception, Assistance Publ Hop Marseille, Immunol Lab, Marseille, France; [Mancini, Julien] Hop La Timone, Serv Sante Publ, APHM, Marseille, France; [Mancini, Julien] Aix Marseille Univ, UMR912, INSERM, IRD, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Chiche, L (corresponding author), Hop Nord Marseille, APHM, Marseille, France.	laurent.chiche@ap-hm.fr	DAUMAS, Aurélie/AAK-3672-2020; Vivier, Eric/F-8939-2010; guervilly, christophe/C-1083-2016; Vély, Frédéric/HHM-3894-2022; Mancini, Julien/G-6263-2011	Vivier, Eric/0000-0001-7022-8287; Mancini, Julien/0000-0001-9500-8598; Guervilly, Christophe/0000-0001-9066-6591; Vely, Frederic/0000-0002-1682-0949	Assistance Publique Hopitaux de Marseille (Appel d'Offre Recherche Clinique); Societe de Reanimation de Langue Francaise (SRLF)	Assistance Publique Hopitaux de Marseille (Appel d'Offre Recherche Clinique); Societe de Reanimation de Langue Francaise (SRLF)	This work was supported by the Assistance Publique Hopitaux de Marseille (Appel d'Offre Recherche Clinique) and by a grant from the Societe de Reanimation de Langue Francaise (SRLF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2000, AM J RESP CRIT CARE, V162, P1877, DOI 10.1164/ajrccm.162.5.2003058; Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Andaluz-Ojeda D, 2011, CRIT CARE, V15, DOI 10.1186/cc10501; Andre Pascale, 2008, V415, P291, DOI 10.1007/978-1-59745-570-1_17; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Badgwell B, 2002, SURGERY, V132, P205, DOI 10.1067/msy.2002.125311; BENDER BS, 1988, CLIN EXP IMMUNOL, V71, P120; BLAZAR BA, 1986, J CLIN IMMUNOL, V6, P26, DOI 10.1007/BF00915361; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Bryceson YT, 2010, METHODS MOL BIOL, V612, P335, DOI 10.1007/978-1-60761-362-6_23; Carson WE, 1999, J IMMUNOL, V162, P4943; Cavaillon JM, 2006, J ENDOTOXIN RES, V12, P151, DOI 10.1179/096805106X102246; Chiche L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/986491; de Pablo R, 2012, CRIT CARE, V16, DOI 10.1186/cc11204; Emoto M, 2002, J IMMUNOL, V169, P1426, DOI 10.4049/jimmunol.169.3.1426; Etogo AO, 2008, J IMMUNOL, V180, P6334, DOI 10.4049/jimmunol.180.9.6334; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Fumeaux T, 2002, AM J RESP CRIT CARE, V166, P1475, DOI 10.1164/rccm.200203-217OC; Giamarellos-Bourboulis EJ, 2006, CRIT CARE, V10, DOI 10.1186/cc5111; Gogos C, 2010, CRIT CARE, V14, DOI 10.1186/cc9031; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; HEREMANS H, 1994, EUR J IMMUNOL, V24, P1155, DOI 10.1002/eji.1830240522; Holub M, 2003, CLIN MICROBIOL INFEC, V9, P202, DOI 10.1046/j.1469-0691.2003.00518.x; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kerr AR, 2005, MICROBES INFECT, V7, P845, DOI 10.1016/j.micinf.2005.02.011; KLIMPEL GR, 1986, CLIN EXP IMMUNOL, V66, P384; Lopez-Botet M, 2004, TISSUE ANTIGENS, V63, P195, DOI 10.1111/j.1399-0039.2004.00210.x; MATURANA P, 1991, J CRIT CARE, V6, P42, DOI 10.1016/0883-9441(91)90032-O; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; MUNOZ C, 1991, J CLIN INVEST, V88, P1747, DOI 10.1172/JCI115493; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; PUENTE J, 1993, INT J CLIN PHARM TH, V31, P271; Rayhane N, 1999, J ENDOTOXIN RES, V5, P319, DOI 10.1179/096805199101531895; Schroder M, 2003, J IMMUNOL, V170, P5260, DOI 10.4049/jimmunol.170.10.5260; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Souza-Fonseca-Guimaraes F, 2012, J IMMUNOL; Souza-Fonseca-Guimaraes F, 2012, MOL MED, V18, P270, DOI 10.2119/molmed.2011.00201; STEIN MD, 1984, CELL IMMUNOL, V86, P551, DOI 10.1016/0008-8749(84)90412-X; Takabayashi A, 2003, WORLD J SURG, V27, P659, DOI 10.1007/s00268-003-6926-7; Venet F, 2010, SHOCK, V34, P358, DOI 10.1097/SHK.0b013e3181dc0977; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; von Muller L, 2007, J INFECT DIS, V196, P1288, DOI 10.1086/522429; Ward NS, 2008, CLIN CHEST MED, V29, P617, DOI 10.1016/j.ccm.2008.06.010; Yu JH, 2006, IMMUNITY, V24, P575, DOI 10.1016/j.immuni.2006.03.016	48	50	60	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50446	10.1371/journal.pone.0050446	http://dx.doi.org/10.1371/journal.pone.0050446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236375	Green Published, Green Submitted, gold			2022-12-27	WOS:000312589700015
J	Sindhurakar, A; Bradley, NS				Sindhurakar, Anil; Bradley, Nina S.			Light Accelerates Morphogenesis and Acquisition of Interlimb Stepping in Chick Embryos	PLOS ONE			English	Article							CELL-PROLIFERATION; LOCOMOTOR BEHAVIOR; KINEMATIC ANALYSIS; LEG MOVEMENTS; MOTOR OUTPUT; MUSCLE; GROWTH; PATTERNS; HINDLIMB; PINEAL	Chicks are bipedal precocious vertebrates that achieve adaptive locomotor skill within hours after hatching. Development of limb movement has been extensively studied in the chicken embryo, but few studies have focused on the preparations leading to precocious locomotor skill. Chicks typically hatch after 21 days of incubation, and recent studies provided evidence that the neural circuits for intralimb control of stepping are established between embryonic days (E) 18-20. It has also been shown that variations in light exposure during embryogenesis can accelerate or delay the onset of hatching and walking by 1 to 2 days. Our earlier work revealed that despite these differences in time to hatch, chicks incubated in different light conditions achieved similar locomotor skill on the day of hatching. Results suggested to us that light exposure during incubation may have accelerated development of locomotor circuits in register with earlier hatching. Thus, in this study, embryos were incubated in 1 of 3 light conditions to determine if development of interlimb coordination at a common time point, 19 days of incubation, varied with light exposure during embryogenesis. Leg muscle activity was recorded bilaterally and burst analyses were performed for sequences of spontaneous locomotor-related activity in one or more ankle muscles to quantify the extent of interlimb coordination in ovo. We report findings indicating that the extent of interlimb coordination varied with light exposure, and left-right alternating steps were a more reliable attribute of interlimb coordination for embryos incubated in constant bright light. We provide evidence that morphological development of the leg varied with light exposure. Based on these findings, we propose that light can accelerate the development of interlimb coordination in register with earlier hatching. Our results lead us to further propose that alternating left-right stepping is the default pattern of interlimb coordination produced by locomotor circuits during embryogenesis. Citation: Sindhurakar A, Bradley NS (2012) Light Accelerates Morphogenesis and Acquisition of Interlimb Stepping in Chick Embryos. PLoS ONE 7(12): e51348. doi:10.1371/journal.pone.0051348	[Bradley, Nina S.] Univ So Calif, Ostrow Sch Dent, Los Angeles, CA 90089 USA; [Sindhurakar, Anil] Burke Cornell Med Res Inst, White Plains, NY USA	University of Southern California	Bradley, NS (corresponding author), Univ So Calif, Ostrow Sch Dent, Los Angeles, CA 90089 USA.	nbradley@usc.edu	Bradley, Nina/F-8830-2014	Bradley, Nina/0000-0002-9674-4834	NIH National Institute of Child Health and Human Development [R01 HD-053367]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053367] Funding Source: NIH RePORTER	NIH National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the NIH National Institute of Child Health and Human Development grant R01 HD-053367 awarded to N.S. Bradley. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASAKA K, 1995, BRAIN RES, V692, P283, DOI 10.1016/0006-8993(95)00643-5; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Arendt J., 1995, MELATONIN MAMMALIAN; Batchelet E., 1981, CIRCULAR STAT BIOL, V1st; BEKOFF A, 1979, J EXP BIOL, V83, P1; BEKOFF A, 1982, J COMP PHYSIOL, V145, P497, DOI 10.1007/BF00612815; BEKOFF A, 1975, P NATL ACAD SCI USA, V72, P1245, DOI 10.1073/pnas.72.4.1245; BEKOFF A, 1976, BRAIN RES, V106, P271, DOI 10.1016/0006-8993(76)91025-8; BEKOFF A, 1980, J EXP ZOOL, V214, P173, DOI 10.1002/jez.1402140207; BEKOFF A, 1978, DEV BEHAVIOR COMP EV, P19; BOYNTON AL, 1983, ADV CYCLIC NUCL PROT, V15, P193; Bradley NS, 2008, J NEUROPHYSIOL, V99, P1733, DOI 10.1152/jn.01393.2007; Bradley NS, 2003, J NEUROPHYSIOL, V90, P1408, DOI 10.1152/jn.00393.2003; BRADLEY NS, 1990, DEV PSYCHOBIOL, V23, P763, DOI 10.1002/dev.420230802; Branchereau P, 2000, BRAIN RES BULL, V53, P711, DOI 10.1016/S0361-9230(00)00403-2; CALVO J, 1978, ACTA ANAT, V101, P289, DOI 10.1159/000144980; CHAMBERS SH, 1995, EXP BRAIN RES, V103, P218; COLEMAN MA, 1976, POULTRY SCI, V55, P2483, DOI 10.3382/ps.0552483; Cooper CB, 2011, FUNCT ECOL, V25, P769, DOI 10.1111/j.1365-2435.2011.01847.x; Csernus VJ, 2007, GEN COMP ENDOCR, V152, P148, DOI 10.1016/j.ygcen.2007.01.008; Danilova N, 2004, FASEB J, V18, P751, DOI 10.1096/fj.03-0544fje; Fairchild BD, 2000, POULTRY SCI, V79, P1627, DOI 10.1093/ps/79.11.1627; Ghatpande A, 1995, CELL MOL BIOL RES, V41, P613; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Halevy O, 2006, AM J PHYSIOL-REG I, V290, pR1062, DOI 10.1152/ajpregu.00378.2005; Halevy O, 1998, COMP BIOCHEM PHYS A, V120, P317, DOI 10.1016/S1095-6433(98)10032-6; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; HALL BK, 1990, J MORPHOL, V206, P45, DOI 10.1002/jmor.1052060105; HAMBURGE.V, 1965, J EXP ZOOL, V159, P1, DOI 10.1002/jez.1401590102; HAMBURGER V, 1963, Q REV BIOL, V38, P342, DOI 10.1086/403941; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAMBURGER V, 1963, DEV BIOL, V7, P533, DOI 10.1016/0012-1606(63)90140-4; Hill WL, 2004, DEV PSYCHOBIOL, V45, P174, DOI 10.1002/dev.20021; ISAKSON ST, 1970, COMP BIOCHEM PHYSIOL, V35, P229, DOI 10.1016/0010-406X(70)90925-4; JACOBSON RD, 1982, J NEUROPHYSIOL, V48, P238, DOI 10.1152/jn.1982.48.1.238; Johnston RM, 1996, J COMP PHYSIOL A, V179, P169, DOI 10.1007/BF00222784; JOHNSTON RM, 1992, J EXP BIOL, V171, P43; KARU TI, 1987, NUOVO CIMENTO D, V9, P1245, DOI 10.1007/BF02454725; LAUBER JK, 1975, COMP BIOCHEM PHYS A, V51, P903, DOI 10.1016/0300-9629(75)90073-0; Liu WJ, 2010, ANAT REC, V293, P1315, DOI 10.1002/ar.21174; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Muir GD, 1998, EXP BRAIN RES, V122, P275, DOI 10.1007/s002210050515; Okabayashi N, 2003, BRAIN RES, V990, P231, DOI 10.1016/S0006-8993(03)03531-5; Pang MYC, 2003, J NEUROPHYSIOL, V90, P2731, DOI 10.1152/jn.00407.2003; PROVINE RR, 1980, DEV PSYCHOBIOL, V13, P151, DOI 10.1002/dev.420130207; Robinson SR, 2005, DEV PSYCHOBIOL, V47, P328, DOI 10.1002/dev.20103; Ryu YU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006111; Shafey TM, 2004, BRIT POULTRY SCI, V45, P223, DOI 10.1080/00071660410001715821; SHUTZE JV, 1962, NATURE, V196, P594, DOI 10.1038/196594a0; SIEGEL PB, 1969, COMP BIOCHEM PHYSIOL, V28, P753, DOI 10.1016/0010-406X(69)92108-2; SIEGEL S, 1988, NONPARAMETERIC STAT; Sindhurakar A, 2010, DEV PSYCHOBIOL, V52, P802, DOI 10.1002/dev.20476; STEHOUWER DJ, 1984, DEV PSYCHOBIOL, V17, P217, DOI 10.1002/dev.420170303; Stein PSG, 2004, J NEUROPHYSIOL, V91, P2380, DOI 10.1152/jn.01184.2003; VALCAVI R, 1993, CLIN ENDOCRINOL, V39, P193, DOI 10.1111/j.1365-2265.1993.tb01773.x; Wai MSM, 2006, MICROSC RES TECHNIQ, V69, P99, DOI 10.1002/jemt.20279; Whelan PJ, 2003, J PHYSIOL-LONDON, V553, P695, DOI 10.1113/jphysiol.2003.046219	58	11	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51348	10.1371/journal.pone.0051348	http://dx.doi.org/10.1371/journal.pone.0051348			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236480	gold, Green Published, Green Submitted			2022-12-27	WOS:000312589700037
J	de Vries, FT; Bloem, J; Quirk, H; Stevens, CJ; Bol, R; Bardgett, RD				de Vries, Franciska T.; Bloem, Jaap; Quirk, Helen; Stevens, Carly J.; Bol, Roland; Bardgett, Richard D.			Extensive Management Promotes Plant and Microbial Nitrogen Retention in Temperate Grassland	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SPECIES RICHNESS; BIOMASS RATIOS; SOIL MICROBES; FUNGAL; BACTERIAL; TRAITS; ABUNDANCE; VEGETATION; LINKAGES	Leaching losses of nitrogen (N) from soil and atmospheric N deposition have led to widespread changes in plant community and microbial community composition, but our knowledge of the factors that determine ecosystem N retention is limited. A common feature of extensively managed, species-rich grasslands is that they have fungal-dominated microbial communities, which might reduce soil N losses and increase ecosystem N retention, which is pivotal for pollution mitigation and sustainable food production. However, the mechanisms that underpin improved N retention in extensively managed, species-rich grasslands are unclear. We combined a landscape-scale field study and glasshouse experiment to test how grassland management affects plant and soil N retention. Specifically, we hypothesised that extensively managed, species-rich grasslands of high conservation value would have lower N loss and greater N retention than intensively managed, species-poor grasslands, and that this would be due to a greater immobilisation of N by a more fungal-dominated microbial community. In the field study, we found that extensively managed, species-rich grasslands had lower N leaching losses. Soil inorganic N availability decreased with increasing abundance of fungi relative to bacteria, although the best predictor of soil N leaching was the C/N ratio of aboveground plant biomass. In the associated glasshouse experiment we found that retention of added N-15 was greater in extensively than in intensively managed grasslands, which was attributed to a combination of greater root uptake and microbial immobilisation of N-15 in the former, and that microbial immobilisation increased with increasing biomass and abundance of fungi. These findings show that grassland management affects mechanisms of N retention in soil through changes in root and microbial uptake of N. Moreover, they support the notion that microbial communities might be the key to improved N retention through tightening linkages between plants and microbes and reducing N availability.	[de Vries, Franciska T.; Quirk, Helen; Stevens, Carly J.; Bardgett, Richard D.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Bloem, Jaap] Univ Wageningen & Res Ctr, Alterra, Wageningen, Netherlands; [Bol, Roland] Forschungszentrum Julich, Inst Bio & Geosci, IBG Agrosphere 3, D-52425 Julich, Germany	Lancaster University; Wageningen University & Research; Helmholtz Association; Research Center Julich	de Vries, FT (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, England.	f.devries@lancaster.ac.uk	Bol, Roland/H-9324-2013; de Vries, Franciska/AAD-5760-2021; de Vries, Franciska T/D-3041-2009	Bol, Roland/0000-0003-3015-7706; de Vries, Franciska/0000-0002-6822-8883; de Vries, Franciska T/0000-0002-6822-8883; Stevens, Carly/0000-0002-2390-1763	EU; research program KB IV "Innovative scientific research for sustainable green and blue environment''; Netherlands Ministry of Economic Affairs, Agriculture and Innovation; Leverhulme Early Career fellowship; Natural Environment Research Council [ceh010010] Funding Source: researchfish	EU(European Commission); research program KB IV "Innovative scientific research for sustainable green and blue environment''; Netherlands Ministry of Economic Affairs, Agriculture and Innovation(Ministry of Economic Affairs, Netherlands); Leverhulme Early Career fellowship(Leverhulme Trust); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was part of the EU 7th Framework funded SOILSERVICE project, led by Katarina Hedlund. The contribution of Wageningen University and Research Centre was supported by the research program KB IV "Innovative scientific research for sustainable green and blue environment'' funded by the Netherlands Ministry of Economic Affairs, Agriculture and Innovation. CJS is funded by a Leverhulme Early Career fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CR, 1998, SOIL BIOL BIOCHEM, V30, P767, DOI 10.1016/S0038-0717(97)00168-5; BAKKEN LR, 1983, APPL ENVIRON MICROB, V45, P1188, DOI 10.1128/AEM.45.4.1188-1195.1983; BARDGETT RD, 1993, AGR ECOSYST ENVIRON, V45, P25, DOI 10.1016/0167-8809(93)90057-V; Bardgett RD, 2003, ECOLOGY, V84, P1277, DOI 10.1890/0012-9658(2003)084[1277:SMCEWP]2.0.CO;2; Bardgett RD, 1996, BIOL FERT SOILS, V22, P261, DOI 10.1007/BF00382522; Bardgett RD, 1999, BIOL FERT SOILS, V29, P282, DOI 10.1007/s003740050554; Bloem J., 2004, Molecular microbial ecology manual. Volumes 1 and 2, P861; BLOEM J, 1995, APPL ENVIRON MICROB, V61, P926, DOI 10.1128/AEM.61.3.926-936.1995; Bradley K, 2006, SOIL BIOL BIOCHEM, V38, P1583, DOI 10.1016/j.soilbio.2005.11.011; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; COLEMAN DC, 1983, ADV ECOL RES, V13, P1, DOI 10.1016/S0065-2504(08)60107-5; Crawley M.J., 2007, R BOOK; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; De Deyn GB, 2011, BIOL LETTERS, V7, P75, DOI 10.1098/rsbl.2010.0575; De Deyn GB, 2009, J ECOL, V97, P864, DOI 10.1111/j.1365-2745.2009.01536.x; de Vries FT, 2007, SOIL BIOL BIOCHEM, V39, P1620, DOI 10.1016/j.soilbio.2007.01.013; de Vries FT, 2006, SOIL BIOL BIOCHEM, V38, P2092, DOI 10.1016/j.soilbio.2006.01.008; de Vries FT, 2012, FRONT ECOL ENVIRON, V10, P425, DOI 10.1890/110162; de Vries FT, 2012, ECOL LETT, V15, P1230, DOI 10.1111/j.1461-0248.2012.01844.x; de Vries FT, 2012, NAT CLIM CHANGE, V2, P276, DOI [10.1038/NCLIMATE1368, 10.1038/nclimate1368]; de Vries FT, 2011, SOIL BIOL BIOCHEM, V43, P997, DOI 10.1016/j.soilbio.2011.01.016; de Vries FT, 2009, FEMS MICROBIOL ECOL, V67, P389, DOI 10.1111/j.1574-6941.2008.00643.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Donnison LM, 2000, SOIL BIOL BIOCHEM, V32, P253, DOI 10.1016/S0038-0717(99)00159-5; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Frey SD, 1999, SOIL BIOL BIOCHEM, V31, P573, DOI 10.1016/S0038-0717(98)00161-8; Frey SD, 2003, SOIL BIOL BIOCHEM, V35, P1001, DOI 10.1016/S0038-0717(03)00155-X; FRY JC, 1990, METHOD MICROBIOL, V22, P41; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gordon H, 2008, SOIL BIOL BIOCHEM, V40, P302, DOI 10.1016/j.soilbio.2007.08.008; Harrison KA, 2007, ECOLOGY, V88, P989, DOI 10.1890/06-1018; Harrison KA, 2010, J ECOL, V98, P384, DOI 10.1111/j.1365-2745.2009.01614.x; Helgason BL, 2009, SOIL SCI SOC AM J, V73, P120, DOI 10.2136/sssaj2007.0392; Hopkins DW, 2011, EUR J SOIL SCI, V62, P95, DOI 10.1111/j.1365-2389.2010.01320.x; Joergensen RG, 2008, SOIL BIOL BIOCHEM, V40, P2977, DOI 10.1016/j.soilbio.2008.08.017; Johnson D, 2005, PLANT SOIL, V271, P157, DOI 10.1007/s11104-004-2267-z; Kennedy N, 2005, MICROB ECOL, V50, P463, DOI 10.1007/s00248-005-0256-2; Laughlin DC, 2011, J ECOL, V99, P1091, DOI 10.1111/j.1365-2745.2011.01856.x; Lu M, 2011, NEW PHYTOL, V189, P1040, DOI 10.1111/j.1469-8137.2010.03563.x; Nilsson LO, 2007, OECOLOGIA, V153, P375, DOI 10.1007/s00442-007-0735-x; Orwin KH, 2010, J ECOL, V98, P1074, DOI 10.1111/j.1365-2745.2010.01679.x; Pinheiro J, 2000, MIXED EFFECTS MODELS; Postma-Blaauw MB, 2010, ECOLOGY, V91, P460, DOI 10.1890/09-0666.1; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Raciti SM, 2008, ECOL APPL, V18, P1615, DOI 10.1890/07-1062.1; Ramirez KS, 2012, GLOB CHANGE BIOL, pn/a; Rodwell JS, 1992, BRITISH PLANT COMMUN, V3; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Smith RS, 2008, J APPL ECOL, V45, P670, DOI 10.1111/j.1365-2664.2007.01425.x; Smith RS, 2003, J APPL ECOL, V40, P51, DOI 10.1046/j.1365-2664.2003.00780.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Strickland MS, 2010, SOIL BIOL BIOCHEM, V42, P1385, DOI 10.1016/j.soilbio.2010.05.007; Thiet RK, 2006, SOIL BIOL BIOCHEM, V38, P837, DOI 10.1016/j.soilbio.2005.07.010; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 2010, ECOLOGY, V91, P1163, DOI 10.1890/09-0336.1; van der Heijden MGA, 2009, J ECOL, V97, P1139, DOI 10.1111/j.1365-2745.2009.01570.x; VANVEEN JA, 1979, APPL ENVIRON MICROB, V37, P686, DOI 10.1128/AEM.37.4.686-692.1979; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Zelles L, 1997, SOIL BIOL BIOCHEM, V29, P1325, DOI 10.1016/S0038-0717(97)00062-X; Zogg GP, 2000, ECOLOGY, V81, P1858, DOI 10.1890/0012-9658(2000)081[1858:MIATRO]2.0.CO;2	65	83	83	2	180	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51201	10.1371/journal.pone.0051201	http://dx.doi.org/10.1371/journal.pone.0051201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227252	Green Published, Green Accepted, gold			2022-12-27	WOS:000312588200111
J	Liu, SC; Hsu, CJ; Chen, HT; Tsou, HK; Chuang, SM; Tang, CH				Liu, Shan-Chi; Hsu, Chin-Jung; Chen, Hsien-Te; Tsou, Hsi-Kai; Chuang, Show-Mei; Tang, Chih-Hsin			CTGF Increases IL-6 Expression in Human Synovial Fibroblasts through Integrin-Dependent Signaling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR; RHEUMATOID-ARTHRITIS; INTERLEUKIN-6 IL-6; CELL; OSTEOARTHRITIS; RECEPTOR; STRESS; GENE; PROGRESSION	Background: Connective tissue growth factor (CTGF; also known as CCN2) is an inflammatory mediator, and shows elevated levels in regions of severe injury and inflammatory diseases. CTGF is abundantly expressed in osteoarthritis (OA). However, the relationship between CTGF and IL-6 in OA synovial fibroblasts (OASFs) is mostly unknown. Methodology/Principal Findings: OASFs showed significant expression of CTGF, and expression was higher than in normal SFs. OASFs stimulation with CTGF induced concentration-dependent increases in IL-6 expression. CTGF mediated IL-6 production was attenuated by alpha v beta 5 integrin neutralized antibody and apoptosis signal-regulating kinase 1 (ASK1) shRNA. Pretreatment with p38 inhibitor (SB203580), JNK inhibitor (SP600125), AP-1 inhibitors (Curcumin and Tanshinone IIA), and NF-kappa B inhibitors (PDTC and TPCK) also inhibited the potentiating action of CTGF. CTGF-mediated increase of NF-kappa B and AP-1 luciferase activity was inhibited by SB203580 and SP600125 or ASK1 shRNA or p38 and JNK mutant. Conclusions/Significance: Our results suggest that CTGF increased IL-6 production in OASFs via the avb5 integrin, ASK1, p38/JNK, and AP-1/NF-kappa B signaling pathways.	[Liu, Shan-Chi; Chuang, Show-Mei] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Hsu, Chin-Jung; Chen, Hsien-Te] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Hsu, Chin-Jung; Chen, Hsien-Te] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Chen, Hsien-Te; Tsou, Hsi-Kai] Feng Chia Univ, Dept Mat Sci & Engn, Taichung 40724, Taiwan; [Tsou, Hsi-Kai] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Tsou, Hsi-Kai] Jen Teh Jr Coll Med Nursing & Management, Ctr Gen Educ, Miaoli, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Feng Chia University; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Taiwan	Chuang, SM (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan.	smchuang@dragon.nchu.edu.tw; chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015	Tang, Chih Hsin/0000-0002-7113-8352; Chuang, Show-Mei/0000-0003-2986-0736	National Science Council of Taiwan [NSC99-2320-B-039-003-MY3, 100-2320-B-039-028-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Science Council of Taiwan (NSC99-2320-B-039-003-MY3; 100-2320-B-039-028-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2008, RHEUMATOLOGY, V47, pV8, DOI 10.1093/rheumatology/ken278; Arnott JA, 2011, CRIT REV EUKAR GENE, V21, P43, DOI 10.1615/CritRevEukarGeneExpr.v21.i1.40; Ayral X, 2005, OSTEOARTHR CARTILAGE, V13, P361, DOI 10.1016/j.joca.2005.01.005; Chen PS, 2007, J CELL SCI, V120, P2053, DOI 10.1242/jcs.03460; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; Coluet J, 2009, DRUG DISCOV TODAY, V14, P913, DOI 10.1016/j.drudis.2009.07.012; Davidson ENB, 2006, ARTHRITIS RHEUM-US, V54, P1653, DOI 10.1002/art.21795; Dhar A., 2010, Experimental Oncology, V32, P2; Felson DT, 2006, NEW ENGL J MED, V354, P841, DOI 10.1056/NEJMcp051726; GRAEVE L, 1993, CLIN INVESTIGATOR, V71, P664; Grassl C, 1999, J AM SOC NEPHROL, V10, P1466; Grimble RF, 1998, NUTRITION, V14, P634, DOI 10.1016/S0899-9007(98)00010-0; Hahm ER, 2002, CANCER LETT, V184, P89, DOI 10.1016/S0304-3835(02)00170-2; Hsieh MT, 2003, LIFE SCI, V73, P1007, DOI 10.1016/S0024-3205(03)00372-2; Huang HC, 2003, J BIOL CHEM, V278, P46750, DOI 10.1074/jbc.M305216200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Mor A, 2005, CLIN IMMUNOL, V115, P118, DOI 10.1016/j.clim.2004.12.009; Omoto S, 2004, OSTEOARTHR CARTILAGE, V12, P771, DOI 10.1016/j.joca.2004.06.009; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Persson E, 2005, BONE, V37, P513, DOI 10.1016/j.bone.2005.04.043; Pozgan U, 2010, BIOL CHEM, V391, P571, DOI 10.1515/BC.2010.035; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206; Tan TW, 2009, J CELL BIOCHEM, V107, P345, DOI 10.1002/jcb.22132; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Tang CH, 2010, ARTHRITIS RHEUM-US, V62, P3615, DOI 10.1002/art.27755; Tseng CP, 2003, FEBS LETT, V541, P21, DOI 10.1016/S0014-5793(03)00281-3; Uson J, 1997, J RHEUMATOL, V24, P2069; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Wang YC, 2003, ANAL BIOCHEM, V319, P206, DOI 10.1016/S0003-2697(03)00330-0; Wright AA, 2009, ARTHRIT RHEUM-ARTHR, V61, P925, DOI 10.1002/art.24641; Yokota K, 2006, J RHEUMATOL, V33, P463; Yu CC, 2009, J IMMUNOL, V182, P7916, DOI 10.4049/jimmunol.0801582; Zhang R, 2003, J CLIN INVEST, V111, P1933, DOI 10.1172/JCI200317790	39	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51097	10.1371/journal.pone.0051097	http://dx.doi.org/10.1371/journal.pone.0051097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201YT	23227240	gold, Green Submitted, Green Published			2022-12-27	WOS:000323179700001
J	Smith, KE; Thatje, S				Smith, Kathryn E.; Thatje, Sven			The Secret to Successful Deep-Sea Invasion: Does Low Temperature Hold the Key?	PLOS ONE			English	Article							NEOGASTROPOD BUCCINUM-UNDATUM; CLIMATE-CHANGE; PRESSURE TOLERANCES; HYDROSTATIC-PRESSURE; REPRODUCTIVE-CYCLE; DIVERSITY GRADIENT; SPECIES-DIVERSITY; WATER; DISPERSAL; LARVAL	There is a general consensus that today's deep-sea biodiversity has largely resulted from recurrent invasions and speciations occurring through homogenous waters during periods of the Phanerozoic eon. Migrations likely continue today, primarily via isothermal water columns, such as those typical of Polar Regions, but the necessary ecological and physiological adaptations behind them are poorly understood. In an evolutionary context, understanding the adaptations, which allow for colonisation to high-pressure environments, may enable us to predict future events. In this investigation, we examine pressure tolerance during development, in the shallow-water neogastropod Buccinum undatum using thermally acclimated egg masses from temperate and sub-polar regions across the species range. Fossil records indicate neogastropods to have a deep-water origin, suggesting shallow-water species may be likely candidates for re-emergence into the deep sea. Our results show population level differences in physiological thresholds, which indicate low temperature acclimation to increase pressure tolerance. These findings imply this species is capable of deep-sea penetration through isothermal water columns prevailing at high latitudes. This study gives new insight into the fundamentals behind past and future colonisation events. Such knowledge is instrumental to understand better how changes in climate envelopes affect the distribution and radiation of species along latitudinal as well as bathymetric temperature gradients.	[Smith, Kathryn E.; Thatje, Sven] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England	NERC National Oceanography Centre; University of Southampton	Smith, KE (corresponding author), Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England.	kathryn.smith@noc.soton.ac.uk	Smith, Kathryn/G-5257-2014	Smith, Kathryn/0000-0002-7240-1490	Total Foundation [Abyss2100)]; Malacological Society of London	Total Foundation(Total SA); Malacological Society of London	This work was made possible through a grant (Abyss2100) from the Total Foundation to Sven Thatje and from the Malacological Society of London to Kathryn Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaina N, 2012, MAR BIOL, V159, P1871, DOI 10.1007/s00227-012-1975-9; Allan EL, 2006, J EXP MAR BIOL ECOL, V337, P103, DOI 10.1016/j.jembe.2006.06.006; Anger K, 2003, MAR ECOL PROG SER, V253, P243, DOI 10.3354/meps253243; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Aquino-Souza R, 2008, J MAR BIOL ASSOC UK, V88, P453, DOI 10.1017/S0025315408001148; Balny C, 1997, COMP BIOCHEM PHYS A, V116, P299, DOI 10.1016/S0300-9629(96)00355-6; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Benitez-Villalobos F, 2006, MAR ECOL PROG SER, V314, P109; BENSON BB, 1984, LIMNOL OCEANOGR, V29, P620, DOI 10.4319/lo.1984.29.3.0620; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Brown A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028562; Cancino JM, 2011, J MAR BIOL ASSOC UK, V91, P727, DOI 10.1017/S0025315410001335; Casadei M. A., 1997, HIGH PRESSURE RES BI, P281; Casadei MA, 2002, APPL ENVIRON MICROB, V68, P5965, DOI 10.1128/AEM.68.12.5965-5972.2002; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; CLARKE A, 1993, FUNCT ECOL, V7, P139, DOI 10.2307/2389880; Culver SJ, 2000, DEEP-SEA RES PT I, V47, P259, DOI 10.1016/S0967-0637(99)00055-2; DASARO CN, 1970, B MAR SCI, V20, P414; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; Drinkwater Kenneth F., 2004, Journal of Northwest Atlantic Fishery Science, V34, P85, DOI 10.2960/J.v34.m545; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Fretter V, 1985, J MOLLUS STUD, P435; Hall S, 2009, J BIOGEOGR, V36, P2125, DOI 10.1111/j.1365-2699.2009.02153.x; Hancock D, 1967, WHELKS; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Howell KL, 2002, DEEP-SEA RES PT I, V49, P1901, DOI 10.1016/S0967-0637(02)00090-0; JABLONSKI D, 1986, B MAR SCI, V39, P565; Jablonski D, 2005, J EXP ZOOL PART B, V304B, P504, DOI 10.1002/jez.b.21075; JABLONSKI D, 1991, SCIENCE, V252, P1831, DOI 10.1126/science.252.5014.1831; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jacobs DK, 1998, P NATL ACAD SCI USA, V95, P9396, DOI 10.1073/pnas.95.16.9396; KIDEYS AE, 1993, J MAR BIOL ASSOC UK, V73, P391, DOI 10.1017/S002531540003294X; Kiel S, 2012, GEOLOGY, V40, P839, DOI 10.1130/G33300.1; Kiel S, 2010, GEOLOGY, V38, P955, DOI 10.1130/G31282.1; Macpherson E, 2003, BIOL J LINN SOC, V80, P437, DOI 10.1046/j.1095-8312.2003.00256.x; MARTEL A, 1986, J EXP MAR BIOL ECOL, V96, P27, DOI 10.1016/0022-0981(86)90011-0; Martell KA, 2002, J MOLLUS STUD, V68, P45, DOI 10.1093/mollus/68.1.45; Mestre NC, 2009, P ROY SOC B-BIOL SCI, V276, P717, DOI 10.1098/rspb.2008.1376; Morel GM, 2004, FISH RES, V68, P283, DOI 10.1016/j.fishres.2003.11.010; Nasution S, 2004, AQUACULT INT, V12, P509, DOI 10.1007/s10499-004-5745-7; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Oliphant A, 2011, J EXP BIOL, V214, P1109, DOI 10.1242/jeb.048058; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pedersen RB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1124; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pradillon Florence, 2007, Reviews in Environmental Science and Bio/Technology, V6, P181, DOI 10.1007/s11157-006-9111-2; Raupach MJ, 2009, P ROY SOC B-BIOL SCI, V276, P799, DOI 10.1098/rspb.2008.1063; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; Rex MA, 2000, P NATL ACAD SCI USA, V97, P4082, DOI 10.1073/pnas.050589497; Rosenberg G, 2009, MALACOLOG 4 1 1 DATA; SEPKOSKI JJ, 1988, PALEOBIOLOGY, V14, P221, DOI 10.1017/S0094837300011969; Smith KE, 2013, HELGOLAND MAR RES, V67, P109, DOI 10.1007/s10152-012-0308-1; Smith KE, J SEA RES IN PRESS; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; SOMERO GN, 1992, ANNU REV PHYSIOL, V54, P557, DOI 10.1146/annurev.ph.54.030192.003013; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Thatje S, 2005, TRENDS ECOL EVOL, V20, P534, DOI 10.1016/j.tree.2005.07.010; Thatje S, 2010, J EXP MAR BIOL ECOL, V390, P22, DOI 10.1016/j.jembe.2010.04.028; Thomas E, 1996, GEOLOGY, V24, P355, DOI 10.1130/0091-7613(1996)024<0355:CDSBFT>2.3.CO;2; Tokuda G, 2006, BIOL LETTERS, V2, P257, DOI 10.1098/rsbl.2005.0420; Tyler PA, 1998, DEEP-SEA RES PT II, V45, P253, DOI 10.1016/S0967-0645(97)00091-X; Tyler PA, 2000, MAR ECOL PROG SER, V192, P173, DOI 10.3354/meps192173; Valentinsson D, 2002, MAR BIOL, V140, P1139, DOI 10.1007/s00227-002-0793-x; Weiss M, 2009, J EXP MAR BIOL ECOL, V376, P48, DOI 10.1016/j.jembe.2009.06.002; Weiss M, 2009, J MAR BIOL ASSOC UK, V89, P753, DOI 10.1017/S0025315409003269; WILSON GD, 1980, J NAT HIST, V14, P215, DOI 10.1080/00222938000770201; Young CM, 1997, MAR ECOL PROG SER, V154, P197, DOI 10.3354/meps154197; ZINSMEISTER WJ, 1984, SCIENCE, V224, P281, DOI 10.1126/science.224.4646.281; Zippay ML, 2010, MAR BIOL, V157, P707, DOI 10.1007/s00227-009-1354-3	71	93	97	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51219	10.1371/journal.pone.0051219	http://dx.doi.org/10.1371/journal.pone.0051219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227254	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200113
J	Moss, FJM; Baddeley, R; Canagarajah, N				Moss, Felix Joseph Mercer; Baddeley, Roland; Canagarajah, Nishan			Eye Movements to Natural Images as a Function of Sex and Personality	PLOS ONE			English	Article							BASAL GANGLIA; DOPAMINE-RECEPTORS; GAZE; MODEL; FACES; IMPULSIVITY; PERFORMANCE; OBSERVERS; SELECTION; ESTROGEN	Women and men are different. As humans are highly visual animals, these differences should be reflected in the pattern of eye movements they make when interacting with the world. We examined fixation distributions of 52 women and men while viewing 80 natural images and found systematic differences in their spatial and temporal characteristics. The most striking of these was that women looked away and usually below many objects of interest, particularly when rating images in terms of their potency. We also found reliable differences correlated with the images' semantic content, the observers' personality, and how the images were semantically evaluated. Information theoretic techniques showed that many of these differences increased with viewing time. These effects were not small: the fixations to a single action or romance film image allow the classification of the sex of an observer with 64% accuracy. While men and women may live in the same environment, what they see in this environment is reliably different. Our findings have important implications for both past and future eye movement research while confirming the significant role individual differences play in visual attention.	[Moss, Felix Joseph Mercer; Canagarajah, Nishan] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Baddeley, Roland] Univ Bristol, Dept Expt Psychol, Bristol, Avon, England	University of Bristol; University of Bristol	Moss, FJM (corresponding author), Univ Bristol, Dept Comp Sci, Bristol, Avon, England.	F.MercerMoss@Bristol.ac.uk			Engineering and Physical Sciences Research Counsel (EPSRC); British Telecom	Engineering and Physical Sciences Research Counsel (EPSRC); British Telecom	The funding for this research was from a combination of the Engineering and Physical Sciences Research Counsel (EPSRC) and British Telecom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SL, 2000, NEUROSCI BIOBEHAV R, V24, P137, DOI 10.1016/S0149-7634(99)00044-5; Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Bayliss AP, 2006, PSYCHOL SCI, V17, P514, DOI 10.1111/j.1467-9280.2006.01737.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Campbell R, 1996, VIS COGN, V3, P393, DOI 10.1080/135062896395643; Conway CA, 2007, HORM BEHAV, V51, P202, DOI 10.1016/j.yhbeh.2006.10.002; Cross CP, 2011, PSYCHOL BULL, V137, P97, DOI 10.1037/a0021591; Daniel JM, 2006, HORM BEHAV, V49, P38, DOI 10.1016/j.yhbeh.2005.05.001; Deligianni F, 2011, DEV PSYCHOL, V47, P1499, DOI 10.1037/a0025659; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; GINSBURG HJ, 1982, CHILD DEV, V53, P426, DOI 10.2307/1128985; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; Gur RC, 1999, J NEUROSCI, V19, P4065; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Isaacowitz DM, 2005, PERS SOC PSYCHOL B, V31, P407, DOI 10.1177/0146167204271599; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Jovanovic H, 2008, NEUROIMAGE, V39, P1408, DOI 10.1016/j.neuroimage.2007.10.016; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Leonards U, 2007, CURR BIOL, V17, pR8, DOI 10.1016/j.cub.2006.11.046; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Osgood C.E., 1957, MEASUREMENT MEANING; Perlman SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005952; Rijpkema M, 2011, HUM BRAIN MAPP; Rupp HA, 2007, HORM BEHAV, V51, P524, DOI 10.1016/j.yhbeh.2007.01.008; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; VANHARTESVELDT C, 1986, NEUROSCI BIOBEHAV R, V10, P1, DOI 10.1016/0149-7634(86)90029-1; Vassallo S, 2009, J VISION, V9, DOI 10.1167/9.3.11; Vincent BT, 2009, VIS COGN, V17, P856, DOI 10.1080/13506280902916691; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	34	35	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e47870	10.1371/journal.pone.0047870	http://dx.doi.org/10.1371/journal.pone.0047870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23248740	Green Published, gold, Green Submitted			2022-12-27	WOS:000312376100009
J	Liu, YH; Zhao, ZF; Li, TY; Liao, Q; Kushner, N; Touzjian, NY; Shao, YM; Sun, YT; Strong, AJ; Lu, YC				Liu, Yanhou; Zhao, Zhongfang; Li, Tianyi; Liao, Qi; Kushner, Nicholas; Touzjian, Neal Y.; Shao, Yiming; Sun, Yongtao; Strong, Amie J.; Lu, Yichen			High Resolution Human Leukocyte Antigen Class I Allele Frequencies and HIV-1 Infection Associations in Chinese Han and Uyghur Cohorts	PLOS ONE			English	Article							HLA CLASS-I; VIRUS TYPE-1 INFECTION; T-CELL RESPONSES; YI ETHNIC-GROUP; DISEASE PROGRESSION; POPULATION; HAPLOTYPES; GENES; SUSCEPTIBILITY; POLYMORPHISMS	Background: Host immunogenetic factors such as HLA class I polymorphism are important to HIV-1 infection risk and AIDS progression. Previous studies using high-resolution HLA class I profile data of Chinese populations appeared insufficient to provide information for HIV-1 vaccine development and clinical trial design. Here we reported HLA class I association with HIV-1 susceptibility in a Chinese Han and a Chinese Uyghur cohort. Methodology/Principal Findings: Our cohort included 327 Han and 161 Uyghur ethnic individuals. Each cohort included HIV-1 seropositive and HIV-1 seronegative subjects. Four-digit HLA class I typing was performed by sequencing-based typing and high-resolution PCR-sequence specific primer. We compared the HLA class I allele and inferred haplotype frequencies between HIV-1 seropositive and seronegative groups. A neighbor-joining tree between our cohorts and other populations was constructed based on allele frequencies of HLA-A and HLA-B loci. We identified 58 HLA-A, 75 HLA-B, and 32 HLA-Cw distinct alleles from our cohort and no novel alleles. The frequency of HLA-B*5201 and A*0301 was significantly higher in the Han HIV-1 negative group. The frequency of HLA-B*5101 was significantly higher in the Uyghur HIV-1 negative group. We observed statistically significant increases in expectation-maximization (EM) algorithm predicted haplotype frequencies of HLA-A*0201-B*5101 in the Uyghur HIV-1 negative group, and of Cw*0304-B*4001 in the Han HIV-1 negative group. The B62s supertype frequency was found to be significantly higher in the Han HIV-1 negative group than in the Han HIV-1 positive group. Conclusions: At the four-digit level, several HLA class I alleles and haplotypes were associated with lower HIV-1 susceptibility. Homogeneity of HLA class I and Bw4/Bw6 heterozygosity were not associated with HIV-1 susceptibility in our cohort. These observations contribute to the Chinese HLA database and could prove useful in the development of HIV-1 vaccine candidates.	[Liu, Yanhou; Zhao, Zhongfang; Li, Tianyi; Liao, Qi] Nankai Univ, Vaccine Lab, Tianjin 300071, Peoples R China; [Kushner, Nicholas; Touzjian, Neal Y.; Strong, Amie J.; Lu, Yichen] Vaccine Technol Inc, Wellesley, MA USA; [Shao, Yiming] Natl Ctr AIDS Prevent & Control, Beijing, Peoples R China; [Sun, Yongtao] Fourth Mil Med Univ, Tangdu Hosp, Xian 710032, Peoples R China; [Lu, Yichen] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Nankai University; Air Force Military Medical University; Harvard University; Harvard T.H. Chan School of Public Health	Lu, YC (corresponding author), Vaccine Technol Inc, Wellesley, MA USA.	yichenlu@hsph.harvard.edu			Nankai University Vaccine Laboratory; Partners AIDS Research Center at Massachusetts General Hospital [NO1-AI-30024]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030024] Funding Source: NIH RePORTER	Nankai University Vaccine Laboratory; Partners AIDS Research Center at Massachusetts General Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study is supported by the research subcontract between Nankai University Vaccine Laboratory and the Partners AIDS Research Center at Massachusetts General Hospital (NO1-AI-30024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird TG, 2002, AIDS, V16, P1899, DOI 10.1097/00002030-200209270-00006; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Cao JH, 2003, J VIROL, V77, P6867, DOI 10.1128/JVI.77.12.6867-6878.2003; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Chen S, 2006, INT J IMMUNOGENET, V33, P439, DOI 10.1111/j.1744-313X.2006.00637.x; Chen S, 2007, HUM IMMUNOL, V68, P928, DOI 10.1016/j.humimm.2007.09.006; China's Ministry of Health World Health Organization UNAIDS, CHIN AIDS EP ASS REP; de Sorrentino AH, 2000, J INFECT DIS, V182, P1523, DOI 10.1086/315854; Erickson AL, 2008, CLIN VACCINE IMMUNOL, V15, P1745, DOI 10.1128/CVI.00247-08; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FABIO G, 1990, BRIT J HAEMATOL, V75, P531, DOI 10.1111/j.1365-2141.1990.tb07794.x; Harrer T, 1996, J IMMUNOL, V156, P2616; Hoa BK, 2008, TISSUE ANTIGENS, V71, P127, DOI 10.1111/j.1399-0039.2007.00982.x; Hong Kun-xue, 2007, Virologica Sinica, V22, P301; Hong WG, 2007, HUM IMMUNOL, V68, P439, DOI 10.1016/j.humimm.2007.01.020; Huang X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-201; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Koehler RN, 2010, J INFECT DIS, V202, P1562, DOI 10.1086/656913; Lee KW, 2005, TISSUE ANTIGENS, V65, P437, DOI 10.1111/j.1399-0039.2005.00386.x; Li S, 2007, JAIDS-J ACQ IMM DEF, V44, P121, DOI 10.1097/01.qai.0000248355.40877.2a; Middleton D, 2004, TISSUE ANTIGENS, V63, P555, DOI 10.1111/j.0001-2815.2004.00234.x; Ministry of Health of the People's Republic of China, 2011, CHIN HLTH STAT YB 20; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Ogata S, 2007, TISSUE ANTIGENS, V69, P154, DOI 10.1111/j.1399-0039.2006.00698.x; Qing ML, 2006, JAIDS-J ACQ IMM DEF, V41, P137, DOI 10.1097/01.qai.0000195607.25262.92; Roshorm Y, 2009, EUR J IMMUNOL, V39, P1831, DOI 10.1002/eji.200939309; Rowland-Jones SL, 2001, IMMUNOL LETT, V79, P15, DOI 10.1016/S0165-2478(01)00261-9; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; Saito S, 2000, TISSUE ANTIGENS, V56, P522, DOI 10.1034/j.1399-0039.2000.560606.x; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006; Selvaraj P, 2006, JAIDS-J ACQ IMM DEF, V43, P497, DOI 10.1097/01.qai.0000233312.36226.76; Shen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013458; Shi L, 2010, TISSUE ANTIGENS, V75, P159, DOI 10.1111/j.1399-0039.2009.01407.x; Shi L, 2008, HUM IMMUNOL, V69, P58, DOI 10.1016/j.humimm.2007.11.007; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Song W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023469; Stephens HAF, 2005, TRENDS IMMUNOL, V26, P41, DOI 10.1016/j.it.2004.11.001; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tang JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009629; Trachtenberg E, 2007, TISSUE ANTIGENS, V70, P455, DOI 10.1111/j.1399-0039.2007.00932.x; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; Welzel TM, 2007, AIDS, V21, P225, DOI 10.1097/QAD.0b013e3280123840; Wen SH, 2008, HUM IMMUNOL, V69, P430, DOI 10.1016/j.humimm.2008.05.012; Xu MY, 2004, BIOMED ENVIRON SCI, V17, P203; Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017; Yang G, 2006, TISSUE ANTIGENS, V67, P146, DOI 10.1111/j.1399-0039.2006.00529.x; Yuliwulandari R, 2009, TISSUE ANTIGENS, V73, P46, DOI 10.1111/j.1399-0039.2008.01178.x; Zhai S, 2008, CURR HIV RES, V6, P335, DOI 10.2174/157016208785132473; Zhu BF, 2010, J ZHEJIANG UNIV-SC B, V11, P127, DOI 10.1631/jzus.B0900232	50	1	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50656	10.1371/journal.pone.0050656	http://dx.doi.org/10.1371/journal.pone.0050656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251376	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200033
J	Pariyadath, V; Eagleman, DM				Pariyadath, Vani; Eagleman, David M.			Subjective Duration Distortions Mirror Neural Repetition Suppression	PLOS ONE			English	Article							TIME PERCEPTION; REPRESENTATION; ILLUSIONS; CORTEX; BRAIN; AREA	Background: Subjective duration is strongly influenced by repetition and novelty, such that an oddball stimulus in a stream of repeated stimuli appears to last longer in duration in comparison. We hypothesize that this duration illusion, called the temporal oddball effect, is a result of the difference in expectation between the oddball and the repeated stimuli. Specifically, we conjecture that the repeated stimuli contract in duration as a result of increased predictability; these duration contractions, we suggest, result from decreased neural response amplitude with repetition, known as repetition suppression. Methodology/Principal Findings: Participants viewed trials consisting of lines presented at a particular orientation (standard stimuli) followed by a line presented at a different orientation (oddball stimulus). We found that the size of the oddball effect correlates with the number of repetitions of the standard stimulus as well as the amount of deviance from the oddball stimulus; both of these results are consistent with a repetition suppression hypothesis. Further, we find that the temporal oddball effect is sensitive to experimental context - that is, the size of the oddball effect for a particular experimental trial is influenced by the range of duration distortions seen in preceding trials. Conclusions/Significance: Our data suggest that the repetition-related duration contractions causing the oddball effect are a result of neural repetition suppression. More generally, subjective duration may reflect the prediction error associated with a stimulus and, consequently, the efficiency of encoding that stimulus. Additionally, we emphasize that experimental context effects need to be taken into consideration when designing duration-related tasks.	[Pariyadath, Vani; Eagleman, David M.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Eagleman, David M.] Baylor Coll Med, Dept Psychiat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Eagleman, DM (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	eagleman@cpu.bcm.edu	Pariyadath, Vani/B-7904-2009	Pariyadath, Vani/0000-0001-6340-0771	NIH [RO1 NS053960]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053960] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH RO1 NS053960 (DME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Cui X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000167; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Eagleman DM, 2009, PHILOS T R SOC B, V364, P1841, DOI 10.1098/rstb.2009.0026; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Helson H, 1964, ADAPTATION LEVEL THE; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; Luce RD, 1986, RESPONSE TIMES THEIR; Matthews WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019815; Noguchi Y, 2006, CEREB CORTEX, V16, P1797, DOI 10.1093/cercor/bhj117; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Pariyadath V, 2008, J VISION, V8, DOI 10.1167/8.16.11; ROSE D, 1995, PERCEPTION, V24, P1177, DOI 10.1068/p241177; Sadeghi NG, 2011, J COGNITIVE NEUROSCI, V23, P3829, DOI 10.1162/jocn_a_00071; Schindel R, 2011, J VISION, V11, DOI 10.1167/11.2.17; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; van Wassenhove V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001437; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X	21	43	46	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49362	10.1371/journal.pone.0049362	http://dx.doi.org/10.1371/journal.pone.0049362			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251340	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200013
J	Muller, K; Bouyer, D; Schnittger, A; Kermode, AR				Mueller, Kerstin; Bouyer, Daniel; Schnittger, Arp; Kermode, Allison R.			Evolutionarily Conserved Histone Methylation Dynamics during Seed Life-Cycle Transitions	PLOS ONE			English	Article							FLOWERING-LOCUS-C; ABSCISIC-ACID; DORMANCY MAINTENANCE; ARABIDOPSIS CVI; GENE; GERMINATION; EXPRESSION; PROTEIN; ABI3; H3	Plants have a remarkable ability to react to seasonal changes by synchronizing life-cycle transitions with environmental conditions. We addressed the question of how transcriptional re-programming occurs in response to an environmental cue that triggers the major life cycle transition from seed dormancy to germination and seedling growth. We elucidated an important mechanistic aspect of this process by following the chromatin dynamics of key regulatory genes with a focus on the two antagonistic marks, H3K4me3 and H3K27me3. Histone methylation patterns of major dormancy regulators changed during the transition to germination and seedling growth. We observed a switch from H3K4me3 and high transcription levels to silencing by the repressive H3K27me3 mark when dormancy was broken through exposure to moist chilling, underscoring that a functional PRC2 complex is necessary for this transition. Moreover, this reciprocal regulation by H3K4me3 and H3K27me3 is evolutionarily conserved from gymnosperms to angiosperms. Citation: Muller K, Bouyer D, Schnittger A, Kermode AR (2012) Evolutionarily Conserved Histone Methylation Dynamics during Seed Life-Cycle Transitions. PLoS ONE 7(12): e51532. doi:10.1371/journal.pone.0051532	[Mueller, Kerstin; Kermode, Allison R.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Bouyer, Daniel; Schnittger, Arp] CNRS, IBMP, UPR2357, Strasbourg, France	Simon Fraser University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Muller, K (corresponding author), Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada.	kermode@sfu.ca; kermode@sfu.ca	Schnittger, Arp/AAO-6920-2020; Schnittger, Arp/F-8989-2010; Bouyer, Daniel/P-5119-2016	Schnittger, Arp/0000-0001-7067-0091; Schnittger, Arp/0000-0001-7067-0091; Berger, Frederic/0000-0002-3609-8260; Bouyer, Daniel/0000-0002-7438-5551	German Research Foundation [MU 3114/1-1]; European Research Council Starting Independent Researcher Grant; Natural Sciences and Engineering Research Council of Canada Discovery grant	German Research Foundation(German Research Foundation (DFG)); European Research Council Starting Independent Researcher Grant; Natural Sciences and Engineering Research Council of Canada Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors gratefully acknowledge funding from the German Research Foundation to KM (MU 3114/1-1), a European Research Council Starting Independent Researcher Grant to AS, and a Natural Sciences and Engineering Research Council of Canada Discovery grant to ARK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichinger E, 2011, PLANT CELL, V23, P1047, DOI 10.1105/tpc.111.083352; Alonso-Blanco C, 2003, GENETICS, V164, P711; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; Coustham V, 2012, SCIENCE, V337, P584, DOI 10.1126/science.1221881; Dambacher S, 2010, HEREDITY, V105, P24, DOI 10.1038/hdy.2010.49; de Casas RR, 2012, NEW PHYTOL, V194, P868, DOI 10.1111/j.1469-8137.2012.04097.x; Deal RB, 2011, CURR OPIN PLANT BIOL, V14, P116, DOI 10.1016/j.pbi.2010.11.005; Feurtado JA, 2011, METHODS MOL BIOL, V773, P53, DOI 10.1007/978-1-61779-231-1_4; Finch-Savage WE, 2007, PLANT J, V51, P60, DOI 10.1111/j.1365-313X.2007.03118.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Graeber K, 2011, PLANT CELL, V23, P2045, DOI 10.1105/tpc.111.084103; Graeber K, 2010, PLANT MOL BIOL, V73, P67, DOI 10.1007/s11103-009-9583-x; He YH, 2009, MOL PLANT, V2, P554, DOI 10.1093/mp/ssp005; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kermode AR, 2005, J PLANT GROWTH REGUL, V24, P319, DOI 10.1007/s00344-005-0110-2; Kim DH, 2008, PLANT CELL, V20, P1260, DOI 10.1105/tpc.108.058859; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Li HC, 2005, PLANT J, V44, P1010, DOI 10.1111/j.1365-313X.2005.02602.x; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; MEINKE DW, 1994, PLANT CELL, V6, P1049, DOI 10.1105/tpc.6.8.1049; Mosquna A, 2009, DEVELOPMENT, V136, P2433, DOI 10.1242/dev.035048; Quatrano RS, 2007, CURR OPIN PLANT BIOL, V10, P182, DOI 10.1016/j.pbi.2007.01.005; Ren CW, 1999, J EXP BOT, V50, P1403, DOI 10.1093/jexbot/50.337.1403; Rohde A, 2006, TRENDS PLANT SCI, V10, P418; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Rozen S, 2000, Methods Mol Biol, V132, P365; Saleh A, 2008, GENE, V423, P43, DOI 10.1016/j.gene.2008.06.022; Springer NM, 2003, PLANT PHYSIOL, V132, P907, DOI 10.1104/pp.102.013722; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Sung S, 2006, J EXP BOT, V57, P3369, DOI 10.1093/jxb/erl105; Suzuki M, 2001, PLANT J, V28, P409, DOI 10.1046/j.1365-313X.2001.01165.x; Tamada Y, 2009, PLANT CELL, V21, P3257, DOI 10.1105/tpc.109.070060; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Zeng Y, 2004, PLANT MOL BIOL, V56, P731, DOI 10.1007/s11103-004-4952-y; Zeng Y, 2003, PLANT MOL BIOL, V51, P39, DOI 10.1023/A:1020762304937; Zhang XW, 2011, INT P ECON DEV RES, V4, P62; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	46	51	53	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51532	10.1371/journal.pone.0051532	http://dx.doi.org/10.1371/journal.pone.0051532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240039	Green Published, gold			2022-12-27	WOS:000312290800075
J	do Amaral, AM; Antoniw, J; Rudd, JJ; Hammond-Kosack, KE				do Amaral, Alexandre Morais; Antoniw, John; Rudd, Jason J.; Hammond-Kosack, Kim E.			Defining the Predicted Protein Secretome of the Fungal Wheat Leaf Pathogen Mycosphaerella graminicola	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; SEPTORIA-TRITICI; HYDROGEN-PEROXIDE; EFFECTOR PROTEINS; VIRULENCE; GENOME; PLANTA; GENE; COLLETOTRICHUM; IDENTIFICATION	The Dothideomycete fungus Mycosphaerella graminicola is the causal agent of Septoria tritici blotch, a devastating disease of wheat leaves that causes dramatic decreases in yield. Infection involves an initial extended period of symptomless intercellular colonisation prior to the development of visible necrotic disease lesions. Previous functional genomics and gene expression profiling studies have implicated the production of secreted virulence effector proteins as key facilitators of the initial symptomless growth phase. In order to identify additional candidate virulence effectors, we re-analysed and catalogued the predicted protein secretome of M. graminicola isolate IPO323, which is currently regarded as the reference strain for this species. We combined several bioinformatic approaches in order to increase the probability of identifying truly secreted proteins with either a predicted enzymatic function or an as yet unknown function. An initial secretome of 970 proteins was predicted, whilst further stringent selection criteria predicted 492 proteins. Of these, 321 possess some functional annotation, the composition of which may reflect the strictly intercellular growth habit of this pathogen, leaving 171 with no functional annotation. This analysis identified a protein family encoding secreted peroxidases/chloroperoxidases (PF01328) which is expanded within all members of the family Mycosphaerellaceae. Further analyses were done on the non-annotated proteins for size and cysteine content (effector protein hallmarks), and then by studying the distribution of homologues in 17 other sequenced Dothideomycete fungi within an overall total of 91 predicted proteomes from fungal, oomycete and nematode species. This detailed M. graminicola secretome analysis provides the basis for further functional and comparative genomics studies.	[do Amaral, Alexandre Morais] Rothamsted Res, Embrapa LabEx Programme, Harpenden, Herts, England; [do Amaral, Alexandre Morais; Antoniw, John; Rudd, Jason J.; Hammond-Kosack, Kim E.] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	do Amaral, AM (corresponding author), Rothamsted Res, Embrapa LabEx Programme, Harpenden, Herts, England.	alexandre.amaral@embrapa.br		Rudd, Jason/0000-0002-4743-1401; Hammond-Kosack, kim/0000-0002-9699-485X	Embrapa LabEx Programme; Biotechnology and Biological Sciences Research Council of the UK (BBSRC) through the Institute Strategic Programme 20:20 Wheat(R); BBSRC; BBSRC [BBS/E/C/00005203] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005203] Funding Source: researchfish	Embrapa LabEx Programme(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Biotechnology and Biological Sciences Research Council of the UK (BBSRC) through the Institute Strategic Programme 20:20 Wheat(R); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AMDA is supported by the Embrapa LabEx Programme. JRR and KEHK are supported by the Biotechnology and Biological Sciences Research Council of the UK (BBSRC) through the Institute Strategic Programme 20:20 Wheat (R). JA is supported by additional BBSRC funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniw J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-447; Battaglia E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-38; Bayry J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002700; Birch PRJ, 2008, CURR OPIN PLANT BIOL, V11, P373, DOI 10.1016/j.pbi.2008.04.005; Bolton MD, 2008, MOL MICROBIOL, V69, P119, DOI 10.1111/j.1365-2958.2008.06270.x; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Brown NA, 2010, FUNGAL BIOL-UK, V114, P555, DOI 10.1016/j.funbio.2010.04.006; Couturier M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-57; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Deller S, 2011, J PLANT PHYSIOL, V168, P63, DOI 10.1016/j.jplph.2010.05.024; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Godfrey D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-317; Goodwin SB, 2004, PHYTOPATHOLOGY, V94, P800, DOI 10.1094/PHYTO.2004.94.8.800; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; Gout L, 2006, MOL MICROBIOL, V60, P67, DOI 10.1111/j.1365-2958.2006.05076.x; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Heger A, 2000, PROTEINS, V41, P224, DOI 10.1002/1097-0134(20001101)41:2<224::AID-PROT70>3.0.CO;2-Z; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Joly DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-422; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kema GHJ, 2008, MOL PLANT MICROBE IN, V21, P1249, DOI 10.1094/MPMI-21-9-1249; Kema GHJ, 1996, PHYTOPATHOLOGY, V86, P777, DOI 10.1094/Phyto-86-777; Keon J, 2005, MOL PLANT PATHOL, V6, P527, DOI 10.1111/J.1364-3703.2005.00304.X; Keon J, 2005, FUNGAL GENET BIOL, V42, P376, DOI 10.1016/j.fgb.2004.12.005; Keon J, 2007, MOL PLANT MICROBE IN, V20, P178, DOI 10.1094/MPMI-20-2-0178; Kleemann J, 2008, MICROBIOL-SGM, V154, P1204, DOI 10.1099/mic.0.2007/014944-0; Lum G, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar001; Marshall R, 2011, PLANT PHYSIOL, V156, P756, DOI 10.1104/pp.111.176347; Motteram J, 2009, MOL PLANT MICROBE IN, V22, P790, DOI 10.1094/MPMI-22-7-0790; Mueller O, 2008, FUNGAL GENET BIOL, V45, pS63, DOI 10.1016/j.fgb.2008.03.012; Muller O, 2008, MOL GENET GENOMICS, V279, P27, DOI 10.1007/s00438-007-0291-4; Neidleman S, 1992, BIOHALOGENATION PRIN; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Paper JM, 2007, PROTEOMICS, V7, P3171, DOI 10.1002/pmic.200700184; Perfect SE, 1999, FUNGAL GENET BIOL, V27, P186, DOI 10.1006/fgbi.1999.1143; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Quaedvlieg W, 2011, PERSOONIA, V26, P57, DOI 10.3767/003158511X571841; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Rudd JJ, 2008, PLANT PHYSIOL, V147, P802, DOI 10.1104/pp.108.119511; Rudd JJ, 2010, FUNGAL GENET BIOL, V47, P19, DOI 10.1016/j.fgb.2009.10.009; Shetty NP, 2007, NEW PHYTOL, V174, P637, DOI 10.1111/j.1469-8137.2007.02026.x; Shetty NP, 2003, PHYSIOL MOL PLANT P, V62, P333, DOI 10.1016/S0885-5765(03)00079-1; Stergiopoulos I, 2010, P NATL ACAD SCI USA, V107, P7610, DOI 10.1073/pnas.1002910107; Stukenbrock EH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001189; Tyler BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/j.1462-5822.2008.01240.x; Wittenberg AHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005863	54	59	59	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e49904	10.1371/journal.pone.0049904	http://dx.doi.org/10.1371/journal.pone.0049904			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236356	gold, Green Published, Green Submitted			2022-12-27	WOS:000312064100008
J	Guo, JJ; Ren, W; Ding, Y; Li, AM; Jia, L; Su, DM; Liu, X; Xu, KF; Yang, T				Guo, Jianjin; Ren, Wei; Ding, Ying; Li, Aimei; Jia, Lu; Su, Dongming; Liu, Xiang; Xu, Kuanfeng; Yang, Tao			Fat Mass and Obesity Associated Gene (FTO) Expression Is Regulated Negatively by the Transcription Factor Foxa2	PLOS ONE			English	Article							LIVER DEVELOPMENT; ADULT OBESITY; CANCER-RISK; INSULIN; METAANALYSIS; CHILDHOOD; VARIANTS; HUMANS	Fat mass and obesity associated gene (FTO) is the first gene associated with body mass index (BMI) and risk for diabetes. FTO is highly expressed in the brain and pancreas, and is involved in regulating dietary intake and energy expenditure. To investigate the transcriptional regulation of FTO expression, we created 5'-deletion constructs of the FTO promoter to determine which transcription factors are most relevant to FTO expression. The presence of an activation region at -201/+34 was confirmed by luciferase activity analysis. A potential Foxa2 (called HNF-3 beta) binding site and an upstream stimulatory factor (USF)-binding site was identified in the -100 bp fragment upstream of the transcription start site (TSS). Furthermore, using mutagenesis, we identified the Foxa2 binding sequence (-26/-14) as a negative regulatory element to the activity of the human FTO promoter. The USF binding site did not affect the FTO promoter activity. Chromatin immunoprecipitation (ChIP) assays were performed to confirm Foxa2 binding to the FTO promoter. Overexpression of Foxa2 in HEK 293 cells significantly down-regulated FTO promoter activity and expression. Conversely, knockdown of Foxa2 by siRNA significantly up-regulated FTO expression. These findings suggest that Foxa2 negatively regulates the basal transcription and expression of the human FTO gene.	[Guo, Jianjin; Xu, Kuanfeng; Yang, Tao] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Ren, Wei] Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Hosp 6, Shanghai Diabet Inst, Shanghai 200030, Peoples R China; [Ren, Wei] Shanghai Clin Ctr Diabet, Shanghai, Peoples R China; [Ding, Ying; Li, Aimei; Jia, Lu; Su, Dongming] Nanjing Med Univ, Ctr Metab Dis Res, Nanjing, Jiangsu, Peoples R China; [Liu, Xiang] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA	Nanjing Medical University; Shanghai Jiao Tong University; Nanjing Medical University; Medical University of South Carolina	Yang, T (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	yangt@njmu.edu.cn			National Natural Science Foundation of China [30971405, 81170252, 81070656]; National Basic Research Program of China [2010CB535008]; Jiangsu Province Innovation Project for Graduate Students of China [CXZZ11_0708]; China Postdoctoral Science Foundation [2012M510850]; Shanghai Postdoctoral Sustentation Fund [12R21414700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Jiangsu Province Innovation Project for Graduate Students of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Sustentation Fund	This work was supported by National Natural Science Foundation of China (30971405, 81170252, 81070656), the National Basic Research Program of China (2010CB535008, 973 Program), the Jiangsu Province Innovation Project for Graduate Students of China (CXZZ11_0708), the China Postdoctoral Science Foundation (2012M510850) and Shanghai Postdoctoral Sustentation Fund (12R21414700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281; Brennan P, 2009, INT J EPIDEMIOL, V38, P971, DOI 10.1093/ije/dyp162; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Do R, 2008, DIABETES, V57, P1147, DOI 10.2337/db07-1267; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hertel JK, 2011, DIABETES, V60, P1637, DOI 10.2337/db10-1340; Kaklamani V, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-52; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lurie G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016756; Mei H, 2010, HUM GENET, V128, P589, DOI 10.1007/s00439-010-0883-7; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Roberts DL, 2010, ANNU REV MED, V61, P301, DOI 10.1146/annurev.med.080708.082713; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Speakman JR, 2010, NATURE, V464, pE1, DOI 10.1038/nature08807; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Tanimizu N, 2007, INT REV CYTOL, V259, P1, DOI 10.1016/S0074-7969(06)59001-1; Tschritter O, 2007, DIABETOLOGIA, V50, P2602, DOI 10.1007/s00125-007-0839-1; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047	26	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51082	10.1371/journal.pone.0051082	http://dx.doi.org/10.1371/journal.pone.0051082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236435	gold, Green Published, Green Submitted			2022-12-27	WOS:000312064100064
J	Schurmann, C; Heim, K; Schillert, A; Blankenberg, S; Carstensen, M; Dorr, M; Endlich, K; Felix, SB; Gieger, C; Grallert, H; Herder, C; Hoffmann, W; Homuth, G; Illig, T; Kruppa, J; Meitinger, T; Muller, C; Nauck, M; Peters, A; Rettig, R; Roden, M; Strauch, K; Volker, U; Volzke, H; Wahl, S; Wallaschofski, H; Wild, PS; Zeller, T; Teumer, A; Prokisch, H; Ziegler, A				Schurmann, Claudia; Heim, Katharina; Schillert, Arne; Blankenberg, Stefan; Carstensen, Maren; Doerr, Marcus; Endlich, Karlhans; Felix, Stephan B.; Gieger, Christian; Grallert, Harald; Herder, Christian; Hoffmann, Wolfgang; Homuth, Georg; Illig, Thomas; Kruppa, Jochen; Meitinger, Thomas; Mueller, Christian; Nauck, Matthias; Peters, Annette; Rettig, Rainer; Roden, Michael; Strauch, Konstantin; Voelker, Uwe; Voelzke, Henry; Wahl, Simone; Wallaschofski, Henri; Wild, Philipp S.; Zeller, Tanja; Teumer, Alexander; Prokisch, Holger; Ziegler, Andreas			Analyzing Illumina Gene Expression Microarray Data from Different Tissues: Methodological Aspects of Data Analysis in the MetaXpress Consortium	PLOS ONE			English	Article							BREAST-CANCER; GENOME BROWSER; METAANALYSIS; POPULATION; SIGNATURE; PROFILES; SURVIVAL; CLASSIFICATION; INFORMATION; HEALTH	Microarray profiling of gene expression is widely applied in molecular biology and functional genomics. Experimental and technical variations make meta-analysis of different studies challenging. In a total of 3358 samples, all from German population-based cohorts, we investigated the effect of data preprocessing and the variability due to sample processing in whole blood cell and blood monocyte gene expression data, measured on the Illumina HumanHT-12 v3 BeadChip array. Gene expression signal intensities were similar after applying the log(2) or the variance-stabilizing transformation. In all cohorts, the first principal component (PC) explained more than 95% of the total variation. Technical factors substantially influenced signal intensity values, especially the Illumina chip assignment (33-48% of the variance), the RNA amplification batch (12-24%), the RNA isolation batch (16%), and the sample storage time, in particular the time between blood donation and RNA isolation for the whole blood cell samples (2-3%), and the time between RNA isolation and amplification for the monocyte samples (2%). White blood cell composition parameters were the strongest biological factors influencing the expression signal intensities in the whole blood cell samples (3%), followed by sex (1-2%) in both sample types. Known single nucleotide polymorphisms (SNPs) were located in 38% of the analyzed probe sequences and 4% of them included common SNPs (minor allele frequency >5%). Out of the tested SNPs, 1.4% significantly modified the probe-specific expression signals (Bonferroni corrected p-value<0.05), but in almost half of these events the signal intensities were even increased despite the occurrence of the mismatch. Thus, the vast majority of SNPs within probes had no significant effect on hybridization efficiency. In summary, adjustment for a few selected technical factors greatly improved reliability of gene expression analyses. Such adjustments are particularly required for meta-analyses.	[Heim, Katharina; Meitinger, Thomas; Prokisch, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Schillert, Arne; Kruppa, Jochen; Ziegler, Andreas] Univ Lubeck, Univ Klinikum Schleswig Holstein, Inst Med Biometrie & Stat, Lubeck, Germany; [Blankenberg, Stefan; Mueller, Christian] Univ Herzzentrum Hamburg, Klin Allgemeine & Intervent Kardiol, Hamburg, Germany; [Blankenberg, Stefan; Zeller, Tanja] DZHK German Ctr Cardiovasc Res, Hamburg, Germany; [Carstensen, Maren; Herder, Christian; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany; [Doerr, Marcus; Felix, Stephan B.] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Doerr, Marcus; Felix, Stephan B.; Hoffmann, Wolfgang; Nauck, Matthias; Voelker, Uwe; Voelzke, Henry; Wallaschofski, Henri] DZHK German Ctr Cardiovasc Res, Greifswald, Germany; [Endlich, Karlhans] Univ Med Greifswald, Inst Anat & Cell Biol, Greifswald, Germany; [Gieger, Christian; Strauch, Konstantin] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Grallert, Harald; Hoffmann, Wolfgang; Illig, Thomas; Peters, Annette; Wahl, Simone] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Hoffmann, Wolfgang; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, D-3000 Hannover, Germany; [Meitinger, Thomas; Peters, Annette; Prokisch, Holger] DZHK German Ctr Cardiovasc Res, Munich, Germany; [Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Humangenet, Munich, Germany; [Meitinger, Thomas; Peters, Annette] Munich Heart Alliance, Munich, Germany; [Nauck, Matthias; Wallaschofski, Henri] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Rettig, Rainer] Univ Med Greifswald, Inst Physiol, Karlsburg, Germany; [Roden, Michael] Univ Dusseldorf, Univ Hosp Dusseldorf, Dept Metab Dis, D-40225 Dusseldorf, Germany; [Strauch, Konstantin] Univ Munich, Chair Genet Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Wild, Philipp S.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 2, Mainz, Germany; [Wild, Philipp S.] DZHK German Ctr Cardiovasc Res, Mainz, Germany; [Schillert, Arne; Kruppa, Jochen; Ziegler, Andreas] DZHK German Ctr Cardiovasc Res, Lubeck, Germany; [Schurmann, Claudia; Homuth, Georg; Voelker, Uwe; Teumer, Alexander] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Greifswald Medical School; German Centre for Cardiovascular Research; Greifswald Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Greifswald Medical School; Hannover Medical School; German Centre for Cardiovascular Research; Technical University of Munich; Munich Heart Alliance; Greifswald Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Greifswald Medical School; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Munich; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; German Centre for Cardiovascular Research; German Centre for Cardiovascular Research; Ernst Moritz Arndt Universitat Greifswald	Teumer, A (corresponding author), Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany.	ateumer@uni-greifswald.de; prokisch@helmholtz-muenchen.de; ziegler@imbs.uni-luebeck.de	Meitinger, Thomas/O-1318-2015; Peters, Annette/A-6117-2011; Prokisch, Holger/N-8964-2013; Endlich, Karlhans/G-5485-2013; Roden, Michael/AAD-3843-2019; Wild, Philipp S./M-2106-2019; Teumer, Alexander/S-7438-2019; Dörr, Marcus/F-1919-2010; Schurmann, Claudia/L-1204-2016; Grallert, Harald/B-3424-2013; Ziegler, Andreas/G-4246-2012	Peters, Annette/0000-0001-6645-0985; Teumer, Alexander/0000-0002-8309-094X; Dörr, Marcus/0000-0001-7471-475X; Schurmann, Claudia/0000-0003-4158-9192; Volker, Uwe/0000-0002-5689-3448; Endlich, Karlhans/0000-0001-6052-6061; Muller, Christian/0000-0002-9449-6865; Prokisch, Holger/0000-0003-2379-6286; Ziegler, Andreas/0000-0002-8386-5397; Gieger, Christian/0000-0001-6986-9554; Meitinger, Thomas/0000-0002-8838-8403; Wild, Philipp/0000-0003-4413-9752; Zeller, Tanja/0000-0003-3379-2641; Kruppa, Jochen/0000-0001-8376-8864	BMBF (German Ministry of Education and Research); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; BMBF [03IS2061A, 03ZIK012, 0315494A, 01GS0834, BMBF 01KU0908A, ANR 09 GENO 106 01, 01KU0908A, 01KU0908B, 0315536F]; Siemens Healthcare, Erlangen; Federal State of Mecklenburg, West Pomerania; Helmholtz Zentrum Munchen; German Research Center for Environmental Health; BMBF; State of Bavaria; German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westphalia; German Research Foundation (DFG) [RA 459/2-1]; Leibniz Association; government of Rheinland-Pfalz [AZ 961-386261/733]; Johannes Gutenberg-University of Mainz; PHILIPS Medical Systems; National Genome Network "NGFNplus" [01GS0833, 01GS0831]; Agence Nationale de la Recherche, France [BMBF 01KU0908A, ANR 09 GENO 106 01]; European Union [HEALTH-2011-278913]; DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung - German Centre for Cardiovascular Research); Siemens Healthcare, Erlangen, Germany; InterSystems GmbH; Boehringer Ingelheim; Medical Research Council [G9817803B] Funding Source: researchfish	BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; BMBF(Federal Ministry of Education & Research (BMBF)); Siemens Healthcare, Erlangen; Federal State of Mecklenburg, West Pomerania; Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health; BMBF(Federal Ministry of Education & Research (BMBF)); State of Bavaria; German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westphalia; German Research Foundation (DFG)(German Research Foundation (DFG)); Leibniz Association; government of Rheinland-Pfalz; Johannes Gutenberg-University of Mainz; PHILIPS Medical Systems; National Genome Network "NGFNplus"; Agence Nationale de la Recherche, France(French National Research Agency (ANR)); European Union(European Commission); DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung - German Centre for Cardiovascular Research); Siemens Healthcare, Erlangen, Germany; InterSystems GmbH; Boehringer Ingelheim(Boehringer Ingelheim); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the BMBF (German Ministry of Education and Research, http://www.bmbf.de), the Ministry of Cultural Affairs (http://www.regierung-mv.de/cms2/Regierungsportal_prod/Regierungsportal/de/bm/) as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania (http://www.regierung-mv.de/cms2/Regierungsportal_prod/Regierungsportal/de/sm/). Analyses were supported by the "Greifswald Approach to Individualized Medicine (GANI_MED, http://www.gani-med.de/)" consortium funded by the BMBF (grant 03IS2061A). Genome-wide genotyping and expression data have been supported by the BMBF (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany (http://www.siemens.com/) and the Federal State of Mecklenburg, West Pomerania (http://www.regierung-mv.de/). The University of Greifswald is a member of the 'Center of Knowledge Interchange' program of the Siemens AG and the Cache Campus program of the InterSystems GmbH (http://www.intersystems.com). The KORA research platform and the KORA Augsburg studies are financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health (http://www.helmholtz-muenchen.de/), which is funded by the BMBF and by the State of Bavaria (http://www.bayern.de/). The German Diabetes Center is funded by the German Federal Ministry of Health (http://www.bmg.bund.de/) and the Ministry of School, Science and Research of the State of North-Rhine-Westphalia (http://www.innovation.nrw.de/). The Diabetes Cohort Study was funded by a German Research Foundation (http://www.dfg.de) project grant to W. R. (DFG; RA 459/2-1). This study was supported in part by a grant from the BMBF to the German Center for Diabetes Research (DZD e. V., http://www.dzd-ev.de/). This work was supported by the BMBF funded Systems Biology of Metabotypes grant (SysMBo#0315494A). Additional support was obtained from the BMBF (National Genome Research Network NGFNplus Atherogenomics, 01GS0834) and the Leibniz Association (http://www.wgl.de/) (WGL Pakt fur Forschung und Innovation). The Gutenberg Health Study is funded through the government of Rheinland-Pfalz (http://www.rlp.de/) ("Stiftung Rheinland Pfalz fur Innovation", contract AZ 961-386261/733), the research programs "Wissen schafft Zukunft" and "Schwerpunkt Vaskulare Pravention" of the Johannes Gutenberg-University of Mainz (http://www.uni-mainz.de/), and its contract with Boehringer Ingelheim (http://www.boehringer-ingelheim.de/) and PHILIPS Medical Systems (http://www.healthcare.philips.com/), including an unrestricted grant for the Gutenberg Health Study. Specifically, the research reported in this article was supported by the National Genome Network "NGFNplus" (http://www.ngfn.de/en/start.html) (contract 01GS0833 and 01GS0831) by the BMBF, and a joint funding grant from the BMBF, and the Agence Nationale de la Recherche, France (http://www.agence-nationale-recherche.fr/) (contract BMBF 01KU0908A and ANR 09 GENO 106 01). This work was supported in part by the European Union (http://europa.eu/) (HEALTH-2011-278913), the BMBF (grants 01KU0908A, 01KU0908B, 0315536F), and supported by the DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung - German Centre for Cardiovascular Research, http://www.bmbf.de/de/16542.php, http://www.dzhk.de) and by the BMBF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following interest: They received funding from a commercial source (Siemens Healthcare, Erlangen, Germany, InterSystems GmbH, Boehringer Ingelheim, PHILIPS Medical Systems). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Co-authors Tanja Zeller and Christian Herder are PLOS ONE Editorial Board members. This does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Allen JD, 2011, BRIEF BIOINFORM; Arasappan D, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-65; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Brannon AR, 2012, EUR UROL, V61, P258, DOI 10.1016/j.eururo.2011.10.007; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Campain A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-408; Chen LS, 2008, BIOINFORMATICS, V24, P2260, DOI 10.1093/bioinformatics/btn411; Choi H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-364; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; EYSENCK HJ, 1994, BRIT MED J, V309, P789, DOI 10.1136/bmj.309.6957.789; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Fekete T, 2012, INT J CANCER, V131, P95, DOI 10.1002/ijc.26364; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Gyorffy B, 2009, BREAST CANCER RES TR, V118, P433, DOI 10.1007/s10549-008-0242-8; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Martini P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-92; Miller BG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009466; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Ochsner SA, 2009, CANCER RES, V69, P23, DOI 10.1158/0008-5472.CAN-08-3492; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; R Development Core Team, 2006, R LANG ENV STAT COMP; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Repsilber D, 2005, METHOD INFORM MED, V44, P461, DOI 10.1055/s-0038-1633994; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Robert J, 2004, CRIT REV ONCOL HEMAT, V51, P205, DOI 10.1016/S1040-8428(04)00111-8; Roder C, 2012, NEUROSCIENCE, V201, P105, DOI 10.1016/j.neuroscience.2011.10.033; Schmid R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-349; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Starling RC, 2006, J HEART LUNG TRANSPL, V25, P1389, DOI 10.1016/j.healun.2006.10.002; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Wild PS, 2010, CIRC-CARDIOVASC IMAG, V3, P604, DOI 10.1161/CIRCIMAGING.109.911933; Xu QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026905; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	45	60	61	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50938	10.1371/journal.pone.0050938	http://dx.doi.org/10.1371/journal.pone.0050938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236413	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100047
J	Thomas, EC; Gunter, JH; Webster, JA; Schieber, NL; Oorschot, V; Parton, RG; Whitehead, JP				Thomas, Elaine C.; Gunter, Jennifer H.; Webster, Julie A.; Schieber, Nicole L.; Oorschot, Viola; Parton, Robert G.; Whitehead, Jonathan P.			Different Characteristics and Nucleotide Binding Properties of Inosine Monophosphate Dehydrogenase (IMPDH) Isoforms	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; CYSTATHIONINE BETA-SYNTHASE; REGULATED PROTEIN-KINASE; NUCLEIC-ACID BINDING; 5-MONOPHOSPHATE DEHYDROGENASE; MYCOPHENOLIC-ACID; 5'-MONOPHOSPHATE DEHYDROGENASE; INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE; CRYSTAL-STRUCTURE; LIGAND-BINDING	We recently reported that Inosine Monophosphate Dehydrogenase (IMPDH), a rate-limiting enzyme in de novo guanine nucleotide biosynthesis, clustered into macrostructures in response to decreased nucleotide levels and that there were differences between the IMPDH isoforms, IMPDH1 and IMPDH2. We hypothesised that the Bateman domains, which are present in both isoforms and serve as energy-sensing/allosteric modules in unrelated proteins, would contribute to isoform-specific differences and that mutations situated in and around this domain in IMPDH1 which give rise to retinitis pigmentosa (RP) would compromise regulation. We employed immuno-electron microscopy to investigate the ultrastructure of IMPDH macrostructures and live-cell imaging to follow clustering of an IMPDH2-GFP chimera in real-time. Using a series of IMPDH1/IMPDH2 chimera we demonstrated that the propensity to cluster was conferred by the N-terminal 244 amino acids, which includes the Bateman domain. A protease protection assay suggested isoform-specific purine nucleotide binding characteristics, with ATP protecting IMPDH1 and AMP protecting IMPDH2, via a mechanism involving conformational changes upon nucleotide binding to the Bateman domain without affecting IMPDH catalytic activity. ATP binding to IMPDH1 was confirmed in a nucleotide binding assay. The RP-causing mutation, R224P, abolished ATP binding and nucleotide protection and this correlated with an altered propensity to cluster. Collectively these data demonstrate that (i) the isoforms are differentially regulated by AMP and ATP by a mechanism involving the Bateman domain, (ii) communication occurs between the Bateman and catalytic domains and (iii) the RP-causing mutations compromise such regulation. These findings support the idea that the IMPDH isoforms are subject to distinct regulation and that regulatory defects contribute to human disease.	[Thomas, Elaine C.; Gunter, Jennifer H.; Webster, Julie A.; Whitehead, Jonathan P.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metabol Med, Brisbane, Qld, Australia; [Webster, Julie A.; Whitehead, Jonathan P.] Mater Med Res Inst, Brisbane, Qld, Australia; [Schieber, Nicole L.; Oorschot, Viola; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Queensland; Mater Research; University of Queensland	Thomas, EC (corresponding author), Univ Bristol, Sch Biochem, Bristol, Avon, England.	elaine.thomas@bristol.ac.uk; jwhitehead@mmri.mater.org.au	Parton, Robert G/C-5673-2009; Gunter, Jennifer H/B-8960-2016; Webster, Julie A/N-6081-2015	Parton, Robert G/0000-0002-7494-5248; Gunter, Jennifer H/0000-0003-2447-5732; Webster, Julie A/0000-0003-2879-700X; Schieber, Nicole L./0000-0002-3212-5057; Whitehead, Jonathan/0000-0003-3978-3148; Thomas, Elaine/0000-0002-9435-3653	National Health and Medical Research Council of Australia [401677, 511005, 361310]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants (401677, to JPW; 511005, to RGP) and a scholarship (361310, to ECT) from the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne A, 2004, HUM MOL GENET, V13, P641, DOI 10.1093/hmg/ddh061; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Bowne SJ, 2006, INVEST OPHTH VIS SCI, V47, P34, DOI 10.1167/iovs.05-0868; Bowne SJ, 2002, HUM MOL GENET, V11, P559, DOI 10.1093/hmg/11.5.559; Carcamo WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029690; CARR SF, 1993, J BIOL CHEM, V268, P27286; Colby TD, 1999, P NATL ACAD SCI USA, V96, P3531, DOI 10.1073/pnas.96.7.3531; COLLART FR, 1988, J BIOL CHEM, V263, P15769; Day P, 2007, ACTA CRYSTALLOGR D, V63, P587, DOI 10.1107/S0907444907009110; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; GLESNE DA, 1991, MOL CELL BIOL, V11, P5417, DOI 10.1128/MCB.11.11.5417; Gunter JH, 2008, INT J BIOCHEM CELL B, V40, P1716, DOI 10.1016/j.biocel.2007.12.018; HAGER PW, 1995, BIOCHEM PHARMACOL, V49, P1323, DOI 10.1016/0006-2952(95)00026-V; Hnizda A, 2010, BIOCHEMISTRY-US, V49, P10526, DOI 10.1021/bi101384m; HOLMES EW, 1974, BIOCHIM BIOPHYS ACTA, V364, P209, DOI 10.1016/0005-2744(74)90006-0; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; JACKSON RC, 1975, NATURE, V256, P331, DOI 10.1038/256331a0; Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p; Ji YS, 2006, J BIOL CHEM, V281, P206, DOI 10.1074/jbc.M507056200; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; Kennan A, 2002, HUM MOL GENET, V11, P547, DOI 10.1093/hmg/11.5.547; Kozhevnikova EN, 2012, MOL CELL, V47, P133, DOI 10.1016/j.molcel.2012.04.030; Link JO, 1996, J AM CHEM SOC, V118, P2091, DOI 10.1021/ja9534056; Lucas M, 2010, J MOL BIOL, V396, P800, DOI 10.1016/j.jmb.2009.12.012; Martin S, 2005, J BIOL CHEM, V280, P42325, DOI 10.1074/jbc.M506651200; McLean JE, 2004, BIOCHEM J, V379, P243, DOI 10.1042/BJ20031585; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Mortimer SE, 2008, J BIOL CHEM, V283, P36354, DOI 10.1074/jbc.M806143200; Mortimer SE, 2005, BIOCHEM J, V390, P41, DOI 10.1042/BJ20042051; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; NATSUMEDA Y, 1990, J BIOL CHEM, V265, P5292; Nimmesgern E, 1999, PROTEIN EXPRES PURIF, V17, P282, DOI 10.1006/prep.1999.1136; Nimmesgern E, 1996, J BIOL CHEM, V271, P19421, DOI 10.1074/jbc.271.32.19421; Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; OKADA M, 1983, J BIOCHEM-TOKYO, V94, P1605; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pimkin M, 2008, MOL MICROBIOL, V68, P342, DOI 10.1111/j.1365-2958.2008.06153.x; Pimkin M, 2009, J BIOL CHEM, V284, P7960, DOI 10.1074/jbc.M808541200; Risal D, 2003, CRYSTAL STR IN PRESS; Schieber NL, 2010, METHOD CELL BIOL, V96, P425, DOI 10.1016/S0091-679X(10)96018-4; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; SENDA M, 1994, LIFE SCI, V54, P1917, DOI 10.1016/0024-3205(94)90150-3; Sintchak MD, 1996, CELL, V85, P921, DOI 10.1016/S0092-8674(00)81275-1; Su H, 2009, BIOCHEM BIOPH RES CO, V386, P351, DOI 10.1016/j.bbrc.2009.06.040; Whitehead JP, 2004, TRAFFIC, V5, P739, DOI 10.1111/j.1600-0854.2004.00217.x; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xu D, 2008, ARCH BIOCHEM BIOPHYS, V472, P100, DOI 10.1016/j.abb.2008.02.012; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zhou X, 1997, J BIOL CHEM, V272, P21977, DOI 10.1074/jbc.272.35.21977	57	46	48	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51096	10.1371/journal.pone.0051096	http://dx.doi.org/10.1371/journal.pone.0051096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236438	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100067
J	Wu, DM; Lin, XC; Bernloehr, C; Hildebrandt, T; Doods, H				Wu, Dongmei; Lin, Xinchun; Bernloehr, Christian; Hildebrandt, Tobias; Doods, Henri			Effects of a Novel Bradykinin B1 Receptor Antagonist and Angiotensin II Receptor Blockade on Experimental Myocardial Infarction in Rats	PLOS ONE			English	Article							KININ B-1 RECEPTOR; CONVERTING-ENZYME-INHIBITORS; KALLIKREIN GENE-TRANSFER; HUMAN TISSUE KALLIKREIN; NECROSIS-FACTOR-ALPHA; KNOCKOUT MICE; HYPERTENSIVE-RATS; TYPE-1 RECEPTOR; UP-REGULATION; NEOVASCULARIZATION	Background: The aim of the present study was to evaluate the cardiovascular effects of the novel bradykinin B1 receptor antagonist BI-113823 following myocardial infarction (MI) and to determine whether B1 receptor blockade alters the cardiovascular effects of an angiotensin II type 1 (AT1) receptor antagonist after MI in rats. Methodology/Principal Findings: Sprague Dawley rats were subjected to permanent occlusion of the left descending coronary artery. Cardiovascular function was determined at 7 days post MI. Treatment with either B1 receptor antagonist (BI-113823) or AT1 receptor antagonist (irbesartan) alone or in combination improved post-MI cardiac function as evidenced by attenuation of elevated left ventricular end diastolic pressure (LVEDP); greater first derivative of left ventricular pressure (+/- dp/dt max), left ventricle ejection fraction, fractional shorting, and better wall motion; as we as reductions in post-MI up-regulation of matrix metalloproteinases 2 (MMP-2) and collagen III. In addition, the cardiac up-regulation of B1 receptor and AT1 receptor mRNA were markedly reduced in animals treated with BI 113823, although bradykinin B2 receptor and angiotensin 1 converting enzyme (ACE1) mRNA expression were not significantly affected by B1 receptor blockade. Conclusions/Significance: The present study demonstrates that treatment with the novel B1 receptor antagonist, BI-113823 improves post-MI cardiac function and does not influence the cardiovascular effects of AT1 receptor antagonist following MI.	[Wu, Dongmei; Lin, Xinchun] Mt Sinai Med Ctr, Dept Res, Miami Beach, FL 33140 USA; [Wu, Dongmei] Chonbuk Natl Univ, WCU Program, Dept BIN Fus Technol, Jeollabuk Do, South Korea; [Bernloehr, Christian; Hildebrandt, Tobias; Doods, Henri] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany	Mount Sinai Medical Center; Jeonbuk National University; Boehringer Ingelheim	Wu, DM (corresponding author), Mt Sinai Med Ctr, Dept Res, Miami Beach, FL 33140 USA.	dongmeiwu@bellsouth.net	Wu, Dongmei/I-3213-2016		Boehringer Ingelheim Pharma KG, Biberach, Germany; World Class University Program [R31-20029]; Ministry of Education, Science and Technology, Republic of Korea	Boehringer Ingelheim Pharma KG, Biberach, Germany(Boehringer Ingelheim); World Class University Program; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Boehringer Ingelheim Pharma KG, Biberach, Germany; and in part by the World Class University Program (R31-20029) funded by the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This was a collabrative research between MSMC and BI.	Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673; BENY JL, 1987, REGUL PEPTIDES, V17, P181, DOI 10.1016/0167-0115(87)90061-9; Berthonneche C, 2005, CARDIOVASC DRUG THER, V19, P251, DOI 10.1007/s10557-005-3695-6; Bradham WS, 2002, CARDIOVASC RES, V53, P822, DOI 10.1016/S0008-6363(01)00503-X; Cyr M, 2001, TRANSFUSION, V41, P136, DOI 10.1046/j.1537-2995.2001.41010136.x; Doods H, 2012, PAIN PRACT, V12, P18; Emanueli C, 2004, CIRCULATION, V110, P1638, DOI 10.1161/01.CIR.0000142051.36244.83; Emanueli C, 2004, ARCH MAL COEUR VAISS, V97, P679; Emanueli C, 2002, CIRCULATION, V105, P360, DOI 10.1161/hc0302.102142; Emanueli C, 2001, HYPERTENSION, V38, P136, DOI 10.1161/01.HYP.38.1.136; Erdos EG, 2010, HYPERTENSION, V55, P214, DOI 10.1161/HYPERTENSIONAHA.109.144600; Gera L, 2008, INT IMMUNOPHARMACOL, V8, P289, DOI 10.1016/j.intimp.2007.06.006; Golias Ch, 2007, Hippokratia, V11, P124; GUIMARAES JA, 1986, EUR J PHARMACOL, V130, P177, DOI 10.1016/0014-2999(86)90266-9; HASHIMOTO K, 1978, AM HEART J, V95, P619, DOI 10.1016/0002-8703(78)90304-6; Klein J, 2010, J AM SOC NEPHROL, V21, P1157, DOI 10.1681/ASN.2009090887; Krankel N, 2008, CIRC RES, V103, P1335, DOI 10.1161/CIRCRESAHA.108.179952; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; Lagneux C, 2002, INT IMMUNOPHARMACOL, V2, P815, DOI 10.1016/S1567-5769(02)00022-X; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; MacNeil T, 1997, CAN J PHYSIOL PHARM, V75, P735, DOI 10.1139/cjpp-75-6-735; Madeddu P, 2000, HYPERTENSION, V35, P391, DOI 10.1161/01.HYP.35.1.391; Maestri R, 2003, HYPERTENSION, V41, P1151, DOI 10.1161/01.HYP.0000064180.55222.DF; Masutomo K, 1999, J MOL CELL CARDIOL, V31, P1607, DOI 10.1006/jmcc.1999.0997; MINSHALL RD, 1995, CIRC RES, V76, P773, DOI 10.1161/01.RES.76.5.773; Parenti A, 2001, FASEB J, V15, P1487, DOI 10.1096/fj.00-0503fje; Savvatis K, 2010, NEUROPEPTIDES, V44, P119, DOI 10.1016/j.npep.2009.11.007; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Spillmann F, 2006, REGEN MED, V1, P235, DOI 10.2217/17460751.1.2.235; Spinetti G, 2011, CIRC RES, V108, P284, DOI 10.1161/CIRCRESAHA.110.236786; Stauss H M, 1994, J Cardiovasc Risk, V1, P255; Stone OA, 2009, ARTERIOSCL THROM VAS, V29, P657, DOI 10.1161/ATVBAHA.108.182139; Su JB, 2006, CURR PHARM DESIGN, V12, P3423; Sun Y, 2002, BASIC RES CARDIOL, V97, P343, DOI 10.1007/s00395-002-0365-8; Tanaka Y, 2004, HYPERTENS RES, V27, P865, DOI 10.1291/hypres.27.865; Tschope C, 2004, CARDIOVASC RES, V61, P559, DOI 10.1016/j.cardiores.2003.10.018; Tschope C, 2000, BRAZ J MED BIOL RES, V33, P701, DOI 10.1590/S0100-879X2000000600011; Vianna RMJ, 2003, BRIT J PHARMACOL, V138, P13, DOI 10.1038/sj.bjp.0704999; Wang PHM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003050; Westermann D, 2008, BIOL CHEM, V389, P713, DOI 10.1515/BC.2008.070; Westermann D, 2009, DIABETES, V58, P1373, DOI 10.2337/db08-0329; WHALLEY ET, 1983, N-S ARCH PHARMACOL, V324, P296, DOI 10.1007/BF00502627; Whitehurst RM, 1999, J APPL PHYSIOL, V86, P61, DOI 10.1152/jappl.1999.86.1.61; Wu DM, 2012, RESUSCITATION, V83, P774, DOI 10.1016/j.resuscitation.2011.11.025; Xu J, 2009, EXP PHYSIOL, V94, P322, DOI 10.1113/expphysiol.2008.045583; Yang XP, 2001, CIRC RES, V88, P1072, DOI 10.1161/hh1001.090759; Yin H, 2007, PEPTIDES, V28, P1383, DOI 10.1016/j.peptides.2007.05.010; Yokoyama T, 1997, CIRCULATION, V95, P1247	48	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51151	10.1371/journal.pone.0051151	http://dx.doi.org/10.1371/journal.pone.0051151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236443	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100071
J	Granell, S; Serra-Juhe, C; Martos-Moreno, GA; Diaz, F; Perez-Jurado, LA; Baldini, G; Argente, J				Granell, Susana; Serra-Juhe, Clara; Martos-Moreno, Gabriel A.; Diaz, Francisca; Perez-Jurado, Luis A.; Baldini, Giulia; Argente, Jesus			A Novel Melanocortin-4 Receptor Mutation MC4R-P272L Associated with Severe Obesity Has Increased Propensity To Be Ubiquitinated in the ER in the Face of Correct Folding	PLOS ONE			English	Article							AGOUTI-RELATED PROTEIN; FRAMESHIFT MUTATION; CHILDHOOD OBESITY; CELL-SURFACE; MC4R; GENE; PROOPIOMELANOCORTIN; POLYMORPHISMS; INTEGRATION; PREVALENCE	Heterozygous mutations in the melanocortin-4 receptor (MC4R) gene represent the most frequent cause of monogenic obesity in humans. MC4R mutation analysis in a cohort of 77 children with morbid obesity identified previously unreported heterozygous mutations (P272L, N74I) in two patients inherited from their obese mothers. A rare polymorphism (I251L, allelic frequency: 1/100) reported to protect against obesity was found in another obese patient. When expressed in neuronal cells, the cell surface abundance of wild-type MC4R and of the N74I and I251L variants and the cAMP generated by these receptors in response to exposure to the agonist, alpha-MSH, were not different. Conversely, MC4R P272L was retained in the endoplasmic reticulum and had reduced cell surface expression and signaling (by approximate to 3-fold). The chemical chaperone PBA, which promotes protein folding of wild-type MC4R, had minimal effects on the distribution and signaling of the P272L variant. In contrast, incubation with UBE-41, a specific inhibitor of ubiquitin activating enzyme E1, inhibited ubiquitination of MC4R P272L and increased its cell surface expression and signaling to similar levels as wild-type MC4R. UBE41 had much less profound effects on MC4R I316S, another obesity-linked MC4R variant trapped in the ER. These data suggest that P272L is retained in the ER by a propensity to be ubiquitinated in the face of correct folding, which is only minimally shared by MC4R I316S. Thus, studies that combine clinical screening of obese patients and investigation of the functional defects of the obesity-linked MC4R variants can identify specific ways to correct these defects and are the first steps towards personalized medicine.	[Granell, Susana; Baldini, Giulia] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Serra-Juhe, Clara; Perez-Jurado, Luis A.] Univ Pompeu Fabra, Unitat Genet, Barcelona, Spain; [Serra-Juhe, Clara; Perez-Jurado, Luis A.] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Martos-Moreno, Gabriel A.; Diaz, Francisca; Argente, Jesus] Hosp Infantil Univ Nino Jesus, Dept Pediat Endocrinol, Inst Invest La Princesa, Madrid, Spain; [Argente, Jesus] Univ Autonoma Madrid, Dept Pediat, Madrid, Spain; [Argente, Jesus] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain	University of Arkansas System; University of Arkansas Medical Sciences; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Baldini, G (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	gbaldini@uams.edu; argentefen@terra.es	Argente, Jesús/M-5226-2019; Serra-Juhe, Clara/M-6968-2015; Pérez Jurado, Luis Alberto/M-7706-2015; Argente, Jesús/K-1167-2014	Argente, Jesús/0000-0001-5826-0276; Serra-Juhe, Clara/0000-0001-8471-8391; Argente, Jesús/0000-0001-5826-0276; Diaz-Gonzalez, Francisca/0000-0003-1364-7586; Martos-Moreno, Gabriel Angel/0000-0001-5524-2646	Fondo de Investigacion Sanitaria [PI09/91060, PI10/02512, PI01/00747]; CIBERobn Instituto de Salud Carlos III (ISCIII); Fundacion Mutua Madrilena [AP2561/2008]; Fundacion Endocrinologia y Nutricion; National Institutes of Health [R01DK080424]; Arkansas Tobacco Settlement; ISCIII [FI08/00365, CM05/00100]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080424] Funding Source: NIH RePORTER	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); CIBERobn Instituto de Salud Carlos III (ISCIII); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fundacion Endocrinologia y Nutricion; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arkansas Tobacco Settlement; ISCIII(Instituto de Salud Carlos III); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been funded by Fondo de Investigacion Sanitaria (PI09/91060, PI10/02512, PI01/00747), CIBERobn Instituto de Salud Carlos III (ISCIII), Fundacion Mutua Madrilena (AP2561/2008), Fundacion Endocrinologia y Nutricion, the National Institutes of Health (R01DK080424 to GB), and the Arkansas Tobacco Settlement (to GB). CS-J and GAM-M were recipients of fellowships from ISCIII (FI08/00365 and CM05/00100, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EX VAR SERV; Bagnol D, 1999, J NEUROSCI, V19; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Caruso C, 2012, MOL CELL ENDOCRINOL, V348, P47, DOI 10.1016/j.mce.2011.07.036; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Ellacott KLJ, 2004, RECENT PROG HORM RES, V59, P395, DOI 10.1210/rp.59.1.395; EMESON RB, 1986, J NEUROSCI, V6, P837; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Granell S, 2010, MOL ENDOCRINOL, V24, P1805, DOI 10.1210/me.2010-0071; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; Larsen LH, 2005, J CLIN ENDOCR METAB, V90, P219, DOI 10.1210/jc.2004-0497; Lubrano-Berthelier C, 2003, HUM MOL GENET, V12, P145, DOI 10.1093/hmg/ddg016; Martos-Moreno GA, 2011, AN PEDIAT BARC, V75, pe61; Mirshahi UL, 2011, J CLIN ENDOCR METAB, V96, pE2088, DOI 10.1210/jc.2011-1549; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P814, DOI 10.1210/en.140.2.814; Mohammad S, 2007, J BIOL CHEM, V282, P4963, DOI [10.1074/jbc.m608283200, 10.1074/jbc.M608283200]; Neutzner M, 2012, ESSAYS BIOCHEM, V52, P37, DOI [10.1042/bse0520037, 10.1042/BSE0520037]; Nijenhuis WAJ, 2003, J BIOL CHEM, V278, P22939, DOI 10.1074/jbc.M211326200; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Stutzmann F, 2008, DIABETES, V57, P2511, DOI 10.2337/db08-0153; Stutzmann F, 2007, HUM MOL GENET, V16, P1837, DOI 10.1093/hmg/ddm132; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Tao YX, 2003, ENDOCRINOLOGY, V144, P4544, DOI 10.1210/en.2003-0524; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Wan S, 2008, J NEUROSCI, V28, P4957, DOI 10.1523/JNEUROSCI.5398-07.2008; Wang ZQ, 2011, BBA-MOL BASIS DIS, V1812, P1190, DOI 10.1016/j.bbadis.2011.06.008; Xiang ZM, 2006, BIOCHEMISTRY-US, V45, P7277, DOI 10.1021/bi0600300; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Yi CX, 2011, NEUROENDOCRINOLOGY, V93, P143, DOI 10.1159/000324888	32	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50894	10.1371/journal.pone.0050894	http://dx.doi.org/10.1371/journal.pone.0050894			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251400	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200046
J	Li, RH; Yu, JX; Huang, X; Cheng, H				Li, Rong-Hua; Yu, Jeffrey Xu; Huang, Xin; Cheng, Hong			A Framework of Algorithms: Computing the Bias and Prestige of Nodes in Trust Networks	PLOS ONE			English	Article								A trust network is a social network in which edges represent the trust relationship between two nodes in the network. In a trust network, a fundamental question is how to assess and compute the bias and prestige of the nodes, where the bias of a node measures the trustworthiness of a node and the prestige of a node measures the importance of the node. The larger bias of a node implies the lower trustworthiness of the node, and the larger prestige of a node implies the higher importance of the node. In this paper, we define a vector-valued contractive function to characterize the bias vector which results in a rich family of bias measurements, and we propose a framework of algorithms for computing the bias and prestige of nodes in trust networks. Based on our framework, we develop four algorithms that can calculate the bias and prestige of nodes effectively and robustly. The time and space complexities of all our algorithms are linear with respect to the size of the graph, thus our algorithms are scalable to handle large datasets. We evaluate our algorithms using five real datasets. The experimental results demonstrate the effectiveness, robustness, and scalability of our algorithms.	[Li, Rong-Hua; Yu, Jeffrey Xu; Huang, Xin; Cheng, Hong] Chinese Univ Hong Kong, Dept Syst Engn & Engn Management, Sha Tin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Li, RH (corresponding author), Chinese Univ Hong Kong, Dept Syst Engn & Engn Management, Sha Tin, Hong Kong, Peoples R China.	rhli@se.cuhk.hk.edu	Cheng, Hong/F-7228-2011; Zhou, Xiaofang/C-6169-2013; Yu, Jeffrey X/F-6005-2011	Zhou, Xiaofang/0000-0001-6343-1455; Yu, Jeffrey X/0000-0002-9738-827X	Research Grants Council of the Hong Kong SAR, China [419109, 411211]	Research Grants Council of the Hong Kong SAR, China(Hong Kong Research Grants Council)	The work was supported by grant of the Research Grants Council of the Hong Kong SAR, China Nos. 419109 and 411211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R, 2008, INTERNATIONAL WORLD; [Anonymous], 2009, P 18 INT C WORLD WID, DOI DOI 10.1145/1526709.1526809; Apostol T.M., 1974, MATH ANAL; Bachrach Y, 2009, AUTON AGENT MULTI-AG, V19, P153, DOI 10.1007/s10458-008-9073-6; Bahmani B., 2012, P 18 ACM SIGKDD INT, P24, DOI DOI 10.1145/2339530.2339539; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Brin S., 1997, TECHNICAL REPORT; Cruz FL, 2012, INFORM PROCESS MANAG, V48, P271, DOI 10.1016/j.ipm.2011.08.003; de Kerchove G, 2008, SIAM INTERNATIONAL C; Desikan PK, 2005, INCREMENTAL PAGE RAN; Granas A., 2003, FIXED POINT THEORY; Guha R., 2004, P 13 INT C WORLD WID, P403, DOI [10.1145/988672.988727, DOI 10.1145/988672.988727]; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Haveliwala TH, INTERNATIONAL WORLD; Ortega FJ, 2012, COMPUT NETW, V56, P2884, DOI 10.1016/j.comnet.2012.05.002; Jen G, 2003, INTERNATIONAL WORLD; Josang A, 2009, PROCEEDINGS OF THE 5; Josang A, 2007, DECIS SUPPORT SYST, V43, P618, DOI 10.1016/j.dss.2005.05.019; Kamvar SD, 2003, INTERNATIONAL WORLD; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Leskovec J, 2010, ACM SIGCHI CONFERENC; Li RH, 2012, ROBUST REPUTATION BA; Ma H, 2009, ACM INTERNATIONAL CO; Massa P, 2007, RECSYS 07: PROCEEDINGS OF THE 2007 ACM CONFERENCE ON RECOMMENDER SYSTEMS, P17; Mishra A, 2011, INTERNATIONAL WORLD; Procaccia AD, 2007, GOSSIP BASED AGGREGA; Richardson M, 2003, INTERNATIONAL SEMANT; Richters O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018384; Tang J, 2012, ACM INTERNATIONAL CO; Theodorakopoulos G, 2006, IEEE J SEL AREA COMM, V24, P318, DOI 10.1109/JSAC.2005.861390; Vigna S, 2011, SPECTRAL RANKING; Zhou R, 2008, IEEE T KNOWL DATA EN, V20, P1282, DOI 10.1109/TKDE.2008.48; Zhou RF, 2007, IEEE T PARALL DISTR, V18, P460, DOI [10.1109/TPDS.2007.1021, 10.1109/TPDS.2007.1015]	34	1	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50843	10.1371/journal.pone.0050843	http://dx.doi.org/10.1371/journal.pone.0050843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239990	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800027
J	Raghunathan, G; Soundrarajan, N; Sokalingam, S; Yun, H; Lee, SG				Raghunathan, Govindan; Soundrarajan, Nagasundarapandian; Sokalingam, Sriram; Yun, Hyungdon; Lee, Sun-Gu			Deletional Protein Engineering Based on Stable Fold	PLOS ONE			English	Article							GREEN-FLUORESCENT PROTEIN; SECONDARY STRUCTURE ANALYSES; SULFOLOBUS-SOLFATARICUS; NATIVE-LIKE; CRYSTAL-STRUCTURE; INCLUSION-BODIES; SEQUENCE SPACE; STABILITY; EVOLUTION; ACYLPHOSPHATASE	Diversification of protein sequence-structure space is a major concern in protein engineering. Deletion mutagenesis can generate a protein sequence-structure space different from substitution mutagenesis mediated space, but it has not been widely used in protein engineering compared to substitution mutagenesis, because it causes a relatively huge range of structural perturbations of target proteins which often inactivates the proteins. In this study, we demonstrate that, using green fluorescent protein (GFP) as a model system, the drawback of the deletional protein engineering can be overcome by employing the protein structure with high stability. The systematic dissection of N-terminal, C-terminal and internal sequences of GFPs with two different stabilities showed that GFP with high stability (s-GFP), was more tolerant to the elimination of amino acids compared to a GFP with normal stability (n-GFP). The deletion studies of s-GFP enabled us to achieve three interesting variants viz. s-DL4, s-N14, and s-C225, which could not been obtained from n-GFP. The deletion of 191-196 loop sequences led to the variant s-DL4 that was expressed predominantly as insoluble form but mostly active. The s-N14 and s-C225 are the variants without the amino acid residues involving secondary structures around N- and C-terminals of GFP fold respectively, exhibiting comparable biophysical properties of the n-GFP. Structural analysis of the variants through computational modeling study gave a few structural insights that can explain the spectral properties of the variants. Our study suggests that the protein sequence-structure space of deletion mutants can be more efficiently explored by employing the protein structure with higher stability.	[Raghunathan, Govindan; Soundrarajan, Nagasundarapandian; Sokalingam, Sriram; Lee, Sun-Gu] Pusan Natl Univ, Dept Chem Engn, Pusan, South Korea; [Yun, Hyungdon] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea	Pusan National University; Yeungnam University	Lee, SG (corresponding author), Pusan Natl Univ, Dept Chem Engn, Pusan, South Korea.	sungulee@pusan.ac.kr	Raghunathan, Govindan/T-5299-2019	Yun, Hyungdon/0000-0002-9125-975X; Raghunathan, Govindan/0000-0002-1456-0768; Soundrarajan, Nagasundarapandian/0000-0001-5239-7992	Basic Science Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [NRF-2011-0021222]	Basic Science Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2011-0021222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyadurai N, 2011, ANGEW CHEM INT EDIT, V50, P6534, DOI 10.1002/anie.201008289; Ayyadurai N, 2011, BIOCONJUGATE CHEM, V22, P551, DOI 10.1021/bc2000066; Ayyadurai N, 2009, BIOTECHNOL BIOPROC E, V14, P257, DOI [10.1007/s12257-009-0009-z, 10.1007/S12257-009-0009-Z]; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Bemporad F, 2008, BBA-PROTEINS PROTEOM, V1784, P1986, DOI 10.1016/j.bbapap.2008.08.021; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2004, BIOPHYS J, V86, P2758, DOI 10.1016/S0006-3495(04)74329-5; Bulter T, 2004, P NATL ACAD SCI USA, V101, P2299, DOI 10.1073/pnas.0306484101; Caetano-Anolles G, 2010, BIOESSAYS, V32, P655, DOI 10.1002/bies.201000038; Camps M, 2007, CRIT REV BIOCHEM MOL, V42, P313, DOI 10.1080/10409230701597642; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dopf J, 1996, GENE, V173, P39, DOI 10.1016/0378-1119(95)00692-3; EHRIG T, 1995, FEBS LETT, V367, P163, DOI 10.1016/0014-5793(95)00557-P; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gong R, 2011, J BIOL CHEM, V286, P27288, DOI 10.1074/jbc.M111.254219; Haglund E, 2012, J BIOL CHEM, V287, P2731, DOI 10.1074/jbc.M111.312447; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Huang YM, 2011, PROTEIN SCI, V20, P1775, DOI 10.1002/pro.735; Kent KP, 2009, J AM CHEM SOC, V131, P15988, DOI 10.1021/ja906303f; Leconte AM, 2010, ANGEW CHEM INT EDIT, V49, P5921, DOI 10.1002/anie.201001607; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Li YG, 2007, NAT BIOTECHNOL, V25, P1051, DOI 10.1038/nbt1333; Liu LW, 2011, J BIOL CHEM, V286, P44710, DOI 10.1074/jbc.M111.269753; Mata L, 1999, PROTEIN ENG, V12, P681, DOI 10.1093/protein/12.8.681; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Muller MM, 2010, PROTEIN SCI, V19, P1000, DOI 10.1002/pro.377; Nagasundarapandian S, 2010, CHEMBIOCHEM, V11, P2521, DOI 10.1002/cbic.201000380; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Pagano K, 2010, J BIOL CHEM, V285, P14689, DOI 10.1074/jbc.M109.082156; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peternel S, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-34; Plakoutsi G, 2006, STRUCTURE, V14, P993, DOI 10.1016/j.str.2006.03.014; Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105; PutnamEvans C, 1996, PLANT MOL BIOL, V32, P1191, DOI 10.1007/BF00041405; Sample V, 2009, CHEM SOC REV, V38, P2852, DOI 10.1039/b913033k; Santhoshkumar P, 2009, BIOCHEMISTRY-US, V48, P5066, DOI 10.1021/bi900085v; SHORTLE D, 1995, CURR OPIN BIOTECH, V6, P387, DOI 10.1016/0958-1669(95)80067-0; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Trevino RJ, 1998, J BIOL CHEM, V273, P27841, DOI 10.1074/jbc.273.43.27841; Trevino RJ, 1999, J BIOL CHEM, V274, P13938, DOI 10.1074/jbc.274.20.13938; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vamvaca K, 2011, J NEUROCHEM, V119, P389, DOI 10.1111/j.1471-4159.2011.07431.x; Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	49	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51510	10.1371/journal.pone.0051510	http://dx.doi.org/10.1371/journal.pone.0051510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240034	gold, Green Published, Green Submitted			2022-12-27	WOS:000312290800070
J	Panuccio, G; Vicini, S; Avoli, M				Panuccio, Gabriella; Vicini, Stefano; Avoli, Massimo			Cell Type-Specific Properties of Subicular GABAergic Currents Shape Hippocampal Output Firing Mode	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; MEDIATED TONIC INHIBITION; IN-VITRO; PYRAMIDAL NEURONS; GABA(A) RECEPTORS; RODENT MODEL; RAT; NETWORKS; CORTEX; EXCITABILITY	GABAergic function of the subiculum is central to the regulation of hippocampal output activity. Subicular neuronal networks are indeed under potent control by local inhibition. However, information about the properties of GABAergic currents generated by neurons of this parahippocampal area in normal tissue is still missing. Here, we describe GABA(A) receptor (GABA(A)R)-mediated phasic and tonic currents generated by principal cells (PCs) and interneurons (INs) of the rat subiculum. We show that in spite of similar synaptic current densities, INs generate spontaneous IPSCs (sIPSCs) that occur less frequently and exhibit smaller charge transfer, thus receiving less synaptic total current than PCs. Further distinction of PCs between intrinsically bursting (IB) and regular-spiking (RS) neurons suggested that sIPSCs generated by the two PC sub-types are likely to be similar. PCs and INs are also controlled by a similar tonic inhibition. However, whereas a comparable tonic current density is found in RS cells and INs, IB neurons are constrained by a greater inhibitory tone. Finally, pharmacological blockade of GABA(A)R did not promote functional switch of RS neurons to IB mode, but influenced the bursting propensity of IB cells and released fast spiking activity in INs. Our findings reveal differences in GABAergic currents between PCs and INs as well as within PC sub-types. We propose that GABAergic inhibition may shape hippocampal output activity by providing cell type-specific fine-tuning of subicular excitatory and inhibitory drives.	[Panuccio, Gabriella; Avoli, Massimo] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Panuccio, Gabriella; Avoli, Massimo] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Vicini, Stefano] Georgetown Univ, Dept Physiol & Pharmacol, Washington, DC USA	McGill University; McGill University; Georgetown University	Avoli, M (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	massimo.avoli@mcgill.ca	Panuccio, Gabriella/GLR-8478-2022	Panuccio, Gabriella/0000-0002-4059-7193; Vicini, Stefano/0000-0001-8671-5194	CIHR [MOP 8109, 74609]; Epilepsy Canada; Savoy Foundation	CIHR(Canadian Institutes of Health Research (CIHR)); Epilepsy Canada; Savoy Foundation	The authors gratefully acknowledge funding from the CIHR, Grants MOP 8109 and 74609 (http://www.cihr-irsc.gc.ca/). GP received funding from Epilepsy Canada (http://www.epilepsy.ca/) and from the Savoy Foundation (http://www.savoy-foundation.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Benini R, 2005, J PHYSIOL-LONDON, V566, P885, DOI 10.1113/jphysiol.2005.088708; Biagini G, 2010, CURR OPIN NEUROL, V23, P170, DOI 10.1097/WCO.0b013e32833735cf; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Bright DP, 2007, J NEUROSCI, V27, P2560, DOI 10.1523/JNEUROSCI.5100-06.2007; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; Curia G, 2009, CEREB CORTEX, V19, P1515, DOI 10.1093/cercor/bhn159; de Guzman P, 2006, HIPPOCAMPUS, V16, P843, DOI 10.1002/hipo.20215; de la Prida LM, 2003, HIPPOCAMPUS, V13, P728, DOI 10.1002/hipo.10123; de la Prida LM, 2003, J PHYSIOL-LONDON, V549, P219, DOI 10.1113/jphysiol.2003.039305; de la Prida LM, 2002, NEUROSCI LETT, V322, P49, DOI 10.1016/S0304-3940(02)00085-X; DeFazio RA, 2000, J NEUROSCI, V20, P8069; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Kim Y, 2012, HIPPOCAMPUS, V22, P693, DOI 10.1002/hipo.20931; Knopp A, 2008, BRAIN, V131, P1516, DOI 10.1093/brain/awn095; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; de la Prida LM, 2006, BEHAV BRAIN RES, V174, P198, DOI 10.1016/j.bbr.2006.05.033; Moyer JR, 1998, J NEUROSCI METH, V86, P35, DOI 10.1016/S0165-0270(98)00143-5; Naber PA, 2000, ANN NY ACAD SCI, V911, P392; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; Panuccio G, 2010, NEUROBIOL DIS, V39, P372, DOI 10.1016/j.nbd.2010.05.003; Schofield CM, 2007, J NEUROSCI, V27, P7954, DOI 10.1523/JNEUROSCI.0377-07.2007; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; Vardya I, 2008, J NEUROPHYSIOL, V100, P526, DOI 10.1152/jn.01224.2007; Witter MP, 2006, BEHAV BRAIN RES, V174, P251, DOI 10.1016/j.bbr.2006.06.022; Wozny C, 2005, EPILEPSIA, V46, P17, DOI 10.1111/j.1528-1167.2005.01066.x	30	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50241	10.1371/journal.pone.0050241	http://dx.doi.org/10.1371/journal.pone.0050241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251362	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900009
J	Bansal, R; Staib, LH; Laine, AF; Hao, XJ; Xu, DR; Liu, J; Weissman, M; Peterson, BS				Bansal, Ravi; Staib, Lawrence H.; Laine, Andrew F.; Hao, Xuejun; Xu, Dongrong; Liu, Jun; Weissman, Myrna; Peterson, Bradley S.			Anatomical Brain Images Alone Can Accurately Diagnose Chronic Neuropsychiatric Illnesses	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; BASAL GANGLIA VOLUMES; ALZHEIMERS-DISEASE; BIPOLAR DISORDER; REGIONAL BRAIN; GRAY-MATTER; CLASSIFICATION; SCHIZOPHRENIA; RELIABILITY; SCALE	Objective: Diagnoses using imaging-based measures alone offer the hope of improving the accuracy of clinical diagnosis, thereby reducing the costs associated with incorrect treatments. Previous attempts to use brain imaging for diagnosis, however, have had only limited success in diagnosing patients who are independent of the samples used to derive the diagnostic algorithms. We aimed to develop a classification algorithm that can accurately diagnose chronic, well-characterized neuropsychiatric illness in single individuals, given the availability of sufficiently precise delineations of brain regions across several neural systems in anatomical MR images of the brain. Methods: We have developed an automated method to diagnose individuals as having one of various neuropsychiatric illnesses using only anatomical MRI scans. The method employs a semi-supervised learning algorithm that discovers natural groupings of brains based on the spatial patterns of variation in the morphology of the cerebral cortex and other brain regions. We used split-half and leave-one-out cross-validation analyses in large MRI datasets to assess the reproducibility and diagnostic accuracy of those groupings. Results: In MRI datasets from persons with Attention-Deficit/Hyperactivity Disorder, Schizophrenia, Tourette Syndrome, Bipolar Disorder, or persons at high or low familial risk for Major Depressive Disorder, our method discriminated with high specificity and nearly perfect sensitivity the brains of persons who had one specific neuropsychiatric disorder from the brains of healthy participants and the brains of persons who had a different neuropsychiatric disorder. Conclusions: Although the classification algorithm presupposes the availability of precisely delineated brain regions, our findings suggest that patterns of morphological variation across brain surfaces, extracted from MRI scans alone, can successfully diagnose the presence of chronic neuropsychiatric disorders. Extensions of these methods are likely to provide biomarkers that will aid in identifying biological subtypes of those disorders, predicting disease course, and individualizing treatments for a wide range of neuropsychiatric illnesses. Citation: Bansal R, Staib LH, Laine AF, Hao X, Xu D, et al. (2012) Anatomical Brain Images Alone Can Accurately Diagnose Chronic Neuropsychiatric Illnesses. PLoS ONE 7(12): e50698. doi:10.1371/journal.pone.0050698	[Bansal, Ravi; Hao, Xuejun; Xu, Dongrong; Liu, Jun; Weissman, Myrna; Peterson, Bradley S.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Bansal, Ravi; Hao, Xuejun; Xu, Dongrong; Liu, Jun; Weissman, Myrna; Peterson, Bradley S.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Laine, Andrew F.] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Staib, Lawrence H.] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Staib, Lawrence H.] Yale Univ, Dept Elect Engn, New Haven, CT USA; [Staib, Lawrence H.] Yale Univ, Dept Diagnost Radiol, New Haven, CT 06510 USA	Columbia University; New York State Psychiatry Institute; Columbia University; Yale University; Yale University; Yale University	Bansal, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Psychiat, 722 W 168th St, New York, NY 10032 USA.	bansalr@nyspi.columbia.edu		Weissman, Myrna/0000-0003-3490-3075; Staib, Lawrence/0000-0002-9516-5136	National Institute of Mental Health [MH036197, MH068318, K02-74677]; National Institute on Drug Abuse [DA017820]; Suzanne Crosby Murphy endowment at Columbia University; Tom Klingenstein and Nancy Perlman Family Fund; Brain and Behavior Research Foundation Independent Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH036197, R01MH068318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017820] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Suzanne Crosby Murphy endowment at Columbia University; Tom Klingenstein and Nancy Perlman Family Fund(Klingenstein Philanthropies); Brain and Behavior Research Foundation Independent Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Mental Health grants MH036197, MH068318, and K02-74677, National Institute on Drug Abuse grant DA017820, the Suzanne Crosby Murphy endowment at Columbia University, the Tom Klingenstein and Nancy Perlman Family Fund, and The Brain and Behavior Research Foundation Independent Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association Staff, 2000, DIAGN STAT MAN MENT; Angenent S, 1999, IEEE T MED IMAGING, V18, P700, DOI 10.1109/42.796283; [Anonymous], [No title captured]; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bansal R, 2005, NEUROIMAGE, V24, P150, DOI 10.1016/j.neuroimage.2004.08.054; Blumberg HP, 2006, BIOL PSYCHIAT, V59, P611, DOI 10.1016/j.biopsych.2005.08.031; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P1201, DOI 10.1001/archpsyc.60.12.1201; Bromet EJ, 2011, AM J PSYCHIAT, V168, P1186, DOI 10.1176/appi.ajp.2011.11010048; CHRISTENSEN GE, 1994, PHYS MED BIOL, V39, P609, DOI 10.1088/0031-9155/39/3/022; COHEN A, 1993, CR ACAD SCI I-MATH, V316, P417; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P279, DOI 10.1023/A:1022606501530; Csernansky JG, 2004, AM J PSYCHIAT, V161, P896, DOI 10.1176/appi.ajp.161.5.896; Davatzikos C, 2005, ARCH GEN PSYCHIAT, V62, P1218, DOI 10.1001/archpsyc.62.11.1218; Davatzikos C, 2008, NEUROBIOL AGING, V29, P514, DOI 10.1016/j.neurobiolaging.2006.11.010; Duchesnay E, 2007, IEEE T MED IMAGING, V26, P553, DOI 10.1109/TMI.2007.892501; Duda R. O., 1973, PATTERN CLASSIFICATI; DUPAUL GJ, 1991, J CLIN CHILD PSYCHOL, V20, P245, DOI 10.1207/s15374424jccp2003_3; Fan Y, 2005, LECT NOTES COMPUT SC, V3749, P1; Grados JJ, 1999, J CLIN PSYCHOL, V55, P1063, DOI 10.1002/(SICI)1097-4679(199909)55:9<1063::AID-JCLP4>3.0.CO;2-U; Haralick R. M., 1992, COMPUTER ROBOT VISIO, V1; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Ivanov I, 2010, AM J PSYCHIAT, V167, P397, DOI 10.1176/appi.ajp.2009.09030398; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Kates WR, 1997, PSYCHIAT RES-NEUROIM, V75, P31, DOI 10.1016/S0925-4927(97)00019-X; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kawasaki Y, 2007, NEUROIMAGE, V34, P235, DOI 10.1016/j.neuroimage.2006.08.018; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Kraemer HC, 2012, AM J PSYCHIAT, V169, P13, DOI 10.1176/appi.ajp.2011.11010050; Lao ZQ, 2004, NEUROIMAGE, V21, P46, DOI 10.1016/j.neuroimage.2003.09.027; Larsen TK, 1996, SCHIZOPHRENIA BULL, V22, P241, DOI 10.1093/schbul/22.2.241; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Lerch JP, 2008, NEUROBIOL AGING, V29, P23, DOI 10.1016/j.neurobiolaging.2006.09.013; Liu YX, 2004, LECT NOTES COMPUT SC, V3216, P393; Lochhead RA, 2004, BIOL PSYCHIAT, V55, P1154, DOI 10.1016/j.biopsych.2004.02.026; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Luders E, 2005, NEUROIMAGE, V26, P493, DOI 10.1016/j.neuroimage.2005.02.010; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Ou YM, 2009, LECT NOTES COMPUT SC, V5636, P50; PETERSON B, 1993, NEUROLOGY, V43, P941, DOI 10.1212/WNL.43.5.941; Peterson BS, 2010, J AM ACAD CHILD PSY, V49, P533, DOI 10.1016/j.jaac.2010.03.010; Peterson BS, 2009, P NATL ACAD SCI USA, V106, P6273, DOI 10.1073/pnas.0805311106; Peterson BS, 2003, ARCH GEN PSYCHIAT, V60, P415, DOI 10.1001/archpsyc.60.4.415; Peterson BS, 2001, ARCH GEN PSYCHIAT, V58, P427, DOI 10.1001/archpsyc.58.5.427; Peterson BS, 2007, ARCH GEN PSYCHIAT; Plessen KJ, 2006, ARCH GEN PSYCHIAT, V63, P795, DOI 10.1001/archpsyc.63.7.795; Rosenfeld A., 1982, DIGITAL PICTURE PROC; Schroder P., 2019, CIRCULAR EC GLOBAL S, P43, DOI DOI 10.1145/218380.218439; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; SoRelle R, 2000, CIRCULATION, V101, pE66; Substance Abuse and Mental Health Services Administration, 2012, RES 2010 NAT SURV DR; Sweldens W, 1994, LIFTING SCHEME CUSTO; Teipel SJ, 2007, NEUROIMAGE, V38, P13, DOI 10.1016/j.neuroimage.2007.07.008; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Viola P, 1995, ALIGNMENT MAXIMIZATI, P16; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P603, DOI 10.1001/archpsyc.62.6.603; WATSON C, 1992, NEUROLOGY, V42, P1743, DOI 10.1212/WNL.42.9.1743; Wechsler D., 1991, WECHSLER ADULT INTEL; Wechsler D, 1996, WISC 3 MANUAL CANA S; Weissman MM, 2005, ARCH GEN PSYCHIAT, V62, P29, DOI 10.1001/archpsyc.62.1.29; Wexler BE, 2009, AM J PSYCHIAT, V166, P189, DOI 10.1176/appi.ajp.2008.08020258; [No title captured]	66	52	52	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50698	10.1371/journal.pone.0050698	http://dx.doi.org/10.1371/journal.pone.0050698			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236384	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100026
J	de Zeeuw, P; Weusten, J; van Dijk, S; van Belle, J; Durston, S				de Zeeuw, Patrick; Weusten, Juliette; van Dijk, Sarai; van Belle, Janna; Durston, Sarah			Deficits in Cognitive Control, Timing and Reward Sensitivity Appear to be Dissociable in ADHD	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DUAL PATHWAY MODEL; HYPERACTIVITY DISORDER; BASAL GANGLIA; TIME PERCEPTION; CHILDREN; SYSTEMS; HETEROGENEITY; ANTICIPATION; SUBTYPES	Recent neurobiological models of ADHD suggest that deficits in different neurobiological pathways may independently lead to symptoms of this disorder. At least three independent pathways may be involved: a dorsal frontostriatal pathway involved in cognitive control, a ventral frontostriatal pathway involved in reward processing and a frontocerebellar pathway related to temporal processing. Importantly, we and others have suggested that disruptions in these three pathways should lead to separable deficits at the cognitive level. Furthermore, if these truly represent separate biological pathways to ADHD, these cognitive deficits should segregate between individuals with ADHD. The present study tests these hypotheses in a sample of children, adolescents and young adults with ADHD and controls. 149 Subjects participated in a short computerized battery assessing cognitive control, timing and reward sensitivity. We used Principal Component Analysis to find independent components underlying the variance in the data. The segregation of deficits between individuals was tested using Loglinear Analysis. We found four components, three of which were predicted by the model: Cognitive control, reward sensitivity and timing. Furthermore, 80% of subjects with ADHD that had a deficit were deficient on only one component. Loglinear Analysis statistically confirmed the independent segregation of deficits between individuals. We therefore conclude that cognitive control, timing and reward sensitivity were separable at a cognitive level and that deficits on these components segregated between individuals with ADHD. These results support a neurobiological framework of separate biological pathways to ADHD with separable cognitive deficits.	[de Zeeuw, Patrick; Weusten, Juliette; van Dijk, Sarai; van Belle, Janna; Durston, Sarah] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Neuroimaging Lab,Dev Disorders Unit, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	de Zeeuw, P (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Neuroimaging Lab,Dev Disorders Unit, Utrecht, Netherlands.	p.dezeeuw@umcutrecht.nl			Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO) [Vidi-91.776.384]; Unilever Foods	Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO)(Netherlands Organization for Scientific Research (NWO)); Unilever Foods(Unilever)	This work was supported by a grant from the Netherlands Organization for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, NWO, www.nwo.nl) in the Innovational Research Incentives Scheme (also known as the "Veni, Vidi, Vici"-programme) to SD (grant number: Vidi-91.776.384, further information can be found on http://www.nwo.nl/nwohome.nsf/pages/NWOA_4YJDQ3_Eng). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: SD has received a research grant from Unilever Foods. The other authors report no biomedical financial interests or potential conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Achenback TM, 2003, MANUAL ASEBA ADULT F; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Arnsten AFT, 2009, CNS DRUGS, V23, P33, DOI 10.2165/00023210-200923000-00005; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Biederman J, 2004, J CONSULT CLIN PSYCH, V72, P757, DOI 10.1037/0022-006X.72.5.757; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chudasama Y, 2006, BIOL PSYCHOL, V73, P19, DOI 10.1016/j.biopsycho.2006.01.005; de Zeeuw P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035770; Durston S, 2004, J AM ACAD CHILD PSY, V43, P332, DOI 10.1097/00004583-200403000-00016; Durston S, 2008, J AM ACAD CHILD PSY, V47, P61, DOI 10.1097/chi.0b013e31815a5f17; Durston S, 2007, J CHILD PSYCHOL PSYC, V48, P881, DOI 10.1111/j.1469-7610.2007.01754.x; Durston S, 2011, BIOL PSYCHIAT, V69, P1178, DOI 10.1016/j.biopsych.2010.07.037; Fair DA, 2012, P NATL ACAD SCI USA, V109, P6769, DOI 10.1073/pnas.1115365109; Geurts HM, 2005, ARCH CLIN NEUROPSYCH, V20, P457, DOI 10.1016/j.acn.2004.11.001; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hummer TA, 2011, J ABNORM CHILD PSYCH, V39, P11, DOI 10.1007/s10802-010-9449-3; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Johnson KA, 2008, J CHILD PSYCHOL PSYC, V49, P1339, DOI 10.1111/j.1469-7610.2008.01936.x; Killeen Peter R, 2012, Curr Top Behav Neurosci, V9, P391, DOI 10.1007/7854_2011_160; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Konrad K, 2006, BIOL PSYCHIAT, V59, P643, DOI 10.1016/j.biopsych.2005.08.013; Kuntsi J, 2010, ARCH GEN PSYCHIAT, V67, P1159, DOI 10.1001/archgenpsychiatry.2010.139; Lambek R, 2010, J CHILD PSYCHOL PSYC, V51, P895, DOI 10.1111/j.1469-7610.2010.02248.x; Loo SK, 2007, J AM ACAD CHILD PSY, V46, P1594, DOI 10.1097/chi.0b013e3181575014; Makris N, 2009, DEV NEUROSCI-BASEL, V31, P36, DOI 10.1159/000207492; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mulder MJ, 2008, J AM ACAD CHILD PSY, V47, P68, DOI 10.1097/chi.0b013e31815a56dc; Mulder MJ, 2011, HUM BRAIN MAPP, V32, P1511, DOI 10.1002/hbm.21141; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P785, DOI 10.1017/S0954579405050376; Oosterlaan J, 1998, J CHILD PSYCHOL PSYC, V39, P411, DOI 10.1111/1469-7610.00336; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Rubia K, 2009, PHILOS T R SOC B, V364, P1919, DOI 10.1098/rstb.2009.0014; Russell Vivienne A, 2006, Behav Brain Funct, V2, P30, DOI 10.1186/1744-9081-2-30; Sagvolden T, 2005, BEHAV BRAIN SCI, V28, P397, DOI 10.1017/S0140525X05000075; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Seidman LJ, 2006, CLIN PSYCHOL REV, V26, P466, DOI 10.1016/j.cpr.2006.01.004; Sergeant J, 2000, NEUROSCI BIOBEHAV R, V24, P7, DOI 10.1016/S0149-7634(99)00060-3; Sergeant JA, 2002, BEHAV BRAIN RES, V130, P3, DOI 10.1016/S0166-4328(01)00430-2; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sonuga-Barke EJS, 2010, J AM ACAD CHILD PSY, V49, P345, DOI 10.1016/j.jaac.2009.12.018; Sonuga-Barke EJS, 2010, NEUROPSYCHOL REV, V20, P86, DOI 10.1007/s11065-009-9115-0; Sonuga-Barke EJS, 2002, BEHAV BRAIN RES, V130, P29, DOI 10.1016/S0166-4328(01)00432-6; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; Tabachnick B. G., 2001, USING MULTIVARIATE S; Toplak ME, 2006, J NEUROSCI METH, V151, P15, DOI 10.1016/j.jneumeth.2005.09.018; Tripp G, 2008, J CHILD PSYCHOL PSYC, V49, P691, DOI 10.1111/j.1469-7610.2007.01851.x; van Vliet I M, 2007, Tijdschr Psychiatr, V49, P393; Verhulst F.C., 1996, HANDLEIDING CBCL4 18; Vermunt J, 2005, ENCY STAT BEHAV SCI, P1082; Wahlstedt C, 2009, J ABNORM CHILD PSYCH, V37, P551, DOI 10.1007/s10802-008-9286-9; Wechsler D, 2005, WECHSLER INTELLIGENC; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	60	38	38	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51416	10.1371/journal.pone.0051416	http://dx.doi.org/10.1371/journal.pone.0051416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	050OT	23236497	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100116
J	Leng, RX; Wang, W; Cen, H; Zhou, M; Feng, CC; Zhu, Y; Yang, XK; Yang, M; Zhai, Y; Li, BZ; Wang, XS; Li, R; Chen, GM; Chen, H; Pan, HF; Ye, DQ				Leng, Rui-Xue; Wang, Wei; Cen, Han; Zhou, Mo; Feng, Chen-Chen; Zhu, Yan; Yang, Xiao-Ke; Yang, Mei; Zhai, Yu; Li, Bao-Zhu; Wang, Xiao-Song; Li, Rui; Chen, Gui-Mei; Chen, Hong; Pan, Hai-Feng; Ye, Dong-Qing			Gene-Gene and Gene-Sex Epistatic Interactions of MiR146a, IRF5, IKZF1, ETS1 and IL21 in Systemic Lupus Erythematosus	PLOS ONE			English	Article							MULTIFACTOR DIMENSIONALITY REDUCTION; SUSCEPTIBILITY LOCI; AUTOIMMUNE-DISEASE; REVISED CRITERIA; ASSOCIATION; DIFFERENTIATION; CLASSIFICATION; POPULATION; TNFAIP3; CELLS	Several confirmed genetic susceptibility loci involved in the interferon signaling and Th17/B cell response for SLE in Chinese Han populations have been described. Available data also indicate that sex-specific genetic differences contribute to SLE susceptibility. The aim of this study was to test for gene-gene/gene-sex epistasis (interactions) in these known lupus susceptibility loci. Six single-nucleotide polymorphisms (SNPs) in MiR146a, IRF5, IKZF1, ETS1 and IL21 were genotyped by Sequenom MassArray system. A total of 1,825 subjects (858 SLE patients and 967 controls) were included in the final analysis. Epistasis was tested by additive model, multiplicative model and multifactor dimensionality reduction (MDR) method. Additive interaction analysis revealed interactions between IRF5 and IKZF1 (OR 2.26, 95% CI 1.48-3.44 [P = 1.21x10(4)]). A similar tendency was also observed between IL21 and ETS1 by parametric methods. In addition, multiple high dimensional gene-gene or gene-sex interactions (three-and four-way) were identified by MDR analysis. Our study identified novel gene-gene/gene-sex interactions in lupus. Furthermore, these findings highlight sex, interferon pathway, and Th17/B cells as important contributors to the pathogenesis of SLE.	[Leng, Rui-Xue; Wang, Wei; Cen, Han; Zhou, Mo; Feng, Chen-Chen; Zhu, Yan; Yang, Xiao-Ke; Yang, Mei; Zhai, Yu; Li, Bao-Zhu; Wang, Xiao-Song; Li, Rui; Chen, Gui-Mei; Chen, Hong; Pan, Hai-Feng; Ye, Dong-Qing] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China; [Leng, Rui-Xue; Wang, Wei; Cen, Han; Zhou, Mo; Feng, Chen-Chen; Zhu, Yan; Yang, Xiao-Ke; Yang, Mei; Zhai, Yu; Li, Bao-Zhu; Wang, Xiao-Song; Li, Rui; Chen, Gui-Mei; Chen, Hong; Pan, Hai-Feng; Ye, Dong-Qing] Anhui Med Univ, Anhui Prov Lab Populat Hlth & Major Dis Screening, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Ye, DQ (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China.	ydq@ahmu.edu.cn	Li, Bao-Zhu/GLU-3542-2022	Pan, Hai-Feng/0000-0001-6814-1553; Pan, Hai-Feng/0000-0001-8218-5747	National Natural Science Foundation of China [81102192, 30830089]; Anhui Provincial Natural Science Foundation [11040606M183]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	This work was supported by grants from the National Natural Science Foundation of China (81102192, 30830089) and the Anhui Provincial Natural Science Foundation (11040606M183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ding L, 2012, INFLAMMATION, V35, P1781, DOI 10.1007/s10753-012-9497-7; Dolff S, 2011, ARTHRITIS RES THER, V13, pR157, DOI DOI 10.1186/AR3474; Ettinger R, 2008, ANN RHEUM DIS, V67, P83, DOI 10.1136/ard.2008.098400; Eyquem S, 2004, EUR J IMMUNOL, V34, P3187, DOI 10.1002/eji.200425352; Fang CM, 2012, GENES IMMUN, V13, P421, DOI 10.1038/gene.2012.10; Fu QO, 2011, ARTHRITIS RHEUM-US, V63, P749, DOI 10.1002/art.30193; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Han SZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001757; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hu SJ, 2013, MOD RHEUMATOL, V23, P205, DOI 10.1007/s10165-012-0706-x; Hughes T, 2012, ANN RHEUM DIS, V71, P694, DOI 10.1136/annrheumdis-2011-200385; Hughes T, 2012, ARTHRITIS RHEUM-US, V64, P485, DOI 10.1002/art.33354; Hughes T, 2011, ARTHRITIS RHEUM-US, V63, P1689, DOI 10.1002/art.30320; Kariuki SN, 2008, ARTHRITIS RHEUM, V58, P2818, DOI 10.1002/art.23728; Kawasaki A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3134; Leng RX, 2011, AUTOIMMUN REV, V10, P439, DOI 10.1016/j.autrev.2011.01.007; Luo XB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002128; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; Motsinger Alison A., 2006, Human Genomics, V2, P318; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Sawalha AH, 2008, ANN RHEUM DIS, V67, P458, DOI 10.1136/ard.2007.075424; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Su MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030694; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Wang D, 2005, INT IMMUNOL, V17, P1179, DOI 10.1093/intimm/dxh295; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Zhou XJ, 2012, ARTHRITIS RHEUM-US, V64, P222, DOI 10.1002/art.33318	28	34	38	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51090	10.1371/journal.pone.0051090	http://dx.doi.org/10.1371/journal.pone.0051090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236436	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100065
J	Scolz, M; Widlund, PO; Piazza, S; Bublik, DR; Reber, S; Peche, LY; Ciani, Y; Hubner, N; Isokane, M; Monte, M; Ellenberg, J; Hyman, AA; Schneider, C; Bird, AW				Scolz, Massimilano; Widlund, Per O.; Piazza, Silvano; Bublik, Debora Rosa; Reber, Simone; Peche, Leticia Y.; Ciani, Yari; Hubner, Nina; Isokane, Mayumi; Monte, Martin; Ellenberg, Jan; Hyman, Anthony A.; Schneider, Claudio; Bird, Alexander W.			GTSE1 Is a Microtubule Plus-End Tracking Protein That Regulates EB1-Dependent Cell Migration	PLOS ONE			English	Article							INTRINSICALLY DISORDERED PROTEINS; IN-VITRO; BAC TRANSGENEOMICS; CYCLE; DYNAMICS; APC; LOCALIZATION; ENDOCYTOSIS; METASTASIS; PATHWAYS	The regulation of cell migration is a highly complex process that is often compromised when cancer cells become metastatic. The microtubule cytoskeleton is necessary for cell migration, but how microtubules and microtubule-associated proteins regulate multiple pathways promoting cell migration remains unclear. Microtubule plus-end binding proteins (+TIPs) are emerging as important players in many cellular functions, including cell migration. Here we identify a +TIP, GTSE1, that promotes cell migration. GTSE1 accumulates at growing microtubule plus ends through interaction with the EB1+TIP. The EB1-dependent +TIP activity of GTSE1 is required for cell migration, as well as for microtubule-dependent disassembly of focal adhesions. GTSE1 protein levels determine the migratory capacity of both nontransformed and breast cancer cell lines. In breast cancers, increased GTSE1 expression correlates with invasive potential, tumor stage, and time to distant metastasis, suggesting that misregulation of GTSE1 expression could be associated with increased invasive potential.	[Widlund, Per O.; Reber, Simone; Hyman, Anthony A.; Bird, Alexander W.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Scolz, Massimilano; Piazza, Silvano; Bublik, Debora Rosa; Peche, Leticia Y.; Ciani, Yari; Monte, Martin; Schneider, Claudio] Interuniv Consortium Biotechnol, Lab Nazl, Trieste, Italy; [Hubner, Nina] Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands; [Isokane, Mayumi] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany; [Schneider, Claudio] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy	Max Planck Society; Utrecht University; Utrecht University Medical Center; European Molecular Biology Laboratory (EMBL); University of Udine	Hyman, AA (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	hyman@mpi-cbg.de; schneide@lncib.it; Alex.Bird@mpi-dortmund.mpg.de	Hyman, Tony/F-1923-2011; Hubner, Nina C/C-4298-2008; Widlund, Per/J-1238-2019; Ellenberg, Jan/I-4688-2014; Hyman, Anthony A/B-3917-2017	Hubner, Nina C/0000-0002-7864-2877; Widlund, Per/0000-0002-3645-0009; Ellenberg, Jan/0000-0001-5909-701X; Hyman, Anthony A/0000-0003-3664-154X; Monte, Martin/0000-0002-5068-563X; Peche, Leticia Yamila/0000-0002-1666-9433; Piazza, Silvano/0000-0002-7156-5434; Ciani, Yari/0000-0002-9635-2830	Italian Association for Cancer Research (AIRC) IG; AIRC Special Program Molecular Clinical Oncology "5 per mille"; Area Science Park; School of Molecular Biomedicine University of Trieste	Italian Association for Cancer Research (AIRC) IG; AIRC Special Program Molecular Clinical Oncology "5 per mille"; Area Science Park; School of Molecular Biomedicine University of Trieste	Work done in CS's lab at Laboratorio Nazionale The Interuniversity Consortium for Biotechnology has been supported by Italian Association for Cancer Research (AIRC) IG-2010 and AIRC Special Program Molecular Clinical Oncology "5 per mille". MS and LP were supported by fellowships from Area Science Park. YC is supported by a PhD Fellowship from the School of Molecular Biomedicine University of Trieste. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Bhat KMR, 2007, CLIN CANCER RES, V13, P2849, DOI 10.1158/1078-0432.CCR-06-3040; Bird AW, 2012, NAT METHODS, V9, P103, DOI [10.1038/NMETH.1803, 10.1038/nmeth.1803]; Borner GHH, 2012, J CELL BIOL, V197, P141, DOI 10.1083/jcb.201111049; Bublik DR, 2010, J BIOL CHEM, V285, P5274, DOI 10.1074/jbc.M109.045948; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; Collavin L, 2000, FEBS LETT, V481, P57, DOI 10.1016/S0014-5793(00)01969-4; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Fukui R, 2000, AM J PHYSIOL-CELL PH, V279, pC999, DOI 10.1152/ajpcell.2000.279.4.C999; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Gell C, 2011, METHODS MOL BIOL, V777, P15, DOI 10.1007/978-1-61779-252-6_2; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; IWASAKI T, 1995, INT J CANCER, V63, P282, DOI 10.1002/ijc.2910630223; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034456; Levasseur M, 2000, DEVELOPMENT, V127, P631; Li DM, 2011, BREAST CANCER RES TR, V128, P7, DOI 10.1007/s10549-011-1499-x; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Liu XS, 2010, EMBO REP, V11, P626, DOI 10.1038/embor.2010.90; MASUYAMA JI, 1992, J IMMUNOL, V148, P1367; Mitchison TJ, 2012, MOL BIOL CELL, V23, P1, DOI 10.1091/mbc.E10-04-0335; Monte M, 2000, GENE, V254, P229, DOI 10.1016/S0378-1119(00)00260-2; Monte M, 2004, J BIOL CHEM, V279, P11744, DOI 10.1074/jbc.M311123200; Monte M, 2003, J BIOL CHEM, V278, P30356, DOI 10.1074/jbc.M302902200; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pagano A, 2012, BIOCHEM PHARMACOL, V84, P432, DOI 10.1016/j.bcp.2012.05.010; Palazzo Alexander F, 2002, Sci STKE, V2002, ppe31, DOI 10.1126/stke.2002.139.pe31; Palmer TD, 2011, ADV DRUG DELIVER REV, V63, P568, DOI 10.1016/j.addr.2011.04.008; Pfleger CM, 2000, GENE DEV, V14, P655; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; RATNER S, 1988, J IMMUNOL, V140, P583; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rooney C, 2010, EMBO REP, V11, P292, DOI 10.1038/embor.2010.10; Schober JM, 2009, CANCER LETT, V284, P30, DOI 10.1016/j.canlet.2009.04.007; Sironi L, 2011, CYTOSKELETON, V68, P266, DOI 10.1002/cm.20510; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Stehbens S, 2012, J CELL BIOL, V198, P481, DOI 10.1083/jcb.201206050; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson SL, 2011, CHROMOSOME RES, V19, P433, DOI 10.1007/s10577-010-9179-y; Tian T, 2011, ASIAN PAC J CANCER P, V12, P2039; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; van der Vaart B, 2011, J CELL BIOL, V193, P1083, DOI 10.1083/jcb.201012179; Wasilko DJ, 2009, PROTEIN EXPRES PURIF, V65, P122, DOI 10.1016/j.pep.2009.01.002; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wen YD, 2004, KENYON REV, V26, P1; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001; Zhou XF, 2006, NEOPLASIA, V8, P925, DOI 10.1593/neo.06430	73	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51259	10.1371/journal.pone.0051259	http://dx.doi.org/10.1371/journal.pone.0051259			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236459	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100084
J	Tebbenkamp, ATN; Crosby, KW; Siemienski, ZB; Brown, HH; Golde, TE; Borchelt, DR				Tebbenkamp, Andrew T. N.; Crosby, Keith W.; Siemienski, Zoe B.; Brown, Hilda H.; Golde, Todd E.; Borchelt, David R.			Analysis of Proteolytic Processes and Enzymatic Activities in the Generation of Huntingtin N-Terminal Fragments in an HEK293 Cell Model	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE INHIBITOR; FREE TG2576 MICE; MUTANT HUNTINGTIN; TRANSGENIC MICE; INTRANUCLEAR INCLUSIONS; CASPASE CLEAVAGE; REDUCES TOXICITY; CALPAIN CLEAVAGE; NEURONAL CELLS	Background: N-terminal fragments of mutant huntingtin (htt) that terminate between residues 90-115, termed cleavage product A or 1 (cp-A/1), form intracellular and intranuclear inclusion bodies in the brains of patients with Huntington's disease (HD). These fragments appear to be proteolytic products of the full-length protein. Here, we use an HEK293 cell culture model to investigate huntingtin proteolytic processing; previous studies of these cells have demonstrated cleavage of htt to cp-A/1 like htt fragments. Results: Recombinant N-terminal htt fragments, terminating at residue 171 (also referred to as cp-B/2 like), were efficiently cleaved to produce cp-A/1 whereas fragments representing endogenous caspase, calpain, and metalloproteinase cleavage products, terminating between residues 400-600, were inefficiently cleaved. Using cysteine-labeling techniques and antibody binding mapping, we localized the C-terminus of the cp-A/1 fragments produced by HEK293 cells to sequences minimally limited by cysteine 105 and an antibody epitope composed of residues 115-124. A combination of genetic and pharmacologic approaches to inhibit potential proteases, including gamma-secretase and calpain, proved ineffective in preventing production of cp-A/1. Conclusions: Our findings indicate that HEK293 cells express a protease that is capable of efficiently cleaving cp-B/2 like fragments of htt with normal or expanded glutamine repeats. For reasons that remain unclear, this protease cleaves longer htt fragments, with normal or expanded glutamine expansions, much less efficiently. The protease in HEK293 cells that is capable of generating a cp-A/1 like htt fragment may be a novel protease with a high preference for a cp-B/2-like htt fragment as substrate.	[Tebbenkamp, Andrew T. N.; Crosby, Keith W.; Siemienski, Zoe B.; Brown, Hilda H.; Golde, Todd E.; Borchelt, David R.] Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, McKnight Brain Inst, Gainesville, FL 32610 USA; [Tebbenkamp, Andrew T. N.; Crosby, Keith W.; Siemienski, Zoe B.; Brown, Hilda H.; Borchelt, David R.] Univ Florida, SantaFe HealthCare Alzheimers Dis Res Ctr, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Borchelt, DR (corresponding author), Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, McKnight Brain Inst, Gainesville, FL 32610 USA.	borchelt@mbi.ufl.edu		Tebbenkamp, Andrew/0000-0002-9015-3427	Coalition for a Cure; Huntington's Disease Society of America; SantaFe HealthCare Alzheimer's Disease Research Center	Coalition for a Cure; Huntington's Disease Society of America; SantaFe HealthCare Alzheimer's Disease Research Center	This work was supported by the Coalition for a Cure; Huntington's Disease Society of America, and the SantaFe HealthCare Alzheimer's Disease Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cilenti L, 2003, J BIOL CHEM, V278, P11489, DOI 10.1074/jbc.M212819200; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; Dev KK, 2006, EUR J PHARMACOL, V540, P10, DOI 10.1016/j.ejphar.2006.04.011; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fauq AH, 2007, BIOORG MED CHEM LETT, V17, P6392, DOI 10.1016/j.bmcl.2007.07.062; Fortun J, 2007, NEUROBIOL DIS, V25, P252, DOI 10.1016/j.nbd.2006.09.018; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Goffredo D, 2005, PHARMACOL RES, V52, P140, DOI 10.1016/j.phrs.2005.01.006; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Heng MY, 2008, NEUROBIOL DIS, V32, P1, DOI 10.1016/j.nbd.2008.06.005; Herndon ES, 2009, J NEUROPATH EXP NEUR, V68, P250, DOI 10.1097/NEN.0b013e318198d320; Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; Inagaki R, 2008, EUR J NEUROSCI, V28, P30, DOI 10.1111/j.1460-9568.2008.06323.x; Kegel KB, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-58; Kim YJ, 2006, NEUROBIOL DIS, V22, P346, DOI 10.1016/j.nbd.2005.11.012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lanz TA, 2005, J PHARMACOL EXP THER, V312, P399, DOI 10.1124/jpet.104.073965; Lanz TA, 2004, J PHARMACOL EXP THER, V309, P49, DOI 10.1124/jpet.103.060715; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Meyer SL, 1996, BIOCHEM J, V314, P511, DOI 10.1042/bj3140511; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; MYERS RH, 1988, NEUROLOGY, V38, P341, DOI 10.1212/WNL.38.3.341; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; Sadasivan S, 2006, APOPTOSIS, V11, P1573, DOI 10.1007/s10495-006-7690-6; SAIDO TC, 1992, J BIOCHEM, V111, P81, DOI 10.1093/oxfordjournals.jbchem.a123723; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Tebbenkamp ATN, 2011, HUM MOL GENET, V20, P2770, DOI 10.1093/hmg/ddr176; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278	49	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50750	10.1371/journal.pone.0050750	http://dx.doi.org/10.1371/journal.pone.0050750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236391	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100033
J	Saxena, V; Ramdas, S; Ochoa, CR; Wallace, D; Bhide, P; Kohane, I				Saxena, Vishal; Ramdas, Shweta; Ochoa, Courtney Rothrock; Wallace, David; Bhide, Pradeep; Kohane, Isaac			Structural, Genetic, and Functional Signatures of Disordered Neuro-Immunological Development in Autism Spectrum Disorder	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; EXPRESSION; ASSOCIATION; SUSCEPTIBILITY; CYTOKINE; CHILDREN; BRAIN; IDENTIFICATION; PREGNANCY; PROTEINS	Background: Numerous linkage studies have been performed in pedigrees of Autism Spectrum Disorders, and these studies point to diverse loci and etiologies of autism in different pedigrees. The underlying pattern may be identified by an integrative approach, especially since ASD is a complex disorder manifested through many loci. Method: Autism spectrum disorder (ASD) was studied through two different and independent genome-scale measurement modalities. We analyzed the results of copy number variation in autism and triangulated these with linkage studies. Results: Consistently across both genome-scale measurements, the same two molecular themes emerged: immune/chemokine pathways and developmental pathways. Conclusion: Linkage studies in aggregate do indeed share a thematic consistency, one which structural analyses recapitulate with high significance. These results also show for the first time that genomic profiling of pathways using a recombination distance metric can capture pathways that are consistent with those obtained from copy number variations (CNV).	[Saxena, Vishal; Bhide, Pradeep] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Saxena, Vishal] Massachusetts Gen Hosp, Dept Med, Charlestown, MA USA; [Saxena, Vishal; Kohane, Isaac] Harvard Univ, Sch Med, Boston, MA USA; [Saxena, Vishal; Wallace, David] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Ochoa, Courtney Rothrock] Univ S Alabama Coll, Ctr Lung Biol, Mobile, AL USA; [Saxena, Vishal; Kohane, Isaac] Childrens Hosp, Dept Endocrinol, Boston, MA 02115 USA; [Ramdas, Shweta] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; University of Michigan System; University of Michigan	Saxena, V (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA.	vishal@mit.edu	saxena, vishal/GRJ-5665-2022; Ramdas, Shweta/J-7712-2019	Ramdas, Shweta/0000-0001-8888-4661; Bhide, Pradeep/0000-0003-4236-9415	Conte Center for Computational System Genomics of Neuropsychiatric Phenotypes(National Institutes of Health) [P50MH94267]; Nancy Lurie Marks Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094267] Funding Source: NIH RePORTER	Conte Center for Computational System Genomics of Neuropsychiatric Phenotypes(National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy Lurie Marks Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was funded in part by Conte Center for Computational System Genomics of Neuropsychiatric Phenotypes(National Institutes of Health P50MH94267). ISK was supported in part by the Nancy Lurie Marks Foundation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; Barrett S, 1999, AM J MED GENET, V88, P609; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Brown AS, 2002, MENT RETARD DEV D R, V8, P51, DOI 10.1002/mrdd.10004; Chung WK, 1996, GENOME RES, V6, P1192, DOI 10.1101/gr.6.12.1192; Corbett BA, 2007, MOL PSYCHIATR, V12, P292, DOI 10.1038/sj.mp.4001943; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Eaves LC, 2004, J AUTISM DEV DISORD, V34, P367, DOI 10.1023/B:JADD.0000037414.33270.a8; Enstrom A, 2009, BRAIN BEHAV IMMUN, V23, P389, DOI 10.1016/j.bbi.2008.12.005; Enstrom AM, 2010, BRAIN BEHAV IMMUN, V24, P64, DOI 10.1016/j.bbi.2009.08.001; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Filipovic R, 2003, DEV NEUROSCI-BASEL, V25, P279, DOI 10.1159/000072275; Filipovic R, 2008, GLIA, V56, P1, DOI 10.1002/glia.20582; Forton JT, 2007, GENOME RES, V17, P82, DOI 10.1101/gr.5663007; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Grigorenko EL, 2008, PEDIATRICS, V122, pE438, DOI 10.1542/peds.2007-3604; Hannum G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000782; Hintzen C, 2009, ARTHRITIS RHEUM-US, V60, P1932, DOI 10.1002/art.24602; Hohlfeld R, 2007, NEUROLOGY, V68, pS58, DOI 10.1212/01.wnl.0000275234.43506.9b; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hosking MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000937; Jyonouchi H, 2002, NEUROPSYCHOBIOLOGY, V46, P76, DOI 10.1159/000065416; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lee KS, 2009, CELL MOL IMMUNOL, V6, P143, DOI 10.1038/cmi.2009.20; Ma DQ, 2009, ANN HUM GENET, V73, P263, DOI 10.1111/j.1469-1809.2009.00523.x; Manousou P, 2010, CLIN EXP IMMUNOL, V162, P337, DOI 10.1111/j.1365-2249.2010.04248.x; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nawa H, 2000, MOL PSYCHIATR, V5, P594, DOI 10.1038/sj.mp.4000730; Owczarek W, 2010, CYTOKINE, V50, P181, DOI 10.1016/j.cyto.2010.02.016; Ponzio NM, 2007, ANN NY ACAD SCI, V1107, P118, DOI 10.1196/annals.1381.013; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Saxena V, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl766; Strachan T, 1999, HUM MOL GENET, V2, pxxiii; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Daalen E, 2009, EUR CHILD ADOLES PSY, V18, P663, DOI 10.1007/s00787-009-0025-8; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Wilkins JM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-141; Yang MS, 2007, INT J DEV NEUROSCI, V25, P69, DOI 10.1016/j.ijdevneu.2006.12.002; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778	47	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2012	7	12							e48835	10.1371/journal.pone.0048835	http://dx.doi.org/10.1371/journal.pone.0048835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051EQ	23239965	Green Published, gold			2022-12-27	WOS:000312108500002
J	Swaminathan, S; Menon, PA; Gopalan, N; Perumal, V; Santhanakrishnan, RK; Ramachandran, R; Chinnaiyan, P; Iliayas, S; Chandrasekaran, P; Navaneethapandian, PD; Elangovan, T; Pho, MT; Wares, F; Ramalyengar, NP				Swaminathan, Soumya; Menon, Pradeep Aravindan; Gopalan, Narendran; Perumal, Venkatesan; Santhanakrishnan, Ramesh Kumar; Ramachandran, Ranjani; Chinnaiyan, Ponnuraja; Iliayas, Sheik; Chandrasekaran, Padmapriyadarsini; Navaneethapandian, Pooranaganga Devi; Elangovan, Thiruvalluvan; Mai Tuyet Pho; Wares, Fraser; Ramalyengar, Narayanan Paranji			Efficacy of a Six-Month versus a 36-Month Regimen for Prevention of Tuberculosis in HIV-Infected Persons in India: A Randomized Clinical Trial	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-RESISTANCE; SOUTH-INDIA; THERAPY; ADULTS; RISK; PEOPLE; IMPLEMENTATION; PYRAZINAMIDE; EPIDEMIC	Background: The optimal duration of preventive therapy for tuberculosis (TB) among HIV-infected persons in TB-endemic countries is unknown. Methods: An open-label randomized clinical trial was performed and analyzed for equivalence. Seven hundred and twelve HIV-infected, ART-naive patients without active TB were randomized to receive either ethambutol 800 mg and isoniazid 300 mg daily for six-months (6EH) or isoniazid 300 mg daily for 36-months (36H). Drugs were dispensed fortnightly and adherence checked by home visits. Patients had chest radiograph, sputum smear and culture performed every six months, in addition to investigations if they developed symptoms. The primary endpoint was incident TB while secondary endpoints were all-cause mortality and adverse events. Survival analysis was performed on the modified intent to treat population (m-ITT) and rates compared. Findings: Tuberculosis developed in 22 (6.4%) of 344 subjects in the 6EH arm and 13 (3.8%) of 339 subjects in the 36H arm with incidence rates of 2.4/100py (95% CI-1.4-3.5) and 1.6/100py (95% CI-0.8-3.0)with an adjusted rate ratio (aIRR) of 1.6 (0.8-3.2). Among TST-positive subjects, the aIRR of 6EH was 1.7 (0.6-4.3) compared to 36H, p = 0.8. All-cause mortality and toxicity were similar in the two arms. Among 15 patients with confirmed TB, 4 isolates were resistant to isoniazid and 2 were multidrug-resistant. Interpretation: Both regimens were similarly effective in preventing TB, when compared to historical incidence rates. However, there was a trend to lower TB incidence with 36H. There was no increase in isoniazid resistance compared to the expected rate in HIV-infected patients. The trial is registered at ClinicalTrials.gov, NCT00351702. Citation: Swaminathan S, Menon PA, Gopalan N, Perumal V, Santhanakrishnan RK, et al. (2012) Efficacy of a Six-Month versus a 36-Month Regimen for Prevention of Tuberculosis in HIV-Infected Persons in India: A Randomized Clinical Trial. PLoS ONE 7(12): e47400. doi: 10.1371/journal.pone.0047400	[Swaminathan, Soumya; Menon, Pradeep Aravindan; Gopalan, Narendran; Perumal, Venkatesan; Santhanakrishnan, Ramesh Kumar; Ramachandran, Ranjani; Chinnaiyan, Ponnuraja; Iliayas, Sheik; Chandrasekaran, Padmapriyadarsini; Navaneethapandian, Pooranaganga Devi; Elangovan, Thiruvalluvan; Ramalyengar, Narayanan Paranji] Indian Council Med Res, Natl Inst Res TB, Formerly TB Res Ctr, Chennai, Tamil Nadu, India; [Mai Tuyet Pho] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Infect Dis, Boston, MA 02215 USA; [Wares, Fraser] Off WHO Representat India, Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; World Health Organization	Swaminathan, S (corresponding author), Indian Council Med Res, Natl Inst Res TB, Formerly TB Res Ctr, Chennai, Tamil Nadu, India.	doctorsoumya@yahoo.com	perumal, venkatesan/B-5377-2010	perumal, venkatesan/0000-0001-5279-8964	World Health Organization; United States Agency for International Development under the WHO/TRC Collaborative Model DOTS Project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433] Funding Source: NIH RePORTER	World Health Organization(World Health Organization); United States Agency for International Development under the WHO/TRC Collaborative Model DOTS Project(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported in part by the World Health Organization, with financial assistance provided by the United States Agency for International Development under the WHO/TRC Collaborative Model DOTS Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Khaled N, 2009, INT J TUBERC LUNG D, V13, P927; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Allen B W, 1968, MYCOBACTERIA ISOLATI; Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Berger VW, 1999, CONTROL CLIN TRIALS, V20, P319, DOI 10.1016/S0197-2456(99)00014-8; Central TB Division Government of India, 2011, RNTCP GLANC; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P1072; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Getahun H, 2010, AIDS, V24, pS57, DOI 10.1097/01.aids.0000391023.03037.1f; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Gordin FM, 1997, NEW ENGL J MED, V337, P315, DOI 10.1056/NEJM199707313370505; Grant A D, 1997, AIDS, V11 Suppl B, pS43; Grant AD, 2010, AIDS, V24, pS15, DOI 10.1097/01.aids.0000391011.40892.ff; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Johnson JL, 2001, AIDS, V15, P2137, DOI 10.1097/00002030-200111090-00009; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Martinson NB, 2009, C RETR OPP INF 8 11; Mwinga A, 1998, AIDS, V12, P2447, DOI 10.1097/00002030-199818000-00014; Narayanan S, 2010, J INFECT DIS, V201, P691, DOI 10.1086/650528; Pereira M, 2005, INDIAN J MED RES, V121, P235; Quigley MA, 2001, AIDS, V15, P215, DOI 10.1097/00002030-200101260-00011; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Swaminathan S, 2008, INT J TUBERC LUNG D, V12, P168; Swaminathan S, 2000, INT J TUBERC LUNG D, V4, P839; Swaminathan S, 2005, INT J TUBERC LUNG D, V9, P896; SWAMINATHAN S, 2010, C RETR OPP INF 16 19; US National Institutes of Health. Cancer Therapy Evaluation Program, 2011, COMM TERM CRIT ADV E; van Halsema CL, 2010, AIDS, V24, P1051, DOI 10.1097/QAD.0b013e32833849df; van Hest R, 2004, CLIN INFECT DIS, V39, P488, DOI 10.1086/422645; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; WHO, 2004, INT POL COLL TB HIV; WHO, 1998, POL STAT PREV THER T; WOLDEHANNA S, 2004, COCHRANE LIB; World Health Organization, 2009, WHOTB98225	36	33	33	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e47400	10.1371/journal.pone.0047400	http://dx.doi.org/10.1371/journal.pone.0047400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251327	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000312386800001
J	Wong, YT; Ng, YM; Mak, ANS; Sze, KH; Wong, KB; Shaw, PC				Wong, Yuen-Ting; Ng, Yiu-Ming; Mak, Amanda Nga-Sze; Sze, Kong-Hung; Wong, Kam-Bo; Shaw, Pang-Chui			Maize Ribosome-Inactivating Protein Uses Lys158-Lys161 to Interact with Ribosomal Protein P2 and the Strength of Interaction Is Correlated to the Biological Activities	PLOS ONE			English	Article							POKEWEED ANTIVIRAL PROTEIN; RICIN-A-CHAIN; SHIGA TOXIN; BINDING; STALK; TRICHOSANTHIN; RNA; DEPURINATION; MECHANISM; SUBUNIT	Ribosome-inactivating proteins (RIPs) inactivate prokaryotic or eukaryotic ribosomes by removing a single adenine in the large ribosomal RNA. Here we show maize RIP (MOD), an atypical RIP with an internal inactivation loop, interacts with the ribosomal stalk protein P2 via Lys158-Lys161, which is located in the N-terminal domain and at the base of its internal loop. Due to subtle differences in the structure of maize RIP, hydrophobic interaction with the 'FGLFD' motif of P2 is not as evidenced in MOD-P2 interaction. As a result, interaction of P2 with MOD was weaker than those with trichosanthin and shiga toxin A as reflected by the dissociation constants (K-D) of their interaction, which are 1037.50 +/- 65.75 mu M, 611.70 +/- 28.13 mu M and 194.84 +/- 9.47 mu M respectively. Despite MOD and TCS target at the same ribosomal protein P2, MOD was found 48 and 10 folds less potent than trichosanthin in ribosome depurination and cytotoxicity to 293T cells respectively, implicating the strength of interaction between RIPs and ribosomal proteins is important for the biological activity of RIPs. Our work illustrates the flexibility on the docking of RIPs on ribosomal proteins for targeting the sarcin-ricin loop and the importance of protein-protein interaction for ribosome-inactivating activity.	[Wong, Yuen-Ting; Ng, Yiu-Ming; Mak, Amanda Nga-Sze; Wong, Kam-Bo; Shaw, Pang-Chui] Chinese Univ Hong Kong, Sch Life Sci, Biochem Programme, Shatin, Hong Kong, Peoples R China; [Wong, Yuen-Ting; Ng, Yiu-Ming; Mak, Amanda Nga-Sze; Wong, Kam-Bo; Shaw, Pang-Chui] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China; [Sze, Kong-Hung] Univ Hong Kong, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong	Shaw, PC (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Biochem Programme, Shatin, Hong Kong, Peoples R China.	pcshaw@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021	Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373	Research Fund for the Control of Infectious Diseases [10090452]; University Grants Council, Hong Kong SAR [SEG CUHK08]	Research Fund for the Control of Infectious Diseases; University Grants Council, Hong Kong SAR	This work was supported in part by a Research Fund for the Control of Infectious Diseases (reference number: 10090452) and a University Grants Council One-Off Special Equipment Grant (SEG CUHK08) from Hong Kong SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayub MJ, 2008, BIOCHEM BIOPH RES CO, V369, P314, DOI 10.1016/j.bbrc.2008.01.170; Barbieri L, 2004, FEBS LETT, V563, P219, DOI 10.1016/S0014-5793(04)00286-8; BRIGOTTI M, 1989, BIOCHEM J, V257, P723, DOI 10.1042/bj2570723; Chaddock JA, 1996, EUR J BIOCHEM, V235, P159, DOI 10.1111/j.1432-1033.1996.00159.x; Chan DSB, 2007, NUCLEIC ACIDS RES, V35, P1660, DOI 10.1093/nar/gkm065; Chan SH, 2001, EUR J BIOCHEM, V268, P2107, DOI 10.1046/j.1432-1327.2001.02091.x; Chiou JC, 2011, INT J BIOCHEM CELL B, V43, P1792, DOI 10.1016/j.biocel.2011.08.018; Chiou JC, 2008, MOL MICROBIOL, V70, P1441, DOI 10.1111/j.1365-2958.2008.06492.x; de Virgilio M, 2010, TOXINS, V2, P2699, DOI 10.3390/toxins2112699; Endo Y, 1988, Nucleic Acids Symp Ser, P139; FERNANDEZPUENTES C, 1977, FEBS LETT, V78, P143, DOI 10.1016/0014-5793(77)80292-5; Girbes T, 2004, MINI-REV MED CHEM, V4, P461, DOI 10.2174/1389557043403891; HEY TD, 1995, PLANT PHYSIOL, V107, P1323, DOI 10.1104/pp.107.4.1323; Hudak KA, 1999, J BIOL CHEM, V274, P3859, DOI 10.1074/jbc.274.6.3859; Lancaster L, 2008, RNA, V14, P1999, DOI 10.1261/rna.1202108; Lapadula WJ, 2012, TOXICON, V59, P427, DOI 10.1016/j.toxicon.2011.12.014; Law SKY, 2010, NUCLEIC ACIDS RES, V38, P6803, DOI 10.1093/nar/gkq551; Li XP, 2009, BIOCHEMISTRY-US, V48, P3853, DOI 10.1021/bi802371h; Mak ANS, 2007, NUCLEIC ACIDS RES, V35, P6259, DOI 10.1093/nar/gkm687; McCluskey AJ, 2008, J MOL BIOL, V378, P375, DOI 10.1016/j.jmb.2008.02.014; McCluskey AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031191; Melchior WB, 2010, ANAL BIOCHEM, V396, P204, DOI 10.1016/j.ab.2009.09.024; MONTANARO L, 1975, BIOCHEM J, V146, P127, DOI 10.1042/bj1460127; Nagasawa Y, 2008, PHYTOCHEMISTRY, V69, P1653, DOI 10.1016/j.phytochem.2008.02.012; Narayanan S, 2005, FEBS LETT, V579, P1324, DOI 10.1016/j.febslet.2005.01.038; Rajamohan F, 2001, BIOCHEMISTRY-US, V40, P9104, DOI 10.1021/bi002851p; Robertus JD, 2004, MINI-REV MED CHEM, V4, P477, DOI 10.2174/1389557043403837; Spedding G, 1990, RIBOSOMES PROTEIN SY, P9; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Stirpe F, 2004, TOXICON, V44, P371, DOI 10.1016/j.toxicon.2004.05.004; Suh JK, 1998, BIOCHEMISTRY-US, V37, P9394, DOI 10.1021/bi980424u; Too PHM, 2009, NUCLEIC ACIDS RES, V37, P602, DOI 10.1093/nar/gkn922; VATER CA, 1995, J BIOL CHEM, V270, P12933, DOI 10.1074/jbc.270.21.12933; WALSH TA, 1991, J BIOL CHEM, V266, P23422; Yang YH, 2010, J MOL BIOL, V395, P897, DOI 10.1016/j.jmb.2009.10.051	35	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49608	10.1371/journal.pone.0049608	http://dx.doi.org/10.1371/journal.pone.0049608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251345	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200018
J	Luo, W; Wang, CY; Jin, LJ				Luo, Wei; Wang, Cun-Yu; Jin, Lijian			Baicalin Downregulates Porphyromonas gingivalis Lipopolysaccharide-Upregulated IL-6 and IL-8 Expression in Human Oral Keratinocytes by Negative Regulation of TLR Signaling	PLOS ONE			English	Article							NF-KAPPA-B; COLONY-STIMULATING FACTOR; PROTEIN-KINASE INHIBITOR; TOLL-LIKE RECEPTORS; CANCER CELL-LINES; GENE-EXPRESSION; LIPID-A; CUTTING EDGE; INTERLEUKIN-1 RECEPTOR; INFLAMMATORY RESPONSE	Periodontal (gum) disease is one of the main global oral health burdens and severe periodontal disease (periodontitis) is a leading cause of tooth loss in adults globally. It also increases the risk of cardiovascular disease and diabetes mellitus. Porphyromonas gingivalis lipopolysaccharide (LPS) is a key virulent attribute that significantly contributes to periodontal pathogenesis. Baicalin is a flavonoid from Scutellaria radix, an herb commonly used in traditional Chinese medicine for treating inflammatory diseases. The present study examined the modulatory effect of baicalin on P. gingivalis LPS-induced expression of IL-6 and IL-8 in human oral keratinocytes (HOKs). Cells were pre-treated with baicalin (0-80 mu M) for 24 h, and subsequently treated with P. gingivalis LPS at 10 mu g/ml with or without baicalin for 3 h. IL-6 and IL-8 transcripts and proteins were detected by real-time polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. The expression of nuclear factor-kappa B (NF-kappa B), p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) proteins was analyzed by western blot. A panel of genes related to toll-like receptor (TLR) signaling was examined by PCR array. We found that baicalin significantly downregulated P. gingivalis LPS-stimulated expression of IL-6 and IL-8, and inhibited P. gingivalis LPS-activated NF-kappa B, p38 MAPK and JNK. Furthermore, baicalin markedly downregulated P. gingivalis LPS-induced expression of genes associated with TLR signaling. In conclusion, the present study shows that baicalin may significantly downregulate P. gingivalis LPS-upregulated expression of IL-6 and IL-8 in HOKs via negative regulation of TLR signaling.	[Luo, Wei; Jin, Lijian] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	University of Hong Kong; University of California System; University of California Los Angeles	Jin, LJ (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	ljjin@hkucc.hku.hk		Jin, Lijian/0000-0003-4305-1337	Hong Kong Research Grants Council [HKU766909M, HKU768411M]; Modern Dental Laboratory/HKU Endowment Fund	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Modern Dental Laboratory/HKU Endowment Fund	This study was supported by the Hong Kong Research Grants Council (HKU766909M and HKU768411M to LJJ), and the Modern Dental Laboratory/HKU Endowment Fund to LJJ. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Benakanakere MR, 2009, J BIOL CHEM, V284, P23107, DOI 10.1074/jbc.M109.013862; Berman KS, 2002, CLIN CANCER RES, V8, P354; Bhatavadekar NB, 2009, INT DENT J, V59, P305, DOI 10.1922/IDJ_2157Bhatavadekar04; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Cai X, 2008, J PERIODONTAL RES, V43, P14, DOI 10.1111/j.1600-0765.2007.00989.x; Campbell IK, 2011, J IMMUNOL, V186, P5468, DOI 10.4049/jimmunol.1002923; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Cao ZG, 2010, EUR J PHARMACOL, V641, P1, DOI 10.1016/j.ejphar.2010.04.042; Carayol N, 2006, J BIOL CHEM, V281, P31142, DOI 10.1074/jbc.M603417200; Carboni S, 2004, J PHARMACOL EXP THER, V310, P25, DOI 10.1124/jpet.103.064246; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; DEMETRI GD, 1991, BLOOD, V78, P2791; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dominguez C, 2005, CURR OPIN DRUG DISC, V8, P421; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Hajishengallis G, 2009, PERIODONTOL 2000, V51, P181, DOI 10.1111/j.1600-0757.2009.00304.x; Hasturk H, 2007, J IMMUNOL, V179, P7021, DOI 10.4049/jimmunol.179.10.7021; Herath TDK, 2011, J CLIN PERIODONTOL, V38, P694, DOI 10.1111/j.1600-051X.2011.01741.x; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Ikemoto S, 2000, UROLOGY, V55, P951, DOI 10.1016/S0090-4295(00)00467-2; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Jin L J, 2011, Adv Dent Res, V23, P221, DOI 10.1177/0022034511402080; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; KOGA T, 1985, INFECT IMMUN, V47, P638, DOI 10.1128/IAI.47.3.638-647.1985; Kumada H, 2008, ORAL MICROBIOL IMMUN, V23, P60, DOI 10.1111/j.1399-302X.2007.00392.x; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li X, 2011, J DENT RES, V90, P1062, DOI 10.1177/0022034510397194; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; Macagno A, 2006, J EXP MED, V203, P1481, DOI 10.1084/jem.20060136; Maruyama M, 2009, HYBRIDOMA, V28, P431, DOI 10.1089/hyb.2009.0055; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Ogawa T, 2002, INT IMMUNOL, V14, P1325, DOI 10.1093/intimm/dxf097; Ogawa T, 2007, FRONT BIOSCI-LANDMRK, V12, P3795, DOI 10.2741/2353; Oringer RJ, 2002, J PERIODONTOL, V73, P835, DOI 10.1902/jop.2002.73.8.835; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; Parahitiyawa NB, 2009, CLIN MICROBIOL REV, V22, P46, DOI 10.1128/CMR.00028-08; Park HJ, 2009, ARCH PHARM RES, V32, P583, DOI 10.1007/s12272-009-1415-7; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Preshaw PM, 2004, J CLIN PERIODONTOL, V31, P697, DOI 10.1111/j.1600-051X.2004.00558.x; Rogers JE, 2007, J PERIODONTOL, V78, P1992, DOI 10.1902/jop.2007.070101; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Saporito MS, 1999, J PHARMACOL EXP THER, V288, P421; Sawada N, 2007, CLIN EXP IMMUNOL, V148, P529, DOI 10.1111/j.1365-2249.2007.03346.x; Seo T, 2012, J MICROBIOL, V50, P311, DOI 10.1007/s12275-012-2146-x; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; Souza PPC, 2010, J DENT RES, V89, P802, DOI 10.1177/0022034510366898; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Toshchakov VY, 2007, J IMMUNOL, V178, P2655, DOI 10.4049/jimmunol.178.5.2655; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang GF, 2006, PHARMACOLOGY, V77, P71, DOI 10.1159/000092853; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yilmaz Ozlem, 2008, Microbiology (Reading), V154, P2897, DOI 10.1099/mic.0.2008/021220-0; Yoshimura A, 2002, INFECT IMMUN, V70, P218, DOI 10.1128/IAI.70.1.218-225.2002; Zhu GX, 2007, J ETHNOPHARMACOL, V109, P325, DOI 10.1016/j.jep.2006.08.001	77	41	46	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51008	10.1371/journal.pone.0051008	http://dx.doi.org/10.1371/journal.pone.0051008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239998	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800034
J	Tang, W; Zhu, JJ; Su, SC; Wu, W; Liu, Q; Su, FX; Yu, FY				Tang, Wei; Zhu, Jiujun; Su, Shicheng; Wu, Wei; Liu, Qiang; Su, Fengxi; Yu, Fengyan			MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival	PLOS ONE			English	Article							PROTEIN TRANSCRIPTION FACTORS; CELL-CYCLE PROGRESSION; ONCOGENIC MICRORNA-27A; DRUG-RESISTANCE; GENE-EXPRESSION; DOWN-REGULATION; TUMOR-GROWTH; ANGIOGENESIS; ADENOCARCINOMA; PROLIFERATION	Background: MicroRNA-27a (miR-27a) is thought to be an onco-microRNA that promotes tumor growth and metastasis by downregulating ZBTB10. The potential predictive value of miR-27a was studied in breast cancer patients. Methods: The expression of miR-27a and ZBTB10 was examined in 102 breast cancer cases using in situ hybridization (ISH) and immunohistochemistry techniques and were evaluated semi-quantitatively by examining the staining index. The Correlation of miR-27a and ZBTB10 expression was analyed by Spearman Rank Correlation. The association of miR-27a and ZBTB10 expression with clinicopathological characteristics was analyzed using the chi(2) test, and their effects on patient survival were analyzed by a log-rank test and the Kaplan-Meier method. Univariate and multivariate Cox regression analyses were used to evaluate the prognostic values of miR-27a and ZBTB10. Results: miR-27a was markedly up-regulated in invasive breast cancers that expressed low levels of ZBTB10 (P<0.001). A reverse correlation between miR-27a and ZBTB10 was also observed in breast cancer tissue samples (r(s) = -0.478, P<0.001). Furthermore, the expression of miR-27a and ZBTB10 was significantly correlated with clinicopathological parameters, including tumor size, lymph node metastasis and distant metastasis (P<0.05), but not with receptor status. Patients with high miR-27a or low ZBTB10 expression tended to have significantly shorter disease-free survival times (57 months and 53 months, respectively, P,0.001) and overall survival times (58 months and 55 months, respectively, P <0.001). Univariate and multivariate analysis showed that both miR-27a and ZBTB10 were independent prognostic factors of disease-free survival in breast cancer patients (P <0.001), while only miR-27a was an independent predictor of overall survival (P <0.001). Conclusions: High miR-27a expression is associated with poor overall survival in patients with breast cancer, which suggests that miR-27a could be a valuable marker of breast cancer progression.	[Tang, Wei; Zhu, Jiujun; Su, Shicheng; Wu, Wei; Liu, Qiang; Su, Fengxi; Yu, Fengyan] Sun Yat Sen Univ, Dept Breast Surg, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Wei] Guangzhou Med Univ, Dept Breast Surg, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou Medical University	Su, FX (corresponding author), Sun Yat Sen Univ, Dept Breast Surg, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	fengxisu@vip.163.com; fengyanyu_summer@163.com	ZHU, JIUJUN/GRJ-0173-2022; Liu, Qiang/HHZ-3181-2022	ZHU, JIUJUN/0000-0001-7083-0155; Liu, Qiang/0000-0002-5451-4862	Natural Science Foundation of China [30921140312, 30973396, 30830110, 30972785, 81172524]; Public Health Administration of China; Ministry of Health of China [2011ZX09102-010-02]; HuoYingdong Educational Foundation [121042]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Health Administration of China; Ministry of Health of China; HuoYingdong Educational Foundation	This work was supported by Natural Science Foundation of China grants (30921140312, 30973396, 30830110, 30972785 and 81172524), a Clinical Key Project of the Public Health Administration of China, a grant for Development of Important New Drugs from the Ministry of Health of China (2011ZX09102-010-02) and a Young Teacher grant from the HuoYingdong Educational Foundation (121042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Abdelrahim M, 2002, J BIOL CHEM, V277, P28815, DOI 10.1074/jbc.M203828200; Abdelrahim M, 2006, J NATL CANCER I, V98, P855, DOI 10.1093/jnci/djj232; Banerjee N, 2012, BREAST CANCER RES TR, V136, P21, DOI 10.1007/s10549-012-2224-0; Chadalapaka G, 2012, CARCINOGENESIS, V33, P886, DOI 10.1093/carcin/bgs102; Chintharlapalli S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-371; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Han BW, 2011, HUM MOL GENET, V20, P4903, DOI 10.1093/hmg/ddr428; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Iyevleva AG, 2012, BREAST CANCER RES TR, V131, P1049, DOI 10.1007/s10549-011-1845-z; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Lerner M, 2011, CELL CYCLE, V10, P2172, DOI 10.4161/cc.10.13.16248; Li XR, 2010, ENDOCRINOLOGY, V151, P2462, DOI 10.1210/en.2009-1150; Li ZM, 2010, GYNECOL ONCOL, V119, P125, DOI 10.1016/j.ygyno.2010.06.004; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Mertens-Talcott SU, 2012, MOL CARCINOGENESIS; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Pathi SS, 2011, MOL CANCER RES, V9, P195, DOI 10.1158/1541-7786.MCR-10-0363; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wu FS, 2009, BIOCHEM BIOPH RES CO, V386, P549, DOI 10.1016/j.bbrc.2009.06.075; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang HW, 2010, DIGEST DIS SCI, V55, P2545, DOI 10.1007/s10620-009-1051-6; Zhang ZP, 2011, CANCER GENET-NY, V204, P486, DOI 10.1016/j.cancergen.2011.07.004; Zhao XH, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-55	36	92	106	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51702	10.1371/journal.pone.0051702	http://dx.doi.org/10.1371/journal.pone.0051702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240057	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800093
J	Qi, WB; Tian, J; Zhang, CH; He, J; Ning, ZY; Jiao, PR; Liao, M				Qi, Wenbao; Tian, Jin; Zhang, Changhui; He, Jun; Ning, Zhangyong; Jiao, Peirong; Liao, Ming			Potential Role of HPA Axis and Sympathetic Nervous Responses in Depletion of B Cells Induced by H9N2 Avian Influenza Virus Infection	PLOS ONE			English	Article							BONE-MARROW; CYTOKINE PRODUCTION; INDUCED APOPTOSIS; IMMUNE-SYSTEM; HOST-DEFENSE; A VIRUS; GLUCOCORTICOIDS; BRAIN; BACTERIAL; SELECTION	Except severe pulmonary disease caused by influenza virus infection, an impaired immune system is also a clinic characteristic. However, the mechanism(s) of influenza virus infection-induced depletion of B cells was unknown. Here, we compared the effect of two variant virulence H9N2 virus infections on mouse B cells. Our study found that the infection with highly pathogenic virus (V) of led to depletion of spleen B cells and bone marrow (BM) early B cells, compared to lowly pathogenic virus (Ts). Moreover, high apoptosis and cell cycle arrest in spleen and BM were detected, suggesting important factors for the reduction of B cells in both organs. Further, this effect was not caused by virus replication in spleen and BM. Compared to Ts virus infection, V virus resulted in higher glucocorticoids (GCs) and lower leptin level in plasma. Intraperitoneal GCs receptor antagonist RU486 injection was sufficient to prevent the loss of spleen B cell and BM pro-and immature B cells, but similar result was not observed in leptin-treated mice. Depletion of spleen B cells and BM pro-B cells was also reversed by chemical sympathectomy mediated by the norepinephrine (NE) analog 6-hydroxydopamine (6-OHDA), but the treatment didn't affect the GCs level. This study demonstrated that depletion of B cells induced by H9N2 AIV was dependent on HPA axis and sympathetic response.	[Qi, Wenbao; Tian, Jin; Zhang, Changhui; He, Jun; Ning, Zhangyong; Jiao, Peirong; Liao, Ming] S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Qi, Wenbao; Tian, Jin; Zhang, Changhui; He, Jun; Ning, Zhangyong; Jiao, Peirong; Liao, Ming] MOA Key Lab Anim Vaccine Dev, Guangzhou, Guangdong, Peoples R China; [Qi, Wenbao; Tian, Jin; Zhang, Changhui; He, Jun; Ning, Zhangyong; Jiao, Peirong; Liao, Ming] Key Lab Zoonoses Control & Prevent Guangdong, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Liao, M (corresponding author), S China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.	mliao@scau.edu.cn	Jiao, Peirong/R-3060-2019	Jiao, Peirong/0000-0001-7750-239X	National Science Foundation of China [81001375]; Program for National Broiler Industry [nycytx-42-G3-03]; Natural Science Foundation of Guangdong Province [10251064201000004]; Science and Technology Projects of Guangdong Province [20100206]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for National Broiler Industry; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Projects of Guangdong Province	This work was supported by the National Science Foundation of China (No. 81001375), Program for National Broiler Industry (nycytx-42-G3-03), Natural Science Foundation of Guangdong Province (No. 10251064201000004), Science and Technology Projects of Guangdong Province (No. 20100206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ADER R, 1990, ANNU REV PHARMACOL, V30, P561, DOI 10.1146/annurev.pa.30.040190.003021; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Beishuizen A, 2003, J ENDOTOXIN RES, V9, P3, DOI 10.1179/096805103125001298; Busso N, 2002, J IMMUNOL, V168, P875, DOI 10.4049/jimmunol.168.2.875; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cariappa A, 2007, BLOOD, V109, P2339, DOI 10.1182/blood-2006-05-021089; Cole SW, 1998, J IMMUNOL, V161, P610; Cuss AK, 2006, J IMMUNOL, V176, P1506, DOI 10.4049/jimmunol.176.3.1506; DUNN AJ, 1989, PHYSIOL BEHAV, V45, P591, DOI 10.1016/0031-9384(89)90078-4; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Fukuda M, 2005, J VIROL, V79, P8655, DOI 10.1128/JVI.79.13.8655-8660.2005; Grebe KM, 2010, J IMMUNOL, V184, P540, DOI 10.4049/jimmunol.0903395; Grebe KM, 2009, P NATL ACAD SCI USA, V106, P5300, DOI 10.1073/pnas.0808851106; HARMON JM, 1979, J CELL PHYSIOL, V98, P267, DOI 10.1002/jcp.1040980203; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Herold MJ, 2006, CELL MOL LIFE SCI, V63, P60, DOI 10.1007/s00018-005-5390-y; Jamieson AM, 2010, CELL HOST MICROBE, V7, P103, DOI 10.1016/j.chom.2010.01.010; KAWAHITO Y, 1995, GUT, V37, P544, DOI 10.1136/gut.37.4.544; King KL, 1998, ANNU REV PHYSIOL, V60, P601, DOI 10.1146/annurev.physiol.60.1.601; Lam QLK, 2010, P NATL ACAD SCI USA, V107, P13812, DOI 10.1073/pnas.1004185107; Lill-Elghanian D, 2002, EXP BIOL MED, V227, P763, DOI 10.1177/153537020222700907; Mancuso P, 2002, J IMMUNOL, V168, P4018, DOI 10.4049/jimmunol.168.8.4018; Mansour E, 2006, ENDOCRINOLOGY, V147, P5470, DOI 10.1210/en.2006-0223; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Sedger LM, 2002, J IMMUNOL, V169, P6193, DOI 10.4049/jimmunol.169.11.6193; Smallman-Raynor M, 2007, EMERG INFECT DIS, V13, P510, DOI 10.3201/eid1303.060849; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Strasser A, 2003, IMMUNOL REV, V193, P82, DOI 10.1034/j.1600-065X.2003.00036.x; Tanaka M, 2011, J NEUROSCI, V31, P8373, DOI 10.1523/JNEUROSCI.6562-10.2011; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Vogel AB, 2010, J IMMUNOL, V185, P4824, DOI 10.4049/jimmunol.0903631; Webster JI, 2004, J ENDOCRINOL, V181, P207, DOI 10.1677/joe.0.1810207	35	11	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51029	10.1371/journal.pone.0051029	http://dx.doi.org/10.1371/journal.pone.0051029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251416	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900033
J	Johnson, IM; Prakash, H; Prathiba, J; Raghunathan, R; Malathi, R				Johnson, Irudayam Maria; Prakash, Halan; Prathiba, Jeyaguru; Raghunathan, Raghavachary; Malathi, Raghunathan			Spectral Analysis of Naturally Occurring Methylxanthines (Theophylline, Theobromine and Caffeine) Binding with DNA	PLOS ONE			English	Article							INTERCALATOR ACRIDINE-ORANGE; ANTITUMOR-ACTIVITY; AQUEOUS-SOLUTION; NUCLEIC-ACIDS; CELLS; DERIVATIVES; INHIBITION; ADRIAMYCIN; RNA; DOXORUBICIN	Nucleic acids exist in a dynamic equilibrium with a number of molecules that constantly interact with them and regulate the cellular activities. The inherent nature of the structure and conformational integrity of these macromolecules can lead to altered biological activity through proper targeting of nucleic acids binding ligands or drug molecules. We studied the interaction of naturally occurring methylxanthines such as theophylline, theobromine and caffeine with DNA, using UV absorption and Fourier transform infrared (FTIR) spectroscopic methods, and especially monitored their binding affinity in the presence of Mg2+ and during helix-coil transitions of DNA by temperature (T-m) or pH melting profiles. The study indicates that all these molecules effectively bind to DNA in a dose dependent manner. The overall binding constants of DNA-theophylline = 3.5x10(3) M 21, DNA-theobromine = 1.1x10(3) M-1, and DNA-Caffeine = 3.8x10(3) M-1. On the other hand T-m/pH melting profiles showed 24-35% of enhanced binding activity of methylxanthines during helix-coil transitions of DNA rather than to its native double helical structure. The FTIR analysis divulged that theophylline, theobromine and caffeine interact with all the base pairs of DNA (A-T; G-C) and phosphate group through hydrogen bond (H-bond) interaction. In the presence of Mg2+, methylxanthines altered the structure of DNA from B to A-family. However, the B-family structure of DNA remained unaltered in DNA-methylxanthines complexes or in the absence of Mg2+. The spectral analyses indicated the order of binding affinity as "caffeine >= theophylline>theobromine" to the native double helical DNA, and "theophylline >= theobromine>caffeine to the denatured form of DNA and in the presence of divalent metal ions.	[Johnson, Irudayam Maria] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Prakash, Halan] Univ Madras, Natl Ctr Ultrafast Proc, Madras, Tamil Nadu, India; [Prathiba, Jeyaguru; Malathi, Raghunathan] Univ Madras, Dept Genet, Madras, Tamil Nadu, India; [Raghunathan, Raghavachary] Univ Madras, Dept Organ Chem, Chennai, Tamil Nadu, India	University of Tennessee System; University of Tennessee Health Science Center; University of Madras; University of Madras; University of Madras	Johnson, IM (corresponding author), St Jude Childrens Res Hosp, Dept Hematol, 332 N Lauderdale St, Memphis, TN 38105 USA.	i_mariajohnson@yahoo.com; r_malathi@hotmail.com			CSIR-SRF; CSIR, New Delhi	CSIR-SRF(Council of Scientific & Industrial Research (CSIR) - India); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	IMJ was a recipient of CSIR-SRF, and the financial support from CSIR, New Delhi, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017669; Ahmad R, 2003, BIOPHYS J, V84, P2460, DOI 10.1016/S0006-3495(03)75050-4; Bedner E, 2001, CYTOMETRY, V43, P38, DOI 10.1002/1097-0320(20010101)43:1<38::AID-CYTO1017>3.0.CO;2-S; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Bravo-Cuellar A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-114; CAKE MH, 1978, EUR J BIOCHEM, V82, P97, DOI 10.1111/j.1432-1033.1978.tb12000.x; Charak S, 2012, INT J BIOL MACROMOL, V51, P406, DOI 10.1016/j.ijbiomac.2012.06.012; Chou CC, 2003, AM J VET RES, V64, P216, DOI 10.2460/ajvr.2003.64.216; Davies DB, 2001, EUR BIOPHYS J BIOPHY, V30, P354, DOI 10.1007/s002490100150; Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200; Fredholm BB, 1999, PHARMACOL REV, V51, P83; FRITZSCHE H, 1980, BIOPHYS CHEM, V11, P109, DOI 10.1016/0301-4622(80)85013-7; FRITZSCHE H, 1980, BIOPHYS CHEM, V11, P121, DOI 10.1016/0301-4622(80)85014-9; Froehlich E, 2012, BIOMACROMOLECULES, V13, P282, DOI 10.1021/bm2016515; Gonzalez-Bosquet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014522; Hsu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043792; Johnson IM, 2005, ANAL BIOCHEM, V339, P179, DOI 10.1016/j.ab.2004.09.032; Johnson IM, 2003, J BIOMOL STRUCT DYN, V20, P687, DOI 10.1080/07391102.2003.10506885; Johnson IM, 2003, J BIOMOL STRUCT DYN, V20, P677, DOI 10.1080/07391102.2003.10506884; Johnson RM, 2009, CLIN CHIM ACTA, V400, P74, DOI 10.1016/j.cca.2008.10.006; Kakuyama A, 2001, CURR DRUG METAB, V2, P379, DOI 10.2174/1389200013338270; Kawano Y, 2012, BIOL PHARM BULL, V35, P400, DOI 10.1248/bpb.35.400; Khandelwal G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012433; Kleinstiver BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023804; Kwong A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043994; Lee TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042051; Li FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029664; Lyles MB, 2002, CELL BIOL INT, V26, P145, DOI 10.1006/cbir.2001.0810; Lyles MB, 2001, J MED CHEM, V44, P4650, DOI 10.1021/jm9904708; Lyles MB, 2002, BIOPHYS CHEM, V96, P53, DOI 10.1016/S0301-4622(02)00036-4; Nafisi S, 2008, J MOL STRUCT, V875, P392, DOI 10.1016/j.molstruc.2007.05.010; Natarajan G, 1996, ANAL BIOCHEM, V237, P152, DOI 10.1006/abio.1996.0216; Nunnari G, 2005, VIROLOGY, V335, P177, DOI 10.1016/j.virol.2005.02.015; Ouameur AA, 2003, J BIOMOL STRUCT DYN, V20, P561, DOI 10.1080/07391102.2003.10506872; Sabisz M, 2008, CURR PHARM BIOTECHNO, V9, P325, DOI 10.2174/138920108785161497; SADZUKA Y, 1995, JPN J CANCER RES, V86, P594, DOI 10.1111/j.1349-7006.1995.tb02439.x; SADZUKA Y, 1995, BIOL PHARM BULL, V18, P159; SELBY CP, 1990, P NATL ACAD SCI USA, V87, P3522, DOI 10.1073/pnas.87.9.3522; Sinn B, 2010, MOL CANCER THER, V9, P480, DOI 10.1158/1535-7163.MCT-09-0498; TRAGANOS F, 1991, CANCER RES, V51, P3682; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043872; Zhu HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025020	42	23	24	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50019	10.1371/journal.pone.0050019	http://dx.doi.org/10.1371/journal.pone.0050019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236361	gold, Green Submitted, Green Published			2022-12-27	WOS:000312064100011
J	Rateri, DL; Moorleghen, JJ; Knight, V; Balakrishnan, A; Howatt, DA; Cassis, LA; Daugherty, A				Rateri, Debra L.; Moorleghen, Jessica J.; Knight, Victoria; Balakrishnan, Anju; Howatt, Deborah A.; Cassis, Lisa A.; Daugherty, Alan			Depletion of Endothelial or Smooth Muscle Cell-Specific Angiotensin II Type 1a Receptors Does Not Influence Aortic Aneurysms or Atherosclerosis in LDL Receptor Deficient Mice	PLOS ONE			English	Article							HYPERCHOLESTEROLEMIA-INDUCED ATHEROSCLEROSIS; BONE-MARROW-TRANSPLANTATION; AMERICAN-HEART-ASSOCIATION; CHOLESTEROL-FED RABBITS; BLOOD-PRESSURE; VASCULAR-LESIONS; RENIN INHIBITION; SYSTEM; ATHEROGENESIS; INFUSION	Background: Whole body genetic deletion of AT1a receptors in mice uniformly reduces hypercholesterolemia and angiotensin II-(AngII) induced atherosclerosis and abdominal aortic aneurysms (AAAs). However, the role of AT1a receptor stimulation of principal cell types resident in the arterial wall remains undefined. Therefore, the aim of this study was to determine whether deletion of AT1a receptors in either endothelial cells or smooth muscle cells influences the development of atherosclerosis and AAAs. Methodology/Principal Findings: AT1a receptor floxed mice were developed in an LDL receptor -/- background. To generate endothelial or smooth muscle cell specific deficiency, AT1a receptor floxed mice were bred with mice expressing Cre under the control of either Tie2 or SM22, respectively. Groups of males and females were fed a saturated fat-enriched diet for 3 months to determine effects on atherosclerosis. Deletion of AT1a receptors in either endothelial or smooth muscle cells had no discernible effect on the size of atherosclerotic lesions. We also determined the effect of cell-specific AT1a receptor deficiency on atherosclerosis and AAAs using male mice fed a saturated fat-enriched diet and infused with AngII (1,000 ng/kg/min). Again, deletion of AT1a receptors in either endothelial or smooth muscle cells had no discernible effects on either AngII-induced atherosclerotic lesions or AAAs. Conclusions: Although previous studies have demonstrated whole body AT1a receptor deficiency diminishes atherosclerosis and AAAs, depletion of AT1a receptors in either endothelial or smooth muscle cells did not affect either of these vascular pathologies.	[Rateri, Debra L.; Moorleghen, Jessica J.; Knight, Victoria; Balakrishnan, Anju; Howatt, Deborah A.; Daugherty, Alan] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40506 USA; [Cassis, Lisa A.; Daugherty, Alan] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY USA	University of Kentucky; University of Kentucky	Daugherty, A (corresponding author), Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40506 USA.	Alan.Daugherty@uky.edu	Daugherty, Alan/C-8282-2009	Daugherty, Alan/0000-0003-2093-3775	National Institutes of Health [RO1 HL62846, HL80100]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062846, P01HL080100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health RO1 HL62846 and HL80100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERG G, 1990, J CARDIOVASC PHARM, V15, pS65, DOI 10.1097/00005344-199000155-00010; Barisione C, 2006, J VASC SURG, V44, P372, DOI 10.1016/j.jvs.2006.04.047; Benicky J, 2012, CELL MOL NEUROBIOL; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Cassis LA, 2007, ARTERIOSCL THROM VAS, V27, P380, DOI 10.1161/01.ATV.0000254680.71485.92; Chen XL, 1998, CIRC RES, V83, P952; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; DAUGHERTY A, 1994, ARTERIOSCLER THROMB, V14, P2017, DOI 10.1161/01.ATV.14.12.2017; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2005, METHODS, V36, P129, DOI 10.1016/j.ymeth.2004.11.008; Daugherty A, 2004, CIRCULATION, V110, P3849, DOI 10.1161/01.CIR.0000150540.54220.C4; Daugherty A, 2001, BRIT J PHARMACOL, V134, P865, DOI 10.1038/sj.bjp.0704331; DAUGHERTY A, 2009, J VIS EXP, V1291; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; Deng GG, 2003, CIRC RES, V92, P510, DOI 10.1161/01.RES.0000061571.49375.E1; Eto H, 2008, HYPERTENS RES, V31, P1631, DOI 10.1291/hypres.31.1631; Fukuda D, 2007, ARTERIOSCLER THROMB, V28, P72; Grafe M, 1997, CIRC RES, V81, P804; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Gurley SB, 2011, CELL METAB, V13, P469, DOI 10.1016/j.cmet.2011.03.001; Henriques TA, 2004, ENDOCRINOLOGY, V145, P3866, DOI 10.1210/en.2003-1615; Henriques T, 2008, ARTERIOSCL THROM VAS, V28, P1251, DOI 10.1161/ATVBAHA.107.160382; Imanishi T, 2008, HYPERTENSION, V52, P563, DOI 10.1161/HYPERTENSIONAHA.108.111120; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Kato H, 2008, LAB INVEST, V88, P731, DOI 10.1038/labinvest.2008.42; Kim JA, 1996, BIOCHEM BIOPH RES CO, V226, P862, DOI 10.1006/bbrc.1996.1441; Kogai J, 2008, HYPERTENS RES, V31, P1791, DOI 10.1291/hypres.31.1791; KOWALA MC, 1994, ATHEROSCLEROSIS, V108, P61, DOI 10.1016/0021-9150(94)90037-X; Li J, 1999, ATHEROSCLEROSIS, V143, P315, DOI 10.1016/S0021-9150(98)00309-8; Li Z, 2004, HYPERTENSION, V44, P758, DOI 10.1161/01.HYP.0000145179.44166.0f; Lu Hong, 2007, V139, P77; Lu H, 2008, J CLIN INVEST, V118, P984, DOI 10.1172/JCI32970; Lu H, 2007, CURR DRUG TARGETS, V8, P1181, DOI 10.2174/138945007782403829; Lu H, 2012, CLIN SCI, V123, P531, DOI 10.1042/CS20120097; Lu H, 2012, BRIT J PHARMACOL, V165, P2000, DOI 10.1111/j.1476-5381.2011.01712.x; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Nussberger J, 2008, HYPERTENSION, V51, P1306, DOI 10.1161/HYPERTENSIONAHA.108.110932; Poduri A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048462; Police SB, 2009, ARTERIOSCL THROM VAS, V29, P1458, DOI 10.1161/ATVBAHA.109.192658; Pueyo ME, 2000, ARTERIOSCL THROM VAS, V20, P645, DOI 10.1161/01.ATV.20.3.645; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Schiller NK, 2001, ARTERIOSCL THROM VAS, V21, P1674, DOI 10.1161/hq1001.096724; SCHUH JR, 1993, J CLIN INVEST, V91, P1453, DOI 10.1172/JCI116350; Sparks MA, 2011, HYPERTENSION, V57, P577, DOI 10.1161/HYPERTENSIONAHA.110.165274; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; STARY HC, 1994, ARTERIOSCLER THROMB, V14, P840, DOI 10.1161/01.ATV.14.5.840; Strawn WB, 2000, CIRCULATION, V101, P1586, DOI 10.1161/01.CIR.101.13.1586; Subramanian V, 2010, CIRC RES, V107, P953, DOI 10.1161/CIRCRESAHA.110.219089; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Uchida HA, 2011, ARTERIOSCL THROM VAS, V31, P2845, DOI 10.1161/ATVBAHA.111.234997; Wassmann S, 2004, CIRCULATION, V110, P3062, DOI 10.1161/01.CIR.0000137970.47771.AF; Wolfsgruber W, 2003, P NATL ACAD SCI USA, V100, P13519, DOI 10.1073/pnas.1936024100; Yamamoto S, 2011, ARTERIOSCL THROM VAS, V31, P2856, DOI 10.1161/ATVBAHA.111.237198; Zhang X, 2012, CIRC RES, V110, pE73, DOI 10.1161/CIRCRESAHA.111.253880	58	41	42	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51483	10.1371/journal.pone.0051483	http://dx.doi.org/10.1371/journal.pone.0051483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236507	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100123
J	Jusiak, B; Abulimiti, A; Haelterman, N; Chen, R; Mardon, G				Jusiak, Barbara; Abulimiti, Abuduaini; Haelterman, Nele; Chen, Rui; Mardon, Graeme			MAPK Target Sites of Eyes Absent Are Not Required for Eye Development or Survival in Drosophila	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; RETINAL DETERMINATION GENES; KINASE SIGNALING PATHWAY; SINE-OCULIS; CELL FATE; TRANSCRIPTION FACTORS; CROSS-TALK; EXPRESSION; EYELESS; MELANOGASTER	Eyes absent (Eya) is a highly conserved transcription cofactor and protein phosphatase that plays an essential role in eye development and survival in Drosophila. Ectopic eye induction assays using cDNA transgenes have suggested that mitogen activated protein kinase (MAPK) activates Eya by phosphorylating it on two consensus target sites, S402 and S407, and that this activation potentiates the ability of Eya to drive eye formation. However, this mechanism has never been tested in normal eye development. In the current study, we generated a series of genomic rescue transgenes to investigate how loss- and gain-of-function mutations at these two MAPK target sites within Eya affect Drosophila survival and normal eye formation: eya(+)GR, the wild-type control; eya(SA)GR, which lacks phosphorylation at the two target residues; and eya(SDE)GR, which contains phosphomimetic amino acids at the same two residues. Contrary to the previous studies in ectopic eye development, all eya genomic transgenes tested rescue both eye formation and survival equally effectively. We conclude that, in contrast to ectopic eye formation, MAPK-mediated phosphorylation of Eya on S402 and S407 does not play a role in normal development. This is the first study in Drosophila to evaluate the difference in outcomes between genomic rescue and ectopic cDNA-based overexpression of the same gene. These findings indicate similar genomic rescue strategies may prove useful for re-evaluating other long-standing Drosophila developmental models.	[Jusiak, Barbara; Haelterman, Nele; Chen, Rui; Mardon, Graeme] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Abulimiti, Abuduaini; Chen, Rui] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Abulimiti, Abuduaini; Chen, Rui; Mardon, Graeme] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Program Cell & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Mardon, G (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	gmardon@bcm.edu		/0000-0001-6439-0456	Retina Research Foundation; National Eye Institute [R01 EY011232]; NEI/NIH Core Grant for Vision Research [EY-002520]; NATIONAL EYE INSTITUTE [P30EY002520, R01EY011232] Funding Source: NIH RePORTER	Retina Research Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI/NIH Core Grant for Vision Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the Retina Research Foundation (http://retinaresearchfnd.org/), the National Eye Institute (www.nei.nih.gov) grant R01 EY011232 and the NEI/NIH Core Grant for Vision Research EY-002520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Ahmed M, 2012, DEV CELL, V22, P377, DOI 10.1016/j.devcel.2011.12.006; Anderson AM, 2012, DEVELOPMENT, V139, P991, DOI 10.1242/dev.077255; Bessa J, 2002, GENE DEV, V16, P2415, DOI 10.1101/gad.1009002; Bonini NM, 1998, DEV BIOL, V196, P42, DOI 10.1006/dbio.1997.8845; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Bonini NM, 1997, DEVELOPMENT, V124, P4819; Boyle M, 1997, DEVELOPMENT, V124, P971; Braid LR, 2008, GENETICS, V180, P283, DOI 10.1534/genetics.108.092155; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Chen R, 1999, DEVELOPMENT, V126, P935; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; Curtiss J, 2000, DEVELOPMENT, V127, P1325; Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8; Doroquez DB, 2006, CRIT REV BIOCHEM MOL, V41, P339, DOI 10.1080/10409230600914344; Fabrizio JJ, 2003, DEV BIOL, V258, P117, DOI 10.1016/S0012-1606(03)00127-1; Firth LC, 2009, DEV BIOL, V327, P366, DOI 10.1016/j.ydbio.2008.12.021; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HADORN E, 1965, BROOKHAVEN SYM BIOL, P148; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Halder G, 1998, DEVELOPMENT, V125, P2181; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; HEISENBERG M, 1971, J EXP BIOL, V55, P85; Hsiao FC, 2001, DEV CELL, V1, P51, DOI 10.1016/S1534-5807(01)00011-9; Kango-Singh M, 2003, DEV BIOL, V256, P48, DOI 10.1016/S0012-1606(02)00123-9; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; MAVES L, 1995, DEVELOPMENT, V121, P1263; Miller SJ, 2010, ONCOGENE, V29, P368, DOI 10.1038/onc.2009.360; Morillo SA, 2012, DEV BIOL, V365, P267, DOI 10.1016/j.ydbio.2012.02.030; Mutsuddi M, 2005, GENETICS, V170, P687, DOI 10.1534/genetics.104.039156; Niimi T, 1999, DEVELOPMENT, V126, P2253; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Pappu KS, 2005, DEVELOPMENT, V132, P2895, DOI 10.1242/dev.01869; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pauli T, 2005, DEVELOPMENT, V132, P2771, DOI 10.1242/dev.01841; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Rebay I, 2005, TRENDS GENET, V21, P163, DOI 10.1016/j.tig.2005.01.005; Rebay I, 2000, GENETICS, V154, P695; Robin TP, 2012, MOL CANC RES MCR; Salzer CL, 2010, GENETICS, V184, P185, DOI 10.1534/genetics.109.110122; Salzer CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008510; Shen WP, 1997, DEVELOPMENT, V124, P45; Silver SJ, 2003, MOL CELL BIOL, V23, P5989, DOI 10.1128/MCB.23.17.5989-5999.2003; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Weasner BM, 2009, DEV BIOL, V334, P492, DOI 10.1016/j.ydbio.2009.04.027; Weasner B, 2007, DEV BIOL, V303, P756, DOI 10.1016/j.ydbio.2006.10.040; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Xiong WJ, 2009, DEV CELL, V16, P271, DOI 10.1016/j.devcel.2008.12.005; Zhang L, 2005, CANCER RES, V65, P925; Zimmerman JE, 2000, GENETICS, V154, P237	58	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50776	10.1371/journal.pone.0050776	http://dx.doi.org/10.1371/journal.pone.0050776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251383	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200038
J	Hoekzema, E; Carmona, S; Ramos-Quiroga, JA; Fernandez, VR; Picado, M; Bosch, R; Soliva, JC; Rovira, M; Vives, Y; Bulbena, A; Tobena, A; Casas, M; Vilarroya, O				Hoekzema, Elseline; Carmona, Susana; Antoni Ramos-Quiroga, J.; Richarte Fernandez, Vanesa; Picado, Marisol; Bosch, Rosa; Carlos Soliva, Juan; Rovira, Mariana; Vives, Yolanda; Bulbena, Antonio; Tobena, Adolf; Casas, Miguel; Vilarroya, Oscar			Laminar Thickness Alterations in the Fronto-Parietal Cortical Mantle of Patients with Attention-Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; AUTOMATED 3-D EXTRACTION; NEURAL MECHANISMS; VISUAL-ATTENTION; MATTER DEFICITS; CEREBRAL-CORTEX; FOLLOW-UP; CHILDREN; ADULTS; BRAIN	Although Attention-Deficit/Hyperactivity Disorder (ADHD) was initially regarded as a disorder exclusive to childhood, nowadays its prevalence in adulthood is well established. The development of novel techniques for quantifying the thickness of the cerebral mantle allows the further exploration of the neuroanatomical profiles underlying the child and adult form of the disorder. To examine the cortical mantle in children and adults with ADHD, we applied a vertex-wise analysis of cortical thickness to anatomical brain MRI scans acquired from children with (n = 43) and without ADHD (n = 41), as well as a group of adult neurotypical individuals (n = 31), adult patients with a history of stimulant treatment (n = 31) and medication-naive adults with ADHD (n = 24). We observed several clusters of reduced laminar cortical thickness in ADHD patients in comparison to neurotypical individuals. These differences were primarily located in the dorsal attention network, including the bilateral inferior and superior parietal cortex and a section of the frontal cortex (centered on the superior frontal and precentral gyrus bilaterally). Further laminar thickness deficits were observed in the bilateral orbitofrontal cortex and medial occipital cortex. The deficits in the cortical surface were especially pronounced in the child sample, while adult patients showed a more typical laminar thickness across the cerebral mantle. These findings show that the neuroanatomical profile of ADHD, especially the childhood form of the disorder, involves robust alterations in the cortical mantle, which are most prominent in brain regions subserving attentional processing. Citation: Hoekzema E, Carmona S, Ramos-Quiroga JA, Fernandez VR, Picado M, et al. (2012) Laminar Thickness Alterations in the Fronto-Parietal Cortical Mantle of Patients with Attention-Deficit/Hyperactivity Disorder. PLoS ONE 7(12): e48286. doi:10.1371/journal.pone.0048286	[Hoekzema, Elseline; Carmona, Susana; Picado, Marisol; Carlos Soliva, Juan; Tobena, Adolf; Vilarroya, Oscar] Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, Unitat Recerca Neurociencia Cognit, Bellaterra, Barcelona, Spain; [Hoekzema, Elseline; Carmona, Susana; Picado, Marisol; Carlos Soliva, Juan; Vilarroya, Oscar] Fundacio IMIM, Grp Recerca Neuroimatge, Barcelona, Spain; [Carmona, Susana] Harvard Univ, Harvard Social Cognit & Affect Neurosci Lab, Cambridge, MA 02138 USA; [Antoni Ramos-Quiroga, J.; Richarte Fernandez, Vanesa; Bosch, Rosa; Casas, Miguel] Hosp Univ Vall dHebron, CIBERSAM, Dept Psychiat, Barcelona, Spain; [Rovira, Mariana] CRC Corp Sanitaria, Barcelona, Spain; [Vives, Yolanda] Univ Autonoma Barcelona, IFAE, Inst Fis Altes Energies, Bellaterra, Barcelona, Spain; [Bulbena, Antonio] Hosp Mar, Inst Neuropsiquiat & Adicc, Barcelona, Spain	Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Harvard University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institute for High Energy Physics (IFAE); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Hoekzema, E (corresponding author), Univ Autonoma Barcelona, Dept Psiquiatria & Med Legal, Unitat Recerca Neurociencia Cognit, Bellaterra, Barcelona, Spain.	hoekzema@gmail.com	tobena, adolf/G-1032-2010; Vilarroya, Oscar/AAH-3283-2021; vilarroya, oscar/K-7021-2013; Vives-Gilabert, Yolanda/ABB-7461-2021; Bulbena, Antonio/AAG-5411-2019	Vilarroya, Oscar/0000-0001-8285-5624; Bulbena, Antonio/0000-0003-2404-2478; Tobena, Adolf/0000-0001-6137-0660; Casas Brugue, Miquel/0000-0003-3496-8522; Hoekzema, Elseline/0000-0001-5814-8647; Carmona, Susanna/0000-0001-5853-6527; Ramos-Quiroga, Josep Antoni/0000-0003-1622-0350; Vives-Gilabert, Yolanda/0000-0002-3744-5893; Bosch, Rosa/0000-0002-7596-183X	Ministerio de Ciencia e Innovacion research grant from the Centro para el Desarrollo Tecnologico Industrial [SAF2009-10901]; Ministerio de Educacion y Ciencia (Spanish Government)	Ministerio de Ciencia e Innovacion research grant from the Centro para el Desarrollo Tecnologico Industrial(Ministry of Science and Innovation, Spain (MICINN)); Ministerio de Educacion y Ciencia (Spanish Government)(Spanish Government)	The authors want to thank TDAH Catalunya for their collaboration and for referring patients for their study. This work was supported by the Ministerio de Ciencia e Innovacion research grant (SAF2009-10901) from the Centro para el Desarrollo Tecnologico Industrial. EH received a PhD grant and SC a postdoctoral grant from the Ministerio de Educacion y Ciencia (Spanish Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LG, 2010, J PSYCHIATR RES, V44, P1214, DOI 10.1016/j.jpsychires.2010.04.026; Almeida Montes LG, 2012, J ATTEN DISORD; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Biederman J, 2011, J PSYCHIATR RES, V45, P150, DOI 10.1016/j.jpsychires.2010.06.009; Carmona S, 2005, NEUROSCI LETT, V389, P88, DOI 10.1016/j.neulet.2005.07.020; Carmona S, 2011, HUM BRAIN MAPP; Carmona S, 2009, BIOL PSYCHIAT, V66, P972, DOI 10.1016/j.biopsych.2009.05.013; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 1998, PHILOS T ROY SOC B, V353, P1353, DOI 10.1098/rstb.1998.0289; Duerden EG, 2012, BRAIN RES, V1445, P82, DOI 10.1016/j.brainres.2012.01.034; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hesslinger B, 2002, NEUROSCI LETT, V328, P319, DOI 10.1016/S0304-3940(02)00554-2; Hoekzema E, 2012, BRAIN STRUC IN PRESS; Hoekzema E, 2012, INDEPENDENT IN PRESS; Hoekzema E, 2011, HUM BRAIN MAPP, V32, P1741, DOI 10.1002/hbm.21143; Hoekzema E, 2010, HUM BRAIN MAPP, V31, P1942, DOI 10.1002/hbm.20988; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; HYND GW, 1990, ARCH NEUROL-CHICAGO, V47, P919, DOI 10.1001/archneur.1990.00530080107018; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kobel M, 2010, PSYCHIAT RES-NEUROIM, V183, P230, DOI 10.1016/j.pscychresns.2010.03.010; Konrad K, 2005, NEUROIMAGE, V28, P429, DOI 10.1016/j.neuroimage.2005.06.065; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; Narr KL, 2009, J AM ACAD CHILD PSY, V48, P1014, DOI 10.1097/CHI.0b013e3181b395c0; Overmeyer S, 2001, PSYCHOL MED, V31, P1425, DOI 10.1017/S0033291701004706; Proal E, 2011, ARCH GEN PSYCHIAT, V68, P1122, DOI 10.1001/archgenpsychiatry.2011.117; Qiu MG, 2011, BRAIN TOPOGR, V24, P243, DOI 10.1007/s10548-010-0168-4; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Sasayama D, 2010, PSYCHIAT CLIN NEUROS, V64, P394, DOI 10.1111/j.1440-1819.2010.02102.x; Seidman LJ, 2006, BIOL PSYCHIAT, V60, P1071, DOI 10.1016/j.biopsych.2006.04.031; Seidman LJ, 2011, BIOL PSYCHIAT, V69, P857, DOI 10.1016/j.biopsych.2010.09.053; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Shaw P, 2007, ARCH GEN PSYCHIAT, V64, P921, DOI 10.1001/archpsyc.64.8.921; Shaw P, 2011, AM J PSYCHIAT, V168, P143, DOI 10.1176/appi.ajp.2010.10030385; Shaw P, 2009, ARCH GEN PSYCHIAT, V66, P888, DOI 10.1001/archgenpsychiatry.2009.103; Shaw P, 2009, AM J PSYCHIAT, V166, P58, DOI 10.1176/appi.ajp.2008.08050781; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; Talairach J., 1988, COPLANAR STEREOTAXIC; Tremols V, 2008, PSYCHIAT RES-NEUROIM, V163, P270, DOI 10.1016/j.pscychresns.2007.04.017; Woldorff MG, 2004, J COGNITIVE NEUROSCI, V16, P149, DOI 10.1162/089892904322755638; Wolosin SM, 2009, HUM BRAIN MAPP, V30, P175, DOI 10.1002/hbm.20496	51	26	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e48286	10.1371/journal.pone.0048286	http://dx.doi.org/10.1371/journal.pone.0048286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239964	gold, Green Published			2022-12-27	WOS:000312290800003
J	Kim, JM; Stewart, R; Park, MS; Kang, HJ; Kim, SW; Shin, IS; Kim, HR; Shin, MG; Cho, KH; Yoon, JS				Kim, Jae-Min; Stewart, Robert; Park, Man-Seok; Kang, Hee-Ju; Kim, Sung-Wan; Shin, Il-Seon; Kim, Hye-Ran; Shin, Myung-Geun; Cho, Ki-Hyun; Yoon, Jin-Sang			Associations of BDNF Genotype and Promoter Methylation with Acute and Long-Term Stroke Outcomes in an East Asian Cohort	PLOS ONE			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; FORCED ARM USE; NEUROTROPHIC FACTOR; VAL66MET POLYMORPHISM; EPIGENETIC REGULATION; MET ALLELE; RAT-BRAIN; RECOVERY; GENE; DEPRESSION	Background: Brain derived neurotrophic factor (BDNF) has been shown to play an important role in poststroke recovery. BDNF secretion is influenced by genetic and epigenetic profiles. This study aimed to investigate whether BDNF val66met polymorphism and promoter methylation status were associated with outcomes at two weeks and one year after stroke. Methods and Findings: A total of 286 patients were evaluated at the time of admission and two weeks after stroke, and 222 (78%) were followed one year later in order to evaluate consequences of stroke at both acute and chronic stages. Stroke outcomes were dichotomised into good and poor by the modified Rankin Scale. Stroke severity (National Institutes of Health Stroke Scale), physical disability (Barthel Index), and cognitive function (Mini-Mental State Examination) were measured. Associations of BDNF genotype and methylation status on stroke outcomes and assessment scale scores were investigated using logistic regression, repeated measures ANOVA and partial correlation tests. BDNF val66met polymorphism was independently associated with poor outcome at 2 weeks and at 1 year, and with worsening physical disability and cognitive function over that period. Higher BDNF promoter methylation status was independently associated with worse outcomes at 1 year, and with the worsening of physical disability and cognitive function. No significant genotype-methylation interactions were found. Conclusions: A role for BDNF in poststroke recovery was supported, and clinical utility of BDNF genetic and epigenetic profile as prognostic biomarkers and a target for drug development was suggested.	[Kim, Jae-Min; Kang, Hee-Ju; Kim, Sung-Wan; Shin, Il-Seon; Yoon, Jin-Sang] Chonnam Natl Univ, Sch Med, Dept Psychiat, Kwangju, South Korea; [Stewart, Robert] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Park, Man-Seok; Cho, Ki-Hyun] Chonnam Natl Univ, Sch Med, Dept Neurol, Kwangju, South Korea; [Kim, Hye-Ran] Chonnam Natl Univ, Sch Med, Brain Korea Project 21, Kwangju, South Korea; [Kim, Hye-Ran] Chonnam Natl Univ, Sch Med, Ctr Biomed Human Resources, Kwangju, South Korea; [Shin, Myung-Geun] Chonnam Natl Univ, Sch Med, Dept Lab Med, Kwangju, South Korea	Chonnam National University; University of London; King's College London; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University	Kim, JM (corresponding author), Chonnam Natl Univ, Sch Med, Dept Psychiat, Kwangju, South Korea.	jmkim@chonnam.ac.kr	KIM, Jae-Min/S-7637-2019; Stewart, Robert/B-1667-2010	Stewart, Robert/0000-0002-4435-6397	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0087344]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0087344). The funders had no role in study desing, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bejot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029405; Berger C, 2004, EXP NEUROL, V185, P305, DOI 10.1016/j.expneurol.2003.10.008; Cramer SC, 2012, EUR J NEUROL, V19, P718, DOI 10.1111/j.1468-1331.2011.03615.x; Devlin AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012201; Di Lazzaro V, 2007, NEUROSCI LETT, V422, P128, DOI 10.1016/j.neulet.2007.06.001; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gomez-Pinilla F, 2011, EUR J NEUROSCI, V33, P383, DOI 10.1111/j.1460-9568.2010.07508.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Kasner SE, 1999, STROKE, V30, P1534, DOI 10.1161/01.STR.30.8.1534; Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020; Kim JM, 2012, J AFFECT DISORDERS, V136, P833, DOI 10.1016/j.jad.2011.09.029; Kunugi H, 2004, BIOL PSYCHIAT, V56, P376, DOI 10.1016/j.biopsych.2004.06.017; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; MAHONEY F I, 1965, Md State Med J, V14, P61; Manso H, 2012, EUR J NEUROL, V19, P1151, DOI 10.1111/j.1468-1331.2011.03625.x; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Muller HD, 2008, STROKE, V39, P1012, DOI 10.1161/STROKEAHA.107.495069; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Qin LY, 2011, J NEUROSCI, V31, P775, DOI 10.1523/JNEUROSCI.4547-10.2011; Rickhag M, 2007, BRAIN RES, V1151, P203, DOI 10.1016/j.brainres.2007.03.005; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Siironen J, 2007, STROKE, V38, P2858, DOI 10.1161/STROKEAHA.107.485441; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vilkki J, 2008, NEUROSURGERY, V63, P198, DOI 10.1227/01.NEU.0000320382.21577.8E	33	54	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51280	10.1371/journal.pone.0051280	http://dx.doi.org/10.1371/journal.pone.0051280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240009	Green Published, gold			2022-12-27	WOS:000312290800045
J	Saxena, A; Bjorkbacka, H; Strom, A; Rattik, S; Berg, KE; Gomez, MF; Fredrikson, GN; Nilsson, J; Hultgardh-Nilsson, A				Saxena, Amit; Bjorkbacka, Harry; Strom, Asa; Rattik, Sara; Berg, Katarina E.; Gomez, Maria F.; Fredrikson, Gunilla Nordin; Nilsson, Jan; Hultgardh-Nilsson, Anna			Mobilization of Regulatory T Cells in Response to Carotid Injury Does Not Influence Subsequent Neointima Formation	PLOS ONE			English	Article							VASCULAR INJURY; IMMUNE-RESPONSES; ARTERIAL INJURY; MICE; ATHEROSCLEROSIS; INVOLVEMENT; LYMPHOCYTES; DEFICIENCY	Aim: T cells have been attributed an important role in modulating repair responses following vascular injury. The aim of this study was to investigate the role of different T cell subsets in this context. Methods and Results: A non-obstructive collar was introduced to inflict carotid artery injury in mice and subsequent activation of immune cells in draining lymph nodes and spleen were studied by flow cytometry. Carotid artery injury of wild type mice was associated with mobilization of both Th1 type CD4(+)IFN gamma(+) and regulatory CD4(+)CD25(+)FoxP3(+) T cells in draining lymph nodes. Studies using FoxP3-green fluorescent protein (GFP) transgenic C57/Bl6 mice demonstrated scattered presence of regulatory T cells in the adventitial tissue of injured arteries as well as a massive emigration of regulatory T cells from the spleen in response to carotid injury. However, deletion of antigen presentation to CD4+ T cells (H2(0) mice), as well as deletion of regulatory T cells (through treatment with blocking anti-CD25 antibodies), did not affect neointima formation. Also deletion of antigen presentation to CD8(+) T cells (Tap1(0) mice) was without effect on carotid collar-induced neointima formation. Conclusion: The results demonstrate that carotid artery injury is associated with mobilization of regulatory T cells. Depletion of regulatory T cells does not, however, influence the subsequent repair processes leading to the formation of a neointima. The results also demonstrate that lack of CD8(+) T cells does not influence neointima formation in presence of functional CD4(+) T cells and B cells.	[Saxena, Amit; Bjorkbacka, Harry; Rattik, Sara; Berg, Katarina E.; Gomez, Maria F.; Fredrikson, Gunilla Nordin; Nilsson, Jan] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden; [Strom, Asa; Hultgardh-Nilsson, Anna] Lund Univ, Dept Expt Med, Lund, Sweden; [Fredrikson, Gunilla Nordin] Malmo Univ, Dept Hlth & Soc, Malmo, Sweden	Lund University; Lund University; Malmo University	Nilsson, J (corresponding author), Lund Univ, Dept Clin Sci Malmo, Lund, Sweden.	jan.nilsson@med.lu.se	Gomez, Maria F/D-3696-2014; Björkbacka, Harry/I-7157-2019	Gomez, Maria F/0000-0001-6210-3142; Björkbacka, Harry/0000-0003-3918-0857	Swedish Heart Lung Foundation; Swedish Research Council; Albert Pahlsson Foundation; Crafoord Foundation; Magnus Bergvall Foundation; Lars Hierta Foundation; Malmo University Hospital Foundation; Swedish Society of Medicine; Thelma Zoega Foundation; Swedish Strategic research Foundation; Vascular Wall Program, Lund University	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Albert Pahlsson Foundation; Crafoord Foundation; Magnus Bergvall Foundation; Lars Hierta Foundation; Malmo University Hospital Foundation; Swedish Society of Medicine; Thelma Zoega Foundation; Swedish Strategic research Foundation(Swedish Foundation for Strategic Research); Vascular Wall Program, Lund University	This work was supported by grants from the Swedish Heart Lung Foundation, The Swedish Research Council, The Albert Pahlsson Foundation, The Crafoord Foundation, The Magnus Bergvall Foundation, The Lars Hierta Foundation, The Malmo University Hospital Foundation, The Swedish Society of Medicine, The Thelma Zoega Foundation and the Swedish Strategic research Foundation. Amit Saxena was supported by the Vascular Wall Program, Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Bienvenu B, 2005, J IMMUNOL, V175, P246, DOI 10.4049/jimmunol.175.1.246; Cercek B, 1997, ATHEROSCLEROSIS, V131, P59, DOI 10.1016/S0021-9150(96)06767-6; Dimayuga P, 2002, ARTERIOSCL THROM VAS, V22, P644, DOI 10.1161/01.ATV.0000012455.62765.BF; Dimayuga PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020214; Dimayuga PC, 2010, CURR OPIN LIPIDOL, V21, P416, DOI 10.1097/MOL.0b013e32833cacbe; Dimayuga PC, 2005, ARTERIOSCL THROM VAS, V25, P2528, DOI 10.1161/01.ATV.0000190606.41121.00; Gotsman I, 2006, CIRCULATION, V114, P2047, DOI 10.1161/CIRCULATIONAHA.106.633263; HANSSON GK, 1991, P NATL ACAD SCI USA, V88, P10530, DOI 10.1073/pnas.88.23.10530; Hollestelle SCG, 2004, CIRCULATION, V109, P393, DOI 10.1161/01.CIR.0000109140.51366.72; Kolbus D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033932; Kolbus D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-58; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; Oguchi S, 2000, ARTERIOSCL THROM VAS, V20, P1729, DOI 10.1161/01.ATV.20.7.1729; Rectenwald JE, 2000, CIRCULATION, V102, P1697, DOI 10.1161/01.CIR.102.14.1697; Sandberg JK, 1996, EUR J IMMUNOL, V26, P288, DOI 10.1002/eji.1830260203; Saxena A, 2011, CARDIOVASC RES, V91, P350, DOI 10.1093/cvr/cvr075; Stroem A, 2007, CIRC RES, V101, pE83, DOI 10.1161/CIRCRESAHA.107.160705; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Xu QB, 2004, AM J PATHOL, V165, P1, DOI 10.1016/S0002-9440(10)63270-1; Zernecke A, 2006, BLOOD, V107, P4240, DOI 10.1182/blood-2005-09-3922	21	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51556	10.1371/journal.pone.0051556	http://dx.doi.org/10.1371/journal.pone.0051556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240042	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800078
J	Yuan, CZ; Li, X; Yan, S; Yang, QF; Liu, XY; Kong, BH				Yuan, Cunzhong; Li, Xiao; Yan, Shi; Yang, Qifeng; Liu, Xiaoyan; Kong, Beihua			The MTDH (-470G > A) Polymorphism Is Associated with Ovarian Cancer Susceptibility	PLOS ONE			English	Article							ASTROCYTE ELEVATED GENE-1; BREAST-CANCER; GERMLINE MUTATIONS; CELL CARCINOMA; AEG-1; OVEREXPRESSION; PROGRESSION; EXPRESSION; PATHOGENESIS; METASTASIS	MTDH(metadherin), an important oncogene that is widely overexpressed in various cancers, is a potential biomarker of tumor malignancy. Variants in MTDH have been associated with susceptibility to breast cancer. However, no studies assessing MTDH gene polymorphisms and their potential relationship to ovarian cancer susceptibility have been reported. Thus, we investigated the association of MTDH (-470G>A) polymorphism with ovarian cancer development in 145 ovarian cancer patients and 254 matched control subjects, using sequence analysis. We found that the MTDH (-470G>A) polymorphism was statistically correlated with ovarian cancer risk (under the additive genetic model, GG vs. GA vs AA, P = 0.042). Compared with genotypes containing the G allele (GG and GA), the AA genotype may decrease the risk of ovarian cancer (P = 0.0198, OR = 0.33, 95% CI [0.12 similar to 0.78]). Compared with the G allele, the A allele is protective against ovarian cancer risk (P = 0.01756, OR = 0.66, 95% CI [0.46 similar to 0.93]). Furthermore, a statistically significant association between the GG and GA+AA genotypes and the clinical stage was observed (P = 0.038). These data suggest that MTDH (-470G>A) could be a useful molecular marker for assessing ovarian cancer risk and for predicting ovarian cancer patient prognosis.	[Yuan, Cunzhong; Li, Xiao; Yan, Shi; Liu, Xiaoyan; Kong, Beihua] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan, Shandong, Peoples R China; [Yuan, Cunzhong; Li, Xiao; Yan, Shi; Liu, Xiaoyan; Kong, Beihua] Shandong Univ, Qilu Hosp, Gynecol Oncol Key Lib Shandong Prov, Jinan, Shandong, Peoples R China; [Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Yuan, CZ (corresponding author), Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan, Shandong, Peoples R China.	yuancunzhong@126.com; kongbeihua@yahoo.com.cn	yang, qiang/GYJ-0971-2022	Yuan, Cunzhong/0000-0002-8785-2139; Li, Xiao/0000-0001-9504-605X; Yang, Qifeng/0000-0003-0576-8513	National Natural Science Foundation of China [81001166, 30872738]; Natural Science Foundation of Shandong Province [ZR2010HQ050]; Foundation of Shandong Public Health Department [2009Q2012]; China Postdoctoral Science Foundation [201104636, 20100471551]; Independent Innovation Foundation of Shandong University [2012TS142]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Foundation of Shandong Public Health Department; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Independent Innovation Foundation of Shandong University	This work was supported by the National Natural Science Foundation of China (81001166, 30872738), Natural Science Foundation of Shandong Province (ZR2010HQ050), Foundation of Shandong Public Health Department (2009Q2012), China Postdoctoral Science Foundation (201104636, 20100471551), Independent Innovation Foundation of Shandong University (2012TS142). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Braem MGM, 2011, BBA-REV CANCER, V1816, P132, DOI 10.1016/j.bbcan.2011.05.002; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Chen W, 2010, NEOPLASMA, V57, P522, DOI 10.4149/neo_2010_06_522; Emdad L, 2009, P NATL ACAD SCI USA, V106, P21300, DOI 10.1073/pnas.0910936106; Gnosa S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-109; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Lee SG, 2009, ONCOGENE, V28, P2476, DOI 10.1038/onc.2009.93; Li C, 2012, HISTOPATHOLOGY, V60, P953, DOI 10.1111/j.1365-2559.2012.04182.x; Li C, 2011, INT J GYNECOL CANCER, V21, P602, DOI 10.1097/IGC.0b013e3182145561; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Liu XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017582; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Ma XD, 2011, GYNECOL ONCOL, V122, P554, DOI 10.1016/j.ygyno.2011.05.031; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Meng FL, 2011, INT J GYNECOL PATHOL, V30, P145, DOI 10.1097/PGP.0b013e3181ffd2f7; Pelttari LM, 2011, HUM MOL GENET, V20, P3278, DOI 10.1093/hmg/ddr229; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; Ramus SJ, 2012, HUM MUTAT; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Song LB, 2009, J PATHOL, V219, P317, DOI 10.1002/path.2595; Srivastava J, 2012, HEPATOLOGY; Thirkettle HJ, 2009, CLIN CANCER RES, V15, P3003, DOI 10.1158/1078-0432.CCR-08-2046; Xu JB, 2011, MED ONCOL, V28, P455, DOI 10.1007/s12032-010-9475-6; Yin JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025559; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yu CP, 2009, CARCINOGENESIS, V30, P894, DOI 10.1093/carcin/bgp064; Yuan C, 2008, PROTEOMICS, V8, P2230, DOI 10.1002/pmic.200700760; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhang N, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-48; Zhao Y, 2012, ONCOL REP, V27, P1520, DOI 10.3892/or.2012.1692; Zhao YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029363	36	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51561	10.1371/journal.pone.0051561	http://dx.doi.org/10.1371/journal.pone.0051561			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240043	gold, Green Published, Green Submitted			2022-12-27	WOS:000312290800079
J	Fernando, P; Leimgruber, P; Prasad, T; Pastorini, J				Fernando, Prithiviraj; Leimgruber, Peter; Prasad, Tharaka; Pastorini, Jennifer			Problem-Elephant Translocation: Translocating the Problem and the Elephant?	PLOS ONE			English	Article							ASIAN ELEPHANTS; AFRICAN ELEPHANTS; PROTECTED AREA; MANAGEMENT; MOVEMENTS; BEHAVIOR; SELECTION; CONFLICT	Human-elephant conflict (HEC) threatens the survival of endangered Asian elephants (Elephas maximus). Translocating "problem-elephants" is an important HEC mitigation and elephant conservation strategy across elephant range, with hundreds translocated annually. In the first comprehensive assessment of elephant translocation, we monitored 16 translocations in Sri Lanka with GPS collars. All translocated elephants were released into national parks. Two were killed within the parks where they were released, while all the others left those parks. Translocated elephants showed variable responses: "homers" returned to the capture site, "wanderers" ranged widely, and "settlers" established home ranges in new areas soon after release. Translocation caused wider propagation and intensification of HEC, and increased elephant mortality. We conclude that translocation defeats both HEC mitigation and elephant conservation goals.	[Fernando, Prithiviraj; Pastorini, Jennifer] Ctr Conservat & Res, Rajagiriya, Sri Lanka; [Leimgruber, Peter] Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Prasad, Tharaka] Dept Wildlife Conservat, Battaramulla, Sri Lanka; [Pastorini, Jennifer] Univ Zurich, Inst Anthropol, Zurich, Switzerland	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Zurich	Pastorini, J (corresponding author), Ctr Conservat & Res, Rajagiriya, Sri Lanka.	jenny@aim.uzh.ch	Pastorini, Jennifer/A-9959-2012; Leimgruber, Peter/O-1304-2015; Fernando, Prithiviraj/I-8238-2012	Pastorini, Jennifer/0000-0001-5883-0208; Leimgruber, Peter/0000-0002-3682-0153; Fernando, Prithiviraj/0000-0001-6968-4189	U.S. Fish and Wildlife Service; Asian Elephant Conservation Fund; Alexander Abraham Foundation; Sidney S. Byers Charitable Trust; Eco Health Alliance; Friends of the National Zoo (FONZ); Circus Knie; Smithsonian Women's Committee; Vontobel Stiftung; PAM-WCP Project of the DWC	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Asian Elephant Conservation Fund; Alexander Abraham Foundation; Sidney S. Byers Charitable Trust; Eco Health Alliance; Friends of the National Zoo (FONZ); Circus Knie; Smithsonian Women's Committee; Vontobel Stiftung; PAM-WCP Project of the DWC	This work was funded by the U.S. Fish and Wildlife Service, Asian Elephant Conservation Fund, Alexander Abraham Foundation, Sidney S. Byers Charitable Trust, Eco Health Alliance, Friends of the National Zoo (FONZ), Circus Knie, Smithsonian Women's Committee, Vontobel Stiftung, and the PAM-WCP Project of the DWC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TJ, 1986, T NE SECT WILDL SOC, V43, P64; Arivazhagan Chelliya, 2008, Gajah, V29, P11; Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Banks J., 1979, Loris, V15, P113; Baskaran N, 1996, RANGING BEHAV ASIAN, V15, P41; Benson JF, 2007, J WILDLIFE MANAGE, V71, P2393, DOI 10.2193/2006-142; BOSHOFF AF, 1988, S AFR J WILDL RES, V18, P38; Bradley EH, 2005, CONSERV BIOL, V19, P1498, DOI 10.1111/j.1523-1739.2005.00102.x; Bradshaw GA, 2005, NATURE, V433, P807, DOI 10.1038/433807a; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Butler H, 2005, WILDLIFE RES, V32, P165, DOI 10.1071/WR04020; Chiyo PI, 2011, ANIM BEHAV, V81, P1093, DOI 10.1016/j.anbehav.2011.02.013; Craven S, 1998, WILDLIFE SOC B, V26, P171; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; EBERHARDT L E, 1979, Southwestern Naturalist, V24, P705, DOI 10.2307/3670543; Ekanayaka Sampath K.K., 2011, Gajah, V34, P20; Fernando P, 2000, BEHAV ECOL SOCIOBIOL, V48, P84, DOI 10.1007/s002650000218; FERNANDO P, 1997, SRI LANKA NATURE, V1, P4; Fernando P., 2011, LORIS, V25, P32; Fernando P, 2008, MAMM BIOL, V73, P2, DOI 10.1016/j.mambio.2007.07.007; Fernando Prithiviraj, 2011, P151; Fernando Prithiviraj, 2011, Gajah, V35, P93; Fernando Prithiviraj, 2011, Gajah, V35, P15; FRITTS SH, 1984, J WILDLIFE MANAGE, V48, P709, DOI 10.2307/3801418; Garai Marion E., 2001, Pachyderm, V31, P52; Goodrich JM, 2005, ORYX, V39, P454, DOI 10.1017/S0030605305001146; Holevinski RA, 2006, WILDLIFE SOC B, V34, P845, DOI 10.2193/0091-7648(2006)34[845:CHOTNC]2.0.CO;2; IUCN, 1998, IUCN GUID REINTR; Lahiri-Choudhury D. K., 1993, Oryx, V27, P53; LEHENAFF D, 1989, CAN J ZOOL, V67, P1102; Leimgruber P, 2003, ANIM CONSERV, V6, P347, DOI 10.1017/S1367943003003421; Lenain DM, 2001, J ARID ENVIRON, V48, P205, DOI 10.1006/jare.2000.0754; Lin L, 2008, ACTA THERIOL, V53, P365, DOI 10.1007/BF03195197; Linnell JDC, 1997, BIODIVERS CONSERV, V6, P1245, DOI 10.1023/B:BIOC.0000034011.05412.cd; Loredo-Prendeville I, 1994, P 16 VERT PEST C; Loveridge Andrew J., 2010, P161; Massei G, 2010, WILDLIFE RES, V37, P428, DOI 10.1071/WR08179; MILLER SD, 1982, J WILDLIFE MANAGE, V46, P869, DOI 10.2307/3808219; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Niskanen L., 2003, IUCN SSC AFESG GUIDE; O'Donnell MA, 2006, WILDLIFE SOC B, V34, P366, DOI 10.2193/0091-7648(2006)34[366:DSSOLF]2.0.CO;2; Oliver GW, 1998, MAR MAMMAL SCI, V14, P245, DOI 10.1111/j.1748-7692.1998.tb00714.x; PHILLIPS JB, 1995, ANIM BEHAV, V50, P855, DOI 10.1016/0003-3472(95)80146-4; Pinter-Wollman N, 2009, BEHAVIOUR, V146, P1171, DOI 10.1163/156853909X413105; Read MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000949; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Rogers L.L., 1988, P76; ROGERS LL, 1986, WILDLIFE SOC B, V14, P76; Roy Mukti, 2010, Gajah, V33, P8; Ruth TK, 1998, J WILDLIFE MANAGE, V62, P1264, DOI 10.2307/3801990; Saaban Salman, 2011, Gajah, V35, P67; Sandell M., 1989, P164; Santiapillai C., 1990, ASIAN ELEPHANT ACTIO; Shier DM, 2012, CONSERV BIOL, V26, P116, DOI 10.1111/j.1523-1739.2011.01748.x; Short J, 2009, AUSTR ANIMAL WELFARE; Slotow R., 2004, Koedoe, V47, P91; Slotow R, 2008, ELEPHANT MANAGEMENT; Stuwe M, 1998, ORYX, V32, P68, DOI 10.1046/j.1365-3008.1998.00019.x; SUKUMAR R, 1991, BIOL CONSERV, V55, P93, DOI 10.1016/0006-3207(91)90007-V; Sukumar R., 2012, FIELD KEY ELEPHANT P; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; Sullivan BK, 2004, BIOL CONSERV, V117, P235, DOI 10.1016/j.biocon.2003.07.002; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Weilenmann M, 2010, WILDLIFE RES, V37, P702, DOI 10.1071/WR10013; Wolf CM, 1996, CONSERV BIOL, V10, P1142, DOI 10.1046/j.1523-1739.1996.10041142.x	65	48	50	8	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50917	10.1371/journal.pone.0050917	http://dx.doi.org/10.1371/journal.pone.0050917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236404	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000312064100042
J	Topel, M; Antonelli, A; Yesson, C; Eriksen, B				Topel, Mats; Antonelli, Alexandre; Yesson, Chris; Eriksen, Bente			Past Climate Change and Plant Evolution in Western North America: A Case Study in Rosaceae	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACERS; EVENING PRIMROSES OENOTHERA; PHYLOGENY; CLASSIFICATION; DNA; PHYLOGEOGRAPHY; CONSERVATISM; SEQUENCES; HISTORY; MODELS	Species in the ivesioid clade of Potentilla (Rosaceae) are endemic to western North America, an area that underwent widespread aridification during the global temperature decrease following the Mid-Miocene Climatic Optimum. Several morphological features interpreted as adaptations to drought are found in the clade, and many species occupy extremely dry habitats. Recent phylogenetic analyses have shown that the sister group of this clade is Potentilla section Rivales, a group with distinct moist habitat preferences. This has led to the hypothesis that the ivesioids (genera Ivesia, Horkelia and Horkeliella) diversified in response to the late Tertiary aridification of western North America. We used phyloclimatic modeling and a fossil-calibrated dated phylogeny of the family Rosaceae to investigate the evolution of the ivesioid clade. We have combined occurrence-and climate data from extant species, and used ancestral state reconstruction to model past climate preferences. These models have been projected into paleo-climatic scenarios in order to identify areas where the ivesioids may have occurred. Our analysis suggests a split between the ivesioids and Potentilla sect. Rivales around Late Oligocene/Early Miocene (similar to 23 million years ago, Ma), and that the ivesioids then diversified at a time when summer drought started to appear in the region. The clade is inferred to have originated on the western slopes of the Rocky Mountains from where a westward range expansion to the Sierra Nevada and the coast of California took place between similar to 12-2 Ma. Our results support the idea that climatic changes in southwestern North America have played an important role in the evolution of the local flora, by means of in situ adaptation followed by diversification.	[Topel, Mats; Antonelli, Alexandre; Eriksen, Bente] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Antonelli, Alexandre] Gothenburg Bot Garden, Gothenburg, Sweden; [Yesson, Chris] Zool Soc London, Inst Zool, London NW1 4RY, England	University of Gothenburg; Zoological Society of London	Topel, M (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	mats.topel@bioenv.gu.se	Antonelli, Alexandre/ABE-6321-2020; Antonelli, Alexandre/A-5353-2011; Yesson, Chris/Q-1196-2017	Antonelli, Alexandre/0000-0003-1842-9297; Antonelli, Alexandre/0000-0003-1842-9297; Yesson, Chris/0000-0002-6731-4229; Topel, Mats/0000-0001-7989-696X	Helge Ax:son Johnsons stiftelse; Nilsson-Ehle donationerna [24966]; Swedish Research council [2004-1698]; Carl Tryggers Stiftelse; Wilhelm och Martina Lundgrens Vetenskapsfond [vet1-348/2007]; Adlerbertska forskningsstiftelsen [B 432 835/07]; Gothenburg Bioinformatics Network (GOTBIN)	Helge Ax:son Johnsons stiftelse; Nilsson-Ehle donationerna; Swedish Research council(Swedish Research CouncilEuropean Commission); Carl Tryggers Stiftelse; Wilhelm och Martina Lundgrens Vetenskapsfond; Adlerbertska forskningsstiftelsen; Gothenburg Bioinformatics Network (GOTBIN)	This work was supported by Helge Ax:son Johnsons stiftelse (http://www.haxsonj.se/), Nilsson-Ehle donationerna (http://www.fysiografen.se/) (nr: 24966) (MT); The Swedish Research council (http://vr.se/), Carl Tryggers Stiftelse (http://www.carltryggersstiftelse.se/) and Helge Ax:son Johnsons Stiftelse (AA); Wilhelm och Martina Lundgrens Vetenskapsfond (http://www.wmlundgren.se/) (vet1-348/2007), Adlerbertska forskningsstiftelsen (B 432 835/07) and The Swedish Research council (2004-1698) (BE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to Barbara Ertter for help with locating and identifying ivesioids in the field, gathering locality data from herbarium material, and for discussions during the initial stages of the project. We thank the UC Botanical garden at Berkeley and Gothenburg Botanical Garden for providing and caring for plant material used in this investigation. We also like to acknowledge Paul Valdes, University of Bristol, for his advice on use of the paleoclimate layers, Paula Topel for preparing all graphics, and two anonymous reviewers for their suggestions for improving the manuscript. Support from the Gothenburg Bioinformatics Network (GOTBIN) is also gratefully acknowledged.	[Anonymous], 2014, TRACER V1 6; Axelrod D. I., 1987, LATE OLIGOCENE CREED, V130, P1; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Dobes C, 2010, MOL PHYLOGENET EVOL, V56, P156, DOI 10.1016/j.ympev.2010.03.005; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eriksson T, 1998, PLANT SYST EVOL, V211, P155, DOI 10.1007/BF00985357; Eriksson T, 2003, INT J PLANT SCI, V164, P197, DOI 10.1086/346163; ERTTER B, 1989, SYST BOT, V14, P231, DOI 10.2307/2418909; ERTTER B, 1993, SYST BOT, V18, P137, DOI 10.2307/2419793; Ertter B, 1993, JEPSON MANUAL HIGHER; Evans MEK, 2009, AM NAT, V173, P225, DOI 10.1086/595757; Evans MEK, 2005, EVOLUTION, V59, P1914, DOI 10.1111/j.0014-3820.2005.tb01061.x; Faegri K., 1979, PRINCIPLES POLLINATI; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hayashi K, 1998, PLANT SPEC BIOL, V13, P129; Heibl C., 2009, PHYLOCLIM INTEGRATIN; Hendry AP, 2010, EVOLUTION, V64, P1517, DOI 10.1111/j.1558-5646.2010.00947.x; Herman AB, 2002, REV PALAEOBOT PALYNO, V122, P1, DOI 10.1016/S0034-6667(02)00085-4; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hilbert DW, 2004, BIOL CONSERV, V116, P367, DOI 10.1016/S0006-3207(03)00230-1; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Jacobs DK, 2004, ANNU REV EARTH PL SC, V32, P601, DOI 10.1146/annurev.earth.32.092203.122436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kelley SP, 1999, CRETACEOUS RES, V20, P97, DOI 10.1006/cres.1998.0140; Lanphere MA, 2000, GEOL S AM S, P71; Li JQ, 2002, SYST BOT, V27, P408; Mai Dieter Hans, 2001, Palaeontographica Abteilung B Palaeophytologie, V258, P1; MATHEWS WH, 1964, GEOL SOC AM BULL, V75, P465, DOI 10.1130/0016-7606(1964)75[465:PADOCV]2.0.CO;2; Matthews JV, 2003, QUATERNARY RES, V60, P9, DOI 10.1016/S0033-5894(03)00087-5; MATTHEWS JV, 1990, ARCTIC, V43, P364; McIntosh WC., 2004, GEOCHRONOLOGY CENTRA, V160, P205; Meyer H.W., 2003, FOSSILS FLORISSANT; Minnich RA, 2007, TERESTRIAL VEGETATIO; Nix H.A., 1986, ATLAS ELAPID SNAKES, P4; NYLANDER J.A.A., 2004, MRAIC PL PROGRAM DIS; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peterson AT, 2004, DIVERS DISTRIB, V10, P237, DOI 10.1111/j.1366-9516.2004.00097.x; Pierrehumbert RT, 2002, NATURE, V419, P191, DOI 10.1038/nature01088; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; R Core Team, 2020, R LANG ENV STAT COMP; Samylina VA., 1960, BOT ZH, V45, P335; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schorn, 1998, PALEOBIOS, V18, P21; STANDKE G, 1993, GEOL RUNDSCH, V82, P295; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thompson JD, 2005, TAXON, V54, P967, DOI 10.2307/25065481; Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P424, DOI 10.1111/j.1365-2486.2006.01115.x; Topel M, 2011, PLOS CURRENTS TREE L, V16; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wehr W. C., 1994, WASHINGTON GEOL, V22, P27; Wolfe JA, 1990, US GEOLOGICAL SURVEY, V1923, P1; Yesson C, 2006, SYST BIOL, V55, P785, DOI 10.1080/1063515060081570; Yesson C, 2011, CLIMATE CHANGE ECOLO, P265; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	61	36	38	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50358	10.1371/journal.pone.0050358	http://dx.doi.org/10.1371/journal.pone.0050358			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236369	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100015
J	Lindenmayer, DB; Zammit, C; Attwood, SJ; Burns, E; Shepherd, CL; Kay, G; Wood, J				Lindenmayer, David B.; Zammit, Charles; Attwood, Simon J.; Burns, Emma; Shepherd, Claire L.; Kay, Geoff; Wood, Jeff			A Novel and Cost-Effective Monitoring Approach for Outcomes in an Australian Biodiversity Conservation Incentive Program	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; RIVER RESTORATION; SPECIES RICHNESS; POLICY-MAKERS; MANAGEMENT; INFORMATION; VEGETATION; ABUNDANCE; WOODLAND; PAYMENTS	We report on the design and implementation of ecological monitoring for an Australian biodiversity conservation incentive scheme - the Environmental Stewardship Program. The Program uses competitive auctions to contract individual land managers for up to 15 years to conserve matters of National Environmental Significance (with an initial priority on nationally threatened ecological communities). The ecological monitoring was explicitly aligned with the Program's policy objective and desired outcomes and was applied to the Program's initial Project which targeted the critically endangered White Box-Yellow Box-Blakely's Red Gum Grassy Woodland and Derived Native Grassland ecological community in south eastern Australia. These woodlands have been reduced to <3% of their original extent and persist mostly as small remnants of variable condition on private farmland. We established monitoring sites on 153 farms located over 172,232 sq km. On each farm we established a monitoring site within the woodland patch funded for management and, wherever possible, a matched control site. The monitoring has entailed gathering data on vegetation condition, reptiles and birds. We also gathered data on the costs of experimental design, site establishment, field survey, and data analysis. The costs of monitoring are approximately 8.5% of the Program's investment in the first four years and hence are in broad accord with the general rule of thumb that 5-10% of a program's funding should be invested in monitoring. Once initial monitoring and site benchmarking are completed we propose to implement a novel rotating sampling approach that will maintain scientific integrity while achieving an annual cost-efficiency of up to 23%. We discuss useful lessons relevant to other monitoring programs where there is a need to provide managers with reliable early evidence of program effectiveness and to demonstrate opportunities for cost-efficiencies. Citation: Lindenmayer DB, Zammit C, Attwood SJ, Burns E, Shepherd CL, et al. (2012) A Novel and Cost-Effective Monitoring Approach for Outcomes in an Australian Biodiversity Conservation Incentive Program. PLoS ONE 7(12): e50872. doi:10.1371/journal.pone.0050872	[Lindenmayer, David B.; Burns, Emma; Shepherd, Claire L.; Kay, Geoff; Wood, Jeff] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Lindenmayer, David B.; Shepherd, Claire L.; Wood, Jeff] Australian Natl Univ, Australian Res Council Ctr Excellence Environm De, Canberra, ACT, Australia; [Lindenmayer, David B.; Shepherd, Claire L.] Australian Natl Univ, Natl Environm Res Program, Canberra, ACT, Australia; [Zammit, Charles; Attwood, Simon J.] Australian Govt Dept Sustainabil Environm Water P, Biodivers Conservat Branch, Canberra, ACT, Australia	Australian National University; Australian National University; Australian National University	Lindenmayer, DB (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	david.lindenmayer@anu.edu.au	Lindenmayer, David B/P-7183-2017	Lindenmayer, David B/0000-0002-4766-4088				Alberts B, 2011, SCIENCE, V334, P1031, DOI 10.1126/science.1216650; [Anonymous], 2010, TEMPERATE WOODLAND C; Australian National Audit Office, 2007, AUDIT REPORT NO 21 2; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Bernhardt ES, 2005, BIOSCIENCE, V55, P219, DOI 10.1641/0006-3568(2005)055[0219:ACSTFF]2.0.CO;2; Brooks SS, 2007, RESTOR ECOL, V15, P584, DOI 10.1111/j.1526-100X.2007.00253.x; Cardwell M., 2010, INT J LAND LAW AGR S, V4, P1; Carey PD, 2007, 25 YEARS OF LANDSCAP, P70; Cheng D, 2008, COMMUNICATING SCIENCE IN SOCIAL CONTEXTS: NEW MODELS, NEW PRACTICES, P1, DOI 10.1007/978-1-4020-8598-7; Commonwealth of Australia, 2009, ENVIRONMENTAL STEWAR; Commonwealth of Australia, 2011, ENVIRONMENTAL STEWAR; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; Cunningham RB, 2007, ECOL APPL, V17, P609, DOI 10.1890/05-1892; Dripps K, 2008, LANDSCAPE ANALYIS AN; Driscoll D, 2000, IMPACT AND USE OF FI; Ecker S, 2010, PARTICIPATION IN THE; Eigenraam M, 2007, AGR ECON-BLACKWELL, V37, P261, DOI 10.1111/j.1574-0862.2007.00250.x; European Commission, 2005, AGRI ENVIRONMENT MEA; European Commission, 2006, RURAL DEVELOPMENT PO; Ferraro PJ, 2011, CONSERV BIOL, V25, P1134, DOI 10.1111/j.1523-1739.2011.01791.x; Field SA, 2002, AUSTRAL ECOL, V27, P624, DOI 10.1046/j.1442-9993.2002.01223.x; Field SA, 2007, AUSTRAL ECOL, V32, P485, DOI 10.1111/j.1442-9993.2007.01715.x; Ford HA, 2009, BIOL CONSERV, V142, P3182, DOI 10.1016/j.biocon.2009.08.022; Franklin JF, 1999, PAPER PRESENTED TO T; Fuentes-Montemayor E, 2011, BIOL CONSERV, V144, P2233, DOI 10.1016/j.biocon.2011.05.015; Gardner T., 2010, MONITORING FOREST BI; Gibbons JM, 2011, J APPL ECOL, V48, P1218, DOI 10.1111/j.1365-2664.2011.02022.x; Gibbons Philip, 2008, Ecological Management & Restoration, V9, P182, DOI 10.1111/j.1442-8903.2008.00416.x; Hajkowicz S, 2009, LAND USE POLICY, V26, P471, DOI 10.1016/j.landusepol.2008.06.004; Henderson B, 2008, AUSTRALAS J ENVIRON, V15, P113; Hodgson JA, 2010, ECOL LETT, V13, P1358, DOI 10.1111/j.1461-0248.2010.01528.x; Kerr JT, 2004, ECOL LETT, V7, P1163, DOI 10.1111/j.1461-0248.2004.00676.x; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2004, CONSERV BIOL, V18, P775, DOI 10.1111/j.1523-1739.2004.00550.x; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Kwok ABC, 2011, AUSTRAL ECOL, V36, P800, DOI 10.1111/j.1442-9993.2010.02219.x; Lawton JH, 2007, J APPL ECOL, V44, P465, DOI 10.1111/j.1365-2664.2007.01315.x; Lee Y, 2006, GENERALIZED LINEAR M; Lindenmayer D, 2012, BIODIVERSITY MONITORING IN AUSTRALIA, P1; Lindenmayer D, 2012, LAND USE INTENSIFICATION: EFFECTS ON AGRICULTURE, BIODIVERSITY AND ECOLOGICAL PROCESSES, P1; Lindenmayer D, 2012, BIOL CONSERV, V152, P62, DOI 10.1016/j.biocon.2012.02.026; Lindenmayer DB, 2009, EMU, V109, P100, DOI 10.1071/MU08029; Lindenmayer DB, 2010, EFFECTIVE ECOLOGICAL MONITORING, P1; Lindenmayer DB, 2003, BIOL CONSERV, V110, P161, DOI 10.1016/S0006-3207(02)00171-4; Lindenmayer DB, 2011, WHAT MAKES A GOOD FA; Maron M, 2005, BIOL CONSERV, V124, P439, DOI 10.1016/j.biocon.2005.02.002; Martin TG, 2007, CONSERV BIOL, V21, P504, DOI 10.1111/j.1523-1739.2006.00624.x; McIntyre S, 2000, MANAGEMENT SUSTAINAB; McNie EC, 2007, ENVIRON SCI POLICY, V10, P17, DOI 10.1016/j.envsci.2006.10.004; Montague-Drake RM, 2009, BIOL CONSERV, V142, P2896, DOI 10.1016/j.biocon.2009.07.009; Muir MJ, 2010, REPORT TO CONSERVATI; Munro N, 2011, PLANTING FOR WILDLIF; Ninan KN, 2009, CONSERVING AND VALUI; OECD, 2010, PAYING FOR BIODIVERS; Pannell DJ, 2010, AUST J AGR RESOUR EC, V54, P437, DOI 10.1111/j.1467-8489.2010.00504.x; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; Perkins AJ, 2011, J APPL ECOL, V48, P514, DOI 10.1111/j.1365-2664.2011.01958.x; Pyke G.H., 1983, METHODS CENSUSING BI, P55; Roth T, 2008, AGR ECOSYST ENVIRON, V125, P167, DOI 10.1016/j.agee.2007.12.012; Rudd MA, 2011, CONSERV BIOL, V25, P860, DOI 10.1111/j.1523-1739.2011.01712.x; Shanley P, 2009, BIOTROPICA, V41, P535, DOI 10.1111/j.1744-7429.2009.00561.x; Shine R, 1998, WILDLIFE RES, V25, P285, DOI 10.1071/WR97022; Spellerberg I. F., 2005, MONITORING ECOLOGICA, DOI DOI 10.1017/CBO9780511614699; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Welsh AH, 2000, BIOMETRICS, V56, P22, DOI 10.1111/j.0006-341X.2000.00022.x; Whitfield J, 2006, NATURE, V439, P908, DOI 10.1038/439908a; Whittingham MJ, 2007, J APPL ECOL, V44, P1, DOI 10.1111/j.1365-2664.2006.01263.x; World Bank, 1998, GUIDELINES FOR MONIT; Zammit C., 2010, TEMPERATE WOODLAND C	70	13	13	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50872	10.1371/journal.pone.0050872	http://dx.doi.org/10.1371/journal.pone.0050872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236399	Green Published, Green Submitted, gold			2022-12-27	WOS:000312589700020
J	Cucherousset, J; Bouletreau, S; Azemar, F; Compin, A; Guillaume, M; Santoul, F				Cucherousset, Julien; Bouletreau, Stephanie; Azemar, Frederic; Compin, Arthur; Guillaume, Mathieu; Santoul, Frederic			"Freshwater Killer Whales": Beaching Behavior of an Alien Fish to Hunt Land Birds	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSES; CATFISH SILURUS-GLANIS; INDIVIDUAL SPECIALIZATION; TROPHIC POSITION; TERRESTRIAL; ASSUMPTIONS; ECOLOGY; BIOLOGY; FRANCE; MODELS	The behavioral strategies developed by predators to capture and kill their prey are fascinating, notably for predators that forage for prey at, or beyond, the boundaries of their ecosystem. We report here the occurrence of a beaching behavior used by an alien and large-bodied freshwater predatory fish (Silurus glanis) to capture birds on land (i.e. pigeons, Columbia livia). Among a total of 45 beaching behaviors observed and filmed, 28% were successful in bird capture. Stable isotope analyses (delta C-13 and delta N-15) of predators and their putative prey revealed a highly variable dietary contribution of land birds among individuals. Since this extreme behavior has not been reported in the native range of the species, our results suggest that some individuals in introduced predator populations may adapt their behavior to forage on novel prey in new environments, leading to behavioral and trophic specialization to actively cross the water-land interface. Citation: Cucherousset J, Bouletreau S, Azemar F, Compin A, Guillaume M, et al. (2012) "Freshwater Killer Whales": Beaching Behavior of an Alien Fish to Hunt Land Birds. PLoS ONE 7(12): e50840. doi:10.1371/journal.pone.0050840	[Bouletreau, Stephanie; Azemar, Frederic; Compin, Arthur; Guillaume, Mathieu; Santoul, Frederic] Univ Toulouse, INP, UPS, EcoLab Lab Ecol Fonct & Environm, Toulouse, France; [Cucherousset, Julien] Univ Toulouse 3, CNRS, ENFA, Lab Evolut & Diversite Biol,UMR EDB 5174, F-31062 Toulouse, France; [Cucherousset, Julien] Univ Toulouse, UMR EDB 5174, Toulouse, France; [Bouletreau, Stephanie; Azemar, Frederic; Compin, Arthur; Guillaume, Mathieu; Santoul, Frederic] CNRS, EcoLab, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Santoul, F (corresponding author), Univ Toulouse, INP, UPS, EcoLab Lab Ecol Fonct & Environm, Toulouse, France.	frederic.santoul@univ-tlse3.fr	Azémar, Frédéric/A-9041-2010; COMPIN, Arthur/D-3826-2014; Bouletreau, Stephanie/T-2915-2019	Azémar, Frédéric/0000-0002-3098-8676; Santoul, Frederic/0000-0002-2932-2172; Bouletreau, Stephanie/0000-0002-0094-0196; Compin, Arthur/0000-0002-0756-8649; Cucherousset, Julien/0000-0003-0533-9479	"ERG Marie Curie" grant in the lab EDB, part of the "Laboratoire d"Excellence (LABEX) entitled TULIP [PERG08-GA-2010-276969, ANR - 10-LABX-41]	"ERG Marie Curie" grant in the lab EDB, part of the "Laboratoire d"Excellence (LABEX) entitled TULIP	JC was supported by an "ERG Marie Curie" grant (PERG08-GA-2010- 276969) in the lab EDB, part of the "Laboratoire d"Excellence (LABEX) entitled TULIP (ANR -10-LABX-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MS, 2007, OECOLOGIA, V152, P643, DOI 10.1007/s00442-007-0687-1; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Bartels P, 2012, ECOLOGY, V93, P1173, DOI 10.1890/11-1210.1; Baxter CV, 2005, FRESHWATER BIOL, V50, P201, DOI 10.1111/j.1365-2427.2004.01328.x; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bouletreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025732; Copp GH, 2009, FISH FISH, V10, P252, DOI 10.1111/j.1467-2979.2008.00321.x; Cucherousset J, 2012, FISHERIES MANAG ECOL, V19, P111, DOI 10.1111/j.1365-2400.2011.00824.x; Cucherousset J, 2011, OECOLOGIA, V167, P75, DOI 10.1007/s00442-011-1974-4; Cucherousset J, 2011, FISHERIES, V36, P215, DOI 10.1080/03632415.2011.574578; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; Fry B., 2006, STABLE ISOTOPE ECOLO; GUINET C, 1995, CAN J ZOOL, V73, P27, DOI 10.1139/z95-004; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Poulet N, 2011, J FISH BIOL, V79, P1436, DOI 10.1111/j.1095-8649.2011.03084.x; Pruetz JD, 2007, CURR BIOL, V17, P412, DOI 10.1016/j.cub.2006.12.042; R Development Core Team, 2012, R LANG ENV STAT COMP; Rutz C, 2010, SCIENCE, V329, P1523, DOI 10.1126/science.1192053; Sargeant BL, 2005, CAN J ZOOL, V83, P1400, DOI 10.1139/Z05-136; Schuster S, 2004, CURR BIOL, V14, P1565, DOI 10.1016/j.cub.2004.08.050; Stone R, 2007, SCIENCE, V316, P1684, DOI 10.1126/science.316.5832.1684; Syvaranta J, 2010, AQUAT BIOL, V8, P137, DOI 10.3354/ab00220; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762	28	40	41	4	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50840	10.1371/journal.pone.0050840	http://dx.doi.org/10.1371/journal.pone.0050840			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227213	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200073
J	Domart, MC; Hobday, TMC; Peddie, CJ; Chung, GHC; Wang, A; Yeh, K; Jethwa, N; Zhang, QF; Wakelam, MJO; Woscholski, R; Byrne, RD; Collinson, LM; Poccia, DL; Larijani, B				Domart, Marie-Charlotte; Hobday, Tina M. C.; Peddie, Christopher J.; Chung, Gary H. C.; Wang, Alan; Yeh, Karen; Jethwa, Nirmal; Zhang, Qifeng; Wakelam, Michael J. O.; Woscholski, Rudiger; Byrne, Richard D.; Collinson, Lucy M.; Poccia, Dominic L.; Larijani, Banafshe			Acute Manipulation of Diacylglycerol Reveals Roles in Nuclear Envelope Assembly & Endoplasmic Reticulum Morphology	PLOS ONE			English	Article							PROTEIN-KINASE-C; LAMIN-B-RECEPTOR; MEMBRANE-FUSION; MAMMALIAN-CELLS; SEA-URCHIN; DYNAMICS; LIPIDS; ER; PHOSPHORYLATION; ORGANIZATION	The functions and morphology of cellular membranes are intimately related and depend not only on their protein content but also on the repertoire of lipids that comprise them. In the absence of in vivo data on lipid asymmetry in endomembranes, it has been argued that motors, scaffolding proteins or integral membrane proteins rather than non-lamellar bilayer lipids such as diacylglycerol (DAG), are responsible for shaping of organelles, local membrane curvature and fusion. The effects of direct alteration of levels of such lipids remain predominantly uninvestigated. Diacylglycerol (DAG) is a well documented second messenger. Here we demonstrate two additional conserved functions of DAG: a structural role in organelle morphology, and a role in localised extreme membrane curvature required for fusion for which proteins alone are insufficient. Acute and inducible DAG depletion results in failure of the nuclear envelope (NE) to reform at mitosis and reorganisation of the ER into multi-lamellar sheets as revealed by correlative light and electron microscopy and 3D reconstructions. Remarkably, depleted cells divide without a complete NE, and unless rescued by 1,2 or 1,3 DAG soon die. Attenuation of DAG levels by enzyme microinjection into echinoderm eggs and embryos also results in alterations of ER morphology and nuclear membrane fusion. Our findings demonstrate that DAG is an in vivo modulator of organelle morphology in mammalian and echinoderm cells, indicating a fundamental role conserved across the deuterostome superphylum.	[Domart, Marie-Charlotte; Hobday, Tina M. C.; Chung, Gary H. C.; Jethwa, Nirmal; Byrne, Richard D.; Larijani, Banafshe] Canc Res United Kingdom, Cell Biophys Lab, London Res Inst, London, England; [Peddie, Christopher J.; Collinson, Lucy M.] Canc Res United Kingdom, Elect Microscopy Unit, London Res Inst, London, England; [Wang, Alan; Yeh, Karen; Poccia, Dominic L.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA; [Zhang, Qifeng; Wakelam, Michael J. O.] Babraham Inst, Cambridge, England; [Woscholski, Rudiger] Univ London Imperial Coll Sci Technol & Med, Dept Chem, Fac Nat Sci, London SW7 2AY, England; [Woscholski, Rudiger] Univ London Imperial Coll Sci Technol & Med, Inst Biol Chem, London, England	Cancer Research UK; University of London; University College London; Cancer Research UK; University of London; University College London; Amherst College; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Imperial College London; Imperial College London	Larijani, B (corresponding author), Canc Res United Kingdom, Cell Biophys Lab, London Res Inst, London, England.	banafshe.larijani@cancer.org.uk	Larijani, Banafshe/H-3909-2015	Larijani, Banafshe/0000-0003-4735-1169; Chung, Gary Hong Chun/0000-0001-6764-3041; Wakelam, Michael/0000-0003-4059-9276; Collinson, Lucy/0000-0003-0260-613X; Peddie, Christopher/0000-0002-8329-5419; Domart, Marie-Charlotte/0000-0002-5703-2922	Cancer Research United Kingdom core funding; Amherst College Faculty Research Award; Biotechnology and Biological Sciences Research Council (BBSRC) (MJOW); BBSRC [BBS/E/B/000C0415] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0415] Funding Source: researchfish	Cancer Research United Kingdom core funding; Amherst College Faculty Research Award; Biotechnology and Biological Sciences Research Council (BBSRC) (MJOW); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The project was funded by Cancer Research United Kingdom core funding to London Research Institute (BL), an Amherst College Faculty Research Award of the H. Axel Schupf '57 Fund for Intellectual Life (DLP) and the Biotechnology and Biological Sciences Research Council (BBSRC) (MJOW). AW received support as a Schupf Fellow, Amherst College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barona T, 2005, J BIOL CHEM, V280, P41171, DOI 10.1074/jbc.M412863200; Basanez G, 1996, BIOPHYS J, V70, P2299, DOI 10.1016/S0006-3495(96)79795-3; Chernomordik L, 1996, CHEM PHYS LIPIDS, V81, P203, DOI 10.1016/0009-3084(96)02583-2; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Collas P, 1998, METHOD CELL BIOL, V53, P417; CULLIS PR, 1978, NATURE, V271, P672, DOI 10.1038/271672a0; DAS S, 1986, BIOCHEMISTRY-US, V25, P2882, DOI 10.1021/bi00358a022; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dumas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012208; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Fili N, 2006, P NATL ACAD SCI USA, V103, P15473, DOI 10.1073/pnas.0607040103; GORDON SE, 1995, BIOPHYS J, V69, P409, DOI 10.1016/S0006-3495(95)79913-1; Gorjanacz M, 2009, J CELL SCI, V122, P1963, DOI 10.1242/jcs.044750; Hurley JH, 1997, CURR OPIN STRUC BIOL, V7, P557, DOI 10.1016/S0959-440X(97)80122-4; KIEHART DP, 1982, METHOD CELL BIOL, V25, P13, DOI 10.1016/S0091-679X(08)61418-1; Knorr RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032753; KONING AJ, 1993, CELL MOTIL CYTOSKEL, V25, P111, DOI 10.1002/cm.970250202; Larijani B, 2000, LIPIDS, V35, P1289, DOI 10.1007/s11745-000-0645-4; Larijani B, 2009, ANNU REV BIOPHYS, V38, P107, DOI 10.1146/annurev.biophys.050708.133625; LONGO FJ, 1972, J MORPHOL, V138, P207, DOI 10.1002/jmor.1051380206; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; Ma Y, 2007, J CELL SCI, V120, P520, DOI 10.1242/jcs.03355; Mattaj IW, 2004, NAT REV MOL CELL BIO, V5, P65, DOI 10.1038/nrm1263; Pettitt TR, 1999, J BIOL CHEM, V274, P36181, DOI 10.1074/jbc.274.51.36181; Poccia D, 2009, BIOCHEM J, V418, P233, DOI 10.1042/BJ20082105; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; Sanchez-Pinera P, 1999, BIOCHEM J, V337, P387, DOI 10.1042/0264-6021:3370387; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Siniossoglou S, 2009, TRAFFIC, V10, P1181, DOI 10.1111/j.1600-0854.2009.00923.x; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; TERASAKI M, 1991, J CELL BIOL, V114, P929, DOI 10.1083/jcb.114.5.929; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Volkova EG, 2011, J ELECTRON MICROSC, V60, P57, DOI 10.1093/jmicro/dfq067; Watt S, 2002, SUBCELLULAR LOCALIZA, V81; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; WORMAN HJ, 1988, P NATL ACAD SCI USA, V85, P8531, DOI 10.1073/pnas.85.22.8531; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	41	46	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51150	10.1371/journal.pone.0051150	http://dx.doi.org/10.1371/journal.pone.0051150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227247	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200106
J	Liu, JX; Zhao, L; Li, GY; Xiong, SW; Nan, JF; Li, J; Yuan, K; von Deneen, KM; Liang, FR; Qin, W; Tian, J				Liu, Jixin; Zhao, Ling; Li, Guoying; Xiong, Shiwei; Nan, Jiaofen; Li, Jing; Yuan, Kai; von Deneen, Karen M.; Liang, Fanrong; Qin, Wei; Tian, Jie			Hierarchical Alteration of Brain Structural and Functional Networks in Female Migraine Sufferers	PLOS ONE			English	Article							HYPOTHALAMIC ACTIVATION; CORTICAL THICKNESS; MATTER CHANGES; CONNECTIVITY; ORGANIZATION; HEADACHE; VOXEL; PAIN; MODULARITY; FREQUENCY	Background: Little is known about the changes of brain structural and functional connectivity networks underlying the pathophysiology in migraine. We aimed to investigate how the cortical network reorganization is altered by frequent cortical overstimulation associated with migraine. Methodology/Principal Findings: Gray matter volumes and resting-state functional magnetic resonance imaging signal correlations were employed to construct structural and functional networks between brain regions in 43 female patients with migraine (PM) and 43 gender-matched healthy controls (HC) by using graph theory-based approaches. Compared with the HC group, the patients showed abnormal global topology in both structural and functional networks, characterized by higher mean clustering coefficients without significant change in the shortest absolute path length, which indicated that the PM lost optimal topological organization in their cortical networks. Brain hubs related to pain-processing revealed abnormal nodal centrality in both structural and functional networks, including the precentral gyrus, orbital part of the inferior frontal gyrus, parahippocampal gyrus, anterior cingulate gyrus, thalamus, temporal pole of the middle temporal gyrus and the inferior parietal gyrus. Negative correlations were found between migraine duration and regions with abnormal centrality. Furthermore, the dysfunctional connections in patients' cortical networks formed into a connected component and three dysregulated modules were identified involving pain-related information processing and motion-processing visual networks. Conclusions: Our results may reflect brain alteration dynamics resulting from migraine and suggest that long-term and high-frequency headache attacks may cause both structural and functional connectivity network reorganization. The disrupted information exchange between brain areas in migraine may be reshaped into a hierarchical modular structure progressively.	[Liu, Jixin; Li, Guoying; Xiong, Shiwei; Nan, Jiaofen; Li, Jing; Yuan, Kai; von Deneen, Karen M.; Qin, Wei; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China; [Zhao, Ling; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Chengdu University of Traditional Chinese Medicine; Chinese Academy of Sciences; Institute of Automation, CAS	Qin, W (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Peoples R China.	wqin@xidian.edu.cn; tian@ieee.org	秦, 伟/J-9770-2016; Yuan, Kai/I-4150-2016; tian, jie/M-6336-2013; Tian, Jie/H-1190-2011; Yuan, Kai/M-9403-2013; Life, PAM/M-9552-2013	秦, 伟/0000-0003-4583-0406; Yuan, Kai/0000-0002-3098-1124; Tian, Jie/0000-0003-0498-0432; Liang, Fanrong/0000-0003-2210-2027	National Key Basic Research and Development Program (973) [2012CB518501, 2011CB707702]; National Natural Science Foundation of China [30930112, 30970774, 81000640, 81000641, 81101036, 81101108, 31150110171, 30901900, 81271644, 31200837]; Fundamental Research Funds for the Central Universities	National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Project for the National Key Basic Research and Development Program (973) under Grant Nos. 2012CB518501, 2011CB707702, the National Natural Science Foundation of China under Grant Nos. 30930112, 30970774, 81000640, 81000641, 81101036, 81101108, 31150110171, 30901900, 81271644, 31200837, the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerra NE, 2005, NEUROLOGY, V65, P751, DOI 10.1212/01.wnl.0000178745.11996.8c; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Aderjan D, 2010, PAIN, V151, P97, DOI 10.1016/j.pain.2010.06.024; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Chiapparini L, 2010, NEUROL SCI, V31, P19, DOI 10.1007/s10072-010-0266-9; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; Detsky ME, 2006, JAMA-J AM MED ASSOC, V296, P1274, DOI 10.1001/jama.296.10.1274; Donaghy M, 2002, J NEUROL NEUROSUR PS, V73, P747, DOI 10.1136/jnnp.73.6.747; Eck J, 2011, PAIN, V152, P1104, DOI 10.1016/j.pain.2011.01.026; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Granziera C, 2006, PLOS MED, V3, P1915, DOI 10.1371/journal.pmed.0030402; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hintze A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040023; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; KAISER M, 2011, NEUROIMAGE; Kaiser M, 2007, EUR J NEUROSCI, V25, P3185, DOI 10.1111/j.1460-9568.2007.05574.x; Kim J, 2008, CEPHALALGIA, V28, P598, DOI 10.1111/j.1468-2982.2008.01550.x; Lipton RB, 2004, JAMA-J AM MED ASSOC, V291, P493, DOI 10.1001/jama.291.4.493; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027049; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023098; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Matharu MS, 2006, ANN NEUROL, V59, P535, DOI 10.1002/ana.20763; May A, 2009, NAT REV NEUROL, V5, P199, DOI 10.1038/nrneurol.2009.28; Moulton EA, 2011, CEREB CORTEX, V21, P435, DOI 10.1093/cercor/bhq109; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Park CH, 2008, PHYSICA A, V387, P5958, DOI 10.1016/j.physa.2008.06.048; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Rocca MA, 2006, STROKE, V37, P1765, DOI 10.1161/01.STR.0000226589.00599.4d; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Spirin V, 2006, P NATL ACAD SCI USA, V103, P8774, DOI 10.1073/pnas.0510258103; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Sprenger T, 2005, PAIN, V113, P422, DOI 10.1016/j.pain.2004.09.021; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valfre W, 2008, HEADACHE, V48, P109, DOI 10.1111/j.1526-4610.2007.00723.x; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019608; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Yu DH, 2012, NMR BIOMED, V25, P806, DOI 10.1002/nbm.1796; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	59	71	80	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51250	10.1371/journal.pone.0051250	http://dx.doi.org/10.1371/journal.pone.0051250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227257	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200116
J	Mi, DH; Jia, Q; Zheng, HH; Hoff, K; Zhao, XQ; Wang, CX; Liu, GF; Wang, YL; Liu, LP; Wang, XW; Wang, YJ				Mi, Donghua; Jia, Qian; Zheng, Huaguang; Hoff, Kolin; Zhao, Xingquan; Wang, Chunxue; Liu, Gaifen; Wang, Yilong; Liu, Liping; Wang, Xianwei; Wang, Yongjun		Invest Survey Abnormal Glucose	Metabolic Syndrome and Stroke Recurrence in Chinese Ischemic Stroke Patients - The ACROSS-China Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; CEREBRAL INFARCTION; ATTACK; IMPACT; MULTIFACTORIAL; PREVALENCE; PROGNOSIS; MORTALITY; SURVIVAL	Objective: Metabolic syndrome has emerged as a novel risk factor in cardiovascular disease due to its potential for predicting stroke in population-based studies. We investigated the relationship of metabolic syndrome with stroke recurrence. Methods: This was a retrospective analysis of Chinese patients enrolled in the prospective Abnormal gluCose Regulation in patients with acute strOke acroSS China (ACROSS-China) study after their first ischemic stroke. Metabolic syndrome was defined using the International Diabetes Federation (IDF) criteria. Vascular risk factors were assessed. Outcome was defined as recurrence of stroke within one year after the index ischemic stroke. Cox proportional hazards regression was performed to identify potential predictors of stroke recurrence. Results: The prevalence of metabolic syndrome among 2639 ischemic stroke patients was 51.35%. During the one-year follow-up, 195 strokes (7.4%) recurred. The multivariate hazard ratio (95% CI) of stroke recurrence was 1.94 (1.39-2.73) for metabolic syndrome. After adjustment for components, metabolic syndrome lost its association with stroke recurrence; in this model, high fasting plasma glucose (IDF definition) was a predictor for stroke recurrence. Conclusion: Metabolic syndrome may not be predictive for stroke recurrence beyond its component individual factors for Chinese ischemic stroke patients.	[Mi, Donghua; Jia, Qian; Zheng, Huaguang; Zhao, Xingquan; Wang, Chunxue; Liu, Gaifen; Wang, Yilong; Liu, Liping; Wang, Xianwei; Wang, Yongjun] Capital Med Univ, Dept Neurol, Beijing Tiantan Hosp, Beijing, Peoples R China; [Hoff, Kolin] Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA	Capital Medical University; University of Pennsylvania; Pennsylvania Medicine	Wang, YJ (corresponding author), Capital Med Univ, Dept Neurol, Beijing Tiantan Hosp, Beijing, Peoples R China.	yongjunwang111@126.com	liu, li/HGC-0900-2022		Ministry of Science and Technology; Ministry of Health of the People's Republic of China; National Science and Technology Major Project of China [2008ZX09312 -008]; State Key Development Program of (for) Basic Research of China [2009CB521905]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China; National Science and Technology Major Project of China; State Key Development Program of (for) Basic Research of China(National Basic Research Program of ChinaState Key Development Program for Basic Research of China)	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China. The grants were National Science and Technology Major Project of China (2008ZX09312 -008) and State Key Development Program of (for) Basic Research of China (2009CB521905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; ALTER M, 1994, STROKE, V25, P1605, DOI 10.1161/01.STR.25.8.1605; Arenillas JF, 2008, NEUROLOGY, V71, P190, DOI 10.1212/01.wnl.0000317092.21210.e6; Boden-Albala B, 2008, STROKE, V39, P30, DOI 10.1161/STROKEAHA.107.496588; Bogousslavsky J, 1996, NEUROLOGY, V46, P1301, DOI 10.1212/WNL.46.5.1301; Boysen G, 2003, STROKE, V34, P1258, DOI 10.1161/01.STR.0000069017.78624.37; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Callahan A, 2011, ARCH NEUROL-CHICAGO, V68, P1245, DOI 10.1001/archneurol.2011.146; Elneihoum AM, 1998, STROKE, V29, P2114, DOI 10.1161/01.STR.29.10.2114; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; HIER DB, 1991, STROKE, V22, P155, DOI 10.1161/01.STR.22.2.155; Hillen T, 2003, STROKE, V34, P1457, DOI 10.1161/01.STR.0000072985.24967.7F; Iso H, 2007, STROKE, V38, P1744, DOI 10.1161/STROKEAHA.106.469072; Jia Q, 2012, STROKE, V43, P650, DOI 10.1161/STROKEAHA.111.633784; Jia Q, 2011, STROKE, V42, P2758, DOI 10.1161/STROKEAHA.111.621649; Karapanayiotides T, 2004, NEUROLOGY, V62, P1558, DOI 10.1212/01.WNL.0000123252.55688.05; Katsnelson M, 2011, STROKE, V42, P3331, DOI 10.1161/STROKEAHA.111.632471; KIERS L, 1992, J NEUROL NEUROSUR PS, V55, P263, DOI 10.1136/jnnp.55.4.263; Koren-Morag N, 2005, STROKE, V36, P1366, DOI 10.1161/01.STR.0000169945.75911.33; Kurl S, 2006, STROKE, V37, P806, DOI 10.1161/01.STR.0000204354.06965.44; LAI SM, 1994, STROKE, V25, P958, DOI 10.1161/01.STR.25.5.958; Liou CW, 2008, EUR J NEUROL, V15, P802, DOI 10.1111/j.1468-1331.2008.02181.x; Liu Chuan, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P358, DOI 10.3760/cma.j.issn.0253-3758.2011.04.016; Megherbi SE, 2003, STROKE, V34, P688, DOI 10.1161/01.STR.0000057975.15221.40; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; Ovbiagele B, 2006, NEUROLOGY, V66, P1344, DOI 10.1212/01.wnl.0000210530.46058.5c; Reaven GM, 2006, AM J CLIN NUTR, V83, P1237, DOI 10.1093/ajcn/83.6.1237; Sacco RL, 2006, CIRCULATION, V113, pE409, DOI 10.1161/circ.113.10.e409; SACCO RL, 1994, NEUROLOGY, V44, P626, DOI 10.1212/WNL.44.4.626; SACCO RL, 1995, NEUROLOGY, V45, pS10; Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94; TAKANO K, 1992, STROKE, V23, P194, DOI 10.1161/01.STR.23.2.194; Towfighi A, 2009, STROKE, V40, P2704, DOI 10.1161/STROKEAHA.109.550228; Vemmos K, 2011, STROKE, V42, P30, DOI 10.1161/STROKEAHA.110.593434; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Weimar C, 2009, STROKE, V40, P350, DOI 10.1161/STROKEAHA.108.521419; Wu G, 2002, CHIN J PREV MED CHIN, V36, P298; Xu GL, 2007, CEREBROVASC DIS, V23, P117, DOI 10.1159/000097047	41	18	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51406	10.1371/journal.pone.0051406	http://dx.doi.org/10.1371/journal.pone.0051406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227264	Green Submitted, gold, Green Published			2022-12-27	WOS:000312588200123
J	Sabri, F; Boughter, JD; Gerth, D; Skalli, O; Phung, TCN; Tamula, GRM; Leventis, N				Sabri, Firouzeh; Boughter, John D., Jr.; Gerth, David; Skalli, Omar; Phung, Thien-Chuong N.; Tamula, George-Rudolph M.; Leventis, Nicholas			Histological Evaluation of the Biocompatibility of Polyurea Crosslinked Silica Aerogel Implants in a Rat Model: A Pilot Study	PLOS ONE			English	Article							RESPONSIVE CONTROLLED-RELEASE; DELIVERY-SYSTEMS; PORE-SIZE; NANOPARTICLES; POROSITY; BIOMATERIALS; SCAFFOLDS; MATRICES; DESIGN; DNA	Background: Aerogels are a versatile group of nanostructured/nanoporous materials with physical and chemical properties that can be adjusted to suit the application of interest. In terms of biomedical applications, aerogels are particularly suitable for implants such as membranes, tissue growth scaffolds, and nerve regeneration and guidance inserts. The mesoporous nature of aerogels can also be used for diffusion based release of drugs that are loaded during the drying stage of the material. From the variety of aerogels polyurea crosslinked silica aerogels have the most potential for future biomedical applications and are explored here. Methodology: This study assessed the short and long term biocompatibility of polyurea crosslinked silica aerogel implants in a Sprague-Dawley rat model. Implants were inserted at two different locations a) subcutaneously (SC), at the dorsum and b) intramuscularly (IM), between the gluteus maximus and biceps femoris of the left hind extremity. Nearby muscle and other internal organs were evaluated histologically for inflammation, tissue damage, fibrosis and movement (travel) of implant. Conclusion/Significance: In general polyurea crosslinked silica aerogel (PCSA) was well tolerated as a subcutaneous and an intramuscular implant in the Sprague-Dawley rat with a maximum incubation time of twenty months. In some cases a thin fibrous capsule surrounded the aerogel implant and was interpreted as a normal response to foreign material. No noticeable toxicity was found in the tissues surrounding the implants nor in distant organs. Comparison was made with control rats without any implants inserted, and animals with suture material present. No obvious or noticeable changes were sustained by the implants at either location. Careful necropsy and tissue histology showed age-related changes only. An effective sterilization technique for PCSA implants as well as staining and sectioning protocol has been established. These studies further support the notion that silica-based aerogels could be useful as biomaterials.	[Sabri, Firouzeh; Phung, Thien-Chuong N.; Tamula, George-Rudolph M.] Univ Memphis, Dept Phys, Memphis, TN 38152 USA; [Boughter, John D., Jr.] UTHSC, Dept Anat & Neurobiol, Memphis, TN USA; [Gerth, David] UTHSC, Dept Otolaryngol Head & Neck Surg, Memphis, TN USA; [Skalli, Omar] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Leventis, Nicholas] Missouri Univ Sci & Technol, Dept Chem, Rolla, MO USA	University of Memphis; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Missouri System; Missouri University of Science & Technology	Sabri, F (corresponding author), Univ Memphis, Dept Phys, Memphis, TN 38152 USA.	fsabri@memphis.edu	Skalli, Omar/D-4980-2013		FedEx Institute of Technology, University of Memphis	FedEx Institute of Technology, University of Memphis	The first author would like to thank the FedEx Institute of Technology, University of Memphis, for finanical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; Boccaccini AR, 1998, J MATER SCI LETT, V17, P1273, DOI 10.1023/A:1006503524162; Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7; Doherty P, 2009, BIOMEDICAL MATERIALS, P201, DOI 10.1007/978-0-387-84872-3_7; Dunn B, 1998, ACTA MATER, V46, P737, DOI 10.1016/S1359-6454(97)00254-1; Giri S, 2005, ANGEW CHEM INT EDIT, V44, P5038, DOI 10.1002/anie.200501819; Giri S, 2007, NANOMEDICINE-UK, V2, P99, DOI 10.2217/17435889.2.1.99; Hrubesh LW, 1998, J NON-CRYST SOLIDS, V225, P335, DOI 10.1016/S0022-3093(98)00135-5; Hughes GA, 2005, NANOMED-NANOTECHNOL, V1, P22, DOI 10.1016/j.nano.2004.11.009; Jahanshahi M, 2008, AFR J BIOTECHNOL, V7, P4926; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3; Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358; Lai CY, 2003, J AM CHEM SOC, V125, P4451, DOI 10.1021/ja028650l; Leventis N, 2002, NANO LETT, V2, P957, DOI 10.1021/nl025690e; Leventis N, 2007, ACCOUNTS CHEM RES, V40, P874, DOI 10.1021/ar600033s; Leveson NG, 2011, ENG SYST, P251; Liu DM, 1997, CERAM INT, V23, P135, DOI 10.1016/S0272-8842(96)00009-0; Liu HY, 2012, NANOSCALE, V4, P3523, DOI 10.1039/c2nr30396e; Lyons L, 1999, 76 ANN M SE SECT APS, V54; Park JC, 1999, YONSEI MED J, V40, P530, DOI 10.3349/ymj.1999.40.6.530; Power M, 2001, J NON-CRYST SOLIDS, V285, P303, DOI 10.1016/S0022-3093(01)00471-9; Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0; Roy I, 2005, P NATL ACAD SCI USA, V102, P279, DOI 10.1073/pnas.0408039101; Sabri F, 2011, ADV SPACE RES, V47, P419, DOI 10.1016/j.asr.2010.09.014; Sabri F, 2011, P 3 ANN ORNL BIOM SC; Sabri F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033242; Schneider M, 1997, CATAL TODAY, V35, P339, DOI 10.1016/S0920-5861(96)00164-2; Schuh JCL, 2008, TOXICOL PATHOL, V36, P63, DOI 10.1177/0192623307309926; Slack M, 2006, INT UROGYNECOL J, V17, P106, DOI 10.1007/s00192-005-1320-7; Smirnova I, 2004, J NON-CRYST SOLIDS, V350, P54, DOI 10.1016/j.jnoncrysol.2004.06.031; SPECTOR M, 1989, CRIT REV BIOCOMPAT, V5, P269; Thomas V, 2006, CURR NANOSCI, V2, P155; Torney F, 2007, NAT NANOTECHNOL, V2, P295, DOI 10.1038/nnano.2007.108; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645; Yin W, 2010, J BIOMED MATER RES A, V92A, P1431, DOI 10.1002/jbm.a.32476	36	28	28	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50686	10.1371/journal.pone.0050686	http://dx.doi.org/10.1371/journal.pone.0050686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251378	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200035
J	Tran, DA; Shakeshaft, A; Ngo, AD; Rule, J; Wilson, DP; Zhang, L; Doran, C				Dam Anh Tran; Shakeshaft, Anthony; Ngo, Anh Duc; Rule, John; Wilson, David P.; Zhang, Lei; Doran, Christopher			Structural Barriers to Timely Initiation of Antiretroviral Treatment in Vietnam: Findings from Six Outpatient Clinics	PLOS ONE			English	Article							UP HIV TREATMENT; SCALE-UP; THERAPY; STIGMA; ZAMBIA; CARE; ART	In Vietnam, premature mortality due to AIDS-related conditions is commonly associated with late initiation to antiretroviral therapy (ART). This study explores reasons for late ART initiation among people living with HIV (PLHIV) from the perspectives of health care providers and PLHIV. The study was undertaken in six clinics from five provinces in Vietnam. Baseline CD4 counts were collected from patient records and grouped into three categories: very late initiators (<= 100 cells/mm(3) CD4), late initiators (100-200 cells/mm(3)) and timely initiators (200-350 cells/mm(3)). Thirty in-depth interviews with patients who started ART and 15 focus group discussions with HIV service providers were conducted and thematic analysis of the content performed. Of 934 patients, 62% started ART very late and 11% initiated timely treatment. The proportion of patients for whom a CD4 count was obtained within six months of their HIV diagnosis ranged from 22% to 72%. The proportion of patients referred to ART clinics by voluntary testing and counselling centres ranged from 1% to 35%. Structural barriers to timely ART initiation were poor linkage between HIV testing and HIV care and treatment services, lack of patient confidentiality and a shortage of HIV/AIDS specialists. If Vietnam's treatment practice is to align with WHO recommendations then the connection between voluntary counselling and testing service and ART clinics must be improved. Expansion and decentralization of HIV/AIDS services to allow implementation at the community level increased task sharing between doctors and nurses to overcome limited human resources, and improved patient confidentiality are likely to increase timely access to HIV treatment services for more patients.	[Dam Anh Tran; Shakeshaft, Anthony] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Dam Anh Tran; Wilson, David P.; Zhang, Lei] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Ngo, Anh Duc] Univ S Australia, Sch Populat Hlth, Adelaide, SA 5001, Australia; [Rule, John] Univ New S Wales, Sch Publ Hlth, Sydney, NSW, Australia; [Doran, Christopher] Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW 2308, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute; University of South Australia; University of New South Wales Sydney; Hunter Medical Research Institute; University of Newcastle	Tran, DA (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia.	d.tran@unsw.edu.au; lzhang@kirby.unsw.edu.au	Wilson, David P/G-4614-2013; Shakeshaft, Anthony/U-4637-2017; Zhang, Lei/D-4039-2011	Shakeshaft, Anthony/0000-0002-5472-0930; Zhang, Lei/0000-0003-2343-084X; Tran, Anh Dam/0000-0001-8677-4637				[Anonymous], 2010, VIETN 2010 COUNTR PR; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Barnighausen T, 2007, AIDS PATIENT CARE ST, V21, P799, DOI 10.1089/apc.2007.0193; Crisp N, 2008, LANCET, V371, P689, DOI 10.1016/S0140-6736(08)60309-8; Fox MP, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-8; George G, 2010, AIDS CARE, V22, P77, DOI 10.1080/09540120903544439; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Kudale A, 2010, AIDS CARE, V22, P85, DOI 10.1080/09540121003758531; Maher L, 2007, INT J DRUG POLICY, V18, P296, DOI 10.1016/j.drugpo.2006.12.006; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; Muhamadi L, 2010, HEALTH POLICY, V97, P187, DOI 10.1016/j.healthpol.2010.06.003; Nhan TD, 2010, CONTR NAT HIV AIDS C; Ha PN, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.4625; Pharris A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-705; Pharris A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016017; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Riyarto S, 2010, HEALTH POLICY PLANN, V25, P272, DOI 10.1093/heapol/czq004; Srikantiah P, 2010, AIDS, V24, pS62, DOI 10.1097/01.aids.0000390091.45435.ea; Turan J, 2011, AIDS BEHAV; Vietnam Administrative for HIV/AIDS Control, 2011, NAT HIV AIDS EP 1 3; Vietnam Ministry of Health, 2009, NAT GUID HIV AIDS DI; Vu VT, 2011, AIDS CARE, V23, P139, DOI 10.1080/09540121.2010.507741; Walsh A, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-272; WHO, 2010, ANT THER HIV INF AD; WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; World Health Organization, 2006, ANT THER HIV INF AD	26	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51289	10.1371/journal.pone.0051289	http://dx.doi.org/10.1371/journal.pone.0051289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053RN	23240013	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000312290800049
J	Diaz-Ramos, A; Roig-Borrellas, A; Garcia-Melero, A; Llorens, A; Lopez-Alemany, R				Diaz-Ramos, Angels; Roig-Borrellas, Anna; Garcia-Melero, Ana; Llorens, Ana; Lopez-Alemany, Roser			Requirement of Plasminogen Binding to Its Cell-Surface Receptor alpha-Enolase for Efficient Regeneration of Normal and Dystrophic Skeletal Muscle	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; ACTIVATOR UPA; EXPRESSION; BETA; MYOGENESIS; MONOCYTES; IDENTIFICATION; INHIBITION; ISOFORMS; SYSTEM	Adult regenerative myogenesis is central for restoring normal tissue structure and function after muscle damage. In muscle repair after injury, as in severe myopathies, damaged and necrotic fibers are removed by infiltrating inflammatory cells and then replaced by muscle stem cells or satellite cells, which will fuse to form new myofibers. Extracellular proteolysis mediated by uPA-generated plasmin plays a critical role in controlling inflammation and satellite-cell-dependent myogenesis. alpha-enolase has been described as plasminogen receptor in several cell types, where it acts concentrating plasmin proteolytic activity on the cell surface. In this study, we investigated whether alpha-enolase plasminogen receptor plays a regulatory role during the muscular repair process. Inhibitors of alpha-enolase/plasminogen binding: MAb11G1 (a monoclonal antibody against alpha-enolase) and e-aminocaproic acid, EACA (a lysine analogue) inhibited the myogenic abilities of satellite cells-derived myoblasts. Furthermore, knockdown of alpha-enolase decreased myogenic fusion of myoblasts. Injured wild-type mice and dystrophic mdx mice were also treated with MAb11G1 and EACA. These treatments had negative impacts on muscle repair impairing satellite cell functions in vitro in agreement with blunted growth of new myofibers in vivo. Furthermore, both MAb11G1 and EACA treatments impaired adequate inflammatory cell infiltration and promoted extracellular matrix deposition in vivo, which resulted in persistent degeneration. These results demonstrate the novel requirement of alpha-enolase for restoring homeostasis of injured muscle tissue, by controlling the pericellular localization of plasmin activity.	[Diaz-Ramos, Angels; Roig-Borrellas, Anna; Garcia-Melero, Ana; Llorens, Ana; Lopez-Alemany, Roser] IDIBELL Inst Invest Biomed Bellvitge, Biol Clues Invas & Metastat Phenotype Res Grp, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Lopez-Alemany, R (corresponding author), IDIBELL Inst Invest Biomed Bellvitge, Biol Clues Invas & Metastat Phenotype Res Grp, Barcelona, Spain.	rlopez@idibell.cat	Lopez-Alemany, Roser/R-3565-2018	Lopez-Alemany, Roser/0000-0002-0913-0691	Ministerio de Ciencia e Innovacion, Spain [SAF2004-04717, SAF2007-63596]; Association Francaise des Myopathies, France [AFM 9869]; AFM	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Association Francaise des Myopathies, France; AFM(Association Francaise contre les Myopathies)	This study was supported by the Ministerio de Ciencia e Innovacion, Spain (SAF2004-04717, SAF2007-63596) and Association Francaise des Myopathies, France (AFM 9869). M.A.D. was supported by an AFM pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae GU, 2008, J BIOL CHEM, V283, P8301, DOI 10.1074/jbc.M706730200; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bryer SC, 2007, AM J PHYSIOL-REG I, V293, pR1152, DOI 10.1152/ajpregu.00132.2007; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Burysek L, 2002, J BIOL CHEM, V277, P33509, DOI 10.1074/jbc.M201941200; Butterfield DA, 2009, J NEUROCHEM, V111, P915, DOI 10.1111/j.1471-4159.2009.06397.x; Chen XP, 2009, CELL ADHES MIGR, V3, P337, DOI 10.4161/cam.3.4.9338; Das R, 2009, CIRC RES, V105, P167, DOI 10.1161/CIRCRESAHA.109.200311; De Sousa LP, 2005, BIOCHEM BIOPH RES CO, V329, P237, DOI 10.1016/j.bbrc.2005.01.123; Fisher BA, 2011, ANN RHEUM DIS, V70, P1095, DOI 10.1136/ard.2010.138909; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Herren T, 2006, BIOCHEMISTRY-US, V45, P9463, DOI 10.1021/bi060756w; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Irigoyen JP, 1999, CELL MOL LIFE SCI, V56, P104, DOI 10.1007/PL00000615; Keller A, 2007, BBA-GEN SUBJECTS, V1770, P919, DOI 10.1016/j.bbagen.2007.01.015; Koh TJ, 2005, AM J PHYSIOL-CELL PH, V289, pC217, DOI 10.1152/ajpcell.00555.2004; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; Lluis F, 2001, BLOOD, V97, P1703, DOI 10.1182/blood.V97.6.1703; Lopez-Alemany R, 2003, THROMB HAEMOSTASIS, V90, P724, DOI 10.1160/TH03-04-0291; Lopez-Alemany R, 2003, AM J HEMATOL, V72, P234, DOI 10.1002/ajh.10299; LOPEZALEMANY R, 1994, THROMB RES, V75, P371, DOI 10.1016/0049-3848(94)90252-6; Merkulova T, 2000, EUR J BIOCHEM, V267, P3735, DOI 10.1046/j.1432-1327.2000.01408.x; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Montes A, 2011, ARTHRITIS RHEUM-US, V63, P654, DOI 10.1002/art.30186; MunozCanoves P, 1997, THROMB HAEMOSTASIS, V77, P526; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Petrak J, 2008, PROTEOMICS, V8, P1744, DOI 10.1002/pmic.200700919; PimoradyEsfahani A, 1997, MUSCLE NERVE, V20, P158, DOI 10.1002/(SICI)1097-4598(199702)20:2<158::AID-MUS4>3.0.CO;2-B; REDLITZ A, 1995, EUR J BIOCHEM, V227, P407, DOI 10.1111/j.1432-1033.1995.tb20403.x; Sousa LP, 2005, BIOCHEM BIOPH RES CO, V337, P1065, DOI 10.1016/j.bbrc.2005.09.154; STEIN O, 1993, ARTERIOSCLER THROMB, V13, P1350, DOI 10.1161/01.ATV.13.9.1350; Suelves M, 2005, FRONT BIOSCI-LANDMRK, V10, P2978, DOI 10.2741/1754; Suelves M, 2002, BLOOD, V99, P2835, DOI 10.1182/blood.V99.8.2835; Suelves M, 2007, J CELL BIOL, V178, P1039, DOI 10.1083/jcb.200705127; Syrovets T, 2001, BLOOD, V97, P3941, DOI 10.1182/blood.V97.12.3941; TAYLOR JM, 1995, J BIOL CHEM, V270, P2535, DOI 10.1074/jbc.270.6.2535; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Wold F., 1971, ENZYMES, P499; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837; Zhou WD, 2010, J PROTEOME RES, V9, P2929, DOI 10.1021/pr901109w	42	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50477	10.1371/journal.pone.0050477	http://dx.doi.org/10.1371/journal.pone.0050477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239981	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800019
J	Evans, RD; Murray, KL; Field, SN; Moore, JAY; Shedrawi, G; Huntley, BG; Fearns, P; Broomhall, M; McKinna, LIW; Marrable, D				Evans, Richard D.; Murray, Kathy L.; Field, Stuart N.; Moore, James A. Y.; Shedrawi, George; Huntley, Barton G.; Fearns, Peter; Broomhall, Mark; McKinna, Lachlan I. W.; Marrable, Daniel			Digitise This! A Quick and Easy Remote Sensing Method to Monitor the Daily Extent of Dredge Plumes	PLOS ONE			English	Article							ENVIRONMENTAL IMPACTS; SEDIMENTATION; TECHNOLOGIES; TEMPERATURE; SETTLEMENT	Technological advancements in remote sensing and GIS have improved natural resource managers' abilities to monitor large-scale disturbances. In a time where many processes are heading towards automation, this study has regressed to simple techniques to bridge a gap found in the advancement of technology. The near-daily monitoring of dredge plume extent is common practice using Moderate Resolution Imaging Spectroradiometer (MODIS) imagery and associated algorithms to predict the total suspended solids (TSS) concentration in the surface waters originating from floods and dredge plumes. Unfortunately, these methods cannot determine the difference between dredge plume and benthic features in shallow, clear water. This case study at Barrow Island, Western Australia, uses hand digitising to demonstrate the ability of human interpretation to determine this difference with a level of confidence and compares the method to contemporary TSS methods. Hand digitising was quick, cheap and required very little training of staff to complete. Results of ANOSIM R statistics show remote sensing derived TSS provided similar spatial results if they were thresholded to at least 3 mg L-1. However, remote sensing derived TSS consistently provided false-positive readings of shallow benthic features as Plume with a threshold up to TSS of 6 mg L-1, and began providing false-negatives (excluding actual plume) at a threshold as low as 4 mg L-1. Semi-automated processes that estimate plume concentration and distinguish between plumes and shallow benthic features without the arbitrary nature of human interpretation would be preferred as a plume monitoring method. However, at this stage, the hand digitising method is very useful and is more accurate at determining plume boundaries over shallow benthic features and is accessible to all levels of management with basic training.	[Evans, Richard D.; Murray, Kathy L.; Field, Stuart N.; Moore, James A. Y.; Shedrawi, George; Huntley, Barton G.] Dept Environm & Conservat, Kensington, WA, Australia; [Evans, Richard D.; Field, Stuart N.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Fearns, Peter; Broomhall, Mark; McKinna, Lachlan I. W.; Marrable, Daniel] Curtin Univ Technol, Remote Sensing & Satellite Res Grp, Dept Imaging & Appl Phys, Bentley, WA 6102, Australia	University of Western Australia; Curtin University	Evans, RD (corresponding author), Dept Environm & Conservat, Kensington, WA, Australia.	richard.evans@dec.wa.gov.au	Evans, Richard D./O-3559-2019; Evans, Richard D/K-5779-2013; Broomhall, Mark/C-1658-2013; Moore, James/K-3698-2013; McKinna, Lachlan/E-4312-2013; Fearns, Peter/A-5291-2008	Evans, Richard D./0000-0003-4364-4810; Broomhall, Mark/0000-0002-0255-4205; Moore, James/0000-0003-4641-8667; Fearns, Peter/0000-0002-2747-9037; Huntley, Barton/0000-0002-9519-4105; Shedrawi, George/0000-0002-4507-7293	Dredging Audit and Surveillance Program by the Gorgon Joint Venture as part of the environmental offsets	Dredging Audit and Surveillance Program by the Gorgon Joint Venture as part of the environmental offsets	This project was funded as part of the Dredging Audit and Surveillance Program by the Gorgon Joint Venture as part of the environmental offsets. The Gorgon project is a joint venture of the Australian subsidiaries of Chevron, Exxonmobil, Shell, Osaka Gas, Tokyo Gas and Chubu Electric Power. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Perez F, 2003, OCEAN COAST MANAGE, V46, P583, DOI 10.1016/S0964-5691(03)00036-X; BABCOCK R, 1991, CORAL REEFS, V9, P205, DOI 10.1007/BF00290423; Bainbridge ZT, 2012, MAR POLLUT BULL, V65, P236, DOI 10.1016/j.marpolbul.2012.01.043; Baith K., 2001, EOS T AM GEOPHYS UN, V82, P202, DOI [10.1029/01eo00109, DOI 10.1029/01E000109, DOI 10.1029/01EO00109]; BAK RPM, 1978, MAR POLLUT BULL, V9, P14, DOI 10.1016/0025-326X(78)90275-8; Chevron-Australia, 2009, G1NTPLNX0000373 CHEV, P255; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; DEC (Department of Environment and Conservation), 2007, MAN PLAN MONT BARR I; Devlin MJ, 2012, MAR POLLUT BULL, V65, P224, DOI 10.1016/j.marpolbul.2012.03.001; Dickins D, 2011, COLD REG SCI TECHNOL, V65, P275, DOI 10.1016/j.coldregions.2010.10.015; Eastman J. R., 2009, IDRISI TAIGA; Erftemeijer PLA, 2006, MAR POLLUT BULL, V52, P1553, DOI 10.1016/j.marpolbul.2006.09.006; ESRI, 1999, ARCGIS 9.2 Build 1500, Patent No. [Patent No. 5 710 835, 5710835]; Gilmour J, 1999, MAR BIOL, V135, P451, DOI 10.1007/s002270050645; Gorley C.K., 2006, GETTING STARTED PRIM; Gutman G, 2012, INT J REMOTE SENS, V33, P4700, DOI 10.1080/01431161.2011.638341; Heath B, 2002, P 11 AUSTR RERM SENS, P476; IMCRA, 2006, GUID INT MAR COAST R; Islam A, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2834768; Johnston CA, 1998, GEOGRAPHIC INFORM SY; Kutser T, 2007, J COASTAL RES, P180; Lambrechts J, 2010, ESTUAR COAST SHELF S, V89, P154, DOI 10.1016/j.ecss.2010.06.009; Lyngby JE, 1996, MAR ECOL-P S Z N I, V17, P345, DOI 10.1111/j.1439-0485.1996.tb00513.x; Mas JF, 2004, ENVIRON MODELL SOFTW, V19, P461, DOI 10.1016/S1364-8152(03)00161-0; Miller RL, 2004, REMOTE SENS ENVIRON, V93, P259, DOI 10.1016/j.rse.2004.07.012; Modarres R, 2007, J STAT PLAN INFER, V137, P3643, DOI 10.1016/j.jspi.2007.03.040; Ni-Meister W., 2000, REMOTE SENSING REV, V18, P441; Partridge GJ, 2010, J FISH BIOL, V77, P227, DOI 10.1111/j.1095-8649.2010.02679.x; Pope RM, 1997, APPL OPTICS, V36, P8710, DOI 10.1364/AO.36.008710; Purdy R, 2010, J ENVIRON LAW, V22, P59, DOI 10.1093/jel/eqp027; Qian YG, 2012, INT J REMOTE SENS, V33, P5009, DOI 10.1080/01431161.2012.657365; Rodriguez-Guzman V., 2009, INT J SYSTEMS APPL E, V1, P36; Satapathy DR, 2008, INT J REMOTE SENS, V29, P355, DOI 10.1080/01431160701269002; Scott LP, 2007, J APPL REMOTE SENS, V1; Smith R, 1998, ANTIGONISH REV, P9; Vargas-Angel B, 2007, J INVERTEBR PATHOL, V95, P140, DOI 10.1016/j.jip.2007.01.003; Wells FE, 2000, RECORDS W AUSTR MUSE, P9; William BG, 2007, J APPL REMOTE SENS, V1; Wilson JS, 2005, J URBAN PLAN DEV, V131, P159, DOI 10.1061/(ASCE)0733-9488(2005)131:3(159)	39	26	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51668	10.1371/journal.pone.0051668	http://dx.doi.org/10.1371/journal.pone.0051668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240055	gold, Green Published, Green Submitted			2022-12-27	WOS:000312290800091
J	Rafiq, S; Russell, ML; Webby, R; Fonseca, K; Smieja, M; Singh, P; Loeb, M				Rafiq, Sajjad; Russell, Margaret L.; Webby, Richard; Fonseca, Kevin; Smieja, Marek; Singh, Pardeep; Loeb, Mark			Serological Response to Influenza Vaccination among Children Vaccinated for Multiple Influenza Seasons	PLOS ONE			English	Article								Background: To evaluate if, among children aged 3 to 15 years, influenza vaccination for multiple seasons affects the proportion sero-protected. Methodology/Principal Findings: Participants were 131 healthy children aged 3-15 years. Participants were vaccinated with trivalent inactivated seasonal influenza vaccine (TIV) over the 2005-06, 2006-07 and 2007-8 seasons. Number of seasons vaccinated were categorized as one (2007-08); two (2007-08 and 2006-07 or 2007-08 and 2005-06) or three (2005-06, 2006-07, and 2007-08). Pre- and post-vaccination sera were collected four weeks apart. Antibody titres were determined by hemagglutination inhibition (HAI) assay using antigens to A/Solomon Islands/03/06 (H1N1), A/Wisconsin/67/05 (H3N2) and B/Malaysia/2506/04. The proportions sero-protected were compared by number of seasons vaccinated using cut-points for seroprotection of 1:40 vs. 1:320. The proportions of children sero-protected against H1N1 and H3N2 was high (>85%) regardless of number of seasons vaccinated and regardless of cut-point for seroprotection. For B Malaysia there was no change in proportions sero-protected by number of seasons vaccinated; however the proportions protected were lower than for H1N1 and H3N2, and there was a lower proportion sero-protected when the higher, compared to lower, cut-point was used for sero-protection. Conclusion/Significance: The proportion of children sero-protected is not affected by number of seasons vaccinated.	[Russell, Margaret L.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Rafiq, Sajjad; Smieja, Marek; Singh, Pardeep; Loeb, Mark] McMaster Univ, Dept Pathol, Hamilton, ON, Canada; [Webby, Richard] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Fonseca, Kevin] Prov Lab Publ Hlth, Calgary, AB, Canada; [Smieja, Marek; Loeb, Mark] McMaster Univ, Dept Mol Med, Hamilton, ON, Canada; [Smieja, Marek; Loeb, Mark] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada; [Smieja, Marek; Loeb, Mark] McMaster Univ, Dept Biostat, Hamilton, ON, Canada	University of Calgary; McMaster University; St Jude Children's Research Hospital; McMaster University; McMaster University; McMaster University	Russell, ML (corresponding author), Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.	mlrussel@ucalgary.ca	Webby, Richard J/N-5657-2018	Rafiq, Sajjad/0000-0003-4873-4540; kumbara, arya/0000-0002-0395-1245	Canadian Institutes for Health Research (CIHR) [XIP 85564]; National Institute of Allergy and Infectious Diseases (NIH) [1 R34 AI072268-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R34AI072268] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute of Allergy and Infectious Diseases (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Canadian Institutes for Health Research (CIHR): Grant XIP 85564 (http://www.cihr-irsc.gc.ca/) and National Institute of Allergy and Infectious Diseases (NIH): Grant 1 R34 AI072268-01 (http://www.niaid.nih.gov/Pages/default.aspx). Alberta Health and Wellness donated seasonal influenza vaccine for 2005-06 and for 2006-07 (Fluviral (R) GlaxoSmithKline Inc) but provided no funding for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advisory Committee on Immunization Practices, 2006, MMWR Recomm Rep, V55, P1; Beyer WEP, 2004, VIRUS RES, V103, P125, DOI 10.1016/j.virusres.2004.02.024; BLACK SC, 2011, PEDIATR INFECT DIS J, V40, P30; Canada Health Canada, 2004, Canada Communicable Disease Report, V30, P1; Canada National Advisory Committee on Immunization, 2006, Canada Communicable Disease Report, V32, P1; CDC, 2008, MMWR EARLY RELEASE, V57, P1; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Gross PA, 1999, VACCINE, V17, P2284, DOI 10.1016/S0264-410X(98)00478-2; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Morens DM, 2010, EMERG INFECT DIS, V16, P1023, DOI 10.3201/eid1606.100453; National Advisory Committee on Immunization (NACI), 2007, Can Commun Dis Rep, V33, P1; Orr P., 2005, Canada Communicable Disease Report, V31, P1; World Health Organization, 2002, WHO MAN AN INFL DIAG; Zeman AM, 2007, PEDIATR INFECT DIS J, V26, P107, DOI 10.1097/01.inf.0000253251.03785.9b	15	0	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51498	10.1371/journal.pone.0051498	http://dx.doi.org/10.1371/journal.pone.0051498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240030	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800066
J	Sokolov, V; Ehrich, D; Yoccoz, NG; Sokolov, A; Lecomte, N				Sokolov, Vasiliy; Ehrich, Dorothee; Yoccoz, Nigel G.; Sokolov, Alexander; Lecomte, Nicolas			Bird Communities of the Arctic Shrub Tundra of Yamal: Habitat Specialists and Generalists	PLOS ONE			English	Article							POPULATION TRENDS; BIOTIC HOMOGENIZATION; ELLESMERE-ISLAND; ALEXANDRA FJORD; RESILIENCE; PENINSULA; FOREST; WILLOW	Background: The ratio of habitat generalists to specialists in birds has been suggested as a good indicator of ecosystem changes due to e. g. climate change and other anthropogenic perturbations. Most studies focusing on this functional component of biodiversity originate, however, from temperate regions. The Eurasian Arctic tundra is currently experiencing an unprecedented combination of climate change, change in grazing pressure by domestic reindeer and growing human activity. Methodology/Principal Findings: Here we monitored bird communities in a tundra landscape harbouring shrub and open habitats in order to analyse bird habitat relationships and quantify habitat specialization. We used ordination methods to analyse habitat associations and estimated the proportions of specialists in each of the main habitats. Correspondence Analysis identified three main bird communities, inhabiting upland, lowland and dense willow shrubs. We documented a stable structure of communities despite large multiannual variations of bird density (from 90 to 175 pairs/km(2)). Willow shrub thickets were a hotspot for bird density, but not for species richness. The thickets hosted many specialized species whose main distribution area was south of the tundra. Conclusion/Significance: If current arctic changes result in a shrubification of the landscape as many studies suggested, we would expect an increase in the overall bird abundance together with an increase of local specialists, since they are associated with willow thickets. The majority of these species have a southern origin and their increase in abundance would represent a strengthening of the boreal component in the southern tundra, perhaps at the expense of species typical of the subarctic zone, which appear to be generalists within this zone.	[Sokolov, Vasiliy] Russian Acad Sci, Ural Div, Inst Plant & Anim Ecol, Ekaterinburg, Russia; [Ehrich, Dorothee; Yoccoz, Nigel G.; Lecomte, Nicolas] Univ Tromso, Dept Arct & Marine Biol, Tromso, Norway; [Sokolov, Alexander] Russian Acad Sci, Ural Div, Inst Plant & Anim Ecol, Ecol Res Stn, Labytnangi, Russia	Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; UiT The Arctic University of Tromso; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences	Sokolov, V (corresponding author), Russian Acad Sci, Ural Div, Inst Plant & Anim Ecol, Ekaterinburg, Russia.	vskolov@inbox.ru; nigel.yoccoz@uit.no	Ehrich, Dorothee/F-6492-2015; Sokolov, Aleksandr/P-3421-2017; Sokolov, Vasiliy/B-3657-2013; Yoccoz, Nigel/C-8561-2014	Ehrich, Dorothee/0000-0002-3028-9488; Sokolov, Aleksandr/0000-0002-1521-3856; Sokolov, Vasiliy/0000-0002-0115-3151; Yoccoz, Nigel/0000-0003-2192-1039; Lecomte, Nicolas/0000-0002-8473-5375	Russian Academy of Sciences [12-Pi-4-1043, 12-4-7-022-Arctic]; Russian Foundation for Basic Research support [11-04-01153-a]; Research Council of Norway through the Yggdrasil program [195738/V11]; University of Tromso; IPY project "Arctic Predators''; Natural Sciences and Engineering Research Council of Canada	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research support; Research Council of Norway through the Yggdrasil program(Research Council of Norway); University of Tromso; IPY project "Arctic Predators''; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Russian Academy of Sciences through the project no. 12-Pi-4-1043 and 12-4-7-022-Arctic (Ural Branch), the Russian Foundation for Basic Research support (grant no. 11-04-01153-a), the Research Council of Norway through the Yggdrasil program (project no. 195738/V11 to V.S.), University of Tromso, and the IPY project "Arctic Predators'' (http://www.arctic-predators.uit.no), as well as a postdoctoral fellowship from Natural Sciences and Engineering Research Council of Canada to N.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres BA, 2006, ARCTIC, V59, P311, DOI 10.14430/arctic316; [Anonymous], 2010, R LANG ENV STAT COMP; Baril Lisa M., 2009, Yellowstone Science, V17, P19; Barnagaud JY, 2011, GLOBAL ECOL BIOGEOGR, V20, P630, DOI 10.1111/j.1466-8238.2010.00629.x; Brathen KA, 2007, ECOSYSTEMS, V10, P773, DOI 10.1007/s10021-007-9058-3; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; Chernov YI, 1997, ECOSY WORLD, V3, P361; Chessel D., 2004, R NEWS, V4, P5; Chessel D, 1987, REV STAT APPL, V35, P55; Clavel J, 2010, FRONTIERS ECOLOGY EN; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Clavero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018581; Danilov NN, 1984, BIRDS YAMAL; Danilov NN, 1966, P I BIOL UD RAS, P1; Davey CM, 2012, GLOBAL ECOL BIOGEOGR, V21, P568, DOI 10.1111/j.1466-8238.2011.00693.x; Den Herder M, 2004, J APPL ECOL, V41, P870, DOI 10.1111/j.0021-8901.2004.00952.x; den Herder M, 2008, BASIC APPL ECOL, V9, P324, DOI 10.1016/j.baae.2007.03.005; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Filippi-Codaccioni O, 2010, BIOL CONSERV, V143, P1493, DOI 10.1016/j.biocon.2010.03.031; Forbes BC, 2004, AMBIO, V33, P377, DOI 10.1639/0044-7447(2004)033[0377:GVIADT]2.0.CO;2; Forbes BC, 2009, P NATL ACAD SCI USA, V106, P22041, DOI 10.1073/pnas.0908286106; FREEDMAN B, 1982, CAN FIELD NAT, V96, P56; Golovatin MG, 2010, ENVIRON RES ADV, P1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Greenacre M, 2010, ECOLOGY, V91, P958, DOI 10.1890/09-0239.1; Gregory RD, 2010, ORNITHOL SCI, V9, P3, DOI 10.2326/osj.9.3; Hausner VH, 2003, ECOL APPL, V13, P999, DOI 10.1890/1051-0761(2003)13[999:SITFML]2.0.CO;2; Ims RA, 2007, ECOSYSTEMS, V10, P607, DOI 10.1007/s10021-007-9060-9; Ims RA, 2012, BIOL CONSERV, V149, P2, DOI 10.1016/j.biocon.2012.02.008; Jackson CR, 2011, J NAT CONSERV, V19, P87, DOI 10.1016/j.jnc.2010.06.006; JARVINEN O, 1979, Holarctic Ecology, V2, P75; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Killengreen ST, 2012, DIVERS DISTRIB, V18, P563, DOI 10.1111/j.1472-4642.2011.00861.x; Killengreen ST, 2011, J ANIM ECOL, V80, P1049, DOI 10.1111/j.1365-2656.2011.01840.x; KUCHERUK V V, 1975, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V80, P52; Liebezeit JR, 2009, ECOL APPL, V19, P1628, DOI 10.1890/08-1661.1; Magomedova MA., 2006, YAMAL PENINSULA VEGE; Naito AT, 2011, PROG PHYS GEOG, V35, P423, DOI 10.1177/0309133311403538; Niemi GJ, 2004, ANNU REV ECOL EVOL S, V35, P89, DOI 10.1146/annurev.ecolsys.35.112202.130132; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Reif J, 2008, BIODIVERS CONSERV, V17, P3307, DOI 10.1007/s10531-008-9430-4; Ripple WJ, 2005, WEST N AM NATURALIST, V65, P269; RODRIGUES R, 1994, ECOL APPL, V4, P110, DOI 10.2307/1942120; Ryabitsev VK, 1993, DISTRIBUTION DYNAMIC; Sammler JE, 2008, CONDOR, V110, P325, DOI 10.1525/cond.2008.8438; Sdobnikov VM, 1937, P ALLUNION ARCTIC I, V94, P1; Shiyatov S., 1995, NATURE YAMAL, P32; Sokolov V.A., 2006, Izvestiya Chelyabinskogo Nauchnogo Tsentra, V3, P109; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TOMIALOJC L, 1990, AUK, V107, P447; Trefry SA, 2010, ARCTIC, V63, P308; Uspenskiy SM, 1960, LATITUDINAL ZONALITY, P55; Virkkala R, 2008, BIOL CONSERV, V141, P1343, DOI 10.1016/j.biocon.2008.03.007; Walker DA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045004; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Wiens J.A., 1992, ECOLOGY BIRD COMMUNI; Zhitkov BM, 1912, YB ZOOLOGICAL MUSEUM, V17, P311	63	31	33	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50335	10.1371/journal.pone.0050335	http://dx.doi.org/10.1371/journal.pone.0050335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239978	Green Published, gold			2022-12-27	WOS:000312290800016
J	Chen, Z; Wang, X; Ding, Z; Fan, PY; Ma, GS				Chen, Zhong; Wang, Xin; Ding, Zhen; Fan, Peiying; Ma, Genshan			Differences in Statin Usage and Target-Goal Achievement between Departments at the Same Hospital	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LOW-DENSITY-LIPOPROTEIN; PANEL-III GUIDELINES; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; CHOLESTEROL LEVELS; DIABETES-MELLITUS; RISK-FACTORS; SECONDARY PREVENTION; RANDOMIZED-TRIALS	Objective: To compare use of statins and target-goal achievement in patients with type 2 diabetes mellitus (T2DM), with or without stable coronary artery disease (CAD), between cardiology and endocrinology departments at a tertiary hospital. Methods: A total of 966 patients with T2DM were enrolled, including 553 with stable CAD, from the departments of endocrinology and cardiology. Baseline characteristics, prescription of statins, and target-goal achievement of low-density lipoprotein cholesterol (LDL-C) during a 6-month follow-up period were analyzed. Results: There was lower ratio of statin use in patients with T2DM, with or without CAD, in the department of endocrinology than in the department of cardiology (all P<0.05). At the 6-month follow-up, compared to patients with T2DM in the endocrinology department, target-goal achievement among patients with T2DM in the department of cardiology was higher (52.90% vs. 41.46%, P<0.01), indicating a significant improvement among patients in the department of cardiology but not for those in the department of endocrinology when compared to baseline. According to the new Chinese guidelines, the goal attainment rate was higher among patients with T2DM combined with CAD in the department of cardiology than in the department of endocrinology (27.62% vs. 19.05%, P<0.05). However, with regard to ATP III 2004, the goal attainment rate was similar for patients with T2DM combined with CAD in both departments during the 6-month follow-up (9.21% vs. 8.84%, P>0.05), with no apparent improvement compared to baseline. Conclusions: There was differential and sub-optimal use of statins as well as low target-goal achievement among patients with T2DM, with or without CAD, in the departments of cardiology and endocrinology at the same tertiary hospital, with a lower rate of statin prescription and target-goal achievement of LDL-C in the department of endocrinology.	[Chen, Zhong] Southeast Univ, Dept Cardiol, Affiliated Zhongda Hosp, Nanjing, Jiangsu, Peoples R China; Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Chen, Z (corresponding author), Southeast Univ, Dept Cardiol, Affiliated Zhongda Hosp, Nanjing, Jiangsu, Peoples R China.	zhongchen7498@hotmail.com						Allen JK, 2010, J CARDIOVASC NURS, V25, P207, DOI 10.1097/JCN.0b013e3181cc79be; Almdal T, 2004, ARCH INTERN MED, V164, P1422, DOI 10.1001/archinte.164.13.1422; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Ansell BJ, 2006, AM HEART J, V152, P976, DOI 10.1016/j.ahj.2006.05.013; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bouillon K, 2011, HEART, V97, P923, DOI 10.1136/hrt.2010.216309; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen Z, 2010, MOL BIOL REP, V37, P207, DOI 10.1007/s11033-009-9597-0; Chen Z, 2009, ACTA CARDIOL, V64, P379, DOI 10.2143/AC.64.3.2038025; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Ford ES, 2011, DIABETES CARE, V34, P1337, DOI 10.2337/dc10-2251; Genser B, 2006, CLIN RES CARDIOL, V95, P393, DOI 10.1007/s00392-006-0403-x; Gong YJ, 2012, J ZHEJIANG UNIV-SC B, V13, P231, DOI 10.1631/jzus.B1100299; Gregg EW, 2012, DIABETES CARE, V35, P1252, DOI 10.2337/dc11-1162; Gregg EW, 2009, JAMA-J AM MED ASSOC, V301, P1596, DOI 10.1001/jama.2009.519; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; HU YH, 1991, ACTA DIABETOL, V28, P169, DOI 10.1007/BF00579721; Kahn R, 2008, CIRCULATION, V118, P576, DOI 10.1161/CIRCULATIONAHA.108.190186; Leeper NJ, 2007, CIRCULATION, V116, P613, DOI 10.1161/CIRCULATIONAHA.107.694117; Lewis SJ, 1998, ANN INTERN MED, V129, P681, DOI 10.7326/0003-4819-129-9-199811010-00002; Li R, 2010, DIABETES CARE, V33, P1872, DOI 10.2337/dc10-0843; Maki KC, 2006, CAN J CARDIOL, V22, P315, DOI 10.1016/S0828-282X(06)70916-3; Miettinen H, 1998, DIABETES CARE, V21, P69, DOI 10.2337/diacare.21.1.69; Morales-Villegas EC, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/904742; Nicholls SJ, 2010, AM J CARDIOL, V105, P69, DOI 10.1016/j.amjcard.2009.08.651; PEDERSEN TR, 1994, LANCET, V344, P1383; Preis SR, 2009, CIRCULATION, V120, P212, DOI 10.1161/CIRCULATIONAHA.108.846519; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Soran OZ, 2010, J CARD FAIL, V16, P859, DOI 10.1016/j.cardfail.2010.05.028; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Virani SS, 2011, AM J MED, V124, P876, DOI 10.1016/j.amjmed.2011.02.012; Virani SS, 2011, AM HEART J, V161, P1140, DOI 10.1016/j.ahj.2011.03.023; Wu Yang-feng, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P420; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	39	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50466	10.1371/journal.pone.0050466	http://dx.doi.org/10.1371/journal.pone.0050466			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251371	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900013
J	Huang, ZX; Chen, ZS; Ke, CH; Zhao, J; You, WW; Zhang, J; Dong, WT; Chen, J				Huang, Zi-Xia; Chen, Zhi-Sen; Ke, Cai-Huan; Zhao, Jing; You, Wei-Wei; Zhang, Jie; Dong, Wei-Ting; Chen, Jun			Pyrosequencing of Haliotis diversicolor Transcriptomes: Insights into Early Developmental Molluscan Gene Expression	PLOS ONE			English	Article							LARVAL DEVELOPMENT; GASTROPOD HALIOTIS; RNA-SEQ; ABALONE; PROTEIN; IDENTIFICATION; METAMORPHOSIS; SPECIFICATION; TRANSITION; GENERATION	Background: The abalone Haliotis diversicolor is a good model for study of the settlement and metamorphosis, which are widespread marine ecological phenomena. However, information on the global gene backgrounds and gene expression profiles for the early development of abalones is lacking. Methodology/Principal Findings: In this study, eight non-normalized and multiplex barcode-labeled transcriptomes were sequenced using a 454 GS system to cover the early developmental stages of the abalone H. diversicolor. The assembly generated 35,415 unigenes, of which 7,566 were assigned GO terms. A global gene expression profile containing 636 scaffolds/contigs was constructed and was proven reliable using qPCR evaluation. It indicated that there may be existing dramatic phase transitions. Bioprocesses were proposed, including the 'lock system' in mature eggs, the collagen shells of the trochophore larvae and the development of chambered extracellular matrix (ECM) structures within the earliest postlarvae. Conclusion: This study globally details the first 454 sequencing data for larval stages of H. diversicolor. A basic analysis of the larval transcriptomes and cluster of the gene expression profile indicates that each stage possesses a batch of specific genes that are indispensable during embryonic development, especially during the two-cell, trochophore and early postlarval stages. These data will provide a fundamental resource for future physiological works on abalones, revealing the mechanisms of settlement and metamorphosis at the molecular level.	[Huang, Zi-Xia; Chen, Zhi-Sen; Ke, Cai-Huan; Chen, Jun] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Huang, Zi-Xia; Chen, Zhi-Sen; Ke, Cai-Huan; Zhao, Jing; You, Wei-Wei; Zhang, Jie; Dong, Wei-Ting; Chen, Jun] Xiamen Univ, Coll Ocean & Earth Sci, Dept Marine Biol, Xiamen, Peoples R China	Xiamen University; Xiamen University	Chen, J (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	chenjun@xmu.edu.cn	Ke, CH/G-4635-2010; Huang, Zixia/AAO-6936-2021	Huang, Zixia/0000-0002-1298-0486	National Natural Science Foundation of China [40976093]; National Basic Research Program of China (973) [2010CB126403]; Hi-Tech Research and Development (863) Program of China [2012AA10A412]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973)(National Basic Research Program of China); Hi-Tech Research and Development (863) Program of China(National High Technology Research and Development Program of China)	This research was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn) (General Program, number 40976093), by the National Basic Research Program of China (973) (http://www.973.gov.cn/English/Index.aspx) (number 2010CB126403), and by the Hi-Tech Research and Development (863) Program of China (http://www.863.gov.cn/) (number 2012AA10A412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolopoulos J, 2001, DNA CELL BIOL, V20, P625, DOI 10.1089/104454901753340613; Becker S, 2001, GENE, V262, P15, DOI 10.1016/S0378-1119(00)00548-5; Chen J, 2012, INT J DEV BIOL, V56, P369, DOI 10.1387/ijdb.113487zc; Clark ME, 2000, GENOMICS, V67, P343, DOI 10.1006/geno.2000.6246; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; CONSUL PC, 1973, TECHNOMETRICS, V15, P791, DOI 10.2307/1267389; Craft JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008875; DEAN RB, 1951, ANAL CHEM, V23, P636, DOI 10.1021/ac60052a025; Degnan Bernard M., 1993, Molecular Marine Biology and Biotechnology, V2, P1; DEGNAN BM, 1995, AM ZOOL, V35, P391; Fiedler TJ, 2010, COMP BIOCHEM PHYS D, V5, P165, DOI 10.1016/j.cbd.2010.03.003; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Franchini Paolo, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-59; Giusti AF, 2000, EVOL DEV, V2, P294, DOI 10.1046/j.1525-142x.2000.00071.x; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Heyland A, 2011, J EXP ZOOL PART B, V316B, P113, DOI 10.1002/jez.b.21383; Hinman VF, 2003, EVOL DEV, V5, P508, DOI 10.1046/j.1525-142X.2003.03056.x; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Huan P, 2011, MAR BIOTECHNOL; Isachenko N, 2006, ONCOGENE, V25, P317, DOI 10.1038/sj.onc.1209022; Jackson D, 2005, MAR BIOL, V147, P681, DOI 10.1007/s00227-005-1603-z; Jackson D, 2002, INT J DEV BIOL, V46, P679; Jackson DJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-40; Jiang JZ, 2011, MAR GENOM, V4, P189, DOI 10.1016/j.margen.2011.05.001; Kamei N, 2000, DEV BIOL, V225, P267, DOI 10.1006/dbio.2000.9837; KITAMOTO Y, 1994, P NATL ACAD SCI USA, V91, P7588, DOI 10.1073/pnas.91.16.7588; Lambert JD, 2010, INTEGR COMP BIOL, V50, P768, DOI 10.1093/icb/icq121; Larade K, 2004, BIOCHEM CELL BIOL, V82, P285, DOI 10.1139/o04-001; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin AYM, 2008, ACTA BIOMATER, V4, P131, DOI 10.1016/j.actbio.2007.05.005; Luetjens CM, 1998, ZYGOTE, V6, P239, DOI 10.1017/S0967199498000185; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Milan M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-234; Miles WO, 2012, GENE DEV, V26, P356, DOI 10.1101/gad.182568.111; Moran AL, 2003, BIOL BULL-US, V204, P270, DOI 10.2307/1543598; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; MORSE DE, 1979, SCIENCE, V204, P407, DOI 10.1126/science.204.4391.407; Page LR, 2006, EVOL DEV, V8, P458, DOI 10.1111/j.1525-142X.2006.00119.x; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Quilang J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-157; RD R, 2001, J SHELLFISH RES, V20; Roberts RJ, 2001, J FISH DIS, V24, P1; Sawatpeera S, 2001, J SHELLFISH RES, V20, P593; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; vandenBiggelaar JAM, 1997, SEMIN CELL DEV BIOL, V8, P367, DOI 10.1006/scdb.1997.0161; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Williams EA, 2009, MOL ECOL, V18, P4434, DOI 10.1111/j.1365-294X.2009.04371.x; Williams EA, 2009, MOL ECOL, V18, P1006, DOI 10.1111/j.1365-294X.2008.04078.x; Wong YH, 2010, J NEUROSCI, V30, P4428, DOI 10.1523/JNEUROSCI.0473-10.2010; YANG Q, 1989, Science (Washington D C), V246, P806, DOI 10.1126/science.2814501; You WW, 2010, AQUAC RES, V41, P921, DOI 10.1111/j.1365-2109.2009.02376.x; Zhang JC, 1998, J BIOL CHEM, V273, P32273, DOI 10.1074/jbc.273.48.32273	58	31	34	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51279	10.1371/journal.pone.0051279	http://dx.doi.org/10.1371/journal.pone.0051279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236463	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100087
J	Isaias, IU; Volkmann, J; Marzegan, A; Marotta, G; Cavallari, P; Pezzoli, G				Isaias, Ioannis U.; Volkmann, Jens; Marzegan, Alberto; Marotta, Giorgio; Cavallari, Paolo; Pezzoli, Gianni			The Influence of Dopaminergic Striatal Innervation on Upper Limb Locomotor Synergies	PLOS ONE			English	Article							PARKINSONS-DISEASE; BASAL GANGLIA; SPINAL-CORD; WALKING; GAIT; ARM; COORDINATION; MOVEMENTS; PET	To determine the role of striatal dopaminergic innervation on upper limb synergies during walking, we measured arm kinematics in 13 subjects with Parkinson disease. Patients were recruited according to several inclusion criteria to represent the best possible in vivo model of dopaminergic denervation. Of relevance, we included only subjects with normal spatio-temporal parameters of the stride and gait speed to avoid an impairment of upper limbs locomotor synergies as a consequence of gait impairment per se. Dopaminergic innervation of the striatum was measured by FP-CIT and SPECT. All patients showed a reduction of gait-associated arms movement. No linear correlation was found between arm ROM reduction and contralateral dopaminergic putaminal innervation loss. Still, a partition analysis revealed a 80% chance of reduced arm ROM when putaminal dopamine content loss was >47%. A significant correlation was described between the asymmetry indices of the swinging of the two arms and dopaminergic striatal innervation. When arm ROM was reduced, we found a positive correlation between upper-lower limb phase shift modulation ( at different gait velocities) and striatal dopaminergic innervation. These findings are preliminary evidence that dopaminergic striatal tone plays a modulatory role in upper-limb locomotor synergies and upper-lower limb coupling while walking at different velocities.	[Isaias, Ioannis U.; Marzegan, Alberto; Cavallari, Paolo] Univ Milan, Sect Human Physiol Dept, LAMB P&L Mariani, Milan, Italy; [Isaias, Ioannis U.; Pezzoli, Gianni] ICP, CTO, Ctr Malattia Parkinson & Disturbi Movimento, Milan, Italy; [Isaias, Ioannis U.; Volkmann, Jens] Univ Klin Wurzburg, Neurol Klin & Poliklin, Wurzburg, Germany; [Marotta, Giorgio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dipartimento Med Nucl, Milan, Italy	University of Milan; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; IRCCS Ca Granda Ospedale Maggiore Policlinico	Isaias, IU (corresponding author), Univ Milan, Sect Human Physiol Dept, LAMB P&L Mariani, Milan, Italy.	iuisaias@yahoo.it	Cavallari, Paolo/C-5145-2012; Volkmann, Jens/AAK-7570-2020; Isaias, Ioannis Ugo/F-4492-2014; Marzegan, Alberto/AAA-8480-2020	Cavallari, Paolo/0000-0003-3160-9030; Isaias, Ioannis Ugo/0000-0002-3552-5144; Marzegan, Alberto/0000-0002-8389-7655; Pezzoli, Gianni/0000-0003-4665-6710; Volkmann, Jens/0000-0002-9570-593X; Marotta, Giorgio/0000-0002-5945-8628	Fondazione Grigioni per la malattia di Parkinson	Fondazione Grigioni per la malattia di Parkinson	The study was supported by the Fondazione Grigioni per la malattia di Parkinson. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLESTEROS ML, 1965, ACTA PHYSIOL SCAND, V63, P296, DOI 10.1111/j.1748-1716.1965.tb04069.x; Baltadjeva R, 2006, J COMP NEUROL, V24, P1815; Benamer HTS, 2000, MOVEMENT DISORD, V15, P692, DOI 10.1002/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V; BUCHTAHL F, 1965, BRAIN, V88, P875, DOI 10.1093/brain/88.5.875; Calvini P, 2007, EUR J NUCL MED MOL I, V34, P1240, DOI 10.1007/s00259-006-0357-2; Carpinella I, 2007, IEEE T NEUR SYS REH, V15, P543, DOI 10.1109/TNSRE.2007.908933; Craik R., 1976, NEURAL CONTROL LOCOM, P51; Crenna P, 2008, BRAIN, V131, P3410, DOI 10.1093/brain/awn272; Dietz V, 2002, TRENDS NEUROSCI, V25, P462, DOI 10.1016/S0166-2236(02)02229-4; Donker SF, 2005, J MOTOR BEHAV, V37, P217, DOI 10.3200/JMBR.37.3.217-230; Doyon J, 1998, NEUROPSYCHOLOGIA, V36, P625, DOI 10.1016/S0028-3932(97)00168-1; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; GARCIARILL E, 1986, BRAIN RES REV, V11, P47, DOI 10.1016/0165-0173(86)90009-3; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; HELLSTRAND E, 1985, ACTA PHYSIOL SCAND, V125, P555, DOI 10.1111/j.1748-1716.1985.tb07756.x; Hirato M, 1995, ADV STER F, V11, P5; Hornykiewicz O, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.2_Suppl_2.S2; Isaias IU, 2010, MOVEMENT DISORD, V25, P679, DOI 10.1002/mds.22870; LINDVALL O, 1983, ANN NEUROL, V14, P255, DOI 10.1002/ana.410140302; Madriaga MA, 2004, J NEUROPHYSIOL, V92, P1566, DOI 10.1152/jn.01181.2003; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Morris ME, 1999, HUM MOVEMENT SCI, V18, P461, DOI 10.1016/S0167-9457(99)00020-2; Nandhagopal R, 2009, BRAIN, V132, P2970, DOI 10.1093/brain/awp209; Ouchi Y, 2001, BRAIN, V124, P784, DOI 10.1093/brain/124.4.784; Reiner A, 1998, BRAIN RES REV, V28, P235, DOI 10.1016/S0165-0173(98)00016-2; Stolze H, 2001, J NEUROL NEUROSUR PS, V70, P289, DOI 10.1136/jnnp.70.3.289; Takakusaki K, 2004, NEUROSCI RES, V50, P137, DOI 10.1016/j.neures.2004.06.015; Takakusaki K, 2003, NEUROSCIENCE, V119, P293, DOI 10.1016/S0306-4522(03)00095-2; Thompson RH, 2008, EUR J NEUROSCI, V27, P1452, DOI 10.1111/j.1460-9568.2008.06125.x; Wannier T, 2001, EXP BRAIN RES, V141, P375, DOI 10.1007/s002210100875; Winn Philip, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS194, DOI 10.1016/j.parkreldis.2008.04.030; Zehr EP, 2004, CAN J PHYSIOL PHARM, V82, P556, DOI 10.1139/Y04-056; Zifchock RA, 2008, GAIT POSTURE, V27, P622, DOI 10.1016/j.gaitpost.2007.08.006	33	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51464	10.1371/journal.pone.0051464	http://dx.doi.org/10.1371/journal.pone.0051464			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236504	Green Published, gold			2022-12-27	WOS:000312064100121
J	Macher, HC; Martinez-Broca, MA; Rubio-Calvo, A; Leon-Garcia, C; Conde-Sanchez, M; Costa, A; Navarro, E; Guerrero, JM				Macher, Hada C.; Martinez-Broca, Maria A.; Rubio-Calvo, Amalia; Leon-Garcia, Cristina; Conde-Sanchez, Manuel; Costa, Alzenira; Navarro, Elena; Guerrero, Juan M.			Non-Invasive Prenatal Diagnosis of Multiple Endocrine Neoplasia Type 2A Using COLD-PCR Combined with HRM Genotyping Analysis from Maternal Serum	PLOS ONE			English	Article							CELL-FREE DNA; RESOLUTION MELTING ANALYSIS; CIRCULATING NUCLEIC-ACIDS; FETAL DNA; PREGNANT-WOMEN; BLOOD-PLASMA; DIGITAL PCR; CANCER; SENSITIVITY; MUTATIONS	The multiple endocrine neoplasia type 2A (MEN2A) is a monogenic disorder characterized by an autosomal dominant pattern of inheritance which is characterized by high risk of medullary thyroid carcinoma in all mutation carriers. Although this disorder is classified as a rare disease, the patients affected have a low life quality and a very expensive and continuous treatment. At present, MEN2A is diagnosed by gene sequencing after birth, thus trying to start an early treatment and by reduction of morbidity and mortality. We first evaluated the presence of MEN2A mutation (C634Y) in serum of 25 patients, previously diagnosed by sequencing in peripheral blood leucocytes, using HRM genotyping analysis. In a second step, we used a COLD-PCR approach followed by HRM genotyping analysis for non-invasive prenatal diagnosis of a pregnant woman carrying a fetus with a C634Y mutation. HRM analysis revealed differences in melting curve shapes that correlated with patients diagnosed for MEN2A by gene sequencing analysis with 100% accuracy. Moreover, the pregnant woman carrying the fetus with the C634Y mutation revealed a melting curve shape in agreement with the positive controls in the COLD-PCR study. The mutation was confirmed by sequencing of the COLD-PCR amplification product. In conclusion, we have established a HRM analysis in serum samples as a new primary diagnosis method suitable for the detection of C634Y mutations in MEN2A patients. Simultaneously, we have applied the increase of sensitivity of COLD-PCR assay approach combined with HRM analysis for the non-invasive prenatal diagnosis of C634Y fetal mutations using pregnant women serum.	[Macher, Hada C.; Rubio-Calvo, Amalia; Leon-Garcia, Cristina; Conde-Sanchez, Manuel; Costa, Alzenira; Guerrero, Juan M.] Univ Seville, SAS, CSIC, Dept Clin Biochem,Virgen del Rocio Univ Hosp,IBiS, Seville, Spain; [Martinez-Broca, Maria A.; Navarro, Elena] Univ Seville, SAS, CSIC, Dept Endocrinol,Virgen del Rocio Univ Hosp,IBiS, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Guerrero, JM (corresponding author), Univ Seville, SAS, CSIC, Dept Clin Biochem,Virgen del Rocio Univ Hosp,IBiS, Seville, Spain.	guerrero@us.es	IBIS, HIPERCOLESTERO/P-3953-2015; IBIS, NEUROINMUNO/O-9306-2015; Guerrero, Josep M./Y-2929-2019; Rubio, Amalia/L-1992-2017; Guerrero, Josep M./D-5519-2014	Rubio, Amalia/0000-0002-5905-0534; Guerrero, Josep M./0000-0001-5236-4592; Costa-Martins, Alzenira de Fatima/0000-0003-1788-743X; Guerrero, Juan Miguel/0000-0001-7553-0119; Macher, Hada/0000-0002-8622-1175	Instituto de Salud Carlos III [Red RETICEF RD06/00130001]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by a grant from the Instituto de Salud Carlos III (Red RETICEF RD06/00130001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom G, 2009, SURG CLIN N AM, V89, P1047, DOI 10.1016/j.suc.2009.06.016; Antonatos D, 2006, ANN NY ACAD SCI, V1075, P278, DOI 10.1196/annals.1368.037; Chiu RWK, 2011, SEMIN FETAL NEONAT M, V16, P88, DOI 10.1016/j.siny.2010.10.003; Finning K, 2008, BRIT MED J, V336, P816, DOI 10.1136/bmj.39518.463206.25; Gagel R F, 1975, Trans Assoc Am Physicians, V88, P177; Moreira VG, 2009, CLIN CHEM, V55, P1958, DOI 10.1373/clinchem.2009.129072; Garcia-Moreira V, 2008, CLIN CHEM LAB MED, V44, P1410; Garcia-Olmo D, 2001, ANN NY ACAD SCI, V945, P265; Garcia-Olmo DC, 2004, HISTOL HISTOPATHOL, V19, P575, DOI 10.14670/HH-19.575; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Illanes S, 2007, EARLY HUM DEV, V83, P563, DOI 10.1016/j.earlhumdev.2006.11.001; Jahr S, 2001, CANCER RES, V61, P1659; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; Macher HC, 2012, CLIN CHIM ACTA, V413, P490, DOI 10.1016/j.cca.2011.11.004; Margraf RL, 2006, CLIN CHEM, V52, P138, DOI 10.1373/clinchem.2005.052951; Marini F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-45; Milbury CA, 2011, EXPERT REV MOL DIAGN, V11, P159, DOI [10.1586/ERM.10.115, 10.1586/erm.10.115]; Milbury CA, 2009, CLIN CHEM, V55, P2130, DOI 10.1373/clinchem.2009.131029; Minon JM, 2008, TRANSFUSION, V48, P373, DOI 10.1111/j.1537-2995.2007.01533.x; Moline J, 2011, GENET MED, V13, P755, DOI 10.1097/GIM.0b013e318216cc6d; Norbury G, 2008, SEMIN FETAL NEONAT M, V13, P76, DOI 10.1016/j.siny.2007.12.008; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Pinzani P, 2010, METHODS, V50, P302, DOI 10.1016/j.ymeth.2010.02.004; Punales MK, 2003, J CLIN ENDOCR METAB, V88, P2644, DOI 10.1210/jc.2002-021422; Quayle FJ, 2007, SURGERY, V142, P800, DOI 10.1016/j.surg.2007.09.013; Rainer TH, 2003, CLIN CHEM, V49, P562, DOI 10.1373/49.4.562; RAUE F, 1995, J INTERN MED, V238, P369, DOI 10.1111/j.1365-2796.1995.tb01212.x; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Schwarzenbach H, 2009, CLIN CANCER RES, V15, P1032, DOI 10.1158/1078-0432.CCR-08-1910; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Wright CF, 2009, HUM REPROD UPDATE, V15, P139, DOI 10.1093/humupd/dmn047; Zhong XY, 2007, CLIN CHEM, V53, P1609, DOI 10.1373/clinchem.2006.084509	40	16	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51024	10.1371/journal.pone.0051024	http://dx.doi.org/10.1371/journal.pone.0051024			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236420	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100052
J	Ishida, E; Hashimoto, K; Shimizu, H; Okada, S; Satoh, T; Kato, I; Yamada, M; Mori, M				Ishida, Emi; Hashimoto, Koshi; Shimizu, Hiroyuki; Okada, Shuichi; Satoh, Tetsurou; Kato, Ikuo; Yamada, Masanobu; Mori, Masatomo			Nesfatin-1 Induces the Phosphorylation Levels of cAMP Response Element-Binding Protein for Intracellular Signaling in a Neural Cell Line	PLOS ONE			English	Article							HYPOTHALAMUS; BRAIN	Nesfatin-1 is a novel anorexic peptide that reduces the food intake of rodents when administered either intraventricularly or intraperitoneally. However, the molecular mechanism of intracellular signaling via Nesfatin-1 is yet to be resolved. In the current study, we investigated the ability of different neuronal cell lines to respond to Nesfatin-1 and further elucidated the signal transduction pathway of Nesfatin-1. To achieve this, we transfected several cell lines with various combinations of reporter vectors containing different kinds of response elements and performed reporter assays with Nesfatin-1, its active midsegment encoding 30 amino acid residues (M30) and M30-derived mutants. Notably, we found that both Nesfatin-1 as well as M30, significantly increased cAMP response element (CRE) reporter activity in a mouse neuroblastoma cell line, NB41A3. An antagonist of Melanocortin 3/4 receptor, SHU9119, aborted the promoter activity, and a mutant M30, which exerts no anorexic effect in vivo did not induce the CRE reporter activity in NB41A3 cells. Western blotting analyses revealed that Nesfatin-1 and M30 significantly increased the phosphorylation levels of CRE-binding protein (CREB), without altering the intracellular cAMP levels. Further, our study showed that a mitogen-activated protein kinase (MAPK) kinase inhibitor and an L-type Calcium (Ca2+) channel blocker abolished the M30-induced CREB phosphorylation. Furthermore, the radioreceptor assay revealed that I-125-Nesfatin-1 binds in a saturable fashion to the membrane fractions of the mouse hypothalamus and NB41A3 cells, with Kd values of 0.79 nM and 0.17 nM, respectively. Collectively, our findings indicate the presence of a Nesfatin-1-specific receptor on the cell surface of NB41A3 cells and mouse hypothalamus. Our study highlights that Nesfatin-1, via its receptor, induces the phosphorylation of CREB, thus activating the intracellular signaling cascade in neurons. Citation: Ishida E, Hashimoto K, Shimizu H, Okada S, Satoh T, et al. (2012) Nesfatin-1 Induces the Phosphorylation Levels of cAMP Response Element-Binding Protein for Intracellular Signaling in a Neural Cell Line. PLoS ONE 7(12): e50918. doi:10.1371/journal.pone.0050918	[Ishida, Emi; Hashimoto, Koshi; Shimizu, Hiroyuki; Okada, Shuichi; Satoh, Tetsurou; Yamada, Masanobu; Mori, Masatomo] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Gunma, Japan; [Shimizu, Hiroyuki] Takasaki Univ Hlth & Welf, Fac Hlth & Welf, Dept Hlth & Nutr, Gunma, Japan; [Kato, Ikuo] Hokuriku Univ, Fac Pharmaceut Sci, Dept Bioorgan Chem, Kanazawa, Ishikawa 92011, Japan	Gunma University; Hokuriku University	Hashimoto, K (corresponding author), Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Gunma, Japan.	khashimo@gunma-u.ac.jp	Hashimoto, Koshi/AAL-7339-2020	Hashimoto, Koshi/0000-0002-3530-689X	Japan Society for the Promotion of Science (JSPS) [20591045, 23591296]; JSPS [19209035, 22249038]; Grants-in-Aid for Scientific Research [22249038, 23591296] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) (20591045, 23591296) from the Japan Society for the Promotion of Science (JSPS) to K. Hashimoto and Grants-in-Aid for Scientific Research (A) (19209035, 22249038) from JSPS to M. Mori. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brailoiu GC, 2007, ENDOCRINOLOGY, V148, P5088, DOI 10.1210/en.2007-0701; BYLUND DB, 1993, AM J PHYSIOL, V265, pL421, DOI 10.1152/ajplung.1993.265.5.L421; Gonzalez R, 2011, ENDOCRINOLOGY, V152, P3628, DOI 10.1210/en.2010-1471; Gonzalez R, 2011, J ENDOCRINOL, V208, pR9, DOI 10.1530/JOE-10-0492; Iwasaki Y, 2009, BIOCHEM BIOPH RES CO, V390, P958, DOI 10.1016/j.bbrc.2009.10.085; Nakata M, 2011, ENDOCR J, V58, P305, DOI 10.1507/endocrj.K11E-056; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Sheriff S, 1997, MOL PHARMACOL, V51, P597, DOI 10.1124/mol.51.4.597; Shimizu H, 2009, ENDOCRINOLOGY, V150, P662, DOI 10.1210/en.2008-0598; Shimizu H, 2009, ENDOCR J, V56, P537, DOI 10.1507/endocrj.K09E-117; Shimizu H, 2009, PEPTIDES, V30, P995, DOI 10.1016/j.peptides.2009.01.002; Shimizu-Albergine M, 2001, J NEUROSCI, V21, P1238; Stengel A, 2011, ENDOCRINOLOGY, V152, P4033, DOI 10.1210/en.2011-1500	13	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50918	10.1371/journal.pone.0050918	http://dx.doi.org/10.1371/journal.pone.0050918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236405	Green Submitted, Green Published, gold			2022-12-27	WOS:000312589700021
J	Almoguera, C; Prieto-Dapena, P; Personat, JM; Tejedor-Cano, J; Lindahl, M; Diaz-Espejo, A; Jordano, J				Almoguera, Concepcion; Prieto-Dapena, Pilar; Personat, Jose-Maria; Tejedor-Cano, Javier; Lindahl, Marika; Diaz-Espejo, Antonio; Jordano, Juan			Protection of the Photosynthetic Apparatus from Extreme Dehydration and Oxidative Stress in Seedlings of Transgenic Tobacco	PLOS ONE			English	Article							PHOTOSYSTEM-II; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; HEAT-STRESS; PROTEIN; PHOTOINHIBITION; OVEREXPRESSION; PLANTS	A genetic program that in sunflower seeds is activated by Heat Shock transcription Factor A9 (HaHSFA9) has been analyzed in transgenic tobacco seedlings. The ectopic overexpression of the HSFA9 program protected photosynthetic membranes, which resisted extreme dehydration and oxidative stress conditions. In contrast, heat acclimation of seedlings induced thermotolerance but not resistance to the harsh stress conditions employed. The HSFA9 program was found to include the expression of plastidial small Heat Shock Proteins that accumulate only at lower abundance in heat-stressed vegetative organs. Photosystem II (PSII) maximum quantum yield was higher for transgenic seedlings than for non-transgenic seedlings, after either stress treatment. Furthermore, protection of both PSII and Photosystem I (PSI) membrane protein complexes was observed in the transgenic seedlings, leading to their survival after the stress treatments. It was also shown that the plastidial D1 protein, a labile component of the PSII reaction center, and the PSI core protein PsaB were shielded from oxidative damage and degradation. We infer that natural expression of the HSFA9 program during embryogenesis may protect seed pro-plastids from developmental desiccation.	[Almoguera, Concepcion; Prieto-Dapena, Pilar; Personat, Jose-Maria; Tejedor-Cano, Javier; Diaz-Espejo, Antonio; Jordano, Juan] CSIC, Inst Recursos Nat & Agrobiol Sevilla, E-41080 Seville, Spain; [Lindahl, Marika] CSIC, Inst Biol Vegetal & Fotosintesis, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Consejo Superior de Investigaciones Cientificas (CSIC)	Jordano, J (corresponding author), CSIC, Inst Recursos Nat & Agrobiol Sevilla, E-41080 Seville, Spain.	juan.jordano@csic.es	Diaz-Espejo, Antonio/B-5361-2008; Lindahl, Marika/H-2259-2017; Diaz-Espejo, Antonio/S-3744-2019; Jordano, Juan/J-5829-2012; Almoguera, Concepción/J-7026-2014; Prieto-Dapena, Pilar/K-2090-2014	Diaz-Espejo, Antonio/0000-0002-4711-2494; Diaz-Espejo, Antonio/0000-0002-4711-2494; Jordano, Juan/0000-0002-2583-4453; Almoguera, Concepción/0000-0002-7961-6507; Prieto-Dapena, Pilar/0000-0002-2826-8688; Lindahl, Marika/0000-0003-1627-0809	European Regional Development Fund (FEDER); Spanish Ministry of Science and Innovation [BIO2008-00634, BIO2011-23440]; Andalusian Regional Government [BIO148]	European Regional Development Fund (FEDER)(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Andalusian Regional Government	This work was cofinanced by the European Regional Development Fund (FEDER) and the Spanish Ministry of Science and Innovation (Grants BIO2008-00634 and BIO2011-23440). Additional funds were obtained from the Andalusian Regional Government (Grant BIO148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P541, DOI 10.1007/s11120-008-9331-0; Almoguera C, 2002, J BIOL CHEM, V277, P43866, DOI 10.1074/jbc.M207330200; Armbruster U, 2010, PLANT CELL, V22, P3439, DOI 10.1105/tpc.110.077453; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Barua D, 2003, FUNCT PLANT BIOL, V30, P1071, DOI 10.1071/FP03106; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Deng X, 2003, PLANT SCI, V165, P851, DOI 10.1016/S0168-9452(03)00284-X; Dinakar C, 2012, PLANT SCI, V182, P29, DOI 10.1016/j.plantsci.2011.01.018; Garcia-Cerdan JG, 2011, PLANT J, V65, P368, DOI 10.1111/j.1365-313X.2010.04429.x; Georgieva K, 2009, J PLANT PHYSIOL, V166, P1520, DOI 10.1016/j.jplph.2009.03.010; Guo SJ, 2007, J PLANT PHYSIOL, V164, P126, DOI 10.1016/j.jplph.2006.01.004; Harndahl U, 1999, CELL STRESS CHAPERON, V4, P129; Kotak S, 2007, PLANT CELL, V19, P182, DOI 10.1105/tpc.106.048165; Lepisto A, 2009, PLANT PHYSIOL, V149, P1261, DOI 10.1104/pp.108.133777; Lu Y, 2011, PLANT CELL, V23, P1861, DOI 10.1105/tpc.111.085456; Lundin B, 2008, PHOTOSYNTH RES, V98, P405, DOI 10.1007/s11120-008-9325-y; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MIYAO M, 1995, BIOCHEMISTRY-US, V34, P10019, DOI 10.1021/bi00031a025; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Neta-Sharir I, 2005, PLANT CELL, V17, P1829, DOI 10.1105/tpc.105.031914; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Nishiyama Y, 2011, PHYSIOL PLANTARUM, V142, P35, DOI 10.1111/j.1399-3054.2011.01457.x; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Osteryoung KW, 1992, RES PHOTOSYNTHESIS, VIV, P129; Prieto-Dapena P, 2008, PLANT J, V54, P1004, DOI 10.1111/j.1365-313X.2008.03465.x; Prieto-Dapena P, 2006, PLANT PHYSIOL, V142, P1102, DOI 10.1104/pp.106.087817; Sonoike K, 2011, PHYSIOL PLANTARUM, V142, P56, DOI 10.1111/j.1399-3054.2010.01437.x; Sugliani M, 2009, NEW PHYTOL, V184, P898, DOI 10.1111/j.1469-8137.2009.03023.x; Tejedor-Cano J, 2010, PLANT CELL ENVIRON, V33, P1408, DOI 10.1111/j.1365-3040.2010.02159.x	30	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51443	10.1371/journal.pone.0051443	http://dx.doi.org/10.1371/journal.pone.0051443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227265	gold, Green Published			2022-12-27	WOS:000312588200124
J	Cavallo, MG; Sentinelli, F; Barchetta, I; Costantino, C; Incani, M; Perra, L; Capoccia, D; Romeo, S; Cossu, E; Leonetti, F; Agati, L; Baroni, MG				Cavallo, Maria Gisella; Sentinelli, Federica; Barchetta, Ilaria; Costantino, Carmine; Incani, Michela; Perra, Laura; Capoccia, Danila; Romeo, Stefano; Cossu, Efisio; Leonetti, Frida; Agati, Luciano; Baroni, Marco G.			Altered Glucose Homeostasis Is Associated with Increased Serum Apelin Levels in Type 2 Diabetes Mellitus	PLOS ONE			English	Article							BETA-CELL FUNCTION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; EXPRESSION; LIPOLYSIS; MUSCLE; LIGAND	Background: Apelin is an adipokine that plays a role in the regulation of glucose homeostasis and in obesity. The relationship between apelin serum concentration and dysmetabolic conditions such as type 2 diabetes (T2D) is still controversial. Aims of our study are: 1) determine the circulating levels of apelin in a large cohort of Italian subjects with T2D, T1D and in non-diabetic controls; 2) identify putative metabolic determinants of modified apelin concentrations, in order to search possible mechanism of apelin control; 3) investigate changes in apelin levels in response to sharp modifications of glucose/insulin metabolism in T2D obese subjects before and 3 days after bariatric surgery. Methods: We recruited 369 subjects, 119 with T2D, 113 with T1D and 137 non-diabetic controls. All subjects underwent a complete clinical examination, including anthropometric and laboratory measurements. Serum apelin levels were determined by EIA (immunoenzyme assay). Results: Patients with T2D had significantly higher serum apelin levels compared to controls (1.23 +/- 1.1 ng/mL vs 0.91 +/- 0.7 ng/mL, P<0.001) and to T1D subjects (0.73 +/- 0.39 ng/mL, P<0.001). Controls and T1D subjects did not differ significantly in apelin levels. Apelin concentrations were directly associated with fasting blood glucose (FBG), body mass index (BMI), basal Disposition Index (DI-0), age, and diagnosis of T2D at bivariate correlation analysis. Multiple regression analysis confirmed that diagnosis of T2D, basal DI-0 and FBG were all determinants of serum apelin levels independently from age and BMI. Bariatric surgery performed in a subgroup of obese diabetic subjects (n = 12) resulted in a significant reduction of apelin concentrations compared to baseline levels (P = 0.01). Conclusions: Our study demonstrates that T2D, but not T1D, is associated with increased serum apelin levels compared to non-diabetic subjects. This association is dependent on impaired glucose homeostasis, and disappears after bariatric surgery, providing further evidence regarding the relationship between apelin and the regulation of glucose metabolism.	[Sentinelli, Federica; Incani, Michela; Perra, Laura; Romeo, Stefano; Cossu, Efisio; Baroni, Marco G.] Univ Cagliari, Dept Med Sci, Cagliari, Italy; [Cavallo, Maria Gisella; Barchetta, Ilaria; Costantino, Carmine] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, Rome, Italy; [Capoccia, Danila; Leonetti, Frida] Univ Roma La Sapienza, Dept Clin Sci, Rome, Italy; [Romeo, Stefano] Univ Gothenburg, Dept Mol & Clin Med, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden; [Agati, Luciano] Univ Roma La Sapienza, Dept Cardiovasc Sci, Rome, Italy	University of Cagliari; Sapienza University Rome; Sapienza University Rome; University of Gothenburg; Sapienza University Rome	Baroni, MG (corresponding author), Univ Cagliari, Dept Med Sci, Cagliari, Italy.	marcobaroni@medicina.unica.it	Agati, Luciano/AFQ-4559-2022; Romeo, Stefano/L-6861-2015; Leonetti, Frida/AAL-1295-2020; Sentinelli, Federica/AAF-1563-2020; Capoccia, Danila/AAT-2026-2020; Baroni, Marco Giorgio/AAH-3476-2020; Barchetta, Ilaria/I-3016-2019	Agati, Luciano/0000-0003-3186-1797; Romeo, Stefano/0000-0001-9168-4898; Baroni, Marco Giorgio/0000-0002-3224-6078; Barchetta, Ilaria/0000-0003-0530-8568; Sentinelli, Federica/0000-0002-5379-0590; INCANI, MICHELA/0000-0003-1623-5376; cavallo, maria gisella/0000-0001-6630-8049; LEONETTI, Frida/0000-0002-5606-8448	University of Cagliari; Ministry of Education, University and Research [2008J2FS4T]; Foundation Banco di Sardegna; Sapienza University of Rome	University of Cagliari; Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Foundation Banco di Sardegna(Fondazione Banco di Sardegna); Sapienza University of Rome	This work was funded by research grants from the University of Cagliari (ex-60% 2009-11 http://www.unica.it/), from the Ministry of Education, University and Research (PRIN 2008, n. 2008J2FS4T, http://prin.cineca.it/) and from the Foundation Banco di Sardegna (Research Projects 2011, http://www.fondazionebancodisardegna.it/), all awarded to MGB. MGC was funded by a research grant from Sapienza University of Rome (http://www.uniroma1.it/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Attane C, 2011, J MOL ENDOCRINOL, V46, P21, DOI 10.1677/JME-10-0105; Attane C, 2012, DIABETES, V61, P310, DOI 10.2337/db11-0100; Bergman RN, 2002, DIABETES, V51, pS212, DOI 10.2337/diabetes.51.2007.S212; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Castan-Iaurell I, 2012, TRENDS ENDOCRIN MET, V23, P234, DOI 10.1016/j.tem.2012.02.005; Cobelli C, 2007, AM J PHYSIOL-ENDOC M, V293, pE1, DOI 10.1152/ajpendo.00421.2006; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Dray C, 2010, AM J PHYSIOL-ENDOC M, V298, pE1161, DOI 10.1152/ajpendo.00598.2009; Erdem G, 2008, EXP CLIN ENDOCR DIAB, V116, P289, DOI 10.1055/s-2007-1004564; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guo L, 2009, ENDOCR RES, V34, P142, DOI 10.3109/07435800903287079; Heinonen MV, 2009, NUTR METAB CARDIOVAS, V19, P626, DOI 10.1016/j.numecd.2008.12.008; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Ramon JM, 2012, J GASTROINTEST SURG, V16, P1116, DOI 10.1007/s11605-012-1855-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Meral C, 2010, J PEDIATR ENDOCR MET, V23, P497, DOI 10.1515/jpem.2010.081; Messari SE, 2004, J NEUROCHEM, V90, P1290, DOI 10.1111/j.1471-4159.2004.02591.x; Peterli R, 2012, OBES SURG, V22, P740, DOI 10.1007/s11695-012-0622-3; Soriguer F, 2009, OBES SURG, V19, P1574, DOI 10.1007/s11695-009-9955-y; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Telejko B, 2010, DIABETES RES CLIN PR, V87, P176, DOI 10.1016/j.diabres.2009.10.018; Yue P, 2011, ENDOCRINOLOGY, V152, P59, DOI 10.1210/en.2010-0576; Yue P, 2010, AM J PHYSIOL-ENDOC M, V298, pE59, DOI 10.1152/ajpendo.00385.2009; Zhang Yu, 2009, Diabetes Care, V32, pe150, DOI 10.2337/dc09-1146	28	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51236	10.1371/journal.pone.0051236	http://dx.doi.org/10.1371/journal.pone.0051236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227256	Green Submitted, gold, Green Published			2022-12-27	WOS:000312588200115
J	Pilar, DR; Jaeger, A; Gomes, CFA; Stein, LM				Pilar, Denise Ranghetti; Jaeger, Antonio; Gomes, Carlos F. A.; Stein, Lilian Milnitsky			Passwords Usage and Human Memory Limitations: A Survey across Age and Educational Background	PLOS ONE			English	Article							FUZZY-TRACE THEORY; SECURITY; MEMORABILITY	The present article reports a survey conducted to identify the practices on passwords usage, focusing particularly on memory limitations and the use of passwords across individuals with different age and education backgrounds. A total of 263 participants were interviewed, with ages ranging from 18 to 93 years, and education level ranging from grade school to graduate degree. Contrary to our expectations, effects of cognitive decline due to aging were not observed on memory performance for passwords. The results suggested instead, that the number of password uses was the most influential factor on memory performance. That is, as the number of circumstances in which individuals utilized passwords increased, the incidence of forgotten and mixed-up passwords also increased. The theoretical significance of these findings and their implications for good practices on password usage are discussed.	[Pilar, Denise Ranghetti; Jaeger, Antonio; Stein, Lilian Milnitsky] Pontificia Univ Catolica Rio Grande do Sul, Dept Psychol, Porto Alegre, RS, Brazil; [Gomes, Carlos F. A.] Cornell Univ, Dept Human Dev, Ithaca, NY USA	Pontificia Universidade Catolica Do Rio Grande Do Sul; Cornell University	Jaeger, A (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Dept Psychol, Porto Alegre, RS, Brazil.	lilian@pucrs.br	jaeger, antonio/F-7120-2013		Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1999, COMMUN ACM, V42, P41, DOI 10.1145/322796.322806; Adams A., 1997, People and Computers XII. Proceedings of HCI '97, P1; Alley D, 2007, RES AGING, V29, P73, DOI 10.1177/0164027506294245; Armstrong L, 2002, BUS WEEK, P89; Barro RJ, 2010, 15902 NBER, DOI [10.1016/j.jdeveco.2012.10.001, DOI 10.1016/J.JDEVECO.2012.10.001]; Brainerd CJ, 2002, CURR DIR PSYCHOL SCI, V11, P164, DOI 10.1111/1467-8721.00192; Brown AS, 2004, APPL COGNITIVE PSYCH, V18, P641, DOI 10.1002/acp.1014; Brown Scott C, 2000, OXFORD HDB MEMORY, P93, DOI DOI 10.1016/J.ADOLESCENCE.2017.05.018; Carstens D., 2004, INFORM SCI J, V7, P67, DOI DOI 10.28945/503; Charoen D, 2008, SYST PRACT ACT RES, V21, P55, DOI 10.1007/s11213-007-9082-4; Colsher Patricia L., 1991, Annals of Epidemiology, V1, P215; CRAIK FIM, 1994, CURR DIR PSYCHOL SCI, V3, P155, DOI 10.1111/1467-8721.ep10770653; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Dempster F.N., 1995, INTERFERENCE INHIBIT; DOBBS AR, 1989, PSYCHOL AGING, V4, P500, DOI 10.1037/0882-7974.4.4.500; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Evans D A, 1993, Ann Epidemiol, V3, P71; GARDINER JM, 1991, MEM COGNITION, V19, P617, DOI 10.3758/BF03197157; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Harada Y, 1996, SCIENCE, V37, P21; Hoonakker P, 2009, PROCEEDINGS OF THE H; Horowitz AS, 2001, COMPUTERWORLD, V35, P38; Leibovici D, 1996, AGE AGEING, V25, P392, DOI 10.1093/ageing/25.5.392; MORRIS R, 1979, COMMUN ACM, V22, P594, DOI 10.1145/359168.359172; Nelson D, 2010, COMPUT HUM BEHAV, V26, P705, DOI 10.1016/j.chb.2010.01.007; Nyberg L, 1996, J GERONTOL B-PSYCHOL, V51, pP234, DOI 10.1093/geronb/51B.4.P234; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Papalia D. E., 2004, HUMAN DEV; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Porter S. N., 1982, Computers & Security, V1, P54, DOI 10.1016/0167-4048(82)90025-6; REYNA VF, 1995, LEARN INDIVID DIFFER, V7, P1, DOI 10.1016/1041-6080(95)90031-4; Yan J, 2004, IEEE SECUR PRIV, V2, P25, DOI 10.1109/MSP.2004.81; Zhang J, 2009, EUR J INFORM SYST, V18, P165, DOI 10.1057/ejis.2009.9; ZVIRAN M, 1993, COMPUT J, V36, P227, DOI 10.1093/comjnl/36.3.227; Zviran M., 1999, Journal of Management Information Systems, V15, P161	35	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51067	10.1371/journal.pone.0051067	http://dx.doi.org/10.1371/journal.pone.0051067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227232	gold, Green Published, Green Submitted			2022-12-27	WOS:000312588200092
J	Takao, D; Taniguchi, A; Takeda, T; Sonobe, S; Nonaka, S				Takao, Daisuke; Taniguchi, Atsushi; Takeda, Takaaki; Sonobe, Seiji; Nonaka, Shigenori			High-Speed Imaging of Amoeboid Movements Using Light-Sheet Microscopy	PLOS ONE			English	Article							PLANE ILLUMINATION MICROSCOPY; AMOEBA-PROTEUS; CELLS; SURFACE	Light-sheet microscopy has been developed as a powerful tool for live imaging in biological studies. The efficient illumination of specimens using light-sheet microscopy makes it highly amenable to high-speed imaging. We therefore applied this technology to the observation of amoeboid movements, which are too rapid to capture with conventional microscopy. To simplify the setup of the optical system, we utilized the illumination optics from a conventional confocal laser scanning microscope. Using this set-up we achieved high-speed imaging of amoeboid movements. Three-dimensional images were captured at the recording rate of 40 frames/s and clearly outlined the fine structures of fluorescent-labeled amoeboid cellular membranes. The quality of images obtained by our system was sufficient for subsequent quantitative analysis for dynamics of amoeboid movements. This study demonstrates the application of light-sheet microscopy for high-speed imaging of biological specimens. Citation: Takao D, Taniguchi A, Takeda T, Sonobe S, Nonaka S (2012) High-Speed Imaging of Amoeboid Movements Using Light-Sheet Microscopy. PLoS ONE 7(12): e50846. doi:10.1371/journal.pone.0050846	[Takao, Daisuke; Nonaka, Shigenori] Natl Inst Basic Biol, Lab Spatiotemporal Regulat, Okazaki, Aichi 444, Japan; [Taniguchi, Atsushi; Sonobe, Seiji] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kamigori, Hyogo, Japan; [Takeda, Takaaki] Natl Inst Nat Sci, Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of Hyogo; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ)	Nonaka, S (corresponding author), Natl Inst Basic Biol, Lab Spatiotemporal Regulat, Okazaki, Aichi 444, Japan.	snonaka@nibb.ac.jp	Nonaka, Shigenori/I-2132-2013; Takao, Daisuke/U-1849-2019	Nonaka, Shigenori/0000-0002-8093-0325; Takao, Daisuke/0000-0001-6136-6733; Taniguchi, Atsushi/0000-0001-5500-0671	Human Frontier Science Program (HFSP); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS); CREST	Human Frontier Science Program (HFSP)(Human Frontier Science Program); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST(Core Research for Evolutional Science and Technology (CREST))	This work was supported by the Human Frontier Science Program (HFSP, http://www.hfsp.org/), the Ministry of Education, Culture, Sports, Science and Technology (MEXT, http://www.mext.go.jp/english/), the Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/index.html) and CREST (http://www.jst.go.jp/kisoken/crest/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulbitch A, 2000, PHYS REV E, V62, P3974, DOI 10.1103/PhysRevE.62.3974; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; GREBECKI A, 1986, J CELL SCI, V83, P23; GRIFFIN JL, 1960, EXP CELL RES, V21, P170, DOI 10.1016/0014-4827(60)90358-X; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2007, OPT LETT, V32, P2608, DOI 10.1364/OL.32.002608; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2007, NAT METHODS, V4, P843, DOI 10.1038/NMETH1087; KOKUBO EIICHIRO, 2005, Journal of the Korean Astronomical Society, V38, P153; Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007; LEE J, 1990, SCIENCE, V247, P1229, DOI 10.1126/science.2315695; Nishihara E, 2007, PROTOPLASMA, V231, P25, DOI 10.1007/s00709-007-0247-x; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Soll DR, 2009, EUKARYOT CELL, V8, P1381, DOI 10.1128/EC.00121-09; Wessels D, 1998, CELL MOTIL CYTOSKEL, V41, P225, DOI 10.1002/(SICI)1097-0169(1998)41:3<225::AID-CM4>3.3.CO;2-9; Wu YC, 2011, P NATL ACAD SCI USA, V108, P17708, DOI 10.1073/pnas.1108494108	18	11	11	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50846	10.1371/journal.pone.0050846	http://dx.doi.org/10.1371/journal.pone.0050846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227214	gold, Green Published, Green Submitted			2022-12-27	WOS:000312588200075
J	Schafer, NP; Hoffman, RMB; Burger, A; Craig, PO; Komives, EA; Wolynes, PG				Schafer, Nicholas P.; Hoffman, Ryan M. B.; Burger, Anat; Craig, Patricio O.; Komives, Elizabeth A.; Wolynes, Peter G.			Discrete Kinetic Models from Funneled Energy Landscape Simulations	PLOS ONE			English	Article							ANKYRIN REPEAT PROTEINS; STATISTICAL-MECHANICS; RANDOM HETEROPOLYMERS; FOLDING MECHANISM; STOCHASTIC-MODELS; CONSENSUS DESIGN; TRANSITION-STATE; PREDICTION; DYNAMICS; BEHAVIOR	A general method for facilitating the interpretation of computer simulations of protein folding with minimally frustrated energy landscapes is detailed and applied to a designed ankyrin repeat protein (4ANK). In the method, groups of residues are assigned to foldons and these foldons are used to map the conformational space of the protein onto a set of discrete macrobasins. The free energies of the individual macrobasins are then calculated, informing practical kinetic analysis. Two simple assumptions about the universality of the rate for downhill transitions between macrobasins and the natural local connectivity between macrobasins lead to a scheme for predicting overall folding and unfolding rates, generating chevron plots under varying thermodynamic conditions, and inferring dominant kinetic folding pathways. To illustrate the approach, free energies of macrobasins were calculated from biased simulations of a non-additive structure-based model using two structurally motivated foldon definitions at the full and half ankyrin repeat resolutions. The calculated chevrons have features consistent with those measured in stopped flow chemical denaturation experiments. The dominant inferred folding pathway has an "inside-out'', nucleation-propagation like character.	[Schafer, Nicholas P.; Hoffman, Ryan M. B.; Burger, Anat; Craig, Patricio O.; Wolynes, Peter G.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Schafer, Nicholas P.; Hoffman, Ryan M. B.; Burger, Anat; Craig, Patricio O.; Wolynes, Peter G.] Rice Univ, Houston, TX USA	University of California System; University of California San Diego; Rice University	Wolynes, PG (corresponding author), Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA.	pwolynes@rice.edu		Schafer, Nicholas/0000-0001-9789-2516	National Institute of General Medical Sciences [P01 GM071862]; D. R. Bullard-Welch Chair at Rice University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM071862, T32GM008326] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); D. R. Bullard-Welch Chair at Rice University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project described was supported by Grant P01 GM071862 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of National Institute of General Medical Sciences or the National Institutes of Health. Additional support was also provided by the D. R. Bullard-Welch Chair at Rice University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick D, 2008, CURR OPIN STRUC BIOL, V18, P27, DOI 10.1016/j.sbi.2007.12.004; Berezhkovskii A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3139063; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Best RB, 2012, CURR OPIN STRUC BIOL, V22, P52, DOI 10.1016/j.sbi.2011.12.001; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; BRYNGELSON JD, 1989, J PHYS CHEM-US, V93, P6902, DOI 10.1021/j100356a007; Buchete NV, 2008, J PHYS CHEM B, V112, P6057, DOI 10.1021/jp0761665; Chan HS, 2011, ANNU REV PHYS CHEM, V62, P301, DOI 10.1146/annurev-physchem-032210-103405; Craig PO, 2011, J AM CHEM SOC, V133, P17463, DOI 10.1021/ja207506z; Davtyan A, 2012, J PHYS CHEM B, V116, P8494, DOI 10.1021/jp212541y; Devi VS, 2004, PROTEIN SCI, V13, P2864, DOI 10.1110/ps.04935704; DeVries I, 2011, J MOL BIOL, V408, P163, DOI 10.1016/j.jmb.2011.02.021; Eastwood MP, 2002, J CHEM PHYS, V117, P4602, DOI 10.1063/1.1494417; Eastwood MP, 2001, J CHEM PHYS, V114, P4702, DOI 10.1063/1.1315994; Ejtehadi MR, 2004, P NATL ACAD SCI USA, V101, P15088, DOI 10.1073/pnas.0403486101; Ellson J, 2004, MATH VIS, P127; Ferreiro DU, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000070; Ferreiro DU, 2007, J MOL BIOL, V365, P1201, DOI 10.1016/j.jmb.2006.11.044; Ferreiro DU, 2005, J MOL BIOL, V354, P679, DOI 10.1016/j.jmb.2005.09.078; Forrer P, 2004, CHEMBIOCHEM, V5, P183, DOI 10.1002/cbic.200300762; Forrer P, 2003, FEBS LETT, V539, P2, DOI 10.1016/S0014-5793(03)00177-7; GOLDSTEIN RA, 1992, P NATL ACAD SCI USA, V89, P4918, DOI 10.1073/pnas.89.11.4918; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jonsson T, 1996, BIOCHEMISTRY-US, V35, P4795, DOI 10.1021/bi953056s; Kaya H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.258104; Kaya H, 2005, BIOPHYS J, V89, P520, DOI 10.1529/biophysj.104.057471; Kohl A, 2003, P NATL ACAD SCI USA, V100, P1700, DOI 10.1073/pnas.0337680100; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kubelka J, 2006, J MOL BIOL, V359, P546, DOI 10.1016/j.jmb.2006.03.034; Levy Y, 2002, PHYS CHEM CHEM PHYS, V4, P5052, DOI 10.1039/b203534k; Lindberg MO, 2007, CURR OPIN STRUC BIOL, V17, P21, DOI 10.1016/j.sbi.2007.01.008; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lowe AR, 2007, P NATL ACAD SCI USA, V104, P2679, DOI 10.1073/pnas.0604653104; Bradley CM, 2006, STRUCTURE, V14, P1303, DOI 10.1016/j.str.2006.06.013; MATOUSCHEK A, 1993, P NATL ACAD SCI USA, V90, P7814, DOI 10.1073/pnas.90.16.7814; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; Munoz V, 2001, CURR OPIN STRUC BIOL, V11, P212, DOI 10.1016/S0959-440X(00)00192-5; Panchenko AR, 1997, J MOL BIOL, V272, P95, DOI 10.1006/jmbi.1997.1205; Plotkin SS, 1997, PHYSICA D, V107, P322, DOI 10.1016/S0167-2789(97)00100-0; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3592153; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; Shen TY, 2005, BIOCHEMISTRY-US, V44, P6433, DOI 10.1021/bi0500170; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; Socci ND, 1998, PROTEINS, V32, P136, DOI 10.1002/(SICI)1097-0134(19980801)32:2<136::AID-PROT2>3.3.CO;2-5; Sutto L, 2007, P NATL ACAD SCI USA, V104, P19825, DOI 10.1073/pnas.0709922104; Tamaskovic R, 2012, METHOD ENZYMOL, V503, P101, DOI 10.1016/B978-0-12-396962-0.00005-7; Tang KS, 2003, STRUCTURE, V11, P67, DOI 10.1016/S0969-2126(02)00929-2; Wang J, 1996, J CHEM PHYS, V105, P11276, DOI 10.1063/1.472869; Wang J, 1997, J PHYS I, V7, P395, DOI 10.1051/jp1:1997168; Werbeck ND, 2008, P NATL ACAD SCI USA, V105, P9982, DOI 10.1073/pnas.0705300105; Wetzel SK, 2008, J MOL BIOL, V376, P241, DOI 10.1016/j.jmb.2007.11.046; WIDOM B, 1965, SCIENCE, V148, P1555, DOI 10.1126/science.148.3677.1555; WIDOM B, 1974, J CHEM PHYS, V61, P672, DOI 10.1063/1.1681944; WIDOM B, 1971, J CHEM PHYS, V55, P44, DOI 10.1063/1.1675541; Zheng WH, 2011, J PHYS CHEM B, V115, P1512, DOI 10.1021/jp1089596; Zong CH, 2006, BIOCHEMISTRY-US, V45, P6458, DOI 10.1021/bi060025w	60	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50635	10.1371/journal.pone.0050635	http://dx.doi.org/10.1371/journal.pone.0050635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251375	Green Published, gold			2022-12-27	WOS:000313236200032
J	Wan, Z; Perry, CGR; Macdonald, T; Chan, CB; Holloway, GP; Wright, DC				Wan, Zhongxiao; Perry, Christopher G. R.; Macdonald, Tara; Chan, Catherine B.; Holloway, Graham P.; Wright, David C.			IL-6 Is Not Necessary for the Regulation of Adipose Tissue Mitochondrial Content	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; INDUCED INSULIN-RESISTANCE; RECEPTOR-GAMMA; SKELETAL-MUSCLE; GENE-EXPRESSION; INTERLEUKIN-6; FAT; PGC-1-ALPHA; MICE; COACTIVATOR	Background: Adipose tissue mitochondria have been implicated as key mediators of systemic metabolism. We have shown that IL-6 activates AMPK, a mediator of mitochondrial biogenesis, in adipose tissue; however, IL-6(-/-) mice fed a high fat diet have been reported to develop insulin resistance. These findings suggest that IL-6 may control adipose tissue mitochondrial content in vivo, and that reductions in adipose tissue mitochondria may be causally linked to the development of insulin resistance in IL-6(-/-) mice fed a high fat diet. On the other hand, IL-6 has been implicated as a negative regulator of insulin action. Given these discrepancies the purpose of the present investigation was to further evaluate the relationship between IL-6, adipose tissue mitochondrial content and whole body insulin action. Methodology and Principal Findings: In cultured epididymal mouse adipose tissue IL-6 (75 ng/ml) induced the expression of the transcriptional co-activators PGC-1 alpha and PRC, reputed mediators of mitochondrial biogenesis. Similarly, IL-6 increased the expression of COXIV and CPT-1. These effects were absent in cultured subcutaneous adipose tissue and were associated with lower levels of GP130 and IL-6 receptor alpha protein content. Markers of mitochondrial content were intact in adipose tissue from chow fed IL-6(-/-) mice. When fed a high fat diet IL-6(-/-) mice were more glucose and insulin intolerant than controls fed the same diet; however this was not explained by decreases in adipose tissue mitochondrial content or respiration. Conclusions and Significance: Our findings demonstrate depot-specific differences in the ability of IL-6 to induce PGC-1 alpha and mitochondrial enzymes and demonstrate that IL-6 is not necessary for the maintenance of adipose tissue mitochondrial content in vivo. Moreover, reductions in adipose tissue mitochondria do not explain the greater insulin resistance in IL-6(-/-) mice fed a high fat diet. These results question the role of adipose tissue mitochondrial dysfunction in the etiology of insulin resistance.	[Perry, Christopher G. R.; Macdonald, Tara; Holloway, Graham P.; Wright, David C.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Wan, Zhongxiao; Chan, Catherine B.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	University of Guelph; University of Alberta	Wright, DC (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	dcwright@uoguelph.ca	Chan, Catherine/C-1162-2011	Chan, Catherine/0000-0003-3882-0592; Wright, David/0000-0003-3867-8901	Canadian Institutes of Health Research [MOP 115708-2011]; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by an Operating Grant from the Canadian Institutes of Health Research (MOP 115708-2011) to DW and Natural Sciences and Engineering Research Council of Canada Discovery Grants to GH and CC. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adser H, 2011, ACTA PHYSIOL, V202, P165, DOI 10.1111/j.1748-1716.2011.02269.x; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Barger PM, 2001, J BIOL CHEM, V276, P44495, DOI 10.1074/jbc.M105945200; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bruce CR, 2004, AM J PHYSIOL-ENDOC M, V287, pE616, DOI 10.1152/ajpendo.00150.2004; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chen XH, 2010, MOL CELL ENDOCRINOL, V328, P63, DOI 10.1016/j.mce.2010.07.005; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Deng T, 2011, J BIOL CHEM, V286, P30723, DOI 10.1074/jbc.M111.251926; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE182, DOI 10.1152/ajpendo.00189.2003; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fried SK, 2000, METH MOL B, V155, P197; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Fritsche L, 2010, DIABETOLOGIA, V53, P1732, DOI 10.1007/s00125-010-1754-4; Fujimoto M, 2003, TRENDS IMMUNOL, V24, P659, DOI 10.1016/j.it.2003.10.008; He JY, 2006, MOL ENDOCRINOL, V20, P114, DOI 10.1210/me.2005-0107; Ijichi N, 2007, BIOCHEM BIOPH RES CO, V358, P813, DOI 10.1016/j.bbrc.2007.04.209; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Ji C, 2011, J BIOENERG BIOMEMBR; Karamitri A, 2009, J BIOL CHEM, V284, P20738, DOI 10.1074/jbc.M109.021766; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Kraunsoe R, 2010, J PHYSIOL-LONDON, V588, P2023, DOI 10.1113/jphysiol.2009.184754; Kubo M, 2009, BBA-GENE REGUL MECH, V1789, P71, DOI 10.1016/j.bbagrm.2008.08.012; Lagathu C, 2003, BIOCHEM BIOPH RES CO, V311, P372, DOI 10.1016/j.bbrc.2003.10.013; Laye MJ, 2009, J PHYSIOL-LONDON, V587, P3729, DOI 10.1113/jphysiol.2009.172601; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Mitra R, 2012, J MOL CELL CARDIOL, V52, P701, DOI 10.1016/j.yjmcc.2011.10.010; Nielsen NB, 2009, REGUL PEPTIDES, V155, P39, DOI 10.1016/j.regpep.2009.04.010; Pardo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026989; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Smith BK, 2011, BIOCHEM J, V437, P125, DOI 10.1042/BJ20101861; Sopasakis VR, 2004, OBES RES, V12, P454, DOI 10.1038/oby.2004.51; Sutherland LN, 2008, AM J PHYSIOL-ENDOC M, V295, pE1076, DOI 10.1152/ajpendo.90408.2008; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; Wada T, 2011, AM J PHYSIOL-ENDOC M, V300, pE1112, DOI 10.1152/ajpendo.00370.2010; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wan ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041719; Wan ZX, 2012, OBESITY, V20, P453, DOI 10.1038/oby.2011.252; Wan ZX, 2010, AM J PHYSIOL-CELL PH, V299, pC1162, DOI 10.1152/ajpcell.00188.2010; White UA, 2011, CURR PHARM DESIGN, V17, P340; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wolsk E, 2010, AM J PHYSIOL-ENDOC M, V299, pE832, DOI 10.1152/ajpendo.00328.2010	51	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51233	10.1371/journal.pone.0051233	http://dx.doi.org/10.1371/journal.pone.0051233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240005	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800041
J	Gonzalez, P; Fernandez-Martos, CM; Gonzalez-Fernandez, C; Arenas, E; Rodriguez, FJ				Gonzalez, Pau; Maria Fernandez-Martos, Carmen; Gonzalez-Fernandez, Carlos; Arenas, Ernest; Javier Rodriguez, Francisco			Spatio-Temporal Expression Pattern of Frizzled Receptors after Contusive Spinal Cord Injury in Adult Rats	PLOS ONE			English	Article							CORTICAL AXON OUTGROWTH; NEURAL STEM-CELLS; WNT PATHWAY; INFLAMMATORY RESPONSE; INDUCTION; GROWTH; REGENERATION; ACTIVATION; DICKKOPF-1; ASTROCYTES	Background: Wnt proteins are a large family of molecules that are critically involved in multiple central nervous system (CNS) developmental processes. Experimental evidences suggest a role for this family of proteins in many CNS disorders, including spinal cord injury (SCI), which is a major neuropathology owing to its high prevalence and chronic sensorimotor functional sequelae. Interestingly, most Wnt proteins and their inhibitors are expressed in the uninjured spinal cord, and their temporal expression patterns are dramatically altered after injury. However, little is known regarding the expression of their better-known receptors, the Frizzled family, after SCI. Thus, the aim of the present study was to evaluate the expression of Frizzled receptors in the damaged spinal cord. Findings: Based on the evidence that Wnts are expressed in the spinal cord and are transcriptionally regulated by SCI in adulthood, we analysed the spatio-temporal mRNA and protein expression patterns of Frizzled receptors after contusive SCI using quantitative RT-PCR and single and double immunohistochemistry, respectively. Our results show that almost all of the 10 known Frizzled receptors were expressed in specific spatial patterns in the uninjured spinal cords. Moreover, the Frizzled mRNAs and proteins were expressed after SCI, although their expression patterns were altered during the temporal progression of SCI. Finally, analysis of cellular Frizzled 5 expression pattern by double immunohistochemistry showed that, in the uninjured spinal cord, this receptor was expressed in neurons, oligodendrocytes, astrocytes, microglia and NG2(+) glial precursors. After injury, Frizzled 5 was not only still expressed in oligodendrocytes, astrocytes and NG2(+) glial precursors but also in axons at all evaluated time points. Moreover, Frizzled 5 was expressed in reactive microglia/macrophages from 3 to 14 days post-injury. Conclusions: Our data suggest the involvement of Frizzled receptors in physiological spinal cord function and in the cellular and molecular events that characterise its neuropathology.	[Gonzalez, Pau; Maria Fernandez-Martos, Carmen; Gonzalez-Fernandez, Carlos; Javier Rodriguez, Francisco] Hosp Nacl Paraplejicos, Mol Neurol Lab, Toledo, Spain; [Arenas, Ernest] Karolinska Inst, Mol Neurobiol Unit, Dept Med Biochem & Biophys, Stockholm, Sweden	Hospital Nacional de Paraplejicos; Karolinska Institutet	Rodriguez, FJ (corresponding author), Hosp Nacl Paraplejicos, Mol Neurol Lab, Toledo, Spain.	fjrodriguez@sescam.jccm.es	González, Carlos/AAG-9659-2019; Sanchez, Pau Gonzalez/J-2530-2019; Rodríguez Muñoz, Francisco Javier/GZM-5286-2022; Arenas, Ernest/AAO-5231-2020; Fernandez-Martos, Carmen/J-7770-2014	González, Carlos/0000-0002-3415-0723; Sanchez, Pau Gonzalez/0000-0002-8871-8054; Rodríguez Muñoz, Francisco Javier/0000-0001-5902-7556; Arenas, Ernest/0000-0003-0197-6577; Fernandez-Martos, Carmen/0000-0002-6387-4456	Fondo de Investigacion Sanitaria de Castilla la Mancha (FISCAM) [PI2008-39]; Fondo de Investigacion Sanitaria (FIS) [PI08-1475]; Fondo Europeo de Desarrollo Regional [FEDER]	Fondo de Investigacion Sanitaria de Castilla la Mancha (FISCAM); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional [FEDER](European Commission)	This research was supported by grants obtained from the Fondo de Investigacion Sanitaria de Castilla la Mancha (FISCAM) (Grant PI2008-39) and Fondo de Investigacion Sanitaria (FIS) (Grant PI08-1475, co-funded by Fondo Europeo de Desarrollo Regional [FEDER]). The funding agencies had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Bournat JC, 2000, J NEUROSCI RES, V61, P21, DOI 10.1002/1097-4547(20000701)61:1<21::AID-JNR3>3.0.CO;2-7; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Busceti CL, 2007, EPILEPSIA, V48, P694, DOI 10.1111/j.1528-1167.2007.01055.x; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Cappuccio I, 2005, J NEUROSCI, V25, P2647, DOI 10.1523/JNEUROSCI.5230-04.2005; Caraci F, 2008, NEUROCHEM RES, V33, P2401, DOI 10.1007/s11064-008-9710-0; Caricasole A, 2005, BIOSCIENCE REP, V25, P309, DOI 10.1007/s10540-005-2893-6; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chan Carmen C M, 2008, Recent Pat CNS Drug Discov, V3, P189, DOI 10.2174/157488908786242434; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cui XP, 2011, IRISH J MED SCI, V180, P387, DOI 10.1007/s11845-010-0566-3; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32; Decimo I, 2011, STEM CELLS, V29, P2062, DOI 10.1002/stem.766; George SJ, 2008, ARTERIOSCL THROM VAS, V28, P400, DOI 10.1161/ATVBAHA.107.160952; Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081; Hendrickx M, 2008, DEV GROWTH DIFFER, V50, P229, DOI [10.1111/j.1440-169x.2008.01016.x, 10.1111/j.1440-169X.2008.01016.x]; Horner PJ, 2002, J NEUROCYTOL, V31, P469, DOI 10.1023/A:1025739630398; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Jin X, 2011, CANCER RES, V71, P3066, DOI 10.1158/0008-5472.CAN-10-1495; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kilander MBC, 2011, ACTA PHYSIOL, V203, P363, DOI 10.1111/j.1748-1716.2011.02324.x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LEpiscopo F, 2011, NEUROBIOL DIS; Li L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3147pt2; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Liebner S, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-1; Liu C, 2008, J NEUROSCI, V28, P5641, DOI 10.1523/JNEUROSCI.1056-08.2008; Liu YB, 2008, J NEUROSCI, V28, P8376, DOI 10.1523/JNEUROSCI.1939-08.2008; Lovestone S, 2007, TRENDS NEUROSCI, V30, P142, DOI 10.1016/j.tins.2007.02.002; Lytle JM, 2009, GLIA, V57, P270, DOI 10.1002/glia.20755; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Malaterre J, 2007, FRONT BIOSCI-LANDMRK, V12, P492, DOI 10.2741/2077; Fernandez-Martos CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035594; Fernandez-Martos CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027000; Mastroiacovo F, 2009, J CEREBR BLOOD F MET, V29, P264, DOI 10.1038/jcbfm.2008.111; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Michaelidis TM, 2008, CELL TISSUE RES, V331, P193, DOI 10.1007/s00441-007-0476-5; Miyashita T, 2009, J NEUROTRAUM, V26, P955, DOI 10.1089/neu.2008.0776; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1998, GLIA, V22, P390, DOI 10.1002/(SICI)1098-1136(199804)22:4<390::AID-GLIA8>3.0.CO;2-7; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Polakis P, 2008, J CELL BIOL, V183, P371, DOI 10.1083/jcb.200810040; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; Renault-Mihara F, 2008, INT J BIOCHEM CELL B, V40, P1649, DOI 10.1016/j.biocel.2008.03.009; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Seitz R, 2010, J NEUROSCI, V30, P5998, DOI 10.1523/JNEUROSCI.0730-10.2010; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Tan AM, 2005, J ANAT, V207, P717, DOI 10.1111/j.1469-7580.2005.00452.x; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Varela-Nallar L, 2012, CYTOSKELETON HOBOKEN; Varela-Nallar L, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-41; Wang YS, 2006, J NEUROSCI, V26, P355, DOI 10.1523/JNEUROSCI.3221-05.2006; Widelitz R, 2005, GROWTH FACTORS, V23, P111, DOI 10.1080/08977190500125746; Yin ZS, 2008, NEUROL RES, V30, P480, DOI 10.1179/174313208X284133; Zhang Z, 2006, NEUROPATH APPL NEURO, V32, P615, DOI 10.1111/j.1365-2990.2006.00770.x	76	19	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50793	10.1371/journal.pone.0050793	http://dx.doi.org/10.1371/journal.pone.0050793			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251385	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900018
J	Baraki, H; Zinne, N; Wedekind, D; Meier, M; Bleich, A; Glage, S; Hedrich, HJ; Kutschka, I; Haverich, A				Baraki, Hassina; Zinne, Norman; Wedekind, Dirk; Meier, Martin; Bleich, Andre; Glage, Silke; Hedrich, Hans-Juergen; Kutschka, Ingo; Haverich, Axel			Magnetic Resonance Imaging of Soft Tissue Infection with Iron Oxide Labeled Granulocytes in a Rat Model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; COLONY-STIMULATING FACTOR; MR CONTRAST AGENTS; IN-VIVO; BONE-MARROW; STAPHYLOCOCCUS-AUREUS; PARTICLES; SUSCEPTIBILITY; MEDIASTINITIS; MACROPHAGES	Object: We sought to detect an acute soft tissue infection in rats by magnetic resonance imaging (MRI) using granulocytes, previously labeled with superparamagnetic particles of iron oxide (SPIO). Materials and Methods: Parasternal infection was induced by subcutaneous inoculation of Staphylococcus aureus suspension in rats. Granulocytes isolated from isogenic donor rats were labeled with SPIO. Infected rats were imaged by MRI before, 6 and 12 hours after intravenous injection of SPIO-labeled or unlabeled granulocytes. MR findings were correlated with histological analysis by Prussian blue staining and with re-isolated SPIO-labeled granulocytes from the infectious area by magnetic cell separation. Results: Susceptibility effects were present in infected sites on post-contrast T2*-weighted MR images in all animals of the experimental group. Regions of decreased signal intensity (SI) in MRI were detected at 6 hours after granulocyte administration and were more pronounced at 12 hours. SPIO-labeled granulocytes were identified by Prussian blue staining in the infected tissue and could be successfully re-isolated from the infected area by magnetic cell separation. Conclusion: The application of SPIO-labeled granulocytes in MRI offers new perspectives in diagnostic specificity and sensitifity to detect early infectious processes.	[Baraki, Hassina; Zinne, Norman; Kutschka, Ingo; Haverich, Axel] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, D-3000 Hannover, Germany; [Wedekind, Dirk; Meier, Martin; Bleich, Andre; Glage, Silke; Hedrich, Hans-Juergen] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany	Hannover Medical School; Hannover Medical School	Baraki, H (corresponding author), Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, D-3000 Hannover, Germany.	baraki.hassina@mh-hannover.de	Haverich, Axel/AAC-7552-2022	Meier, Martin/0000-0001-8642-0409				Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Bakhru SH, 2012, INT J NANOMED, V7, P4613, DOI 10.2147/IJN.S28294; Bennewitz MF, 2012, MOL IMAGING BIOL; Bierry G, 2008, RADIOLOGY, V248, P114, DOI 10.1148/radiol.2481071260; Bierry G, 2012, SKELETAL RADIOL, V41, P1509, DOI 10.1007/s00256-012-1397-2; Bowen CV, 2002, MAGNET RESON MED, V48, P52, DOI 10.1002/mrm.10192; Bruggink JLM, 2010, EUR J VASC ENDOVASC, V40, P348, DOI 10.1016/j.ejvs.2010.05.016; Bulte JWM, 2004, CURR PHARM BIOTECHNO, V5, P567; Cheng JL, 2010, CHIN J TRAUMATOL, V13, P173, DOI 10.3760/cma.j.issn.1008-1275.2010.03.008; Daldrup-Link HE, 2005, RADIOLOGY, V234, P197, DOI 10.1148/radiol.2341031236; Dodd SJ, 1999, BIOPHYS J, V76, P103, DOI 10.1016/S0006-3495(99)77182-1; ElOakley RM, 1996, ANN THORAC SURG, V61, P1030, DOI 10.1016/0003-4975(95)01035-1; FERRUCCI JT, 1990, AM J ROENTGENOL, V155, P943, DOI 10.2214/ajr.155.5.2120963; Gemmel F, 2012, EUR J NUCL MED MOL I, V39, P892, DOI 10.1007/s00259-012-2062-7; Cavalcanti JLG, 2011, EUR J RADIOL, V80, P60, DOI 10.1016/j.ejrad.2010.12.102; Gummert JF, 2002, THORAC CARDIOV SURG, V50, P87, DOI 10.1055/s-2002-26691; Guo RF, 2006, J IMMUNOL, V177, P1306, DOI 10.4049/jimmunol.177.2.1306; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hamm J, 2008, NMR BIOMED, V21, P120, DOI 10.1002/nbm.1168; Heiken Jay P, 2008, Cancer Imaging, V8 Spec No A, pS124, DOI 10.1102/1470-7330.2008.9018; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Hoehn M, 2007, J PHYSIOL-LONDON, V584, P25, DOI 10.1113/jphysiol.2007.139451; Jaatinen Taina, 2007, Curr Protoc Stem Cell Biol, VChapter 2, DOI [10.1002/9780470151808.sc02a02s1, 10.1002/9780470151808.sc02a01s1]; Jendelova P, 2004, J NEUROSCI RES, V76, P232, DOI 10.1002/jnr.20041; Ju SH, 2007, RADIOLOGY, V245, P206, DOI 10.1148/radiol.2443061290; Kaim AH, 2003, RADIOLOGY, V227, P169, DOI 10.1148/radiol.2272020490; Kaim AH, 2002, RADIOLOGY, V225, P808, DOI 10.1148/radiol.2253011485; Karzai W, 2005, ANESTHESIOLOGY, V103, P996, DOI 10.1097/00000542-200511000-00014; Kato N, 2002, INVEST RADIOL, V37, P292, DOI 10.1097/00004424-200205000-00007; Kiessling F, 2009, RADIOLOGY, V253, P462, DOI 10.1148/radiol.2532081815; Kircher MF, 2003, CANCER RES, V63, P6838; Krishna S, 2012, SEMIN IMMUNOPATHOL, V34, P261, DOI 10.1007/s00281-011-0292-6; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; LANDAY AL, 1989, CLIN IMMUNOL IMMUNOP, V52, P48, DOI 10.1016/0090-1229(89)90192-X; LANGE JMA, 1990, NEW ENGL J MED, V322, P1375, DOI 10.1056/NEJM199005103221907; Lee JS, 2006, RADIOLOGY, V241, P142, DOI 10.1148/radiol.2403051156; Lefevre S, 2011, RADIOLOGY, V258, P722, DOI 10.1148/radiol.10101272; Love Charito, 2004, J Nucl Med Technol, V32, P47; Lush CW, 2000, MICROCIRCULATION, V7, P83, DOI 10.1038/sj.mn.7300096; Lutz AM, 2004, RADIOLOGY, V233, P149, DOI 10.1148/radiol.2331031402; Misselwitz B, 2006, EUR J RADIOL, V58, P375, DOI 10.1016/j.ejrad.2005.12.044; Modo M, 2005, MOL IMAGING, V4, P143; MORIMOTO A, 1990, J PHYSIOL-LONDON, V427, P227, DOI 10.1113/jphysiol.1990.sp018169; Mulder WJM, 2006, NMR BIOMED, V19, P142, DOI 10.1002/nbm.1011; Namasivayam Saravanan, 2007, Cancer Imaging, V7, P2, DOI 10.1102/1470-7330.2007.0002; Ozcan AV, 2006, TEX HEART I J, V33, P107; Saleem BR, 2010, AM J SURG, V200, P47, DOI 10.1016/j.amjsurg.2009.05.018; Satta J, 1998, SCAND CARDIOVASC J, V32, P29; Specht K, 2005, NEUROIMAGE, V25, P287, DOI 10.1016/j.neuroimage.2004.11.022; TANAKA H, 1989, J PHARMACOL EXP THER, V251, P1199; Tang TY, 2009, ARTERIOSCL THROM VAS, V29, P1001, DOI 10.1161/ATVBAHA.108.165514; Tanimoto A, 2001, J MAGN RESON IMAGING, V14, P72, DOI 10.1002/jmri.1153; van desBank BL, 2012, NMR BIOMED, V26, P367, DOI [10.1002/nbm.2868, DOI 10.1002/NBM.2868]; Wang YXJ, 2008, BRIT J RADIOL, V81, P987, DOI 10.1259/bjr/55991430; WEISSKOFF RM, 1992, MAGNET RESON MED, V24, P375, DOI 10.1002/mrm.1910240219; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; Yamaguchi H, 2001, Ann Thorac Cardiovasc Surg, V7, P94; Yamashiro T, 2008, RADIAT MED, V26, P343, DOI 10.1007/s11604-008-0238-7	59	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51770	10.1371/journal.pone.0051770	http://dx.doi.org/10.1371/journal.pone.0051770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236524	gold, Green Published, Green Submitted			2022-12-27	WOS:000312064100140
J	Karolemeas, K; Donnelly, CA; Conlan, AJK; Mitchell, AP; Clifton-Hadley, RS; Upton, P; Wood, JLN; McKinley, TJ				Karolemeas, Katerina; Donnelly, Christl A.; Conlan, Andrew J. K.; Mitchell, Andrew P.; Clifton-Hadley, Richard S.; Upton, Paul; Wood, James L. N.; McKinley, Trevelyan J.			The Effect of Badger Culling on Breakdown Prolongation and Recurrence of Bovine Tuberculosis in Cattle Herds in Great Britain	PLOS ONE			English	Article							HUSBANDRY PRACTICES; RISK-FACTORS; IMPACT; REMOVAL; MODEL	Bovine tuberculosis is endemic in cattle herds in Great Britain, with a substantial economic impact. A reservoir of Mycobacterium bovis within the Eurasian badger (Meles meles) population is thought to have hindered disease control. Cattle herd incidents, termed breakdowns, that are either 'prolonged' (lasting >= 240 days) or 'recurrent' (with another breakdown within a specified time period) may be important foci for onward spread of infection. They drain veterinary resources and can be demoralising for farmers. Randomised Badger Culling Trial (RBCT) data were re-analysed to examine the effects of two culling strategies on breakdown prolongation and recurrence, during and after culling, using a Bayesian hierarchical model. Separate effect estimates were obtained for the 'core' trial areas (where culling occurred) and the 'buffer' zones (up to 2 km outside of the core areas). For breakdowns that started during the culling period, 'reactive' (localised) culling was associated with marginally increased odds of prolongation, with an odds ratio (OR) of 1.7 (95% credible interval [CI] 1.1-2.4) within the core areas. This effect was not present after the culling ceased. There was no notable effect of 'proactive' culling on prolongation. In contrast, reactive culling had no effect on breakdown recurrence, though there was evidence of a reduced risk of recurrence in proactive core areas during the culling period (ORs and 95% CIs: 0.82 (0.64-1.0) and 0.69 (0.54-0.86) for 24- and 36-month recurrence respectively). Again these effects were not present after the culling ceased. There seemed to be no effect of culling on breakdown prolongation or recurrence in the buffer zones. These results suggest that the RBCT badger culling strategies are unlikely to reduce either the prolongation or recurrence of breakdowns in the long term, and that reactive strategies (such as employed during the RBCT) are, if anything, likely to impact detrimentally on breakdown persistence.	[Karolemeas, Katerina; Conlan, Andrew J. K.; Wood, James L. N.; McKinley, Trevelyan J.] Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge, England; [Donnelly, Christl A.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England; [Mitchell, Andrew P.; Clifton-Hadley, Richard S.; Upton, Paul] Anim Hlth & Vet Labs Agcy, Surrey, England	University of Cambridge; Imperial College London	McKinley, TJ (corresponding author), Univ Cambridge, Dept Vet Med, Dis Dynam Unit, Cambridge, England.	tjm44@cam.ac.uk	Conlan, Andrew/Q-3861-2019; Mitchell, Andrew P/L-6141-2014; Wood, James/A-1626-2008	Conlan, Andrew/0000-0002-2593-6353; Wood, James/0000-0002-0258-3188; Donnelly, Christl/0000-0002-0195-2463	Department for Environment, Food and Rural Affairs (Defra) [VT0105]; BBSRC [BB/I012192/1]; Alborada Trust; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Defra [SE3230, PU/T/WL/07/46]; Veterinary Laboratories Agency; Defra, United Kingdom [SE3230]; MRC; Hefce; Biotechnology and Biological Sciences Research Council [BB/I012192/1] Funding Source: researchfish; Medical Research Council [G0600719, G0600719B] Funding Source: researchfish; MRC [G0600719] Funding Source: UKRI	Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alborada Trust; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Veterinary Laboratories Agency; Defra, United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hefce(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	KK, TJM and JLNW were supported by grant VT0105 from the Department for Environment, Food and Rural Affairs (Defra) and Hefce. TJM is also supported by BBSRC grant (BB/I012192/1). JLNW is also supported by the Alborada Trust and the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security. AJKC was funded by Defra grant SE3230 Cambridge reference PU/T/WL/07/46), sponsored by the Veterinary Laboratories Agency. The work was also funded by Defra, United Kingdom, under contract SE3230. CAD thanks the MRC for Centre funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy DA, 2010, P SOC VET EP PREV ME, P167; [Anonymous], 2012, VET REC, V171, P413, DOI 10.1136/vr.e7175; Bourne J, 2011, RACE CLASS, V52, P1, DOI 10.1177/0306396810392114; Christiansen KH, 1992, CASE CONTROL STUDY H, P45; Conlan AJK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002730; Corner LAL, 2011, J COMP PATHOL, V144, P1, DOI 10.1016/j.jcpa.2010.10.003; Cox DR, 2005, P NATL ACAD SCI USA, V102, P17588, DOI 10.1073/pnas.0509003102; COX DR, 1955, J ROY STAT SOC B, V17, P129; Defra, 2005, GOV STRAT FRAM SUST; Defra, 2010, BOV TUB GOV APPR TAC; Defra, 2010, BOV TB BADG VACC DEP; Defra, 2005, BOV TB HIST BADG CON; Defra, 2012, BOV TB PIL AR CONF; Defra, 2005, REP IND SCI REV GROU; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Donnelly CA, 2007, INT J INFECT DIS, V11, P300, DOI 10.1016/j.ijid.2007.04.001; Eves JA, 1999, IRISH VET J, V52, P199; Farm Crisis Network, 2009, STRESS LOSS REP IMP; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Godfray CJ, 2004, INDEPENDENT SCI REV; Green DM, 2008, P R SOC B, V275, P1001, DOI 10.1098/rspb.2007.1601; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; GRIFFIN JM, 1993, PREV VET MED, V17, P145, DOI 10.1016/0167-5877(93)90025-O; Jenkins HE, 2007, J APPL ECOL, V44, P897, DOI 10.1111/j.1365-2664.2007.01372.x; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; Johnston WT, 2005, BIOL LETT-UK, V1, P53, DOI 10.1098/rsbl.2004.0249; Karolemeas K, 2011, PREV VET MED, V102, P22, DOI 10.1016/j.prevetmed.2011.06.004; Karolemeas K, 2010, PREV VET MED, V97, P183, DOI 10.1016/j.prevetmed.2010.09.007; King D., 2007, BOVINE TUBERCULOSIS; More SJ, 2007, VET REC, V161, P208, DOI 10.1136/vr.161.6.208; Olea-Popelka FJ, 2004, PREV VET MED, V63, P163, DOI 10.1016/j.prevetmed.2004.03.001; R Core Development Team, 2011, R LANG ENV STAT COMP; Reilly LA, 2007, PREV VET MED, V80, P129, DOI 10.1016/j.prevetmed.2007.02.002; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Vial F, 2012, BIOL LETTERS, V8, P50, DOI 10.1098/rsbl.2011.0554; Vial F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018058; [Welsh Assembly Government wales.gov.uk/topics/environmentaluntryside/ahw/disease/bovinetuberculosis/?lang=en], 2012, BADG VACC N PEMBR WA; Wolfe DM, 2010, PREV VET MED, V94, P170, DOI 10.1016/j.prevetmed.2010.02.010; Woodroffe R, 2008, J ZOOL, V274, P28, DOI 10.1111/j.1469-7998.2007.00353.x; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; Woodroffe R, 2006, P NATL ACAD SCI USA, V103, P14713, DOI 10.1073/pnas.0606251103; Woodroffe R, 2009, J WILDLIFE DIS, V45, P128, DOI 10.7589/0090-3558-45.1.128	43	6	6	0	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51342	10.1371/journal.pone.0051342	http://dx.doi.org/10.1371/journal.pone.0051342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236478	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100100
J	Malinowski, M; Pietraszek, K; Perreau, C; Boguslawski, M; Decot, V; Stoltz, JF; Vallar, L; Niewiarowska, J; Cierniewski, C; Maquart, FX; Wegrowski, Y; Brezillon, S				Malinowski, Mariusz; Pietraszek, Katarzyna; Perreau, Corinne; Boguslawski, Mateusz; Decot, Veronique; Stoltz, Jean-Francois; Vallar, Laurent; Niewiarowska, Jolanta; Cierniewski, Czeslaw; Maquart, Francois-Xavier; Wegrowski, Yanusz; Brezillon, Stephane			Effect of Lumican on the Migration of Human Mesenchymal Stem Cells and Endothelial Progenitor Cells: Involvement of Matrix Metalloproteinase-14	PLOS ONE			English	Article							HUMAN BONE-MARROW; ISCHEMIA-INDUCED NEOVASCULARIZATION; LEUCINE-RICH PROTEOGLYCAN; EXTRACELLULAR-MATRIX; TUMOR ANGIOGENESIS; GENE-EXPRESSION; STROMAL CELLS; IN-VITRO; CLEAVAGE; GROWTH	Background: Increasing number of evidence shows that soluble factors and extracellular matrix (ECM) components provide an optimal microenvironment controlling human bone marrow mesenchymal stem cell (MSC) functions. Successful in vivo administration of stem cells lies in their ability to migrate through ECM barriers and to differentiate along tissue-specific lineages, including endothelium. Lumican, a protein of the small leucine-rich proteoglycan (SLRP) family, was shown to impede cell migration and angiogenesis. The aim of the present study was to analyze the role of lumican in the control of MSC migration and transition to functional endothelial progenitor cell (EPC). Methodology/Principal Findings: Lumican inhibited tube-like structures formation on Matrigel (R) by MSC, but not EPC. Since matrix metalloproteinases (MMPs), in particular MMP-14, play an important role in remodelling of ECM and enhancing cell migration, their expression and activity were investigated in the cells grown on different ECM substrata. Lumican down-regulated the MMP-14 expression and activity in MSC, but not in EPC. Lumican inhibited MSC, but not EPC migration and invasion. The inhibition of MSC migration and invasion by lumican was reversed by MMP-14 overexpression. Conclusion/Significance: Altogether, our results suggest that lumican inhibits MSC tube-like structure formation and migration via mechanisms that involve a decrease of MMP-14 expression and activity. Citation: Malinowski M, Pietraszek K, Perreau C, Boguslawski M, Decot V, et al. (2012) Effect of Lumican on the Migration of Human Mesenchymal Stem Cells and Endothelial Progenitor Cells: Involvement of Matrix Metalloproteinase-14. PLoS ONE 7(12): e50709. doi:10.1371/journal.pone.0050709	[Malinowski, Mariusz; Pietraszek, Katarzyna; Perreau, Corinne; Boguslawski, Mateusz; Maquart, Francois-Xavier; Wegrowski, Yanusz; Brezillon, Stephane] Univ Reims, CNRS FRE 3481, Lab Biochim Med & Biol Mol, Reims, France; [Malinowski, Mariusz; Cierniewski, Czeslaw] Polish Acad Sci, Inst Med Biol, Lodz, Poland; [Decot, Veronique; Stoltz, Jean-Francois] CHU Brabois, CNRS, Unite Therapie Cellulaire & Banque Tissus, Fac Med,UMR 7561, Vandoeuvre Les Nancy, France; [Vallar, Laurent] CRP Sante, Microarray Ctr, Luxembourg, Luxembourg; [Niewiarowska, Jolanta] Med Univ Lodz, Dept Mol & Med Biophys, Lodz, Poland; [Maquart, Francois-Xavier] CHU Reims, Reims, France	Universite de Reims Champagne-Ardenne; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CHU de Nancy; Universite de Lorraine; Luxembourg Institute of Health; Medical University Lodz; CHU de Reims	Brezillon, S (corresponding author), Univ Reims, CNRS FRE 3481, Lab Biochim Med & Biol Mol, Reims, France.	stephane.brezillon@univ-reims.fr	Karamanos, Nikos/A-3616-2008; Pietraszek-Gremplewicz, Katarzyna/AAM-2454-2020	Karamanos, Nikos/0000-0003-3618-0288; Niewiarowska, Jolanta/0000-0003-0561-7766; BREZILLON, stephane/0000-0001-7954-8340; Vallar, Laurent/0000-0002-4404-1010; Pietraszek-Gremplewicz, Katarzyna/0000-0002-4081-5314; Malinowski, Mariusz/0000-0002-1632-8647	INCa-CNRS-Polish Academy of Sciences program; Institut National du Cancer (INCa) (ACI Canceropoles); Region Champagne-Ardenne; Fonds Europeen de Developpement Regional (FEDER) (contrat de projet Etat-region (CPER)); Ligue Nationale contre le Cancer (comite de la Mame)	INCa-CNRS-Polish Academy of Sciences program; Institut National du Cancer (INCa) (ACI Canceropoles)(Region Grand-EstInstitut National du Cancer (INCA) France); Region Champagne-Ardenne(Region Grand-Est); Fonds Europeen de Developpement Regional (FEDER) (contrat de projet Etat-region (CPER)); Ligue Nationale contre le Cancer (comite de la Mame)	The authors thank the INCa-CNRS-Polish Academy of Sciences program, Institut National du Cancer (INCa) (ACI Canceropoles 2007-2009), the Region Champagne-Ardenne, the Fonds Europeen de Developpement Regional (FEDER) (contrat de projet Etat-region (CPER), CPER 2007-2013) and the Ligue Nationale contre le Cancer (comite de la Mame) for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, BIOCHEM BIOPH RES CO, V400, P284, DOI 10.1016/j.bbrc.2010.08.073; Albig Allan R., 2007, Angiogenesis, V10, P197, DOI 10.1007/s10456-007-9075-z; Berthelemy N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005514; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brezillon S, 2007, CLIN EXP DERMATOL, V32, P405, DOI 10.1111/j.1365-2230.2007.02437.x; Brezillon S, 2009, J PHYSIOL PHARMACOL, V60, P15; Brezillon S, 2009, CANCER LETT, V283, P92, DOI 10.1016/j.canlet.2009.03.032; Caiado F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003752; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Chen XD, 2010, BIRTH DEFECTS RES C, V90, P45, DOI 10.1002/bdrc.20171; Cheng XW, 2007, CIRC RES, V100, P904, DOI 10.1161/01.RES.0000260801.12916.b5; Corpuz LM, 1996, J BIOL CHEM, V271, P9759, DOI 10.1074/jbc.271.16.9759; D'Onofrio MF, 2008, BIOCHEM BIOPH RES CO, V365, P266, DOI 10.1016/j.bbrc.2007.10.155; Davis GE, 2006, J INVEST DERM SYMP P, V11, P44, DOI 10.1038/sj.jidsymp.5650008; Dolhnikoff M, 1998, AM J RESP CELL MOL, V19, P582, DOI 10.1165/ajrcmb.19.4.2979; Gao DC, 2009, BBA-REV CANCER, V1796, P33, DOI 10.1016/j.bbcan.2009.05.001; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; GROVER J, 1995, J BIOL CHEM, V270, P21942, DOI 10.1074/jbc.270.37.21942; Gruber R, 2005, TISSUE ENG, V11, P896, DOI 10.1089/ten.2005.11.896; Ho IAW, 2009, STEM CELLS, V27, P1366, DOI 10.1002/stem.50; Huang PH, 2009, ARTERIOSCL THROM VAS, V29, P1179, DOI 10.1161/ATVBAHA.109.189175; Jazayeri M, 2008, CELL BIOL INT, V32, P1183, DOI 10.1016/j.cellbi.2008.07.020; Kao WWY, 2006, EXP EYE RES, V82, P3, DOI 10.1016/j.exer.2005.08.012; Lecomte J, 2011, CELL MOL LIFE SCI, V68, P677, DOI 10.1007/s00018-010-0476-6; Lee S, 2009, J BIOL CHEM, V284, P23662, DOI 10.1074/jbc.M109.026229; Li YY, 2004, CANCER RES, V64, P7058, DOI 10.1158/0008-5472.CAN-04-1038; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Liu Y, 2007, BIOMATERIALS, V28, P1393, DOI 10.1016/j.biomaterials.2006.11.019; Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344; Lozito TP, 2009, J CELL BIOCHEM, V107, P714, DOI 10.1002/jcb.22167; Lu CL, 2010, BLOOD, V115, P221, DOI 10.1182/blood-2009-06-228494; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mimura T, 2011, CORNEA, V30, pS45, DOI 10.1097/ICO.0b013e31822816e0; Moby V, 2011, J BIOMED MATER RES A, V96A, P313, DOI 10.1002/jbm.a.32981; Niewiarowska J, 2011, THROMB RES, V128, P452, DOI 10.1016/j.thromres.2011.06.011; Omoteyama K, 2007, BIOCHEM BIOPH RES CO, V353, P159, DOI 10.1016/j.bbrc.2006.11.145; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Radwanska A, 2008, LIFE SCI, V83, P651, DOI 10.1016/j.lfs.2008.09.008; Rafii S, 2002, SEMIN CELL DEV BIOL, V13, P61, DOI 10.1006/scdb.2001.0285; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Semon JA, 2010, CELL TISSUE RES, V341, P147, DOI 10.1007/s00441-010-0994-4; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Thevenard J, 2010, INT J CANCER, V126, P1055, DOI 10.1002/ijc.24688; Troup S, 2003, CLIN CANCER RES, V9, P207; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Vuillermoz B, 2004, EXP CELL RES, V296, P294, DOI 10.1016/j.yexcr.2004.02.005; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Williams KE, 2011, CANCER MICROENVIRON, V4, P115, DOI 10.1007/s12307-010-0056-1; Zeltz C, 2010, EXP CELL RES, V316, P2922, DOI 10.1016/j.yexcr.2010.08.002	51	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50709	10.1371/journal.pone.0050709	http://dx.doi.org/10.1371/journal.pone.0050709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236386	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100028
J	Martin, KL; Hill, GA; Klein, RR; Arnett, DG; Burd, R; Limesand, KH				Martin, Katie L.; Hill, Grace A.; Klein, Rob R.; Arnett, Deborah G.; Burd, Randy; Limesand, Kirsten H.			Prevention of Radiation-Induced Salivary Gland Dysfunction Utilizing a CDK Inhibitor in a Mouse Model	PLOS ONE			English	Article							IN-VIVO; ACINAR-CELLS; APOPTOSIS; RADIOTHERAPY; SENSITIVITY; SUPPRESSION; P53; ENHANCEMENT; ROSCOVITINE; ANTAGONISTS	Background: Treatment of head and neck cancer with radiation often results in damage to surrounding normal tissues such as salivary glands. Permanent loss of function in the salivary glands often leads patients to discontinue treatment due to incapacitating side effects. It has previously been shown that IGF-1 suppresses radiation-induced apoptosis and enhances G2/M arrest leading to preservation of salivary gland function. In an effort to recapitulate the effects of IGF-1, as well as increase the likelihood of translating these findings to the clinic, the small molecule therapeutic Roscovitine, is being tested. Roscovitine is a cyclin-dependent kinase inhibitor that acts to transiently inhibit cell cycle progression and allow for DNA repair in damaged tissues. Methodology/Principal Findings: Treatment with Roscovitine prior to irradiation induced a significant increase in the percentage of cells in the G(2)/M phase, as demonstrated by flow cytometry. In contrast, mice treated with radiation exhibit no differences in the percentage of cells in G(2)/M when compared to unirradiated controls. Similar to previous studies utilizing IGF-1, pretreatment with Roscovitine leads to a significant up-regulation of p21 expression and a significant decrease in the number of PCNA positive cells. Radiation treatment leads to a significant increase in activated caspase-3 positive salivary acinar cells, which is suppressed by pretreatment with Roscovitine. Administration of Roscovitine prior to targeted head and neck irradiation preserves normal tissue function in mouse parotid salivary glands, both acutely and chronically, as measured by salivary output. Conclusions/Significance: These studies suggest that induction of transient G(2)/M cell cycle arrest by Roscovitine allows for suppression of apoptosis, thus preserving normal salivary function following targeted head and neck irradiation. This could have an important clinical impact by preventing the negative side effects of radiation therapy in surrounding normal tissues. Citation: Martin KL, Hill GA, Klein RR, Arnett DG, Burd R, et al. (2012) Prevention of Radiation-Induced Salivary Gland Dysfunction Utilizing a CDK Inhibitor in a Mouse Model. PLoS ONE 7(12): e51363. doi: 10.1371/journal.pone.0051363	[Martin, Katie L.; Limesand, Kirsten H.] Univ Arizona, Physiol Sci Grad Interdisciplinary Program, Tucson, AZ 85721 USA; [Klein, Rob R.] Univ Arizona, Dept Pathol, Tucson, AZ USA; [Hill, Grace A.; Arnett, Deborah G.; Burd, Randy; Limesand, Kirsten H.] Univ Arizona, Dept Nutr Sci, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona	Limesand, KH (corresponding author), Univ Arizona, Physiol Sci Grad Interdisciplinary Program, Tucson, AZ 85721 USA.	limesank@u.arizona.edu		Limesand, Kirsten/0000-0003-4295-4665; Burd, Randy/0000-0001-9195-2733	Cancer Center Support Grant [CCSG- CA 023074]; National Institutes of Health [R01 (DE18888)]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018888] Funding Source: NIH RePORTER	Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The Flow Cytometry Core Facility is supported in part from a Cancer Center Support Grant CCSG- CA 023074. This work was supported by the National Institutes of Health R01 (DE18888). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila JL, 2009, INT J RADIAT ONCOL, V73, P523, DOI 10.1016/j.ijrobp.2008.09.036; Braam PM, 2006, INT J RADIAT ONCOL, V66, P975, DOI 10.1016/j.ijrobp.2006.06.045; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen YNP, 1999, P NATL ACAD SCI USA, V96, P4325, DOI 10.1073/pnas.96.8.4325; Cmielova J, 2011, J CELL BIOCHEM, V112, P3502, DOI 10.1002/jcb.23296; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Hall E, 2000, RADIOBIOLOGY RADIOLO; Hui ABY, 2009, CLIN CANCER RES, V15, P3716, DOI 10.1158/1078-0432.CCR-08-2790; Jerjes W, 2012, HEAD NECK ONCOL, V4, DOI 10.1186/1758-3284-4-6; Li Y, 2007, INT J RADIAT ONCOL, V67, P660, DOI 10.1016/j.ijrobp.2006.09.021; Limesand KH, 2003, CELL DEATH DIFFER, V10, P345, DOI 10.1038/sj.cdd.4401153; Limesand KH, 2006, MOL CELL BIOL, V26, P8840, DOI 10.1128/MCB.01846-05; Limesand KH, 2010, INT J RADIAT ONCOL, V78, P579, DOI 10.1016/j.ijrobp.2010.03.035; Limesand KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004663; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maggiorella L, 2003, CANCER RES, V63, P2513; Meijer L, 1996, TRENDS CELL BIOL, V6, P393, DOI 10.1016/0962-8924(96)10034-9; Mendoza N, 2003, CANCER RES, V63, P1020; Mitchell GC, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.28; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Raynaud FI, 2005, CLIN CANCER RES, V11, P4875, DOI 10.1158/1078-0432.CCR-04-2264; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Wallace M, 2001, ONCOGENE, V20, P3597, DOI 10.1038/sj.onc.1204496; Zhang F, 2008, J RADIAT RES, V49, P541, DOI 10.1269/jrr.08024	25	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51363	10.1371/journal.pone.0051363	http://dx.doi.org/10.1371/journal.pone.0051363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236487	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100106
J	Tian, SZ; Ning, TY; Zhao, HX; Wang, BW; Li, N; Han, HF; Li, ZJ; Chi, SY				Tian, Shenzhong; Ning, Tangyuan; Zhao, Hongxiang; Wang, Bingwen; Li, Na; Han, Huifang; Li, Zengjia; Chi, Shuyun			Response of CH4 and N2O Emissions and Wheat Yields to Tillage Method Changes in the North China Plain	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; AGRICULTURAL SOILS; METHANE OXIDATION; NO-TILLAGE; FLUXES; CO2; LAND	The objective of this study was to quantify soil methane (CH4) and nitrous oxide (N2O) emissions when converting from minimum and no-tillage systems to subsoiling (tilled soil to a depth of 40 cm to 45 cm) in the North China Plain. The relationships between CH4 and N2O flux and soil temperature, moisture, NH4+-N, organic carbon (SOC) and pH were investigated over 18 months using a split-plot design. The soil absorption of CH4 appeared to increase after conversion from no-tillage (NT) to subsoiling (NTS), from harrow tillage (HT) to subsoiling (HTS) and from rotary tillage (RT) to subsoiling (RTS). N2O emissions also increased after conversion. Furthermore, after conversion to subsoiling, the combined global warming potential (GWP) of CH4 and N2O increased by approximately 0.05 kg CO2 ha(-1) for HTS, 0.02 kg CO2 ha(-1) for RTS and 0.23 kg CO2 ha(-1) for NTS. Soil temperature, moisture, SOC, NH4+-N and pH also changed after conversion to subsoiling. These changes were correlated with CH4 uptake and N2O emissions. However, there was no significant correlation between N2O emissions and soil temperature in this study. The grain yields of wheat improved after conversion to subsoiling. Under HTS, RTS and NTS, the average grain yield was elevated by approximately 42.5%, 27.8% and 60.3% respectively. Our findings indicate that RTS and HTS would be ideal rotation tillage systems to balance GWP decreases and grain yield improvements in the North China Plain region. Citation: Tian S, Ning T, Zhao H, Wang B, Li N, et al. (2012) Response of CH4 and N2O Emissions and Wheat Yields to Tillage Method Changes in the North China Plain. PLoS ONE 7(12): e51206. doi:10.1371/journal.pone.0051206	[Tian, Shenzhong; Ning, Tangyuan; Zhao, Hongxiang; Wang, Bingwen; Li, Na; Han, Huifang; Li, Zengjia] Shandong Agr Univ, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Chi, Shuyun] Shandong Agr Univ, Coll Mech & Elect Engn, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Ning, TY (corresponding author), Shandong Agr Univ, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	ningty@163.com; chishujun1955@163.com	han, han/HDL-7807-2022; Tian, Shenzhong/AAA-6890-2020	, TIAN/0000-0002-6264-5758	Nature Science Fund of China [30900876, 31101127]; National Science and Technology Research Projects of China [2012BAD14B17]; Special Research Funding for Public Benefit Industries (Agriculture) of China [201103001]	Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Research Projects of China; Special Research Funding for Public Benefit Industries (Agriculture) of China	This work was financially supported by the Nature Science Fund of China (30900876 and 31101127), the National Science and Technology Research Projects of China (2012BAD14B17), and Special Research Funding for Public Benefit Industries (Agriculture) of China (201103001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2009, SOIL TILL RES, V106, P54, DOI 10.1016/j.still.2009.09.005; Bai XiaoLin, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P282; Balbuena HR, 1998, P 4 CADIR ARG C AGR, V1, P197; Ball BC, 1999, SOIL TILL RES, V53, P29, DOI 10.1016/S0167-1987(99)00074-4; Bao S.D, 2000, SOIL AGR CHEM ANAL; Bayer C, 2012, SOIL TILL RES, V124, P1, DOI 10.1016/j.still.2012.03.006; Berisso FE, 2012, SOIL TILL RES, V122, P42, DOI 10.1016/j.still.2012.02.005; Bhatia A, 2010, AGR ECOSYST ENVIRON, V136, P247, DOI 10.1016/j.agee.2010.01.004; BOUWMAN AF, 1990, SOILS AND THE GREENHOUSE EFFECT, P61; Bowen H. D., 1981, Modifying the root environment to reduce crop stress, P21; Bradford MA, 2001, SOIL BIOL BIOCHEM, V33, P1625, DOI 10.1016/S0038-0717(01)00078-5; Chatskikh D, 2007, SOIL TILL RES, V97, P5, DOI 10.1016/j.still.2007.08.004; CLAYTON H, 1994, J GEOPHYS RES-ATMOS, V99, P16599, DOI 10.1029/94JD00218; Conen F, 2000, GLOBAL CHANGE BIOL, V6, P417, DOI 10.1046/j.1365-2486.2000.00319.x; Czyz EA, 2004, SOIL TILL RES, V79, P153, DOI 10.1016/j.still.2004.07.004; Daum D, 1998, PLANT SOIL, V203, P279, DOI 10.1023/A:1004350628266; Dijkstra FA, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001288; Dong Yuhong, 2005, Ying Yong Sheng Tai Xue Bao, V16, P1303; Elder JW, 2008, SOIL TILL RES, V98, P45, DOI 10.1016/j.still.2007.10.003; Forster P., 2007, CLIMATE CHANGE 2007, DOI DOI 10.1103/PHYSREVB.77.220407; [宫秀杰 GONG Xiu-jie], 2009, [玉米科学, Maize Science], V17, P134; GOULDING KWT, 1995, PHILOS T R SOC A, V351, P313, DOI 10.1098/rsta.1995.0036; Gregorich EG, 2005, SOIL TILL RES, V83, P53, DOI 10.1016/j.still.2005.02.009; Groffman PM, 2006, GLOBAL CHANGE BIOL, V12, P1748, DOI 10.1111/j.1365-2486.2006.01194.x; Han Bin, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P48; He Jin, 2006, Transactions of the Chinese Society of Agricultural Engineering, V22, P62; Huang Ming, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P50; Hutsch BW, 1998, BIOL FERT SOILS, V27, P284, DOI 10.1007/s003740050435; IPCC, 2001, 3 IPCC WORK GROUP 1; Jassal RS, 2011, GEODERMA, V162, P182, DOI 10.1016/j.geoderma.2011.02.002; Koponen HT, 2004, SOIL BIOL BIOCHEM, V36, P757, DOI 10.1016/j.soilbio.2003.12.011; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lee J, 2006, J ENVIRON QUAL, V35, P714, DOI 10.2134/jeq2005.0337; Li G., 2006, J HENAN U SCI TECHNO, V4, P74, DOI [10.15926/j.cnki.hkdsk.2006.04.019, DOI 10.15926/J.CNKI.HKDSK.2006.04.019, DOI 10.15926/J.CNKI.ISSN1672-6871.2006.02.022]; Merino P, 2012, SOIL TILL RES, V123, P29, DOI 10.1016/j.still.2012.03.005; Ouyang XueJun, 2005, China Environmental Science, V25, P465; Paustian K, 1997, SOIL USE MANAGE, V13, P230, DOI 10.1111/j.1475-2743.1997.tb00594.x; [齐玉春 Qi Yuchun], 2002, [农村生态环境, Rural Eco-Environment], V18, P56; [秦红灵 QIN Hongling], 2008, [中国农业科学, Scientia Agricultura Sinica], V41, P78; Robertson G. Philip, 1993, V55, P95; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Robertson L. A., 1991, Microbial production and consumption of greenhouse gases: methane, nitrogen oxides, and halomethanes., P189; Sehy U, 2003, AGR ECOSYST ENVIRON, V99, P97, DOI 10.1016/S0167-8809(03)00139-7; Six J, 2004, GLOBAL CHANGE BIOL, V10, P155, DOI 10.1111/j.1529-8817.2003.00730.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; [田慎重 Tian Shenzhong], 2012, [生态学报, Acta Ecologica Sinica], V32, P879; Wang ZP, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005548; Watanabe T, 2007, SOIL BIOL BIOCHEM, V39, P2877, DOI 10.1016/j.soilbio.2007.05.030; Wu FenLin, 2008, Scientia Agricultura Sinica, V41, P2703; Xu YangChun, 2002, Acta Pedologica Sinica, V39, P89; Zhang HaiLin, 2005, Journal of China Agricultural University, V10, P16; ZHENG X., 1997, SCI ATMOS SIN, V21, P231, DOI DOI 10.1007/S10705-011-9462-0	52	16	18	10	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51206	10.1371/journal.pone.0051206	http://dx.doi.org/10.1371/journal.pone.0051206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236456	Green Submitted, gold, Green Published			2022-12-27	WOS:000312589700033
J	Ciani, AC; Pellizzari, E				Ciani, Andrea Camperio; Pellizzari, Elena			Fecundity of Paternal and Maternal Non-Parental Female Relatives of Homosexual and Heterosexual Men	PLOS ONE			English	Article							KIN SELECTION HYPOTHESIS; MALE SEXUAL ORIENTATION; FRATERNAL BIRTH-ORDER; HIDDEN POPULATIONS; SAMOAN FAAFAFINE; MALE ANDROPHILIA; OLDER BROTHERS; BBC INTERNET; FAMILY-SIZE; COVARIANCE	A variety of social, developmental, biological and genetic factors influence sexual orientation in males. Thus, several hypotheses have attempted to explain the sustenance of genetic factors that influence male homosexuality, despite decreased fecundity within the homosexuals. Kin selection, the existence of maternal effects and two forms of balancing selection, sexually antagonistic selection and overdominance, have been proposed as compensatory mechanisms for reduced homosexual fecundity. Here, we suggest that the empirical support for kin selection and maternal effects cannot account for the low universal frequency and stability of the distribution of homosexuals. To identify the responsible compensatory mechanism, we analyzed fecundity in 2,100 European female relatives, i.e., aunts and grandmothers, of either homosexual or heterosexual probands who were matched in terms of age, culture and sampling strategy. Female relatives were chosen to avoid the sampling bias of the fraternal birth order effect, which occurs when indirectly sampling mothers though their homosexual sons. We observed that the maternal aunts and grandmothers of homosexual probands were significantly more fecund compared with the maternal aunts and maternal grandmothers of the heterosexual probands. No difference in fecundity was observed in the paternal female lines (grandmothers or aunts) from either of the two proband groups. Moreover, due to the selective increase in maternal female fecundity, the total female fecundity was significantly higher in homosexual than heterosexual probands, thus compensating for the reduced fecundity of homosexuals. Altogether, these data support an X-linked multi-locus sexually antagonistic hypothesis rather than an autosomal multi-locus overdominance hypothesis.	[Ciani, Andrea Camperio] Univ Padua, Dept Gen Psychol, Padua, Italy; [Pellizzari, Elena] GEA, Int Assoc Study & Conservat Ecosyst, Padua, Italy	University of Padua	Ciani, AC (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	andrea.camperio@unipd.it	Ciani, Andrea Camperio/A-8290-2013	Ciani, Andrea Camperio/0000-0002-4689-1799	University of Padova [CPDA 102089/10]	University of Padova	This research was partly funded by research grant CPDA 102089/10, from University of Padova (www.unipd.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Extra funding was provided personally by the authors' interest in science progress; no additional external fundings were received for this study.	BAILEY JM, 1993, BEHAV GENET, V23, P313, DOI 10.1007/BF01067431; BAILEY JM, 1991, ARCH GEN PSYCHIAT, V48, P1089; Bell A. P., 1978, HOMOSEXUALITIES A ST; Blanchard R, 2001, HORM BEHAV, V40, P105, DOI 10.1006/hbeh.2001.1681; Blanchard R, 2004, J THEOR BIOL, V230, P173, DOI 10.1016/j.jtbi.2004.04.021; Blanchard R, 2008, LATERALITY, V13, P51, DOI 10.1080/13576500701710432; Blanchard R, 2007, ARCH SEX BEHAV, V36, P163, DOI 10.1007/s10508-006-9159-7; Blanchard R, 2012, ARCH SEX BEHAV, V41, P551, DOI 10.1007/s10508-011-9888-0; Bobrow D, 2001, EVOL HUM BEHAV, V22, P361, DOI 10.1016/S1090-5138(01)00074-5; Bogaert AE, 1998, ARCH SEX BEHAV, V27, P467, DOI 10.1023/A:1018752513198; Bogaert AF, 2006, P NATL ACAD SCI USA, V103, P10771, DOI 10.1073/pnas.0511152103; Bogaert AF, 2011, FRONT NEUROENDOCRIN, V32, P247, DOI 10.1016/j.yfrne.2011.02.004; Camperio Ciani A, 2012, JOURNAL OF SEXUAL ME; Camperio Ciani A., 2011, EVOLUTION PERSONALIT, P425; Camperio-Ciani A, 2004, P ROY SOC B-BIOL SCI, V271, P2217, DOI 10.1098/rspb.2004.2872; Cantor JM, 2002, ARCH SEX BEHAV, V31, P63, DOI 10.1023/A:1014031201935; CHAHNAZARIAN A, 1988, SOC BIOL, V35, P214; Ciani AC, 2009, J SEX MED, V6, P449, DOI 10.1111/j.1743-6109.2008.00944.x; Ciani AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002282; Dawood K, 2000, ARCH SEX BEHAV, V29, P155, DOI 10.1023/A:1001955721992; EVANS SH, 1968, PSYCHOL BULL, V69, P225, DOI 10.1037/h0025666; Forrester D, 2011, J COGNITION CULTURE, V11, P3; GAMES PA, 1976, J EXP EDUC, V44, P51, DOI 10.1080/00220973.1976.11011551; Gavrilets S, 2007, P BIOL SCI, V273, P3031; Goodman L. A., 1961, ANN MATH STAT, V32; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Herdt, 1997, SAME SEX DIFFERENT C; Hollimon S, 1997, WOMEN PREHISTORY N A, P173; Hoyle RL, 1998, ARTE EROTICO EN EL A; HU S, 1995, NAT GENET, V11, P248, DOI 10.1038/ng1195-248; Iemmola F, 2009, ARCH SEX BEHAV, V38, P393, DOI 10.1007/s10508-008-9381-6; ISTAT, 1995, ITALIAN WOMENS FECUN; JAMES WH, 1987, HUM BIOL, V59, P721; Jannini EA, 2010, J SEX MED, V7, P3245, DOI 10.1111/j.1743-6109.2010.02024.x; Jones J., 2005, VITAL HLTH STAT, V23; Jones MB, 1998, HUM BIOL, V70, P775; Kendler KS, 2000, AM J PSYCHIAT, V157, P1843, DOI 10.1176/appi.ajp.157.11.1843; King M, 2005, ARCH SEX BEHAV, V34, P117, DOI 10.1007/s10508-005-1006-8; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; LeVay S, 2010, GAY STRAIGHT AND THE; LeVay S., 2011, GAY STRAIGHT AND THE; [林振林 LIN Zhen-Lin], 2010, [心理科学进展, Advances in Psychological Science], V18, P262; LORD FM, 1967, PSYCHOL BULL, V68, P304, DOI 10.1037/h0025105; Miller EM, 2000, ARCH SEX BEHAV, V29, P1, DOI 10.1023/A:1001836320541; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Mustanski BS, 2005, HUM GENET, V116, P272, DOI 10.1007/s00439-004-1241-4; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nash G., 2001, INDECENT EXPOSURE SE, P43; Pattatucci AM, 1998, HUM BIOL, V70, P367; PEREZ MD, 1992, FAM PLANN PERSPECT, V24, P162, DOI 10.2307/2136019; Pillard RC, 1998, HUM BIOL, V70, P347; PILLARD RC, 1982, ARCH SEX BEHAV, V11, P511, DOI 10.1007/BF01542476; Rahman Q, 2005, ARCH SEX BEHAV, V34, P461, DOI 10.1007/s10508-005-4345-6; Rahman Q, 2008, ARCH SEX BEHAV, V37, P962, DOI 10.1007/s10508-007-9191-2; Reimers S, 2007, ARCH SEX BEHAV, V36, P147, DOI 10.1007/s10508-006-9143-2; Rieger G, 2012, ARCH SEX BEHAV, V41, P529, DOI 10.1007/s10508-012-9942-6; Schwartz G, 2010, ARCH SEX BEHAV, V39, P93, DOI 10.1007/s10508-009-9499-1; SLOANE DM, 1983, DEMOGRAPHY, V20, P353, DOI 10.2307/2061247; Spreen M., 1992, B METHODOLOGIE SOCIO, V36, P34, DOI [10.1177/075910639203600103, DOI 10.1177/075910639203600103]; SPROTT DA, 1970, PSYCHOL BULL, V73, P303, DOI 10.1037/h0028923; Trivers RL., 1972, SEXUAL SELECTION DES; VanderLaan DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036088; VanderLaan DP, 2011, ARCH SEX BEHAV, V40, P495, DOI 10.1007/s10508-009-9576-5; Vasey PL, 2007, P ROY SOC B-BIOL SCI, V274, P1437, DOI 10.1098/rspb.2007.0120; Vasey PL, 2007, EVOL HUM BEHAV, V28, P159, DOI 10.1016/j.evolhumbehav.2006.08.004; Vasey PL, 2012, ARCH SEX BEHAV, V41, P209, DOI 10.1007/s10508-011-9763-z; Vasey PL, 2010, EVOL HUM BEHAV, V31, P373, DOI 10.1016/j.evolhumbehav.2010.04.001; Vasey PL, 2009, HUM NATURE-INT BIOS, V20, P269, DOI 10.1007/s12110-009-9066-4; Vasey PL, 2010, ARCH SEX BEHAV, V39, P821, DOI 10.1007/s10508-008-9404-3; Wattenberg B, 1985, THE BIRTH DEARTH; WATTERS JK, 1989, SOC PROBL, V36, P416, DOI 10.1525/sp.1989.36.4.03a00070; WHITAM FL, 1993, ARCH SEX BEHAV, V22, P187, DOI 10.1007/BF01541765; Wilson E.O., 1975, P1; WOOD CH, 1977, J MARRIAGE FAM, V39, P129, DOI 10.2307/351069; Yates T., 1993, INTERPRETATIVE ARCHA, P31; Zietsch BP, 2008, EVOL HUM BEHAV, V29, P424, DOI 10.1016/j.evolhumbehav.2008.07.002	78	23	23	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51088	10.1371/journal.pone.0051088	http://dx.doi.org/10.1371/journal.pone.0051088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227237	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200097
J	Kilpinen, O; Liu, DZ; Adamsen, APS				Kilpinen, Ole; Liu, Dezhao; Adamsen, Anders Peter S.			Real-Time Measurement of Volatile Chemicals Released by Bed Bugs during Mating Activities	PLOS ONE			English	Article							TRAUMATIC INSEMINATION; PTR-MS; CIMEX; PHEROMONE	In recent years, bed bug (Hemiptera: Cimicidae) problems have increased dramatically in many parts of the world, leading to a renewed interest in their chemical ecology. Most studies of bed bug semiochemicals have been based on the collection of volatiles over a period of time followed by chemical analysis. Here we present for the first time, a combination of proton transfer reaction mass spectrometry and video analysis for real-time measurement of semiochemicals emitted by isolated groups of bed bugs during specific behavioural activities. The most distinct peaks in the proton transfer reaction mass spectrometry recordings were always observed close to the termination of mating attempts, corresponding to the defensive emissions that bed bugs have been suspected to exploit for prevention of unwanted copulations. The main components of these emissions were (E)-2-hexenal and (E)-2-octenal recorded in ratios between 1:3 and 3:1. In the current study, the quantity varied over 1000 fold for both of the compounds with up to 40 mu g total release in a single emission. Males also emit defensive compounds due to homosexual copulation attempts by other males, and no significant differences were observed in the ratio or the amount of the two components released from males or females. In summary, this study has demonstrated that combining proton-transfer-reaction mass spectrometry with video analysis can provide detailed information about semiochemicals emitted during specific behavioural activities. Citation: Kilpinen O, Liu D, Adamsen APS (2012) Real-Time Measurement of Volatile Chemicals Released by Bed Bugs during Mating Activities. PLoS ONE 7(12): e50981. doi:10.1371/journal.pone.0050981	[Kilpinen, Ole] Aarhus Univ, Fac Sci & Technol, Dept Agroecol, Slagelse, Denmark; [Liu, Dezhao; Adamsen, Anders Peter S.] Aarhus Univ, Fac Sci & Technol, Dept Engn, Tjele, Denmark	Aarhus University; Aarhus University	Kilpinen, O (corresponding author), Aarhus Univ, Fac Sci & Technol, Dept Agroecol, Slagelse, Denmark.	Ole.Kilpinen@agrsci.dk	Liu, Dezhao/L-7842-2019	Liu, Dezhao/0000-0003-0859-8775	Faculty of Agricultural Science, Aarhus University	Faculty of Agricultural Science, Aarhus University	The study was financed by a grant from the Faculty of Agricultural Science, Aarhus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos NG, 1998, J CHEM ECOL, V24, P1161, DOI 10.1023/A:1022442818196; Bisignano G, 2001, FEMS MICROBIOL LETT, V198, P9, DOI 10.1111/j.1574-6968.2001.tb10611.x; Blake RS, 2009, CHEM REV, V109, P861, DOI 10.1021/cr800364q; COLLINS RP, 1968, ANN ENTOMOL SOC AM, V61, P1338, DOI 10.1093/aesa/61.5.1338; Feilberg A, 2010, ENVIRON SCI TECHNOL, V44, P5894, DOI 10.1021/es100483s; Feldlaufer MF, 2010, J MED ENTOMOL, V47, P140, DOI 10.1603/ME09210; GILBY AR, 1965, PROC R SOC SER B-BIO, V162, P105, DOI 10.1098/rspb.1965.0027; Gross J, 2008, J CHEM ECOL, V34, P179, DOI 10.1007/s10886-007-9416-9; Harraca V, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-121; ISHIWATARI T, 1976, Applied Entomology and Zoology, V11, P38; ISHIWATARI T, 1974, Applied Entomology and Zoology, V9, P153; LEVINSON HZ, 1974, NATURWISSENSCHAFTEN, V61, P684, DOI 10.1007/BF00606522; LEVINSON HZ, 1971, EXPERIENTIA, V27, P102, DOI 10.1007/BF02137766; Liedtke HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018156; Lindinger W, 1998, INT J MASS SPECTROM, V173, P191, DOI 10.1016/S0168-1176(97)00281-4; Maleknia SD, 2007, INT J MASS SPECTROM, V262, P203, DOI 10.1016/j.ijms.2006.11.010; Panagiotakopulu E, 1999, ANTIQUITY, V73, P908, DOI 10.1017/S0003598X00065674; Pfiester M, 2009, J MED ENTOMOL, V46, P1015, DOI 10.1603/033.046.0506; Reinhardt K, 2003, P ROY SOC B-BIOL SCI, V270, P2371, DOI 10.1098/rspb.2003.2515; Reinhardt K, 2009, EVOLUTION, V63, P29, DOI 10.1111/j.1558-5646.2008.00502.x; Riffell JA, 2008, J CHEM ECOL, V34, P837, DOI 10.1007/s10886-008-9490-7; Ryne C, 2009, ANIM BEHAV, V78, P1471, DOI 10.1016/j.anbehav.2009.09.033; *SAS I, 2000, SAS US GUID REL 8 01; Schaub A, 2010, PHYSIOL PLANTARUM, V138, P123, DOI 10.1111/j.1399-3054.2009.01322.x; Siljander E, 2008, J CHEM ECOL, V34, P708, DOI 10.1007/s10886-008-9446-y; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Tasin M, 2012, SENSORS-BASEL, V12, P4091, DOI 10.3390/s120404091; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; Weeks ENI, 2011, PEST MANAG SCI, V67, P10, DOI 10.1002/ps.2024	29	11	11	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50981	10.1371/journal.pone.0050981	http://dx.doi.org/10.1371/journal.pone.0050981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227225	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200086
J	LaKind, JS; Goodman, M; Naiman, DQ				LaKind, Judy S.; Goodman, Michael; Naiman, Daniel Q.			Use of NHANES Data to Link Chemical Exposures to Chronic Diseases: A Cautionary Tale	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; NUTRITION EXAMINATION SURVEY; URINARY BISPHENOL-A; PERSISTENT ORGANIC POLLUTANTS; NATIONAL-HEALTH; SERUM CONCENTRATIONS; METABOLIC SYNDROME; ADULT-POPULATION; ASSOCIATION; HYPERTENSION	Background: The National Health and Nutrition Examination Survey (NHANES) is one example of cross-sectional datasets that have been used to draw causal inferences regarding environmental chemical exposures and adverse health outcomes. Our objectives were to analyze four NHANES datasets using consistent a priori selected methods to address the following questions: Is there a consistent association between urinary bisphenol A (BPA) measures and diabetes, coronary heart disease (CHD), and/or heart attack across surveys? Is NHANES an appropriate dataset for investigating associations between chemicals with short physiologic half-lives such as BPA and chronic diseases with multi-factorial etiologies? Data on urinary BPA and health outcomes from 2003-2004, 2005-2006, 2007-2008, and 2009-2010 were available. Methodology and Findings: Regression models were adjusted for creatinine, age, gender, race/ethnicity, education, income, smoking, heavy drinking, BMI, waist circumference, calorie intake, family history of heart attack, hypertension, sedentary time, and total cholesterol. Urinary BPA was not significantly associated with adverse health outcomes for any of the NHANES surveys, with ORs (95% CIs) ranging from 0.996 (0.951-1.04) to 1.03 (0.978-1.09) for CHD, 0.987 (0.941-1.04) to 1.04 (0.996-1.09) for heart attack, and 0.957 (0.899-1.02) to 1.01 (0.980-1.05) for diabetes. Conclusions: Using scientifically and clinically supportable exclusion criteria and outcome definitions, we consistently found no associations between urinary BPA and heart disease or diabetes. These results do not support associations and causal inferences reported in previous studies that used different criteria and definitions. We are not drawing conclusions regarding whether BPA is a risk factor for these diseases. We are stating the opposite-that using cross-sectional datasets like NHANES to draw such conclusions about short-lived environmental chemicals and chronic complex diseases is inappropriate. We need to expend resources on appropriately designed epidemiologic studies and toxicological explorations to understand whether these types of chemicals play a causal role in chronic diseases.	[LaKind, Judy S.] LaKind Associates LLC, Catonsville, MD USA; [LaKind, Judy S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [LaKind, Judy S.] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA USA; [Goodman, Michael] Emory Univ, Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA; [Naiman, Daniel Q.] Johns Hopkins Univ, Dept Appl Math & Stat, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Emory University; Johns Hopkins University	LaKind, JS (corresponding author), LaKind Associates LLC, Catonsville, MD USA.	lakindassoc@comcast.net		LaKind, Judy/0000-0002-0323-9178	Polycarbonate/BPA Global Group of the American Chemistry Council	Polycarbonate/BPA Global Group of the American Chemistry Council	This research was supported by the Polycarbonate/BPA Global Group of the American Chemistry Council (http://plastics.americanchemistry.com/Product-Groups-and-Stats/PolycarbonateBPA-Global-Group). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder was given the opportunity to proffer ONLY non-substantive editorial suggestions.	Adami HO, 2011, TOXICOL SCI, V122, P223, DOI 10.1093/toxsci/kfr113; American Heart Association, 2012, WHAT YOUR CHOL LEV M; [Anonymous], 2007, SCIENCEDAILY; Arif AA, 2007, INT ARCH OCC ENV HEA, V80, P711, DOI 10.1007/s00420-007-0183-2; Athyros VG, 2007, ANGIOLOGY, V58, P689, DOI 10.1177/0003319707306146; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Carwile JL, 2011, ENVIRON RES, V111, P825, DOI 10.1016/j.envres.2011.05.014; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Centers for Disease Control and Prevention, 2012, NAT REP HUM EXP ENV; Centers for Disease Control and Prevention National Center for Health Statistics, 2006, GEN INF NHANES 2003; Charreire H, 2011, BRIT J NUTR, V105, P902, DOI 10.1017/S000711451000440X; Claassen L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-248; Clayton EMR, 2011, ENVIRON HEALTH PERSP, V119, P390, DOI 10.1289/ehp.1002883; DeNoon DJ, 2010, WEBMD HLTH NEWS 0112; Egeghy PP, 2011, INT J ENV RES PUB HE, V8, P1727, DOI 10.3390/ijerph8051727; Elobeid MA, 2010, INT J ENV RES PUB HE, V7, P2988, DOI 10.3390/ijerph7072988; Evenson KR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110109; Everett CJ, 2008, ENVIRON RES, V108, P94, DOI 10.1016/j.envres.2008.05.006; Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Goldberg M, 2011, ENVIRON RES, V111, P1007, DOI 10.1016/j.envres.2011.08.010; Ha MH, 2009, J HUM HYPERTENS, V23, P274, DOI 10.1038/jhh.2008.124; Harik-Khan RI, 2004, AM J EPIDEMIOL, V159, P351, DOI 10.1093/aje/kwh053; Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lee DH, 2007, DIABETOLOGIA, V50, P1841, DOI 10.1007/s00125-007-0755-4; Long AN, 2011, J CLIN HYPERTENS, V13, P244, DOI 10.1111/j.1751-7176.2011.00434.x; Matthews VL, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-71; Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673; National High Blood Pressure Education Program, 2004, NIH PUBL, P25; Pearson N, 2011, AM J PREV MED, V41, P178, DOI 10.1016/j.amepre.2011.05.002; Psaltopoulou Theodora, 2010, Rev Diabet Stud, V7, P26, DOI 10.1900/RDS.2010.7.26; Ranjit N, 2010, PEDIATRICS, V126, pE754, DOI 10.1542/peds.2010-1229; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P25; Shankar A, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/481641; Shankar A, 2011, J CLIN ENDOCR METAB, V96, P3822, DOI 10.1210/jc.2011-1682; Silver MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026868; Stone NJ, 1996, CIRCULATION, V94, P2337, DOI 10.1161/01.CIR.94.9.2337; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wannamethee SG, 2002, J EPIDEMIOL COMMUN H, V56, P542, DOI 10.1136/jech.56.7.542; Wei M, 2009, JAMA-J AM MED ASSOC, V301, P720, DOI 10.1001/jama.2009.120; Weuve J, 2010, ENVIRON HEALTH PERSP, V118, P825, DOI 10.1289/ehp.0901543; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wolff M, 2011, C EN NEWS       0718, V89; WONG ND, 1991, ANN INTERN MED, V115, P687, DOI 10.7326/0003-4819-115-9-687; You L, 2011, ENVIRON HEALTH PERSP, V119, P527, DOI 10.1289/ehp.1002572	49	67	69	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51086	10.1371/journal.pone.0051086	http://dx.doi.org/10.1371/journal.pone.0051086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227235	Green Submitted, gold, Green Published			2022-12-27	WOS:000312588200095
J	Petta, S; Macaluso, FS; Barcellona, MR; Camma, C; Cabibi, D; Di Marco, V; Craxi, A				Petta, Salvatore; Macaluso, Fabio Salvatore; Barcellona, Maria Rosa; Camma, Calogero; Cabibi, Daniela; Di Marco, Vito; Craxi, Antonio			Serum gamma-glutamyl Transferase Levels, Insulin Resistance and Liver Fibrosis in Patients with Chronic Liver Diseases	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; METABOLIC SYNDROME; MORTALITY RISK; WEIGHT-LOSS; GENOTYPE-1; STEATOSIS; INDEX; TRANSPEPTIDASE; VIRUS	Background and Aims: Serum levels of gamma-glutamyl-transpeptidase(c-GT) were associated with liver disease severity and metabolic alterations, which in turn are able to affect hepatic damage. In patients with nonalcoholic fatty liver disease (NAFLD), genotype 1 chronic hepatitis C (G1CHC) and chronic hepatitis B (CHB), we assessed the link between liver fibrosis and c-GT serum levels, and we evaluated if normal or high gamma-GT serum levels affect the association between insulin resistance (IR) and severity of liver fibrosis. Methods: 843 consecutive patients with chronic liver disease (CLD)(193 NAFLD, 481 G1CHC, 169 CHB) were evaluated by liver biopsy (Kleiner and Scheuer scores) and clinical and metabolic measurements. IR was diagnosed if HOMA>3. A serum gamma-GT concentration of > 36 IU/L in females and > 61 IU/L in males was considered the threshold value for identifying high levels of gamma-GT. Results: By multivariate logistic regression analysis, abnormal gamma-GT serum levels were independently linked to severe liver fibrosis in patients with NAFLD (OR2.711, CI1.120-6.564, p = 0.02), G1CHC (OR3.461, CI2.138-5.603, p < 0.001) and CHB (OR2.778, CI1.042-7.414, p = 0.04), together with IR and liver necroinflammation, and with a negative predictive value > 80%. Interestingly, among patients with high or normal gamma-GT values, even if IR prevalence was significantly higher in patients with severe fibrosis compared to those without, IR remained significantly associated with severe fibrosis in patients with abnormal gamma-GT values only (OR4.150, CI1.079-15.970, p = 0.03 for NAFLD; OR2.250, CI1.211-4.181, p = 0.01 for G1CHC; OR3.096, CI2.050-34.220, p = 0.01 for CHB). Conclusions: In patients with CLD, IR is independently linked to liver fibrosis only in patients with abnormal gamma-GT values, without differences according to liver disease etiology, and suggesting a role of gamma-GT as a marker of metabolic-induced liver damage. These data could be useful for the clinical and pharmacologic management of patients with CLD.	[Petta, Salvatore; Macaluso, Fabio Salvatore; Barcellona, Maria Rosa; Camma, Calogero; Di Marco, Vito; Craxi, Antonio] Univ Palermo, Sez Gastroenterol, DiBiMIS, Palermo, Italy; [Cabibi, Daniela] Univ Palermo, Cattedra Anat Patol, Palermo, Italy	University of Palermo; University of Palermo	Petta, S (corresponding author), Univ Palermo, Sez Gastroenterol, DiBiMIS, Palermo, Italy.	petsa@inwind.it	Di Marco, Vito/AAC-4612-2022; Macaluso, Fabio Salvatore/AFB-9138-2022; cabibi, daniela/D-7438-2013; Craxi, Antonio/K-9529-2016	Macaluso, Fabio Salvatore/0000-0001-5128-3846; cabibi, daniela/0000-0001-6571-6577; Craxi, Antonio/0000-0002-4480-9544; Petta, Salvatore/0000-0002-0822-9673; CAMMA', CALOGERO/0000-0002-9224-1914; DI MARCO, VITO/0000-0001-6397-4206				Belfort R, 2006, NEW ENGL J MED, V355, P22997; Calori G, 2011, HEPATOLOGY, V54, P145, DOI 10.1002/hep.24356; Camma C, 2006, HEPATOLOGY, V43, P64, DOI 10.1002/hep.20983; Camma C, 2009, J HEPATOL, V50, P648, DOI 10.1016/j.jhep.2009.01.003; Dixon JB, 2006, OBES SURG, V16, P1278, DOI 10.1381/096089206778663805; Everhart JE, 2009, GASTROENTEROLOGY, V137, P549, DOI 10.1053/j.gastro.2009.05.007; Gavin JR, 2000, DIABETES CARE, V23, pS4; Haring R, 2009, HEPATOLOGY, V50, P1403, DOI 10.1002/hep.23135; Herzer K, 2007, LIVER INT, V27, P293, DOI 10.1111/j.1478-3231.2006.01422.x; Ikeda Y, 2001, ENDOCR J, V48, P81, DOI 10.1507/endocrj.48.81; Jo SK, 2009, CLIN CHIM ACTA, V403, P234, DOI 10.1016/j.cca.2009.03.035; Kazemi-Shirazi L, 2007, CLIN CHEM, V53, P940, DOI 10.1373/clinchem.2006.081620; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lee DH, 2003, CLIN CHEM, V49, P1358, DOI 10.1373/49.8.1358; Lee DS, 2007, ARTERIOSCL THROM VAS, V27, P127, DOI 10.1161/01.ATV.0000251993.20372.40; Leite NC, 2011, LIVER INT, V31, P700, DOI 10.1111/j.1478-3231.2011.02482.x; Loomba R, 2010, GASTROENTEROLOGY, V139, P836, DOI 10.1053/j.gastro.2010.06.009; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Middelberg RP, 2011, HUM MOL GENET, V21, P446; Moucari R, 2008, GASTROENTEROLOGY, V134, P416, DOI 10.1053/j.gastro.2007.11.010; NEMESANSZKY E, 1985, CLIN CHEM, V31, P797; Park SH, 2009, AM J GASTROENTEROL, V104, P1135, DOI 10.1038/ajg.2009.6; Petta S, 2010, CURR PHARM DESIGN, V16, P741, DOI 10.2174/138161210790883787; Petta S, 2009, DIGEST LIVER DIS, V41, P615, DOI 10.1016/j.dld.2009.01.004; Petta S, 2008, AM J GASTROENTEROL, V103, P1136, DOI 10.1111/j.1572-0241.2008.01813.x; Petta S, 2012, J HEPATOL, V56, P1356, DOI 10.1016/j.jhep.2012.01.007; Petta S, 2011, LIVER INT, V31, P507, DOI 10.1111/j.1478-3231.2011.02453.x; Petta S, 2010, HEPATOLOGY, V52, P1543, DOI 10.1002/hep.23859; Poynard T, 2002, J VIRAL HEPATITIS, V9, P128, DOI 10.1046/j.1365-2893.2002.00341.x; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; *SAS I INC, 1992, SAS STAT SOFTW CHANG; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Seto WK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023077; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227	35	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51165	10.1371/journal.pone.0051165	http://dx.doi.org/10.1371/journal.pone.0051165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227248	gold, Green Published, Green Submitted			2022-12-27	WOS:000312588200107
J	Serviene, E; Luksa, J; Orentaite, I; Lafontaine, DLJ; Urbonavicius, J				Serviene, Elena; Luksa, Juliana; Orentaite, Irma; Lafontaine, Denis L. J.; Urbonavicius, Jaunius			Screening the Budding Yeast Genome Reveals Unique Factors Affecting K2 Toxin Susceptibility	PLOS ONE			English	Article							K1 KILLER TOXIN; CELL-WALL; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; GENE; PREPROTOXIN; EXPRESSION; LETHALITY; TRANSPORT; PROTEINS	Background: Understanding how biotoxins kill cells is of prime importance in biomedicine and the food industry. The budding yeast (S. cerevisiae) killers serve as a convenient model to study the activity of biotoxins consistently supplying with significant insights into the basic mechanisms of virus-host cell interactions and toxin entry into eukaryotic target cells. K1 and K2 toxins are active at the cell wall, leading to the disruption of the plasma membrane and subsequent cell death by ion leakage. K28 toxin is active in the cell nucleus, blocking DNA synthesis and cell cycle progression, thereby triggering apoptosis. Genome-wide screens in the budding yeast S. cerevisiae identified several hundred effectors of K1 and K28 toxins. Surprisingly, no such screen had been performed for K2 toxin, the most frequent killer toxin among industrial budding yeasts. Principal Findings: We conducted several concurrent genome-wide screens in S. cerevisiae and identified 332 novel K2 toxin effectors. The effectors involved in K2 resistance and hypersensitivity largely map in distinct cellular pathways, including cell wall and plasma membrane structure/biogenesis and mitochondrial function for K2 resistance, and cell wall stress signaling and ion/pH homeostasis for K2 hypersensitivity. 70% of K2 effectors are different from those involved in K1 or K28 susceptibility. Significance: Our work demonstrates that despite the fact that K1 and K2 toxins share some aspects of their killing strategies, they largely rely on different sets of effectors. Since the vast majority of the host factors identified here is exclusively active towards K2, we conclude that cells have acquired a specific K2 toxin effectors set. Our work thus indicates that K1 and K2 have elaborated different biological pathways and provides a first step towards the detailed characterization of K2 mode of action.	[Serviene, Elena; Luksa, Juliana; Orentaite, Irma] Nat Res Ctr, Inst Bot, Genet Lab, Vilnius, Lithuania; [Serviene, Elena] Vilnius Gediminas Tech Univ, Dept Chem & Bioengn, Vilnius, Lithuania; [Orentaite, Irma] Vytautas Magnus Univ, Dept Biochem & Biotechnol, Kaunas, Lithuania; [Lafontaine, Denis L. J.] Univ Libre Bruxelles, Fonds Rech Sci, Gosselies, Belgium; [Lafontaine, Denis L. J.; Urbonavicius, Jaunius] Acad Wallonie Bruxelles, Ctr Microscopy & Mol Imaging, Gosselies, Belgium	Nature Research Center - Lithuania; Vilnius Gediminas Technical University; Vytautas Magnus University; Fonds de la Recherche Scientifique - FNRS; Universite Libre de Bruxelles	Serviene, E (corresponding author), Nat Res Ctr, Inst Bot, Genet Lab, Vilnius, Lithuania.	elena.serviene@botanika.lt; denis.lafontaine@ulb.ac.be	Lafontaine, Denis/I-7673-2013; Urbonavičius, Jaunius/AAB-4740-2022; Serviene, Elena/AFJ-8073-2022; Serviene, Elena/AAF-4940-2022	Lafontaine, Denis/0000-0001-7295-6288; 	Research Council of Lithuania (LMT) grant [MIP-061/2011]; FEDER (Fonds Europeen de Developpement Regional); Region Wallones (Programme Cibles); FRS-F.N.R.S; EMBO; FEBS Central and Eastern European collaborative	Research Council of Lithuania (LMT) grant(Research Council of Lithuania (LMTLT)); FEDER (Fonds Europeen de Developpement Regional)(European Commission); Region Wallones (Programme Cibles); FRS-F.N.R.S(Fonds de la Recherche Scientifique - FNRS); EMBO(European Molecular Biology Organization (EMBO)); FEBS Central and Eastern European collaborative	Research in the laboratory of ES was supported by the Research Council of Lithuania (LMT) grant MIP-061/2011. Research in the laboratory of DLJL was supported by FEDER (Fonds Europeen de Developpement Regional), Region Wallones (Programme Cibles) and the FRS-F.N.R.S. ES and IO were recipients of respective short-term fellowships (EMBO - to ES and FEBS Central and Eastern European collaborative - to LO) to visit the Lafontaine Lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384; BOSTIAN KA, 1984, CELL, V36, P741, DOI 10.1016/0092-8674(84)90354-4; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Breinig F, 2002, CELL, V108, P395, DOI 10.1016/S0092-8674(02)00634-7; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; BUSSEY H, 1973, BIOCHIM BIOPHYS ACTA, V298, P868, DOI 10.1016/0005-2736(73)90391-X; BUSSEY H, 1990, EXPERIENTIA, V46, P193, DOI 10.1007/BF02027313; BUSSEY H, 1991, MOL MICROBIOL, V5, P2339, DOI 10.1111/j.1365-2958.1991.tb02079.x; Carroll SY, 2009, DEV CELL, V17, P552, DOI 10.1016/j.devcel.2009.08.006; Conti S, 2000, MOL MED, V6, P613, DOI 10.1007/BF03401799; DELAPENA P, 1980, BIOCHEM BIOPH RES CO, V96, P544, DOI 10.1016/0006-291X(80)91390-X; DELAPENA P, 1981, J BIOL CHEM, V256, P420; DIGNARD D, 1991, MOL GEN GENET, V227, P127, DOI 10.1007/BF00260717; Eisfeld K, 2000, MOL MICROBIOL, V37, P926, DOI 10.1046/j.1365-2958.2000.02063.x; Flegelova H, 2002, FEMS YEAST RES, V2, P73, DOI 10.1111/j.1567-1364.2002.tb00070.x; Gulbiniene G, 2004, FOOD TECHNOL BIOTECH, V42, P159; HAUSLER A, 1992, P NATL ACAD SCI USA, V89, P6846, DOI 10.1073/pnas.89.15.6846; HILL K, 1992, GENETICS, V130, P273; HUTCHINS K, 1983, J BACTERIOL, V154, P161, DOI 10.1128/JB.154.1.161-169.1983; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Kovacech B, 1996, MOL CELL BIOL, V16, P3264; Lebionka A., 2002, BIOLOGIJA, V4, P7; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; Magliani W, 1997, CLIN MICROBIOL REV, V10, P369, DOI 10.1128/CMR.10.3.369; Mapes J, 2004, EMBO J, V23, P302, DOI 10.1038/sj.emboj.7600036; MARTINAC B, 1990, P NATL ACAD SCI USA, V87, P6228, DOI 10.1073/pnas.87.16.6228; MESKAUSKAS A, 1992, GENE, V111, P135, DOI 10.1016/0378-1119(92)90615-V; Novotna D, 2004, FEMS YEAST RES, V4, P803, DOI 10.1016/j.femsyr.2004.04.007; Page N, 2003, GENETICS, V163, P875; PFEIFFER P, 1984, ARCH MICROBIOL, V137, P357, DOI 10.1007/BF00410734; Polonelli L, 2000, MED MYCOL, V38, P281, DOI 10.1080/mmy.38.s1.281.292; Rodriguez-Cousino N, 2011, APPL ENVIRON MICROB, V77, P1822, DOI 10.1128/AEM.02501-10; Schmitt MJ, 2006, NAT REV MICROBIOL, V4, P212, DOI 10.1038/nrmicro1347; SCHMITT MJ, 1995, VIROLOGY, V213, P341, DOI 10.1006/viro.1995.0007; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; VANVUUREN HJJ, 1992, AM J ENOL VITICULT, V43, P119; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005	41	14	15	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50779	10.1371/journal.pone.0050779	http://dx.doi.org/10.1371/journal.pone.0050779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227207	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200066
J	Chang, CM; Chu, CH; Tseng, ML; Huang, YW; Huang, HW; Chen, BH; Huang, DW; Tsai, DP				Chang, Chia Min; Chu, Cheng Hung; Tseng, Ming Lun; Huang, Yao-Wei; Huang, Hsin Wei; Chen, Bo Han; Huang, Ding-Wei; Tsai, Din Ping			Light Manipulation by Gold Nanobumps	PLASMONICS			English	Article						Surface plasmons; Nanostructures; Optics at surfaces; Scattering light; Focusing	SURFACE-PLASMON POLARITONS; GE2SB2TE5 THIN-FILMS; NEAR-FIELD; ENERGY-TRANSFER; SCATTERING; NANOPARTICLES; COMPONENTS; RESONANCE; OPTICS; CHAINS	Backward and forward scattering of surface plasmonic wave interactions from gold nanobumps on the surface of a 30-nm gold thin film demonstrate three-dimensional (3-D) focusing and diverging properties. Fan-shaped forward scattering of an individual nanobump is observed. A quarter-circle structure composed of nanobumps is exploited to manipulate scattering from each nanobump. Experimental results show that 3-D propagation vectors generated by the gold nanobumps with their heights of 16 nm can deflect the surface plasmonic waves to produce 3-D focusing at 3.6 mu m above the surface of the gold film. We clearly demonstrate that 3-D forward and backward focusing from gold nanobumps are with different amplitudes and directions of the vertical propagation vectors.	[Chang, Chia Min; Chu, Cheng Hung; Huang, Hsin Wei; Chen, Bo Han; Tsai, Din Ping] Natl Taiwan Univ, Dept Phys, Taipei 106, Taiwan; [Chang, Chia Min; Huang, Ding-Wei] Natl Taiwan Univ, Grad Inst Photon & Optoelect, Taipei 106, Taiwan; [Tseng, Ming Lun; Huang, Yao-Wei; Tsai, Din Ping] Natl Taiwan Univ, Grad Inst Appl Phys, Taipei 106, Taiwan; [Tsai, Din Ping] Acad Sinica, Res Ctr Appl Sci, Taipei 115, Taiwan; [Tsai, Din Ping] Natl Appl Res Labs, Instrument Technol Res Ctr, Hsinchu 300, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Applied Research Laboratories - Taiwan	Tsai, DP (corresponding author), Natl Taiwan Univ, Dept Phys, Taipei 106, Taiwan.	dptsai@phys.ntu.edu.tw	Chu, Cheng Hung/B-3258-2015; Han, Chen Bo/L-5535-2017; Tseng, Ming Lun/J-8127-2012; Chang, Chia Min/H-5646-2012; Huang, Yao-Wei/J-7444-2012; Tsai, Din Ping/F-1734-2011; Kok, Victor/C-1437-2013	Chu, Cheng Hung/0000-0002-8749-3930; Han, Chen Bo/0000-0003-3009-8822; Tseng, Ming Lun/0000-0003-0418-8162; Chang, Chia Min/0000-0003-3316-4530; Huang, Yao-Wei/0000-0001-8983-413X; Tsai, Din Ping/0000-0002-0883-9906; Kok, Victor/0000-0003-3440-8154	National Science Council, Taiwan [99-2911-I-002-127, 99-2120-M-002-012, 100-2923-M-002-007-MY3, 100-2120-M-002-008]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The authors thank the National Science Council, Taiwan, for the financial support of this project under grant numbers 99-2911-I-002-127, 99-2120-M-002-012, 100-2923-M-002-007-MY3, and 100-2120-M-002-008. They also thank the Molecular Imaging Center of the National Taiwan University for technical support.	Bozhevolnyi SI, 2006, NATURE, V440, P508, DOI 10.1038/nature04594; Chang CM, 2011, OPT EXPRESS, V19, P9492, DOI 10.1364/OE.19.009492; Chau YF, 2011, APPL PHYS A-MATER, V104, P801, DOI 10.1007/s00339-011-6416-y; Chau YF, 2011, PLASMONICS, V6, P581, DOI 10.1007/s11468-011-9238-z; Chen MW, 2008, PLASMONICS, V3, P157, DOI 10.1007/s11468-008-9069-8; Chen WT, 2011, OPT EXPRESS, V19, P12837, DOI 10.1364/OE.19.012837; Chen WT, 2010, OPT EXPRESS, V18, P19665, DOI 10.1364/OE.18.019665; Chiu KP, 2005, J KOREAN PHYS SOC, V47, pS119; Chu CH, 2011, OPT EXPRESS, V19, P12652, DOI 10.1364/OE.19.012652; Chu CH, 2010, OPT EXPRESS, V18, P18383, DOI 10.1364/OE.18.018383; Chung HY, 2010, PLASMONICS, V5, P363, DOI 10.1007/s11468-010-9151-x; Ditlbacher H, 2002, APPL PHYS LETT, V81, P1762, DOI 10.1063/1.1506018; Drezet A, 2005, APPL PHYS LETT, V86, P3; Drezet A, 2006, PLASMONICS, V1, P141, DOI 10.1007/s11468-006-9016-5; Evlyukhin AB, 2007, OPT EXPRESS, V15, P16667, DOI 10.1364/OE.15.016667; Fang ZY, 2010, PLASMONICS, V5, P207, DOI 10.1007/s11468-010-9135-x; Felidj N, 2006, PLASMONICS, V1, P35, DOI 10.1007/s11468-005-9004-1; Huang HJ, 2007, OPT EXPRESS, V15, P7132, DOI 10.1364/OE.15.007132; Kawazoe T, 2006, J NON-CRYST SOLIDS, V352, P2492, DOI 10.1016/j.jnoncrysol.2006.03.023; Kim H, 2008, OPT EXPRESS, V16, P3049, DOI 10.1364/OE.16.003049; Kiyan R, 2007, OPT EXPRESS, V15, P4205, DOI 10.1364/OE.15.004205; Lin WC, 2011, PLASMONICS, V6, P201, DOI 10.1007/s11468-010-9188-x; Nomura W, 2006, APPL PHYS B-LASERS O, V84, P257, DOI 10.1007/s00340-006-2165-6; Nomura W, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1920419; Peng TC, 2011, PLASMONICS, V6, P29, DOI 10.1007/s11468-010-9165-4; Radko IP, 2009, OPT EXPRESS, V17, P7228, DOI 10.1364/OE.17.007228; Radko IP, 2007, OPT EXPRESS, V15, P6576, DOI 10.1364/OE.15.006576; Samson ZL, 2010, PHYS STATUS SOLIDI-R, V4, P274, DOI 10.1002/pssr.201004252; Sanchez-Gil JA, 1999, PHYS REV B, V60, P8359, DOI 10.1103/PhysRevB.60.8359; Shchegrov AV, 1997, PHYS REV LETT, V78, P4269, DOI 10.1103/PhysRevLett.78.4269; Sterligov VA, 2005, OPT EXPRESS, V13, P4134, DOI 10.1364/OPEX.13.004134; Teperik TV, 2009, OPT EXPRESS, V17, P17483, DOI 10.1364/OE.17.017483; Wang Q, 2008, OPT EXPRESS, V16, P19271, DOI 10.1364/OE.16.019271; Yi MF, 2011, PLASMONICS, V6, P213, DOI 10.1007/s11468-010-9190-3; Yin LL, 2005, NANO LETT, V5, P1399, DOI 10.1021/nl050723m; Zayats AV, 2005, PHYS REP, V408, P131, DOI 10.1016/j.physrep.2004.11.001; Zhang DG, 2009, OPT EXPRESS, V17, P11315, DOI 10.1364/OE.17.011315	37	29	29	0	22	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1955			PLASMONICS	Plasmonics	SEP	2012	7	3					563	569		10.1007/s11468-012-9343-7	http://dx.doi.org/10.1007/s11468-012-9343-7			7	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science	985YZ	23236389	Green Submitted			2022-12-27	WOS:000307307700024
J	Jena, P; Mohanty, S; Mohanty, T; Kallert, S; Morgelin, M; Lindstrom, T; Borregaard, N; Stenger, S; Sonawane, A; Sorensen, OE				Jena, Prajna; Mohanty, Soumitra; Mohanty, Tirthankar; Kallert, Stephanie; Morgelin, Matthias; Lindstrom, Thomas; Borregaard, Niels; Stenger, Steffen; Sonawane, Avinash; Sorensen, Ole E.			Azurophil Granule Proteins Constitute the Major Mycobactericidal Proteins in Human Neutrophils and Enhance the Killing of Mycobacteria in Macrophages	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; TUBERCULOSIS INFECTION; BACTERICIDAL ACTIVITY; GENE-EXPRESSION; CATHEPSIN-G; PEPTIDES; LUNG; BCG; PHAGOCYTOSIS; ACTIVATION	Pathogenic mycobacteria reside in, and are in turn controlled by, macrophages. However, emerging data suggest that neutrophils also play a critical role in innate immunity to tuberculosis, presumably by their different antibacterial granule proteins. In this study, we purified neutrophil azurophil and specific granules and systematically analyzed the antimycobacterial activity of some purified azurophil and specific granule proteins against M. smegmatis, M. bovis-BCG and M. tuberculosis H37Rv. Using gel overlay and colony forming unit assays we showed that the defensin-depleted azurophil granule proteins (AZP) were more active against mycobacteria compared to other granule proteins and cytosolic proteins. The proteins showing antimycobacterial activity were identified by MALDI-TOF mass spectrometry. Electron microscopic studies demonstrate that the AZP disintegrate bacterial cell membrane resulting in killing of mycobacteria. Exogenous addition of AZP to murine macrophage RAW 264.7, THP-1 and peripheral blood monocyte-derived macrophages significantly reduced the intracellular survival of mycobacteria without exhibiting cytotoxic activity on macrophages. Immunofluorescence studies showed that macrophages actively endocytose neutrophil granular proteins. Treatment with AZP resulted in increase in co-localization of BCG containing phagosomes with lysosomes but not in increase of autophagy. These data demonstrate that neutrophil azurophil proteins may play an important role in controlling intracellular survival of mycobacteria in macrophages. Citation: Jena P, Mohanty S, Mohanty T, Kallert S, Morgelin M, et al. (2012) Azurophil Granule Proteins Constitute the Major Mycobactericidal Proteins in Human Neutrophils and Enhance the Killing of Mycobacteria in Macrophages. PLoS ONE 7(12): e50345. doi:10.1371/journal.pone.0050345	[Jena, Prajna; Mohanty, Soumitra; Sonawane, Avinash] KIIT Univ, Sch Biotechnol, Bhubaneswar, Orissa, India; [Mohanty, Tirthankar; Morgelin, Matthias; Sorensen, Ole E.] Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Kallert, Stephanie; Stenger, Steffen] Univ Ulm, Inst Med Microbiol & Hyg, Ulm, Germany; [Lindstrom, Thomas] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Borregaard, Niels] Univ Copenhagen, Dept Hematol, Copenhagen, Denmark	Kalinga Institute of Industrial Technology (KIIT); Lund University; Ulm University; Statens Serum Institut; University of Copenhagen	Sonawane, A (corresponding author), KIIT Univ, Sch Biotechnol, Campus 11, Bhubaneswar, Orissa, India.	asonawane@kiitbiotech.ac.in; Ole_E.Sorensen@med.lu.se	Sonawane, Avinash/S-9889-2019; Lindenstrøm, Thomas/ABE-4203-2020	Lindenstrøm, Thomas/0000-0002-7162-8124; Sorensen, Ole E./0000-0001-8681-6921; Mohanty, Soumitra/0000-0003-0919-5062	Department of Biotechnology, Government of India [BT/PR13488/GBD/27/270/2010]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by grant (BT/PR13488/GBD/27/270/2010) from Department of Biotechnology, Government of India to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON KB, 1988, SCAND J IMMUNOL, V28, P241, DOI 10.1111/j.1365-3083.1988.tb02437.x; Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; APPELBERG R, 1992, J LEUKOCYTE BIOL, V51, P472, DOI 10.1002/jlb.51.5.472; Appleberg R, 1990, CLIN EXP IMMUNOL, V83, P231; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Barrios-Payan Jorge, 2006, Gac Med Mex, V142, P273; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; CAMPANELLI D, 1990, J CLIN INVEST, V85, P904, DOI 10.1172/JCI114518; Driss V, 2009, BLOOD, V113, P3235, DOI 10.1182/blood-2008-07-166595; Edstrom AML, 2008, J IMMUNOL, V181, P3413, DOI 10.4049/jimmunol.181.5.3413; EGESTEN A, 1994, BLOOD, V83, P2985, DOI 10.1182/blood.V83.10.2985.2985; Faurschou M, 2002, BBA-MOL CELL RES, V1591, P29, DOI 10.1016/S0167-4889(02)00243-4; Feng CG, 2006, J IMMUNOL, V177, P7086, DOI 10.4049/jimmunol.177.10.7086; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fu LM, 2003, INT J TUBERC LUNG D, V7, P1027; Fulton SA, 2002, INFECT IMMUN, V70, P5322, DOI 10.1128/IAI.70.9.5322-5327.2002; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HEIFETS L, 1980, J RETICULOENDOTH SOC, V28, P391; Hwang SA, 2009, TUBERCULOSIS, V89, pS49, DOI 10.1016/S1472-9792(09)70012-5; JONES GS, 1990, J INFECT DIS, V162, P700, DOI 10.1093/infdis/162.3.700; Kalita A, 2004, J INFECT DIS, V190, P1476, DOI 10.1086/424463; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Maisetta G, 2008, PEPTIDES, V29, P1, DOI 10.1016/j.peptides.2007.10.013; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; MAY ME, 1987, INFECT IMMUN, V55, P2304, DOI 10.1128/IAI.55.9.2304-2307.1987; N'Diaye EN, 1998, J IMMUNOL, V161, P4983; Niederweis M, 2008, MICROBIOL-SGM, V154, P679, DOI 10.1099/mic.0.2007/012872-0; Pedrosa J, 2000, INFECT IMMUN, V68, P577, DOI 10.1128/IAI.68.2.577-583.2000; Ribeiro-Gomes FL, 2007, J IMMUNOL, V179, P3988, DOI 10.4049/jimmunol.179.6.3988; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Sharma S, 2001, ANTIMICROB AGENTS CH, V45, P639, DOI 10.1128/AAC.45.2.639-640.2001; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Soehnlein O, 2008, J CLIN INVEST, V118, P3491, DOI 10.1172/JCI35740; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; Sonawane A, 2011, CELL MICROBIOL, V13, P1601, DOI 10.1111/j.1462-5822.2011.01644.x; Steinwede K, 2012, J IMMUNOL, V188, P4476, DOI 10.4049/jimmunol.1103346; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Suttmann H, 2003, INFECT IMMUN, V71, P4647, DOI 10.1128/IAI.71.8.4647-4656.2003; Tan BH, 2006, J IMMUNOL, V177, P1864, DOI 10.4049/jimmunol.177.3.1864; WALLIS RS, 1994, J LEUKOCYTE BIOL, V55, P676, DOI 10.1002/jlb.55.5.676; YING X, 2010, MICROBES INFECT, V12, P683; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; ZHANG YH, 1995, J CLIN INVEST, V95, P586, DOI 10.1172/JCI117702; Zhu LM, 2011, INT J TUBERC LUNG D, V15, P369	50	54	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e5034	10.1371/journal.pone.0050345	http://dx.doi.org/10.1371/journal.pone.0050345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251364	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800012
J	Cousins, MM; Swan, D; Magaret, CA; Hoover, DR; Eshleman, SH				Cousins, Matthew M.; Swan, David; Magaret, Craig A.; Hoover, Donald R.; Eshleman, Susan H.			Analysis of HIV Using a High Resolution Melting (HRM) Diversity Assay: Automation of HRM Data Analysis Enhances the Utility of the Assay for Analysis of HIV Incidence	PLOS ONE			English	Article							LOCALLY WEIGHTED REGRESSION; INFECTION	Background: HIV diversity may be a useful biomarker for discriminating between recent and non-recent HIV infection. The high resolution melting (HRM) diversity assay was developed to quantify HIV diversity in viral populations without sequencing. In this assay, HIV diversity is expressed as a single numeric HRM score that represents the width of a melting peak. HRM scores are highly associated with diversity measures obtained with next generation sequencing. In this report, a software package, the HRM Diversity Assay Analysis Tool (DivMelt), was developed to automate calculation of HRM scores from melting curve data. Methods: DivMelt uses computational algorithms to calculate HRM scores by identifying the start (T1) and end (T2) melting temperatures for a DNA sample and subtracting them (T2-T1 = HRM score). DivMelt contains many user-supplied analysis parameters to allow analyses to be tailored to different contexts. DivMelt analysis options were optimized to discriminate between recent and non-recent HIV infection and to maximize HRM score reproducibility. HRM scores calculated using DivMelt were compared to HRM scores obtained using a manual method that is based on visual inspection of DNA melting curves. Results: HRM scores generated with DivMelt agreed with manually generated HRM scores obtained from the same DNA melting data. Optimal parameters for discriminating between recent and non-recent HIV infection were identified. DivMelt provided greater discrimination between recent and non-recent HIV infection than the manual method. Conclusion: DivMelt provides a rapid, accurate method of determining HRM scores from melting curve data, facilitating use of the HRM diversity assay for large-scale studies.	[Cousins, Matthew M.; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Swan, David; Magaret, Craig A.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Hoover, Donald R.] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ USA; [Hoover, Donald R.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, Piscataway, NJ USA	Johns Hopkins University; Fred Hutchinson Cancer Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Eshleman, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	seshlem@jhmi.edu		Cousins, Matthew/0000-0003-0067-9087	HIV Prevention Trials Network (HPTN); National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Drug Abuse (NIDA); National Institute of Mental Health; Office of AIDS Research of the National Institutes of Health and Department of Health and Human Services [U01AI068613, UM1AI068613]; NIAID [1R01-AI095068]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068613, R01AI095068, U01AI068613] Funding Source: NIH RePORTER	HIV Prevention Trials Network (HPTN); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of AIDS Research of the National Institutes of Health and Department of Health and Human Services; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the HIV Prevention Trials Network (HPTN) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health, and the Office of AIDS Research of the National Institutes of Health and Department of Health and Human Services [U01AI068613 and UM1AI068613 to SHE] and NIAID [1R01-AI095068 to SHE]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cousins MM, 2012, J CLIN MICROBIOL, V50, P3054, DOI 10.1128/JCM.01460-12; Cousins MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027211; Cousins MM, 2012, J MOL DIAGN IN PRESS; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Erali M, 2007, MOL BEACONS SIGNALIN; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; James MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018642; James MM, 2012, PEDIAT INFECT DIS J; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Montgomery JL, 2010, EXPERT REV MOL DIAGN, V10, P219, DOI [10.1586/erm.09.84, 10.1586/ERM.09.84]; Murphy G, 2008, EURO SURVEILL, V13; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Towler WI, 2010, AIDS RES HUM RETROV, V26, P913, DOI 10.1089/aid.2009.0259; WITTWER CT, 2004, DIAGNOSTIC MOL MICRO, P71	18	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51359	10.1371/journal.pone.0051359	http://dx.doi.org/10.1371/journal.pone.0051359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240016	gold, Green Submitted, Green Published			2022-12-27	WOS:000312290800052
J	Hu, YD; Huang, XS; Shen, DL; Ding, MP; Sun, HB; Peng, B; Hu, XS; Li, H; Zeng, KB; Xi, ZQ; Zhang, Y; Cao, QQ; Liu, J; Zhou, Y; Wu, MJ; Lu, YD; Chen, GJ; Wang, XF				Hu, Yida; Huang, Xishun; Shen, Dinglie; Ding, Meiping; Sun, Hongbin; Peng, Bin; Hu, Xiangshu; Li, Hua; Zeng, Kebin; Xi, Zhiqin; Zhang, Ying; Cao, Qingqing; Liu, Jing; Zhou, Yan; Wu, Mengjiao; Lu, Yaodong; Chen, Guojun; Wang, Xuefeng			Outcomes of Sustained-Release Formulation of Valproate and Topiramate Monotherapy in Patients with Epilepsy: A Multi-Centre, Cohort Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NEWLY-DIAGNOSED EPILEPSY; ANTIEPILEPTIC DRUGS; LAMOTRIGINE; CARBAMAZEPINE; TOLERABILITY; GABAPENTIN; EFFICACY; SEIZURES; THERAPY	Background: New-generation antiepileptic drugs (AEDs) tend to replace traditional AEDs as the first-line choice for epilepsy. However, whether this change results in better outcome, especially in China, remains unknown. Methodology/Principal Findings: Two broad spectrum AEDs, the traditional drug of sustained-release formulation of valproate (SRVPA) and the new-generation drug of topiramate, were compared in patients with epilepsy as monotherapy in this multi-centre, observational cohort study from 2000 to 2011. The primary outcome was time to treatment failure. The secondary outcomes included time to first seizure, time to 12-month remission, and time to 24-month remission. Drug tolerability was assessed. Cox proportional hazard models (95% confidence interval [CI]) were used to analyse the relative risks expressed as hazard ratios (HR). Of the 1008 recruited patients, 519 received SRVPA and 489 received topiramate. SRVPA was better than topiramate (28.3% vs. 41.5%; HR = 0.62, [95% CI 0.49-0.77]; p<0.0001) in primary outcome, and in time to first seizure (56.1% vs. 69.3%; HR = 0.73, [95% CI 0.62-0.86]; p = 0.0002). No significant difference was observed between two groups in time to 12-month remission (52.6% vs. 42.5%; HR = 1.01, [95% CI 0.84-1.23]; p = 0.88) and time to 24-month remission (34.7% vs. 25.2%; HR = 1.11, [95% CI 0.88-1.42]; p = 0.38). 36 patients (6.9%) in SRVPA group and 37 patients (7.6%) in topiramate group presented treatment failure associated with intolerable adverse events, there was no significant difference between the two groups (p = 0.70). Conclusions: The SRVPA is more suitable than topiramate for Chinese epileptic patients, and our results support the viewpoint that traditional AEDs should be the first-line choice for epilepsy rather than new-generation AEDs. Citation: Hu Y, Huang X, Shen D, Ding M, Sun H, et al. (2012) Outcomes of Sustained-Release Formulation of Valproate and Topiramate Monotherapy in Patients with Epilepsy: A Multi-Centre, Cohort Study. PLoS ONE 7(12): e47982. doi: 10.1371/journal.pone.0047982	[Hu, Yida; Zeng, Kebin; Xi, Zhiqin; Zhang, Ying; Cao, Qingqing; Liu, Jing; Zhou, Yan; Wu, Mengjiao; Lu, Yaodong; Chen, Guojun; Wang, Xuefeng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Huang, Xishun] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou, Peoples R China; [Shen, Dinglie; Hu, Xiangshu; Li, Hua] Guangdong 999 Brain Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Ding, Meiping] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Neurol, Hangzhou, Zhejiang, Peoples R China; [Sun, Hongbin] Sichuan Acad Med Sci, Dept Neurol, Sichuan, Peoples R China; [Sun, Hongbin] Sichuan Prov Peoples Hosp, Sichuan, Peoples R China; [Peng, Bin] Chongqing Med Univ, Sch Publ Hlth, Chongqing, Peoples R China; [Chen, Guojun] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA USA	Chongqing Medical University; Zhengzhou University; Zhejiang University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Chongqing Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, GJ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	woodchen2015@163.com; kudosai@163.com		Chen, Guo-Jun/0000-0001-8148-9810	National Natural Science of China [81071039]; Preeminent Medical Doctors' Foundation in Chongqing Medical University; Chongqing Medical Science and Technology Bureau of Research Projects [2009-2-356]; Natural Science Foundation Project of CQ [CSTCX1263-0200190012]; Chongqing Health Bureau funding [2011-2-118]	National Natural Science of China(National Natural Science Foundation of China (NSFC)); Preeminent Medical Doctors' Foundation in Chongqing Medical University; Chongqing Medical Science and Technology Bureau of Research Projects; Natural Science Foundation Project of CQ(Natural Science Foundation Project of CQ CSTC); Chongqing Health Bureau funding	The data collection and the analysis of this study were funded by National Natural Science of China No. 81071039 (XFW), the Preeminent Medical Doctors' Foundation in Chongqing Medical University (YDH), and the grants of the Chongqing Medical Science and Technology Bureau of Research Projects (2009-2-356) (ZQX). The preparation of this manuscript was funded by the Natural Science Foundation Project of CQ CSTCX1263-0200190012 (ZQX) and the Chongqing Health Bureau funding (2011-2-118) (KBZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Beghi E, 2004, LANCET NEUROL, V3, P618, DOI 10.1016/S1474-4422(04)00882-8; Ben-Menachem E, 2008, CLIN THER, V30, P1180, DOI 10.1016/S0149-2918(08)80045-8; Bootsma HPR, 2004, EPILEPSY BEHAV, V5, P380, DOI 10.1016/j.yebeh.2004.03.002; Brodie MJ, 1997, EPILEPSIA, V38, P1245, DOI 10.1111/j.1528-1157.1997.tb01224.x; BRODIE MJ, 1995, LANCET, V345, P476, DOI 10.1016/S0140-6736(95)90581-2; Chadwick D, 1998, EPILEPSIA, V39, P799; Cho YJ, 2009, EPILEPSIA, V50, P1910, DOI 10.1111/j.1528-1167.2009.02177.x; Ding YX, 2011, CHILD NERV SYST, V27, P279, DOI 10.1007/s00381-010-1255-2; Gilliam FG, 2003, NEUROLOGY, V60, P196, DOI 10.1212/01.WNL.0000048200.12663.BC; Glasziou P, 2004, BMJ-BRIT MED J, V328, P39, DOI 10.1136/bmj.328.7430.39; Glauser TA, 2010, NEW ENGL J MED, V362, P790, DOI 10.1056/NEJMoa0902014; Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1; Jones MW, 1998, CAN J NEUROL SCI, V25, pS13, DOI 10.1017/S0317167100034855; Lhatoo SD, 2000, EPILEPSIA, V41, P1592; Mant D, 1999, LANCET, V353, P743, DOI 10.1016/S0140-6736(98)09102-8; Marson AG, 2002, EPILEPSIA, V43, P505, DOI 10.1046/j.1528-1157.2002.20801.x; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; McCorry D, 2004, LANCET NEUROL, V3, P729, DOI 10.1016/S1474-4422(04)00935-4; Perucca E, 2004, BMJ-BRIT MED J, V328, P1273, DOI 10.1136/bmj.328.7451.1273; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; Privitera MD, 2003, ACTA NEUROL SCAND, V107, P165, DOI 10.1034/j.1600-0404.2003.00093.x; Sackett DL, 1997, BRIT MED J, V315, P1636, DOI 10.1136/bmj.315.7123.1636; Tomson T, 2004, J NEUROL, V251, P1043, DOI 10.1007/s00415-004-0344-0	26	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e47982	10.1371/journal.pone.0047982	http://dx.doi.org/10.1371/journal.pone.0047982			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239963	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800002
J	Garcia-Garcia, FJ; Mullol, J; Perez-Gonzalez, M; Pujols, L; Alobid, I; Roca-Ferrer, J; Picado, C				Josep Garcia-Garcia, Francesc; Mullol, Joaquim; Perez-Gonzalez, Maria; Pujols, Laura; Alobid, Isam; Roca-Ferrer, Jordi; Picado, Cesar			Signal Transduction Pathways (MAPKs, NF-kappa B, and C/EBP) Regulating COX-2 Expression in Nasal Fibroblasts from Asthma Patients with Aspirin Intolerance	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; BINDING-PROTEIN-BETA; SMOOTH-MUSCLE-CELLS; CYCLOOXYGENASE-2 EXPRESSION; TRANSCRIPTIONAL REGULATION; SENSITIVE ASTHMATICS; ENDOTHELIAL-CELLS; PROSTAGLANDIN E-2; EPITHELIAL-CELLS; UP-REGULATION	Background: Recent studies have revealed that cyclooxygenase-2 (COX-2) expression is down-regulated in aspirin-induced asthma (AIA). Various signal pathways (MAPKs, NF-kappa B and C/EBP) are involved in COX-2 regulation. Objective: To investigate the regulation of COX-2 expression through MAP-kinase pathway activation and nuclear factor translocation in aspirin-induced asthma (AIA). Methods: Fibroblasts were isolated from specimens of nasal mucosa (NM, N = 5) and nasal polyps (NP, N = 5). After IL-1 beta (1 ng/ml) incubation, COX-2 and phosphorylated forms of ERK, JNK and p38 MAPK were measured by Western blot. MAPK's role in IL-1 beta-induced COX-2 expression was assessed by treating cells with ERK (PD98059), JNK (SP600125) and p38 MAPK (SB203580) inhibitors (0.1-10 mM) prior to IL-1 beta exposure. NF-kappa B and C/EBP nuclear translocation was measured by Western blot and TransAM (R) after IL-1 beta (10 ng/ml) exposure. Results: No differences were observed in the MAPK phosphorylation time-course between NM and NP-AIA fibroblasts. The p38 MAPK inhibitor at 10 mM significantly reduced IL-1 beta-induced COX-2 expression in NM fibroblasts (85%). In NP-AIA fibroblasts the COX-2 inhibition (65%) at 1 and 10 mM was not statistically significant compared to non-treated cells. ERK and JNK inhibitors had no significant effect in either the NM or NP-AIA cultures. The effect of IL-1 beta on NF-kappa B and C/EBP subunits' nuclear translocation was similar between NM and NP-AIA fibroblasts. Conclusions: These results suggest that p38 MAPK is the only MAPK involved in IL-1 beta-induced COX-2 expression. NM and NP-AIA fibroblasts have similar MAPK phosphorylation dynamics and nuclear factor translocation (NF-kappa B and C/EBP). COX-2 downregulation observed in AIA patients appears not to be caused by differences in MAPK dynamics or transcription factor translocation.	[Josep Garcia-Garcia, Francesc; Mullol, Joaquim; Perez-Gonzalez, Maria; Pujols, Laura; Alobid, Isam; Roca-Ferrer, Jordi; Picado, Cesar] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Catalonia, Spain; [Josep Garcia-Garcia, Francesc; Mullol, Joaquim; Perez-Gonzalez, Maria; Pujols, Laura; Alobid, Isam; Roca-Ferrer, Jordi; Picado, Cesar] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Barcelona, Catalonia, Spain; [Mullol, Joaquim] Hosp Clin Barcelona, Unitat Rinol & Clin Olfacte, Serv Otorinolaringol, Barcelona, Catalonia, Spain; [Picado, Cesar] Univ Barcelona, Serv Pneumol & Al Lergia Resp, Hosp Clin, Barcelona, Catalonia, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona	Picado, C (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Catalonia, Spain.	idib402@clinic.ub.es	Roca-Ferrer, Jordi/AFQ-4652-2022; /AAL-7347-2021; Pujols, Laura/G-8920-2015; /AFX-9519-2022; Gonzalez, Maria Perez/J-5846-2017	Roca-Ferrer, Jordi/0000-0002-9527-2273; Pujols, Laura/0000-0003-3708-5098; Gonzalez, Maria Perez/0000-0001-9013-6785; Perez Gonzalez, Maria/0000-0001-5525-5543	Spanish Ministry of Health [FIS PI030033, FIS PI080249]; Fundacio Catalana de Pneumologia (FUCAP); Fundacion Respira (Spanish Respiratory Society)	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Fundacio Catalana de Pneumologia (FUCAP); Fundacion Respira (Spanish Respiratory Society)	This work was supported by grants from the Spanish Ministry of Health (FIS PI030033, FIS PI080249), Fundacio Catalana de Pneumologia (FUCAP), and Fundacion Respira (Spanish Respiratory Society). The funders had no role in the study design, data collection or analysis, or the decision to publish, or the preparation of the manuscript.	Ackerman WE, 2008, BIOL REPROD, V78, P68, DOI 10.1095/biolreprod.107.061663; Birkenkamp KU, 2000, BRIT J PHARMACOL, V131, P99, DOI 10.1038/sj.bjp.0703534; Branski RC, 2010, LARYNGOSCOPE, V120, P1826, DOI 10.1002/lary.21017; Casadevall J, 2000, THORAX, V55, P921, DOI 10.1136/thorax.55.11.921; Caughey GE, 2001, J IMMUNOL, V167, P2831, DOI 10.4049/jimmunol.167.5.2831; Chen P, 2006, RESPIROLOGY, V11, P18, DOI 10.1111/j.1440-1843.2006.00779.x; Cho YH, 2003, MOL PHARMACOL, V63, P512, DOI 10.1124/mol.63.3.512; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Coward WR, 2009, MOL CELL BIOL, V29, P4325, DOI 10.1128/MCB.01776-08; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI [10.4193/Rhino50E2, 10.4193/Rhino12.000]; Griffin BD, 2006, J BIOL CHEM, V281, P10316, DOI 10.1074/jbc.M509973200; Higashi N, 2010, J ALLERGY CLIN IMMUN, V125, P1084, DOI 10.1016/j.jaci.2009.12.977; Jedrzejczak-Czechowicz M, 2008, CLIN EXP ALLERGY, V38, P1108, DOI 10.1111/j.1365-2222.2008.02989.x; Joo M, 2004, J BIOL CHEM, V279, P6658, DOI 10.1074/jbc.M306267200; Kowalski ML, 2000, AM J RESP CRIT CARE, V161, P391, DOI 10.1164/ajrccm.161.2.9902034; Laporte JD, 2000, AM J PHYSIOL-LUNG C, V279, pL932, DOI 10.1152/ajplung.2000.279.5.L932; Liu WV, 2003, CANCER RES, V63, P3632; Nie M, 2003, MOL CELL BIOL, V23, P9233, DOI 10.1128/MCB.23.24.9233-9244.2003; Nieminen R, 2005, MEDIAT INFLAMM, P249, DOI 10.1155/MI.2005.249; Ogata S, 2007, J DENT RES, V86, P186, DOI 10.1177/154405910708600215; Picado C, 2003, ALLERGY, V58, P122, DOI 10.1034/j.1398-9995.2003.23792.x; Picado C, 2006, CURR ALLERGY ASTHM R, V6, P198, DOI 10.1007/s11882-006-0035-2; Pierzchalska M, 2003, J ALLERGY CLIN IMMUN, V111, P1041, DOI 10.1067/mai.2003.1491; Pujols L, 2004, J ALLERGY CLIN IMMUN, V114, P814, DOI 10.1016/j.jaci.2004.07.050; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Roca-Ferrer J, 2006, THORAX, V61, P592, DOI 10.1136/thx.2004.039842; Roca-Ferrer J, 2011, J ALLERGY CLIN IMMUN, V128, P66, DOI 10.1016/j.jaci.2011.01.065; Saunders MA, 2001, J BIOL CHEM, V276, P18897, DOI 10.1074/jbc.M011147200; Schafer D, 1999, EUR RESPIR J, V13, P638, DOI 10.1183/09031936.99.13363899; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Stevenson DD, 2006, J ALLERGY CLIN IMMUN, V118, P773, DOI 10.1016/j.jaci.2006.07.024; Syeda F, 2006, J BIOL CHEM, V281, P11792, DOI 10.1074/jbc.M509292200; Ulivi V, 2008, J CELL BIOCHEM, V104, P1393, DOI 10.1002/jcb.21717; Wadleigh DJ, 2000, J BIOL CHEM, V275, P6259, DOI 10.1074/jbc.275.9.6259; Wu KK, 2005, ARTERIOSCL THROM VAS, V25, P679, DOI 10.1161/01.ATV.0000157899.35660.61; Wu MH, 2005, J CLIN ENDOCR METAB, V90, P286, DOI 10.1210/jc.2004-1612; Xaubet A, 2004, SARCOIDOSIS VASC DIF, V21, P35	38	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51281	10.1371/journal.pone.0051281	http://dx.doi.org/10.1371/journal.pone.0051281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240010	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800046
J	Shi, ZM; Yuan, BJ; Wittert, GA; Pan, XQ; Dai, Y; Adams, R; Taylor, AW				Shi, Zumin; Yuan, Baojun; Wittert, Gary A.; Pan, Xiaoqun; Dai, Yue; Adams, Robert; Taylor, Anne W.			Monosodium Glutamate Intake, Dietary Patterns and Asthma in Chinese Adults	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; INCIDENT ASTHMA; PREVALENCE; SYMPTOMS; OBESITY; OVERWEIGHT; SENSITIVITY; NUTRITION; ALCOHOL	Objectives: Emerging evidence shows that diet is related to asthma. The aim of this analysis was to investigate the association between monosodium glutamate (MSG) intake, overall dietary patterns and asthma. Methods: Data from 1486 Chinese men and women who participated in the Jiangsu Nutrition Study (JIN) were analyzed. In this study, MSG intake and dietary patterns were quantitatively assessed in 2002. Information on asthma history was collected during followed-up in 2007. Results: Of the sample, 1.4% reported ever having asthma. MSG intake was not positively associated with asthma. There was a significant positive association between 'traditional' (high loadings on rice, wheat flour, and vegetable) food pattern and asthma. No association between 'macho' (rich in meat and alcohol), 'sweet tooth' (high loadings on cake, milk, and yoghurt) 'vegetable rich' (high loadings on whole grain, fruit, and vegetable) food patterns and asthma was found. Smoking and overweight were not associated with asthma in the sample. Conclusion: While a 'Traditional' food pattern was positively associated with asthma among Chinese adults, there was no significant association between MSG intake and asthma.	[Shi, Zumin; Yuan, Baojun; Pan, Xiaoqun; Dai, Yue] Jiangsu Prov Ctr Dis Control & Prevent, Dept Nutr & Foodborne Dis Prevent, Nanjing, Jiangsu, Peoples R China; [Shi, Zumin; Wittert, Gary A.; Adams, Robert; Taylor, Anne W.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia	Jiangsu Provincial Center for Disease Control & Prevention; University of Adelaide	Shi, ZM (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Nutr & Foodborne Dis Prevent, Nanjing, Jiangsu, Peoples R China.	zumin.shi@adelaide.edu.au	Shi, Zumin/A-1093-2009; Adams, Robert/Z-3197-2019; Taylor, Anne w/F-5708-2010; wittert, gary/AAE-2398-2019	Shi, Zumin/0000-0002-3099-3299; Taylor, Anne w/0000-0002-4422-7974; Wittert, Gary/0000-0001-6818-6065	Jiangsu Provincial Natural Science Foundation [BK2008464]; Jiangsu Provincial Health Bureau, China; International Glutamate Technical Committee	Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Provincial Health Bureau, China; International Glutamate Technical Committee	The study was funded by Jiangsu Provincial Natural Science Foundation BK2008464 and Jiangsu Provincial Health Bureau, China. The data analysis was supported a research grant from International Glutamate Technical Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DH, 1981, NEW ENGL J MED, V305, P1154; ALLEN DH, 1987, J ALLERGY CLIN IMMUN, V80, P530, DOI 10.1016/0091-6749(87)90003-0; Arshi M, 2010, RESPIROLOGY, V15, P779, DOI 10.1111/j.1440-1843.2010.01767.x; Bakolis I, 2010, ALLERGY, V65, P606, DOI 10.1111/j.1398-9995.2009.02215.x; Balmes J, 2003, AM J RESP CRIT CARE, V167, P787, DOI 10.1164/rccm.167.5.787; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Beyreuther K, 2007, EUR J CLIN NUTR, V61, P304, DOI 10.1038/sj.ejcn.1602526; Butler LM, 2006, AM J RESP CRIT CARE, V173, P264, DOI 10.1164/rccm.200506-901OC; Chan-Yeung M, 2002, EUR RESPIR J, V19, P853, DOI 10.1183/09031936.02.00250602; Chittleborough CR, 2010, RESPIROLOGY, V15, P107, DOI 10.1111/j.1440-1843.2009.01638.x; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; Devereux G, 2010, P NUTR SOC, V69, P1, DOI 10.1017/S0029665109991753; He K, 2008, OBESITY, V16, P1875, DOI 10.1038/oby.2008.274; He K, 2011, AM J CLIN NUTR, V93, P1328, DOI 10.3945/ajcn.110.008870; Henkin S, 2008, ANN ALLERG ASTHMA IM, V100, P447, DOI 10.1016/S1081-1206(10)60469-3; Hernandez AF, 2011, CURR OPIN ALLERGY CL, V11, P90, DOI 10.1097/ACI.0b013e3283445939; Ho WC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-542; Hooper R, 2010, BRIT J NUTR, V103, P1354, DOI 10.1017/S0007114509993266; Insawang T, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-50; KING G, 2001, POLITICAL ANAL, V0009; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Liu AH, 2006, J ALLERGY CLIN IMMUN, V117, P1063, DOI 10.1016/j.jaci.2006.03.027; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; McKeever TM, 2010, AM J CLIN NUTR, V92, P408, DOI 10.3945/ajcn.2009.29021; MONERET-VAUTRIN D A, 1987, Allergie et Immunologie (Paris), V19, P29; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Santamaria F, 2011, OBESITY, V19, P1623, DOI 10.1038/oby.2011.1; SCHWARTZSTEIN RM, 1987, J ASTHMA, V24, P167, DOI 10.3109/02770908709070933; SEATON A, 1994, THORAX, V49, P171, DOI 10.1136/thx.49.2.171; Shaheen SO, 2009, THORAX, V64, P411, DOI 10.1136/thx.2008.104703; Shi Z, 2008, INT J OBESITY, V32, P975, DOI 10.1038/ijo.2008.21; Shi ZM, 2011, J HYPERTENS, V29, P846, DOI 10.1097/HJH.0b013e328344da8e; Shi ZM, 2011, BRIT J NUTR, V105, P1047, DOI 10.1017/S0007114510004630; Shi ZM, 2010, BRIT J NUTR, V104, P457, DOI 10.1017/S0007114510000760; Sisson JH, 2007, ALCOHOL, V41, P293, DOI 10.1016/j.alcohol.2007.06.003; Stevenson DD, 2000, J NUTR, V130, p1067S, DOI 10.1093/jn/130.4.1067S; Thu Hien VT, 2012, PUBLIC HEALTH NUTR, P1; Thuesen BH, 2009, CLIN EXP ALLERGY, V39, P700, DOI 10.1111/j.1365-2222.2008.03197.x; Varraso R, 2009, EUR RESPIR J, V33, P33, DOI 10.1183/09031936.00130807; Wilson D, 2008, RESP MED, V102, P1536, DOI 10.1016/j.rmed.2008.06.010; Woessner KM, 1999, J ALLERGY CLIN IMMUN, V104, P305, DOI 10.1016/S0091-6749(99)70371-4; Wood LG, 2009, PHARMACOL THERAPEUT, V123, P37, DOI 10.1016/j.pharmthera.2009.03.015; Woods RK, 1998, J ALLERGY CLIN IMMUN, V101, P762, DOI 10.1016/S0091-6749(98)70305-7; Yangzong YZ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-860; Yoneda J, 2011, FOOD CHEM TOXICOL, V49, P299, DOI 10.1016/j.fct.2010.10.032; Zhao WH, 2002, PUBLIC HEALTH NUTR, V5, P829, DOI 10.1079/PHN2002374; Zhou Y, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004357.pub4	47	15	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51567	10.1371/journal.pone.0051567	http://dx.doi.org/10.1371/journal.pone.0051567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240044	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800080
J	Praslickova, D; Torchia, EC; Sugiyama, MG; Magrane, EJ; Zwicker, BL; Kolodzieyski, L; Agellon, LB				Praslickova, Dana; Torchia, Enrique C.; Sugiyama, Michael G.; Magrane, Elijah J.; Zwicker, Brittnee L.; Kolodzieyski, Lev; Agellon, Luis B.			The Ileal Lipid Binding Protein Is Required for Efficient Absorption and Transport of Bile Acids in the Distal Portion of the Murine Small Intestine	PLOS ONE			English	Article							ALPHA-OST-BETA; ORGANIC SOLUTE TRANSPORTER; MOLECULAR-CLONING; MICE; CHOLESTEROL; EXPRESSION; PLASMA; LIVER; RAT; CHROMATOGRAPHY	The ileal lipid binding protein (ilbp) is a cytoplasmic protein that binds bile acids with high affinity. However evidence demonstrating the role of this protein in bile acid transport and homeostasis is missing. We created a mouse strain lacking ilbp (Fabp6(-/-) mice) and assessed the impact of ilbp deficiency on bile acid homeostasis and transport in vivo. Elimination of ilbp increased fecal bile acid excretion (54.2%, P<0.05) in female but not male Fabp6(-/-) mice. The activity of cholesterol 7 alpha-hydroxylase (cyp7a1), the rate-controlling enzyme of the classical bile acid biosynthetic pathway, was significantly increased in female (63.5%, P<0.05) but not in male Fabp6(-/-) mice. The amount of [H-3] taurocholic acid (TCA) excreted by 24 h after oral administration was 102% (P<0.025) higher for female Fabp6(-/-) mice whereas it was 57.3% (P<0.01) lower for male Fabp6(-/-) mice, compared to wild-type mice. The retained fraction of the [H-3] TCA localized in the small and large intestines was increased by 22% (P<0.02) and decreased by 62.7% (P<0.01), respectively, in male Fabp6(-/-) mice relative wild-type mice, whereas no changes were seen in female Fabp6(-/-) mice. Mucosal to serosal bile acid transport using everted distal gut sacs was decreased by 74% (P<0.03) in both sexes of Fabp6(-/-) mice as compared to wild-type mice. The results demonstrate that ilbp is involved in the apical to basolateral transport of bile acids in ileal enterocytes, and is vital for the maintenance of bile acid homeostasis in the enterohepatic circulation (EHC) in mice.	[Praslickova, Dana; Sugiyama, Michael G.; Magrane, Elijah J.; Zwicker, Brittnee L.; Kolodzieyski, Lev; Agellon, Luis B.] McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ, Canada; [Torchia, Enrique C.; Agellon, Luis B.] Univ Alberta, Canadian Inst Hlth, Res Grp Mol & Cell Biol Lipids, Edmonton, AB, Canada; [Kolodzieyski, Lev] ITR Labs Canada, Baie Durfe, PQ, Canada	McGill University; University of Alberta	Agellon, LB (corresponding author), McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ, Canada.	luis.agellon@mcgill.ca			Canadian Institutes of Health Research; Canada Foundation for Innovation; Novartis Pharmaceuticals Canada; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Novartis Pharmaceuticals Canada; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This research was supported in parts by grants (to LBA) from the Canadian Institutes of Health Research, Canada Foundation for Innovation and Novartis Pharmaceuticals Canada. ECT held a studentship from the Alberta Heritage Foundation for Medical Research. LBA holds the Canada Research Chair in Biochemistry and Molecular Biology of Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agellon LB, 1997, BIOCHEM CELL BIOL, V75, P255, DOI 10.1139/bcb-75-3-255; Agellon LB, 2000, BBA-MOL CELL BIOL L, V1486, P198, DOI 10.1016/S1388-1981(00)00057-3; Agellon LB, 2002, MOL CELL BIOCHEM, V239, P79, DOI 10.1023/A:1020520521025; Ballatori N, 2008, AM J PHYSIOL-GASTR L, V295, pG179, DOI 10.1152/ajpgi.90319.2008; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dawson PA, 2005, J BIOL CHEM, V280, P6960, DOI 10.1074/jbc.M412752200; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; FUJITA M, 1995, EUR J BIOCHEM, V233, P406, DOI 10.1111/j.1432-1033.1995.406_2.x; GONG YZ, 1994, P NATL ACAD SCI USA, V91, P4741, DOI 10.1073/pnas.91.11.4741; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Labonte ED, 2003, PROTEIN EXPRES PURIF, V28, P25, DOI 10.1016/S1046-5928(02)00561-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOHNINGER A, 1990, ANAL BIOCHEM, V186, P243, DOI 10.1016/0003-2697(90)90074-J; Oelkers P, 1997, J CLIN INVEST, V99, P1880, DOI 10.1172/JCI119355; Rao A, 2008, P NATL ACAD SCI USA, V105, P3891, DOI 10.1073/pnas.0712328105; SACCHETTINI JC, 1990, J BIOL CHEM, V265, P19199; SHAPIRO DJ, 1974, BIOCHIM BIOPHYS ACTA, V370, P369, DOI 10.1016/0005-2744(74)90098-9; SPADY DK, 1995, J CLIN INVEST, V96, P700, DOI 10.1172/JCI118113; TAKIKAWA H, 1986, ARCH BIOCHEM BIOPHYS, V251, P385, DOI 10.1016/0003-9861(86)90086-X; Torchia EC, 2001, ANAL BIOCHEM, V298, P293, DOI 10.1006/abio.2001.5379; Torchia EC, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-11; Van der Meer R., 1985, CHOLESTEROL METABOLI, P113; Wang RX, 2001, P NATL ACAD SCI USA, V98, P2011, DOI 10.1073/pnas.031465498; Zimmerman AW, 2001, INT J BIOCHEM CELL B, V33, P865, DOI 10.1016/S1357-2725(01)00070-X	24	40	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50810	10.1371/journal.pone.0050810	http://dx.doi.org/10.1371/journal.pone.0050810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251388	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900021
J	Tucker, JA; Bennett, N; Brassington, C; Durant, ST; Hassall, G; Holdgate, G; McAlister, M; Nissink, JWM; Truman, C; Watson, M				Tucker, Julie A.; Bennett, Neil; Brassington, Claire; Durant, Stephen T.; Hassall, Giles; Holdgate, Geoff; McAlister, Mark; Nissink, J. Willem M.; Truman, Caroline; Watson, Martin			Structures of the Human Poly (ADP-Ribose) Glycohydrolase Catalytic Domain Confirm Catalytic Mechanism and Explain Inhibition by ADP-HPD Derivatives	PLOS ONE			English	Article							STRAND BREAK REPAIR; POLY(ADP-RIBOSE) GLYCOHYDROLASE; MAXIMUM-LIKELIHOOD; PROTEIN CRYSTALLIZATION; PARG; REFINEMENT; IDENTIFICATION; SENSITIVITY; PREDICTION; REDUCTION	Poly(ADP-ribose) glycohydrolase (PARG) is the only enzyme known to catalyse hydrolysis of the O-glycosidic linkages of ADP-ribose polymers, thereby reversing the effects of poly(ADP-ribose) polymerases. PARG deficiency leads to cell death whilst PARG depletion causes sensitisation to certain DNA damaging agents, implicating PARG as a potential therapeutic target in several disease areas. Efforts to develop small molecule inhibitors of PARG activity have until recently been hampered by a lack of structural information on PARG. We have used a combination of bio-informatic and experimental approaches to engineer a crystallisable, catalytically active fragment of human PARG (hPARG). Here, we present high-resolution structures of the catalytic domain of hPARG in unliganded form and in complex with three inhibitors: ADP-ribose (ADPR), adenosine 59-diphosphate (hydroxymethyl) pyrrolidinediol (ADP-HPD) and 8-n-octyl-amino-ADP-HPD. Our structures confirm conservation of overall fold amongst mammalian PARG glycohydrolase domains, whilst revealing additional flexible regions in the catalytic site. These new structures rationalise a body of published mutational data and the reported structure-activity relationship for ADP-HPD based PARG inhibitors. In addition, we have developed and used biochemical, isothermal titration calorimetry and surface plasmon resonance assays to characterise the binding of inhibitors to our PARG protein, thus providing a starting point for the design of new inhibitors.	[Tucker, Julie A.; Bennett, Neil; Brassington, Claire; Durant, Stephen T.; Hassall, Giles; Holdgate, Geoff; McAlister, Mark; Nissink, J. Willem M.; Truman, Caroline; Watson, Martin] AstraZeneca UK Ltd, Innovat Med, Macclesfield, Cheshire, England	AstraZeneca	Tucker, JA (corresponding author), AstraZeneca UK Ltd, Innovat Med, Macclesfield, Cheshire, England.	julie.tucker@astrazeneca.com	Nissink, J. Willem M./C-1507-2010; Tucker, Julie/AAT-1513-2021	Nissink, J. Willem M./0000-0003-2572-9140; Watson, Martin/0000-0001-8803-478X; Tucker, Julie/0000-0002-6119-676X; mcalister, mark/0000-0003-3986-1767	AstraZeneca	AstraZeneca(AstraZeneca)	This work was carried out at and financially supported by AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Affar EB, 2001, J BIOL CHEM, V276, P2935, DOI 10.1074/jbc.M007269200; Ame JC, 1999, CYTOGENET CELL GENET, V85, P269, DOI 10.1159/000015310; Ame JC, 2009, J CELL SCI, V122, P1990, DOI 10.1242/jcs.039115; Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; Botta D, 2010, BIOCHEMISTRY-US, V49, P7674, DOI 10.1021/bi100973m; BRAUN SA, 1994, EUR J BIOCHEM, V220, P369, DOI 10.1111/j.1432-1033.1994.tb18633.x; BROCHU G, 1994, BBA-GENE STRUCT EXPR, V1219, P342, DOI 10.1016/0167-4781(94)90058-2; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cooper DR, 2007, ACTA CRYSTALLOGR D, V63, P636, DOI 10.1107/S0907444907010931; Cortes U, 2004, MOL CELL BIOL, V24, P7163, DOI 10.1128/MCB.24.16.7163-7178.2004; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cuzzocrea S, 2005, FASEB J, V19, P558, DOI 10.1096/fj.04-3117com; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Derewenda ZS, 2006, ACTA CRYSTALLOGR D, V62, P116, DOI 10.1107/S0907444905035237; Dunstan MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1889; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fathers C, 2012, CELL CYCLE, V11, P990, DOI 10.4161/cc.11.5.19482; Fauzee NJS, 2010, PATHOL ONCOL RES, V16, P469, DOI 10.1007/s12253-010-9266-6; Finch KE, 2012, ACS CHEM BIOL, V7, P563, DOI 10.1021/cb200506t; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Hassler M, 2011, STRUCTURE, V19, P1351, DOI 10.1016/j.str.2011.09.007; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Keil C, 2006, J BIOL CHEM, V281, P34394, DOI 10.1074/jbc.M606470200; Kim IK, 2012, NAT STRUCT MOL BIOL, V19, P653, DOI 10.1038/nsmb.2305; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Koh DW, 2003, J MED CHEM, V46, P4322, DOI 10.1021/jm020541u; Koh DW, 2003, BIOCHEMISTRY-US, V42, P4855, DOI 10.1021/bi0272048; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; MALANGA M, 1994, J BIOL CHEM, V269, P17691; Meyer RG, 2007, EXP CELL RES, V313, P2920, DOI 10.1016/j.yexcr.2007.03.043; Meyer-Ficca ML, 2004, EXP CELL RES, V297, P521, DOI 10.1016/j.yexcr.2004.03.050; Min W, 2009, FRONT BIOSCI-LANDMRK, V14, P1619, DOI 10.2741/3329; MIWA M, 1979, P NATL ACAD SCI USA, V76, P595, DOI 10.1073/pnas.76.2.595; MIWA M, 1974, J BIOL CHEM, V249, P3475; MIWA M, 1984, METHOD ENZYMOL, V106, P441; MIWA M, 1977, NUCLEIC ACIDS RES, V4, P3997, DOI 10.1093/nar/4.11.3997; Mortusewicz O, 2011, NUCLEIC ACIDS RES, V39, P5045, DOI 10.1093/nar/gkr099; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Patel CN, 2005, BIOCHEM J, V388, P2; Patel NSA, 2005, J AM SOC NEPHROL, V16, P712, DOI 10.1681/ASN.2004080677; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shimokawa T, 1999, J BIOCHEM-TOKYO, V126, P748, DOI 10.1093/oxfordjournals.jbchem.a022512; Shirato M, 2007, BIOCHEM BIOPH RES CO, V355, P451, DOI 10.1016/j.bbrc.2007.01.171; Slade D, 2011, NATURE, V477, P616, DOI 10.1038/nature10404; SLAMA JT, 1995, J MED CHEM, V38, P389, DOI 10.1021/jm00002a021; Steffen JD, 2011, J MED CHEM; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wlodek S, 2006, ACTA CRYSTALLOGR D, V62, P741, DOI 10.1107/S0907444906016076; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	72	38	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50889	10.1371/journal.pone.0050889	http://dx.doi.org/10.1371/journal.pone.0050889			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251397	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900025
J	Wang, K; Li, H; Yuan, Y; Etheridge, A; Zhou, Y; Huang, D; Wilmes, P; Galas, D				Wang, Kai; Li, Hong; Yuan, Yue; Etheridge, Alton; Zhou, Yong; Huang, David; Wilmes, Paul; Galas, David			The Complex Exogenous RNA Spectra in Human Plasma: An Interface with Human Gut Biota?	PLOS ONE			English	Article							MICROBIOME; MICRORNAS; GENOME; POPULATION; MECHANISM; HEALTH	Human plasma has long been a rich source for biomarker discovery. It has recently become clear that plasma RNA molecules, such as microRNA, in addition to proteins are common and can serve as biomarkers. Surveying human plasma for microRNA biomarkers using next generation sequencing technology, we observed that a significant fraction of the circulating RNA appear to originate from exogenous species. With careful analysis of sequence error statistics and other controls, we demonstrated that there is a wide range of RNA from many different organisms, including bacteria and fungi as well as from other species. These RNAs may be associated with protein, lipid or other molecules protecting them from RNase activity in plasma. Some of these RNAs are detected in intracellular complexes and may be able to influence cellular activities under in vitro conditions. These findings raise the possibility that plasma RNAs of exogenous origin may serve as signaling molecules mediating for example the human-microbiome interaction and may affect and/or indicate the state of human health.	[Wang, Kai; Li, Hong; Yuan, Yue; Etheridge, Alton; Zhou, Yong; Huang, David; Galas, David] Inst Syst Biol, Seattle, WA USA; [Wilmes, Paul; Galas, David] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg; [Etheridge, Alton; Huang, David; Galas, David] Pacific NW Diabet Res, Seattle, WA USA	Institute for Systems Biology (ISB); University of Luxembourg; Pacific Northwest Diabetes Research Institute (PNDRI)	Wang, K (corresponding author), Inst Syst Biol, Seattle, WA USA.	kwang@systemsbiology.org; paul.wilmes@uni.lu; dgalas@pnri.org	Wilmes, Paul/B-1707-2017	Wilmes, Paul/0000-0002-6478-2924	University of Luxemburg; Department of Defense [W911SR-07-C-0101, W81XWH-09-1-0107, HDTRA 1-08-C-0023]; ATTRACT program grant by the Luxembourg National Research Fund [ATTRACT/A09/03]	University of Luxemburg; Department of Defense(United States Department of Defense); ATTRACT program grant by the Luxembourg National Research Fund(Luxembourg National Research Fund)	This work was supported by the University of Luxemburg program, research contracts from the Department of Defense (W911SR-07-C-0101, W81XWH-09-1-0107 and HDTRA 1-08-C-0023), and ATTRACT program grant (ATTRACT/A09/03) awarded by the Luxembourg National Research Fund (to PW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Asmann YW, 2008, GASTROENTEROLOGY, V135, P1466, DOI 10.1053/j.gastro.2008.09.042; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Camussi G, 2011, AM J CANCER RES, V1, P98; Fleischhacker M, 2010, CANCER BIOMARK, V6, P211, DOI 10.3233/CBM-2009-0131; Fliessbach A, 2009, MICROB ECOL, V57, P611, DOI 10.1007/s00248-009-9489-9; Foster JA, 2012, BRIEFINGS BIOINFORMA; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Gregory Richard I., 2006, V342, P33, DOI 10.1385/1-59745-123-1:33; Haller D, 2006, NEUROGASTROENT MOTIL, V18, P184, DOI 10.1111/j.1365-2982.2006.00762.x; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; KIREDJIAN M, 1986, INT J SYST BACTERIOL, V36, P282, DOI 10.1099/00207713-36-2-282; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Lee A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000299; Luo Shujun, 2012, Methods Mol Biol, V822, P183, DOI 10.1007/978-1-61779-427-8_12; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Roume H, 2012, ISME J; Semenov DV, 2012, EXPERT OPIN BIOL TH, V12, pS43, DOI 10.1517/14712598.2012.679653; Stoneking M, 2011, NAT REV GENET, V12, P603, DOI 10.1038/nrg3029; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729; Zhu BL, 2010, PROTEIN CELL, V1, P718, DOI 10.1007/s13238-010-0093-z	29	130	136	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e51009	10.1371/journal.pone.0051009	http://dx.doi.org/10.1371/journal.pone.0051009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251414	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900032
J	Elbers, CC; Guo, YR; Tragante, V; van Iperen, EPA; Lanktree, MB; Castillo, BA; Chen, F; Yanek, LR; Wojczynski, MK; Li, YR; Ferwerda, B; Ballantyne, CM; Buxbaum, SG; Chen, YDI; Chen, WM; Cupples, LA; Cushman, M; Duan, YA; Duggan, D; Evans, MK; Fernandes, JK; Fornage, M; Garcia, M; Garvey, WT; Glazer, N; Gomez, F; Harris, TB; Halder, I; Howard, VJ; Keller, MF; Kamboh, MI; Kooperberg, C; Kritchevsky, SB; LaCroix, A; Liu, K; Liu, YM; Musunuru, K; Newman, AB; Onland-Moret, NC; Ordovas, J; Peter, I; Post, W; Redline, S; Reis, SE; Saxena, R; Schreiner, PJ; Volcik, KA; Wang, XB; Yusuf, S; Zonderland, AB; Anand, SS; Becker, DM; Psaty, B; Rader, DJ; Reiner, AP; Rich, SS; Rotter, JI; Sale, MM; Tsai, MY; Borecki, IB; Hegele, RA; Kathiresan, S; Nalls, MA; Taylor, HA; Hakonarson, H; Sivapalaratnam, S; Asselbergs, FW; Drenos, F; Wilson, JG; Keating, BJ				Elbers, Clara C.; Guo, Yiran; Tragante, Vinicius; van Iperen, Erik P. A.; Lanktree, Matthew B.; Castillo, Berta Almoguera; Chen, Fang; Yanek, Lisa R.; Wojczynski, Mary K.; Li, Yun R.; Ferwerda, Bart; Ballantyne, Christie M.; Buxbaum, Sarah G.; Chen, Yii-Der Ida; Chen, Wei-Min; Cupples, L. Adrienne; Cushman, Mary; Duan, Yanan; Duggan, David; Evans, Michele K.; Fernandes, Jyotika K.; Fornage, Myriam; Garcia, Melissa; Garvey, W. Timothy; Glazer, Nicole; Gomez, Felicia; Harris, Tamara B.; Halder, Indrani; Howard, Virginia J.; Keller, Margaux F.; Kamboh, M. Ilyas; Kooperberg, Charles; Kritchevsky, Stephen B.; LaCroix, Andrea; Liu, Kiang; Liu, Yongmei; Musunuru, Kiran; Newman, Anne B.; Onland-Moret, N. Charlotte; Ordovas, Jose; Peter, Inga; Post, Wendy; Redline, Susan; Reis, Steven E.; Saxena, Richa; Schreiner, Pamela J.; Volcik, Kelly A.; Wang, Xingbin; Yusuf, Salim; Zonderland, Alan B.; Anand, Sonia S.; Becker, Diane M.; Psaty, Bruce; Rader, Daniel J.; Reiner, Alex P.; Rich, Stephen S.; Rotter, Jerome I.; Sale, Michele M.; Tsai, Michael Y.; Borecki, Ingrid B.; Hegele, Robert A.; Kathiresan, Sekar; Nalls, Michael A.; Taylor, Herman A., Jr.; Hakonarson, Hakon; Sivapalaratnam, Suthesh; Asselbergs, Folkert W.; Drenos, Fotios; Wilson, James G.; Keating, Brendan J.			Gene-Centric Meta-Analysis of Lipid Traits in African, East Asian and Hispanic Populations	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; DENSITY-LIPOPROTEIN-CHOLESTEROL; SINGLE-NUCLEOTIDE POLYMORPHISM; NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; CHAIN FATTY-ACIDS; METABOLIC SYNDROME; ASSOCIATION RESOURCE; NATURAL-SELECTION; YOUNG-ADULTS	Meta-analyses of European populations has successfully identified genetic variants in over 100 loci associated with lipid levels, but our knowledge in other ethnicities remains limited. To address this, we performed dense genotyping of similar to 2,000 candidate genes in 7,657 African Americans, 1,315 Hispanics and 841 East Asians, using the IBC array, a custom similar to 50,000 SNP genotyping array. Meta-analyses confirmed 16 lipid loci previously established in European populations at genome-wide significance level, and found multiple independent association signals within these lipid loci. Initial discovery and in silico follow-up in 7,000 additional African American samples, confirmed two novel loci: rs5030359 within ICAM1 is associated with total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) (p = 8.8x10(-7) and p = 1.5x10(-6) respectively) and a nonsense mutation rs3211938 within CD36 is associated with high-density lipoprotein cholesterol (HDL-C) levels (p = 13.5x10(-1)2). The rs3211938-G allele, which is nearly absent in European and Asian populations, has been previously found to be associated with CD36 deficiency and shows a signature of selection in Africans and African Americans. Finally, we have evaluated the effect of SNPs established in European populations on lipid levels in multi-ethnic populations and show that most known lipid association signals span across ethnicities. However, differences between populations, especially differences in allele frequency, can be leveraged to identify novel signals, as shown by the discovery of ICAM1 and CD36 in the current report.	[Elbers, Clara C.; Ferwerda, Bart; Gomez, Felicia] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Elbers, Clara C.; Tragante, Vinicius; Onland-Moret, N. Charlotte; Asselbergs, Folkert W.] Univ Med Ctr, Dept Med Genet, Utrecht, Netherlands; [Elbers, Clara C.; Onland-Moret, N. Charlotte; Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Guo, Yiran; Castillo, Berta Almoguera; Li, Yun R.; Hakonarson, Hakon; Keating, Brendan J.] Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Gen, Philadelphia, PA 19104 USA; [Guo, Yiran] BGI Shenzhen, Shenzhen, Peoples R China; [Tragante, Vinicius; Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [van Iperen, Erik P. A.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Lanktree, Matthew B.] Univ Western Ontario, Dept Med, Schulich Sch Med & Dent, London, ON, Canada; [Lanktree, Matthew B.] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada; [Chen, Fang; Chen, Wei-Min; Rich, Stephen S.; Sale, Michele M.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Yanek, Lisa R.; Becker, Diane M.] Johns Hopkins Sch Med, GeneSTAR Res Program, Div Gen Internal Med, Baltimore, MD USA; [Wojczynski, Mary K.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Ballantyne, Christie M.] Baylor Coll Med, Houston, TX 77030 USA; [Buxbaum, Sarah G.] Jackson State Univ, Jackson Heart Study, Jackson, MS USA; [Chen, Yii-Der Ida; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Chen, Wei-Min] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Cupples, L. Adrienne; Glazer, Nicole] Boston Univ, Boston, MA 02215 USA; [Cupples, L. Adrienne] NHLBI, Framingham Heart Study, Framingham, MA USA; [Wojczynski, Mary K.; Duan, Yanan; Borecki, Ingrid B.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO USA; [Wojczynski, Mary K.; Duan, Yanan; Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Duggan, David] Translat Genom Res Inst, Phoenix, AZ USA; [Garcia, Melissa; Harris, Tamara B.] NIA, Lab Epidemiol Demog & Biometry, NIH, Bethesda, MD 20892 USA; [Reis, Steven E.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Kooperberg, Charles; LaCroix, Andrea; Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Kritchevsky, Stephen B.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [Kritchevsky, Stephen B.] Wake Forest Univ, Sticht Ctr Aging, Winston Salem, NC 27109 USA; [Liu, Kiang] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Liu, Yongmei] Wake Forest Univ, Div Publ Hlth Sci, Dept Epidemiol & Prevent, Winston Salem, NC 27109 USA; [Kamboh, M. Ilyas; Wang, Xingbin] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Ordovas, Jose] Tufts Univ, JM USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Peter, Inga] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Post, Wendy] Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD USA; [Redline, Susan] Brigham & Womens Hosp, Boston, MA 02115 USA; [Redline, Susan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Saxena, Richa] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Saxena, Richa] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Schreiner, Pamela J.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Volcik, Kelly A.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Yusuf, Salim; Anand, Sonia S.] McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Psaty, Bruce] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98195 USA; [Psaty, Bruce] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Rader, Daniel J.] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA USA; [Sale, Michele M.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Sale, Michele M.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Tsai, Michael Y.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Hegele, Robert A.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Keller, Margaux F.; Nalls, Michael A.] NIA, Neurogenet Lab, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Taylor, Herman A., Jr.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Taylor, Herman A., Jr.] Jackson State Univ, Tougaloo Coll, Jackson, MS USA; [Sivapalaratnam, Suthesh] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Drenos, Fotios] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London, England; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Cushman, Mary] Univ Vermont, Dept Med, Thrombosis & Hemostasis Program, Burlington, VT USA; [Fernandes, Jyotika K.] Med Univ S Carolina, Coll Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29425 USA; [Garvey, W. Timothy] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Howard, Virginia J.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Zonderland, Alan B.] NIA, Lab Personal & Cognit, NIH, Bethesda, MD 20892 USA; [Evans, Michele K.] NIA, Hlth Dispar Unit, NIH, Baltimore, MD 21224 USA; [Halder, Indrani] Univ Pittsburgh, Inst Heart & Vasc, Sch Med, Pittsburgh, PA USA; [Buxbaum, Sarah G.] Jackson State Univ, Sch Hlth Sci, Dept Epidemiol & Biostat, Jackson, MS USA	University of Pennsylvania; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Beijing Genomics Institute (BGI); Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Virginia; Johns Hopkins University; Johns Hopkins Medicine; University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine; Jackson State University; Cedars Sinai Medical Center; University of Virginia; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Washington University (WUSTL); Washington University (WUSTL); Translational Genomics Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fred Hutchinson Cancer Center; University of Tennessee System; University of Tennessee Health Science Center; Wake Forest University; Northwestern University; Feinberg School of Medicine; Wake Forest University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tufts University; United States Department of Agriculture (USDA); Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; McMaster University; Population Health Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Pennsylvania; Pennsylvania Medicine; University of Virginia; University of Virginia; University of Minnesota System; University of Minnesota Twin Cities; Western University (University of Western Ontario); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Mississippi; University of Mississippi Medical Center; Jackson State University; Tougaloo College; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; University of Mississippi; University of Mississippi Medical Center; University of Vermont; Medical University of South Carolina; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jackson State University	Elbers, CC (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	bkeating@mail.med.upenn.edu	Onland-Moret, N. Charlotte/G-9185-2011; Lanktree, Matthew Bruce/I-9790-2019; Newman, Anne B./C-6408-2013; Rotter, Jerome/AAY-6598-2021; Hegele, Robert/AAF-6482-2020; Stumvoll, Michael/ABE-1121-2021; Reis, Steven E/J-3957-2014; Ballantyne, Christie/A-6599-2008; Hegele, Robert/G-3301-2011; Zonderman, Alan B/A-5807-2013; Buxbaum, Sarah G./E-1970-2013; Evans, Michele Kim/AAE-4776-2019; Saxena, Richa/AAG-7279-2020; Asselbergs, Folkert W./ABD-6752-2021; Guo, Yiran/H-4120-2011; Ordovas, Jose/B-8727-2013	Onland-Moret, N. Charlotte/0000-0002-2360-913X; Lanktree, Matthew Bruce/0000-0002-5750-6286; Newman, Anne B./0000-0002-0106-1150; Hegele, Robert/0000-0003-2861-5325; Stumvoll, Michael/0000-0001-6225-8240; Zonderman, Alan B/0000-0003-3530-2319; Buxbaum, Sarah G./0000-0002-4886-3564; Asselbergs, Folkert W./0000-0002-1692-8669; Ballantyne, Christie/0000-0002-6432-1730; Tsai, Michael/0000-0001-7553-3408; Li, Yun Rose/0000-0002-8077-4975; Glazer, Nicole/0000-0002-6397-609X; van Iperen, Erik/0000-0001-7107-3168; Evans, Michele/0000-0002-8546-2831; Ordovas, Jose/0000-0002-7581-5680; Rich, Stephen/0000-0003-3872-7793; Drenos, Fotios/0000-0003-2469-5516; Kritchevsky, Stephen/0000-0003-3336-6781; Cushman, Mary/0000-0002-7871-6143; Cupples, L. Adrienne/0000-0003-0273-7965; Kamboh, M. Ilyas/0000-0002-3453-1438; Saxena, Richa/0000-0003-2233-1065; Ferwerda, Bart/0000-0002-7050-5931; Reis, Steven/0000-0001-8023-0102; Schreiner, Pamela/0000-0002-9920-6257; Yusuf, Salim/0000-0003-4776-5601	National Heart, Lung, and Blood Institute; Massachusetts Institute of Technology - Broad Institute [N01-HC-65226]; Netherlands Organization for Scientific Research (NWO); Netherlands Organisation for Health Research and Development (ZonMw) [90700342]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088215] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000513] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Massachusetts Institute of Technology - Broad Institute; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The CARe Consortium wishes to acknowledge the support of the National Heart, Lung, and Blood Institute and the contributions of the research institutions, study investigators, field staff and study participants in creating this resource for biomedical research. The following nine parent studies have contributed parent study data, ancillary study data, and DNA samples through the Massachusetts Institute of Technology - Broad Institute (N01-HC-65226) to create this genotype/phenotype database for wide dissemination to the biomedical research community: the Atherosclerosis Risk in Communities (ARIC) study, the Cardiovascular Health Study (CHS), the Cleveland Family Study (CFS), the Cooperative Study of Sickle Cell Disease (CSSCD), the Coronary Artery Risk Development in Young Adults (CARDIA) study, the Framingham Heart Study (FHS), the Jackson Heart Study (JHS), the Multi-Ethnic Study of Atherosclerosis (MESA), and the Sleep Heart Health Study (SHHS). C. C. E is supported by a Rubicon grant from the Netherlands Organization for Scientific Research (NWO). F. W. A. is supported by a clinical fellowship from the Netherlands Organisation for Health Research and Development (ZonMw grant 90700342). Additional funding information can be found in the Supporting Information S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Arsenault BJ, 2011, NAT REV CARDIOL, V8, P197, DOI 10.1038/nrcardio.2010.223; Asselbergs FW, 2012, AM J HUM GENET; Asselbergs FWGY, 2012, AJHG UNPUB; Ayodo G, 2007, AM J HUM GENET, V81, P234, DOI 10.1086/519221; Bhatia G, 2011, AM J HUM GENET, V89, P368, DOI 10.1016/j.ajhg.2011.07.025; Bielinski SJ, 2011, ATHEROSCLEROSIS, V216, P390, DOI 10.1016/j.atherosclerosis.2011.02.018; Bokor S, 2010, OBESITY, V18, P1398, DOI 10.1038/oby.2009.412; Butterworth AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002260; Calvo D, 1998, J LIPID RES, V39, P777; Choquet H, 2011, OBESITY, V19, P833, DOI 10.1038/oby.2010.226; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fox ER, 2011, HUM MOL GENET, V20, P2273, DOI 10.1093/hmg/ddr092; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fry AE, 2009, HUM MOL GENET, V18, P2683, DOI 10.1093/hmg/ddp192; Gaillard D, 2008, FASEB J, V22, P1458, DOI 10.1096/fj.07-8415com; Goyenechea E, 2008, TWIN RES HUM GENET, V11, P621, DOI 10.1375/twin.11.6.621; Gross MD, 2012, CLIN CHEM, V58, P411, DOI 10.1373/clinchem.2011.168559; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Karasek D, 2011, INT ANGIOL, V30, P441; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Lanktree MB, 2009, J LIPID RES, V50, P1487, DOI 10.1194/jlr.P900008-JLR200; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024014; Morii T, 2009, BIOMARKERS, V14, P207, DOI 10.1080/13547500902811274; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; Nguyen QM, 2010, ANN EPIDEMIOL, V20, P53, DOI 10.1016/j.annepidem.2009.10.001; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; Pare G, 2008, PLOS GENET, V4; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pulit SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012600; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Saxena R, 2012, AM J HUM GENET; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Song YQ, 2007, DIABETES, V56, P1898, DOI 10.2337/db07-0250; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6	52	39	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50198	10.1371/journal.pone.0050198	http://dx.doi.org/10.1371/journal.pone.0050198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236364	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100013
J	Ndibazza, J; Mpairwe, H; Webb, EL; Mawa, PA; Nampijja, M; Muhangi, L; Kihembo, M; Lule, SA; Rutebarika, D; Apule, B; Akello, F; Akurut, H; Oduru, G; Naniima, P; Kizito, D; Kizza, M; Kizindo, R; Tweyongere, R; Alcock, KJ; Muwanga, M; Elliott, AM				Ndibazza, Juliet; Mpairwe, Harriet; Webb, Emily L.; Mawa, Patrice A.; Nampijja, Margaret; Muhangi, Lawrence; Kihembo, Macklyn; Lule, Swaib A.; Rutebarika, Diana; Apule, Barbara; Akello, Florence; Akurut, Hellen; Oduru, Gloria; Naniima, Peter; Kizito, Dennison; Kizza, Moses; Kizindo, Robert; Tweyongere, Robert; Alcock, Katherine J.; Muwanga, Moses; Elliott, Alison M.			Impact of Anthelminthic Treatment in Pregnancy and Childhood on Immunisations, Infections and Eczema in Childhood: A Randomised Controlled Trial	PLOS ONE			English	Article							TRANSMITTED HELMINTH INFECTIONS; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PRESCHOOL-CHILDREN; IMMUNE-RESPONSE; UGANDA; ALBENDAZOLE; SUSCEPTIBILITY; TUBERCULOSIS; DISEASE	Background: Helminth infections may modulate immune responses to unrelated pathogens and allergens; these effects may commence prenatally. We addressed the hypothesis that anthelminthic treatment in pregnancy and early childhood would improve responses to immunisation and modulate disease incidence in early childhood with both beneficial and detrimental effects. Methods and Findings: A randomised, double-blind, placebo-controlled trial was conducted in Entebbe, Uganda [ISRCTN32849447]. In three independent randomisations, 2507 pregnant women were allocated to receive single-dose albendazole or placebo, and praziquantel or placebo; 2016 of their offspring were randomised to receive quarterly single-dose albendazole or placebo from age 15 months to 5 years. Primary outcomes were post-immunisation recall responses to BCG and tetanus antigens, and incidence of malaria, diarrhoea, and pneumonia; incidence of eczema was an important secondary outcome. Analysis was by intention-to-treat. Of 2345 live births, 1622 (69%) children remained in follow-up at age 5 years. 68% of mothers at enrolment, and 11% of five-year-olds, had helminth infections. Maternal hookworm and Schistosoma mansoni were effectively treated by albendazole and praziquantel, respectively; and childhood hookworm and Ascaris by quarterly albendazole. Incidence rates of malaria, diarrhoea, pneumonia, and eczema were 34, 65, 10 and 5 per 100 py, respectively. Albendazole during pregnancy caused an increased rate of eczema in the children (HR 1.58 (95% CI 1.15-2.17), p = 0.005). Quarterly albendazole during childhood was associated with reduced incidence of clinical malaria (HR 0.85 (95% CI 0.73-0.98), p = 0.03). There were no consistent effects of the interventions on any other outcome. Conclusions: Routine use of albendazole in pregnancy may not always be beneficial, even in tropical developing countries. By contrast, regular albendazole treatment in preschool children may have an additional benefit for malaria control where helminths and malaria are co-endemic. Given the low helminth prevalence in our children, the effect of albendazole on malaria is likely to be direct.	[Ndibazza, Juliet; Mpairwe, Harriet; Mawa, Patrice A.; Nampijja, Margaret; Muhangi, Lawrence; Kihembo, Macklyn; Lule, Swaib A.; Rutebarika, Diana; Akurut, Hellen; Kizito, Dennison; Kizza, Moses; Kizindo, Robert; Elliott, Alison M.] Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda; [Apule, Barbara; Akello, Florence; Oduru, Gloria; Muwanga, Moses] Entebbe Hosp, Entebbe, Uganda; [Nampijja, Margaret; Alcock, Katherine J.] Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England; [Tweyongere, Robert] Makerere Univ, Sch Vet Med, Kampala, Uganda; [Webb, Emily L.; Elliott, Alison M.] London Sch Hyg & Trop Med, London WC1, England	Uganda Virus Research Institute; Lancaster University; Makerere University; University of London; London School of Hygiene & Tropical Medicine	Ndibazza, J (corresponding author), Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda.	alison.tom@infocom.co.ug	Alcock, Katie/F-8219-2011	Alcock, Katie/0000-0001-5219-5442; Elliott, Alison/0000-0003-2818-9549; Mawa, Akusa Patrice/0000-0002-4819-8904; Webb, Emily/0000-0002-4019-7456; Lule, Swaib/0000-0002-6271-2033; Mpairwe, Harriet/0000-0003-1199-4859; Nampijja, Margaret/0000-0002-1200-6042	Wellcome Trust [064693, 079110, 074791, WT084289MA]; National Institutes of Health [NOI-AI-25147]; Malaria Capacity Development Consortium; United Kingdom Medical Research Council through the Medical Research Council/Uganda Virus Research Institute Uganda Research Unit on AIDS; United Kingdom Medical Research Council; European Community under EC-GA [241642]; United Kingdom Medical Research Council (MRC UK); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025147] Funding Source: NIH RePORTER; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Malaria Capacity Development Consortium; United Kingdom Medical Research Council through the Medical Research Council/Uganda Virus Research Institute Uganda Research Unit on AIDS(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community under EC-GA; United Kingdom Medical Research Council (MRC UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by Wellcome Trust grant numbers 064693 and 079110. Albendazole and matching placebo were provided by GlaxoSmithKline; mycobacterial antigens were provided through the National Institutes of Health contract NOI-AI-25147. HM was supported by a Wellcome Trust PhD studentship, grant number 074791, JN was supported in part by a PhD fellowship from the Malaria Capacity Development Consortium which is funded by Wellcome Trust (grant number WT084289MA), and MN by PhD funding from the United Kingdom Medical Research Council through the Medical Research Council/Uganda Virus Research Institute Uganda Research Unit on AIDS. EW was supported in part by the United Kingdom Medical Research Council. Additional funding was received from the European Community's Seventh Framework Programme (FP7/2007-2013) under EC-GA number 241642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare the following: the study was supported principally by funds from the Wellcome Trust, with contributions from the European Union and United Kingdom Medical Research Council; albendazole is a GlaxoSmithKline product, and albendazole and placebo were provided free of charge by GlaxoSmithKline; EW and MN were supported in part by funds from the United Kingdom Medical Research Council (MRC UK) and MRC UK supported travel costs for KA to Uganda; no author has any financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years and no other relationships or activities that could appear to have influenced the submitted work. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Addo-Yobo EOD, 2007, PLOS MED, V4, P355, DOI 10.1371/journal.pmed.0040070; AfDB, 2011, AFR DEV BANK MIDDL P; Alderman H, 2006, BRIT MED J, V333, P122, DOI 10.1136/bmj.38877.393530.7C; [Anonymous], 2011, WORLD HLTH STAT; [Anonymous], 1998, LANCET, V351, P1225; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bentwich Z, 1999, IMMUNOL TODAY, V20, P485, DOI 10.1016/S0167-5699(99)01499-1; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brooker S, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-42; Cooper PJ, 2006, LANCET, V367, P1598, DOI 10.1016/S0140-6736(06)68697-2; Cousens S, 1988, WHOCDDEDP882; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Dow GS, 2000, EXP PARASITOL, V94, P259, DOI 10.1006/expr.2000.4491; Elliott AM, 2007, CLIN TRIALS, V4, P42, DOI 10.1177/1740774506075248; Elliott AM, 2010, VACCINE, V29, P247, DOI 10.1016/j.vaccine.2010.10.047; Elliott AM, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-115; Elliott AM, 1999, INT J TUBERC LUNG D, V3, P239; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Flohr C, 2010, CLIN EXP ALLERGY, V40, P131, DOI 10.1111/j.1365-2222.2009.03346.x; FRIEND J, 1996, PRACTICAL MED MICROB; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; KHAN EA, 1995, EMERG INFECT DIS, V1, P115, DOI 10.3201/eid0104.950402; Kirwan P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-277; Knopp S, 2009, T ROY SOC TROP MED H, V103, P347, DOI 10.1016/j.trstmh.2008.11.013; LaBeaud AD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000442; Malhotra I, 2006, J INFECT DIS, V193, P1005, DOI 10.1086/500472; Martino D, 2011, CHEST, V139, P640, DOI 10.1378/chest.10-1800; McGuinness D, 1997, J IMMUNOL METHODS, V201, P99, DOI 10.1016/S0022-1759(96)00216-5; Melrose WD, 2000, T ROY SOC TROP MED H, V94, P176, DOI 10.1016/S0035-9203(00)90266-9; Morley D, 1973, PAEDIAT PRIORITIES D, P207; Mpairwe H, 2011, PEDIAT ALLERG IMM-UK, V22, P305, DOI 10.1111/j.1399-3038.2010.01122.x; Nacher M, 2008, PARASITOLOGY, V135, P861, DOI 10.1017/S0031182008000358; Nampijja M, 2009, BR J ED PSYCHOL; Ndibazza J, 2010, CLIN INFECT DIS, V50, P531, DOI 10.1086/649924; Ndibazza J, 2011, BIRTH DEFECTS RES A, V91, P857, DOI 10.1002/bdra.20838; Rogerson SJ, 2010, LANCET INFECT DIS, V10, P51, DOI 10.1016/S1473-3099(09)70322-6; SkinnerAdams TS, 1997, T ROY SOC TROP MED H, V91, P580, DOI 10.1016/S0035-9203(97)90035-3; Utzinger J, 2001, PARASITOLOGY, V122, P537, DOI 10.1017/S0031182001007752; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; Webb EL, 2011, LANCET, V377, P52, DOI 10.1016/S0140-6736(10)61457-2; WHO, 2009, WHOHTMTB2009411; WHO, 1990, ARI905 WHO; World Health Organization, 2002, PREV CONTR SCHIST SO	43	57	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50325	10.1371/journal.pone.0050325	http://dx.doi.org/10.1371/journal.pone.0050325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236367	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000312064100014
J	No, DY; Lee, SA; Choi, YY; Park, D; Jang, JY; Kim, DS; Lee, SH				No, Da Yoon; Lee, Seung-A; Choi, Yoon Young; Park, DoYeun; Jang, Ju Yun; Kim, Dong-Sik; Lee, Sang-Hoon			Functional 3D Human Primary Hepatocyte Spheroids Made by Co-Culturing Hepatocytes from Partial Hepatectomy Specimens and Human Adipose-Derived Stem Cells	PLOS ONE			English	Article							IN-VITRO; HEPATIC LINEAGE; DIFFERENTIATION; LIVER; TISSUE; SIZE; SCAFFOLDS; VIVO	We have generated human hepatocyte spheroids with uniform size and shape by co-culturing 1:1 mixtures of primary human hepatocytes (hHeps) from partial hepatectomy specimens and human adipose-derived stem cells (hADSCs) in concave microwells. The hADSCs in spheroids could compensate for the low viability and improve the functional maintenance of hHeps. Co-cultured spheroids aggregated and formed compact spheroidal shapes more rapidly, and with a significantly higher viability than mono-cultured spheroids. The liver-specific functions of co-cultured spheroids were greater, although they contained half the number of hepatocytes as mono-cultured spheroids. Albumin secretion by co-cultured spheroids was 10% higher on day 7, whereas urea secretion was similar, compared with mono-cultured spheroids. A quantitative cytochrome P450 assay showed that the enzymatic activity of co-cultured spheroids cultured for 9 days was 28% higher than that of mono-cultured spheroids. These effects may be due to the transdifferentiation potential and paracrine healing effects of hADSCs on hHeps. These co-cultured spheroids may be useful for creating artificial three-dimensional hepatic tissue constructs and for cell therapy with limited numbers of human hepatocytes. Citation: No DY, Lee S-A, Choi YY, Park D, Jang JY, et al. (2012) Functional 3D Human Primary Hepatocyte Spheroids Made by Co-Culturing Hepatocytes from Partial Hepatectomy Specimens and Human Adipose-Derived Stem Cells. PLoS ONE 7(12): e50723. doi:10.1371/journal.pone.0050723	[Kim, Dong-Sik] Korea Univ, Dept Surg, Seoul, South Korea; [No, Da Yoon; Lee, Seung-A; Choi, Yoon Young; Park, DoYeun; Lee, Sang-Hoon] Korea Univ, Dept Biomed Engn, Seoul, South Korea; [Jang, Ju Yun] Real Aesthet Plast Surg Clin, Seoul, South Korea	Korea University; Korea University	Kim, DS (corresponding author), Korea Univ, Dept Surg, Seoul, South Korea.	kimds1@korea.ac.kr; dbiomed@korea.ac.kr		Kim, Dong-Sik/0000-0002-0608-1580	Converging Research Center Program; Ministry of Education, Science and Technology [2012K001360]; National Research Laboratory (NRL) program; Korea Science and Engineering Foundation (KOSEF), Republic of Korea [2012026340]	Converging Research Center Program; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Laboratory (NRL) program(Korea Science and Engineering Foundation); Korea Science and Engineering Foundation (KOSEF), Republic of Korea(Korea Science and Engineering Foundation)	This research was supported by the Converging Research Center Program funded by the Ministry of Education, Science and Technology (No. 2012K001360) and the National Research Laboratory (NRL) program, the Korea Science and Engineering Foundation (KOSEF), Republic of Korea (No. 2012026340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarani U, 2003, LIVER TRANSPLANT, V9, P506, DOI 10.1053/jlts.2003.50087; Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; Choi YY, 2010, BIOMATERIALS, V31, P4296, DOI 10.1016/j.biomaterials.2010.01.115; Dandri M, 2001, HEPATOLOGY, V33, P981, DOI 10.1053/jhep.2001.23314; Decaens C, 2008, BIOL CELL, V100, P387, DOI 10.1042/BC20070127; Dvir-Ginzberg M, 2004, TISSUE ENG, V10, P1806, DOI 10.1089/ten.2004.10.1806; Elkayam T, 2006, TISSUE ENG, V12, P1357, DOI 10.1089/ten.2006.12.1357; Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Hong SH, 2005, BIOCHEM BIOPH RES CO, V330, P1153, DOI 10.1016/j.bbrc.2005.03.086; Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V59, P1; Lee KH, 2011, LAB CHIP, V11, P1168, DOI [10.1039/c0lc00540a, 10.1039/c01c00540a]; LI AP, 1992, IN VITRO CELL DEV-AN, V28A, P673; Okura H, 2010, TISSUE ENG PART C-ME, V16, P761, DOI [10.1089/ten.tec.2009.0208, 10.1089/ten.TEC.2009.0208]; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x; Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158; Talens-Visconti R, 2007, TOXICOL IN VITRO, V21, P324, DOI 10.1016/j.tiv.2006.08.009; Talens-Visconti R, 2006, WORLD J GASTROENTERO, V12, P5834, DOI 10.3748/wjg.v12.i36.5834; TONG JZ, 1994, BIOL CELL, V81, P77, DOI 10.1016/0248-4900(94)90058-2; van de Kerkhove MP, 2004, ANN SURG, V240, P216, DOI 10.1097/01.sla.0000132986.75257.19; Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764; Vondran FWR, 2008, ARTIF ORGANS, V32, P205, DOI 10.1111/j.1525-1594.2007.00524.x; Wong SF, 2011, BIOMATERIALS, V32, P8087, DOI 10.1016/j.biomaterials.2011.07.028; Zhang QH, 2007, DNA CELL BIOL, V26, P497, DOI 10.1089/dna.2006.0562; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	27	50	51	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50723	10.1371/journal.pone.0050723	http://dx.doi.org/10.1371/journal.pone.0050723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236387	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100029
J	Davies, JL; Cazier, JB; Dunlop, MG; Houlston, RS; Tomlinson, IP; Holmes, CC				Davies, Joanna L.; Cazier, Jean-Baptiste; Dunlop, Malcolm G.; Houlston, Richard S.; Tomlinson, Ian P.; Holmes, Chris C.			A Novel Test for Gene-Ancestry Interactions in Genome-Wide Association Data	PLOS ONE			English	Article							CANCER SUSCEPTIBILITY LOCUS; COLORECTAL-CANCER; IRON; SCAN; RISK; METAANALYSIS; DISEASE; VARIANT	Genome-wide association study (GWAS) data on a disease are increasingly available from multiple related populations. In this scenario, meta-analyses can improve power to detect homogeneous genetic associations, but if there exist ancestry-specific effects, via interactions on genetic background or with a causal effect that co-varies with genetic background, then these will typically be obscured. To address this issue, we have developed a robust statistical method for detecting susceptibility gene-ancestry interactions in multi-cohort GWAS based on closely-related populations. We use the leading principal components of the empirical genotype matrix to cluster individuals into "ancestry groups" and then look for evidence of heterogeneous genetic associations with disease or other trait across these clusters. Robustness is improved when there are multiple cohorts, as the signal from true gene-ancestry interactions can then be distinguished from gene-collection artefacts by comparing the observed interaction effect sizes in collection groups relative to ancestry groups. When applied to colorectal cancer, we identified a missense polymorphism in iron-absorption gene CYBRD1 that associated with disease in individuals of English, but not Scottish, ancestry. The association replicated in two additional, independently-collected data sets. Our method can be used to detect associations between genetic variants and disease that have been obscured by population genetic heterogeneity. It can be readily extended to the identification of genetic interactions on other covariates such as measured environmental exposures. We envisage our methodology being of particular interest to researchers with existing GWAS data, as ancestry groups can be easily defined and thus tested for interactions. Citation: Davies JL, Cazier J-B, Dunlop MG, Houlston RS, Tomlinson IP, et al. (2012) A Novel Test for Gene-Ancestry Interactions in Genome-Wide Association Data. PLoS ONE 7(12): e48687. doi:10.1371/journal.pone.0048687	[Davies, Joanna L.; Holmes, Chris C.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Cazier, Jean-Baptiste; Tomlinson, Ian P.; Holmes, Chris C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Dunlop, Malcolm G.] Univ Edinburgh, Inst Genet & Mol Med, Colon Canc Genet Grp, Edinburgh, Midlothian, Scotland; [Dunlop, Malcolm G.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Tomlinson, Ian P.] John Radcliffe Hosp, Oxford Comprehens Biomed Res Ctr, Oxford OX3 9DU, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Edinburgh; University of Edinburgh; University of London; Institute of Cancer Research - UK; University of Oxford	Holmes, CC (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	cholmes@stats.well.ox.ac.uk	Cazier, Jean-Baptiste/F-2369-2010; Dunlop, Malcolm G/F-1973-2011; Cazier, Jean-Baptiste/GLR-2949-2022	Cazier, Jean-Baptiste/0000-0001-7581-9051; Dunlop, Malcolm G/0000-0002-3033-5851; Cazier, Jean-Baptiste/0000-0001-7581-9051; Houlston, Richard/0000-0002-5268-0242; Holmes, Christopher/0000-0002-6667-4943	Wellcome Trust; Medical Research Council UK; Cancer Research UK (Programme Grant) [C348/A12076]; Cancer Research UK (Bobby Moore Fund); Medical Research Council [G0000657-53203]; MRC [MC_U127527198, MC_PC_U127527198] Funding Source: UKRI; Cancer Research UK [12076] Funding Source: researchfish; Medical Research Council [MC_U127527198, MC_PC_U127527198] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIACP010181] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK (Programme Grant)(Cancer Research UK); Cancer Research UK (Bobby Moore Fund); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for salaries of authors include Wellcome Trust (http://www.wellcome.ac.uk/) and Medical Research Council UK (http://www.mrc.ac.uk/index.htm). This work is partly funded by Cancer Research UK (Programme Grant C348/A12076 and the Bobby Moore Fund) and Medical Research Council (G0000657-53203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Brookes MJ, 2006, GUT, V55, P1449, DOI 10.1136/gut.2006.094060; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; Chua ACG, 2010, WORLD J GASTROENTERO, V16, P663, DOI 10.3748/wjg.v16.i6.663; Constantine CC, 2009, BRIT J HAEMATOL, V147, P140, DOI 10.1111/j.1365-2141.2009.07843.x; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Jasra A, 2005, STAT SCI, V20, P50, DOI 10.1214/088342305000000016; Lee DH, 2004, JNCI-J NATL CANCER I, V96, P403, DOI 10.1093/jnci/djh047; NELSON RL, 1994, JNCI-J NATL CANCER I, V86, P455, DOI 10.1093/jnci/86.6.455; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tuupanen S, 2009, NATURE GENETICS; Vlachodimitropoulou E, 2010, FREE RADICAL BIO MED, V48, P1366, DOI 10.1016/j.freeradbiomed.2010.02.021; Wurzelmann JI, 1996, CANCER EPIDEM BIOMAR, V5, P503; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191	32	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e48687	10.1371/journal.pone.0048687	http://dx.doi.org/10.1371/journal.pone.0048687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236349	Green Published, Green Submitted, gold			2022-12-27	WOS:000312589700004
J	Grason, EW; Miner, BG				Grason, Emily W.; Miner, Benjamin G.			Preference Alters Consumptive Effects of Predators: Top-Down Effects of a Native Crab on a System of Native and Introduced Prey	PLOS ONE			English	Article							INTRAGUILD PREDATION; WASHINGTON-STATE; FOOD WEB; HABITAT; COMMUNITY; CHOICE; POPULATIONS; COMPETITION; OYSTERS; DESIGN	Top-down effects of predators in systems depend on the rate at which predators consume prey, and on predator preferences among available prey. In invaded communities, these parameters might be difficult to predict because ecological relationships are typically evolutionarily novel. We examined feeding rates and preferences of a crab native to the Pacific Northwest, Cancer productus, among four prey items: two invasive species of oyster drill (the marine whelks Urosalpinx cinerea and Ocenebra inornata) and two species of oyster (Crassostrea gigas and Ostrea lurida) that are also consumed by U. cinerea and O. inornata. This system is also characterized by intraguild predation because crabs are predators of drills and compete with them for prey (oysters). When only the oysters were offered, crabs did not express a preference and consumed approximately 9 juvenile oysters crab(-1) day(-1). We then tested whether crabs preferred adult drills of either U. cinerea or O. inornata, or juvenile oysters (C. gigas). While crabs consumed drills and oysters at approximately the same rate when only one type of prey was offered, they expressed a strong preference for juvenile oysters over drills when they were allowed to choose among the three prey items. This preference for oysters might negate the positive indirect effects that crabs have on oysters by crabs consuming drills (trophic cascade) because crabs have a large negative direct effect on oysters when crabs, oysters, and drills co-occur. Citation: Grason EW, Miner BG (2012) Preference Alters Consumptive Effects of Predators: Top-Down Effects of a Native Crab on a System of Native and Introduced Prey. PLoS ONE 7(12): e51322. doi:10.1371/journal.pone.0051322	[Grason, Emily W.; Miner, Benjamin G.] Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA; [Grason, Emily W.; Miner, Benjamin G.] Shannon Point Marine Ctr, Anacortes, WA USA	Western Washington University	Grason, EW (corresponding author), Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA.	egrason@u.washington.edu		Miner, Benjamin/0000-0002-0996-2252; Grason, Emily/0000-0002-1560-6772	NSF [OCE-0741372]; Washington Sea Grant Program, University of Washington [NA07OAR4170007]; Western Washington University Office of Sponsored Programs and Biology Departments	NSF(National Science Foundation (NSF)); Washington Sea Grant Program, University of Washington; Western Washington University Office of Sponsored Programs and Biology Departments	This work was also funded in part by NSF award OCE-0741372, and a grant from the Washington Sea Grant Program, University of Washington, pursuant to National Oceanic and Atmospheric Administration Award No. NA07OAR4170007. The views expressed in the manuscript are those of the authors and do not necessarily reflect the views of NOAA or any of its sub-agencies. Additional financial support was received from the Western Washington University Office of Sponsored Programs and Biology Departments. The funders provided financials support only, and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buhle ER, 2009, J SHELLFISH RES, V28, P87, DOI 10.2983/035.028.0115; Carlsson NOL, 2009, FRONT ECOL ENVIRON, V7, P525, DOI 10.1890/080093; Chapman WM, 1949, CONTRIBUTIONS LIFE H; Chew KK, 1960, STUDY FOOD PREFERENC; Cook AE, 2000, J SHELLFISH RES, V19, P409; Courchamp F, 1999, J ANIM ECOL, V68, P282, DOI 10.1046/j.1365-2656.1999.00285.x; FITZNER RE, 1994, NORTHWEST SCI, V68, P37; Gherardi F, 2007, FRESHWATER BIOL, V52, P1249, DOI 10.1111/j.1365-2427.2007.01760.x; Grason EW, 2012, OECOLOGIA, V169, P105, DOI 10.1007/s00442-011-2188-5; Grosholz ED, 2005, P NATL ACAD SCI USA, V102, P1088, DOI 10.1073/pnas.0308547102; Gurevitch J, 2000, AM NAT, V155, P435, DOI 10.1086/303337; Hall RJ, 2011, BIOL LETTERS, V7, P307, DOI 10.1098/rsbl.2010.0766; HANKS JE, 1957, BIOL BULL, V112, P330, DOI 10.2307/1539125; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Holsman KK, 2006, MAR ECOL PROG SER, V308, P183, DOI 10.3354/meps308183; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; Holt RD, 2007, ECOLOGY, V88, P2706, DOI 10.1890/06-1525.1; Jackson AC, 2007, J EXP MAR BIOL ECOL, V341, P1, DOI 10.1016/j.jembe.2006.11.002; KAVANAGH RP, 1988, AUST J ECOL, V13, P445, DOI 10.1111/j.1442-9993.1988.tb00992.x; Kimbro DL, 2009, OECOLOGIA, V160, P563, DOI 10.1007/s00442-009-1322-0; Korpimaki E, 1996, BIOSCIENCE, V46, P754, DOI 10.2307/1312851; MANLY BFJ, 1993, OECOLOGIA, V93, P149, DOI 10.1007/BF00321205; MENGE BA, 1986, OECOLOGIA, V71, P75, DOI 10.1007/BF00377324; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; Navarrete SA, 2000, ECOLOGY, V81, P2264, DOI 10.1890/0012-9658(2000)081[2264:SIIIFW]2.0.CO;2; PAINE R T, 1974, Oecologia (Berlin), V15, P93, DOI 10.1007/BF00345739; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; R Core Team, 2020, R LANG ENV STAT COMP; Ruesink JL, 2005, ANNU REV ECOL EVOL S, V36, P643, DOI 10.1146/annurev.ecolsys.36.102003.152638; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Singer MC, 2000, ECOL LETT, V3, P159; Taplin RH, 2007, J EXP MAR BIOL ECOL, V344, P116, DOI 10.1016/j.jembe.2006.12.028; Underwood AJ, 2007, J EXP MAR BIOL ECOL, V344, P113, DOI 10.1016/j.jembe.2006.12.029; Underwood AJ, 2004, J EXP MAR BIOL ECOL, V300, P161, DOI 10.1016/j.jembe.2003.12.006; Underwood AJ, 2005, J EXP MAR BIOL ECOL, V318, P227, DOI [10.1016/j.jembe.2004.12.014, 10.1016/j.jembre.2004.12.014]; White J, 2009, J SHELLFISH RES, V28, P43, DOI 10.2983/035.028.0109; WOOTTON JT, 1994, ANNU REV ECOL SYST, V25, P443, DOI 10.1146/annurev.es.25.110194.002303; Yamada SB, 1996, J EXP MAR BIOL ECOL, V204, P59, DOI 10.1016/0022-0981(96)02579-8	39	13	13	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51322	10.1371/journal.pone.0051322	http://dx.doi.org/10.1371/journal.pone.0051322			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236472	Green Published, gold			2022-12-27	WOS:000312589700035
J	Hui, DS; Chow, BK; Chu, L; Ng, SS; Lee, N; Gin, T; Chan, MTV				Hui, David S.; Chow, Benny K.; Chu, Leo; Ng, Susanna S.; Lee, Nelson; Gin, Tony; Chan, Matthew T. V.			Exhaled Air Dispersion during Coughing with and without Wearing a Surgical or N95 Mask	PLOS ONE			English	Article							HEALTH-CARE PERSONNEL; H1N1 2009 INFLUENZA; AEROSOL TRANSMISSION; OXYGEN DELIVERY; VIRUS; VENTILATION; INFECTION; OUTBREAK; HEMATOLOGY; MANAGEMENT	Objectives: We compared the expelled air dispersion distances during coughing from a human patient simulator (HPS) lying at 45 degrees with and without wearing a surgical mask or N95 mask in a negative pressure isolation room. Methods: Airflow was marked with intrapulmonary smoke. Coughing bouts were generated by short bursts of oxygen flow at 650, 320, and 220L/min to simulate normal, mild and poor coughing efforts, respectively. The coughing jet was revealed by laser light-sheet and images were captured by high definition video. Smoke concentration in the plume was estimated from the light scattered by smoke particles. Significant exposure was arbitrarily defined where there was >= 20% of normalized smoke concentration. Results: During normal cough, expelled air dispersion distances were 68, 30 and 15 cm along the median sagittal plane when the HPS wore no mask, a surgical mask and a N95 mask, respectively. In moderate lung injury, the corresponding air dispersion distances for mild coughing efforts were reduced to 55, 27 and 14 cm, respectively, p < 0.001. The distances were reduced to 30, 24 and 12 cm, respectively during poor coughing effort as in severe lung injury. Lateral dispersion distances during normal cough were 0, 28 and 15 cm when the HPS wore no mask, a surgical mask and a N95 mask, respectively. Conclusions: Normal cough produced a turbulent jet about 0.7 m towards the end of the bed from the recumbent subject. N95 mask was more effective than surgical mask in preventing expelled air leakage during coughing but there was still significant sideway leakage. Citation: Hui DS, Chow BK, Chu L, Ng SS, Lee N, et al. (2012) Exhaled Air Dispersion during Coughing with and without Wearing a Surgical or N95 Mask. PLoS ONE 7(12): e50845. doi:10.1371/journal.pone.0050845	[Hui, David S.; Ng, Susanna S.; Lee, Nelson] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Hui, David S.; Chow, Benny K.; Lee, Nelson] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Chow, Benny K.] Chinese Univ Hong Kong, Ctr Housing Innovat, Hong Kong, Hong Kong, Peoples R China; [Chu, Leo; Gin, Tony; Chan, Matthew T. V.] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Hui, DS (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	dschui@cuhk.edu.hk	Chan, Matthew/J-2884-2013; Ng, Susanna SS/G-7431-2017; Lee, Nelson/B-6418-2008; Ng, Susanna/ABI-4965-2020; GIN, Tony/J-2521-2013; Hui, David Shu-Cheong/O-2754-2015	Chan, Matthew/0000-0002-3574-7855; Ng, Susanna SS/0000-0002-4554-7312; Lee, Nelson/0000-0002-0783-6607; GIN, Tony/0000-0001-7283-6761; Hui, David Shu-Cheong/0000-0003-4382-2445; CHOW, Benny/0000-0002-7391-233X	Research Fund for the Control of Infectious Diseases, Food and Health Bureau, Government of the Hong Kong Special Administrative Region [CU-09-01-05, PHE18]	Research Fund for the Control of Infectious Diseases, Food and Health Bureau, Government of the Hong Kong Special Administrative Region	This work was supported by the Research Fund for the Control of Infectious Diseases (# CU-09-01-05, PHE18), Food and Health Bureau, Government of the Hong Kong Special Administrative Region. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchbinder N, 2011, J HOSP INFECT, V79, P155, DOI 10.1016/j.jhin.2011.04.019; Chan MTV, 2012, AM J RESP C IN PRESS; Chan YJ, 2010, J CHIN MED ASSOC, V73, P62, DOI 10.1016/S1726-4901(10)70003-4; Chen LF, 2011, J INFECT DIS, V203, P838, DOI 10.1093/infdis/jiq124; Enstone JE, 2011, EMERG INFECT DIS, V17, P592, DOI 10.3201/eid1704.101679; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Godwin JA, 2004, ANESTH ANALG, V99, P1655, DOI 10.1213/01.ANE.0000134797.52793.AF; Gupta JK, 2009, INDOOR AIR, V19, P517, DOI 10.1111/j.1600-0668.2009.00619.x; Hui DS, 2007, CHEST, V132, P540, DOI 10.1378/chest.07-0636; Hui DS, 2006, CHEST, V130, P822, DOI 10.1378/chest.130.3.822; Hui DS, 2006, CHEST, V130, P730, DOI 10.1378/chest.130.3.730; Hui DS, 2011, RESPIROLOGY, V16, P1005, DOI 10.1111/j.1440-1843.2011.01995.x; Hui DS, 2010, CHEST, V137, P916, DOI 10.1378/chest.09-2344; Hui DS, 2009, CHEST, V136, P998, DOI 10.1378/chest.09-0434; Hui DS, 2009, CHEST, V135, P648, DOI 10.1378/chest.08-1998; Hui DS, 2008, RESPIROLOGY S, pS10; Jefferson T, 2011, COCHRANE DB SYST REV, V7; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3675; Johnson DF, 2009, CLIN INFECT DIS, V49, P275, DOI 10.1086/600041; Kwon SB, 2012, CHEMOSPHERE, V87, P1260, DOI 10.1016/j.chemosphere.2012.01.032; Lampotang S, 2006, ANESTH ANALG, V102, P168, DOI 10.1213/01.ANE.0000181833.23904.4E; Lavietes MH, 1998, EUR RESPIR J, V11, P156, DOI 10.1183/09031936.98.11010156; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466; MathSoft Inc, 2000, MATHC 8 0 WIND US GU; Moore C, 2011, J INFECT DIS, V203, P18, DOI 10.1093/infdis/jiq007; Musher DM, 2003, NEW ENGL J MED, V348, P1256, DOI 10.1056/NEJMra021771; Noti JD, 2012, CLIN INFECT DIS, V54, P1569, DOI 10.1093/cid/cis237; Pantelic J, 2009, J R SOC INTERFACE, V6, pS715, DOI 10.1098/rsif.2009.0311.focus; Soo S.L., 1967, FLUID DYNAMICS MULTI; Suarez AA, 2002, AM J PHYS MED REHAB, V81, P506, DOI 10.1097/00002060-200207000-00007; Tang JW, 2008, NEW ENGL J MED, V359, pE19, DOI 10.1056/NEJMicm072576; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tang JW, 2007, LANCET INFECT DIS, V7, P758, DOI 10.1016/S1473-3099(07)70268-2; Tang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034818; Tang JW, 2009, J R SOC INTERFACE, V6, pS727, DOI 10.1098/rsif.2009.0295.focus; Tang JWT, 2009, NEW ENGL J MED, V361, pE62, DOI 10.1056/NEJMicm0904279; WHO, 2009, INF PREV CONTR HEALT; Wise ME, 2011, CLIN INFECT DIS, V52, pS198, DOI 10.1093/cid/ciq038; Wong BCK, 2010, CLIN INFECT DIS, V51, P1176, DOI 10.1086/656743; Yang W, 2011, J R SOC INTERFACE, V8, P1176, DOI 10.1098/rsif.2010.0686; Zhu SW, 2006, BUILD ENVIRON, V41, P1691, DOI 10.1016/j.buildenv.2005.06.024	44	90	93	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50845	10.1371/journal.pone.0050845	http://dx.doi.org/10.1371/journal.pone.0050845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23239991	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200074
J	Westphal, C; Schubert, C; Prelle, K; Penkalla, A; Fliegner, D; Petrov, G; Regitz-Zagrosek, V				Westphal, Christina; Schubert, Carola; Prelle, Katja; Penkalla, Adam; Fliegner, Daniela; Petrov, George; Regitz-Zagrosek, Vera			Effects of Estrogen, an ER alpha Agonist and Raloxifene on Pressure Overload Induced Cardiac Hypertrophy	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; RECEPTOR-BETA; MYOCARDIAL-INFARCTION; POSTMENOPAUSAL WOMEN; HEART-FAILURE; MATRIX METALLOPROTEINASE-2; CARDIOMYOCYTE HYPERTROPHY; CARDIOVASCULAR EVENTS; RANDOMIZED-TRIAL; AORTIC-STENOSIS	The aim of this study was to investigate the effects of 17 beta-estradiol (E2), the selective ER alpha agonist 16 alpha-LE2, and the selective estrogen receptor modulator (SERM) raloxifene on remodeling processes during the development of myocardial hypertrophy (MH) in a mouse model of pressure overload. Myocardial hypertrophy in ovariectomized female C57BI/6J mice was induced by transverse aortic constriction (TAC). Two weeks after TAC, placebo treated mice developed left ventricular hypertrophy and mild systolic dysfunction. Estrogen treatment, but not 16 alpha-LE2 or raloxifene reduced TAC induced MH compared to placebo. E2, 16 alpha-LE2 and raloxifene supported maintenance of cardiac function in comparison with placebo. Nine weeks after induction of pressure overload, MH was present in all TAC groups, most pronounced in the raloxifene treated group. Ejection fraction (EF) was decreased in all animals. However, 16 alpha-LE2 treated animals showed a smaller reduction of EF than animals treated with placebo. E2 and 16 alpha-LE2, but not raloxifene diminished the development of fibrosis and reduced the TGF beta and CTGF gene expression. Treatment with E2 or 16 alpha-LE2 but not with raloxifene reduced survival rate after TAC significantly in comparison with placebo treatment. In conclusion, E2 and 16 alpha-LE2 slowed down the progression of MH and reduced systolic dysfunction after nine weeks of pressure overload. Raloxifene did not reduce MH but improved cardiac function two weeks after TAC. However, raloxifene was not able to maintain EF in the long term period.	[Westphal, Christina; Schubert, Carola; Fliegner, Daniela; Regitz-Zagrosek, Vera] Charite, Inst Gender Med, D-13353 Berlin, Germany; [Westphal, Christina; Schubert, Carola; Fliegner, Daniela; Regitz-Zagrosek, Vera] Ctr Cardiovasc Res, Berlin, Germany; [Prelle, Katja] Bayer Pharma, Wuppertal, Germany; [Penkalla, Adam; Petrov, George] German Heart Inst, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Bayer AG; Bayer Healthcare Pharmaceuticals; German Heart Center Berlin	Westphal, C (corresponding author), Charite, Inst Gender Med, D-13353 Berlin, Germany.	christina.westphal@mdc-berlin.de	Petrov, George/H-4033-2013	Petrov, George/0000-0002-1045-6592; Regitz-Zagrosek, Vera/0000-0002-3566-3467; Schubert, Carola/0000-0002-9116-9105	Deutsche Forschungsgemeinschaft [DFG-GK-754II-III, FOR1054]; Commission of the European Community [EUGeneHeart-LSHM-CT-2005-018833]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Commission of the European Community(European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft Grants DFG-GK-754II-III, FOR1054, and a grant from the Commission of the European Community (EUGeneHeart-LSHM-CT-2005-018833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Loza PA, 2007, HYPERTENSION, V50, P432, DOI 10.1161/HYPERTENSIONAHA.106.084798; Babiker FA, 2007, ACTA PHYSIOL, V189, P23, DOI 10.1111/j.1748-1716.2006.01633.x; Babiker FA, 2006, ARTERIOSCL THROM VAS, V26, P1524, DOI 10.1161/01.ATV.0000223344.11128.23; Backhaus K, 2008, MULTIVARIATE ANALYSE, V12, P323; Barrett-Connor E, 2002, JAMA-J AM MED ASSOC, V287, P847, DOI 10.1001/jama.287.7.847; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Bender R, 2007, Dtsch Med Wochenschr, V132 Suppl 1, pe24, DOI 10.1055/s-2007-959034; CARROLL JD, 1992, CIRCULATION, V86, P1099, DOI 10.1161/01.CIR.86.4.1099; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Donaldson C, 2009, CIRC RES, V104, P265, DOI 10.1161/CIRCRESAHA.108.190397; Fliegner D, 2010, AM J PHYSIOL-REG I, V298, pR1597, DOI 10.1152/ajpregu.00825.2009; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Gardner JD, 2008, AM J PHYSIOL-HEART C, V294, pH198, DOI 10.1152/ajpheart.00281.2007; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Mahmoodzadeh S, 2010, CARDIOVASC RES, V85, P719, DOI 10.1093/cvr/cvp350; MENDELSON ME, 1994, CURR OPIN CARDIOL, V9, P619, DOI 10.1097/00001573-199409000-00018; Ogita H, 2004, HYPERTENSION, V43, P237, DOI 10.1161/01.HYP.0000109320.25921.b1; Patten RD, 2008, J CARD FAIL, V14, P245, DOI 10.1016/j.cardfail.2007.10.024; Pedram A, 2008, ENDOCRINOLOGY, V149, P3361, DOI 10.1210/en.2008-0133; Pelzer T, 2005, CARDIOVASC RES, V67, P604, DOI 10.1016/j.cardiores.2005.04.035; Petrov G, 2010, CIRCULATION, V122, pS23, DOI 10.1161/CIRCULATIONAHA.109.927764; Regitz-Zagrosek V, 2006, NAT REV DRUG DISCOV, V5, P425, DOI 10.1038/nrd2032; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Skavdahl M, 2005, AM J PHYSIOL-HEART C, V288, pH469, DOI 10.1152/ajpheart.00723.2004; Tamura T, 1999, HYPERTENSION, V33, P676, DOI 10.1161/01.HYP.33.2.676; van Eickels M, 2001, CIRCULATION, V104, P1419, DOI 10.1161/hc3601.095577; van Eickels M, 2003, J AM COLL CARDIOL, V41, P2084, DOI 10.1016/S0735-1097(03)00423-6; Villar AV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008476; WEBER KT, 1994, J MOL CELL CARDIOL, V26, P279, DOI 10.1006/jmcc.1994.1036; Wingrove CS, 1998, BBA-MOL BASIS DIS, V1406, P169, DOI 10.1016/S0925-4439(97)00097-5; Xu Y, 2003, CARDIOVASC RES, V57, P388, DOI 10.1016/S0008-6363(02)00705-8	38	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50802	10.1371/journal.pone.0050802	http://dx.doi.org/10.1371/journal.pone.0050802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227210	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200070
J	Zhang, C; Lu, XM; Tan, Y; Li, B; Miao, X; Jin, LT; Shi, X; Zhang, X; Miao, LN; Li, XK; Cai, L				Zhang, Chi; Lu, Xuemian; Tan, Yi; Li, Bing; Miao, Xiao; Jin, Litai; Shi, Xue; Zhang, Xiang; Miao, Lining; Li, Xiaokun; Cai, Lu			Diabetes-Induced Hepatic Pathogenic Damage, Inflammation, Oxidative Stress, and Insulin Resistance Was Exacerbated in Zinc Deficient Mouse Model	PLOS ONE			English	Article							FATTY LIVER-DISEASE; APOPTOSIS; ACTIVATION; PATHWAY; TPEN; DEGRADATION; MORTALITY; CHELATOR; DEFENSE; TYPE-2	Objectives: Zinc (Zn) deficiency often occurs in the patients with diabetes. Effects of Zn deficiency on diabetes-induced hepatic injury were investigated. Methods: Type 1 diabetes was induced in FVB mice with multiple low-dose streptozotocin. Hyperglycemic and age-matched control mice were treated with and without Zn chelator, N,N,N',N'-tetrakis (2-pyridylemethyl) ethylenediamine (TPEN), at 5 mg/kg body-weight daily for 4 months. Hepatic injury was examined by serum alanine aminotransferase (ALT) level and liver histopathological and biochemical changes. Results: Hepatic Zn deficiency (lower than control level, p<0.05) was seen in the mice with either diabetes or TPEN treatment and more evident in the mice with both diabetes and TPEN. Zn deficiency exacerbated hepatic injuries, shown by further increased serum ALT, hepatic lipid accumulation, inflammation, oxidative damage, and endoplasmic reticulum stress-related cell death in Diabetes/TPEN group compared to Diabetes alone. Diabetes/TPEN group also showed a significant decrease in nuclear factor-erythroid 2-related factor 2 (Nrf2) expression and transcription action along with significant increases in Akt negative regulators, decrease in Akt and GSK-3 beta phosphorylation, and increase in nuclear accumulation of Fyn (a Nrf2 negative regulator). In vitro study with HepG2 cells showed that apoptotic effect of TPEN at 0.5-1.0 mu M could be completely prevented by simultaneous Zn supplementation at the dose range of 30-50 mu M. Conclusions: Zn is required for maintaining Akt activation by inhibiting the expression of Akt negative regulators; Akt activation can inhibit Fyn nuclear translocation to export nuclear Nrf2 to cytoplasm for degradation. Zn deficiency significantly enhanced diabetes-induced hepatic injury likely through down-regulation of Nrf2 function.	[Zhang, Chi; Lu, Xuemian; Li, Xiaokun; Cai, Lu] Wenzhou Med Coll, Affiliated Hosp 3, Chinese Amer Res Inst Diabet Complicat, Ruian Ctr, Wenzhou, Zhejiang, Peoples R China; [Zhang, Chi; Tan, Yi; Li, Bing; Miao, Xiao; Cai, Lu] Univ Louisville, Sch Med, Dept Pediat, Kosair Children Hosp Res Inst, Louisville, KY 40292 USA; [Li, Bing; Miao, Xiao; Miao, Lining] Jilin Univ, Hosp 2, Changchun 130023, Peoples R China; [Shi, Xue; Zhang, Xiang] Univ Louisville, Dept Chem, Louisville, KY 40292 USA; [Cai, Lu] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Cai, Lu] Univ Louisville, Dept Radiat Oncol, Louisville, KY 40292 USA	Wenzhou Medical University; University of Louisville; Jilin University; University of Louisville; University of Louisville; University of Louisville	Li, XK (corresponding author), Wenzhou Med Coll, Affiliated Hosp 3, Chinese Amer Res Inst Diabet Complicat, Ruian Ctr, Wenzhou, Zhejiang, Peoples R China.	xiaokunli@163.net; l0cai001@louisville.edu	Shi, Xue/N-6907-2015; Cai, Lu/AAG-9920-2019	Shi, Xue/0000-0003-2040-7425; 	American Diabetes Association [1-11-BA-17]; Zhejiang Province Extremely Key Subject Building Project; Wenzhou Medical College; National Science Foundation of China [81000294]	American Diabetes Association(American Diabetes Association); Zhejiang Province Extremely Key Subject Building Project; Wenzhou Medical College; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by a Basic Research Award from American Diabetes Association (1-11-BA-17, to LC), Zhejiang Province Extremely Key Subject Building Project (Pharmacology and Biochemical Pharmaceutics 2009) and a Starting-Up Fund for Chinese-American Research Institute for Diabetic Complications from Wenzhou Medical College (to LC, XL & YT), and Young Scientist Award from National Science Foundation of China (81000294, to CZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2008, CURR DIABETES REP, V8, P60, DOI 10.1007/s11892-008-0011-4; Adler M, 1997, TOXICON, V35, P1089, DOI 10.1016/S0041-0101(96)00215-2; Alexandraki KI, 2008, J CLIN IMMUNOL, V28, P314, DOI 10.1007/s10875-007-9164-1; Baig NA, 2001, CLIN LAB MED, V21, P193; BODE JC, 1988, HEPATOLOGY, V8, P1605, DOI 10.1002/hep.1840080622; Brandao-Neto J, 2000, BIOMETALS, V13, P141, DOI 10.1023/A:1009223105246; Bulum T, 2011, DIGEST DIS SCI, V56, P3655, DOI 10.1007/s10620-011-1807-7; Cai Lu, 2002, Int J Exp Diabetes Res, V3, P193, DOI 10.1080/15604280214281; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Chai FG, 1999, IMMUNOL CELL BIOL, V77, P272, DOI 10.1046/j.1440-1711.1999.00825.x; de Marco R, 1999, DIABETES CARE, V22, P756, DOI 10.2337/diacare.22.5.756; DEFRONZO RA, 1982, DIABETES, V31, P795, DOI 10.2337/diab.31.9.795; DISILVESTRO RA, 1994, FREE RADICAL BIO MED, V16, P57, DOI 10.1016/0891-5849(94)90243-7; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; EXTREMERA BG, 1990, ACTA GASTRO-ENT BELG, V53, P292; GOODE HF, 1990, GUT, V31, P694, DOI 10.1136/gut.31.6.694; Haase H, 2005, J TRACE ELEM MED BIO, V19, P37, DOI 10.1016/j.jtemb.2005.02.004; Haase H, 2005, BIOMETALS, V18, P333, DOI 10.1007/s10534-005-3707-9; Hambidge KM, 2007, J NUTR, V137, P1101, DOI 10.1093/jn/137.4.1101; Harrison SA, 2006, J CLIN GASTROENTEROL, V40, P68, DOI 10.1097/01.mcg.0000190774.91875.d2; He XQ, 2009, J MOL CELL CARDIOL, V46, P47, DOI 10.1016/j.yjmcc.2008.10.007; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jansen J, 2009, J NUTR BIOCHEM, V20, P399, DOI 10.1016/j.jnutbio.2009.01.009; Ji C, 2006, J HEPATOL, V45, P321, DOI 10.1016/j.jhep.2006.06.004; KINLAW WB, 1983, AM J MED, V75, P273, DOI 10.1016/0002-9343(83)91205-6; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lopez JJ, 2009, J THROMB HAEMOST, V7, P992, DOI 10.1111/j.1538-7836.2009.03431.x; Manna P, 2010, FREE RADICAL BIO MED, V48, P1465, DOI 10.1016/j.freeradbiomed.2010.02.025; Mocanu MM, 2009, AM J PHYSIOL-HEART C, V296, pH233, DOI 10.1152/ajpheart.00985.2008; Mohommad MK, 2012, NUTR CLIN PRACT, V27, P8, DOI 10.1177/0884533611433534; Nakatani T, 2000, CHEM-BIOL INTERACT, V125, P151, DOI 10.1016/S0009-2797(99)00166-0; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Prasad AS, 2004, FREE RADICAL BIO MED, V37, P1182, DOI 10.1016/j.freeradbiomed.2004.07.007; Ra H, 2009, FEBS LETT, V583, P1516, DOI 10.1016/j.febslet.2009.04.008; Shen HY, 2008, J AM COLL NUTR, V27, P577, DOI 10.1080/07315724.2008.10719741; Shumaker DK, 1998, CELL CALCIUM, V23, P151, DOI 10.1016/S0143-4160(98)90114-2; Smith BW, 2011, NAT REV ENDOCRINOL, V7, P456, DOI 10.1038/nrendo.2011.72; Szuster-Ciesielska A, 2005, TOXICOLOGY, V212, P124, DOI 10.1016/j.tox.2005.04.009; Takamatsu S, 2008, HEPATO-GASTROENTEROL, V55, P609; Vignolini F, 1997, LIFE SCI, V62, P131, DOI 10.1016/S0024-3205(97)01059-X; Walker CLF, 2009, EUR J CLIN NUTR, V63, P591, DOI 10.1038/ejcn.2008.9; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200; Xu JC, 2009, J CELL MOL MED, V13, P1499, DOI 10.1111/j.1582-4934.2009.00833.x; Yamaguchi S, 2009, P NATL ACAD SCI USA, V106, P10859, DOI 10.1073/pnas.0900602106; YIP J, 1993, LANCET, V342, P883, DOI 10.1016/0140-6736(93)91943-G; Zhao YG, 2011, TOXICOL LETT, V200, P100, DOI 10.1016/j.toxlet.2010.11.001; Zhou ZX, 2005, AM J PATHOL, V166, P1681, DOI 10.1016/S0002-9440(10)62478-9	47	74	79	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49257	10.1371/journal.pone.0049257	http://dx.doi.org/10.1371/journal.pone.0049257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251339	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200012
J	Guo, W; Wong, S; Li, M; Liang, WT; Liesa, M; Serra, C; Jasuja, R; Bartke, A; Kirkland, JL; Shirihai, O; Bhasin, S				Guo, Wen; Wong, Siu; Li, Michelle; Liang, Wentao; Liesa, Marc; Serra, Carlo; Jasuja, Ravi; Bartke, Andrzej; Kirkland, James L.; Shirihai, Orian; Bhasin, Shalender			Testosterone Plus Low-Intensity Physical Training in Late Life Improves Functional Performance, Skeletal Muscle Mitochondrial Biogenesis, and Mitochondrial Quality Control in Male Mice	PLOS ONE			English	Article							OXIDATIVE STRESS; OLDER MEN; SIGNAL-TRANSDUCTION; BODY-COMPOSITION; EXPRESSION; AUTOPHAGY; EXERCISE; PATHWAYS; MOBILITY; SENSITIVITY	Testosterone supplementation increases muscle mass in older men but has not been shown to consistently improve physical function and activity. It has been hypothesized that physical exercise is required to induce the adaptations necessary for translation of testosterone-induced muscle mass gain into functional improvements. However, the effects of testosterone plus low intensity physical exercise training (T/PT) on functional performance and bioenergetics are unknown. In this pilot study, we tested the hypothesis that combined administration of T/PT would improve functional performance and bioenergetics in male mice late in life more than low-intensity physical training alone. 28-month old male mice were randomized to receive T/PT or vehicle plus physical training (V/PT) for 2 months. Compare to V/PT control, administration of T/PT was associated with improvements in muscle mass, grip strength, spontaneous physical movements, and respiratory activity. These changes were correlated with increased mitochondrial DNA copy number and expression of markers for mitochondrial biogenesis. Mice receiving T/PT also displayed increased expression of key elements for mitochondrial quality control, including markers for mitochondrial fission-and-fusion and mitophagy. Concurrently, mice receiving T/PT also displayed increased expression of markers for reduced tissue oxidative damage and improved muscle quality. Conclusion: Testosterone administered with low-intensity physical training improves grip strength, spontaneous movements, and respiratory activity. These functional improvements were associated with increased muscle mitochondrial biogenesis and improved mitochondrial quality control. Citation: Guo W, Wong S, Li M, Liang W, Liesa M, et al. (2012) Testosterone Plus Low-Intensity Physical Training in Late Life Improves Functional Performance, Skeletal Muscle Mitochondrial Biogenesis, and Mitochondrial Quality Control in Male Mice. PLoS ONE 7(12): e51180. doi:10.1371/journal.pone.0051180	[Guo, Wen; Wong, Siu; Li, Michelle; Liang, Wentao; Liesa, Marc; Jasuja, Ravi; Shirihai, Orian; Bhasin, Shalender] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Bartke, Andrzej] So Illinois Sch Med, Dept Internal Med, Springfield, IL USA; [Kirkland, James L.] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN USA	Boston University; Southern Illinois University System; Southern Illinois University; Mayo Clinic	Guo, W (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	wguo@bu.edu	Kirkland, James/F-9159-2016; Bartke, Andzej/D-6640-2017; Liesa, Marc/K-8590-2019	Bartke, Andzej/0000-0002-2569-557X; Liesa, Marc/0000-0002-5909-8570; Liang, Wentao/0000-0002-0609-6280; Shirihai, Orian/0000-0002-9502-2661; Guo, Wen/0000-0002-4474-2837	National Institutes of Health (NIH) [1R21AG037859, RO1AG037193, AG13925, DK074778, PO1AG031736]; Boston Claude D. Pepper Older Americans Independence Center [5P30AG031679]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031736, R01AG037193, P30AG031679, R01AG013925, R21AG037859] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Claude D. Pepper Older Americans Independence Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants 1R21AG037859 (WG), RO1AG037193 (SB), AG13925 (JLK), DK074778 (OS) and PO1AG031736 (AB) and by the Boston Claude D. Pepper Older Americans Independence Center (5P30AG031679). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Apostolova N, 2011, CURR PHARM DESIGN, V17, P4047, DOI 10.2174/138161211798764924; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Bori Z, 2012, EXP GERONTOL, V47, P417, DOI 10.1016/j.exger.2012.03.004; Caminiti G, 2009, J AM COLL CARDIOL, V54, P919, DOI 10.1016/j.jacc.2009.04.078; Carter CS, 2012, J GERONTOL A-BIOL, V67, P17, DOI 10.1093/gerona/glr042; Carter CS, 2002, J GERONTOL A-BIOL, V57, pB193, DOI 10.1093/gerona/57.5.B193; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; Cuevas-Ramos D, 2012, CURR OPIN PEDIATR, V24, P523, DOI 10.1097/MOP.0b013e3283557d22; Dhatariya KK, 2008, MAYO CLIN PROC, V83, P1218, DOI 10.4065/83.11.1218; Egan B, 2011, PROTEOMICS, V11, P1413, DOI 10.1002/pmic.201000597; Fernando SM, 2010, ENDOCRINOLOGY, V151, P3125, DOI 10.1210/en.2010-0018; Ferrando AA, 2002, AM J PHYSIOL-ENDOC M, V282, pE601, DOI 10.1152/ajpendo.00362.2001; Gorar S, 2010, GYNECOL ENDOCRINOL, V26, P819, DOI 10.3109/09513590.2010.487587; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Hirota Y., 2012, INT J CELL BIOL, V2012; Hofer T, 2008, EXP GERONTOL, V43, P563, DOI 10.1016/j.exger.2008.02.007; Ibebunjo C, 2011, AM J PHYSIOL-ENDOC M, V300, pE327, DOI 10.1152/ajpendo.00402.2010; Ichimura Y, 2010, SEMIN IMMUNOPATHOL, V32, P431, DOI 10.1007/s00281-010-0220-1; Ikeda Y, 2010, MOL ENDOCRINOL, V24, P1338, DOI 10.1210/me.2009-0402; Jamart C, 2012, J APPL PHYSIOL, V112, P1529, DOI 10.1152/japplphysiol.00952.2011; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Koltai E, 2012, AM J PHYSIOL-REG I, V303, pR127, DOI 10.1152/ajpregu.00337.2011; Komatsu M, 2012, PHARM RES; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; Krasnoff JB, 2010, J CLIN ENDOCR METAB, V95, P2790, DOI 10.1210/jc.2009-2680; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; Lanza IR, 2010, ACTA PHYSIOL, V199, P529, DOI 10.1111/j.1748-1716.2010.02124.x; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Liu Y, 2012, AGE DORDR; Liu YL, 2012, TOXICOL APPL PHARM, V264, P212, DOI 10.1016/j.taap.2012.08.003; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; MCNABNEY LA, 1992, AM J PHYSIOL, V263, pC429, DOI 10.1152/ajpcell.1992.263.2.C429; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Musa M, 2011, J ENDOCRINOL, V210, P93, DOI 10.1530/JOE-11-0071; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Pansarasa O, 2002, EUR J APPL PHYSIOL, V87, P550, DOI 10.1007/s00421-002-0668-3; Parise G, 2010, INTERD T GERONT GERI, V37, P142, DOI 10.1159/000319999; Perrini S, 2010, J ENDOCRINOL, V205, P201, DOI 10.1677/JOE-09-0431; Pitteloud N, 2005, DIABETES CARE, V28, P1636, DOI 10.2337/diacare.28.7.1636; Rodriguez-Cuenca S, 2007, AM J PHYSIOL-ENDOC M, V292, pE340, DOI 10.1152/ajpendo.00175.2006; Rosser EM, 2004, ORG BIOMOL CHEM, V2, P142, DOI 10.1039/b311242j; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Salehzadeh F, 2011, J ENDOCRINOL, V210, P219, DOI 10.1530/JOE-10-0497; Schaap LA, 2005, CLIN ENDOCRINOL, V63, P152, DOI 10.1111/j.1365-2265.2005.02315.x; Schafer A, 2009, BIOL CHEM, V390, P707, DOI 10.1515/BC.2009.086; Seidman SN, 2007, PSYCHOPHARMACOL BULL, V40, P205; Sestili P, 2009, MOL NUTR FOOD RES, V53, P1187, DOI 10.1002/mnfr.200800504; Shaid S, 2012, CELL DEATH DIFFER; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Travison TG, 2011, J GERONTOL A-BIOL, V66, P1090, DOI 10.1093/gerona/glr100; Tu P, 2009, DIABETES, V58, P1739, DOI 10.2337/db09-0349; Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Widegren U, 2001, ACTA PHYSIOL SCAND, V172, P227, DOI 10.1046/j.1365-201x.2001.00855.x; Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002; Wong YT, 2009, FREE RADICAL BIO MED, V46, P799, DOI 10.1016/j.freeradbiomed.2008.12.016; Wu JX, 2006, BIOCHEM BIOPH RES CO, V339, P437, DOI 10.1016/j.bbrc.2005.10.211; Xu JZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010572; Zahavi A, 2011, J THEOR BIOL, V280, P146, DOI 10.1016/j.jtbi.2011.04.013	67	37	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51180	10.1371/journal.pone.0051180	http://dx.doi.org/10.1371/journal.pone.0051180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240002	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800038
J	Kaufmann, KW; Meiler, J				Kaufmann, Kristian W.; Meiler, Jens			Using ROSETTALIGAND for Small Molecule Docking into Comparative Models	PLOS ONE			English	Article							PROTEIN-LIGAND DOCKING; ALL-ATOM REFINEMENT; STRUCTURE PREDICTION; HOMOLOGY MODELS; DATA-BANK; CASP8; ACCURACY; DESIGN; FLEXIBILITY; SEQUENCE	Computational small molecule docking into comparative models of proteins is widely used to query protein function and in the development of small molecule therapeutics. We benchmark ROSETTALIGAND docking into comparative models for nine proteins built during CASP8 that contain ligands. We supplement the study with 21 additional protein/ligand complexes to cover a wider space of chemotypes. During a full docking run in 21 of the 30 cases, ROSETTALIGAND successfully found a native-like binding mode among the top ten scoring binding modes. From the benchmark cases we find that careful template selection based on ligand occupancy provides the best chance of success while overall sequence identity between template and target do not appear to improve results. We also find that binding energy normalized by atom number is often less than -0.4 in native-like binding modes. Citation: Kaufmann KW, Meiler J (2012) Using ROSETTALIGAND for Small Molecule Docking into Comparative Models. PLoS ONE 7(12): e50769. doi:10.1371/journal.pone.0050769	[Kaufmann, Kristian W.; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Kaufmann, Kristian W.; Meiler, Jens] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN USA; [Meiler, Jens] Vanderbilt Univ, Inst Biol Chem, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Meiler, J (corresponding author), Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA.	jens.meiler@vanderbilt.edu		Meiler, Jens/0000-0001-8945-193X	National Institutes of Health (NIH), National Institute on Drug Abuse, National Research Service Awards [5F31DA024528-02]; National Institutes of Health [1R01MH090192, 1R01GM080403]; NIH [R01 GM080403, R01 MH090192, R01 GM099842]; NSF [0742762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080403, R01GM099842, T32GM008320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA024528] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute on Drug Abuse, National Research Service Awards; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	KK was supported by National Institutes of Health (NIH), National Institute on Drug Abuse, National Research Service Awards 5F31DA024528-02. JM was supported by National Institutes of Health grants 1R01MH090192 and 1R01GM080403. Work in the Meiler laboratory is supported through NIH (R01 GM080403, R01 MH090192, R01 GM099842) and NSF (Career 0742762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester PJ, 2010, BIOINFORMATICS, V26, P1169, DOI 10.1093/bioinformatics/btq112; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Brylinski M, 2009, J COMPUT CHEM; Brylinski M, 2008, J COMPUT CHEM, V29, P1574, DOI 10.1002/jcc.20917; Brylinski M, 2010, J COMPUT CHEM, V31, P1093, DOI 10.1002/jcc.21395; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; Davis IW, 2009, PROTEIN SCI, V18, P1998, DOI 10.1002/pro.192; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Durrant JD, 2011, J CHEM INF MODEL, V51, P2897, DOI 10.1021/ci2003889; Fan H, 2009, J CHEM INF MODEL, V49, P2512, DOI 10.1021/ci9003706; Ferrara P, 2007, J MOL MODEL, V13, P897, DOI 10.1007/s00894-007-0207-6; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Guvench O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000435; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hernandez M, 2009, NUCLEIC ACIDS RES, V37, pW413, DOI 10.1093/nar/gkp281; Jain AN, 2009, J COMPUT AID MOL DES, V23, P355, DOI 10.1007/s10822-009-9266-3; Kairys V, 2006, J CHEM INF MODEL, V46, P365, DOI 10.1021/ci050238c; Kaufmann K, 2008, LECT NOTES INFORM, V136, P148; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin JH, 2002, J AM CHEM SOC, V124, P5632, DOI 10.1021/ja0260162; London N, 2007, PROTEINS, V69, P809, DOI 10.1002/prot.21736; MacCallum JL, 2009, PROTEINS, V77, P66, DOI 10.1002/prot.22538; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; McGovern SL, 2003, J MED CHEM, V46, P2895, DOI 10.1021/jm0300330; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Misura KMS, 2006, P NATL ACAD SCI USA, V103, P5361, DOI 10.1073/pnas.0509355103; Nannemann DP, 2010, PROTEIN ENG DES SEL, V23, P607, DOI 10.1093/protein/gzq033; Nayeem A, 2006, PROTEIN SCI, V15, P808, DOI 10.1110/ps.051892906; R Development Core Team, 2005, R LANG ENV STAT COMP; Raman S, 2009, PROTEINS; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Rester U, 2006, QSAR COMB SCI, V25, P605, DOI 10.1002/qsar.200510183; Saxena A, 2009, METHOD ENZYMOL, V467, P307, DOI 10.1016/S0076-6879(09)67012-9; Sousa SF, 2006, PROTEINS, V65, P15, DOI 10.1002/prot.21082; Taylor RD, 2002, J COMPUT AID MOL DES, V16, P151, DOI 10.1023/A:1020155510718; Tress ML, 2009, PROTEINS, V77, P10, DOI 10.1002/prot.22497; Verdonk ML, 2008, J CHEM INF MODEL, V48, P2214, DOI 10.1021/ci8002254; Warren GL, 2006, J MED CHEM, V49, P5912, DOI 10.1021/jm050362n; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	47	32	33	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50769	10.1371/journal.pone.0050769	http://dx.doi.org/10.1371/journal.pone.0050769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239984	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800022
J	Sa-Pinto, A; Branco, MS; Alexandrino, PB; Fontaine, MC; Baird, SJE				Sa-Pinto, Alexandra; Branco, Madalena S.; Alexandrino, Paulo B.; Fontaine, Michael C.; Baird, Stuart J. E.			Barriers to Gene Flow in the Marine Environment: Insights from Two Common Intertidal Limpet Species of the Atlantic and Mediterranean	PLOS ONE			English	Article							CERASTODERMA-GLAUCUM BIVALVIA; POPULATION-STRUCTURE; ALLOZYME VARIATION; PATELLA-RUSTICA; SEA; PATTERNS; PHYLOGEOGRAPHY; EASTERN; DIFFERENTIATION; CONNECTIVITY	Knowledge of the scale of dispersal and the mechanisms governing gene flow in marine environments remains fragmentary despite being essential for understanding evolution of marine biota and to design management plans. We use the limpets Patella ulyssiponensis and Patella rustica as models for identifying factors affecting gene flow in marine organisms across the North-East Atlantic and the Mediterranean Sea. A set of allozyme loci and a fragment of the mitochondrial gene cytochrome C oxidase subunit I were screened for genetic variation through starch gel electrophoresis and DNA sequencing, respectively. An approach combining clustering algorithms with clinal analyses was used to test for the existence of barriers to gene flow and estimate their geographic location and abruptness. Sharp breaks in the genetic composition of individuals were observed in the transitions between the Atlantic and the Mediterranean and across southern Italian shores. An additional break within the Atlantic cluster separates samples from the Alboran Sea and Atlantic African shores from those of the Iberian Atlantic shores. The geographic congruence of the genetic breaks detected in these two limpet species strongly supports the existence of transpecific barriers to gene flow in the Mediterranean Sea and Northeastern Atlantic. This leads to testable hypotheses regarding factors restricting gene flow across the study area. Citation: Sa-Pinto A, Branco MS, Alexandrino PB, Fontaine MC, Baird SJE (2012) Barriers to Gene Flow in the Marine Environment: Insights from Two Common Intertidal Limpet Species of the Atlantic and Mediterranean. PLoS ONE 7(12): e50330. doi:10.1371/journal.pone.0050330	[Sa-Pinto, Alexandra; Branco, Madalena S.; Alexandrino, Paulo B.; Baird, Stuart J. E.] Ctr Invest Biodiversidade & Recursos Genet CIBIO, Vairao, Portugal; [Alexandrino, Paulo B.] Univ Porto, Fac Ciencias, Dept Zool Antropol, P-4100 Oporto, Portugal; [Fontaine, Michael C.] Univ Paris 11, Orsay, France; [Fontaine, Michael C.] CNRS, F-91405 Orsay, France; [Fontaine, Michael C.] Univ Paris 07, Ecoanthropol & Ethnobiol UMR 5145, CNRS, MNHN,Musee Homme, Paris, France; [Baird, Stuart J. E.] CBGP, Montpelier Lez, France	Universidade do Porto; Universidade do Porto; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD)	Sa-Pinto, A (corresponding author), Ctr Invest Biodiversidade & Recursos Genet CIBIO, Campus Agrario Vairao, Vairao, Portugal.	xanasapinto@gmail.com; palexan@mail.icav.up.pt	Alexandrino, Paulo/A-3582-2010; Baird, Stuart J. E./B-3872-2011; Sa-Pinto, Alexandra Isabel/L-7809-2013; Branco, Madalena/L-8304-2013; Fontaine, Michael/G-5350-2011	Alexandrino, Paulo/0000-0002-8968-2452; Sa-Pinto, Alexandra Isabel/0000-0002-6049-110X; Branco, Madalena/0000-0003-4439-1923; Fontaine, Michael/0000-0003-1156-4154	FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE; national funds through FCT Fundacao para a Ciencia e a Tecnologia [POCTI/BSE/42300/2001, FCOMP-01-0124-FEDER-PTDC/MAR/118205/2010]; FCT [SFRH/BPD/48750/2008, SFRH/BPD/40073/2007]; FRS-FNRS ("mandat Aspirant''); ANR 'NUTGENEVOL' [07-BLAN-0064]; FCT's Ciencia programme	FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE; national funds through FCT Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FRS-FNRS ("mandat Aspirant'')(Fonds de la Recherche Scientifique - FNRS); ANR 'NUTGENEVOL'(French National Research Agency (ANR)); FCT's Ciencia programme	This work was financed by FEDER funds through the Programa Operacional Factores de Competitividade - COMPETE and national funds through FCT Fundacao para a Ciencia e a Tecnologia - within the scope of the projects POCTI/BSE/42300/2001 and FCOMP-01-0124-FEDER-PTDC/MAR/118205/2010. A. Sa-Pinto and M. Branco are supported by FCT grants SFRH/BPD/48750/2008 and SFRH/BPD/40073/2007, respectively. M.C. Fontaine was supported by a Belgian research fellowship from the FRS-FNRS ("mandat Aspirant'') and now by an ANR 'NUTGENEVOL' (07-BLAN-0064) Post-doctoral fellowship. S.J.E. Baird is financed by the FCT's Ciencia 2007 programme. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams DC, 2004, ECOLOGY, V85, P2664, DOI 10.1890/04-0648; Arnaud-Haond S, 2007, J BIOGEOGR, V34, P963, DOI 10.1111/j.1365-2699.2006.01671.x; Bahri-Sfar L, 2000, P ROY SOC B-BIOL SCI, V267, P929, DOI 10.1098/rspb.2000.1092; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Bargelloni L, 2005, MOL PHYLOGENET EVOL, V36, P523, DOI 10.1016/j.ympev.2005.04.017; Bargelloni L, 2003, J EVOLUTION BIOL, V16, P1149, DOI 10.1046/j.1420-9101.2003.00620.x; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P13; Barton NH, 1995, ANAL APPL ANAL HYBRI; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Borsa P, 1997, MAR BIOL, V129, P233, DOI 10.1007/s002270050164; Calderon I, 2008, MAR BIOL, V154, P137, DOI 10.1007/s00227-008-0908-0; Christiaens J, 1973, B MUSEUM NATL HIST N, V3, P1305; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corander J, 2003, GENETICS, V163, P367; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2006, FISH B-NOAA, V104, P550; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; DODD J. M., 1957, PUBBL STAZ ZOOL NAPOLI, V29, P172; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Fischer-Piette E., 1959, Journal de Conchyliologie, V99, P135; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Gaines Steven D., 2009, P227; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Goldson AJ, 2001, MAR BIOL, V138, P1037, DOI 10.1007/s002270000511; Guedj B, 2011, MOL ECOL RESOUR, V11, P1119, DOI 10.1111/j.1755-0998.2011.03045.x; Guerra-Garcia JM, 2004, BIOL CONSERV, V116, P319, DOI 10.1016/S0006-3207(03)00201-5; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KNOWLTON N, 1986, B MAR SCI, V39, P213; Koufopanou V, 1999, MOL PHYLOGENET EVOL, V11, P138, DOI 10.1006/mpev.1998.0557; Kruuk LEB, 1999, GENETICS, V153, P1959; Lemaire C, 2005, J EVOLUTION BIOL, V18, P70, DOI 10.1111/j.1420-9101.2004.00828.x; Longhurst AR, 1998, ECOLOGICAL GEOGRAPHY; Macholan M, 2007, EVOLUTION, V61, P746, DOI 10.1111/j.1558-5646.2007.00065.x; Manel S, 2007, MOL ECOL, V16, P2031, DOI 10.1111/j.1365-294X.2007.03293.x; MANTEL N, 1967, CANCER RES, V27, P209; Mariani S, 2002, MAR BIOL, V140, P687, DOI 10.1007/s00227-001-0753-x; Mattiangeli V, 2003, MAR ECOL-P S Z N I, V24, P247, DOI 10.1046/j.0173-9565.2003.00795.x; Nikula R, 2003, MAR BIOL, V143, P339, DOI 10.1007/s00227-003-1088-6; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Peijnenburg KTCA, 2006, MOL ECOL, V15, P3319, DOI 10.1111/j.1365-294X.2006.03002.x; Perez-Losada M, 2002, HEREDITY, V89, P417, DOI 10.1038/sj.hdy.6800160; Perez-Losada M, 2007, MOL ECOL, V16, P2667, DOI 10.1111/j.1365-294X.2007.03333.x; Pritchard JK, 2000, GENETICS, V155, P945; Ramon MM, 1997, HEREDITY, V78, P520, DOI 10.1038/hdy.1997.81; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ribeiro PA, 2010, J BIOGEOGR, V37, P1782, DOI 10.1111/j.1365-2699.2010.02330.x; Ribeiro PMA., 2008, THESIS U SOUTHAMPTON; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riginos C, 2001, MOL ECOL, V10, P1439, DOI 10.1046/j.1365-294X.2001.01294.x; Rios C, 2002, J EXP MAR BIOL ECOL, V267, P223, DOI 10.1016/S0022-0981(01)00371-9; Rohling EJ, 2009, PHYS GEOGRAPHY MEDIT; Rolland JL, 2007, MAR BIOL, V151, P327, DOI 10.1007/s00227-006-0484-0; Sa-Pinto A, 2005, J EXP MAR BIOL ECOL, V325, P95, DOI 10.1016/j.jembe.2005.04.025; Sa-Pinto A, 2008, MOL ECOL, V17, P519, DOI 10.1111/j.1365-294X.2007.03563.x; Sa-Pinto A, 2007, SCI MAR, V71, P801, DOI 10.3989/scimar.2007.71n4801; Sa-Pinto A, 2010, BIOL J LINN SOC, V100, P154, DOI 10.1111/j.1095-8312.2010.01405.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmidt PS, 2001, EVOLUTION, V55, P1336; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Smith FGW, 1935, PHILOS T ROY SOC B, V225, P95, DOI 10.1098/rstb.1935.0008; Sotka EE, 2004, MOL ECOL, V13, P2143, DOI 10.1111/j.1365-294X.2004.02225.x; Stefanni S, 2003, MOL PHYLOGENET EVOL, V28, P601, DOI 10.1016/S1055-7903(03)00054-X; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; SZYMURA JM, 1986, EVOLUTION, V40, P1141, DOI 10.1111/j.1558-5646.1986.tb05740.x; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Veliz D, 2004, J EVOLUTION BIOL, V17, P953, DOI 10.1111/j.1420-9101.2004.00753.x; Weber LI, 2005, MAR BIOL, V147, P153, DOI 10.1007/s00227-004-1540-2; Wolfram Research Inc., 2008, MATH VERS 7 0; WOMBLE WH, 1951, SCIENCE, V114, P315, DOI 10.1126/science.114.2961.315; Wright S, 1943, GENETICS, V28, P114; Xavier R, 2009, MOL ECOL, V18, P3283, DOI 10.1111/j.1365-294X.2009.04260.x; Zhan AB, 2009, MAR BIOTECHNOL, V11, P223, DOI 10.1007/s10126-008-9138-1	89	39	40	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50330	10.1371/journal.pone.0050330	http://dx.doi.org/10.1371/journal.pone.0050330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239977	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800015
J	Sebina, I; Cliff, JM; Smith, SG; Nogaro, S; Webb, EL; Riley, EM; Dockrell, HM; Elliott, AM; Hafalla, JCR; Cose, S				Sebina, Ismail; Cliff, Jacqueline M.; Smith, Steven G.; Nogaro, Sarah; Webb, Emily L.; Riley, Eleanor M.; Dockrell, Hazel M.; Elliott, Alison M.; Hafalla, Julius C. R.; Cose, Stephen			Long-Lived Memory B-Cell Responses following BCG Vaccination	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; INFECTION; LYMPHOCYTES; ASSAY; PERSISTENCE; BIOMARKERS; PROTECTION; PROFILES; ANTIGENS	The role of T-cells in immunity against Mycobacterium tuberculosis (M. tuberculosis) infection has been extensively studied, however, that of B-cells still remains comparatively unexplored. In this study, we determined the presence and frequencies of mycobacteria-specific memory B-cells (MBCs) in peripheral blood from clinically healthy, Bacillus Calmette Guerin (BCG) vaccinated (n = 79) and unvaccinated (n = 14) donors. Purified protein derivative (PPD)-specific MBCs were present in most donors (both vaccinated and unvaccinated) but their frequencies were significantly higher in vaccinated than in unvaccinated donors. MBCs specific for other mycobacterial antigens [antigen-85A (Ag85A), antigen-85B (Ag85B), 6 kDalton early secretory antigenic target (ESAT-6) and the 10 kDalton-culture filtrate protein (CFP-10)] were less prevalent than those recognising PPD. Furthermore, PPD-specific MBCs were detected in BCG vaccinated donors without ESAT-6 and CFP-10 specific responses. Together, these results indicate that BCG vaccination induces long-lived MBC responses. Similar patterns of response were seen when we examined mycobacteria-specific antibody and T-cell responses in these donors. Our data show for the first time that BCG vaccination elicits long-lived mycobacteria-specific MBC responses in healthy individuals, suggesting a more substantial role of B-cells in the response to BCG and other mycobacterial infections than previously thought.	[Sebina, Ismail; Cliff, Jacqueline M.; Smith, Steven G.; Nogaro, Sarah; Riley, Eleanor M.; Dockrell, Hazel M.; Hafalla, Julius C. R.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Webb, Emily L.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Elliott, Alison M.; Cose, Stephen] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Sebina, Ismail; Elliott, Alison M.; Cose, Stephen] MRC, Coinfect Studies Programme, Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Uganda Virus Research Institute	Sebina, I (corresponding author), London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England.	ismail.sebina@mrcuganda.org; Stephen.Cose@mrcuganda.org	Cose, Stephen/H-4851-2019; Riley, Eleanor M/C-8960-2013; Riley, Eleanor/AAL-1382-2020	Cose, Stephen/0000-0002-5156-037X; Riley, Eleanor M/0000-0003-3447-3570; Riley, Eleanor/0000-0003-3447-3570; Webb, Emily/0000-0002-4019-7456; Elliott, Alison/0000-0003-2818-9549; Sebina, Ismail/0000-0003-3232-3472; Dockrell, Hazel/0000-0003-1869-9107; Smith, Steven/0000-0001-5623-7806; Cliff, Jackie/0000-0002-5653-1818	Wellcome Trust [092779]; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (grant number: 092779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2009, CLIN EXP IMMUNOL, V157, P235, DOI 10.1111/j.1365-2249.2009.03967.x; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Ashenafi S, 2013, THORAX, V68, P269, DOI 10.1136/thoraxjnl-2012-201817; Balu S, 2011, J IMMUNOL, V186, P3113, DOI 10.4049/jimmunol.1003189; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Blanchard-Rohner G, 2009, BLOOD, V114, P4998, DOI 10.1182/blood-2009-03-211052; Bosio CM, 2000, J IMMUNOL, V164, P6417, DOI 10.4049/jimmunol.164.12.6417; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cooper AM, 2009, EUR J IMMUNOL, V39, P649, DOI 10.1002/eji.200839090; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Elliott AM, 1999, INT J TUBERC LUNG D, V3, P239; Feng L, 2011, EUR J IMMUNOL, V41, P3261, DOI 10.1002/eji.201141625; Gonzalez-Juarrero M, 2001, INFECT IMMUN, V69, P1722, DOI 10.1128/IAI.69.3.1722-1728.2001; Hernandez J, 2010, IMMUNOL INVEST, V39, P197, DOI 10.3109/08820130903586346; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Kelly DF, 2005, JAMA-J AM MED ASSOC, V294, P3019, DOI 10.1001/jama.294.23.3019; Lalor MK, 2010, VACCINE, V28, P1635, DOI 10.1016/j.vaccine.2009.11.004; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Maglione PJ, 2009, EUR J IMMUNOL, V39, P676, DOI 10.1002/eji.200839148; Nogaro SI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025582; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Rohner GB, 2008, J IMMUNOL, V180, P2165, DOI 10.4049/jimmunol.180.4.2165; Sutherland JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025230; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; Tjanlund A, 2006, INT IMMUNOL, V18, P807, DOI 10.1093/intimm/dxl017; Wallis RS, 2010, LANCET INFECT DIS, V10, P68, DOI 10.1016/S1473-3099(10)70003-7; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; WEIR RE, 1994, J IMMUNOL METHODS, V176, P93, DOI 10.1016/0022-1759(94)90353-0; Weir RE, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-9; Weiss GE, 2012, J IMMUNOL METHODS, V375, P68, DOI 10.1016/j.jim.2011.09.006; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Yoon SO, 2009, J LEUKOCYTE BIOL, V86, P1311, DOI 10.1189/jlb.0409268	36	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51381	10.1371/journal.pone.0051381	http://dx.doi.org/10.1371/journal.pone.0051381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240017	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000312290800053
J	Wappenschmidt, B; Becker, AA; Hauke, J; Weber, U; Engert, S; Kohler, J; Kast, K; Arnold, N; Rhiem, K; Hahnen, E; Meindl, A; Schmutzler, RK				Wappenschmidt, Barbara; Becker, Alexandra A.; Hauke, Jan; Weber, Ute; Engert, Stefanie; Koehler, Juliane; Kast, Karin; Arnold, Norbert; Rhiem, Kerstin; Hahnen, Eric; Meindl, Alfons; Schmutzler, Rita K.			Analysis of 30 Putative BRCA1 Splicing Mutations in Hereditary Breast and Ovarian Cancer Families Identifies Exonic Splice Site Mutations That Escape In Silico Prediction	PLOS ONE			English	Article							SEQUENCE VARIANTS; UNCLASSIFIED VARIANTS; SUSCEPTIBILITY GENE; MISSENSE MUTATIONS; GERMLINE MUTATIONS; HIGH PROPORTION; RNA; RISK; WOMEN; SUBSTITUTIONS	Screening for pathogenic mutations in breast and ovarian cancer genes such as BRCA1/2, CHEK2 and RAD51C is common practice for individuals from high-risk families. However, test results may be ambiguous due to the presence of unclassified variants (UCV) in the concurrent absence of clearly cancer-predisposing mutations. Especially the presence of intronic or exonic variants within these genes that possibly affect proper pre-mRNA processing poses a challenge as their functional implications are not immediately apparent. Therefore, it appears necessary to characterize potential splicing UCV and to develop appropriate classification tools. We investigated 30 distinct BRCA1 variants, both intronic and exonic, regarding their spliceogenic potential by commonly used in silico prediction algorithms (HSF, MaxEntScan) along with in vitro transcript analyses. A total of 25 variants were identified spliceogenic, either causing/enhancing exon skipping or activation of cryptic splice sites, or both. Except from a single intronic variant causing minor effects on BRCA1 pre-mRNA processing in our analyses, 23 out of 24 intronic variants were correctly predicted by MaxEntScan, while HSF was less accurate in this cohort. Among the 6 exonic variants analyzed, 4 severely impair correct pre-mRNA processing, while the remaining two have partial effects. In contrast to the intronic alterations investigated, only half of the spliceogenic exonic variants were correctly predicted by HSF and/or MaxEntScan. These data support the idea that exonic splicing mutations are commonly disease-causing and concurrently prone to escape in silico prediction, hence necessitating experimental in vitro splicing analysis. Citation: Wappenschmidt B, Becker AA, Hauke J, Weber U, Engert S, et al. (2012) Analysis of 30 Putative BRCA1 Splicing Mutations in Hereditary Breast and Ovarian Cancer Families Identifies Exonic Splice Site Mutations That Escape In Silico Prediction. PLoS ONE 7(12): e50800. doi: 10.1371/journal.pone.0050800	[Wappenschmidt, Barbara; Becker, Alexandra A.; Hauke, Jan; Weber, Ute; Koehler, Juliane; Rhiem, Kerstin; Hahnen, Eric; Schmutzler, Rita K.] Univ Hosp Cologne, Dept Obstet & Gynaecol, Div Mol Gynaecooncol, Cologne, Germany; [Wappenschmidt, Barbara; Becker, Alexandra A.; Hauke, Jan; Weber, Ute; Koehler, Juliane; Rhiem, Kerstin; Hahnen, Eric; Schmutzler, Rita K.] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Hauke, Jan] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Engert, Stefanie; Meindl, Alfons] Tech Univ Munich, Klinikum Rechts Isar, Dept Obstet & Gynaecol, D-8000 Munich, Germany; [Kast, Karin] Tech Univ Dresden, Dept Gynecol & Obstet, D-01062 Dresden, Germany; [Arnold, Norbert] Univ Kiel, Univ Hosp Schleswig Holstein, Dept Obstet & Gynaecol, Div Oncol, Kiel, Germany	University of Cologne; University of Cologne; University of Cologne; Technical University of Munich; Technische Universitat Dresden; University of Kiel; Schleswig Holstein University Hospital	Schmutzler, RK (corresponding author), Univ Hosp Cologne, Dept Obstet & Gynaecol, Div Mol Gynaecooncol, Cologne, Germany.	Rita.Schmutzler@uk-koeln.de	Arnold, Norbert/E-3012-2010	Arnold, Norbert/0000-0003-4523-8808; Hauke, Jan/0000-0001-8236-4075	Deutsche Krebshilfe [107364]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This study was kindly supported by the Deutsche Krebshilfe to R.S. and B.W. (grant no 107364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adem C, 2003, CANCER, V97, P1, DOI 10.1002/cncr.11048; Anczukow O, 2008, GENE CHROMOSOME CANC, V47, P418, DOI 10.1002/gcc.20546; Bergthorsson JT, 2001, J MED GENET, V38, P361, DOI 10.1136/jmg.38.6.361; Bonnet C, 2008, J MED GENET, V45, P438, DOI 10.1136/jmg.2007.056895; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Claes K, 2002, ONCOGENE, V21, P4171, DOI 10.1038/sj.onc.1205520; Coupier I, 2004, ONCOGENE, V23, P914, DOI 10.1038/sj.onc.1207191; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Diez O, 2003, HUM MUTAT, V22, P301, DOI 10.1002/humu.10260; Dong J, 1998, HUM GENET, V103, P154; Dosil V, 2010, CLIN CHEM, V56, P53, DOI 10.1373/clinchem.2009.132274; Evans DGR, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.9.e107; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; Gaildrat P, 2010, J MED GENET, V47, P398, DOI 10.1136/jmg.2009.074047; Gross E, 2000, HUM MUTAT, V16, P345, DOI 10.1002/1098-1004(200010)16:4<345::AID-HUMU7>3.0.CO;2-#; Hofmann W, 2002, INT J CANCER, V97, P472, DOI 10.1002/ijc.1626; Houdayer C, 2008, HUM MUTAT, V29, P975, DOI 10.1002/humu.20765; Kiechle M, 2000, Hum Mutat, V16, P529, DOI 10.1002/1098-1004(200012)16:6<529::AID-HUMU14>3.0.CO;2-K; KRAWCZAK M, 1992, HUM GENET, V90, P41; Kroiss R, 2005, HUM MUTAT, V26, P583, DOI 10.1002/humu.20261; Lastella P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-243; Lu ML, 1996, CANCER RES, V56, P4578; McKean-Cowdin R, 2005, HUM GENET, V116, P497, DOI 10.1007/s00439-004-1240-5; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mirkovic N, 2004, CANCER RES, V64, P3790, DOI 10.1158/0008-5472.CAN-03-3009; Pettigrew CA, 2008, BREAST CANCER RES TR, V110, P227, DOI 10.1007/s10549-007-9714-5; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Raponi M, 2011, HUM MUTAT, V32, P436, DOI 10.1002/humu.21458; Scholl T, 1999, AM J MED GENET, V85, P113, DOI 10.1002/(SICI)1096-8628(19990716)85:2<113::AID-AJMG3>3.3.CO;2-M; Schwartz GF, 2008, CANCER, V113, P2627, DOI 10.1002/cncr.23903; Scott CL, 2003, HUM GENET, V112, P542, DOI 10.1007/s00439-003-0908-6; ShattuckEidens D, 1997, JAMA-J AM MED ASSOC, V278, P1242, DOI 10.1001/jama.278.15.1242; Spearman AD, 2008, J CLIN ONCOL, V26, P5393, DOI 10.1200/JCO.2008.17.8228; Spurdle AB, 2008, HUM MUTAT, V29, P1304, DOI 10.1002/humu.20901; TAKAHASHI H, 1995, CANCER RES, V55, P2998; Tesoriero A A, 2005, Hum Mutat, V26, P495, DOI 10.1002/humu.9379; Thery JC, 2011, EUR J HUM GENET, V19, P1052, DOI 10.1038/ejhg.2011.100; Thomassen M, 2012, BREAST CANCER RES TR, V132, P1009, DOI 10.1007/s10549-011-1674-0; Vreeswijk MPG, 2009, HUM MUTAT, V30, P107, DOI 10.1002/humu.20811; Walker LC, 2010, HUM MUTAT, V31, pE1484, DOI 10.1002/humu.21267; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Whiley PJ, 2011, HUM MUTAT, V32, P678, DOI 10.1002/humu.21495; Whiley PJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-80; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zatkova A, 2004, HUM MUTAT, V24, P491, DOI 10.1002/humu.20103	49	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50800	10.1371/journal.pone.0050800	http://dx.doi.org/10.1371/journal.pone.0050800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239986	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800023
J	Campi-Azevedo, AC; de Araujo-Porto, LP; Luiza-Silva, M; Batista, MA; Martins, MA; Sathler-Avelar, R; da Silveira-Lemos, D; Camacho, LAB; Martins, RD; Maia, MDD; Farias, RHG; Freire, MD; Galler, R; Homma, A; Ribeiro, JGL; Lemos, JAC; Auxiliadora-Martins, M; Caldas, IR; Eloi-Santos, SM; Teixeira-Carvalho, A; Martins, OA				Campi-Azevedo, Ana Carolina; de Araujo-Porto, Luiza Pacheco; Luiza-Silva, Maria; Batista, Mauricio Azevedo; Martins, Marina Angela; Sathler-Avelar, Renato; da Silveira-Lemos, Denise; Bastos Camacho, Luiz Antonio; Martins, Reinaldo de Menezes; de Sousa Maia, Maria de Lourdes; Guedes Farias, Roberto Henrique; Freire, Marcos da Silva; Galler, Ricardo; Homma, Akira; Leite Ribeiro, Jose Geraldo; Campos Lemos, Jandira Aparecida; Auxiliadora-Martins, Maria; Caldas, Iramaya Rodrigues; Eloi-Santos, Silvana Maria; Teixeira-Carvalho, Andrea; Martins-Filho, Olindo Assis			17DD and 17D-213/77 Yellow Fever Substrains Trigger a Balanced Cytokine Profile in Primary Vaccinated Children	PLOS ONE			English	Article							DOUBLE-BLIND; NEUTRALIZING ANTIBODY; PHASE-III; IMMUNOGENICITY; IMMUNITY; TRIAL; IMMUNIZATION; INFANTS; MEASLES; INNATE	Background: This study aimed to compare the cytokine-mediated immune response in children submitted to primary vaccination with the YF-17D-213/77 or YF-17DD yellow fever (YF) substrains. Methods: A non-probabilistic sample of eighty healthy primary vaccinated (PV) children was selected on the basis of their previously known humoral immune response to the YF vaccines. The selected children were categorized according to their YF-neutralizing antibody titers (PRNT) and referred to as seroconverters (PV-PRNT+) or nonseroconverters (PV-PRNT-). Following revaccination with the YF-17DD, the PV-PRNT- children (YF-17D-213/77 and YF-17DD groups) seroconverted and were referred as RV-PRNT+. The cytokine-mediated immune response was investigated after short-term in vitro cultures of whole blood samples. The results are expressed as frequency of high cytokine producers, taking the global median of the cytokine index (YF-Ag/control) as the cut-off. Results: The YF-17D-213/77 and the YF-17DD substrains triggered a balanced overall inflammatory/regulatory cytokine pattern in PV-PRNT+, with a slight predominance of IL-12 in YF-17DD vaccinees and a modest prevalence of IL-10 in YF-17D-213/77. Prominent frequency of neutrophil-derived TNF-alpha and neutrophils and monocyte-producing IL-12 were the major features of PV-PRNT+ in the YF-17DD, whereas relevant inflammatory response, mediated by IL-12(+)CD8(+) T cells, was the hallmark of the YF-17D-213/77 vaccinees. Both substrains were able to elicit particular but relevant inflammatory events, regardless of the anti-YF PRNT antibody levels. PV-PRNT 2 children belonging to the YF-17DD arm presented gaps in the inflammatory cytokine signature, especially in terms of the innate immunity, whereas in the YF-17D-213/77 arm the most relevant gap was the deficiency of IL-12-producing CD8(+)T cells. Revaccination with YF-17DD prompted a balanced cytokine profile in YF-17DD nonresponders and a robust inflammatory profile in YF-17D-213/77 nonresponders. Conclusion: Our findings demonstrated that, just like the YF-17DD reference vaccine, the YF-17D-213/77 seed lot induced a mixed pattern of inflammatory and regulatory cytokines, supporting its universal use for immunization.	[Campi-Azevedo, Ana Carolina; de Araujo-Porto, Luiza Pacheco; Luiza-Silva, Maria; Martins, Marina Angela; Sathler-Avelar, Renato; Teixeira-Carvalho, Andrea; Martins-Filho, Olindo Assis] Fiocruz MS, Lab Biomarcadores Diagnost & Monitoraco, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Batista, Mauricio Azevedo; da Silveira-Lemos, Denise] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil; [Bastos Camacho, Luiz Antonio] Fiocruz MS, Escola Nacl Sau Publ, BR-21045900 Rio De Janeiro, Brazil; [Martins, Reinaldo de Menezes; de Sousa Maia, Maria de Lourdes; Guedes Farias, Roberto Henrique; Freire, Marcos da Silva; Galler, Ricardo; Homma, Akira] Fiocruz MS, Inst Tecnol Imunobiol, BR-21045900 Rio De Janeiro, Brazil; [Leite Ribeiro, Jose Geraldo; Campos Lemos, Jandira Aparecida] Governo Estado Minas Gerais, Secretaria Estado Saude, Belo Horizonte, MG, Brazil; [Auxiliadora-Martins, Maria] Univ Sa Paulo USP, Hosp Clin, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Caldas, Iramaya Rodrigues] Fiocruz MS, Diretoria Reg Brasilia, Brasilia, DF, Brazil; [Eloi-Santos, Silvana Maria] Univ Fed Minas Gerais, Dept Propedeut Complementar, Fac Med, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Ouro Preto; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Campi-Azevedo, AC (corresponding author), Fiocruz MS, Lab Biomarcadores Diagnost & Monitoraco, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	accampi@cpqrr.fiocruz.br	Auxiliadora-Martins, Maria/L-2412-2014; Martins, Reinaldo/I-3413-2015; Galler, Ricardo/B-3280-2014; Campi-Azevedo, Ana Carolina/ABE-8321-2021; Martins-Filho, Olindo Assis/ABE-6278-2021	Martins, Reinaldo/0000-0002-0667-532X; Campi-Azevedo, Ana Carolina/0000-0001-6306-3605; Martins-Filho, Olindo Assis/0000-0002-5494-4889; Auxiliadora-Martins, Maria/0000-0003-3923-4464	Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG) [APQ 01183-08, APQ-01877-10, PDJ 00265/09]; Bio-Manguinhos/Fundacao Oswaldo Cruz (FIOCRUZ) [05/05; 05/08]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [422782/09, 479663/2004-1, 308651/2006-5]; FAPEMIG [PDJ 00265/09]	Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Bio-Manguinhos/Fundacao Oswaldo Cruz (FIOCRUZ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Fundacao de Amparo a Pesquisa do estado de Minas Gerais (FAPEMIG) - Grant# APQ 01183-08; #APQ-01877-10; PDJ 00265/09; Bio-Manguinhos/Fundacao Oswaldo Cruz (FIOCRUZ) - Grant 05/05; 05/08; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - Grant #422782/09, Grant #479663/2004-1; #308651/2006-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the program for technological development in tools for health-PDTIS-FIOCRUZ for the use of its facilities. OAMF and ATC thank CNPq for fellowships (PQ). ACCA acknowledges the FAPEMIG for the fellowship (PDJ 00265/09). We are also thankful to Dr. Ivone Perez de Castro from the Secretaria de Saude do Distrito Federal for coordinating the field work in Brasilia, DF, Brazil and Rosangela Aparecida de Azevedo for the logistical support during field work in Minas Gerais, Brazil.	Ahmed R, 2011, J EXP MED, V208, P2347, DOI 10.1084/jem.20112321; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Bae HG, 2008, J INFECT DIS, V197, P1577, DOI 10.1086/587844; Camacho LAB, 2007, VACCINE, V25, P3118, DOI 10.1016/j.vaccine.2007.01.053; Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189; Camacho LAB, 2005, REV SAUDE PUBL, V39, P413, DOI 10.1590/S0034-89102005000300012; Camacho LAB, 2004, REV SAUDE PUBL, V38, P671, DOI 10.1590/S0034-89102004000500009; Centers for Disease Control and Prevention, 2011, NEWS YELL FEV BRAZ C; Neves PCD, 2009, VACCINE, V27, P5543, DOI 10.1016/j.vaccine.2009.07.028; Fleiss J. L., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923, DOI 10.1002/9781118032923]; Freestone DS., 1994, VACCINES, P741; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; GEORGES AJ, 1985, VACCINE, V3, P313, DOI 10.1016/S0264-410X(85)90182-3; Levitz SM, 2012, CELL, V148, P1284, DOI 10.1016/j.cell.2012.02.012; LHUILLIER M, 1989, J BIOL STAND, V17, P9, DOI 10.1016/0092-1157(89)90023-1; Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439; Marchevsky RS, 2006, BIOLOGICALS, V34, P191, DOI 10.1016/j.biologicals.2005.09.005; Martins MA, 2008, VACCINE, V26, P1173, DOI 10.1016/j.vaccine.2007.12.035; MEYER HARRY M., 1964, BULL WORLD HEALTH ORGAN, V30, P783; Ministerio da Saude, 2001, MAN PROC PAR VAC; Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553; Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533; MOUCHON D, 1990, B SOC PATHOL EXOT, V83, P537; POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Robertson SE, 1993, MODULE 8 YELLOW FEVE; Santos AP, 2008, CYTOKINE, V42, P152, DOI 10.1016/j.cyto.2008.02.007; Santos Claudia N. Duarte Dos, 1995, Virus Research, V35, P35; Silva ML, 2010, CLIN VACCINE IMMUNOL, V17, P118, DOI 10.1128/CVI.00369-09; Stefano I, 1999, VACCINE, V17, P1042, DOI 10.1016/S0264-410X(98)00320-X; *WHO, 1998, WHO TECH REP SER, V872, P31; World Health Oraganization, 2007, INT TRAV HLTH, P93; World Health Organization. Global programme for vaccines and immunization, 1998, YELL FEV; Wuthrich M, 2003, J EXP MED, V197, P1405, DOI 10.1084/jem.20030109	35	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e49828	10.1371/journal.pone.0049828	http://dx.doi.org/10.1371/journal.pone.0049828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251351	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900004
J	Zhang, L; Diaz-Diaz, N; Zarringhalam, K; Hermansson, M; Somerharju, P; Chuang, J				Zhang, Lu; Diaz-Diaz, Norberto; Zarringhalam, Kourosh; Hermansson, Martin; Somerharju, Pentti; Chuang, Jeffrey			Dynamics of the Ethanolamine Glycerophospholipid Remodeling Network	PLOS ONE			English	Article							MASS-SPECTROMETRY; INDEPENDENT TRANSACYLASE; ELECTROSPRAY-IONIZATION; PARAMETER-ESTIMATION; LIPIDOMICS; CARDIOLIPIN; METABOLISM; PHOSPHATIDYLCHOLINE; PHOSPHOLIPIDS; INHIBITORS	Acyl chain remodeling in lipids is a critical biochemical process that plays a central role in disease. However, remodeling remains poorly understood, despite massive increases in lipidomic data. In this work, we determine the dynamic network of ethanolamine glycerophospholipid (PE) remodeling, using data from pulse-chase experiments and a novel bioinformatic network inference approach. The model uses a set of ordinary differential equations based on the assumptions that (1) sn1 and sn2 acyl positions are independently remodeled; (2) remodeling reaction rates are constant over time; and (3) acyl donor concentrations are constant. We use a novel fast and accurate two-step algorithm to automatically infer model parameters and their values. This is the first such method applicable to dynamic phospholipid lipidomic data. Our inference procedure closely fits experimental measurements and shows strong cross-validation across six independent experiments with distinct deuterium-labeled PE precursors, demonstrating the validity of our assumptions. In constrast, fits of randomized data or fits using random model parameters are worse. A key outcome is that we are able to robustly distinguish deacylation and reacylation kinetics of individual acyl chain types at the sn1 and sn2 positions, explaining the established prevalence of saturated and unsaturated chains in the respective positions. The present study thus demonstrates that dynamic acyl chain remodeling processes can be reliably determined from dynamic lipidomic data.	[Zhang, Lu; Zarringhalam, Kourosh; Chuang, Jeffrey] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Diaz-Diaz, Norberto] Pablo de Olavide Univ, Sch Engn, Seville, Spain; [Hermansson, Martin; Somerharju, Pentti] Univ Helsinki, Inst Biomed, Dept Biochem & Dev Biol, Helsinki, Finland	Boston College; Universidad Pablo de Olavide; University of Helsinki	Chuang, J (corresponding author), Jackson Lab Genom Med, Farmington, CT USA.	chuangj@bc.edu	Hermansson, Martin/B-7854-2008; Diaz-Diaz, Norberto/G-3309-2013	Hermansson, Martin/0000-0003-3387-8365; Diaz-Diaz, Norberto/0000-0001-8100-8781; Chuang, Jeffrey/0000-0002-3298-2358	Boston College Biology Department; Ministry of Science and Innovation [TIN2007-68084-C02-00, PCI2006-A7-0575]; Junta de Andalucia [P07-TIC-02611, TIC-200]	Boston College Biology Department; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia)	JC was supported by funds from the Boston College Biology Department. NDD was in part supported by the Ministry of Science and Innovation, projects TIN2007-68084-C02-00 and PCI2006-A7-0575, and by the Junta de Andalucia, projects P07-TIC-02611 and TIC-200. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADEN N, 1982, CHEM ENG J BIOCH ENG, V23, P1, DOI 10.1016/0300-9467(82)85001-6; BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527; BELLMAN RICHARD, 1967, MATH BIOSCI, V1, P71, DOI 10.1016/0025-5564(67)90027-2; Bilgin M, 2011, BBA-MOL CELL BIOL L, V1811, P1081, DOI 10.1016/j.bbalip.2011.09.018; BISHOP WR, 1988, ANNU REV CELL BIOL, V4, P579, DOI 10.1146/annurev.cb.04.110188.003051; Brewer D, 2008, PHILOS T R SOC A, V366, P519, DOI 10.1098/rsta.2007.2108; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; CHILTON FH, 1995, BIOCHEMISTRY-US, V34, P5403, DOI 10.1021/bi00016a011; De Boor C., 1978, APPL MATH SCI, V27, DOI DOI 10.1007/978-1-4612-6333-3; de Kroon AIPM, 2007, BBA-MOL CELL BIOL L, V1771, P343, DOI 10.1016/j.bbalip.2006.07.010; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Dennis EA, 2009, P NATL ACAD SCI USA, V106, P2089, DOI 10.1073/pnas.0812636106; Ejsing CS, 2009, P NATL ACAD SCI USA, V106; Forrester JS, 2004, MOL PHARMACOL, V65, P813, DOI 10.1124/mol.65.4.813; Golub GH, 1992, SCI COMPUTING DIFFER; Gupta S, 2009, BIOPHYS J, V96, P4542, DOI 10.1016/j.bpj.2009.03.011; Haimi P, 2010, J BIOL CHEM, V285, P751, DOI 10.1074/jbc.M109.061218; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hou WM, 2011, RAPID COMMUN MASS SP, V25, P205, DOI 10.1002/rcm.4846; Hsu FF, 2009, J CHROMATOGR B, V877, P2673, DOI 10.1016/j.jchromb.2009.02.033; Kainu V, 2008, J BIOL CHEM, V283, P3676, DOI 10.1074/jbc.M709176200; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Kiebish MA, 2010, J LIPID RES, V51, P2153, DOI 10.1194/jlr.M004796; LANDS WEM, 1965, ANNU REV BIOCHEM, V34, P313, DOI 10.1146/annurev.bi.34.070165.001525; Li ZF, 2005, IMA J NUMER ANAL, V25, P264, DOI 10.1093/imanum/drh016; Meikle PJ, 2011, CURR OPIN LIPIDOL, V22, P210, DOI 10.1097/MOL.0b013e3283453dbe; Pietilainen KH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000623; Postle AD, 2009, J CHROMATOGR B, V877, P2716, DOI 10.1016/j.jchromb.2009.03.046; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Trimboli AJ, 1999, CANCER RES, V59, P6171; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Yetukuri L, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-12; Zarringhalam K, 2012, PLOS ONE; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]	38	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50858	10.1371/journal.pone.0050858	http://dx.doi.org/10.1371/journal.pone.0050858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251394	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900023
J	Canete, R; Diaz, MM; Garcia, RA; Martinez, PML; Ponce, FM				Canete, Roberto; Morales Diaz, Mariuska; Avalos Garcia, Roxana; Laud Martinez, Pedro Miguel; Manuel Ponce, Felix			Intestinal Parasites in Children from a Day Care Centre in Matanzas City, Cuba	PLOS ONE			English	Article							JUAN-Y-MARTINEZ; PINAR-DEL-RIO; RISK-FACTORS; MINAS-GERAIS; HAVANA CITY; PREVALENCE; BLASTOCYSTIS; BRAZIL; INFECTIONS; GIARDIASIS	Background: Intestinal parasitic infections are widely distributed throughout the world and children are the most affected population. Day care centres are environments where children have proven to be more susceptible to acquiring IP. Methods and Principal Findings: A cross-sectional study was carried to determine the prevalence of intestinal parasites in stool samples among children who attend to a day care centre in an urban area of Matanzas city, Cuba, from March to June 2012. 104 children under five years old were included on the study after informed consent form was signed by parents or legal guardians. Three fresh faecal samples were collected from each child in different days and were examined by direct wet mount, formalin-ether, and Kato-Katz techniques. Data relating to demography, socioeconomic status, source of drinking water, and personal hygiene habits were also collected using a standardized questionnaire. In total, 71.1% of children harbored at least one type of intestinal parasite and 47 (45.2%) were infected by more than one species. Giardia duodenalis and Blastocystis sp. were the most common parasites found, with prevalence rates of 54.8% and 38.5% respectively. Conclusions: Despite public health campaigns, improvement in the level of education, and the availability of and access to medical services in Cuba infections by intestinal protozoan is high in this centre. Almost nothing is published regarding intestinal parasites in Matanzas province during the last 40 years so this work could also be the initial point to carry out other studies to clarify the IP status in this region.	[Canete, Roberto] Ctr Hyg Epidemiol & Microbiol, Matanzas City, Cuba; [Morales Diaz, Mariuska; Avalos Garcia, Roxana; Laud Martinez, Pedro Miguel; Manuel Ponce, Felix] Faustino Perez Hernandez Hosp, Matanzas, Cuba; [Canete, Roberto] Cuban Inst Gastroenterol, Havana, Cuba		Canete, R (corresponding author), Ctr Hyg Epidemiol & Microbiol, Matanzas City, Cuba.	parasitologia.mtz@infomed.sld.cu						Artieda J., 2012, EURO SURVEILL, V17; Pereira Maria das Graças Cabral, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P139; Cartwright CP, 1999, J CLIN MICROBIOL, V37, P2408, DOI 10.1128/JCM.37.8.2408-2411.1999; Chirdan O O, 2010, Niger J Med, V19, P219; Dominguez Leon SI, 2011, REV MED ELECT, V33; Escobedo AA, 2007, TROP DOCT, V37, P236, DOI 10.1258/004947507782332991; Escobedo AA, 2008, W INDIAN MED J, V57, P377; Escobedo AA, 2011, ACTA TROP, V119, P99, DOI 10.1016/j.actatropica.2011.04.014; GRAHAM CLARENCE F., 1941, AMER JOUR TROP MED, V21, P159; Gurgel RQ, 2005, REV SOC BRAS MED TRO, V38, P267, DOI 10.1590/S0037-86822005000300014; Mehraj V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003680; Menezes AL, 2008, REV INST MED TROP SP, V50, P57, DOI 10.1590/S0036-46652008000100013; Ngui R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000974; Nunez FA, 1999, ACTA TROP, V73, P237, DOI 10.1016/S0001-706X(99)00032-7; Núñez Fidel Ángel, 2003, Cad. Saúde Pública, V19, P677, DOI 10.1590/S0102-311X2003000200036; Goncalves ALR, 2011, REV SOC BRAS MED TRO, V44, P191, DOI 10.1590/S0037-86822011005000022; Rivero LR, 2008, TRENDS PARASITOL, V24, P440, DOI 10.1016/j.pt.2008.06.008; Sagebiel D, 2009, PARASITOL RES, V105, P681, DOI 10.1007/s00436-009-1438-5; Staat MA, 2011, PEDIATRICS, V128, pE613, DOI 10.1542/peds.2010-3032; Stensvold CR, 2007, TRENDS PARASITOL, V23, P93, DOI 10.1016/j.pt.2007.01.004; Stensvold CR, 2009, TRENDS PARASITOL, V25, P23, DOI 10.1016/j.pt.2008.09.010; Stensvold CR, 2010, J CLIN GASTROENTEROL, V44, P85, DOI 10.1097/MCG.0b013e3181bb86ba; Wordemann M, 2006, TROP MED INT HEALTH, V11, P1813, DOI 10.1111/j.1365-3156.2006.01745.x	23	32	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51394	10.1371/journal.pone.0051394	http://dx.doi.org/10.1371/journal.pone.0051394			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236493	Green Submitted, gold, Green Published			2022-12-27	WOS:000312064100112
J	Tang, M; Ivakine, E; Mahadevan, V; Salter, MW; McInnes, RR				Tang, Man; Ivakine, Evgueni; Mahadevan, Vivek; Salter, Michael W.; McInnes, Roderick R.			Neto2 Interacts with the Scaffolding Protein GRIP and Regulates Synaptic Abundance of Kainate Receptors	PLOS ONE			English	Article							MOSSY-FIBER SYNAPSES; RAT-BRAIN; GLUTAMATE RECEPTORS; GLUR6-DEFICIENT MICE; AUXILIARY SUBUNIT; NERVOUS-SYSTEM; AMPA; EXPRESSION; MODULATION; ACTIVATION	Kainate receptors (KARs) are a class of ionotropic glutamate receptors that are expressed throughout the central nervous system. The function and subcellular localization of KARs are tightly regulated by accessory proteins. We have previously identified the single-pass transmembrane proteins, Neto1 and Neto2, to be associated with native KARs. In the hippocampus, Neto1, but not Neto2, controls the abundance and modulates the kinetics of postsynaptic KARs. Here we evaluated whether Neto2 regulates synaptic KAR levels in the cerebellum where Neto1 expression is limited to the deep cerebellar nuclei. In the cerebellum, where Neto2 is present abundantly, we found a,similar to 40% decrease in GluK2-KARs at the postsynaptic density (PSD) of Neto2-null mice. No change, however, was observed in total level of GluK2-KARs, thereby suggesting a critical role of Neto2 on the synaptic localization of cerebellar KARs. The presence of a putative class II PDZ binding motif on Neto2 led us to also investigate whether it interacts with PDZ domain-containing proteins previously implicated in regulating synaptic abundance of KARs. We identified a PDZ-dependent interaction between Neto2 and the scaffolding protein GRIP. Furthermore, coexpression of Neto2 significantly increased the amount of GRIP associated with GluK2, suggesting that Neto2 may promote and/or stabilize GluK2: GRIP interactions. Our results demonstrate that Neto2, like Neto1, is an important auxiliary protein for modulating the synaptic levels of KARs. Moreover, we propose that the interactions of Neto1/2 with various scaffolding proteins is a critical mechanism by which KARs are stabilized at diverse synapses. Citation: Tang M, Ivakine E, Mahadevan V, Salter MW, McInnes RR (2012) Neto2 Interacts with the Scaffolding Protein GRIP and Regulates Synaptic Abundance of Kainate Receptors. PLoS ONE 7(12): e51433. doi:10.1371/journal.pone.0051433	[Salter, Michael W.] Hosp Sick Children, Res Inst, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Tang, Man; Ivakine, Evgueni; Mahadevan, Vivek; McInnes, Roderick R.] Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Tang, Man; McInnes, Roderick R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [McInnes, Roderick R.] McGill Univ, Jewish Gen Hosp, Lady Davis Res Inst, Montreal, PQ H3T 1E2, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University	Salter, MW (corresponding author), Hosp Sick Children, Res Inst, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	mike.salter@utoronto.ca; rod.mcinnes@mcgill.ca	Mahadevan, Vivek/O-4114-2018; Mahadevan, Vivek/M-9153-2014	Mahadevan, Vivek/0000-0002-0805-827X; Mahadevan, Vivek/0000-0002-0805-827X; Ivakine, Evgueni/0000-0003-2132-4699	Canadian Institutes of Health Research (CIHR) [MOP-7315, IOP-54037]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by grants from the Canadian Institutes of Health Research (CIHR) to RRM (MOP-7315 and IOP-54037). RRM and MWS hold Canada Research Chairs. MWS is the Anne and Max Tanenbaum Chair in Molecular Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHN S, 1994, J NEUROSCI, V14, P5525; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; Bureau I, 1999, J NEUROSCI, V19, P653; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Chow RL, 2004, P NATL ACAD SCI USA, V101, P1754, DOI 10.1073/pnas.0306520101; Contractor A, 2003, J NEUROSCI, V23, P422, DOI 10.1523/JNEUROSCI.23-02-00422.2003; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Copits BA, 2011, J NEUROSCI, V31, P7334, DOI 10.1523/JNEUROSCI.0100-11.2011; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Delaney AJ, 2002, NEURON, V36, P475, DOI 10.1016/S0896-6273(02)01008-5; Fernandes HB, 2009, NEURON, V63, P818, DOI 10.1016/j.neuron.2009.08.010; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim YJ, 2012, GENES DEV; Michishita M, 2004, DEV BRAIN RES, V153, P135, DOI 10.1016/j.devbrainres.2004.06.012; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Ripellino JA, 1998, NEUROSCIENCE, V82, P485; Rodriguez-Moreno A, 2007, TRENDS NEUROSCI, V30, P630, DOI 10.1016/j.tins.2007.10.001; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Straub C, 2011, NAT NEUROSCI, V14, P866, DOI 10.1038/nn.2837; Straub C, 2011, J NEUROSCI, V31, P8078, DOI 10.1523/JNEUROSCI.0024-11.2011; Tang M, 2011, J NEUROSCI, V31, P10009, DOI 10.1523/JNEUROSCI.6617-10.2011; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WISDEN W, 1993, J NEUROSCI, V13, P3582; Wyszynski M, 1998, NEUROPHARMACOLOGY, V37, P1335, DOI 10.1016/S0028-3908(98)00120-8; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	33	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51433	10.1371/journal.pone.0051433	http://dx.doi.org/10.1371/journal.pone.0051433			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236500	gold, Green Submitted, Green Published			2022-12-27	WOS:000312589700040
J	Hart, V; Kusta, T; Nemec, P; Blahova, V; Jezek, M; Novakova, P; Begall, S; Cerveny, J; Hanzal, V; Malkemper, EP; Stipek, K; Vole, C; Burda, H				Hart, Vlastimil; Kusta, Tomas; Nemec, Pavel; Blahova, Veronika; Jezek, Milos; Novakova, Petra; Begall, Sabine; Cerveny, Jaroslav; Hanzal, Vladimir; Malkemper, Erich Pascal; Stipek, Kamil; Vole, Christiane; Burda, Hynek			Magnetic Alignment in Carps: Evidence from the Czech Christmas Fish Market	PLOS ONE			English	Article							SOCKEYE-SALMON; COMPASS ORIENTATION; ONCORHYNCHUS-NERKA; ANGUILLA-JAPONICA; CYPRINUS-CARPIO; EUROPEAN EEL; COMMON CARP; FIELD; SENSE; RIVER	While magnetoreception in birds has been studied intensively, the literature on magnetoreception in bony fish, and particularly in non-migratory fish, is quite scarce. We examined alignment of common carps (Cyprinus carpio) at traditional Christmas sale in the Czech Republic. The sample comprised measurements of the directional bearings in 14,537 individual fish, distributed among 80 large circular plastic tubs, at 25 localities in the Czech Republic, during 817 sampling sessions, on seven subsequent days in December 2011. We found that carps displayed a statistically highly significant spontaneous preference to align their bodies along the North-South axis. In the absence of any other common orientation cues which could explain this directional preference, we attribute the alignment of the fish to the geomagnetic field lines. It is apparent that the display of magnetic alignment is a simple experimental paradigm of great heuristic potential.	[Hart, Vlastimil; Kusta, Tomas; Jezek, Milos; Novakova, Petra; Cerveny, Jaroslav; Hanzal, Vladimir; Stipek, Kamil; Burda, Hynek] Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Forest Protect & Wildlife Management, Prague, Czech Republic; [Nemec, Pavel; Blahova, Veronika] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic; [Begall, Sabine; Malkemper, Erich Pascal; Vole, Christiane; Burda, Hynek] Univ Duisburg Essen, Fac Biol, Dept Gen Zool, Essen, Germany	Czech University of Life Sciences Prague; Charles University Prague; University of Duisburg Essen	Burda, H (corresponding author), Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Forest Protect & Wildlife Management, Prague, Czech Republic.	hynek.burda@uni-due.de	Hart, Vlastimil/P-4604-2016; Červený, Jaroslav/A-2809-2015; Malkemper, Erich Pascal/J-9891-2015; Nemec, Pavel/K-1163-2012; Hanzal, Vladimir/AAD-9567-2019; Ježek, Miloš/AAB-8880-2021; Červený, Jaroslav/AGZ-6188-2022; Malkemper, Erich Pascal/AAV-2989-2021	Malkemper, Erich Pascal/0000-0003-1099-0119; Nemec, Pavel/0000-0003-0277-0239; Ježek, Miloš/0000-0002-4127-9947; Červený, Jaroslav/0000-0002-2723-0936; Malkemper, Erich Pascal/0000-0003-1099-0119; Hart, Vlastimil/0000-0003-4901-3817	Grant Agency of the Czech Republic [506/11/2121]; Grant Agency of the Charles University [116510]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of the Charles University	The study was supported by the Grant Agency of the Czech Republic (Grant 506/11/2121 to HB) and Grant Agency of the Charles University [Grant 116510 to PN]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batschelet E, 1981, CIRCULAR STAT BIOL; BECKER G, 1974, NATURWISSENSCHAFTEN, V61, P220, DOI 10.1007/BF00599929; BECKER G, 1963, NATURWISSENSCHAFTEN, V50, P455, DOI 10.1007/BF00601615; BECKER GUNTHER, 1964, Z VERGLEICHENDE PHYSIOL, V49, P301, DOI 10.1007/BF00302681; Begall S, 2011, J COMP PHYSIOL A, V197, P1127, DOI 10.1007/s00359-011-0674-1; Begall S, 2012, MAMMAL BIOL; Begall S, 2008, P NATL ACAD SCI USA, V105, P13451, DOI 10.1073/pnas.0803650105; Burda H, 2009, P NATL ACAD SCI USA, V106, P5708, DOI 10.1073/pnas.0811194106; Cerveny J, 2011, BIOL LETTERS, V7, P355, DOI 10.1098/rsbl.2010.1145; CHEW GL, 1989, CAN J ZOOL, V67, P641, DOI 10.1139/z89-092; Daniel AJ, 2011, N AM J FISH MANAGE, V31, P352, DOI 10.1080/02755947.2011.576205; Eder SHK, 2012, P NATL ACAD SCI USA, V109, P12022, DOI 10.1073/pnas.1205653109; Formicki K, 2004, J APPL ICHTHYOL, V20, P402, DOI 10.1111/j.1439-0426.2004.00568.x; Formicki K, 2004, J APPL ICHTHYOL, V20, P290, DOI 10.1111/j.1439-0426.2004.00556.x; HANSON M, 1987, J MAGN MAGN MATER, V66, P1, DOI 10.1016/0304-8853(87)90120-X; HANSON M, 1987, COMP BIOCHEM PHYS A, V86, P169, DOI 10.1016/0300-9629(87)90296-9; Haugh CV, 1998, J NAVIGATION, V51, P35, DOI 10.1017/S0373463397007595; Hellinger J, 2012, J COMP PHYSIOL A, V198, P593, DOI 10.1007/s00359-012-0732-3; Hellinger J, 2009, J COMP PHYSIOL A, V195, P873, DOI 10.1007/s00359-009-0466-z; Jones MJ, 2009, ECOL FRESHW FISH, V18, P72, DOI 10.1111/j.1600-0633.2008.00324.x; Nishi T, 2006, NIPPON SUISAN GAKK, V72, P27, DOI 10.2331/suisan.72.27; Nishi T, 2005, J FISH BIOL, V67, P1213, DOI 10.1111/j.1095-8649.2005.00817.x; Nishi T, 2004, J EXP BIOL, V207, P2965, DOI 10.1242/jeb.01131; Oca J, 2004, AQUACULT ENG, V31, P221, DOI 10.1016/j.aquaeng.2004.04.002; Phillips JB, 2002, J EXP BIOL, V205, P3903; QUINN TP, 1982, J COMP PHYSIOL, V147, P547, DOI 10.1007/BF00612020; QUINN TP, 1981, J EXP ZOOL, V217, P137, DOI 10.1002/jez.1402170114; QUINN TP, 1980, J COMP PHYSIOL, V137, P243, DOI 10.1007/BF00657119; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; ROMMEL SA, 1973, J FISH RES BOARD CAN, V30, P657, DOI 10.1139/f73-114; Schlegel PA, 2007, J ETHOL, V25, P177, DOI 10.1007/s10164-006-0016-x; Shcherbakov D, 2005, CURR BIOL, V15, pR161, DOI 10.1016/j.cub.2005.02.039; Stuart IG, 2006, FISHERIES MANAG ECOL, V13, P213, DOI 10.1111/j.1365-2400.2006.00495.x; Takebe A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00727; TESCH F W, 1973, Netherlands Journal of Sea Research, V7, P46, DOI 10.1016/0077-7579(73)90031-8; TESCH FW, 1974, HELGOLAND WISS MEER, V26, P382, DOI 10.1007/BF01627623; Thake MA, 1981, IBIS, V123, P47; Vacha M, 2010, BEHAVIOUR, V147, P425, DOI 10.1163/000579509X12580965484148; van Ginneken V, 2005, ENVIRON BIOL FISH, V72, P313, DOI 10.1007/s10641-004-2585-2; WALKER MM, 1988, J EXP BIOL, V140, P51; WALKER MM, 1984, J COMP PHYSIOL, V155, P673, DOI 10.1007/BF00610853; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; WALKER MM, 1986, NATURWISSENSCHAFTEN, V73, P12, DOI 10.1007/BF01168800; Wiltschko R., 1995, TIEROSYCHOL; Wiltschko Roswitha, 2009, Communicative & Integrative Biology, V2, P100; Yano A, 1996, NIPPON SUISAN GAKK, V62, P911; Yano A, 1997, MAR BIOL, V129, P523, DOI 10.1007/s002270050193	47	28	29	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51100	10.1371/journal.pone.0051100	http://dx.doi.org/10.1371/journal.pone.0051100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227241	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200100
J	van Rijn, H; Dalenberg, JR; Borst, JP; Sprenger, SA				van Rijn, Hedderik; Dalenberg, Jelle R.; Borst, Jelmer P.; Sprenger, Simone A.			Pupil Dilation Co-Varies with Memory Strength of Individual Traces in a Delayed Response Paired-Associate Task	PLOS ONE			English	Article							PICTURE-WORD INTERFERENCE; PUPILLOMETRIC ANALYSIS; RETRIEVAL EFFORT; LOAD; STIMULATION; ALLOCATION; DECISIONS; SELECTION; DYNAMICS; INSIGHTS	Studies on cognitive effort have shown that pupil dilation is a reliable indicator of memory load. However, it is conceivable that there are other sources of effort involved in memory that also affect pupil dilation. One of these is the ease with which an item can be retrieved from memory. Here, we present the results of an experiment in which we studied the way in which pupil dilation acts as an online marker for memory processing during the retrieval of paired associates while reducing confounds associated with motor responses. Paired associates were categorized into sets containing either 4 or 7 items. After learning the paired associates once, pupil dilation was measured during the presentation of the retrieval cue during four repetitions of each set. Memory strength was operationalized as the number of repetitions (frequency) and set-size, since having more items per set results in a lower average recency. Dilation decreased with increased memory strength, supporting the hypothesis that the amplitude of the evoked pupillary response correlates positively with retrieval effort. Thus, while many studies have shown that "memory load'' influences pupil dilation, our results indicate that the task-evoked pupillary response is also sensitive to the experimentally manipulated memory strength of individual items. As these effects were observed well before the response had been given, this study also suggests that pupil dilation can be used to assess an item's memory strength without requiring an overt response.	[van Rijn, Hedderik] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands; [Dalenberg, Jelle R.; Borst, Jelmer P.] Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands; [Sprenger, Simone A.] Univ Groningen, Dept English Language & Linguist, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van Rijn, H (corresponding author), Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	hedderik@van-rijn.org	Borst, Jelmer/C-4666-2008; van Rijn, Hedderik/L-3685-2014	Borst, Jelmer/0000-0002-4493-8223; van Rijn, Hedderik/0000-0002-0461-9850; Dalenberg, Jelle R./0000-0001-8580-5358	University of Groningen	University of Groningen	This study was funded by the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, CANADIAN PSYCHOL; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bagiella E, 2000, PSYCHOPHYSIOLOGY, V37, P13, DOI 10.1017/S0048577200980648; Barbur JL, 2004, THE VISUAL NEUROSCIE, P641; Barbur L, 2007, OPHTHAL PHYSL OPT, V12, P137; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Beatty J., 2000, HDB PSYCHOPHYSIOL, V2, P142; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Chapman CR, 1999, PSYCHOPHYSIOLOGY, V36, P44, DOI 10.1017/S0048577299970373; Chua FK, 2005, PERCEPT PSYCHOPHYS, V67, P770, DOI 10.3758/BF03193532; Einhauser W, 2008, P NATL ACAD SCI USA, V105, P1704, DOI 10.1073/pnas.0707727105; Finnigan S, 2002, NEUROPSYCHOLOGIA, V40, P2288, DOI 10.1016/S0028-3932(02)00113-6; Freeman E, 2010, J MEM LANG, V62, P1, DOI 10.1016/j.jml.2009.09.004; Gagl B, 2011, BEHAV RES METHODS, V43, P1171, DOI 10.3758/s13428-011-0109-5; Gamlin PDR, 1998, VISION RES, V38, P3353, DOI 10.1016/S0042-6989(98)00096-0; Grainger J, 1996, PSYCHOL REV, V103, P518, DOI 10.1037/0033-295X.103.3.518; Granholm E, 1996, PSYCHOPHYSIOLOGY, V33, P457, DOI 10.1111/j.1469-8986.1996.tb01071.x; Hupe JM, 2009, J VISION, V9, DOI 10.1167/9.7.10; Hyona J, 2007, Q J EXPT PSYCHOL A, V1995; Jainta S, 2010, INT J PSYCHOPHYSIOL, V77, P1, DOI 10.1016/j.ijpsycho.2010.03.008; Jainta Stephanie, 2011, Front Hum Neurosci, V5, P97, DOI 10.3389/fnhum.2011.00097; Kafkas A, 2012, NEUROPSYCHO IN PRESS; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Karatekin C, 2004, INT J PSYCHOPHYSIOL, V52, P7, DOI 10.1016/j.ijpsycho.2003.12.002; Kietzmann TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022614; Koch G, 2009, PHILOS T R SOC B, V364, P1907, DOI 10.1098/rstb.2009.0018; Kononowicz TW, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00048; Kuchinke L, 2007, INT J PSYCHOPHYSIOL, V65, P132, DOI 10.1016/j.ijpsycho.2007.04.004; MAGLIERO A, 1983, MEM COGNITION, V11, P609, DOI 10.3758/BF03198285; Michelet T, 2010, J NEUROPHYSIOL, V104, P119, DOI 10.1152/jn.00819.2009; Moresi S, 2008, INT J PSYCHOPHYSIOL, V67, P124, DOI 10.1016/j.ijpsycho.2007.10.011; Newman AJ, 2012, J COGNITIVE NEUROSCI, V24, P1205, DOI 10.1162/jocn_a_00143; Pinheiro J, 2001, MIXED EFFECTS MODELS; Porter G, 2007, Q J EXP PSYCHOL, V60, P211, DOI 10.1080/17470210600673818; Privitera CM, 2010, J VISION, V10, DOI 10.1167/10.10.3; Raaijmakers J. G. W., 2008, LEARNING MEMORY COMP, V2, P445; RICHER F, 1983, J EXP PSYCHOL HUMAN, V9, P360, DOI 10.1037/0096-1523.9.3.360; Robb WGK, 2002, PSYCHON B REV, V9, P583, DOI 10.3758/BF03196316; Selen LPJ, 2012, J NEUROSCI, V32, P2276, DOI 10.1523/JNEUROSCI.5273-11.2012; Smallwood J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018298; SR Research Ltd, 2009, EYELINK 1000 US MAN; Van der Meer E, 2010, PSYCHOPHYSIOLOGY, V47, P158, DOI 10.1111/j.1469-8986.2009.00884.x; Van Gerven PWM, 2004, PSYCHOPHYSIOLOGY, V41, P167, DOI 10.1111/j.1469-8986.2003.00148.x; van Maanen L, 2012, COGNITIVE SCI, V36, P62, DOI 10.1111/j.1551-6709.2011.01213.x; van Maanen L, 2010, TOP COGN SCI, V2, P168, DOI 10.1111/j.1756-8765.2009.01069.x; van Maanen L, 2009, PSYCHON B REV, V16, P987, DOI 10.3758/PBR.16.6.987; VANDERMOLEN MW, 1989, PSYCHOPHYSIOLOGY, V26, P70; Vo MLH, 2008, PSYCHOPHYSIOLOGY, V45, P130, DOI 10.1111/j.1469-8986.2007.00606.x; Wagenmakers EJ, 2004, COGNITIVE PSYCHOL, V48, P332, DOI 10.1016/j.cogpsych.2003.08.001; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Wolffsohn JS, 2001, OPHTHAL PHYSL OPT, V21, P108, DOI 10.1016/S0275-5408(00)00050-8; Zylberberg A, 2012, FRONTIERS COGNITION, V3	55	38	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51134	10.1371/journal.pone.0051134	http://dx.doi.org/10.1371/journal.pone.0051134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227244	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200103
J	Vermeire, J; Naessens, E; Vanderstraeten, H; Landi, A; Iannucci, V; Van Nuffel, A; Taghon, T; Pizzato, M; Verhasselt, B				Vermeire, Jolien; Naessens, Evelien; Vanderstraeten, Hanne; Landi, Alessia; Iannucci, Veronica; Van Nuffel, Anouk; Taghon, Tom; Pizzato, Massimo; Verhasselt, Bruno			Quantification of Reverse Transcriptase Activity by Real-Time PCR as a Fast and Accurate Method for Titration of HIV, Lenti- and Retroviral Vectors	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PORCINE ENDOGENOUS RETROVIRUSES; POLYMERASE-CHAIN-REACTION; REPLICATION-COMPETENT; MONITOR RETROVIRUS; CELL-CULTURE; ASSAY; INFECTIVITY; TYPE-1; STEP	Quantification of retroviruses in cell culture supernatants and other biological preparations is required in a diverse spectrum of laboratories and applications. Methods based on antigen detection, such as p24 for HIV, or on genome detection are virus specific and sometimes suffer from a limited dynamic range of detection. In contrast, measurement of reverse transcriptase (RT) activity is a generic method which can be adapted for higher sensitivity using real-time PCR quantification (qPCR-based product-enhanced RT (PERT) assay). We present an evaluation of a modified SYBR Green I-based PERT assay (SG-PERT), using commercially available reagents such as MS2 RNA and ready-to-use qPCR mixes. This assay has a dynamic range of 7 logs, a sensitivity of 10 nU HIV-1 RT and outperforms p24 ELISA for HIV titer determination by lower inter-run variation, lower cost and higher linear range. The SG-PERT values correlate with transducing and infectious units in HIV-based viral vector and replication-competent HIV-1 preparations respectively. This assay can furthermore quantify Moloney Murine Leukemia Virus-derived vectors and can be performed on different instruments, such as Roche Lightcycler (R) 480 and Applied Biosystems ABI 7300. We consider this test to be an accurate, fast and relatively cheap method for retroviral quantification that is easily implemented for use in routine and research laboratories.	[Vermeire, Jolien; Naessens, Evelien; Vanderstraeten, Hanne; Landi, Alessia; Iannucci, Veronica; Van Nuffel, Anouk; Taghon, Tom; Verhasselt, Bruno] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium; [Pizzato, Massimo] Univ Trento, Ctr Integrat Biol CIBIO, Trento, Italy	Ghent University; University of Trento	Verhasselt, B (corresponding author), Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium.	bruno.verhasselt@ugent.be	Pizzato, Massimo/AFL-0051-2022	Pizzato, Massimo/0000-0002-9491-1483; Verhasselt, Bruno/0000-0002-4645-1144; Taghon, Tom/0000-0002-5781-0288	SBO CellCoVir grant from the agency for Innovation by Science and Technology (IWT) Flanders, Belgium; HIV-STOP Interuniversity Attraction Poles program of Belgian Science Policy; European Union [Health-2007-2.3.2-1]; Ghent University [BOF11/GOA/013]; Research Foundation - Flanders (FWO)	SBO CellCoVir grant from the agency for Innovation by Science and Technology (IWT) Flanders, Belgium(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); HIV-STOP Interuniversity Attraction Poles program of Belgian Science Policy; European Union(European Commission); Ghent University(Ghent University); Research Foundation - Flanders (FWO)(FWO)	This work was supported by SBO CellCoVir grant from the agency for Innovation by Science and Technology (IWT) Flanders, Belgium; HIV-STOP Interuniversity Attraction Poles program of Belgian Science Policy, European Union FP7 Health-2007-2.3.2-1 Collaborative Project iNEF, Ghent University grant BOF11/GOA/013 and grants from the Research Foundation - Flanders (FWO) to BV. JV and AL are PhD fellows, TT is a postdoctoral researcher and BV is a Senior Clinical Investigator of the FWO. VI is a PhD fellow supported by the BOF program of the Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold BA, 1998, BIOTECHNIQUES, V25, P98, DOI 10.2144/98251st06; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; Boni J, 1996, CLIN DIAGN VIROL, V5, P43, DOI 10.1016/0928-0197(95)00159-X; BOURINBAIAR AS, 1994, ACTA VIROL, V38, P59; Brorson K, 2002, BIOLOGICALS, V30, P15, DOI 10.1006/biol.2001.0290; Brorson K, 2001, BIOTECHNOL PROGR, V17, P188, DOI 10.1021/bp000153q; Chang A, 1997, J VIROL METHODS, V65, P45, DOI 10.1016/S0166-0934(96)02168-4; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Clemenceau B, 2001, DIABETOLOGIA, V44, P2044, DOI 10.1007/s001250100010; Cortes MJ, 2002, J BIOL CHEM, V277, P1770, DOI 10.1074/jbc.M109807200; D'Costa J, 2009, CURR OPIN MOL THER, V11, P554; Delenda C, 2005, GENE THER, V12, pS36, DOI 10.1038/sj.gt.3302614; Dropulic B, 2011, HUM GENE THER, V22, P649, DOI 10.1089/hum.2011.058; EBERLE J, 1992, J VIROL METHODS, V40, P347, DOI 10.1016/0166-0934(92)90092-R; Fan XY, 2006, J CLIN VIROL, V37, P305, DOI 10.1016/j.jcv.2006.08.007; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; Heneine W, 2001, J INFECT DIS, V183, P648, DOI 10.1086/318540; Hussain AI, 2003, J VIROL, V77, P1105, DOI 10.1128/JVI.77.2.1105-1111.2003; Ikeda Y, 2002, GENE THER, V9, P932, DOI 10.1038/sj.gt.3301708; Imbeault M, 2009, VIROLOGY, V393, P160, DOI 10.1016/j.virol.2009.07.009; Johnson JA, 2001, J VIROL, V75, P3605, DOI 10.1128/JVI.75.8.3605-3612.2001; Khan AS, 1998, J CLIN VIROL, V11, P7, DOI 10.1016/S0928-0197(98)00042-7; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; Lerma JGG, 1998, J INFECT DIS, V177, P1221, DOI 10.1086/515272; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Lizee G, 2003, HUM GENE THER, V14, P497, DOI 10.1089/104303403764539387; Logan AC, 2004, HUM GENE THER, V15, P976, DOI 10.1089/hum.2004.15.976; Lovatt A, 1999, J VIROL METHODS, V82, P185, DOI 10.1016/S0166-0934(99)00111-1; Ma YK, 2009, J VIROL METHODS, V157, P133, DOI 10.1016/j.jviromet.2009.01.002; Marozsan AJ, 2004, J VIROL, V78, P11130, DOI 10.1128/JVI.78.20.11130-11141.2004; Maudru T, 1998, J CLIN VIROL, V11, P19, DOI 10.1016/S0928-0197(98)00044-0; Maudru T, 1998, BIOTECHNIQUES, V25, P972, DOI 10.2144/98256bm08; Michael NL, 1999, J CLIN MICROBIOL, V37, P2557, DOI 10.1128/JCM.37.8.2557-2563.1999; Munch J, 2007, J VIROL, V81, P13852, DOI 10.1128/JVI.00904-07; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; Platt EJ, 2010, J VIROL, V84, P3106, DOI 10.1128/JVI.01958-09; PYRA H, 1994, P NATL ACAD SCI USA, V91, P1544, DOI 10.1073/pnas.91.4.1544; ROYBURMAN P, 1976, J VIROL, V19, P1107, DOI 10.1128/JVI.19.3.1107-1110.1976; Sanchez-Antequera Y, 2011, BLOOD, V117, pE171, DOI 10.1182/blood-2010-08-302646; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Sears JF, 1999, J CLIN MICROBIOL, V37, P1704, DOI 10.1128/JCM.37.6.1704-1708.1999; Sears JF, 2003, J VIROL METHODS, V108, P139, DOI 10.1016/S0166-0934(02)00287-2; Shahabuddin M, 2001, J CLIN MICROBIOL, V39, P675, DOI 10.1128/JCM.39.2.675-684.2001; SILVER J, 1993, NUCLEIC ACIDS RES, V21, P3593, DOI 10.1093/nar/21.15.3593; Stove V, 2005, J VIROL, V79, P11422, DOI 10.1128/JVI.79.17.11422-11433.2005; Stove V, 2003, BLOOD, V102, P2925, DOI 10.1182/blood-2003-03-0833; Stove V, 2006, ELECTRON J BIOTECHN, V9, P572, DOI 10.2225/vol9-issue5-fulltext-13; Thomas JA, 2007, J VIROL, V81, P4367, DOI 10.1128/JVI.02357-06; Tschochner M, 2007, J VIROL METHODS, V141, P87, DOI 10.1016/j.jviromet.2006.11.040; Verhasselt B, 1999, BLOOD, V94, P2809, DOI 10.1182/blood.V94.8.2809.420k11_2809_2818; Yamamoto S, 1996, J VIROL METHODS, V61, P135, DOI 10.1016/0166-0934(96)02078-2; Zhang Bing, 2004, Genet Vaccines Ther, V2, P6, DOI 10.1186/1479-0556-2-6	54	102	104	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50859	10.1371/journal.pone.0050859	http://dx.doi.org/10.1371/journal.pone.0050859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227216	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200077
J	Wang, D; Zhai, B; Hu, FL; Liu, C; Zhao, JP; Xu, J				Wang, Dong; Zhai, Bo; Hu, Fengli; Liu, Chang; Zhao, Jinpeng; Xu, Jun			High YKL-40 Serum Concentration Is Correlated with Prognosis of Chinese Patients with Breast Cancer	PLOS ONE			English	Article							EXPRESSION; PROTEIN; GLYCOPROTEIN; MARKER; GRADE	This study aimed to investigate the association between serum YKL-40 and prognosis of breast cancer in a Chinese population. Expression of YKL-40 of 120 Chinese patients with breast cancer and 30 controls (benign breast lesions) was measured in tumor tissue by immunohistochemistry and in serum by ELISA. Differences in YKL-40 positivity grouped by specific patients' characteristics were compared using Pearson Chi-square test for rates of intratumoral staining, one-way ANOVA with a Bonferroni post-hoc comparison, or two-sample t-test for mean YKL-40 serum concentrations. Factors associated with overall survival were identified by univariate and multivariate cox-regression analyses. YKL-40 was elevated in approximately 75% of Chinese patients with breast cancer. A significantly higher percentage of patients with YKL-40 positive tumors had larger tumor size, higher TNM stage, and/or lymph node metastasis. Significantly higher mean YKL-40 serum concentrations were observed in patient subgroups with invasive lobular carcinoma (P < 0.0167), higher TNM stage (P < 0.001), and positive lymph node metastasis (P < 0.001). The estimated mean survival time of patients with YKL-40 positive tumors was significantly shorter than for patients with YKL-40 negative tumors (55.13 months vs 65.78 months, P=0.017). Multivariable Cox-regression analysis identified a significant association of overall survival time with YKL-40 serum concentration. Patients with YKL-40 positive tumors had significantly shorter disease free survival times than those with YKL-40 negative tumors. We propose that the potential utility of YKL-40 intratumoral staining or serum concentration as a biomarker for breast cancer is greatest within 5 years of diagnosis.	[Wang, Dong; Zhai, Bo; Liu, Chang; Zhao, Jinpeng; Xu, Jun] Harbin Med Univ, Dept Gen Surg, Hosp 4, Harbin, Peoples R China; [Hu, Fengli] Harbin Med Univ, Dept Gastroenterol, Hosp 4, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Wang, D (corresponding author), Harbin Med Univ, Dept Gen Surg, Hosp 4, Harbin, Peoples R China.	doctorwd1975@163.com			Heilongjiang Province Education Bureau [12511251, 11551208]; Heilongjiang Province Health Bureau [2010-148, 2010-147]	Heilongjiang Province Education Bureau; Heilongjiang Province Health Bureau	This work is supported in part by funding from Heilongjiang Province Education Bureau (12511251 and 11551208), and Heilongjiang Province Health Bureau (2010-148 and 2010-147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BREAST CANC FACTS FI; Bi J, 2009, HUM PATHOL, V40, P1790, DOI 10.1016/j.humpath.2009.07.005; Bojesen SE, 2011, CLIN CHIM ACTA, V412, P709, DOI 10.1016/j.cca.2011.01.022; Cintin C, 1999, BRIT J CANCER, V79, P1494, DOI 10.1038/sj.bjc.6690238; Faibish M, 2011, MOL CANCER THER, V10, P742, DOI 10.1158/1535-7163.MCT-10-0868; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jensen BV, 2003, CLIN CANCER RES, V9, P4423; Johansen JS, 2003, BREAST CANCER RES TR, V80, P15, DOI 10.1023/A:1024431000710; JOHANSEN JS, 1995, EUR J CANCER, V31A, P1437, DOI 10.1016/0959-8049(95)00196-P; Johansen JS, 2009, FUTURE ONCOL, V5, P1065, DOI 10.2217/FON.09.66; Junker N, 2005, LUNG CANCER, V48, P223, DOI 10.1016/j.lungcan.2004.11.011; Kim Steve H, 2007, World J Surg Oncol, V5, P17, DOI 10.1186/1477-7819-5-17; Peng C, 2010, J INT MED RES, V38, P1448, DOI 10.1177/147323001003800427; Qin WY, 2007, INT J CANCER, V121, P1536, DOI 10.1002/ijc.22881; Roslind A, 2008, BREAST CANCER RES TR, V112, P275, DOI 10.1007/s10549-007-9870-7; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Shao R, 2011, BRIT J CANCER, V105, P1203, DOI 10.1038/bjc.2011.347; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Stawerski P, 2011, PATHOL RES PRACT, V207, P573, DOI 10.1016/j.prp.2011.06.008; Thom I, 2010, CANCER-AM CANCER SOC, V116, P4114, DOI 10.1002/cncr.25196; Xiao XQ, 2011, HEPATOB PANCREAT DIS, V10, P605, DOI 10.1016/S1499-3872(11)60103-3; Yamac D, 2008, ADV THER, V25, P801, DOI 10.1007/s12325-008-0082-2	23	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51127	10.1371/journal.pone.0051127	http://dx.doi.org/10.1371/journal.pone.0051127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227243	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200102
J	Hawkins, CB; Nosek, BA				Hawkins, Carlee Beth; Nosek, Brian A.			When Ingroups Aren't "In": Perceived Political Belief Similarity Moderates Religious Ingroup Favoritism	PLOS ONE			English	Article							IN-GROUP IDENTIFICATION; SOCIAL IDENTITY; INTRAGROUP DISSONANCE; MORAL FOUNDATIONS; SELF-ESTEEM; GROUP BIAS; CATEGORIZATION; BEHAVIOR; PROJECTION; DOMINANCE	Motivated thinking leads people to perceive similarity between the self and ingroups, but under some conditions, people may recognize that personal beliefs are misaligned with the beliefs of ingroups. In two focal experiments and two replications, we find evidence that perceived belief similarity moderates ingroup favoritism. As part of a charity donation task, participants donated money to a community charity or a religious charity. Compared to non-religious people, Christians favored religious charities, but within Christians, conservative Christians favored religious charities more than liberal Christians did. Experiment 2 demonstrated that the perceived political beliefs of the charity accounted for the differences in ingroup favoritism between liberal and conservative Christians. While reporting little awareness of the influence of ideology, Christian conservatives favored religious charities because they perceived them as conservative and liberal Christians favored the community charity because they perceived it as liberal.	[Hawkins, Carlee Beth; Nosek, Brian A.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA	University of Virginia	Hawkins, CB (corresponding author), Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA.	cbh2z@virginia.edu		Nosek, Brian/0000-0001-6797-5476				ALLEN VL, 1975, J PERS SOC PSYCHOL, V32, P971, DOI 10.1037/0022-3514.32.6.971; Bettencourt BA, 1999, BRIT J SOC PSYCHOL, V38, P265, DOI 10.1348/014466699164167; Brewer MB, 2007, AM PSYCHOL, V62, P728, DOI 10.1037/0003-066X.62.8.728; BREWER MB, 1979, PSYCHOL BULL, V86, P307, DOI 10.1037/0033-2909.86.2.307; BREWER MB, 1991, PERS SOC PSYCHOL B, V17, P475, DOI 10.1177/0146167291175001; Buchan NR, 2011, PSYCHOL SCI, V22, P821, DOI 10.1177/0956797611409590; Cadinu MR, 1996, J PERS SOC PSYCHOL, V70, P661, DOI 10.1037/0022-3514.70.4.661; Chen FF, 2002, J PERS SOC PSYCHOL, V83, P111, DOI 10.1037//0022-3514.83.1.111; Clement RW, 2002, J EXP SOC PSYCHOL, V38, P219, DOI 10.1006/jesp.2001.1503; Davis JA, 2008, GEN SOCIAL SURVEYS 1; Fastnow C, 1999, SOC SCI QUART, V80, P687; Glasford DE, 2008, J EXP SOC PSYCHOL, V44, P1057, DOI 10.1016/j.jesp.2007.10.004; Glasford DE, 2009, PERS SOC PSYCHOL B, V35, P415, DOI 10.1177/0146167208329216; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Haidt J, 2009, PSYCHOL INQ, V20, P110, DOI 10.1080/10478400903028573; Hout M, 2002, AM SOCIOL REV, V67, P165, DOI 10.2307/3088891; Hunter JA, 2001, J SOC PSYCHOL, V141, P401, DOI 10.1080/00224540109600561; Jackson JW, 1999, PERS SOC PSYCHOL B, V25, P120, DOI 10.1177/0146167299025001010; Jost JT, 2008, PERSPECT PSYCHOL SCI, V3, P126, DOI 10.1111/j.1745-6916.2008.00070.x; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; Layman GC, 1997, PUBLIC OPIN QUART, V61, P288, DOI 10.1086/297796; List of charities, CHARITY NAVIGATOR YO; LUHTANEN R, 1992, PERS SOC PSYCHOL B, V18, P302, DOI 10.1177/0146167292183006; McDermott ML, 2009, POLIT RES QUART, V62, P340, DOI 10.1177/1065912908320668; MILLER AH, 1984, PUBLIC OPINION Q, V0048; MULLEN B, 1992, EUR J SOC PSYCHOL, V22, P103, DOI 10.1002/ejsp.2420220202; Nosek BA, 2009, SOCIAL PSYCHOL BASES, P480, DOI [10.1093/acprof:oso/9780195320916.003.020, DOI 10.1093/ACPROF:OSO/9780195320916.003.020]; Otten S, 2006, PERS SOC PSYCHOL B, V32, P957, DOI 10.1177/0146167206287254; Pickett CL, 2002, J PERS SOC PSYCHOL, V82, P543, DOI 10.1037//0022-3514.82.4.543; Robbins JM, 2005, PERS SOC PSYCHOL REV, V9, P32, DOI 10.1207/s15327957pspr0901_3; Rowatt WC, 2009, PSYCHOL RELIG SPIRIT, V1, P14, DOI 10.1037/a0014989; Samuelson W, 1988, J RISK UNCERTAINTY, V1, P7, DOI 10.1007/BF00055564; Sani F, 2002, PERS SOC PSYCHOL B, V28, P1647, DOI 10.1177/014616702237646; Sani F, 1998, EUR J SOC PSYCHOL, V28, P623, DOI 10.1002/(SICI)1099-0992(199807/08)28:4<623::AID-EJSP885>3.0.CO;2-G; Sani F., 1999, GROUP PROCESS INTERG, V2, P279, DOI DOI 10.1177/1368430299023005; Sidanius J, 1996, J PERS SOC PSYCHOL, V70, P476, DOI 10.1037/0022-3514.70.3.476; SIDANIUS J, 1994, J SOC PSYCHOL, V134, P151, DOI 10.1080/00224545.1994.9711378; Sidanius James, 1993, DUKE STUDIES POLITIC, DOI [10.1215/9780822396697-009, DOI 10.1215/9780822396697-009]; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Turner J.C., 1987, REDISCOVERING SOCIAL; Verkuyten M, 1999, EUR J SOC PSYCHOL, V29, P411, DOI 10.1002/(SICI)1099-0992(199903/05)29:2/3<411::AID-EJSP952>3.0.CO;2-8; Verkuyten M, 2007, GROUP PROCESS INTERG, V10, P341, DOI 10.1177/1368430207078695; WILCOX C, 1986, J POLIT, V48, P1041, DOI 10.2307/2131012; Yamane D, 2006, LEGISLATIVE STUDIES, VXXXI, P443; Ysseldyk R, 2010, PERS SOC PSYCHOL REV, V14, P60, DOI 10.1177/1088868309349693	48	5	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50945	10.1371/journal.pone.0050945	http://dx.doi.org/10.1371/journal.pone.0050945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251406	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200050
J	Russell, BD; Connell, SD; Mellin, C; Brook, BW; Burnell, OW; Fordham, DA				Russell, Bayden D.; Connell, Sean D.; Mellin, Camille; Brook, Barry W.; Burnell, Owen W.; Fordham, Damien A.			Predicting the Distribution of Commercially Important Invertebrate Stocks under Future Climate	PLOS ONE			English	Article							BLACKLIP HALIOTIS-RUBRA; ABALONE GENUS-HALIOTIS; H-LAEVIGATA ABALONE; AUSTRALIAN ABALONE; GREENLIP ABALONE; MARINE FISHES; TEMPERATURE; ECOLOGY; COMMUNITIES; RECRUITMENT	The future management of commercially exploited species is challenging because techniques used to predict the future distribution of stocks under climate change are currently inadequate. We projected the future distribution and abundance of two commercially harvested abalone species (blacklip abalone, Haliotis rubra and greenlip abalone, H. laevigata) inhabiting coastal South Australia, using multiple species distribution models (SDM) and for decadal time slices through to 2100. Projections are based on two contrasting global greenhouse gas emissions scenarios. The SDMs identified August (winter) Sea Surface Temperature (SST) as the best descriptor of abundance and forecast that warming of winter temperatures under both scenarios may be beneficial to both species by allowing increased abundance and expansion into previously uninhabited coasts. This range expansion is unlikely to be realised, however, as projected warming of March SST is projected to exceed temperatures which cause up to 10-fold increases in juvenile mortality. By linking fine-resolution forecasts of sea surface temperature under different climate change scenarios to SDMs and physiological experiments, we provide a practical first approximation of the potential impact of climate-induced change on two species of marine invertebrates in the same fishery.	[Russell, Bayden D.; Connell, Sean D.; Burnell, Owen W.] Univ Adelaide, Sch Earth & Environm Sci, So Seas Ecol Labs, Adelaide, SA, Australia; [Mellin, Camille] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Mellin, Camille; Brook, Barry W.; Fordham, Damien A.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia	University of Adelaide; Australian Institute of Marine Science; University of Adelaide	Russell, BD (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, So Seas Ecol Labs, Adelaide, SA, Australia.	bayden.russell@adelaide.edu.au	Brook, Barry W./G-2686-2011; Connell, Sean D/A-8874-2008; Russell, Bayden D./A-9942-2008; Mellin, Camille/X-9161-2019; Mellin, Camille/AAB-1768-2019; Fordham, Damien A/E-9255-2013; Russell, Bayden D./R-9325-2019	Brook, Barry W./0000-0002-2491-1517; Connell, Sean D/0000-0002-5350-6852; Russell, Bayden D./0000-0003-1282-9978; Mellin, Camille/0000-0002-7369-2349; Fordham, Damien A/0000-0003-2137-5592; Russell, Bayden D./0000-0003-1282-9978	Australian Research Council; Marine Biodiversity Hub; Australian Government's National Environmental Research Program (NERP)	Australian Research Council(Australian Research Council); Marine Biodiversity Hub; Australian Government's National Environmental Research Program (NERP)(Australian Government)	The research was partly funded by Australian Research Council Grants to D.A. Fordham, B.W. Brook and S.D. Connell. C. Mellin was funded by the Marine Biodiversity Hub, a collaborative partnership supported through funding from the Australian Government's National Environmental Research Program (NERP). NERP Marine Biodiversity Hub partners include the Institute for Marine and Antarctic Studies, University of Tasmania; CSIRO, Geoscience Australia, Australian Institute of Marine Science, Museum Victoria, Charles Darwin University and the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Brook BW, 2009, BIOL LETTERS, V5, P723, DOI 10.1098/rsbl.2009.0480; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Buisson L, 2009, DIVERS DISTRIB, V15, P613, DOI 10.1111/j.1472-4642.2009.00565.x; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Convertino M, 2012, ECOL MODEL, V240, P1, DOI 10.1016/j.ecolmodel.2012.04.012; Fordham DA, 2011, ECOL APPL, V21, P3317, DOI 10.1890/11-0314.1; Fordham DA, 2012, ECOGRAPHY, V35, P4, DOI 10.1111/j.1600-0587.2011.07398.x; Fordham DA, 2010, BIODIVERS CONSERV, V19, P329, DOI 10.1007/s10531-008-9529-7; Gilroy A, 1998, AQUAC RES, V29, P481, DOI 10.1046/j.1365-2109.1998.00241.x; Grubert MA, 2004, INVERTEBR REPROD DEV, V45, P185, DOI 10.1080/07924259.2004.9652590; Grubert MA, 2004, INVERTEBR REPROD DEV, V45, P197, DOI 10.1080/07924259.2004.9652591; Harris JO, 2005, AQUAC RES, V36, P1400, DOI 10.1111/j.1365-2109.2005.01360.x; Hawkins SJ, 2008, CLIM RES, V37, P123, DOI 10.3354/cr00768; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Hiddink JG, 2008, GLOBAL CHANGE BIOL, V14, P453, DOI 10.1111/j.1365-2486.2007.01518.x; HULME M, 1995, ENERG POLICY, V23, P347, DOI 10.1016/0301-4215(95)90159-5; Hutchinson M.F, 2006, ANUSPLIN VERSION 4 3; IPCC, 2007, INT PAN CLIM CHANG A; Kamenos NA, 2010, P NATL ACAD SCI USA, V107, P22442, DOI 10.1073/pnas.1006141107; Mayfield S, 2011, REV FISH SCI, V19, P216, DOI 10.1080/10641262.2011.585431; Mayfield S, REV FISHERI IN PRESS; Mellin C, 2012, DIVERS DISTRIB, V18, P133, DOI 10.1111/j.1472-4642.2011.00822.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pierce DW, 2009, P NATL ACAD SCI USA, V106, P8441, DOI 10.1073/pnas.0900094106; Planque B, 1999, CAN J FISH AQUAT SCI, V56, P2069, DOI 10.1139/cjfas-56-11-2069; Randall DA, 2007, PHYS SCI BASIS CONTR, P589; Robinson LM, 2011, GLOBAL ECOL IN PRESS; Rogers LA, 2011, P NATL ACAD SCI USA, V108, P1961, DOI 10.1073/pnas.1010314108; Rossetto M, 2012, OECOLOGIA, V168, P989, DOI 10.1007/s00442-011-2163-1; Russell BD, 2012, BIOL LETTERS, V8, P164, DOI 10.1098/rsbl.2011.0779; Searle T, 2006, AQUAC RES, V37, P1441, DOI 10.1111/j.1365-2109.2006.01580.x; Sequeira A, 2011, DIVERSITY D IN PRESS; Shephard S, 2010, MAR BIOL, V157, P91, DOI 10.1007/s00227-009-1298-7; SHEPHERD SA, 1993, CAN J FISH AQUAT SCI, V50, P2001, DOI 10.1139/f93-224; SHEPHERD SA, 1973, AUST J MAR FRESH RES, V24, P217, DOI 10.1071/MF9730217; Shepherd SA, 1998, J SHELLFISH RES, V17, P839; SHEPHERD SA, 1995, MAR FRESHWATER RES, V46, P669, DOI 10.1071/MF9950669; Smale DA, 2009, MAR ECOL PROG SER, V387, P27, DOI 10.3354/meps08132; Stock CA, 2011, PROG OCEANOGR, V88, P1, DOI 10.1016/j.pocean.2010.09.001; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Takami H, 2008, MAR ECOL PROG SER, V367, P203, DOI 10.3354/meps07557; Watts MJ, 2011, ECOL MODEL, V222, P2606, DOI 10.1016/j.ecolmodel.2011.04.024; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Wigley TML, 2009, CLIMATIC CHANGE, V97, P85, DOI 10.1007/s10584-009-9585-3; Wigley TML, 1996, NATURE, V379, P240, DOI 10.1038/379240a0; Wilby R, 2004, GUIDELINES USE CLIMA; Wilby RL, 2000, GEOPHYS RES LETT, V27, P1199, DOI 10.1029/1999GL006078	52	9	9	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e46554	10.1371/journal.pone.0046554	http://dx.doi.org/10.1371/journal.pone.0046554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251326	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200001
J	Huillet, E; Tempelaars, MH; Andre-Leroux, G; Wanapaisan, P; Bridoux, L; Makhzami, S; Panbangred, W; Martin-Verstraete, I; Abee, T; Lereclus, D				Huillet, Eugenie; Tempelaars, Marcel H.; Andre-Leroux, Gwenaelle; Wanapaisan, Pagakrong; Bridoux, Ludovic; Makhzami, Samira; Panbangred, Watanalai; Martin-Verstraete, Isabelle; Abee, Tjakko; Lereclus, Didier			PlcRa, a New Quorum-Sensing Regulator from Bacillus cereus, Plays a Role in Oxidative Stress Responses and Cysteine Metabolism in Stationary Phase	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; CELL-CELL COMMUNICATION; III PANTOTHENATE KINASE; GENE-EXPRESSION; VIRULENCE REGULON; GLOBAL REGULATOR; BINDING PROTEIN; TOXIN GENE; SUBTILIS; ANTHRACIS	We characterized a new quorum-sensing regulator, PlcRa, which is present in various members of the B. cereus group and identified a signaling heptapeptide for PlcRa activity: PapRa(7). We demonstrated that PlcRa is a 3D structural paralog of PlcR using sequence analysis and homology modeling. A comparison of the transcriptomes at the onset of stationary phase of a Delta plcRa mutant and the wild-type B. cereus ATCC 14579 strain showed that 68 genes were upregulated and 49 genes were downregulated in the DplcRa mutant strain (>3-fold change). Genes involved in the cysteine metabolism (putative CymR regulon) were downregulated in the Delta plcRa mutant strain. We focused on the gene with the largest difference in expression level between the two conditions, which encoded -AbrB2-a new regulator of the AbrB family. We demonstrated that purified PlcRa bound specifically to the abrB2 promoter in the presence of synthetic PapRa(7), in an electrophoretic mobility shift assay. We further showed that the AbrB2 regulator controlled the expression of the yrrT operon involved in methionine to cysteine conversion. We found that the DplcRa mutant strain was more sensitive to hydrogen peroxide-and disulfide-induced stresses than the wild type. When cystine was added to the culture of the DplcRa mutant, challenged with hydrogen peroxide, growth inhibition was abolished. In conclusion, we identified a new RNPP transcriptional regulator in B. cereus that activated the oxidative stress response and cysteine metabolism in transition state cells.	[Huillet, Eugenie; Wanapaisan, Pagakrong; Bridoux, Ludovic; Lereclus, Didier] INRA, Micalis Genet Microbienne & Environm UMR1319, Guyancourt, France; [Tempelaars, Marcel H.; Abee, Tjakko] Wageningen Univ, Food Microbiol Lab, Wageningen, Netherlands; [Andre-Leroux, Gwenaelle] Inst Pasteur, CNRS, UMR 3528, Paris, France; [Wanapaisan, Pagakrong; Panbangred, Watanalai] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Makhzami, Samira] INRA, UMR GABI, ICE, Jouy En Josas, France; [Martin-Verstraete, Isabelle] Inst Pasteur, Lab Pathogenese Bacteries Anaerobies, Paris, France; [Martin-Verstraete, Isabelle] Univ Paris Diderot, Paris, France	INRAE; Wageningen University & Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mahidol University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Huillet, E (corresponding author), INRA, Micalis Genet Microbienne & Environm UMR1319, Guyancourt, France.	Eugenie.Huillet@jouy.inra.fr; Didier.Lereclus@jouy.inra.fr	Martin-Verstraete, Isabelle/R-7109-2019; Lereclus, Didier/AAD-8293-2019; Tempelaars, Marcel/C-5077-2008	Martin-Verstraete, Isabelle/0000-0002-8376-7690; Wanapaisan, Pagakrong/0000-0002-7682-5936; Lereclus, Didier/0000-0001-9047-9104; Tempelaars, Marcel/0000-0003-0635-5606	French National Research Agency [ANR-09-Blan-0253]; INRA (MICA department)	French National Research Agency(French National Research Agency (ANR)); INRA (MICA department)	This work was supported by the French National Research Agency (Cell.com project; NoANR-09-Blan-0253) and by INRA (MICA department). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x; AGAISSE H, 1994, MOL MICROBIOL, V13, P97, DOI 10.1111/j.1365-2958.1994.tb00405.x; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Auger S, 2002, J BACTERIOL, V184, P5179, DOI 10.1128/JB.184.18.5179-5186.2002; Bouillaut L, 2008, NUCLEIC ACIDS RES, V36, P3791, DOI 10.1093/nar/gkn149; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Burguiere P, 2004, J BACTERIOL, V186, P4875, DOI 10.1128/JB.186.15.4875-4884.2004; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Ceragioli M, 2010, APPL ENVIRON MICROB, V76, P3352, DOI 10.1128/AEM.03003-09; Choi SY, 2006, J BACTERIOL, V188, P5741, DOI 10.1128/JB.00443-06; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Declerck N, 2007, P NATL ACAD SCI USA, V104, P18490, DOI 10.1073/pnas.0704501104; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Dunny GM, 1997, ANNU REV MICROBIOL, V51, P527, DOI 10.1146/annurev.micro.51.1.527; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Even S, 2006, J BACTERIOL, V188, P2184, DOI 10.1128/JB.188.6.2184-2197.2006; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Gominet M, 2001, MOL MICROBIOL, V40, P963, DOI 10.1046/j.1365-2958.2001.02440.x; Graumann PL, 2009, CHROMOSOME RES, V17, P265, DOI 10.1007/s10577-008-9014-x; Hadjifrangiskou M, 2007, J BACTERIOL, V189, P1874, DOI 10.1128/JB.01333-06; Hochgrafe F, 2007, J BIOL CHEM, V282, P25981, DOI 10.1074/jbc.C700105200; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Hullo MF, 2007, J BACTERIOL, V189, P187, DOI 10.1128/JB.01273-06; Hullo MF, 2010, FEMS MICROBIOL LETT, V309, P201, DOI 10.1111/j.1574-6968.2010.02043.x; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; LERECLUS D, 1989, FEMS MICROBIOL LETT, V60, P211, DOI 10.1016/0378-1097(89)90511-9; LERECLUS D, 1992, BIO-TECHNOL, V10, P418, DOI 10.1038/nbt0492-418; Mols M, 2011, ENVIRON MICROBIOL, V13, P1387, DOI 10.1111/j.1462-2920.2011.02433.x; Moran Charles P. Jr., 1993, P653; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Nicely NI, 2007, BIOCHEMISTRY-US, V46, P3234, DOI 10.1021/bi062299p; Paige C, 2008, J BACTERIOL, V190, P6271, DOI 10.1128/JB.00860-08; Parashar V, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000589; Perchat S, 2011, MOL MICROBIOL, V82, P619, DOI 10.1111/j.1365-2958.2011.07839.x; Phillips ZEV, 2002, CELL MOL LIFE SCI, V59, P392, DOI 10.1007/s00018-002-8431-9; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Pohl S, 2011, PROTEOMICS, V11, P3036, DOI 10.1002/pmic.201100085; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Ross CL, 2006, J BACTERIOL, V188, P7823, DOI 10.1128/JB.00525-06; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salvetti S, 2011, APPL ENVIRON MICROB, V77, P5149, DOI 10.1128/AEM.00245-11; Sanchis V, 1996, J BIOTECHNOL, V48, P81, DOI 10.1016/0168-1656(96)01404-6; Shi K, 2005, P NATL ACAD SCI USA, V102, P18596, DOI 10.1073/pnas.0506163102; Slamti L, 2002, EMBO J, V21, P4550, DOI 10.1093/emboj/cdf450; Smeesters PR, 2011, RES MICROBIOL, V162, P446, DOI 10.1016/j.resmic.2011.02.009; Solomon JM, 1996, GENE DEV, V10, P2014, DOI 10.1101/gad.10.16.2014; Soutourina O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000894; STRAUCH MA, 1989, EMBO J, V8, P1615, DOI 10.1002/j.1460-2075.1989.tb03546.x; Tanous C, 2008, J BIOL CHEM, V283, P35551, DOI 10.1074/jbc.M805951200; Tu WY, 2012, J BACTERIOL, V194, P925, DOI 10.1128/JB.06005-11; van Schaik W, 2007, J BACTERIOL, V189, P4384, DOI 10.1128/JB.00313-07; Wang L, 2012, APPL MICROBIOL BIOTE; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241	55	19	20	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51047	10.1371/journal.pone.0051047	http://dx.doi.org/10.1371/journal.pone.0051047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239999	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800035
J	Nfon, C; Berhane, Y; Pasick, J; Embury-Hyatt, C; Kobinger, G; Kobasa, D; Babiuk, S				Nfon, Charles; Berhane, Yohannes; Pasick, John; Embury-Hyatt, Carissa; Kobinger, Gary; Kobasa, Darwyn; Babiuk, Shawn			Prior Infection of Chickens with H1N1 or H1N2 Avian Influenza Elicits Partial Heterologous Protection against Highly Pathogenic H5N1	PLOS ONE			English	Article							A VIRUS; HONG-KONG; HETEROSUBTYPIC IMMUNITY; MONOCLONAL-ANTIBODY; POULTRY; MICE; CHALLENGE; VACCINE; HEMAGGLUTININ; TRANSMISSION	There is a critical need to have vaccines that can protect against emerging pandemic influenza viruses. Commonly used influenza vaccines are killed whole virus that protect against homologous and not heterologous virus. Using chickens we have explored the possibility of using live low pathogenic avian influenza (LPAI) A/goose/AB/223/2005 H1N1 or A/WBS/MB/325/2006 H1N2 to induce immunity against heterologous highly pathogenic avian influenza (HPAI) A/chicken/Vietnam/14/2005 H5N1. H1N1 and H1N2 replicated in chickens but did not cause clinical disease. Following infection, chickens developed nucleoprotein and H1 specific antibodies, and reduced H5N1 plaque size in vitro in the absence of H5 neutralizing antibodies at 21 days post infection (DPI). In addition, heterologous cell mediated immunity (CMI) was demonstrated by antigen-specific proliferation and IFN-gamma secretion in PBMCs re-stimulated with H5N1 antigen. Following H5N1 challenge of both pre-infected and naive controls chickens housed together, all naive chickens developed acute disease and died while H1N1 or H1N2 pre-infected chickens had reduced clinical disease and 70-80% survived. H1N1 or H1N2 pre-infected chickens were also challenged with H5N1 and naive chickens placed in the same room one day later. All pre-infected birds were protected from H5N1 challenge but shed infectious virus to naive contact chickens. However, disease onset, severity and mortality was reduced and delayed in the naive contacts compared to directly inoculated naive controls. These results indicate that prior infection with LPAI virus can generate heterologous protection against HPAI H5N1 in the absence of specific H5 antibody. Citation: Nfon C, Berhane Y, Pasick J, Embury-Hyatt C, Kobinger G, et al. (2012) Prior Infection of Chickens with H1N1 or H1N2 Avian Influenza Elicits Partial Heterologous Protection against Highly Pathogenic H5N1. PLoS ONE 7(12): e51933. doi: 10.1371/journal.pone.0051933	[Nfon, Charles; Berhane, Yohannes; Pasick, John; Embury-Hyatt, Carissa; Babiuk, Shawn] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Kobinger, Gary; Kobasa, Darwyn] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Berhane, Yohannes] Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada; [Kobinger, Gary; Kobasa, Darwyn] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Babiuk, Shawn] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada	Canadian Food Inspection Agency; Public Health Agency of Canada; University of Manitoba; University of Manitoba; University of Manitoba	Babiuk, S (corresponding author), Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.	shawn.babiuk@inspection.gc.ca			Canadian Institutes of Health Research influenza team grant FRN [90191]	Canadian Institutes of Health Research influenza team grant FRN(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Canadian Institutes of Health Research influenza team grant FRN# 90191. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNINK JR, 1987, J VIROL, V61, P1098, DOI 10.1128/JVI.61.4.1098-1102.1987; Berhane Y, 2010, AVIAN DIS, V54, P548, DOI 10.1637/8841-040309-Reg.1; Bodewes R, 2011, J VIROL, V85, P2695, DOI 10.1128/JVI.02371-10; Bridges CB, 2000, J INFECT DIS, V181, P344, DOI 10.1086/315213; Butler D, 2010, NATURE, V464, P1112, DOI 10.1038/4641112a; Claas ECJ, 1998, VACCINE, V16, P977, DOI 10.1016/S0264-410X(98)00005-X; Costa TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015987; Dalgaard TS, 2010, VACCINE, V28, P4506, DOI 10.1016/j.vaccine.2010.04.044; Drew TW, 2008, OIE MANUAL DIAGNOSTI, P465; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Fouchier RAM, 2012, SCIENCE, V335, P662, DOI 10.1126/science.1218376; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Grund C, 2011, VACCINE, V29, P5567, DOI 10.1016/j.vaccine.2011.01.006; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Kawaoka Y, 2012, NATURE, V482, P155, DOI 10.1038/nature10884; Lee CW, 2004, J VIROL, V78, P8372, DOI [10.1128/JVI.78.15.8372-8381.2004, 10.1128/jvi.78.15.8372-8381.2004]; Masic A, 2009, J VIROL, V83, P10198, DOI 10.1128/JVI.00926-09; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; O'Neill E, 2000, J GEN VIROL, V81, P2689, DOI 10.1099/0022-1317-81-11-2689; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pasick J, 2005, J GEN VIROL, V86, P727, DOI 10.1099/vir.0.80478-0; Patel A, 2009, VACCINE, V27, P3083, DOI 10.1016/j.vaccine.2009.03.023; Pederson J, 2008, METHODS MOL BIOL AVI; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Shi JZ, 2012, ANTIVIR RES, V93, P346, DOI 10.1016/j.antiviral.2012.01.001; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Suarez DL, 2000, AVIAN DIS, V44, P356, DOI 10.2307/1592550; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Van Reeth K, 2009, VACCINE, V27, P6330, DOI 10.1016/j.vaccine.2009.03.021; Webster R, 2002, WHO MANUAL ANIMAL IN; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhou EM, 1998, AVIAN DIS, V42, P517, DOI 10.2307/1592678	40	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51933	10.1371/journal.pone.0051933	http://dx.doi.org/10.1371/journal.pone.0051933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240067	gold, Green Published, Green Submitted			2022-12-27	WOS:000312290800103
J	Osamor, VC; Adebiyi, EF; Oyelade, JO; Doumbia, S				Osamor, Victor Chukwudi; Adebiyi, Ezekiel Femi; Oyelade, Jelilli Olarenwaju; Doumbia, Seydou			Reducing the Time Requirement of k-Means Algorithm	PLOS ONE			English	Article							EXPRESSION DATA	Traditional k-means and most k-means variants are still computationally expensive for large datasets, such as microarray data, which have large datasets with large dimension size d. In k-means clustering, we are given a set of n data points in d-dimensional space R-d and an integer k. The problem is to determine a set of k points in R-d, called centers, so as to minimize the mean squared distance from each data point to its nearest center. In this work, we develop a novel k-means algorithm, which is simple but more efficient than the traditional k-means and the recent enhanced k-means. Our new algorithm is based on the recently established relationship between principal component analysis and the k-means clustering. We provided the correctness proof for this algorithm. Results obtained from testing the algorithm on three biological data and six non-biological data (three of these data are real, while the other three are simulated) also indicate that our algorithm is empirically faster than other known k-means algorithms. We assessed the quality of our algorithm clusters against the clusters of a known structure using the Hubert-Arabie Adjusted Rand index (ARI(HA)). We found that when k is close to d, the quality is good (ARI(HA)> 0.8) and when k is not close to d, the quality of our new k-means algorithm is excellent (ARI(HA)> 0.9). In this paper, emphases are on the reduction of the time requirement of the k-means algorithm and its application to microarray data due to the desire to create a tool for clustering and malaria research. However, the new clustering algorithm can be used for other clustering needs as long as an appropriate measure of distance between the centroids and the members is used. This has been demonstrated in this work on six non-biological data. Citation: Osamor VC, Adebiyi EF, Oyelade JO, Doumbia S (2012) Reducing the Time Requirement of k-Means Algorithm. PLoS ONE 7(12): e49946. doi:10.1371/journal.pone.0049946	[Osamor, Victor Chukwudi; Adebiyi, Ezekiel Femi; Oyelade, Jelilli Olarenwaju] Covenant Univ, Coll Sci & Technol, Dept Comp & Informat Sci, Ota, Ogun State, Nigeria; [Doumbia, Seydou] Univ Bamako, MRTC, Bamako, Mali	Covenant University; University of Bamako	Adebiyi, EF (corresponding author), Covenant Univ, Coll Sci & Technol, Dept Comp & Informat Sci, Ota, Ogun State, Nigeria.	e.adebiyi@daad-alumni.de	Osamor, Victor/P-1264-2019; Oyelade, Jelili/O-2157-2019; Oyelade, Jelili O./M-8123-2013	Oyelade, Jelili/0000-0002-5476-4992; Osamor, Victor/0000-0003-1868-0967	Covenant University Staff Development grant	Covenant University Staff Development grant	This work was funded by the Covenant University Staff Development grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2002, DNA MICROARRAYS GENE; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Dash B., 2010, J INT J ENG SCI TECH, V2, P59, DOI [10.4314/ijest.v2i2.59139, DOI 10.4314/IJEST.V2I2.59139]; Deelers S, 2007, PROC WRLD ACAD SCI E, V26, P323; Dembele D, 2003, BIOINFORMATICS, V19, P973, DOI 10.1093/bioinformatics/btg119; Ding C, 2004, SIAM PROC S, P497; Ding C., 2004, ACM INT C P SERIES, V69, P29; Fahim A., 2006, J ZHEJIANG U SCI A, V7, P1626, DOI 10.1631/jzus.2006.A1626; FAN K, 1949, P NATL ACAD SCI USA, V35, P652, DOI 10.1073/pnas.35.11.652; Feng Yu, 2006, P 20 ANN C NEUR INF; Hamerly G., 2003, P 17 ANN C NEUR INF; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Kanungo T, 2004, COMP GEOM-THEOR APPL, V28, P89, DOI 10.1016/j.comgeo.2004.03.003; Kumar A, 2004, ANN IEEE SYMP FOUND, P454, DOI 10.1109/FOCS.2004.7; Kumar R., 2011, INT J INNOVATION MAN, V2, P49; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lloyd S., 1957, IEEE T INFORM THEORY; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Nazeer KAA, 2009, LECT NOTES ENG COMP, P308; Osamor V, 2009, INT J ENG TECHNOL, V2, P215; Pelleg D., 2000, P 17 INT C MACH LEAR, P727, DOI DOI 10.1007/3-540-44491-2_3; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; SELIM SZ, 1984, IEEE T PATTERN ANAL, V6, P81, DOI 10.1109/TPAMI.1984.4767478; Steinley D, 2004, PSYCHOL METHODS, V9, P386, DOI 10.1037/1082-989X.9.3.386; Tajunisha N., 2011, INT J DATABASE MGT S, V3, P196; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Yedla M., 2010, INT J COMPUT SCI INF, V1, P121; Yona Golan, 2009, V541, P479, DOI 10.1007/978-1-59745-243-4_21; Zha HY, 2002, ADV NEUR IN, V14, P1057	30	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49946	10.1371/journal.pone.0049946	http://dx.doi.org/10.1371/journal.pone.0049946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239974	Green Published, gold			2022-12-27	WOS:000312290800012
J	Pinheiro, MB; Antonelli, LR; Sathler-Avelar, R; Vitelli-Avelar, DM; Spindola-de-Miranda, S; Guimaraes, TMPD; Teixeira-Carvalho, A; Martins, OA; Toledo, VPCP				Pinheiro, Melina B.; Antonelli, Lis R.; Sathler-Avelar, Renato; Vitelli-Avelar, Danielle M.; Spindola-de-Miranda, Silvana; Guimaraes, Tania M. P. D.; Teixeira-Carvalho, Andrea; Martins-Filho, Olindo A.; Toledo, Vicente P. C. P.			CD4-CD8-alpha beta and gamma delta T Cells Display Inflammatory and Regulatory Potentials during Human Tuberculosis	PLOS ONE			English	Article							DOUBLE-NEGATIVE CD4(-)CD8(-); ACTIVE PULMONARY TUBERCULOSIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NECROSIS-FACTOR-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; RHEUMATOID-ARTHRITIS; TH1 RESPONSES; LYMPHOCYTES-T; INFECTION	T-cells play an important role controlling immunity against pathogens and therefore influence the outcome of human diseases. Although most T-lymphocytes co-express either CD4 or CD8, a smaller T-cell subset found the in the human peripheral blood that expresses the alpha beta or gamma delta T-cell-receptor (TCR) lacks the CD4 and CD8 co-receptors. These double negative (DN) T-cells have been shown to display important immunological functions in human diseases. To better understand the role of DN T-cells in human Mycobacterium tuberculosis, we have characterized their frequency, activation and cytokine profile in a well-defined group of tuberculosis patients, categorized as severe and non-severe based on their clinical status. Our data showed that whereas high frequency of alpha beta DN T-cells observed in M. tuberculosis-infected patients are associated with disease severity, decreased proportion of gamma delta DN T-cells are found in patients with severe tuberculosis. Together with activation of CD4(+) and CD8(+) T-cells, higher frequencies of both alpha beta and gamma delta DN T-cells from tuberculosis patients also express the chronic activation marker HLA-DR. However, the expression of CD69, an early activation marker, is selectively observed in DN T-cells. Interestingly, while alpha beta and gamma delta DN T-cells from patients with non-severe tuberculosis display a pro-inflammatory cytokine profile, characterized by enhanced IFN-gamma, the gamma delta DN T-cells from patients with severe disease express a modulatory profile exemplified by enhanced interleukin-10 production. Overall, our findings suggest that alpha beta and gamma delta DN T-cell present disparate immunoregulatory potentials and seems to contribute to the development/maintenance of distinct clinical aspects of TB, as part of the complex immunological network triggered by the TB infection.	[Antonelli, Lis R.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Imunopatol, Belo Horizonte, MG, Brazil; [Pinheiro, Melina B.; Guimaraes, Tania M. P. D.; Toledo, Vicente P. C. P.] Univ Fed Minas Gerais, Fac Farm, Dept Anal Clin & Toxicol, Belo Horizonte, MG, Brazil; [Sathler-Avelar, Renato; Vitelli-Avelar, Danielle M.; Teixeira-Carvalho, Andrea; Martins-Filho, Olindo A.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, Belo Horizonte, MG, Brazil; [Spindola-de-Miranda, Silvana] Univ Fed Minas Gerais, Dept Clin Med, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Antonelli, LR (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Imunopatol, Belo Horizonte, MG, Brazil.	lisantonelli@cpqrr.fiocruz.br; toledovp.bh@terra.com.br	Martins-Filho, Olindo Assis/ABE-6278-2021; guimarães, Tania Mara Pinto Dabés/ABD-1337-2021; Antonelli, Lis/R-4910-2019; de Miranda, S Spindola/A-7335-2013; Antonelli, Lis/G-2907-2012; Antonelli, Guido/K-7915-2016	Martins-Filho, Olindo Assis/0000-0002-5494-4889; Antonelli, Lis/0000-0002-4969-8812; 	Foundation for Research Support of Minas Gerais (FAPEMIG); National Counsel of Technological and Scientific Development (CNPq)	Foundation for Research Support of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank Foundation for Research Support of Minas Gerais (FAPEMIG) and National Counsel of Technological and Scientific Development (CNPq) for the financial support and the Program for Technological Development in Tools for Health - PDTIS - FIOCRUZ for use of its facilities. LRA, ATC and OAMF are CNPq fellows (PQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LB, 1995, J INFECT DIS, V171, P400, DOI 10.1093/infdis/171.2.400; Al-Moamary MS, 1999, CHEST, V116, P726, DOI 10.1378/chest.116.3.726; Almeida AS, 2009, J IMMUNOL, V183, P718, DOI 10.4049/jimmunol.0801212; Villani FNA, 2010, INFECT IMMUN, V78, P4421, DOI 10.1128/IAI.00179-10; Antonelli LRV, 2006, INFECT IMMUN, V74, P6317, DOI 10.1128/IAI.00890-06; BARNES PF, 1992, J INFECT DIS, V165, P506, DOI 10.1093/infdis/165.3.506; Botha T, 2003, J IMMUNOL, V171, P3110, DOI 10.4049/jimmunol.171.6.3110; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Byrd TF, 1997, J CLIN INVEST, V99, P2518, DOI 10.1172/JCI119436; Casetti R, 2008, CELL MOL IMMUNOL, V5, P161, DOI 10.1038/cmi.2008.20; Del Prete G.F., 1993, J IMMUNOL, V150, P1; DELLABONA P, 1993, J EXP MED, V177, P1763, DOI 10.1084/jem.177.6.1763; Derrick SC, 2007, IMMUNOLOGY, V120, P192, DOI 10.1111/j.1365-2567.2006.02491.x; Feng CG, 2006, J IMMUNOL, V177, P7086, DOI 10.4049/jimmunol.177.10.7086; Fischer K, 2005, BLOOD, V105, P2828, DOI 10.1182/blood-2004-07-2583; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Gioia C, 2003, INT J IMMUNOPATH PH, V16, P247, DOI 10.1177/039463200301600310; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; JANIS EM, 1989, SCIENCE, V244, P713, DOI 10.1126/science.2524098; Jankovic D, 2007, NAT IMMUNOL, V8, P1281, DOI 10.1038/ni1207-1281; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Liu MF, 1999, CLIN RHEUMATOL, V18, P227, DOI 10.1007/s100670050089; Liu MF, 1998, SCAND J RHEUMATOL, V27, P130; Montoya CJ, 2008, CLIN IMMUNOL, V127, P1, DOI 10.1016/j.clim.2007.12.006; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Lazzarini LCO, 2008, J CLIN MICROBIOL, V46, P2175, DOI 10.1128/JCM.00065-08; Ottenhoff THM, 2005, TUBERCULOSIS, V85, P53, DOI 10.1016/j.tube.2004.09.011; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Priya VHS, 2010, CYTOKINE, V52, P190, DOI 10.1016/j.cyto.2010.07.001; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Sieling PA, 2000, J IMMUNOL, V165, P5338, DOI 10.4049/jimmunol.165.9.5338; Stenger S, 1997, SCIENCE, V276, P1684, DOI 10.1126/science.276.5319.1684; Streitz M, 2011, J INFECT DIS, V203, P378, DOI 10.1093/infdis/jiq065; Thomson CW, 2006, IMMUNOL RES, V35, P163, DOI 10.1385/IR:35:1:163; THOMSSEN H, 1995, IMMUNOLOGY, V85, P33; UETA C, 1994, INFECT IMMUN, V62, P5434, DOI 10.1128/IAI.62.12.5434-5441.1994; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960	42	36	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50923	10.1371/journal.pone.0050923	http://dx.doi.org/10.1371/journal.pone.0050923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239994	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800030
J	Wintermute, S; Betts, S; Ferris, JL; Fincham, JM; Anderson, JR				Wintermute, Samuel; Betts, Shawn; Ferris, Jennifer L.; Fincham, Jon M.; Anderson, John R.			Brain Networks Supporting Execution of Mathematical Skills versus Acquisition of New Mathematical Competence	PLOS ONE			English	Article							COGNITIVE CONTROL; PARIETAL CORTEX; FRONTAL-CORTEX; REPRESENTATION; NUMBER; VISUALIZATION; ORGANIZATION; ACTIVATION; SOFTWARE	This fMRI study examines how students extend their mathematical competence. Students solved a set of algebra-like problems. These problems included Regular Problems that have a known solution technique and Exception Problems that but did not have a known technique. Two distinct networks of activity were uncovered. There was a Cognitive Network that was mainly active during the solution of problems and showed little difference between Regular Problems and Exception Problems. There was also a Metacognitive Network that was more engaged during a reflection period after the solution and was much more engaged for Exception Problems than Regular Problems. The Cognitive Network overlaps with prefrontal and parietal regions identified in the ACT-R theory of algebra problem solving and regions identified in the triple-code theory as involved in basic mathematical cognition. The Metacognitive Network included angular gyrus, middle temporal gyrus, and anterior prefrontal regions. This network is mainly engaged by the need to modify the solution procedure and not by the difficulty of the problem. Only the Metacognitive Network decreased with practice on the Exception Problems. Activity in the Cognitive Network during the solution of an Exception Problem predicted both success on that problem and future mastery. Activity in the angular gyrus and middle temporal gyrus during feedback on errors predicted future mastery.	[Wintermute, Samuel; Betts, Shawn; Ferris, Jennifer L.; Fincham, Jon M.; Anderson, John R.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Anderson, JR (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	ja+@cmu.edu			National Science Foundation [DRL-1007945]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation grant DRL-1007945 to JRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.R., 2007, CAN HUMAN MIND OCCUR; Anderson JR, 2011, COGN AFFECT BEHAV NE, V11, P52, DOI 10.3758/s13415-010-0011-0; Anderson JR, 2005, COGNITIVE SCI, V29, P313, DOI 10.1207/s15516709cog0000_22; Anderson JR, 2004, PSYCHOL REV, V111, P1036, DOI 10.1037/0033-295x.111.4.1036; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Baldo JV, 2006, NEUROPSYCHOLOGY, V20, P529, DOI 10.1037/0894-4105.20.5.529; Baldo JV, 2010, BRAIN LANG, V113, P59, DOI 10.1016/j.bandl.2010.01.004; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Buckner RL, 2003, J NEUROSCI, V23, P3999; Cantlon JF, 2009, J COGNITIVE NEUROSCI, V21, P2217, DOI 10.1162/jocn.2008.21159; Castelli F, 2006, P NATL ACAD SCI USA, V103, P4693, DOI 10.1073/pnas.0600444103; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Danker JF, 2007, NEUROIMAGE, V35, P1365, DOI 10.1016/j.neuroimage.2007.01.032; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Desco M, 2011, NEUROIMAGE, V57, P281, DOI 10.1016/j.neuroimage.2011.03.063; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Goel V, 1998, J COGNITIVE NEUROSCI, V10, P293, DOI 10.1162/089892998562744; Kadosh RC, 2008, PROG NEUROBIOL, V84, P132, DOI 10.1016/j.pneurobio.2007.11.001; Klein E, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-70; Krueger F, 2008, NEUROREPORT, V19, P1095, DOI 10.1097/WNR.0b013e328303fd85; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; Molko N, 2003, NEURON, V40, P847, DOI 10.1016/S0896-6273(03)00670-6; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Qin YL, 2004, P NATL ACAD SCI USA, V101, P5686, DOI 10.1073/pnas.0401227101; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ravizza SM, 2008, BRAIN RES, V1238, P118, DOI 10.1016/j.brainres.2008.08.030; Rosenberg-Lee M, 2009, COGN AFFECT BEHAV NE, V9, P270, DOI 10.3758/CABN.9.3.270; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Sohn MH, 2004, NAT NEUROSCI, V7, P1193, DOI 10.1038/nn1337; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027	40	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50154	10.1371/journal.pone.0050154	http://dx.doi.org/10.1371/journal.pone.0050154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	052ML	23251361	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900008
J	Steenhard, BM; Vanacore, R; Friedman, D; Zelenchuk, A; Stroganova, L; Isom, K; St John, PL; Hudson, BG; Abrahamson, DR				Steenhard, Brooke M.; Vanacore, Roberto; Friedman, David; Zelenchuk, Adrian; Stroganova, Larysa; Isom, Kathryn; St John, Patricia L.; Hudson, Billy G.; Abrahamson, Dale R.			Upregulated Expression of Integrin alpha 1 in Mesangial Cells and Integrin alpha 3 and Vimentin in Podocytes of Col4a3-Null (Alport) Mice	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEINS; EXTRACELLULAR-MATRIX RECEPTORS; BASEMENT-MEMBRANES; IV COLLAGEN; MOUSE MODEL; KIDNEY; LACKING; LAMININ; NESTIN; DESMIN	Alport disease in humans, which usually results in proteinuria and kidney failure, is caused by mutations to the COL4A3, COL4A4, or COL4A5 genes, and absence of collagen alpha 3 alpha 4 alpha 5(IV) networks found in mature kidney glomerular basement membrane (GBM). The Alport mouse harbors a deletion of the Col4a3 gene, which also results in the lack of GBM collagen alpha 3 alpha 4 alpha 5(IV). This animal model shares many features with human Alport patients, including the retention of collagen alpha 1 alpha 2 alpha 1(IV) in GBMs, effacement of podocyte foot processes, gradual loss of glomerular barrier properties, and progression to renal failure. To learn more about the pathogenesis of Alport disease, we undertook a discovery proteomics approach to identify proteins that were differentially expressed in glomeruli purified from Alport and wild-type mouse kidneys. Pairs of cy3- and cy5-labeled extracts from 5-week old Alport and wild-type glomeruli, respectively, underwent 2-dimensional difference gel electrophoresis. Differentially expressed proteins were digested with trypsin and prepared for mass spectrometry, peptide ion mapping/fingerprinting, and protein identification through database searching. The intermediate filament protein, vimentin, was upregulated similar to 2.5 fold in Alport glomeruli compared to wild-type. Upregulation was confirmed by quantitative real time RT-PCR of isolated Alport glomeruli (5.4 fold over wild-type), and quantitative confocal immunofluorescence microscopy localized over-expressed vimentin specifically to Alport podocytes. We next hypothesized that increases in vimentin abundance might affect the basement membrane protein receptors, integrins, and screened Alport and wild-type glomeruli for expression of integrins likely to be the main receptors for GBM type IV collagen and laminin. Quantitative immunofluorescence showed an increase in integrin alpha 1 expression in Alport mesangial cells and an increase in integrin alpha 3 in Alport podocytes. We conclude that overexpression of mesangial integrin alpha 1 and podocyte vimentin and integrin alpha 3 may be important features of glomerular Alport disease, possibly affecting cell-signaling, cell shape and cellular adhesion to the GBM.	[Steenhard, Brooke M.; Zelenchuk, Adrian; Stroganova, Larysa; Isom, Kathryn; St John, Patricia L.; Abrahamson, Dale R.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Steenhard, Brooke M.; Zelenchuk, Adrian; Stroganova, Larysa; Isom, Kathryn; St John, Patricia L.; Abrahamson, Dale R.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA; [Vanacore, Roberto; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Friedman, David] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Vanderbilt University; Vanderbilt University	Abrahamson, DR (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA.	dabrahamson@kumc.edu	Vanacore, Roberto/AAD-6399-2020; Singh, Shree Ram/B-7614-2008	Vanacore, Roberto/0000-0002-2886-0606; Hudson, Billy/0000-0002-5420-4100; Singh, Shree Ram/0000-0001-6545-583X	National Institutes of Health [P01DK065123, P20GM104936]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK065123, R01DK018381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health grants P01DK065123 and P20GM104936. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2007, J AM SOC NEPHROL, V18, P2465, DOI 10.1681/ASN.2007030328; Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; Abrahamson DR, 2003, KIDNEY INT, V63, P826, DOI 10.1046/j.1523-1755.2003.00800.x; ABRAHAMSON DR, 1989, J CELL BIOL, V109, P3477, DOI 10.1083/jcb.109.6.3477; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Chen XW, 2004, AM J PATHOL, V165, P617, DOI 10.1016/S0002-9440(10)63326-3; Colucci-Guyon E, 1999, GLIA, V25, P33, DOI 10.1002/(SICI)1098-1136(19990101)25:1<33::AID-GLIA4>3.0.CO;2-J; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Cortes P, 2000, KIDNEY INT, V58, P2452, DOI 10.1046/j.1523-1755.2000.00428.x; Cosgrove D, 2007, KIDNEY INT, V71, P615, DOI 10.1038/sj.ki.5002115; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Cosgrove D, 2000, AM J PATHOL, V157, P1649, DOI 10.1016/S0002-9440(10)64802-X; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; DRENCKHAHN D, 1988, LAB INVEST, V59, P673; Eckes B, 2000, J CELL SCI, V113, P2455; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Franco AT, 2009, MOL CELL PROTEOMICS, V8, P1947, DOI 10.1074/mcp.M900139-MCP200; Haraldsson B, 2012, CURR OPIN NEPHROL HY, V21, P258, DOI 10.1097/MNH.0b013e3283522e7a; Heidet L, 2003, AM J PATHOL, V163, P1633, DOI 10.1016/S0002-9440(10)63520-1; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; HOLTHOFER H, 1984, LAB INVEST, V50, P552; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Kalluri R, 1997, J CLIN INVEST, V99, P2470, DOI 10.1172/JCI119431; Kashtan CE, 2001, J AM SOC NEPHROL, V12, P252, DOI 10.1681/ASN.V122252; Kashtan CE, 2011, NEPHRON CLIN PRACT, V118, pC9, DOI 10.1159/000320876; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Kreis S, 2005, EXP CELL RES, V305, P110, DOI 10.1016/j.yexcr.2004.12.023; Kuhara T, 1997, J AM SOC NEPHROL, V8, P1679; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; Mathew S, 2012, PEDIATR NEPHROL, V27, P891, DOI 10.1007/s00467-011-1890-1; Meehan DT, 2009, KIDNEY INT, V76, P968, DOI 10.1038/ki.2009.324; Miner JH, 2011, ORGANOGENESIS, V7, P75, DOI 10.4161/org.7.2.15275; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; Miner JH, 1999, KIDNEY INT, V56, P2016, DOI 10.1046/j.1523-1755.1999.00785.x; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Ostalska-Nowicka D, 2004, HISTOCHEM CELL BIOL, V121, P109, DOI 10.1007/s00418-004-0619-7; Patrakka J, 2010, BIOCHEM BIOPH RES CO, V396, P164, DOI 10.1016/j.bbrc.2010.04.069; Perry J, 2007, PEDIATR DEVEL PATHOL, V10, P369, DOI 10.2350/06-11-0193.1; Pozzi A, 2011, CURR OPIN CELL BIOL, V23, P547, DOI 10.1016/j.ceb.2011.04.003; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; Sachs N, 2006, J CELL BIOL, V175, P33, DOI 10.1083/jcb.200603073; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; SHIKATA K, 1995, AM J KIDNEY DIS, V25, P680, DOI 10.1016/0272-6386(95)90542-1; STAMENKOVIC I, 1986, AM J PATHOL, V125, P465; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Wang RX, 2000, KIDNEY INT, V57, P1847, DOI 10.1046/j.1523-1755.2000.00034.x; Wyss HM, 2011, AM J PHYSIOL-CELL PH, V300, pC397, DOI 10.1152/ajpcell.00438.2010; Yaoita E, 1999, HISTOCHEM CELL BIOL, V111, P107, DOI 10.1007/s004180050340; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284; Zent R, 2006, KIDNEY INT, V70, P460, DOI 10.1038/sj.ki.5000359; Zou J, 2006, VIRCHOWS ARCH, V448, P485, DOI 10.1007/s00428-005-0134-9; Zou J, 2007, CHINESE MED J-PEKING, V120, P1203, DOI 10.1097/00029330-200707010-00018	62	13	15	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50745	10.1371/journal.pone.0050745	http://dx.doi.org/10.1371/journal.pone.0050745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236390	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100032
J	Wigelsworth, DJ; Ruthel, G; Schnell, L; Herrlich, P; Blonder, J; Veenstra, TD; Carman, RJ; Wilkins, TD; Guy, TVN; Pauillac, S; Gibert, M; Sauvonnet, N; Stiles, BG; Popoff, MR; Barth, H				Wigelsworth, Darran J.; Ruthel, Gordon; Schnell, Leonie; Herrlich, Peter; Blonder, Josip; Veenstra, Timothy D.; Carman, Robert J.; Wilkins, Tracy D.; Guy Tran Van Nhieu; Pauillac, Serge; Gibert, Maryse; Sauvonnet, Nathalie; Stiles, Bradley G.; Popoff, Michel R.; Barth, Holger			CD44 Promotes Intoxication by the Clostridial Iota-Family Toxins	PLOS ONE			English	Article							BOTULINUM C2 TOXIN; BINDING DOMAIN; LIPID RAFTS; RECEPTOR; ACTIN; PROTEINS; ASSOCIATION; COMPONENT; INTERNALIZATION; POLYMERIZATION	Various pathogenic clostridia produce binary protein toxins associated with enteric diseases of humans and animals. Separate binding/translocation (B) components bind to a protein receptor on the cell surface, assemble with enzymatic (A) component(s), and mediate endocytosis of the toxin complex. Ultimately there is translocation of A component(s) from acidified endosomes into the cytosol, leading to destruction of the actin cytoskeleton. Our results revealed that CD44, a multifunctional surface protein of mammalian cells, facilitates intoxication by the iota family of clostridial binary toxins. Specific antibody against CD44 inhibited cytotoxicity of the prototypical Clostridium perfringens iota toxin. Versus CD44(+) melanoma cells, those lacking CD44 bound less toxin and were dose-dependently resistant to C. perfringens iota, as well as Clostridium difficile and Clostridium spiroforme iota-like, toxins. Purified CD44 specifically interacted in vitro with iota and iota-like, but not related Clostridium botulinum C2, toxins. Furthermore, CD44 knockout mice were resistant to iota toxin lethality. Collective data reveal an important role for CD44 during intoxication by a family of clostridial binary toxins.	[Stiles, Bradley G.] Wilson Coll, Dept Biol, Chambersburg, PA 17201 USA; [Ruthel, Gordon] Univ Penn, Core Imaging Facil, Sch Vet Med, Philadelphia, PA 19104 USA; [Schnell, Leonie; Barth, Holger] Univ Ulm, Inst Pharmacol & Toxicol, Med Ctr, Ulm, Germany; [Wigelsworth, Darran J.] USA, Med Res Inst Infect Dis, Integrated Toxicol Div, Frederick, MD USA; [Herrlich, Peter] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Blonder, Josip; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, Frederick, MD 21701 USA; [Carman, Robert J.; Wilkins, Tracy D.] TechLab Inc, Blacksburg, VA USA; [Guy Tran Van Nhieu] Coll France, Dept Intracellular Commun & Infect Microorgan, F-75231 Paris, France; [Pauillac, Serge; Gibert, Maryse; Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France; [Sauvonnet, Nathalie] Inst Pasteur, Unite Biol Interact Cellulaires, Paris, France	University of Pennsylvania; Ulm University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); TechLab; UDICE-French Research Universities; PSL Research University Paris; College de France; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Stiles, BG (corresponding author), Wilson Coll, Dept Biol, Chambersburg, PA 17201 USA.	bstiles@wilson.edu; mpopoff@pasteur.fr; holger.barth@uni-ulm.de	Barth, Holger/E-7920-2013; Popoff, Michel/O-7719-2016; Van Nhieu, Guy Tran/Y-6359-2018; Ruthel, Gordon/GYU-9133-2022	Popoff, Michel/0000-0001-9305-8989; Van Nhieu, Guy Tran/0000-0002-3901-2186; Ruthel, Gordon/0000-0001-9193-5589; sauvonnet, nathalie/0000-0003-0306-3376	Institut Pasteur; Faculty Fund for Research at Wilson College; Faculty of Medicine at the University of Ulm plus Deutsche Forschungsgemeinschaft (DFG) [BA 2087/2-1]	Institut Pasteur(European Commission); Faculty Fund for Research at Wilson College; Faculty of Medicine at the University of Ulm plus Deutsche Forschungsgemeinschaft (DFG)	Funding was provided in part by the Institut Pasteur (MRP), Faculty Fund for Research at Wilson College (BGS), as well as the Faculty of Medicine at the University of Ulm plus Deutsche Forschungsgemeinschaft (DFG grant BA 2087/2-1) to HB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKTORIES K, 1992, MOL MICROBIOL, V6, P2905, DOI 10.1111/j.1365-2958.1992.tb01749.x; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Aktories K, 2012, TOXICON, V60, P572, DOI 10.1016/j.toxicon.2012.04.338; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; BENNETT KL, 1995, J CELL BIOL, V131, P1623, DOI 10.1083/jcb.131.6.1623; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; Blocker D, 2000, INFECT IMMUN, V68, P4566, DOI 10.1128/IAI.68.8.4566-4573.2000; Blocker D, 2003, J BIOL CHEM, V278, P37360, DOI 10.1074/jbc.M305849200; Blocker D, 2001, INFECT IMMUN, V69, P2980, DOI 10.1128/IAI.69.5.2980-2987.2001; Blonder J, 2005, J PROTEOME RES, V4, P523, DOI 10.1021/pr049790s; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; Eckhardt M, 2000, J BIOL CHEM, V275, P2328, DOI 10.1074/jbc.275.4.2328; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Freistadt MS, 1997, MOL IMMUNOL, V34, P1247, DOI 10.1016/S0161-5890(98)00003-0; FRITZ G, 1995, INFECT IMMUN, V63, P2334, DOI 10.1128/IAI.63.6.2334-2340.1995; Gibert M, 2011, CELL MICROBIOL, V13, P154, DOI 10.1111/j.1462-5822.2010.01527.x; Hale ML, 2004, INFECT IMMUN, V72, P2186, DOI 10.1128/IAI.72.4.2186-2193.2004; Heine K, 2008, INFECT IMMUN, V76, P4600, DOI 10.1128/IAI.00651-08; Hilger H, 2009, INFECT IMMUN, V77, P5593, DOI 10.1128/IAI.00710-09; Holdeman L.V., 1975, ANAEROBE LAB MANUAL; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; Jung C, 2009, MOL MICROBIOL, V72, P1196, DOI 10.1111/j.1365-2958.2009.06716.x; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Lee JL, 2008, MOL CELL BIOL, V28, P5710, DOI 10.1128/MCB.00186-08; Lefebvre DC, 2010, MOL IMMUNOL, V47, P1882, DOI 10.1016/j.molimm.2010.03.018; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Liu D, 1996, J EXP MED, V183, P1987, DOI 10.1084/jem.183.5.1987; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; Martchenko M, 2010, P NATL ACAD SCI USA, V107, P15583, DOI 10.1073/pnas.1010145107; Montecucco C, 2004, TRENDS MICROBIOL, V12, P442, DOI 10.1016/j.tim.2004.08.002; Nagahama M, 2004, INFECT IMMUN, V72, P3267, DOI 10.1128/IAI.72.6.3267-3275.2004; Nagahama M, 2002, INFECT IMMUN, V70, P1909, DOI 10.1128/IAI.70.4.1909-1914.2002; Nagahama M, 2009, INFECT IMMUN, V77, P5139, DOI 10.1128/IAI.00638-09; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Papatheodorou P, 2012, INFECT IMMUN, V80, P1418, DOI 10.1128/IAI.06378-11; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Perelle S, 1997, FEMS MICROBIOL LETT, V146, P117, DOI [10.1016/S0378-1097(96)00463-6, 10.1111/j.1574-6968.1997.tb10180.x]; Pilpa RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002354; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Protin U, 1999, J IMMUNOL, V163, P4917; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Richard JF, 2002, MOL MICROBIOL, V43, P907, DOI 10.1046/j.1365-2958.2002.02806.x; Rouschop KMA, 2006, J IMMUNOL, V177, P7225, DOI 10.4049/jimmunol.177.10.7225; Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137; Scobie HM, 2005, CURR OPIN MICROBIOL, V8, P106, DOI 10.1016/j.mib.2004.12.005; SHEPLEY MP, 1994, J VIROL, V68, P1301, DOI 10.1128/JVI.68.3.1301-1308.1994; Skoudy A, 2000, CELL MICROBIOL, V2, P19, DOI 10.1046/j.1462-5822.2000.00028.x; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; STILES BG, 1986, INFECT IMMUN, V54, P683, DOI 10.1128/IAI.54.3.683-688.1986; Stiles BG, 2002, BIOCHEM J, V367, P801, DOI 10.1042/BJ20020566; Stiles BG, 2000, INFECT IMMUN, V68, P3475, DOI 10.1128/IAI.68.6.3475-3484.2000; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; van der Goot G, 2009, MOL ASPECTS MED, V30, P406, DOI 10.1016/j.mam.2009.08.007; VANDEKERCKHOVE J, 1987, FEBS LETT, V225, P48, DOI 10.1016/0014-5793(87)81129-8; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509	60	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51356	10.1371/journal.pone.0051356	http://dx.doi.org/10.1371/journal.pone.0051356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236484	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100104
J	Zhao, QH; Lv, YR; Zhou, Y; Hong, Z; Guo, QH				Zhao, Qianhua; Lv, Yingru; Zhou, Yan; Hong, Zhen; Guo, Qihao			Short-Term Delayed Recall of Auditory Verbal Learning Test Is Equivalent to Long-Term Delayed Recall for Identifying Amnestic Mild Cognitive Impairment	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MEMORY; DIAGNOSIS; VERSION	Delayed recall of words in a verbal learning test is a sensitive measure for the diagnosis of amnestic mild cognitive impairment (aMCI) and early Alzheimer's disease (AD). The relative validity of different retention intervals of delayed recall has not been well characterized. Using the Auditory Verbal Learning Test-Huashan version, we compared the differentiating value of short-term delayed recall (AVL-SR, that is, a 3- to 5-minute delay time) and long-term delayed recall (AVL-LR, that is, a 20-minute delay time) in distinguishing patients with aMCI (n = 897) and mild AD (n = 530) from the healthy elderly (n = 1215). In patients with aMCI, the correlation between AVL-SR and AVL-LR was very high (r = 0.94), and the difference between the two indicators was less than 0.5 points. There was no difference between AVL-SR and AVL-LR in the frequency of zero scores. In the receiver operating characteristic curves analysis, although the area under the curve (AUC) of AVL-SR and AVL-LR for diagnosing aMCI was significantly different, the cut-off scores of the two indicators were identical. In the subgroup of ages 80 to 89, the AUC of the two indicators showed no significant difference. Therefore, we concluded that AVL-SR could substitute for AVL-LR in identifying aMCI, especially for the oldest patients.	[Zhao, Qianhua; Zhou, Yan; Hong, Zhen; Guo, Qihao] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Zhao, Qianhua; Zhou, Yan; Hong, Zhen; Guo, Qihao] Fudan Univ, Huashan Hosp, Inst Neurol, Shanghai 200433, Peoples R China; [Lv, Yingru] Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Guo, QH (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	dr.guoqihao@126.com			Natural Science Foundation of China [81171019, 81200835]; Shanghai Science and Technology Municipality [09DZ1950400, 08411951000]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Municipality	The study was supported by The Natural Science Foundation of China (81171019 and 81200835) and Shanghai Science and Technology Municipality (09DZ1950400, 08411951000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandt J, 2001, HOPKINS VERBAL LEARN; Delis DC., 2000, CALIFORNIA VERBAL LE; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Gomar JJ, 2011, ARCH GEN PSYCHIAT, V68, P961, DOI 10.1001/archgenpsychiatry.2011.96; Goodglass H., 1983, BOSTON NAMING TEST; Guo Q, 2000, CHINESE J CLIN PSYCH, V8, P205, DOI DOI 10.16128/J.CNKI.1005-3611.2000.04.003; Guo Q.H., 2005, CHINESE J NEUROMEDIC, V4, P701, DOI DOI 10.3760/CMA.J.ISSN.1671-8925.2005.07-17; Guo QH, 2008, CHIN J NEUROL, V41, P4; Guo QH, 2001, CHINESE MENT HLTH J, V15, P3, DOI DOI 10.3321/J.ISSN:1000-6729.2001.01.004; Guo QHSY, 2007, CHIN J BEHAV MED SCI, V16, P4; Guo QH, 2009, ALZ DIS ASSOC DIS, V23, P253, DOI 10.1097/WAD.0b013e3181999e92; [郭起浩 GUO QiHao], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P81; Kalbe E, 2004, INT J GERIATR PSYCH, V19, P136, DOI 10.1002/gps.1042; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Lacritz L H, 2001, Appl Neuropsychol, V8, P180, DOI 10.1207/S15324826AN0803_8; Lu JC, 2006, CHIN J CLIN PSYCHOL, V14, P118; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOHS RC, 1983, PSYCHOPHARMACOL BULL, V19, P448; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; MORRIS JC, 1988, PSYCHOPHARMACOL BULL, V24, P641; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Rey A., 1958, EXAMENCLINIQUE PSYCH; Shankle WR, 2005, P NATL ACAD SCI USA, V102, P4919, DOI 10.1073/pnas.0501157102; Sheridan LK, 2006, ARCH CLIN NEUROPSYCH, V21, P23, DOI 10.1016/j.acn.2005.07.003; Strauss E, 2006, COMPENDIUM NEUROPSYC; Wagner M, 2012, NEUROLOGY, V78, P379, DOI 10.1212/WNL.0b013e318245f447; Wolk DA, 2011, NEUROIMAGE, V54, P1530, DOI 10.1016/j.neuroimage.2010.09.005; Yu H, 2005, NERV DIS MENT HYG, V5, P89; Zhao QH, 2007, CHINESE J CLIN PSYCH, V15, P9	31	90	97	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51157	10.1371/journal.pone.0051157	http://dx.doi.org/10.1371/journal.pone.0051157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236445	Green Submitted, gold, Green Published			2022-12-27	WOS:000312064100073
J	Schaal, JB; Tran, D; Tran, P; Osapay, G; Trinh, K; Roberts, KD; Brasky, KM; Tongaonkar, P; Ouellette, AJ; Selsted, ME				Schaal, Justin B.; Dat Tran; Patti Tran; Oesapay, George; Trinh, Katie; Roberts, Kevin D.; Brasky, Kathleen M.; Tongaonkar, Prasad; Ouellette, Andre J.; Selsted, Michael E.			Rhesus Macaque Theta Defensins Suppress Inflammatory Cytokines and Enhance Survival in Mouse Models of Bacteremic Sepsis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ANTIMICROBIAL ACTIVITIES; RHEUMATOID-ARTHRITIS; CECAL LIGATION; RAT MODELS; PEPTIDES; NEOVASCULARIZATION; PROTEGRIN-1; MECHANISMS; LEUKOCYTES	Theta-defensins (theta-defensins) are macrocyclic antimicrobial peptides expressed in leukocytes of Old World monkeys. The peptides are broad spectrum microbicides in vitro and numerous theta-defensin isoforms have been identified in granulocytes of rhesus macaques and Olive baboons. Several mammalian alpha- and beta-defensins, genetically related to theta-defensins, have proinflammatory and immune-activating properties that bridge innate and acquired immunity. In the current study we analyzed the immunoregulatory properties of rhesus theta-defensins 1-5 (RTDs 1-5). RTD-1, the most abundant theta-defensin in macaques, reduced the levels of TNF, IL-1 alpha, IL-1 beta, IL-6, and IL-8 secreted by blood leukocytes stimulated by several TLR agonists. RTDs 1-5 suppressed levels of soluble TNF released by bacteria- or LPS-stimulated blood leukocytes and THP-1 monocytes. Despite their highly conserved conformation and amino acid sequences, the anti-TNF activities of RTDs 1-5 varied by as much as 10-fold. Systemically administered RTD-1 was non-toxic for BALB/c mice, and escalating intravenous doses were well tolerated and non-immunogenic in adult chimpanzees. The peptide was highly stable in serum and plasma. Single dose administration of RTD-1 at 5 mg/kg significantly improved survival of BALB/c mice with E. coli peritonitis and cecal ligation-and-puncture induced polymicrobial sepsis. Peptide treatment reduced serum levels of several inflammatory cytokines/chemokines in bacteremic animals. Collectively, these results indicate that the anti-inflammatory properties of theta-defensins in vitro and in vivo are mediated by the suppression of numerous proinflammatory cytokines and blockade of TNF release may be a primary effect. Citation: Schaal JB, Tran D, Tran P, Osapay G, Trinh K, et al. (2012) Rhesus Macaque Theta Defensins Suppress Inflammatory Cytokines and Enhance Survival in Mouse Models of Bacteremic Sepsis. PLoS ONE 7(12): e51337. doi:10.1371/journal.pone.0051337	[Schaal, Justin B.; Dat Tran; Patti Tran; Trinh, Katie; Roberts, Kevin D.; Tongaonkar, Prasad; Ouellette, Andre J.; Selsted, Michael E.] Univ So Calif, Keck Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90033 USA; [Ouellette, Andre J.; Selsted, Michael E.] Univ So Calif, Kenneth Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Oesapay, George] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA; [Brasky, Kathleen M.] Texas Biomed Res Inst, San Antonio, TX USA	University of Southern California; University of Southern California; University of California System; University of California Irvine; Texas Biomedical Research Institute	Selsted, ME (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90033 USA.	selsted@usc.edu			National Institutes of Health [AI22931, AI58129, DE021341, AI078321, DK044632, AI059346]; University of Southern California Norris Comprehensive Cancer Center Support Grant from the National Cancer Institute [P30 CA014089]; SC CTSI (NIH/NCRR/NCATS) [UL1RR031986]; NATIONAL CANCER INSTITUTE [P30CA014089] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR013986, UL1RR031986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059346, R01AI058129, R01AI022931, R37AI022931, R56AI078321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044632, R55DK044632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southern California Norris Comprehensive Cancer Center Support Grant from the National Cancer Institute; SC CTSI (NIH/NCRR/NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants to M. Selsted, (AI22931, AI58129 and DE021341), P. Tongaonkar (AI078321), A. Ouellette (DK044632 and AI059346) by the University of Southern California Norris Comprehensive Cancer Center Support Grant (P30 CA014089) from the National Cancer Institute, and SC CTSI (NIH/NCRR/NCATS) through Grant UL1RR031986. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No funds have been received from Resolve Therapeutics.	Apostolaki M, 2010, CURR DIR AUTOIMMUN, V11, P1, DOI 10.1159/000289195; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chaly YV, 2000, EUR CYTOKINE NETW, V11, P257; Chavakis T, 2004, FASEB J, V18, P1306, DOI 10.1096/fj.03-1009fje; Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Cirioni O, 2008, SHOCK, V30, P443, DOI 10.1097/SHK.0b013e31816d2269; Economopoulou M, 2005, BLOOD, V106, P3831, DOI 10.1182/blood-2005-03-0889; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia AE, 2008, INFECT IMMUN, V76, P5883, DOI 10.1128/IAI.01100-08; Ghiselli R, 2008, CRIT CARE MED, V36, P240, DOI 10.1097/01.CCM.0000292157.60632.89; Giacometti A, 2003, PEPTIDES, V24, P1747, DOI 10.1016/j.peptides.2003.07.027; Giacometti A, 2004, AM J RESP CRIT CARE, V169, P187, DOI 10.1164/rccm.200307-971OC; Giacometti A, 2002, ANTIMICROB AGENTS CH, V46, P2132, DOI 10.1128/AAC.46.7.2132-2136.2002; Hollox EJ, 2008, GENOME RES, V18, P1686, DOI 10.1101/gr.080945.108; Khine AA, 2006, BLOOD, V107, P2936, DOI 10.1182/blood-2005-06-2314; Kollias G, 1999, ANN RHEUM DIS, V58, P32, DOI 10.1136/ard.58.2008.i32; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lehrer RI, 2012, J BIOL CHEM; Medford ARL, 2005, THORAX, V60, P244, DOI 10.1136/thx.2004.034785; Moraes TJ, 2006, CURR OPIN HEMATOL, V13, P21, DOI 10.1097/01.moh.0000190113.31027.d5; Motzkus D, 2006, FASEB J, V20, P1701, DOI 10.1096/fj.05-4970fje; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Presicce P, 2009, J LEUKOCYTE BIOL, V86, P941, DOI 10.1189/jlb.0708412; REMICK D, 1995, SHOCK, V4, P89, DOI 10.1097/00024382-199508000-00002; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Selsted ME, 2004, CURR PROTEIN PEPT SC, V5, P365, DOI 10.2174/1389203043379459; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; Steinstraesser L, 2003, CRIT CARE MED, V31, P221, DOI 10.1097/00003246-200301000-00034; Syeda F, 2008, J CELL PHYSIOL, V214, P820, DOI 10.1002/jcp.21279; Tan XX, 2005, ANTIMICROB AGENTS CH, V49, P3203, DOI 10.1128/AAC.49.8.3203-3207.2005; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Tongaonkar P, 2011, J LEUKOCYTE BIOL, V89, P283, DOI 10.1189/jlb.0910535; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Tran D, 2008, ANTIMICROB AGENTS CH, V52, P944, DOI 10.1128/AAC.01090-07; vanWetering S, 1997, AM J PHYSIOL-LUNG C, V272, pL888, DOI 10.1152/ajplung.1997.272.5.L888; Wohlford-Lenane CL, 2009, J VIROL, V83, P11385, DOI 10.1128/JVI.01363-09; Yang D, 2009, TRENDS IMMUNOL, V30, P531, DOI 10.1016/j.it.2009.07.004	45	52	55	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51337	10.1371/journal.pone.0051337	http://dx.doi.org/10.1371/journal.pone.0051337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236475	gold, Green Published			2022-12-27	WOS:000312589700036
J	Xiang, BG; Zhang, GY; Ren, HM; Sunkara, M; Morris, AJ; Gartner, TK; Smyth, SS; Li, ZY				Xiang, Binggang; Zhang, Guoying; Ren, Hongmei; Sunkara, Manjula; Morris, Andrew J.; Gartner, T. Kent; Smyth, Susan S.; Li, Zhenyu			The P2Y(12) Antagonists, 2MeSAMP and Cangrelor, Inhibit Platelet Activation through P2Y(12)/G(i)-Dependent Mechanism	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; ANTIPLATELET THERAPY; ANTITHROMBOTIC DRUGS; IN-VITRO; RECEPTOR; ADP; AGGREGATION; RAP1B; PHOSPHORYLATION; IDENTIFICATION	Background: ADP is an important physiological agonist that induces integrin activation and platelet aggregation through its receptors P2Y(1) (G alpha(q)-coupled) and P2Y(12) (G alpha(i)-coupled). P2Y(12) plays a critical role in platelet activation and thrombosis. Adenosine-based P2Y(12) antagonists, 2-methylthioadenosine 5'-monophosphate triethylammonium salt hydrate (2MeSAMP) and Cangrelor (AR-C69931MX) have been widely used to demonstrate the role of P2Y(12) in platelet function. Cangrelor is being evaluated in clinical trials of thrombotic diseases. However, a recent study reported that both 2MeSAMP and Cangrelor raise intra-platelet cAMP levels and inhibit platelet aggregation through a P2Y(12)-independent mechanism. Methodology/Principal Findings: The present work, using P2Y(12) deficient mice, sought to clarify previous conflicting reports and to elucidate the mechanisms by which 2MeSAMP and Cangrelor inhibit platelet activation and thrombosis. 2MeSAMP and Cangrelor inhibited aggregation and ATP release of wild-type but not P2Y(12) deficient platelets. 2MeSAMP and Cangrelor neither raised intracellular cAMP concentrations nor induced phosphorylation of vasodilator-stimulated phosphoprotein (VASP) in washed human or mouse platelets. Furthermore, unlike the activators (PGI(2) and forskolin) of the cAMP pathway, 2MeSAMP and Cangrelor failed to inhibit Ca2+ mobilization, Akt phosphorylation, and Rap1b activation in P2Y(12) deficient platelets. Importantly, while injection of Cangrelor inhibited thrombus formation in a FeCl3-induced thrombosis model in wild-type mice, it failed to affect thrombus formation in P2Y(12) deficient mice. Conclusions: These data together demonstrate that 2MeSAMP and Cangrelor inhibit platelet function through the P2Y(12)-dependent mechanism both in vitro and in vivo. Citation: Xiang B, Zhang G, Ren H, Sunkara M, Morris AJ, et al. (2012) The P2Y(12) Antagonists, 2MeSAMP and Cangrelor, Inhibit Platelet Activation through P2Y(12)/G(i)-Dependent Mechanism. PLoS ONE 7(12): e51037. doi:10.1371/journal.pone.0051037	[Xiang, Binggang; Zhang, Guoying; Ren, Hongmei; Sunkara, Manjula; Morris, Andrew J.; Smyth, Susan S.; Li, Zhenyu] Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY USA; [Gartner, T. Kent] Univ Memphis, Dept Biol, Memphis, TN 38152 USA; [Smyth, Susan S.] Lexington VA Med Ctr, Lexington, KY USA	University of Kentucky; University of Memphis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Li, ZY (corresponding author), Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY USA.	zhenyuli08@uky.edu	sunkara, Manjula/H-7944-2016; Xiang, Binggang/N-6494-2013	sunkara, Manjula/0000-0001-6151-1929; 	American Heart Association Midwest [0855698G]; Centers of Biomedical Research Excellence in Obesity and Cardiovascular Disease Grant from the National Institutes of Health/National Center for Research Resources [P20RR021954]; American Heart Association Postdoctoral Fellowship Award; Lexington VA Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598, P20RR021954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078663] Funding Source: NIH RePORTER	American Heart Association Midwest(American Heart Association); Centers of Biomedical Research Excellence in Obesity and Cardiovascular Disease Grant from the National Institutes of Health/National Center for Research Resources; American Heart Association Postdoctoral Fellowship Award(American Heart Association); Lexington VA Medical Center(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by American Heart Association Midwest affiliate Grant-in-Aid 0855698G (to ZL), and in part by the Centers of Biomedical Research Excellence in Obesity and Cardiovascular Disease Grant P20RR021954 from the National Institutes of Health/National Center for Research Resources. B. Xiang is a recipient of the American Heart Association Postdoctoral Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by resources provided by the Lexington VA Medical Center. We are grateful to Dr. Richard Charnigo for his assistance with statistical analysis and Susan Quick for editorial assistance. Cangrelor was provided free of charge from The Medicine's Company.	Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864; Angiolillo DJ, 2012, JAMA-J AM MED ASSOC, V307, P265, DOI 10.1001/jama.2011.2002; AU JLS, 1989, CLIN CHEM, V35, P48; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bodnar RJ, 2002, J BIOL CHEM, V277, P47080, DOI 10.1074/jbc.M208329200; BUTT E, 1994, J BIOL CHEM, V269, P14509; CATTANEO M, 1992, BLOOD, V80, P2787; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Cifuni SM, 2008, BLOOD, V112, P1696, DOI 10.1182/blood-2008-02-139733; Damman P, 2012, J THROMB THROMBOLYS, V33, P143, DOI 10.1007/s11239-011-0667-5; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; Faxon DP, 2010, NAT REV CARDIOL, V7, P124, DOI 10.1038/nrcardio.2009.247; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Jantzen HM, 2001, J CLIN INVEST, V108, P477; Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030; Johnston-Cox HA, 2011, J CELL PHYSIOL, V226, P46, DOI 10.1002/jcp.22379; Kim S, 2002, BLOOD, V99, P3629, DOI 10.1182/blood.V99.10.3629; Kim S, 2009, J BIOL CHEM, V284, P33763, DOI 10.1074/jbc.M109.048553; Kunapuli SP, 2003, CURR PHARM DESIGN, V9, P2303, DOI 10.2174/1381612033453947; Larson MK, 2003, BLOOD, V101, P1409, DOI 10.1182/blood-2002-05-1533; Liu J, 2008, J THROMB HAEMOST, V6, P1915, DOI 10.1111/j.1538-7836.2008.03135.x; Liu MY, 1996, NATURE, V382, P83, DOI 10.1038/382083a0; Lova P, 2004, J BIOL CHEM, V279, P25299, DOI 10.1074/jbc.M313199200; Lova P, 2002, J BIOL CHEM, V277, P12009, DOI 10.1074/jbc.M111803200; Maloney SF, 2010, INTEGR BIOL-UK, V2, P183, DOI 10.1039/b919728a; Ohlmann P, 1995, BIOCHEM J, V312, P775, DOI 10.1042/bj3120775; Paul BZS, 1999, J BIOL CHEM, V274, P29108, DOI 10.1074/jbc.274.41.29108; Shankar H, 2006, BLOOD, V108, P3027, DOI 10.1182/blood-2006-03-010330; Smyth SS, 2009, ARTERIOSCL THROM VAS, V29, P449, DOI 10.1161/ATVBAHA.108.176388; Srinivasan S, 2009, J BIOL CHEM, V284, P16108, DOI 10.1074/jbc.M809780200; Steg PG, 2010, CIRCULATION, V122, P2131, DOI 10.1161/CIRCULATIONAHA.109.927582; Storey RF, 2001, PLATELETS, V12, P443, DOI 10.1080/09537100120085450; Woulfe D, 2002, J BIOL CHEM, V277, P23382, DOI 10.1074/jbc.M202212200; Woulfe DS, 2010, EXPERT REV HEMATOL, V3, P81, DOI 10.1586/EHM.09.75; Xiang B, 2010, J THROMB HAEMOST, V8, P2032, DOI 10.1111/j.1538-7836.2010.03969.x; Zhang GY, 2011, J BIOL CHEM, V286, P39466, DOI 10.1074/jbc.M111.239608; Zhang GY, 2011, BLOOD, V118, P3670, DOI 10.1182/blood-2011-03-341107	41	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51037	10.1371/journal.pone.0051037	http://dx.doi.org/10.1371/journal.pone.0051037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236426	Green Published, Green Submitted, gold			2022-12-27	WOS:000312589700028
J	Chen, HD; Hayek, S; Guzman, JR; Gillitt, ND; Ibrahim, SA; Jobin, C; Sang, SM				Chen, Huadong; Hayek, Saeed; Guzman, Javier Rivera; Gillitt, Nicholas D.; Ibrahim, Salam A.; Jobin, Christian; Sang, Shengmin			The Microbiota Is Essential for the Generation of Black Tea Theaflavins-Derived Metabolites	PLOS ONE			English	Article							CANCER CALU-6 CELLS; GALLIC ACID; COLON CARCINOGENESIS; MASS-SPECTROMETRY; BACILLUS-SUBTILIS; GUT MICROBIOME; POLYPHENOLS; APOPTOSIS; HUMANS; GROWTH	Background: Theaflavins including theaflavin (TF), theaflavin-3-gallate (TF3G), theaflavin-3'-gallate (TF3'G), and theaflavin-3,3'-digallate (TFDG), are the most important bioactive polyphenols in black tea. Because of their poor systemic bioavailability, it is still unclear how these compounds can exert their biological functions. The objective of this study is to identify the microbial metabolites of theaflavins in mice and in humans. Methods and Findings: In the present study, we gavaged specific pathogen free (SPF) mice and germ free (GF) mice with 200 mg/kg TFDG and identified TF, TF3G, TF3'G, and gallic acid as the major fecal metabolites of TFDG in SPF mice. These metabolites were absent in TFDG- gavaged GF mice. The microbial bioconversion of TFDG, TF3G, and TF3'G was also investigated in vitro using fecal slurries collected from three healthy human subjects. Our results indicate that TFDG is metabolized to TF, TF3G, TF3'G, gallic acid, and pyrogallol by human microbiota. Moreover, both TF3G and TF3'G are metabolized to TF, gallic acid, and pyrogallol by human microbiota. Importantly, we observed interindividual differences on the metabolism rate of gallic acid to pyrogallol among the three human subjects. In addition, we demonstrated that Lactobacillus plantarum 299v and Bacillus subtilis have the capacity to metabolize TFDG. Conclusions: The microbiota is important for the metabolism of theaflavins in both mice and humans. The in vivo functional impact of microbiota-generated theaflavins-derived metabolites is worthwhile of further study. Citation: Chen H, Hayek S, Rivera Guzman J, Gillitt ND, Ibrahim SA, et al. (2012) The Microbiota Is Essential for the Generation of Black Tea Theaflavins-Derived Metabolites. PLoS ONE 7(12): e51001. doi:10.1371/journal.pone.0051001	[Guzman, Javier Rivera; Jobin, Christian] Univ N Carolina, Dept Med Pharmacol & Immunol Microbiol, Chapel Hill, NC 27515 USA; [Guzman, Javier Rivera; Jobin, Christian] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA; [Chen, Huadong; Hayek, Saeed; Sang, Shengmin] N Carolina Agr & Tech State Univ, Ctr Excellence Postharvest Technol, Kannapolis, NC USA; [Hayek, Saeed; Ibrahim, Salam A.] N Carolina Agr & Tech State Univ, Dept Family & Consumer Sci, Greensboro, NC USA; [Gillitt, Nicholas D.] Dole Nutr Res Lab, Kannapolis, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina A&T State University; University of North Carolina; North Carolina A&T State University	Jobin, C (corresponding author), Univ N Carolina, Dept Med Pharmacol & Immunol Microbiol, Chapel Hill, NC 27515 USA.	job@med.un.ed; ssang@nact.edu	Ibrahim, Salam/AAC-7678-2019; Chen, Huadong/H-2272-2013	Rivera Guzman, Javier/0000-0001-9004-6739	United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) [2009-65503-21116, 2012-67017-30175]; USDA-NIFA Transdisciplinary Graduate Training from the National Institute of Food and Agriculture Bioactive Food Components for Optimal Health and Improving Food Quality and Value programs [2010-65200-20354]; National Institutes of Health (NIH) [R01 DK73338, R01 DK47700]; NIH Training, Workforce Development, and Diversity division of the National Institute of General Medical Sciences [K12GM000678, P30 DK034987]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047700, P30DK034987, R01DK073338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000678] Funding Source: NIH RePORTER	United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA)(United States Department of Agriculture (USDA)); USDA-NIFA Transdisciplinary Graduate Training from the National Institute of Food and Agriculture Bioactive Food Components for Optimal Health and Improving Food Quality and Value programs; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training, Workforce Development, and Diversity division of the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by funding from United States Department of Agriculture-National Institute of Food and Agriculture (USDA-NIFA) grants 2009-65503-21116 (SS) and 2012-67017-30175 (SS), the USDA-NIFA Transdisciplinary Graduate Training grant no. 2010-65200-20354 from the National Institute of Food and Agriculture Bioactive Food Components for Optimal Health and Improving Food Quality and Value programs (SH), National Institutes of Health (NIH) R01 DK73338 (CJ), R01 DK47700 (CJ), the NIH Training, Workforce Development, and Diversity division of the National Institute of General Medical Sciences K12GM000678 (JRG and by P30 DK034987 to CGIBD. The funders had no role in study desigh, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne S, 1998, J APPL MICROBIOL, V85, P88; Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13; Chen HD, 2011, J CHROMATOGR A, V1218, P7297, DOI 10.1016/j.chroma.2011.08.056; Choi KC, 2009, MOL CANCER RES, V7, P2011, DOI 10.1158/1541-7786.MCR-09-0239; Daykin CA, 2005, J AGR FOOD CHEM, V53, P1428, DOI 10.1021/jf048439o; Droge MJ, 2001, EUR J BIOCHEM, V268, P3332, DOI 10.1046/j.1432-1327.2001.02238.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fotakopoulou I, 2007, J ORG CHEM, V72, P782, DOI 10.1021/jo061871f; Giftson JS, 2010, INVEST NEW DRUG, V28, P251, DOI 10.1007/s10637-009-9241-9; Gordon JI, 2011, P NATL ACAD SCI USA, V108, P4513, DOI 10.1073/pnas.1101958108; Gross G, 2010, J AGR FOOD CHEM, V58, P10236, DOI 10.1021/jf101475m; GUSTAFSSON BE, 1982, SCAND J GASTROENTERO, V17, P117; Han YH, 2008, INT J ONCOL, V33, P1099, DOI 10.3892/ijo_00000099; Han YH, 2008, TOXICOL IN VITRO, V22, P1605, DOI 10.1016/j.tiv.2008.06.014; Han YH, 2008, LUNG CANCER, V59, P301, DOI 10.1016/j.lungcan.2007.08.034; Han YH, 2009, J BIOCHEM MOL TOXIC, V23, P36, DOI 10.1002/jbt.20263; Han YH, 2009, CHEM-BIOL INTERACT, V177, P107, DOI 10.1016/j.cbi.2008.10.014; Henning SM, 2006, J NUTR, V136, P1839, DOI 10.1093/jn/136.7.1839; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hodgson JM, 2000, J AGR FOOD CHEM, V48, P2276, DOI 10.1021/jf000089s; Hong HA, 2009, RES MICROBIOL, V160, P134, DOI 10.1016/j.resmic.2008.11.002; JOHANSSON ML, 1993, APPL ENVIRON MICROB, V59, P15, DOI 10.1128/AEM.59.1.15-20.1993; Kaur M, 2009, PHARM RES-DORDR, V26, P2133, DOI 10.1007/s11095-009-9926-y; Kawada M, 2001, ANTI-CANCER DRUG, V12, P847, DOI 10.1097/00001813-200111000-00009; Kohri T, 2003, J AGR FOOD CHEM, V51, P5561, DOI 10.1021/jf034450x; Kumar G, 2010, MINI-REV MED CHEM, V10, P492, DOI 10.2174/138955710791384063; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lo C, 2010, INT J ONCOL, V37, P377, DOI 10.3892/ijo_00000686; Macfarlane GT, 2007, CURR OPIN BIOTECH, V18, P156, DOI 10.1016/j.copbio.2007.01.011; Marco ML, 2010, ISME J, V4, P1481, DOI 10.1038/ismej.2010.61; Meselhy MR, 1997, CHEM PHARM BULL, V45, P888; MOLIN G, 1993, J APPL BACTERIOL, V74, P314, DOI 10.1111/j.1365-2672.1993.tb03031.x; Mulder TPJ, 2001, J CHROMATOGR B, V760, P271, DOI 10.1016/S0378-4347(01)00285-7; Niculescu MD, 2007, J NUTR BIOCHEM, V18, P380, DOI 10.1016/j.jnutbio.2006.06.002; Raina K, 2008, MOL CANCER THER, V7, P1258, DOI 10.1158/1535-7163.MCT-07-2220; Ribitsch D, 2011, BIOTECHNOL PROG; Roowi S, 2010, J AGR FOOD CHEM, V58, P1296, DOI 10.1021/jf9032975; Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007; Sang SM, 2004, BIOORGAN MED CHEM, V12, P459, DOI 10.1016/j.bmc.2003.10.024; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Senapathy JG, 2011, FOOD CHEM TOXICOL, V49, P887, DOI 10.1016/j.fct.2010.12.012; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Sharma V, 2009, CRIT REV FOOD SCI, V49, P379, DOI 10.1080/10408390802068066; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Tabasco R, 2011, FOOD MICROBIOL, V28, P1345, DOI 10.1016/j.fm.2011.06.005; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van de Wiele T, 2007, J APPL MICROBIOL, V102, P452, DOI 10.1111/j.1365-2672.2006.03084.x; van Duynhoven J, 2011, P NATL ACAD SCI USA, V108, P4531, DOI 10.1073/pnas.1000098107; Yang CJ, 2009, LUNG CANCER, V66, P162, DOI 10.1016/j.lungcan.2009.01.016; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641	50	52	53	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51001	10.1371/journal.pone.0051001	http://dx.doi.org/10.1371/journal.pone.0051001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227227	Green Submitted, gold, Green Published			2022-12-27	WOS:000312588200088
J	Drew, DR; Hodder, AN; Wilson, DW; Foley, M; Mueller, I; Siba, PM; Dent, AE; Cowman, AF; Beeson, JG				Drew, Damien R.; Hodder, Anthony N.; Wilson, Danny W.; Foley, Michael; Mueller, Ivo; Siba, Peter M.; Dent, Arlene E.; Cowman, Alan F.; Beeson, James G.			Defining the Antigenic Diversity of Plasmodium falciparum Apical Membrane Antigen 1 and the Requirements for a Multi-Allele Vaccine against Malaria	PLOS ONE			English	Article							GROWTH-INHIBITORY ANTIBODIES; VARIANT SURFACE-ANTIGENS; BLOOD-STAGE MALARIA; ERYTHROCYTE INVASION; CANDIDATE ANTIGEN; PREGNANT-WOMEN; IN-VITRO; BINDING; GENES; PROTECTION	Apical Membrane Antigen 1 (AMA1) is a leading malaria vaccine candidate and a target of naturally-acquired human immunity. Plasmodium falciparum AMA1 is polymorphic and in vaccine trials it induces strain-specific protection. This antigenic diversity is a major roadblock to development of AMA1 as a malaria vaccine and understanding how to overcome it is essential. To assess how AMA1 antigenic diversity limits cross-strain growth inhibition, we assembled a panel of 18 different P. falciparum isolates which are broadly representative of global AMA1 sequence diversity. Antibodies raised against four well studied AMA1 alleles (W2Mef, 3D7, HB3 and FVO) were tested for growth inhibition of the 18 different P. falciparum isolates in growth inhibition assays (GIA). All antibodies demonstrated substantial cross-inhibitory activity against different isolates and a mixture of the four different AMA1 antibodies inhibited all 18 isolates tested, suggesting significant antigenic overlap between AMA1 alleles and limited antigenic diversity of AMA1. Cross-strain inhibition by antibodies was only moderately and inconsistently correlated with the level of sequence diversity between AMA1 alleles, suggesting that sequence differences are not a strong predictor of antigenic differences or the cross-inhibitory activity of anti-allele antibodies. The importance of the highly polymorphic C1-L region for inhibitory antibodies and potential vaccine escape was assessed by generating novel transgenic P. falciparum lines for testing in GIA. While the polymorphic C1-L epitope was identified as a significant target of some growth-inhibitory antibodies, these antibodies only constituted a minor proportion of the total inhibitory antibody repertoire, suggesting that the antigenic diversity of inhibitory epitopes is limited. Our findings support the concept that a multi-allele AMA1 vaccine would give broad coverage against the diversity of AMA1 alleles and establish new tools to define polymorphisms important for vaccine escape. Citation: Drew DR, Hodder AN, Wilson DW, Foley M, Mueller I, et al. (2012) Defining the Antigenic Diversity of Plasmodium falciparum Apical Membrane Antigen 1 and the Requirements for a Multi-Allele Vaccine against Malaria. PLoS ONE 7(12): e51023. doi:10.1371/journal.pone.0051023	[Drew, Damien R.; Mueller, Ivo; Beeson, James G.] Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia; [Drew, Damien R.; Hodder, Anthony N.; Wilson, Danny W.; Cowman, Alan F.; Beeson, James G.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Foley, Michael] La Trobe Univ, Bundoora, Vic, Australia; [Mueller, Ivo; Siba, Peter M.] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; [Dent, Arlene E.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Beeson, James G.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia	Burnet Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute; La Trobe University; PNG Institute Of Medical Research; Case Western Reserve University; Monash University	Beeson, JG (corresponding author), Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia.	beeson@burnet.edu.au	Cowman, Alan F/C-7642-2013; Wilson, Danny W/E-6186-2019; Mueller, Ivo/C-7251-2013	Cowman, Alan F/0000-0001-5145-9004; Wilson, Danny W/0000-0002-5073-1405; Mueller, Ivo/0000-0001-6554-6889; Foley, Michael/0000-0003-1349-4698	PATH Malaria Vaccine Initiative; US Agency for International Development; National Health and Medical Research Council of Australia; Infrastructure for Research Institutes Support Scheme Grant; Australian Research Council; Victorian State Government Operational Infrastructure Support grant	PATH Malaria Vaccine Initiative; US Agency for International Development(United States Agency for International Development (USAID)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Infrastructure for Research Institutes Support Scheme Grant; Australian Research Council(Australian Research Council); Victorian State Government Operational Infrastructure Support grant	Funding was provided by the PATH Malaria Vaccine Initiative; US Agency for International Development; National Health and Medical Research Council of Australia (program grant to JGB and AFC; Infrastructure for Research Institutes Support Scheme Grant); Australian Research Council (Future Fellowship to JGB); and a Victorian State Government Operational Infrastructure Support grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Anders RF, 2010, HUM VACCINES, V6, P39, DOI 10.4161/hv.6.1.10712; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; Beeson JG, 2004, J INFECT DIS, V189, P540, DOI 10.1086/381186; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; BHASIN VK, 1984, AM J TROP MED HYG, V33, P534, DOI 10.4269/ajtmh.1984.33.534; BURKOT TR, 1984, AM J TROP MED HYG, V33, P783, DOI 10.4269/ajtmh.1984.33.783; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; Crabb BS, 1997, MOL BIOCHEM PARASIT, V90, P131, DOI 10.1016/S0166-6851(97)00143-6; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Duan JH, 2008, P NATL ACAD SCI USA, V105, P7857, DOI 10.1073/pnas.0802328105; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Dutta S, 2010, INFECT IMMUN, V78, P661, DOI 10.1128/IAI.00866-09; Elliott SR, 2007, AM J TROP MED HYG, V76, P860, DOI 10.4269/ajtmh.2007.76.860; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Fowler EV, 2002, MOL BIOCHEM PARASIT, V120, P117, DOI 10.1016/S0166-6851(01)00443-1; Harris KS, 2005, INFECT IMMUN, V73, P6981, DOI 10.1128/IAI.73.10.6981-6989.2005; Healer J, 2005, INFECT IMMUN, V73, P2444, DOI 10.1128/IAI.73.4.2444-2451.2005; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; Kusi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-182; Kusi KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015391; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; Pearce JA, 2004, INFECT IMMUN, V72, P2321, DOI 10.1128/IAI.72.4.2321-2328.2004; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2003, GENETICS, V165, P555; Rayner JC, 2005, AM J TROP MED HYG, V72, P666, DOI 10.4269/ajtmh.2005.72.666; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; THOMAS AW, 1990, MOL BIOCHEM PARASIT, V42, P285, DOI 10.1016/0166-6851(90)90172-I; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Wilson DW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-152	49	58	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51023	10.1371/journal.pone.0051023	http://dx.doi.org/10.1371/journal.pone.0051023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227229	Green Published, gold			2022-12-27	WOS:000312588200090
J	Roggero, P; Gianni, ML; Orsi, A; Amato, O; Piemontese, P; Liotto, N; Morlacchi, L; Taroni, F; Garavaglia, E; Bracco, B; Agosti, M; Mosca, F				Roggero, Paola; Gianni, Maria L.; Orsi, Anna; Amato, Orsola; Piemontese, Pasqua; Liotto, Nadia; Morlacchi, Laura; Taroni, Francesca; Garavaglia, Elisa; Bracco, Beatrice; Agosti, Massimo; Mosca, Fabio			Implementation of Nutritional Strategies Decreases Postnatal Growth Restriction in Preterm Infants	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; RANDOMIZED CONTROLLED-TRIAL; BODY-COMPOSITION; NEONATAL OUTCOMES; PROTEIN	Background: Prevention of postnatal growth restriction of very preterm infants still represents a challenge for neonatologists. As standard feeding regimens have proven to be inadequate. Improved feeding strategies are needed to promote growth. Aim of the present study was to evaluate whether a set of nutritional strategies could limit the postnatal growth restriction of a cohort of preterm infants. Methodology/Principal Findings: We performed a prospective non randomized interventional cohort study. Growth and body composition were assessed in 102 very low birth weight infants after the introduction of a set of nutritional practice changes. 69 very low birth weight infants who had received nutrition according to the standard nutritional feeding strategy served as a historical control group. Weight was assessed daily, length and head circumference weekly. Body composition at term corrected age was assessed using an air displacement plethysmography system. The cumulative parenteral energy and protein intakes during the first 7 days of life were higher in the intervention group than in the historical group (530 +/- 81 vs 300 +/- 93 kcal/kg, p<0.001 and 21 +/- 2.9 vs 15 +/- 3.2 g/kg, p<0.01). During weaning from parenteral nutrition, the intervention group received higher parental/enteral energy and protein intakes than the historical control group (1380 +/- 58 vs 1090 +/- 70 kcal/kg; 52.6 +/- 7 vs 42.3 +/- 10 g/kg, p<0.01). Enteral energy (kcal/kg/d) and protein (g/kg/d) intakes in the intervention group were higher than in the historical group (130 +/- 11 vs 100 +/- 13; 3.5 +/- 0.5 vs 2.2 +/- 0.6, p<0.01). The negative changes in z score from birth to discharge for weight and head circumference were significantly lower in the intervention group as compared to the historical group. No difference in fat mass percentage between the intervention and the historical groups was found. Conclusions: The optimization and the individualization of nutritional intervention promote postnatal growth of preterm infants without any effect on percentage of fat mass.	[Roggero, Paola; Gianni, Maria L.; Orsi, Anna; Amato, Orsola; Piemontese, Pasqua; Liotto, Nadia; Morlacchi, Laura; Taroni, Francesca; Garavaglia, Elisa; Bracco, Beatrice; Agosti, Massimo; Mosca, Fabio] Univ Milan, NICU, Dept Clin Sci & Comun Hlth, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Agosti, Massimo] Del Ponte Hosp, Maternal & Child Hlth Dept, AO Circolo Fdn, Varese, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Roggero, P (corresponding author), Univ Milan, NICU, Dept Clin Sci & Comun Hlth, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy.	paola.roggero@unimi.it	Taroni, Francesca/AAC-6481-2022; Mosca, Fabio/C-5826-2017; Giannì, Maria/C-2026-2017; Agosti, Massimo/Q-6222-2016	Mosca, Fabio/0000-0001-6477-0299; Giannì, Maria/0000-0003-3901-9131; Agosti, Massimo/0000-0003-1828-821X; taroni, francesca/0000-0001-7710-7795; LIOTTO, NADIA/0000-0003-0425-5046; AMATO, ORSOLA/0000-0003-4687-4654; orsi, anna/0000-0002-5862-0371				Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; Costa-Orvay JA, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-140; Belfort MB, 2011, PEDIATRICS, V128, pE899, DOI 10.1542/peds.2011-0282; BERTINO E, 2012, MATERN FETAL NEON S1, V25, P67, DOI DOI 10.3109/14767058.2012.664889; Cooke RJ, 2009, ACTA PAEDIATR, V98, P1269, DOI 10.1111/j.1651-2227.2009.01354.x; Corpeleijn WE, 2011, ANN NUTR METAB, V58, P20, DOI 10.1159/000323384; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Embleton ND, 2007, EARLY HUM DEV, V83, P831, DOI 10.1016/j.earlhumdev.2007.10.001; Fenton TR, 2003, BMC PEDIATR, V16, P3; Ma GS, 2004, AM J CLIN NUTR, V79, P653; Miller J, 2012, AM J CLIN NUTR, V95, P648, DOI 10.3945/ajcn.111.026351; Patel AL, 2009, J PERINATOL, V29, P618, DOI 10.1038/jp.2009.55; Rochow N, 2012, CLIN NUTR, V31, P124, DOI 10.1016/j.clnu.2011.07.004; Roggero P, 2012, PEDIAT RES IN PRESS; Roggero P, 2009, EARLY HUM DEV, V85, P349, DOI 10.1016/j.earlhumdev.2008.12.011; Senterre T, 2012, ACTA PAEDIATR, V101, pE64, DOI 10.1111/j.1651-2227.2011.02443.x; Senterre T, 2011, J PEDIATR GASTR NUTR, V53, P536, DOI 10.1097/MPG.0b013e31822a009d; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Tan MJ, 2008, ARCH DIS CHILD-FETAL, V93, pF337, DOI 10.1136/adc.2007.124230; Tsang RC., 2005, NUTR PRETERM INFANT; Vlaardingerbroek H, 2009, EARLY HUM DEV, V85, P691, DOI 10.1016/j.earlhumdev.2009.08.052	21	46	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51166	10.1371/journal.pone.0051166	http://dx.doi.org/10.1371/journal.pone.0051166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227249	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200108
J	Wang, LH; Liu, W; Jiang, W; Lin, J; Jiang, YD; Li, B; Pang, D				Wang, Lihong; Liu, Wei; Jiang, Wei; Lin, Jing; Jiang, Yongdong; Li, Bo; Pang, Da			A miRNA Binding Site Single-Nucleotide Polymorphism in the 3 '-UTR Region of the IL23R Gene Is Associated with Breast Cancer	PLOS ONE			English	Article							INTERLEUKIN-23 RECEPTOR; CHINESE POPULATION; IL-23; RISK; DIFFERENTIATION; SUSCEPTIBILITY; INFLAMMATION; CELLS; AXIS	Background: Research into the etiology of breast cancer has recently focused on the role of the immunity and inflammation. Interleukin-23 and its receptor (IL23R) guide T cells towards the Th17 phenotype. IL23R single nucleotide polymorphisms (SNPs) have been shown to be associated with digestive system cancers. To evaluate the influences of IL23R gene polymorphisms on the risk of sporadic breast cancer, a case-control study was conducted in Chinese Han women. Methodology and Principal Findings: We genotyped two tag SNPs (rs10889677 in the 3'-UTR region and nonsynonymous variants rs1884444 in exon 2) in IL23R gene of 491 breast cancer patients and 502 matched healthy controls. The genotypes were determined using the SNaPshot technique. The differences in the genotypic distribution between breast cancer patients and healthy controls were analyzed with the Chi-square test for trends. For rs10889677 in IL23R, the frequencies of the AA genotype and the A allele were statistical significant higher in breast cancer patients than in controls (P = 0.0084 and P = 0.0171, respectively), whereas the C allele was associated with an earlier age of breast cancer onset (50.6 years for AA, 48.7 years for AC and 46.0 years for CC (P = 0.0114)) in case-only study. The clinical features analysis demonstrated significant associations between rs1884444 in IL23R and human epidermal growth factor receptor 2 (Her-2) and tumor size status. Conclusions and Significance: Our results suggest that a miRNA binding site SNP in the 39-UTR region of the IL23R gene may be associated with the risk of breast cancer and contribute to the early development of breast cancer in Chinese women.	[Wang, Lihong; Lin, Jing; Pang, Da] Harbin Med Univ, Inst Canc Prevent & Treatment, Harbin, Peoples R China; [Liu, Wei] Harbin Med Univ, Affiliated Hosp 1, Dept Pathol, Harbin, Peoples R China; [Jiang, Wei] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Jiang, Yongdong; Pang, Da] Harbin Med Univ, Affiliated Hosp 3, Dept Breast Surg, Harbin, Peoples R China; [Li, Bo] Harbin Med Univ, Dept Immunol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Pang, D (corresponding author), Harbin Med Univ, Inst Canc Prevent & Treatment, Harbin, Peoples R China.	2824607@qq.com; pangdasir@163.com			Key Science and Technology Program of Heilongjiang Province, China [GC08C501]; National Natural Science Foundation of China [30900837]	Key Science and Technology Program of Heilongjiang Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Science and Technology Program of Heilongjiang Province, China (Grant number GC08C501) and National Natural Science Foundation of China (Grant Number 30900837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan C, 2011, EXPERT OPIN THER TAR, V15, P21, DOI 10.1517/14656566.2011.537260; Chalmin F, 2012, IMMUNITY; Chen J, 2010, INT J OBESITY, V34, P1227, DOI 10.1038/ijo.2010.29; Chen JJ, 2010, MOL CARCINOGEN, V49, P862, DOI 10.1002/mc.20661; Chien MH, 2012, HEAD NECK-J SCI SPEC, V34, P551, DOI 10.1002/hed.21779; Chu HJ, 2012, INT J CANCER, V130, P1093, DOI 10.1002/ijc.26130; Cole SW, 2009, J CLIN ONCOL, V27, P3418, DOI 10.1200/JCO.2009.21.9782; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Huber AK, 2008, J CLIN ENDOCR METAB, V93, P1077, DOI 10.1210/jc.2007-2190; Kan SH, 2008, GENES IMMUN, V9, P631, DOI 10.1038/gene.2008.64; Langowski JL, 2007, TRENDS IMMUNOL, V28, P207, DOI 10.1016/j.it.2007.03.006; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Schmidt-Weber CB, 2007, J ALLERGY CLIN IMMUN, V120, P247, DOI 10.1016/j.jaci.2007.06.039; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Shime H, 2008, J IMMUNOL, V180, P7175, DOI 10.4049/jimmunol.180.11.7175; Tan ZY, 2009, INT J BIOCHEM CELL B, V41, P733, DOI 10.1016/j.biocel.2008.04.027; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034400; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Zwiers A, 2012, J IMMUNOL, V188, P1573, DOI 10.4049/jimmunol.1101494	21	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49823	10.1371/journal.pone.0049823	http://dx.doi.org/10.1371/journal.pone.0049823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239971	gold, Green Published, Green Submitted			2022-12-27	WOS:000312290800009
J	Yamamoto, S; Ouchi, Y; Nakatsuka, D; Tahara, T; Mizuno, K; Tajima, S; Onoe, H; Yoshikawa, E; Tsukada, H; Iwase, M; Yamaguti, K; Kuratsune, H; Watanabe, Y				Yamamoto, Shigeyuki; Ouchi, Yasuomi; Nakatsuka, Daisaku; Tahara, Tsuyoshi; Mizuno, Kei; Tajima, Seiki; Onoe, Hirotaka; Yoshikawa, Etsuji; Tsukada, Hideo; Iwase, Masao; Yamaguti, Kouzi; Kuratsune, Hirohiko; Watanabe, Yasuyoshi			Reduction of [C-11](+)3-MPB Binding in Brain of Chronic Fatigue Syndrome with Serum Autoantibody against Muscarinic Cholinergic Receptor	PLOS ONE			English	Article							ACETYLCHOLINESTERASE ACTIVITY; NEUROTRANSMITTER RECEPTORS; PET LIGANDS; BARRIER; IMPAIRMENT; IMMUNOGLOBULIN; SCHIZOPHRENIA; TRANSPORTERS; PERMEABILITY; HYPOTHESIS	Background: Numerous associations between brain-reactive antibodies and neurological or psychiatric symptoms have been proposed. Serum autoantibody against the muscarinic cholinergic receptor (mAChR) was increased in some patients with chronic fatigue syndrome (CFS) or psychiatric disease. We examined whether serum autoantibody against mAChR affected the central cholinergic system by measuring brain mAChR binding and acetylcholinesterase activity using positron emission tomography (PET) in CFS patients with positive [CFS(+)] and negative [CFS(-)] autoantibodies. Methodology: Five CFS(+) and six CFS(-) patients, as well as 11 normal control subjects underwent a series of PET measurements with N-[C-11]methyl-3-piperidyl benzilate [C-11](+)3-MPB for the mAChR binding and N-[C-11]methyl-4-piperidyl acetate [C-11]MP4A for acetylcholinesterase activity. Cognitive function of all subjects was assessed by neuropsychological tests. Although the brain [C-11](+)3-MPB binding in CFS(-) patients did not differ from normal controls, CFS(+) patients showed significantly lower [C-11](+) 3-MPB binding than CFS(-) patients and normal controls. In contrast, the [C-11] MP4A index showed no significant differences among these three groups. Neuropsychological measures were similar among groups. Conclusion: The present results demonstrate that serum autoantibody against the mAChR can affect the brain mAChR without altering acetylcholinesterase activity and cognitive functions in CFS patients. Citation: Yamamoto S, Ouchi Y, Nakatsuka D, Tahara T, Mizuno K, et al. (2012) Reduction of [C-11](+)3-MPB Binding in Brain of Chronic Fatigue Syndrome with Serum Autoantibody against Muscarinic Cholinergic Receptor. PLoS ONE 7(12): e51515. doi:10.1371/journal.pone.0051515	[Yamamoto, Shigeyuki; Nakatsuka, Daisaku; Tajima, Seiki; Yamaguti, Kouzi; Watanabe, Yasuyoshi] Osaka City Univ, Grad Sch Med, Dept Physiol, Abeno Ku, Osaka 558, Japan; [Yamamoto, Shigeyuki; Yoshikawa, Etsuji; Tsukada, Hideo] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan; [Ouchi, Yasuomi] Hamamatsu Univ Sch Med, Mol Imaging Frontier Res Ctr, Hamamatsu, Shizuoka, Japan; [Tahara, Tsuyoshi; Mizuno, Kei; Onoe, Hirotaka; Watanabe, Yasuyoshi] RIKEN Ctr Mol Imaging Sci CMIS, Kobe, Hyogo, Japan; [Iwase, Masao] Osaka Univ, Grad Sch Med, Dept Clin Neurosci, Suita, Osaka, Japan; [Kuratsune, Hirohiko] Kansai Univ Welf Sci, Fac Hlth Sci Welf, Dept Hlth Sci, Kashiwara, Japan	Osaka Metropolitan University; Hamamatsu Photonics; Hamamatsu University School of Medicine; RIKEN; Osaka University	Watanabe, Y (corresponding author), Osaka City Univ, Grad Sch Med, Dept Physiol, Abeno Ku, Osaka 558, Japan.	yywata@riken.jp			Special Coordination Funds for Promoting Science and Technology; 21st Century COE Program "Base to Overcome Fatigue'' from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Ministry of Health, Labor, and Welfare	Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 21st Century COE Program "Base to Overcome Fatigue'' from the Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Special Coordination Funds for Promoting Science and Technology, the 21st Century COE Program "Base to Overcome Fatigue'' from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, and grants from Japanese Ministry of Health, Labor, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Afari N, 2003, AM J PSYCHIAT, V160, P221, DOI 10.1176/appi.ajp.160.2.221; AHLSKOG JE, 1991, ANN NEUROL, V30, P185, DOI 10.1002/ana.410300210; Argaw AT, 2006, J IMMUNOL, V177, P5574, DOI 10.4049/jimmunol.177.8.5574; AXELSSON R, 1982, BRIT J PSYCHIAT, V141, P273, DOI 10.1192/bjp.141.3.273; Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684; Bauer B, 2007, MOL PHARMACOL, V71, P667, DOI 10.1124/mol.106.029512; Borda T, 2002, J IMMUNOL, V168, P3667, DOI 10.4049/jimmunol.168.7.3667; Buck A, 2000, J CEREBR BLOOD F MET, V20, P253, DOI 10.1097/00004647-200002000-00005; Bymaster FP, 2002, CNS NEUROL DISORD-DR, V1, P163, DOI 10.2174/1568007024606249; COLLERTON D, 1986, NEUROSCIENCE, V19, P1, DOI 10.1016/0306-4522(86)90002-3; Crook JM, 2000, BIOL PSYCHIAT, V48, P381, DOI 10.1016/S0006-3223(00)00918-5; Dean B, 2002, MOL PSYCHIATR, V7, P1083, DOI 10.1038/sj.mp.4001199; Diamond B, 2006, ADV IMMUNOL, V89, P289, DOI 10.1016/S0065-2776(05)89007-8; Diamond B, 2009, NAT REV IMMUNOL, V9, P449, DOI 10.1038/nri2529; Eggers C, 2007, EUR J NEUROL, V14, P690, DOI 10.1111/j.1468-1331.2007.01737.x; ENNA SJ, 1976, NEW ENGL J MED, V294, P1305, DOI 10.1056/NEJM197606102942402; FLYNN DD, 1995, J NEUROCHEM, V64, P1888; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Ganzinelli S, 2006, NEUROPHARMACOLOGY, V50, P362, DOI 10.1016/j.neuropharm.2005.09.013; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hatcher S, 2003, PSYCHOL MED, V33, P1185, DOI 10.1017/S0033291703008274; Hohmann C, 1998, PSYCHOPHARMACOLOGY A, P69; Horikoshi T., 2004, International Journal of Cosmetic Science, V26, P9, DOI 10.1111/j.0142-5463.2004.00200.x; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Irie T, 1996, J NUCL MED, V37, P649; Kobayashi Y, 2002, J NEUROPHYSIOL, V88, P715, DOI 10.1152/jn.2002.88.2.715; Kuang F, 2004, INT J NEUROSCI, V114, P575, DOI 10.1080/00207450490422731; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; LANGE KW, 1992, J NEUROL, V239, P103, DOI 10.1007/BF00862983; LEVY JA, 1994, CLIN INFECT DIS, V18, pS117, DOI 10.1093/clinids/18.Supplement_1.S117; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lyall M, 2003, J PSYCHOSOM RES, V55, P79, DOI 10.1016/S0022-3999(02)00515-9; Matsumura M, 1997, NEUROSCI RES, V28, P155, DOI 10.1016/S0168-0102(97)00039-4; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Morshed SA, 2001, BIOL PSYCHIAT, V50, P566, DOI 10.1016/S0006-3223(01)01096-4; Namba H, 1998, LANCET, V351, P881, DOI 10.1016/S0140-6736(05)70293-2; Namba H, 1999, EUR J NUCL MED, V26, P135, DOI 10.1007/s002590050369; Nishiyama S, 2001, SYNAPSE, V40, P159, DOI 10.1002/syn.1038; NOY S, 1994, NEUROPSYCHOBIOLOGY, V30, P157, DOI 10.1159/000119155; Ota T, 2004, ANN NUCL MED, V18, P187, DOI 10.1007/BF02984999; Paul R, 2003, BRAIN, V126, P1873, DOI 10.1093/brain/awg171; Perlmutter SJ, 1999, LANCET, V354, P1153, DOI 10.1016/S0140-6736(98)12297-3; PERRY EK, 1986, BRIT MED BULL, V42, P63, DOI 10.1093/oxfordjournals.bmb.a072100; Raison CL, 2009, BRAIN BEHAV IMMUN, V23, P327, DOI 10.1016/j.bbi.2008.11.005; Reina S, 2004, J NEUROIMMUNOL, V150, P107, DOI 10.1016/j.jneuroim.2004.01.019; REINIKAINEN KJ, 1987, LIFE SCI, V41, P453, DOI 10.1016/0024-3205(87)90221-9; Reitan R, 1956, TRAIL MAKING TEST MA; RINNE JO, 1985, BRAIN RES, V336, P19, DOI 10.1016/0006-8993(85)90411-1; Schwarz MJ, 1998, NEUROSCI LETT, V253, P201, DOI 10.1016/S0304-3940(98)00655-7; Sellin AK, 2008, CNS SPECTRUMS, V13, P985, DOI 10.1017/S1092852900014048; Spreen O, 1998, COMPENDIUM NEUROPSYC; STERIADE M, 1992, NEUROLOGY, V42, P9; Tajima S, 2010, NEUROL RES INT, V2010, DOI 10.1155/2010/671421; Takahashi K, 1998, THESIS TOHOKU U, V3041, P1; Tanaka M, 2010, MED HYPOTHESES, V75, P244, DOI 10.1016/j.mehy.2010.02.032; Tanaka S, 2003, J NEUROIMMUNOL, V141, P155, DOI 10.1016/S0165-5728(03)00252-2; Tanaka S, 2003, INT J MOL MED, V12, P225; Terry AV, 2003, J PHARMACOL EXP THER, V306, P821, DOI 10.1124/jpet.102.041616; Tsuchiya H, 2000, NEUROPSYCHOLOGIA, V38, P645, DOI 10.1016/S0028-3932(99)00108-6; Tsukada H, 2001, SYNAPSE, V39, P182, DOI 10.1002/1098-2396(200102)39:2<182::AID-SYN10>3.0.CO;2-Q; WASTEK GJ, 1978, MOL PHARMACOL, V14, P768; Wechsler D, 1987, WMS R WECHSLER MEMOR; Yamamoto S, 2004, NEUROREPORT, V15, P2571, DOI 10.1097/00001756-200412030-00002; Yamamoto S, 2011, NEUROIMAGE, V58, P1, DOI 10.1016/j.neuroimage.2011.06.031; Yamamoto S, 2011, NEUROPSYCHOPHARMACOL, V36, P1455, DOI 10.1038/npp.2011.31; Yamamoto S, 2011, SYNAPSE, V65, P548, DOI 10.1002/syn.20881; Zavitsanou K, 2004, NEUROPSYCHOPHARMACOL, V29, P1585, DOI 10.1038/sj.npp.1300509	67	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51515	10.1371/journal.pone.0051515	http://dx.doi.org/10.1371/journal.pone.0051515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240035	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800071
J	Zou, H; Zhang, J; Li, WX; Wu, SG; Wang, GT				Zou, Hong; Zhang, Jin; Li, Wenxiang; Wu, Shangong; Wang, Guitang			Mitochondrial Genome of the Freshwater Jellyfish Craspedacusta sowerbyi and Phylogenetics of Medusozoa	PLOS ONE			English	Article							CLASS-LEVEL RELATIONSHIPS; PHYLUM-CNIDARIA; EVOLUTION; HYDROZOA; SEQUENCE; LANKESTER; INSIGHTS; MEDUSAE; MODELS; TAXA	The 17,922 base pairs (bp) nucleotide sequence of the linear mitochondrial DNA (mtDNA) molecule of the freshwater jellyfish Craspedacusta sowerbyi (Hydrozoa, Trachylina, Limnomedusae) has been determined. This sequence exhibits surprisingly low A+T content (57.1%), containing genes for 13 energy pathway proteins, a small and a large subunit rRNAs, and methionine and tryptophan tRNAs. Mitochondrial ancestral medusozoan gene order (AMGO) was found in the C. sowerbyi, as those found in Cubaia aphrodite (Hydrozoa, Trachylina, Limnomedusae), discomedusan Scyphozoa and Staurozoa. The genes of C. sowerbyi mtDNA are arranged in two clusters with opposite transcriptional polarities, whereby transcription proceeds toward the ends of the DNA molecule. Identical inverted terminal repeats (ITRs) flank the ends of the mitochondrial DNA molecule, a characteristic typical of medusozoans. In addition, two open reading frames (ORFs) of 354 and 1611 bp in length were found downstream of the large subunit rRNA gene, similar to the two ORFs of ORF314 and polB discovered in the linear mtDNA of C. aphrodite, discomedusan Scyphozoa and Staurozoa. Phylogenetic analyses of C. sowerbyi and other cnidarians were carried out based on both nucleotide and inferred amino acid sequences of the 13 mitochondrial energy pathway genes. Our working hypothesis supports the monophyletic Medusozoa being a sister group to Octocorallia (Cnidaria, Anthozoa). Within Medusozoa, the phylogenetic analysis suggests that Staurozoa may be the earliest diverging class and the sister group of all other medusozoans. Cubozoa and coronate Scyphozoa form a clade that is the sister group of Hydrozoa plus discomedusan Scyphozoa. Hydrozoa is the sister group of discomedusan Scyphozoa. Semaeostomeae is a paraphyletic clade with Rhizostomeae, while Limnomedusae (Trachylina) is the sister group of hydroidolinans and may be the earliest diverging lineage among Hydrozoa.	[Zou, Hong; Zhang, Jin; Li, Wenxiang; Wu, Shangong; Wang, Guitang] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei Province, Peoples R China; [Zou, Hong; Zhang, Jin; Li, Wenxiang; Wu, Shangong; Wang, Guitang] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei Province, Peoples R China; [Zou, Hong; Zhang, Jin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, GT (corresponding author), Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei Province, Peoples R China.	gtwang@ihb.ac.cn			National Technology System for Conventional Freshwater Fish Industries [CARS-46-08]; National Program on Key Basic Research Project [2009CB118705]	National Technology System for Conventional Freshwater Fish Industries; National Program on Key Basic Research Project(National Basic Research Program of China)	This research was supported by the National Technology System for Conventional Freshwater Fish Industries (CARS-46-08) and the National Program on Key Basic Research Project (Grant no. 2009CB118705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKER TS, 1976, AM MIDL NAT, V95, P323, DOI 10.2307/2424397; Boore JL, 2000, MOL BIOL EVOL, V17, P87, DOI 10.1093/oxfordjournals.molbev.a026241; Boothroyd IKG, 2002, HYDROBIOLOGIA, V468, P23, DOI 10.1023/A:1015206320300; Bouillon J., 2000, THALASSIA SALENTINA, V24, P3, DOI DOI 10.1285/I15910725V24P3; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Cao Y, 1998, J MOL EVOL, V47, P307, DOI 10.1007/PL00006389; Cartwright P, 2008, J MAR BIOL ASSOC UK, V88, P1663, DOI 10.1017/S0025315408002257; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Collins AG, 2000, SCI MAR, V64, P5, DOI 10.3989/scimar.2000.64s15; Collins AG, 2008, J MAR BIOL ASSOC UK, V88, P1673, DOI 10.1017/S0025315408001732; Fritz GB, 2009, J LIMNOL, V68, P46, DOI 10.4081/jlimnol.2009.46; Hall B.G., 2004, PHYLOGENETIC TREES M; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Jankowski T, 2001, HYDROBIOLOGIA, V462, P91, DOI 10.1023/A:1013126015171; Jankowski T, 2008, HYDROBIOLOGIA, V595, P35, DOI 10.1007/s10750-007-9001-9; Kayal E, 2008, GENE, V410, P177, DOI 10.1016/j.gene.2007.12.002; Kayal E, 2012, GENOME BIOL EVOL, V4, P1, DOI 10.1093/gbe/evr123; Kim JH, 1999, MOL BIOL EVOL, V16, P423, DOI 10.1093/oxfordjournals.molbev.a026124; KRAMP PL, 1950, P ZOOL SOC LOND, V120, P165, DOI 10.1111/j.1096-3642.1950.tb01469.x; Kramp PL, 1961, J MAR BIOL ASSOC UK, V40, P213; Lavrov DV, 2005, MOL BIOL EVOL, V22, P1231, DOI 10.1093/molbev/msi108; LEONARD JL, 1980, NATURE, V284, P377, DOI 10.1038/284377a0; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Loytynoja A, 2001, BIOINFORMATICS, V17, P573, DOI 10.1093/bioinformatics/17.6.573; Marques AC, 2004, INVERTEBR BIOL, V123, P23; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Park E, 2012, MOL PHYLOGENET EVOL, V62, P329, DOI 10.1016/j.ympev.2011.10.008; PENNAK ROBERT W., 1956, TRANS AMER MICROSC SOC, V75, P324, DOI 10.2307/3223963; PETERSEN KW, 1990, ZOOL J LINN SOC-LOND, V100, P101, DOI 10.1111/j.1096-3642.1990.tb01862.x; PETERSEN KW, 1979, BIOL SYSTEMATICS COL, P105; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Salvini-Plawen, 1978, Z ZOOL SYST EVOL, V16, P40; Sambrook J., 2002, MOL CLONING LAB MANU; SATTERLIE RA, 1980, NATURE, V284, P377, DOI 10.1038/284377b0; SCHUCHERT P, 1993, Z ZOOL SYST EVOL, V31, P161; Shao ZY, 2006, GENE, V381, P92, DOI 10.1016/j.gene.2006.06.021; Silva WM, 2007, BIOTA NEOTROP, V7, P227; Smith DR, 2012, GENOME BIOL EVOL, V4, P52, DOI 10.1093/gbe/evr127; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Iten H, 2006, J SYST PALAEONTOL, V4, P109, DOI 10.1017/S1477201905001793; van Oppen MJH, 2002, J MOL EVOL, V55, P1, DOI 10.1007/s00239-001-0075-0; Voigt O, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-350; Werner B., 1973, Publications Seto Mar Biol Lab, V20, P35; Yang ZH, 1998, MOL BIOL EVOL, V15, P1600, DOI 10.1093/oxfordjournals.molbev.a025888; Zhang LQ, 2009, J PLANKTON RES, V31, P563, DOI 10.1093/plankt/fbp005	52	42	43	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51465	10.1371/journal.pone.0051465	http://dx.doi.org/10.1371/journal.pone.0051465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240028	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800064
J	Qin, H; Luo, J; Zhu, YP; Xie, HL; Yang, WQ; Lei, WB				Qin, Hao; Luo, Jie; Zhu, Yuan-Ping; Xie, Hai-Li; Yang, Wei-Qiang; Lei, Wen-Bin			Combination of Taxanes, Cisplatin and Fluorouracil as Induction Chemotherapy for Locally Advanced Head and Neck Cancer: A Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PHASE-III; RANDOMIZED-TRIAL; DOCETAXEL; CHEMORADIOTHERAPY; RADIOTHERAPY; PACLITAXEL; STANDARD; SURVIVAL; THERAPY	Background: Some investigations have suggested that induction chemotherapy with a combination of taxanes, cisplatin and fluorouracil (TPF) is effective in locally advanced head and neck cancer. However, other trials have indicated that TPF does not improve outcomes. The objective of this study was to compare the efficacy and safety of TPF with a cisplatin and fluorouracil (PF) regimen through a meta-analysis. Methods: Four randomized clinical trials were identified, which included 1,552 patients with locally advanced head and neck cancer who underwent induction chemotherapy with either a TPF or PF protocol. The outcomes included the 3-year survival rate, overall response rate and different types of adverse events. Risk ratios (RRs) and their 95% confidence intervals (CIs) were pooled using RevMan 5.1 software. Results: The 3-year survival rate (51.0% vs. 42.4%; p = 0.002), 3-year progression-free survival rate (35.9% vs. 27.2%; p = 0.007) and overall response to chemotherapy (72.9% vs. 62.1%; p < 0.00001) of the patients in the TPF group was statistically superior to those in the PF group. In terms of toxicities, the incidence of febrile neutropenia (7.0% vs. 3.2%; p = 0.001) and alopecia (10.8% vs. 1.1%; p < 0.00001) was higher in the TPF group. Conclusion: The TPF induction chemotherapy regimen leads to a significant survival advantage with acceptable toxicity rates for patients with locally advanced head and neck cancer compared with the PF regimen.	[Qin, Hao; Luo, Jie; Zhu, Yuan-Ping; Yang, Wei-Qiang; Lei, Wen-Bin] Sun Yat Sen Univ, Otorhinolaryngol Inst, Affiliated Hosp 1, Dept Otorhinolaryngol, Guangzhou 510275, Guangdong, Peoples R China; [Xie, Hai-Li] Sun Yat Sen Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Lei, WB (corresponding author), Sun Yat Sen Univ, Otorhinolaryngol Inst, Affiliated Hosp 1, Dept Otorhinolaryngol, Guangzhou 510275, Guangdong, Peoples R China.	leiwb2003@yahoo.com.cn	Zhu, Yuanping/AAM-2950-2021	Zhu, Yuanping/0000-0001-8057-8061	National Natural Science Foundation of China [81072224]; Young Faculty Cultivation Project of Sun Yat-sen University [10ykpy10]; Science and Technology Planning Project of Guangdong Province [2009B030801109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Faculty Cultivation Project of Sun Yat-sen University; Science and Technology Planning Project of Guangdong Province	This study was supported by National Natural Science Foundation of China (81072224), Young Faculty Cultivation Project of Sun Yat-sen University (10ykpy10) and Science and Technology Planning Project of Guangdong Province (2009B030801109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brockstein B, 2004, ANN ONCOL, V15, P1179, DOI 10.1093/annonc/mdh308; Chandana SR, 2009, CURR OPIN ONCOL, V21, P218, DOI 10.1097/CCO.0b013e328329abe5; Denis F, 2004, J CLIN ONCOL, V22, P69, DOI 10.1200/JCO.2004.08.021; Forastiere AA, 2006, LONG TERM RESULTS IN; FRANCIS PA, 1995, LUNG CANCER-J IASLC, V12, pS163, DOI 10.1016/0169-5002(95)00432-Z; Harari PM, 1997, J CLIN ONCOL, V15, P2050, DOI 10.1200/JCO.1997.15.5.2050; Hitt R, 2005, J CLIN ONCOL, V23, P8636, DOI 10.1200/JCO.2004.00.1990; Hitt R, 2009, ASCO M, V27, P6009; HORWITZ SB, 1992, TRENDS PHARMACOL SCI, V13, P134; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kutter J, 2005, EUR ARCH OTO-RHINO-L, V262, P1, DOI 10.1007/s00405-003-0725-5; Lefebvre JL, 1996, J NATL CANCER I, V88, P890, DOI 10.1093/jnci/88.13.890; Lorch JH, 2011, LANCET ONCOL, V12, P153, DOI 10.1016/S1470-2045(10)70279-5; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; PACCAGNELLA A, 1994, J NATL CANCER I, V86, P265, DOI 10.1093/jnci/86.4.265; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parthan A, 2009, HEAD NECK-J SCI SPEC, V31, P1255, DOI 10.1002/hed.21096; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Pignon JP, 2004, ANTI-CANCER DRUG, V15, P331, DOI 10.1097/00001813-200404000-00004; Pointreau Y, 2009, JNCI-J NATL CANCER I, V101, P498, DOI 10.1093/jnci/djp007; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; ROWINSKY EK, 1990, JNCI-J NATL CANCER I, V82, P1247, DOI 10.1093/jnci/82.15.1247; Schrijvers D, 2000, Oncologist, V5, P199, DOI 10.1634/theoncologist.5-3-199; Seiwert TY, 2005, BRIT J CANCER, V92, P1341, DOI 10.1038/sj.bjc.6602510; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Yano R, 2011, INT J CLIN ONCOL	28	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51526	10.1371/journal.pone.0051526	http://dx.doi.org/10.1371/journal.pone.0051526			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236511	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100127
J	Willer, R; Sharkey, A; Frey, S				Willer, Robb; Sharkey, Amanda; Frey, Seth			Reciprocity on the Hardwood: Passing Patterns among Professional Basketball Players	PLOS ONE			English	Article							EVOLUTION; GRATITUDE; EXCHANGE	Past theory and research view reciprocal resource sharing as a fundamental building block of human societies. Most studies of reciprocity dynamics have focused on trading among individuals in laboratory settings. But if motivations to engage in these patterns of resource sharing are powerful, then we should observe forms of reciprocity even in highly structured group environments in which reciprocity does not clearly serve individual or group interests. To this end, we investigated whether patterns of reciprocity might emerge among teammates in professional basketball games. Using data from logs of National Basketball Association (NBA) games of the 2008-9 season, we estimated a series of conditional logistic regression models to test the impact of different factors on the probability that a given player would assist another player in scoring a basket. Our analysis found evidence for a direct reciprocity effect in which players who had "received" assists in the past tended to subsequently reciprocate their benefactors. Further, this tendency was time-dependent, with the probability of repayment highest soon after receiving an assist and declining as game time passed. We found no evidence for generalized reciprocity - a tendency to "pay forward" assists - and only very limited evidence for indirect reciprocity - a tendency to reward players who had sent others many assists. These findings highlight the power of reciprocity to shape human behavior, even in a setting characterized by extensive planning, division of labor, quick decision-making, and a focus on inter-group competition.	[Willer, Robb] Univ Calif Berkeley, Dept Sociol, Berkeley, CA 94720 USA; [Sharkey, Amanda] Univ Chicago, Booth Sch Business, Chicago, IL 60637 USA; [Frey, Seth] Indiana Univ, Cognit Sci Program, Bloomington, IN USA	University of California System; University of California Berkeley; University of Chicago; Indiana University System; Indiana University Bloomington	Willer, R (corresponding author), Univ Calif Berkeley, Dept Sociol, Berkeley, CA 94720 USA.	willer@berkeley.edu	Frey, Seth/AAF-8499-2021	Frey, Seth/0000-0002-5298-5089				Akcay C, 2010, ANIM BEHAV, V80, P1041, DOI 10.1016/j.anbehav.2010.09.009; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barclay P, 2007, P ROY SOC B-BIOL SCI, V274, P749, DOI 10.1098/rspb.2006.0209; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Bearman P, 1997, AM J SOCIOL, V102, P1383, DOI 10.1086/231087; Cheshire C, 2007, SOC PSYCHOL QUART, V70, P82, DOI 10.1177/019027250707000109; Ekeh P., 1974, SOCIAL EXCHANGE THEO; Gouldner AW, 1960, SCAND J PSYCHOL, V25, P161; Levi-Strauss C., 1969, ELEMENTARY STRUCTURE; Long JS, 1997, REGRESSION MODELS CA; Milinski M, 2002, P ROY SOC B-BIOL SCI, V269, P881, DOI 10.1098/rspb.2002.1964; Milinski M, 1990, BEHAV ECOL SOCIOBIOL, V27, DOI [10.1007/BF00183308, DOI 10.1007/BF00183308]; Moody M, 2008, SOCIOL THEOR, V26, P130, DOI 10.1111/j.1467-9558.2008.00322.x; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2007, P R SOC B, V274, P605, DOI 10.1098/rspb.2006.0125; Parks C.D., 1998, INT NEGOT, V3, P151, DOI [10.1163/15718069820848166, DOI 10.1163/15718069820848166]; Rutte C, 2007, PLOS BIOL, V5, P1421, DOI 10.1371/journal.pbio.0050196; Sahlins Marshall., 1969, STONE AGE EC, P185; Willer R, 2009, AM SOCIOL REV, V74, P23, DOI 10.1177/000312240907400102	20	9	9	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e49807	10.1371/journal.pone.0049807	http://dx.doi.org/10.1371/journal.pone.0049807			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	050OT	23236354	gold, Green Published, Green Submitted			2022-12-27	WOS:000312064100006
J	Bessadottir, M; Egilsson, M; Einarsdottir, E; Magnusdottir, IH; Ogmundsdottir, MH; Omarsdottir, S; Ogmundsdottir, HM				Bessadottir, Margret; Egilsson, Mar; Einarsdottir, Eydis; Magnusdottir, Iris H.; Ogmundsdottir, Margret H.; Omarsdottir, Sesselja; Ogmundsdottir, Helga M.			Proton-Shuttling Lichen Compound Usnic Acid Affects Mitochondrial and Lysosomal Function in Cancer Cells	PLOS ONE			English	Article							WILD-TYPE P53; TARGETING AUTOPHAGY; PANCREATIC-CANCER; MTOR INHIBITORS; SUPPRESSION; RECEPTOR; PROTEIN; STRESS; AGENTS; DEATH	The lichen compound usnic acid (UA) is a lipophilic weak acid that acts as a proton shuttle and causes loss of mitochondrial inner membrane potential. In the current study we show that UA treatment induced the formation of autophagosomes in human cancer cells, but had minimal effects on normal human fibroblasts. However, autophagic flux was incomplete, degradation of autophagosomal content did not occur and acidification was defective. UA-treated cells showed reduced ATP levels and activation of AMP kinase as well as signs of cellular stress. UA is thus likely to trigger autophagosome formation both by energy depletion and stress conditions. Our findings indicate that the H+-shuttling effect of UA operates not only in mitochondria as previously shown, but also in lysosomes, and have implications for therapeutic manipulation of autophagy and pH-determined drug distribution.	[Bessadottir, Margret; Egilsson, Mar; Ogmundsdottir, Margret H.; Ogmundsdottir, Helga M.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Bessadottir, Margret; Einarsdottir, Eydis; Magnusdottir, Iris H.; Omarsdottir, Sesselja] Univ Iceland, Fac Pharmaceut Sci, Reykjavik, Iceland	University of Iceland; University of Iceland	Ogmundsdottir, HM (corresponding author), Univ Iceland, Fac Med, Reykjavik, Iceland.	helgaogm@hi.is	Ögmundsdóttir, Helga M/L-6970-2015	Multhoff, Gabriele/0000-0002-2616-3137; Bessadottir, Margret/0000-0002-9750-8892	Eimskip Doctoral Fund; University of Iceland Research Fund	Eimskip Doctoral Fund; University of Iceland Research Fund	This work was supported by the Eimskip Doctoral Fund and the University of Iceland Research Fund (www.hi.is). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Khatwa A. N., 1996, Natural Toxins, V4, P96, DOI 10.1002/19960402NT7; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Bezivin C, 2004, PLANTA MED, V70, P874, DOI 10.1055/s-2004-827240; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; Cardarelli M, 1997, CELL MOL LIFE SCI, V53, P667, DOI 10.1007/s000180050086; CASEY G, 1991, ONCOGENE, V6, P1791; Ding WX, 2009, MOL CANCER THER, V8, P2036, DOI 10.1158/1535-7163.MCT-08-1169; Einarsdottir E, 2010, PLANTA MED, V76, P969, DOI 10.1055/s-0029-1240851; Eisold S, 2004, WORLD J GASTROENTERO, V10, P3583, DOI 10.3748/wjg.v10.i24.3583; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Garrido-Laguna I, 2010, BRIT J CANCER, V103, P649, DOI 10.1038/sj.bjc.6605819; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Gong YP, 2000, LEUKEMIA RES, V24, P769, DOI 10.1016/S0145-2126(00)00048-5; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Han D, 2004, BIOCHEM PHARMACOL, V67, P439, DOI 10.1016/j.bcp.2003.09.032; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Ingolfsdottir K, 2002, PHYTOCHEMISTRY, V61, P729, DOI 10.1016/S0031-9422(02)00383-7; Joseph A, 2009, MITOCHONDRION, V9, P149, DOI 10.1016/j.mito.2009.02.002; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaushik S, 2010, DIABETES OBES METAB, V12, P4, DOI 10.1111/j.1463-1326.2010.01263.x; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Koparal AT, 2006, NAT PROD RES, V20, P1300, DOI 10.1080/14786410601101910; KUPCHAN SM, 1975, EXPERIENTIA, V31, P625; LOZY F, 2012, SEMIN CELL DEV BIOL; Mancias JD, 2011, ONCOTARGET, V2, P1302; Mayer M, 2005, ANTI-CANCER DRUG, V16, P805, DOI 10.1097/01.cad.0000175588.09070.77; Nash TH., 1996, LICHEN BIOL; Ndolo Rosemary A, 2010, Mol Cell Pharmacol, V2, P131; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; TAKAI M, 1979, J MED CHEM, V22, P1380, DOI 10.1021/jm00197a019; Ulivieri C, 2010, TISSUE CELL, V42, P339, DOI 10.1016/j.tice.2010.10.004; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	37	21	22	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51296	10.1371/journal.pone.0051296	http://dx.doi.org/10.1371/journal.pone.0051296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227259	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200118
J	Brucker, RM; Bordenstein, SR				Brucker, Robert M.; Bordenstein, Seth R.			In Vitro Cultivation of the Hymenoptera Genetic Model, Nasonia	PLOS ONE			English	Article								The wasp genus Nasonia is a genetic model with unique advantages for the study of interspecific differences, including haplodiploidy and interfertile species. However, as a parasitoid, Nasonia is confined within a fly host, thus restricting direct observations and manipulation of development over time. Here, we present the first in vitro cultivation method for this system that decouples Nasonia from its host, allowing continuous observations from embryo to adulthood. Using transwell plates and a simple Nasonia rearing medium, we demonstrate a technique that will significantly expand the utility of the Nasonia model.	[Brucker, Robert M.; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Bordenstein, Seth R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Brucker, RM (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	bruckerm@gmail.com; s.bordenstein@vanderbilt.edu	Brucker, Robert/F-3052-2013	Brucker, Robert/0000-0002-0854-848X	NSF [DEB 1046149]; Division Of Environmental Biology [1046149] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support of this work was provided by NSF award DEB 1046149 to SRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grenier S., 2012, KARAELMAS SCI ENG J, V2, P1; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Muers Mary, 2010, Nat Rev Genet, V11, P170; Werren J.H, 2009, COLD SPRING HARB PRO; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028	5	13	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51269	10.1371/journal.pone.0051269	http://dx.doi.org/10.1371/journal.pone.0051269			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227258	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200117
J	Kerper, LF; Spies, CD; Lossner, M; Salz, AL; Tafelski, S; Balzer, F; Weiss-Gerlach, E; Neumann, T; Lau, A; Glaesmer, H; Brahler, E; Krampe, H				Kerper, Leonie F.; Spies, Claudia D.; Loessner, Maria; Salz, Anna-Lena; Tafelski, Sascha; Balzer, Felix; Weiss-Gerlach, Edith; Neumann, Tim; Lau, Alexandra; Glaesmer, Heide; Braehler, Elmar; Krampe, Henning			Persistence of Psychological Distress in Surgical Patients with Interest in Psychotherapy: Results of a 6-Month Follow-Up	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; BYPASS GRAFT-SURGERY; QUALITY-OF-LIFE; IDENTIFICATION TEST; RISK-FACTORS; DEPRESSION; ANXIETY; PERFORMANCE; PREVALENCE; SYMPTOMS	Objectives: This prospective observational study investigated whether self-reported psychological distress and alcohol use problems of surgical patients change between preoperative baseline assessment and postoperative 6-month follow-up examination. Patients with preoperative interest in psychotherapy were compared with patients without interest in psychotherapy. Methods: A total of 1,157 consecutive patients from various surgical fields completed a set of psychiatric questionnaires preoperatively and at 6 months postoperatively, including Patient Health Questionnaire-4 (PHQ-4), Brief Symptom Inventory (BSI), Center for Epidemiologic Studies Depression Scale (CES-D), World Health Organization 5-item Well-Being Index (WHO-5), and Alcohol Use Disorder Identification Test (AUDIT). Additionally, patients were asked for their interest in psychotherapy. Repeated measure ANCOVA was used for primary data analysis. Results: 16.7% of the patients were interested in psychotherapy. Compared to uninterested patients, they showed consistently higher distress at both baseline and month 6 regarding all of the assessed psychological measures (p's between<0.001 and 0.003). At 6-month follow-up, neither substantial changes over time nor large time x group interactions were found. Results of ANCOVA's controlling for demographic variables were confirmed by analyses of frequencies of clinically significant distress. Conclusion: In surgical patients with interest in psychotherapy, there is a remarkable persistence of elevated self-reported general psychological distress, depression, anxiety, and alcohol use disorder symptoms over 6 months. This suggests high and chronic psychiatric comorbidity and a clear need for psychotherapeutic and psychiatric treatment rather than transient worries posed by facing surgery.	[Kerper, Leonie F.; Spies, Claudia D.; Loessner, Maria; Salz, Anna-Lena; Tafelski, Sascha; Balzer, Felix; Weiss-Gerlach, Edith; Neumann, Tim; Lau, Alexandra; Krampe, Henning] Charite, Dept Anesthesiol & Intens Care Med, Campus Charite Mitte, D-10117 Berlin, Germany; [Kerper, Leonie F.; Spies, Claudia D.; Loessner, Maria; Salz, Anna-Lena; Tafelski, Sascha; Balzer, Felix; Weiss-Gerlach, Edith; Neumann, Tim; Lau, Alexandra; Krampe, Henning] Charite, Campus Virchow Klinikum, D-10117 Berlin, Germany; [Glaesmer, Heide; Braehler, Elmar] Univ Leipzig, Dept Med Psychol & Med Sociol, Leipzig, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University	Krampe, H (corresponding author), Charite, Dept Anesthesiol & Intens Care Med, Campus Charite Mitte, Charite Pl 1, D-10117 Berlin, Germany.	henning.krampe@charite.de	Loessner, Martin J/B-4316-2012; Braehler, Elmar/C-6535-2009	Loessner, Martin J/0000-0002-8162-2631; Braehler, Elmar/0000-0002-2648-2728; Tafelski, Sascha/0000-0002-5623-8400; Neumann, Tim/0000-0003-2344-2162; Spies, Claudia/0000-0002-1062-0495; Balzer, Felix/0000-0003-1575-2056	DFG (German Research Foundation) [KR 3836/3-1]	DFG (German Research Foundation)(German Research Foundation (DFG))	This work was supported by the DFG (German Research Foundation, Grant KR 3836/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badura-Brzoza K, 2009, EUR PSYCHIAT, V24, P119, DOI 10.1016/j.eurpsy.2008.06.009; Borowicz L, 2002, PSYCHOSOMATICS, V43, P464, DOI 10.1176/appi.psy.43.6.464; Bosch JA, 2007, PSYCHOSOM MED, V69, P597, DOI 10.1097/PSY.0B013E318148C682; Caumo W, 2001, ANAESTHESIA, V56, P720, DOI 10.1046/j.1365-2044.2001.01842.x; deGroot KI, 1997, PAIN, V69, P19, DOI 10.1016/S0304-3959(96)03228-9; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT, V18; Gallagher R, 2009, J ADV NURS, V65, P2386, DOI 10.1111/j.1365-2648.2009.05101.x; Hautzinger M., 1992, ALLGEMEINE DEPRESSIO; Hobby JL, 2005, J BONE JOINT SURG BR, V87B, P196, DOI 10.1302/0301-620X.87B2.15055; Kip MJ, 2008, ANESTHESIOLOGY, V109, P171, DOI 10.1097/ALN.0b013e31817f5be3; Kleinwachter R, 2010, MINERVA ANESTESIOL, V76, P29; Krannich JHA, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-47; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Lange LF, 2011, CLIN HLTH PROMOT, V1, P41; Linnen H, 2011, EUR J ANAESTH, V28, P733, DOI 10.1097/EJA.0b013e3283478361; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; McKhann GM, 1997, LANCET, V349, P1282, DOI 10.1016/S0140-6736(96)09466-4; Montin L, 2007, CHRONIC ILLN, V3, P219, DOI 10.1177/1742395307084405; Neumann T, 2004, ALCOHOL CLIN EXP RES, V28, P1693, DOI 10.1097/01.ALC.0000145696.58084.08; OHARA MW, 1989, PSYCHOSOM MED, V51, P356, DOI 10.1097/00006842-198905000-00010; Pirraglia PA, 1999, INT J GERIATR PSYCH, V14, P668, DOI 10.1002/(SICI)1099-1166(199908)14:8<668::AID-GPS988>3.0.CO;2-9; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Rosenberger PH, 2006, J AM ACAD ORTHOP SUR, V14, P397, DOI 10.5435/00124635-200607000-00002; Rymaszewska J, 2003, EUR PSYCHIAT, V18, P155, DOI 10.1016/S0924-9338(03)00052-X; SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005; Sinikallio S, 2009, SPINE, V34, P2573, DOI 10.1097/BRS.0b013e3181b317bd; Smith PJ, 2009, ANESTHESIOLOGY, V110, P781, DOI 10.1097/ALN.0b013e31819b5bc2; Spies CD, 1996, ACTA ANAESTH SCAND, V40, P649, DOI 10.1111/j.1399-6576.1996.tb04505.x; Stroobant N, 2008, PSYCHOSOMATICS, V49, P326, DOI 10.1176/appi.psy.49.4.326; Timberlake N, 1997, J PSYCHOSOM RES, V43, P197, DOI 10.1016/S0022-3999(96)00002-5; Tonnesen H, 2009, BRIT J ANAESTH, V102, P297, DOI 10.1093/bja/aen401; Tsapakis EM, 2009, EUR PSYCHIAT, V24, P112, DOI 10.1016/j.eurpsy.2008.09.002; Vaeroy H, 2003, NORD J PSYCHIAT, V57, P13, DOI 10.1080/08039480310000202; Vingerhoets G, 1998, PSYCHOSOMATICS, V39, P30, DOI 10.1016/S0033-3182(98)71378-7; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wolters U, 1996, BRIT J ANAESTH, V77, P217, DOI 10.1093/bja/77.2.217; World Health Organization [WHO], 1998, INF PACK MAST DEPR P; Zhong BL, 2010, GEN HOSP PSYCHIAT, V32, P268, DOI 10.1016/j.genhosppsych.2010.01.016	38	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51167	10.1371/journal.pone.0051167	http://dx.doi.org/10.1371/journal.pone.0051167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227250	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200109
J	MacIntosh, AJJ; Jacobs, A; Garcia, C; Shimizu, K; Mouri, K; Huffman, MA; Hernandez, AD				MacIntosh, Andrew J. J.; Jacobs, Armand; Garcia, Cecile; Shimizu, Keiko; Mouri, Keiko; Huffman, Michael A.; Hernandez, Alexander D.			Monkeys in the Middle: Parasite Transmission through the Social Network of a Wild Primate	PLOS ONE			English	Article							FECAL EGG COUNTS; GROOMING SITE PREFERENCES; JAPANESE MACAQUES; CONTACT NETWORKS; PATHOGEN TRANSMISSION; SPECIES RICHNESS; INFECTION; BEHAVIOR; ORGANIZATION; POPULATION	In wildlife populations, group-living is thought to increase the probability of parasite transmission because contact rates increase at high host densities. Physical contact, such as social grooming, is an important component of group structure, but it can also increase the risk of exposure to infection for individuals because it provides a mechanism for transmission of potentially pathogenic organisms. Living in groups can also create variation in susceptibility to infection among individuals because circulating levels of immunosuppressive hormones like glucocorticoids often depend on an individual's position within the group's social structure. Yet, little is known about the relative roles of socially mediated exposure versus susceptibility in parasite transmission among free-living animal groups. To address this issue, we investigate the relationship between host dominance hierarchy and nematode parasite transmission among females in a wild group of Japanese macaques (Macaca fuscata yakui). We use social network analysis to describe each individual female's position within the grooming network in relation to dominance rank and relative levels of infection. Our results suggest that the number of directly-transmitted parasite species infecting each female, and the relative amount of transmission stages that one of these species sheds in faeces, both increase with dominance rank. Female centrality within the network, which shows positive associations with dominance hierarchy, is also positively associated with infection by certain parasite species, suggesting that the measured rank-bias in transmission may reflect variation in exposure rather than susceptibility. This is supported by the lack of a clear relationship between rank and faecal cortisol, as an indicator of stress, in a subset of these females. Thus, socially mediated exposure appears to be important for direct transmission of nematode parasites, lending support to the idea that a classical fitness trade-off inherent to living in groups can exist.	[MacIntosh, Andrew J. J.; Huffman, Michael A.] Kyoto Univ, Primate Res Inst, Ctr Int Collaborat & Adv Studies Primatol, Inuyama, Aichi 484, Japan; [Jacobs, Armand] Univ Strasbourg, Dept Ecol Physiol & Ethol, Inst Pluridisciplinaire Hubert Curien, CNRS,UMR7178, Strasbourg, Alsace, France; [Garcia, Cecile] CNRS, Lab Dynam Evolut Humaine, UPR 2147, Paris, Ile De France, France; [Shimizu, Keiko; Mouri, Keiko] Okayama Univ Sci, Dept Zool, Fac Sci, Okayama, Japan; [Hernandez, Alexander D.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA	Kyoto University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Okayama University of Science; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	MacIntosh, AJJ (corresponding author), Kyoto Univ, Primate Res Inst, Ctr Int Collaborat & Adv Studies Primatol, Inuyama, Aichi 484, Japan.	macintosh@pri.kyoto-u.ac.jp	MacIntosh, Andrew/B-2242-2013; Hernandez, Alexander/E-8705-2010; Hernandez, Alexander D/AGK-6452-2022	MacIntosh, Andrew/0000-0002-9136-7099; Hernandez, Alexander/0000-0001-8708-3774; Hernandez, Alexander D/0000-0001-8708-3774; Huffman, Michael A/0000-0002-6166-7795	Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT); French Ministry of Higher Education and Research; Japan Society for the Promotion of Science (JSPS)	Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); French Ministry of Higher Education and Research; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	A.J.J. MacIntosh was financially supported by the Japan Ministry of Education, Culture, Sports, Science and Technology (MEXT, http://www.mext.go.jp/english/:Monbukagakusho scholarship), A. Jacobs and C. Garcia by a grant from the French Ministry of Higher Education and Research, and C. Garcia and A. D. Hernandez by a Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/) postdoctoral fellowship, inclusive of Grants-in-Aid from JSPS to M. A. Huffman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Acha P.N., 2003, ZOONOSES COMMUNICABL; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; ANDERSON R M, 1991; Arizono N, 2012, KOREAN J PARASITOL, V50, P253, DOI 10.3347/kjp.2012.50.3.253; Arneberg P, 2002, ECOGRAPHY, V25, P88, DOI 10.1034/j.1600-0587.2002.250110.x; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; BARGER IA, 1989, VET PARASITOL, V32, P21, DOI 10.1016/0304-4017(89)90153-2; Bartolomucci A, 2007, FRONT NEUROENDOCRIN, V28, P28, DOI 10.1016/j.yfrne.2007.02.001; BARTON R, 1985, INT J PRIMATOL, V6, P519, DOI 10.1007/BF02735574; Bates D., 2010, LME4 LINEAR MIXED EF; Bohm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005016; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Chapman CA, 2011, AM J PRIMATOL ONLINE; Christley RM, 2005, AM J EPIDEMIOL, V162, P1024, DOI 10.1093/aje/kwi308; Combes Claude., 2001, PARASITISM ECOLOGY E; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Croll NA., 1977, BIOL NEMATODES, P152; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; Drewe JA, 2010, P ROY SOC B-BIOL SCI, V277, P633, DOI 10.1098/rspb.2009.1775; Fooden J, 2003, PRIMATES, V44, P109, DOI 10.1007/s10329-002-0011-y; FREELAND W J, 1976, Biotropica, V8, P12, DOI 10.2307/2387816; FREELAND WJ, 1979, ECOLOGY, V60, P719, DOI 10.2307/1936609; Godfrey SS, 2010, INT J PARASITOL, V40, P1575, DOI 10.1016/j.ijpara.2010.06.002; Godfrey SS, 2009, BEHAV ECOL SOCIOBIOL, V63, P1045, DOI 10.1007/s00265-009-0730-9; Gotoh S, 2000, PRIMATES, V41, P291, DOI 10.1007/BF02557598; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; GRANZER M, 1991, INT J PARASITOL, V21, P429, DOI 10.1016/0020-7519(91)90100-L; Griffin RH, 2012, EVOL ECOL, V26, P779, DOI 10.1007/s10682-011-9526-2; GUST DA, 1993, HORM BEHAV, V27, P318, DOI 10.1006/hbeh.1993.1024; Hamede RK, 2009, ECOL LETT, V12, P1147, DOI 10.1111/j.1461-0248.2009.01370.x; HAUSFATER G, 1976, NATURE, V262, P688, DOI 10.1038/262688a0; Hernandez AD, 1995, J PARASITOL, V81, P865, DOI 10.2307/3284031; Hernandez AD, 2009, CAM S BIO EVOL ANTHR, V57, P387; Hoffman CL, 2010, AM J PRIMATOL, V72, P559, DOI 10.1002/ajp.20793; Hudson P. J., 1995, P144, DOI 10.1017/CBO9780511629396.006; ITOH K, 1988, JPN J VET RES, V36, P235; JUDGE PG, 1994, FOLIA PRIMATOL, V63, P63, DOI 10.1159/000156792; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Klein SL, 2000, BEHAV PROCESS, V51, P149, DOI 10.1016/S0376-6357(00)00125-X; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Macinnis A.J., 1976, P3; MacIntosh AJJ, 2011, J R SOC INTERFACE, V8, P1497, DOI 10.1098/rsif.2011.0049; MacIntosh AJJ, 2010, PRIMATES, V51, P353, DOI 10.1007/s10329-010-0211-9; Madden JR, 2009, BEHAV ECOL SOCIOBIOL, V64, P81, DOI 10.1007/s00265-009-0820-8; MOLLER AP, 1993, ADV STUD BEHAV, V22, P65, DOI 10.1016/S0065-3454(08)60405-2; Moore J, 2001, PARASITES BEHAV ANIM; Mooring MS, 2004, BIOL J LINN SOC, V81, P17, DOI 10.1111/j.1095-8312.2004.00273.x; Muehlenbein MP, 2006, AM J PHYS ANTHROPOL, V130, P546, DOI 10.1002/ajpa.20391; MullerGraf CDM, 1996, PARASITOLOGY, V112, P489, DOI 10.1017/S0031182000076952; Naug D, 2002, J THEOR BIOL, V215, P427, DOI 10.1006/jtbi.2001.2524; Nunn CL, 2004, AM NAT, V164, pS90, DOI 10.1086/424608; Nunn CL, 2011, PLOS ONE, V6; Nunn CL, 2006, INFECT DIS PRIMATES; Otterstatter MC, 2007, OECOLOGIA, V154, P411, DOI 10.1007/s00442-007-0834-8; Perkins SE, 2009, J ANIM ECOL, V78, P1015, DOI 10.1111/j.1365-2656.2009.01557.x; Poulin R, 2007, PARASITOLOGY, V134, P763, DOI 10.1017/S0031182006002150; R Core Team, 2012, R LANG ENV STAT COMP; ROBERTS JL, 1981, VET PARASITOL, V8, P165, DOI 10.1016/0304-4017(81)90044-3; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Saunders LM, 2001, J HELMINTHOL, V75, P367, DOI 10.1017/S0022149X01000579; Schino G, 2001, ANIM BEHAV, V62, P265, DOI 10.1006/anbe.2001.1750; Schmidt-Hempel P, 1998, PARASITES SOCIAL INS; Seivwright LJ, 2004, J HELMINTHOL, V78, P69, DOI 10.1079/JOH2003220; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; SHIDELER SE, 1993, BIOL REPROD, V48, P1290, DOI 10.1095/biolreprod48.6.1290; SPARKS JOHN, 1967, P148; STEAR MJ, 1995, INT J PARASITOL, V25, P375, DOI 10.1016/0020-7519(94)00136-C; Takahata Y, 1998, PRIMATES, V39, P339, DOI 10.1007/BF02573082; Talvik H, 1997, PARASITOL RES, V83, P563, DOI 10.1007/s004360050298; TANAKA I, 1993, ANTHROPOL SCI, V101, P187, DOI 10.1537/ase.101.187; Tanaka T., 1967, Primates, V8, P91, DOI 10.1007/BF01772154; VANSCHAIK CP, 1991, PRIMATES, V32, P345, DOI 10.1007/BF02382675; Vitone ND, 2004, EVOL ECOL RES, V6, P183; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Whitehead H, 1997, ANIM BEHAV, V53, P1053, DOI 10.1006/anbe.1996.0358; Yamagiwa J, 1998, PRIMATES, V39, P257, DOI 10.1007/BF02573076; YOUNG KH, 1979, J CLIN MICROBIOL, V10, P852, DOI 10.1128/JCM.10.6.852-853.1979; Zamma K, 2002, PRIMATES, V43, P41, DOI 10.1007/BF02629575; Zuur Alain F., 2009, P1	86	115	121	1	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51144	10.1371/journal.pone.0051144	http://dx.doi.org/10.1371/journal.pone.0051144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227246	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200105
J	McGuigan, N; Gladstone, D; Cook, L				McGuigan, Nicola; Gladstone, Daryl; Cook, Lisa			Is the Cultural Transmission of Irrelevant Tool Actions in Adult Humans (Homo Sapiens) Best Explained as the Result of an Evolved Conformist Bias?	PLOS ONE			English	Article							OVER-IMITATION; SOCIAL-INFLUENCE; MAJORITY; CHILDREN; CHIMPANZEES; NORMS; SCOPE	Background: Recent studies of social learning have revealed that adult humans are "over-imitators" who frequently reproduce a model's causally irrelevant tool actions to the detriment of task efficiency. At present our knowledge of adult over-imitation is limited to the fact that adults do over-imitate, we know very little about the causes of this behavior. The current study aimed to provide novel insights into adult over-imitation by extending a paradigm recently used with human children to explore social aspects of over-imitation. In the child study observers saw two models demonstrate a tool-use task using the same inefficient approach, or two models demonstrate different approaches to the task (one inefficient and one efficient). The manipulation of social influence came in the testing phase where the observer completed the task in the presence of either an inefficient model or an efficient model. Methodology/Principal Findings: We adapted the paradigm used in the child study to provide the first systematic exploration of factors which may lead to adult over-imitation including: 1) the presence of the model(s) during testing, 2) the presence of a competing efficient task demonstration, 3) the presence of a majority displaying the inefficient approach, and 4) the 'removal' of the experimental context during task completion. We show that the adult participants only over-imitated in conditions where the inefficient strategy was the majority approach witnessed. This tendency towards over-imitated was almost entirely eliminated when the participants interacted with the task when they believed the experiment to be complete. Conclusions: Our results suggest that adult over-imitation is best explained as a result of an evolved 'conformist bias' argued to be crucial to the transmission of human cultural behavior and one which may be unique in the animal kingdom.	[McGuigan, Nicola; Gladstone, Daryl; Cook, Lisa] Heriot Watt Univ, Sch Life Sci, Edinburgh, Midlothian, Scotland	Heriot Watt University	McGuigan, N (corresponding author), Heriot Watt Univ, Sch Life Sci, Edinburgh, Midlothian, Scotland.	N.McGuigan@hw.ac.uk			Heriot Watt University	Heriot Watt University	The work was funded by internal funds from Heriot Watt University. No external grants supported the current research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Boyd R., 1985, CULTURE EVOLUTIONARY; CAMPBELL JD, 1989, J PERS SOC PSYCHOL, V57, P457, DOI 10.1037/0022-3514.57.3.457; Cialdini R.B., 1998, HDB SOCIAL PSYCHOL 4, P151; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Cialdini RB, 2007, PSYCHOMETRIKA, V72, P263, DOI 10.1007/s11336-006-1560-6; Claidiere N, 2012, PSYCHOL BULL, V138, P126, DOI 10.1037/a0025868; Corriveau KH, 2010, DEV PSYCHOL, V46, P437, DOI 10.1037/a0017553; Haun DBM, 2012, CURR BIOL, V22, P727, DOI 10.1016/j.cub.2012.03.006; Haun DBM, 2011, CHILD DEV, V82, P1759, DOI 10.1111/j.1467-8624.2011.01666.x; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Kelley HH, 1954, AM SOCIOL REV, V19, P667, DOI 10.2307/2087913; Kenward B, 2012, J EXP CHILD PSYCHOL, V112, P195, DOI 10.1016/j.jecp.2012.02.006; Kenward B, 2011, P ROY SOC B-BIOL SCI, V278, P1239, DOI 10.1098/rspb.2010.1399; Lyons DE, 2007, P NATL ACAD SCI USA, V104, P19751, DOI 10.1073/pnas.0704452104; Lyons DE, 2011, PHILOS T R SOC B, V366, P1158, DOI 10.1098/rstb.2010.0335; McGuigan N, 2007, COGNITIVE DEV, V22, P353, DOI 10.1016/j.cogdev.2007.01.001; McGuigan N, 2012, J COMP PSYCHOL, V126, P150, DOI 10.1037/a0025525; McGuigan N, 2011, BRIT J PSYCHOL, V102, P1, DOI 10.1348/000712610X493115; McGuigan N, 2009, J EXP CHILD PSYCHOL, V104, P367, DOI 10.1016/j.jecp.2009.07.001; Nielsen M., 2011, DEVELOPMENTAL PSYCHO, P153; Nielsen M, 2006, DEV PSYCHOL, V42, P555, DOI 10.1037/0012-1649.42.3.555; Nielsen M, 2011, DEV PSYCHOL, V47, P1050, DOI 10.1037/a0023866; Nielsen M, 2010, PSYCHOL SCI, V21, P729, DOI 10.1177/0956797610368808; Richerson PJ., 2005, NOT GENES ALONE CULT; Simpson A, 2011, DEV PSYCHOL, V47, P834, DOI 10.1037/a0023270; TANFORD S, 1984, PSYCHOL BULL, V95, P189, DOI 10.1037/0033-2909.95.2.189; Whiten A, 2012, DEV SOCIAL COGNITION; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069	31	21	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50863	10.1371/journal.pone.0050863	http://dx.doi.org/10.1371/journal.pone.0050863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251395	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200043
J	Egger, J; Kapur, T; Nimsky, C; Kikinis, R				Egger, Jan; Kapur, Tina; Nimsky, Christopher; Kikinis, Ron			Pituitary Adenoma Volumetry with 3D Slicer	PLOS ONE			English	Article							TUMOR VOLUME; GROWTH; PEGVISOMANT	In this study, we present pituitary adenoma volumetry using the free and open source medical image computing platform for biomedical research: (3D) Slicer. Volumetric changes in cerebral pathologies like pituitary adenomas are a critical factor in treatment decisions by physicians and in general the volume is acquired manually. Therefore, manual slice-by-slice segmentations in magnetic resonance imaging (MRI) data, which have been obtained at regular intervals, are performed. In contrast to this manual time consuming slice-by-slice segmentation process Slicer is an alternative which can be significantly faster and less user intensive. In this contribution, we compare pure manual segmentations of ten pituitary adenomas with semi-automatic segmentations under Slicer. Thus, physicians drew the boundaries completely manually on a slice-by-slice basis and performed a Slicer-enhanced segmentation using the competitive region-growing based module of Slicer named GrowCut. Results showed that the time and user effort required for GrowCut-based segmentations were on average about thirty percent less than the pure manual segmentations. Furthermore, we calculated the Dice Similarity Coefficient (DSC) between the manual and the Slicer-based segmentations to proof that the two are comparable yielding an average DSC of 81.97 +/- 3.39%.	[Egger, Jan; Kapur, Tina; Kikinis, Ron] Harvard Univ, Brigham & Womens Hosp, Dept Radiol, Sch Med, Boston, MA 02115 USA; [Egger, Jan; Nimsky, Christopher] Univ Hosp Marburg, Dept Neurosurg, Marburg, Germany; [Egger, Jan] Univ Marburg, Dept Math & Comp Sci, Marburg, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University Hospital of Giessen & Marburg; Philipps University Marburg	Egger, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Radiol, Sch Med, Boston, MA 02115 USA.	egger@bwh.harvard.edu	Nimsky, Christopher/E-3702-2014	Nimsky, Christopher/0000-0002-8216-9410	National Institutes of Health (NIH) [P41EB015898]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013218, P41RR019703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB005149, P41EB015898] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health (NIH) grant P41EB015898. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biller BMK, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-10; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Buchfelder M, 2009, BEST PRACT RES CL EN, V23, P677, DOI 10.1016/j.beem.2009.05.002; Buhk JH, 2010, J CLIN ENDOCR METAB, V95, P552, DOI 10.1210/jc.2009-1239; Cootes T. F., 1992, BMVC92. Proceedings of the British Machine Vision Conference, P266; Cootes T. F., 2004, TECHNICAL REPORT; Descoteaux Maxime, 2006, Comput Aided Surg, V11, P247, DOI 10.3109/10929080601017212; Egger J., 2010, P BIOSIGNAL, P1; Egger J, 2007, COMP MED SY, P177, DOI 10.1109/CBMS.2007.5; Egger J, 2012, J MED SYST, V36, P2097, DOI 10.1007/s10916-011-9673-6; Egger J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00420; Felkel P, 2001, COMPUT GRAPH FORUM, V20, pC26, DOI 10.1111/1467-8659.00495; Gondim JA, 2006, ARQ NEURO-PSIQUIAT, V64, P971, DOI 10.1590/S0004-282X2006000600016; Greiner K., 2008, P BILDV MED BVM BERL, P51; Honegger J, 2008, EUR J ENDOCRINOL, V158, P287, DOI 10.1530/EJE-07-0502; Jimenez C, 2008, EUR J ENDOCRINOL, V159, P517, DOI 10.1530/EJE-08-0205; JONES AP, 1990, ACTA NEUROCHIR, V107, P61, DOI 10.1007/BF01402614; Korsisaari N, 2008, CLIN CANCER RES, V14, P249, DOI 10.1158/1078-0432.CCR-07-1552; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; National Cancer Institute-Pituitary Tumors Treatment, PITUITARY TUMORS TRE; Neubauer A, 2005, IEEE T VIS COMPUT GR, V11, P497, DOI 10.1109/TVCG.2005.70; Neuberger A, 2005, ZI SCH BUS FIN MA, P1; Nobels FRE, 2000, EUR J ENDOCRINOL, V143, P615, DOI 10.1530/eje.0.1430615; Pamir MN, 2007, NEUROSURGERY, V61, P270, DOI 10.1227/01.NEU.0000255519.96837.C7; Sampa MP, 2006, IEEE IMAGE PROC, P81, DOI 10.1109/ICIP.2006.312367; Weber MA, 2007, RADIOLOGE, V47, P492, DOI 10.1007/s00117-007-1495-7; Wolfsberger S, 2006, NEUROSURGERY, V59, P1001, DOI 10.1227/01.NEU.0000245594.61828.41; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8; Zukic D, 2011, PROC SPIE, V7963, DOI 10.1117/12.877660	30	48	49	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51788	10.1371/journal.pone.0051788	http://dx.doi.org/10.1371/journal.pone.0051788			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240062	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800098
J	Hausner, VH; Fauchald, P; Jernsletten, JL				Hausner, Vera H.; Fauchald, Per; Jernsletten, Johnny-Leo			Community-Based Management: Under What Conditions Do Sami Pastoralists Manage Pastures Sustainably?	PLOS ONE			English	Article							REINDEER MANAGEMENT; COLLECTIVE ACTION; NORWAY; GOVERNANCE; CONSERVATION; FINLAND; PARTICIPATION; RESILIENCE; RESOURCES; HUSBANDRY	Community-based management (CBM) has been implemented in socio-ecological systems (SES) worldwide. CBM has also been the prevailing policy in Sami pastoral SES in Norway, but the outcomes tend to vary extensively among resource groups ("siidas"). We asked why do some siidas self-organize to manage common pool resources sustainably and others do not? To answer this question we used a mixed methods approach. First, in the statistical analyses we analyzed the relationship between sustainability indicators and structural variables. We found that small winter pastures that are shared by few siidas were managed more sustainably than larger pastures. Seasonal siida stability, i.e., a low turnover of pastoralists working together throughout the year, and equality among herders, also contributed to more sustainable outcomes. Second, interviews were conducted in the five largest pastures to explain the relationships between the structural variables and sustainability. The pastoralists expressed a high level of agreement with respect to sustainable policies, but reported a low level of trust and cooperation among the siidas. The pastoralists requested siida tenures or clear rules and sanctioning mechanisms by an impartial authority rather than flexible organization or more autonomy for the siidas. The lack of nestedness in self-organization for managing pastures on larger scales, combined with the past economic policies, could explain why CBM is less sustainable on the largest winter pastures. We conclude that the scale mis-match between self-organization and the formal governance is a key condition for sustainability. Citation: Hausner VH, Fauchald P, Jernsletten J-L (2012) Community-Based Management: Under What Conditions Do Sami Pastoralists Manage Pastures Sustainably? PLoS ONE 7(12): e51187. doi:10.1371/journal.pone.0051187	[Hausner, Vera H.] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Fauchald, Per] FRAM Ctr, Norwegian Inst Nat Res, Dept Arctic Ecol, Tromso, Norway; [Jernsletten, Johnny-Leo] Ctr Sami Studies, Tromso, Norway	UiT The Arctic University of Tromso; Norwegian Institute Nature Research	Hausner, VH (corresponding author), Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway.	vera.hausner@uit.no	Fauchald, Per/AAV-4242-2021		Norwegian Research Council; Ecosystem Finnmark; "TUNDRA" project	Norwegian Research Council(Research Council of NorwayEuropean Commission); Ecosystem Finnmark; "TUNDRA" project	The "Ecosystem Finnmark" and the "TUNDRA" project, both financed by the Norwegian Research Council, financed this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 1999, WORLD DEV, V27, P629, DOI 10.1016/S0305-750X(98)00161-2; Agrawal A, 2001, WORLD DEV, V29, P1649, DOI 10.1016/S0305-750X(01)00063-8; Agrawal A, 2011, ENVIRON PLANN A, V43, P328, DOI 10.1068/a42302; [Anonymous], 2010, RESSURSREGNSKAP REIN; Berkes F, 2007, P NATL ACAD SCI USA, V104, P15188, DOI 10.1073/pnas.0702098104; Berkes F, 2010, ENVIRON CONSERV, V37, P489, DOI 10.1017/S037689291000072X; Beyene F, 2010, HUM ECOL, V38, P555, DOI 10.1007/s10745-010-9335-1; Brannlund I, 2011, GLOBAL ENVIRON CHANG, V21, P1095, DOI 10.1016/j.gloenvcha.2011.03.005; Brathen KA, 2007, ECOSYSTEMS, V10, P773, DOI 10.1007/s10021-007-9058-3; Brondizio ES, 2009, ANNU REV ENV RESOUR, V34, P253, DOI 10.1146/annurev.environ.020708.100707; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cook Karen S, 2005, COOPERATION TRUST, P52; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006253; Forbes B. C., 2006, REINDEER MANAGEMENT, P245, DOI [10.1007/3-540-31392-3, DOI 10.1007/3-540-31392-3]; Forbes BC, 2009, P NATL ACAD SCI USA, V106, P22041, DOI 10.1073/pnas.0908286106; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Hausner V, 2011, E S, V16; Helle TP, 2008, ANN ZOOL FENN, V45, P81, DOI 10.5735/086.045.0201; Johannesen AB, 2011, ENVIRON RESOUR ECON, V48, P679, DOI 10.1007/s10640-010-9421-2; Kalstad J. K., 1999, REINDRIFTSPOLITIKK S; KOJOLA I, 1993, J WILDLIFE MANAGE, V57, P451, DOI 10.2307/3809269; Laakso AM, 2008, ACTA BOREAL, V25, P138, DOI 10.1080/08003830802496703; Lieberman ES, 2005, AM POLIT SCI REV, V99, P435, DOI 10.1017/S0003055405051762; Naess MW, 2010, HUM ECOL, V38, P3, DOI 10.1007/s10745-009-9288-4; Niamir-Fuller M., 1998, LINKING SOCIAL ECOLO, P250; Olofsson Anna, 2011, Rangifer, V31, P7; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Ostrom E, 2010, AGR ECON-BLACKWELL, V41, P155, DOI 10.1111/j.1574-0862.2010.00497.x; Paine, 1994, HERDS TUNDRA PORTRAI; Pape R, 2012, AMBIO, V41, P421, DOI 10.1007/s13280-012-0257-6; Persha L, 2011, SCIENCE, V331, P1606, DOI 10.1126/science.1199343; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Poteete AR, 2010, WORKING TOGETHER: COLLECTIVE ACTION, THE COMMONS, AND MULTIPLE METHODS IN PRACTICE, P1; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ravna O, 2011, SEDVANERETTSLIGE OPP; Raymond L, 2006, POLICY STUD J, V34, P37, DOI 10.1111/j.1541-0072.2006.00144.x; Riseth JA, 2006, BRIT FOOD J, V108, P541, DOI 10.1108/00070700610676361; Riseth JA, 2009, LAND ECON, V85, P87, DOI 10.3368/le.85.1.87; Robinson LW, 2010, HUM ECOL, V38, P335, DOI 10.1007/s10745-010-9327-1; Sara MN, 2011, ARCTIC REV LAW POLIT; Turner MD, 2011, SOC NATUR RESOUR, V24, P469, DOI 10.1080/08941920903236291; Tveraa T, 2003, OECOLOGIA, V137, P370, DOI 10.1007/s00442-003-1373-6; Tveraa T, 2007, OIKOS, V116, P706, DOI [10.1111/j.2006.0030-1299.15257.x, 10.1111/j.0030-1299.2007.15257.x]; Ulvevadet B, 2010, J ENV MAN, V92, P2794; Ulvevadet Birgitte, 2008, Rangifer, V28, P53; Ulvevadet Birgitte, 2011, Rangifer, V31, P161; Young O.R., 2002, I DIMENSIONS ENV CHA, V1st ed., DOI DOI 10.7551/MITPRESS/3807.001.0001	49	23	23	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51187	10.1371/journal.pone.0051187	http://dx.doi.org/10.1371/journal.pone.0051187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053RN	23240003	gold, Green Published, Green Submitted			2022-12-27	WOS:000312290800039
J	Khosh, N; Brown, CE; Aboody, KS; Barish, ME				Khosh, Nousha; Brown, Christine E.; Aboody, Karen S.; Barish, Michael E.			Contact and Encirclement of Glioma Cells In Vitro Is an Intrinsic Behavior of a Clonal Human Neural Stem Cell Line	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; GENE-THERAPY; BONE-MARROW; MYOSIN-II; BRAIN REPAIR; MIGRATION; TROPISM; PROGENITORS; TUMORS; GROWTH	Pathotropic neural stem and/or progenitor cells (NSCs) can potentially deliver therapeutic agents to otherwise inaccessible cancers. In glioma, NSCs are found in close contact with tumor cells, raising the possibility that specificity of NSC contact with glioma targets originates in the tumor cells themselves. Alternatively, target preferences may originate, at least in part, in the tumor microenvironment. To better understand mechanisms underlying NSC interactions with glioma cells, we examined NSC-target cell contacts in a highly simplified 3-dimensional peptide hydrogel (Puramatrix) in which cell behaviors can be studied in the relative absence of external cues. HB1.F3 is an immortalized clonal human NSC line extensively characterized in preclinical investigations. To study contact formation between HB1.F3 NSCs and glioma cells, we first examined co-cultures of eGFP-expressing HB1.F3 (HB1.F3.eGFP) NSCs and dsRed-expressing U251 glioma (U251.dsRed) cells. Using confocal microscopy, HB1.F3.eGFP cells were observed contacting or encircling U251.dsRed glioma cells, but never the reverse. Next, examining specificity of these contacts, no significant quantitative differences in either percentages of HB1.F3 NSCs contacting targets, or in the extent of target cell encirclement, were observed when HB1.F3.eGFP cells were presented with various potential target cells (human glioma and breast cancer cell lines, patient-derived brain tumor lines, non-tumor fibroblasts, primary mouse and human astroglial cells, and primary adult and newborn human dermal fibroblasts) except that interactions between HB1.F3 cells did not progress beyond establishing contacts. Finally cytoskeletal mechanisms employed by HB1.F3.eGFP cells varied with the substrate. When migrating in Puramatrix, HB1.F3 NSCs exhibited intermittent process extension followed by soma translocation, while during encirclement their movements were more amoeboid. We conclude that formation of contacts and subsequent encirclement of target cells by HB1.F3 NSCs is an intrinsic property of these NSCs, and that preferential contact formation with tumor cells in vivo must therefore be highly dependent on microenvironmental cues. Citation: Khosh N, Brown CE, Aboody KS, Barish ME (2012) Contact and Encirclement of Glioma Cells In Vitro Is an Intrinsic Behavior of a Clonal Human Neural Stem Cell Line. PLoS ONE 7(12): e51859. doi: 10.1371/journal.pone.0051859	[Khosh, Nousha; Aboody, Karen S.; Barish, Michael E.] Beckman Res Inst City Hope, Dept Neurosci, Duarte, CA 91010 USA; [Brown, Christine E.] Beckman Res Inst City Hope, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA; [Aboody, Karen S.] Beckman Res Inst City Hope, Div Neurosurg, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Barish, ME (corresponding author), Beckman Res Inst City Hope, Dept Neurosci, Duarte, CA 91010 USA.	mbarish@coh.org		Brown, Christine/0000-0003-4915-8207	California Institute for Regenerative Medicine (CIRM) Disease Team [DR1-01421]; Rosalinde and Arthur Gilbert Foundation; Beckman Research Institute	California Institute for Regenerative Medicine (CIRM) Disease Team; Rosalinde and Arthur Gilbert Foundation; Beckman Research Institute	Supported by California Institute for Regenerative Medicine (CIRM) Disease Team grant DR1-01421, the Rosalinde and Arthur Gilbert Foundation, and the Beckman Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2008, GENE THER, V15, P739, DOI 10.1038/gt.2008.41; Aboody K, 2011, NEURON, V70, P597, DOI 10.1016/j.neuron.2011.05.007; Aboody KS, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000023; Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Achanta P, 2010, ANTI-CANCER AGENT ME, V10, P121, DOI 10.2174/187152010790909290; Ahmed AU, 2011, MOL PHARMACEUT, V8, P1559, DOI 10.1021/mp200161f; Ahmed AU, 2010, CURR OPIN MOL THER, V12, P546; An JH, 2009, J PROTEOME RES, V8, P2873, DOI 10.1021/pr900020q; Arocena M, 2010, J NEUROSCI RES, V88, P3267, DOI 10.1002/jnr.22502; Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; Bexell D, 2010, MOL THER, V18, P1067, DOI 10.1038/mt.2010.58; Brown AB, 2003, HUM GENE THER, V14, P1777, DOI 10.1089/104303403322611782; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Brustle O, 1996, CURR OPIN NEUROBIOL, V6, P688, DOI 10.1016/S0959-4388(96)80104-8; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Cho T, 2002, NEUROREPORT, V13, P1447, DOI 10.1097/00001756-200208070-00020; Colombo E, 2006, STEM CELLS, V24, P825, DOI 10.1634/stemcells.2005-0313; Ehtesham M, 2002, CANCER RES, V62, P5657; Ehtesham Moneeb, 2005, Neurosurg Focus, V19, pE5; Elvira G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044466; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Gutova M, 2008, STEM CELLS, V26, P1406, DOI 10.1634/stemcells.2008-0141; He M, 2010, J NEUROSCI, V30, P10885, DOI 10.1523/JNEUROSCI.0240-10.2010; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jurvansuu J, 2008, CANCER RES, V68, P4614, DOI 10.1158/0008-5472.CAN-07-5291; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kendall SE, 2008, STEM CELLS, V26, P1575, DOI 10.1634/stemcells.2007-0887; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim DS, 2009, STEM CELLS DEV, V18, P511, DOI 10.1089/scd.2008.0050; Kim SU, 2007, BRAIN DEV-JPN, V29, P193, DOI 10.1016/j.braindev.2006.07.012; Kim SU, 2011, STEM CELL REV REP, V7, P130, DOI 10.1007/s12015-010-9154-1; Kim Seung U., 2008, V438, P103, DOI 10.1007/978-1-59745-133-8_10; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Kolega J, 2006, MOL BIOL CELL, V17, P4435, DOI 10.1091/mbc.E06-05-0431; Kosztowski T, 2009, EXPERT REV ANTICANC, V9, P597, DOI 10.1586/ERA.09.22; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lee DH, 2009, CLIN CANCER RES, V15, P4925, DOI 10.1158/1078-0432.CCR-08-3076; Lin D, 2007, NEUROIMAGE, V37, pS18, DOI 10.1016/j.neuroimage.2007.03.076; Marin O, 2006, TRENDS NEUROSCI, V29, P655, DOI 10.1016/j.tins.2006.10.001; Momin EN, 2010, CURR STEM CELL RES T, V5, P326; Najbauer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035150; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; RASHEED BKA, 1994, CANCER RES, V54, P1324; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Rosner H, 2007, BRAIN RES, V1176, P1, DOI 10.1016/j.brainres.2007.07.081; Schmidt NO, 2005, NEOPLASIA, V7, P623, DOI 10.1593/neo.04781; Staflin K, 2007, J NEUROSCI RES, V85, P2147, DOI 10.1002/jnr.21344; Staflin K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-206; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tormin A, 2009, CYTOTHERAPY, V11, P114, DOI 10.1080/14653240802716590; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Yuan XP, 2006, CANCER RES, V66, P2630, DOI 10.1158/0008-5472.CAN-05-1682; Zerlin M, 1997, J COMP NEUROL, V387, P537, DOI 10.1002/(SICI)1096-9861(19971103)387:4<537::AID-CNE5>3.0.CO;2-3; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; Zhao DH, 2008, MOL CANCER RES, V6, P1819, DOI 10.1158/1541-7786.MCR-08-0146; Zhong J, 2010, J ONCOL, V2010, DOI 10.1155/2010/430142	62	3	4	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51859	10.1371/journal.pone.0051859	http://dx.doi.org/10.1371/journal.pone.0051859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240066	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800102
J	Sirbu, A; Kerr, G; Crane, M; Ruskin, HJ				Sirbu, Alina; Kerr, Grainne; Crane, Martin; Ruskin, Heather J.			RNA-Seq vs Dual- and Single-Channel Microarray Data: Sensitivity Analysis for Differential Expression and Clustering	PLOS ONE			English	Article							GENE-EXPRESSION; OLIGONUCLEOTIDE	With the fast development of high-throughput sequencing technologies, a new generation of genome-wide gene expression measurements is under way. This is based on mRNA sequencing (RNA-seq), which complements the already mature technology of microarrays, and is expected to overcome some of the latter's disadvantages. These RNA-seq data pose new challenges, however, as strengths and weaknesses have yet to be fully identified. Ideally, Next (or Second) Generation Sequencing measures can be integrated for more comprehensive gene expression investigation to facilitate analysis of whole regulatory networks. At present, however, the nature of these data is not very well understood. In this paper we study three alternative gene expression time series datasets for the Drosophila melanogaster embryo development, in order to compare three measurement techniques: RNA-seq, single-channel and dual-channel microarrays. The aim is to study the state of the art for the three technologies, with a view of assessing overlapping features, data compatibility and integration potential, in the context of time series measurements. This involves using established tools for each of the three different technologies, and technical and biological replicates (for RNA-seq and microarrays, respectively), due to the limited availability of biological RNA-seq replicates for time series data. The approach consists of a sensitivity analysis for differential expression and clustering. In general, the RNA-seq dataset displayed highest sensitivity to differential expression. The single-channel data performed similarly for the differentially expressed genes common to gene sets considered. Cluster analysis was used to identify different features of the gene space for the three datasets, with higher similarities found for the RNA-seq and single-channel microarray dataset.	[Sirbu, Alina; Crane, Martin; Ruskin, Heather J.] Dublin City Univ, Ctr Sci Comp & Complex Syst Modelling, Dublin 9, Ireland; [Sirbu, Alina] Inst Sci Interchange Fdn, Turin, Italy; [Kerr, Grainne] German Canc Res Ctr, D-6900 Heidelberg, Germany	Dublin City University; Helmholtz Association; German Cancer Research Center (DKFZ)	Sirbu, A (corresponding author), Dublin City Univ, Ctr Sci Comp & Complex Syst Modelling, Dublin 9, Ireland.	asirbu@computing.dcu.ie	Crane, Martin/V-6823-2019; Sirbu, Alina/I-3288-2014	Crane, Martin/0000-0001-7598-3126; Sirbu, Alina/0000-0002-3947-7143	Irish Research Council for Science Engineering and Technology EMBARK Initiative; Future and Emerging Technologies program (IST-FET) of the European Commission under the EU RD [IST-265432]	Irish Research Council for Science Engineering and Technology EMBARK Initiative(Irish Research Council for Science, Engineering and Technology); Future and Emerging Technologies program (IST-FET) of the European Commission under the EU RD	Most of this work has been conducted with support from the Irish Research Council for Science Engineering and Technology EMBARK Initiative. The authors also thank the EveryAware project funded by the Future and Emerging Technologies program (IST-FET) of the European Commission under the EU RD contract IST-265432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldi P, 2002, DNA MICROARRAY GENE; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Bottomly D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017820; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Cabanski CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009905; Datta S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-397; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hurd Paul J., 2009, Briefings in Functional Genomics & Proteomics, V8, P174, DOI 10.1093/bfgp/elp013; Kaiser S, 2008, TECHNICAL REPORTS, V28; Kerr G, 2008, COMPUT BIOL MED, V38, P283, DOI 10.1016/j.compbiomed.2007.11.001; Kerr G, 2009, THESIS DUBLIN CITY U; Kumar R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00202; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Leisch F, 2006, COMPUT STAT DATA AN, V51, P526, DOI 10.1016/j.csda.2005.10.006; Li J, 2002, TOXICOL SCI, V69, P383, DOI 10.1093/toxsci/69.2.383; Liu J, 2009, SCIENCE, V323, P1218, DOI 10.1126/science.1157669; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Sirbu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013822; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Speed T., 2003, STAT ANAL GENE EXPRE	33	55	55	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50986	10.1371/journal.pone.0050986	http://dx.doi.org/10.1371/journal.pone.0050986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251411	Green Submitted, gold, Green Published			2022-12-27	WOS:000312201900030
J	Awaya, T; Kato, T; Mizuno, Y; Chang, H; Niwa, A; Umeda, K; Nakahata, T; Heike, T				Awaya, Tomonari; Kato, Takeo; Mizuno, Yuta; Chang, Hsi; Niwa, Akira; Umeda, Katsutsugu; Nakahata, Tatsutoshi; Heike, Toshio			Selective Development of Myogenic Mesenchymal Cells from Human Embryonic and Induced Pluripotent Stem Cells	PLOS ONE			English	Article							SATELLITE CELL; MUSCLE DEVELOPMENT; DIFFERENTIATION; GENERATION; MOUSE; DERIVATION; ESTABLISHMENT; REGENERATION; FIBROBLASTS; MAINTENANCE	Human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells are promising sources for the cell therapy of muscle diseases and can serve as powerful experimental tools for skeletal muscle research, provided an effective method to induce skeletal muscle cells is established. However, the current methods for myogenic differentiation from human ES cells are still inefficient for clinical use, while myogenic differentiation from human iPS cells remains to be accomplished. Here, we aimed to establish a practical differentiation method to induce skeletal myogenesis from both human ES and iPS cells. To accomplish this goal, we developed a novel stepwise culture method for the selective expansion of mesenchymal cells from cell aggregations called embryoid bodies. These mesenchymal cells, which were obtained by dissociation and re-cultivation of embryoid bodies, uniformly expressed CD56 and the mesenchymal markers CD73, CD105, CD166, and CD29, and finally differentiated into mature myotubes in vitro. Furthermore, these myogenic mesenchymal cells exhibited stable long-term engraftment in injured muscles of immunodeficient mice in vivo and were reactivated upon subsequent muscle damage, increasing in number to reconstruct damaged muscles. Our simple differentiation system facilitates further utilization of ES and iPS cells in both developmental and pathological muscle research and in serving as a practical donor source for cell therapy of muscle diseases.	[Awaya, Tomonari; Kato, Takeo; Mizuno, Yuta; Chang, Hsi; Niwa, Akira; Umeda, Katsutsugu; Heike, Toshio] Kyoto Univ, Dept Pediat, Grad Sch Med, Kyoto, Japan; [Niwa, Akira; Nakahata, Tatsutoshi] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan	Kyoto University; Kyoto University	Awaya, T (corresponding author), Kyoto Univ, Dept Pediat, Grad Sch Med, Kyoto, Japan.	awaya@kuhp.kyoto-u.ac.jp	Awaya, Tomonari/O-2757-2015	Awaya, Tomonari/0000-0002-9004-3172	Japan Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [22249042, 23791170] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Japan Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bismuth K, 2010, EXP CELL RES, V316, P3081, DOI 10.1016/j.yexcr.2010.08.018; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cerletti M, 2008, COLD SH Q B, V73, P317, DOI 10.1101/sqb.2008.73.054; Chang H, 2009, FASEB J, V23, P1907, DOI 10.1096/fj.08-123661; DANGAIN J, 1984, MUSCLE NERVE, V7, P700, DOI 10.1002/mus.880070903; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Guan K, 1999, CYTOTECHNOLOGY, V30, P211, DOI 10.1023/A:1008041420166; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Mahmood A, 2010, J BONE MINER RES, V25, P1216, DOI 10.1002/jbmr.34; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Meregalli M, 2010, BIODRUGS, V24, P237, DOI 10.2165/11534300-000000000-00000; Mizuno Y, 2010, FASEB J, V24, P2245, DOI 10.1096/fj.09-137174; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648; Ozasa S, 2007, BIOCHEM BIOPH RES CO, V357, P957, DOI 10.1016/j.bbrc.2007.04.032; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; Ryan T, 2012, STEM CELL REV REP, V8, P482, DOI 10.1007/s12015-011-9284-0; Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x; Scharner J, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-28; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Zheng JK, 2006, CELL RES, V16, P713, DOI 10.1038/sj.cr.7310080	39	57	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51638	10.1371/journal.pone.0051638	http://dx.doi.org/10.1371/journal.pone.0051638			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236522	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100138
J	Ene, CI; Edwards, L; Riddick, G; Baysan, M; Woolard, K; Kotliarova, S; Lai, C; Belova, G; Cam, M; Walling, J; Zhou, M; Stevenson, H; Kim, HS; Killian, K; Veenstra, T; Bailey, R; Song, H; Zhang, W; Fine, HA				Ene, Chibawanye I.; Edwards, Lincoln; Riddick, Gregory; Baysan, Mehmet; Woolard, Kevin; Kotliarova, Svetlana; Lai, Chen; Belova, Galina; Cam, Maggie; Walling, Jennifer; Zhou, Ming; Stevenson, Holly; Kim, Hong Sug; Killian, Keith; Veenstra, Timothy; Bailey, Rolanda; Song, Hua; Zhang, Wei; Fine, Howard A.			Histone Demethylase Jumonji D3 (JMJD3) as a Tumor Suppressor by Regulating p53 Protein Nuclear Stabilization	PLOS ONE			English	Article							INITIATING CELLS; GENOME BROWSER; HUMAN GLIOBLASTOMA; H3K27 DEMETHYLASE; DNA METHYLATION; STEM-CELLS; DIFFERENTIATION; PATHWAY; REPRESSION; UCSC	Histone methylation regulates normal stem cell fate decisions through a coordinated interplay between histone methyltransferases and demethylases at lineage specific genes. Malignant transformation is associated with aberrant accumulation of repressive histone modifications, such as polycomb mediated histone 3 lysine 27 (H3K27me3) resulting in a histone methylation mediated block to differentiation. The relevance, however, of histone demethylases in cancer remains less clear. We report that JMJD3, a H3K27me3 demethylase, is induced during differentiation of glioblastoma stem cells (GSCs), where it promotes a differentiation-like phenotype via chromatin dependent (INK4A/ARF locus activation) and chromatin independent (nuclear p53 protein stabilization) mechanisms. Our findings indicate that deregulation of JMJD3 may contribute to gliomagenesis via inhibition of the p53 pathway resulting in a block to terminal differentiation.	[Fine, Howard A.] NYU, Ctr Canc, Langone Med Ctr, New York, NY 10003 USA; [Ene, Chibawanye I.; Edwards, Lincoln; Riddick, Gregory; Baysan, Mehmet; Woolard, Kevin; Kotliarova, Svetlana; Lai, Chen; Belova, Galina; Cam, Maggie; Walling, Jennifer; Kim, Hong Sug; Bailey, Rolanda; Song, Hua; Zhang, Wei] NINDS, Neurooncol Branch, Ctr Canc Res, NCI,NIH, Bethesda, MD 20892 USA; [Ene, Chibawanye I.] NIH, NIH Oxford Cambridge Res Scholars Program, Bethesda, MD 20892 USA; [Zhou, Ming; Veenstra, Timothy] NCI, Lab Prote & Analyt Technol, Frederick Natl Lab Canc Res, NIH, Frederick, MD 21701 USA; [Stevenson, Holly; Killian, Keith] NCI, Mol Profiling Core, Genet Branch, NIH, Bethesda, MD 20892 USA	New York University; NYU Langone Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Fine, HA (corresponding author), NYU, Ctr Canc, Langone Med Ctr, New York, NY 10003 USA.	Howard.Fine@nyumc.org	kim, Hong Sug/G-2731-2014; baysan, mehmet/O-1710-2018; Ene, Cosmin-Victor/W-3630-2017	baysan, mehmet/0000-0001-7359-2965; Ene, Chibawanye/0000-0002-2653-281X; Ene, Cosmin-Victor/0000-0002-1357-9504	Howard Hughes Medical Institute National Cancer Institute, National Institute of Health; NATIONAL CANCER INSTITUTE [ZICBC011041] Funding Source: NIH RePORTER	Howard Hughes Medical Institute National Cancer Institute, National Institute of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Howard Hughes Medical Institute National Cancer Institute, National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Al-Mayhani TMF, 2009, J NEUROSCI METH, V176, P192, DOI 10.1016/j.jneumeth.2008.07.022; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho W, 2009, J NEUROCHEM, V110, P343, DOI 10.1111/j.1471-4159.2009.06146.x; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kachirskaia I, 2008, J BIOL CHEM, V283, P34660, DOI 10.1074/jbc.M806020200; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lu C, 2012, NATURE; Lu J, 2010, J NEUROSURG, V113, P225, DOI 10.3171/2009.11.JNS091272; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Park DM, 2007, CELL CYCLE, V6, P467, DOI 10.4161/cc.6.4.3856; Pereira JD, 2010, P NATL ACAD SCI USA, V107, P15957, DOI 10.1073/pnas.1002530107; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sola S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018421; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stadler M. B., 2011, NATURE; Testa G, 2011, BIOESSAYS, V33, P519, DOI 10.1002/bies.201100021; Turcan S, 2012, NATURE; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	45	78	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51407	10.1371/journal.pone.0051407	http://dx.doi.org/10.1371/journal.pone.0051407			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236496	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100115
J	Glukhov, AS; Krutilina, AI; Shlyapnikov, MG; Severinov, K; Lavysh, D; Kochetkov, VV; McGrath, JW; de Leeuwe, C; Shaburova, OV; Krylov, VN; Akulenko, NV; Kulakov, LA				Glukhov, Anatoly S.; Krutilina, Antonina I.; Shlyapnikov, Michael G.; Severinov, Konstantin; Lavysh, Daria; Kochetkov, Vladimir V.; McGrath, John W.; de Leeuwe, Colin; Shaburova, Olga V.; Krylov, Victor N.; Akulenko, Natalia V.; Kulakov, Leonid A.			Genomic Analysis of Pseudomonas putida Phage tf with Localized Single-Strand DNA Interruptions	PLOS ONE			English	Article							TEMPERATE BACTERIOPHAGE; SEQUENCE; AERUGINOSA; RESEMBLES; ALIGNMENT; PROTEINS; HOMOLOGY; MUTANTS; KT2440	The complete sequence of the 46,267 bp genome of the lytic bacteriophage tf specific to Pseudomonas putida PpG1 has been determined. The phage genome has two sets of convergently transcribed genes and 186 bp long direct terminal repeats. The overall genomic architecture of the tf phage is similar to that of the previously described Pseudomonas aeruginosa phages PaP3, LUZ24 and phiMR299-2, and 39 out of the 72 products of predicted tf open reading frames have orthologs in these phages. Accordingly, tf was classified as belonging to the LUZ24-like bacteriophage group. However, taking into account very low homology levels between tf DNA and that of the other phages, tf should be considered as an evolutionary divergent member of the group. Two distinguishing features not reported for other members of the group were found in the tf genome. Firstly, a unique end structure - a blunt right end and a 4-nucleotide 3'-protruding left end - was observed. Secondly, 14 single-chain interruptions (nicks) were found in the top strand of the tf DNA. All nicks were mapped within a consensus sequence 5'-TACT/RTGMC-3'. Two nicks were analyzed in detail and were shown to be present in more than 90% of the phage population. Although localized nicks were previously found only in the DNA of T5-like and phiKMV-like phages, it seems increasingly likely that this enigmatic structural feature is common to various other bacteriophages.	[McGrath, John W.; de Leeuwe, Colin; Akulenko, Natalia V.; Kulakov, Leonid A.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Glukhov, Anatoly S.; Krutilina, Antonina I.] Russian Acad Sci, Inst Prot Res, Pushchino 142292, Russia; [Shlyapnikov, Michael G.; Kochetkov, Vladimir V.] Russian Acad Sci, Skryabin Inst Biochem & Physiol Microorganisms, Pushchino 142292, Russia; [Severinov, Konstantin; Lavysh, Daria; Akulenko, Natalia V.] Russian Acad Sci, Inst Mol Genet, Moscow, Russia; [Severinov, Konstantin; Lavysh, Daria; Akulenko, Natalia V.] Russian Acad Sci, Inst Gene Biol, Moscow, Russia; [Severinov, Konstantin; Akulenko, Natalia V.] Rutgers State Univ, Waksman Inst, Piscataway, NJ USA; [Shaburova, Olga V.; Krylov, Victor N.] RAMS, II Mechnikov Res Inst Vaccines & Sera, Lab Genet Bacteriophages, Dept Microbiol, Moscow, Russia	Queens University Belfast; Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Rutgers State University New Brunswick; Russian Academy of Medical Sciences; Research Institute of Vaccines and Sera Mechnikov, RAMS	Kulakov, LA (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.	l.kulakov@qub.ac.uk	Shaburova, Olga/AAK-2332-2021; Severinov, Konstantin/C-8545-2016	, Olga/0000-0003-0368-3794	School of Biological Sciences; QUESTOR Centre; Russian Academy of Science [02.740.11.077]; Charles and Johanna Busch Biomedical Foundation	School of Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); QUESTOR Centre; Russian Academy of Science(Russian Academy of Sciences); Charles and Johanna Busch Biomedical Foundation	Work of LAK group was supported by the School of Biological Sciences and the QUESTOR Centre. Work in KS laboratory was supported by a Russian Academy of Science program grant in Molecular and Cellular Biology and Federal Program "Scientific and scientific-pedagogical personnel of innovative Russia 2009-2012", state contract 02.740.11.077. NVA was partially supported by a fellowship from Charles and Johanna Busch Biomedical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON J, 1966, J MOL BIOL, V18, P262, DOI 10.1016/S0022-2836(66)80245-0; ADHIN MR, 1990, J MOL BIOL, V213, P811, DOI 10.1016/S0022-2836(05)80265-7; Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAUER CE, 1985, J MOL BIOL, V181, P187, DOI 10.1016/0022-2836(85)90084-1; BECKMAN LD, 1971, J MOL BIOL, V62, P551, DOI 10.1016/0022-2836(71)90155-0; Casjens Sherwood R., 2009, V502, P91, DOI 10.1007/978-1-60327-565-1_7; Ceyssens PJ, 2008, VIROLOGY, V377, P233, DOI 10.1016/j.virol.2008.04.038; Ceyssens PJ, 2006, J BACTERIOL, V188, P6924, DOI 10.1128/JB.00831-06; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; Cornelissen A, 2012, J VIROL, V86, P1844, DOI 10.1128/JVI.06330-11; Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597; Davis R.W., 1971, METHODS ENZYMOL, V21, P413; Jonston JV, 1977, J VIROL, V22, P510; Kim S, 2012, J VIROL, V86, P3400, DOI 10.1128/JVI.07191-11; Kimura K, 2003, APPL ENVIRON MICROB, V69, P2491, DOI 10.1128/AEM.69.5.2491-2497.2003; Kovalyova IV, 2003, VIROLOGY, V311, P305, DOI 10.1016/S0042-6822(03)00124-7; KULAKOV LA, 1981, GENETIKA+, V17, P1737; KULAKOV LA, 1985, MOL GEN GENET, V200, P123, DOI 10.1007/BF00383324; Kulakov LA, 1988, MOL GENET MIKROBIOL, V6, P12; Kulakov LA, 2009, VIROLOGY, V391, P1, DOI 10.1016/j.virol.2009.06.024; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; LEE LF, 1966, J BACTERIOL, V92, P1821, DOI 10.1128/JB.92.6.1821-1827.1966; Miller J.H., 1972, EXPT MOL GENETICS; Mironov A. A., 2000, Molekulyarnaya Biologiya (Moscow), V34, P253; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nilsson M, 2011, ENVIRON MICROBIOL, V13, P1357, DOI 10.1111/j.1462-2920.2011.02447.x; Rhoades M, 1984, J VIROL, V51, P533; Robison K, 1998, J MOL BIOL, V284, P241, DOI 10.1006/jmbi.1998.2160; ROGERS SG, 1979, J VIROL, V29, P716, DOI 10.1128/JVI.29.2.716-725.1979; Sambrook J., 2002, MOL CLONING LAB MANU; Savalia D, 2008, J MOL BIOL, V377, P774, DOI 10.1016/j.jmb.2007.12.077; SHAW AR, 1979, J VIROL, V29, P220, DOI 10.1128/JVI.29.1.220-231.1979; Tan YL, 2007, CELL MICROBIOL, V9, P479, DOI 10.1111/j.1462-5822.2006.00804.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tremblay DM, 1999, VIROLOGY, V255, P63, DOI 10.1006/viro.1998.9525; Wang JB, 2005, VIROLOGY, V332, P45, DOI 10.1016/j.virol.2004.10.049	38	15	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51163	10.1371/journal.pone.0051163	http://dx.doi.org/10.1371/journal.pone.0051163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236447	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100075
J	Grabowski, TB; Boswell, KM; McAdam, BJ; Wells, RJD; Marteinsdottir, G				Grabowski, Timothy B.; Boswell, Kevin M.; McAdam, Bruce J.; Wells, R. J. David; Marteinsdottir, Gudrun			Characterization of Atlantic Cod Spawning Habitat and Behavior in Icelandic Coastal Waters	PLOS ONE			English	Article							NORTHEAST ARCTIC COD; GADUS-MORHUA L.; REPRODUCTIVE SUCCESS; MIGRATORY BEHAVIOR; RELATIVE DENSITY; TARGET-STRENGTH; SITE FIDELITY; MATE CHOICE; FISHES; SIZE	The physical habitat used during spawning may potentially be an important factor affecting reproductive output of broadcast spawning marine fishes, particularly for species with complex, substrate-oriented mating systems and behaviors, such as Atlantic cod Gadus morhua. We characterized the habitat use and behavior of spawning Atlantic cod at two locations off the coast of southwestern Iceland during a 2-d research cruise (15-16 April 2009). We simultaneously operated two different active hydroacoustic gear types, a split beam echosounder and a dual frequency imaging sonar (DIDSON), as well as a remotely operated underwater vehicle (ROV). A total of five fish species were identified through ROV surveys: including cusk Brosme brosme, Atlantic cod, haddock Melanogrammus aeglefinus, lemon sole Microstomus kitt, and Atlantic redfish Sebastes spp. Of the three habitats identified in the acoustic surveys, the transitional habitat between boulder/lava field and sand habitats was characterized by greater fish density and acoustic target strength compared to that of sand or boulder/lava field habitats independently. Atlantic cod were observed behaving in a manner consistent with published descriptions of spawning. Individuals were observed ascending 1-5 m into the water column from the bottom at an average vertical swimming speed of 0.20-0.25 m s(-1) and maintained an average spacing of 1.0-1.4 m between individuals. Our results suggest that cod do not choose spawning locations indiscriminately despite the fact that it is a broadcast spawning fish with planktonic eggs that are released well above the seafloor.	[Grabowski, Timothy B.; McAdam, Bruce J.; Marteinsdottir, Gudrun] Univ Iceland, Inst Biol, Reykjavik, Iceland; [Grabowski, Timothy B.] Texas Tech Univ, US Geol Survey, Texas Cooperat Fish & Wildlife Res Unit, Lubbock, TX 79409 USA; [Boswell, Kevin M.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Boswell, Kevin M.] Florida Int Univ, Marine Sci Program, Dept Biol Sci, N Miami, FL USA; [McAdam, Bruce J.] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Wells, R. J. David] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	University of Iceland; Texas Tech University System; Texas Tech University; United States Department of the Interior; United States Geological Survey; Louisiana State University System; Louisiana State University; State University System of Florida; Florida International University; University of Stirling; Texas A&M University System	Grabowski, TB (corresponding author), Univ Iceland, Inst Biol, Reykjavik, Iceland.	t.grabowski@ttu.edu	Boswell, Kevin M./B-6380-2016	Boswell, Kevin M./0000-0002-2037-1541; Grabowski, Timothy/0000-0001-9763-8948; Marteinsdottir, Gudrun/0000-0001-6939-2434	Icelandic Ministry of Fisheries and Agriculture (Sjavarutvegs-og Landbunaoarraoherra)	Icelandic Ministry of Fisheries and Agriculture (Sjavarutvegs-og Landbunaoarraoherra)	Funding for this project was provided by the Icelandic Ministry of Fisheries and Agriculture (Sjavarutvegs-og Landbunaoarraoherra). Funding was used to support the salary of two authors while they were employed at the University of Iceland (TBG, BJM), the travel costs of two authors (KMB, RJDW), and the costs associated with chartering the research vessel and transportation and insurance of equipment used in this study. The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD GP, 1992, ICES J MAR SCI, V49, P357, DOI 10.1093/icesjms/49.3.357; BALON EK, 1975, J FISH RES BOARD CAN, V32, P821, DOI 10.1139/f75-110; Bekkevold D, 2002, MOL ECOL, V11, P91, DOI 10.1046/j.0962-1083.2001.01424.x; Bigelow H. B., 1953, FISHERY B FISH WILDL; Boswell KM, 2010, MAR COAST FISH, V2, P83, DOI 10.1577/C09-022.1; BRANDER K, 2005, 274 ICES COOP RES; Brandt Stephen B., 1996, P385; BRAWN VIVIEN M., 1961, BEHAVIOUR, V18, P177, DOI 10.1163/156853961X00114; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Checkley David M. Jr., 1999, Fisheries Oceanography, V8, P22; Choat JH, 2012, FISH FISH SER, V35, P85, DOI 10.1007/978-94-007-1980-4_4; ELLIS DM, 1995, FISH B-NOAA, V93, P67; Ermolchev VA, 2009, ICES J MAR SCI, V66, P1225, DOI 10.1093/icesjms/fsp024; Florin AB, 2010, FISH RES, V102, P207, DOI 10.1016/j.fishres.2009.12.002; Fudge SB, 2009, ICES J MAR SCI, V66, P1259, DOI 10.1093/icesjms/fsp097; Godo OR, 2000, FISH RES, V48, P127, DOI 10.1016/S0165-7836(00)00177-6; Grabowski TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017528; Hunter E, 2003, P ROY SOC B-BIOL SCI, V270, P2097, DOI 10.1098/rspb.2003.2473; Hutchings JA, 1999, CAN J FISH AQUAT SCI, V56, P97, DOI 10.1139/cjfas-56-1-97; HUTCHINGS JA, 1993, CAN J FISH AQUAT SCI, V50, P2468, DOI 10.1139/f93-271; JONES FRH, 1985, J COMP PHYSIOL B, V155, P319; Jonsdottir IG, 2010, MARINE RES ICELAND, V155; Jonsdottir IG, 2006, ICES J MAR SCI, V63, P1501, DOI 10.1016/j.icesjms.2006.05.006; Jonsson G., 2006, ISLENSKIR FISKAR; Knickle DC, 2012, FISH RES, V129, P8, DOI 10.1016/j.fishres.2012.05.013; Kristjansson L, 1983, ISLENSKIR SJAVARHAET, V3; Lawson GL, 2000, CAN J FISH AQUAT SCI, V57, P1011, DOI 10.1139/cjfas-57-5-1011; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Marteinsdottir G, 2000, ICES J MAR SCI, V57, P824, DOI 10.1006/jmsc.2000.0568; Marteinsdottir G, 1995, ICES C G, P15; Meager JJ, 2010, CAN J FISH AQUAT SCI, V67, P1221, DOI 10.1139/F10-066; Meager JJ, 2009, MAR ECOL PROG SER, V389, P233, DOI 10.3354/meps08156; Nemerson D, 2000, FISH B-NOAA, V98, P118; Nordeide JT, 2000, FISH FISH, V1, P90, DOI 10.1046/j.1467-2979.2000.00005.x; Nordeide JT, 1998, SARSIA, V83, P373, DOI 10.1080/00364827.1998.10413696; Ona E, 1996, ICES J MAR SCI, V53, P677, DOI 10.1006/jmsc.1996.0087; PETERSEN CW, 1992, ECOLOGY, V73, P391, DOI 10.2307/1940747; Petursdottir G, 2006, FISH RES, V80, P182, DOI 10.1016/j.fishres.2006.05.002; Rakitin A, 2001, MAR BIOL, V138, P1077, DOI 10.1007/s002270100551; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Robichaud D, 2001, CAN J FISH AQUAT SCI, V58, P2325, DOI 10.1139/cjfas-58-12-2325; Rose GA, 1996, ICES J MAR SCI, V53, P259, DOI 10.1006/jmsc.1996.0032; ROSE GA, 1993, NATURE, V366, P458, DOI 10.1038/366458a0; Rowe S, 2003, TRENDS ECOL EVOL, V18, P567, DOI 10.1016/j.tree.2003.09.004; Rowe S, 2008, MAR ECOL PROG SER, V354, P257, DOI 10.3354/meps07175; Schabenberger O.., 2005, INTRO GLIMMIX PROCED; Simmonds J., 2005, FISHERIES ACOUSTICS, V2nd edn; Skjaeraasen JE, 2011, ICES J MAR SCI, V68, P1472, DOI 10.1093/icesjms/fsr055; Sundby S, 2008, ICES J MAR SCI, V65, P953, DOI 10.1093/icesjms/fsn085; Svedang H, 2007, MAR ECOL PROG SER, V345, P1, DOI 10.3354/meps07140; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; WARNER RR, 1990, AM NAT, V135, P205, DOI 10.1086/285039; Wells RJD, 2007, AM FISH S S, V60, P39; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Wright PJ, 2006, FISH RES, V77, P148, DOI 10.1016/j.fishres.2005.10.008	57	13	13	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51321	10.1371/journal.pone.0051321	http://dx.doi.org/10.1371/journal.pone.0051321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236471	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100095
J	Merbah, M; Arakelyan, A; Edmonds, T; Ochsenbauer, C; Kappes, JC; Shattock, RJ; Grivel, JC; Margolis, LB				Merbah, Melanie; Arakelyan, Anush; Edmonds, Tara; Ochsenbauer, Christina; Kappes, John C.; Shattock, Robin J.; Grivel, Jean-Charles; Margolis, Leonid B.			HIV-1 Expressing the Envelopes of Transmitted/Founder or Control/Reference Viruses Have Similar Infection Patterns of CD4 T-Cells in Human Cervical Tissue Ex Vivo	PLOS ONE			English	Article							HUMAN LYMPHOID-TISSUE; SIMIAN IMMUNODEFICIENCY VIRUS; SEXUAL TRANSMISSION; CXCR4-TROPIC HIV-1; TYPE-1 INFECTION; MOLECULAR CLONES; PATHOGENESIS; CCR5; DISSEMINATION; DETERMINANTS	Recently, it was found that 80% of sexual HIV-1 transmissions are established by a single virion/viral genome. To investigate whether the transmitted/founder (T/F) viruses have specific biological properties favoring sexual transmission, we inoculated human cervical tissue explants with isogenic HIV-1 viruses encoding Env sequences from T/F and control reference (C/R) HIV-1 variants as well as with full length T/F HIV-1 and compared their replication efficiencies, T cell depletion, and the activation status of infected cells. We found that all the HIV-1 variants were capable of transmitting infection to cervical tissue ex vivo and in this system preferentially replicate in activated CD4 T cells and deplete these cells. There was no difference in the biological properties of T/F and C/R HIV-1 variants as evaluated in ex vivo cervical tissue. Citation: Merbah M, Arakelyan A, Edmonds T, Ochsenbauer C, Kappes JC, et al. (2012) HIV-1 Expressing the Envelopes of Transmitted/Founder or Control/Reference Viruses Have Similar Infection Patterns of CD4 T-Cells in Human Cervical Tissue Ex Vivo. PLoS ONE 7(12): e50839. doi:10.1371/journal.pone.0050839	[Merbah, Melanie; Arakelyan, Anush; Grivel, Jean-Charles; Margolis, Leonid B.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Intercellular Interact, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Edmonds, Tara; Ochsenbauer, Christina; Kappes, John C.] Univ Alabama Birmingham, Birmingham, AL USA; [Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, London, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Alabama System; University of Alabama Birmingham; Imperial College London	Grivel, JC (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Intercellular Interact, Program Phys Biol, NIH, Bethesda, MD 20892 USA.	grigri@helix.nih.gov		Grivel, Jean-Charles/0000-0003-0365-3181; Merbah, Melanie/0000-0002-5641-8612	Intramural NICHD Program; Center for HIV/AIDS Vaccine Immunology (CHAVI) [U19 AI067854-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767, U19AI067854] Funding Source: NIH RePORTER	Intramural NICHD Program; Center for HIV/AIDS Vaccine Immunology (CHAVI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work of MM, AA, J-CG and LBM was supported by the Intramural NICHD Program. RS, CO, TGE and JCK were supported by the Center for HIV/AIDS Vaccine Immunology (CHAVI) # U19 AI067854-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballweber L, 2011, J VIROL, V85, P13443, DOI 10.1128/JVI.05615-11; Biancotto A, 2008, BLOOD, V111, P699, DOI 10.1182/blood-2007-05-088435; Blanchet F, 2011, CURR OPIN HIV AIDS, V6, P391, DOI 10.1097/COH.0b013e328349b0a0; Boeras DI, 2011, P NATL ACAD SCI USA, V108, pE1156, DOI 10.1073/pnas.1103764108; Chung NPY, 2010, J BIOL CHEM, V285, P2100, DOI 10.1074/jbc.M109.030619; Duncan CJA, 2011, VIRUSES-BASEL, V3, P2255, DOI 10.3390/v3112255; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Grivel JC, 1999, NAT MED, V5, P344, DOI 10.1038/6565; Grivel JC, 2007, AIDS, V21, P1263, DOI 10.1097/QAD.0b013e3281864667; Grivel JC, 2009, NAT PROTOC, V4, P256, DOI 10.1038/nprot.2008.245; Gupta P, 2002, J VIROL, V76, P9868, DOI 10.1128/JVI.76.19.9868-9876.2002; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Karlsson I, 2005, J VIROL, V79, P11151, DOI 10.1128/JVI.79.17.11151-11160.2005; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Saba E, 2010, MUCOSAL IMMUNOL, V3, P280, DOI 10.1038/mi.2010.2; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Shen CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032539; Shen RZ, 2011, AM J REPROD IMMUNOL, V65, P261, DOI 10.1111/j.1600-0897.2010.00939.x; Shen R, 2009, J VIROL, V83, P3258, DOI 10.1128/JVI.01796-08; Turville SG, 2006, CURR OPIN HIV AIDS, V1, P3, DOI 10.1097/01.COH.0000194109.14601.20; Veazey RS, 2003, J INFECT DIS, V187, P769, DOI 10.1086/368386; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960	30	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50839	10.1371/journal.pone.0050839	http://dx.doi.org/10.1371/journal.pone.0050839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236398	Green Published, Green Submitted, gold			2022-12-27	WOS:000312589700019
J	Stieglitz, J; Blackwell, AD; Gutierrez, RQ; Linares, EC; Gurven, M; Kaplan, H				Stieglitz, Jonathan; Blackwell, Aaron D.; Quispe Gutierrez, Raul; Cortez Linares, Edhitt; Gurven, Michael; Kaplan, Hillard			Modernization, Sexual Risk-Taking, and Gynecological Morbidity among Bolivian Forager-Horticulturalists	PLOS ONE			English	Article							REPRODUCTIVE-TRACT INFECTIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; RURAL WOMEN; TRANSMITTED-DISEASES; BACTERIAL VAGINOSIS; 1ST INTERCOURSE; HIV; PREVALENCE; BEHAVIOR; COMMUNITY	Sexual risk-taking and reproductive morbidity are common among rapidly modernizing populations with little material wealth, limited schooling, minimal access to modern contraception and healthcare, and gendered inequalities in resource access that limit female autonomy in cohabiting relationships. Few studies have examined how modernization influences sexual risk-taking and reproductive health early in demographic transition. Tsimane are a natural fertility population of Bolivian forager-farmers; they are not urbanized, reside in small-scale villages, and lack public health infrastructure. We test whether modernization is associated with greater sexual risk-taking, report prevalence of gynecological morbidity (GM), and test whether modernization, sexual risk-taking and parity are associated with greater risk of GM. Data were collected from 2002-2010 using interviews, clinical exams, and laboratory analysis of cervical cells. We find opposing effects of modernization on both sexual risk-taking and risk of GM. Residential proximity to town and Spanish fluency are associated with greater likelihood of men's infidelity, and with number of lifetime sexual partners for men and women. However, for women, literacy is associated with delayed sexual debut after controlling for town proximity. Fifty-five percent of women present at least one clinical indicator of GM (n = 377); 48% present inflammation of cervical cells, and in 11% the inflammation results from sexually transmitted infection (trichomoniasis). Despite having easier access to modern healthcare, women residing near town experience greater likelihood of cervical inflammation and trichomoniasis relative to women in remote villages; women who are fluent in Spanish are also more likely to present trichomoniasis relative to women with moderate or no fluency. However, literate women experience lower likelihood of trichomoniasis. Parity has no effect on risk of GM. Our results suggest a net increase in risk of reproductive morbidity among rapidly modernizing, resource-stressed populations. Citation: Stieglitz J, Blackwell AD, Quispe Gutierrez R, Cortez Linares E, Gurven M, et al. (2012) Modernization, Sexual Risk-Taking, and Gynecological Morbidity among Bolivian Forager-Horticulturalists. PLoS ONE 7(12): e50384. doi:10.1371/journal.pone.0050384	[Stieglitz, Jonathan; Kaplan, Hillard] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Blackwell, Aaron D.; Gurven, Michael] Univ Calif Santa Barbara, Integrat Anthropol Sci Unit, Santa Barbara, CA 93106 USA; [Quispe Gutierrez, Raul; Cortez Linares, Edhitt] Proyecto Salud & Antropol Tsimane, San Borja, Beni, Bolivia	University of New Mexico; University of California System; University of California Santa Barbara	Stieglitz, J (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.	jonathan.stieglitz@gmail.com	Blackwell, Aaron/B-5258-2008	Blackwell, Aaron/0000-0002-5871-9865; Kaplan, Hillard/0000-0002-7398-7358; Gurven, Michael/0000-0002-5661-527X	National Science Foundation [BCS-0422690]; National Institutes of Health/National Institute on Aging [R01AG024119, R56AG024119]; NATIONAL INSTITUTE ON AGING [R56AG024119, R01AG024119] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by the National Science Foundation (http://www.nsf.gov), BCS-0422690, and the National Institutes of Health/National Institute on Aging (http://www.nia.nih.gov), R01AG024119 and R56AG024119. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afable-Munsuz A, 2006, PERSPECT SEX REPRO H, V38, P208, DOI 10.1111/j.1931-2393.2006.tb00281.x; Arrossi S, 2003, SALUD PUBLICA MEXICO, V45, pS306; Bhatia J, 2000, STUD FAMILY PLANN, V31, P267, DOI 10.1111/j.1728-4465.2000.00267.x; Bhatia JC, 1997, STUD FAMILY PLANN, V28, P95, DOI 10.2307/2138112; Blackwell AD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001218; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Garcia PJ, 2004, B WORLD HEALTH ORGAN, V82, P483; GLENN ND, 1977, ANN AM ACAD POLIT SS, V429, P36, DOI 10.1177/000271627742900105; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gueye M, 2001, INT FAM PLAN PERSPEC, V27, P56, DOI 10.2307/2673815; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Gurven M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006590; Gurven M, 2009, HUM NATURE-INT BIOS, V20, P151, DOI 10.1007/s12110-009-9062-8; Kaestle CE, 2005, AM J EPIDEMIOL, V161, P774, DOI 10.1093/aje/kwi095; Kahn JA, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e5; Kirby D, 2002, J SEX RES, V39, P27, DOI 10.1080/00224490209552116; Koenig MA, 2004, INT FAM PLAN PERSPEC, V30, P156, DOI 10.1363/3015604; LANDMAN K, 2008, PLOS ONE, V3, P1; Levine WC, 1998, AIDS, V12, P1899, DOI 10.1097/00002030-199814000-00022; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Miller HG, 1999, FAM PLANN PERSPECT, V31, P4, DOI 10.2307/2991550; MOSHA F, 1993, GENITOURIN MED, V69, P415; NICHOLS D, 1986, STUD FAMILY PLANN, V17, P100, DOI 10.2307/1967070; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; Norris AE, 1999, SEX TRANSM DIS, V26, P17, DOI 10.1097/00007435-199901000-00004; Nunn CL, 2003, ANIM BEHAV, V66, P37, DOI 10.1006/anbe.2003.2130; O'Donnell L, 2001, FAM PLANN PERSPECT, V33, P268, DOI 10.2307/3030194; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Pan American Health Organization, 2009, CHALL POS HIV EP LAT; Passey M, 1998, SEX TRANSM INFECT, V74, P120, DOI 10.1136/sti.74.2.120; Patel V, 2006, SEX TRANSM INFECT, V82, P243, DOI 10.1136/sti.2005.016451; Schiff M, 2000, INT J EPIDEMIOL, V29, P983, DOI 10.1093/ije/29.6.983; SCHULZ KF, 1987, GENITOURIN MED, V63, P320; Shaw M, 2001, SEX TRANSM INFECT, V77, P358, DOI 10.1136/sti.77.5.358; Silverman JG, 2008, JAMA-J AM MED ASSOC, V300, P703, DOI 10.1001/jama.300.6.703; Smith DJ, 2007, AM J PUBLIC HEALTH, V97, P997, DOI 10.2105/AJPH.2006.088583; Stephenson R, 2006, INT FAM PLAN PERSPEC, V32, P201, DOI 10.1363/3220106; Stieglitz J, 2012, EVOL HUM BEHAV, V33, P438, DOI 10.1016/j.evolhumbehav.2011.12.006; Stieglitz J, 2011, AM J HUM BIOL, V23, P445, DOI 10.1002/ajhb.21149; TANNER JM, 1973, NATURE, V243, P95, DOI 10.1038/243095a0; Tonon SA, 2004, INT J INFECT DIS, V8, P13, DOI 10.1016/j.ijid.2003.03.001; Trent M, 2011, SEX TRANSM DIS, V38, P879, DOI 10.1097/OLQ.0b013e31821f918c; United Nations Population Fund, 2011, STAT WORLD POP 2011; United Nations Statistics Division, 2005, DES HOUS SURV SAMPL; United States Agency for International Development, 2011, LAT AM CAR SEL EC SO; Verstraelen H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-81; Walraven G, 2001, LANCET, V357, P1161, DOI 10.1016/S0140-6736(00)04333-6; Wardlow H, 2007, AM J PUBLIC HEALTH, V97, P1006, DOI 10.2105/AJPH.2006.088559; WEIS DL, 1985, J MARRIAGE FAM, V47, P173, DOI 10.2307/352079; Yang XS, 2008, SOC PROBL, V55, P322, DOI 10.1525/sp.2008.55.3.322; YOUNIS N, 1993, STUD FAMILY PLANN, V24, P175, DOI 10.2307/2939232; Zabin LS, 2009, STUD FAMILY PLANN, V40, P1, DOI 10.1111/j.1728-4465.2009.00182.x; ZABIN LS, 1986, DEMOGRAPHY, V23, P595, DOI 10.2307/2061353; Zurayk H, 1993, Health Transit Rev, V3, P17	58	11	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50384	10.1371/journal.pone.0050384	http://dx.doi.org/10.1371/journal.pone.0050384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057UO	23236371	gold, Green Published			2022-12-27	WOS:000312589700013
J	Xu, J; Wang, S; Zhao, WJ; Xi, YB; Yan, YB; Yao, K				Xu, Jia; Wang, Sha; Zhao, Wei-Jie; Xi, Yi-Bo; Yan, Yong-Bin; Yao, Ke			The Congenital Cataract-Linked A2V Mutation Impairs Tetramer Formation and Promotes Aggregation of beta B2-Crystallin	PLOS ONE			English	Article							LENS BETA-CRYSTALLIN; SITE-DIRECTED MUTAGENESIS; CHINESE FAMILY; EYE LENS; ASSOCIATION PROPERTIES; MASS-SPECTROMETRY; BETA-B1-CRYSTALLIN; BETA-A3-CRYSTALLIN; EXTENSION; FLUORESCENCE	beta/gamma-Crystallins, the major structural proteins in human lens, are highly conserved in their tertiary structures but distinct in the quaternary structures. The N- and C-terminal extensions have been proposed to play a crucial role in mediating the size of beta-crystallin assembly. In this research, we investigated the molecular mechanism underlying the congenital hereditary cataract caused by the recently characterized A2V mutation in beta B2-crystallin. Spectroscopic experiments indicated that the mutation did not affect the secondary and tertiary structures of beta B2-crystallin. The mutation did not affect the formation of beta B2/beta A3-crystallin heteromer as well as the stability and folding of the heteromer, suggesting that the mutation might not interfere with the protein interacting network in the lens. However, the tetramerization of beta B2-crystallin at high protein concentrations was retarded by the A2V mutation. The mutation slightly decreased the thermal stability and promoted the thermal aggregation of beta B2-crystallin. Although it did not influence the stability of beta B2-crystallin against denaturation induced by chemical denaturants and UV irradiation, the A2V mutant was more prone to be trapped in the off-pathway aggregation process during kinetic refolding. Our results suggested that the A2V mutation might lead to injury of lens optical properties by decreasing beta B2-crystallin stability against heat treatment and by impairing beta B2-crystallin assembly into high-order homo-oligomers. Citation: Xu J, Wang S, Zhao W-J, Xi Y-B, Yan Y-B, et al. (2012) The Congenital Cataract-Linked A2V Mutation Impairs Tetramer Formation and Promotes Aggregation of beta B2-Crystallin. PLoS ONE 7(12): e51200. doi:10.1371/journal.pone.0051200	[Wang, Sha; Zhao, Wei-Jie; Xi, Yi-Bo; Yan, Yong-Bin] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Xu, Jia; Yao, Ke] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310003, Zhejiang, Peoples R China; [Xi, Yi-Bo] Lanzhou Univ, Inst Biophys, Lanzhou 730000, Peoples R China	Tsinghua University; Zhejiang University; Lanzhou University	Yan, YB (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ybyan@tsinghua.edu.cn; xlren@zju.edu.cn	Yao, Ke/AAM-6866-2021; Yan, Yong-Bin/A-4282-2008	Yan, Yong-Bin/0000-0002-8565-3558; Yao, Ke/0000-0002-6764-7365	National Key Basic Research and Development Program of China [2010CB912402]; National Natural Science Foundation of China [81130018, 30970559]; National Twelfth Five-Year Plan Foundation of China [2012BAI08B01]; Zhejiang Key Innovation Team Project [2009R50039]; Zhejiang Key Laboratory Fund [2011E10006]	National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Twelfth Five-Year Plan Foundation of China; Zhejiang Key Innovation Team Project; Zhejiang Key Laboratory Fund	This study was supported by the National Key Basic Research and Development Program of China (No. 2010CB912402), National Natural Science Foundation of China (Nos. 81130018 and 30970559), National Twelfth Five-Year Plan Foundation of China (No. 2012BAI08B01), Zhejiang Key Innovation Team Project (No. 2009R50039) and Zhejiang Key Laboratory Fund (No. 2011E10006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar A, 1996, Methods Mol Biol, V57, P177; Ajaz MS, 1997, J BIOL CHEM, V272, P11250; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Banh A, 2006, PROG RETIN EYE RES, V25, P189, DOI 10.1016/j.preteyeres.2005.10.001; BAX B, 1990, NATURE, V347, P776, DOI 10.1038/347776a0; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan MP, 2008, BIOCHEMISTRY-US, V47, P11062, DOI 10.1021/bi8012438; COOPER PG, 1993, EUR J BIOCHEM, V213, P321, DOI 10.1111/j.1432-1033.1993.tb17765.x; Dolinska MB, 2009, BIOCHEMISTRY; Fu L, 2002, J STRUCT BIOL, V139, P191, DOI 10.1016/S1047-8477(02)00545-2; Gu F, 2008, HUM MUTAT, V29, P769, DOI 10.1002/humu.20724; He GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033700; Hejtmancik JF, 2004, EXP EYE RES, V79, P377, DOI 10.1016/j.exer.2004.06.011; Hejtmancik JF, 1997, PROTEIN ENG, V10, P1347, DOI 10.1093/protein/10.11.1347; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Koteiche HA, 2007, FEBS LETT, V581, P1933, DOI 10.1016/j.febslet.2007.04.004; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Li XQ, 2012, HUM MUTAT, V33, P391, DOI 10.1002/humu.21648; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Moreau KL, 2009, J BIOL CHEM, V284, P33285, DOI 10.1074/jbc.M109.031344; NALINI V, 1994, J MOL BIOL, V236, P1250, DOI 10.1016/0022-2836(94)90025-6; Pang M, 2010, BBA-PROTEINS PROTEOM, V1804, P948, DOI 10.1016/j.bbapap.2010.01.001; Sergeev YV, 2004, BIOCHEMISTRY-US, V43, P415, DOI 10.1021/bi034617f; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; SLINGSBY C, 1990, BIOCHEMISTRY-US, V29, P6592, DOI 10.1021/bi00480a007; Slingsby C, 1999, EYE, V13, P395, DOI 10.1038/eye.1999.113; Srivastava K, 2009, BIOCHEMISTRY-US, V48, P7179, DOI 10.1021/bi900313c; Takata T, 2009, MOL VIS, V15, P241; TUROVEROV KK, 1976, FEBS LETT, V62, P4, DOI 10.1016/0014-5793(76)80003-8; Van Montfort RLM, 2003, PROTEIN SCI, V12, P2606, DOI 10.1110/ps.03265903; Wang BB, 2011, HUM MUTAT, V32, pE1939, DOI 10.1002/humu.21386; Wang KJ, 2011, HUM MUTAT, V32, pE2050, DOI 10.1002/humu.21436; Wang S, 2011, BIOCHEMISTRY-US, V50, P10451, DOI 10.1021/bi201375p; Wieligmann K, 1999, J MOL BIOL, V286, P989, DOI 10.1006/jmbi.1999.2554; Yao K, 2011, MOL VIS, V17, P144; Zhang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020564; Zhang ZL, 2001, EXP EYE RES, V73, P203, DOI 10.1006/exer.2001.1023; ZIGLER JS, 1980, EXP EYE RES, V31, P41, DOI 10.1016/0014-4835(80)90089-5	40	16	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51200	10.1371/journal.pone.0051200	http://dx.doi.org/10.1371/journal.pone.0051200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236454	Green Published, Green Submitted, gold			2022-12-27	WOS:000312589700031
J	Karjalainen, MK; Huusko, JM; Ulvila, J; Sotkasiira, J; Luukkonen, A; Teramo, K; Plunkett, J; Anttila, V; Palotie, A; Haataja, R; Muglia, LJ; Hallman, M				Karjalainen, Minna K.; Huusko, Johanna M.; Ulvila, Johanna; Sotkasiira, Jenni; Luukkonen, Aino; Teramo, Kari; Plunkett, Jevon; Anttila, Verneri; Palotie, Aarno; Haataja, Ritva; Muglia, Louis J.; Hallman, Mikko			A Potential Novel Spontaneous Preterm Birth Gene, AR, Identified by Linkage and Association Analysis of X Chromosomal Markers	PLOS ONE			English	Article							ANDROGEN RECEPTOR GENE; FACTOR-I RECEPTOR; SINGLE-NUCLEOTIDE POLYMORPHISM; TUMOR-NECROSIS-FACTOR; PROSTATE-CANCER; FAMILIAL PATTERNS; GESTATIONAL-AGE; GENOME; DISEQUILIBRIUM; DELIVERY	Preterm birth is the major cause of neonatal mortality and morbidity. In many cases, it has severe life-long consequences for the health and neurological development of the newborn child. More than 50% of all preterm births are spontaneous, and currently there is no effective prevention. Several studies suggest that genetic factors play a role in spontaneous preterm birth (SPTB). However, its genetic background is insufficiently characterized. The aim of the present study was to perform a linkage analysis of X chromosomal markers in SPTB in large northern Finnish families with recurrent SPTBs. We found a significant linkage signal (HLOD = 3.72) on chromosome locus Xq13.1 when the studied phenotype was being born preterm. There were no significant linkage signals when the studied phenotype was giving preterm deliveries. Two functional candidate genes, those encoding the androgen receptor (AR) and the interleukin-2 receptor gamma subunit (IL2RG), located near this locus were analyzed as candidates for SPTB in subsequent case-control association analyses. Nine single-nucleotide polymorphisms (SNPs) within these genes and an AR exon-1 CAG repeat, which was previously demonstrated to be functionally significant, were analyzed in mothers with preterm delivery (n = 272) and their offspring (n = 269), and in mothers with exclusively term deliveries (n = 201) and their offspring (n = 199), all originating from northern Finland. A replication study population consisting of individuals born preterm (n = 111) and term (n = 197) from southern Finland was also analyzed. Long AR CAG repeats (>= 26) were overrepresented and short repeats (<= 19) underrepresented in individuals born preterm compared to those born at term. Thus, our linkage and association results emphasize the role of the fetal genome in genetic predisposition to SPTB and implicate AR as a potential novel fetal susceptibility gene for SPTB.	[Karjalainen, Minna K.; Huusko, Johanna M.; Ulvila, Johanna; Sotkasiira, Jenni; Luukkonen, Aino; Haataja, Ritva; Hallman, Mikko] Univ Oulu, Dept Pediat, Inst Clin Med, SF-90100 Oulu, Finland; [Teramo, Kari] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; [Plunkett, Jevon] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Anttila, Verneri; Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Anttila, Verneri; Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge, England; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; [Palotie, Aarno] Broad Inst MIT & Harvard, Cambridge, MA USA; [Haataja, Ritva] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Muglia, Louis J.] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Ctr Prevent Preterm Birth, Cincinnati, OH USA	University of Oulu; University of Helsinki; Helsinki University Central Hospital; Stanford University; University of Helsinki; Wellcome Trust Sanger Institute; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oulu; Cincinnati Children's Hospital Medical Center	Karjalainen, MK (corresponding author), Univ Oulu, Dept Pediat, Inst Clin Med, SF-90100 Oulu, Finland.	minna.k.karjalainen@oulu.fi	Hallman, Niilo/AHD-9810-2022; Huusko, Johanna M/H-9448-2019	Palotie, Aarno/0000-0002-2527-5874; Karjalainen, Minna K/0000-0003-3184-3775; Saastamoinen, Ritva/0000-0002-8899-0381; Anttila, Verneri/0000-0002-0073-4675	Academy of Finland [105734, 126662, 125911]; Sigrid Juselius Foundation; Emil Aaltonen Foundation; Alma and K.A. Snellman Foundation; Foundation of Pediatric Research in Finland; University of Oulu Faculty of Medicine; Ministry of Social Affairs and Health; Wellcome Trust [WTO89062]; Academy of Finland Center of Excellence for Complex Disease Genetics [200923]; March of Dimes; Children's Discovery Institute at Washington University School of Medicine and St. Louis Children's Hospital; National Center for Research Resources [U54 RR020278]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Emil Aaltonen Foundation; Alma and K.A. Snellman Foundation; Foundation of Pediatric Research in Finland; University of Oulu Faculty of Medicine; Ministry of Social Affairs and Health; Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Finland Center of Excellence for Complex Disease Genetics(Academy of Finland); March of Dimes(March of Dimes); Children's Discovery Institute at Washington University School of Medicine and St. Louis Children's Hospital; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the Academy of Finland (grant number 105734 to RH, 126662 and 125911 to MH), the Sigrid Juselius Foundation (MH), the Emil Aaltonen Foundation (MKK), the Alma and K.A. Snellman Foundation (MKK), the Foundation of Pediatric Research in Finland (RH), and University of Oulu Faculty of Medicine (RH). Oulu University Hospital was supported by the Ministry of Social Affairs and Health (MH), the Wellcome Trust (grant number WTO89062 to AP), the Academy of Finland Center of Excellence for Complex Disease Genetics 200923 (AP) and by a grant from the March of Dimes, the Children's Discovery Institute at Washington University School of Medicine and St. Louis Children's Hospital awarded to LJM. The Broad Institute Center for Genotyping and Analysis was supported by grant U54 RR020278 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman CM, 2012, J ANDROL, V33, P210, DOI 10.2164/jandrol.111.013391; Adams MM, 2000, JAMA-J AM MED ASSOC, V283, P1591, DOI 10.1001/jama.283.12.1591; Aidoo M, 2001, GENET EPIDEMIOL, V21, P201, DOI 10.1002/gepi.1029; Annells MF, 2004, AM J OBSTET GYNECOL, V191, P2056, DOI 10.1016/j.ajog.2004.04.021; Aruna M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017718; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basso O, 1999, J EPIDEMIOL COMMUN H, V53, P20, DOI 10.1136/jech.53.1.20; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bhattacharya S, 2010, OBSTET GYNECOL, V115, P1125, DOI 10.1097/AOG.0b013e3181dffcdb; Boyd HA, 2009, AM J EPIDEMIOL, V170, P1358, DOI 10.1093/aje/kwp324; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chaudhari BP, 2008, CLIN GENET, V74, P493, DOI 10.1111/j.1399-0004.2008.01124.x; Chen Dafang, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P377; Di Renzo GC, 2007, GENDER MED, V4, P19, DOI 10.1016/S1550-8579(07)80004-0; Di Renzo GC, 2011, EUR J OBSTET GYN R B, V159, P342, DOI 10.1016/j.ejogrb.2011.09.024; Eberle MA, 2006, PLOS GENET, V2, P1319, DOI 10.1371/journal.pgen.0020142; Engel SAM, 2005, EPIDEMIOLOGY, V16, P469, DOI 10.1097/01.ede.0000164539.09250.31; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goode EL, 2005, GENET EPIDEMIOL, V29, pS72, DOI 10.1002/gepi.20112; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Haataja R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001293; Haram K, 2003, ACTA OBSTET GYN SCAN, V82, P687, DOI 10.1034/j.1600-0412.2003.00218.x; Hartel C, 2004, MOL HUM REPROD, V10, P911, DOI 10.1093/molehr/gah120; Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070; Hiekkalinna T, 2005, TWIN RES HUM GENET, V8, P16, DOI 10.1375/twin.8.1.16; Hiekkalinna T, 2011, HUM HERED, V71, P256, DOI 10.1159/000329467; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Hsu TY, 2009, TAIWAN J OBSTET GYNE, V48, P262, DOI 10.1016/S1028-4559(09)60301-6; Iacovidou N, 2010, ANN NY ACAD SCI, V1205, P130, DOI 10.1111/j.1749-6632.2010.05657.x; Ibanez L, 2003, J CLIN ENDOCR METAB, V88, P3333, DOI 10.1210/jc.2002-021791; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Karjalainen MK, 2011, THESIS U OULU; Karvela M, 2008, FERTIL STERIL, V90, DOI 10.1016/j.fertnstert.2008.04.071; KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523; Kistka ZAF, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.12.014; Kumar R, 2011, LIFE SCI, V88, P565, DOI 10.1016/j.lfs.2011.01.021; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Meazza R, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/861920; Michels G, 2008, FRONT NEUROENDOCRIN, V29, P182, DOI 10.1016/j.yfrne.2007.08.004; Miles HL, 2010, ARCH DIS CHILD-FETAL, V95, pF435, DOI 10.1136/adc.2009.173575; Myking S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-174; Nelson LR, 2001, J AM ACAD DERMATOL, V45, pS116, DOI 10.1067/mjd.2001.117432; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Palazzolo I, 2008, J STEROID BIOCHEM, V108, P245, DOI 10.1016/j.jsbmb.2007.09.016; Pandini G, 2005, CANCER RES, V65, P1849, DOI 10.1158/0008-5472.CAN-04-1837; Pandini G, 2009, ANN NY ACAD SCI, V1155, P263, DOI 10.1111/j.1749-6632.2009.04361.x; Payseur BA, 2008, AM J HUM GENET, V82, P1039, DOI 10.1016/j.ajhg.2008.02.018; Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181; Plunkett J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001365; Plunkett J, 2009, HUM HERED, V68, P209, DOI 10.1159/000224641; Porter TF, 1997, OBSTET GYNECOL, V90, P63, DOI 10.1016/S0029-7844(97)00215-9; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romero R, 2010, AM J OBSTET GYNECOL, V202; Sajjad Y, 2007, ASIAN J ANDROL, V9, P751, DOI 10.1111/j.1745-7262.2007.00320.x; Schayek H, 2010, MOL CELL ENDOCRINOL, V323, P239, DOI 10.1016/j.mce.2010.04.017; Schayek H, 2010, EXP CELL RES, V316, P1479, DOI 10.1016/j.yexcr.2010.03.007; Simard M, 2010, MOL CELL ENDOCRINOL, V319, P79, DOI 10.1016/j.mce.2009.12.007; Simmons LE, 2010, SEMIN PERINATOL, V34, P408, DOI 10.1053/j.semperi.2010.09.005; Strauch K, 2003, HUM HERED, V55, P202, DOI 10.1159/000073204; Svensson AC, 2009, AM J EPIDEMIOL, V170, P1365, DOI 10.1093/aje/kwp328; THL (The Finnish National Institute for Health and Welfare), 2010, 262010 THL, V26; Ulgen A, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S13; Van Nieuwerburgh F, 2008, GYNECOL ENDOCRINOL, V24, P669, DOI 10.1080/09513590802342841; Varilo T, 1999, THESIS U HELSINKI; Vladic-Stjernholm Y, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-116; Wilcox AJ, 2008, AM J EPIDEMIOL, V167, P474, DOI 10.1093/aje/kwm319; Wilson CM, 1996, MOL CELL ENDOCRINOL, V120, P51, DOI 10.1016/0303-7207(96)03819-1; Winkvist A, 1998, INT J EPIDEMIOL, V27, P248, DOI 10.1093/ije/27.2.248; York TP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012391	70	30	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51378	10.1371/journal.pone.0051378	http://dx.doi.org/10.1371/journal.pone.0051378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227263	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200122
J	Ong, SS; Wickneswari, R				Ong, Seong Siang; Wickneswari, Ratnam			Characterization of microRNAs Expressed during Secondary Wall Biosynthesis in Acacia mangium	PLOS ONE			English	Article							CLASS IIIHD-ZIP; ALTERED LIGNIN BIOSYNTHESIS; TRANSCRIPTIONAL REGULATION; COMPRESSION WOOD; PLANT MICRORNAS; DOWN-REGULATION; LEAF POLARITY; GENE FAMILY; ARABIDOPSIS; POPULUS	MicroRNAs (miRNAs) play critical regulatory roles by acting as sequence specific guide during secondary wall formation in woody and non-woody species. Although thousands of plant miRNAs have been sequenced, there is no comprehensive view of miRNA mediated gene regulatory network to provide profound biological insights into the regulation of xylem development. Herein, we report the involvement of six highly conserved amg-miRNA families (amg-miR166, amg-miR172, amg-miR168, amg-miR159, amg-miR394, and amg-miR156) as the potential regulatory sequences of secondary cell wall biosynthesis. Within this highly conserved amg-miRNA family, only amg-miR166 exhibited strong differences in expression between phloem and xylem tissue. The functional characterization of amg-miR166 targets in various tissues revealed three groups of HD-ZIP III: ATHB8, ATHB15, and REVOLUTA which play pivotal roles in xylem development. Although these three groups vary in their functions, -psRNA target analysis indicated that miRNA target sequences of the nine different members of HD-ZIP III are always conserved. We found that precursor structures of amg-miR166 undergo exhaustive sequence variation even within members of the same family. Gene expression analysis showed three key lignin pathway genes: C4H, CAD, and CCoAOMT were upregulated in compression wood where a cascade of miRNAs was downregulated. This study offers a comprehensive analysis on the involvement of highly conserved miRNAs implicated in the secondary wall formation of woody plants.	[Ong, Seong Siang; Wickneswari, Ratnam] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Ong, SS (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Bangi 43600, Selangor, Malaysia.	ong.siang@gmail.com; wicki@ukm.my	Ratnam, Wickneswari/V-7863-2017; Ratnam, Wickneswari/AAR-5100-2020	Ratnam, Wickneswari/0000-0002-2085-6434	Ministry of Science, Technology and Innovation Malaysia [05-01-02-SF1020]	Ministry of Science, Technology and Innovation Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This research was funded by e-Science Grant No. 05-01-02-SF1020 from the Ministry of Science, Technology and Innovation Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambavaram MMR, 2011, PLANT PHYSIOL, V155, P916, DOI 10.1104/pp.110.168641; Andersson-Gunneras S, 2006, PLANT J, V45, P144, DOI 10.1111/j.1365-313X.2005.02584.x; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bomal C, 2008, J EXP BOT, V59, P3925, DOI 10.1093/jxb/ern234; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Cano-Delgado A, 2010, ANNU REV CELL DEV BI, V26, P605, DOI 10.1146/annurev-cellbio-100109-104107; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Chaffey N, 1999, TREES-STRUCT FUNCT, V13, P138, DOI 10.1007/PL00009745; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; del Rio JC, 2005, J ANAL APPL PYROL, V74, P110, DOI 10.1016/j.jaap.2004.10.010; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Du JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017458; Du J, 2009, PLANT J, V60, P1000, DOI 10.1111/j.1365-313X.2009.04017.x; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Goicoechea M, 2005, PLANT J, V43, P553, DOI 10.1111/j.1365-313X.2005.02480.x; Green KA, 2005, PLANT CELL, V17, P691, DOI 10.1105/tpc.104.026179; Groover AT, 2006, PLANT MOL BIOL, V61, P917, DOI 10.1007/s11103-006-0059-y; Groover AT, 2005, TRENDS PLANT SCI, V10, P210, DOI 10.1016/j.tplants.2005.03.001; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Han KH, 2007, BIOFUEL BIOPROD BIOR, V1, P135, DOI 10.1002/bbb.14; Hancock JE, 2008, PLANT SOIL, V308, P239, DOI 10.1007/s11104-008-9624-2; Hancock JE, 2007, NEW PHYTOL, V173, P732, DOI 10.1111/j.1469-8137.2006.01965.x; Hu WJ, 1999, NAT BIOTECHNOL, V17, P808, DOI 10.1038/11758; Ibarra D, 2005, J ANAL APPL PYROL, V74, P116, DOI 10.1016/j.jaap.2004.12.009; Jia CH, 2004, CHINESE SCI BULL, V49, P905, DOI 10.1360/03wc0529; Jin H, 2009, J WOOD SCI, V55, P401, DOI 10.1007/s10086-009-1053-1; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Ko JH, 2006, NEW PHYTOL, V169, P469, DOI 10.1111/j.1469-8137.2005.01623.x; Krol J, 2004, J BIOL CHEM, V279, P42230, DOI 10.1074/jbc.M404931200; Legrand S, 2010, GENE, V450, P55, DOI 10.1016/j.gene.2009.10.004; Leple JC, 2007, PLANT CELL, V19, P3669, DOI 10.1105/tpc.107.054148; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; Lohrasebi H, 1999, J WOOD CHEM TECHNOL, V19, P13, DOI 10.1080/02773819909349597; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; McConnell JR, 1998, DEVELOPMENT, V125, P2935; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Mellerowicz EJ, 2008, CURR OPIN PLANT BIOL, V11, P293, DOI 10.1016/j.pbi.2008.03.003; Moon D, 2011, FOR SCI TECHNOL, V7, P53, DOI 10.1080/21580103.2011.572612; Newman LJ, 2000, EXPTL BIOL REV, P437; Nicolas FE, 2008, RNA, V14, P2513, DOI 10.1261/rna.1221108; Novaes E, 2010, PLANT PHYSIOL, V154, P555, DOI 10.1104/pp.110.161281; Oh S, 2003, J EXP BOT, V54, P2709, DOI 10.1093/jxb/erg304; Ohashi-Ito K, 2005, PLANT CELL PHYSIOL, V46, P1646, DOI 10.1093/pcp/pci180; Ong SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S13; Pang SL, 2008, THESIS U KEBANGSAAN; Patzlaff A, 2003, PLANT J, V36, P743, DOI 10.1046/j.1365-313X.2003.01916.x; Pilate G, 2004, CR BIOL, V327, P889, DOI 10.1016/j.crvi.2004.07.006; Pilate G, 2002, NAT BIOTECHNOL, V20, P607, DOI 10.1038/nbt0602-607; Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.010816; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Quentin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000264; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Sibout R, 2008, CURR BIOL, V18, P458, DOI 10.1016/j.cub.2008.02.070; Song CNA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010861; Spicer R, 2010, NEW PHYTOL, V186, P577, DOI 10.1111/j.1469-8137.2010.03236.x; SUNDBERG B, 2000, CELL MOL BIOL WOOD F; TIMELL TE, 1982, WOOD SCI TECHNOL, V16, P83, DOI 10.1007/BF00351097; Timell TE, 1986, COMPRESSION WOOD GYM, P1338; Turner S, 2007, ANNU REV PLANT BIOL, V58, P407, DOI 10.1146/annurev.arplant.57.032905.105236; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Varkonyi-Gasic E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-159; Victor M., 2006, MICRORNAS DIFFERENTI; Voelker SL, 2010, PLANT PHYSIOL, V110, P159; Wang HZ, 2012, MOL PLANT, V5, P297, DOI 10.1093/mp/ssr098; Yeh TF, 2005, HOLZFORSCHUNG, V59, P669, DOI 10.1515/HF.2005.107; Yong SYC, 2011, TREE GENET GENOMES, V7, P143, DOI 10.1007/s11295-010-0321-y; Zhang J, 2010, ACM T SENSOR NETWORK, V7, DOI 10.1145/1806895.1806897; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Zhong R, 2007, PLANT SIGNAL BEHAV, V2, P351, DOI 10.4161/psb.2.5.4119; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	91	27	28	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49662	10.1371/journal.pone.0049662	http://dx.doi.org/10.1371/journal.pone.0049662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23251324	Green Published, gold, Green Submitted			2022-12-27	WOS:000311885800013
J	Geerts, H; Spiros, A; Roberts, P; Twyman, R; Alphs, L; Grace, AA				Geerts, Hugo; Spiros, Athan; Roberts, Patrick; Twyman, Roy; Alphs, Larry; Grace, Anthony A.			Blinded Prospective Evaluation of Computer-Based Mechanistic Schizophrenia Disease Model for Predicting Drug Response	PLOS ONE			English	Article							DOPAMINE-D-2 RECEPTOR-BINDING; ATYPICAL ANTIPSYCHOTICS; SEROTONIN RECEPTOR; IN-VIVO; OCCUPANCY; PROTEIN; D-2; HALOPERIDOL; RISPERIDONE; ANTAGONIST	The tremendous advances in understanding the neurobiological circuits involved in schizophrenia have not translated into more effective treatments. An alternative strategy is to use a recently published 'Quantitative Systems Pharmacology' computer-based mechanistic disease model of cortical/subcortical and striatal circuits based upon preclinical physiology, human pathology and pharmacology. The physiology of 27 relevant dopamine, serotonin, acetylcholine, norepinephrine, gamma-aminobutyric acid (GABA) and glutamate-mediated targets is calibrated using retrospective clinical data on 24 different antipsychotics. The model was challenged to predict quantitatively the clinical outcome in a blinded fashion of two experimental antipsychotic drugs; JNJ37822681, a highly selective low-affinity dopamine D2 antagonist and ocaperidone, a very high affinity dopamine D2 antagonist, using only pharmacology and human positron emission tomography (PET) imaging data. The model correctly predicted the lower performance of JNJ37822681 on the positive and negative syndrome scale (PANSS) total score and the higher extra-pyramidal symptom (EPS) liability compared to olanzapine and the relative performance of ocaperidone against olanzapine, but did not predict the absolute PANSS total score outcome and EPS liability for ocaperidone, possibly due to placebo responses and EPS assessment methods. Because of its virtual nature, this modeling approach can support central nervous system research and development by accounting for unique human drug properties, such as human metabolites, exposure, genotypes and off-target effects and can be a helpful tool for drug discovery and development. Citation: Geerts H, Spiros A, Roberts P, Twyman R, Alphs L, et al. (2012) Blinded Prospective Evaluation of Computer-Based Mechanistic Schizophrenia Disease Model for Predicting Drug Response. PLoS ONE 7(12): e49732. doi:10.1371/journal.pone.0049732	[Geerts, Hugo; Spiros, Athan; Roberts, Patrick] In Silico Biosci, Berwyn, PA USA; [Twyman, Roy] Johnson & Johnson Pharmaceut Res & Dev, Cent Nervous Syst Dev, Titusville, NJ USA; [Alphs, Larry] Janssen Sci Affairs LLC, Titusville, NJ USA; [Grace, Anthony A.] Univ Pittsburgh, Dept Neurosci Psychiat & Psychol, Pittsburgh, PA USA	Johnson & Johnson; Johnson & Johnson USA; Johnson & Johnson; Janssen Pharmaceuticals; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Geerts, H (corresponding author), In Silico Biosci, Berwyn, PA USA.	Hugo-Geerts@In-Silico-Biosciences.com	Alphs, Larry D/O-3683-2017	Grace, Anthony/0000-0003-1864-5504	Johnson Johnson; Lundbeck; Pfizer; GSK; Puretech Ventures; Merck; Takeda; Dainippon Sumimoto; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH057440] Funding Source: NIH RePORTER	Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Lundbeck(Lundbeck Corporation); Pfizer(Pfizer); GSK(GlaxoSmithKline); Puretech Ventures; Merck(Merck & Company); Takeda(Takeda Pharmaceutical Company Ltd); Dainippon Sumimoto; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors have read the journal's policy and have the following conflicts: H.G., A.S. and P.R. are employees of In Silico Biosciences, the funder of this study. R.T. is an employee of J&J, L.A. is an employee of Janssen Scientific Affairs and A.G. is a consultant for J&J and Lundbeck and has financial relationships with Johnson & Johnson, Lundbeck, Pfizer, GSK, Puretech Ventures, Merck, Takeda, and Dainippon Sumimoto. The computer-based platform is covered by the recently granted US patent "Method and apparatus for computer modeling of the interaction between cortical and subcortical areas in the human brain'' - Hugo Geerts, Athan Spiros. PCT/US2006/043887, US patent 8,150,629 B2, granted on April 30, 2012.'' A patent for the composition of matter for JNJ37822681 has been applied for. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abdallah L, 2009, J NEUROSCI, V29, P8156, DOI 10.1523/JNEUROSCI.3905-08.2009; Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Advokat C, 2004, PROG NEURO-PSYCHOPH, V28, P487, DOI 10.1016/j.pnpbp.2003.11.015; Agid O, 2003, ARCH GEN PSYCHIAT, V60, P1228, DOI 10.1001/archpsyc.60.12.1228; Alphs L, 2012, INT J NEUROPSYCHOPH, P1, DOI DOI 10.1017/S1461145711001738; ANDERSEN J, 1990, ACTA PSYCHIAT SCAND, V82, P104, DOI 10.1111/j.1600-0447.1990.tb05299.x; Arvanitis LA, 1997, BIOL PSYCHIAT, V42, P233, DOI 10.1016/S0006-3223(97)00190-X; Aznar S, 2003, BRAIN RES, V959, P58, DOI 10.1016/S0006-8993(02)03727-7; Bamford NS, 2004, J NEUROSCI, V24, P9541, DOI 10.1523/JNEUROSCI.2891-04.2004; Braga MFM, 2004, NEUROPSYCHOPHARMACOL, V29, P45, DOI 10.1038/sj.npp.1300297; Brown P, 2004, EXP NEUROL, V188, P480, DOI 10.1016/j.expneurol.2004.05.009; Carlson CD, 2003, J CLIN PSYCHIAT, V64, P898, DOI 10.4088/JCP.v64n0807; Carr DB, 2002, J NEUROSCI, V22, P6846; Copolov DL, 2000, PSYCHOL MED, V30, P95, DOI 10.1017/S0033291799001476; Davis JM, 2003, ARCH GEN PSYCHIAT, V60, P553, DOI 10.1001/archpsyc.60.6.553; Dayalu P, 2008, EXPERT OPIN PHARMACO, V9, P1451, DOI [10.1517/14656566.9.9.1451, 10.1517/14656566.9.9.1451 ]; Werneck ALD, 2009, ARQ NEURO-PSIQUIAT, V67, P407, DOI 10.1590/S0004-282X2009000300007; Falk T, 2008, NEUROSCIENCE, V155, P114, DOI 10.1016/j.neuroscience.2008.04.075; Foehring RC, 1996, J NEUROPHYSIOL, V75, P648, DOI 10.1152/jn.1996.75.2.648; Geddes J, 2000, BRIT MED J, V321, P1371, DOI 10.1136/bmj.321.7273.1371; Grace AA, 2000, BRAIN RES REV, V31, P330, DOI 10.1016/S0165-0173(99)00049-1; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gruber AJ, 2003, J NEUROPHYSIOL, V90, P1095, DOI 10.1152/jn.00618.2002; Gurevich EV, 1997, ARCH GEN PSYCHIAT, V54, P225; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P1, DOI 10.1038/npp.2009.146; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; HERSCH SM, 1994, J NEUROSCI, V14, P3351; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Jaaro-Peled H, 2010, SCHIZOPHRENIA BULL, V36, P301, DOI 10.1093/schbul/sbp133; Kapur S, 1998, AM J PSYCHIAT, V155, P921, DOI 10.1176/ajp.155.7.921; Kemp AS, 2010, SCHIZOPHRENIA BULL, V36, P504, DOI 10.1093/schbul/sbn110; Koh PO, 2003, ARCH GEN PSYCHIAT, V60, P311, DOI 10.1001/archpsyc.60.3.311; Kuzhikandathil EV, 2002, MOL PHARMACOL, V62, P119, DOI 10.1124/mol.62.1.119; Laakso A, 2001, SCHIZOPHR RES, V52, P115, DOI 10.1016/S0920-9964(00)00095-5; Langlois X, 2012, J PHARMACOL EXP THER, V342, P91, DOI 10.1124/jpet.111.190702; LEYSEN JE, 1992, MOL PHARMACOL, V41, P494; Lieberman Jeffrey A, 2007, J Clin Psychiatry, V68, pe04; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Magnin M, 2000, NEUROSCIENCE, V96, P549, DOI 10.1016/S0306-4522(99)00583-7; Marek GJ, 2001, NEUROSCIENCE, V105, P379, DOI 10.1016/S0306-4522(01)00199-3; MEGENS AAHP, 1992, J PHARMACOL EXP THER, V260, P146; Mermelstein PG, 1998, J NEUROSCI, V18, P6650; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; NORDSTROM AL, 1993, BIOL PSYCHIAT, V33, P227, DOI 10.1016/0006-3223(93)90288-O; Nyberg S, 1998, INT J NEUROPSYCHOPH, V1, P95, DOI 10.1017/S1461145798001229; Perez-Rosello T, 2005, J NEUROPHYSIOL, V93, P2507, DOI 10.1152/jn.00853.2004; Porras G, 2003, EUR J NEUROSCI, V17, P771, DOI 10.1046/j.1460-9568.2003.02512.x; SACHDEV P, 1994, ARCH GEN PSYCHIAT, V51, P963; Samtani MN, 2011, CNS DRUGS, V25, P829, DOI 10.2165/11591690-000000000-00000; Scarr E, 2006, LIFE SCI, V78, P1231, DOI 10.1016/j.lfs.2005.06.038; Schmidt ME, 2012, EUR NEUROPSYCHO 0330; Seeman P, 2002, CAN J PSYCHIAT, V47, P27, DOI 10.1177/070674370204700106; Seeman P, 1999, AM J PSYCHIAT, V156, P876, DOI 10.1176/ajp.156.6.876; Shen WX, 2005, J NEUROSCI, V25, P7449, DOI 10.1523/JNEUROSCI.1381-05.2005; Silvestri S, 2000, PSYCHOPHARMACOLOGY, V152, P174, DOI 10.1007/s002130000532; Sorger P. K., 2011, QUANTITATIVE SYSTEMS; Spiros A, 2012, DRUG DEVELOP RES, V73, P1098; Spiros A, 2010, NEUROPSYCH DIS TREAT, V6, P589, DOI 10.2147/NDT.S12460; Talvik M, 2006, PSYCHIAT RES-NEUROIM, V148, P165, DOI 10.1016/j.pscychresns.2006.05.009; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Tresadern G, 2011, BIOORGAN MED CHEM, V19, P2231, DOI 10.1016/j.bmc.2011.02.033; Turner JA, 2006, NEUROINFORMATICS, V4, P21, DOI 10.1385/NI:4:1:21; Van Oekelen D, 2003, BRAIN RES REV, V42, P123, DOI 10.1016/S0165-0173(03)00153-X	64	28	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e49732	10.1371/journal.pone.0049732	http://dx.doi.org/10.1371/journal.pone.0049732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055AJ	23251349	Green Submitted, Green Published, gold			2022-12-27	WOS:000312386800008
J	Huang, HY; Cheng, YY; Liao, WC; Tien, YW; Yang, CHJ; Hsu, SM; Huang, PH				Huang, Hsin-Yi; Cheng, Yu-Yao; Liao, Wei-Chih; Tien, Yu-Wen; Yang, Chih-Hsin James; Hsu, Su-Ming; Huang, Pei-Hsin			SOX4 Transcriptionally Regulates Multiple SEMA3/Plexin Family Members and Promotes Tumor Growth in Pancreatic Cancer	PLOS ONE			English	Article							IN-VITRO; PROGNOSTIC-SIGNIFICANCE; LUNG-CANCER; CELL-DEATH; EXPRESSION; GENES; CARCINOMA; TARGET; OVEREXPRESSION; SEMAPHORINS	Semaphorin signaling through Plexin frequently participates in tumorigenesis and malignant progression in various types of cancer. In particular, the role of semaphorin signaling in pancreatic ductal adenocarcinoma (PDAC) remains unexplored, despite a high likelihood of metastasis and mortality. Unlike other epithelial malignancies that often express a small number of specific genes in the Semaphorin/Plexin family, five or more are often expressed in human PDAC. Such concomitant expression of these SEMA3/Plexin family members is not a result of gene amplification, but (at least partially) from increased gene transcription activated by SOX4 de novo expressed in PDAC. Via chromatin-immunoprecipitation, luciferase promoter activity assay and electrophoresis mobility shift assay, SOX4 is demonstrated to bind to the consensus site at the promoter of each SEMA3 and Plexin gene to enhance transcription activity. Conversely, RNAi-knockdown of SOX4 in PDAC cell lines results in decreased expression of SEMA3/Plexin family members and is associated with restricted tumor growth both in vitro and in SCID mice. We further demonstrate that SOX4 levels parallel with the summed expression of SEMA3/Plexin family members (P = 0.033, NPar Kruskal-Wallis one-way analysis), which also correlates with poor survival in human PDAC (P = 0.0409, Kaplan-Meier analysis). Intriguingly, miR-129-2 and miR-335, both of which target SOX4 for degradation, are core-pressed in human PDAC cases associated with up-regulated SOX4 in a statistically significant way. In conclusion, we disclose a miR-129-2(miR-335)/SOX4/Semaphorin-Plexin regulatory axis in the tumorigenesis of pancreatic cancer.	[Huang, Hsin-Yi; Hsu, Su-Ming; Huang, Pei-Hsin] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10764, Taiwan; [Huang, Hsin-Yi; Hsu, Su-Ming; Huang, Pei-Hsin] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Cheng, Yu-Yao; Liao, Wei-Chih] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Tien, Yu-Wen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Yang, Chih-Hsin James] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Huang, PH (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10764, Taiwan.	phhuang@ntu.edu.tw		LIAO, WEI-CHIH/0000-0001-5362-6953; Huang, Hsin-Yi/0000-0003-0062-3091; HUANG, PEI-HSIN/0000-0002-2414-1487; TIEN, YU-WEN/0000-0002-9126-2705	National Taiwan University Hospital [NTUH.96-M-037]	National Taiwan University Hospital(National Taiwan University)	This work was supported by National Taiwan University Hospital internal fund granted to P-H Huang and to H-Y Huang (NTUH.96-M-037). The funder had no role in study design, data collection and analysis, decision to publish, or preparation the manuscript.	Aaboe M, 2006, CANCER RES, V66, P3434, DOI 10.1158/0008-5472.CAN-05-3456; Ahn SG, 2002, EXP MOL MED, V34, P243, DOI 10.1038/emm.2002.34; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Baumgart M, 2005, CELL ONCOL, V27, P3; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Bielenberg DR, 2007, CANCER METAST REV, V26, P421, DOI 10.1007/s10555-007-9097-4; Castillo SD, 2012, CANCER RES, V72, P176, DOI 10.1158/0008-5472.CAN-11-3506; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Frierson HF, 2002, AM J PATHOL, V161, P1315, DOI 10.1016/S0002-9440(10)64408-2; Fu BJ, 2008, CANCER BIOL THER, V7, P1593, DOI 10.4161/cbt.7.10.6565; Gaur P, 2009, CLIN CANCER RES, V15, P6763, DOI 10.1158/1078-0432.CCR-09-1810; Hatziapostolou M, 2011, CELL MOL LIFE SCI, V68, P1681, DOI 10.1007/s00018-010-0624-z; Heidenblad M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-3; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Hur EH, 2004, BIOCHEM BIOPH RES CO, V325, P59, DOI 10.1016/j.bbrc.2004.09.215; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Jafarnejad SM, 2010, AM J PATHOL, V177, P2741, DOI 10.2353/ajpath.2010.100377; Jiang SX, 2007, MOL CELL BIOL, V27, P1696, DOI 10.1128/MCB.01760-06; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim EJ, 2011, CURR OPIN GASTROEN, V27, P460, DOI 10.1097/MOG.0b013e328349e31f; Kim HD, 2011, MOL ENDOCRINOL, V25, P1184, DOI 10.1210/me.2010-0332; Kodo K, 2009, P NATL ACAD SCI USA, V106, P13933, DOI 10.1073/pnas.0904744106; Kusy S, 2005, BBA-GENE STRUCT EXPR, V1730, P66, DOI 10.1016/j.bbaexp.2005.05.008; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; Liao YH, 2007, CANCER RES, V67, P11547, DOI 10.1158/0008-5472.CAN-07-1930; Lin BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010210; Lioubinski O, 2003, DEV DYNAM, V227, P402, DOI 10.1002/dvdy.10311; Liu ET, 2008, CURR OPIN GENET DEV, V18, P251, DOI 10.1016/j.gde.2008.07.014; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Moreno CS, 2010, AM J PATHOL, V176, P518, DOI 10.2353/ajpath.2010.090657; Mueller MW, 2007, INT J CANCER, V121, P2421, DOI 10.1002/ijc.22949; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Nissen-Meyer LSH, 2007, J CELL SCI, V120, P2785, DOI 10.1242/jcs.003855; Potzner MR, 2010, DEVELOPMENT, V137, P775, DOI 10.1242/dev.042101; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; Sato N, 2003, CANCER RES, V63, P4158; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Schilham MW, 1997, EUR J IMMUNOL, V27, P1292, DOI 10.1002/eji.1830270534; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Shen RZ, 2010, BIOCHEM BIOPH RES CO, V394, P1047, DOI 10.1016/j.bbrc.2010.03.121; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tsai KW, 2011, INT J CANCER, V129, P2600, DOI 10.1002/ijc.25919; Tseng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019396; van der Weyden L, 2005, GENESIS, V41, P171, DOI 10.1002/gene.20111; Zhang S, 2012, MOL CANCER THER, V11, P108, DOI 10.1158/1535-7163.MCT-11-0548	52	36	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48637	10.1371/journal.pone.0048637	http://dx.doi.org/10.1371/journal.pone.0048637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251334	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200007
J	Mavromatis, K; Land, ML; Brettin, TS; Quest, DJ; Copeland, A; Clum, A; Goodwin, L; Woyke, T; Lapidus, A; Klenk, HP; Cottingham, RW; Kyrpides, NC				Mavromatis, Konstantinos; Land, Miriam L.; Brettin, Thomas S.; Quest, Daniel J.; Copeland, Alex; Clum, Alicia; Goodwin, Lynne; Woyke, Tanja; Lapidus, Alla; Klenk, Hans Peter; Cottingham, Robert W.; Kyrpides, Nikos C.			The Fast Changing Landscape of Sequencing Technologies and Their Impact on Microbial Genome Assemblies and Annotation	PLOS ONE			English	Article							GENERATION	Background: The emergence of next generation sequencing (NGS) has provided the means for rapid and high throughput sequencing and data generation at low cost, while concomitantly creating a new set of challenges. The number of available assembled microbial genomes continues to grow rapidly and their quality reflects the quality of the sequencing technology used, but also of the analysis software employed for assembly and annotation. Methodology/Principal Findings: In this work, we have explored the quality of the microbial draft genomes across various sequencing technologies. We have compared the draft and finished assemblies of 133 microbial genomes sequenced at the Department of Energy-Joint Genome Institute and finished at the Los Alamos National Laboratory using a variety of combinations of sequencing technologies, reflecting the transition of the institute from Sanger-based sequencing platforms to NGS platforms. The quality of the public assemblies and of the associated gene annotations was evaluated using various metrics. Results obtained with the different sequencing technologies, as well as their effects on downstream processes, were analyzed. Our results demonstrate that the Illumina HiSeq 2000 sequencing system, the primary sequencing technology currently used for de novo genome sequencing and assembly at JGI, has various advantages in terms of total sequence throughput and cost, but it also introduces challenges for the downstream analyses. In all cases assembly results although on average are of high quality, need to be viewed critically and consider sources of errors in them prior to analysis. Conclusion: These data follow the evolution of microbial sequencing and downstream processing at the JGI from draft genome sequences with large gaps corresponding to missing genes of significant biological role to assemblies with multiple small gaps (Illumina) and finally to assemblies that generate almost complete genomes (Illumina+PacBio).	[Mavromatis, Konstantinos; Copeland, Alex; Clum, Alicia; Woyke, Tanja; Lapidus, Alla; Kyrpides, Nikos C.] DOE Joint Genome Inst, Walnut Creek, CA USA; [Land, Miriam L.; Brettin, Thomas S.; Quest, Daniel J.; Cottingham, Robert W.] Oak Ridge Natl Lab, Oak Ridge, TN USA; [Goodwin, Lynne] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA; [Klenk, Hans Peter] Leibniz Inst DSMZ German Collect Microorganisms &, Braunschweig, Germany	United States Department of Energy (DOE); United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Mavromatis, K (corresponding author), DOE Joint Genome Inst, Walnut Creek, CA USA.	KMavrommatis@lbl.gov	Kyrpides, Nikos C./A-6305-2014; Lapidus, Alla L/I-4348-2013; Land, Miriam L/A-6200-2011; Cottingham, Robert/D-2628-2014	Kyrpides, Nikos C./0000-0002-6131-0462; Lapidus, Alla L/0000-0003-0427-8731; Land, Miriam L/0000-0001-7102-0031; Cottingham, Robert/0000-0002-2775-3905; Mavrommatis, Konstantinos/0000-0003-4549-385X	US Department of Energy Office of Science, Biological and Environmental Research Program; University of California; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; Oak Ridge National Laboratory [DE-AC05-00OR22725]	US Department of Energy Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California(University of California System); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Oak Ridge National Laboratory(United States Department of Energy (DOE))	This work was performed under the auspices of the US Department of Energy Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract no. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract no. DE-AC02-06NA25396, Oak Ridge National Laboratory under contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Elahi Elahe, 2004, Methods Mol Biol, V255, P211; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Nagarajan N, 2009, J COMPUT BIOL, V16, P897, DOI 10.1089/cmb.2009.0005; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Ribeiro F., 2012, GENOME RES; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112	19	112	114	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48837	10.1371/journal.pone.0048837	http://dx.doi.org/10.1371/journal.pone.0048837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251337	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200011
J	de St Pierre, M; Gandini, F; Perego, UA; Bodner, M; Gomez-Carballa, A; Corach, D; Angerhofer, N; Woodward, SR; Semino, O; Salas, A; Parson, W; Moraga, M; Achilli, A; Torroni, A; Olivieri, A				de St Pierre, Michelle; Gandini, Francesca; Perego, Ugo A.; Bodner, Martin; Gomez-Carballa, Alberto; Corach, Daniel; Angerhofer, Norman; Woodward, Scott R.; Semino, Ornella; Salas, Antonio; Parson, Walther; Moraga, Mauricio; Achilli, Alessandro; Torroni, Antonio; Olivieri, Anna			Arrival of Paleo-Indians to the Southern Cone of South America: New Clues from Mitogenomes	PLOS ONE			English	Article							HUMAN MITOCHONDRIAL-DNA; DEL-FUEGO-PATAGONIA; Y-CHROMOSOME; AMERINDIAN POPULATIONS; EXTINCT ABORIGINES; MTDNA HAPLOGROUPS; GENETIC-STRUCTURE; NEW-WORLD; LINEAGES; HISTORY	With analyses of entire mitogenomes, studies of Native American mitochondrial DNA (mtDNA) variation have entered the final phase of phylogenetic refinement: the dissection of the founding haplogroups into clades that arose in America during and after human arrival and spread. Ages and geographic distributions of these clades could provide novel clues on the colonization processes of the different regions of the double continent. As for the Southern Cone of South America, this approach has recently allowed the identification of two local clades (D1g and D1j) whose age estimates agree with the dating of the earliest archaeological sites in South America, indicating that Paleo-Indians might have reached that region from Beringia in less than 2000 years. In this study, we sequenced 46 mitogenomes belonging to two additional clades, termed B2i2 (former B2l) and C1b13, which were recently identified on the basis of mtDNA control-region data and whose geographical distributions appear to be restricted to Chile and Argentina. We confirm that their mutational motifs most likely arose in the Southern Cone region. However, the age estimate for B2i2 and C1b13 (11-13,000 years) appears to be younger than those of other local clades. The difference could reflect the different evolutionary origins of the distinct South American-specific sub-haplogroups, with some being already present, at different times and locations, at the very front of the expansion wave in South America, and others originating later in situ, when the tribalization process had already begun. A delayed origin of a few thousand years in one of the locally derived populations, possibly in the central part of Chile, would have limited the geographical and ethnic diffusion of B2i2 and explain the present-day occurrence that appears to be mainly confined to the Tehuelche and Araucanian-speaking groups.	[Gandini, Francesca; Perego, Ugo A.; Semino, Ornella; Torroni, Antonio; Olivieri, Anna] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy; [de St Pierre, Michelle] Univ Chile, Fac Ciencias, Dept Ecol, Inst Ecol & Biodiversidad, Santiago, Chile; [de St Pierre, Michelle; Moraga, Mauricio] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Genet Humana, Santiago 7, Chile; [Perego, Ugo A.; Angerhofer, Norman; Woodward, Scott R.] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA; [Bodner, Martin; Parson, Walther] Innsbruck Med Univ, Inst Legal Med, Innsbruck, Austria; [Gomez-Carballa, Alberto; Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Dept Anat Patolox & Ciencias Forenses, Fac Med, Santiago De Compostela, Galicia, Spain; [Gomez-Carballa, Alberto; Salas, Antonio] Univ Santiago de Compostela, Inst Ciencias Forenses, Fac Med, Santiago De Compostela, Galicia, Spain; [Corach, Daniel] Univ Buenos Aires, Fac Farm & Bioquim, Serv Huellas Digitales Genet, RA-1113 Buenos Aires, DF, Argentina; [Angerhofer, Norman; Woodward, Scott R.] AncestryDNA, Provo, UT USA; [Parson, Walther] Penn State Univ, Eberly Coll Sci, University Pk, PA 16802 USA; [Moraga, Mauricio] Univ Chile, Fac Ciencias Sociales, Dept Antropol, Santiago, Chile; [Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy	University of Pavia; Universidad de Chile; Universidad de Chile; Medical University of Innsbruck; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; University of Buenos Aires; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidad de Chile; University of Perugia	Torroni, A (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol, Via Palestro 3, I-27100 Pavia, Italy.	antonio.torroni@unipv.it; anna.olivieri@unipv.it	Achilli, Alessandro/I-9236-2012; Perego, Ugo/AAG-9327-2019; Salas, Antonio/E-3977-2012; Torroni, Antonio/E-1557-2011; de Saint Pierre, Michelle/K-3894-2015; OLIVIERI, ANNA/I-9235-2012; Parson, Walther/AAD-6845-2020; Salas, Antonio/U-2029-2019; Gómez-Carballa, Alberto/I-4610-2014; Gandini, Francesca/H-8936-2015	Achilli, Alessandro/0000-0001-6871-3451; Salas, Antonio/0000-0002-2336-702X; Torroni, Antonio/0000-0002-4163-4478; de Saint Pierre, Michelle/0000-0001-6516-5314; OLIVIERI, ANNA/0000-0002-3941-8098; Salas, Antonio/0000-0002-2336-702X; Gómez-Carballa, Alberto/0000-0003-0927-1272; Gandini, Francesca/0000-0001-8930-8295; Bodner, Martin/0000-0002-3870-9862; SEMINO, Ornella/0000-0002-9675-9403; Parson, Walther/0000-0002-5692-2392; Corach, Daniel/0000-0002-0662-7424	Fondazione Alma Mater Ticinensis; Sorenson Molecular Genealogy Foundation; Ministerio de Ciencia e Innovacion [SAF2011-26983]; Italian Ministry of the University: Progetti Ricerca Interesse Nazionale; FIRB-Futuro in Ricerca (Italian Ministry of the University); CONICYT; MECESUP UCH; Austrian Science Fund (FWF) [P22880-B12]	Fondazione Alma Mater Ticinensis; Sorenson Molecular Genealogy Foundation; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Italian Ministry of the University: Progetti Ricerca Interesse Nazionale; FIRB-Futuro in Ricerca (Italian Ministry of the University); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); MECESUP UCH; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research received support from the Fondazione Alma Mater Ticinensis (to AT and OS), the Sorenson Molecular Genealogy Foundation (to UAP and SRW), the Ministerio de Ciencia e Innovacion grant SAF2011-26983 (to AS), the Italian Ministry of the University: Progetti Ricerca Interesse Nazionale 2009 (to AA, OS and AT) and FIRB-Futuro in Ricerca (Italian Ministry of the University) (to AA and AO). MSP was supported by a doctoral fellowship from CONICYT and an intern scholarship from the MECESUP UCH 0803 project. WP was supported by the Austrian Science Fund (FWF): P22880-B12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Behar DM, 2012, AM J HUM GENET, V90, P486, DOI 10.1016/j.ajhg.2012.01.002; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bodner M, 2012, GENOME RES, V22, P811, DOI 10.1101/gr.131722.111; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Cabana GS, 2006, AM J PHYS ANTHROPOL, V131, P108, DOI 10.1002/ajpa.20410; Catelli ML, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-77; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Bobillo MC, 2010, INT J LEGAL MED, V124, P263, DOI 10.1007/s00414-009-0366-3; Curry A, 2012, NATURE, V485, P30, DOI 10.1038/485030a; Pierre MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043486; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; EMPOP, 2012, EUR DNA PROF GROUP M; Erlandson JM, 2008, J ISL COAST ARCHAEOL, V3, P277; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fagundes NJR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003157; Fix AG, 2005, AM J PHYS ANTHROPOL, V128, P430, DOI 10.1002/ajpa.20230; Forster P, 1996, AM J HUM GENET, V59, P935; Garcia-Bour J, 2004, AM J PHYS ANTHROPOL, V123, P361, DOI 10.1002/ajpa.10337; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Gilbert T., 2008, LOGIC CIRCUITS CARBO, V320, P786; GINTHER C, 1993, EXS, V67, P211; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gomez-Carballa A, 2012, AM J PHYS ANTHROPOL, V147, P78, DOI 10.1002/ajpa.21629; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Hrdlika A., 1925, OLD AM; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Kashani BH, 2012, AM J PHYS ANTHROPOL, V147, P35, DOI 10.1002/ajpa.21614; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kemp BM, 2010, P NATL ACAD SCI USA, V107, P6759, DOI 10.1073/pnas.0905753107; Keyeux G, 2002, HUM BIOL, V74, P211, DOI 10.1353/hub.2002.0022; Kumar S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-293; Lalueza C, 1997, HUM MOL GENET, V6, P41, DOI 10.1093/hmg/6.1.41; Lalueza-Fox C, 2001, ANN HUM GENET, V65, P137, DOI 10.1017/S0003480001008533; Luiselli D, 2000, AM J PHYS ANTHROPOL, V113, P5, DOI 10.1002/1096-8644(200009)113:1<5::AID-AJPA2>3.0.CO;2-U; Malhi RS, 2010, AM J PHYS ANTHROPOL, V141, P494, DOI 10.1002/ajpa.21238; Malhi RS, 2003, AM J PHYS ANTHROPOL, V120, P108, DOI 10.1002/ajpa.10138; Moraga M, 2010, MAGALLANIA, V38, P103, DOI 10.4067/S0718-22442010000200006; Moraga ML, 2000, AM J PHYS ANTHROPOL, V113, P19, DOI 10.1002/1096-8644(200009)113:1<19::AID-AJPA3>3.0.CO;2-X; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; PENA SDJ, 1995, NAT GENET, V11, P15, DOI 10.1038/ng0995-15; Perego UA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038337; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pucciarelli HM, 2006, HOMO, V57, P133, DOI 10.1016/j.jchb.2005.12.003; Raff J, 2010, HUM BIOL, V82, P677, DOI 10.3378/027.082.0510; Ray N, 2010, MOL BIOL EVOL, V27, P337, DOI 10.1093/molbev/msp238; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Rothhammer F, 2001, HIGH ALT MED BIOL, V2, P227, DOI 10.1089/152702901750265323; Rothhammer F, 2009, ANN HUM GENET, V73, P540, DOI 10.1111/j.1469-1809.2009.00537.x; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Salas A, 2008, J HUM GENET, V53, P662, DOI 10.1007/s10038-008-0297-8; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Schurr TG, 2004, ANNU REV ANTHROPOL, V33, P551, DOI 10.1146/annurev.anthro.33.070203.143932; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SMGF, 2012, SOR MOL GEN FDN MIT; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tarazona-Santos E, 2001, AM J HUM GENET, V68, P1485, DOI 10.1086/320601; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; WALLACE DC, 1985, AM J PHYS ANTHROPOL, V68, P149, DOI 10.1002/ajpa.1330680202; WALLACE DC, 1992, HUM BIOL, V64, P403; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Waters MR, 2011, SCIENCE, V331, P1599, DOI 10.1126/science.1201855; Yang NN, 2010, ANN HUM GENET, V74, P525, DOI 10.1111/j.1469-1809.2010.00608.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	81	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51311	10.1371/journal.pone.0051311	http://dx.doi.org/10.1371/journal.pone.0051311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053RN	23240014	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000312290800050
J	Dwivedi, V; Manickam, C; Binjawadagi, B; Joyappa, D; Renukaradhya, GJ				Dwivedi, Varun; Manickam, Cordelia; Binjawadagi, Basavaraj; Joyappa, Dechamma; Renukaradhya, Gourapura J.			Biodegradable Nanoparticle-Entrapped Vaccine Induces Cross-Protective Immune Response against a Virulent Heterologous Respiratory Viral Infection in Pigs	PLOS ONE			English	Article							DENDRITIC CELL MATURATION; SYNDROME VIRUS-VACCINE; INTRANASAL DELIVERY; PORCINE; MICROSPHERES; ANTIGEN; SYSTEM; MICE; IMMUNIZATION; ANTIBODY	Biodegradable nanoparticle-based vaccine development research is unexplored in large animals and humans. In this study, we illustrated the efficacy of nanoparticle-entrapped UV-killed virus vaccine against an economically important respiratory viral disease of pigs called porcine reproductive and respiratory syndrome virus (PRRSV). We entrapped PLGA [poly (lactide-co-glycolides)] nanoparticles with killed PRRSV antigens (Nano-KAg) and detected its phagocytosis by pig alveolar macrophages. Single doses of Nano-KAg vaccine administered intranasally to pigs upregulated innate and PRRSV specific adaptive responses. In a virulent heterologous PRRSV challenge study, Nano-KAg vaccine significantly reduced the lung pathology and viremia, and the viral load in the lungs. Immunologically, enhanced innate and adaptive immune cell population and associated cytokines with decreased secretion of immunosuppressive mediators were observed at both mucosal sites and blood. In summary, we demonstrated the benefits of intranasal delivery of nanoparticle-based viral vaccine in eliciting cross-protective immune response in pigs, a potential large animal model.	[Dwivedi, Varun; Manickam, Cordelia; Binjawadagi, Basavaraj; Renukaradhya, Gourapura J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Dwivedi, Varun; Manickam, Cordelia; Binjawadagi, Basavaraj; Renukaradhya, Gourapura J.] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Joyappa, Dechamma] Indian Vet Res Inst, Foot & Mouth Dis Lab, Hebbal, Bengaluru, India	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Renukaradhya, GJ (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA.	gourapura.1@osu.edu		Gourapura, Renukaradhya/0000-0003-2861-180X	National Pork Board (NPB) [09-213]; United States Department of Agriculture-National Institute of Food and Agriculture PRRSCAP2 [2008-55620-19132]	National Pork Board (NPB); United States Department of Agriculture-National Institute of Food and Agriculture PRRSCAP2	This work was supported by National Pork Board (NPB# 09-213) and United States Department of Agriculture-National Institute of Food and Agriculture PRRSCAP2 (2008-55620-19132) awards to GJR. Salaries and research support were provided by state and federal funds appropriated to Ohio Agricultural Research and Development Center and Public Health Preparedness for Infectious Diseases, The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUADO MT, 1992, IMMUNOBIOLOGY, V184, P113, DOI 10.1016/S0171-2985(11)80470-5; AIBA S, 1992, INT J BIOL MACROMOL, V14, P225, DOI 10.1016/S0141-8130(05)80032-7; Albina E, 1998, J INTERF CYTOK RES, V18, P485, DOI 10.1089/jir.1998.18.485; Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429; Baras B, 1999, INFECT IMMUN, V67, P2643, DOI 10.1128/IAI.67.5.2643-2648.1999; Bassaganya-Riera J, 2004, VIRAL IMMUNOL, V17, P25, DOI 10.1089/088282404322875430; Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0; Carrasco CP, 2001, IMMUNOLOGY, V104, P175, DOI 10.1046/j.1365-2567.2001.01299.x; Cavanagh D, 1997, ARCH VIROL, V142, P629; Christopher-Hennings J, 2001, J VET DIAGN INVEST, V13, P133, DOI 10.1177/104063870101300207; DONE SH, 1995, VET REC, V136, P32, DOI 10.1136/vr.136.2.32; Dwivedi V, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-45; Dwivedi V, 2011, VACCINE, V29, P4058, DOI 10.1016/j.vaccine.2011.03.006; Dwivedi V, 2011, VACCINE, V29, P4067, DOI 10.1016/j.vaccine.2011.03.005; Ganter M, 1997, RES VET SCI, V63, P215, DOI 10.1016/S0034-5288(97)90023-0; Greenway TE, 1998, VACCINE, V16, P1314, DOI 10.1016/S0264-410X(98)00008-5; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Gupta RK, 1998, DEV BIOLOGICALS, V92, P63; HALBUR PG, 1995, VET PATHOL, V32, P200, DOI 10.1177/030098589503200218; Hein WR, 2003, NAT REV IMMUNOL, V3, P79, DOI 10.1038/nri977; HOLMGREN J, 1992, IMMUNOBIOLOGY, V184, P157, DOI 10.1016/S0171-2985(11)80473-0; Holtkamp D., 2011, PRRS COSTS IND 664 M; INABA K, 1993, J EXP MED, V178, P479, DOI 10.1084/jem.178.2.479; Jung K, 2007, J VIROL, V81, P13681, DOI 10.1128/JVI.01702-07; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kim WI, 2007, VET MICROBIOL, V123, P1, DOI 10.1016/j.vetmic.2007.03.007; LeRoith T, 2011, VET IMMUNOL IMMUNOP, V140, P312, DOI 10.1016/j.vetimm.2010.12.011; Li B, 2009, EMERG INFECT DIS, V15, P2032, DOI 10.3201/eid1512.090390; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; MCGHEE JR, 1992, VACCINE, V10, P75, DOI 10.1016/0264-410X(92)90021-B; Mengeling WL, 2003, VET MICROBIOL, V93, P13, DOI 10.1016/S0378-1135(02)00427-3; Mestecky J, 1997, Behring Inst Mitt, P33; Miyake A, 2004, J MED VIROL, V73, P368, DOI 10.1002/jmv.20100; Nagao G, 2011, COLLOID SURFACE B, V84, P317, DOI 10.1016/j.colsurfb.2011.01.018; Nielsen HS, 2001, J GEN VIROL, V82, P1263, DOI 10.1099/0022-1317-82-6-1263; OGRA PL, 1969, J IMMUNOL, V102, P1423; Olin MR, 2005, VIRAL IMMUNOL, V18, P490, DOI 10.1089/vim.2005.18.490; PARK TG, 1994, J CONTROL RELEASE, V30, P161, DOI 10.1016/0168-3659(94)90263-1; Piotrowicz A, 2005, APPL CHEM CHEM ENG, P108; Rajapaksa TE, 2010, J BIOL CHEM, V285, P23739, DOI 10.1074/jbc.M110.126359; Renukaradhya Gourapura J., 2012, Animal Health Research Reviews, V13, P21, DOI 10.1017/S1466252312000023; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Schaumann F, 2004, AM J RESP CRIT CARE, V170, P898, DOI 10.1164/rccm.200403-423OC; Shephard MJ, 2003, RES VET SCI, V74, P187, DOI 10.1016/S0034-5288(02)00180-7; Shibata Y, 1997, INFECT IMMUN, V65, P1734, DOI 10.1128/IAI.65.5.1734-1741.1997; Singh M, 2001, J CONTROL RELEASE, V70, P267, DOI 10.1016/S0168-3659(00)00330-8; Thomas C, 2011, MOL PHARMACEUT, V8, P405, DOI 10.1021/mp100255c; Welsh RM, 1997, IMMUNOL REV, V159, P79, DOI 10.1111/j.1600-065X.1997.tb01008.x; Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798	50	27	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51794	10.1371/journal.pone.0051794	http://dx.doi.org/10.1371/journal.pone.0051794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240064	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800100
J	Lussier, YA; Khodarev, NN; Regan, K; Corbin, K; Li, HQ; Ganai, S; Khan, SA; Gnerlich, J; Darga, TE; Fan, HL; Karpenko, O; Paty, PB; Posner, MC; Chmura, SJ; Hellman, S; Ferguson, MK; Weichselbaum, RR				Lussier, Yves A.; Khodarev, Nikolai N.; Regan, Kelly; Corbin, Kimberly; Li, Haiquan; Ganai, Sabha; Khan, Sajid A.; Gnerlich, Jennifer; Darga, Thomas E.; Fan, Hanli; Karpenko, Oleksiy; Paty, Philip B.; Posner, Mitchell C.; Chmura, Steven J.; Hellman, Samuel; Ferguson, Mark K.; Weichselbaum, Ralph R.			Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs	PLOS ONE			English	Article							BODY RADIATION-THERAPY; GERM-CELL TUMORS; PULMONARY METASTASES; COLORECTAL-CANCER; HEPATIC RESECTION; EXPRESSION; GENE; PHASE; SIGNATURES; PATHOGENESIS	Rationale: Strategies to stage and treat cancer rely on a presumption of either localized or widespread metastatic disease. An intermediate state of metastasis termed oligometastasis(es) characterized by limited progression has been proposed. Oligometastases are amenable to treatment by surgical resection or radiotherapy. Methods: We analyzed microRNA expression patterns from lung metastasis samples of patients with <= 5 initial metastases resected with curative intent. Results: Patients were stratified into subgroups based on their rate of metastatic progression. We prioritized microRNAs between patients with the highest and lowest rates of recurrence. We designated these as high rate of progression (HRP) and low rate of progression (LRP); the latter group included patients with no recurrences. The prioritized microRNAs distinguished HRP from LRP and were associated with rate of metastatic progression and survival in an independent validation dataset. Conclusion: Oligo-and poly-metastasis are distinct entities at the clinical and molecular level.	[Lussier, Yves A.; Weichselbaum, Ralph R.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Lussier, Yves A.] Univ Chicago, Ctr Biomed Informat, Dept Med, Chicago, IL 60637 USA; [Lussier, Yves A.; Khodarev, Nikolai N.; Hellman, Samuel; Weichselbaum, Ralph R.] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA; [Lussier, Yves A.; Regan, Kelly; Li, Haiquan; Fan, Hanli] Univ Illinois, Dept Med, Chicago, IL USA; [Lussier, Yves A.] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Lussier, Yves A.; Karpenko, Oleksiy] Univ Illinois, Ctr Intervent Hlth Informat, Chicago, IL USA; [Lussier, Yves A.] Univ Illinois, Ctr Canc, Chicago, IL USA; [Khodarev, Nikolai N.; Corbin, Kimberly; Chmura, Steven J.; Hellman, Samuel; Weichselbaum, Ralph R.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Ganai, Sabha; Khan, Sajid A.; Gnerlich, Jennifer; Darga, Thomas E.; Posner, Mitchell C.; Ferguson, Mark K.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Paty, Philip B.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Robert H. Lurie Comprehensive Cancer Center; University of Chicago; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Chicago; Memorial Sloan Kettering Cancer Center	Lussier, YA (corresponding author), Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA.	yLussier@uic.edu; rrw@radonc.uchicago.edu	khan, sajid/HGE-2406-2022; Lussier, Yves/N-4891-2017; Chmura, Steven Joseph/ACU-8438-2022; , haiquan/H-3507-2019; Ganai, Sabha/M-8022-2016	Lussier, Yves/0000-0001-9854-1005; , haiquan/0000-0002-8049-0278; Ganai, Sabha/0000-0001-6160-3559; Darga, Thomas/0000-0002-8968-6701; Regan-Fendt, Kelly/0000-0002-7033-6787	Ludwig Center for Metastasis Research Grant; Center for Radiation Therapy; Chicago Tumor Institute; Ludwig Foundation for Cancer Research; Foglia Foundation; Lung Cancer Research Foundation; Cancer Research Foundation; Institutes of Health (NIH) [K22 LM008308-04, 5UL1RR024999-04]; University of Chicago Comprehensive Cancer Center [5P30CA014599-35]; University of Illinois Cancer Center; University of Illinois Center for Clinical and Translational Science [UL1RR029879]; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999, UL1RR029879] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	Ludwig Center for Metastasis Research Grant; Center for Radiation Therapy; Chicago Tumor Institute; Ludwig Foundation for Cancer Research; Foglia Foundation; Lung Cancer Research Foundation; Cancer Research Foundation; Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Comprehensive Cancer Center; University of Illinois Cancer Center; University of Illinois Center for Clinical and Translational Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by the Ludwig Center for Metastasis Research Grant, the Center for Radiation Therapy, the Chicago Tumor Institute, The Ludwig Foundation for Cancer Research, Mr. and Mrs. Vincent Foglia and the Foglia Foundation, Lung Cancer Research Foundation, the Cancer Research Foundation and the following National Institutes of Health (NIH) Grants: K22 LM008308-04, 5UL1RR024999-04, University of Chicago Comprehensive Cancer Center (5P30CA014599-35), the University of Illinois Cancer Center, and the University of Illinois Center for Clinical and Translational Science (UL1RR029879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah-Sayani A, 2006, NAT CLIN PRACT ONCOL, V3, P501, DOI 10.1038/ncponc0587; Brennecke J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-228; Brown RE, 2010, SURG CLIN N AM, V90, P839, DOI 10.1016/j.suc.2010.04.012; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Capulli M, 2012, J BONE MINER RES, V27, P2387, DOI 10.1002/jbmr.1686; Chen J, 2010, J BIOMED INFORM, V43, P385, DOI 10.1016/j.jbi.2010.03.009; de Jong MC, 2009, ANN SURG, V250, P440, DOI 10.1097/SLA.0b013e3181b4539b; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Engels B, 2012, SEMIN CANCER BIOL, V22, P41, DOI 10.1016/j.semcancer.2011.12.008; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FIDLER IJ, 1977, CANCER-AM CANCER SOC, V40, P46, DOI 10.1002/1097-0142(197707)40:1<46::AID-CNCR2820400110>3.0.CO;2-T; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Garcia-Yuste M, 2010, J THORAC ONCOL, V5, pS161, DOI 10.1097/JTO.0b013e3181dcf787; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gupta N, 2006, CLIN CANCER RES, V12, P3115, DOI 10.1158/1078-0432.CCR-05-0513; HELLMAN S, 1995, J CLIN ONCOL, V13, P8, DOI 10.1200/JCO.1995.13.1.8; Hoyer M, 2006, ACTA ONCOL, V45, P823, DOI 10.1080/02841860600904854; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Lee JH, 1997, CANCER RES, V57, P2384; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lussier YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028650; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Metha N, 2004, INT J ONCOL, V25, P1677; Milano MT, 2008, CANCER-AM CANCER SOC, V112, P650, DOI 10.1002/cncr.23209; Morgan SC, 2011, NAT REV CLIN ONCOL, V8, P504, DOI 10.1038/nrclinonc.2011.88; Nichols FC, 2012, THORAC SURG CLIN, V22, P91, DOI 10.1016/j.thorsurg.2011.08.017; NICHOLSON BJ, 1985, IEEE T RELIAB, V34, P227, DOI 10.1109/TR.1985.5222126; Pastorino U, 1997, J THORAC CARDIOV SUR, V113, P37, DOI 10.1016/S0022-5223(97)70397-0; Pitroda SP, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-68; Rusthoven KE, 2009, J CLIN ONCOL, V27, P1579, DOI 10.1200/JCO.2008.19.6386; Salama JK, 2008, CLIN CANCER RES, V14, P5255, DOI 10.1158/1078-0432.CCR-08-0358; Saxman SB, 1998, J CLIN ONCOL, V16, P702, DOI 10.1200/JCO.1998.16.2.702; Seftor EA, 2002, CLIN EXP METASTAS, V19, P233, DOI 10.1023/A:1015591624171; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sousa JF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-19; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang WZ, 2011, INT J CANCER, V129, P1624, DOI 10.1002/ijc.25818; Weichselbaum RR, 2011, NAT REV CLIN ONCOL, V8, P378, DOI 10.1038/nrclinonc.2011.44; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302; Wuttig D, 2009, INT J CANCER, V125, P474, DOI 10.1002/ijc.24353; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang XA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002350	48	158	163	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50141	10.1371/journal.pone.0050141	http://dx.doi.org/10.1371/journal.pone.0050141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251360	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900007
J	Brinkman, DL; Aziz, A; Loukas, A; Potriquet, J; Seymour, J; Mulvenna, J				Brinkman, Diane L.; Aziz, Ammar; Loukas, Alex; Potriquet, Jeremy; Seymour, Jamie; Mulvenna, Jason			Venom Proteome of the Box Jellyfish Chironex fleckeri	PLOS ONE			English	Article							SEA WASP; PARTIAL-PURIFICATION; STATISTICAL-MODEL; HYDRA-VULGARIS; PROTEINS; GENE; IDENTIFICATION; ENVENOMATION; NEMATOCYSTS; DIVERSITY	The nematocyst is a complex intracellular structure unique to Cnidaria. When triggered to discharge, the nematocyst explosively releases a long spiny, tubule that delivers an often highly venomous mixture of components. The box jellyfish, Chironex fleckeri, produces exceptionally potent and rapid-acting venom and its stings to humans cause severe localized and systemic effects that are potentially life-threatening. In an effort to identify toxins that could be responsible for the serious health effects caused by C. fleckeri and related species, we used a proteomic approach to profile the protein components of C. fleckeri venom. Collectively, 61 proteins were identified, including toxins and proteins important for nematocyte development and nematocyst formation (nematogenesis). The most abundant toxins identified were isoforms of a taxonomically restricted family of potent cnidarian proteins. These toxins are associated with cytolytic, nociceptive, inflammatory, dermonecrotic and lethal properties and expansion of this important protein family goes some way to explaining the destructive and potentially fatal effects of C. fleckeri venom. Venom proteins and their post-translational modifications (PTMs) were further characterized using toxin-specific antibodies and phosphoprotein/glycoprotein-specific stains. Results indicated that glycosylation is a common PTM of the toxin family while a lack of cross-reactivity by toxin-specific antibodies infers there is significant divergence in structure and possibly function among family members. This study provides insight into the depth and diversity of protein toxins produced by harmful box jellyfish and represents the first description of a cubozoan jellyfish venom proteome.	[Mulvenna, Jason] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Brinkman, Diane L.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Aziz, Ammar; Loukas, Alex; Potriquet, Jeremy; Seymour, Jamie] James Cook Univ, Queensland Trop Hlth Alliance, Douglas, Qld, Australia; [Seymour, Jamie] Queensland Emergency Med Res Fdn, Milton, Qld, Australia	QIMR Berghofer Medical Research Institute; Australian Institute of Marine Science; James Cook University	Mulvenna, J (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	jason.mulvenna@qimr.edu.au	Brinkman, Diane L/A-1084-2010; Mulvenna, Jason/H-7110-2014; Seymour, Jamie E/C-9748-2013; Loukas, Alex/B-7355-2014	Brinkman, Diane L/0000-0002-6954-7667; Mulvenna, Jason/0000-0003-3521-8061; Seymour, Jamie E/0000-0002-4805-3289; Loukas, Alex/0000-0002-0896-8441	National Health and Medical Research Council, Australia (NHMRC); NHMRC	National Health and Medical Research Council, Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported using infrastructure provided by the Australian Government through the Linkage Infrastructure, Equipment and Facilities scheme from the Australian Research Council. JM is supported by a Career Development Fellowship from the National Health and Medical Research Council, Australia (NHMRC). AL is supported by a senior research fellowship from NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Avila Soria G., 2009, THESIS J COOK U; Baek JH, 2009, ARCH INSECT BIOCHEM, V71, P205, DOI 10.1002/arch.20316; Balasubramanian PG, 2012, J BIOL CHEM, V287, P9672, DOI 10.1074/jbc.M111.328203; BEADNELL CE, 1992, MED J AUSTRALIA, V156, P655, DOI 10.5694/j.1326-5377.1992.tb121467.x; Birrell GW, 2007, MOL CELL PROTEOMICS, V6, P973, DOI 10.1074/mcp.M600419-MCP200; Bloom DA, 1998, TOXICON, V36, P1075, DOI 10.1016/S0041-0101(98)00096-8; Brinkman D, 2008, TOXICON, V51, P853, DOI 10.1016/j.toxicon.2007.12.017; Brinkman D, 2007, TOXICON, V50, P850, DOI 10.1016/j.toxicon.2007.06.016; Brinkman DL, 2009, TOXICON, V54, P1162, DOI 10.1016/j.toxicon.2009.02.006; Casewell NR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-564; Datu BJD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000130; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Engel U, 2002, J CELL SCI, V115, P3923, DOI 10.1242/jcs.00084; Fedders H, 2004, DEV GENES EVOL, V214, P72, DOI 10.1007/s00427-003-0378-9; Fenner PJ, 1996, MED J AUSTRALIA, V165, P658, DOI 10.5694/j.1326-5377.1996.tb138679.x; Halai R, 2009, NAT PROD REP, V26, P526, DOI 10.1039/b819311h; Hidaka Michio, 1993, Advances in Comparative and Environmental Physiology, V15, P45; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hwang JS, 2007, P NATL ACAD SCI USA, V104, P14735, DOI 10.1073/pnas.0703331104; Hwang JS, 2010, P NATL ACAD SCI USA, V107, P18539, DOI 10.1073/pnas.1003256107; Kass-Simon G, 2002, CAN J ZOOL, V80, P1772, DOI 10.1139/Z02-135; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KLUG M, 1991, TOXICON, V29, P129, DOI 10.1016/0041-0101(91)90046-T; Koch AW, 1998, J CELL SCI, V111, P1545; KURZ EM, 1991, J CELL BIOL, V115, P1159, DOI 10.1083/jcb.115.4.1159; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lassen S, 2011, TOXICON, V57, P721, DOI 10.1016/j.toxicon.2011.02.004; Lewis C, 2009, ZOOTAXA, P59, DOI 10.11646/zootaxa.2030.1.5; Lottaz C, 2003, BIOINFORMATICS, V19, pII103, DOI 10.1093/bioinformatics/btg1067; LUMLEY J, 1988, MED J AUSTRALIA, V148, P527, DOI 10.5694/j.1326-5377.1988.tb99466.x; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; Milde S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r8; Mulvenna J, 2009, MOL CELL PROTEOMICS, V8, P109, DOI 10.1074/mcp.M800206-MCP200; Nagai H, 2002, BIOSCI BIOTECH BIOCH, V66, P97, DOI 10.1271/bbb.66.97; Nagai H, 2000, BIOCHEM BIOPH RES CO, V275, P589, DOI 10.1006/bbrc.2000.3352; Nagai H, 2000, BIOCHEM BIOPH RES CO, V275, P582, DOI 10.1006/bbrc.2000.3353; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nuchter T, 2006, CURR BIOL, V16, pR316, DOI 10.1016/j.cub.2006.03.089; Ozbek S, 2009, TOXICON, V54, P1038, DOI 10.1016/j.toxicon.2009.03.006; Pereira P, 2010, CLIN TOXICOL, V48, P390, DOI 10.3109/15563651003662675; Ruyssers NE, 2009, INFLAMM BOWEL DIS, V15, P491, DOI 10.1002/ibd.20787; Seipel K, 2004, INT J DEV BIOL, V48, P1, DOI 10.1387/ijdb.15005568; SLAUTTERBACK DB, 1959, J BIOPHYS BIOCHEM CY, V5, P441, DOI 10.1083/jcb.5.3.441; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P1942, DOI 10.1074/mcp.M600030-MCP200; Steele RE, 2011, TRENDS GENET, V27, P7, DOI 10.1016/j.tig.2010.10.002; Szczepanek S, 2002, J CELL SCI, V115, P745; WEBER J, 1995, ROUX ARCH DEV BIOL, V205, P171, DOI 10.1007/BF00357763; WEBER J, 1994, COMP BIOCHEM PHYS B, V107, P21, DOI 10.1016/0305-0491(94)90220-8	50	45	45	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e47866	10.1371/journal.pone.0047866	http://dx.doi.org/10.1371/journal.pone.0047866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236347	gold, Green Published, Green Accepted			2022-12-27	WOS:000312064100002
J	Tan, L; Lemey, P; Houspie, L; Viveen, MC; Jansen, NJG; van Loon, AM; Wiertz, E; van Bleek, GM; Martin, DP; Coenjaerts, FE				Tan, Lydia; Lemey, Philippe; Houspie, Lieselot; Viveen, Marco C.; Jansen, Nicolaas J. G.; van Loon, Anton M.; Wiertz, Emmanuel; van Bleek, Grada M.; Martin, Darren P.; Coenjaerts, Frank E.			Genetic Variability among Complete Human Respiratory Syncytial Virus Subgroup A Genomes: Bridging Molecular Evolutionary Dynamics and Epidemiology	PLOS ONE			English	Article							CIRCULATION PATTERNS; FUSION PROTEIN; G-GLYCOPROTEIN; GROUP-A; B STRAINS; RS VIRUS; INFECTION; CHILDREN; RECOMBINATION; DISEASE	Human respiratory syncytial virus (RSV) is an important cause of severe lower respiratory tract infections in infants and the elderly. In the vast majority of cases, however, RSV infections run mild and symptoms resemble those of a common cold. The immunological, clinical, and epidemiological profile of severe RSV infections suggests a disease caused by a virus with typical seasonal transmission behavior, lacking clear-cut virulence factors, but instead causing disease by modifying the host's immune response in a way that stimulates pathogenesis. Yet, the interplay between RSV-evoked immune responses and epidemic behavior, and how this affects the genomic evolutionary dynamics of the virus, remains poorly understood. Here, we present a comprehensive collection of 33 novel RSV subgroup A genomes from strains sampled over the last decade, and provide the first measurement of RSV-A genomic diversity through time in a phylodynamic framework. In addition, we map amino acid substitutions per protein to determine mutational hotspots in specific domains. Using Bayesian genealogical inference, we estimated the genomic evolutionary rate to be 6.47x10(-4) (credible interval: 5.56x10(-4), 7.38x10(-4)) substitutions/site/year, considerably slower than previous estimates based on G gene sequences only. The G gene is however marked by elevated substitution rates compared to other RSV genes, which can be attributed to relaxed selective constraints. In line with this, site-specific selection analyses identify the G gene as the major target of diversifying selection. Importantly, statistical analysis demonstrates that the immune driven positive selection does not leave a measurable imprint on the genome phylogeny, implying that RSV lineage replacement mainly follows nonselective epidemiological processes. The roughly 50 years of RSV-A genomic evolution are characterized by a constant population size through time and general co-circulation of lineages over many epidemic seasons - a conclusion that might be taken into account when developing future therapeutic and preventive strategies.	[Tan, Lydia; Viveen, Marco C.; van Loon, Anton M.; Wiertz, Emmanuel; Coenjaerts, Frank E.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Lemey, Philippe; Houspie, Lieselot] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Louvain, Belgium; [Jansen, Nicolaas J. G.; van Bleek, Grada M.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat, Utrecht, Netherlands; [Martin, Darren P.] Univ Cape Town, Fac Hlth Sci, Computat Biol Dept, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	Utrecht University; Utrecht University Medical Center; KU Leuven; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of Cape Town	Coenjaerts, FE (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	f.e.j.coenjaerts@umcutrecht.nl	Martin, Darren/ABE-3614-2021; Martin, Darren P/C-4599-2008; Lemey, Philippe/C-3755-2018	Lemey, Philippe/0000-0003-2826-5353	European Union under project GRACE; EC [LSHM-CT-2005-518226]; European Union [278433-PREDEMICS]; ERC [260864]	European Union under project GRACE; EC(European CommissionEuropean Commission Joint Research Centre); European Union(European Commission); ERC(European Research Council (ERC)European Commission)	The research leading to these results has received funding from the European Union Sixth Framework Programme under the project GRACE, EC Grant Agreement number LSHM-CT-2005-518226 (to FC and MV), as well as the European Union Seventh Framework Programme [FP7/2007-2013] under Grant Agreement no. 278433-PREDEMICS (to PL) and ERC Grant agreement no. 260864 (to PL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors has any relevant financial or nonfinancial relationship to disclose.	ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; ANDERSON LJ, 1991, J INFECT DIS, V163, P687, DOI 10.1093/infdis/163.4.687; Baele G., 2012, MOL BIOL EVOL; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; CANE PA, 1994, J CLIN MICROBIOL, V32, P1; Castilow EM, 2008, J VIROL, V82, P2196, DOI 10.1128/JVI.01949-07; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; ENGLUND JA, 1991, J CLIN MICROBIOL, V29, P115, DOI 10.1128/JCM.29.1.115-119.1991; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; FLEMING DM, 1993, LANCET, V342, P1507, DOI 10.1016/S0140-6736(05)80082-0; FRIEDEWALD WT, 1968, J AMER MED ASSOC, V204, P690, DOI 10.1001/jama.1968.03140210044011; Gaunt ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017427; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; HALL CB, 1990, J INFECT DIS, V162, P1283, DOI 10.1093/infdis/162.6.1283; HENDRY RM, 1989, J INFECT DIS, V160, P185, DOI 10.1093/infdis/160.2.185; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Holmes EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000505; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIM HW, 1971, PEDIATRICS, V48, P745; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Klouwenberg PK, 2009, CRIT REV IMMUNOL, V29, P531, DOI 10.1615/CritRevImmunol.v29.i6.40; Kruijsen D, 2011, VACCINE, V29, P2730, DOI 10.1016/j.vaccine.2011.01.087; Kruijsen D, 2010, J IMMUNOL, V185, P6489, DOI 10.4049/jimmunol.1002645; Kumaria R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-372; Langedijk JPM, 1998, VIROLOGY, V243, P293, DOI 10.1006/viro.1998.9066; Lefeuvre P, 2009, J VIROL, V83, P2697, DOI 10.1128/JVI.02152-08; Lemey P, 2012, BIOINFORMATICS; Lemey P, 2007, PLOS COMPUT BIOL, V3, P282, DOI 10.1371/journal.pcbi.0030029; Martin DP, 2011, MOL ECOL RESOUR, V11, P943, DOI 10.1111/j.1755-0998.2011.03026.x; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin D, 2006, J GEN VIROL, V87, P1649, DOI 10.1099/vir.0.81715-0; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; MUFSON MA, 1988, J INFECT DIS, V157, P143, DOI 10.1093/infdis/157.1.143; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; MURPHY BR, 1988, J CLIN MICROBIOL, V26, P1595, DOI 10.1128/JCM.26.8.1595-1597.1988; MURPHY BR, 1994, VIRUS RES, V32, P13, DOI 10.1016/0168-1702(94)90059-0; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Olson MR, 2007, J IMMUNOL, V179, P5415, DOI 10.4049/jimmunol.179.8.5415; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Plotnicky-Gilquin H, 1999, J VIROL, V73, P5637, DOI 10.1128/JVI.73.7.5637-5645.1999; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468; Rixon HWM, 2002, J GEN VIROL, V83, P61, DOI 10.1099/0022-1317-83-1-61; RUEDA P, 1991, J VIROL, V65, P3374, DOI 10.1128/JVI.65.6.3374-3378.1991; Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262; Siebenga JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000884; Simard C, 1995, ANTIVIR RES, V28, P303, DOI 10.1016/0166-3542(95)00053-4; Spann KM, 2003, J VIROL, V77, P11201, DOI 10.1128/JVI.77.20.11201-11211.2003; Sullender WM, 2000, CLIN MICROBIOL REV, V13, P1, DOI 10.1128/CMR.13.1.1-15.2000; Tang YW, 1997, J CLIN INVEST, V99, P2183, DOI 10.1172/JCI119391; Wertheim JO, 2009, J VIROL, V83, P4690, DOI 10.1128/JVI.02358-08; White LJ, 2007, MATH BIOSCI, V209, P222, DOI 10.1016/j.mbs.2006.08.018; Woelk CH, 2001, J MOL EVOL, V52, P182, DOI 10.1007/s002390010147; WRIGHT PF, 1971, J INFECT DIS, V124, P505, DOI 10.1093/infdis/124.5.505; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Zimmer G, 2001, J VIROL, V75, P4744, DOI 10.1128/JVI.75.10.4744-4751.2001; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005; Zlateva KT, 2004, J VIROL, V78, P4675, DOI 10.1128/JVI.78.9.4675-4683.2004	72	60	65	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51439	10.1371/journal.pone.0051439	http://dx.doi.org/10.1371/journal.pone.0051439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236501	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100119
J	Michel, T; Poli, A; Domingues, O; Mauffray, M; Theresine, M; Brons, NHC; Hentges, F; Zimmer, J				Michel, Tatiana; Poli, Aurelie; Domingues, Olivia; Mauffray, Marion; Theresine, Maud; Brons, Nicolaas H. C.; Hentges, Francois; Zimmer, Jacques			Mouse Lung and Spleen Natural Killer Cells Have Phenotypic and Functional Differences, in Part Influenced by Macrophages	PLOS ONE			English	Article							NK-CELLS; VIRUS INFECTION; INTERLEUKIN-15; MATURATION; TRAFFICKING; EXPRESSION; RECEPTOR; SUBSETS; RAT	NK cells are lymphocytes of the innate immune system which are a first line of defense against infections and tumor cells, in bone marrow and peripheral organs like lung and spleen. The lung is an organ in contact with respiratory pathogens and the site of inflammatory disorders triggered by the respiratory environment. In contrast, spleen is a lymphatic organ connected to the blood system which regulates the systemic immune response. Here we compare NK cell maturation and expansion as well as expression of NK cell receptors in spleen and lung compartments. We show that spleen and lung NK cells differ in phenotypic and functional characteristics due to a difference of maturity and cellular microenvironment. Indeed we observe that spleen and lung macrophages have the capacity to influence the cytotoxicity of NK cells by cell-to-cell contact. This suggests that the differences of NK cell subsets are in part due to a modulation by the organ environment.	[Michel, Tatiana; Poli, Aurelie; Domingues, Olivia; Mauffray, Marion; Theresine, Maud; Hentges, Francois; Zimmer, Jacques] Ctr Rech Publ Sante CRP Sante, Lab Immunogenet & Allergol, Luxembourg, Luxembourg; [Brons, Nicolaas H. C.] Ctr Rech Publ Sante CRP Sante, Core Facil Flow Cytometry, Luxembourg, Luxembourg	Luxembourg Institute of Health; Luxembourg Institute of Health	Michel, T (corresponding author), Ctr Rech Publ Sante CRP Sante, Lab Immunogenet & Allergol, Luxembourg, Luxembourg.	tatiana.michel@crp-sante.lu		Michel, Tatiana/0000-0002-0146-9236; Zimmer, Jacques/0000-0002-7118-6944; Poli, Aurelie/0000-0002-7986-0761	Ministry of Higher Education and Research of Luxembourg; FNR (Fond National de la Recherche), Luxembourg	Ministry of Higher Education and Research of Luxembourg; FNR (Fond National de la Recherche), Luxembourg(Luxembourg National Research Fund)	This work was supported by the Ministry of Higher Education and Research of Luxembourg and by a grant from the FNR (Fond National de la Recherche), Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2006, CLIN EXP IMMUNOL, V143, P180, DOI 10.1111/j.1365-2249.2005.02976.x; Baratin M, 2005, P NATL ACAD SCI USA, V102, P14747, DOI 10.1073/pnas.0507355102; BORDIGNON C, 1982, CLIN EXP IMMUNOL, V47, P437; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Culley FJ, 2009, IMMUNOLOGY, V128, P151, DOI 10.1111/j.1365-2567.2009.03167.x; Doherty TM, 1996, J IMMUNOL, V156, P735; Grant LR, 2008, GENES IMMUN, V9, P316, DOI 10.1038/gene.2008.20; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Grundy MA, 2006, EXP CELL RES, V312, P3920, DOI 10.1016/j.yexcr.2006.08.019; Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Hazeldine J, 2012, AGING CELL; Hochweller K, 2008, EUR J IMMUNOL, V38, P2776, DOI 10.1002/eji.200838659; Hocke AC, 2007, CYTOKINE, V38, P61, DOI 10.1016/j.cyto.2007.05.009; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Nedvetzki S, 2007, BLOOD, V109, P3776, DOI 10.1182/blood-2006-10-052977; Poli A, 2010, IMMUNOLOGY; Prlic M, 2005, J IMMUNOL, V175, P2152, DOI 10.4049/jimmunol.175.4.2152; Raulet DH, 2004, NAT IMMUNOL, V5, P996, DOI 10.1038/ni1114; REYNOLDS CW, 1981, J NATL CANCER I, V66, P837; Robbins SH, 2004, J IMMUNOL, V173, P259, DOI 10.4049/jimmunol.173.1.259; STEINSTREILEIN J, 1983, J IMMUNOL, V131, P2699; Takeda K, 2000, J IMMUNOL, V164, P1741, DOI 10.4049/jimmunol.164.4.1741; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Wang J, 2012, IMMUNOLOGY; WEISSMAN DN, 1986, J ALLERGY CLIN IMMUN, V78, P571, DOI 10.1016/0091-6749(86)90073-4; ZOLLER M, 1982, IMMUNOBIOLOGY, V163, P497	31	30	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51230	10.1371/journal.pone.0051230	http://dx.doi.org/10.1371/journal.pone.0051230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227255	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200114
J	Sailasuta, N; Ross, W; Ananworanich, J; Chalermchai, T; DeGruttola, V; Lerdlum, S; Pothisri, M; Busovaca, E; Ratto-Kim, S; Jagodzinski, L; Spudich, S; Michael, N; Kim, JH; Valcour, V				Sailasuta, Napapon; Ross, William; Ananworanich, Jintanat; Chalermchai, Thep; DeGruttola, Victor; Lerdlum, Sukalaya; Pothisri, Mantana; Busovaca, Edgar; Ratto-Kim, Silvia; Jagodzinski, Linda; Spudich, Serena; Michael, Nelson; Kim, Jerome H.; Valcour, Victor		RV254 SEARCH 010 Protocol Teams	Change in Brain Magnetic Resonance Spectroscopy after Treatment during Acute HIV Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS DEMENTIA COMPLEX; MR SPECTROSCOPY; NEUROTOXICITY; IMPAIRMENT; METABOLISM; GLUTAMATE; REGION	Objective: Single voxel proton magnetic resonance spectroscopy (MRS) can be used to monitor changes in brain inflammation and neuronal integrity associated with HIV infection and its treatments. We used MRS to measure brain changes during the first weeks following HIV infection and in response to antiretroviral therapy (ART). Methods: Brain metabolite levels of N-acetyl aspartate (NAA), choline (tCHO), creatine (CR), myoinositol (MI), and glutamate and glutamine (GLX) were measured in acute HIV subjects (n = 31) and compared to chronic HIV+ individuals (n = 26) and HIV negative control subjects (n = 10) from Bangkok, Thailand. Metabolites were measured in frontal gray matter (FGM), frontal white matter (FWM), occipital gray matter (OGM), and basal ganglia (BG). Repeat measures were obtained in 17 acute subjects 1, 3 and 6 months following initiation of ART. Results: After adjustment for age we identified elevated BG tCHO/CR in acute HIV cases at baseline (median 14 days after HIV infection) compared to control (p = 0.0014), as well as chronic subjects (p = 0.0023). A similar tCHO/CR elevation was noted in OGM; no other metabolite abnormalities were seen between acute and control subjects. Mixed longitudinal models revealed resolution of BG tCHO/CR elevation after ART (p = 0.022) with tCHO/CR similar to control subjects at 6 months. Interpretation: We detected cellular inflammation in the absence of measurable neuronal injury within the first month of HIV infection, and normalization of this inflammation following acutely administered ART. Our findings suggest that early ART may be neuroprotective in HIV infection by mitigating processes leading to CNS injury.	[Busovaca, Edgar; Valcour, Victor] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Sailasuta, Napapon; Ross, William] Huntington Med Res Inst, Pasadena, CA USA; [Ananworanich, Jintanat; Chalermchai, Thep] SE Asia Res Collaborat Hawaii SEARCH Thailand, Bangkok, Thailand; [Ananworanich, Jintanat; Lerdlum, Sukalaya; Pothisri, Mantana] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand; [Ananworanich, Jintanat] Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand; [Ratto-Kim, Silvia; Jagodzinski, Linda; Michael, Nelson; Kim, Jerome H.] Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD USA; [DeGruttola, Victor] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Spudich, Serena] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Valcour, Victor] Univ Calif San Francisco, Dept Med, Div Geriatr Med, San Francisco, CA USA	University of California System; University of California San Francisco; Huntington Medical Research Institutes; Chulalongkorn University; Thai Red Cross Society; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Harvard University; Harvard T.H. Chan School of Public Health; Yale University; University of California System; University of California San Francisco	Valcour, V (corresponding author), Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA.	vvalcour@memory.ucsf.edu	Ananworanich, Jintanat/AAC-6348-2021	Ananworanich, Jintanat/0000-0003-1369-3224; Ratto-Kim, Silvia/0000-0003-2025-6399; Chalermchai, Thep/0000-0001-7839-7835	National Institutes of Health [R21-MH086341, R01-MH095613, R01-NS061696, R01-NS053359]; U.S. Military HIV Research Program [W81XWH-07-2-0067]; National Cancer Institute [HHSN261200800001E]; Vaccine and Gene Therapy Institute; Gilead; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095613, R21MH086341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053359, R01NS061696] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Military HIV Research Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vaccine and Gene Therapy Institute; Gilead(Gilead Sciences); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institutes of Health grants R21-MH086341 (VV), R01-MH095613 (VV), R01-NS061696 (VV), R01-NS053359 (SRK), the U.S. Military HIV Research Program (W81XWH-07-2-0067), the National Cancer Institute (Contract No. HHSN261200800001E), and an intramural grant from the Vaccine and Gene Therapy Institute. Antiretroviral therapy was supported by Gilead (Truvada (R), Atripla (R)), Merck (Sustiva (R), Isentress (R)) and Pfizer (Selzentry (R)). Monogram Biosciences supported the Trofile (R) test. The URLs are as follows: NIH: www.nih.gov, U. S. Military HIV Research Program: www.hivresearch.org, National Cancer Institute: www.cancer.gov, Vaccine and Gene Therapy Institute: www.vgtifl.org, Gilead: www.gilead.com, Merck: www.merck.com, Pfizer: www.pfizer.com, and Monogram Biosciences: www.monogrambio.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: SEARCH received a grant from Gilead. Antiretroviral therapy was supported by Gilead (Truvada (R), Atripla (R)), Merck (Sustiva (R), Isentress (R)) and Pfizer (Selzentry (R)). Monogram Biosciences supported the Trofile (R) test. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Budka H, 1991, BRAIN PATHOL, V1, P163, DOI 10.1111/j.1750-3639.1991.tb00656.x; CHAKRABARTI L, 1991, AM J PATHOL, V139, P1273; Cohen RA, 2010, J NEUROVIROL, V16, P435, DOI 10.3109/13550284.2010.520817; Ellis RJ, 2002, ARCH NEUROL-CHICAGO, V59, P923, DOI 10.1001/archneur.59.6.923; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Grachev ID, 2000, NEUROIMAGE, V11, P554, DOI 10.1006/nimg.2000.0557; Grovit-Ferbas K, 2010, IMMUNOL RES, V48, P40, DOI 10.1007/s12026-010-8166-x; Jiang ZG, 2001, J NEUROIMMUNOL, V117, P97, DOI 10.1016/S0165-5728(01)00315-0; Lentz MR, 2009, NEUROLOGY, V72, P1465, DOI 10.1212/WNL.0b013e3181a2e90a; Lentz MR, 2011, J NEUROVIROL, V17, P220, DOI 10.1007/s13365-011-0030-9; MEYERHOFF DJ, 1994, MAGN RESON IMAGING, V12, P653, DOI 10.1016/0730-725X(94)92460-0; O'Donnell LA, 2006, J NEUROSCI, V26, P981, DOI 10.1523/JNEUROSCI.4617-05.2006; Paley M, 1996, AIDS RES HUM RETROV, V12, P213, DOI 10.1089/aid.1996.12.213; Paul RH, 2007, J NEUROPSYCH CLIN N, V19, P283, DOI 10.1176/appi.neuropsych.19.3.283; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Ragin A, 2011, ABSTRACT 55LB VIRAL; Ratai EM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-63; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Ross B, 2001, ANAT RECORD, V265, P54, DOI 10.1002/ar.1058; Sailasuta N, 2009, NMR BIOMED, V22, P326, DOI 10.1002/nbm.1329; Schirmer T, 2000, NMR BIOMED, V13, P28, DOI 10.1002/(SICI)1099-1492(200002)13:1<28::AID-NBM606>3.0.CO;2-L; TALLAN HH, 1957, J BIOL CHEM, V224, P41; (UNAIDS) JUNPoHA, 2010, GLOB REP UNAIDS REP; Valcour V, 2012, JID IN PRESS; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Wilkinson ID, 1997, AIDS, V11, P289, DOI 10.1097/00002030-199703110-00005; Wright SM, 1997, NMR BIOMED, V10, P394, DOI 10.1002/(SICI)1099-1492(199712)10:8<394::AID-NBM494>3.0.CO;2-0; Yiannoutsos CT, 2004, NEUROIMAGE, V23, P928, DOI 10.1016/j.neuroimage.2004.07.033	30	79	83	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49272	10.1371/journal.pone.0049272	http://dx.doi.org/10.1371/journal.pone.0049272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23229129	Green Published, gold, Green Submitted			2022-12-27	WOS:000311885300023
J	Hatch, SL; Woodhead, C; Frissa, S; Fear, NT; Verdecchia, M; Stewart, R; Reichenberg, A; Morgan, C; Bebbington, P; McManus, S; Brugha, T; Kankulu, B; Clark, JL; Gazard, B; Medcalf, R; Hotopf, M				Hatch, Stephani L.; Woodhead, Charlotte; Frissa, Souci; Fear, Nicola T.; Verdecchia, Maria; Stewart, Robert; Reichenberg, Abraham; Morgan, Craig; Bebbington, Paul; McManus, Sally; Brugha, Traolach; Kankulu, Bwalya; Clark, Jennifer L.; Gazard, Billy; Medcalf, Robert; Hotopf, Matthew		SELCoH Study Team	Importance of Thinking Locally for Mental Health: Data from Cross-Sectional Surveys Representing South East London and England	PLOS ONE			English	Article							PSYCHIATRIC MORBIDITY; NEUROTIC DISORDERS; GREAT-BRITAIN; POPULATION; DEPRESSION; PREVALENCE; EPIDEMIOLOGY; COMMUNITY; CARE	Background: Reliance on national figures may be underestimating the extent of mental ill health in urban communities. This study demonstrates the necessity for local information on common mental disorder (CMD) and substance use by comparing data from the South East London Community Health (SELCoH) study with those from a national study, the 2007 English Adult Psychiatric Morbidity Study (APMS). Methodology/Principal Findings: Data were used from two cross-sectional surveys, 1698 men and women residing in south London and 7403 men and women in England. The main outcome, CMD, was indicated by a score of 12 or above on the Revised Clinical Interview Schedule. Secondary outcomes included hazardous alcohol use and illicit drug use. SELCoH sample prevalence estimates of CMD were nearly twice that of the APMS England sample estimates. There was a four-fold greater proportion of depressive episode in the SELCoH sample than the APMS sample. The prevalence of hazardous alcohol use was higher in the national sample. Illicit drug use in the past year was higher in the SELCoH sample, with cannabis and cocaine the illicit drugs reported most frequently in both samples. In comparisons of the SELCoH sample with the APMS England sample and the APMS sample from the Greater London area in combined datasets, these differences remained after adjusting for socio-demographic and socioeconomic indicators for all outcomes. Conclusions/Significance: Local information for estimating the prevalence of CMD and substance use is essential for surveillance and service planning. There were similarities in the demographic and socioeconomic factors related to CMD and substance use across samples.	[Hatch, Stephani L.; Woodhead, Charlotte; Frissa, Souci; Verdecchia, Maria; Reichenberg, Abraham; Kankulu, Bwalya; Clark, Jennifer L.; Gazard, Billy; Medcalf, Robert; Hotopf, Matthew] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Fear, Nicola T.] Kings Coll London, Acad Ctr Def Mental Hlth, London WC2R 2LS, England; [Stewart, Robert] Kings Coll London, Epidemiol Sect, Hlth Serv, London WC2R 2LS, England; [Stewart, Robert; Morgan, Craig] Inst Psychiat, Populat Res Dept, London, England; [Morgan, Craig] Kings Coll London, Sect Social Psychiat, Hlth Serv, London WC2R 2LS, England; [Bebbington, Paul] UCL, Dept Mental Hlth Sci, London, England; [McManus, Sally] Natl Ctr Social Res, London, England; [Brugha, Traolach] Leicester Gen Hosp, Dept Hlth Sci, New Acad Unit, Leicester LE5 4PW, Leics, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; University College London; University Hospitals of Leicester NHS Trust; Leicester General Hospital	Hatch, SL (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	stephani.hatch@kcl.ac.uk	Brugha, Traolach/T-9326-2019; Hatch, Stephani L/B-4235-2010; McManus, Sally/HGD-4860-2022; Medcalf, Robert L/E-9632-2011; McManus, Sally/S-4697-2019; Reichenberg, Abraham/GQB-1227-2022; Stewart, Robert/B-1667-2010; Fear, Nicola/A-1917-2012; Bebbington, Paul Ernest/C-1939-2008; Hotopf, Matthew/E-4971-2010; Morgan, Craig/B-2100-2010	Brugha, Traolach/0000-0002-9786-9591; McManus, Sally/0000-0003-2711-0819; Stewart, Robert/0000-0002-4435-6397; Fear, Nicola/0000-0002-5792-2925; Bebbington, Paul Ernest/0000-0002-6030-7456; Morgan, Craig/0000-0002-1386-2369; Hatch, Stephani/0000-0001-9103-2427; Hotopf, Matthew/0000-0002-3980-4466; Gazard, Billy/0000-0002-7562-5393	Biomedical Research Nucleus data management and informatics facility at South London; Maudsley NHS Foundation Trust; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London; King's College London; Guy's and St Thomas' Charity; Maudsley Charity; Department of Health	Biomedical Research Nucleus data management and informatics facility at South London; Maudsley NHS Foundation Trust; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); King's College London(General Electric); Guy's and St Thomas' Charity; Maudsley Charity; Department of Health	This research was supported by the Biomedical Research Nucleus data management and informatics facility at South London and Maudsley NHS Foundation Trust, which is funded by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London and a joint infrastructure grant from Guy's and St Thomas' Charity and the Maudsley Charity. These funders had no involvement in study design, data collection, analysis or the decision to submit for publication. The Department of Health funded the APMS 2007 and had no involvement in study design, data collection, analysis or the decision to submit for publication.	Bebbington PE, 2000, PSYCHOL MED, V30, P1359, DOI 10.1017/S0033291799002950; Bebbington PE, 2000, PSYCHOL MED, V30, P1369, DOI 10.1017/S0033291799002974; BEBBINGTON PE, 1981, SOC PSYCHIATR, V16, P43, DOI 10.1007/BF00578068; Brugha T, 2009, ADULT PSYCHIAT MORBI; Brugha TS, 1999, PSYCHOL MED, V29, P1013, DOI 10.1017/S0033291799008880; Coulthard M, 2002, TOBACCO ALCOHOL DRUG; Das-Munshi J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5367; Dye C, 2008, SCIENCE, V319, P766, DOI 10.1126/science.1150198; Eaton WW, 2008, EPIDEMIOL REV, V30, P1, DOI 10.1093/epirev/mxn011; Galea S, 2005, J EPIDEMIOL COMMUN H, V59, P822, DOI 10.1136/jech.2005.033084; Galea S, 2005, ANNU REV PUBL HEALTH, V26, P341, DOI 10.1146/annurev.publhealth.26.021304.144708; Galea S, 2004, EPIDEMIOL REV, V26, P36, DOI 10.1093/epirev/mxh007; Galea S, 2007, ANN EPIDEMIOL, V17, P171, DOI 10.1016/j.annepidem.2006.07.008; Glover G, 2004, SOC PSYCH PSYCH EPID, V39, P730, DOI 10.1007/s00127-004-0779-8; Hatch SL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-861; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Jenkins R, 2003, INT REV PSYCHIATR, V15, P188, DOI 10.1080/0954026021000046164; Jenkins R, 1997, PSYCHOL MED, V27, P765, DOI 10.1017/S003329179700531X; Kirkbride JB, 2007, SOC PSYCH PSYCH EPID, V42, P438, DOI 10.1007/s00127-007-0193-0; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Lorant V, 2007, BRIT J PSYCHIAT, V190, P293, DOI 10.1192/bjp.bp.105.020040; Midanik LT, 2007, DRUG ALCOHOL DEPEN, V90, P72, DOI 10.1016/j.drugalcdep.2007.02.024; Paykel ES, 2000, PSYCHOL MED, V30, P269, DOI 10.1017/S003329179900183X; Peen J, 2007, SOC PSYCH PSYCH EPID, V42, P984, DOI 10.1007/s00127-007-0256-2; Reijneveld SA, 1998, J EPIDEMIOL COMMUN H, V52, P2, DOI 10.1136/jech.52.1.2; Rezaeian M, 2004, SOC PSYCH PSYCH EPID, V39, P947, DOI 10.1007/s00127-004-0829-2; Singleton N, 2003, INT REV PSYCHIATR, V15, P65, DOI 10.1080/0954026021000045967; StataCorp, 2021, STATA STAT SOFTWARE; Stuckler D, 2011, DEPRESSION AMIDST DE; Uutela A, 2010, CURR OPIN PSYCHIATR, V23, P127, DOI 10.1097/YCO.0b013e328336657d; Weich S, 2003, AM J EPIDEMIOL, V157, P730, DOI 10.1093/aje/kwg035; Whitley R, 2005, J EPIDEMIOL COMMUN H, V59, P893, DOI 10.1136/jech.2004.030353; World Health Organization website, 2011, IMP EC CRIS MENT HLT	34	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48012	10.1371/journal.pone.0048012	http://dx.doi.org/10.1371/journal.pone.0048012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251330	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000313236200004
J	Li, K; Jiang, TY; Yu, B; Wang, LM; Gao, C; Ma, CQ; Xu, P; Ma, YH				Li, Kun; Jiang, Tianyi; Yu, Bo; Wang, Limin; Gao, Chao; Ma, Cuiqing; Xu, Ping; Ma, Yanhe			Transcription Elongation Factor GreA Has Functional Chaperone Activity	PLOS ONE			English	Article							CLEAVAGE FACTORS GREA; PAPD-LIKE CHAPERONES; ESCHERICHIA-COLI; RNA-POLYMERASE; CRYSTAL-STRUCTURE; HIGH-TEMPERATURE; SALT TOLERANCE; PROTEIN; STRESS; HEAT	Background: Bacterial GreA is an indispensable factor in the RNA polymerase elongation complex. It plays multiple roles in transcriptional elongation, and may be implicated in resistance to various stresses. Methodology/Principal Findings: In this study, we show that Escherichia coli GreA inhibits aggregation of several substrate proteins under heat shock condition. GreA can also effectively promote the refolding of denatured proteins. These facts reveal that GreA has chaperone activity. Distinct from many molecular chaperones, GreA does not form stable complexes with unfolded substrates. GreA overexpression confers the host cells with enhanced resistance to heat shock and oxidative stress. Moreover, GreA expression in the greA/greB double mutant could suppress the temperature-sensitive phenotype, and dramatically alleviate the in vivo protein aggregation. The results suggest that bacterial GreA may act as chaperone in vivo. Conclusions/Significance: These results suggest that GreA, in addition to its function as a transcription factor, is involved in protection of cellular proteins against aggregation.	[Li, Kun; Yu, Bo; Wang, Limin; Ma, Yanhe] Chinese Acad Sci, Natl Engn Lab Ind Enzymes, Inst Microbiol, Beijing, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Li, Kun; Jiang, Tianyi; Gao, Chao; Ma, Cuiqing; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Li, Kun] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shandong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, P (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	pingxu@sjtu.edu.cn	MA, YAN/HHN-2912-2022	Gao, Chao/0000-0002-5205-0670; Ma, Cuiqing/0000-0002-7468-1027	National Basic Research Program of China [2011CBA00800]; Chinese National Programs for High Technology Research [2011AA02A202, 2011AA02A207]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Programs for High Technology Research	The work was supported by National Basic Research Program of China (2011CBA00800) and Chinese National Programs for High Technology Research (2011AA02A202 and 2011AA02A207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart MM, 2000, P NATL ACAD SCI USA, V97, P7709, DOI 10.1073/pnas.130183897; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Bitto E, 2008, J BIOL CHEM, V283, P30184, DOI 10.1074/jbc.M804746200; BORUKHOV S, 1992, P NATL ACAD SCI USA, V89, P8899, DOI 10.1073/pnas.89.19.8899; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; CAI H, 1994, J BIOL CHEM, V269, P24550; Caldas T, 2000, J BIOL CHEM, V275, P855, DOI 10.1074/jbc.275.2.855; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Chaurasia AK, 2009, APPL ENVIRON MICROB, V75, P6008, DOI 10.1128/AEM.00838-09; Doherty GP, 2006, J BACTERIOL, V188, P4101, DOI 10.1128/JB.01934-05; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HSU LM, 1995, P NATL ACAD SCI USA, V92, P11588, DOI 10.1073/pnas.92.25.11588; Huo YW, 2010, STRUCTURE, V18, P1270, DOI 10.1016/j.str.2010.07.009; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Jofre A, 2003, PLANTA, V217, P813, DOI 10.1007/s00425-003-1048-x; Kawamoto J, 2007, EXTREMOPHILES, V11, P819, DOI 10.1007/s00792-007-0098-6; Kern R, 2003, BIOCHEM J, V371, P965, DOI 10.1042/BJ20030093; Knight SD, 2002, ACTA CRYSTALLOGR D, V58, P1016, DOI 10.1107/S0907444902005954; Kotlyar AB, 2010, FEBS LETT, V584, P159, DOI 10.1016/j.febslet.2009.11.022; Lamour V, 2006, J MOL BIOL, V356, P179, DOI 10.1016/j.jmb.2005.10.083; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Len ACL, 2004, MICROBIOL-SGM, V150, P1339, DOI 10.1099/mic.0.27008-0; Montero-Barrientos M, 2007, CURR GENET, V52, P45, DOI 10.1007/s00294-007-0140-3; Nogales J, 2002, MOL PLANT MICROBE IN, V15, P225, DOI 10.1094/MPMI.2002.15.3.225; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Quigley PM, 2004, PROTEIN SCI, V13, P269, DOI 10.1110/ps.03399604; Sauer FG, 2000, SEMIN CELL DEV BIOL, V11, P27, DOI 10.1006/scdb.1999.0348; Singh R, 2002, FEBS LETT, V527, P234, DOI 10.1016/S0014-5793(02)03243-X; SPARKOWSKI J, 1990, NUCLEIC ACIDS RES, V18, P6443, DOI 10.1093/nar/18.21.6443; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Trautinger BW, 2002, EMBO J, V21, P6944, DOI 10.1093/emboj/cdf654; Wei W, 2004, LETT APPL MICROBIOL, V39, P278, DOI 10.1111/j.1472-765X.2004.01577.x	36	21	23	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e47521	10.1371/journal.pone.0047521	http://dx.doi.org/10.1371/journal.pone.0047521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251328	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200002
J	Roberts, SE; Button, LA; Williams, JG				Roberts, Stephen E.; Button, Lori A.; Williams, John G.			Prognosis following Upper Gastrointestinal Bleeding	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; POPULATION-BASED COHORT; NONVARICEAL UPPER; HOSPITAL ADMISSION; ENGLISH POPULATION; NATIONWIDE COHORT; LIVER-CIRRHOSIS; RECORD LINKAGE; HEMORRHAGE; OUTCOMES	Background: Upper gastrointestinal (GI) bleeding is one of the most common, high risk emergency disorders in the western world. Almost nothing has been reported on longer term prognosis following upper GI bleeding. The aim of this study was to establish mortality up to three years following hospital admission with upper GI bleeding and its relationship with aetiology, co-morbidities and socio-demographic factors. Methods: Systematic record linkage of hospital inpatient and mortality data for 14 212 people in Wales, UK, hospitalised with upper GI bleeding between 1999 and 2004 with three year follow-up to 2007. The main outcome measures were mortality rates, standardised mortality ratios (SMRs) and relative survival. Results: Mortality at three years was 36.7% overall, based on 5215 fatalities. It was highest for upper GI malignancy (95% died within three years) and varices (52%). Compared with the general population, mortality was increased 27-fold during the first month after admission. It fell to 4.3 by month four, but remained significantly elevated during every month throughout the three years following admission. The most important independent prognostic predictors of mortality at three years were older age (mortality increased 53 fold for people aged 85 years and over compared with those under 40 years); oesophageal and gastric/duodenal malignancy (48 and 32 respectively) and gastric varices aetiologies (2.8) when compared with other bleeds; non-upper GI malignancy, liver disease and renal failure co-morbidities (15, 7.9 and 3.9); social deprivation (29% increase for quintile V vs I); incident bleeds as an inpatient (31% vs admitted with bleeding) and male patients (25% vs female). Conclusion: Our study shows a high late as well as early mortality for upper GI bleeding, with very poor longer term prognosis following bleeding due to malignancies and varices. Aetiologies with the worst prognosis were often associated with high levels of social deprivation.	[Roberts, Stephen E.; Button, Lori A.; Williams, John G.] Swansea Univ, Coll Med, Swansea, W Glam, Wales	Swansea University	Roberts, SE (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	stephen.e.roberts@swansea.ac.uk			Health Foundation [5091]; Wales Office of Research and Development	Health Foundation; Wales Office of Research and Development	The study was funded by The Health Foundation [Grant no: 5091] (http://www.health.org.uk/). The views expressed in this manuscript are those of the authors and not necessarily those of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Ashley Akbari and Mark Atkinson, College of Medicine, Swansea University, for data programming and extraction; and the Health Information Research Unit (HIRU), College of Medicine, Swansea University, for preparing and providing access to the project specific linked datasets from the Secure Anonymised Information Linkage (SAIL) system, which is funded by the Wales Office of Research and Development.	Ahsberg K, 2010, SCAND J GASTROENTERO, V45, P1404, DOI 10.3109/00365521.2010.510567; Ali F, 2007, GUT, V56, P1, DOI 10.1136/gut.2006.117598; Ananthakrishnan AN, 2009, CLIN GASTROENTEROL H, V7, P296, DOI 10.1016/j.cgh.2008.08.013; Barkun A, 2004, AM J GASTROENTEROL, V99, P1238, DOI 10.1111/j.1572-0241.2004.30272.x; Blatchford O, 1997, BMJ-BRIT MED J, V315, P510, DOI 10.1136/bmj.315.7107.510; Brooks CJ, 2010, PHARMACOEPIDEM DR S, V19, P983, DOI 10.1002/pds.2012; Button LA, 2011, ALIMENT PHARM THER, V33, P64, DOI 10.1111/j.1365-2036.2010.04495.x; Button LA, 2010, WORLD J GASTROENTERO, V16, P431, DOI 10.3748/wjg.v16.i4.431; Crooks C, 2011, GASTROENTEROLOGY, V141, P62, DOI 10.1053/j.gastro.2011.03.048; Crooks CJ, 2012, GUT, V61, P514, DOI 10.1136/gutjnl-2011-300186; Di Fiore F, 2005, EUR J GASTROEN HEPAT, V17, P641, DOI 10.1097/00042737-200506000-00008; Fleming KM, 2012, LIVER INT, V32, P79, DOI 10.1111/j.1478-3231.2011.02517.x; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Goldacre MJ, 2004, BRIT MED J, V328, P1466, DOI 10.1136/bmj.328.7454.1466; GOLDACRE MJ, 1993, J EPIDEMIOL COMMUN H, V47, P491, DOI 10.1136/jech.47.6.491; Hearnshaw SA, 2011, GUT, V60, P1327, DOI 10.1136/gut.2010.228437; HUDSON N, 1995, GUT, V37, P177, DOI 10.1136/gut.37.2.177; Jepsen P, 2010, HEPATOLOGY, V51, P1675, DOI 10.1002/hep.23500; Kapur KC, 1998, J ROY COLL PHYS LOND, V32, P246; Lanas A, 2011, ALIMENT PHARM THER, V33, P1225, DOI 10.1111/j.1365-2036.2011.04651.x; Lyons RA, 2003, INJ PREV, V9, P33, DOI 10.1136/ip.9.1.33; Lyons RA, 2008, ACCIDENT ANAL PREV, V40, P1406, DOI 10.1016/j.aap.2008.03.011; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Marmo R, 2008, AM J GASTROENTEROL, V103, P1639, DOI 10.1111/j.1572-0241.2008.01865.x; Office for National Statistics, 2007, INT MIGR 2006; Office for National Statistics, POP EST UK ENGL WAL; Palmer KR, 2003, POSTGRAD MED J, V31, P19; Paranjothy S, 2009, ARCH DIS CHILD, V94, P421, DOI 10.1136/adc.2008.144881; Public Health Wales Observatory, MORT DAT MAIN CAUS; Roberts SE, 2005, GUT, V54, P1615, DOI 10.1136/gut.2004.058636; Roberts SE, 2012, EUR RESPIR J, V40, P785, DOI 10.1183/09031936.00043311; Roberts SE, 2011, FRONTLINE GASTROENTE, V2, P153, DOI 10.1136/fg.2009.000208; ROCKALL TA, 1995, BRIT MED J, V311, P222, DOI 10.1136/bmj.311.6999.222; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316; Sanders DS, 2004, EUR J GASTROEN HEPAT, V16, P487, DOI 10.1097/00042737-200405000-00009; SAUNDERS JB, 1981, BRIT MED J, V282, P263, DOI 10.1136/bmj.282.6260.263; Sorensen HT, 2003, J CLIN EPIDEMIOL, V56, P88, DOI 10.1016/S0895-4356(02)00531-0; Targownik LE, 2006, CLIN GASTROENTEROL H, V4, P1459, DOI 10.1016/j.cgh.2006.08.018; van Leerdam ME, 2003, AM J GASTROENTEROL, V98, P1494, DOI 10.1016/S0002-9270(03)00299-5; vonHolstein CS, 1997, EUR J GASTROEN HEPAT, V9, P33, DOI 10.1097/00042737-199701000-00010; Vreeburg EM, 1997, AM J GASTROENTEROL, V92, P236; Welsh Assembly Government, 2010, 942010 SB WELSH ASS; Welsh Government, WELSH IND MULT DEPR	43	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49507	10.1371/journal.pone.0049507	http://dx.doi.org/10.1371/journal.pone.0049507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251344	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200017
J	Chen, SY; Lewis, B; Moran, A; Xie, T				Chen, Shuyi; Lewis, Brandy; Moran, Andrea; Xie, Ting			Cadherin-Mediated Cell Adhesion Is Critical for the Closing of the Mouse Optic Fissure	PLOS ONE			English	Article							EYE DEVELOPMENT; ALPHA-CATENIN; ADHERENS JUNCTIONS; VERTEBRATE RETINA; CRE RECOMBINASE; CHARGE-SYNDROME; BETA-CATENIN; GENE; MORPHOGENESIS; MUTATION	Coloboma is a congenital disease that contributes significantly to childhood blindness. It results from the failure in closing the optic fissure, a transient opening on the ventral side of the developing eye. Although human and mouse genetic studies have identified a number of genes associated with coloboma, the detailed cellular mechanisms underlying the optic fissure closure and coloboma formation remain largely undefined. N-cadherin-mediated cell adhesion has been shown to be important for the optic fissure closure in zebrafish, but it remains to be determined experimentally how cell-cell adhesions are involved in the mammalian optic fissure closing process. alpha-catenin is required for cell adhesion mediated by all of the classic cadherin molecules, including N-cadherin. In this study, we used the Cre-mediated conditional knockout technique to specifically delete alpha-catenin from the developing mouse eye to show that it is required for the successful closing of the optic fissure. In alpha-catenin conditional mutant optic cups, the major cell fates, including the optic fissure margin, neural retina and retinal pigmented epithelium, are specified normally, and the retinal progenitor cells proliferate normally. However, adherens junctions components, including N-cadherin, beta-catenin and filamentous actin, fail to accumulate on the apical side of alpha-catenin mutant retinal progenitor cells, where adherens junctions are normally abundant, and the organization of the neural retina and the optic fissure margin is disrupted. Finally, the alpha-catenin mutant retina gradually degenerates in the adult mouse eye. Therefore, our results show that alpha-catenin-mediated cell adhesion and cell organization are important for the fissure closure in mice, and further suggest that genes that regulate cell adhesion may underlie certain coloboma cases in humans.	[Chen, Shuyi; Lewis, Brandy; Moran, Andrea; Xie, Ting] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Xie, Ting] Univ Kansas, Med Ctr, Dept Cell Biol & Anat, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Chen, SY (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	sch@stowers.org; tgx@stowers.org			Stowers Institute for Medical Research	Stowers Institute for Medical Research	This work is supported by The Stowers Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Barbieri AM, 2002, DEVELOPMENT, V129, P805; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Favor J, 1996, P NATL ACAD SCI USA, V93, P13870, DOI 10.1073/pnas.93.24.13870; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gregory-Evans CY, 2004, J MED GENET, V41, P881, DOI 10.1136/jmg.2004.025494; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; HERO I, 1990, INVEST OPHTH VIS SCI, V31, P197; Kaufman MH, 1992, ATLAS MOUSE DEV, Vxvi; Kim TH, 2007, DEV CELL, V13, P87, DOI 10.1016/j.devcel.2007.04.018; Lalani SR, 2006, AM J HUM GENET, V78, P303, DOI 10.1086/500273; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Maiden SL, 2011, J CELL BIOL, V195, P543, DOI 10.1083/jcb.201103106; Martin AC, 2010, DEV BIOL, V341, P114, DOI 10.1016/j.ydbio.2009.10.031; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; Morcillo J, 2006, DEVELOPMENT, V133, P3179, DOI 10.1242/dev.02493; Mui SH, 2005, GENE DEV, V19, P1249, DOI 10.1101/gad.1276605; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Oliver G, 1995, DEVELOPMENT, V121, P4045; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Martinez-Morales JR, 2009, CURR OPIN GENET DEV, V19, P511, DOI 10.1016/j.gde.2009.08.003; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Schimmenti LA, 2003, AM J MED GENET A, V116A, P215, DOI 10.1002/ajmg.a.10884; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Torres MA, 1996, DEVELOPMENT, V122, P3381; Uemonsa T, 2002, DEV BIOL, V248, P319, DOI 10.1006/dbio.2002.0737; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	41	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51705	10.1371/journal.pone.0051705	http://dx.doi.org/10.1371/journal.pone.0051705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240058	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800094
J	Fahnoe, KC; Flanagan, ME; Gibson, G; Shanmugasundaram, V; Che, Y; Tomaras, AP				Fahnoe, Kelly C.; Flanagan, Mark E.; Gibson, Glenn; Shanmugasundaram, Veerabahu; Che, Ye; Tomaras, Andrew P.			Non-Traditional Antibacterial Screening Approaches for the Identification of Novel Inhibitors of the Glyoxylate Shunt in Gram-Negative Pathogens	PLOS ONE			English	Article							CYSTIC-FIBROSIS ISOLATE; PSEUDOMONAS-AERUGINOSA; ISOCITRATE LYASE; MALATE SYNTHASE; MYCOBACTERIUM-TUBERCULOSIS; BAD BUGS; RESISTANCE; PERSISTENCE; CHALLENGES; INFECTION	Antibacterial compounds that affect bacterial viability have traditionally been identified, confirmed, and characterized in standard laboratory media. The historical success of identifying new antibiotics via this route has justifiably established a traditional means of screening for new antimicrobials. The emergence of multi-drug-resistant (MDR) bacterial pathogens has expedited the need for new antibiotics, though many in the industry have questioned the source(s) of these new compounds. As many pharmaceutical companies' chemical libraries have been exhaustively screened via the traditional route, we have concluded that all compounds with any antibacterial potential have been identified. While new compound libraries and platforms are being pursued, it also seems prudent to screen the libraries we currently have in hand using alternative screening approaches. One strategy involves screening under conditions that better reflect the environment pathogens experience during an infection, and identifying in vivo essential targets and pathways that are dispensable for growth in standard laboratory media in vitro. Here we describe a novel screening strategy for identifying compounds that inhibit the glyoxylate shunt in Pseudomonas aeruginosa, a pathway that is required for bacterial survival in the pulmonary environment. We demonstrate that these compounds, which were not previously identified using traditional screening approaches, have broad-spectrum antibacterial activity when they are tested under in vivo-relevant conditions. We also show that these compounds have potent activity on both enzymes that comprise the glyoxylate shunt, a feature that was supported by computational homology modeling. By dual-targeting both enzymes in this pathway, we would expect to see a reduced propensity for resistance development to these compounds. Taken together, these data suggest that understanding the in vivo environment that bacterial pathogens must tolerate, and adjusting the antibacterial screening paradigm to reflect those conditions, could identify novel antibiotics for the treatment of serious MDR pathogens.	[Fahnoe, Kelly C.; Flanagan, Mark E.; Gibson, Glenn; Shanmugasundaram, Veerabahu; Che, Ye; Tomaras, Andrew P.] Pfizer Worldwide Res & Dev, Antibacterials Res Unit, Groton, CT 06340 USA	Pfizer	Tomaras, AP (corresponding author), Pfizer Worldwide Res & Dev, Antibacterials Res Unit, Groton, CT 06340 USA.	andrew.tomaras@pfizer.com		Che, Ye/0000-0002-1278-4442; SHANMUGASUNDARAM, VEERABAHU/0000-0003-0566-6779	Pfizer	Pfizer(Pfizer)	The work was solely funded by Pfizer. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstrom DM, 2006, PROTEIN SCI, V15, P2002, DOI 10.1110/ps.062300206; ARMSTRONG GD, 1995, J INFECT DIS, V171, P1042, DOI 10.1093/infdis/171.4.1042; Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BLACK PN, 1994, BBA-LIPID LIPID MET, V1210, P123, DOI 10.1016/0005-2760(94)90113-9; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; CHELL RM, 1978, BIOCHEM J, V173, P165, DOI 10.1042/bj1730165; Clinical and Laboratory Standards Institute (CLSI), 2009, CLSI PUBL, VM07-A8; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Hagins JM, 2011, CAN J MICROBIOL, V57, P186, DOI 10.1139/W10-118; Hearn EM, 2009, NATURE, V458, P367, DOI 10.1038/nature07678; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Hoffmann N, 2005, INFECT IMMUN, V73, P2504, DOI 10.1128/IAI.73.4.2504-2514.2005; Hu JF, 2006, J NAT PROD, V69, P118, DOI 10.1021/np049600s; KHAN AS, 1993, PROTEIN EXPRES PURIF, V4, P519, DOI 10.1006/prep.1993.1068; Levy SB, 1997, CIBA F SYMP, V207, P1; Lindsey TL, 2008, MICROBIOL-SGM, V154, P1616, DOI 10.1099/mic.0.2007/014506-0; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Miller RM, 2008, J BACTERIOL, V190, P4038, DOI 10.1128/JB.00129-08; Ogawa W, 2005, BIOL PHARM BULL, V28, P1505, DOI 10.1248/bpb.28.1505; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Rogers SA, 2010, ORG BIOMOL CHEM, V8, P3857, DOI 10.1039/c0ob00063a; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHLOSS JV, 1982, BIOCHEMISTRY-US, V21, P4420, DOI 10.1021/bi00261a035; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; Sharma V, 2000, NAT STRUCT BIOL, V7, P663, DOI 10.1038/77964; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shingnapurkar D, 2012, BIOORG MED CHEM LETT, V22, P3172, DOI 10.1016/j.bmcl.2012.03.047; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Smith CV, 2003, J BIOL CHEM, V278, P1735, DOI 10.1074/jbc.M209248200; Smith KM, 2003, CHEM BIOL, V10, P81, DOI 10.1016/s1074-5521(03)00002-4; Svensson A, 2001, CHEMBIOCHEM, V2, P915, DOI 10.1002/1439-7633(20011203)2:12<915::AID-CBIC915>3.3.CO;2-D; Umland TG, 2012, MBIO, P3; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	39	36	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51732	10.1371/journal.pone.0051732	http://dx.doi.org/10.1371/journal.pone.0051732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240059	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800095
J	Kahramanogullari, O; Fantaccini, G; Lecca, P; Morpurgo, D; Priami, C				Kahramanogullari, Ozan; Fantaccini, Gianluca; Lecca, Paola; Morpurgo, Daniele; Priami, Corrado			Algorithmic Modeling Quantifies the Complementary Contribution of Metabolic Inhibitions to Gemcitabine Efficacy	PLOS ONE			English	Article							JAPANESE CANCER-PATIENTS; PANCREATIC-CANCER; RIBONUCLEOTIDE REDUCTASE; DEOXYCYTIDINE KINASE; SYSTEMS PHARMACOLOGY; PATIENTS IMPACT; IN-VITRO; RESISTANCE; PHARMACOKINETICS; MECHANISMS	Gemcitabine (2,2-difluorodeoxycytidine, dFdC) is a prodrug widely used for treating various carcinomas. Gemcitabine exerts its clinical effect by depleting the deoxyribonucleotide pools, and incorporating its triphosphate metabolite (dFdC-TP) into DNA, thereby inhibiting DNA synthesis. This process blocks the cell cycle in the early S phase, eventually resulting in apoptosis. The incorporation of gemcitabine into DNA takes place in competition with the natural nucleoside dCTP. The mechanisms of indirect competition between these cascades for common resources are given with the race for DNA incorporation; in clinical studies dedicated to singling out mechanisms of resistance, ribonucleotide reductase (RR) and deoxycytidine kinase (dCK) and human equilibrative nucleoside transporter1 (hENT1) have been associated to efficacy of gemcitabine with respect to their roles in the synthesis cascades of dFdC-TP and dCTP. However, the direct competition, which manifests itself in terms of inhibitions between these cascades, remains to be quantified. We propose an algorithmic model of gemcitabine mechanism of action, verified with respect to independent experimental data. We performed in silico experiments in different virtual conditions, otherwise difficult in vivo, to evaluate the contribution of the inhibitory mechanisms to gemcitabine efficacy. In agreement with the experimental data, our model indicates that the inhibitions due to the association of dCTP with dCK and the association of gemcitabine diphosphate metabolite (dFdC-DP) with RR play a key role in adjusting the efficacy. While the former tunes the catalysis of the rate-limiting first phosphorylation of dFdC, the latter is responsible for depletion of dCTP pools, thereby contributing to gemcitabine efficacy with a dependency on nucleoside transport efficiency. Our simulations predict the existence of a continuum of non-efficacy to high-efficacy regimes, where the levels of dFdC-TP and dCTP are coupled in a complementary manner, which can explain the resistance to this drug in some patients. Citation: Kahramanogullari O, Fantaccini G, Lecca P, Morpurgo D, Priami C (2012) Algorithmic Modeling Quantifies the Complementary Contribution of Metabolic Inhibitions to Gemcitabine Efficacy. PLoS ONE 7(12): e50176. doi:10.1371/journal.pone.0050176	[Kahramanogullari, Ozan; Fantaccini, Gianluca; Lecca, Paola; Morpurgo, Daniele; Priami, Corrado] Microsoft Res Univ Trento Ctr Computat & Syst Bio, Rovereto, Trento, Italy; [Priami, Corrado] Univ Trento, Dept Math, Povo, Trento, Italy	University of Trento	Kahramanogullari, O (corresponding author), Microsoft Res Univ Trento Ctr Computat & Syst Bio, Rovereto, Trento, Italy.	ozan@cosbi.eu	Lecca, Paola/AAJ-2457-2021	Lecca, Paola/0000-0002-7224-136X				Albano G, 2006, J THEOR BIOL, V242, P329, DOI 10.1016/j.jtbi.2006.03.001; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Artin E, 2009, BIOCHEMISTRY-US, V48, P11622, DOI 10.1021/bi901590q; Battaglia MA, 2011, IET SYST BIOL, V5, P34, DOI 10.1049/iet-syb.2009.0073; Bergman AM, 2000, EUR J CANCER, V36, P1974, DOI 10.1016/S0959-8049(00)00246-X; Beumer JH, 2008, CLIN CANCER RES, V14, P3529, DOI 10.1158/1078-0432.CCR-07-4885; Cardelli L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00656; Cucurull-Sanchez L, 2012, DRUG DISCOV TODAY, V17, P665, DOI 10.1016/j.drudis.2012.01.015; Dalchau N, 2011, PLOS COMPUTATIONAL B, V7, P1; Danesi R, 2003, PHARMACOL REV, V55, P57, DOI 10.1124/pr.55.1.4; Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; Dematte L, 2008, LECT NOTES COMPUT SC, V5016, P313; Dematte L, 2010, SYST BIO, V1, P777, DOI 10.1007/978-1-4419-5797-9_31; Dumontet C, 1999, BRIT J HAEMATOL, V106, P78, DOI 10.1046/j.1365-2141.1999.01509.x; Duxbury MS, 2004, ONCOGENE, V23; Eriksson S, 2002, CELLULAR MOL LIFE SC, V59; Fryer RA, 2011, ANTICANCER RES, V31, P3747; Fujita H, 2010, NEOPLASIA, V12, P807, DOI 10.1593/neo.10458; Funel N, 2008, LAB INVEST, V88, P773, DOI 10.1038/labinvest.2008.40; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; Garcia-Manteiga J, 2003, CLIN CANCER RES, V9, P5000; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Giovannetti E, 2004, CLIN CANCER RES, V10, P2936, DOI 10.1158/1078-0432.CCR-03-0520; Goan YG, 1999, CANCER RES, V59, P4204; Guerriero ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-40; HEINEMANN V, 1992, CANCER RES, V52, P533; Kahramanogullari O, 2011, ENVIRON MODELL SOFTW, V26, P685, DOI 10.1016/j.envsoft.2010.12.007; Kim MY, 1989, BIOCHEMISTRY-US, V28; Kroep JR, 2002, MOL CANCER THER, V1, P371; Lecca P., 2011, 2011 UkSim 13th International Conference on Computer Modelling and Simulation (UKSim 2011), P75, DOI 10.1109/UKSIM.2011.24; Lo CF, 2009, P WORLD C ENG WCE 20; Macheras P., 2006, MODELING BIOPHARMACE; Mackey JR, 1998, CANCER RES, V58, P4349; Maring JG, 2010, EUR J CLIN PHARMACOL, V66, P611, DOI 10.1007/s00228-010-0799-0; Metharom E, 2010, ANTICANCER RES, V30, P3669; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Nakahira S, 2007, INT J CANCER, V120, P1355, DOI 10.1002/ijc.22390; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; PLUNKETT W, 1995, SEMIN ONCOL, V22, P3; Priami C, 2009, P 7 INT C COMP METH, DOI [10.1007/978-3-642-03845-7_3, DOI 10.1007/978-3-642-03845-7_3]; Priami C, 2009, COMMUN ACM, V52, P80, DOI 10.1145/1506409.1506427; Regine WF, 2008, JAMA-J AM MED ASSOC, V299, P1019, DOI 10.1001/jama.299.9.1019; Ren QF, 1998, CLIN CANCER RES, V4, P2811; Romanel A, 2011, PLOS ONE, V7, P1; Rosell R, 2004, CLIN CANCER RES, V10, p4215S, DOI 10.1158/1078-0432.CCR-040006; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Sebastiani V, 2006, CLIN CANCER RES, V12, P2492, DOI 10.1158/1078-0432.CCR-05-2655; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Skrypek N, 2013, ONCOGENE, V32, P1714, DOI 10.1038/onc.2012.179; Sugiyama E, 2007, J CLIN ONCOL, V25, P32, DOI 10.1200/JCO.2006.06.7405; Sugiyama E, 2010, CLIN PHARMACOKINET, V49, P549, DOI 10.2165/11532970-000000000-00000; Tham LS, 2008, CLIN CANCER RES, V14, P4213, DOI 10.1158/1078-0432.CCR-07-4754; van der Graaf PH, 2011, PHARM RES-DORDR, V28, P1460, DOI 10.1007/s11095-011-0467-9; Veltkamp SA, 2008, MOL CANCER THER, V7, P2415, DOI 10.1158/1535-7163.MCT-08-0137; Veltkamp SA, 2008, ONCOLOGIST, V13, P261, DOI 10.1634/theoncologist.2007-0215; Voutsadakis IA, 2011, WORLD J GASTRO ONCOL, V3, P153, DOI 10.4251/wjgo.v3.i11.153; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; Wang SS, 2010, CHEM RES TOXICOL, V23, P1653, DOI 10.1021/tx1003547; Xie KC, 1996, CANCER RES, V56, P3030; XU YZ, 1992, BIOCHEM PHARMACOL, V44, P1819	63	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50176	10.1371/journal.pone.0050176	http://dx.doi.org/10.1371/journal.pone.0050176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239976	gold, Green Submitted, Green Published			2022-12-27	WOS:000312290800014
J	McEvoy, AL; Hoi, H; Bates, M; Platonova, E; Cranfill, PJ; Baird, MA; Davidson, MW; Ewers, H; Liphardt, J; Campbell, RE				McEvoy, Ann L.; Hoi, Hiofan; Bates, Mark; Platonova, Evgenia; Cranfill, Paula J.; Baird, Michelle A.; Davidson, Michael W.; Ewers, Helge; Liphardt, Jan; Campbell, Robert E.			mMaple: A Photoconvertible Fluorescent Protein for Use in Multiple Imaging Modalities	PLOS ONE			English	Article							QUANTUM YIELD; RESOLUTION; MICROSCOPY; CELLS; CHEMOTAXIS; EVOLUTION; NANOSCOPY; BRIGHT; GUIDE; LIMIT	Recent advances in fluorescence microscopy have extended the spatial resolution to the nanometer scale. Here, we report an engineered photoconvertible fluorescent protein (pcFP) variant, designated as mMaple, that is suited for use in multiple conventional and super-resolution imaging modalities, specifically, widefield and confocal microscopy, structured illumination microscopy (SIM), and single-molecule localization microscopy. We demonstrate the versatility of mMaple by obtaining super-resolution images of protein organization in Escherichia coli and conventional fluorescence images of mammalian cells. Beneficial features of mMaple include high photostability of the green state when expressed in mammalian cells and high steady state intracellular protein concentration of functional protein when expressed in E. coli. mMaple thus enables both fast live-cell ensemble imaging and high precision single molecule localization for a single pcFP-containing construct.	[McEvoy, Ann L.; Liphardt, Jan] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Hoi, Hiofan; Campbell, Robert E.] Univ Alberta, Dept Chem, Edmonton, AB, Canada; [Bates, Mark] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Platonova, Evgenia; Ewers, Helge] Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland; [Cranfill, Paula J.; Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Cranfill, Paula J.; Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Liphardt, Jan] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Liphardt, Jan] Univ Calif Berkeley, Bay Area Phys Sci Oncol Ctr, Berkeley, CA 94720 USA; [Liphardt, Jan] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Cranfill, Paula J.; Baird, Michelle A.; Davidson, Michael W.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of Alberta; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	McEvoy, AL (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	almcevoy@berkeley.edu; robert.e.campbell@ualberta.ca	Ewers, Helge/ABF-3629-2021	Ewers, Helge/0000-0003-3948-4332; Campbell, Robert E./0000-0003-0604-092X; Liphardt, Jan/0000-0003-2835-5025; , ENIGMA/0000-0002-0894-2831	National Science Foundation (NSF); Natural Sciences and Engineering Research Council (NSERC); Canada Research Chair in Bioanalytical Chemistry; European Molecular Biology Organization; National Institutes of Health [GM77856, GM084716]; National Cancer Institute (NCI) Physical Sciences Oncology program [U54CA143836]; Department of Energy (DOE) Office of Basic Energy Sciences (FWP SISGRKN); Office of Science, of the U.S. Department of Energy [DE-AC02-05CH11231]; National Centre of Competence in Research (NCCR) Neural Plasticity and Repair; Holcim Foundation; National Competence Center in Biomedical Imaging (NCCBI); NATIONAL CANCER INSTITUTE [U54CA143836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084716, R01GM077856] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Bioanalytical Chemistry; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI) Physical Sciences Oncology program; Department of Energy (DOE) Office of Basic Energy Sciences (FWP SISGRKN)(United States Department of Energy (DOE)); Office of Science, of the U.S. Department of Energy(United States Department of Energy (DOE)); National Centre of Competence in Research (NCCR) Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Holcim Foundation; National Competence Center in Biomedical Imaging (NCCBI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ALM was funded by the National Science Foundation (NSF) graduate fellowship. REC is funded by Natural Sciences and Engineering Research Council (NSERC) and holds a Canada Research Chair in Bioanalytical Chemistry. MB is funded by the European Molecular Biology Organization. This work was partially funded by the National Institutes of Health (GM77856 and GM084716 to JTL), the National Cancer Institute (NCI) Physical Sciences Oncology program (U54CA143836 to JTL), the Department of Energy (DOE) Office of Basic Energy Sciences (FWP SISGRKN), and the Director, Office of Science, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. HE was supported by the National Centre of Competence in Research (NCCR) Neural Plasticity and Repair and the Holcim Foundation, EP was supported by the National Competence Center in Biomedical Imaging (NCCBI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Annibale P, 2010, J PHYS CHEM LETT, V1, P1506, DOI 10.1021/jz1003523; Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bates M., 2011, IMAGING LAB MANUAL, P547; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BRANNON JH, 1978, J PHYS CHEM-US, V82, P705, DOI 10.1021/j100495a018; Cogger VC, 2010, J STRUCT BIOL, V171, P382, DOI 10.1016/j.jsb.2010.06.001; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Donnert G, 2007, BIOPHYS J, V92, pL67, DOI 10.1529/biophysj.107.104497; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Fischer M, 1996, CHEM PHYS LETT, V260, P115, DOI 10.1016/0009-2614(96)00838-X; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Habuchi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003944; Heilemann M, 2009, ANGEW CHEM INT EDIT, V48, P6903, DOI 10.1002/anie.200902073; Hein B, 2010, BIOPHYS J, V98, P158, DOI 10.1016/j.bpj.2009.09.053; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Henderson JN, 2005, P NATL ACAD SCI USA, V102, P12712, DOI 10.1073/pnas.0502250102; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoi HF, 2010, J MOL BIOL, V401, P776, DOI 10.1016/j.jmb.2010.06.056; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Iafolla MAJ, 2008, PROTEINS, V72, P1233, DOI 10.1002/prot.22024; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Lee HLD, 2010, J AM CHEM SOC, V132, P15099, DOI 10.1021/ja1044192; Lefman J, 2011, MICROSC MICROANAL, V17, P191, DOI 10.1017/S1431927611000158; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Rankin BR, 2011, BIOPHYS J, V100, pL63, DOI 10.1016/j.bpj.2011.05.020; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; SANDERS DA, 1989, J BACTERIOL, V171, P6271, DOI 10.1128/jb.171.11.6271-6278.1989; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schmidt R, 2008, NAT METHODS, V5, P539, DOI 10.1038/nmeth.1214; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Vaziri A, 2008, P NATL ACAD SCI USA, V105, P20221, DOI 10.1073/pnas.0810636105; Ward WW, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P45; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Willig KI, 2006, NAT METHODS, V3, P721, DOI 10.1038/NMETH922; Zhao HM, 2006, NAT PROTOC, V1, P1865, DOI 10.1038/nprot.2006.309	54	89	91	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51314	10.1371/journal.pone.0051314	http://dx.doi.org/10.1371/journal.pone.0051314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240015	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800051
J	Berger, WT; Ralph, BP; Kaczocha, M; Sun, J; Balius, TE; Rizzo, RC; Haj-Dahmane, S; Ojima, I; Deutsch, DG				Berger, William T.; Ralph, Brian P.; Kaczocha, Martin; Sun, Jing; Balius, Trent E.; Rizzo, Robert C.; Haj-Dahmane, Samir; Ojima, Iwao; Deutsch, Dale G.			Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters - A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; ALPHA-TRUXILLIC ACID; DERIVATIVES; PAIN	Fatty acid binding proteins (FABPs), in particular FABP5 and FABP7, have recently been identified by us as intracellular transporters for the endocannabinoid anandamide (AEA). Furthermore, animal studies by others have shown that elevated levels of endocannabinoids resulted in beneficial pharmacological effects on stress, pain and inflammation and also ameliorate the effects of drug withdrawal. Based on these observations, we hypothesized that FABP5 and FABP7 would provide excellent pharmacological targets. Thus, we performed a virtual screening of over one million compounds using DOCK and employed a novel footprint similarity scoring function to identify lead compounds with binding profiles similar to oleic acid, a natural FABP substrate. Forty-eight compounds were purchased based on their footprint similarity scores (FPS) and assayed for biological activity against purified human FABP5 employing a fluorescent displacement-binding assay. Four compounds were found to exhibit approximately 50% inhibition or greater at 10 mu M, as good as or better inhibitors of FABP5 than BMS309403, a commercially available inhibitor. The most potent inhibitor, gamma-truxillic acid 1-naphthyl ester (ChemDiv 8009-2334), was determined to have K-i value of 1.19+/-0.01 mu M. Accordingly a novel alpha-truxillic acid 1-naphthyl mono-ester (SB-FI-26) was synthesized and assayed for its inhibitory activity against FABP5, wherein SB-FI-26 exhibited strong binding (K-i 0.93+/-0.08 mu M). Additionally, we found SB-FI-26 to act as a potent anti-nociceptive agent with mild anti-inflammatory activity in mice, which strongly supports our hypothesis that the inhibition of FABPs and subsequent elevation of anandamide is a promising new approach to drug discovery. Truxillic acids and their derivatives were also shown by others to have anti-inflammatory and anti-nociceptive effects in mice and to be the active component of Chinese a herbal medicine (Incarvillea sinensis) used to treat rheumatism and pain in humans. Our results provide a likely mechanism by which these compounds exert their effects.	[Berger, William T.; Ojima, Iwao] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Haj-Dahmane, Samir] SUNY Buffalo, Res Inst Addict, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Ojima, I (corresponding author), SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA.	Iwao.Ojima@stonybrook.edu; Dale.Deutsch@stonybrook.edu	Berger, William/E-7452-2013	Ojima, Iwao/0000-0002-3628-1161; Kaczocha, Martin/0000-0002-2527-1398; Balius, Trent/0000-0002-6811-4667	United States National Institutes of Health [DA02695301, DA01641904, DA032232]; SUNY-REACH; SBU/BNL; SBU TRO FUSION; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA032232] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SUNY-REACH; SBU/BNL; SBU TRO FUSION; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by United States National Institutes of Health grants DA02695301 (D. G. D.), DA01641904 (D. G. D.), and DA032232 (M. K.). SUNY-REACH (D. G. D. and S. H-D.) SBU/BNL Seed Grant (D. G. D. and I. W.) and SBU TRO FUSION Award (D. G. D. and I.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2009, EXPERT OPIN DRUG DIS, V4, P763, DOI 10.1517/17460440903018857; [Anonymous], 2011, DOCK6 5; Arendaruk AP SA, 1967, KHIM FARM ZH, P18; Balius TE, 2011, J COMPUT CHEM, V32, P2273, DOI 10.1002/jcc.21814; Barf T, 2009, BIOORG MED CHEM LETT, V19, P1745, DOI 10.1016/j.bmcl.2009.01.084; Chi YM, 2006, BIOL PHARM BULL, V29, P580, DOI 10.1248/bpb.29.580; Chi YM, 2005, BIOL PHARM BULL, V28, P1776, DOI 10.1248/bpb.28.1776; Churi SB, 2008, J PAIN, V9, P639, DOI 10.1016/j.jpain.2008.02.002; Cravatt BF, 2004, J NEUROBIOL, V61, P149, DOI 10.1002/neu.20080; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Fowler CJ, 2012, TRENDS PHARMACOL SCI, V33, P181, DOI 10.1016/j.tips.2012.01.001; Fu J, 2012, NAT NEUROSCI, V15, P64, DOI 10.1038/nn.2986; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Haj-Dahmane S, 2005, J NEUROSCI, V25, P896, DOI 10.1523/JNEUROSCI.3258-04.2005; Haj-Dahmane S, 2009, J PHARMACOL EXP THER, V331, P186, DOI 10.1124/jpet.109.153858; Holden PM, 2012, BIOORG MED CHEM LETT, V22, P3011, DOI 10.1016/j.bmcl.2012.02.017; Howlett AC, 2011, BRIT J PHARMACOL, V163, P1329, DOI 10.1111/j.1476-5381.2011.01364.x; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Lichtman A H, 1990, NIDA Res Monogr, V105, P422; LoVerme J, 2006, J PHARMACOL EXP THER, V319, P1051, DOI 10.1124/jpet.106.111385; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; Mukherjee S, 2010, J CHEM INF MODEL, V50, P1986, DOI 10.1021/ci1001982; Nakamura M, 1999, J NAT PROD, V62, P1293, DOI 10.1021/np990041c; Steri R, 2010, BIOORG MED CHEM LETT, V20, P2920, DOI 10.1016/j.bmcl.2010.03.026; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; Veerkamp JH, 2001, J MOL NEUROSCI, V16, P133, DOI 10.1385/JMN:16:2-3:133; Yang H, 2011, MACROMOLECULES, V44, P159, DOI 10.1021/ma1016264	31	100	103	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50968	10.1371/journal.pone.0050968	http://dx.doi.org/10.1371/journal.pone.0050968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236415	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100048
J	Doidge, R; Mittal, S; Aslam, A; Winkler, GS				Doidge, Rachel; Mittal, Saloni; Aslam, Akhmed; Winkler, G. Sebastiaan			The Anti-Proliferative Activity of BTG/TOB Proteins Is Mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) Deadenylase Subunits of the Ccr4-Not Complex	PLOS ONE			English	Article							MESSENGER-RNA DEADENYLATION; POLY(A)-BINDING PROTEIN; TRANSCRIPTION FACTOR; CELL-PROLIFERATION; GROWTH-INHIBITION; STRUCTURAL BASIS; TOB; BTG2; PHOSPHORYLATION; OVEREXPRESSION	The human BTG/TOB protein family comprises six members (BTG1, BTG2/PC3/Tis21, BTG3/Ana, BTG4/PC3B, TOB1/Tob, and TOB2) that are characterised by a conserved BTG domain. This domain mediates interactions with the highly similar Caf1a (CNOT7) and Caf1b (CNOT8) catalytic subunits of the Ccr4-Not deadenylase complex. BTG/TOB proteins have anti-proliferative activity: knockdown of BTG/TOB can result in increased cell proliferation, whereas over-expression of BTG/TOB leads to inhibition of cell cycle progression. It was unclear whether the interaction between BTG/TOB proteins and the Caf1a/Caf1b deadenylases is necessary for the anti-proliferative activity of BTG/TOB. To address this question, we further characterised surface-exposed amino acid residues of BTG2 and TOB1 that mediate the interaction with the Caf1a and Caf1b deadenylase enzymes. We then analysed the role of BTG2 and TOB1 in the regulation of cell proliferation, translation and mRNA abundance using a mutant that is no longer able to interact with the Caf1a/Caf1b deadenylases. We conclude that the anti-proliferative activity of BTG/TOB proteins is mediated through interactions with the Caf1a and Caf1b deadenylase enzymes. Furthermore, we show that the activity of BTG/TOB proteins in the regulation of mRNA abundance and translation is dependent on Caf1a/Caf1b, and does not appear to require other Ccr4-Not components, including the Ccr4a (CNOT6)/Ccr4b (CNOT6L) deadenylases, or the non-catalytic subunits CNOT1 or CNOT3.	[Doidge, Rachel; Mittal, Saloni; Aslam, Akhmed; Winkler, G. Sebastiaan] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Nottingham	Winkler, GS (corresponding author), Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Univ Pk, Nottingham NG7 2RD, England.	sebastiaan.winkler@nottingham.ac.uk	Aslam, Akhmed/C-4493-2019	Aslam, Akhmed/0000-0002-0416-936X; Winkler, Sebastiaan/0000-0002-0476-162X	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/002338X/1]; Association for International Cancer Research (AICR) [07-0494]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/E02338X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E02338X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Association for International Cancer Research (AICR); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants to GSW from the Biotechnology and Biological Sciences Research Council (BBSRC grant BB/002338X/1; www.bbsrc.ac.uk) and the Association for International Cancer Research (AICR grant 07-0494; www.aicr.org). RD was supported by a studentship from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam A, 2009, MOL BIOL CELL, V20, P3840, DOI 10.1091/mbc.E09-02-0146; Bartlam M, 2010, PROTEIN CELL, V1, P443, DOI 10.1007/s13238-010-0060-8; Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Doidge R, 2012, BIOCHEM SOC T, V40, P896, DOI 10.1042/BST20120074; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Ezzeddine N, 2012, MOL CELL BIOL, V32, P1089, DOI 10.1128/MCB.06370-11; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Gehring NH, 2008, METHOD ENZYMOL, V448, P467, DOI 10.1016/S0076-6879(08)02623-2; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Hata K, 2007, EXP CELL RES, V313, P2356, DOI 10.1016/j.yexcr.2007.03.021; Hong JW, 2005, J BIOL CHEM, V280, P21256, DOI 10.1074/jbc.M500318200; Horiuchi M, 2009, J BIOL CHEM, V284, P13244, DOI 10.1074/jbc.M809250200; Hosoda N, 2011, EMBO J, V30, P1311, DOI 10.1038/emboj.2011.37; Ito Y, 2005, CANCER LETT, V220, P237, DOI 10.1016/j.canlet.2004.08.017; Iwanaga K, 2003, CANCER LETT, V202, P71, DOI 10.1016/j.canlet.2003.08.019; Kawakubo H, 2006, CANCER RES, V66, P7075, DOI 10.1158/0008-5472.CAN-06-0379; Lim IK, 1998, MOL CARCINOGEN, V23, P25, DOI 10.1002/(SICI)1098-2744(199809)23:1<25::AID-MC4>3.0.CO;2-G; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Mauxion F, 2009, TRENDS BIOCHEM SCI, V34, P640, DOI 10.1016/j.tibs.2009.07.008; Mittal S, 2011, MOL BIOL CELL, V22, P748, DOI 10.1091/mbc.E10-11-0898; Montagnoli A, 1996, CELL GROWTH DIFFER, V7, P1327; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morita M, 2007, MOL CELL BIOL, V27, P4980, DOI 10.1128/MCB.02304-06; O'Malley S, 2009, INT J CANCER, V125, P1805, DOI 10.1002/ijc.24490; Okochi K, 2005, GENES CELLS, V10, P151, DOI 10.1111/j.1365-2443.2005.00826.x; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Ruan L, 2010, J BIOL CHEM, V285, P27624, DOI 10.1074/jbc.M110.138867; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Temme C, 2004, EMBO J, V23, P2862, DOI 10.1038/sj.emboj.7600273; Temme C, 2010, RNA, V16, P1356, DOI 10.1261/rna.2145110; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Waanders E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002533; Wiederhold K, 2010, BIOCHEM SOC T, V38, P1531, DOI 10.1042/BST0381531; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yang X, 2008, NUCLEIC ACIDS RES, V36, P6872, DOI 10.1093/nar/gkn825; Yoneda M, 2009, CANCER SCI, V100, P225, DOI 10.1111/j.1349-7006.2008.01030.x; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003	46	51	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51331	10.1371/journal.pone.0051331	http://dx.doi.org/10.1371/journal.pone.0051331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236473	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100096
J	Goh, SL; Wang, Q; Byrnes, LJ; Sondermann, H				Goh, Shih Lin; Wang, Qi; Byrnes, Laura J.; Sondermann, Holger			Versatile Membrane Deformation Potential of Activated Pacsin	PLOS ONE			English	Article							F-BAR DOMAIN; SYNDAPIN-I; MEDIATED ENDOCYTOSIS; AMPHIPATHIC HELICES; DYNAMIN ISOFORMS; STRUCTURAL BASIS; RICH DOMAIN; SH3 DOMAIN; N-WASP; CURVATURE	Endocytosis is a fundamental process in signaling and membrane trafficking. The formation of vesicles at the plasma membrane is mediated by the G protein dynamin that catalyzes the final fission step, the actin cytoskeleton, and proteins that sense or induce membrane curvature. One such protein, the F-BAR domain-containing protein pacsin, contributes to this process and has been shown to induce a spectrum of membrane morphologies, including tubules and tube constrictions in vitro. Full-length pacsin isoform 1 (pacsin-1) has reduced activity compared to its isolated F-BAR domain, implicating an inhibitory role for its C-terminal Src homology 3 (SH3) domain. Here we show that the autoinhibitory, intramolecular interactions in pacsin-1 can be released upon binding to the entire proline-rich domain (PRD) of dynamin-1, resulting in potent membrane deformation activity that is distinct from the isolated F-BAR domain. Most strikingly, we observe the generation of small, homogenous vesicles with the activated protein complex under certain experimental conditions. In addition, liposomes prepared with different methods yield distinct membrane deformation morphologies of BAR domain proteins and apparent activation barriers to pacsin-1's activity. Theoretical free energy calculations suggest bimodality of the protein-membrane system as a possible source for the different outcomes, which could account for the coexistence of energetically equivalent membrane structures induced by BAR domain-containing proteins in vitro. Taken together, our results suggest a versatile role for pacsin-1 in sculpting cellular membranes that is likely dependent both on protein structure and membrane properties.	[Goh, Shih Lin; Wang, Qi; Byrnes, Laura J.; Sondermann, Holger] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Sondermann, H (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	hs293@cornell.edu			PEW scholarship in the Biomedical Sciences	PEW scholarship in the Biomedical Sciences	The work was supported by a PEW scholarship in the Biomedical Sciences (to H.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson F, 2008, J NEUROSCI, V28, P3925, DOI 10.1523/JNEUROSCI.1754-07.2008; Anggono V, 2007, J NEUROCHEM, V102, P931, DOI 10.1111/j.1471-4159.2007.04574.x; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Barylko B, 2010, BIOCHEMISTRY-US, V49, P10592, DOI 10.1021/bi101343p; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Buboltz JT, 1999, BBA-BIOMEMBRANES, V1417, P232, DOI 10.1016/S0005-2736(99)00006-1; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Campelo F, 2010, FEBS LETT, V584, P1830, DOI 10.1016/j.febslet.2009.10.023; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Dharmalingam E, 2009, J NEUROSCI, V29, P13315, DOI 10.1523/JNEUROSCI.3973-09.2009; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Edeling MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008150; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; HIGASHI K, 1987, J BIOCHEM-TOKYO, V101, P433, DOI 10.1093/oxfordjournals.jbchem.a121928; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Kiessling V, 2009, BBA-BIOMEMBRANES, V1788, P64, DOI 10.1016/j.bbamem.2008.09.003; Koch D, 2011, EMBO J, V30, P4955, DOI 10.1038/emboj.2011.339; Kumar V, 2009, MOL BIOL CELL, V20, P2254, DOI 10.1091/mbc.E08-10-1072; Liu AP, 2008, NAT PHYS, V4, P789, DOI 10.1038/nphys1071; Liu YW, 2011, P NATL ACAD SCI USA, V108, pE234, DOI 10.1073/pnas.1102710108; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Llobet A, 2011, J NEUROSCI, V31, P8512, DOI 10.1523/JNEUROSCI.6223-09.2011; Manneville JB, 2012, METHOD CELL BIOL, V108, P47, DOI 10.1016/B978-0-12-386487-1.00003-1; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MAYER LD, 1985, BIOCHIM BIOPHYS ACTA, V817, P193, DOI 10.1016/0005-2736(85)90084-7; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Modregger J, 2000, J CELL SCI, V113, P4511; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Okamoto PM, 1997, J BIOL CHEM, V272, P11629; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; PICK U, 1981, ARCH BIOCHEM BIOPHYS, V212, P186, DOI 10.1016/0003-9861(81)90358-1; Plomann M, 2010, J MOL BIOL, V400, P129, DOI 10.1016/j.jmb.2010.05.008; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Pykalainen A, 2011, NAT STRUCT MOL BIOL, V18, P902, DOI 10.1038/nsmb.2079; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Quana A, 2012, P NATL ACAD SCI USA, V109, P3760, DOI 10.1073/pnas.1108294109; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Shimada A, 2010, FEBS LETT, V584, P1111, DOI 10.1016/j.febslet.2010.02.058; Shpetner HS, 1996, J BIOL CHEM, V271, P13, DOI 10.1074/jbc.271.1.13; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Stachowiak JC, 2010, P NATL ACAD SCI USA, V107, P7781, DOI 10.1073/pnas.0913306107; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Wang Q, 2008, STRUCTURE, V16, P1574, DOI 10.1016/j.str.2008.07.016; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wu M, 2010, NAT CELL BIOL, V12, P902, DOI 10.1038/ncb2094; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Zhao J, 2007, BBA-BIOMEMBRANES, V1768, P2764, DOI 10.1016/j.bbamem.2007.07.008; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	75	19	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51628	10.1371/journal.pone.0051628	http://dx.doi.org/10.1371/journal.pone.0051628			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236520	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100136
J	Hu, RM; Liao, ST; Huang, CC; Huang, YW; Yang, TC				Hu, Rouh-Mei; Liao, Sih-Ting; Huang, Chiang-Ching; Huang, Yi-Wei; Yang, Tsuey-Ching			An Inducible Fusaric Acid Tripartite Efflux Pump Contributes to the Fusaric Acid Resistance in Stenotrophomonas maltophilia	PLOS ONE			English	Article							L2 BETA-LACTAMASES; ESCHERICHIA-COLI; GENOME SEQUENCE; SYSTEM; GENE; EXPRESSION; MECHANISM; ENDOPHYTE; RESPONSES; CLONING	Background: Fusaric acid (5-butylpicolinic acid), a mycotoxin, is noxious to some microorganisms. Stenotrophomonas maltophilia displays an intrinsic resistance to fusaric acid. This study aims to elucidate the mechanism responsible for the intrinsic fusaric acid resistance in S. maltophilia. Methodology: A putative fusaric acid resistance-involved regulon fuaR-fuaABC was identified by the survey of the whole genome sequence of S. maltophilia K279a. The fuaABC operon was verified by reverse transcriptase-PCR. The contribution of the fuaABC operon to the antimicrobial resistance was evaluated by comparing the antimicrobials susceptibility between the wild-type strain and fuaABC knock-out mutant. The regulatory role of fuaR in the expression of the fuaABC operon was assessed by promoter transcription fusion assay. Results: The fuaABC operon was inducibly expressed by fusaric acid and the inducibility was fuaR dependent. FuaR functioned as a repressor of the fuaABC operon in absence of a fusaric acid inducer and as an activator in its presence. Overexpression of the fuaABC operon contributed to the fusaric acid resistance. Significance: A novel tripartite fusaric acid efflux pump, FuaABC, was identified in this study. Distinct from the formally classification, the FuaABC may constitute a new type of subfamily of the tripartite efflux pump.	[Liao, Sih-Ting; Yang, Tsuey-Ching] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan; [Hu, Rouh-Mei] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Huang, Chiang-Ching] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Huang, Yi-Wei] Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Taichung 40227, Taiwan	National Yang Ming Chiao Tung University; Asia University Taiwan; China Medical University Taiwan; National Chung Hsing University	Yang, TC (corresponding author), Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan.	tcyang@ym.edu.tw	Huang, Yi-Wei/K-9717-2019		National Science Council, Taiwan [NSC 101-2320-B-010-053-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grant NSC 101-2320-B-010-053-MY3 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon CW, 1996, APPL ENVIRON MICROB, V62, P4039, DOI 10.1128/AEM.62.11.4039-4043.1996; Bolhuis H, 1997, FEMS MICROBIOL REV, V21, P55, DOI 10.1016/S0168-6445(97)00051-X; Bouizgarne B, 2006, NEW PHYTOL, V169, P209, DOI 10.1111/j.1469-8137.2005.01561.x; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; *CLIN LAB STAND I, 2011, M100S21 CLSI; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Dunne C, 1997, MICROBIOL-UK, V143, P3921, DOI 10.1099/00221287-143-12-3921; Fetherston JD, 1996, MOL MICROBIOL, V22, P315, DOI 10.1046/j.1365-2958.1996.00118.x; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hu RM, 2008, ANTIMICROB AGENTS CH, V52, P1198, DOI 10.1128/AAC.00682-07; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jakobi M, 1996, J ANTIBIOT, V49, P1101, DOI 10.7164/antibiotics.49.1101; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kuzniak E, 2001, PLANT SCI, V160, P723, DOI 10.1016/S0168-9452(00)00457-X; Lin CW, 2008, LETT APPL MICROBIOL, V47, P393, DOI 10.1111/j.1472-765X.2008.02443.x; Lin CW, 2009, RES MICROBIOL, V160, P152, DOI 10.1016/j.resmic.2008.11.001; Lira F, 2012, J BACTERIOL, V194, P3563, DOI 10.1128/JB.00602-12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P2242, DOI 10.1128/AAC.44.9.2242-2246.2000; Pan JH, 2011, ARCH PHARM RES, V34, P1177, DOI 10.1007/s12272-011-0716-9; Pietras Z, 2008, CURR DRUG TARGETS, V9, P719, DOI 10.2174/138945008785747743; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Rosner JL, 1997, CURR TOP CELL REGUL, V35, P163, DOI 10.1016/S0070-2137(97)80007-6; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Sanchez MB, 2009, FUTURE MICROBIOL, V4, P655, DOI 10.2217/FMB.09.45; Schleif R, 2010, FEMS MICROBIOL REV, V34, P779, DOI 10.1111/j.1574-6976.2010.00226.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; UTSUMI R, 1991, AGR BIOL CHEM TOKYO, V55, P1913, DOI 10.1080/00021369.1991.10870864; WALLACE RG, 1980, GENE, V12, P179, DOI 10.1016/0378-1119(80)90100-6; Yang TC, 2009, ANTIMICROB AGENTS CH, V53, P2902, DOI 10.1128/AAC.01513-08; Zhang Z, 2001, PHYTOPATHOLOGY, V91, P204, DOI 10.1094/PHYTO.2001.91.2.204; Zhu B, 2012, J BACTERIOL, V194, P1280, DOI 10.1128/JB.06702-11	35	33	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51053	10.1371/journal.pone.0051053	http://dx.doi.org/10.1371/journal.pone.0051053			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236431	gold, Green Submitted, Green Published			2022-12-27	WOS:000312064100060
J	Iglesias-Gutierrez, E; Egan, B; Diaz-Martinez, AE; Penalvo, JL; Gonzalez-Medina, A; Martinez-Camblor, P; O'Gorman, DJ; Ubeda, N				Iglesias-Gutierrez, Eduardo; Egan, Brendan; Diaz-Martinez, Angel Enrique; Penalvo, Jose Luis; Gonzalez-Medina, Antonio; Martinez-Camblor, Pablo; O'Gorman, Donal J.; Ubeda, Natalia			Transient Increase in Homocysteine but Not Hyperhomocysteinemia during Acute Exercise at Different Intensities in Sedentary Individuals	PLOS ONE			English	Article							PLASMA TOTAL HOMOCYSTEINE; CARDIOVASCULAR RISK; PHYSICAL-ACTIVITY; DISEASE; PEOPLE; BOUTS	Considering that hyperhomocysteinemia is an independent risk factor for cardiovascular disease, the purpose of this study was to determine the kinetics of serum homocysteine (tHcy) and the vitamins involved in its metabolism (folates, B-12, and B-6) in response to acute exercise at different intensities. Eight sedentary males (18-27 yr) took part in the study. Subjects were required to complete two isocaloric (400 kcal) acute exercise trials on separate occasions at 40% (low intensity, LI) and 80% VO2peak (high intensity, HI). Blood samples were drawn at different points before (pre4 and pre0 h), during (exer10, exer20, exer30, exer45, and exer60 min), and after exercise (post0, post3, and post19 h). Dietary, genetic, and lifestyle factors were controlled. Maximum tHcy occurred during exercise, both at LI (8.6 (8.0-10.1) mu mol/L, 9.3% increase from pre0) and HI (9.4 (8.2-10.6) mu mol/L, 25.7% increase from pre0), coinciding with an accumulated energy expenditure independent of the exercise intensity. From this point onwards tHcy declined until the cessation of exercise and continued descending. At post19, tHcy was not different from pre-exercise values. No values of hyperhomocysteinemia were observed at any sampling point and intensity. In conclusion, acute exercise in sedentary individuals, even at HI, shows no negative effect on tHcy when at least 400 kcal are spent during exercise and the nutritional status for folate, B-12, and B-6 is adequate, since no hyperhomocysteinemia has been observed and basal concentrations were recovered in less than 24 h. This could be relevant for further informing healthy exercise recommendations.	[Iglesias-Gutierrez, Eduardo; Gonzalez-Medina, Antonio; Ubeda, Natalia] CEU San Pablo Univ, Dept Pharmaceut & Food Sci, Madrid, Spain; [Egan, Brendan; O'Gorman, Donal J.] Dublin City Univ, Ctr Prevent Med, Sch Hlth & Human Performance, Dublin 9, Ireland; [Diaz-Martinez, Angel Enrique] Ctr Sports Med, Clin Lab, Higher Council Sports, Madrid, Spain; [Penalvo, Jose Luis] Natl Ctr Cardiovasc Res CNIC, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain; [Martinez-Camblor, Pablo] Fdn Asturias Promot Appl Sci Res & Technol FICYT, Biosanitary Res Off Asturias, Oviedo, Spain	San Pablo CEU University; Dublin City University; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Iglesias-Gutierrez, E (corresponding author), Univ Oviedo, Dept Funct Biol, Area Physiol, Oviedo, Spain.	iglesiaseduardo@uniovi.es	Martinez-Camblor, Pablo/Q-1715-2015; O'Gorman, Donal J./J-7182-2015; Úbeda, Natalia/J-9865-2017; Penalvo, Jose L./AAA-9210-2020; Egan, Brendan/AAR-7017-2020; Camblor, Pablo Martinez/Z-4834-2019; Iglesias-Gutierrez, Eduardo/ABH-4544-2020; Diaz Martinez, Angel Enrique/ABH-4351-2020; RG, SMABSS/N-3322-2018	O'Gorman, Donal J./0000-0002-8228-1488; Úbeda, Natalia/0000-0002-8866-0745; Penalvo, Jose L./0000-0003-0096-6238; Egan, Brendan/0000-0001-8327-9016; Camblor, Pablo Martinez/0000-0001-7845-3905; Iglesias-Gutierrez, Eduardo/0000-0002-3063-1562; Diaz Martinez, Angel Enrique/0000-0002-6215-0093; Research Group, SMIRE+CoDiRE/0000-0002-8871-4942; RG, SMABSS/0000-0001-9944-3861; Martinez-Camblor, Pablo/0000-0003-3032-9598	Higher Council for Sports of the Government of Spain [03/UPR10/08, 002/UPR10/12]; San Pablo-CEU University [USP-BSCH-PPC11/09]; University of Oviedo [UNOV-11-MBSAN-01]	Higher Council for Sports of the Government of Spain; San Pablo-CEU University; University of Oviedo	This work was supported by grants from the Higher Council for Sports of the Government of Spain (03/UPR10/08 and 002/UPR10/12), San Pablo-CEU University (USP-BSCH-PPC11/09), and University of Oviedo (UNOV-11-MBSAN-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, DIET REF INT EN CARB; Bacon SL, 2009, THROMB HAEMOSTASIS, V101, P452, DOI 10.1160/TH08-10-0630; Bellamy MF, 1998, CIRCULATION, V98, P1848, DOI 10.1161/01.CIR.98.18.1848; BIJNEN FCH, 1994, B WORLD HEALTH ORGAN, V72, P1; Boreham CAG, 2005, BRIT J SPORT MED, V39, P590, DOI 10.1136/bjsm.2002.001131; Borrione P, 2008, BRIT J SPORT MED, V42, P594; Bouchard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037887; Chrysohoou C, 2004, VASC MED, V9, P117, DOI 10.1191/1358863x04vm542oa; CROZIER PG, 1994, AM J CLIN NUTR, V60, P552, DOI 10.1093/ajcn/60.4.552; Duncan GE, 2004, PREV MED, V39, P894, DOI 10.1016/j.ypmed.2004.03.012; Durnin JVGA, 1996, EUR J CLIN NUTR, V50, pS2; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Eurobarometer, 2010, SPORT PHYS ACT; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gelecek N, 2007, ANN NUTR METAB, V51, P53, DOI 10.1159/000100821; Gonzalez Gonzalez MP, 2005, NUTR HOSP, VXX, P28; Harris JA., 1919, BIOMETRIC STUDY BASA; Henderson GC, 2010, EUR J APPL PHYSIOL, V109, P721, DOI 10.1007/s00421-010-1409-7; Herrmann M, 2003, CLIN CHEM LAB MED, V41, P1518, DOI 10.1515/CCLM.2003.233; Ireland (FSAI), 1999, FSA REC DIET ALL IR; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Jeukendrup AE, 2003, BIOCHEM SOC T, V31, P1270, DOI 10.1042/BST0311270; Joubert LM, 2008, MED SCI SPORT EXER, V40, P1923, DOI 10.1249/MSS.0b013e31817f36f9; Joubert LM, 2006, INT J SPORT NUTR EXE, V16, P341, DOI 10.1123/ijsnem.16.4.341; Konig D, 2003, ANN NUTR METAB, V47, P114, DOI 10.1159/000070032; Mangoni AA, 2011, J AM COLL CARDIOL, V58, P1034, DOI 10.1016/j.jacc.2011.05.029; Moat SJ, 2008, ANN CLIN BIOCHEM, V45, P345, DOI 10.1258/acb.2008.008053; Murakami H, 2011, EUR J APPL PHYSIOL, V111, P2997, DOI 10.1007/s00421-011-1926-z; Pollock ML, 1998, MED SCI SPORT EXER, V30, P975, DOI 10.1097/00005768-199806000-00032; Public Health England, 2021, MCCANCE WIDDOWSONS C; Real JT, 2005, NUTR METAB CARDIOVAS, V15, P134, DOI 10.1016/j.numecd.2004.05.004; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Siri W. E., 1961, NUTRITION; Sotgia S, 2007, CLIN NUTR, V26, P444, DOI 10.1016/j.clnu.2007.05.003; Ubeda N, 2011, NUTRITION, V27, P925, DOI 10.1016/j.nut.2010.10.017; UELAND PM, 1993, CLIN CHEM, V39, P1764; Varela-Moreiras G, 2007, NUTR HOSP, V22, P363; Veeranna V, 2011, J AM COLL CARDIOL, V58, P1025, DOI 10.1016/j.jacc.2011.05.028; Venta R, 2009, MED SCI SPORT EXER, V41, P1645, DOI 10.1249/MSS.0b013e31819e02f2; Wald DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016473; WALSH DJ, 1992, J FORENSIC SCI, V37, P387; Wang ZG, 2011, AM J PHYSIOL-ENDOC M, V301, pE703, DOI 10.1152/ajpendo.00050.2011; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Yung LM, 2009, SPORTS MED, V39, P45, DOI 10.2165/00007256-200939010-00004; Zinellu A, 2007, SCAND J MED SCI SPOR, V17, P452, DOI 10.1111/j.1600-0838.2006.00542.x	47	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51185	10.1371/journal.pone.0051185	http://dx.doi.org/10.1371/journal.pone.0051185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236449	gold, Green Published, Green Submitted			2022-12-27	WOS:000312064100077
J	Niemantsverdriet, M; Nagle, P; Chiu, RK; Langendijk, JA; Kampinga, HH; Coppes, RP				Niemantsverdriet, Maarten; Nagle, Peter; Chiu, Roland K.; Langendijk, Johannes A.; Kampinga, Harm H.; Coppes, Robert P.			Delta Np73 Enhances Promoter Activity of TGF-beta Induced Genes	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SERIAL ANALYSIS; MICE DEFICIENT; P53; EXPRESSION; P73; IDENTIFICATION; INHIBITOR; RADIATION; BINDING	The p53 homolog p73 is frequently overexpressed in cancers. Especially the transactivation domain truncated isoform Delta Np73 has oncogenic properties and its upregulation is associated with poor patient survival. It has been shown that Delta Np73 has an inhibitory effect on the transactivation capacity of p53 and other p73 isoforms. Here, we confirm this finding but surprisingly find that Delta Np73 may also stimulate the expression of TGF-beta signaling targets. Promoter-reporter analysis indicated that the presence of Smad Binding Elements (SBE) in the promoter is sufficient for stimulation of gene expression by Delta Np73. TGF-beta signaling was less efficient in Delta Np73 downregulated cells, whereas tetracycline induced Delta Np73 increased expression of endogenous TGF-beta regulated genes PAI-1 and Col1a1. Pull-down assays with SBE DNA suggest that Delta Np73 enhances smad3/4 binding to SBEs, thereby stimulating TGF-beta signaling. Chromatin immunoprecipitation assays confirmed a direct interaction between Delta Np73 and SBE. Given the role of TGF-beta signaling in carcinogenesis, tumor invasion and metastasis via targets like PAI-1 and Col1a1, our data suggest a model on how this effect of Delta Np73 could be a contributing factor in cancer progression.	[Niemantsverdriet, Maarten; Nagle, Peter; Chiu, Roland K.; Kampinga, Harm H.; Coppes, Robert P.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Radiat & Stress Cell Biol, Groningen, Netherlands; [Niemantsverdriet, Maarten; Nagle, Peter; Chiu, Roland K.; Langendijk, Johannes A.; Coppes, Robert P.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands	University of Groningen; University of Groningen	Coppes, RP (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Radiat & Stress Cell Biol, Groningen, Netherlands.	r.p.coppes@umcg.nl	Nagle, Peter/AGI-9589-2022; Nagle, Peter/ABA-2482-2020; Coppes, Robert P/B-4089-2008	Nagle, Peter/0000-0001-6150-2571; Coppes, Robert P/0000-0001-5503-1064; Langendijk, Johannes A./0000-0003-1083-372X; Kampinga, Harm/0000-0002-8966-8466				Andreasen PA, 2007, CURR DRUG TARGETS, V8, P1030, DOI 10.2174/138945007781662346; Boldrup L, 2007, J PATHOL, V213, P384, DOI 10.1002/path.2237; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Craig AL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-195; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; deCaestecker MP, 1997, J BIOL CHEM, V272, P13690, DOI 10.1074/jbc.272.21.13690; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; deWinter JP, 1997, ONCOGENE, V14, P1891, DOI 10.1038/sj.onc.1201017; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Falanga V, 2002, J CELL PHYSIOL, V191, P42, DOI 10.1002/jcp.10065; Fujitani M, 2010, CURR BIOL, V20, P2058, DOI 10.1016/j.cub.2010.10.029; Grob TJ, 2001, CELL DEATH DIFFER, V8, P1213, DOI 10.1038/sj.cdd.4400962; Hageman J, 2005, CLIN CANCER RES, V11, P5956, DOI 10.1158/1078-0432.CCR-05-0427; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; KEETON MR, 1991, J BIOL CHEM, V266, P23048; Killick R, 2011, MOL NEUROBIOL, V43, P139, DOI 10.1007/s12035-011-8172-6; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lasfer M, 2006, FEBS LETT, V580, P2547, DOI 10.1016/j.febslet.2006.03.089; Liu G, 2004, MOL CELL BIOL, V24, P487, DOI 10.1128/MCB.24.2.487-501.2004; Liu SS, 2006, CLIN CANCER RES, V12, P3922, DOI 10.1158/1078-0432.CCR-05-2573; Markl B, 2010, J SURG ONCOL, V102, P235, DOI 10.1002/jso.21611; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Niemantsverdriet M, 2005, EXP CELL RES, V310, P237, DOI 10.1016/j.yexcr.2005.07.016; Niemantsverdriet M, 2010, RADIOTHER ONCOL, V97, P33, DOI 10.1016/j.radonc.2010.04.002; Oswald C, 2008, CELL CYCLE, V7, P1726, DOI 10.4161/cc.7.12.6148; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Piccolo S, 2008, CELL, V133, P767, DOI 10.1016/j.cell.2008.05.013; Rundle CH, 2008, CALCIFIED TISSUE INT, V83, P276, DOI 10.1007/s00223-008-9169-7; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Saramaki A, 2006, NUCLEIC ACIDS RES, V34, P543, DOI 10.1093/nar/gkj460; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Takebayashi-Suzuki K, 2003, DEVELOPMENT, V130, P3929, DOI 10.1242/dev.00615; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Uramoto H, 2004, CLIN CANCER RES, V10, P6905, DOI 10.1158/1078-0432.CCR-04-0290; Vella V, 2009, INT J CANCER, V124, P2539, DOI 10.1002/ijc.24221; Vilgelm AE, 2010, ONCOGENE, V29, P5861, DOI 10.1038/onc.2010.319; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Whitman M, 2003, CELL, V113, P275, DOI 10.1016/S0092-8674(03)00317-9; Wierenga ATJ, 2002, LEUKEMIA RES, V26, P1105, DOI 10.1016/S0145-2126(02)00054-1; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yasui W, 2004, CANCER SCI, V95, P385, DOI 10.1111/j.1349-7006.2004.tb03220.x; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179	53	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50815	10.1371/journal.pone.0050815	http://dx.doi.org/10.1371/journal.pone.0050815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236396	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100036
J	Yu, PL; Wang, Q; Zhang, LH; Lee, HC; Zhang, LR; Yue, JB				Yu, Peilin; Wang, Qian; Zhang, Li-He; Lee, Hon-Cheung; Zhang, Liangren; Yue, Jianbo			A Cell Permeable NPE Caged ADP-Ribose for Studying TRPM2	PLOS ONE			English	Article							OXIDATIVE STRESS; ION-CHANNEL; INTRACELLULAR CALCIUM; INSULIN-SECRETION; BIPOLAR DISORDER; CATION CHANNELS; BETA-CELLS; ACTIVATION; ZINC; CA2+	Transient potential receptor melastatin-2 (TRPM2) is a non-selective Ca2+-permeable cation channel of the TRPM channel subfamily and is mainly activated by intracellular adenosine diphosphate ribose (ADPR). Here we synthesized a 1-(2-nitrophenyl) ethyl caged ADPR (NPE-ADPR) and found that uncaging of NPE-ADPR efficiently stimulated Ca2+, Mg2+, and Zn2+ influx in a concentration-dependent manner in intact human Jurkat T-lymphocytes. The cation influx was inhibited by inhibitors or knockdown of TRPM2. Likewise, uncaging of NPE-ADPR markedly induced cation entry in HEK 293 cells that overexpress TRPM2. As expected, high temperature increased the ability of the photolyzed NPE-ADPR to induce cation entry, whereas acidic pH inhibited. Moreover, the absence of extracellular Ca2+ significantly inhibited Mg2+ and Zn2+ influx after uncaging NPE-ADPR. On the other hand, the absence of extracellular Na+ or Mg2+ had no effect on photolyzed NPE-ADPR induced Ca2+ entry. Taken together, our results indicated that NPE-ADPR is a cell permeable ADPR analogue that is useful for studying TRPM2-mediated cation entry in intact cells.	[Yu, Peilin; Wang, Qian; Yue, Jianbo] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Yu, Peilin; Zhang, Li-He; Lee, Hon-Cheung; Zhang, Liangren] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Yu, Peilin] Zhejiang Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou 310003, Zhejiang, Peoples R China	University of Hong Kong; Peking University; Zhejiang University	Yue, JB (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	jyue@hku.hk	Yue, Jianbo/AAC-4588-2019; WANG, Qian/R-3192-2017; Zhang, Liang/GWM-6088-2022; Lee, Hon Cheung/C-4329-2009; Yue, Jianbo/K-8002-2015	Yue, Jianbo/0000-0001-6384-5447	Research Grant Council (RGC) [HKU 784710M, HKU 782709M, HKU 785911M]; National Natural Science Foundation of China (NSFC)/RGC grant from Hong Kong [N_HKU 737/09]; NSFC [20910094]; Leukemia and Lymphoma Society of America	Research Grant Council (RGC)(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)/RGC grant from Hong Kong; NSFC(National Natural Science Foundation of China (NSFC)); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society)	This work was supported by Research Grant Council (RGC) grants (HKU 784710M, HKU 782709M, HKU 785911M) and a National Natural Science Foundation of China (NSFC)/RGC grant from Hong Kong (N_HKU 737/09) and NSFC (20910094), and a Special Fellow Award from the Leukemia and Lymphoma Society of America (J.Y). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Du JY, 2009, J GEN PHYSIOL, V134, P471, DOI 10.1085/jgp.200910254; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Grubisha O, 2006, J BIOL CHEM, V281, P14057, DOI 10.1074/jbc.M513741200; Gustafsson AJ, 2011, MOL CELL ENDOCRINOL, V333, P8, DOI 10.1016/j.mce.2010.11.004; Heiner I, 2006, BIOCHEM J, V398, P225, DOI 10.1042/BJ20060183; Hermosura MC, 2008, P NATL ACAD SCI USA, V105, P18029, DOI 10.1073/pnas.0808218105; Islam MS, 2011, ADV EXP MED BIOL, V704, P811, DOI 10.1007/978-94-007-0265-3_42; Jiang LH, 2010, EXPERT OPIN THER TAR, V14, P973, DOI 10.1517/14728222.2010.510135; Kashio M, 2012, P NATL ACAD SCI USA, V109, P6745, DOI 10.1073/pnas.1114193109; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Lambert S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202945; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Lange I, 2008, CELL CALCIUM, V44, P604, DOI 10.1016/j.ceca.2008.05.001; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031905; Magnone M, 2012, J BIOL CHEM, V287, P21067, DOI 10.1074/jbc.M111.324269; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Naziroglu M, J MEMBR BIOL, V241, P51; Partida-Sanchez S, 2007, J IMMUNOL, V179, P7827, DOI 10.4049/jimmunol.179.11.7827; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; Sauve AA, 2004, CURR MED CHEM, V11, P807, DOI 10.2174/0929867043455675; Scharenberg AM, 2009, ISLETS, V1, P165, DOI 10.4161/isl.1.2.9434; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Starkus J, 2007, J GEN PHYSIOL, V130, P427, DOI 10.1085/jgp.200709836; Sumoza-Toledo A., 2010, J PHYSL, V589, P1515; Sumoza-Toledo A, 2011, FASEB J, V25, P3529, DOI 10.1096/fj.10-178483; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Takahashi N, CELL CALCIUM, V50, P279; Takahashi N, 2011, CELL CALCIUM, V50, P279, DOI 10.1016/j.ceca.2011.04.006; Takeda A, 2009, BRAIN RES REV, V62, P33, DOI 10.1016/j.brainresrev.2009.09.003; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Uchida K, 2011, DIABETES, V60, P119, DOI 10.2337/db10-0276; von Kugelgen I, 2000, N-S ARCH PHARMACOL, V362, P310, DOI 10.1007/s002100000310; Wagner TFJ, 2010, PFLUG ARCH EUR J PHY, V460, P755, DOI 10.1007/s00424-010-0838-9; WALKER JW, 1988, J AM CHEM SOC, V110, P7170, DOI 10.1021/ja00229a036; WALKER JW, 1989, METHOD ENZYMOL, V172, P288; Wei WJ, 2012, J BIOL CHEM, V287, P35599, DOI 10.1074/jbc.M112.392530; Xia R, 2008, J BIOL CHEM, V283, P27426, DOI 10.1074/jbc.M801049200; Xie Yu-Feng, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P95; Xu C, 2006, AM J MED GENET B, V141B, P36, DOI 10.1002/ajmg.b.30239; Xu C, 2009, BIPOLAR DISORD, V11, P1, DOI 10.1111/j.1399-5618.2008.00655.x; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yang KT, 2006, CELL DEATH DIFFER, V13, P1815, DOI 10.1038/sj.cdd.4401813; Yang W, 2011, J BIOL CHEM, V286, P23789, DOI 10.1074/jbc.M111.247478; Yang W, 2010, J BIOL CHEM, V285, P30411, DOI 10.1074/jbc.M110.139774; Yu PL, 2012, J BIOL CHEM, V287, P24774, DOI 10.1074/jbc.M111.329854; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767	55	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51028	10.1371/journal.pone.0051028	http://dx.doi.org/10.1371/journal.pone.0051028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236422	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100053
J	Vlachakis, D; Pavlopoulou, A; Tsiliki, G; Komiotis, D; Stathopoulos, C; Balatsos, NAA; Kossida, S				Vlachakis, Dimitrios; Pavlopoulou, Athanasia; Tsiliki, Georgia; Komiotis, Dimitri; Stathopoulos, Constantinos; Balatsos, Nikolaos A. A.; Kossida, Sophia			An Integrated In Silico Approach to Design Specific Inhibitors Targeting Human Poly(A)-Specific Ribonuclease	PLOS ONE			English	Article							MESSENGER-RNA DEADENYLATION; STRUCTURAL BASIS; BINDING PROTEIN; POLY(A) BINDING; CAP-BINDING; DOMAIN; DECAY; PARN; IDENTIFICATION; ALGORITHMS	Poly(A)-specific ribonuclease (PARN) is an exoribonuclease/deadenylase that degrades 3'-end poly(A) tails in almost all eukaryotic organisms. Much of the biochemical and structural information on PARN comes from the human enzyme. However, the existence of PARN all along the eukaryotic evolutionary ladder requires further and thorough investigation. Although the complete structure of the full-length human PARN, as well as several aspects of the catalytic mechanism still remain elusive, many previous studies indicate that PARN can be used as potent and promising anti-cancer target. In the present study, we attempt to complement the existing structural information on PARN with in-depth bioinformatics analyses, in order to get a hologram of the molecular evolution of PARNs active site. In an effort to draw an outline, which allows specific drug design targeting PARN, an unequivocally specific platform was designed for the development of selective modulators focusing on the unique structural and catalytic features of the enzyme. Extensive phylogenetic analysis based on all the publicly available genomes indicated a broad distribution for PARN across eukaryotic species and revealed structurally important amino acids which could be assigned as potentially strong contributors to the regulation of the catalytic mechanism of PARN. Based on the above, we propose a comprehensive in silico model for the PARN's catalytic mechanism and moreover, we developed a 3D pharmacophore model, which was subsequently used for the introduction of DNP-poly(A) amphipathic substrate analog as a potential inhibitor of PARN. Indeed, biochemical analysis revealed that DNP-poly(A) inhibits PARN competitively. Our approach provides an efficient integrated platform for the rational design of pharmacophore models as well as novel modulators of PARN with therapeutic potential. Citation: Vlachakis D, Pavlopoulou A, Tsiliki G, Komiotis D, Stathopoulos C, et al. (2012) An Integrated In Silico Approach to Design Specific Inhibitors Targeting Human Poly(A)-Specific Ribonuclease. PLoS ONE 7(12): e51113. doi:10.1371/journal.pone.0051113	[Komiotis, Dimitri; Balatsos, Nikolaos A. A.] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Vlachakis, Dimitrios; Pavlopoulou, Athanasia; Tsiliki, Georgia; Kossida, Sophia] Acad Athens, Biomed Res Fdn, Bioinformat & Med Informat Lab, Athens, Greece; [Stathopoulos, Constantinos] Univ Patras, Sch Med, Dept Biochem, Rion, Greece	University of Thessaly; Academy of Athens; University of Patras	Balatsos, NAA (corresponding author), Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece.	balatsos@bio.uth.gr; skossida@bioacademy.gr	Pavlopoulou, Athanasia/AAH-1204-2020; Kossida, Sofia/ABG-3526-2020; Vlachakis, Dimitrios/O-4323-2018; Pavlopoulou, Athanasia/ABB-3275-2021	Vlachakis, Dimitrios/0000-0003-1823-6102; Stathopoulos, Constantinos/0000-0002-5699-4118; Pavlopoulou, Athanasia/0000-0002-0815-3808; Tsiliki, Georgia/0000-0001-7209-3670; Balatsos, Nikolaos/0000-0002-1146-1174				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], MOL OP ENV MOE 2011; Ashun MA, 1996, ANTIMICROB AGENTS CH, V40, P2311, DOI 10.1128/AAC.40.10.2311; ASTROM J, 1991, EMBO J, V10, P3067, DOI 10.1002/j.1460-2075.1991.tb07858.x; ASTROM J, 1992, J BIOL CHEM, V267, P18154; Balatsos NAA, 2006, J BIOL CHEM, V281, P4517, DOI 10.1074/jbc.M508590200; Balatsos N, 2012, BIOCHIMIE, V94, P214, DOI 10.1016/j.biochi.2011.10.011; Balatsos NAA, 2009, BIOCHEMISTRY-US, V48, P6044, DOI 10.1021/bi900236k; Balatsos NAA, 2009, J ENZYM INHIB MED CH, V24, P516, DOI [10.1080/14756360802218763, 10.1080/14756360802218763 ]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Cheng YA, 2006, PROTEIN PEPTIDE LETT, V13, P125, DOI 10.2174/092986606775101580; Chiba Y, 2004, GENE, V328, P95, DOI 10.1016/j.gene.2003.11.028; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; Copeland PR, 2001, RNA, V7, P875, DOI 10.1017/S1355838201010020; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; CRAMER RD, 1988, J AM CHEM SOC, V110, P5959, DOI 10.1021/ja00226a005; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Henriksson N, 2010, J BIOL CHEM, V285, P163, DOI 10.1074/jbc.M109.043893; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jones G, 1995, J COMPUT AID MOL DES, V9, P532, DOI 10.1007/BF00124324; Kazius J, 2005, J MED CHEM, V48, P312, DOI 10.1021/jm040835a; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; Kim JH, 2008, METHOD ENZYMOL, V448, P119, DOI 10.1016/S0076-6879(08)02607-4; Korner CG, 1997, J BIOL CHEM, V272, P10448; Labute P, 2001, J MED CHEM, V44, P1483, DOI 10.1021/jm0002634; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lin S.K., 2000, MOLECULES, V5, P987, DOI [10.3390/50700987, DOI 10.3390/50700987]; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Manful T, 2011, RNA, V17, P2039, DOI 10.1261/rna.2837311; Maragozidis P, ACTA HAEMATOL, V128, P39; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Marshall G.R., 1979, COMPUTER ASSISTED DR, P205; Martin YC, 1995, DISTANCE COMP DISCO, P318; Martinez J, 2001, J BIOL CHEM, V276, P27923, DOI 10.1074/jbc.M102270200; Martinez J, 2000, J BIOL CHEM, V275, P24222, DOI 10.1074/jbc.M001705200; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Nilsson P, 2007, J BIOL CHEM, V282, P32902, DOI 10.1074/jbc.M702375200; Olsen DS, 1998, GENETICS, V149, P1495; Opyrchal M, 2005, INSECT BIOCHEM MOLEC, V35, P1321, DOI 10.1016/j.ibmb.2005.08.004; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pettifer S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S19; R Development Core Team, 2012, R LANG ENV STAT COMP; Ren YG, 2002, J BIOL CHEM, V277, P5982, DOI 10.1074/jbc.M111515200; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Seal R, 2005, NUCLEIC ACIDS RES, V33, P376, DOI 10.1093/nar/gki169; Sellis D, 2009, BIOINFORM BIOL INSIG, V3, P99; Smith G. M., 1990, TETRAHEDRON COMPUT M, V3, P615; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Thore S, 2003, EMBO REP, V4, P1150, DOI 10.1038/sj.embor.7400020; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Venables W., 2013, MODERN APPL STAT S P, DOI DOI 10.1007/978-0-387-21706-2; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wu MS, 2009, STRUCTURE, V17, P276, DOI 10.1016/j.str.2008.11.012; Wu MS, 2005, EMBO J, V24, P4082, DOI 10.1038/sj.emboj.7600869	70	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51113	10.1371/journal.pone.0051113	http://dx.doi.org/10.1371/journal.pone.0051113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236441	Green Published, Green Submitted, gold			2022-12-27	WOS:000312589700030
J	Yadav, A; Yadav, S; Kesarwani, R				Yadav, Awdhesh; Yadav, Suryakant; Kesarwani, Ranjana			Decelerating Mortality Rates in Older Ages and its Prospects through Lee-Carter Approach	PLOS ONE			English	Article								The present study attempts to study the age pattern mortality and prospects through Lee-Carter approach. The objectives of the study are to examine the trend of mortality decline and life expectancy. Contemporaneously, we have projected life expectancy up to 2025, projecting ASDR using Lee-Carter method. Life table aging rate (LAR) used to estimate the rate of mortality deceleration. Overtime, LAR increased and during recent decade it remained more or less unchanged. By age, LAR significant increased in the oldest of old. The slope is steepest in the oldest of old in the recent decade. The rates of mortality increased in oldest of old as the age group is more vulnerable to chronic disease and vulnerable to identifiable risk factors for virtually every disease, marked by senility. The analysis revealed that the level of mortality is not declining but rate of acceleration is declining and is further expected to decline. By the year 2025, the age specific death rates for the age group 5-9 and 10-14 will go below one per thousand. Life expectancy will attained as high as 73 and 79 years for male and female and is further expected to increase linearly. 71 percent of total female birth and 57 percent of total male birth will survive up to age 70+. Also the findings revealed that mortality rate is declining with constant rate up to age 70 and thereafter, the mortality rate accelerates and this holds true for both sexes. Citation: Yadav A, Yadav S, Kesarwani R (2012) Decelerating Mortality Rates in Older Ages and its Prospects through Lee-Carter Approach. PLoS ONE 7(12): e50941. doi:10.1371/journal.pone.0050941	[Yadav, Awdhesh; Yadav, Suryakant; Kesarwani, Ranjana] IIPS, Bombay, Maharashtra, India	International Institute for Population Sciences	Yadav, A (corresponding author), IIPS, Bombay, Maharashtra, India.	awdhesh.stat@gmail.com	Yadav, Suryakant/O-3907-2016	Yadav, Suryakant/0000-0003-1579-9524				[Anonymous], 2004, SRS BAS ABR LIF TABL; Beard R.E., 1959, CIBA FDN C AGEING, P302; Bhat P N, 1991, J Inst Econ Res, V26, P49; Bhatt PNM, 2000, POPULATION STUDIES, V56, P119; CAREY JR, 1995, EXP GERONTOL, V30, P315, DOI 10.1016/0531-5565(94)00041-Z; COALE AJ, 1991, DEMOGRAPHY, V28, P293, DOI 10.2307/2061281; DAVIS K, 1956, AM ECON REV, V46, P305; Demeny Coale AJ., 1966, REGIONAL MODEL LIFE; ELO IT, 1992, POPUL INDEX, V58, P186, DOI 10.2307/3644718; Eurostat, 2022, LIF TABL EUR COUNTR; Finch CE, 1990, LONGEVITY SENESCENCE; Greville TNE, 1943, RECORD AM I ACTUARIE, V32, P29; GROVE GL, 1983, J GERONTOL, V38, P137, DOI 10.1093/geronj/38.2.137; Heligman L., 1980, J I ACTUAR, V107, P49, DOI [DOI 10.1017/S0020268100040257, 10.1017/S0020268100040257]; Horiuchi S, 1983, Popul Bull UN, P80; Horiuchi S, 1997, J GERONTOL A-BIOL, V52, pB78, DOI 10.1093/gerona/52A.1.B78; Horiuchi S, 1998, DEMOGRAPHY, V35, P391, DOI 10.2307/3004009; Houriuchi S, 1990, MATH POPUL STUD, V2, P245; KAESBERG PR, 1989, SEMIN ONCOL, V16, P28; KANNISTO V, 1994, POPUL DEV REV, V20, P793, DOI 10.2307/2137662; KHAZAELI AA, 1995, EXP GERONTOL, V30, P177; Lee R, 2000, ANN M POP AM LOS ANG; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; Manton KG, 1997, DEMOGRAPHY, V34, P135, DOI 10.2307/2061664; Masoro EJ, 1985, METABOLISM HDB BIOL; Masoro EJ, 1981, JAMA-J AM MED ASSOC; MCNOWN R, 1989, DEMOGRAPHY, V26, P645, DOI 10.2307/2061263; OROURKE MA, 1987, JAMA-J AM MED ASSOC, V258, P921, DOI 10.1001/jama.258.7.921; PEER PGM, 1993, CANCER, V71, P3547, DOI 10.1002/1097-0142(19930601)71:11<3547::AID-CNCR2820711114>3.0.CO;2-C; Redington FM, 1969, J I ACTUARIES, V95, P243; Registrar General of India, 2011, SAMPL REG SYST 1981; Roy TK, 1987, DYNAMICS POPULATION; Sohal R.S., 1986, P23; STREHLER BL, 1960, SCIENCE, V132, P14, DOI 10.1126/science.132.3418.14; Vaupal JW, 1986, WP8659 IIASA; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; VAUPEL JW, 1993, SCIENCE, V260, P1666, DOI 10.1126/science.8503016; *WHO, 2007, WHO MORT DAT; WILMOTH JR, 1995, POP STUD-J DEMOG, V49, P281, DOI 10.1080/0032472031000148516	40	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50941	10.1371/journal.pone.0050941	http://dx.doi.org/10.1371/journal.pone.0050941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057UO	23236414	Green Published, gold, Green Submitted			2022-12-27	WOS:000312589700025
J	Schmidt-Roach, S; Miller, KJ; Woolsey, E; Gerlach, G; Baird, AH				Schmidt-Roach, Sebastian; Miller, Karen J.; Woolsey, Erika; Gerlach, Gabriele; Baird, Andrew H.			Broadcast Spawning by Pocillopora Species on the Great Barrier Reef	PLOS ONE			English	Article							ASEXUAL REPRODUCTION; GENOTYPIC DIVERSITY; LUNAR PERIODICITY; GENETIC-STRUCTURE; EASTERN PACIFIC; CORALS; POPULATIONS; DAMICORNIS; PATTERNS; SCLERACTINIA	The coral genus Pocillopora is one of the few to include some species that broadcast spawn gametes and some species that brood larvae, although reports of reproductive mode and timing vary within and among species across their range. Notably, the ubiquitous Pocillopora damicornis has been described as both a brooder and spawner, although evidence of broadcast spawning is rare. Here, we report observations of broadcast-spawning in four species of Pocillopora on the Great Barrier Reef (GBR), including P. damicornis. All species spawned predictably during the early morning, two days following the full moon, and spawning was observed in multiple months over the summer period (November to February). Eggs and sperm were free-spawned concurrently. Eggs were negatively buoyant and contained Symbiodinium. This newfound knowledge on the mode, timing and regularity of broadcast spawning in Pocillopora spp. on the GBR brings us one step closer to elucidating the complex reproductive ecology of these species.	[Schmidt-Roach, Sebastian; Miller, Karen J.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Schmidt-Roach, Sebastian] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Woolsey, Erika; Baird, Andrew H.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Gerlach, Gabriele] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, D-2900 Oldenburg, Germany	University of Tasmania; Australian Institute of Marine Science; James Cook University; Carl von Ossietzky Universitat Oldenburg	Schmidt-Roach, S (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	s.schmidt-roach@aims.gov.au	Baird, Andrew Hamilton/C-8449-2009; Miller, Karen/A-7902-2011; Schmidt-Roach, Sebastian/N-7129-2013; Miller, Karen/V-4098-2019; Gerlach, Gabriele/K-5919-2012	Baird, Andrew Hamilton/0000-0001-8504-4077; Schmidt-Roach, Sebastian/0000-0002-7783-0198; Woolsey, Erika/0000-0002-5339-3499	Commonwealth Environment Research Facilities (CERF) program; Australian Government initiative supporting world class, public good research; Winifred Violet Scott Estate Trust; Endeavour International Postgraduate Research Scholarship (EIPRS); CERF Marine Biodiversity Hub scholarship	Commonwealth Environment Research Facilities (CERF) program; Australian Government initiative supporting world class, public good research(Australian Government); Winifred Violet Scott Estate Trust; Endeavour International Postgraduate Research Scholarship (EIPRS)(Australian Government); CERF Marine Biodiversity Hub scholarship	This work has been funded through the Commonwealth Environment Research Facilities (CERF) program, an Australian Government initiative supporting world class, public good research. The CERF Marine Biodiversity Hub is a collaborative partnership between the University of Tasmania, CSIRO Wealth from Oceans Flagship, Geoscience Australia, Australian Institute of Marine Science and Museum Victoria. Additionally this study was kindly supported by a research award from the Winifred Violet Scott Estate Trust. S. S-R is also supported by an Endeavour International Postgraduate Research Scholarship (EIPRS) and CERF Marine Biodiversity Hub scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayre DJ, 2004, MAR ECOL PROG SER, V277, P95, DOI 10.3354/meps277095; AYRE DJ, 1986, MAR BIOL, V90, P187, DOI 10.1007/BF00569126; Ayre DJ, 2000, EVOLUTION, V54, P1590; Babcock RC, 2003, ZOOL STUD, V42, P211; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baird AH, 2000, CORAL REEFS, V19, P179, DOI 10.1007/PL00006955; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; BENZIE JAH, 1995, MAR BIOL, V121, P731, DOI 10.1007/BF00349309; Bouwmeester J., 2011, GALAXEA J CORAL REEF, V13, P23; Combosch DJ, 2008, MOL ECOL, V17, P1304, DOI 10.1111/j.1365-294X.2007.03672.x; Combosch DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021200; Cumbo VR, 2012, MAR BIOL, V159, P2853, DOI 10.1007/s00227-012-2046-y; Douek J, 2011, GENETICA, V139, P1531, DOI 10.1007/s10709-012-9653-x; Fadlallah YH, 1985, 5TH P INT COR REEF C, V4, P313, DOI 10.1007/BF00347520; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fiene-Severns P, 1998, 42 U HAW; Flot JF, 2008, CR BIOL, V331, P239, DOI 10.1016/j.crvi.2007.12.003; Flot JF, 2007, GENE, V401, P80, DOI 10.1016/j.gene.2007.07.006; GLYNN PW, 1991, MAR BIOL, V109, P355, DOI 10.1007/BF01313501; Harii S, 2002, MAR BIOL, V141, P39, DOI 10.1007/s00227-002-0812-y; Harriott V.J., 1983, Coral Reefs, V2, P9, DOI 10.1007/BF00304727; Harrison P.L., 1990, CORAL REEFS, V25, P133; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Hirose M, 2000, BIOL BULL, V199, P68, DOI 10.2307/1542708; Kinzie Robert A. Iii, 1993, Galaxea, V11, P93; Kuanui P, 2008, MAR FRESHWATER RES, V11, P375; Marshall S. M., 1933, Scientific Reports Great Barrier Reef Expedition, V3, P219; Miller K, 1997, BIOL BULL, V192, P98, DOI 10.2307/1542579; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; Miller KJ, 2004, HEREDITY, V92, P557, DOI 10.1038/sj.hdy.6800459; Muir P, 1984, THESIS J COOK U, P60; Paz-Garcia DA, 2012, PAC SCI, V66, P43, DOI 10.2984/66.1.3; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; RICHMOND RH, 1984, B MAR SCI, V34, P280; Riddle D, 2009, 1 REPORT POCILLOPORA; Riddle D., 2008, ADV AQUARISTS ONLINE, V7, P10; Rodriguez-Troncoso AP, 2011, MAR BIOL, V158, P2673, DOI 10.1007/s00227-011-1765-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakai K, 1997, MAR ECOL PROG SER, V151, P67, DOI 10.3354/meps151067; Schmidt-Roach S, 2013, CORAL REEFS, V32, P161, DOI 10.1007/s00338-012-0959-z; Schmidt-Roach S, 2008, J EXP MAR BIOL ECOL, V367, P37, DOI 10.1016/j.jembe.2008.08.012; Sere MG, 2010, J EXP MAR BIOL ECOL, V395, P63, DOI 10.1016/j.jembe.2010.08.014; Sherman CDH, 2008, HEREDITY, V100, P296, DOI 10.1038/sj.hdy.6801076; Sherman CDH, 2006, CORAL REEFS, V25, P7, DOI 10.1007/s00338-005-0053-x; SHLESINGER Y, 1985, SCIENCE, V228, P1333, DOI 10.1126/science.228.4705.1333; SIER CJS, 1994, MAR BIOL, V118, P713, DOI 10.1007/BF00347520; STIMSON JS, 1978, MAR BIOL, V48, P173, DOI 10.1007/BF00395017; STODDART JA, 1984, CORAL REEFS, V3, P149, DOI 10.1007/BF00301959; STODDART JA, 1984, MAR BIOL, V81, P19, DOI 10.1007/BF00397621; STODDART JA, 1983, MAR BIOL, V76, P279, DOI 10.1007/BF00393029; STODDART JA, 1985, MAR ECOL PROG SER, V23, P153, DOI 10.3354/meps023153; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanner JE, 1996, CORAL REEFS, V15, P59, DOI 10.1007/s003380050028; Veron J.E.N., 2000, CORALS WORLD, V2, P429; Villanueva RD, 2008, MAR ECOL PROG SER, V370, P111, DOI 10.3354/meps07659; WARD S, 1992, MAR BIOL, V112, P641, DOI 10.1007/BF00346182; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242; Yeoh SR, 2010, MAR BIOL, V157, P351, DOI 10.1007/s00227-009-1322-y	59	53	53	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50847	10.1371/journal.pone.0050847	http://dx.doi.org/10.1371/journal.pone.0050847			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227215	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000312588200076
J	Hosseinpour, B; HajiHoseini, V; Kashfi, R; Ebrahimie, E; Hemmatzadeh, F				Hosseinpour, Batool; HajiHoseini, Vahid; Kashfi, Rafieh; Ebrahimie, Esmaeil; Hemmatzadeh, Farhid			Protein Interaction Network of Arabidopsis thaliana Female Gametophyte Development Identifies Novel Proteins and Relations	PLOS ONE			English	Article							POLYCOMB GROUP GENE; ENDOSPERM DEVELOPMENT; JASMONIC ACID; CENTRAL CELL; EXPRESSION; AUXIN; DEFENSE; FAMILY; SPECIFICATION; MUTATIONS	Although the female gametophyte in angiosperms consists of just seven cells, it has a complex biological network. In this study, female gametophyte microarray data from Arabidopsis thaliana were integrated into the Arabidopsis interactome database to generate a putative interaction map of the female gametophyte development including proteome map based on biological processes and molecular functions of proteins. Biological and functional groups as well as topological characteristics of the network were investigated by analyzing phytohormones, plant defense, cell death, transporters, regulatory factors, and hydrolases. This approach led to the prediction of critical members and bottlenecks of the network. Seventy-four and 24 upregulated genes as well as 171 and 3 downregulated genes were identified in subtracted networks based on biological processes and molecular function respectively, including novel genes such as the pathogenesis-related protein 4, ER type Ca2+ ATPase 3, dihydroflavonol reductase, and ATP disulfate isomerase. Biologically important relationships between genes, critical nodes, and new essential proteins such as AT1G26830, AT5G20850, CYP74A, AT1G42396, PR4 and MEA were found in the interactome's network. The positions of novel genes, both upregulated and downregulated, and their relationships with biological pathways, in particular phytohormones, were highlighted in this study. Citation: Hosseinpour B, HajiHoseini V, Kashfi R, Ebrahimie E, Hemmatzadeh F (2012) Protein Interaction Network of Arabidopsis thaliana Female Gametophyte Development Identifies Novel Proteins and Relations. PLoS ONE 7(12): e49931. doi:10.1371/journal.pone.0049931	[Kashfi, Rafieh; Ebrahimie, Esmaeil] Shiraz Univ, Coll Agr, Dept Crop Prod & Plant Breeding, Shiraz, Iran; [Hosseinpour, Batool] Iranian Res Org Sci & Technol, Inst Agr, Tehran, Iran; [HajiHoseini, Vahid] Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Hemmatzadeh, Farhid] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia	Shiraz University; University of Tehran; University of Adelaide; University of Adelaide	Ebrahimie, E (corresponding author), Shiraz Univ, Coll Agr, Dept Crop Prod & Plant Breeding, Shiraz, Iran.	esmaeil.ebrahimie@adelaide.edu.au; farhid.hemmatzadeh@adelaide.edu.au	Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mansour/AAO-9096-2021	Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mansour/0000-0001-7011-2567; Hemmatzadeh, Farhid/0000-0002-4572-8869				Amien S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000388; Bader GD, 2000, BIOINFORMATICS, V16, P465, DOI 10.1093/bioinformatics/16.5.465; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Burbulis IE, 1999, P NATL ACAD SCI USA, V96, P12929, DOI 10.1073/pnas.96.22.12929; Chautard E, 2009, PATHOL BIOL, V57, P324, DOI 10.1016/j.patbio.2008.10.004; Chevalier E, 2011, NEW PHYTOL, V192, P13, DOI 10.1111/j.1469-8137.2011.03836.x; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Collinge MA, 2004, PLANT CELL, V16, P1035, DOI 10.1105/tpc.019059; FALK A, 1995, PLANT PHYSIOL, V108, P1369, DOI 10.1104/pp.108.4.1369; Feuerstein A, 2010, PLANT BIOLOGY, V12, P105, DOI 10.1111/j.1438-8677.2010.00389.x; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Ge XC, 2010, CURR BIOL, V20, pR988, DOI 10.1016/j.cub.2010.09.040; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Goetz M, 2006, PLANT CELL, V18, P1873, DOI 10.1105/tpc.105.037192; He F, 2010, PLANT PHYSIOL, V153, P1492, DOI 10.1104/pp.110.153650; Houston NL, 2005, PLANT PHYSIOL, V137, P762, DOI 10.1104/pp.104.056507; Hwang S, 2008, J THEOR BIOL, V252, P722, DOI 10.1016/j.jtbi.2008.02.011; Idowu OC, 2004, BACILLUS SUBTILIS PR, V2004, P623; Johnston AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r204; Kagi C, 2010, P NATL ACAD SCI USA, V107, P22350, DOI 10.1073/pnas.1012795108; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; KIYOSUE T, 1994, PLANT J, V6, P259, DOI 10.1046/j.1365-313X.1994.6020259.x; Li L, 2001, PLANT PHYSIOL, V127, P1414, DOI 10.1104/pp.010705; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; Martin MN, 2007, PLANT PHYSIOL, V144, P1715, DOI 10.1104/pp.106.094409; Mills RF, 2008, PLANT PHYSIOL, V146, P116, DOI 10.1104/pp.107.110817; Mitchell AG, 1997, J BIOL CHEM, V272, P28281, DOI 10.1074/jbc.272.45.28281; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Norman-Setterblad C, 2000, MOL PLANT MICROBE IN, V13, P430, DOI 10.1094/MPMI.2000.13.4.430; Ohad N, 1999, PLANT CELL, V11, P407, DOI 10.1105/tpc.11.3.407; Pagnussat GC, 2009, SCIENCE, V324, P1684, DOI 10.1126/science.1167324; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Portereiko MF, 2006, PLANT CELL, V18, P1862, DOI 10.1105/tpc.106.040824; Rask L, 2000, PLANT MOL BIOL, V42, P93, DOI 10.1023/A:1006380021658; Running MP, 2004, P NATL ACAD SCI USA, V101, P7815, DOI 10.1073/pnas.0402385101; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Skrabanek L, 2008, MOL BIOTECHNOL, V38, P1, DOI 10.1007/s12033-007-0069-2; Steffen JG, 2007, PLANT J, V51, P281, DOI 10.1111/j.1365-313X.2007.03137.x; Wang D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-110; Wen HC, 2003, CELL SIGNAL, V15, P37, DOI 10.1016/S0898-6568(02)00047-5; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Yadegari R, 2000, PLANT CELL, V12, P2367, DOI 10.1105/tpc.12.12.2367; Yang WC, 2010, ANNU REV PLANT BIOL, V61, P89, DOI 10.1146/annurev-arplant-042809-112203; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yu HJ, 2005, PLANT PHYSIOL, V139, P1853, DOI 10.1104/pp.105.067314; Yu QB, 2008, CELL RES, V18, P1007, DOI 10.1038/cr.2008.286; ZHANG XS, 1993, PLANT CELL, V5, P403, DOI 10.1105/tpc.5.4.403	59	20	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49931	10.1371/journal.pone.0049931	http://dx.doi.org/10.1371/journal.pone.0049931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239973	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800011
J	Warchol, ME; Schwendener, RA; Hirose, K				Warchol, Mark E.; Schwendener, Reto A.; Hirose, Keiko			Depletion of Resident Macrophages Does Not Alter Sensory Regeneration in the Avian Cochlea	PLOS ONE			English	Article							LIPOSOME-MEDIATED DEPLETION; HAIR-CELLS; SUPPORTING CELLS; ORGAN-CULTURES; HYALINE CELLS; MECHANISM; DAMAGE; ATP	Macrophages are the primary effector cells of the innate immune system and are also activated in response to tissue injury. The avian cochlea contains a population of resident macrophages, but the precise function of those cells is not known. The present study characterized the behavior of cochlear macrophages after aminoglycoside ototoxicity and also examined the possible role of macrophages in sensory regeneration. We found that the undamaged chick cochlea contains a large resting population of macrophages that reside in the hyaline cell region, immediately outside the abneural (inferior) border of the sensory epithelium. Following ototoxic injury, macrophages appear to migrate out of the hyaline cell region and towards the basilar membrane, congregating immediately below the lesioned sensory epithelium. In order to determine whether recruited macrophages contribute to the regeneration of sensory receptors, we quantified supporting cell proliferation and hair cell recovery after the elimination of most resident macrophages via application of liposomally-encapsulated clodronate. Examination of macrophage-depleted specimens at two days following ototoxic injury revealed no deficits in hair cell clearance, when compared to normal controls. In addition, we found that elimination of macrophages did not affect either regenerative proliferation of supporting cells or the production of replacement hair cells. However, we did find that macrophage-depleted cochleae contained reduced numbers of proliferative mesothelial cells below the basilar membrane. Our data suggest that macrophages are not required for normal debris clearance and regeneration, but that they may play a role in the maintenance of the basilar membrane.	[Warchol, Mark E.; Hirose, Keiko] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA; [Warchol, Mark E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Schwendener, Reto A.] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland	Washington University (WUSTL); Washington University (WUSTL); University of Zurich	Warchol, ME (corresponding author), Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA.	warcholm@ent.wustl.edu	Schwendener, Reto A/F-6373-2011	Schwendener, Reto/0000-0002-8114-6321	 [R01DC006283];  [R01DC011315];  [P30DC004665]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006283, R01DC011315, P30DC004665] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by grants R01DC006283 (to MEW) and R01DC011315 (to KH). Additional support for imaging was provided by grant P30DC004665. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrashkin KA, 2006, HEARING RES, V218, P20, DOI 10.1016/j.heares.2006.04.001; BALAK KJ, 1990, J NEUROSCI, V10, P2502; Bhave SA, 1998, J COMP NEUROL, V398, P241, DOI 10.1002/(SICI)1096-9861(19980824)398:2<241::AID-CNE6>3.0.CO;2-0; Bird JE, 2010, J NEUROSCI, V30, P12545, DOI 10.1523/JNEUROSCI.3042-10.2010; COTANCHE DA, 1987, HEARING RES, V30, P181, DOI 10.1016/0378-5955(87)90135-3; COTANCHE DA, 1992, J COMP NEUROL, V324, P353, DOI 10.1002/cne.903240306; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Gale JE, 2004, CURR BIOL, V14, P526, DOI 10.1016/j.cub.2004.03.002; GIROD DA, 1989, HEARING RES, V42, P175, DOI 10.1016/0378-5955(89)90143-3; Hirose K, 2005, J COMP NEUROL, V489, P180, DOI 10.1002/cne.20619; Hirose K, 2004, J COMP NEUROL, V470, P164, DOI 10.1002/cne.11046; Jones JE, 1996, J NEUROSCI, V16, P649; Lahne M, 2008, J NEUROSCI, V28, P4918, DOI 10.1523/JNEUROSCI.4914-07.2008; Lippe WR, 2002, J COMP PHYSIOL A, V188, P381, DOI 10.1007/s00359-002-0312-z; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Matsui JI, 2002, J NEUROSCI, V22, P1218, DOI 10.1523/JNEUROSCI.22-04-01218.2002; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; O'Halloran EK, 2004, J COMP NEUROL, V475, P340, DOI 10.1002/cne.20162; ROBERSON DW, 1994, AM J OTOL, V15, P28; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Sato E, 2010, JARO-J ASSOC RES OTO, V11, P223, DOI 10.1007/s10162-009-0198-3; Shang JL, 2010, JARO-J ASSOC RES OTO, V11, P203, DOI 10.1007/s10162-009-0206-7; Sieger D, 2012, DEV CELL, V22, P1138, DOI 10.1016/j.devcel.2012.04.012; Slepecky N. B., 1996, COCHLEA, V8, P44; Stefater JA, 2011, TRENDS MOL MED, V17, P743, DOI 10.1016/j.molmed.2011.07.009; Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js; Stone JS, 1996, J NEUROSCI, V16, P6157; Taylor RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030577; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Warchol ME, 2011, HEARING RES, V273, P72, DOI 10.1016/j.heares.2010.05.004; Warchol ME, 1996, J NEUROSCI, V16, P5466; Warchol ME, 1997, J NEUROBIOL, V33, P724, DOI 10.1002/(SICI)1097-4695(19971120)33:6<724::AID-NEU2>3.0.CO;2-B; Warchol ME, 1999, J NEUROCYTOL, V28, P889, DOI 10.1023/A:1007026306730; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zidanic M, 2002, J COMP NEUROL, V445, P159, DOI 10.1002/cne.10160	36	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51574	10.1371/journal.pone.0051574	http://dx.doi.org/10.1371/journal.pone.0051574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240046	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800082
J	Riese, A; Eilert, Y; Meyer, Y; Arin, M; Baron, JM; Eming, S; Krieg, T; Kurschat, P				Riese, Anna; Eilert, Yvonne; Meyer, Yvonne; Arin, Meral; Baron, Jens M.; Eming, Sabine; Krieg, Thomas; Kurschat, Peter			Epidermal Expression of Neuropilin 1 Protects Murine keratinocytes from UVB-induced apoptosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AUTOCRINE SURVIVAL FACTOR; TUMOR-CELLS; SEMAPHORIN; SKIN; INITIATION; RECEPTORS; CARCINOMA; MCL-1	Background: Neuropilin 1 (NRP1) is expressed on several cell types including neurons and endothelial cells, where it functions as an important regulator in development and during angiogenesis. As a cell surface receptor, NRP1 is able to bind to members of the VEGF family of growth factors and to secreted class 3 semaphorins. Neuropilin 1 is also highly expressed in keratinocytes, but the function of NRP1 in epidermal physiology and pathology is still unclear. Methods and Results: To elucidate the role of NRP1 in skin in vivo we generated an epidermis-specific neuropilin 1 knock out mouse model by using the Cre-LoxP-System. Mice were viable and fertile and did not display any obvious skin or hair defects. After challenge with UVB irradiation, we found that deletion of epidermal NRP1 leads to increased rates of apoptosis both in vitro and in vivo. NRP1-deficient primary keratinocytes cultured in vitro showed significantly higher rates of apoptosis 24 hours after UVB. Likewise, there is a significant increase of active caspase 3 positive cells in the epidermis of Keratin 14-Cre-NRP1 (-/-) mice 24 hours after UVB irradiation. By Western Blot analysis we could show that NRP1 influences the cytosolic levels of Bcl-2, a pro-survival member of the Bcl-2 family. After UVB irradiation the amounts of Bcl-2 decrease in both protein extracts from murine epidermis and in NRP1-deficient keratinocytes in vitro, whereas wild type cells retain their Bcl-2 levels. Likewise, levels of phospho-Erk and Rac1 were lower in NRP1-knock out keratinocytes, whereas levels of pro-apoptotic p53 were higher. Conclusion: NRP1 expression in keratinocytes is dispensable for normal skin development. Upon UVB challenge, NRP1 contributes to the prevention of keratinocyte apoptosis. This pro-survival function of NRP1 is accompanied by the maintenance of high levels of the antiapoptotic regulator Bcl-2 and by lower levels of pro-apoptotic p53.	[Riese, Anna; Eilert, Yvonne; Meyer, Yvonne; Arin, Meral; Eming, Sabine; Krieg, Thomas; Kurschat, Peter] Univ Hosp Cologne, Dept Dermatol & Venerol, Cologne, Germany; [Baron, Jens M.] Rhein Westfal TH Aachen, Dept Dermatol & Allergol, D-52062 Aachen, Germany	University of Cologne; RWTH Aachen University	Kurschat, P (corresponding author), Univ Hosp Cologne, Dept Dermatol & Venerol, Cologne, Germany.	peter.kurschat@uk-koeln.de	Baron, Jens M/N-2934-2016	Baron, Jens M/0000-0002-1174-6946	Deutsche Forschungsgemeinschaft (DFG) [SFB 829]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) to PK (SFB 829, project B5) and SE (SFB 829, project B7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assefa Z, 2005, BBA-REV CANCER, V1755, P90, DOI 10.1016/j.bbcan.2005.04.001; Bachelder RE, 2001, CANCER RES, V61, P5736; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375; Brusselmans K, 2005, J BIOL CHEM, V280, P3493, DOI 10.1074/jbc.M406613200; Buckman SY, 1998, CARCINOGENESIS, V19, P723, DOI 10.1093/carcin/19.5.723; Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200; Cariboni A, 2011, DEVELOPMENT, V138, P3723, DOI 10.1242/dev.063362; Chang FM, 2003, INT J ONCOL, V22, P469; DETMAR M, 1994, J EXP MED, V180, P1141, DOI 10.1084/jem.180.3.1141; Droin NM, 2004, BBA-MOL CELL RES, V1644, P179, DOI 10.1016/j.bbamcr.2003.10.011; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Gagnon ML, 2000, P NATL ACAD SCI USA, V97, P2573, DOI 10.1073/pnas.040337597; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Kawakami T, 2002, CANCER, V95, P2196, DOI 10.1002/cncr.10936; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Klagsbrun M, 2002, ADV EXP MED BIOL, V515, P33; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kurschat P, 2006, J BIOL CHEM, V281, P2721, DOI 10.1074/jbc.M507860200; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Lippens S, 2005, CELL DEATH DIFFER, V12, P1497, DOI 10.1038/sj.cdd.4401722; Lippens S, 2009, APOPTOSIS, V14, P549, DOI 10.1007/s10495-009-0324-z; Mac Gabhann F, 2005, AM J PHYSIOL-HEART C, V288, pH2851, DOI 10.1152/ajpheart.01218.2004; Man XY, 2006, MOL MED, V12, P127, DOI 10.2119/2006-00024.Man; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Naik E, 2007, J CELL BIOL, V176, P415, DOI 10.1083/jcb.200608070; Nakabeppu Y, 2006, BIOL CHEM, V387, P373, DOI 10.1515/BC.2006.050; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Nishigori C, 2006, PHOTOCH PHOTOBIO SCI, V5, P208, DOI 10.1039/b507471a; Rodust PM, 2009, BRIT J DERMATOL, V161, P107, DOI 10.1111/j.1365-2133.2009.09458.x; Romeo PH, 2002, ADV EXP MED BIOL, V515, P49; Rygiel TP, 2008, J CELL SCI, V121, P1183, DOI 10.1242/jcs.017194; Sitailo LA, 2009, J INVEST DERMATOL, V129, P1351, DOI 10.1038/jid.2008.363; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Takahashi H, 2001, PHOTOCHEM PHOTOBIOL, V74, P579, DOI 10.1562/0031-8655(2001)074<0579:IVAIVT>2.0.CO;2; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Trakatelli M, 2007, BRIT J DERMATOL, V156, P1, DOI 10.1111/j.1365-2133.2007.07861.x; Wilgus TA, 2005, AM J PATHOL, V167, P1257, DOI 10.1016/S0002-9440(10)61213-8	41	17	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50944	10.1371/journal.pone.0050944	http://dx.doi.org/10.1371/journal.pone.0050944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251405	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900027
J	Thal, SC; Luh, C; Schaible, EV; Timaru-Kast, R; Hedrich, J; Luhmann, HJ; Engelhard, K; Zehendner, CM				Thal, Serge C.; Luh, Clara; Schaible, Eva-Verena; Timaru-Kast, Ralph; Hedrich, Jana; Luhmann, Heiko J.; Engelhard, Kristin; Zehendner, Christoph M.			Volatile Anesthetics Influence Blood-Brain Barrier Integrity by Modulation of Tight Junction Protein Expression in Traumatic Brain Injury	PLOS ONE			English	Article							ISOFLURANE ANESTHESIA; OCCLUDIN EXPRESSION; NEUROVASCULAR UNIT; CEREBRAL VESSELS; EDEMA FORMATION; SEVOFLURANE; FLOW; GLUTAMATE; ISCHEMIA; WATER	Disruption of the blood-brain barrier (BBB) results in cerebral edema formation, which is a major cause for high mortality after traumatic brain injury (TBI). As anesthetic care is mandatory in patients suffering from severe TBI it may be important to elucidate the effect of different anesthetics on cerebral edema formation. Tight junction proteins (TJ) such as zonula occludens-1 (ZO-1) and claudin-5 (cl5) play a central role for BBB stability. First, the influence of the volatile anesthetics sevoflurane and isoflurane on in-vitro BBB integrity was investigated by quantification of the electrical resistance (TEER) in murine brain endothelial monolayers and neurovascular co-cultures of the BBB. Secondly brain edema and TJ expression of ZO-1 and cl5 were measured in-vivo after exposure towards volatile anesthetics in native mice and after controlled cortical impact (CCI). In in-vitro endothelial monocultures, both anesthetics significantly reduced TEER within 24 hours after exposure. In BBB co-cultures mimicking the neurovascular unit (NVU) volatile anesthetics had no impact on TEER. In healthy mice, anesthesia did not influence brain water content and TJ expression, while 24 hours after CCI brain water content increased significantly stronger with isoflurane compared to sevoflurane. In line with the brain edema data, ZO-1 expression was significantly higher in sevoflurane compared to isoflurane exposed CCI animals. Immunohistochemical analyses revealed disruption of ZO-1 at the cerebrovascular level, while cl5 was less affected in the pericontusional area. The study demonstrates that anesthetics influence brain edema formation after experimental TBI. This effect may be attributed to modulation of BBB permeability by differential TJ protein expression. Therefore, selection of anesthetics may influence the barrier function and introduce a strong bias in experimental research on pathophysiology of BBB dysfunction. Future research is required to investigate adverse or beneficial effects of volatile anesthetics on patients at risk for cerebral edema.	[Thal, Serge C.; Luh, Clara; Schaible, Eva-Verena; Timaru-Kast, Ralph; Engelhard, Kristin] Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, Mainz, Germany; [Hedrich, Jana; Luhmann, Heiko J.; Zehendner, Christoph M.] Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, D-6500 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, Mainz, Germany.	thal@uni-mainz.de; zehendner@uni-mainz.de	Thal, Serge/D-6593-2011; Luhmann, Heiko J./N-8797-2019	Thal, Serge/0000-0002-1222-8729; Luhmann, Heiko J./0000-0002-7934-8661	Deutsche Forschungsgemeinschaft [TH1430/3-1]; Focus Program Translational Neurosciences (FTN); University Medical Center of the Johannes Gutenberg-University; University Medical Center of the Johannes Gutenberg-University Mainz; IMB Core Facility Microscopy of the Institute of Molecular Biology (IMB), Mainz	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Focus Program Translational Neurosciences (FTN); University Medical Center of the Johannes Gutenberg-University; University Medical Center of the Johannes Gutenberg-University Mainz; IMB Core Facility Microscopy of the Institute of Molecular Biology (IMB), Mainz	This work was supported by grants of the Deutsche Forschungsgemeinschaft (TH1430/3-1), the Focus Program Translational Neurosciences (FTN) and a stage 1 grant of the University Medical Center of the Johannes Gutenberg-University to SCT. CMZ is supported by a stage 1 grant of the University Medical Center of the Johannes Gutenberg-University Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no conflicting financial interest to declare.; The authors want to thank Dana Pieter, Tobias Hirnet, Sabine Rickheim-Lowack, Beate Kohler and Beate Krumm for her excellent technical assistance. Support by the IMB Core Facility Microscopy of the Institute of Molecular Biology (IMB), Mainz is gratefully acknowledged.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Antonetti DA, 2002, J NEUROCHEM, V80, P667, DOI 10.1046/j.0022-3042.2001.00740.x; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; D'Atri F, 2002, MOL MEMBR BIOL, V19, P103, DOI 10.1080/09687680210129236; Dittmar MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038260; Eberspacher E, 2009, ACTA ANAESTH SCAND, V53, P774, DOI 10.1111/j.1399-6576.2009.01954.x; FISCHER S, 1995, ANESTHESIOLOGY, V82, P451, DOI 10.1097/00000542-199502000-00015; Fischer S, 1996, BRAIN RES, V707, P47, DOI 10.1016/0006-8993(95)01219-2; Fukui K, 2010, J CLIN NEUROPHYSIOL, V27, P110, DOI 10.1097/WNP.0b013e3181d64da1; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hoffmann U, 2013, ACTA NEUROCHIR SUPPL, V115, P161, DOI 10.1007/978-3-7091-1192-5_31; Holmstrom A, 2004, J NEUROSURG ANESTH, V16, P136, DOI 10.1097/00008506-200404000-00005; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Iida H, 1998, ANESTHESIOLOGY, V89, P954, DOI 10.1097/00000542-199810000-00020; Jiang WG, 1998, BIOCHEM BIOPH RES CO, V244, P414, DOI 10.1006/bbrc.1998.8288; Kandatsu N, 2005, ANESTHESIOLOGY, V102, P1182, DOI 10.1097/00000542-200506000-00018; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Lu H, 1998, ANESTH ANALG, V87, P854, DOI 10.1097/00000539-199810000-00020; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; LUNDEEN G, 1983, ANESTH ANALG, V62, P499; MANOHAR M, 1984, J PHARMACOL EXP THER, V231, P640; Matta BF, 1999, ANESTHESIOLOGY, V91, P677, DOI 10.1097/00000542-199909000-00019; Mills CD, 1997, J NEUROTRAUM, V14, P943, DOI 10.1089/neu.1997.14.943; Ritz MF, 2006, INT J NEUROSCI, V116, P191, DOI 10.1080/00207450500341555; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; SCHETTINI A, 1979, BRIT J ANAESTH, V51, P1117, DOI 10.1093/bja/51.12.1117; Seo JH, 2012, CURRENT PHARM DESIGN; Shulga A, 2012, J NEUROSCI, V32, P1757, DOI 10.1523/JNEUROSCI.3282-11.2012; SMITH AL, 1976, ANESTHESIOLOGY, V45, P64, DOI 10.1097/00000542-197607000-00012; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stover JF, 2005, ACTA NEUROCHIR, V147, P847, DOI 10.1007/s00701-005-0562-y; Stover JF, 2004, ACTA NEUROCHIR, V146, P819, DOI 10.1007/s00701-004-0281-9; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2009, CRIT CARE MED, V37, P2228, DOI 10.1097/CCM.0b013e3181a068fc; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wachtel M, 2001, J NEUROCHEM, V78, P155, DOI 10.1046/j.1471-4159.2001.00399.x; Werner C, 2009, CAN J ANAESTH, V56, P883, DOI 10.1007/s12630-009-9166-y; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zehendner CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016760; Zehendner CM, 2009, J CEREBR BLOOD F MET, V29, P1879, DOI 10.1038/jcbfm.2009.103; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	48	62	66	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50752	10.1371/journal.pone.0050752	http://dx.doi.org/10.1371/journal.pone.0050752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251381	gold, Green Published			2022-12-27	WOS:000312201900015
J	Burgel, PR; Paillasseur, JL; Peene, B; Dusser, D; Roche, N; Coolen, J; Troosters, T; Decramer, M; Janssens, W				Burgel, Pierre-Regis; Paillasseur, Jean-Louis; Peene, Bernard; Dusser, Daniel; Roche, Nicolas; Coolen, Johan; Troosters, Thierry; Decramer, Marc; Janssens, Wim			Two Distinct Chronic Obstructive Pulmonary Disease (COPD) Phenotypes Are Associated with High Risk of Mortality	PLOS ONE			English	Article								Rationale: In COPD patients, mortality risk is influenced by age, severity of respiratory disease, and comorbidities. With an unbiased statistical approach we sought to identify clusters of COPD patients and to examine their mortality risk. Methods: Stable COPD subjects (n = 527) were classified using hierarchical cluster analysis of clinical, functional and imaging data. The relevance of this classification was validated using prospective follow-up of mortality. Results: The most relevant patient classification was that based on three clusters (phenotypes). Phenotype 1 included subjects at very low risk of mortality, who had mild respiratory disease and low rates of comorbidities. Phenotype 2 and 3 were at high risk of mortality. Phenotype 2 included younger subjects with severe airflow limitation, emphysema and hyperinflation, low body mass index, and low rates of cardiovascular comorbidities. Phenotype 3 included older subjects with less severe respiratory disease, but higher rates of obesity and cardiovascular comorbidities. Mortality was associated with the severity of airflow limitation in Phenotype 2 but not in Phenotype 3 subjects, and subjects in Phenotype 2 died at younger age. Conclusions: We identified three COPD phenotypes, including two phenotypes with high risk of mortality. Subjects within these phenotypes may require different therapeutic interventions to improve their outcome.	[Burgel, Pierre-Regis; Dusser, Daniel] Hop Cochin, AP HP, Serv Pneumol, F-75674 Paris, France; [Burgel, Pierre-Regis; Dusser, Daniel; Roche, Nicolas] Univ Paris 05, Paris, France; [Paillasseur, Jean-Louis] Clindatafirst, Clamart, France; [Peene, Bernard; Troosters, Thierry; Decramer, Marc; Janssens, Wim] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Div Resp, Louvain, Belgium; [Roche, Nicolas] Hop Hotel Dieu, AP HP, Serv Pneumol, F-75181 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; KU Leuven; University Hospital Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Burgel, PR (corresponding author), Hop Cochin, AP HP, Serv Pneumol, 27 Rue Faubourg St Jacques, F-75674 Paris, France.	pierre-regis.burgel@cch.aphp.fr	Roche, Nicolas/AAE-9206-2021; Roche, Nicolas/AAP-4445-2021	Burgel, Pierre Regis/0000-0003-0903-9828; roche, nicolas/0000-0002-3162-5033; Janssens, Wim/0000-0003-1830-2982	Association Cardif (Paris, France); Fonds de Recherche en Sante Respiratoire (Paris, France)	Association Cardif (Paris, France); Fonds de Recherche en Sante Respiratoire (Paris, France)	This study was funded by grants from Association Cardif (Paris, France) and Fonds de Recherche en Sante Respiratoire (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2011, EUR RESPIR J, V38, P749, DOI 10.1183/09031936.00062211; Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Burgel PR, 2010, EUR RESPIR J, V36, P531, DOI 10.1183/09031936.00175109; Dolan S, 2005, CURR OPIN PULM MED, V11, P149, DOI 10.1097/01.mcp.0000153548.36054.8f; Fingleton J, 2011, THORAX, V66, P363, DOI 10.1136/thx.2010.155564; Fishman A, 2001, NEW ENGL J MED, V345, P1075; Foreman MG, 2011, AM J RESP CRIT CARE, V184, P414, DOI 10.1164/rccm.201011-1928OC; Garcia-Aymerich J, 2011, THORAX, V66, P430, DOI 10.1136/thx.2010.154484; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Lambrechts D, 2010, AM J RESP CRIT CARE, V181, P486, DOI 10.1164/rccm.200909-1364OC; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rutten FH, 2005, EUR HEART J, V26, P1887, DOI 10.1093/eurheartj/ehi291; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; van der Molen Thys, 2003, Health Qual Life Outcomes, V1, P13, DOI 10.1186/1477-7525-1-13; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; Wardlaw AJ, 2005, CLIN EXP ALLERGY, V35, P1254, DOI 10.1111/j.1365-2222.2005.02344.x; Weatherall M, 2010, EUR RESPIR J, V36, P472, DOI 10.1183/09031936.00035210; Weatherall M, 2009, EUR RESPIR J, V34, P812, DOI 10.1183/09031936.00174408	20	93	96	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51048	10.1371/journal.pone.0051048	http://dx.doi.org/10.1371/journal.pone.0051048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236428	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100058
J	Daltrozzo, J; Claude, L; Tillmann, B; Bastuji, H; Perrin, F				Daltrozzo, Jerome; Claude, Lea; Tillmann, Barbara; Bastuji, Helene; Perrin, Fabien			Working Memory Is Partially Preserved during Sleep	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; WORD RECOGNITION; SPEECH; COMPONENT; COMPREHENSION; MECHANISMS; REPETITION; COGNITION; CHILDREN; NOISE	Although several cognitive processes, including speech processing, have been studied during sleep, working memory (WM) has never been explored up to now. Our study assessed the capacity of WM by testing speech perception when the level of background noise and the sentential semantic length (SSL) (amount of semantic information required to perceive the incongruence of a sentence) were modulated. Speech perception was explored with the N400 component of the event-related potentials recorded to sentence final words (50% semantically congruent with the sentence, 50% semantically incongruent). During sleep stage 2 and paradoxical sleep: (1) without noise, a larger N400 was observed for (short and long SSL) sentences ending with a semantically incongruent word compared to a congruent word (i.e. an N400 effect); (2) with moderate noise, the N400 effect (observed at wake with short and long SSL sentences) was attenuated for long SSL sentences. Our results suggest that WM for linguistic information is partially preserved during sleep with a smaller capacity compared to wake.	[Daltrozzo, Jerome; Claude, Lea; Tillmann, Barbara; Perrin, Fabien] Lyon Neurosci Res Ctr, CNRS, UMR5292, Auditory Cognit & Psychoacoust Team, Lyon, France; [Daltrozzo, Jerome; Claude, Lea; Tillmann, Barbara; Perrin, Fabien] Lyon Neurosci Res Ctr, INSERM, U1028, Auditory Cognit & Psychoacoust Team, Lyon, France; [Claude, Lea; Bastuji, Helene] Lyon Neurosci Res Ctr, CNRS, UMR5292, Cent Integrat Pain Human Team, Lyon, France; [Claude, Lea; Bastuji, Helene] Lyon Neurosci Res Ctr, Cent Integrat Pain Human Team, INSERM, U1028, Lyon, France; [Daltrozzo, Jerome; Claude, Lea; Tillmann, Barbara; Bastuji, Helene; Perrin, Fabien] Lyon Univ, Lyon, France; [Claude, Lea; Bastuji, Helene] Hosp Civils Lyon, Neurol Hosp, Sleep Unit, Bron, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Daltrozzo, J (corresponding author), Lyon Neurosci Res Ctr, CNRS, UMR5292, Auditory Cognit & Psychoacoust Team, Lyon, France.	jerome.daltrozzo@gmail.com		BASTUJI, Helene/0000-0002-6690-2707; , Fabien/0000-0002-1444-3414	French National Agency for Research [ANR-07-JCJC-0095 - CSD 8]; French National Agency for Research (ANR PICS)	French National Agency for Research(French National Research Agency (ANR)); French National Agency for Research (ANR PICS)(French National Research Agency (ANR))	The work was supported by the French National Agency for Research (grant ANR-07-JCJC-0095 - CSD 8 and ANR PICS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American National Standards Institute, 2004, S362004 ANSI; Baddeley A, 1998, CR ACAD SCI III-VIE, V321, P167, DOI 10.1016/S0764-4469(97)89817-4; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bastuji H, 2002, INT J PSYCHOPHYSIOL, V46, P243, DOI 10.1016/S0167-8760(02)00116-2; Bayles KA, 2003, J COMMUN DISORD, V36, P209, DOI 10.1016/S0021-9924(03)00020-0; BESSON M, 1993, J EXP PSYCHOL LEARN, V19, P1115, DOI 10.1037/0278-7393.19.5.1115; BRADY S, 1983, J EXP CHILD PSYCHOL, V35, P345, DOI 10.1016/0022-0965(83)90087-5; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Brualla J, 1998, EVOKED POTENTIAL, V108, P283, DOI 10.1016/S0168-5597(97)00102-0; Campbell K, 2010, NOISE HEALTH, V12, P137, DOI 10.4103/1463-1741.63216; CARSKADON MA, 2000, PRINCIPLES PRACTICE, P15; Choi S, 2008, J SPEECH LANG HEAR R, V51, P1042, DOI 10.1044/1092-4388(2008/076); Cohen J.E., 1988, STAT POWER ANAL BEHA; CONNOLLY JF, 1992, BRAIN LANG, V43, P1, DOI 10.1016/0093-934X(92)90018-A; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Daltrozzo J, 2012, BRAIN SCI, V2, P267, DOI 10.3390/brainsci2030267; DANEMAN M, 1991, J PSYCHOLINGUIST RES, V20, P445, DOI 10.1007/BF01067637; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Edin F, 2009, P NATL ACAD SCI USA, V106, P6802, DOI 10.1073/pnas.0901894106; GROSJEAN F, 1980, PERCEPT PSYCHOPHYS, V28, P267, DOI 10.3758/BF03204386; Grosjean F, 1996, LANG COGNITIVE PROC, V11, P597, DOI 10.1080/016909696386999; Haarmann HJ, 1997, BRAIN LANG, V59, P76, DOI 10.1006/brln.1997.1814; Ibanez A, 2006, BRAIN LANG, V98, P264, DOI 10.1016/j.bandl.2006.05.005; Iber C, 2007, AASM MANUAL SCORING; Kotchoubey B, 2006, NEUROSCI BIOBEHAV R, V30, P42, DOI 10.1016/j.neubiorev.2005.04.002; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; LAVIE P, 1984, INT J NEUROSCI, V23, P111, DOI 10.3109/00207458408985352; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Maquet P, 2000, J SLEEP RES, V9, P207; Maquet P, 1997, J NEUROSCI, V17, P2807; Mattys SL, 2009, COGNITIVE PSYCHOL, V59, P203, DOI 10.1016/j.cogpsych.2009.04.001; Montgomery JW, 2003, J COMMUN DISORD, V36, P221, DOI 10.1016/S0021-9924(03)00021-2; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Olichney JM, 2000, BRAIN, V123, P1948, DOI 10.1093/brain/123.9.1948; Perrin F, 2002, NEUROREPORT, V13, P1345, DOI 10.1097/00001756-200207190-00026; Pisoni DB, 2003, EAR HEARING, V24, p106S, DOI 10.1097/01.AUD.0000051692.05140.8E; Qin MK, 2003, J ACOUST SOC AM, V114, P446, DOI 10.1121/1.1579009; Ronnberg J, 2007, AG SPEECH COMM 2 INT; Ronnberg J, 2010, NOISE HEALTH, V12, P263, DOI 10.4103/1463-1741.70505; Ronnberg J, 2008, INT J AUDIOL, V47, pS99, DOI 10.1080/14992020802301167; SALAME P, 1987, ERGONOMICS, V30, P1185, DOI 10.1080/00140138708966007; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Stickgold R, 1999, J COGNITIVE NEUROSCI, V11, P182, DOI 10.1162/089892999563319; Surprenant AM, 1999, INT J PSYCHOL, V34, P328, DOI 10.1080/002075999399648; Zhou S, 2004, BRAIN TOPOGR, V17, P27, DOI 10.1023/B:BRAT.0000047334.48256.9f	49	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50997	10.1371/journal.pone.0050997	http://dx.doi.org/10.1371/journal.pone.0050997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	050OT	23236418	gold, Green Submitted, Green Published			2022-12-27	WOS:000312064100050
J	Fujino, K; Horie, M; Honda, T; Nakamura, S; Matsumoto, Y; Francischetti, IMB; Tomonaga, K				Fujino, Kan; Horie, Masayuki; Honda, Tomoyuki; Nakamura, Shoko; Matsumoto, Yusuke; Francischetti, Ivo M. B.; Tomonaga, Keizo			Evolutionarily Conserved Interaction between the Phosphoproteins and X Proteins of Bornaviruses from Different Vertebrate Species	PLOS ONE			English	Article							BORNA-DISEASE VIRUS; PROVENTRICULAR DILATATION DISEASE; NUCLEAR-LOCALIZATION; AVIAN BORNAVIRUS; RNA; IMPORT; CANADA; DOMAIN; SIGNAL; GEESE	Bornavirus, a non-segmented, negative-strand RNA viruses, is currently classified into several genetically distinct genotypes, such as Borna disease virus (BDV) and avian bornaviruses (ABVs). Recent studies revealed that bornavirus genotypes show unique sequence variability in the putative 5' untranslated region (5' UTR) of X/P mRNA, a bicistronic mRNA for the X protein and phosphoprotein (P). In this study, to understand the evolutionary relationship among the bornavirus genotypes, we investigated the functional interaction between the X and P proteins of four bornavirus genotypes, BDV, ABV genotype 4 and 5 and reptile bornavirus (RBV), the putative 5' UTRs of which exhibit variation in the length. Immunofluorescence and immunoprecipitation analyses using mammalian and avian cell lines revealed that the X proteins of bornaviruses conserve the ability to facilitate the export of P from the nucleus to the cytoplasm via interaction with P. Furthermore, we showed that inter-genotypic interactions may occur between X and P among the genotypes, except for X of RBV. In addition, a BDV minireplicon assay demonstrated that the X and P proteins of ABVs, but not RBV, can affect the polymerase activity of BDV. This study demonstrates that bornaviruses may have conserved the fundamental function of a regulatory protein during their evolution, whereas RBV has evolved distinctly from the other bornavirus genotypes.	[Fujino, Kan; Horie, Masayuki; Honda, Tomoyuki; Nakamura, Shoko; Matsumoto, Yusuke; Tomonaga, Keizo] Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Kyoto 606, Japan; [Francischetti, Ivo M. B.] NIAID, Sect Vector Biol, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Tomonaga, K (corresponding author), Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Kyoto 606, Japan.	tomonaga@virus.kyoto-u.ac.jp	Fujino, Kan/AAS-2464-2021	Horie, Masayuki/0000-0003-4682-7698; Matsumoto, Yusuke/0000-0003-3500-2279	Japan Society for the Promotion of Science (JSPS); Takeda Science Foundation; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by Funding Program for Next Generation World-Leading Researchers (NEXT program) from Japan Society for the Promotion of Science (JSPS) (KT), Research Grants from Takeda Science Foundation (KT) and the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (IMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Delnatte P, 2011, VET REC, V169, P108, DOI 10.1136/vr.d4620; Francischetti IMB, 2004, GENE, V337, P55, DOI 10.1016/j.gene.2004.03.024; GonzalezDunia D, 1997, BRAIN RES BULL, V44, P647, DOI 10.1016/S0361-9230(97)00276-1; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; Horie M, 2012, MICROBIOL IMMUNOL, V56, P346, DOI 10.1111/j.1348-0421.2012.00436.x; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Jordan I, 2001, REV MED VIROL, V11, P37, DOI 10.1002/rmv.300; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Kobayashi T, 2003, J VIROL, V77, P8099, DOI 10.1128/JVI.77.14.8099-8107.2003; Kolodziejek J, 2005, J GEN VIROL, V86, P385, DOI 10.1099/vir.0.80587-0; Malik TH, 2000, J VIROL, V74, P3413, DOI 10.1128/JVI.74.7.3413-3417.2000; Nakamura Y, 2000, J VIROL, V74, P4601, DOI 10.1128/JVI.74.10.4601-4611.2000; Payne S, 2011, J VIROL, V85, P12053, DOI 10.1128/JVI.05700-11; Pleschka S, 2001, J GEN VIROL, V82, P2681, DOI 10.1099/0022-1317-82-11-2681; Poenisch M, 2008, J GEN VIROL, V89, P1442, DOI 10.1099/vir.0.2008/000638-0; Poenisch M, 2009, J VIROL, V83, P4297, DOI 10.1128/JVI.02321-08; ROTT R, 1995, CURR TOP MICROBIOL, V190, P17; Rubbenstroth D, 2012, VET MICROBIOL; SCHNEIDER PA, 1994, J VIROL, V68, P63, DOI 10.1128/JVI.68.1.63-68.1994; Schneider U, 2003, J VIROL, V77, P11781, DOI 10.1128/JVI.77.21.11781-11789.2003; Schwemmle M, 1998, J BIOL CHEM, V273, P9007, DOI 10.1074/jbc.273.15.9007; Schwemmle M, 1999, J GEN VIROL, V80, P97, DOI 10.1099/0022-1317-80-1-97; Shoya Y, 1998, J VIROL, V72, P9755, DOI 10.1128/JVI.72.12.9755-9762.1998; Tomonaga K, 2002, MICROBES INFECT, V4, P491, DOI 10.1016/S1286-4579(02)01564-2; Watanabe Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000654; Weissenbock H, 2009, J VIROL, V83, P11367, DOI 10.1128/JVI.01343-09; Weissenbock H, 2009, EMERG INFECT DIS, V15, P1453, DOI 10.3201/eid1509.090353; Wolff T, 2002, J BIOL CHEM, V277, P12151, DOI 10.1074/jbc.M109103200; Yanai H, 2006, J VIROL, V80, P1121, DOI 10.1128/JVI.80.3.1121-1129.2006; Yanai H, 2006, MICROBES INFECT, V8, P1522, DOI 10.1016/j.micinf.2006.01.010	30	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51161	10.1371/journal.pone.0051161	http://dx.doi.org/10.1371/journal.pone.0051161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236446	Green Submitted, gold, Green Published			2022-12-27	WOS:000312064100074
J	Li, W; Gao, KS; Beardall, J				Li, Wei; Gao, Kunshan; Beardall, John			Interactive Effects of Ocean Acidification and Nitrogen-Limitation on the Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							CARBON CONCENTRATING MECHANISMS; ULTRAVIOLET-RADIATION; CO2 CONCENTRATION; MARINE; PHOTOSYNTHESIS; PHYTOPLANKTON; SEAWATER; GROWTH; IRON; SENSITIVITY	Climate change is expected to bring about alterations in the marine physical and chemical environment that will induce changes in the concentration of dissolved CO2 and in nutrient availability. These in turn are expected to affect the physiological performance of phytoplankton. In order to learn how phytoplankton respond to the predicted scenario of increased CO2 and decreased nitrogen in the surface mixed layer, we investigated the diatom Phaeodactylum tricornutum as a model organism. The cells were cultured in both low CO2 (390 mu atm) and high CO2 (1000 mu atm) conditions at limiting (10 mu mol L-1) or enriched (110 mu mol L-1) nitrate concentrations. Our study shows that nitrogen limitation resulted in significant decreases in cell size, pigmentation, growth rate and effective quantum yield of Phaeodactylum tricornutum, but these parameters were not affected by enhanced dissolved CO2 and lowered pH. However, increased CO2 concentration induced higher rETR(max) and higher dark respiration rates and decreased the CO2 or dissolved inorganic carbon (DIC) affinity for electron transfer (shown by higher values for K-1/2 DIC or K-1/2 CO2). Furthermore, the elemental stoichiometry (carbon to nitrogen ratio) was raised under high CO2 conditions in both nitrogen limited and nitrogen replete conditions, with the ratio in the high CO2 and low nitrate grown cells being higher by 45% compared to that in the low CO2 and nitrate replete grown ones. Our results suggest that while nitrogen limitation had a greater effect than ocean acidification, the combined effects of both factors could act synergistically to affect marine diatoms and related biogeochemical cycles in future oceans.	[Li, Wei; Gao, Kunshan] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Beardall, John] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Xiamen University; Monash University	Gao, KS (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	ksgao@xmu.edu.cn	Beardall, John/L-5262-2019; gao, kunshan/G-3374-2010	Beardall, John/0000-0001-7684-446X; Gao, Kunshan/0000-0001-7365-6332	National Basic Research Program of China [2009CB421207, 2011CB200902]; National Natural Science Foundation [40930846, 41120164007]; Program for Changjiang Scholars and Innovative Research Team [IRT0941]; China-Japan collaboration project from MOST [S2012GR0290]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); China-Japan collaboration project from MOST	This study was supported by National Basic Research Program of China (No. 2009CB421207 and 2011CB200902), National Natural Science Foundation (No. 40930846, No. 41120164007), Program for Changjiang Scholars and Innovative Research Team (IRT0941) and China-Japan collaboration project from MOST (S2012GR0290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2011, NATURE, V473, P203, DOI 10.1038/nature10074; Beardall J, 2002, FUNCT PLANT BIOL, V29, P335, DOI 10.1071/PP01195; Beardall J, 2001, AQUAT SCI, V63, P44, DOI 10.1007/PL00001344; BEARDALL J, 1982, J EXP BOT, V33, P729, DOI 10.1093/jxb/33.4.729; Beardall J, 2009, PHOTOCH PHOTOBIO SCI, V8, P1257, DOI 10.1039/b9pp00034h; Beman JM, 2011, P NATL ACAD SCI USA, V108, P208, DOI 10.1073/pnas.1011053108; Burkhardt S, 1999, LIMNOL OCEANOGR, V44, P683, DOI 10.4319/lo.1999.44.3.0683; Burkhardt S, 1999, GEOCHIM COSMOCHIM AC, V63, P3729, DOI 10.1016/S0016-7037(99)00217-3; Burkhardt S, 2001, LIMNOL OCEANOGR, V46, P1378, DOI 10.4319/lo.2001.46.6.1378; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CARACO N, 1990, BIOGEOCHEMISTRY, V9, P277; Cermeno P, 2008, P NATL ACAD SCI USA, V105, P20344, DOI 10.1073/pnas.0811302106; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Doney SC, 2006, SCI AM, V294, P58, DOI 10.1038/scientificamerican0306-58; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; DOUCETTE GJ, 1990, MAR ECOL PROG SER, V62, P293, DOI 10.3354/meps062293; EILERS PHC, 1988, ECOL MODEL, V42, P199, DOI 10.1016/0304-3800(88)90057-9; Flynn KJ, 2012, NAT CLIM CHANGE, V2, P510, DOI 10.1038/NCLIMATE1489; Gao Kun-shan, 2011, Xiamen Daxue Xuebao (Ziran Kexue Ban), V50, P411; Gao KS, 2012, NAT CLIM CHANGE, V2, P519, DOI 10.1038/NCLIMATE1507; Gordillo FJL, 2003, PLANTA, V218, P315, DOI 10.1007/s00425-003-1087-3; HIPKIN CR, 1983, MAR BIOL, V77, P101, DOI 10.1007/BF00396306; Hopkinson BM, 2011, P NATL ACAD SCI USA, V108, P3830, DOI 10.1073/pnas.1018062108; Kaffes A, 2010, J EXP MAR BIOL ECOL, V393, P1, DOI 10.1016/j.jembe.2010.06.004; LARSSON CM, 1985, J EXP BOT, V36, P1387, DOI 10.1093/jxb/36.9.1387; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Litchman E, 2002, LIMNOL OCEANOGR, V47, P86, DOI 10.4319/lo.2002.47.1.0086; Millero FJ, 2009, OCEANOGRAPHY, V22, P72, DOI 10.5670/oceanog.2009.98; MOREL FMM, 1979, J PHYCOL, V15, P135, DOI 10.1111/j.0022-3646.1979.00135.x; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Portner H. O., 2010, GUIDE BEST PRACTICES, P167; Raven JA, 2011, PHOTOSYNTH RES, V109, P281, DOI 10.1007/s11120-011-9632-6; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Riegman R, 2000, J PHYCOL, V36, P87, DOI 10.1046/j.1529-8817.2000.99023.x; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Sobrino C, 2008, LIMNOL OCEANOGR, V53, P494, DOI 10.4319/lo.2008.53.2.0494; Strickland J.D., 1972, J FISH RES BOARD CAN; Trimborn S, 2008, PHYSIOL PLANTARUM, V133, P92, DOI 10.1111/j.1399-3054.2007.01038.x; Trimborn S, 2009, J EXP MAR BIOL ECOL, V376, P26, DOI 10.1016/j.jembe.2009.05.017; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Watson R, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, pIX; Wichard T, 2007, CHEMBIOCHEM, V8, P1146, DOI 10.1002/cbic.200700053; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; Yang GY, 2012, MAR ENVIRON RES, V79, P142, DOI 10.1016/j.marenvres.2012.06.002; Young EB, 2005, CAN J BOT, V83, P917, DOI 10.1139/B05-081	52	67	71	2	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51590	10.1371/journal.pone.0051590	http://dx.doi.org/10.1371/journal.pone.0051590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236517	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100133
J	Maslanik, T; Tannura, K; Mahaffey, L; Loughridge, AB; Benninson, L; Ursell, L; Greenwood, BN; Knight, R; Fleshner, M				Maslanik, Thomas; Tannura, Kate; Mahaffey, Lucas; Loughridge, Alice Brianne; Benninson, Lida; Ursell, Luke; Greenwood, Benjamin N.; Knight, Rob; Fleshner, Monika			Commensal Bacteria and MAMPs Are Necessary for Stress-Induced Increases in IL-1 beta and IL-18 but Not IL-6, IL-10 or MCP-1	PLOS ONE			English	Article							NLRP3 INFLAMMASOME ACTIVATION; EXTRACELLULAR HSP72; INTESTINAL SENSITIZATION; ENDOTOXIN INHIBITOR; IMMUNE-RESPONSES; INNATE IMMUNITY; T-CELL; EXPOSURE; COLONIZATION; BRAIN	Regular interactions between commensal bacteria and the enteric mucosal immune environment are necessary for normal immunity. Alterations of the commensal bacterial communities or mucosal barrier can disrupt immune function. Chronic stress interferes with bacterial community structure (specifically, alpha-diversity) and the integrity of the intestinal barrier. These interferences can contribute to chronic stress-induced increases in systemic IL-6 and TNF-alpha. Chronic stress, however, produces many physiological changes that could indirectly influence immune activity. In addition to IL-6 and TNF-alpha, exposure to acute stressors upregulates a plethora of inflammatory proteins, each having unique synthesis and release mechanisms. We therefore tested the hypothesis that acute stress-induced inflammatory protein responses are dependent on the commensal bacteria, and more specifically, lipopolysaccharide (LPS) shed from Gram-negative intestinal commensal bacteria. We present evidence that both reducing commensal bacteria using antibiotics and neutralizing LPS using endotoxin inhibitor (EI) attenuates increases in some (inflammasome dependent, IL-1 and IL-18), but not all (inflammasome independent, IL-6, IL-10, and MCP-1) inflammatory proteins in the blood of male F344 rats exposed to an acute tail shock stressor. Acute stress did not impact alpha- or beta-diversity measured using 16S rRNA diversity analyses, but selectively reduced the relative abundance of Prevotella. These findings indicate that commensal bacteria contribute to acute stress-induced inflammatory protein responses, and support the presence of LPS-mediated signaling in stress-evoked cytokine and chemokine production. The selectivity of the commensal bacteria in stress-evoked IL-1 beta and IL-18 responses may implicate the inflammasome in this response.	[Maslanik, Thomas; Tannura, Kate; Mahaffey, Lucas; Loughridge, Alice Brianne; Benninson, Lida; Greenwood, Benjamin N.; Fleshner, Monika] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Maslanik, Thomas; Tannura, Kate; Mahaffey, Lucas; Loughridge, Alice Brianne; Benninson, Lida; Greenwood, Benjamin N.; Fleshner, Monika] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; [Ursell, Luke; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Ursell, Luke; Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Fleshner, M (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.	fleshner@colorado.edu	Knight, Rob/D-1299-2010	Knight, Rob/0000-0002-0975-9019; Fleshner, Monika/0000-0002-0470-0827	National Science Foundation [IOS 1022451]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The studies published in this manuscript were funded by the National Science Foundation, grant number IOS 1022451. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RG, 2012, BRAIN BEHAV IMMUN, V26, P371, DOI 10.1016/j.bbi.2011.11.002; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Bailey MT, 2009, PHYSIOL BEHAV, V98, P351, DOI 10.1016/j.physbeh.2009.06.013; Bailey MT, 2006, J NEUROIMMUNOL, V171, P29, DOI 10.1016/j.jneuroim.2005.09.008; Bailey MT, 2004, J PEDIATR GASTR NUTR, V38, P414, DOI 10.1097/00005176-200404000-00009; Bailey MT, 1999, DEV PSYCHOBIOL, V35, P146, DOI 10.1002/(SICI)1098-2302(199909)35:2<146::AID-DEV7>3.0.CO;2-G; Barker LA, 2005, BRIT J PHARMACOL, V145, P872, DOI 10.1038/sj.bjp.0706257; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Brown AP, 2000, CONTEMP TOP LAB ANIM, V39, P17; Campisi J, 2003, J APPL PHYSIOL, V94, P43, DOI 10.1152/japplphysiol.00681.2002; Campisi J, 2003, CELL STRESS CHAPERON, V8, P272, DOI 10.1379/1466-1268(2003)008<0272:SEHIAF>2.0.CO;2; Campisi J, 2003, AM J PHYSIOL-REG I, V284, pR520, DOI 10.1152/ajpregu.00513.2002; Campisi J, 2002, PHYSIOL BEHAV, V77, P291, DOI 10.1016/S0031-9384(02)00861-2; Campisi J, 2012, STRESS; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caso JR, 2009, AM J PHYSIOL-REG I, V296, pR979, DOI 10.1152/ajpregu.90825.2008; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dhabhar FS, 2000, ANN NY ACAD SCI, V917, P876, DOI 10.1111/j.1749-6632.2000.tb05454.x; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Febbraio MA, 2002, J PHYSIOL-LONDON, V544, P957, DOI 10.1113/jphysiol.2002.025148; Fleshner M, 2004, PSYCHONEUROENDOCRINO, V29, P1142, DOI 10.1016/j.psyneuen.2004.01.007; Fleshner M, 1996, AM J PHYSIOL-REG I, V271, pR1344, DOI 10.1152/ajpregu.1996.271.5.R1344; FLESHNER M, 1995, BRAIN BEHAV IMMUN, V9, P101, DOI 10.1006/brbi.1995.1011; Fleshner M, 2005, INT J HYPERTHER, V21, P457, DOI 10.1080/02656730500088211; FLESHNER M, 2007, HEAT SHOCK PROTEINS, P235; Fleshner M, 2010, HEAT SHOCK PROTEINS, V5, P193, DOI 10.1007/978-90-481-3381-9_12; Frink M, 2007, AM J PHYSIOL-REG I, V292, pR1110, DOI 10.1152/ajpregu.00650.2006; Gazda LS, 2003, STRESS, V6, P259, DOI 10.1080/10253890310001594441; Girotti M, 2011, PSYCHONEUROENDOCRINO, V36, P1164, DOI 10.1016/j.psyneuen.2011.02.008; GRIFFITHS RJ, 1995, J IMMUNOL, V154, P2821; Grisanti LA, 2011, J PHARMACOL EXP THER, V338, P648, DOI 10.1124/jpet.110.178012; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Gueguinou N, 2011, PSYCHONEUROENDOCRINO; Hamon Y, 1997, BLOOD, V90, P2911, DOI 10.1182/blood.V90.8.2911; HOCHACHKA PW, 1995, COMP BIOCHEM PHYS B, V112, P361, DOI 10.1016/0305-0491(96)85239-4; Hoggatt AF, 2010, J AM ASSOC LAB ANIM, V49, P329; Johnson JD, 2005, NEUROSCIENCE, V135, P1295, DOI 10.1016/j.neuroscience.2005.06.090; Johnson JD, 2008, BRAIN BEHAV IMMUN, V22, P1078, DOI 10.1016/j.bbi.2008.03.007; Johnson JD, 2006, J LEUKOCYTE BIOL, V79, P425, DOI 10.1189/jlb.0905523; Kalueff AV, 2004, BRAIN RES PROTOC, V13, P151, DOI 10.1016/j.brainresprot.2004.04.002; Katafuchi T, 2003, MOL BRAIN RES, V118, P24, DOI 10.1016/S0169-328X(03)00331-0; Keita AV, 2010, NEUROGASTROENT MOTIL, V22, P718, DOI 10.1111/j.1365-2982.2010.01498.x; Knowles SR, 2008, BIOL PSYCHOL, V77, P132, DOI 10.1016/j.biopsycho.2007.09.010; Kranich J, 2011, SEMIN IMMUNOL, V23, P139, DOI 10.1016/j.smim.2011.01.011; Kuhn R, 2005, WORLD J SURG, V29, P766, DOI 10.1007/s00268-005-7409-9; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Kuwahira I, 1999, J APPL PHYSIOL, V86, P181, DOI 10.1152/jappl.1999.86.1.181; Lambert GP, 2009, J ANIM SCI, V87, pE101, DOI 10.2527/jas.2008-1339; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Liu T, 2006, IMMUNOL CELL BIOL, V84, P430, DOI 10.1111/j.1440-1711.2006.01452.x; Lundgren O, 2000, GUT, V47, P33; MacPherson AJ, 2004, ANN NY ACAD SCI, V1029, P36, DOI 10.1196/annals.1309.005; Mah KW, 2006, INT ARCH ALLERGY IMM, V140, P157, DOI 10.1159/000092555; MAIER SF, 1994, AM PSYCHOL, V49, P1004, DOI 10.1037/0003-066X.49.12.1004; MARTI O, 1994, PHYSIOL BEHAV, V55, P747, DOI 10.1016/0031-9384(94)90055-8; Maslanik T, 2012, BRAIN BEHAV IN PRESS; Maslanik T, 2012, BRAIN BEHAV IMMUN, V26, P142, DOI 10.1016/j.bbi.2011.08.006; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Moraska A, 2002, J APPL PHYSIOL, V93, P207, DOI 10.1152/japplphysiol.01151.2001; MYCHAJLONKA M, 1980, ANTIMICROB AGENTS CH, V17, P572, DOI 10.1128/AAC.17.4.572; Namas R, 2009, LIBYAN J MED, V4, P97, DOI 10.4176/090325; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Nickerson M, 2006, J APPL PHYSIOL, V101, P566, DOI 10.1152/japplphysiol.00259.2006; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Ricart-Jane D, 2002, METABOLISM, V51, P925, DOI 10.1053/meta.2002.33353; Sambol JT, 2001, SURG RES, P599; Santos J, 2000, AM J PHYSIOL-GASTR L, V278, pG847, DOI 10.1152/ajpgi.2000.278.6.G847; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Shanahan F, 2002, BEST PRACT RES CL GA, V16, P915, DOI 10.1053/bega.2002.0342; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500; Walsh RC, 2001, CELL STRESS CHAPERON, V6, P386, DOI 10.1379/1466-1268(2001)006<0386:EISHIH>2.0.CO;2; Yang PC, 2006, AM J PATHOL, V168, P104, DOI 10.2353/ajpath.2006.050575; Yatsunenko T, 2012, NATURE; You ZL, 2011, BEHAV BRAIN RES, V225, P135, DOI 10.1016/j.bbr.2011.07.006	88	53	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50636	10.1371/journal.pone.0050636	http://dx.doi.org/10.1371/journal.pone.0050636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236381	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100023
J	Peers, MJL; Thornton, DH; Murray, DL				Peers, Michael J. L.; Thornton, Daniel H.; Murray, Dennis L.			Reconsidering the Specialist-Generalist Paradigm in Niche Breadth Dynamics: Resource Gradient Selection by Canada Lynx and Bobcat	PLOS ONE			English	Article							SPECIES DISTRIBUTION; PHENOTYPIC PLASTICITY; PERFORMANCE; EVOLUTION; COYOTES; JACK; DISTRIBUTIONS; SPECIFICITY; POPULATION; ABUNDANCE	The long-standing view in ecology is that disparity in overall resource selection is the basis for identifying niche breadth patterns, with species having narrow selection being classified "specialists" and those with broader selection being "generalists". The standard model of niche breadth characterizes generalists and specialists as having comparable levels of overall total resource exploitation, with specialists exploiting resources at a higher level of performance over a narrower range of conditions. This view has gone largely unchallenged. An alternate model predicts total resource use being lower for the specialized species with both peaking at a comparable level of performance over a particular resource gradient. To reconcile the niche breadth paradigm we contrasted both models by developing range-wide species distribution models for Canada lynx, Lynx canadensis, and bobcat, Lynx rufus. Using a suite of environmental factors to define each species' niche, we determined that Canada lynx demonstrated higher total performance over a restricted set of variables, specifically those related to snow and altitude, while bobcat had higher total performance across most variables. Unlike predictions generated by the standard model, bobcat level of exploitation was not compromised by the trade-off with peak performance, and Canada lynx were not restricted to exploiting a narrower range of conditions. Instead, the emergent pattern was that specialist species have a higher total resource utilization and peak performance value within a smaller number of resources or environmental axes than generalists. Our results also indicate that relative differences in niche breadth are strongly dependent on the variable under consideration, implying that the appropriate model describing niche breadth dynamics between specialists and generalists may be more complex than either the traditional heuristic or our modified version. Our results demonstrate a need to re-evaluate traditional, but largely untested, assumptions regarding resource utilization in species with broad and narrow niches.	[Peers, Michael J. L.; Thornton, Daniel H.; Murray, Dennis L.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Thornton, Daniel H.] Panthera, New York, NY USA	Trent University	Peers, MJL (corresponding author), Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada.	michaelpeers@trentu.ca			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	NSERC Discovery Grant www.nserc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2009, J EVOLUTION BIOL, V22, P907, DOI 10.1111/j.1420-9101.2009.01694.x; Anderson EM, 2003, WILD MAMMALS N AM BI, P758; Bailey TN, 1979, P BOBC RES C NAT WIL, V6, P62; Barkae ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033506; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Dennis RLH, 2011, BIOL J LINN SOC, V104, P725, DOI 10.1111/j.1095-8312.2011.01789.x; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; DIBELLO FJ, 1990, CAN FIELD NAT, V104, P403; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Garcia-Robledo C, 2012, J EVOLUTION BIOL, V25, P38, DOI 10.1111/j.1420-9101.2011.02401.x; GILCHRIST GW, 1995, AM NAT, V146, P252, DOI 10.1086/285797; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guralnick RP, 2006, PLOS BIOL, V4, P1908, DOI 10.1371/journal.pbio.0040381; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hof AR, 2012, DIVERS DISTRIB, V18, P554, DOI 10.1111/j.1472-4642.2011.00876.x; HUEY RB, 1984, EVOLUTION, V38, P441, DOI 10.1111/j.1558-5646.1984.tb00302.x; Huntley B, 2004, ECOL LETT, V7, P417, DOI 10.1111/j.1461-0248.2004.00598.x; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; KOEHLER GM, 1990, CAN J ZOOL, V68, P845, DOI 10.1139/z90-122; Kou XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023115; Krasnov BR, 2006, PARASITOLOGY, V133, P81, DOI 10.1017/S0031182006000059; Levins R., 1968, EVOLUTION CHANGING E; LITVAITIS JA, 1986, J MAMMAL, V67, P389, DOI 10.2307/1380893; Loxdale HD, 2011, BIOL J LINN SOC, V103, P1, DOI 10.1111/j.1095-8312.2011.01627.x; Lutolf M, 2006, J APPL ECOL, V43, P802, DOI 10.1111/j.1365-2664.2006.01191.x; MacArthur R.H., 1972, pvii; Mandle L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015297; McCord C.M., 1982, P728; McKelvey Kevin S., 2000, P207; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; McNaughton SJ, 1979, GEN ECOLOGY; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; MURRAY DL, 1991, OECOLOGIA, V88, P463, DOI 10.1007/BF00317707; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; O'Donoghue M, 1998, ECOLOGY, V79, P1193, DOI 10.1890/0012-9658(1998)079[1193:FROCAL]2.0.CO;2; Oliver TH, 2012, J APPL ECOL, V49, P581, DOI 10.1111/j.1365-2664.2012.02138.x; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; PARKER GR, 1983, CAN J ZOOL, V61, P770, DOI 10.1139/z83-102; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Russell AJM, 2004, EUR J WILDLIFE RES, V50, P53, DOI 10.1007/s10344-004-0037-0; Simkova A, 2006, EVOLUTION, V60, P1023, DOI 10.1111/j.0014-3820.2006.tb01180.x; Stiling P.D, 1999, ECOLOGY THEORIES APP; Sultan SE, 2001, ECOLOGY, V82, P328, DOI 10.1890/0012-9658(2001)082[0328:PPFFCI]2.0.CO;2; Torres NM, 2012, DIVERS DISTRIB, V18, P615, DOI 10.1111/j.1472-4642.2012.00892.x; Verberk WCEP, 2010, J ANIM ECOL, V79, P589, DOI 10.1111/j.1365-2656.2010.01660.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; WERDELIN L, 1981, ANN ZOOL FENN, V18, P37; WITMER GW, 1986, CAN J ZOOL, V64, P2333, DOI 10.1139/z86-347	57	59	60	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51488	10.1371/journal.pone.0051488	http://dx.doi.org/10.1371/journal.pone.0051488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236508	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100124
J	Schlender, A; Alperin, PE; Grossman, HL; Sutherland, ER				Schlender, Amory; Alperin, Peter E.; Grossman, Helene L.; Sutherland, E. Rand			Modeling the Impact of Increased Adherence to Asthma Therapy	PLOS ONE			English	Article							PERSISTENT ASTHMA; EXACERBATIONS; OUTCOMES; FAILURE; TRIALS	Background: Nonadherence to medications occurs in up to 70% of patients with asthma. The effect of improving adherence is not well quantified. We developed a mathematical model with which to assess the population-level effects of improving medication prescribing and adherence for asthma. Methods: A mathematical model, calibrated to clinical trial data from the U. S. NHLBI-funded SOCS trial and validated using data from the NHLBI SLIC trial, was used to model the effects of increased prescribing and adherence to asthma controllers. The simulated population consisted of 4,930 individuals with asthma, derived from a sample the National Asthma Survey. Main outcomes were controller use, reliever use, unscheduled doctor visits, emergency department (ED) visits, and hospitalizations. Results: For the calibration, simulated outcomes agreed closely with SOCS trial outcomes, with treatment failure hazard ratios [95% confidence interval] of 0.92 [0.58-1.26], 0.97 [0.49-1.45], and 1.01 [0-1.87] for simulation vs. trial in the in placebo, salmeterol, and triamcinolone arms, respectively. For validation, simulated outcomes predicted mid-and end-point treatment failure rates, hazard ratios 1.21 [0.08-2.34] and 0.83 [0.60-1.07], respectively, for patients treated with salmeterol/triamcinolone during the first half of the SLIC study and salmeterol monotherapy during the second half. The model performed less well for patients treated with salmeterol/triamcinolone during the entire study duration, with mid-and end-point hazard ratios 0.83 [0.00-2.12] and 0.37 [0.10-0.65], respectively. Simulation of optimal adherence and prescribing indicated that closing adherence and prescription gaps could prevent as many as nine million unscheduled doctor visits, four million emergency department visits, and one million asthma-related hospitalizations each year in the U. S. Conclusions: Improvements in medication adherence and prescribing could have a substantial impact on asthma morbidity and healthcare utilization.	[Sutherland, E. Rand] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Sutherland, E. Rand] Univ Colorado, Dept Med, Denver, CO USA; [Schlender, Amory; Alperin, Peter E.; Grossman, Helene L.] Archimedes Inc, San Francisco, CA USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Sutherland, ER (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA.	sutherlande@njhealth.org			Archimedes Incorporated	Archimedes Incorporated	This study was funded by Archimedes Incorporated (http://archimedesmodel.com/). Three authors (AS, PEA, HLG) are employees of the funder and were jointly involved in the study design and analysis. The decision to publish and preparation of the manuscript were participated in equally by all authors. Data utilized in this study were obtained from publicly-available datasets and were not collected by the funder.	[Anonymous], 2003, NAT ASTHM SURV 2003; Eddy DM, 2005, ANN INTERN MED, V143, P251, DOI 10.7326/0003-4819-143-4-200508160-00006; Gamble J, 2009, AM J RESP CRIT CARE, V180, P817, DOI 10.1164/rccm.200902-0166OC; Global Initiative for Asthma, GLOB STRAT ASTHM MAN; Hall Margaret Jean, 2010, Natl Health Stat Report, P1; Kahn R, 2008, CIRCULATION, V118, P576, DOI 10.1161/CIRCULATIONAHA.108.190186; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Lemanske RF, 2001, JAMA-J AM MED ASSOC, V285, P2594, DOI 10.1001/jama.285.20.2594; MARTIN TG, 1982, ANN EMERG MED, V11, P466, DOI 10.1016/S0196-0644(82)80063-2; Milgrom H, 1996, J ALLERGY CLIN IMMUN, V98, P1051, DOI 10.1016/S0091-6749(96)80190-4; National Center for Health Statistics, NAT HOSP DISCH SURV; Price D, 2011, NEW ENGL J MED, V364, P1695, DOI 10.1056/NEJMoa1010846; Schappert Susan M, 2011, Vital Health Stat 13, P1; Schlessinger L, 2002, J BIOMED INFORM, V35, P37, DOI 10.1016/S1532-0464(02)00006-0; Tattersfield AE, 1999, AM J RESP CRIT CARE, V160, P594, DOI 10.1164/ajrccm.160.2.9811100; Ward BW, 2010, VITAL HLTH STAT, V10, P1; Ware JH, 2011, NEW ENGL J MED, V364, P1685, DOI 10.1056/NEJMp1103502; Williams LK, 2011, J ALLERGY CLIN IMMUN, V128, P1185, DOI 10.1016/j.jaci.2011.09.011; Wilson SR, 2010, AM J RESP CRIT CARE, V181, P566, DOI 10.1164/rccm.200906-0907OC	20	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51139	10.1371/journal.pone.0051139	http://dx.doi.org/10.1371/journal.pone.0051139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236442	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100070
J	van Mourik, MSM; Moons, KGM; van Solinge, WW; Berkelbach-van der Sprenkel, JW; Regli, L; Troelstra, A; Bonten, MJM				van Mourik, Maaike S. M.; Moons, Karel G. M.; van Solinge, Wouter W.; Berkelbach-van der Sprenkel, Jan-Willem; Regli, Luca; Troelstra, Annet; Bonten, Marc J. M.			Automated Detection of Healthcare Associated Infections: External Validation and Updating of a Model for Surveillance of Drain-Related Meningitis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; NOSOCOMIAL INFECTIONS; VENTRICULAR DRAINAGE; BACTERIAL-MENINGITIS; PROGNOSTIC RESEARCH; RISK-FACTORS; PREDICTION; DIAGNOSIS; PERFORMANCE	Objective: Automated surveillance of healthcare-associated infections can improve efficiency and reliability of surveillance. The aim was to validate and update a previously developed multivariable prediction model for the detection of drain-related meningitis (DRM). Design: Retrospective cohort study using traditional surveillance by infection control professionals as reference standard. Patients: Patients receiving an external cerebrospinal fluid drain, either ventricular (EVD) or lumbar (ELD) in a tertiary medical care center. Children, patients with simultaneous drains, <1 day of follow-up or pre-existing meningitis were excluded leaving 105 patients in validation set (2010-2011) and 653 in updating set (2004-2011). Methods: For validation, the original model was applied. Discrimination, classification and calibration were assessed. For updating, data from all available years was used to optimally re-estimate coefficients and determine whether extension with new predictors is necessary. The updated model was validated and adjusted for optimism (overfitting) using bootstrapping techniques. Results: In model validation, the rate of DRM was 17.4/1000 days at risk. All cases were detected by the model. The area under the ROC curve was 0.951. The positive predictive value was 58.8% (95% CI 40.7-75.4) and calibration was good. The revised model also includes Gram stain results. Area under the ROC curve after correction for optimism was 0.963 (95% CI 0.953-0.974). Group-level prediction was adequate. Conclusions: The previously developed multivariable prediction model maintains discriminatory power and calibration in an independent patient population. The updated model incorporates all available data and performs well, also after elaborate adjustment for optimism.	[van Mourik, Maaike S. M.; Troelstra, Annet; Bonten, Marc J. M.] Univ Med Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Moons, Karel G. M.; Bonten, Marc J. M.] Univ Med Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van Solinge, Wouter W.] Univ Med Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands; [Berkelbach-van der Sprenkel, Jan-Willem; Regli, Luca] Univ Med Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosurg, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center	van Mourik, MSM (corresponding author), Univ Med Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	M.s.m.vanmourik-2@umcutrecht.nl		van Mourik, Maaike/0000-0003-2465-4132; Van Solinge, Wouter/0000-0003-2867-2581	Alexandre Suermann Stipendium from the UMC Utrecht; Netherlands Organization for Scientific Research [918.76.611]	Alexandre Suermann Stipendium from the UMC Utrecht; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	MvM was funded by an Alexandre Suermann Stipendium from the UMC Utrecht. MB was supported by the Netherlands Organization for Scientific Research (NWO VICI Grant 918.76.611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Arabi Y, 2005, AM J INFECT CONTROL, V33, P137, DOI 10.1016/j.ajic.2004.11.008; Chi H, 2010, INT J INFECT DIS, V14, pE216, DOI 10.1016/j.ijid.2009.04.006; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Gastmeier P, 1998, INFECT CONT HOSP EP, V19, P668; Gaynes R, 2001, EMERG INFECT DIS, V7, P295, DOI 10.3201/eid0702.010230; HALEY RW, 1985, AM J EPIDEMIOL, V121, P182, DOI 10.1093/oxfordjournals.aje.a113990; Hoefnagel D, 2008, ACTA NEUROCHIR, V150, P209, DOI 10.1007/s00701-007-1458-9; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Janssen KJM, 2008, J CLIN EPIDEMIOL, V61, P76, DOI 10.1016/j.jclinepi.2007.04.018; KISS, 2012, ITS KISS REF DAT; Klompas M, 2009, CLIN INFECT DIS, V48, P1268, DOI 10.1086/597591; Korinek AM, 2005, ACTA NEUROCHIR, V147, P39, DOI 10.1007/s00701-004-0416-z; Leverstein-van Hall MA, 2010, J NEUROSURG, V112, P345, DOI 10.3171/2009.6.JNS09223; Lin MY, 2010, JAMA-J AM MED ASSOC, V304, P2035, DOI 10.1001/jama.2010.1637; LOPEZCORTES LF, 1995, J INFECT DIS, V172, P581, DOI 10.1093/infdis/172.2.581; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Martinez R, 2002, INTENS CARE MED, V28, P208, DOI 10.1007/s00134-001-1176-3; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Pfisterer W, 2003, J NEUROL NEUROSUR PS, V74, P929, DOI 10.1136/jnnp.74.7.929; Pokorny L, 2006, INFECT CONT HOSP EP, V27, P500, DOI 10.1086/502685; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Rubin DB, 2004, MULTIPLE IMPUTATION; Schade RP, 2006, J NEUROSURG, V104, P101, DOI 10.3171/jns.2006.104.1.101; Schade RP, 2005, J NEUROSURG, V102, P229, DOI 10.3171/jns.2005.102.2.0229; Scheithauer S, 2009, J NEUROL NEUROSUR PS, V80, P1381, DOI 10.1136/jnnp.2008.165357; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2009, CLIN PREDICTION MODE, P361; ten Berg MJ, 2007, CLIN CHEM LAB MED, V45, P13, DOI 10.1515/CCLM.2007.009; Tokars JI, 2004, CLIN INFECT DIS, V39, P1347, DOI 10.1086/425000; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Trick WE, 2004, EMERG INFECT DIS, V10, P1612, DOI 10.3201/eid1009.030978; van der Kooi TII, 2010, J HOSP INFECT, V75, P168, DOI 10.1016/j.jhin.2009.11.020; van Mourik MSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022846	37	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51509	10.1371/journal.pone.0051509	http://dx.doi.org/10.1371/journal.pone.0051509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236510	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000312064100126
J	Buckberry, S; Bianco-Miotto, T; Hiendleder, S; Roberts, CT				Buckberry, Sam; Bianco-Miotto, Tina; Hiendleder, Stefan; Roberts, Claire T.			Quantitative Allele-Specific Expression and DNA Methylation Analysis of H19, IGF2 and IGF2R in the Human Placenta across Gestation Reveals H19 Imprinting Plasticity	PLOS ONE			English	Article							DIFFUSIONAL EXCHANGE CHARACTERISTICS; NONCODING RNA; EPIGENETIC ASYMMETRY; GENETIC CONFLICTS; ANTISENSE RNA; CTCF-BINDING; GROWTH; RECEPTOR; MOUSE; LINEAGE	Imprinted genes play important roles in placental differentiation, growth and function, with profound effects on fetal development. In humans, H19 and IGF2 are imprinted, but imprinting of IGF2R remains controversial. The H19 non-coding RNA is a negative regulator of placental growth and altered placental imprinting of H19-IGF2 has been associated with pregnancy complications such as preeclampsia, which have been attributed to abnormal first trimester placentation. This suggests that changes in imprinting during the first trimester may precede aberrant placental morphogenesis. To better understand imprinting in the human placenta during early gestation, we quantified allele-specific expression for H19, IGF2 and IGF2R in first trimester (6-12 weeks gestation) and term placentae (37-42 weeks gestation) using pyrosequencing. Expression of IGF2R was biallelic, with a mean expression ratio of 49:51 (SD = 0.07), making transient imprinting unlikely. Expression from the repressed H19 alleles ranged from 1-25% and was higher (P<0.001) in first trimester (13.5 +/- 8.2%) compared to term (3.4 +/- 2.1%) placentae. Surprisingly, despite the known co-regulation of H19 and IGF2, little variation in expression of the repressed IGF2 alleles was observed (2.7 +/- 2.0%). To identify regulatory regions that may be responsible for variation in H19 allelic expression, we quantified DNA methylation in the H19-IGF2 imprinting control region and H19 transcription start site (TSS). Unexpectedly, we found positive correlations (P<0.01) between DNA methylation levels and expression of the repressed H19 allele at 5 CpG's 2000 bp upstream of the H19 TSS. Additionally, DNA methylation was significantly higher (P<0.05) in first trimester compared with term placentae at 5 CpG's 39-523 bp upstream of the TSS, but was not correlated with H19 repressed allele expression. Our data suggest that variation in H19 imprinting may contribute to early programming of placental phenotype and illustrate the need for quantitative and robust methodologies to further elucidate the role of imprinted genes in normal and pathological placental development.	[Buckberry, Sam; Bianco-Miotto, Tina; Hiendleder, Stefan; Roberts, Claire T.] Univ Adelaide, Robinson Inst, Res Ctr Reprod Hlth, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Bianco-Miotto, Tina] Univ Adelaide, Robinson Inst, Res Ctr Early Origins Hlth & Dis, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Hiendleder, Stefan] Univ Adelaide, JS Davies Epigenet & Genet Grp, Sch Anim & Vet Sci, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide; Robinson Research Institute; University of Adelaide; University of Adelaide	Roberts, CT (corresponding author), Univ Adelaide, Robinson Inst, Res Ctr Reprod Hlth, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia.	claire.roberts@adelaide.edu.au	Bianco-Miotto, Tina/C-4808-2008; Buckberry, Sam/H-5774-2019	Bianco-Miotto, Tina/0000-0002-8431-5338; Buckberry, Sam/0000-0003-2388-6046; Roberts, Claire/0000-0002-9250-2192	Australian Postgraduate Award; Healthy Development Adelaide and Channel 7 Children's Research Foundation PhD scholarship; W. Bruce Hall Cancer Council of South Australia Fellowship; National Health and Medical Research Council (NHMRC) [APP1020749, 565320]	Australian Postgraduate Award(Australian Government); Healthy Development Adelaide and Channel 7 Children's Research Foundation PhD scholarship; W. Bruce Hall Cancer Council of South Australia Fellowship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	SB is supported by Australian Postgraduate Award and a Healthy Development Adelaide and Channel 7 Children's Research Foundation PhD scholarship. TBM is supported by a W. Bruce Hall Cancer Council of South Australia Fellowship. SH is a JS Davies Fellow. CTR is supported by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship APP1020749. The research described herein was funded by NHMRC Research Project #565320 (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam GIR, 1996, DEVELOPMENT, V122, P839; Andraweera PH, 2012, REPROD SCI, V19, P547, DOI 10.1177/1933719111428520; Arney KL, 2003, TRENDS GENET, V19, P17, DOI 10.1016/S0168-9525(02)00004-5; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Coan PM, 2008, J PHYSIOL-LONDON, V586, P5023, DOI 10.1113/jphysiol.2008.157313; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Daelemans C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-25; Diplas AI, 2009, NUCLEIC ACIDS RES, V37, P7039, DOI 10.1093/nar/gkp749; Ergaz Z, 2005, REPROD TOXICOL, V20, P301, DOI 10.1016/j.reprotox.2005.04.007; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Frost JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001015; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Gao WL, 2011, HYPERTENS RES, V34, P655, DOI 10.1038/hr.2011.9; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Haig D, 1996, AM J REPROD IMMUNOL, V35, P226; Harris LK, 2011, BIOL REPROD, V84, P440, DOI 10.1095/biolreprod.110.088195; Hawkes C, 2004, BRAIN RES REV, V44, P117, DOI 10.1016/j.brainresrev.2003.11.002; Hirasawa R, 2010, ESSAYS BIOCHEM, V48, P187, DOI [10.1042/bse0480187, 10.1042/BSE0480187]; Hu JF, 1999, BIOCHEM BIOPH RES CO, V257, P604, DOI 10.1006/bbrc.1999.0380; JINNO Y, 1995, NAT GENET, V10, P318, DOI 10.1038/ng0795-318; Kaffer CR, 2000, GENE DEV, V14, P1908; KALSCHEUER VM, 1993, NAT GENET, V5, P74, DOI 10.1038/ng0993-74; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Killian JK, 2001, HUM MOL GENET, V10, P1721, DOI 10.1093/hmg/10.17.1721; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lambertini L, 2008, EPIGENETICS-US, V3, P261, DOI 10.4161/epi.3.5.6755; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; McCowan LME, 2010, BJOG-INT J OBSTET GY, V117, P1599, DOI 10.1111/j.1471-0528.2010.02737.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mohammad F, 2012, DEVELOPMENT, V139, P2792, DOI 10.1242/dev.079566; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Monk D, 2008, GENOME RES, V18, P1270, DOI 10.1101/gr.077115.108; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; OGAWA O, 1993, HUM MOL GENET, V2, P2163, DOI 10.1093/hmg/2.12.2163; Okae H, 2012, HUM MOL GENET, V21, P548, DOI 10.1093/hmg/ddr488; Oudejans CBM, 2001, GENOMICS, V73, P331, DOI 10.1006/geno.2001.6522; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Pozharny Y, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.039; Qiu XW, 2008, MOL ENDOCRINOL, V22, P1476, DOI 10.1210/me.2007-0474; Reik W, 2003, PHILOS T R SOC B, V358, P1403, DOI 10.1098/rstb.2003.1326; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Roberts CT, 2010, PLACENTA, V31, pS47, DOI 10.1016/j.placenta.2010.01.001; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; Steck E, 2012, J MOL MED, V90, P1185, DOI 10.1007/s00109-012-0895-y; Tabano S, 2010, EPIGENETICS-US, V5, P313, DOI 10.4161/epi.5.4.11637; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Thorvaldsen JL, 2000, SCIENCE, V288, P2145, DOI 10.1126/science.288.5474.2145; Wang Y, 2010, J GENET, V89, P213; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542; Yamasaki Y, 2005, HUM MOL GENET, V14, P2511, DOI 10.1093/hmg/ddi255; Yu L, 2009, PLACENTA, V30, P443, DOI 10.1016/j.placenta.2009.02.011	59	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51210	10.1371/journal.pone.0051210	http://dx.doi.org/10.1371/journal.pone.0051210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227253	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200112
J	Wang, SK; Chan, HC; Makovey, I; Simmer, JP; Hu, JCC				Wang, Shih-Kai; Chan, Hui-Chen; Makovey, Igor; Simmer, James P.; Hu, Jan C-C.			Novel PAX9 and COL1A2 Missense Mutations Causing Tooth Agenesis and OI/DGI without Skeletal Abnormalities	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT HYPODONTIA; IMPERFECTA TYPE-II; OSTEOGENESIS IMPERFECTA; PAIRED DOMAIN; DENTINOGENESIS IMPERFECTA; DENTIN PHOSPHOPROTEIN; CAUSES OLIGODONTIA; MOLAR OLIGODONTIA; NONSENSE MUTATION; HELICAL DOMAIN	Inherited dentin defects are classified into three types of dentinogenesis imperfecta (DGI) and two types of dentin dysplasia (DD). The genetic etiology of DD-I is unknown. Defects in dentin sialophosphoprotein (DSPP) cause DD type II and DGI types II and III. DGI type I is the oral manifestation of osteogenesis imperfecta (OI), a systemic disease typically caused by defects in COL1A1 or COL1A2. Mutations in MSX1, PAX9, AXIN2, EDA and WNT10A can cause non-syndromic familial tooth agenesis. In this study a simplex pattern of clinical dentinogenesis imperfecta juxtaposed with a dominant pattern of hypodontia (mild tooth agenesis) was evaluated, and available family members were recruited. Mutational analyses of the candidate genes for DGI and hypodontia were performed and the results validated. A spontaneous novel mutation in COL1A2 (c.1171G>A; p.Gly391Ser) causing only dentin defects and a novel mutation in PAX9 (c.43T>A; p.Phe15Ile) causing hypodontia were identified and correlated with the phenotypic presentations in the family. Bone radiographs of the proband's dominant leg and foot were within normal limits. We conclude that when no DSPP mutation is identified in clinically determined isolated DGI cases, COL1A1 and COL1A2 should be considered as candidate genes. PAX9 mutation p.Phe15Ile within the N-terminal beta-hairpin structure of the PAX9 paired domain causes tooth agenesis.	[Wang, Shih-Kai; Chan, Hui-Chen; Makovey, Igor; Simmer, James P.; Hu, Jan C-C.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hu, JCC (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	janhu@umich.edu	Wang, Shih-Kai/AAB-5562-2022; Wang, Shih-Kai/P-3644-2019; Hu, Jan C-C./F-5679-2015	Wang, Shih-Kai/0000-0002-8378-5880; Hu, Jan C-C./0000-0002-9294-0248; Simmer, James/0000-0002-7192-6105	NIDCR National Institute of Dental and Craniofacial Research /NIH [DE015846]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015846] Funding Source: NIH RePORTER	NIDCR National Institute of Dental and Craniofacial Research /NIH; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by NIDCR National Institute of Dental and Craniofacial Research /NIH research grant DE015846. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Basel D, 2009, GENET MED, V11, P375, DOI 10.1097/GIM.0b013e3181a1ff7b; Bodian DL, 2008, BIOCHEMISTRY-US, V47, P5424, DOI 10.1021/bi800026k; Bodian DL, 2009, HUM MOL GENET, V18, P463, DOI 10.1093/hmg/ddn374; Boeira Junior BR, 2012, J ORAL PATHOL MED, V2, P1600; Chan TF, 2008, GENOMICS, V91, P307, DOI 10.1016/j.ygeno.2007.12.008; Das P, 2003, AM J MED GENET A, V118A, P35, DOI 10.1002/ajmg.a.10011; Das P, 2002, HUM GENET, V110, P371, DOI 10.1007/s00439-002-0699-1; Frazier-Bowers SA, 2002, J DENT RES, V81, P129, DOI 10.1177/154405910208100209; Han D, 2008, EUR J MED GENET, V51, P536, DOI 10.1016/j.ejmg.2008.06.002; Hansen L, 2007, EUR J ORAL SCI, V115, P330, DOI 10.1111/j.1600-0722.2007.00457.x; Jumlongras D, 2004, HUM GENET, V114, P242, DOI 10.1007/s00439-003-1066-6; Kapadia H, 2006, EUR J HUM GENET, V14, P403, DOI 10.1038/sj.ejhg.5201574; Kim JW, 2006, J DENT RES, V85, P267, DOI 10.1177/154405910608500312; Klein ML, 2005, J DENT RES, V84, P43, DOI 10.1177/154405910508400107; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Lammi L, 2003, EUR J HUM GENET, V11, P866, DOI 10.1038/sj.ejhg.5201060; Lee KE, 2011, CLIN GENET, V79, P378, DOI 10.1111/j.1399-0004.2010.01483.x; Liang CL, 2007, J HUM GENET, V52, P374, DOI 10.1007/s10038-007-0117-6; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; McKnight DA, 2008, HUM MUTAT, V29, P1392, DOI 10.1002/humu.20783; Mostowska A, 2003, EUR J ORAL SCI, V111, P272, DOI 10.1034/j.1600-0722.2003.00036.x; Nieminen P, 2001, EUR J HUM GENET, V9, P743, DOI 10.1038/sj.ejhg.5200715; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Pallos D, 2001, ARCH ORAL BIOL, V46, P459, DOI 10.1016/S0003-9969(00)00130-8; Rauch F, 2010, EUR J HUM GENET, V18, P642, DOI 10.1038/ejhg.2009.242; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Tallon-Walton V, 2007, EUR J ORAL SCI, V115, P427, DOI 10.1111/j.1600-0722.2007.00492.x; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; Wang SK, 2011, EUR J ORAL SCI, V119, P158, DOI 10.1111/j.1600-0722.2011.00874.x; Wang Y, 2009, CELLS TISSUES ORGANS, V189, P80, DOI 10.1159/000151448; Wang Y, 2009, HUM MOL GENET, V18, P2863, DOI 10.1093/hmg/ddp221; Zhao Ji-lin, 2005, Zhonghua Kou Qiang Yi Xue Za Zhi, V40, P266; Zhao JL, 2007, AM J MED GENET A, V143A, P2592, DOI 10.1002/ajmg.a.31993	38	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51533	10.1371/journal.pone.0051533	http://dx.doi.org/10.1371/journal.pone.0051533			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227268	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200127
J	Poulsen, L; Andersen, MR; Lantz, AE; Thykaer, J				Poulsen, Lars; Andersen, Mikael Rordam; Lantz, Anna Eliasson; Thykaer, Jette			Identification of a Transcription Factor Controlling pH-Dependent Organic Acid Response in Aspergillus niger	PLOS ONE			English	Article							CITRIC-ACID; MORPHOLOGY; GENOMICS; BACTERIA; DELETION; CLONING	Acid formation in Aspergillus niger is known to be subjected to tight regulation, and the acid production profiles are fine-tuned to respond to the ambient pH. Based on transcriptome data, putative trans-acting pH responding transcription factors were listed and through knock out studies, mutants exhibiting an oxalate overproducing phenotype were identified. The yield of oxalate was increased up to 158% compared to the wild type and the corresponding transcription factor was therefore entitled Oxalic Acid repression Factor, OafA. Detailed physiological characterization of one of the Delta oafA mutants, compared to the wild type, showed that both strains produced substantial amounts of gluconic acid, but the mutant strain was more efficient in re-uptake of gluconic acid and converting it to oxalic acid, particularly at high pH (pH 5.0). Transcriptional profiles showed that 241 genes were differentially expressed due to the deletion of oafA and this supported the argument of OafA being a trans-acting transcription factor. Furthermore, expression of two phosphoketolases was down-regulated in the Delta oafA mutant, one of which has not previously been described in fungi. It was argued that the observed oxalate overproducing phenotype was a consequence of the efficient re-uptake of gluconic acid and thereby a higher flux through glycolysis. This results in a lower flux through the pentose phosphate pathway, demonstrated by the down-regulation of the phosphoketolases. Finally, the physiological data, in terms of the specific oxygen consumption, indicated a connection between the oxidative phosphorylation and oxalate production and this was further substantiated through transcription analysis.	[Poulsen, Lars; Andersen, Mikael Rordam; Lantz, Anna Eliasson; Thykaer, Jette] Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark	Technical University of Denmark	Thykaer, J (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark.	jt@bio.dtu.dk	Andersen, Mikael R/F-9377-2013; Andersen, Mikael Rørdam/P-6743-2019; Lantz, Anna Eliasson/G-8569-2012	Andersen, Mikael R/0000-0003-4794-6808; Andersen, Mikael Rørdam/0000-0003-4794-6808; Lantz, Anna Eliasson/0000-0003-1547-9299; Poulsen, Lars/0000-0001-9106-8956	Danish Research Agency for Technology and Production [09-064967]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Danish Research Agency for Technology and Production; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Danish Research Agency for Technology and Production, grant # 09-064967. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; Andersen MR, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r47; Baker SE, 2006, MED MYCOL, V44, pS17, DOI 10.1080/13693780600921037; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CLELAND WW, 1954, J BIOL CHEM, V208, P679; de Jongh WA, 2008, METAB ENG, V10, P87, DOI 10.1016/j.ymben.2007.11.002; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; HEINRICH M, 1982, EUR J APPL MICROBIOL, V15, P88, DOI 10.1007/BF00499512; Ingram-Smith C, 2006, TRENDS MICROBIOL, V14, P249, DOI 10.1016/j.tim.2006.04.001; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; LEGISA M, 1986, ENZYME MICROB TECH, V8, P258, DOI 10.1016/0141-0229(86)90018-9; MA H, 1981, FEMS MICROBIOL LETT, V12, P147; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; McCue LA, 2002, GENOME RES, V12, P1523, DOI 10.1101/gr.323602; McIntyre M, 1997, ENZYME MICROB TECH, V21, P479, DOI 10.1016/S0141-0229(97)00007-0; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Muller C, 2002, APPL ENVIRON MICROB, V68, P1827, DOI 10.1128/AEM.68.4.1827-1836.2002; Nielsen ML, 2011, FEMS MICROBIOL LETT, V321, P157, DOI 10.1111/j.1574-6968.2011.02327.x; Nielsen ML, 2006, FUNGAL GENET BIOL, V43, P54, DOI 10.1016/j.fgb.2005.09.005; Nutzmann HW, 2011, P NATL ACAD SCI USA, V108, P14282, DOI 10.1073/pnas.1103523108; Pedersen H, 2000, MOL GEN GENET, V263, P281, DOI 10.1007/s004380051169; Pedersen H, 2000, METAB ENG, V2, P34, DOI 10.1006/mben.1999.0136; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Punt PJ, 2008, FUNGAL GENET BIOL, V45, P1591, DOI 10.1016/j.fgb.2008.09.007; Reyes-Dominguez Y, 2010, MOL MICROBIOL, V76, P1376, DOI 10.1111/j.1365-2958.2010.07051.x; Roopashri AN, 2009, APPL MICROBIOL BIOT, V83, P1115, DOI 10.1007/s00253-009-1991-y; Ruijter GJG, 1999, MICROBIOL-SGM, V145, P2569, DOI 10.1099/00221287-145-9-2569; Sambrook J., 2001, MOL CLONING LAB MANU; Schumann J, 2006, J BIOTECHNOL, V124, P690, DOI 10.1016/j.jbiotec.2006.03.046; Schuurmans JM, 2008, FEMS YEAST RES, V8, P195, DOI 10.1111/j.1567-1364.2007.00319.x; Shwab EK, 2007, EUKARYOT CELL, V6, P1656, DOI 10.1128/EC.00186-07; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sorensen LM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-255; Thykaer J, 2007, PROCESS BIOCHEM, V42, P1050, DOI 10.1016/j.procbio.2007.04.004; WITTEVEEN CFB, 1993, CURR GENET, V24, P408, DOI 10.1007/BF00351849	37	14	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50596	10.1371/journal.pone.0050596	http://dx.doi.org/10.1371/journal.pone.0050596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251373	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200031
J	Zhang, ZF; Sun, P; Yu, FX; Yan, L; Yuan, F; Zhang, WX; Wang, T; Wan, ZY; Shao, Q; Li, ZD				Zhang, Zifu; Sun, Peng; Yu, Fuxian; Yan, Li; Yuan, Fang; Zhang, Wenxin; Wang, Tao; Wan, Zhiyi; Shao, Qiang; Li, Zandong			Transgenic Quail Production by Microinjection of Lentiviral Vector into the Early Embryo Blood Vessels	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; POSTTRANSCRIPTIONAL REGULATORY ELEMENT; GREEN FLUORESCENT PROTEIN; CHIMERIC CHICKENS; EGG-WHITE; TRANSMISSION; EXPRESSION; MIGRATION; GENERATION; SYSTEM	Several strategies have been used to generate transgenic birds. The most successful method so far has been the injection of lentiviral vectors into the subgerminal cavity of a newly laid egg. We report here a new, easy and effective way to produce transgenic quails through direct injection of a lentiviral vector, containing an enhanced-green fluorescent protein (eGFP) transgene, into the blood vessels of quail embryos at Hamburger-Hamilton stage 13-15 (HH13-15). A total of 80 embryos were injected and 48 G0 chimeras (60%) were hatched. Most injected embryo organs and tissues of hatched quails were positive for eGFP. In five out of 21 mature G0 male quails, the semen was eGFP-positive, as detected by polymerase chain reaction (PCR), indicating transgenic germ line chimeras. Testcross and genetic analyses revealed that the G0 quail produced transgenic G1 offspring; of 46 G1 hatchlings, 6 were transgenic (6/46, 13.0%). We also compared this new method with the conventional transgenesis using stage X subgerminal cavity injection. Total 240 quail embryos were injected by subgerminal cavity injection, of which 34 (14.1%) were hatched, significantly lower than the new method. From these hatched quails semen samples were collected from 19 sexually matured males and tested for the transgene by PCR. The transgene was present in three G0 male quails and only 4/236 G1 offspring (1.7%) were transgenic. In conclusion, we developed a novel bird transgenic method by injection of lentiviral vector into embryonic blood vessel at HH 13-15 stage, which result in significant higher transgenic efficiency than the conventional subgerminal cavity injection.	[Zhang, Zifu; Yu, Fuxian; Yan, Li; Yuan, Fang; Zhang, Wenxin; Wang, Tao; Wan, Zhiyi; Shao, Qiang; Li, Zandong] China Agr Univ, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China; [Sun, Peng] Beijing Educ Examinat Author, Beijing, Peoples R China	China Agricultural University	Li, ZD (corresponding author), China Agr Univ, State Key Labs Agrobiotechnol, Beijing 100094, Peoples R China.	lzdws@cau.edu.cn	Shao, Eric Qiang/I-1359-2019; Rui, Core/AAW-5603-2021	Shao, Eric Qiang/0000-0001-5307-8264; 	State 863 High-technology R&D Project of China [2007AA100504]	State 863 High-technology R&D Project of China	This work was supported by grant 2007AA100504 from the State 863 High-technology R&D Project of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGEGIL V, 1991, RES VET SCI, V50, P139, DOI 10.1016/0034-5288(91)90096-7; ANDO Y, 1983, DEV GROWTH DIFFER, V25, P345; CARSIENCE RS, 1993, DEVELOPMENT, V117, P669; Chapman SC, 2005, DEVELOPMENT, V132, P935, DOI 10.1242/dev.01652; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; EYALGILADI H, 1981, J EMBRYOL EXP MORPH, V65, P139; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Han JY, 2009, COMP IMMUNOL MICROB, V32, P61, DOI 10.1016/j.cimid.2007.11.010; Harvey AJ, 2002, NAT BIOTECHNOL, V20, P396, DOI 10.1038/nbt0402-396; Kamihira M, 2005, J VIROL, V79, P10864, DOI 10.1128/JVI.79.17.10864-10874.2005; Kawabe Y, 2008, J BIOSCI BIOENG, V106, P598, DOI 10.1263/jbb.106.598; Koo BC, 2006, FASEB J, V20, P2251, DOI 10.1096/fj.06-5866com; KUWANA T, 1993, DEV GROWTH DIFFER, V35, P237; Kwon MS, 2004, BIOCHEM BIOPH RES CO, V320, P442, DOI 10.1016/j.bbrc.2004.05.197; Li Hai-Chang, 2001, Journal of Poultry Science, V38, P175; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Lyall J, 2011, SCIENCE, V331, P223, DOI 10.1126/science.1198020; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; MEYER DB, 1964, DEV BIOL, V10, P154, DOI 10.1016/0012-1606(64)90009-0; Motono M, 2010, J BIOSCI BIOENG, V109, P315, DOI 10.1016/j.jbiosc.2009.10.007; Mozdziak PE, 2003, J NUTR, V133, P3076, DOI 10.1093/jn/133.10.3076; NAITO M, 1994, MOL REPROD DEV, V39, P153, DOI 10.1002/mrd.1080390206; Nakamura Y, 2007, POULTRY SCI, V86, P2182, DOI 10.1093/ps/86.10.2182; Park F, 2007, PHYSIOL GENOMICS, V31, P159, DOI 10.1152/physiolgenomics.00069.2007; PERRY MM, 1988, NATURE, V331, P70, DOI 10.1038/331070a0; Sang H, 2004, MECH DEVELOP, V121, P1179, DOI 10.1016/j.mod.2004.05.012; Scott BB, 2005, P NATL ACAD SCI USA, V102, P16443, DOI 10.1073/pnas.0508437102; Scott BB, 2006, NAT PROTOC, V1, P1406, DOI 10.1038/nprot.2006.187; Shin SS, 2008, FASEB J, V22, P2435, DOI 10.1096/fj.07-101485; TAJIMA A, 1993, THERIOGENOLOGY, V40, P509, DOI 10.1016/0093-691X(93)90404-S; UKESHIMA A, 1991, J ELECTRON MICROSC, V40, P124; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	33	15	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50817	10.1371/journal.pone.0050817	http://dx.doi.org/10.1371/journal.pone.0050817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251391	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200040
J	Bao, XF; Beatty, WL; Fan, HZ				Bao, Xiaofeng; Beatty, Wandy L.; Fan, Huizhou			Exploration of Chlamydial Type III Secretion System Reconstitution in Escherichia coli	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; SMALL-MOLECULE INHIBITORS; HOST-CELL CYTOPLASM; PEPTIDE DEFORMYLASE; SURFACE PROJECTIONS; EPITHELIAL-CELLS; INC PROTEINS; TRACHOMATIS; IDENTIFICATION; PNEUMONIAE	Background: Type III secretion system is a virulent factor for many pathogens, and is thought to play multiple roles in the development cycle and pathogenesis of chlamydia, an important human pathogen. However, due to the obligate intracellular parasitical nature of chlamydiae and a lack of convenient genetic methodology for the organisms, very limited approaches are available to study the chlamydial type III secretion system. In this study, we explored the reconstitution of a chlamydial type III secretion in Escherichia coli. Results: We successfully cloned all 6 genomic DNA clusters of the chlamydial type III secretion system into three bacterial plasmids. 5 of the 6 clusters were found to direct mRNA synthesis from their own promoters in Escherichia coli transformed with the three plasmids. Cluster 5 failed to express mRNA using its own promoters. However, fusion of cluster 5 to cluster 6 resulted in the expression of cluster 5 mRNA. Although only two of the type III secretion system proteins were detected transformed E. coli due to limited antibody availability, type III secretion system-like structures were detected in ultrathin sections in a small proportion of transformed E. coli. Conclusions: We have successfully generated E. coli expressing all genes of the chlamydial type III secretion system. This serves as a foundation for optimal expression and assembly of the recombinant chlamydial type III secretion system, which may be extremely useful for the characterization of the chlamydial type III secretion system and for studying its role in chlamydial pathogenicity.	[Bao, Xiaofeng; Fan, Huizhou] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Bao, Xiaofeng] Nantong Univ, Sch Med, Dept Pharmacol, Nantong, Peoples R China; [Beatty, Wandy L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Nantong University; Washington University (WUSTL)	Fan, HZ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.	fanhu@umdnj.edu		FAN, HUIZHOU/0000-0002-4903-926X	National Institutes of Health [AI071954]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071954, R33AI071954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health (AI071954 to HF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey L, 2007, FEBS LETT, V581, P587, DOI 10.1016/j.febslet.2007.01.013; Balakrishnan A, 2006, J BIOL CHEM, V281, P16691, DOI 10.1074/jbc.M513648200; Bao XF, 2012, P NATL ACAD SCI USA, V109, P16870, DOI 10.1073/pnas.1207300109; Bao XF, 2011, MICROBIOL-SGM, V157, P2569, DOI 10.1099/mic.0.049668-0; Brumell JH, 2002, INFECT IMMUN, V70, P3264, DOI 10.1128/IAI.70.6.3264-3270.2002; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Campbell LA, 2004, NAT REV MICROBIOL, V2, P23, DOI 10.1038/nrmicro796; Chellas-Gery B, 2011, INFECT IMMUN, V79, P3036, DOI 10.1128/IAI.00159-11; Clifton DR, 2005, INFECT IMMUN, V73, P3860, DOI 10.1128/IAI.73.7.3860-3868.2005; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dehoux P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-109; Fields KA, 2000, MOL MICROBIOL, V38, P1048, DOI 10.1046/j.1365-2958.2000.02212.x; Fields KA, 2007, CHLAMYDIA GENOMICS P, P219; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; GINOCCHIO C, 1992, P NATL ACAD SCI USA, V89, P5976, DOI 10.1073/pnas.89.13.5976; Gopal V, 1997, EUR J BIOCHEM, V244, P613, DOI 10.1111/j.1432-1033.1997.00613.x; GREGORY WW, 1979, J BACTERIOL, V138, P241, DOI 10.1128/JB.138.1.241-244.1979; Hefty PS, 2007, J BACTERIOL, V189, P198, DOI 10.1128/JB.01034-06; Ho TD, 2005, INFECT IMMUN, V73, P905, DOI 10.1128/IAI.73.2.905-911.2005; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Hybiske K, 2007, INFECT IMMUN, V75, P3925, DOI 10.1128/IAI.00106-07; Jamison WP, 2008, MICROB PATHOGENESIS, V45, P435, DOI 10.1016/j.micpath.2008.10.002; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Lei L, 2011, MICROB PATHOGENESIS, V51, P101, DOI 10.1016/j.micpath.2011.05.002; Li XJ, 2007, CELL RES, V17, P985, DOI 10.1038/cr.2007.98; MATSUMOTO A, 1982, J BACTERIOL, V150, P358, DOI 10.1128/JB.150.1.358-364.1982; Mital J, 2010, CELL MICROBIOL, V12, P1235, DOI 10.1111/j.1462-5822.2010.01465.x; Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; Peters J, 2007, TRENDS MICROBIOL; Qi ML, 2011, J BACTERIOL, V193, P2498, DOI 10.1128/JB.01301-10; Rodgers AK, 2011, FERTIL STERIL, V96, P715, DOI 10.1016/j.fertnstert.2011.06.021; Schachter J, 1999, CHLAMYDIA, P139; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Subtil A, 2000, MICROBES INFECT, V2, P367, DOI 10.1016/S1286-4579(00)00335-X; Subtil A, 2001, MOL MICROBIOL, V39, P792, DOI 10.1046/j.1365-2958.2001.02272.x; Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x	44	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50833	10.1371/journal.pone.0050833	http://dx.doi.org/10.1371/journal.pone.0050833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239989	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800026
J	Angelucci, C; Maulucci, G; Lama, G; Proietti, G; Colabianchi, A; Papi, M; Maiorana, A; De Spirito, M; Micera, A; Balzamino, OB; Di Leone, A; Masetti, R; Sica, G				Angelucci, Cristiana; Maulucci, Giuseppe; Lama, Gina; Proietti, Gabriella; Colabianchi, Anna; Papi, Massimiliano; Maiorana, Alessandro; De Spirito, Marco; Micera, Alessandra; Balzamino, Omar Bijorn; Di Leone, Alba; Masetti, Riccardo; Sica, Gigliola			Epithelial-Stromal Interactions in Human Breast Cancer: Effects on Adhesion, Plasma Membrane Fluidity and Migration Speed and Directness	PLOS ONE			English	Article							SPAN DETERMINANT P66(SHCA); GENE-EXPRESSION PROFILES; TUMOR-GROWTH; IN-VITRO; MESENCHYMAL TRANSITION; CARCINOMA CELLS; FIBROBLASTS; DIFFERENTIATION; METASTASIS; RESISTANCE	Interactions occurring between malignant cells and the stromal microenvironment heavily influence tumor progression. We investigated whether this cross-talk affects some molecular and functional aspects specifically correlated with the invasive phenotype of breast tumor cells (i.e. adhesion molecule expression, membrane fluidity, migration) by co-culturing mammary cancer cells exhibiting different degrees of metastatic potential (MDA-MB-231>MCF-7) with fibroblasts isolated from breast healthy skin (normal fibroblasts, NFs) or from breast tumor stroma (cancer-associated fibroblasts, CAFs) in 2D or 3D (nodules) cultures. Confocal immunofluorescence analysis of the epithelial adhesion molecule E-cadherin on frozen nodule sections demonstrated that NFs and CAFs, respectively, induced or inhibited its expression in MCF-7 cells. An increase in the mesenchymal adhesion protein N-cadherin was observed in CAFs, but not in NFs, as a result of the interaction with both kinds of cancer cells. CAFs, in turn, promoted N-cadherin up-regulation in MDA-MB-231 cells and its de novo expression in MCF-7 cells. Beyond promotion of "cadherin switching", another sign of the CAF-triggered epithelial-mesenchymal transition (EMT) was the induction of vimentin expression in MCF-7 cells. Plasma membrane labeling of monolayer cultures with the fluorescent probe Laurdan showed an enhancement of the membrane fluidity in cancer cells co-cultured with NFs or CAFs. An increase in lipid packing density of fibroblast membranes was promoted by MCF-7 cells. Time-lapsed cell tracking analysis of mammary cancer cells co-cultured with NFs or CAFs revealed an enhancement of tumor cell migration velocity, even with a marked increase in the directness induced by CAFs. Our results demonstrate a reciprocal influence of mammary cancer and fibroblasts on various adhesiveness/invasiveness features. Notably, CAFs' ability to promote EMT, reduction of cell adhesion, increase in membrane fluidity, and migration velocity and directness in mammary cancer cells can be viewed as an overall progression-and invasion-promoting effect.	[Maulucci, Giuseppe; Papi, Massimiliano; Maiorana, Alessandro; De Spirito, Marco] Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy; [Angelucci, Cristiana; Lama, Gina; Proietti, Gabriella; Colabianchi, Anna; Sica, Gigliola] Univ Cattolica Sacro Cuore, Ist Istol & Embriol, Rome, Italy; [Micera, Alessandra; Balzamino, Omar Bijorn] Fdn GB Bietti, Ist Ricovero & Cura Carattere Sci, Rome, Italy; [Di Leone, Alba; Masetti, Riccardo] Univ Cattolica Sacro Cuore, Dipartimento Tutela Salute Donna & Vita Nascente, Unita Operat Chirurg Senol, Fac Med & Chirurg A Gemelli, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	De Spirito, M (corresponding author), Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy.	m.despirito@rm.unicatt.it	De Spirito, Marco/U-3817-2019; Maulucci, Giuseppe/C-7400-2009; balzamino, bijorn omar/A-4433-2013; De Spirito, Marco/C-5386-2008; Papi, Massimiliano/AAC-3657-2022; Micera, Alessandra/J-3373-2013; Di Leone, Alba/AAD-2050-2022; micera, alessandra/AAY-4696-2020	De Spirito, Marco/0000-0003-4260-5107; Maulucci, Giuseppe/0000-0002-2154-319X; balzamino, bijorn omar/0000-0002-2254-1647; De Spirito, Marco/0000-0003-4260-5107; Papi, Massimiliano/0000-0002-0029-1309; micera, alessandra/0000-0002-9375-6071; MASETTI, Riccardo/0000-0002-7520-9111	Susan G. Komen Italian Affiliate (Rome, Italy)	Susan G. Komen Italian Affiliate (Rome, Italy)	Funding was provided by the Susan G. Komen Italian Affiliate (Rome, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 1999, J PATHOL, V187, P82, DOI 10.1002/(SICI)1096-9896(199901)187:1<82::AID-PATH248>3.0.CO;2-8; Balogh G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021182; Beaupain Rene, 1999, Methods in Cell Science, V21, P25, DOI 10.1023/A:1009899527587; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; CAMPS JL, 1990, P NATL ACAD SCI USA, V87, P75, DOI 10.1073/pnas.87.1.75; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Santos RPC, 2011, TUMOR BIOL, V32, P145, DOI 10.1007/s13277-010-0108-7; DELICONSTANTINOS G, 1987, ANTICANCER RES, V7, P1011; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Fu LW, 2002, EUR J CANCER, V38, P418, DOI 10.1016/S0959-8049(01)00356-2; Gao MQ, 2010, J CELL SCI, V123, P3507, DOI 10.1242/jcs.072900; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Giulianelli S, 2008, INT J CANCER, V123, P2518, DOI 10.1002/ijc.23802; Greco E, 2012, P NATL ACAD SCI USA, V109, pE1360, DOI 10.1073/pnas.1200484109; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; HUBNER C, 1989, J NEUROL SCI, V92, P205, DOI 10.1016/0022-510X(89)90137-8; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173; Kleer CG, 2008, CLIN CANCER RES, V14, P5357, DOI 10.1158/1078-0432.CCR-08-0732; Koch OR, 2008, LAB INVEST, V88, P750, DOI 10.1038/labinvest.2008.44; Kunz-Schughart LA, 2003, AM J PHYSIOL-CELL PH, V284, pC209, DOI 10.1152/ajpcell.00557.2001; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P623, DOI 10.14670/HH-17.623; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LeBedis C, 2002, INT J CANCER, V100, P2, DOI 10.1002/ijc.10481; Lebret SC, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1656; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Mardia Kanti V, 1999, DIRECTIONAL STAT; Maulucci G, 2010, NUOVO CIM B, V125, P645, DOI 10.1393/ncb/i2010-10865-7; Maulucci G, 2010, EUR BIOPHYS J BIOPHY, V39, P993, DOI 10.1007/s00249-009-0470-9; Maulucci G, 2009, BIOSENS BIOELECTRON, V25, P682, DOI 10.1016/j.bios.2009.07.038; Maulucci G, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.143pl3; Meijering E, 2009, SEMIN CELL DEV BIOL, V20, P894, DOI 10.1016/j.semcdb.2009.07.004; Montel V, 2006, INT J CANCER, V119, P251, DOI 10.1002/ijc.21757; NAKAZAWA I, 1989, TOHOKU J EXP MED, V157, P193, DOI 10.1620/tjem.157.193; Owen DM, 2010, IMMUNOLOGY, V131, P1, DOI 10.1111/j.1365-2567.2010.03319.x; Panieri E, 2010, AGING-US, V2, P487, DOI 10.18632/aging.100183; Papi M, 2011, J NANOPART RES, V13, P6141, DOI 10.1007/s11051-011-0327-x; Parasassi T, 2008, FASEB J, V22, P2350, DOI 10.1096/fj.07-097774; Peetla C, 2010, MOL PHARMACEUT, V7, P2334, DOI 10.1021/mp100308n; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Polyak K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003244; RABER J, 1989, MED HYPOTHESES, V28, P169, DOI 10.1016/0306-9877(89)90046-7; Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107; Rozenchan PB, 2009, INT J CANCER, V125, P2767, DOI 10.1002/ijc.24646; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Shekhar MPV, 2001, CANCER RES, V61, P1320; SINGER C, 1995, CANCER RES, V55, P2448; Sok M, 2002, ANN THORAC SURG, V73, P1567, DOI 10.1016/S0003-4975(02)03458-6; TARABOLETTI G, 1989, INT J CANCER, V44, P707, DOI 10.1002/ijc.2910440426; Tyan SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015313; Wang TN, 2002, SURGERY, V132, P220, DOI 10.1067/msy.2002.125353; Wells A, 2011, FRONT BIOSCI-LANDMRK, V16, P815, DOI 10.2741/3722; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Zeisig R, 2007, ARCH BIOCHEM BIOPHYS, V459, P98, DOI 10.1016/j.abb.2006.09.030	57	78	78	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50804	10.1371/journal.pone.0050804	http://dx.doi.org/10.1371/journal.pone.0050804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251387	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900020
J	Cai, F; Guo, DK; Chen, HH; Shu, Z				Cai, Fei; Guo, Deke; Chen, Honghui; Shu, Zhen			Your Relevance Feedback Is Essential: Enhancing the Learning to Rank Using the Virtual Feature Based Logistic Regression	PLOS ONE			English	Article								Information retrieval applications have to publish their output in the form of ranked lists. Such a requirement motivates researchers to develop methods that can automatically learn effective ranking models. Many existing methods usually perform analysis on multidimensional features of query-document pairs directly and don't take users' interactive feedback information into account. They thus incur the high computation overhead and low retrieval performance due to an indefinite query expression. In this paper, we propose a Virtual Feature based Logistic Regression (VFLR) ranking method that conducts the logistic regression on a set of essential but independent variables, called virtual features (VF). They are extracted via the principal component analysis (PCA) method with the user's relevance feedback. We then predict the ranking score of each queried document to produce a ranked list. We systematically evaluate our method using the LETOR 4.0 benchmark datasets. The experimental results demonstrate that the proposal outperforms the state-of-the-art methods in terms of the Mean Average Precision (MAP), the Precision at position k (P@k), and the Normalized Discounted Cumulative Gain at position k (NDCG@k).	[Cai, Fei; Guo, Deke; Chen, Honghui; Shu, Zhen] Natl Univ Def Technol, Sci & Technol Informat Syst Engn Lab, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Guo, DK (corresponding author), Natl Univ Def Technol, Sci & Technol Informat Syst Engn Lab, Changsha, Hunan, Peoples R China.	caifei1104@gmail.com			National Natural Science Foundation of China [61070216]; National Basic Research Program of China [613154]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work is funded by the National Natural Science Foundation of China under Grant No. 61070216, and the National Basic Research Program of China under Grant No. 613154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, P 19 INT C NEUR INF; Bennett P.N., 2010, P 19 INT C WORLD WID; Burges C., 2005, P 22 INT C MACH LEAR, V119, P89, DOI [10.1145/1102351.1102363, DOI 10.1145/1102351.1102363]; Cao Z., 2007, P 24 INT C MACH LEAR, P129, DOI DOI 10.1145/1273496.1273513; Chapelle O, 2011, JMLR WORKSHOP C P, P91; Chatterjee S., 1986, STAT SCI, V1, P379, DOI [10.1214/ss/1177013622, DOI 10.1214/SS/1177013622]; Freund Y., 2003, J MACHINE LEARNING R, V4, P933, DOI DOI 10.1162/JMLR.2003.4.6.933; Geng X., 2008, P 31 ANN INT ACM SIG, P115, DOI [10.1145/1390334.1390356, DOI 10.1145/1390334.1390356]; Golub GH., 2013, MATRIX COMPUTATIONS; Herbrich R., 2000, LARGE MARGIN RANK BO; Joachims T., 2002, P 8 ACM SIGKDD INT C, P133, DOI [10.1145/775047.775067, DOI 10.1145/775047.775067]; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Jun Xu, 2007, 30th Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P391; LAFFERTY J, 2001, P 24 ANN INT ACM SIG, P111, DOI DOI 10.1145/383952.383970; Li P., 2007, ADV NEURAL INFORM PR, P897; Liu C., 2011, P ASIST ANNU MEET, V48, P1; Liu C, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P379; Liu TY, 2011, LEARNING TO RANK FOR INFORMATION RETRIEVAL, P1, DOI 10.1007/978-3-642-14267-3; Manning CD, 2009, INTRO INFORM RETRIEV; Nallapati R., 2004, Proceedings of Sheffield SIGIR 2004. The Twenty-Seventh Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P64, DOI 10.1145/1008992.1009006; Newsam S, 2001, 2001 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL III, PROCEEDINGS, P596, DOI 10.1109/ICIP.2001.958189; Phophalia A., 2011, 2011 NIRM U INT C EN, P1, DOI 10.1109/NUiConE.2011.6153228; Qin T., 2006, 156 MICR RES AS; Robertson SE, 1997, J DOC, V53, P3, DOI 10.1108/EUM0000000007186; SALTON G, 1983, COMMUN ACM, V26, P1022, DOI 10.1145/182.358466; Salton G, 1971, SMART RETRIEVAL SYST; Taylor M., 2008, P 2008 INT C WEB SEA, P77, DOI DOI 10.1145/1341531.1341544; Tian AB, 2011, PROCEEDINGS OF THE 34TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL (SIGIR'11), P145; Veloso A, 2008, P 31 ANN INT ACM SIG, P267, DOI DOI 10.1145/1390334.1390381; Xu J., 2008, P 31 ANN INT ACM SIG, P107, DOI DOI 10.1145/1390334.1390355; Zheng Z., 2008, P 21 ANN C NEUR INF, V20, P1697	31	2	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50112	10.1371/journal.pone.0050112	http://dx.doi.org/10.1371/journal.pone.0050112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251359	Green Submitted, gold, Green Published			2022-12-27	WOS:000312201900006
J	Youmans, L; Taylor, C; Shin, E; Harrell, A; Ellis, AE; Seguin, B; Ji, XL; Zhao, SY				Youmans, Lydia; Taylor, Cynthia; Shin, Edwin; Harrell, Adrienne; Ellis, Angela E.; Seguin, Bernard; Ji, Xinglai; Zhao, Shaying			Frequent Alteration of the Tumor Suppressor Gene APC in Sporadic Canine Colorectal Tumors	PLOS ONE			English	Article							DOMESTIC DOG; COLON-CANCER; SOMATIC MUTATIONS; GENOME SEQUENCE; BETA-CATENIN; E-CADHERIN; EXPRESSION; MEDICINE; SCIENCE; CLUSTER	Sporadic canine colorectal cancers (CRCs) should make excellent models for studying the corresponding human cancers. To molecularly characterize canine CRC, we investigated exonic sequence mutations of adenomatous polyposis coli (APC), the best known tumor suppressor gene of human CRC, in 23 sporadic canine colorectal tumors, including 8 adenomas and 15 adenocarcinomas, via exon-resequencing analysis. As a comparison, we also performed the same sequencing analysis on 10 other genes, either located at human 5q22 (the same locus as APC) or 18q21 (also frequently altered in human CRC), or known to play a role in human carcinogenesis. We noted that APC was the most significantly mutated gene in both canine adenomas and adenocarcinomas among the 11 genes examined. Significantly, we detected large deletions of >= 10 bases, many clustered near the mutation cluster region, as well as single or two base deletions in similar to 70% canine tumors of both subtypes. These observations indicate that like in the human, APC is also frequently altered in sporadic colorectal tumors in the dog and its alteration is an early event in canine colorectal tumorigenesis. Our study provides further evidence demonstrating the molecular similarity in pathogenesis between sporadic human and canine CRCs. This work, along with our previous copy number abnormality study, supports that sporadic canine CRCs are valid models of human CRCs at the molecular level.	[Youmans, Lydia; Taylor, Cynthia; Shin, Edwin; Harrell, Adrienne; Zhao, Shaying] Univ Georgia, Dept Biochem & Mol Biol, Inst Bioinformat, Athens, GA 30602 USA; [Ellis, Angela E.] Univ Georgia, Coll Vet Med, Athens, GA 30602 USA; [Seguin, Bernard] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Ji, Xinglai] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Ji, Xinglai] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Oregon State University; Yunnan University; Yunnan University	Zhao, SY (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Inst Bioinformat, Athens, GA 30602 USA.	szhao@bmb.uga.edu		seguin, bernard/0000-0002-3663-983X	American Cancer Society; Georgia Cancer Coalition; National Science Foundation of China [31160021, 31270131]; Science and Technological Project of Yunnan Province [2011CI]; Foundation for Key Teacher of Yunnan University; NCI [P50 CA128613, GM085354]; NATIONAL CANCER INSTITUTE [P50CA128613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Georgia Cancer Coalition; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technological Project of Yunnan Province; Foundation for Key Teacher of Yunnan University; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the American Cancer Society and the Georgia Cancer Coalition (PI: Zhao); the National Science Foundation of China (31160021 and 31270131), Science and Technological Project of Yunnan Province (2011CI) and Foundation for Key Teacher of Yunnan University (PI: Ji); the NCI P50 CA128613 (PI: Dr. Dong M. Shin) and GM085354 (PI: Dr. Stephen Dalton). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CE, 2012, MAMM GENOME, V23, P144, DOI 10.1007/s00335-011-9369-8; Aresu L, 2010, RES VET SCI, V89, P409, DOI 10.1016/j.rvsc.2010.04.008; Argyle DJ, 2005, VET J, V170, P147, DOI 10.1016/j.tvjl.2004.08.003; Berglund J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r73; Camps J, 2008, CANCER RES, V68, P1284, DOI 10.1158/0008-5472.CAN-07-2864; Chang MY, 2007, CANCER RES, V67, P7605, DOI 10.1158/0008-5472.CAN-07-1100; Crist RC, 2010, MAMM GENOME, V21, P450, DOI 10.1007/s00335-010-9288-0; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fishel R, 2008, NAT METHODS, V5, P225, DOI 10.1038/nmeth0308-225; Haber DA, 2007, NATURE, V446, P145, DOI 10.1038/446145a; Habermann JK, 2011, MODERN PATHOL, V24, P542, DOI 10.1038/modpathol.2010.217; Holstege H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-455; Ji XL, 2008, GENOMICS, V91, P249, DOI 10.1016/j.ygeno.2007.10.014; Ji XL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-426; Jin BL, 2009, CANCER RES, V69, P7412, DOI 10.1158/0008-5472.CAN-09-0116; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Laurent-Puig P, 1998, NUCLEIC ACIDS RES, V26, P269, DOI 10.1093/nar/26.1.269; Ledford H, 2010, NATURE, V464, P972, DOI 10.1038/464972a; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LeRoy BE, 2009, VET J, V180, P149, DOI 10.1016/j.tvjl.2008.07.012; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; MA LB, 1994, MOL CELL BIOL, V14, P4126, DOI 10.1128/MCB.14.6.4126; McEntee MF, 1999, VET PATHOL, V36, P228, DOI 10.1354/vp.36-3-228; Michell AR, 2005, VET J, V170, P153, DOI 10.1016/j.tvjl.2004.06.004; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Mullikin JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-406; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Parker HG, 2010, ANNU REV GENET, V44, P309, DOI 10.1146/annurev-genet-102808-115200; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Restucci B, 2009, ANTICANCER RES, V29, P2919; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Shibata H, 2007, P NATL ACAD SCI USA, V104, P18199, DOI 10.1073/pnas.0705730104; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Taketo M M, 2000, Hum Cell, V13, P85; Tang J, 2010, GENOME RES, V20, P341, DOI 10.1101/gr.092726.109; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837	44	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50813	10.1371/journal.pone.0050813	http://dx.doi.org/10.1371/journal.pone.0050813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251390	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900022
J	Au, HHT; Jan, E				Au, Hilda H. T.; Jan, Eric			Insights into Factorless Translational Initiation by the tRNA-Like Pseudoknot Domain of a Viral IRES	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; METHIONINE-INDEPENDENT INITIATION; INTERNAL RIBOSOME; HEPATITIS-C; VIRUS-RNA; DICISTROVIRIDAE; BINDING; PROTEIN; CODON; REGION	The intergenic region internal ribosome entry site (IGR IRES) of the Dicistroviridae family adopts an overlapping triple pseudoknot structure to directly recruit the 80S ribosome in the absence of initiation factors. The pseudoknot I (PKI) domain of the IRES mimics a tRNA-like codon: anticodon interaction in the ribosomal P site to direct translation initiation from a non-AUG initiation codon in the A site. In this study, we have performed a comprehensive mutational analysis of this region to delineate the molecular parameters that drive IRES translation. We demonstrate that IRES-mediated translation can initiate at an alternate adjacent and overlapping start site, provided that basepairing interactions within PKI remain intact. Consistent with this, IGR IRES translation tolerates increases in the variable loop region that connects the anticodon- and codon-like elements within the PKI domain, as IRES activity remains relatively robust up to a 4-nucleotide insertion in this region. Finally, elements from an authentic tRNA anticodon stem-loop can functionally supplant corresponding regions within PKI. These results verify the importance of the codon: anticodon interaction of the PKI domain and further define the specific elements within the tRNA-like domain that contribute to optimal initiator Met-tRNAi-independent IRES translation.	[Au, Hilda H. T.; Jan, Eric] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Jan, E (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	ej@mail.ubc.ca	Jan, Eric/O-1923-2019		Canadian Institute for Health Research [MOPS-81244]; National Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 341459-07]; NSERC CGS M fellowship	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CGS M fellowship	This work was supported by a Canadian Institute for Health Research grant (MOPS-81244) and a National Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (RGPIN 341459-07) to EJ. EJ is a Michael Smith Foundation for Health Research Scholar and a Canadian Institutes of Health Research New Investigator. HA is supported by an NSERC CGS M fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry KE, 2011, STRUCTURE, V19, P1456, DOI 10.1016/j.str.2011.08.002; Berry KE, 2010, RNA, V16, P1559, DOI 10.1261/rna.2197210; Carrasco L, 1974, Methods Enzymol, V30, P282; CHANG YN, 1986, GENE, V48, P165; Costantino D, 2005, RNA, V11, P332, DOI 10.1261/rna.7184705; Costantino DA, 2008, NAT STRUCT MOL BIOL, V15, P57, DOI 10.1038/nsmb1351; Doudna J.A., 2007, COLD SPRING HARB MON, V48, P129; Dreher TW, 2009, VIRUS RES, V139, P217, DOI 10.1016/j.virusres.2008.06.010; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hertz MI, 2011, NUCLEIC ACIDS RES, V39, P7276, DOI 10.1093/nar/gkr427; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Jan E, 2006, VIRUS RES, V119, P16, DOI 10.1016/j.virusres.2005.10.011; Jang CJ, 2010, RNA, V16, P1182, DOI 10.1261/rna.2044610; Jang CJ, 2009, J MOL BIOL, V387, P42, DOI 10.1016/j.jmb.2009.01.042; Kanamori Y, 2001, RNA, V7, P266, DOI 10.1017/S1355838201001741; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Nakashima N, 2009, VIRUS RES, V139, P137, DOI 10.1016/j.virusres.2008.06.006; Nishiyama T, 2003, NUCLEIC ACIDS RES, V31, P2434, DOI 10.1093/nar/gkg336; Nishiyama T, 2007, NUCLEIC ACIDS RES, V35, P1514, DOI 10.1093/nar/gkl1121; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Pfingsten JS, 2007, J MOL BIOL, V370, P856, DOI 10.1016/j.jmb.2007.04.076; Pfingsten JS, 2006, SCIENCE, V314, P1450, DOI 10.1126/science.1133281; Pfingsten JS, 2010, J MOL BIOL, V395, P205, DOI 10.1016/j.jmb.2009.10.047; Ren Q, 2012, P NATL ACAD SCI USA, V109, pE630, DOI 10.1073/pnas.1111303109; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; Schuler M, 2006, NAT STRUCT MOL BIOL, V13, P1092, DOI 10.1038/nsmb1177; SZER W, 1970, Biochimica et Biophysica Acta, V224, P477, DOI 10.1016/0005-2787(70)90580-0; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Yamamoto H, 2007, J BIOL CHEM, V282, P7770, DOI 10.1074/jbc.M610887200; Zhu JY, 2011, P NATL ACAD SCI USA, V108, P1839, DOI 10.1073/pnas.1018582108	37	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51477	10.1371/journal.pone.0051477	http://dx.doi.org/10.1371/journal.pone.0051477			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236506	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100122
J	Chen, YX; Tian, Z; Liang, ZH; Sun, SG; Dai, CL; Lee, MH; LaFerla, FM; Grundke-Iqbal, I; Iqbal, K; Liu, F; Gong, CX				Chen, Yanxing; Tian, Zhu; Liang, Zhihou; Sun, Shenggang; Dai, Chun-ling; Lee, Moon H.; LaFerla, Frank M.; Grundke-Iqbal, Inge; Iqbal, Khalid; Liu, Fei; Gong, Cheng-Xin			Brain Gene Expression of a Sporadic (icv-STZ Mouse) and a Familial Mouse Model (3xTg-AD Mouse) of Alzheimer's Disease	PLOS ONE			English	Article							TRIPLE-TRANSGENIC MODEL; A-BETA; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; SIGNALING MECHANISMS; TAU; PRESENILINS; ACTIVATION; CALPAIN; DEGENERATION	Alzheimer's disease (AD) can be divided into sporadic AD (SAD) and familial AD (FAD). Most AD cases are sporadic and may result from multiple etiologic factors, including environmental, genetic and metabolic factors, whereas FAD is caused by mutations of presenilins or amyloid-beta (A beta) precursor protein (APP). A commonly used mouse model for AD is 3xTg-AD mouse, which is generated by over-expression of mutated presenilin 1, APP and tau in the brain and thus represents a mouse model of FAD. A mouse model generated by intracerebroventricular (icv) administration of streptozocin (STZ), icv-STZ mouse, shows many aspects of SAD. Despite the wide use of these two models for AD research, differences in gene expression between them are not known. Here, we compared the expression of 84 AD-related genes in the hippocampus and the cerebral cortex between icv-STZ mice and 3xTg-AD mice using a custom-designed qPCR array. These genes are involved in APP processing, tau/cytoskeleton, synapse function, apoptosis and autophagy, AD-related protein kinases, glucose metabolism, insulin signaling, and mTOR pathway. We found altered expression of around 20 genes in both mouse models, which affected each of above categories. Many of these gene alterations were consistent with what was observed in AD brain previously. The expression of most of these altered genes was decreased or tended to be decreased in the hippocampus of both mouse models. Significant diversity in gene expression was found in the cerebral cortex between these two AD mouse models. More genes related to synaptic function were dysregulated in the 3xTg-AD mice, whereas more genes related to insulin signaling and glucose metabolism were down-regulated in the icv-STZ mice. The present study provides important fundamental knowledge of these two AD mouse models and will help guide future studies using these two mouse models for the development of AD drugs.	[Chen, Yanxing; Tian, Zhu; Dai, Chun-ling; Grundke-Iqbal, Inge; Iqbal, Khalid; Liu, Fei; Gong, Cheng-Xin] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Chen, Yanxing; Liang, Zhihou; Sun, Shenggang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Neurol, Wuhan 430074, Hubei, Peoples R China; [Tian, Zhu] Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Jilin, Peoples R China; [Lee, Moon H.] New York State Inst Basic Res Dev Disabil, Dept Dev Neurobiol, Staten Isl, NY 10314 USA; [LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA	Institute for Basic Research in Developmental Disabilities; Huazhong University of Science & Technology; Jilin University; Institute for Basic Research in Developmental Disabilities; University of California System; University of California Irvine	Gong, CX (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	chengxin.gong@csi.cuny.edu			New York State Office for People with Developmental Disabilities; National Institutes of Health [R01 AG027429, R03 TW008123]; U.S. Alzheimer's Association [IIRG-10-170405]; National Natural Science Foundation of China [30901386]; Wuhan Science and Technology Bureau, China [200960323132]; FOGARTY INTERNATIONAL CENTER [R03TW008123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027429] Funding Source: NIH RePORTER	New York State Office for People with Developmental Disabilities; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Alzheimer's Association(Alzheimer's Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Science and Technology Bureau, China; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the New York State Office for People with Developmental Disabilities as well as grants from the National Institutes of Health (R01 AG027429, R03 TW008123), the U.S. Alzheimer's Association (IIRG-10-170405), the National Natural Science Foundation of China (30901386), and the Wuhan Science and Technology Bureau, China (200960323132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Bakirtzi K, 2009, J NEUROSCI, V29, P5193, DOI 10.1523/JNEUROSCI.0858-09.2009; Barnett A, 2011, J ALZHEIMERS DIS, V25, P385, DOI 10.3233/JAD-2011-101989; Blanchard J, 2010, ACTA NEUROPATHOL, V120, P605, DOI 10.1007/s00401-010-0734-6; Brooks WM, 2007, BRAIN RES, V1127, P127, DOI 10.1016/j.brainres.2006.09.106; Cardoso S, 2009, J ALZHEIMERS DIS, V18, P483, DOI 10.3233/JAD-2009-1155; Chen Q, 2008, J NEUROSCI RES, V86, P1615, DOI 10.1002/jnr.21601; Ciavardelli D, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.68; Das HK, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2723; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Deng YQ, 2009, AM J PATHOL, V175, P2089, DOI 10.2353/ajpath.2009.090157; Drzezga A, 2003, EUR J NUCL MED MOL I, V30, P1104, DOI 10.1007/s00259-003-1194-1; El Messari S, 1998, J COMP NEUROL, V399, P492, DOI 10.1002/(SICI)1096-9861(19981005)399:4<492::AID-CNE4>3.0.CO;2-X; FINDER VH, 2010, J ALZHEIMERS DIS S3, V22, pS5, DOI DOI 10.3233/JAD-2010-100975; Gerozissis K, 2008, EUR J PHARMACOL, V585, P38, DOI 10.1016/j.ejphar.2008.01.050; Gong CX, 2006, J ALZHEIMERS DIS, V9, P1; Grillo CA, 2009, BRAIN RES, V1296, P35, DOI 10.1016/j.brainres.2009.08.005; Grunblatt E, 2007, J NEUROCHEM, V101, P757, DOI 10.1111/j.1471-4159.2006.04368.x; HEISS WD, 1991, ANN NY ACAD SCI, V640, P65; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Hutton M, 1997, HUM MOL GENET, V6, P1639, DOI 10.1093/hmg/6.10.1639; Iqbal K, 2005, ACTA NEUROPATHOL, V109, P25, DOI 10.1007/s00401-004-0951-y; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; KATZMAN R, 1991, FASEB J, V5, P278, DOI 10.1096/fasebj.5.3.2001787; Lafay-Chebassier C, 2005, J NEUROCHEM, V94, P215, DOI 10.1111/j.1471-4159.2005.03187.x; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Liu Y, 2008, FEBS LETT, V582, P359, DOI 10.1016/j.febslet.2007.12.035; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Liu Y, 2009, J NEUROCHEM, V111, P242, DOI 10.1111/j.1471-4159.2009.06320.x; Love DC, 2005, SCI STKE, V312, P13, DOI DOI 10.1126/STKE.3122005RE13; Lyons MR, 2011, PROG NEUROBIOL, V94, P259, DOI 10.1016/j.pneurobio.2011.05.003; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; Muller M, 2011, P NATL ACAD SCI USA, V108, P13293, DOI 10.1073/pnas.1109297108; Nizzari M, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/187297; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Plaschke K, 2010, J ALZHEIMERS DIS, V19, P691, DOI 10.3233/JAD-2010-1270; Rasgon NL, 2011, NEUROBIOL AGING, V32, P1942, DOI 10.1016/j.neurobiolaging.2009.12.005; Raynaud F, 2006, FEBS J, V273, P3437, DOI 10.1111/j.1742-4658.2006.05352.x; Reddy PH, 2006, NEUROBIOL AGING, V27, P1060, DOI 10.1016/j.neurobiolaging.2005.04.014; ROSSINI AA, 1977, P NATL ACAD SCI USA, V74, P2485, DOI 10.1073/pnas.74.6.2485; Salkovic-Petrisic M, 2006, J NEUROCHEM, V96, P1005, DOI 10.1111/j.1471-4159.2005.03637.x; Salkovic-Petrisic M, 2011, J NEURAL TRANSM, V118, P765, DOI 10.1007/s00702-011-0651-4; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Saura CA, 2011, REV NEUROSCIENCE, V22, P153, DOI 10.1515/RNS.2011.018; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Weinstock M, 2004, J NEURAL TRANSM, V111, P347, DOI 10.1007/s00702-003-0058-y; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zhang C, 2009, NATURE, V460, P632, DOI 10.1038/nature08177; Zhang DW, 2010, J NEUROCHEM, V115, P1215, DOI 10.1111/j.1471-4159.2010.07011.x	59	46	48	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51432	10.1371/journal.pone.0051432	http://dx.doi.org/10.1371/journal.pone.0051432			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236499	Green Published, gold			2022-12-27	WOS:000312064100118
J	Lee, JY; Jeong, W; Kim, JH; Kim, J; Bazer, FW; Han, JY; Song, G				Lee, Jin-Young; Jeong, Wooyoung; Kim, Ji-Hye; Kim, Jinyoung; Bazer, Fuller W.; Han, Jae Yong; Song, Gwonhwa			Distinct Expression Pattern and Post-Transcriptional Regulation of Cell Cycle Genes in the Glandular Epithelia of Avian Ovarian Carcinomas	PLOS ONE			English	Article							MICRORNA EXPRESSION; DIFFERENTIAL EXPRESSION; CANCER; MODEL; PROTEIN; TUMORS; D1; P27(KIP1); CDK2; P21	The cell cycle system is controlled in a timely manner by three groups of cyclins, cyclin dependent kinases and cyclin dependent kinase inhibitors. Abnormal alterations of cell cycle regulatory mechanisms are a common feature of many diseases including numerous tumor types such as ovarian cancer. Although a variety of cell cycle regulatory genes are well known in mammalian species including human and mice, they are not well studied in avian species, especially in laying hens which are recognized as an excellent animal model for research relevant to human ovarian carcinogenesis. Therefore, in the present study, we focused on comparative expression and regulation of expression of candidate genes which might be involved in the cell cycle program in surface epithelial ovarian cancer in laying hens. Our current results indicate that expression levels of cell cycle gene transcripts are greater in cancerous as compared to normal ovaries. In particular, cyclin A2 (CCNA2), CCND1, CCND2, CCND3, CCNE2, cyclin dependent kinase 1 (CDK1), CDK3, CDK5, cyclin dependent kinases inhibitor 1A (CDKN1A) and CDKN1B were upregulated predominantly in the glandular epithelia of cancerous ovaries from laying hens. Further, several microRNAs (miRs), specifically miR-1798, miR-1699, miR-223 and miR-1744 were discovered to influence expression of CCND1, CCNE2, CDK1, and CDK3 mRNAs, respectively, via their 3'-UTR which suggests that post-transcriptional regulation of gene expression influences their expression in laying hens. Moreover, miR-1626 influenced CDKN1A expression and miR-222, miR-1787 and miR-1812 regulated CDKN1B expression via their 3'-UTR regions. Collectively, results of the present study demonstrate increased expression of cell cycle-related genes in cancerous ovaries of laying hens and indicate that expression of these genes is post-transcriptionally regulated by specific microRNAs.	[Lee, Jin-Young; Jeong, Wooyoung; Kim, Ji-Hye; Kim, Jinyoung; Bazer, Fuller W.; Han, Jae Yong; Song, Gwonhwa] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea; [Bazer, Fuller W.] Texas A&M Univ, Ctr Anim Biotechnol & Genom, College Stn, TX USA; [Bazer, Fuller W.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Seoul National University (SNU); Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Song, G (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea.	ghsong@snu.ac.kr	Song, Gwonhwa/H-3647-2015; gwonhwa, song/H-3208-2015; Bazer, Fuller/AAF-4317-2021; Lim, Whasun/F-2060-2013	Bazer, Fuller/0000-0002-5823-5086; 	World Class University (WCU) program through the National Research Foundation of Korea (NRF) [R31-10056]; Ministry of Education, Science, and Technology; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008142]	World Class University (WCU) program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This research was funded by the World Class University (WCU) program (R31-10056) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology, and also by a grant from the Next-Generation BioGreen 21 Program (No. PJ008142), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SE, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-100; Barboule N, 1998, INT J CANCER, V76, P891, DOI 10.1002/(SICI)1097-0215(19980610)76:6<891::AID-IJC20>3.0.CO;2-4; Barrette BA, 1997, MAYO CLIN PROC, V72, P925; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barua A, 2009, INT J GYNECOL CANCER, V19, P531, DOI 10.1111/IGC.0b013e3181a41613; Bast Robert C Jr, 2002, Cancer Treat Res, V107, P61; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Bovicelli A, 2011, J CELL PHYSIOL, V226, P2500, DOI 10.1002/jcp.22662; Courjal F, 1996, INT J CANCER, V69, P247; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; Crum CP, 2012, CLIN OBSTET GYNECOL, V55, P24, DOI 10.1097/GRF.0b013e31824b1725; D'Andrilli G, 2004, CLIN CANCER RES, V10, P8132, DOI 10.1158/1078-0432.CCR-04-0886; Dhar KK, 1999, BRIT J CANCER, V81, P1174, DOI 10.1038/sj.bjc.6690826; FATHALLA MF, 1971, LANCET, V2, P163; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Giles JR, 2006, EXP BIOL MED, V231, P1718, DOI 10.1177/153537020623101108; Giles JR, 2004, GYNECOL ONCOL, V95, P530, DOI 10.1016/j.ygyno.2004.07.061; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Kapranos N, 2001, ANTICANCER RES, V21, P521; Komiya T, 1997, CLIN CANCER RES, V3, P1831; Lee JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034215; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Lim W, 2012, BIOCHEM BIOPH RES CO, V422, P494, DOI 10.1016/j.bbrc.2012.05.026; Lim W, 2012, EXP BIOL MED, V237, P150, DOI 10.1258/ebm.2011.011250; Lim W, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-137; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu X, 1998, CANCER, V82, P2409; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Marone M, 1998, INT J CANCER, V75, P34, DOI 10.1002/(SICI)1097-0215(19980105)75:1<34::AID-IJC6>3.0.CO;2-2; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Masciullo V, 1997, INT J CANCER, V74, P390, DOI 10.1002/(SICI)1097-0215(19970822)74:4<390::AID-IJC5>3.0.CO;2-Q; Masciullo V, 2000, CLIN CANCER RES, V6, P4816; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Roh MH, 2009, AM J SURG PATHOL, V33, P376, DOI 10.1097/PAS.0b013e3181868904; Shimizu M, 1999, CANCER, V85, P669, DOI 10.1002/(SICI)1097-0142(19990201)85:3<669::AID-CNCR17>3.0.CO;2-F; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Smith ER, 2008, LANCET ONCOL, V9, P1108, DOI 10.1016/S1470-2045(08)70281-X; Song G, 2007, REPRODUCTION, V133, P285, DOI 10.1530/REP-06-0092; Stakleff KDS, 2003, INT J GYNECOL CANCER, V13, P405, DOI 10.1046/j.1525-1438.2003.13317.x; Stammer K, 2008, GYNECOL ONCOL, V109, P115, DOI 10.1016/j.ygyno.2007.12.030; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Sui L, 2001, GYNECOL ONCOL, V83, P56, DOI 10.1006/gyno.2001.6308; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Vanderhyden Barbara C, 2003, Reprod Biol Endocrinol, V1, P67, DOI 10.1186/1477-7827-1-67; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zirbes TK, 2000, INT J CANCER, V89, P14, DOI 10.1002/(SICI)1097-0215(20000120)89:1<14::AID-IJC3>3.0.CO;2-L	50	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51592	10.1371/journal.pone.0051592	http://dx.doi.org/10.1371/journal.pone.0051592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236518	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100134
J	Pan, HC; Jenq, CC; Tsai, MH; Fan, PC; Chang, CH; Chang, MY; Tian, YC; Hung, CC; Fang, JT; Yang, CW; Chen, YC				Pan, Heng-Chih; Jenq, Chang-Chyi; Tsai, Ming-Hung; Fan, Pei-Chun; Chang, Chih-Hsiang; Chang, Ming-Yang; Tian, Ya-Chung; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Chen, Yung-Chang			Risk Models and Scoring Systems for Predicting the Prognosis in Critically Ill Cirrhotic Patients with Acute Kidney Injury: A Prospective Validation Study	PLOS ONE			English	Article							SHORT-TERM PROGNOSIS; ORGAN FAILURE ASSESSMENT; ACUTE-RENAL-FAILURE; INTENSIVE-CARE; HOSPITAL MORTALITY; DISEASE; SEPSIS; AGE	Background: Cirrhotic patients with acute kidney injury (AKI) admitted to intensive care units (ICUs) show extremely high mortality rates. We have proposed the MBRS scoring system, which can be used for assessing patients on the day of admission to the ICU; this new system involves determination of mean arterial pressure (MAP) and bilirubin level and assessment of respiratory failure and sepsis. We had used this scoring system to analyze the prognosis of ICU cirrhotic patients with AKI in 2008, and the current study was an external validation of this scoring system. Methods: A total of 190 cirrhotic patients with AKI were admitted to the ICU between March 2008 and February 2011. We prospectively analyzed and recorded the data for 31 demographic parameters and some clinical characteristic variables on day 1 of admission to the ICU; these variables were considered as predictors of mortality. Results: The overall in-hospital mortality rate was 73.2% (139/190), and the 6-month mortality rate was 83.2% (158/190). Hepatitis B viral infection (43%) was observed to be the cause of liver disease in most of the patients. Multiple logistic regression analysis indicated that the MBRS and Acute Physiology and Chronic Health Evaluation III (ACPACHE III) scores determined on the first day of admission to the ICU were independent predictors of in-hospital mortality in patients. In the analysis of the area under the receiver operating characteristic (AUROC) curves, the MBRS scores showed good discrimination (AUROC: 0.863 +/- 0.032, p<0.001) in predicting in-hospital mortality. Conclusion: On the basis of the results of this external validation, we conclude that the MBRS scoring system is a reproducible, simple, easy-to-apply evaluation tool that can increase the prediction accuracy of short-term prognosis in critically ill cirrhotic patients with AKI.	[Pan, Heng-Chih; Jenq, Chang-Chyi; Fan, Pei-Chun; Chang, Chih-Hsiang; Chang, Ming-Yang; Tian, Ya-Chung; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Chen, Yung-Chang] Chang Gung Mem Hosp, Div Nephrol, Kidney Res Ctr, Taipei 10591, Taiwan; [Tsai, Ming-Hung] Chang Gung Mem Hosp, Div Gastroenterol, Taipei 10591, Taiwan; [Jenq, Chang-Chyi; Tsai, Ming-Hung; Chang, Ming-Yang; Tian, Ya-Chung; Hung, Cheng-Chieh; Fang, Ji-Tseng; Yang, Chih-Wei; Chen, Yung-Chang] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chen, YC (corresponding author), Chang Gung Mem Hosp, Div Nephrol, Kidney Res Ctr, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	cyc2356@gmail.com	Chang, Ming-Yang/AGH-5397-2022; Chang, Jason Chih-Hsiang/P-8662-2017	Chang, Ming-Yang/0000-0001-8899-0376; Chang, Jason Chih-Hsiang/0000-0002-7342-335X	National Science Council of Taiwan [NSC 99-2314-B-182A-009-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of Taiwan (NSC 99-2314-B-182A-009-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belcher JM, 2013, HEPATOLOGY, V57, P753, DOI 10.1002/hep.25735; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Cardenas A, 2001, HEPATOLOGY, V34, P671, DOI 10.1053/jhep.2001.27830; Chen YC, 2006, INT J CLIN PRACT, V60, P160, DOI 10.1111/j.1368-5031.2005.00634.x; Chen YC, 2004, CLIN NEPHROL, V61, P111; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Cholongitas E, 2006, ALIMENT PHARM THER, V24, P453, DOI 10.1111/j.1365-2036.2006.02998.x; Cholongitas E, 2006, LIVER TRANSPLANT, V12, P1049, DOI 10.1002/lt.20824; Cholongitas E, 2009, EUR J GASTROEN HEPAT, V21, P744, DOI 10.1097/MEG.0b013e328308bb9c; Fang JT, 2008, NEPHROL DIAL TRANSPL, V23, P1961, DOI 10.1093/ndt/gfm914; Garcia-Tsao G, 2008, HEPATOLOGY, V48, P2064, DOI 10.1002/hep.22605; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; GROSZMANN R, 1972, AM J MED, V53, P715, DOI 10.1016/0002-9343(72)90188-X; Iwakiri Y, 2006, HEPATOLOGY, V43, pS121, DOI 10.1002/hep.20993; Jenq CC, 2007, INTENS CARE MED, V33, P1921, DOI 10.1007/s00134-007-0760-6; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1985, ANN SURG, V202, P685, DOI 10.1097/00000658-198512000-00004; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532; SHELLMAN RG, 1988, CRIT CARE MED, V16, P671, DOI 10.1097/00003246-198807000-00005; Short A, 1999, BRIT MED J, V319, P41, DOI 10.1136/bmj.319.7201.41; Slack A, 2010, CRIT CARE, V14, DOI 10.1186/cc8855; Tandon P, 2011, CLIN GASTROENTEROL H, V9, P260, DOI 10.1016/j.cgh.2010.11.038; TRAN DD, 1990, CRIT CARE MED, V18, P474, DOI 10.1097/00003246-199005000-00002; Tsai MH, 2003, J CLIN GASTROENTEROL, V37, P251, DOI 10.1097/00004836-200309000-00011; Tsai MH, 2008, J CRIT CARE, V23, P468, DOI 10.1016/j.jcrc.2008.04.006; Tu KH, 2011, SHOCK, V36, P445, DOI 10.1097/SHK.0b013e31822fb7e2; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wehler M, 2001, HEPATOLOGY, V34, P255, DOI 10.1053/jhep.2001.26522; Wong F, 2011, GUT, V60, P702, DOI 10.1136/gut.2010.236133	33	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51094	10.1371/journal.pone.0051094	http://dx.doi.org/10.1371/journal.pone.0051094			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236437	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100066
J	Vermeiren, APA; Dukers-Muijrers, NHTM; van Loo, IHM; Stals, F; van Dam, DW; Ambergen, T; Hoebe, CJPA				Vermeiren, Angelique P. A.; Dukers-Muijrers, Nicole H. T. M.; van Loo, Inge H. M.; Stals, Frans; van Dam, Dirk W.; Ambergen, Ton; Hoebe, Christian J. P. A.			Identification of Hidden Key Hepatitis C Populations: An Evaluation of Screening Practices Using Mixed Epidemiological Methods	PLOS ONE			English	Article							CAPTURE-RECAPTURE METHODS; COST-EFFECTIVENESS; PREVALENCE; CARE; NETHERLANDS; INFECTIONS; SERVICES	Background: Hepatitis C virus (HCV) is a major cause of liver diseases worldwide. Due to its asymptomatic nature, screening is necessary for identification. Because screening of the total population is not cost effective, it is important to identify which risk factors for positivity characterize the key populations in which targeting of screening yields the highest numbers of HCV positives, and assess which of these key populations have remained hidden to current care. Methods: Laboratory registry data (2002-2008) were retrieved for all HCV tests (23,800) in the south of the Netherlands (adult population 500,000). Screening trends were tested using Poisson regression and chi-square tests. Risk factors for HCV positivity were assessed using a logistic regression. The hidden HCV-positive population was estimated by a capture-recapture approach. Results: The number of tests increased over time (2,388 to 4,149, p<.01). Nevertheless, the positivity rate among those screened decreased between 2002 and 2008 (6.3% to 2.1%, p<.01). The population prevalence was estimated to be 0.49% (95%CI 0.41-0.59). Of all HCV-positive patients, 66% were hidden to current screening practices. Risk factors associated with positivity were low socio-economic status, male sex, and age between 36-55. In future screening 48% (95%CI 37-63) of total patients and 47% (95%CI 32-70) of hidden patients can be identified by targeting 9% (men with low socio-economic status, between 36-55 years old) of the total population. Conclusions: Although the current HCV screening policy increasingly addresses high-risk populations, it only reaches one third of positive patients. This study shows that combining easily identifiable demographic risk factors can be used to identify key populations as a likely target for effective HCV screening. We recommend strengthening screening among middle-aged man, living in low socio-economic neighborhoods.	[Vermeiren, Angelique P. A.; Dukers-Muijrers, Nicole H. T. M.; Hoebe, Christian J. P. A.] S Limburg Publ Hlth Serv GGD Zuid Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands; [Dukers-Muijrers, Nicole H. T. M.; van Loo, Inge H. M.; Hoebe, Christian J. P. A.] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [Stals, Frans] Atrium Med Ctr Parkstad Heerlen, Dept Med Microbiol, Heerlen, Netherlands; [van Dam, Dirk W.] Orbis Med Ctr, Dept Med Microbiol & Infect Control, Sittard, Netherlands; [Ambergen, Ton] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Methodol & Stat, Maastricht, Netherlands	Maastricht University; Atrium Medical Center; Orbis Medical Center; Maastricht University	Vermeiren, APA (corresponding author), S Limburg Publ Hlth Serv GGD Zuid Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands.	angelique.vermeiren@ggdzl.nl	Dukers-Muijrers, Nicole/M-7178-2014	Hoebe, Christian/0000-0003-1815-0974; Dukers-Muijrers, Nicole/0000-0003-4896-758X	Dutch National Institute for Public Health and the Environment (RIVM)	Dutch National Institute for Public Health and the Environment (RIVM)	This study was funded by the Dutch National Institute for Public Health and the Environment (RIVM, www.rivm.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castelnuovo E, 2006, HEALTH TECHNOL ASSES, V10, P1; CDC, 2001, NAT HEP C PREV STRAT; CDC, 1998, REC PREV CONTR HEP C; Chaves S, 2003, Euro Surveill, V8, P108; Chou R, 2004, ANN INTERN MED, V140, P465, DOI 10.7326/0003-4819-140-6-200403160-00014; Clark PJ, 2012, NEW ENGL J MED, V366, P2436, DOI 10.1056/NEJMp1202608; de Vries MI, 2008, NETH J MED, V66, P40; Fienberg S, 1972, BIOMETRIKA, V59; Gebo KA, 2002, HOPKINS HIV REP S1, V14; Grebely Jason, 2011, Hepatology, V54, P2258, DOI 10.1002/hep.24649; Health Council of the Netherlands, 1997, HLTH COUNC NETH PUBL; Helsper CW, 2012, EPIDEMIOL INFECT, V140, P58, DOI 10.1017/S0950268811000112; Helsper CW, 2010, FAM PRACT, V27, P328, DOI 10.1093/fampra/cmq006; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Kok A, 2007, Ned Tijdschr Geneeskd, V151, P2367; Kretzschmar M, 2004, PREVALENTIE HEPATITI; LAPORTE RE, 1995, AM J EPIDEMIOL, V142, P1069, DOI 10.1093/oxfordjournals.aje.a117560; Manns MP, 2007, NAT REV DRUG DISCOV, V6, P991, DOI 10.1038/nrd2411; McGarry LJ, 2012, HEPATOLOGY IN PRESS; McHutchison JG, 2004, AM J MANAG CARE, V10, pS21; Meffre C, 2010, J MED VIROL, V82, P546, DOI 10.1002/jmv.21734; Papoz L, 1996, INT J EPIDEMIOL, V25, P474, DOI 10.1093/ije/25.3.474; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Roblin DW, 2011, AM J MANAG CARE, V17, P548; Sahajian F, 2007, EUR J PUBLIC HEALTH, V17, P263, DOI 10.1093/eurpub/ckl233; Shatin D, 2004, AM J MANAG CARE, V10, P250; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Slavenburg S, 2008, NETH J MED, V66, P13; Smith BD, 2012, CLIN INFECT DIS, V55, pS49, DOI 10.1093/cid/cis363; Statistics Netherlands, 2011, STATL BEV GESL LEEFT; Statistics Netherlands, 2011, STATL KERNC WIJK BUU; Trimbos-instituut, 2010, NAT DRUG MON; Tweed E, 2010, SEX TRANSM INFECT, V86, P126, DOI 10.1136/sti.2009.036590; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; Vriend HJ, 2012, EPIDEMIOLOG IN PRESS; Vriend HJ, 2012, EUR J PUBLI IN PRESS; YIP PSF, 1995, AM J EPIDEMIOL, V142, P1059, DOI 10.1093/oxfordjournals.aje.a117559; Zuure FR, 2011, AM J PREV MED, V40, P345, DOI 10.1016/j.amepre.2010.11.019	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51194	10.1371/journal.pone.0051194	http://dx.doi.org/10.1371/journal.pone.0051194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236452	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100080
J	Yokoo, H; Chiba, S; Tomita, K; Takashina, M; Sagara, H; Yagisita, S; Takano, Y; Hattori, Y				Yokoo, Hiroki; Chiba, Seiichi; Tomita, Kengo; Takashina, Michinori; Sagara, Hiroshi; Yagisita, Saburo; Takano, Yasuo; Hattori, Yuichi			Neurodegenerative Evidence in Mice Brains with Cecal Ligation and Puncture-Induced Sepsis: Preventive Effect of the Free Radical Scavenger Edaravone	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACUTE LUNG INJURY; SEPTIC ENCEPHALOPATHY; BARRIER BREAKDOWN; PEROXYNITRITE SCAVENGER; PERMEABILITY CHANGES; ANIMAL-MODELS; URIC-ACID; EXPRESSION; NITROTYROSINE	Sepsis is a major clinical challenge and septic encephalopathy is its nasty complication. The pathogenesis and underlying mechanisms of septic encephalopathy are not well understood. This study sought to fully characterize sepsis-associated biochemical and histopathological changes in brains of mice after cecal ligation and puncture, regarded as a highly clinically relevant animal model of polymicrobial sepsis. Real-time PCR analysis showed that gene expression levels of proinflammatory cytokines, including tumor necrosis factor-alpha and interleukin-1 beta, were significantly up-regulated in brain tissues from septic mice, but to a much lesser extent when compared with those in peripheral tissues such as lungs. Blood-brain barrier (BBB) permeability was significantly increased in septic mice, as determined by the measurement of sodium fluorescein and Evans blue content. Sepsis resulted in increases in NADPH oxidase activity and expression of p47(phox) and p67(phox) and up-regulation of inducible nitric oxide (NO) synthase in brains, indicating that superoxide, produced by NADPH oxidase, reacts with NO to form peroxynitrite, that maybe lead to the loss of BBB integrity. Light and electron microscopic examination of septic mouse brain showed serious neuronal degeneration, as indicated by hyperchromatic, shrunken, pyknotic, and electron-dense neurons. These histopathogical changes were prevented by treatment with the free radical scavenger edaravone. Together, these results suggest that sepsis can lead to rapid neurodegenerative changes in brains via free radical species production and possibly subsequent injury to the BBB. We may also provide a potentially useful therapeutic tool for treating septic encephalopathy.	[Yokoo, Hiroki; Tomita, Kengo; Takashina, Michinori; Hattori, Yuichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol & Med Pharmacol, Toyama 930, Japan; [Chiba, Seiichi] Oita Univ, Fac Med, Dept Internal Med, Yufu, Japan; [Sagara, Hiroshi] Univ Tokyo, Inst Med Sci, Med Prote Lab, Tokyo, Japan; [Yagisita, Saburo] Kanagawa Rehabil Ctr, Sect Pathol, Atsugi, Kanagawa, Japan; [Takano, Yasuo] Kanagawa Canc Res Inst, Yokohama, Kanagawa, Japan	University of Toyama; Oita University; University of Tokyo; Kanagawa Prefectural Cancer Center	Yokoo, H (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol & Med Pharmacol, Toyama 930, Japan.	hyokoo@med.u-toyama.ac.jp	Sagara, Hiroshi/GRX-7740-2022	Sagara, Hiroshi/0000-0001-8456-8362; Tomita, Kengo/0000-0002-7310-8093	Ministry of Education, Culture, Sports, Science and Technology of Japan [21590271, 24590315]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21590271, 24590315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Gawad HM, 2001, PHARMACOL RES, V43, P257, DOI 10.1006/phrs.2000.0781; Ahmad A, 2012, MOL CELL BIOCHEM, V367, P215, DOI 10.1007/s11010-012-1335-6; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Berg RMG, 2011, J CEREBR BLOOD F MET, V31, P1532, DOI 10.1038/jcbfm.2011.48; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Candolfi M, 2004, NEUROENDOCRINOLOGY, V80, P83, DOI 10.1159/000081313; Chang CC, 2011, TOXICOL APPL PHARM, V257, P137, DOI 10.1016/j.taap.2011.08.027; CLAWSON CC, 1966, J COMP NEUROL, V127, P183; Dal-Pizzol F, 2010, NEUROCHEM RES, V35, P1, DOI 10.1007/s11064-009-0043-4; Davies DC, 2002, J ANAT, V200, P639, DOI 10.1046/j.1469-7580.2002.00065.x; Davies NWS, 2006, J NEUROL, V253, P833, DOI 10.1007/s00415-006-0092-4; DENG XM, 1995, J APPL PHYSIOL, V78, P2052, DOI 10.1152/jappl.1995.78.6.2052; Ebersoldt M, 2007, INTENS CARE MED, V33, P941, DOI 10.1007/s00134-007-0622-2; Eidelman LA, 1996, JAMA-J AM MED ASSOC, V275, P470, DOI 10.1001/jama.275.6.470; Ganopolsky JG, 2004, AM J PATHOL, V165, P1433, DOI 10.1016/S0002-9440(10)63401-3; Gursoy-Ozdemir Y, 2000, STROKE, V31, P1974, DOI 10.1161/01.STR.31.8.1974; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; Houkin K, 1998, J Stroke Cerebrovasc Dis, V7, P315, DOI 10.1016/S1052-3057(98)80049-9; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Jacob A, 2011, NEUROCHEM INT, V58, P472, DOI 10.1016/j.neuint.2011.01.004; JEPPSSON B, 1981, AM J SURG, V141, P136, DOI 10.1016/0002-9610(81)90026-X; Jiao L, 2011, NEUROSCIENCE, V182, P177, DOI 10.1016/j.neuroscience.2011.01.017; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kean RB, 2000, J IMMUNOL, V165, P6511, DOI 10.4049/jimmunol.165.11.6511; Kuhlmann CRW, 2007, J NEUROCHEM, V102, P501, DOI 10.1111/j.1471-4159.2007.04506.x; Lagrange P, 1999, FREE RADICAL BIO MED, V27, P667, DOI 10.1016/S0891-5849(99)00112-4; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Liu JSH, 2001, AM J PATHOL, V158, P2057, DOI 10.1016/S0002-9440(10)64677-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcus JS, 2003, GLIA, V41, P152, DOI 10.1002/glia.10168; Matsuda N, 2008, BIOCHEM PHARMACOL, V75, P1065, DOI 10.1016/j.bcp.2007.10.036; Matsuda N, 2010, AM J PHYSIOL-HEART C, V298, pH92, DOI 10.1152/ajpheart.00069.2009; Matsuda N, 2009, CRIT CARE MED, V37, P2791, DOI 10.1097/CCM.0b013e3181ab844d; Nag S, 2001, LAB INVEST, V81, P41, DOI 10.1038/labinvest.3780210; Otani H, 2005, EUR J PHARMACOL, V512, P129, DOI 10.1016/j.ejphar.2005.01.050; Papadopoulos MC, 2000, CRIT CARE MED, V28, P3019, DOI 10.1097/00003246-200008000-00057; Piazza O, 2009, NEUROCHEM RES, V34, P1289, DOI 10.1007/s11064-008-9907-2; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Siami S, 2008, CRIT CARE CLIN, V24, P67, DOI 10.1016/j.ccc.2007.10.001; Streck EL, 2008, NEUROCHEM RES, V33, P2171, DOI 10.1007/s11064-008-9671-3; Takano K, 2011, J PHARMACOL EXP THER, V336, P381, DOI 10.1124/jpet.110.171462; Toklu HZ, 2009, J SURG RES, V152, P238, DOI 10.1016/j.jss.2008.03.013; Tsujimoto I, 2005, HYPERTENSION, V45, P921, DOI 10.1161/01.HYP.0000163461.71943.e9; Vincent JL, 2007, CONTRIB NEPHROL, V156, P64; WATANABE T, 1994, J PHARMACOL EXP THER, V268, P1597; Wilson JX, 2003, CAN J NEUROL SCI, V30, P98, DOI 10.1017/S031716710005335X; YOUNG GB, 1992, J CLIN NEUROPHYSIOL, V9, P145, DOI 10.1097/00004691-199201000-00016; Zhang XH, 2003, EUR J PHARMACOL, V476, P131, DOI 10.1016/S0014-2999(03)02151-4	51	28	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51539	10.1371/journal.pone.0051539	http://dx.doi.org/10.1371/journal.pone.0051539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236515	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100131
J	Wang, J; Zou, LJ; Song, ZG; Lang, XL; Huang, SD; Lu, FL; Han, L; Xu, ZY				Wang, Jun; Zou, Lianjiang; Song, Zhigang; Lang, Xilong; Huang, Shengdong; Lu, Fanglin; Han, Lin; Xu, Zhiyun			Meta-Analysis of RAGE Gene Polymorphism and Coronary Heart Disease Risk	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; ARTERY-DISEASE; DIABETIC-PATIENTS; CARDIOVASCULAR-DISEASE; INFLAMMATORY RESPONSE; NONDIABETIC PATIENTS; RECEPTOR; ASSOCIATION; POPULATION; COMPLICATIONS	Background: Recent data from human and animal studies have shown an upregulated expression of advanced glycosylation end product-specific receptor (RAGE) in human atherosclerotic plaques 1 and in retina, messangial, and aortic vessels, suggesting an important role of RAGE in the pathogenesis of atherothrombotic diseases. In the past few years, the relationship between RAGE polymorphisms (-429T/C, -374T/A, and G82S) and coronary heart disease (CHD) has been reported in various ethnic groups; however, these studies have yielded contradictory results. Methods: PubMed, ISI web of science, EMBASE and the Chinese National Knowledge Infrastructure databases were systematically searched to identify relevant studies. Data were abstracted independently by two reviewers. A meta-analysis was performed to examine the association between RAGE polymorphisms and susceptibility to CHD. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. Results: A total of 17 studies including 4343 patients and 5402 controls were involved in this meta-analysis. Overall, no significant results were observed for 2429T/C (OR = 1.01, 95% CI: 0.92-1.12, P = 0.78), -374T/A (OR = 1.11, 95% CI: 0.9-1.26, P = 0.09) and G82S (OR = 1.12, 95% CI: 0.86-1.45, P = 0.41) polymorphism. In the stratified analyses according to ethnicity, sample size, CHD endpoint and Hardy-Weinberg status, no evidence of any gene-disease association was obtained. Conclusions: This meta-analysis demonstrates that there is no association between the RAGE -429T/C, -374T/A and G82S polymorphisms and CHD. Citation: Wang J, Zou L, Song Z, Lang X, Huang S, et al. (2012) Meta-Analysis of RAGE Gene Polymorphism and Coronary Heart Disease Risk. PLoS ONE 7(12): e50790. doi:10.1371/journal.pone.0050790	[Wang, Jun; Zou, Lianjiang; Song, Zhigang; Lang, Xilong; Huang, Shengdong; Lu, Fanglin; Han, Lin; Xu, Zhiyun] Second Med Univ, Changhai Hosp, Dept Cardiothorac Surg, Shanghai, Peoples R China	Naval Medical University	Xu, ZY (corresponding author), Second Med Univ, Changhai Hosp, Dept Cardiothorac Surg, Shanghai, Peoples R China.	zhiyunxu001@hotmail.com						Aydogan HY, 2012, GENET TEST MOL BIOMA, V16, P134, DOI 10.1089/gtmb.2011.0077; Boiocchi C, 2011, REJUV RES, V14, P67, DOI 10.1089/rej.2010.1091; Chavakis T, 2004, MICROBES INFECT, V6, P1219, DOI 10.1016/j.micinf.2004.08.004; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; dos Santos KG, 2005, MOL GENET METAB, V85, P149, DOI 10.1016/j.ymgme.2005.02.010; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Falcone C, 2005, ARTERIOSCL THROM VAS, V25, P1032, DOI 10.1161/01.ATV.0000160342.20342.00; Falcone C, 2005, CLIN CHIM ACTA, V354, P111, DOI 10.1016/j.cccn.2004.11.021; Falcone C, 2004, INT J MOL MED, V14, P1061; Forbes Josephine M, 2005, Clin Biochem Rev, V26, P123; Gao JX, 2010, J HUM GENET, V55, P668, DOI 10.1038/jhg.2010.85; Hofmann MA, 2005, ATHEROSCLEROSIS, V182, P301, DOI 10.1016/j.atherosclerosis.2005.02.006; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hou XW, 2011, XIN NAO XUE GUAN BIN, V11, P272; Hudson BI, 2004, PHARM RES-DORDR, V21, P1079, DOI 10.1023/B:PHAM.0000032992.75423.9b; Hudson BI, 2003, ARCH BIOCHEM BIOPHYS, V419, P80, DOI 10.1016/j.abb.2003.08.030; Hudson BI, 2001, DIABETES, V50, P1505, DOI 10.2337/diabetes.50.6.1505; Kalousova M, 2007, NEPHROL DIAL TRANSPL, V22, P2020, DOI 10.1093/ndt/gfm050; Kanauchi M, 2001, DIABETES CARE, V24, P1620, DOI 10.2337/diacare.24.9.1620; Kirbis J, 2004, COLLEGIUM ANTROPOL, V28, P611; Koyama H, 2007, MOL MED, V13, P625, DOI 10.2119/2007-00087.Koyama; Koyama H, 2007, ARTERIOSCL THROM VAS, V27, P147, DOI 10.1161/01.ATV.0000251502.88818.4b; Kucukhuseyin O., 2011, MOL BIOL REP; Kucukhuseyin O, 2009, IN VIVO, V23, P949; Lu L, 2008, CLIN CHIM ACTA, V396, P33, DOI 10.1016/j.cca.2008.06.019; Lu WX, 2010, DIABETES, V59, pA226; MANTEL N, 1959, J NATL CANCER I, V22, P719; Peng WH, 2009, ARCH MED RES, V40, P393, DOI 10.1016/j.arcmed.2009.06.008; Pettersson-Fernholm K, 2003, DIABETES, V52, P891, DOI 10.2337/diabetes.52.3.891; Simm A, 2004, EXP GERONTOL, V39, P407, DOI 10.1016/j.exger.2003.12.006; Stern DM, 2002, AGEING RES REV, V1, P1, DOI 10.1016/S0047-6374(01)00366-9; Wautier JL, 2004, CIRC RES, V95, P233, DOI 10.1161/01.RES.0000137876.28454.64; Xie GT, 2010, LING NAN XIN XUE GUA, V16, P468; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Yoon SJ, 2007, CORONARY ARTERY DIS, V18, P1, DOI 10.1097/MCA.0b013e3280105b4d; Yoshioka K, 2005, METABOLISM, V54, P488, DOI 10.1016/j.metabol.2004.11.001; Zee RYL, 2006, STROKE, V37, P1686, DOI 10.1161/01.STR.0000226994.93914.6c	38	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50790	10.1371/journal.pone.0050790	http://dx.doi.org/10.1371/journal.pone.0050790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236395	Green Submitted, Green Published, gold			2022-12-27	WOS:000312589700018
J	Moreira, B; Pausas, JG				Moreira, Bruno; Pausas, Juli G.			Tanned or Burned: The Role of Fire in Shaping Physical Seed Dormancy	PLOS ONE			English	Article							HEAT-SHOCK; POSTFIRE SUCCESSION; GERMINATION; FLAMMABILITY; SMOKE; INTENSITY; CISTACEAE; DYNAMICS; HISTORY; TRAITS	Plant species with physical seed dormancy are common in mediterranean fire-prone ecosystems. Because fire breaks seed dormancy and enhances the recruitment of many species, this trait might be considered adaptive in fire-prone environments. However, to what extent the temperature thresholds that break physical seed dormancy have been shaped by fire (i.e., for post-fire recruitment) or by summer temperatures in the bare soil (i.e., for recruitment in fire-independent gaps) remains unknown. Our hypothesis is that the temperature thresholds that break physical seed dormancy have been shaped by fire and thus we predict higher dormancy lost in response to fire than in response to summer temperatures. We tested this hypothesis in six woody species with physical seed dormancy occurring in fire-prone areas across the Mediterranean Basin. Seeds from different populations of each species were subject to heat treatments simulating fire (i.e., a single high temperature peak of 100 degrees C, 120 degrees C or 150 degrees C for 5 minutes) and heat treatments simulating summer (i.e., temperature fluctuations; 30 daily cycles of 3 hours at 31 degrees C, 4 hours at 43 degrees C, 3 hours at 33 degrees C and 14 hours at 18 degrees C). Fire treatments broke dormancy and stimulated germination in all populations of all species. In contrast, summer treatments had no effect over the seed dormancy for most species and only enhanced the germination in Ulex parviflorus, although less than the fire treatments. Our results suggest that in Mediterranean species with physical dormancy, the temperature thresholds necessary to trigger seed germination are better explained as a response to fire than as a response to summer temperatures. The high level of dormancy release by the heat produced by fire might enforce most recruitment to be capitalized into a single post-fire pulse when the most favorable conditions occur. This supports the important role of fire in shaping seed traits.	[Moreira, Bruno; Pausas, Juli G.] Ctr Invest Desertificac CIDE CSIC, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE)	Pausas, JG (corresponding author), Ctr Invest Desertificac CIDE CSIC, Valencia, Spain.	juli.g.pausas@uv.es	Moreira, Bruno/G-6080-2011; Pausas, Juli/C-5794-2008	Moreira, Bruno/0000-0002-7319-2555; Pausas, Juli/0000-0003-3533-5786	Spanish Government (VIRRA) [CGL2009-12048/BOS]; Fundacao para a Ciencia e Tecnologia grant (Portugal) [SFRH/BD/41343/2007]	Spanish Government (VIRRA); Fundacao para a Ciencia e Tecnologia grant (Portugal)	The work has been financed by the Spanish Government (VIRRA, CGL2009-12048/BOS). B.M. is supported by the Fundacao para a Ciencia e Tecnologia grant (SFRH/BD/41343/2007, Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AULD TD, 1991, AUST J ECOL, V16, P53, DOI 10.1111/j.1442-9993.1991.tb01481.x; Auld TD, 1996, AUST J ECOL, V21, P106, DOI 10.1111/j.1442-9993.1996.tb00589.x; Baeza MJ, 2011, J VEG SCI, V22, P467, DOI 10.1111/j.1654-1103.2011.01262.x; Baeza MJ, 2008, FOREST ECOL MANAG, V256, P685, DOI 10.1016/j.foreco.2008.05.014; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Baskin Jerry M., 2000, Plant Species Biology, V15, P139, DOI 10.1046/j.1442-1984.2000.00034.x; Bell DT, 1998, AUST J BOT, V46, P221, DOI 10.1071/BT97010; BELL DT, 1993, BOT REV, V59, P24, DOI 10.1007/BF02856612; Benjamini Y, 2001, ANN STAT, V29, P1165; Bond WJ, 2010, NEW PHYTOL, V188, P1137, DOI 10.1111/j.1469-8137.2010.03418.x; BOND WJ, 1990, S AFR J BOT, V56, P326, DOI 10.1016/S0254-6299(16)31060-2; BRADSHAW SD, 2011, TRENDS PLANT SCI, V16, P69, DOI DOI 10.1016/j.tplants.2010.10.007; Buhk C, 2006, J ARID ENVIRON, V66, P193, DOI 10.1016/j.jaridenv.2005.11.007; Clemente AS, 2007, PLANT ECOL, V190, P175, DOI 10.1007/s11258-006-9199-z; Fenner M., 2005, ECOLOGY SEEDS; Segarra-Moragues JG, 2010, EVOLUTION, V64, P3511, DOI 10.1111/j.1558-5646.2010.01064.x; Gomez-Gonzalez S, 2011, P NATL ACAD SCI USA, V108, P18743, DOI 10.1073/pnas.1108863108; Gomez-Gonzalez S, 2011, DIVERS DISTRIB, V17, P58, DOI 10.1111/j.1472-4642.2010.00728.x; He TH, 2012, NEW PHYTOL, V194, P751, DOI 10.1111/j.1469-8137.2012.04079.x; He TH, 2011, NEW PHYTOL, V191, P184, DOI 10.1111/j.1469-8137.2011.03663.x; Herranz JM, 1998, PLANT ECOL, V136, P95, DOI 10.1023/A:1009702318641; Herranz JM, 1999, INT J WILDLAND FIRE, V9, P173, DOI 10.1071/WF00014; Huang XQ, 2010, MOL ECOL, V19, P1335, DOI 10.1111/j.1365-294X.2010.04557.x; Keeley J. E., 2012, FIRE MEDITERRANEAN E; KEELEY JE, 1991, BOT REV, V57, P81, DOI 10.1007/BF02858766; Keeley JE, 1986, RESILIENCE MEDITERRA, P95, DOI DOI 10.1007/978-94-009-4822-8_7; Keeley JE, 1995, ECOLOGY BIOGEOGRAPHY, V108, P239; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Keith DA, 1997, OECOLOGIA, V112, P340, DOI 10.1007/s004420050318; LLORET F, 1993, J VEG SCI, V4, P367, DOI 10.2307/3235595; Luna B, 2007, ENVIRON EXP BOT, V60, P324, DOI 10.1016/j.envexpbot.2006.12.014; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Moreira B, 2012, OECOLOGIA, V168, P671, DOI 10.1007/s00442-011-2127-5; Moreira B, 2010, ANN BOT-LONDON, V105, P627, DOI 10.1093/aob/mcq017; MORENO JM, 1991, ECOLOGY, V72, P1993, DOI 10.2307/1941554; MORENO JM, 1991, OECOLOGIA, V85, P429, DOI 10.1007/BF00320621; Morrison DA, 1998, ANN BOT-LONDON, V82, P35, DOI 10.1006/anbo.1998.0640; Ooi MKJ, 2012, PLANT SOIL, V353, P289, DOI 10.1007/s11104-011-1032-3; Paula S, 2008, J ECOL, V96, P543, DOI 10.1111/j.1365-2745.2008.01359.x; Paula S., 2009, ECOLOGY, V90, P1420, DOI DOI 10.1890/08-1309.1; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; Pausas JG, 2012, NEW PHYTOL, V194, P610, DOI 10.1111/j.1469-8137.2012.04132.x; Pausas JG, 2012, NEW PHYTOL, V193, P301, DOI 10.1111/j.1469-8137.2011.04010.x; Pausas JG, 2012, NEW PHYTOL, V193, P18, DOI 10.1111/j.1469-8137.2011.03945.x; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Santana VM, 2012, ACTA OECOL, V39, P51, DOI 10.1016/j.actao.2011.12.001; Santana VM, 2010, AUST J BOT, V58, P539, DOI 10.1071/BT10144; Saura-Mas S, 2010, INT J WILDLAND FIRE, V19, P783, DOI 10.1071/WF09066; Schwilk DW, 2003, AM NAT, V162, P725, DOI 10.1086/379351; THANOS CA, 1991, ANN BOT-LONDON, V68, P469, DOI 10.1093/oxfordjournals.aob.a088280; THANOS CA, 1992, ISRAEL J BOT, V41, P251; Thomas PB, 2003, AUSTRAL ECOL, V28, P674, DOI 10.1046/j.1442-9993.2003.1330.doc.x; Thompson K, 2010, SEED SCI RES, V20, P209, DOI 10.1017/S0960258510000267; Tieu A, 2001, ANN BOT-LONDON, V88, P259, DOI 10.1006/anbo.2001.1451; TRABAUD L, 1979, ANN SCI FOREST, V36, P13, DOI 10.1051/forest/19790102; Vesk PA, 2004, OIKOS, V107, P72, DOI 10.1111/j.0030-1299.2004.13122.x; [No title captured]	57	100	109	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51523	10.1371/journal.pone.0051523	http://dx.doi.org/10.1371/journal.pone.0051523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227267	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200126
J	Schaevitz, LR; Nicolai, R; Lopez, CM; D'Iddio, S; Iannoni, E; Berger-Sweeney, JE				Schaevitz, Laura R.; Nicolai, Raffaella; Lopez, Carla M.; D'Iddio, Stefania; Iannoni, Emerenziana; Berger-Sweeney, Joanne E.			Acetyl-L-Carnitine Improves Behavior and Dendritic Morphology in a Mouse Model of Rett Syndrome	PLOS ONE			English	Article							DIETARY CHOLINE SUPPLEMENTATION; NEUROTROPHIC FACTOR EXPRESSION; MECP2 MUTANT MICE; CEREBRAL-CORTEX; IN-VIVO; RESPIRATORY-FUNCTION; NEURONAL MATURATION; MOLECULAR-GENETICS; MENTAL-RETARDATION; PYRAMIDAL NEURONS	Rett syndrome (RTT) is a devastating neurodevelopmental disorder affecting 1 in 10,000 girls. Approximately 90% of cases are caused by spontaneous mutations in the X-linked gene encoding methyl-CpG-binding protein 2 (MeCP2). Girls with RTT suffer from severe motor, respiratory, cognitive and social abnomalities attributed to early deficits in synaptic connectivity which manifest in the adult as a myriad of physiological and anatomical abnormalities including, but not limited to, dimished dendritic complexity. Supplementation with acetyl-L-carnitine (ALC), an acetyl group donor, ameliorates motor and cognitive deficits in other disease models through a variety of mechanisms including altering patterns of histone acetylation resulting in changes in gene expression, and stimulating biosynthetic pathways such as acetylcholine. We hypothesized ALC treatment during critical periods in cortical development would promote normal synaptic maturation, and continuing treatment would improve behavioral deficits in the Mecp2(1lox) mouse model of RTT. In this study, wildtype and Mecp2(1lox) mutant mice received daily injections of ALC from birth until death (postnatal day 47). General health, motor, respiratory, and cognitive functions were assessed at several time points during symptom progression. ALC improved weight gain, grip strength, activity levels, prevented metabolic abnormalities and modestly improved cognitive function in Mecp2 null mice early in the course of treatment, but did not significantly improve motor or cognitive functions assessed later in life. ALC treatment from birth was associated with an almost complete rescue of hippocampal dendritic morphology abnormalities with no discernable side effects in the mutant mice. Therefore, ALC appears to be a promising therapeutic approach to treating early RTT symptoms and may be useful in combination with other therapies.	[Schaevitz, Laura R.; Lopez, Carla M.; Berger-Sweeney, Joanne E.] Wellesley Coll, Dept Biol, Wellesley, MA 02181 USA; [Nicolai, Raffaella; D'Iddio, Stefania; Iannoni, Emerenziana] Sigma Tau Pharmaceut Co, Pomezia, Italy	Wellesley College; Leadiant Biosciences	Schaevitz, LR (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.	Laura.Schaevitz@tufts.edu			Sigma-Tau SpA	Sigma-Tau SpA	These studies were sponsored by Sigma-Tau SpA. The funders played a role in the study design, analysis of samples for carnitine measurements, the decision to publish, and reviewed the manuscript prior to submission for publication. The funders played no role in collection or analysis of the behavioral, neuroanatomical, or growth factor analysis data.	Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; BAUMAN ML, 1995, NEUROLOGY, V45, P1581, DOI 10.1212/WNL.45.8.1581; Belichenko PV, 2009, J COMP NEUROL, V514, P240, DOI 10.1002/cne.22009; BELICHENKO PV, 1994, NEUROREPORT, V5, P1509, DOI 10.1097/00001756-199407000-00025; BELICHENKO PV, 1995, J NEUROSCI METH, V57, P55, DOI 10.1016/0165-0270(94)00125-Z; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Berger-Sweeney J, 2011, NEUROBIOL LEARN MEM, V96, P637, DOI 10.1016/j.nlm.2011.05.006; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Blue ME, 1999, EXP NEUROL, V156, P345, DOI 10.1006/exnr.1999.7030; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; CASTORINA M, 1993, EXP GERONTOL, V28, P537, DOI 10.1016/0531-5565(93)90042-C; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Cobb S, 2010, BIOCHEM SOC T, V38, P498, DOI 10.1042/BST0380498; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; DAVIS S, 1993, NEUROBIOL AGING, V14, P107, DOI 10.1016/0197-4580(93)90030-F; DAY J, 1991, PHARMACOL BIOCHEM BE, V38, P723, DOI 10.1016/0091-3057(91)90233-R; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Dunn HG, 2001, CAN J NEUROL SCI, V28, P16; Ellaway C, 1999, J CHILD NEUROL, V14, P162, DOI 10.1177/088307389901400306; Ellaway CJ, 2001, BRAIN DEV-JPN, V23, pS85, DOI 10.1016/S0387-7604(01)00346-1; Fukuda T, 2005, J NEUROPATH EXP NEUR, V64, P537, DOI 10.1093/jnen/64.6.537; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Goulart BK, 2010, NEUROSCIENCE, V167, P969, DOI 10.1016/j.neuroscience.2010.03.032; Guideri F, 2005, PEDIATR CARDIOL, V26, P574, DOI 10.1007/s00246-005-0784-z; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1985, BRAIN DEV-JPN, V7, P372, DOI 10.1016/S0387-7604(85)80048-6; Hagen TM, 1998, P NATL ACAD SCI USA, V95, P9562, DOI 10.1073/pnas.95.16.9562; Halbach NSJ, 2008, AM J MED GENET A, V146A, P1925, DOI 10.1002/ajmg.a.32361; HAMBERGER A, 1992, NEUROPEDIATRICS, V23, P212, DOI 10.1055/s-2008-1071344; Hohmann CF, 1998, PERSPECT DEV NEUROBI, V5, P401; IMPERATO A, 1989, NEUROSCI LETT, V107, P251, DOI 10.1016/0304-3940(89)90826-4; Inano A, 2003, BIOPHARM DRUG DISPOS, V24, P357, DOI 10.1002/bdd.371; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Kishi N, 2010, EXP NEUROL, V222, P51, DOI 10.1016/j.expneurol.2009.12.007; Le Gouill E, 2007, DIABETES, V56, P2690, DOI 10.2337/db06-1228; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; Liu JK, 2002, ANN NY ACAD SCI, V959, P133, DOI 10.1111/j.1749-6632.2002.tb02090.x; McFarlane S, 2000, MOL NEUROBIOL, V22, P1, DOI 10.1385/MN:22:1-3:001; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Meng H, 2007, BRAIN RES, V1160, P47, DOI 10.1016/j.brainres.2007.05.048; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Mullaney BC, 2004, NEUROSCIENCE, V123, P939, DOI 10.1016/j.neuroscience.2003.11.025; Nag N, 2008, BRAIN RES, V1237, P101, DOI 10.1016/j.brainres.2008.08.042; Nag N, 2007, NEUROBIOL DIS, V26, P473, DOI 10.1016/j.nbd.2007.02.003; Naidu S, 2001, BRAIN DEV-JPN, V23, pS62, DOI 10.1016/S0387-7604(01)00381-3; Ogier M, 2007, J NEUROSCI, V27, P10912, DOI 10.1523/JNEUROSCI.1869-07.2007; Pepeu G, 2004, LEARN MEMORY, V11, P21, DOI 10.1101/lm.68104; Rastegar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006810; Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010; Rezvani A. H., 2006, ANIMAL MODELS COGNIT; Ricceri L, 2008, BEHAV PHARMACOL, V19, P501, DOI 10.1097/FBP.0b013e32830c3645; Robinson L, 2012, BRAIN J NEUROLOGY; Romand S, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00005; Roux JC, 2007, EUR J NEUROSCI, V25, P1915, DOI 10.1111/j.1460-9568.2007.05466.x; Scafidi S, 2010, J NEUROCHEM, V114, P820, DOI 10.1111/j.1471-4159.2010.06807.x; Schaefer AT, 2003, J NEUROPHYSIOL, V89, P3143, DOI 10.1152/jn.00046.2003; Schaevitz LR, 2010, PHYSIOL BEHAV, V100, P255, DOI 10.1016/j.physbeh.2009.12.025; Schmid DA, 2012, J NEUROSCI, V32, P1803, DOI 10.1523/JNEUROSCI.0865-11.2012; SERESS L, 1981, J ANAT, V133, P181; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Taglialatela G, 1996, EXP GERONTOL, V31, P577, DOI 10.1016/0531-5565(96)00052-6; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; TOTH E, 1993, NEUROCHEM RES, V18, P573, DOI 10.1007/BF00966933; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Wang H, 2006, J NEUROSCI, V26, P10911, DOI 10.1523/JNEUROSCI.1810-06.2006; Ward BC, 2009, J NEUROCHEM, V108, P361, DOI 10.1111/j.1471-4159.2008.05768.x; WAWRZENCZYK A, 1995, NEUROCHEM INT, V26, P635, DOI 10.1016/0197-0186(94)00162-N; WAWRZENCZYK A, 1995, BIOCHEM BIOPH RES CO, V213, P383, DOI 10.1006/bbrc.1995.2143; Wawrzenczyk A, 2001, EUR J BIOCHEM, V268, P2091, DOI 10.1046/j.1432-1327.2001.02087.x; Wenk GL, 1999, NEUROPEDIATRICS, V30, P125, DOI 10.1055/s-2007-973476; Wu GY, 1999, J NEUROSCI, V19, P4472; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; ZOGHBI HY, 1989, ANN NEUROL, V25, P56, DOI 10.1002/ana.410250109	80	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51586	10.1371/journal.pone.0051586	http://dx.doi.org/10.1371/journal.pone.0051586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227269	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200128
J	Dimmock, NJ; Dove, BK; Scott, PD; Meng, B; Taylor, I; Cheung, L; Hallis, B; Marriott, AC; Carroll, MW; Easton, AJ				Dimmock, Nigel J.; Dove, Brian K.; Scott, Paul D.; Meng, Bo; Taylor, Irene; Cheung, Linda; Hallis, Bassam; Marriott, Anthony C.; Carroll, Miles W.; Easton, Andrew J.			Cloned Defective Interfering Influenza Virus Protects Ferrets from Pandemic 2009 Influenza A Virus and Allows Protective Immunity to Be Established	PLOS ONE			English	Article							RECEPTOR SPECIFICITY; H1N1; OSELTAMIVIR; TRANSMISSION; DISEASE; ANTIVIRALS; INFECTION; EFFICACY; VACCINE; HUMANS	Influenza A viruses are a major cause of morbidity and mortality in the human population, causing epidemics in the winter, and occasional worldwide pandemics. In addition there are periodic outbreaks in domestic poultry, horses, pigs, dogs, and cats. Infections of domestic birds can be fatal for the birds and their human contacts. Control in man operates through vaccines and antivirals, but both have their limitations. In the search for an alternative treatment we have focussed on defective interfering (DI) influenza A virus. Such a DI virus is superficially indistinguishable from a normal virus but has a large deletion in one of the eight RNAs that make up the viral genome. Antiviral activity resides in the deleted RNA. We have cloned one such highly active DI RNA derived from segment 1 (244 DI virus) and shown earlier that intranasal administration protects mice from lethal disease caused by a number of different influenza A viruses. A more cogent model of human influenza is the ferret. Here we found that intranasal treatment with a single dose of 2 or 0.2 mu g 244 RNA delivered as A/PR/8/34 virus particles protected ferrets from disease caused by pandemic virus A/California/04/09 (A/Cal; H1N1). Specifically, 244 DI virus significantly reduced fever, weight loss, respiratory symptoms, and infectious load. 244 DI RNA, the active principle, was amplified in nasal washes following infection with A/Cal, consistent with its amelioration of clinical disease. Animals that were treated with 244 DI RNA cleared infectious and DI viruses without delay. Despite the attenuation of infection and disease by DI virus, ferrets formed high levels of A/Cal-specific serum haemagglutination-inhibiting antibodies and were solidly immune to rechallenge with A/Cal. Together with earlier data from mouse studies, we conclude that 244 DI virus is a highly effective antiviral with activity potentially against all influenza A subtypes.	[Dimmock, Nigel J.; Scott, Paul D.; Meng, Bo; Cheung, Linda; Marriott, Anthony C.; Easton, Andrew J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Dove, Brian K.; Taylor, Irene; Hallis, Bassam; Carroll, Miles W.] Hlth Protect Agcy, Salisbury, Wilts, England	University of Warwick; Health Protection Agency	Dimmock, NJ (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	n.j.dimmock@warwick.ac.uk		Marriott, Anthony/0000-0002-8862-9852	Wellcome Trust [090441Z09Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors received a technology transfer award (no. 090441Z09Z) from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014; BARRETT ADT, 1986, CURR TOP MICROBIOL, V128, P55; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Colman PM, 2009, ANNU REV BIOCHEM, V78, P95, DOI 10.1146/annurev.biochem.78.082207.084029; Cox NJ, 2007, NEW ENGL J MED, V356, P729, DOI 10.1056/NEJMe078003; Dimmock NJ, 2008, J VIROL, V82, P8570, DOI 10.1128/JVI.00743-08; Duan SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001022; Duhaut SD, 1998, VIROLOGY, V248, P241, DOI 10.1006/viro.1998.9267; Duhaut SD, 1996, VIROLOGY, V216, P326, DOI 10.1006/viro.1996.0068; Easton AJ, 2011, VACCINE, V29, P2777, DOI 10.1016/j.vaccine.2011.01.102; Francis T, 1934, SCIENCE, V80, P457, DOI 10.1126/science.80.2081.457-a; GARD S, 1947, ARK KEM MINERAL GEOL, V24, P1; Govorkova EA, 2006, ANTIVIR RES, V70, pA29; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Govorkova EA, 2011, ANTIVIR RES, V91, P81, DOI 10.1016/j.antiviral.2011.05.008; Hamelin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001015; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Herlocher ML, 2001, J INFECT DIS, V184, P542, DOI 10.1086/322801; Hirst GK, 1941, SCIENCE, V94, P22, DOI 10.1126/science.94.2427.22; HUANG AS, 1973, ANNU REV MICROBIOL, V27, P101, DOI 10.1146/annurev.mi.27.100173.000533; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; JENNINGS PA, 1983, CELL, V34, P619, DOI 10.1016/0092-8674(83)90394-X; Laver G, 2002, MICROBES INFECT, V4, P1309, DOI 10.1016/S1286-4579(02)00013-8; Layton RC, 2009, PROCEDIA VACCINOL, V1, P30, DOI 10.1016/j.provac.2009.07.006; Lednicky JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-231; LEIGH MW, 1995, VACCINE, V13, P1468, DOI 10.1016/0264-410X(95)00004-K; Maines TR, 2012, J INFECT DIS, V205, P474, DOI 10.1093/infdis/jir768; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Mann A, 2006, VACCINE, V24, P4290, DOI 10.1016/j.vaccine.2006.03.004; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Meng B, 2010, INFLUENZA OTHER RESP, V4, P147, DOI 10.1111/j.1750-2659.2010.00130.x; Nichol KL, 2008, VACCINE, V26, pD17, DOI 10.1016/j.vaccine.2008.07.048; Oxford JS, 2007, INFLUENZA OTHER RESP, V1, P27, DOI 10.1111/j.1750-2659.2006.00006.x; Peltola VT, 2006, INFECT IMMUN, V74, P2562, DOI 10.1128/IAI.74.5.2562-2567.2006; Scott PD, 2011, J GEN VIROL, V92, P2122, DOI 10.1099/vir.0.034132-0; Scott PD, 2011, VACCINE, V29, P6584, DOI 10.1016/j.vaccine.2011.06.114; Scott PD, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-212; Smith J, 2006, LANCET, V367, P1571, DOI 10.1016/S0140-6736(06)68683-2; Smith W, 1933, LANCET, V2, P66, DOI 10.1016/S0140-6736(00)78541-2; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; SWEET C, 1980, MICROBIOL REV, V44, P303, DOI 10.1128/MMBR.44.2.303-330.1980; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Treanor J, 2004, NEW ENGL J MED, V350, P218, DOI 10.1056/NEJMp038238; Ujike M, 2011, EMERG INFECT DIS, V17, P470, DOI 10.3201/eid1703.101188; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; VONMAGNUS P, 1954, ADV VIRUS RES, V2, P59, DOI 10.1016/S0065-3527(08)60529-1; Webster RG, 2003, AM SCI, V91, P122, DOI 10.1511/2003.2.122; Webster RG, 2000, VACCINE, V18, P1686, DOI 10.1016/S0264-410X(99)00507-1; Yun NE, 2008, VIROLOGY, V374, P198, DOI 10.1016/j.virol.2007.12.029	56	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49394	10.1371/journal.pone.0049394	http://dx.doi.org/10.1371/journal.pone.0049394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251341	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200014
J	Yang, Y; Li, XJ; Chen, Z; Zhu, XX; Wang, J; Zhang, LB; Qiang, L; Ma, YJ; Li, ZY; Guo, QL; You, QD				Yang, Yong; Li, Xian-Jing; Chen, Zhen; Zhu, Xuan-Xuan; Wang, Jing; Zhang, Lin-bo; Qiang, Lei; Ma, Yan-jun; Li, Zhi-yu; Guo, Qing-Long; You, Qi-Dong			Wogonin Induced Calreticulin/Annexin A1 Exposure Dictates the Immunogenicity of Cancer Cells in a PERK/AKT Dependent Manner	PLOS ONE			English	Article							APOPTOTIC CELLS; CA2+-BINDING PROTEIN; EXTRACELLULAR ATP; DNA-PKCS; IN-VIVO; ACTIVATION; KINASE; PKB/AKT; HMGB1; IDENTIFICATION	In response to ionizing irradiation and certain chemotherapeutic agents, dying tumor cells elicit a potent anticancer immune response. However, the potential effect of wogonin (5,7-dihydroxy-8-methoxyflavone) on cancer immunogenicity has not been studied. Here we demonstrated for the first time that wogonin elicits a potent antitumor immunity effect by inducing the translocation of calreticulin (CRT) and Annexin A1 to cell plasma membrane as well as the release of high-mobility group protein 1 (HMGB1) and ATP. Signal pathways involved in this process were studied. We found that wogonin-induced reactive oxygen species (ROS) production causes an endoplasmic reticulum (ER) stress response, including the phosphorylation of PERK (PKR-like endoplasmic reticulum kinase)/PKR (protein kinase R) and eIF2 alpha (eukaryotic initiation factor 2 alpha), which served as upstream signal for the activation of phosphoinositide 3-kinase (PI3K)/AKT, inducing calreticulin (CRT)/Annexin A1 cell membrane translocation. P22/CHP, a Ca2+-binding protein, was associated with CRT and was required for CRT translocation to cell membrane. The releases of HMGB1 and ATP from wogonin treated MFC cells, alone or together with other possible factors, activated dendritic cells and induced cytokine releases. In vivo study confirmed that immunization with wogonin-pretreated tumor cells vaccination significantly inhibited homoplastic grafted gastric tumor growth in mice and a possible inflammatory response was involved. In conclusion, the activation of PI3K pathway elicited by ER stress induced CRT/Annexin A1 translocation ("eat me" signal) and HMGB1 release, mediating wogonin-induced immunity of tumor cell vaccine. This indicated that wogonin is a novel effective candidate of immunotherapy against gastric tumor.	[Yang, Yong; Li, Xian-Jing; Chen, Zhen; Wang, Jing; Zhang, Lin-bo; Qiang, Lei; Ma, Yan-jun; Li, Zhi-yu; Guo, Qing-Long; You, Qi-Dong] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Zhu, Xuan-Xuan] Jiangsu Prov Hosp Tradit Chinese Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; Nanjing University of Chinese Medicine	Guo, QL (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	anticancer_drug@yahoo.com.cn; youqd@cpu.edu.cn	Qiang, Lei/B-2763-2012; ZHANG, LIN/GYD-9123-2022	Qiang, Lei/0000-0002-7164-3164; 	National Natural Science Foundation of China [91129731, 81072661]; Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University [JKGZ201102]; Ministry of Education of China [NCET-09-0771]; Fundamental Research Funds for the Central Universities [JKZ2009006]; Natural Science Foundation of Jiangsu Province [BK2012025, BK2011632]; "Major Drug Discovery'' science and technology major projects of China [2011ZX09102-001-20]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University; Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); "Major Drug Discovery'' science and technology major projects of China	This work was supported by the National Natural Science Foundation of China (Nos. 91129731 and 81072661), the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No. JKGZ201102) the New Century Excellent Talents Program for Dr. Yong Yang supported by Ministry of Education of China (NCET-09-0771), the Fundamental Research Funds for the Central Universities (No. JKZ2009006), the Natural Science Foundation of Jiangsu Province (No. BK2012025 and BK2011632), and "Major Drug Discovery'' science and technology major projects of China (No. 2011ZX09102-001-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Barroso MR, 1996, J BIOL CHEM, V271, P10183, DOI 10.1074/jbc.271.17.10183; Campana L, 2008, CURR OPIN IMMUNOL, V20, P518, DOI 10.1016/j.coi.2008.04.012; Clarke C, 2007, NAT BIOTECHNOL, V25, P192, DOI 10.1038/nbt0207-192; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dragoi AM, 2005, EMBO J, V24, P779, DOI 10.1038/sj.emboj.7600539; Dumitriu IE, 2005, TRENDS IMMUNOL, V26, P381, DOI 10.1016/j.it.2005.04.009; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Fas SC, 2006, BLOOD, V108, P3700, DOI 10.1182/blood-2006-03-011973; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Hamanaka RB, 2009, ONCOGENE, V28, P910, DOI 10.1038/onc.2008.428; Hosoi T, 2007, BRAIN RES, V1152, P27, DOI 10.1016/j.brainres.2007.03.052; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Hyoda K, 2006, BIOCHEM BIOPH RES CO, V340, P286, DOI 10.1016/j.bbrc.2005.12.007; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Kepp O, 2009, CELL CYCLE, V8, P3971, DOI 10.4161/cc.8.23.10191; Kim DY, 2009, J AGR FOOD CHEM, V57, P10573, DOI 10.1021/jf902700h; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kuraishi T, 2007, EXP CELL RES, V313, P500, DOI 10.1016/j.yexcr.2006.10.027; Lee SO, 2006, BIOCHEM BIOPH RES CO, V351, P118, DOI 10.1016/j.bbrc.2006.10.006; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lu N, 2008, LIFE SCI, V82, P956, DOI 10.1016/j.lfs.2008.02.013; Madeo F, 2009, CELL CYCLE, V8, P639, DOI 10.4161/cc.8.4.7794; Martins I, 2011, ONCOGENE; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Srinivasan S, 2005, DIABETES, V54, P968, DOI 10.2337/diabetes.54.4.968; Surucu B, 2008, J BIOL CHEM, V283, P30025, DOI 10.1074/jbc.M803053200; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Timm S, 1999, MOL BIOL CELL, V10, P3473, DOI 10.1091/mbc.10.10.3473; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Yang L, 2009, BIOCHEM CELL BIOL, V87, P933, DOI [10.1139/O09-060, 10.1139/o09-060]; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; Zitvogel L, 2010, CLIN CANCER RES, V16, P3100, DOI 10.1158/1078-0432.CCR-09-2891	44	50	56	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50811	10.1371/journal.pone.0050811	http://dx.doi.org/10.1371/journal.pone.0050811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251389	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200039
J	Alsterberg, C; Sundback, K; Hulth, S				Alsterberg, Christian; Sundback, Kristina; Hulth, Stefan			Functioning of a Shallow-Water Sediment System during Experimental Warming and Nutrient Enrichment	PLOS ONE			English	Article							PHYTOPLANKTON GROWTH; SEAGRASS ECOSYSTEMS; NITROGEN FLUXES; DENITRIFICATION; TEMPERATURE; MICROPHYTOBENTHOS; EUTROPHICATION; RESPIRATION; BACTERIA; CHLOROPHYLL	Effects of warming and nutrient enrichment on intact unvegetated shallow-water sediment were investigated for 5 weeks in the autumn under simulated natural field conditions, with a main focus on trophic state and benthic nitrogen cycling. In a flow-through system, sediment was exposed to either seawater at ambient temperature or seawater heated 4 degrees C above ambient, with either natural or nutrient enriched water. Sediment-water fluxes of oxygen and inorganic nutrients, nitrogen mineralization, and denitrification were measured. Warming resulted in an earlier shift to net heterotrophy due to increased community respiration; primary production was not affected by temperature but (slightly) by nutrient enrichment. The heterotrophic state was, however, not further strengthened by warming, but was rather weakened, probably because increased mineralization induced a shortage of labile organic matter. Climate-related warming of seawater during autumn could therefore, in contrast to previous predictions, induce shorter but more intensive heterotrophic periods in shallow-water sediments, followed by longer autotrophic periods. Increased nitrogen mineralization and subsequent effluxes of ammonium during warming suggested a preferential response of organisms driving nitrogen mineralization when compared to sinks of ammonium such as nitrification and algal assimilation. Warming and nutrient enrichment resulted in non-additive effects on nitrogen mineralization and denitrification (synergism), as well as on benthic fluxes of phosphate (antagonism). The mode of interaction appears to be related to the trophic level of the organisms that are the main drivers of the affected processes. Despite the weak response of benthic microalgae to both warming and nutrient enrichment, the assimilation of nitrogen by microalgae was similar in magnitude to rates of nitrogen mineralization. This implies a sustained filter function and retention capacity of nutrients by the sediment.	[Alsterberg, Christian; Sundback, Kristina] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Hulth, Stefan] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Alsterberg, C (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	christian.alsterberg@bioenv.gu.se	Hulth, Stefan/D-1875-2009		Swedish Research Council for Environment, Agricultural Science and Special Planning (FORMAS); Memorial Fund of Birgit and Birger Wahlstrom; Royal Society of Arts and Sciences in Gothenburg; Sven Loven Centre of Marine Research, University of Gothenburg	Swedish Research Council for Environment, Agricultural Science and Special Planning (FORMAS)(Swedish Research Council Formas); Memorial Fund of Birgit and Birger Wahlstrom; Royal Society of Arts and Sciences in Gothenburg; Sven Loven Centre of Marine Research, University of Gothenburg	Financial support was received from the Swedish Research Council for Environment, Agricultural Science and Special Planning (FORMAS), the Memorial Fund of Birgit and Birger Wahlstrom, the Royal Society of Arts and Sciences in Gothenburg, and the Sven Loven Centre of Marine Research, University of Gothenburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal W, 1984, ECOLOGY ESTUARINE SE; Alsterberg C, 2011, LIMNOL OCEANOGR, V56, P2147, DOI 10.4319/lo.2011.56.6.2147; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1972, B FISHERIES RES BOAR; ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; ASMUS RM, 1994, HELGOLANDER MEERESUN, V48, P257, DOI 10.1007/BF02367040; Baden S, 2010, LIMNOL OCEANOGR, V55, P1435, DOI 10.4319/lo.2010.55.3.1435; Baulch HM, 2005, LIMNOL OCEANOGR, V50, P1377, DOI 10.4319/lo.2005.50.5.1377; Bintz JC, 2003, ESTUARIES, V26, P765, DOI 10.1007/BF02711987; BLACKBURN TH, 1983, LIMNOL OCEANOGR, V28, P477, DOI 10.4319/lo.1983.28.3.0477; Boros G, 2011, HYDROBIOLOGIA, V665, P117, DOI 10.1007/s10750-011-0609-4; Bulling MT, 2010, PHILOS T R SOC B, V365, P2107, DOI 10.1098/rstb.2010.0022; Christensen MR, 2006, GLOBAL CHANGE BIOL, V12, P2316, DOI 10.1111/j.1365-2486.2006.01257.x; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Cook PLM, 2007, AQUAT MICROB ECOL, V49, P165, DOI 10.3354/ame01142; Cook PLM, 2009, MAR ECOL PROG SER, V394, P35, DOI 10.3354/meps08270; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DELIA CF, 1986, CAN J FISH AQUAT SCI, V43, P397, DOI 10.1139/f86-050; Development Core Team R, 2010, LANG ENV STAT COMP; Doyle SA, 2005, LIMNOL OCEANOGR, V50, P1362, DOI 10.4319/lo.2005.50.5.1362; Dueri S, 2009, ECOL MODEL, V220, P2060, DOI 10.1016/j.ecolmodel.2009.04.052; Engelsen A, 2008, ESTUAR COAST SHELF S, V78, P783, DOI 10.1016/j.ecss.2008.02.018; Eyre BD, 2002, MAR ECOL PROG SER, V229, P43, DOI 10.3354/meps229043; Feuchtmayr H, 2009, J APPL ECOL, V46, P713, DOI 10.1111/j.1365-2664.2009.01644.x; Fitch JE, 2011, J EXP MAR BIOL ECOL, V400, P257, DOI 10.1016/j.jembe.2011.02.005; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Gameiro C, 2004, HYDROBIOLOGIA, V525, P113, DOI 10.1023/B:HYDR.0000038858.29164.31; Garcia-Ruiz R, 1998, APPL ENVIRON MICROB, V64, P2533; Glud RN, 2002, MAR ECOL PROG SER, V238, P15, DOI 10.3354/meps238015; Gudmundsdottir R, 2011, FRESHWATER BIOL, V56, P2045, DOI 10.1111/j.1365-2427.2011.02636.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hancke K, 2004, AQUAT MICROB ECOL, V37, P265, DOI 10.3354/ame037265; Heck KL, 2000, LIMNOL OCEANOGR, V45, P1041, DOI 10.4319/lo.2000.45.5.1041; Hillebrand H, 2011, ECOL RES, V26, P533, DOI 10.1007/s11284-011-0810-y; Hochard S, 2010, ECOL MODEL, V221, P1687, DOI 10.1016/j.ecolmodel.2010.04.002; Hulth S, 2005, MAR CHEM, V94, P125, DOI 10.1016/j.marchem.2004.07.013; JONSSON B, 1993, NETH J SEA RES, V31, P83, DOI 10.1016/0077-7579(93)90020-S; Lewandowska A, 2010, MAR ECOL PROG SER, V405, P101, DOI 10.3354/meps08520; Liboriussen L, 2011, FRESHWATER BIOL, V56, P437, DOI 10.1111/j.1365-2427.2010.02510.x; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Lotze HK, 2002, LIMNOL OCEANOGR, V47, P1734, DOI 10.4319/lo.2002.47.6.1734; MACKIN JE, 1984, LIMNOL OCEANOGR, V29, P250, DOI 10.4319/lo.1984.29.2.0250; MARINELLI RL, 1994, LIMNOL OCEANOGR, V39, P303, DOI 10.4319/lo.1994.39.2.0303; McGlathery KJ, 2007, MAR ECOL PROG SER, V348, P1, DOI 10.3354/meps07132; Moksnes PO, 2008, OIKOS, V117, P763, DOI 10.1111/j.0030-1299.2008.16521.x; NILSSON P, 1991, MAR ECOL PROG SER, V71, P275, DOI 10.3354/meps071275; Noyes PD, 2009, ENVIRON INT, V35, P971, DOI 10.1016/j.envint.2009.02.006; Ogilvie BG, 1997, FEMS MICROBIOL ECOL, V23, P11, DOI 10.1016/S0168-6496(97)00004-4; Ouellette D, 2004, MAR ECOL PROG SER, V266, P185, DOI 10.3354/meps266185; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Paerl HW, 2010, ENVIRON SCI TECHNOL, V44, P7756, DOI 10.1021/es102665e; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Petersen DG, 2007, ECOTOXICOLOGY, V16, P371, DOI 10.1007/s10646-007-0139-z; RiveraMonroy VH, 1996, LIMNOL OCEANOGR, V41, P284, DOI 10.4319/lo.1996.41.2.0284; Rysgaard S, 2004, LIMNOL OCEANOGR, V49, P1493, DOI 10.4319/lo.2004.49.5.1493; SANDJENSEN K, 1991, AQUAT BOT, V41, P137, DOI 10.1016/0304-3770(91)90042-4; Scholz B, 2012, DIATOM RES, V27, P65, DOI 10.1080/0269249X.2012.660875; SEITZINGER SP, 1985, LIMNOL OCEANOGR, V30, P1332, DOI 10.4319/lo.1985.30.6.1332; Sommer U, 2008, GLOBAL CHANGE BIOL, V14, P1199, DOI 10.1111/j.1365-2486.2008.01571.x; Sundback K, 2005, COAST ESTUAR STUD, V60, P7; Sundback K, 2000, MAR ECOL PROG SER, V200, P59, DOI 10.3354/meps200059; Sundback K, 2004, LIMNOL OCEANOGR, V49, P1095, DOI 10.4319/lo.2004.49.4.1095; SUNDBACK K, 1991, BOT MAR, V34, P341, DOI 10.1515/botm.1991.34.4.341; Sundback K, 2006, ESTUAR COAST, V29, P1196, DOI 10.1007/BF02781820; Sundback K, 2007, MAR ECOL PROG SER, V330, P13, DOI 10.3354/meps330013; Sundback K, 2010, J EXP MAR BIOL ECOL, V388, P39, DOI 10.1016/j.jembe.2010.03.007; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Thamdrup B, 1998, AQUAT MICROB ECOL, V15, P191, DOI 10.3354/ame015191; Underwood GJC, 1999, ADV ECOL RES, V29, P93; Vouve F, 2000, OCEANOL ACTA, V23, P575, DOI 10.1016/S0399-1784(00)01104-X; Worm B, 2000, INT REV HYDROBIOL, V85, P359; Yvon-Durocher G, 2012, NATURE; Yvon-Durocher G, 2010, PHILOS T R SOC B, V365, P2117, DOI 10.1098/rstb.2010.0038	74	23	23	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51503	10.1371/journal.pone.0051503	http://dx.doi.org/10.1371/journal.pone.0051503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240032	gold, Green Published, Green Submitted			2022-12-27	WOS:000312290800068
J	Berard, AR; Cortens, JP; Krokhin, O; Wilkins, JA; Severini, A; Coombs, KM				Berard, Alicia R.; Cortens, John P.; Krokhin, Oleg; Wilkins, John A.; Severini, Alberto; Coombs, Kevin M.			Quantification of the Host Response Proteome after Mammalian Reovirus T1L Infection	PLOS ONE			English	Article							ONCOLYTIC VIRAL THERAPY; NILE VIRUS-INFECTION; LARGE GENE LISTS; INDUCED APOPTOSIS; ANTIVIRAL PROPERTIES; HEPATITIS-C; DNA-REPAIR; CELLS; EXPRESSION; PROTEINS	All viruses are dependent upon host cells for replication. Infection can induce profound changes within cells, including apoptosis, morphological changes, and activation of signaling pathways. Many of these alterations have been analyzed by gene arrays to measure the cellular "transcriptome." We used SILAC (stable isotope labeling by amino acids in cell culture), combined with high-throughput 2-D HPLC/mass spectrometry, to determine relative quantitative differences in host proteins at 6 and 24 hours after infecting HEK293 cells with reovirus serotype 1 Lang (T1L). 3,076 host proteins were detected at 6hpi, of which 132 and 68 proteins were significantly up or down regulated, respectively. 2,992 cellular proteins, of which 104 and 49 were up or down regulated, respectively, were identified at 24hpi. IPA and DAVID analyses indicated proteins involved in cell death, cell growth factors, oxygen transport, cell structure organization and inflammatory defense response to virus were up-regulated, whereas proteins involved in apoptosis, isomerase activity, and metabolism were down-regulated. These proteins and pathways may be suitable targets for intervention to either attenuate virus infection or enhance oncolytic potential. Citation: Berard AR, Cortens JP, Krokhin O, Wilkins JA, Severini A, et al. (2012) Quantification of the Host Response Proteome after Mammalian Reovirus T1L Infection. PLoS ONE 7(12): e51939. doi: 10.1371/journal.pone.0051939	[Berard, Alicia R.; Wilkins, John A.; Severini, Alberto; Coombs, Kevin M.] Univ Manitoba, Dept Med Microbiol, Fac Med, Winnipeg, MB, Canada; [Berard, Alicia R.; Cortens, John P.; Krokhin, Oleg; Wilkins, John A.; Coombs, Kevin M.] Univ Manitoba, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada; [Severini, Alberto] Natl Microbiol Lab, Winnipeg, MB, Canada; [Coombs, Kevin M.] Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba	Coombs, KM (corresponding author), Univ Manitoba, Dept Med Microbiol, Fac Med, Winnipeg, MB, Canada.	kcoombs@cc.umanitoba.ca		Coombs, Kevin/0000-0001-7667-8430; Berard, Alicia/0000-0002-2210-0577	Canadian Institutes of Health Research [MT-11630]; Manitoba Health Research Council Studentship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council Studentship	This work was supported by grant MT-11630 from the Canadian Institutes of Health Research to K.M.C. A.R.B. was the recipient of a Manitoba Health Research Council Studentship. The authors thank Kolawole Opanubi for expert technical assistance, and members of the laboratory for reviewing the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018; Alloussi SH, 2011, ONCOL REP, V26, P645, DOI 10.3892/or.2011.1331; Barkhash AV, 2010, J INFECT DIS, V202, P1813, DOI 10.1086/657418; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Berard Alicia, 2009, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15c01s14; Berlutti F, 2011, MOLECULES, V16, P6992, DOI 10.3390/molecules16086992; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Clarke P, 2000, J VIROL, V74, P8135, DOI 10.1128/JVI.74.17.8135-8139.2000; Clarke P, 2003, APOPTOSIS, V8, P141, DOI 10.1023/A:1022966508671; Coombs KM, 2006, CURR TOP MICROBIOL, V309, P117; Coombs KM, 2011, EXPERT REV PROTEOMIC, V8, P659, DOI [10.1586/EPR.11.55, 10.1586/epr.11.55]; Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10; COOMBS KM, 1994, J VIROL, V68, P177, DOI 10.1128/JVI.68.1.177-186.1994; Dai JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-468; DeBiasi RL, 2003, J VIROL, V77, P8934, DOI 10.1128/JVI.77.16.8934-8947.2003; Dwivedi RC, 2008, ANAL CHEM, V80, P7036, DOI 10.1021/ac800984n; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Gilar M, 2005, J SEP SCI, V28, P1694, DOI 10.1002/jssc.200500116; Golden JW, 2004, J BIOL CHEM, V279, P8547, DOI 10.1074/jbc.M309758200; Goody RJ, 2007, J NEUROVIROL, V13, P373, DOI 10.1080/13550280701344983; Guergnon J, 2011, BBA-MOL BASIS DIS, V1812, P1498, DOI 10.1016/j.bbadis.2011.07.001; Harrington KJ, 2010, CYTOKINE GROWTH F R, V21, P91, DOI 10.1016/j.cytogfr.2010.02.006; Hishiki T, 2010, J VIROL, V84, P12048, DOI 10.1128/JVI.01063-10; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kuhlmann I, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-8; Lang QL, 2011, J ZHEJIANG UNIV-SC B, V12, P116, DOI 10.1631/jzus.B1000278; Lenschow DJ, 2010, VIRUSES-BASEL, V2, P2154, DOI 10.3390/v2102154; Li LN, 2010, J PROTEOME RES, V9, P2460, DOI 10.1021/pr901151k; Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Lolkema MP, 2011, CLIN CANCER RES, V17, P581, DOI 10.1158/1078-0432.CCR-10-2159; Mertens P, 2004, VIRUS RES, V101, P3, DOI 10.1016/j.virusres.2003.12.002; Morgan KL, 2005, NEUROSCI LETT, V382, P259, DOI 10.1016/j.neulet.2005.03.044; Munday DC, 2010, PROTEOMICS, V10, P4320, DOI 10.1002/pmic.201000228; Nag A, 2004, CANCER RES, V64, P8152, DOI 10.1158/0008-5472.CAN-04-2598; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; O'Donnell SM, 2006, J VIROL, V80, P1077, DOI 10.1128/JVI.80.3.1077-1086.2006; Ohtani N, 2003, J CELL BIOL, V162, P173, DOI 10.1083/jcb.200302085; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ooms LS, 2010, J BIOL CHEM, V285, P41604, DOI 10.1074/jbc.M110.176255; Pan D, 2011, BRIT J CANCER, V105, P1012, DOI 10.1038/bjc.2011.325; Perwitasari O, 2011, J BIOL CHEM, V286, P44412, DOI 10.1074/jbc.M111.285205; Petit A, 2010, LEUKEMIA, V24, P654, DOI 10.1038/leu.2009.241; Plesca D, 2007, CELL CYCLE, V6, P1147, DOI 10.4161/cc.6.10.4259; Poggioli GJ, 2002, J VIROL, V76, P2585, DOI 10.1128/JVI.76.6.2585-2594.2002; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Salgado M, 2011, VIROLOGY, V411, P103, DOI 10.1016/j.virol.2010.12.037; Schiff L.A., 2007, FIELDS VIROLOGY, V2, P1853; SILVERSTEIN SC, 1968, J CELL BIOL, V36, P197, DOI 10.1083/jcb.36.1.197; Smith JA, 2006, J VIROL, V80, P2019, DOI 10.1128/JVI.80.4.2019-2033.2006; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Suzuki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/978312; Tan SL, 2007, NAT BIOTECHNOL, V25, P1383, DOI 10.1038/nbt1207-1383; Thirukkumaran Chandini, 2009, V542, P607, DOI 10.1007/978-1-59745-561-9_31; Thirukkumaran CM, 2010, CANCER RES, V70, P2435, DOI 10.1158/0008-5472.CAN-09-2408; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Ueki T, 2009, CANCER RES, V69, P8752, DOI 10.1158/0008-5472.CAN-09-1809; Villa-Moruzzi E, 2011, ANAL CELL PATHOL, V34, P101, DOI [10.1155/2011/870459, 10.3233/ACP-2011-0008]; Vogels MW, 2011, PROTEOMICS, V11, P64, DOI 10.1002/pmic.201000309; Wang CM, 2009, J BIOL CHEM, V284, P16183, DOI 10.1074/jbc.M109.002105; Yan W, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r54	65	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51939	10.1371/journal.pone.0051939	http://dx.doi.org/10.1371/journal.pone.0051939			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240068	gold, Green Submitted, Green Published			2022-12-27	WOS:000312290800104
J	Duin, D; King, D; van den Besselaar, P				Duin, Daphne; King, David; van den Besselaar, Peter			Identifying Audiences of E-Infrastructures - Tools for Measuring Impact	PLOS ONE			English	Article								Research evaluation should take into account the intended scholarly and non-scholarly audiences of the research output. This holds too for research infrastructures, which often aim at serving a large variety of audiences. With research and research infrastructures moving to the web, new possibilities are emerging for evaluation metrics. This paper proposes a feasible indicator for measuring the scope of audiences who use web-based e-infrastructures, as well as the frequency of use. In order to apply this indicator, a method is needed for classifying visitors to e-infrastructures into relevant user categories. The paper proposes such a method, based on an inductive logic program and a Bayesian classifier. The method is tested, showing that the visitors are efficiently classified with 90% accuracy into the selected categories. Consequently, the method can be used to evaluate the use of the e-infrastructure within and outside academia.	[Duin, Daphne; van den Besselaar, Peter] Vrije Univ Amsterdam, Dept Org Sci, Amsterdam, Netherlands; [Duin, Daphne; van den Besselaar, Peter] Vrije Univ Amsterdam, Network Inst, Amsterdam, Netherlands; [King, David] Open Univ, Dept Comp, Milton Keynes MK7 6AA, Bucks, England	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Open University - UK	van den Besselaar, P (corresponding author), Vrije Univ Amsterdam, Dept Org Sci, Amsterdam, Netherlands.	p.a.a.vanden.besselaar@vu.nl	van den Besselaar, Peter A A/E-5938-2013	van den Besselaar, Peter A A/0000-0002-8304-8565; King, David/0000-0001-7299-9392	EC [261532]	EC(European CommissionEuropean Commission Joint Research Centre)	The work for this paper was part of the EC funded ViBRANT project (261532). Our colleagues of the Natural History Museum in London provided access to the Scratchpads visitor data. We thank in particular Simon Rycroft for his help and advice regarding the visitor data and the use of Google Analytics, Irina Brake for her help with selecting sample data. We thank Laura Hollink for her advice on the initial data, and the two anonymous referees of this journal. A first analysis was presented at the Altmetrics workshop of the ACM Webscience conference in 2011. We also thank the participants of workshop for helpful suggestions.	[Anonymous], 2010, ROL E INFR CREAT GLO; Costello K. L., 2010, PROC AM SOC INFORM S, V47, P1, DOI DOI 10.1002/MEET.14504701201; de Jong SPL, 2011, RES EVALUAT, V20, P61, DOI 10.3152/095820211X12941371876346; Dogan RI, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap018; Dutton W., 2010, WORLD WIDE RES RESHA; Fang W., 2007, USING GOOGLE ANAL IM; Horlings E, 2012, SOC FOOTPRINT BIG SC; Huurnink B, 2010, J AM SOC INF SCI TEC, V61, P1180, DOI 10.1002/asi.21327; JACOBS R, 1980, PERS PSYCHOL, V33, P595, DOI 10.1111/j.1744-6570.1980.tb00486.x; Kousha K, 2010, J INFORMETR, V4, P124, DOI 10.1016/j.joi.2009.10.003; Krell FT, 2000, NATURE, V405, P507, DOI 10.1038/35014664; Krell FT, 2002, NATURE, V415, P957, DOI 10.1038/415957a; Maasen van den Brink M, 2010, EVALUATING SOC BENEF; Martin BR, 2010, BIBLIOMETRIC DATABAS; Moed H. F., 2007, DEV BIBLIOMETRIC IND; Nightingale P, 2007, SCI PUBL POLICY, V34, P543, DOI DOI 10.3152/030234207X254396; Scriven M., 1991, EVALUATION THESAURUS, V4th; SEP, 2010, SEP STAND EV PROT 20; SHAPIN S, 1989, AM SCI, V77, P554; Smith Vincent S, 2009, BMC Res Notes, V2, P113, DOI 10.1186/1756-0500-2-113; Smith VS, 2010, COOP2010 9 INT C DES, P329; Spaapen J., 2007, EVALUATING RES CONTE; Thelwall M., 2004, LINK ANAL INFORM SCI, DOI 10.1108/S1876-0562(2004)04; Van den Besselaar P, 2012, CYBERMETRIC IN PRESS, P16; van Raan AFJ, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P19	25	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50943	10.1371/journal.pone.0050943	http://dx.doi.org/10.1371/journal.pone.0050943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239995	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800031
J	Hartwich, K; Poehlein, A; Daniel, R				Hartwich, Katrin; Poehlein, Anja; Daniel, Rolf			The Purine-Utilizing Bacterium Clostridium acidurici 9a: A Genome-Guided Metabolic Reconsideration	PLOS ONE			English	Article							AMINO-ACID DEGRADATION; GENUS CLOSTRIDIUM; VANCOMYCIN RESISTANCE; GLYCINE METABOLISM; SEQUENCE; FERMENTATION; IDENTIFICATION; CYLINDROSPORUM; PERSPECTIVE; MECHANISM	Clostridium acidurici is an anaerobic, homoacetogenic bacterium, which is able to use purines such as uric acid as sole carbon, nitrogen, and energy source. Together with the two other known purinolytic clostridia C. cylindrosporum and C. purinilyticum, C. acidurici serves as a model organism for investigation of purine fermentation. Here, we present the first complete sequence and analysis of a genome derived from a purinolytic Clostridium. The genome of C. acidurici 9a consists of one chromosome (3,105,335 bp) and one small circular plasmid (2,913 bp). The lack of candidate genes encoding glycine reductase indicates that C. acidurici 9a uses the energetically less favorable glycine-serine-pyruvate pathway for glycine degradation. In accordance with the specialized lifestyle and the corresponding narrow substrate spectrum of C. acidurici 9a, the number of genes involved in carbohydrate transport and metabolism is significantly lower than in other clostridia such as C. acetobutylicum, C. saccharolyticum, and C. beijerinckii. The only amino acid that can be degraded by C. acidurici is glycine but growth on glycine only occurs in the presence of a fermentable purine. Nevertheless, the addition of glycine resulted in increased transcription levels of genes encoding enzymes involved in the glycine-serine-pyruvate pathway such as serine hydroxymethyltransferase and acetate kinase, whereas the transcription levels of formate dehydrogenase-encoding genes decreased. Sugars could not be utilized by C. acidurici but the full genetic repertoire for glycolysis was detected. In addition, genes encoding enzymes that mediate resistance against several antimicrobials and metals were identified. High resistance of C. acidurici towards bacitracin, acriflavine and azaleucine was experimentally confirmed.	[Daniel, Rolf] Univ Gottingen, Dept Genom & Appl Microbiol, Inst Microbiol & Genet, Gottingen, Germany; Univ Gottingen, Inst Microbiol & Genet, Gottingen Genom Lab, Gottingen, Germany	University of Gottingen; University of Gottingen	Daniel, R (corresponding author), Univ Gottingen, Dept Genom & Appl Microbiol, Inst Microbiol & Genet, Gottingen, Germany.	rdaniel@gwdg.de	Daniel, Rolf/AAQ-5933-2021	Daniel, Rolf/0000-0002-8646-7925; Poehlein, Anja/0000-0002-2473-6202	Bundesministerium fur Bildung und Forschung (BMBF); Niedersachsisches Ministerium fur Wissenschaft und Kultur	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Niedersachsisches Ministerium fur Wissenschaft und Kultur	This work was supported by the Bundesministerium fur Bildung und Forschung (BMBF) and the Niedersachsisches Ministerium fur Wissenschaft und Kultur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREESEN JR, 1994, ANTON LEEUW INT J G, V66, P223, DOI 10.1007/BF00871641; Andreesen JR, 1994, ACETOGENESIS, P568, DOI DOI 10.1007/978-1-4615-1777-1_23; Barker HA, 1942, J BACTERIOL, V43, P291, DOI 10.1128/JB.43.3.291-304.1942; Barker HA, 1941, J BIOL CHEM, V141, P3; BARKER HA, 1981, ANNU REV BIOCHEM, V50, P23, DOI 10.1146/annurev.bi.50.070181.000323; *BIOCYC, BIOCYC DAT COLL; BREHM JK, 1992, PLASMID, V28, P1, DOI 10.1016/0147-619X(92)90031-5; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; DURRE P, 1983, J BACTERIOL, V154, P192; DURRE P, 1981, INT J SYST BACTERIOL, V31, P184, DOI 10.1099/00207713-31-2-184; DURRE P, 1982, J GEN MICROBIOL, V128, P1457; DURRE P, 1982, FEMS MICROBIOL LETT, V15, P51; DYKE KGH, 1989, FEMS MICROBIOL LETT, V58, P209; ExPASy, SIB BIOINF RES PORT; Fonknechten N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-555; FRIEDMANN HC, 1970, ANNU REV MICROBIOL, V24, P159, DOI 10.1146/annurev.mi.24.100170.001111; GOTTSCHALK G, 1968, EUR J BIOCHEM, V5, P346, DOI 10.1111/j.1432-1033.1968.tb00376.x; Gupta RS, 2009, INT J SYST EVOL MICR, V59, P285, DOI 10.1099/ijs.0.001792-0; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Hui EKW, 1998, CELL MOL LIFE SCI, V54, P1403, DOI 10.1007/s000180050262; Kalhoefer D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-324; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; McKessar SJ, 2000, ANTIMICROB AGENTS CH, V44, P3224, DOI 10.1128/AAC.44.11.3224-3228.2000; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; RABINOWITZ JC, 1956, J BIOL CHEM, V222, P537; RABINOWITZ JC, 1959, ANNU REV MICROBIOL, V13, P441, DOI 10.1146/annurev.mi.13.100159.002301; RABINOWITZ JC, 1956, J BIOL CHEM, V218, P189; Rabinowitz JG, 1963, METHOD ENZYMOL, P703; Rahlfs S, 1999, FEBS LETT, V453, P35, DOI 10.1016/S0014-5793(99)00576-1; RAKOSKY JOSEPH, 1955, JOUR BACT, V69, P563; SAGERS RD, 1961, J BACTERIOL, V81, P541, DOI 10.1128/JB.81.4.541-549.1961; Sanger F, 1992, Biotechnology, V24, P104; SCHIEFERULLRICH H, 1984, ARCH MICROBIOL, V138, P345, DOI 10.1007/BF00410902; Schmeisser C, 2009, APPL ENVIRON MICROB, V75, P4035, DOI 10.1128/AEM.00515-09; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Self WT, 2000, P NATL ACAD SCI USA, V97, P7208, DOI 10.1073/pnas.97.13.7208; Shakil S, 2008, J BIOMED SCI, V15, P5, DOI 10.1007/s11373-007-9194-y; Skulj M, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-6; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Staden R, 2000, Methods Mol Biol, V132, P115; Steiner E, 2011, MOL MICROBIOL, V80, P641, DOI 10.1111/j.1365-2958.2011.07608.x; Stickland LH, 1934, BIOCHEM J, V28, P1746, DOI 10.1042/bj0281746; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tech Maike, 2003, In Silico Biology, V3, P441; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; WABER LJ, 1979, J BACTERIOL, V140, P468, DOI 10.1128/JB.140.2.468-478.1979; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	63	31	31	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51662	10.1371/journal.pone.0051662	http://dx.doi.org/10.1371/journal.pone.0051662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240052	Green Published, Green Submitted			2022-12-27	WOS:000312290800088
J	Hu, J; Luo, CX; Chu, WH; Shan, YA; Qian, ZM; Zhu, G; Yu, YB; Feng, H				Hu, Jun; Luo, Chun Xia; Chu, Wei Hua; Shan, You An; Qian, Zhong-Ming; Zhu, Gang; Yu, Yan Bing; Feng, Hua			20-Hydroxyecdysone Protects against Oxidative Stress-Induced Neuronal Injury by Scavenging Free Radicals and Modulating NF-kappa B and JNK Pathways	PLOS ONE			English	Article							ISCHEMIC BRAIN-INJURY; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; NITRIC-OXIDE SYNTHASE; CELL-DEATH; CEREBRAL-ISCHEMIA; REACTIVE OXYGEN; SIGNALING PATHWAY; MICE LACKING; PC12 CELLS; MITOCHONDRIA	Oxidative stress plays an important role in the pathological processes of ischemic brain damage. Many antioxidants have been shown to protect against cerebral ischemia injury by inhibiting oxidative stress both in vitro and in vivo. 20-Hydroxyecdysone (20E), an ecdysteroid hormone, exhibits antioxidative effects. For the work described in this paper, we used an in vitro oxidative damage model and an in vivo ischemic model of middle cerebral artery occlusion (MCAO) to investigate the neuroprotective effects of 20E and the mechanisms related to these effects. Treatment of cells with H2O2 led to neuronal injury, intracellular ROS/RNS generation, mitochondrial membrane potential dissipation, cellular antioxidant potential descent, an increase in malondialdehyde (MDA) and an elevation of intracellular [Ca2+], all of which were markedly attenuated by 20E. Inhibition of the activation of the ASK1-MKK4/7-JNK stress signaling pathway and cleaved caspase-3 induced by oxidative stress were involved in the neuroprotection afforded by 20E. In addition, 20E reduced the expression of iNOS protein by inhibition of NF-kappa B activation. The neuroprotective effect of 20E was also confirmed in vivo. 20E significantly decreased infarct volume and the neurological deficit score, restored antioxidant potential and inhibited the increase in MDA and TUNEL-positive and cleaved caspase-3-positive cells in the cerebral cortex in MCAO rats. Together, these results support that 20E protects against cerebral ischemia injury by inhibiting ROS/RNS production and modulating oxidative stress-induced signal transduction pathways. Citation: Hu J, Luo CX, Chu WH, Shan YA, Qian Z-M, et al. (2012) 20-Hydroxyecdysone Protects against Oxidative Stress-Induced Neuronal Injury by Scavenging Free Radicals and Modulating NF-kappa B and JNK Pathways. PLoS ONE 7(12): e50764. doi:10.1371/journal.pone.0050764	[Yu, Yan Bing] China Japan Friendship Hosp, Dept Neurosurg, Beijing, Peoples R China; [Hu, Jun; Luo, Chun Xia; Chu, Wei Hua; Shan, You An; Qian, Zhong-Ming; Zhu, Gang; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China	China-Japan Friendship Hospital; Army Medical University	Yu, YB (corresponding author), China Japan Friendship Hosp, Dept Neurosurg, Beijing, Peoples R China.	zllnd00@yahoo.cn; fenghua88888@yahoo.cn	Qian, Zhong Ming/E-8884-2016; Feng, Hua/AAX-4121-2021	Feng, Hua/0000-0003-4489-9217; Hu, Jun/0000-0002-3038-0206	Natural Science Foundation of Chong-Qing, China [2007BA5010]; National Natural Science Foundation of China [304803920, 81070929]	Natural Science Foundation of Chong-Qing, China(Natural Science Foundation of Chongqing); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of Chong-Qing, China (2007BA5010) and from the National Natural Science Foundation of China (304803920, 81070929). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Benedi J, 2004, LIFE SCI, V75, P1263, DOI 10.1016/j.lfs.2004.05.001; Cai YJ, 2002, CAN J PHYSIOL PHARM, V80, P1187, DOI [10.1139/y02-152, 10.1139/Y02-152]; CATALAN RE, 1985, COMP BIOCHEM PHYS B, V81, P771, DOI 10.1016/0305-0491(85)90403-1; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen Z, 2004, CHIN J CLIN PHARM TH, V9, P540; Chinopoulos C, 2006, FEBS J, V273, P433, DOI 10.1111/j.1742-4658.2005.05103.x; Colasanti M, 2000, TRENDS PHARMACOL SCI, V21, P249, DOI 10.1016/S0165-6147(00)01499-1; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Feng Chun-Yan, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P76; Frantz MC, 2010, ENV MOL MUTAGEN; Friberg H, 2002, NEUROSCI LETT, V334, P111, DOI 10.1016/S0304-3940(02)01116-3; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guan QH, 2006, BRAIN RES, V1092, P36, DOI 10.1016/j.brainres.2006.03.086; Gulden M, 2010, FREE RADICAL BIO MED, V49, P1298, DOI 10.1016/j.freeradbiomed.2010.07.015; Hu J, 2010, J CELL BIOCHEM, V111, P1512, DOI 10.1002/jcb.22877; Huang CY, 2001, J CEREBR BLOOD F MET, V21, P163, DOI 10.1097/00004647-200102000-00008; Iadecola C, 1997, J NEUROSCI, V17, P9157; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kholodova Iu D, 1997, Ukr Biokhim Zh (1978), V69, P3; Kuzmenko A. I., 1999, Ukrainskii Biokhimicheskii Zhurnal, V71, P35; Kuzmenko A. I., 2001, Ukrainskii Biokhimicheskii Zhurnal, V73, P44; Kuzmenko AI, 1997, BIOCHEMISTRY-MOSCOW+, V62, P609; Lafont R, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.7; Le Bras M, 2005, HISTOL HISTOPATHOL, V20, P205, DOI 10.14670/HH-20.205; LI X, 2011, BRAIN RES; Liu Z, 2008, ACTA NEUROCHIR SUPPL, V104, P297; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Love S, 1999, BRAIN PATHOL, V9, P119; Matsuda H, 1970, Nihon Yakurigaku Zasshi, V66, P551; Murin R, 2001, GEN PHYSIOL BIOPHYS, V20, P431; Nurmi A, 2004, STROKE, V35, P987, DOI 10.1161/01.STR.0000120732.45951.26; Oehme I, 2006, CELL DEATH DIFFER, V13, P189, DOI 10.1038/sj.cdd.4401730; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Perez-Asenio FJ, 2005, NEUROBIOL DIS, V18, P375, DOI 10.1016/j.nbd.2004.10.018; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Schaller B, 2005, FREE RADICAL BIO MED, V38, P411, DOI 10.1016/j.freeradbiomed.2004.10.032; Schild L, 2005, FEBS J, V272, P3593, DOI 10.1111/j.1742-4658.2005.04781.x; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; SLAMA K, 1995, EUR J ENTOMOL, V92, P355; Somayajulu M, 2005, NEUROBIOL DIS, V18, P618, DOI 10.1016/j.nbd.2004.10.021; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Sugawara Taku, 2004, NeuroRx, V1, P17, DOI 10.1602/neurorx.1.1.17; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Takeda K, 2003, CELL STRUCT FUNCT, V28, P23; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tang WH, 2008, NEUROL RES, V30, P571, DOI 10.1179/174313208X297986; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Toth N, 2008, PHYTOMEDICINE, V15, P691, DOI 10.1016/j.phymed.2008.04.015; Vosler PS, 2009, STROKE, V40, pS119, DOI 10.1161/STROKEAHA.108.533109; Wang R, 2006, J NEUROCHEM, V99, P1543, DOI 10.1111/j.1471-4159.2006.04201.x; Wang T, 2009, FREE RADICAL BIO MED, V47, P229, DOI 10.1016/j.freeradbiomed.2009.02.027; Wang XD, 2001, GENE DEV, V15, P2922; Zhang F, 2007, STROKE, V38, P2329, DOI 10.1161/STROKEAHA.107.482786; Zhang JJ, 2010, MOL HUM REPROD; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004; Zhao XR, 2000, BRAIN RES, V872, P215, DOI 10.1016/S0006-8993(00)02459-8	62	40	43	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50764	10.1371/journal.pone.0050764	http://dx.doi.org/10.1371/journal.pone.0050764			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239983	gold, Green Published, Green Submitted			2022-12-27	WOS:000312290800021
J	Ishizawa, M; Ogura, M; Kato, S; Makishima, M				Ishizawa, Michiyasu; Ogura, Michitaka; Kato, Shigeaki; Makishima, Makoto			Impairment of Bilirubin Clearance and Intestinal Interleukin-6 Expression in Bile Duct-Ligated Vitamin D Receptor Null Mice	PLOS ONE			English	Article							NF-KAPPA-B; CONSTITUTIVE ANDROSTANE RECEPTOR; FARNESOID-X-RECEPTOR; NUCLEAR RECEPTORS; IN-VIVO; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; GENE-EXPRESSION; ACID; TRANSPORTERS; LACKING	The vitamin D receptor (VDR) mediates the physiological and pharmacological actions of 1 alpha,25-dihydroxyvitamin D-3 in bone and calcium metabolism, cellular growth and differentiation, and immunity. VDR also responds to secondary bile acids and belongs to the NR1I subfamily of the nuclear receptor superfamily, which regulates expression of xenobiotic metabolism genes. When compared to knockout mouse investigations of the other NR1I nuclear receptors, pregnane X receptor and constitutive androstane receptor, an understanding of the role of VDR in xenobiotic metabolism remains limited. We examined the effect of VDR deletion in a mouse model of cholestasis. We performed bile duct ligation (BDL) on VDR-null mice and compared blood biochemistry, mRNA expression of genes involved in bile acid and bilirubin metabolism, cytokine production, and expression of inflammatory regulators with those of wild-type mice. VDR-null mice had elevated plasma conjugated bilirubin levels three days after BDL compared with wild-type mice. Urine bilirubin levels and renal mRNA and/or protein expression of multidrug resistance-associated proteins 2 and 4 were decreased in VDR-null mice, suggesting impaired excretion of conjugated bilirubin into urine. While VDR-null kidney showed mRNA expression of interleukin-6 (IL-6) after BDL and VDR-null macrophages had higher IL-6 protein levels after lipopolysaccharide stimulation, the induction of intestinal Il6 mRNA expression and plasma IL-6 protein levels after BDL was impaired in VDR-null mice. Immunoblotting analysis showed that expression of an immune regulator, I kappa B alpha, was elevated in the jejunum of VDR-null mice, a possible mechanism for the attenuated induction of Il6 expression in the intestine after BDL. Increased expression of I kappa B alpha may be a consequence of compensatory mechanisms for VDR deletion. These results reveal a role of VDR in bilirubin clearance during cholestasis. VDR is also suggested to contribute to tissue-selective immune regulation.	[Ishizawa, Michiyasu; Ogura, Michitaka; Makishima, Makoto] Nihon Univ, Sch Med, Div Biochem, Dept Biomed Sci, Tokyo, Japan; [Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan	Nihon University; University of Tokyo	Makishima, M (corresponding author), Nihon Univ, Sch Med, Div Biochem, Dept Biomed Sci, Tokyo, Japan.	makishima.makoto@nihon-u.ac.jp			Japan Society for the Promotion of Science [22590294]; Ministry of Education, Culture, Sports, Science and Technology, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research (C) 22590294] (to MM) and Strategic Research Base Development Program for Private Universities subsidized by the Ministry of Education, Culture, Sports, Science and Technology, Japan (since 2010) (to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi R, 2005, J LIPID RES, V46, P46, DOI 10.1194/jlr.M400294-JLR200; Aleksunes LM, 2008, TOXICOLOGY, V250, P82, DOI 10.1016/j.tox.2008.06.009; Belinsky MG, 2005, MOL PHARMACOL, V68, P160, DOI 10.1124/mol.104.010587; Bradley MN, 2007, J CLIN INVEST, V117, P2337, DOI 10.1172/JCI31909; Cantorna MT, 2004, AM J CLIN NUTR, V80, p1717S, DOI 10.1093/ajcn/80.6.1717S; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Choi M, 2011, MOL PHARMACOL, V80, P1147, DOI 10.1124/mol.111.074138; Choi M, 2009, EXPERT OPIN THER PAT, V19, P593, DOI 10.1517/13543770902877717; Chow ECY, 2010, BIOPHARM DRUG DISPOS, V31, P91, DOI 10.1002/bdd.694; Chu XY, 2006, J PHARMACOL EXP THER, V317, P579, DOI 10.1124/jpet.105.098665; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Echchgadda I, 2004, MOL PHARMACOL, V65, P720, DOI 10.1124/mol.65.3.720; Fan JH, 2009, J PHARMACOL EXP THER, V330, P389, DOI 10.1124/jpet.108.149815; Froicu M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-5; Gao J, 2010, DRUG METAB DISPOS, V38, P2091, DOI 10.1124/dmd.110.035568; Gascon-Barre M, 2003, HEPATOLOGY, V37, P1034, DOI 10.1053/jhep.2003.50176; Hartmann G, 2002, J PHARMACOL EXP THER, V303, P273, DOI 10.1124/jpet.102.039404; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Huang WD, 2003, P NATL ACAD SCI USA, V100, P4156, DOI 10.1073/pnas.0630614100; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Ishizawa M, 2008, J LIPID RES, V49, P763, DOI 10.1194/jlr.M700293-JLR200; Ishizawa M, 2009, AM J PHYSIOL-ENDOC M, V297, pE728, DOI 10.1152/ajpendo.00168.2009; Iusuf D, 2012, TRENDS PHARMACOL SCI, V33, P100, DOI 10.1016/j.tips.2011.10.005; Kimura A, 2005, P NATL ACAD SCI USA, V102, P17089, DOI 10.1073/pnas.0508517102; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Liu YP, 2003, J CLIN INVEST, V112, P1678, DOI 10.1172/JCI200318945; Makishima M, 2005, EXPERT OPIN THER PAT, V15, P1133, DOI 10.1517/13543776.15.9.1133; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Marschall HU, 2006, J LIPID RES, V47, P582, DOI 10.1194/jlr.M500427-JLR200; Matsubara T, 2008, DRUG METAB DISPOS, V36, P2058, DOI 10.1124/dmd.108.021501; McCarthy TC, 2005, J BIOL CHEM, V280, P23232, DOI 10.1074/jbc.M411520200; Mennone A, 2006, HEPATOLOGY, V43, P1013, DOI 10.1002/hep.21158; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nishida S, 2009, DRUG METAB DISPOS, V37, P2037, DOI 10.1124/dmd.109.027334; Ogura M, 2009, J PHARMACOL EXP THER, V328, P564, DOI 10.1124/jpet.108.145987; Ozeki J, 2011, TOXICOLOGY, V280, P10, DOI 10.1016/j.tox.2010.11.003; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Riis JL, 2004, ARCH DERMATOL RES, V296, P195, DOI 10.1007/s00403-004-0509-9; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sawada N, 2004, BIOCHEMISTRY-US, V43, P4530, DOI 10.1021/bi030207f; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Soroka CJ, 2010, HEPATOLOGY, V51, P181, DOI 10.1002/hep.23265; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stedman C, 2004, J BIOL CHEM, V279, P11336, DOI 10.1074/jbc.M310258200; Stedman CAM, 2005, P NATL ACAD SCI USA, V102, P2063, DOI 10.1073/pnas.0409794102; Stedman C, 2006, P NATL ACAD SCI USA, V103, P11323, DOI 10.1073/pnas.0604772103; Sun J, 2006, AM J PHYSIOL-ENDOC M, V291, pE315, DOI 10.1152/ajpendo.00590.2005; TANABE O, 1988, J IMMUNOL, V141, P3875; Thummel KE, 2001, MOL PHARMACOL, V60, P1399, DOI 10.1124/mol.60.6.1399; Uno S, 2009, BIOCHEM PHARMACOL, V77, P186, DOI 10.1016/j.bcp.2008.10.007; Vlaming MLH, 2006, J PHARMACOL EXP THER, V318, P319, DOI 10.1124/jpet.106.101774; Wagner M, 2005, HEPATOLOGY, V42, P420, DOI 10.1002/hep.20784; Wagner M, 2003, GASTROENTEROLOGY, V125, P825, DOI 10.1016/S0016-5085(03)01068-0; Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998; Wu SP, 2010, INT J BIOCHEM CELL B, V42, P329, DOI 10.1016/j.biocel.2009.11.012; Xie W, 2001, J BIOL CHEM, V276, P37739, DOI 10.1074/jbc.R100033200; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; Xu Y, 2006, MOL PHARMACOL, V69, P56, DOI 10.1124/mol.105.017392; Yan CG, 2010, J BIOL CHEM, V285, P37227, DOI 10.1074/jbc.M110.132084; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Zelcer N, 2006, J HEPATOL, V44, P768, DOI 10.1016/j.jhep.2005.07.022; Zhang J, 2004, J BIOL CHEM, V279, P49517, DOI 10.1074/jbc.M409041200; Zhang YC, 2012, TOXICOL SCI, V127, P451, DOI 10.1093/toxsci/kfs123; Zollner G, 2002, AM J PHYSIOL-GASTR L, V282, pG184, DOI 10.1152/ajpgi.00215.2001; Zollner G, 2006, MOL PHARMACEUT, V3, P231, DOI 10.1021/mp060010s	71	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51664	10.1371/journal.pone.0051664	http://dx.doi.org/10.1371/journal.pone.0051664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240054	Green Submitted, gold, Green Published			2022-12-27	WOS:000312290800090
J	Nikolin, VM; Osterrieder, K; von Messling, V; Hofer, H; Anderson, D; Dubovi, E; Brunner, E; East, ML				Nikolin, Veljko M.; Osterrieder, Klaus; von Messling, Veronika; Hofer, Heribert; Anderson, Danielle; Dubovi, Edward; Brunner, Edgar; East, Marion L.			Antagonistic Pleiotropy and Fitness Trade-Offs Reveal Specialist and Generalist Traits in Strains of Canine Distemper Virus	PLOS ONE			English	Article							INFLUENZA-A VIRUSES; HOST-RANGE; EVOLUTION; HEMAGGLUTININ; SERENGETI; RESIDUES; SLAM; IDENTIFICATION; DIVERSITY; EPIDEMIC	Theoretically, homogeneous environments favor the evolution of specialists whereas heterogeneous environments favor generalists. Canine distemper is a multi-host carnivore disease caused by canine distemper virus (CDV). The described cell receptor of CDV is SLAM (CD150). Attachment of CDV hemagglutinin protein (CDV-H) to this receptor facilitates fusion and virus entry in cooperation with the fusion protein (CDV-F). We investigated whether CDV strains co-evolved in the large, homogeneous domestic dog population exhibited specialist traits, and strains adapted to the heterogeneous environment of smaller populations of different carnivores exhibited generalist traits. Comparison of amino acid sequences of the SLAM binding region revealed higher similarity between sequences from Canidae species than to sequences from other carnivore families. Using an in vitro assay, we quantified syncytia formation mediated by CDV-H proteins from dog and non-dog CDV strains in cells expressing dog, lion or cat SLAM. CDV-H proteins from dog strains produced significantly higher values with cells expressing dog SLAM than with cells expressing lion or cat SLAM. CDV-H proteins from strains of non-dog species produced similar values in all three cell types, but lower values in cells expressing dog SLAM than the values obtained for CDV-H proteins from dog strains. By experimentally changing one amino acid (Y549H) in the CDV-H protein of one dog strain we decreased expression of specialist traits and increased expression of generalist traits, thereby confirming its functional importance. A virus titer assay demonstrated that dog strains produced higher titers in cells expressing dog SLAM than cells expressing SLAM of non-dog hosts, which suggested possible fitness benefits of specialization post-cell entry. We provide in vitro evidence for the expression of specialist and generalist traits by CDV strains, and fitness trade-offs across carnivore host environments caused by antagonistic pleiotropy. These findings extend knowledge on CDV molecular epidemiology of particular relevance to wild carnivores.	[Nikolin, Veljko M.; Hofer, Heribert; East, Marion L.] Leibniz Inst Zoo & Wildlife Res Berlin, Berlin, Germany; [von Messling, Veronika; Anderson, Danielle] INRS Inst Armand Frappier, Quebec City, PQ, Canada; [Nikolin, Veljko M.; Osterrieder, Klaus] Free Univ Berlin, Inst Virol, Berlin, Germany; [von Messling, Veronika; Anderson, Danielle] Duke NUS Grad Med Sch, Emerging Infect Dis Program, Singapore, Singapore; [Dubovi, Edward] Cornell Univ, Anim Hlth Diagnost Ctr, Ithaca, NY USA; [Brunner, Edgar] Univ Gottingen, Dept Med Stat, Gottingen, Germany	Leibniz Institut fur Zoo und Wildtierforschung; University of Quebec; Institut national de la recherche scientifique (INRS); Free University of Berlin; National University of Singapore; Cornell University; University of Gottingen	Nikolin, VM (corresponding author), Leibniz Inst Zoo & Wildlife Res Berlin, Berlin, Germany.	Nikolin@izw-berlin.de	Anderson, Danielle/HCH-2004-2022; Nikolin, Veljko/ABC-6034-2020; Hofer, Heribert/AAF-7854-2021	Hofer, Heribert/0000-0002-2813-7442; Osterrieder, Nikolaus/0000-0002-5313-2176; Anderson, Danielle/0000-0003-4791-5024	Deutsche Forschungsgemeinschaft (DFG) through (Genetic and Immunologic Determinants of Pathogen-Host Interactions) at the Centre of Infection Biology and Immunity (ZIBI) of the Humboldt University Berlin [GRAKO 1121]; Leibniz Institute for Zoo and Wildlife Research Berlin	Deutsche Forschungsgemeinschaft (DFG) through (Genetic and Immunologic Determinants of Pathogen-Host Interactions) at the Centre of Infection Biology and Immunity (ZIBI) of the Humboldt University Berlin(German Research Foundation (DFG)); Leibniz Institute for Zoo and Wildlife Research Berlin	This study was funded by the Deutsche Forschungsgemeinschaft (DFG) through the GRAKO 1121 (Genetic and Immunologic Determinants of Pathogen-Host Interactions) at the Centre of Infection Biology and Immunity (ZIBI) of the Humboldt University Berlin, and the Leibniz Institute for Zoo and Wildlife Research Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almberg ES, 2010, ECOL APPL, V20, P2058, DOI 10.1890/09-1225.1; Alto BW, 2010, EVOL ECOL, V24, P299, DOI 10.1007/s10682-009-9307-3; ANDERSON R M, 1991; Andreasen V, 1997, J MATH BIOL, V35, P825, DOI 10.1007/s002850050079; APPEL M, 1974, AM J VET RES, V35, P803; APPEL MJG, 1995, VET MICROBIOL, V44, P187, DOI 10.1016/0378-1135(95)00011-X; Aversa G, 1997, IMMUNOL CELL BIOL, V75, P202, DOI 10.1038/icb.1997.30; Benetka V, 2011, VET REC, V168, P376, DOI 10.1136/vr.c6404; Bianco S, 2011, B MATH BIOL, V73, P248, DOI 10.1007/s11538-010-9541-4; Biek R, 2003, J VIROL, V77, P9578, DOI 10.1128/JVI.77.17.9578-9589.2003; Brunner E., 2002, NICHTPARAMETRISCHE D; Brunner E, 2002, NONPARAMETRIC ANAL L; Buckee CO, 2004, P NATL ACAD SCI USA, V101, P10839, DOI 10.1073/pnas.0402000101; Carpenter MA, 1998, VET IMMUNOL IMMUNOP, V65, P259, DOI 10.1016/S0165-2427(98)00159-7; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Craft ME, 2009, P ROY SOC B-BIOL SCI, V276, P1777, DOI 10.1098/rspb.2008.1636; Decaro N, 2008, VET MICROBIOL, V132, P221, DOI 10.1016/j.vetmic.2008.06.007; DIETZ K, 1979, J MATH BIOL, V8, P291, DOI 10.1007/BF00276314; Dimcheff DE, 2000, J VIROL, V74, P3984, DOI 10.1128/JVI.74.9.3984-3995.2000; DROCOURT D, 1990, NUCLEIC ACIDS RES, V18, P4009, DOI 10.1093/nar/18.13.4009; Eizirik E, 2010, MOL PHYLOGENET EVOL, V56, P49, DOI 10.1016/j.ympev.2010.01.033; Elena Santiago F, 2009, Open Virol J, V3, P1, DOI 10.2174/1874357900903010001; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Flint S.J., 2004, PRINCIPLES VIROLOGY, VSecond; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gandon S, 2004, EVOLUTION, V58, P455, DOI 10.1111/j.0014-3820.2004.tb01669.x; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Goller KV, 2010, VET MICROBIOL, V146, P245, DOI 10.1016/j.vetmic.2010.05.018; Guiserix M, 2007, J R SOC INTERFACE, V4, P1127, DOI 10.1098/rsif.2007.0235; Haas L, 1996, VET MICROBIOL, V49, P147, DOI 10.1016/0378-1135(95)00180-8; Hueffer K, 2003, J VIROL, V77, P1718, DOI 10.1128/JVI.77.3.1718-1726.2003; Ikeda Y, 2001, CLIN DIAGN LAB IMMUN, V8, P641, DOI 10.1128/CDLI.8.3.641-644.2001; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Kaelber JT, 2012, PLOS PATHOG, V8, P5; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kennedy S, 2000, EMERG INFECT DIS, V6, P637, DOI 10.3201/eid0606.000613; Lajeunesse MJ, 2002, P ROY SOC B-BIOL SCI, V269, P703, DOI 10.1098/rspb.2001.1943; LAMB RA, 1993, VIROLOGY, V197, P1, DOI 10.1006/viro.1993.1561; LEVINS R, 1967, GENETICS, V56, P163; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Martella V, 2006, VET MICROBIOL, V116, P301, DOI 10.1016/j.vetmic.2006.04.019; MAY RM, 1972, P NATL ACAD SCI USA, V69, P1109, DOI 10.1073/pnas.69.5.1109; McCarthy AJ, 2007, P ROY SOC B-BIOL SCI, V274, P3165, DOI 10.1098/rspb.2007.0884; Nikolin VM, 2012, VET MICROBIOL, V156, P45, DOI 10.1016/j.vetmic.2011.10.009; Ohishi K, 2010, COMP IMMUNOL MICROB, V33, P227, DOI 10.1016/j.cimid.2008.10.003; Pomeroy LW, 2008, J MOL EVOL, V66, P98, DOI 10.1007/s00239-007-9040-x; Qu XX, 2005, J BIOL CHEM, V280, P29588, DOI 10.1074/jbc.M500662200; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Sawatsky B, 2010, J VIROL, V84, P2753, DOI 10.1128/JVI.01813-09; Shaw LB, 2007, J MATH BIOL, V55, P1, DOI 10.1007/s00285-007-0074-x; SIDORENKO SP, 1993, J IMMUNOL, V151, P4614; Slattery JP, 1999, GENOME RES, V9, P525; STERN LBL, 1995, J VIROL, V69, P1661, DOI 10.1128/JVI.69.3.1661-1668.1995; SUMMERS BA, 1984, J COMP PATHOL, V94, P65, DOI 10.1016/0021-9975(84)90009-4; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; Truyen U, 1996, VIROLOGY, V215, P186, DOI 10.1006/viro.1996.0021; Turner PE, 2000, GENETICS, V156, P1465; von Messling V, 2001, J VIROL, V75, P6418, DOI 10.1128/JVI.75.14.6418-6427.2001; von Messling V, 2005, J VIROL, V79, P5857, DOI 10.1128/JVI.79.9.5857-5862.2005; von Messling V, 2003, J VIROL, V77, P12579, DOI 10.1128/JVI.77.23.12579-12591.2003; Vongpunsawad S, 2004, J VIROL, V78, P302, DOI 10.1128/JVI.78.1.302-313.2004; Wandeler A.I., 1993, Revue Scientifique et Technique Office International des Epizooties, V12, P51; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; Whitlock MC, 1996, AM NAT, V148, pS65, DOI 10.1086/285902; WILSON DS, 1994, AM NAT, V144, P692, DOI 10.1086/285702; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Zipperle L, 2010, J VIROL, V84, P9618, DOI 10.1128/JVI.01077-10	70	33	36	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50955	10.1371/journal.pone.0050955	http://dx.doi.org/10.1371/journal.pone.0050955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239996	Green Submitted, gold, Green Published			2022-12-27	WOS:000312290800032
J	Polyakova, O; Borman, S; Grimley, R; Vamathevan, J; Hayes, B; Solari, R				Polyakova, Oxana; Borman, Satty; Grimley, Rachel; Vamathevan, Jessica; Hayes, Brian; Solari, Roberto			Identification of Novel Interacting Partners of Sirtuin6	PLOS ONE			English	Article							NF-KAPPA-B; THYMINE-DNA GLYCOSYLASE; DEPENDENT GENE-EXPRESSION; STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; POLYACRYLAMIDE-GELS; MASS-SPECTROMETRY; LIGASE PIAS1; HUMAN SIRT6; TRANSCRIPTION	SIRT6 is a member of the Sirtuin family of histone deacetylases that has been implicated in inflammatory, aging and metabolic pathways. Some of its actions have been suggested to be via physical interaction with NF kappa B and HIF1 alpha and transcriptional regulation through its histone deacetylase activity. Our previous studies have investigated the histone deacetylase activity of SIRT6 and explored its ability to regulate the transcriptional responses to an inflammatory stimulus such as TNF alpha. In order to develop a greater understanding of SIRT6 function we have sought to identify SIRT6 interacting proteins by both yeast-2-hybrid and co-immunoprecipitation studies. We report a number of interacting partners which strengthen previous findings that SIRT6 functions in base excision repair (BER), and novel interactors which suggest a role in nucleosome and chromatin remodeling, the cell cycle and NF kappa B biology.	[Hayes, Brian; Solari, Roberto] GlaxoSmithKline, Allerg Inflammat Discovery Performance Unit, Stevenage, Herts, England; [Polyakova, Oxana; Borman, Satty; Grimley, Rachel] GlaxoSmithKline, Platform Technol Sci, Stevenage, Herts, England; [Vamathevan, Jessica] GlaxoSmithKline, Computat Biol, Stevenage, Herts, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Solari, R (corresponding author), GlaxoSmithKline, Allerg Inflammat Discovery Performance Unit, Stevenage, Herts, England.	roberto.2.solari@gsk.com		Vamathevan, Jessica/0000-0003-2016-9754	GlaxoSmithKline (GSK)	GlaxoSmithKline (GSK)(GlaxoSmithKline)	This work was fully funded by GlaxoSmithKline (GSK) and the authors were all employees of GSK at the time the work was done. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AS, 2008, CELL CYCLE, V7, P556, DOI 10.4161/cc.7.5.5490; Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; Aihara T, 1998, CYTOGENET CELL GENET, V81, P191, DOI 10.1159/000015027; Ardestani PM, 2012, NUCLEUS-PHILA, V3, P442, DOI 10.4161/nucl.21134; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bartel P. L., 1993, CELLULAR INTERACTION, P153; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Chai ZL, 2001, J BIOL CHEM, V276, P33665, DOI 10.1074/jbc.M007681200; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Cox B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011996; Dirscherl SS, 2004, BIOCHEM CELL BIOL, V82, P482, DOI 10.1139/O04-044; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Grimley R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039847; Holmes-McNary M, 2000, CANCER RES, V60, P3477; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim EJ, 2008, BIOCHEM BIOPH RES CO, V377, P838, DOI 10.1016/j.bbrc.2008.10.058; Kuroda T, 2011, EMBO J, V30, P1054, DOI 10.1038/emboj.2011.23; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Liu B, 2010, SCIENCE, V330, P521, DOI 10.1126/science.1193787; Lucey MJ, 2005, NUCLEIC ACIDS RES, V33, P6393, DOI 10.1093/nar/gki940; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Mohan RD, 2010, NUCLEIC ACIDS RES, V38, P1135, DOI 10.1093/nar/gkp1097; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Okubo S, 2004, J BIOL CHEM, V279, P31455, DOI 10.1074/jbc.M403561200; Owen HR, 2007, J MOL BIOL, V366, P725, DOI 10.1016/j.jmb.2006.11.099; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Tao KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021602; Tennen RI, 2011, TRENDS BIOCHEM SCI, V36, P39, DOI 10.1016/j.tibs.2010.07.009; Tennen RI, 2010, MECH AGEING DEV, V131, P185, DOI 10.1016/j.mad.2010.01.006; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Tsai YC, 2012, MOL CELL PROTEOMICS, V11, P60, DOI 10.1074/mcp.A111.015156; Tu YG, 2007, J BIOL CHEM, V282, P11722, DOI 10.1074/jbc.M609623200; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; Vintermist A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019184; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Yang XD, 2010, MOL CELL BIOL, V30, P2170, DOI 10.1128/MCB.01343-09; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	62	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51555	10.1371/journal.pone.0051555	http://dx.doi.org/10.1371/journal.pone.0051555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240041	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800077
J	Savio, AJ; Lemire, M; Mrkonjic, M; Gallinger, S; Zanke, BW; Hudson, TJ; Bapat, B				Savio, Andrea J.; Lemire, Mathieu; Mrkonjic, Miralem; Gallinger, Steven; Zanke, Brent W.; Hudson, Thomas J.; Bapat, Bharati			MLH1 Region Polymorphisms Show a Significant Association with CpG Island Shore Methylation in a Large Cohort of Healthy Individuals	PLOS ONE			English	Article							COLORECTAL-CANCER; CHROMOSOME 8Q24; COLON-CANCER; GENOME; DNA; HYPERMETHYLATION; EXPRESSION; HMLH1; RISK	Single nucleotide polymorphisms (SNPs) are the most common form of genetic variation. We previously demonstrated that SNPs (rs1800734, rs749072, and rs13098279) in the MLH1 gene region are associated with MLH1 promoter island methylation, loss of MLH1 protein expression, and microsatellite instability (MSI) in colorectal cancer (CRC) patients. Recent studies have identified less CpG-dense "shore'' regions flanking many CpG islands. These shores often exhibit distinct methylation profiles between different tissues and matched normal versus tumor cells of patients. To date, most epigenetic studies have focused on somatic methylation events occurring within solid tumors; less is known of the contributions of peripheral blood cell (PBC) methylation to processes such as aging and tumorigenesis. To address whether MLH1 methylation in PBCs is correlated with tumorigenesis we utilized the Illumina 450 K microarrays to measure methylation in PBC DNA of 846 healthy controls and 252 CRC patients from Ontario, Canada. Analysis of a region of chromosome 3p21 spanning the MLH1 locus in healthy controls revealed that a CpG island shore 1 kb upstream of the MLH1 gene exhibits different methylation profiles when stratified by SNP genotypes (rs1800734, rs749072, and rs13098279). Individuals with wild-type genotypes incur significantly higher PBC shore methylation than heterozygous or homozygous variant carriers (p<1.1 x 10(-6); ANOVA). This trend is also seen in CRC cases (p<0.096; ANOVA). Shore methylation also decreases significantly with increasing age in cases and controls. This is the first study of its kind to integrate PBC methylation at a CpG island shore with SNP genotype status in CRC cases and controls. These results indicate that CpG island shore methylation in PBCs may be influenced by genotype as well as the normal aging process. Citation: Savio AJ, Lemire M, Mrkonjic M, Gallinger S, Zanke BW, et al. (2012) MLH1 Region Polymorphisms Show a Significant Association with CpG Island Shore Methylation in a Large Cohort of Healthy Individuals. PLoS ONE 7(12): e51531. doi:10.1371/journal.pone.0051531	[Savio, Andrea J.; Mrkonjic, Miralem; Gallinger, Steven; Bapat, Bharati] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Savio, Andrea J.; Mrkonjic, Miralem; Gallinger, Steven; Bapat, Bharati] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Lemire, Mathieu; Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Gallinger, Steven] Canc Care Ontario, Ontario Familial Colorectal Canc Registry, Toronto, ON, Canada; [Gallinger, Steven] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Zanke, Brent W.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Bapat, Bharati] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Cancer Care Ontario; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Bapat, B (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	BAPAT@lunenfeld.ca	Bapat, Bharati/B-5839-2014; Gallinger, Steven/E-4575-2013		Ontario Research Fund Global Leadership Round in Genomics and Life Sciences (GL2), ORF-RE [GL2-01-043]; National Cancer Institute, National Institutes of Health under RFA [CA-95-011]; Colon Cancer Familial Registry [U01 CA074783]; Ontario Institute for Cancer Research, through support from the Ontario Ministry of Research and Innovation; Interdisciplinary Health Research Team Program studentship; Canadian Institutes of Health Research; Samuel Lunenfeld Research Institute Studentship at Mount Sinai Hospital; University of Toronto Fellowship award; NATIONAL CANCER INSTITUTE [K22CA095011, U24CA074783, U01CA074783] Funding Source: NIH RePORTER	Ontario Research Fund Global Leadership Round in Genomics and Life Sciences (GL2), ORF-RE; National Cancer Institute, National Institutes of Health under RFA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Colon Cancer Familial Registry; Ontario Institute for Cancer Research, through support from the Ontario Ministry of Research and Innovation; Interdisciplinary Health Research Team Program studentship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Samuel Lunenfeld Research Institute Studentship at Mount Sinai Hospital; University of Toronto Fellowship award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the Ontario Research Fund Global Leadership Round in Genomics and Life Sciences (GL2), ORF-RE File# GL2-01-043 (BWZ, TJH, SG, BB). This work was also supported by the National Cancer Institute, National Institutes of Health under RFA # CA-95-011 and through cooperative agreements with members of the Colon Cancer Family Registry and PIs. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the CFRs, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government or the CFR. This work was also supported by funding within the Colon Cancer Familial Registry awarded to the Ontario Registry for Studies of Familial Colorectal Cancer (Grant no. U01 CA074783, Principal Investigator SG). BWZ and TJH are recipients of Senior Investigator Awards from the Ontario Institute for Cancer Research, through support from the Ontario Ministry of Research and Innovation. AJS was supported by the Interdisciplinary Health Research Team Program studentship funded by the Canadian Institutes of Health Research, the Samuel Lunenfeld Research Institute Studentship at Mount Sinai Hospital, and the University of Toronto Fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CR, 2011, J CLIN IMMUNOL, V31, P137, DOI 10.1007/s10875-010-9499-x; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Deng GR, 1999, CANCER RES, V59, P2029; Feber A, 2011, GENOME RES, V21, P515, DOI 10.1101/gr.109678.110; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jiang HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005280; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kane MF, 1997, CANCER RES, V57, P808; Koestler DC, 2012, CANCER EPIDEM BIOMAR, V21, P1293, DOI 10.1158/1055-9965.EPI-12-0361; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Mrkonjic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013314; Muller K, 2001, J BIOL CHEM, V276, P14271; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Perera S, 2011, ONCOL REP, V25, P809, DOI 10.3892/or.2010.1129; Perez-Andres M, 2010, CYTOM PART B-CLIN CY, V78B, pS47, DOI 10.1002/cyto.b.20547; Raptis S, 2007, JNCI-J NATL CANCER I, V99, P463, DOI 10.1093/jnci/djk095; Schumacher FR, 2007, CANCER RES, V67, P2951, DOI 10.1158/0008-5472.CAN-06-3591; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Whiffin N, 2011, CARCINOGENESIS, V32, P1157, DOI 10.1093/carcin/bgr089; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	29	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51531	10.1371/journal.pone.0051531	http://dx.doi.org/10.1371/journal.pone.0051531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240038	gold, Green Published, Green Submitted			2022-12-27	WOS:000312290800074
J	Guillot, R; Ceinos, RM; Cal, R; Rotllant, J; Cerda-Reverter, JM				Guillot, Raul; Maria Ceinos, Rosa; Cal, Rosa; Rotllant, Josep; Miguel Cerda-Reverter, Jose			Transient Ectopic Overexpression of Agouti-Signalling Protein 1 (Asip1) Induces Pigment Anomalies in Flatfish	PLOS ONE			English	Article							NMR STRUCTURE; NEURAL-CREST; RECEPTOR; GOLDFISH; GENE; DIFFERENTIATION; MICROPHTHALMIA; MELANIZATION; INVOLVEMENT; ANTAGONIST	While flatfish in the wild exhibit a pronounced countershading of the dorso-ventral pigment pattern, malpigmentation is commonly observed in reared animals. In fish, the dorso-ventral pigment polarity is achieved because a melanization inhibition factor (MIF) inhibits melanoblast differentiation and encourages iridophore proliferation in the ventrum. A previous work of our group suggested that asip1 is the uncharacterized MIF concerned. In order to further support this hypothesis, we have characterized asip1 mRNAs in both turbot and sole and used deduced peptide alignments to analyze the evolutionary history of the agouti-family of peptides. The putative asip precursors have the characteristics of a secreted protein, displaying a putative hydrophobic signal. Processing of the potential signal peptide produces mature proteins that include an N-terminal region, a basic central domain with a high proportion of lysine residues as well as a proline-rich region that immediately precedes the C-terminal poly-cysteine domain. The expression of asip1 mRNA in the ventral area was significantly higher than in the dorsal region. Similarly, the expression of asip1 within the unpigmented patches in the dorsal skin of pseudoalbino fish was higher than in the pigmented dorsal regions but similar to those levels observed in the ventral skin. In addition, the injection/electroporation of asip1 capped mRNA in both species induced long term dorsal skin paling, suggesting the inhibition of the melanogenic pathways. The data suggest that fish asip1 is involved in the dorsal-ventral pigment patterning in adult fish, where it induces the regulatory asymmetry involved in precursor differentiation into mature chromatophore. Adult dorsal pseudoalbinism seems to be the consequence of the expression of normal developmental pathways in an inaccurate position that results in unbalanced asip1 production levels. This, in turn, generates a ventral-like differentiation environment in dorsal regions.	[Guillot, Raul; Miguel Cerda-Reverter, Jose] Consejo Super Invest Cient IATS CSIC, Dept Fish Physiol & Biotechnol, Inst Acuicultura Torre Sal, Castellon de La Plana, Spain; [Maria Ceinos, Rosa; Rotllant, Josep] Consejo Super Invest Cient IIM CSIC, Aquat Mol Pathobiol Grp, Inst Invest Marinas, Vigo, Spain; [Cal, Rosa] Inst Espanol Oceanog Vigo IEO, Vigo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Cerda-Reverter, JM (corresponding author), Consejo Super Invest Cient IATS CSIC, Dept Fish Physiol & Biotechnol, Inst Acuicultura Torre Sal, Castellon de La Plana, Spain.	cerdarev@iats.csic.es	Rotllant, Josep/K-1146-2014; Cerda-Reverter, Jose Miguel/K-4934-2014; Ceinos, Rosa RM/F-1683-2016; Cal, Rosa/B-8185-2008; Guillot, Raúl/Z-1884-2019	Rotllant, Josep/0000-0001-5331-807X; Cerda-Reverter, Jose Miguel/0000-0003-1405-5750; Ceinos, Rosa RM/0000-0002-3321-2961; Cal, Rosa/0000-0003-4757-9112; Guillot, Raul/0000-0001-9248-7263	Xunta de Galicia Science Program INCITE [Incite09 402 193]; Science and Innovation Ministry [AGL2010-22247-C03-01, ALG2011-23581]; Generalitat Valenciana [PROMETEO 2010/006]; Consejo Superior de Investigaciones Cientificas (CSIC)	Xunta de Galicia Science Program INCITE(Xunta de Galicia); Science and Innovation Ministry; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Consejo Superior de Investigaciones Cientificas (CSIC)	This research was carried out with the financial support of the Xunta de Galicia Science Program INCITE (Incite09 402 193 PR to JR) and Science and Innovation Ministry (AGL2010-22247-C03-01 to JMC-R and ALG2011-23581 to JR). Additional funding was obtained from the "Generalitat Valenciana" (research grant PROMETEO 2010/006) to JMC-R. RMC was recipient of a JAE-postdoctoral fellowship from Consejo Superior de Investigaciones Cientificas (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdam E, 1998, J BIOL CHEM, V273, P19560, DOI 10.1074/jbc.273.31.19560; BAGNARA JT, 1990, PIGM CELL RES, V3, P243, DOI 10.1111/j.1600-0749.1990.tb00296.x; Bolin KA, 1999, FEBS LETT, V451, P125, DOI 10.1016/S0014-5793(99)00553-0; Bolker JA, 2005, ZOOLOGY, V108, P183, DOI 10.1016/j.zool.2005.05.001; Bolker JA, 2000, J FISH BIOL, V56, P1029, DOI 10.1111/j.1095-8649.2000.tb02121.x; Braasch I, 2011, P NATL ACAD SCI USA, V108, pE47, DOI 10.1073/pnas.1101594108; Budi EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002044; Bures EJ, 1998, BIOCHEMISTRY-US, V37, P12172, DOI 10.1021/bi981082v; Burton D, 2010, REV FISH BIOL FISHER, V20, P31, DOI 10.1007/s11160-009-9119-0; Cerda-Reverter JM, 2003, REGUL PEPTIDES, V115, P101, DOI 10.1016/S0167-0115(03)00144-7; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P2336, DOI 10.1210/en.2002-0213; Cerda-Reverter JM, 2005, ENDOCRINOLOGY, V146, P1597, DOI 10.1210/en.2004-1346; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P4552, DOI 10.1210/en.2003-0453; Creemers JWM, 2006, ENDOCRINOLOGY, V147, P1621, DOI 10.1210/en.2005-1373; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Curran K, 2009, DEV BIOL, V332, P408, DOI 10.1016/j.ydbio.2009.06.010; Fujii Ryozo, 1993, P535; FUKUZAWA T, 1988, DEV BIOL, V129, P25, DOI 10.1016/0012-1606(88)90158-3; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Hamre K, 2007, AQUACULT NUTR, V13, P65, DOI 10.1111/j.1365-2095.2007.00467.x; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; Jackson PJ, 2002, BIOCHEMISTRY-US, V41, P7565, DOI 10.1021/bi012000x; Kelsh RN, 2000, DEV BIOL, V225, P277, DOI 10.1006/dbio.2000.9840; Kurokawa T, 2006, PEPTIDES, V27, P3165, DOI 10.1016/j.peptides.2006.09.013; Le Pape E, 2009, P NATL ACAD SCI USA, V106, P1802, DOI 10.1073/pnas.0806753106; Lister JA, 1999, DEVELOPMENT, V126, P3757; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MANNE J, 1995, P NATL ACAD SCI USA, V92, P4721, DOI 10.1073/pnas.92.11.4721; MATSUMOTO J, 1992, PIGM CELL RES, P275; McNulty JC, 2001, BIOCHEMISTRY-US, V40, P15520, DOI 10.1021/bi0117192; MICHAUD EJ, 1993, GENE DEV, V7, P1203, DOI 10.1101/gad.7.7a.1203; Cerda-Reverter JM, 2011, EUR J PHARMACOL, V660, P53, DOI 10.1016/j.ejphar.2010.10.108; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Miltenberger RJ, 1999, P NATL ACAD SCI USA, V96, P8579, DOI 10.1073/pnas.96.15.8579; Miltenberger RJ, 2002, GENETICS, V160, P659; Ollmann MM, 1999, J BIOL CHEM, V274, P15837, DOI 10.1074/jbc.274.22.15837; Patel MP, 2010, J MOL BIOL, V404, P45, DOI 10.1016/j.jmb.2010.08.054; Perry WL, 1996, GENETICS, V144, P255; Sanchez E, 2010, GEN COMP ENDOCR, V165, P163, DOI 10.1016/j.ygcen.2009.06.008; Sanchez E, 2009, AM J PHYSIOL-REG I, V296, pR1293, DOI 10.1152/ajpregu.90948.2008; Schioth HB, 2011, P NATL ACAD SCI USA, V108, pE49, DOI 10.1073/pnas.1102120108; Sugimoto M, 2002, MICROSC RES TECHNIQ, V58, P496, DOI 10.1002/jemt.10168; Sviderskaya EV, 2001, DEV DYNAM, V221, P373, DOI 10.1002/dvdy.1153; Watanabe K, 2008, DEV GROWTH DIFFER, V50, P731, DOI 10.1111/j.1440-169X.2008.01071.x; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Yamada T, 2010, DEV DYNAM, V239, P3147, DOI 10.1002/dvdy.22440; Zhang C, 2010, P NATL ACAD SCI USA, V107, P20164, DOI 10.1073/pnas.1014941107; Zuasti A, 2002, MICROSC RES TECHNIQ, V58, P488, DOI 10.1002/jemt.10167; ZUASTI A, 1992, PIGM CELL RES, V5, P253, DOI 10.1111/j.1600-0749.1992.tb00545.x	49	32	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e48526	10.1371/journal.pone.0048526	http://dx.doi.org/10.1371/journal.pone.0048526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251332	Green Published, gold			2022-12-27	WOS:000312201900002
J	Pealing, L; Perel, P; Prieto-Merino, D; Roberts, I				Pealing, Louise; Perel, Pablo; Prieto-Merino, David; Roberts, Ian		CRASH-2 Trial Collaborators	Risk Factors for Vascular Occlusive Events and Death Due to Bleeding in Trauma Patients; an Analysis of the CRASH-2 Cohort	PLOS ONE			English	Article							SYSTEMIC INFLAMMATION; MYOCARDIAL-INFARCTION; BRAIN-INJURY; THROMBOSIS; THROMBOEMBOLISM	Background: Vascular occlusive events can complicate recovery following trauma. We examined risk factors for venous and arterial vascular occlusive events in trauma patients and the extent to which the risk of vascular occlusive events varies with the severity of bleeding. Methods and Findings: We conducted a cohort analysis using data from a large international, double-blind, randomised, placebo-controlled trial (The CRASH-2 trial) [1]. We studied the association between patient demographic and physiological parameters at hospital admission and the risk of vascular occlusive events. To assess the extent to which risk of vascular occlusive events varies with severity of bleeding, we constructed a prognostic model for the risk of death due to bleeding and assessed the relationship between risk of death due to bleeding and risk of vascular occlusive events. There were 20,127 trauma patients with outcome data including 204 (1.01%) patients with a venous event (pulmonary embolism or deep vein thrombosis) and 200 (0.99%) with an arterial event (myocardial infarction or stroke). There were 81 deaths due to vascular occlusive events. Increasing age, decreasing systolic blood pressure, increased respiratory rates, longer central capillary refill times, higher heart rates and lower Glasgow Coma Scores (all p<0.02) were strong risk factors for venous and arterial vascular occlusive events. Patients with more severe bleeding as assessed by predicted risk of haemorrhage death had a greatly increased risk for all types of vascular occlusive event (all p<0.001). Conclusions: Patients with severe traumatic bleeding are at greatly increased risk of venous and arterial vascular occlusive events. Older age and blunt trauma are also risk factors for vascular occlusive events. Effective treatment of bleeding may reduce venous and arterial vascular occlusive complications in trauma patients.	[Pealing, Louise; Perel, Pablo; Prieto-Merino, David; Roberts, Ian; CRASH-2 Trial Collaborators] Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Pealing, L (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, Keppel St, London WC1E 7HT, England.	louise.pealing@lshtm.ac.uk		/0000-0002-2342-301X; Prieto-Merino, David/0000-0001-5001-0061	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Department of Health [IPF 11-05, 06/303/20, HTA/06/303/20] Funding Source: Medline; National Institute for Health Research [IPF 11-05, 06/303/20] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Carter Angela M, 2005, Diab Vasc Dis Res, V2, P113, DOI 10.3132/dvdr.2005.018; Chien LC, 2007, J TRAUMA, V62, P928, DOI 10.1097/01.ta.0000215411.92950.72; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Devereaux PJ, 2005, CAN MED ASSOC J, V173, P627, DOI 10.1503/cmaj.050011; Gearhart MM, 2000, SURGERY, V128, P631, DOI 10.1067/msy.2000.108224; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; Hirsh J, 2004, CHEST, V126, p172S, DOI 10.1378/chest.126.3_suppl.172S; Ismailov RM, 2005, INT J CARDIOL, V105, P141, DOI 10.1016/j.ijcard.2004.11.025; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Knudson M Margaret, 2004, Curr Opin Crit Care, V10, P539, DOI 10.1097/01.ccx.0000144941.09650.9f; KNUDSON MM, 1992, J TRAUMA, V32, P2, DOI 10.1097/00005373-199201000-00002; Kortbeek JB, 2008, J TRAUMA, V64, P1638, DOI 10.1097/TA.0b013e3181744b03; Lakatta Edward G, 2002, Heart Fail Rev, V7, P29; Landesberg G, 2009, CIRCULATION, V119, P2936, DOI 10.1161/CIRCULATIONAHA.108.828228; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; Lima A, 2009, CRIT CARE MED, V37, P934, DOI 10.1097/CCM.0b013e31819869db; Lucas AR, 2006, CIRCULATION, V113, P728, DOI 10.1161/CIRCULATIONAHA.105.601492; Mann NC, 2001, J TRAUMA, V50, P1111, DOI 10.1097/00005373-200106000-00022; Martinelli I, 2010, CRIT CARE MED, V38, pS3, DOI 10.1097/CCM.0b013e3181c9cbd9; McCartney JS, 1934, AM J PATHOL, V10, P709; Moosikasuwan JB, 2000, J AM COLL SURGEONS, V190, P665, DOI 10.1016/S1072-7515(00)00263-5; Mulvihill NT, 2002, HEART, V87, P201, DOI 10.1136/heart.87.3.201; Namas R, 2009, ACUTE INFLAMMATORY R; Namas R, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.05.025; NAPOLITANO LM, 1995, J TRAUMA, V39, P651, DOI 10.1097/00005373-199510000-00006; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; OMALLEY KF, 1990, J TRAUMA, V30, P748, DOI 10.1097/00005373-199006000-00018; Park MS, 2009, J TRAUMA, V67, P266, DOI 10.1097/TA.0b013e3181ae6f1c; Piotrowski JJ, 1996, AM J SURG, V172, P210, DOI 10.1016/S0002-9610(96)00154-7; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Selby R, 2009, THROMB RES, V124, P281, DOI 10.1016/j.thromres.2008.10.002; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Syrovets T, 2012, J LEUKOC BIOL; Toker S, 2011, THROMBOSIS, V2011; Tolonen H, 2005, INT J EPIDEMIOL, V34; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; WHELTON PK, 1994, LANCET, V344, P101, DOI 10.1016/S0140-6736(94)91285-8; World Bank, WORLD DEV IND; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	45	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50603	10.1371/journal.pone.0050603	http://dx.doi.org/10.1371/journal.pone.0050603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251374	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000312201900014
J	Chen, ZJ; Gropler, MC; Mitra, MS; Finck, BN				Chen, Zhouji; Gropler, Matthew C.; Mitra, Mayurranjan S.; Finck, Brian N.			Complex Interplay between the Lipin 1 and the Hepatocyte Nuclear Factor 4 alpha (HNF4 alpha) Pathways to Regulate Liver Lipid Metabolism	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; APOLIPOPROTEIN-A-IV; PHOSPHATIDIC-ACID PHOSPHATASE; TRANSCRIPTIONAL REGULATION; SUBCELLULAR-LOCALIZATION; ENERGY-METABOLISM; RESPONSE ELEMENT; SKELETAL-MUSCLE; GENE-EXPRESSION; PROTEIN	Lipin 1 is a bifunctional protein that serves as a metabolic enzyme in the triglyceride synthesis pathway and regulates gene expression through direct protein-protein interactions with DNA-bound transcription factors in liver. Herein, we demonstrate that lipin 1 is a target gene of the hepatocyte nuclear factor 4 alpha (HNF4 alpha), which induces lipin 1 gene expression in cooperation with peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) through a nuclear receptor response element in the first intron of the lipin 1 gene. The results of a series of gain-of-function and loss-of-function studies demonstrate that lipin 1 coactivates HNF4 alpha to activate the expression of a variety of genes encoding enzymes involved in fatty acid catabolism. In contrast, lipin 1 reduces the ability of HNF4 alpha to induce the expression of genes encoding apoproteins A4 and C3. Although the ability of lipin to diminish HNF4 alpha activity on these promoters required a direct physical interaction between the two proteins, lipin 1 did not occupy the promoters of the repressed genes and enhances the intrinsic activity of HNF4 alpha in a promoter-independent context. Thus, the induction of lipin 1 by HNF4 alpha may serve as a mechanism to affect promoter selection to direct HNF4 alpha to promoters of genes encoding fatty acid oxidation enzymes.	[Chen, Zhouji; Gropler, Matthew C.; Mitra, Mayurranjan S.; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Finck, BN (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	bfinck@dom.wustl.edu		Finck, Brian/0000-0001-5411-3674	National Institutes of Health [R01 DK78187]; Digestive Diseases Research Core Center [P30 DK52574]; Nutrition Obesity Research Center (NORC) of Washington University School of Medicine [P30 DK56341]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P30DK052574, R01DK078187, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Core Center; Nutrition Obesity Research Center (NORC) of Washington University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was also supported by the National Institutes of Health grant R01 DK78187 (to BNF) and was also supported, in part, by the Digestive Diseases Research Core Center (P30 DK52574) and the Nutrition Obesity Research Center (NORC) (P30 DK56341) of Washington University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Carrier JC, 2004, J BIOL CHEM, V279, P52052, DOI 10.1074/jbc.M410337200; CARTER ME, 1993, J BIOL CHEM, V268, P13805; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Chen ZJ, 2000, J BIOL CHEM, V275, P32807, DOI 10.1074/jbc.M004913200; Croce MA, 2007, DIABETES, V56, P2395, DOI 10.2337/db07-0480; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Duverger N, 1996, SCIENCE, V273, P966, DOI 10.1126/science.273.5277.966; Ebara T, 1997, J CLIN INVEST, V99, P2672, DOI 10.1172/JCI119456; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Gropler MC, 2009, J BIOL CHEM, V284, P6763, DOI 10.1074/jbc.M807882200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hanniman EA, 2006, J LIPID RES, V47, P2503, DOI 10.1194/jlr.M600303-JLR200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hirano T, 2001, AM J PHYSIOL-ENDOC M, V281, pE665, DOI 10.1152/ajpendo.2001.281.4.E665; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; Koh YK, 2008, J BIOL CHEM, V283, P34896, DOI 10.1074/jbc.M804007200; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; KTISTAKI E, 1994, NUCLEIC ACIDS RES, V22, P4689, DOI 10.1093/nar/22.22.4689; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Lai CQ, 2005, CURR OPIN LIPIDOL, V16, P153, DOI 10.1097/01.mol.0000162320.54795.68; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; LEONE TC, 1995, J BIOL CHEM, V270, P24622; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Mitra MS, 2011, J MOL CELL CARDIOL, V51, P120, DOI 10.1016/j.yjmcc.2011.04.009; Pearen MA, 2008, ENDOCRINOLOGY, V149, P2853, DOI 10.1210/en.2007-1202; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Ponugoti B, 2007, MOL ENDOCRINOL, V21, P2698, DOI 10.1210/me.2007-0196; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Reue K, 2007, FEBS LETT; Rhee J, 2006, J BIOL CHEM, V281, P14683, DOI 10.1074/jbc.M512636200; Ryu D, 2009, CELL METAB, V9, P240, DOI 10.1016/j.cmet.2009.01.007; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sheena V, 2005, J LIPID RES, V46, P328, DOI 10.1194/jlr.M400371-JLR200; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; Yin LY, 2011, ARTERIOSCL THROM VAS, V31, P328, DOI 10.1161/ATVBAHA.110.217828; Zannis VI, 2001, FRONT BIOSCI-LANDMRK, V6, pD456, DOI 10.2741/Zannis; Zhang P, 2008, J LIPID RES	46	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51320	10.1371/journal.pone.0051320	http://dx.doi.org/10.1371/journal.pone.0051320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236470	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100094
J	Nagaki, K; Yamamoto, M; Yamaji, N; Mukai, Y; Murata, M				Nagaki, Kiyotaka; Yamamoto, Maki; Yamaji, Naoki; Mukai, Yasuhiko; Murata, Minoru			Chromosome Dynamics Visualized with an Anti-Centromeric Histone H3 Antibody in Allium	PLOS ONE			English	Article							FUNCTIONAL CENTROMERES; TANDEM REPEATS; DNA-SEQUENCES; RETROTRANSPOSONS; IDENTIFICATION; CENH3; ORGANIZATION; SATELLITES; INTERFACE; PROTEINS	Due to the ease with which chromosomes can be observed, the Allium species, and onion in particular, have been familiar materials employed in cytogenetic experiments in biology. In this study, centromeric histone H3 (CENH3)-coding cDNAs were identified in four Allium species (onion, welsh onion, garlic and garlic chives) and cloned. Anti-CENH3 antibody was then raised against a deduced amino acid sequence of CENH3 of welsh onion. The antibody recognized all CENH3 orthologs of the Allium species tested. Immunostaining with the antibody enabled clear visualization of chromosome behavior during mitosis in the species. Furthermore, three-dimensional (3D) observation of mitotic cell division was achieved by subjecting root sections to immunohistochemical techniques. The 3D dynamics of the cells and position of cell-cycle marker proteins (CENH3 and alpha-tubulin) were clearly revealed by immunohistochemical staining with the antibodies. The immunohistochemical analysis made it possible to establish an overview of the location of dividing cells in the root tissues. This breakthrough in technique, in addition to the two centromeric DNA sequences isolated from welsh onion by chromatin immuno-precipitation using the antibody, should lead to a better understanding of plant cell division. A phylogenetic analysis of Allium CENH3s together with the previously reported plant CENH3s showed two separate clades for monocot species tested. One clade was made from CENH3s of the Allium species with those of Poaceae species, and the other from CENH3s of a holocentric species (Luzula nivea). These data may imply functional differences of CENH3s between holocentric and monocentric species. Centromeric localization of DNA sequences isolated from welsh onion by chromatin immunoprecipitation (ChIP) using the antibody was confirmed by fluorescence in situ hybridization and ChIP-quantitative PCR.	[Nagaki, Kiyotaka; Yamaji, Naoki; Murata, Minoru] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan; [Yamamoto, Maki] Kansai Univ Welf Sci, Dept Rehabil Sci, Kashiwara, Japan; [Mukai, Yasuhiko] Osaka Kyoiku Univ, Div Nat Sci, Kashiwara, Japan	Okayama University; Osaka University of Education	Nagaki, K (corresponding author), Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan.	nagaki@rib.okayama-u.ac.jp	YAMAJI, Naoki/B-2524-2011	YAMAJI, Naoki/0000-0002-7499-3004	Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) as part of the Joint Research Program implemented at the Institute of Plant Science and Resources, Okayama University in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2010, MOL BIOL CELL; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; BARNES SR, 1985, CHROMOSOMA, V92, P185, DOI 10.1007/BF00348692; Do GS, 2001, GENES GENET SYST, V76, P53, DOI 10.1266/ggs.76.53; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Fesenko I. A., 2002, Genetika, V38, P894; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Gong Z, 2012, PLANT CELL; Han YH, 2010, CHROMOSOMA, V119, P89, DOI 10.1007/s00412-009-0239-z; Heckmann S, 2011, CYTOGENET GENOME RES, V134, P220, DOI 10.1159/000327713; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Higaki T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-80; Ho CMK, 2011, PLANT CELL, V23, P2606, DOI 10.1105/tpc.111.086892; Houben A, 2007, CHROMOSOMA, V116, P275, DOI 10.1007/s00412-007-0102-z; Houben A, 2011, CHROMOSOME RES, V19, P471, DOI 10.1007/s10577-011-9207-6; Jin WW, 2004, PLANT CELL, V16, P571, DOI 10.1105/tpc.018937; Kumagai F, 2001, PLANT CELL PHYSIOL, V42, P723, DOI 10.1093/pcp/pce091; Lee HR, 2005, P NATL ACAD SCI USA, V102, P11793, DOI 10.1073/pnas.0503863102; Leme DM, 2009, MUTAT RES-REV MUTAT, V682, P71, DOI 10.1016/j.mrrev.2009.06.002; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Liu Z, 2008, CHROMOSOMA, V117, P445, DOI 10.1007/s00412-008-0161-9; Lodish H., 2007, MOL CELL BIOL; Moraes ICR, 2011, PLANT MOL BIOL, V75, P253, DOI 10.1007/s11103-010-9723-3; MUKAI Y, 1993, GENOME, V36, P489, DOI 10.1139/g93-067; Nagaki K, 2005, PLANT CELL, V17, P1886, DOI 10.1105/tpc.105.032961; Nagaki K, 2005, CHROMOSOME RES, V13, P195, DOI 10.1007/s10577-005-0847-2; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Nagaki K, 2003, GENETICS, V163, P1221; Nagaki K, 2012, PLANT CELL REPORTS; Nagaki K, 2011, CHROMOSOME RES, V19, P591, DOI 10.1007/s10577-011-9219-2; Nagaki K, 2009, CHROMOSOMA, V118, P249, DOI 10.1007/s00412-008-0193-1; Neumann P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002777; Pearce SR, 1996, CHROMOSOME RES, V4, P357, DOI 10.1007/BF02257271; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Pich U, 1996, CHROMOSOME RES, V4, P207, DOI 10.1007/BF02254961; Pich U, 1996, PLANT SYST EVOL, V202, P255, DOI 10.1007/BF00983386; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanei M, 2011, P NATL ACAD SCI USA, V108, pE498, DOI 10.1073/pnas.1103190108; Shang WH, 2010, GENOME RES, V20, P1219, DOI 10.1101/gr.106245.110; Shibata F, 2002, CHROMOSOMA, V111, P184, DOI 10.1007/s00412-002-0197-1; Simon EJ, 2010, CAMPBELL ESSENTIAL B; Sugimoto K, 2008, MUTAT RES-GEN TOX EN, V657, P56, DOI 10.1016/j.mrgentox.2008.08.005; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Tek AL, 2011, CHROMOSOME RES, V19, P969, DOI 10.1007/s10577-011-9247-y; Tek AL, 2010, CHROMOSOME RES, V18, P337, DOI 10.1007/s10577-010-9119-x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang GX, 2011, CHROMOSOMA, V120, P353, DOI 10.1007/s00412-011-0315-z; Yamaji N, 2007, PLANT PHYSIOL, V143, P1306, DOI 10.1104/pp.106.093005; Yoneda A, 2005, PLANT CELL PHYSIOL, V46, P531, DOI 10.1093/pcp/pci055; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106	50	23	25	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51315	10.1371/journal.pone.0051315	http://dx.doi.org/10.1371/journal.pone.0051315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236469	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100093
J	Brunelli, M; Bria, E; Nottegar, A; Cingarlini, S; Simionato, F; Calio, A; Eccher, A; Parolini, C; Iannucci, A; Gilioli, E; Pedron, S; Massari, F; Tortora, G; Borze, I; Knuutila, S; Gobbo, S; Santo, A; Tondulli, L; Calabro, F; Martignoni, G; Chilosi, M				Brunelli, Matteo; Bria, Emilio; Nottegar, Alessia; Cingarlini, Sara; Simionato, Francesca; Calio, Anna; Eccher, Albino; Parolini, Claudia; Iannucci, Antonio; Gilioli, Eliana; Pedron, Serena; Massari, Francesco; Tortora, Giampaolo; Borze, Ioana; Knuutila, Sakari; Gobbo, Stefano; Santo, Antonio; Tondulli, Luca; Calabro, Francesco; Martignoni, Guido; Chilosi, Marco			True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; IN-SITU HYBRIDIZATION; COPY NUMBER; CANCER; SOX2; ADENOCARCINOMA; EGFR; CHEMOTHERAPY; EXPRESSION; SURVIVAL	Squamous lung carcinoma lacks specific "ad hoc" therapies. Amplification of chromosome 3q is the most common genomic aberration and this region harbours genes having role as novel targets for therapeutics. There is no standard definition on how to score and report 3q amplification. False versus true 3q chromosomal amplification in squamous cell lung carcinoma may have tremendous impact on trials involving drugs which target DNA zones mapping on 3q. Forty squamous lung carcinomas were analyzed by FISH to assess chromosome 3q amplification. aCGH was performed as gold-standard to avoid false positive amplifications. Three clustered patterns of fluorescent signals were observed. Eight cases out of 40 (20%) showed >= 8 3q signals. Twenty out of 40 (50%) showed from 3 to 7 signals. The remaining showed two fluorescent signals (30%). When corrected by whole chromosome 3 signals, only cases with >= 8 signals maintained a LSI 3q/CEP3 ratio >2. Only the cases showing 3q amplification by aCGH (+3q25.3-3q27.3) showed >= 8 fluorescent signals at FISH evidencing a 3q/3 ratio >2. The remaining cases showed flat genomic portrait at aCGH on chromosome 3. We concluded that: 1) absolute copy number of 3q chromosomal region may harbour false positive interpretation of 3q amplification in squamous cell carcinoma; 2) a case results truly "amplified for chromosome 3q" when showing >= 8 fluorescent 3q signals; 3) trials involving drugs targeting loci on chromosome 3q in squamous lung carcinoma therapy have to consider false versus true 3q chromosomal amplification. Citation: Brunelli M, Bria E, Nottegar A, Cingarlini S, Simionato F, et al. (2012) True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs. PLoS ONE 7(12): e49689. doi:10.1371/journal.pone.0049689	[Brunelli, Matteo; Nottegar, Alessia; Calio, Anna; Parolini, Claudia; Pedron, Serena; Gobbo, Stefano; Martignoni, Guido; Chilosi, Marco] Univ Verona, Azienda Osped Univ Integrata Verona, Dept Pathol & Diagnost, ISH Mol Lab, I-37100 Verona, Italy; [Eccher, Albino; Gilioli, Eliana] Osped Civile, Azienda Osped Univ Integrata Verona, Pathol Unit, I-37126 Verona, Italy; [Borze, Ioana; Knuutila, Sakari] Univ Helsinki, Haartman Insitute, Helsinki, Finland; [Santo, Antonio; Tondulli, Luca] Osped Civile, Azienda Osped Univ Integrata Verona, Oncol Unit, I-37126 Verona, Italy; [Calabro, Francesco] Osped Civile, Azienda Osped Univ Integrata Verona, Thorac Surg Unit, I-37126 Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Helsinki; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Brunelli, M (corresponding author), Univ Verona, Azienda Osped Univ Integrata Verona, Dept Pathol & Diagnost, ISH Mol Lab, I-37100 Verona, Italy.	matteo.brunelli@univr.it	Nottegar, Alessia/Q-4921-2016; cingarlini, sara/ABB-5280-2020; Massari, Francesco/K-7239-2016; Cingarlini, Sara/AAJ-5263-2021; Tortora, Giampaolo/AAA-1252-2019; Brunelli, Matteo/AAA-7679-2019; Tortora, Giampaolo/HGB-6261-2022; Iannucci, Antonio/AAP-9647-2021; Caliò, Anna/Y-1465-2018; Bria, Emilio/A-8574-2019; CHILOSI, MARCO/ABB-8028-2021; Tondulli, Luca/GNP-5039-2022	Nottegar, Alessia/0000-0003-3325-8705; Massari, Francesco/0000-0001-6476-6871; Cingarlini, Sara/0000-0003-4786-4781; Caliò, Anna/0000-0001-7352-6327; Bria, Emilio/0000-0002-2333-704X; eccher, albino/0000-0002-9992-5550; Tortora, Giampaolo/0000-0002-1378-4962; Gobbo, Stefano/0000-0001-5247-5233; BRUNELLI, Matteo/0000-0002-3832-2676	European Union FP7 Health Research Grant [HEALTH-F4-2008-202047]	European Union FP7 Health Research Grant	This study was supported by the European Union FP7 Health Research Grant number HEALTH-F4-2008-202047. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros IM, 2003, J CLIN ONCOL, V21, P2077, DOI 10.1200/JCO.2003.03.025; Balsara BR, 1997, CANCER RES, V57, P2116; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bjorkqvist AM, 1998, BRIT J CANCER, V77, P260, DOI 10.1038/bjc.1998.42; Bjorkqvist AM, 1998, GENE CHROMOSOME CANC, V22, P79; Brass N, 1996, EUR J CANCER, V32A, P1205, DOI 10.1016/0959-8049(96)00016-0; Bria E, 2011, ANN ONCOL, V22, P2277, DOI 10.1093/annonc/mdq742; Bria E, 2009, LUNG CANCER, V63, P50, DOI 10.1016/j.lungcan.2008.05.002; Brunelli M, 2008, PATHOLOGICA, V100, P454; Brunelli M, 2008, MODERN PATHOL, V21, P1, DOI 10.1038/modpathol.3800967; Cai YR, 2011, ONCOL REP, V26, P877, DOI 10.3892/or.2011.1349; Cappuzzo F, 2007, J THORAC ONCOL, V2, P423, DOI 10.1097/01.JTO.0000268676.79872.9b; Chujo M, 2002, LUNG CANCER-J IASLC, V38, P23, DOI 10.1016/S0169-5002(02)00151-4; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Gnjatic S, 2009, J IMMUNOL METHODS, V341, P50, DOI 10.1016/j.jim.2008.10.016; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Horn L, 2009, J CLIN ONCOL, V27, P4232, DOI 10.1200/JCO.2009.23.6661; Hussenet T, 2010, CELL CYCLE, V9; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Kettunen E, 2000, CANCER GENET CYTOGEN, V117, P66, DOI 10.1016/S0165-4608(99)00146-6; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Maddison P, 2010, LUNG CANCER, V70, P335, DOI 10.1016/j.lungcan.2010.03.002; Massion PP, 2002, CANCER RES, V62, P3636; McCaughan F, 2010, AM J RESP CRIT CARE, V182, P83, DOI 10.1164/rccm.201001-0005OC; Pei JM, 2001, GENE CHROMOSOME CANC, V31, P282, DOI 10.1002/gcc.1145; Pelosi G, 2007, CLIN CANCER RES, V13, P1995, DOI 10.1158/1078-0432.CCR-06-2483; Petersen I, 1997, CANCER RES, V57, P2331; Qian J, 2008, J THORAC ONCOL, V3, P212, DOI 10.1097/JTO.0b013e3181663544; Racz A, 1999, EUR J CANCER, V35, P641, DOI 10.1016/S0959-8049(98)00419-5; Sholl LM, 2010, AM J SURG PATHOL, V34, P1193, DOI 10.1097/PAS.0b013e3181e5e024; Singh B, 2001, CANCER RES, V61, P4506; Titulaer MJ, 2009, J CLIN ONCOL, V27, P4260, DOI 10.1200/JCO.2008.20.6169; Tompkins DH, 2011, AM J RESP CELL MOL B; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Varella-Garcia M, 2009, J CLIN PATHOL, V62, P970, DOI 10.1136/jcp.2009.066548; Wilbertz T, 2011, MODERN PATHOL, V24, P944, DOI 10.1038/modpathol.2011.49; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Yokoi S, 2003, CLIN CANCER RES, V9, P4705; Yuan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009112	41	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e49689	10.1371/journal.pone.0049689	http://dx.doi.org/10.1371/journal.pone.0049689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236352	Green Published, Green Submitted, gold			2022-12-27	WOS:000312589700005
J	Batra, R; Harder, N; Gogolin, S; Diessl, N; Soons, Z; Jager-Schmidt, C; Lawerenz, C; Eils, R; Rohr, K; Westermann, F; Konig, R				Batra, Richa; Harder, Nathalie; Gogolin, Sina; Diessl, Nicolle; Soons, Zita; Jaeger-Schmidt, Christina; Lawerenz, Christian; Eils, Roland; Rohr, Karl; Westermann, Frank; Koenig, Rainer			Time-Lapse Imaging of Neuroblastoma Cells to Determine Cell Fate upon Gene Knockdown	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; DNA-BINDING PROTEIN; STATISTICAL-METHODS; THERAPEUTIC TARGET; SPINDLE DYNAMICS; TUMOR-SUPPRESSOR; C-MYC; RNAI; EXPRESSION; IDENTIFICATION	Neuroblastoma is the most common extra-cranial solid tumor of early childhood. Standard therapies are not effective in case of poor prognosis and chemotherapy resistance. To improve drug therapy, it is imperative to discover new targets that play a substantial role in tumorigenesis of neuroblastoma. The mitotic machinery is an attractive target for therapeutic interventions and inhibitors can be developed to target mitotic entry, spindle apparatus, spindle activation checkpoint, and mitotic exit. We present an elaborate analysis pipeline to determine cancer specific therapeutic targets by first performing a focused gene expression analysis to select genes followed by a gene knockdown screening assay of live cells. We interrogated gene expression studies of neuroblastoma tumors and selected 240 genes relevant for tumorigenesis and cell cycle. With these genes we performed time-lapse screening of gene knockdowns in neuroblastoma cells. We classified cellular phenotypes and used the temporal context of the perturbation effect to determine the sequence of events, particularly the mitotic entry preceding cell death. Based upon this phenotype kinetics from the gene knockdown screening, we inferred dynamic gene functions in mitosis and cell proliferation. We identified six genes (DLGAP5, DSCC1, SMO, SNRPD1, SSBP1, and UBE2C) with a vital role in mitosis and these are promising therapeutic targets for neuroblastoma. Images and movies of every time point of all screened genes are available at https://ichip.bioquant.uni-heidelberg.de.	[Batra, Richa; Harder, Nathalie; Soons, Zita; Eils, Roland; Rohr, Karl; Koenig, Rainer] Heidelberg Univ, Dept Bioinformat & Funct Genom, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Batra, Richa; Harder, Nathalie; Soons, Zita; Jaeger-Schmidt, Christina; Lawerenz, Christian; Eils, Roland; Rohr, Karl; Koenig, Rainer] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [Gogolin, Sina; Westermann, Frank] German Canc Res Ctr, Div Tumor Genet, Heidelberg, Germany; [Diessl, Nicolle] German Canc Res Ctr, Dept Genom, Heidelberg, Germany; [Diessl, Nicolle] German Canc Res Ctr, Prote Core Facil, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Konig, R (corresponding author), Heidelberg Univ, Dept Bioinformat & Funct Genom, Inst Pharm & Mol Biotechnol, Heidelberg, Germany.	r.koenig@dkfz.de	Batra, Richa/ABF-1240-2021; Eils, Roland/B-6121-2009; Westermann, Frank/F-7509-2013	Batra, Richa/0000-0003-3708-0086; Eils, Roland/0000-0002-0034-4036; Harder, Nathalie/0000-0002-6171-6462; Soons, Zita/0000-0002-0767-8856	Nationales Genom-Forschungs-Netz (NGFN) project ENGINE [01GS0898]; Helmholtz Alliance on Systems Biology (SB Cancer) [D.141100/07.997]; BMBF CancerSys-Verbundprojekt: MYCNET [0316076C]; Deutscher Akademischer Auslandsdienst (DAAD)	Nationales Genom-Forschungs-Netz (NGFN) project ENGINE; Helmholtz Alliance on Systems Biology (SB Cancer); BMBF CancerSys-Verbundprojekt: MYCNET; Deutscher Akademischer Auslandsdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	The work was supported by the Nationales Genom-Forschungs-Netz (NGFN, www.ngfn.de) project ENGINE (#01GS0898), the Helmholtz Alliance on Systems Biology (SB Cancer, D.141100/07.997, http://www.dkfz.de/en/sbcancer/index.html), the BMBF (www.bmbf.de) CancerSys-Verbundprojekt: MYCNET (0316076C), and the Deutscher Akademischer Auslandsdienst (DAAD, www.daad.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Baguley BC, 2004, EUR J CANCER, V40, P794, DOI 10.1016/j.ejca.2003.12.019; Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000712; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Cole KA, 2011, P NATL ACAD SCI USA, V108, P3336, DOI 10.1073/pnas.1012351108; Conrad C, 2004, GENOME RES, V14, P1130, DOI 10.1101/gr.2383804; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Deyell RJ, 2011, CANCER GENET-NY, V204, P113, DOI 10.1016/j.cancergen.2011.03.001; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Dickey A, 2011, J NEURO-ONCOL, V104, P145, DOI 10.1007/s11060-010-0491-3; Dimitriadou E, 2011, SUPPORT VECTOR MACHI; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Duan Z, CLIN CANC RES; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; Fuchs F, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.25; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harder N, 2011, P 6 INT WORKSH MICR; Harder N, 2006, LECT NOTES COMPUT SC, V4190, P840; Harder N, 2009, GENOME RES, V19, P2113, DOI 10.1101/gr.092494.109; Harrison Michael R, 2009, Clin Adv Hematol Oncol, V7, P54; Hirotsu M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-5; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; HOTHORN T, 2003, COMPUTATIONAL STAT D; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang L, 2010, J CANCER RES CLIN, V136, P211, DOI 10.1007/s00432-009-0651-z; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Korur S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007443; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Lachmann A, 2009, BIOINFORMATICS, V25, P684, DOI 10.1093/bioinformatics/btp026; Li JJ, 2006, PHARMACOL THERAPEUT, V111, P974, DOI 10.1016/j.pharmthera.2006.02.006; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; Markowetz F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000655; Merkle CJ, 2003, J BIOL CHEM, V278, P30051, DOI 10.1074/jbc.M211591200; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2004, AM J HUM GENET, V75, P727, DOI 10.1086/424530; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Oberthuer A, 2010, PHARMACOGENOMICS J, V10, P258, DOI 10.1038/tpj.2010.53; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Terry Therneau, 2012, PACKAGE SURVIVAL ANA; Tuszynski J, 2012, CATOOLS PACKAGE; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Willingham AT, 2004, ONCOGENE, V23, P8392, DOI 10.1038/sj.onc.1208217; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974; Wu TF, 2004, J MACH LEARN RES, V5, P975; Yamanaka A, 2000, MOL BIOL CELL, V11, P2821, DOI 10.1091/mbc.11.8.2821; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhang JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022176; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	70	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50988	10.1371/journal.pone.0050988	http://dx.doi.org/10.1371/journal.pone.0050988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251412	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200052
J	Li, G; Yang, X; Shu, ZH; Chen, XY; Wang, YQ				Li, Guang; Yang, Xi; Shu, ZongHuang; Chen, XiaoYing; Wang, YiQuan			Consecutive Spawnings of Chinese Amphioxus, Branchiostoma belcheri, in Captivity	PLOS ONE			English	Article							DEVELOPMENTAL BIOLOGY; CHORDATE AMPHIOXUS; XIAMEN WATERS; EVOLUTION; CEPHALOCHORDATA; LANCEOLATUM; VERTEBRATES; LANCELETS; GENOME; MODEL	Cephalochordate amphioxus is a promising model animal for studying the evolutionary and developmental mechanisms of vertebrates because its unique phylogenetic position, simple body plan and sequenced genome. However, one major drawback for using amphioxus as a model organism is the restricted supply of living embryos since they are available only during spawning season that varies from a couple of days to several months according to species. Therefore we are aiming to develop methods for obtaining viable amphioxus embryos in non-spawning season. In the current study, we found that Branchiostoma belcheri could develop their gonads and spawn consecutively in the laboratory when cultured in a low density at a high temperature (25-28 degrees C) supplied with sufficient food and proper cleanness. Among the approximate 150 observed animals, which spawned spontaneously between November and December 2011, 10% have spawned twice, 10% three times, and 80% four times, through April 2012. The quality and quantity of the gametes reproduced in the consecutive spawning have no obvious difference with those spawned once naturally. Spawning intervals varied dramatically both among different animals (from 1 to 5 months) and between intervals of a single individual (from 27 to 74 days for one animal). In summary, we developed a method with which, for the first time, consecutive spawnings of amphioxus in captivity can be achieved. This has practical implications for the cultivation of other amphioxus species, and eventually will greatly promote the utilization of amphioxus as a model system.	[Li, Guang; Yang, Xi; Shu, ZongHuang; Chen, XiaoYing; Wang, YiQuan] Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China; [Li, Guang; Wang, YiQuan] Xiamen Univ, Shenzhen Res Inst, Shenzhen, Peoples R China	Xiamen University; Xiamen University	Wang, YQ (corresponding author), Xiamen Univ, Sch Life Sci, Xiamen, Peoples R China.	wangyq@xmu.edu.cn			National High Technology Research and Development Program of China [2008AA092602]; National Natural Science Foundation of China [30830023, 31101631]; Department of Science and Technology of Shenzhen [JSF201006290026A]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Shenzhen	This work was supported by the National High Technology Research and Development Program of China (2008AA092602), the National Natural Science Foundation of China (30830023 and 31101631) and Social Development and Technological Project by the Department of Science and Technology of Shenzhen (JSF201006290026A). The funders had no role in study design, data collection and manuscript.	Beaster-Jones L, 2012, BRIEF FUNCT GENOMICS, V11, P118, DOI 10.1093/bfgp/els006; Bertrand S, 2011, DEVELOPMENT, V138, P4819, DOI 10.1242/dev.066720; Candiani S, 2012, BRIEF FUNCT GENOMICS, V11, P107, DOI 10.1093/bfgp/els004; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Fuentes M, 2004, J EXP ZOOL PART B, V302B, P384, DOI 10.1002/jez.b.20025; Fuentes M, 2007, J EXP ZOOL PART B, V308B, P484, DOI 10.1002/jez.b.21179; GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0; Holland LZ, 2009, NAT REV NEUROSCI, V10, P736, DOI 10.1038/nrn2703; Holland LZ, 2004, CELL MOL LIFE SCI, V61, P2290, DOI 10.1007/s00018-004-4075-2; Holland ND, 2011, ITAL J ZOOL, V78, P478, DOI 10.1080/11250003.2011.594097; Koop Demian, 2008, Birth Defects Research, V84, P175, DOI 10.1002/bdrc.20128; Ma De-you, 2010, Marine Sciences (Beijing), V34, P6; Orton JH., 1914, J MAR BIOL ASSOC UK, V10, P506, DOI [10.1017/S0025315400008262, DOI 10.1017/S0025315400008262]; Paps J, 2012, BRIEF FUNCT GENOMICS, V11, P177, DOI 10.1093/bfgp/els012; Poss Stuart G., 1996, Israel Journal of Zoology, V42, P13; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Stokes D, 1991, INVERTEBRA BIOL, V115, P349; Theodosiou M, 2011, J EXP ZOOL PART B, V316B, P263, DOI 10.1002/jez.b.21397; Wang Y, 2002, NATURAL SCI J HAINAN, V20, P62; Wang Yi-quan, 2006, Zoological Research, V27, P631; Wang Yi-quan, 2005, Zoological Research, V26, P666; Wu Xian-Han, 1994, Chinese Journal of Oceanology and Limnology, V12, P289; Xu QS, 2005, J EXP ZOOL PART B, V304B, P259, DOI 10.1002/jez.b.21036; Yamaguchi T, 2003, ZOOL SCI, V20, P907, DOI 10.2108/zsj.20.907; Zhang QJ, 2007, J EXP ZOOL PART B, V308B, P464, DOI 10.1002/jez.b.21172; Zhang QJ, 2006, ZOOL SCI, V23, P573, DOI 10.2108/zsj.23.573; Zhang Shicui, 2000, Studia Marina Sinica, V42, P74	28	30	32	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50838	10.1371/journal.pone.0050838	http://dx.doi.org/10.1371/journal.pone.0050838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251392	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200041
J	Ni, PH; Xu, H; Chen, CQ; Wang, JY; Liu, XF; Hu, YQ; Fan, QS; Hou, ZY; Lu, Y				Ni, Peihua; Xu, Hong; Chen, Changqiang; Wang, Jiayi; Liu, Xiangfan; Hu, Yiqun; Fan, Qishi; Hou, Zhaoyuan; Lu, Yang			Serum Starvation Induces DRAM Expression in Liver Cancer Cells via Histone Modifications within Its Promoter Locus	PLOS ONE			English	Article							P53 TARGET GENE; TRANSCRIPTIONAL REPRESSION; H3K4 METHYLATION; AUTOPHAGY; DEATH; ROLES; RNA; ACETYLATION; APOPTOSIS; CHROMATIN	DRAM is a lysosomal membrane protein and is critical for p53-mediated autophagy and apoptosis. DRAM has a potential tumor-suppressive function and is downregulated in many human cancers. However, the regulation of DRAM expression is poorly described so far. Here, we demonstrated that serum deprivation strongly induces DRAM expression in liver cancer cells and a core DNA sequence in the DRAM promoter is essential for its responsiveness to serum deprivation. We further observed that euchromatin markers for active transcriptions represented by diacetyl-H3, tetra-acetyl-H4 and the trimethyl-H3K4 at the core promoter region of DRAM gene are apparently increased in a time-dependent manner upon serum deprivation, and concomitantly the dimethyl-H3K9, a herterochromatin marker associated with silenced genes, was time-dependently decreased. Moreover, the chromatin remodeling factor Brg-1 is enriched at the core promoter region of the DRAM gene and is required for serum deprivation induced DRAM expression. These observations lay the ground for further investigation of the DRAM gene expression.	[Ni, Peihua; Lu, Yang] Shanghai Jiao Tong Univ, Dept Pharm, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Ni, Peihua; Chen, Changqiang; Wang, Jiayi; Liu, Xiangfan; Hu, Yiqun; Fan, Qishi] Shanghai Jiao Tong Univ, Dept Lab Med, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Xu, Hong; Hou, Zhaoyuan] Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hou, ZY (corresponding author), Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med, Shanghai 200030, Peoples R China.	houzy@sjtu.edu.cn; luyangssmu@yahoo.com		Wang, Jiayi/0000-0003-1688-2864	Science and Technology Committee of Shanghai Metropolitan [11ZR1423100]; National Science Foundation of China [30772233, 30873057, 81172028]; Key Basic Project of Shanghai Municipal Science and Technology Commission [08JC1413600]; Shanghai Committee of Science and Technology [11DZ2260200]; 985 Tumor Joint Foundation	Science and Technology Committee of Shanghai Metropolitan; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Basic Project of Shanghai Municipal Science and Technology Commission; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); 985 Tumor Joint Foundation	This work was supported by the Science and Technology Committee of Shanghai Metropolitan (11ZR1423100); the National Science Foundation of China (grant No.: 30772233, 30873057 to Y. Lu, and 81172028 to Z. Hou); Key Basic Project of Shanghai Municipal Science and Technology Commission (No.: 08JC1413600); Shanghai Committee of Science and Technology (11DZ2260200); and 985 Tumor Joint Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chandrasekharan MB, 2010, MOL CELL BIOL, V30, P3216, DOI 10.1128/MCB.01008-09; Crighton D, 2007, CELL DEATH DIFFER, V14, P1071, DOI 10.1038/sj.cdd.4402108; Crighton D, 2004, BBA-REV CANCER, V1705, P3, DOI 10.1016/j.bbcan.2004.09.001; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Felsenfeld G, 2000, BIOPHYS CHEM, V86, P231, DOI 10.1016/S0301-4622(00)00134-4; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Galluzzi L, 2008, BIOCHEM SOC T, V36, P786, DOI 10.1042/BST0360786; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANSEN JC, 1994, P NATL ACAD SCI USA, V91, P2339, DOI 10.1073/pnas.91.6.2339; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Kerley-Hamilton JS, 2007, BBA-GENE STRUCT EXPR, V1769, P209, DOI 10.1016/j.bbaexp.2007.02.002; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Malvaez M, 2011, J NEUROSCI, V31, P16941, DOI 10.1523/JNEUROSCI.2747-11.2011; Muchardt C, 1999, SEMIN CELL DEV BIOL, V10, P189, DOI 10.1006/scdb.1999.0300; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Myer VE, 1998, J BIOL CHEM, V273, P27757, DOI 10.1074/jbc.273.43.27757; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Ryan KM, 2011, EUR J CANCER, V47, P44, DOI 10.1016/j.ejca.2010.10.020; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Spencer VA, 1999, GENE, V240, P1, DOI 10.1016/S0378-1119(99)00405-9; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; Wang JY, 2011, NUCLEIC ACIDS RES, V39, P6440, DOI 10.1093/nar/gkr302; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285	32	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50502	10.1371/journal.pone.0050502	http://dx.doi.org/10.1371/journal.pone.0050502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251372	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200030
J	Tilleman, L; De Henau, S; Pauwels, M; Nagy, N; Pintelon, I; Braeckman, BP; De Wael, K; Van Doorslaer, S; Adriaensen, D; Timmermans, JP; Moens, L; Dewilde, S				Tilleman, Lesley; De Henau, Sasha; Pauwels, Martje; Nagy, Nora; Pintelon, Isabel; Braeckman, Bart P.; De Wael, Karolien; Van Doorslaer, Sabine; Adriaensen, Dirk; Timmermans, Jean-Pierre; Moens, Luc; Dewilde, Sylvia			An N-Myristoylated Globin with a Redox-Sensing Function That Regulates the Defecation Cycle in Caenorhabditis elegans	PLOS ONE			English	Article							PROTEIN SUBCELLULAR LOCATION; NH2-TERMINAL BLOCKING GROUP; ELECTRON-PARAMAGNETIC-RES; CYTOCHROME-C PEROXIDASE; HEME-POCKET STRUCTURE; HYDROGEN-PEROXIDE; ACID-COMPOSITION; LIGAND-BINDING; GENE FAMILY; ION-CHANNEL	Globins occur in all kingdoms of life where they fulfill a wide variety of functions. In the past they used to be primarily characterized as oxygen transport/storage proteins, but since the discovery of new members of the globin family like neuroglobin and cytoglobin, more diverse and complex functions have been assigned to this heterogeneous family. Here we propose a function for a membrane-bound globin of C. elegans, GLB-26. This globin was predicted to be myristoylated at its N-terminus, a post-translational modification only recently described in the globin family. In vivo, this globin is found in the membrane of the head mesodermal cell and in the tail stomato-intestinal and anal depressor muscle cells. Since GLB-26 is almost directly oxidized when exposed to oxygen, we postulate a possible function as electron transfer protein. Phenotypical studies show that GLB-26 takes part in regulating the length of the defecation cycle in C. elegans under oxidative stress conditions.	[Tilleman, Lesley; Moens, Luc; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [De Henau, Sasha; Braeckman, Bart P.] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [Pauwels, Martje; De Wael, Karolien] Univ Antwerp, Dept Chem, B-2020 Antwerp, Belgium; [Nagy, Nora; Van Doorslaer, Sabine] Univ Antwerp, Dept Phys, B-2020 Antwerp, Belgium; [Nagy, Nora] Hungarian Acad Sci, Inst Struct Chem, Chem Res Ctr, Budapest, Hungary; [Pintelon, Isabel; Adriaensen, Dirk; Timmermans, Jean-Pierre] Univ Antwerp, Dept Vet Sci, B-2020 Antwerp, Belgium	University of Antwerp; Ghent University; University of Antwerp; University of Antwerp; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Antwerp	Dewilde, S (corresponding author), Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium.	sylvia.dewilde@ua.ac.be	De Wael, Karolien/U-5545-2018; Van Doorslaer, Sabine/E-5050-2017	Van Doorslaer, Sabine/0000-0002-1685-9202; De Wael, Karolien/0000-0003-4495-0748; May, Nora V./0000-0003-4770-4681; Timmermans, Jean-Pierre/0000-0003-2506-6252	University of Antwerp; FWO project [G.0247.09]; Hercules Foundation [Hercules Type 1: AUHA 09/001]	University of Antwerp; FWO project(FWO); Hercules Foundation	SDH is a Ph.D. fellow of the Fund for Scientific Research (FWO). Financial support to SD and LM was provided by the University of Antwerp (BOF UA TOP 2006) and to SD, LM, BPB, by FWO project G.0247.09. The UltraVIEW VoX spinning disk confocal microscope was purchased with support of the Hercules Foundation (Hercules Type 1: AUHA 09/001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN A, 1982, FEBS LETT, V150, P314, DOI 10.1016/0014-5793(82)80759-X; ANDERSSON KK, 1986, J BIOL CHEM, V261, P1126; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Blank M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025292; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Branicky R, 2005, DEVELOPMENT, V132, P4999, DOI 10.1242/dev.02069; CARR SA, 1982, P NATL ACAD SCI-BIOL, V79, P6128, DOI 10.1073/pnas.79.20.6128; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; CROLL NA, 1978, J ZOOL, V184, P507; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; De Wael K, 2012, BIOELECTROCHEMISTRY, V83, P15, DOI 10.1016/j.bioelechem.2011.07.001; De Wael K, 2011, INT J ELECTROCHEM SC, V6, P1810; De Wael K, 2010, TALANTA, V82, P1980, DOI 10.1016/j.talanta.2010.08.019; Desmet F, 2010, J INORG BIOCHEM, V104, P1022, DOI 10.1016/j.jinorgbio.2010.05.009; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dhakal BK, 2006, BIOCH BIOPHYSICAL RE; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Ertas B, 2011, J BIOL CHEM, V286, P3185, DOI 10.1074/jbc.M110.160341; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Geuens E, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-17; GILMOUR R, 1993, BIOCHEM J, V294, P745, DOI 10.1042/bj2940745; Hayashi N, 2010, P JPN ACAD B-PHYS, V86, P494, DOI 10.2183/pjab.86.494; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; HOFER P, 1986, CHEM PHYS LETT, V132, P279, DOI 10.1016/0009-2614(86)80124-5; Hoffmann FG, 2012, MOL BIOL EVOL; Hoogewijs D, 2004, IUBMB LIFE, V56, P697, DOI 10.1080/15216540500037562; Hoogewijs D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-279; Hoogewijs D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-356; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; Ioanitescu AI, 2007, MOL PHYS, V105, P2073, DOI 10.1080/00268970701616030; Ioanitescu AI, 2009, METALLOMICS, V1, P256, DOI 10.1039/b902059b; Iruthayanathan M, 2011, STEROIDS, V76, P1483, DOI 10.1016/j.steroids.2011.08.002; Kakar S, 2010, BIOPHYS CHEM, V152, P1, DOI 10.1016/j.bpc.2010.08.008; Kiger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020478; Kniazeva M, 2003, GENETICS, V163, P159; Kobayashi Y, 2011, GENES CELLS, V16, P565, DOI 10.1111/j.1365-2443.2011.01508.x; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee MS, 2007, MOL CELLS, V23, P1; Lei ZD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-291; Lei ZD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-491; LEIGH JS, 1975, BIOCHIM BIOPHYS ACTA, V387, P95, DOI 10.1016/0005-2728(75)90054-7; LIU DWC, 1994, J NEUROSCI, V14, P1953; MALKIN R, 1980, FEBS LETT, V111, P228, DOI 10.1016/0014-5793(80)80799-X; Martin DDO, 2008, FASEB J, V22, P797, DOI 10.1096/fj.07-9198com; Moran JM, 2010, J BIOCHEM MOL TOXIC, V24, P402, DOI 10.1002/jbt.20348; Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7; ORMEJOHNSON NR, 1974, J BIOL CHEM, V249, P1928; Park BJ, 2001, MOL BIOL CELL, V12, P2835, DOI 10.1091/mbc.12.9.2835; Park J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023211; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Pellegriti K, 2011, INCREASED SUSCEPTIBI; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Rae R, 2012, INT J PARASITOL, V42, P747, DOI 10.1016/j.ijpara.2012.05.005; Ramandeep, 2001, J BIOL CHEM, V276, P24781, DOI 10.1074/jbc.M009808200; RANDLES JEB, 1948, T FARADAY SOC, V44, P327, DOI 10.1039/tf9484400327; Rice ME, 2011, NEUROSCIENTIST, V17, P389, DOI 10.1177/1073858411404531; Sakurai N, 2006, J BIOL CHEM, V281, P14288, DOI 10.1074/jbc.M510338200; SALERNO JC, 1984, J BIOL CHEM, V259, P2331; Sevik A, 1948, COLLECT CZECH CHEM C, V13, P349, DOI [10.1135/cccc19480349, DOI 10.1135/CCCC19480349]; Shen HB, 2006, BIOINFORMATICS, V22, P1717, DOI 10.1093/bioinformatics/btl170; Shibata Y, 2003, SCIENCE, V302, P1779, DOI 10.1126/science.1087167; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Take-uchi M, 1998, P NATL ACAD SCI USA, V95, P11775, DOI 10.1073/pnas.95.20.11775; Take-uchi M, 2005, MOL BIOL CELL, V16, P1355, DOI 10.1091/mbc.E04-04-0273; THOMAS JH, 1990, GENETICS, V124, P855; Tilleman L, 2011, IUBMB LIFE, V63, P166, DOI 10.1002/iub.443; TOWLER DA, 1987, J BIOL CHEM, V262, P1030; Utsumi T, 2003, FEBS LETT, V539, P37, DOI 10.1016/S0014-5793(03)00180-7; Vilas GL, 2006, P NATL ACAD SCI USA, V103, P6542, DOI 10.1073/pnas.0600824103; Vinck E, 2006, J BIOL INORG CHEM, V11, P467, DOI 10.1007/s00775-006-0100-2; Vinck E, 2004, J AM CHEM SOC, V126, P4516, DOI 10.1021/ja0383322; Walker DS, 2004, MOL BIOL CELL, V15, P3073, DOI 10.1091/mbc.E04-01-0039; WALKER FA, 1986, J AM CHEM SOC, V108, P5288, DOI 10.1021/ja00277a038; Walker FA, 1999, COORDIN CHEM REV, V185-6, P471, DOI 10.1016/S0010-8545(99)00029-6; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Yap MC, 2010, J LIPID RES, V51, P1566, DOI 10.1194/jlr.D002790; Yatsunyk LA, 2006, INORG CHEM, V45, P5417, DOI 10.1021/ic060283h; Yoon J, 2010, BIOCHEMISTRY-US, V49, P5662, DOI 10.1021/bi100710a; Yoshida M, 1999, PLANT CELL PHYSIOL, V40, P192, DOI 10.1093/oxfordjournals.pcp.a029527; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zoppellaro G, 2009, BIOPOLYMERS, V91, P1064, DOI 10.1002/bip.21267	95	7	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48768	10.1371/journal.pone.0048768	http://dx.doi.org/10.1371/journal.pone.0048768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251335	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200008
J	Agardh, A; Tumwine, G; Asamoah, BO; Cantor-Graae, E				Agardh, Anette; Tumwine, Gilbert; Asamoah, Benedict O.; Cantor-Graae, Elizabeth			The Invisible Suffering: Sexual Coercion, Interpersonal Violence, and Mental Health - A Cross-Sectional Study among University Students in South-Western Uganda	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; WOMEN; ABUSE; GENDER; EXPERIENCES; ASSAULT; VICTIMIZATION; PREVALENCE; SYMPTOMS; BEHAVIOR	Background: Despite a history of conflicts and widespread human rights violation in sub-Saharan Africa, little is known about the prevalence of interpersonal violence among the population in this region. Evidence from high-income countries suggests that exposure to violence has mental health consequences and violence also has associations with experiences of sexual coercion. Aims: This study sought to investigate the prevalence of physical and perceived threats of violence among university students in Uganda and to assess the possible relationship between such violence, sexual coercion, and symptoms of anxiety, depression, and psychoticism, respectively. Method: In 2005, 980 Ugandan university students responded to a self-administered questionnaire (response rate 80%) that assessed socio-demographic factors, social capital, importance of religion, mental health, experience of violence and sexual coercion, and sexual behaviour factors. Logistic regression analysis was applied as the main analytical tool. Results: Of those who responded, 28% reported perceived threats/threats of violence and 10% exposure to actual physical violence over the previous 12 months, with no significant gender differences in exposure history. Exposure to violence was significantly associated with the experience of sexual coercion among both males and females. Sexual coercion and threats/threats of violence were both significantly associated with poor mental health in males and females, but only males showed a strong association between exposure to physical violence and poor mental health. Conclusion: The current study suggests that in terms of general exposure, both males and females in the study population are equally exposed to sexual coercion and interpersonal violence, and both male and female students show generally similar mental health effects of exposure to such violence. The prevalence of interpersonal violence found in our study population may have long-term negative health implications. Our findings may serve as a baseline for interventions and continuing research aimed at preventing interpersonal violence.	[Agardh, Anette; Asamoah, Benedict O.; Cantor-Graae, Elizabeth] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden; [Agardh, Anette] Univ Melbourne, Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Royal Childrens Hosp,Dept Paediat, Melbourne, Vic 3010, Australia; [Tumwine, Gilbert] St Francis Hosp, Dept Obstet & Gynaecol, Nsambya, Uganda	Lund University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Agardh, A (corresponding author), Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden.	anette.agardh@med.lu.se			Swedish International Development Cooperation Agency (SIDA) [SWE-2004-200A]	Swedish International Development Cooperation Agency (SIDA)	This study was supported by grants from the Swedish International Development Cooperation Agency (SIDA), project grant number SWE-2004-200A (www.sida.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acierno R, 1997, BEHAV MED, V23, P53, DOI 10.1080/08964289709596729; Agardh A, 2012, INT J BEHAV MED, V19, P208, DOI 10.1007/s12529-011-9159-4; Agardh A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-527; Ali TS, 2011, INT J BEHAV MED; Amar AF, 2005, NURS RES, V54, P235; Baker CK, 2005, SOC PSYCH PSYCH EPID, V40, P519, DOI 10.1007/s00127-005-0921-2; Baum K., 2005, BUREAU JUSTICE STAT; Bjorklund K, 2010, SOC SCI MED, V70, P1416, DOI 10.1016/j.socscimed.2009.12.015; Borowsky IW, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.6.e7; Breslau N, 1999, PSYCHOL MED, V29, P813, DOI 10.1017/S0033291799008612; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P1044; Campbell JC, 1997, PSYCHIAT CLIN N AM, V20, P353, DOI 10.1016/S0193-953X(05)70317-8; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; De Visser RO, 2007, ARCH SEX BEHAV, V36, P676, DOI 10.1007/s10508-006-9129-0; Derogatis LR, 1978, PSYCHOPHARMACOLOGY B, V9, P13; Doroszewicz K, 2008, J INTERPERS VIOLENCE, V23, P58, DOI 10.1177/0886260507307651; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fernbrant C, 2011, WOMEN HEALTH ISS, V21, P206, DOI 10.1016/j.whi.2010.12.001; Fisher B.S., 2002, CRIMINOLOGY PUBLIC P, V1, P257, DOI DOI 10.1111/J.1745-9133.2002.TB00091.X; Griffin MJ, 2012, J INTERPERSONAL VIOL; Hayer Manvir Kaur, 2010, J Health Organ Manag, V24, P498; Hines DA, 2007, ARCH SEX BEHAV, V36, P403, DOI 10.1007/s10508-006-9141-4; Humphrey JA, 2000, J ADOLESCENT HEALTH, V27, P419, DOI 10.1016/S1054-139X(00)00168-3; Jackson SM, 2000, J FAM VIOLENCE, V15, P23, DOI 10.1023/A:1007545302987; Kaaya SF, 2002, ACTA PSYCHIAT SCAND, V106, P9, DOI 10.1034/j.1600-0447.2002.01205.x; Karamagi CAS, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-284; Kilpatrick DG, 1997, J CONSULT CLIN PSYCH, V65, P834, DOI 10.1037/0022-006X.65.5.834; Lehrer JA, 2012, ARCH SEXUAL BEHAV; Lindhorst T, 2011, VIOLENCE AGAINST WOM, V17, P480, DOI 10.1177/1077801211404548; Lodico MA, 1996, J ADOLESCENT HEALTH, V18, P211, DOI 10.1016/1054-139X(95)00167-Q; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Lundberg P, 2009, BRIT J PSYCHIAT, V195, P156, DOI 10.1192/bjp.bp.108.051953; Messman-Moore TL, 2010, CHILD ABUSE NEGLECT, V34, P967, DOI 10.1016/j.chiabu.2010.06.004; Miller AK, 2011, PSYCHOL WOMEN QUART, V35, P119, DOI 10.1177/0361684310384104; Mohammadkhani P, 2009, J SEX MED, V6, P2215, DOI 10.1111/j.1743-6109.2009.01338.x; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Moore Ann M, 2007, Afr J Reprod Health, V11, P62, DOI 10.2307/25549732; Pikarinen U, 2007, OBSTET GYNECOL, V109, P1116, DOI 10.1097/01.AOG.0000259906.16474.86; Pimlott-Kubiak S, 2003, J CONSULT CLIN PSYCH, V71, P528, DOI 10.1037/0022-006X.71.3.528; Prospero M, 2010, AM J MENS HEALTH, V4, P98, DOI 10.1177/1557988308330106; Randall M, 1995, Violence Against Women, V1, P6, DOI 10.1177/1077801295001001002; Romito P, 2007, SOC SCI MED, V65, P1222, DOI 10.1016/j.socscimed.2007.05.017; Russell BL, 2002, J INTERPERS VIOLENCE, V17, P273, DOI 10.1177/0886260502017003003; Ryan G, 1996, J AM ACAD CHILD PSY, V35, P17, DOI 10.1097/00004583-199601000-00008; Seto MC, 2010, CHILD MALTREATMENT, V15, P219, DOI 10.1177/1077559510367937; Silverman AB, 1996, CHILD ABUSE NEGLECT, V20, P709, DOI 10.1016/0145-2134(96)00059-2; Siren R, 2007, SUOMALAISTEN KOKEMAV; Straus MA, 2004, VIOLENCE AGAINST WOM, V10, P790, DOI 10.1177/1077801204265552; Thompson MP, 2004, AM J PUBLIC HEALTH, V94, P599, DOI 10.2105/AJPH.94.4.599; Uganda Bureau of Statistics, 2006, 2002 UG POP HOUS CEN; Varma D, 2007, J AFFECT DISORDERS, V102, P227, DOI 10.1016/j.jad.2006.09.026; Wagman J, 2009, J INTERPERS VIOLENCE, V24, P2073, DOI 10.1177/0886260508327707; WATKINS B, 1992, J CHILD PSYCHOL PSYC, V33, P197, DOI 10.1111/j.1469-7610.1992.tb00862.x; World Health Organization, 2002, WORLD REPORT VIOLENC; Zablotska IB, 2009, AIDS BEHAV, V13, P225, DOI 10.1007/s10461-007-9333-5	56	18	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51424	10.1371/journal.pone.0051424	http://dx.doi.org/10.1371/journal.pone.0051424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053RN	23240021	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800057
J	Bae, C; Kalia, J; Song, I; Yu, J; Kim, HH; Swartz, KJ; Kim, JI				Bae, Chanhyung; Kalia, Jeet; Song, Inhye; Yu, JeongHeon; Kim, Ha Hyung; Swartz, Kenton J.; Kim, Jae Il			High Yield Production and Refolding of the Double-Knot Toxin, an Activator of TRPV1 Channels	PLOS ONE			English	Article							FUNNEL-WEB SPIDER; 3-DIMENSIONAL SOLUTION STRUCTURE; CONOTOXIN MVIIA; VENOM; INHIBITOR; PEPTIDES; EXPRESSION; COMPOUND; TYR(13); BLOCKER	A unique peptide toxin, named double-knot toxin (DkTx), was recently purified from the venom of the tarantula Ornithoctonus huwena and was found to stably activate TRPV1 channels by targeting the outer pore domain. DkTx has been shown to consist of two inhibitory cysteine-knot (ICK) motifs, referred to as K1 and K2, each containing six cysteine residues. Beyond this initial characterization, however, the structural and functional details about DkTx remains elusive in large part due to the lack of a high yielding methodology for the synthesis and folding of this cysteine-rich peptide. Here, we overcome this obstacle by generating pure DkTx in quantities sufficient for structural and functional analyses. Our methodology entails expression of DkTx in E. coli followed by oxidative folding of the isolated linear peptide. Upon screening of various oxidative conditions for optimizing the folding yield of the toxin, we observed that detergents were required for efficient folding of the linear peptide. Our synthetic DkTx co-eluted with the native toxin on HPLC, and irreversibly activated TRPV1 in a manner identical to native DkTx. Interestingly, we find that DkTx has two interconvertible conformations present in a 1: 6 ratio at equilibrium. Kinetic analysis of DkTx folding suggests that the K1 and K2 domains influence each other during the folding process. Moreover, the CD spectra of the toxins shows that the secondary structures of K1 and K2 remains intact even after separating the two knots. These findings provide a starting point for detailed studies on the structural and functional characterization of DkTx and utilization of this toxin as a tool to explore the elusive mechanisms underlying the polymodal gating of TRPV1. Citation: Bae C, Kalia J, Song I, Yu J, Kim HH, et al. (2012) High Yield Production and Refolding of the Double-Knot Toxin, an Activator of TRPV1 Channels. PLoS ONE 7(12): e51516. doi:10.1371/journal.pone.0051516	[Bae, Chanhyung; Song, Inhye; Yu, JeongHeon; Kim, Jae Il] Gwangju Inst Sci & Technol GIST, Sch Life Sci, Kwangju, South Korea; [Kalia, Jeet; Swartz, Kenton J.] NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; [Kim, Ha Hyung] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Gwangju Institute of Science & Technology (GIST); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Chung Ang University	Kim, JI (corresponding author), Gwangju Inst Sci & Technol GIST, Sch Life Sci, Kwangju, South Korea.	jikim@gist.ac.kr		Bae, Chanhyung/0000-0003-3407-2857	Next-Generation BioGreen 21 Program [PJ008158]; Rural Development Administration, Republic of Korea; National Research Foundation of Korea grant; Korean Government (MEST) [NRF-C1ABA001-2011-0018559]; Brain Research Center of the 21st Century Frontier Research Program [M103KV010005-06K2201-00610]; BioImaging Research Center at the Gwangju Institute of Science and Technology; Basic Research Projects in High-tech Industrial Technology; Gwangju Institute of Science and Technology; Intramural Research Program of the NINDS, NIH; NINDS competitive fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002945] Funding Source: NIH RePORTER	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea grant(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); BioImaging Research Center at the Gwangju Institute of Science and Technology; Basic Research Projects in High-tech Industrial Technology; Gwangju Institute of Science and Technology; Intramural Research Program of the NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS competitive fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the Next-Generation BioGreen 21 Program (PJ008158); the Rural Development Administration, Republic of Korea; a National Research Foundation of Korea grant funded by the Korean Government (MEST) (NRF-C1ABA001-2011-0018559); the Brain Research Center of the 21st Century Frontier Research Program (M103KV010005-06K2201-00610); the BioImaging Research Center at the Gwangju Institute of Science and Technology and Basic Research Projects in High-tech Industrial Technology funded by the Gwangju Institute of Science and Technology in 2011; the Intramural Research Program of the NINDS, NIH, and by an NINDS competitive fellowship to Jeet Kalia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ME, 1989, J COMP PHYSIOL A, V164, P333, DOI 10.1007/BF00612993; Adams ME, 2004, TOXICON, V43, P509, DOI 10.1016/j.toxicon.2004.02.004; Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Bornstein P, 1977, Methods Enzymol, V47, P132; Bulaj G, 2008, ANTIOXID REDOX SIGN, V10, P141, DOI 10.1089/ars.2007.1856; Corzo G, 2002, J BIOL CHEM, V277, P23627, DOI 10.1074/jbc.M200511200; DeLa Cruz R, 2003, J PEPT RES, V61, P202, DOI 10.1034/j.1399-3011.2003.t01-1-00048.x; Escoubas P, 2000, BIOCHIMIE, V82, P893, DOI 10.1016/S0300-9084(00)01166-4; Fletcher JI, 1997, NAT STRUCT BIOL, V4, P559, DOI 10.1038/nsb0797-559; Gomes PC, 2011, TOXICON, V57, P266, DOI 10.1016/j.toxicon.2010.11.021; HONG SJ, 1995, J PHYSIOL-LONDON, V482, P283, DOI 10.1113/jphysiol.1995.sp020517; Isbister GK, 2011, LANCET, V378, P2039, DOI 10.1016/S0140-6736(10)62230-1; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; KIM JI, 1994, J BIOL CHEM, V269, P23876; KIM JI, 1995, BIOCHEM BIOPH RES CO, V206, P449, DOI 10.1006/bbrc.1995.1063; KIM JI, 1995, J MOL BIOL, V250, P659, DOI 10.1006/jmbi.1995.0406; Kitaguchi T, 2005, BIOCHEMISTRY-US, V44, P15544, DOI 10.1021/bi051494l; Kobayashi K, 2000, BIOCHEMISTRY-US, V39, P14761, DOI 10.1021/bi001506x; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; NICHOLSON GM, 1994, PFLUG ARCH EUR J PHY, V428, P400, DOI 10.1007/BF00724524; Pi CH, 2007, J BIOTECHNOL, V128, P184, DOI 10.1016/j.jbiotec.2006.09.014; Raussens V, 2003, ANAL BIOCHEM, V319, P114, DOI 10.1016/S0003-2697(03)00285-9; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; Sasaki T, 1999, BIOCHEMISTRY-US, V38, P12876, DOI 10.1021/bi990731f; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Steiner AM, 2011, J PEPT SCI, V17, P1, DOI 10.1002/psc.1283; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Wang JM, 2004, J GEN PHYSIOL, V123, P455, DOI 10.1085/jgp.200309005; Zhan JB, 2003, BIOCHEM BIOPH RES CO, V311, P495, DOI 10.1016/j.bbrc.2003.09.234; Zhang H, 2005, PROTEIN EXPRES PURIF, V41, P409, DOI 10.1016/j.pep.2005.03.003	34	22	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51516	10.1371/journal.pone.0051516	http://dx.doi.org/10.1371/journal.pone.0051516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240036	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800072
J	Casanova, V; Naval-Macabuhay, I; Massanella, M; Rodriguez-Garcia, M; Blanco, J; Gatell, JM; Garcia, F; Gallart, T; Lluis, C; Mallol, J; Franco, R; Climent, N; McCormick, PJ				Casanova, Victor; Naval-Macabuhay, Isaac; Massanella, Marta; Rodriguez-Garcia, Marta; Blanco, Julia; Gatell, Jose M.; Garcia, Felipe; Gallart, Teresa; Lluis, Carme; Mallol, Josefa; Franco, Rafael; Climent, Nuria; McCormick, Peter J.			Adenosine Deaminase Enhances the Immunogenicity of Human Dendritic Cells from Healthy and HIV-Infected Individuals	PLOS ONE			English	Article							REGULATORY T-CELLS; CHEMOKINE RECEPTORS; SURFACE EXPRESSION; PEPTIDASE-IV; CD26; ACTIVATION; CYTOKINE; IMMUNITY; BINDING; PROTEIN	ADA is an enzyme implicated in purine metabolism, and is critical to ensure normal immune function. Its congenital deficit leads to severe combined immunodeficiency (SCID). ADA binding to adenosine receptors on dendritic cell surface enables T-cell costimulation through CD26 crosslinking, which enhances T-cell activation and proliferation. Despite a large body of work on the actions of the ecto-enzyme ADA on T-cell activation, questions arise on whether ADA can also modulate dendritic cell maturation. To this end we investigated the effects of ADA on human monocyte derived dendritic cell biology. Our results show that both the enzymatic and non-enzymatic activities of ADA are implicated in the enhancement of CD80, CD83, CD86, CD40 and CCR7 expression on immature dendritic cells from healthy and HIV-infected individuals. These ADA-mediated increases in CD83 and costimulatory molecule expression is concomitant to an enhanced IL-12, IL-6, TNF-alpha, CXCL8(IL-8), CCL3(MIP1-alpha), CCL4(MIP-1 beta) and CCL5(RANTES) cytokine/chemokine secretion both in healthy and HIV-infected individuals and to an altered apoptotic death in cells from HIV-infected individuals. Consistently, ADA-mediated actions on iDCs are able to enhance allogeneic CD4 and CD8-T-cell proliferation, globally yielding increased iDC immunogenicity. Taken together, these findings suggest that ADA would promote enhanced and correctly polarized T-cell responses in strategies targeting asymptomatic HIV-infected individuals.	[Casanova, Victor; Naval-Macabuhay, Isaac; Lluis, Carme; Mallol, Josefa; Franco, Rafael; McCormick, Peter J.] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona, Spain; [Massanella, Marta; Blanco, Julia] Fundacio IrsiCaixa HIVACAT, Inst Invest Ciencies Salut Germans Trias & Pujol, Badalona, Spain; [Rodriguez-Garcia, Marta] Dartmouth Med Sch Lebanon, Dept Physiol & Neurobiol, Lebanon, NH USA; [Gatell, Jose M.; Garcia, Felipe; Gallart, Teresa; Climent, Nuria] Inst Invest Biomed August Pi & Sunyer IDIBAPS, AIDS Res Grp, Barcelona, Spain; [Gatell, Jose M.; Garcia, Felipe; Gallart, Teresa; Climent, Nuria] Catalonian Ctr HIV Vaccines HIVACAT, Barcelona, Spain; [Garcia, Felipe] Hosp Clin Barcelona, Infect Dis & AIDS Unit, Barcelona, Spain; [Gallart, Teresa] Hosp Clin Barcelona, Serv Immunol, Barcelona, Spain	University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Institut de Recerca de la Sida - IrsiCaixa; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	McCormick, PJ (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona, Spain.	pmccormick@ub.edu	Mallol, Josefa/I-4194-2015; , Felipe/F-4242-2014; Blanco, Julià/A-5347-2008; Massanella, Marta/P-8619-2016; Franco, Rafael/C-3694-2015; Gatell, Jose M/ABC-3607-2020; Climent, Núria/AAF-8161-2021; McCormick, Peter/E-7387-2012	Mallol, Josefa/0000-0002-2479-4162; , Felipe/0000-0001-7658-5832; Blanco, Julià/0000-0002-2225-0217; Massanella, Marta/0000-0002-3326-151X; Franco, Rafael/0000-0003-2549-4919; Climent, Núria/0000-0002-0791-656X; Casanova, Victor/0000-0002-4917-260X; McCormick, Peter/0000-0002-2225-5181	FIPSE (Spanish Ministry of Health) [36750/08]; FIPSE (Abbott Laboratories) [36750/08]; FIPSE (Boehringer Ingelheim) [36750/08]; FIPSE (Bristol Myers Squibb) [36750/08]; FIPSE (GlaxoSmithKline) [36750/08]; FIPSE (Merck Sharp and Dohme) [36750/08]; FIPSE (Roche) [36750/08]; FIS (Fondo de Investigacion Sanitaria) [PS09/01297, PI10/02984]; Spanish Ministry of Science [SAF2006-26667-E]; HIVACAT (Catalonian Center for HIV Vaccines)	FIPSE (Spanish Ministry of Health); FIPSE (Abbott Laboratories); FIPSE (Boehringer Ingelheim)(Boehringer Ingelheim); FIPSE (Bristol Myers Squibb); FIPSE (GlaxoSmithKline); FIPSE (Merck Sharp and Dohme); FIPSE (Roche); FIS (Fondo de Investigacion Sanitaria)(Instituto de Salud Carlos III); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); HIVACAT (Catalonian Center for HIV Vaccines)	This study was supported by FIPSE (a non-profit foundation including: Spanish Ministry of Health, Abbott Laboratories, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Merck Sharp and Dohme and Roche) 36750/08, FIS (Fondo de Investigacion Sanitaria) PS09/01297 and PI10/02984, grant from Spanish Ministry of Science (SAF2006-26667-E) and HIVACAT (Catalonian Center for HIV Vaccines). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredondo-Vega FX, 1998, AM J HUM GENET, V63, P1049, DOI 10.1086/302054; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Baratelli F, 2005, J LEUKOCYTE BIOL, V78, P555, DOI 10.1189/jlb.1004569; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blackburn MR, 2012, J IMMUNOL, V188, P933, DOI 10.4049/jimmunol.1103519; Blanco J, 2000, FEBS LETT, V477, P123, DOI 10.1016/S0014-5793(00)01751-8; Blanco J, 2004, J LEUKOCYTE BIOL, V76, P804, DOI 10.1189/jlb.0204100; Cassani B, 2008, BLOOD, V111, P4209, DOI 10.1182/blood-2007-05-092429; Chaudhry A, 2005, J IMMUNOL, V175, P4566, DOI 10.4049/jimmunol.175.7.4566; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Ciruela F, 1996, FEBS LETT, V380, P219, DOI 10.1016/0014-5793(96)00023-3; Climent N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019644; Climent N, 2009, IMMUNOL CELL BIOL, V87, P634, DOI 10.1038/icb.2009.53; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; Cross JL, 2008, J IMMUNOL, V180, P8020, DOI 10.4049/jimmunol.180.12.8020; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; DEMEESTER I, 1994, EUR J IMMUNOL, V24, P566, DOI 10.1002/eji.1830240311; Desrosiers MD, 2007, J IMMUNOL, V179, P1884, DOI 10.4049/jimmunol.179.3.1884; Dong RP, 1996, J IMMUNOL, V156, P1349; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Fan H, 2012, EUR J CELL BIOL, V91, P265, DOI 10.1016/j.ejcb.2011.06.001; FRANCO R, 1986, NEUROCHEM RES, V11, P423, DOI 10.1007/BF00965016; Franco R, 2007, CRIT REV IMMUNOL, V27, P495, DOI 10.1615/CritRevImmunol.v27.i6.10; Frick JS, 2010, INT J MED MICROBIOL, V300, P19, DOI 10.1016/j.ijmm.2009.08.010; Gallois A, 2010, NAT MED, V16, DOI 10.1038/nm0810-854; Garcia F, 2011, J INFECT DIS, V203, P473, DOI 10.1093/infdis/jiq077; Gaspar HB, 2009, BLOOD, V114, P3524, DOI 10.1182/blood-2009-06-189209; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Gracia E, 2011, BIOCHEM J, V435, P701, DOI 10.1042/BJ20101749; Hashikawa T, 2004, FASEB J, V18, P131, DOI 10.1096/fj.03-0011fje; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Herrera C, 2001, MOL PHARMACOL, V59, P127, DOI 10.1124/mol.59.1.127; Hershfield MS, 2005, EUR J IMMUNOL, V35, P25, DOI 10.1002/eji.200425738; Ishii T, 2001, P NATL ACAD SCI USA, V98, P12138, DOI 10.1073/pnas.211439098; KAMEOKA J, 1993, SCIENCE, V261, P466, DOI 10.1126/science.8101391; Klein SA, 1997, AIDS, V11, P1111, DOI 10.1097/00002030-199709000-00005; Kruse M, 2000, J EXP MED, V191, P1581, DOI 10.1084/jem.191.9.1581; Laforge M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002087; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lee AW, 2002, VACCINE, V20, pA8, DOI 10.1016/S0264-410X(02)00382-1; Leon B, 2008, IMMUNOL CELL BIOL, V86, P320, DOI 10.1038/icb.2008.14; Longhi MP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000006; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Mandapathil M, 2010, J BIOL CHEM, V285, P7176, DOI 10.1074/jbc.M109.047423; MARTIN M, 1995, J IMMUNOL, V155, P4630; Martinez-Navio JM, 2011, IMMUNOLOGY CELL BIOL; Martinez-Navio JM, 2011, J LEUKOCYTE BIOL, V89, P127, DOI 10.1189/jlb.1009696; Martinez-Navio JM, 2009, IMMUNOLOGY, V128, P393, DOI 10.1111/j.1365-2567.2009.03121.x; Montoya M, 2006, EUR J IMMUNOL, V36, P2150, DOI 10.1002/eji.200535304; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Nikolova M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002110; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Pacheco R, 2005, P NATL ACAD SCI USA, V102, P9583, DOI 10.1073/pnas.0501050102; Panther E, 2003, BLOOD, V101, P3985, DOI 10.1182/blood-2002-07-2113; Panther E, 2001, FASEB J, V15, P1963, DOI 10.1096/fj.01-0169com; Parish ST, 2010, J IMMUNOL, V184, P2847, DOI 10.4049/jimmunol.0903647; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Piercy J, 2006, IMMUNOLOGY, V118, P250, DOI 10.1111/j.1365-2567.2006.02363.x; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Richard E, 2002, J BIOL CHEM, V277, P19720, DOI 10.1074/jbc.M111901200; Rodriguez-Garcia M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009436; Rollenhagen C, 2010, JAIDS-J ACQ IMM DEF, V54, P463, DOI 10.1097/QAI.0b013e3181e5e12c; Ryzhov S, 2009, PURINERG SIGNAL, V5, P289, DOI 10.1007/s11302-008-9129-8; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Schnurr M, 2004, BLOOD, V103, P1391, DOI 10.1182/blood-2003-06-1959; Shen H, 2009, J AM SOC NEPHROL, V20, P1032, DOI 10.1681/ASN.2008070778; Suchard MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011762; Weihofen WA, 2004, J BIOL CHEM, V279, P43330, DOI 10.1074/jbc.M405001200; Wilson J, 2011, TLS-TIMES LIT SUPPL, P6	76	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51287	10.1371/journal.pone.0051287	http://dx.doi.org/10.1371/journal.pone.0051287			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240012	gold, Green Published, Green Submitted			2022-12-27	WOS:000312290800048
J	Palchesko, RN; Zhang, L; Sun, Y; Feinberg, AW				Palchesko, Rachelle N.; Zhang, Ling; Sun, Yan; Feinberg, Adam W.			Development of Polydimethylsiloxane Substrates with Tunable Elastic Modulus to Study Cell Mechanobiology in Muscle and Nerve	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; MATRIX ELASTICITY; HYDROPHOBIC RECOVERY; PROTEIN ADSORPTION; STIFFNESS; SOFT; RIGIDITY; DIFFERENTIATION; SURFACES; ADHESION	Mechanics is an important component in the regulation of cell shape, proliferation, migration and differentiation during normal homeostasis and disease states. Biomaterials that match the elastic modulus of soft tissues have been effective for studying this cell mechanobiology, but improvements are needed in order to investigate a wider range of physicochemical properties in a controlled manner. We hypothesized that polydimethylsiloxane (PDMS) blends could be used as the basis of a tunable system where the elastic modulus could be adjusted to match most types of soft tissue. To test this we formulated blends of two commercially available PDMS types, Sylgard 527 and Sylgard 184, which enabled us to fabricate substrates with an elastic modulus anywhere from 5 kPa up to 1.72 MPa. This is a three order-of-magnitude range of tunability, exceeding what is possible with other hydrogel and PDMS systems. Uniquely, the elastic modulus can be controlled independently of other materials properties including surface roughness, surface energy and the ability to functionalize the surface by protein adsorption and microcontact printing. For biological validation, PC12 (neuronal inducible-pheochromocytoma cell line) and C2C12 (muscle cell line) were used to demonstrate that these PDMS formulations support cell attachment and growth and that these substrates can be used to probe the mechanosensitivity of various cellular processes including neurite extension and muscle differentiation.	[Palchesko, Rachelle N.; Zhang, Ling; Sun, Yan; Feinberg, Adam W.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Feinberg, Adam W.] Carnegie Mellon Univ, Dept Mat Sci & Engn, Pittsburgh, PA 15213 USA; [Palchesko, Rachelle N.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Louis J Fox Ctr Vis Restorat, Pittsburgh, PA 15261 USA; [Sun, Yan] Beihang Univ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing, Peoples R China	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Beihang University	Feinberg, AW (corresponding author), Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.	feinberg@andrew.cmu.edu	Feinberg, Adam W/A-7103-2009; Feinberg, Adam W/AAM-8547-2020	Feinberg, Adam W/0000-0003-3338-5456; Feinberg, Adam W/0000-0003-3338-5456; Simko, Rachelle/0000-0001-7101-2496	Louis J. Fox Center for Vision Restoration; Ocular Tissue Engineering and Regenerative Ophthalmology program; China Scholarship Council (CSC) [[2008] 3027]; Pittsburgh Tissue Engineering Initiative Inc.; Advanced Regenerative Medicine program	Louis J. Fox Center for Vision Restoration; Ocular Tissue Engineering and Regenerative Ophthalmology program; China Scholarship Council (CSC)(China Scholarship Council); Pittsburgh Tissue Engineering Initiative Inc.; Advanced Regenerative Medicine program	The authors acknowledge financial support from the Louis J. Fox Center for Vision Restoration, Ocular Tissue Engineering and Regenerative Ophthalmology program to RNP and AWF, China Scholarship Council (CSC) for the Scholarship Fund No. [2008] 3027 program to YS and the Pittsburgh Tissue Engineering Initiative Inc. Advanced Regenerative Medicine program to LZ and AWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2011, SOFT MATTER, V7, P7281, DOI 10.1039/c1sm05483j; Bartalena G, 2011, BIOMED MICRODEVICES, V13, P291, DOI 10.1007/s10544-010-9493-3; Boonen KJM, 2011, J TISSUE ENG REGEN M, V5, P60, DOI 10.1002/term.289; Boonen KJM, 2009, AM J PHYSIOL-CELL PH, V296, pC1338, DOI 10.1152/ajpcell.00015.2009; BRASH JL, 1993, J BIOMAT SCI-POLYM E, V4, P591, DOI 10.1163/156856293X00816; Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009; Candiello J, 2007, FEBS J, V274, P2897, DOI 10.1111/j.1742-4658.2007.05823.x; Cartelli D, 2010, J NEUROCHEM, V115, P247, DOI 10.1111/j.1471-4159.2010.06924.x; Chandler EM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015008; Charest JM, 2012, MACROMOL BIOSCI, V12, P12, DOI 10.1002/mabi.201100264; Cheng CM, 2009, J BIOMECH, V42, P187, DOI 10.1016/j.jbiomech.2008.10.014; Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0; Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655; Discher DE, 2008, BIORHEOLOGY, V45, P54; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Evans ND, 2009, EUR CELLS MATER, V18, P1; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Feinberg AW, 2010, NANO LETT, V10, P2184, DOI 10.1021/nl100998p; Feinberg AW, 2003, ABSTR PAP AM CHEM S, V225, pU711; Feinberg AW, 2003, ACS SYM SER, V838, P196; Feinberg AW, 2012, BIOMATERIALS; Fioretta ES, 2012, J BIOMECH, V45, P736, DOI 10.1016/j.jbiomech.2011.11.013; FISHER RF, 1976, PROC R SOC SER B-BIO, V193, P335, DOI 10.1098/rspb.1976.0051; Fuard D, 2008, MICROELECTRON ENG, V85, P1289, DOI 10.1016/j.mee.2008.02.004; GHISTA DN, 1975, MED BIOL ENG, V13, P151, DOI 10.1007/BF02477722; Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Gutierrez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025534; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hiebl B, 2011, J BIOMATER SCI POLYM; Hillborg H, 2004, LANGMUIR, V20, P785, DOI 10.1021/la035552k; Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037; Jiang FX, 2008, ANN BIOMED ENG, V36, P1565, DOI 10.1007/s10439-008-9530-z; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim JH, 2010, LANGMUIR, V26, P13015, DOI 10.1021/la1018746; Kotlarchyk MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020201; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003; Lee MH, 2008, BIOMACROMOLECULES, V9, P2315, DOI 10.1021/bm8002094; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Liao QZ, 2010, MECH MATER, V42, P1043, DOI 10.1016/j.mechmat.2010.09.005; Mancini A, 2007, ONCOGENE, V26, P1020, DOI 10.1038/sj.onc.1209853; Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f; Olah A, 2005, APPL SURF SCI, V239, P410, DOI 10.1016/j.apsusc.2004.06.005; Olson DA, 2006, J AM CHEM SOC, V128, P13625, DOI 10.1021/ja063092m; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Perl A, 2009, ADV MATER, V21, P2257, DOI 10.1002/adma.200801864; RILEY WA, 1992, STROKE, V23, P952, DOI 10.1161/01.STR.23.7.952; Schneider F, 2009, SENSOR ACTUAT A-PHYS, V151, P95, DOI 10.1016/j.sna.2009.01.026; Shebanova O, 2012, BIOTECHNOL J, V7, P397, DOI 10.1002/biot.201100188; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Stabenfeldt SE, 2011, ACTA BIOMATER, V7, P4102, DOI 10.1016/j.actbio.2011.07.026; Sun YB, 2012, LANGMUIR, V28, P10789, DOI 10.1021/la300978x; Tzvetkova-Chevolleau T, 2008, BIOMATERIALS, V29, P1541, DOI 10.1016/j.biomaterials.2007.12.016; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059; Wang LS, 2010, BIOMATERIALS, V31, P8608, DOI 10.1016/j.biomaterials.2010.07.075; Wang L, 2010, J BIOMED MATER RES A, V93A, P1260, DOI 10.1002/jbm.a.32621; Wang PY, 2012, ACTA BIOMATER, V8, P519, DOI 10.1016/j.actbio.2011.09.030; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Williams C, 2009, ADV MATER, V21, P2161, DOI 10.1002/adma.200801027; Yu HY, 2012, ACTA BIOMATER, V8, P1267, DOI 10.1016/j.actbio.2011.09.006; Yu YH, 2006, J ANIM SCI, V84, P2655, DOI 10.2527/jas.2005-645; Zoldan J, 2011, BIOMATERIALS, V32, P9612, DOI 10.1016/j.biomaterials.2011.09.012	71	350	351	7	184	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51499	10.1371/journal.pone.0051499	http://dx.doi.org/10.1371/journal.pone.0051499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240031	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800067
J	Soldati, C; Cacci, E; Biagioni, S; Carucci, N; Lupo, G; Perrone-Capano, C; Saggio, I; Augusti-Tocco, G				Soldati, Chiara; Cacci, Emanuele; Biagioni, Stefano; Carucci, Nicoletta; Lupo, Giuseppe; Perrone-Capano, Carla; Saggio, Isabella; Augusti-Tocco, Gabriella			Restriction of Neural Precursor Ability to Respond to Nurr1 by Early Regional Specification	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MIDBRAIN DOPAMINERGIC-NEURONS; PROGENITOR CELLS; TRANSCRIPTION FACTOR; FATE SPECIFICATION; HUMAN STRIATUM; IN-VITRO; DIFFERENTIATION; INDUCTION; PITX3	During neural development, spatially regulated expression of specific transcription factors is crucial for central nervous system (CNS) regionalization, generation of neural precursors (NPs) and subsequent differentiation of specific cell types within defined regions. A critical role in dopaminergic differentiation in the midbrain (MB) has been assigned to the transcription factor Nurr1. Nurr1 controls the expression of key genes involved in dopamine (DA) neurotransmission, e. g. tyrosine hydroxylase (TH) and the DA transporter (DAT), and promotes the dopaminergic phenotype in embryonic stem cells. We investigated whether cells derived from different areas of the mouse CNS could be directed to differentiate into dopaminergic neurons in vitro by forced expression of the transcription factor Nurr1. We show that Nurr1 overexpression can promote dopaminergic cell fate specification only in NPs obtained from E13.5 ganglionic eminence (GE) and MB, but not in NPs isolated from E13.5 cortex (CTX) and spinal cord (SC) or from the adult subventricular zone (SVZ). Confirming previous studies, we also show that Nurr1 overexpression can increase the generation of TH-positive neurons in mouse embryonic stem cells. These data show that Nurr1 ability to induce a dopaminergic phenotype becomes restricted during CNS development and is critically dependent on the region of NPs derivation. Our results suggest that the plasticity of NPs and their ability to activate a dopaminergic differentiation program in response to Nurr1 is regulated during early stages of neurogenesis, possibly through mechanisms controlling CNS regionalization. Citation: Soldati C, Cacci E, Biagioni S, Carucci N, Lupo G, et al. (2012) Restriction of Neural Precursor Ability to Respond to Nurr1 by Early Regional Specification. PLoS ONE 7(12): e51798. doi: 10.1371/journal.pone.0051798	[Soldati, Chiara; Cacci, Emanuele; Biagioni, Stefano; Carucci, Nicoletta; Lupo, Giuseppe; Augusti-Tocco, Gabriella] Univ Roma La Sapienza, Dept Biol, Rome, Italy; [Soldati, Chiara; Cacci, Emanuele; Biagioni, Stefano; Carucci, Nicoletta; Lupo, Giuseppe; Augusti-Tocco, Gabriella] Univ Roma La Sapienza, Biotechnol Neurobiol Res Unit, Rome, Italy; [Soldati, Chiara; Cacci, Emanuele; Biagioni, Stefano; Carucci, Nicoletta; Lupo, Giuseppe; Augusti-Tocco, Gabriella] Univ Roma La Sapienza, Daniel Bovet Neurobiol Res Ctr, Rome, Italy; [Soldati, Chiara; Cacci, Emanuele; Carucci, Nicoletta; Lupo, Giuseppe; Saggio, Isabella] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Perrone-Capano, Carla] Univ Naples Federico II, Dept Biol Sci, Naples, Italy; [Perrone-Capano, Carla] IGB A Buzzati Traverso, Naples, Italy; [Saggio, Isabella] Univ Roma La Sapienza, Dept Biol & Biotechnol, Rome, Italy; [Saggio, Isabella] CNR, Inst Mol Biol & Pathol, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Augusti-Tocco, G (corresponding author), Univ Roma La Sapienza, Dept Biol, Rome, Italy.	gabriella.tocco@uniroma1.it	Biagioni, Stefano/D-4734-2009; Saggio, Isabella/H-2417-2015; Perrone-Capano, Carla/O-7708-2015; Perrone-Capano, Carla/AAX-3217-2020; Lupo, Giuseppe/J-3062-2012	Perrone-Capano, Carla/0000-0002-6327-9753; Perrone-Capano, Carla/0000-0002-6327-9753; Lupo, Giuseppe/0000-0001-7218-4003; saggio, isabella/0000-0002-9497-7415	PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale) [20088JEHW3_002]; Facolta and Ateneo "La Sapienza"; MIUR program "Rientro dei Cervell"; Institute Pasteur - Fondazione Cenci Bolognetti; Fondazione Cenci Bolognetti; CNR; MIUR; FP7 braincav; Fondo per gli Investimenti di Ricerca di Base [FIRB-RBIN062YH4]; Medical Research Italy [MERIT-RBNE08LN4P]	PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Facolta and Ateneo "La Sapienza"; MIUR program "Rientro dei Cervell"; Institute Pasteur - Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); CNR(Consiglio Nazionale delle Ricerche (CNR)); MIUR(Ministry of Education, Universities and Research (MIUR)); FP7 braincav; Fondo per gli Investimenti di Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Medical Research Italy	This work was supported by grants from: PRIN (Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale progetto no 20088JEHW3_002 "Ruolo dei neurotrasmettitori e di fattori di trascrizione ad essi correlati nel differenziamento neurale") and Facolta and Ateneo "La Sapienza". It was also supported by the MIUR program "Rientro dei Cervell" and a start-up grant from Institute Pasteur - Fondazione Cenci Bolognetti to GL, and by a fellowship from Fondazione Cenci Bolognetti to CS, and funding from Fondazione Cenci Bolognetti to EC. IS received grants from CNR, Fondazione Cenci Bolognetti, MIUR and FP7 braincav funding. This work was supported by "Fondo per gli Investimenti di Ricerca di Base" FIRB-RBIN062YH4 and "Medical Research Italy" MERIT-RBNE08LN4P to CP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTABA ARI, 1992, DEVELOPMENT, V116, P67; Andersson EKI, 2007, EXP CELL RES, V313, P1172, DOI 10.1016/j.yexcr.2006.12.014; Armando S, 2007, NEUROREPORT, V18, P1539, DOI 10.1097/WNR.0b013e3282f03d54; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bithell A, 2008, STEM CELLS, V26, P1565, DOI 10.1634/stemcells.2007-0832; Castillo SO, 1998, MOL CELL NEUROSCI, V11, P36, DOI 10.1006/mcne.1998.0673; Christophersen NS, 2006, BRAIN RES BULL, V70, P457, DOI 10.1016/j.brainresbull.2006.07.001; Chung S, 2002, EUR J NEUROSCI, V16, P1829, DOI 10.1046/j.1460-9568.2002.02255.x; Chung S, 2006, STEM CELLS, V24, P1583, DOI 10.1634/stemcells.2005-0558; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Cossette M, 2003, ANN NY ACAD SCI, V991, P346; Cossette M, 2004, EUR J NEUROSCI, V20, P2089, DOI 10.1111/j.1460-9568.2004.03661.x; Deacon T, 1998, EXP NEUROL, V149, P28, DOI 10.1006/exnr.1997.6674; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; Hitoshi S, 2002, DEVELOPMENT, V129, P233; Hodges H, 2007, CELL TRANSPLANT, V16, P101; Huot P, 2007, J NEUROCHEM, V101, P1441, DOI 10.1111/j.1471-4159.2006.04430.x; Jacobs FMJ, 2009, DEVELOPMENT, V136, P531, DOI 10.1242/dev.029769; Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153; Kallur T, 2006, J NEUROSCI RES, V84, P1630, DOI 10.1002/jnr.21066; Kelly TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004213; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; Kim HJ, 2007, EXP NEUROL, V203, P394, DOI 10.1016/j.expneurol.2006.08.029; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kim JY, 2003, J NEUROCHEM, V85, P1443, DOI 10.1046/j.1471-4159.2003.01780.x; LENDAHL U, 1990, TRENDS NEUROSCI, V13, P132, DOI 10.1016/0166-2236(90)90004-T; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Nakagawa Y, 1996, DEVELOPMENT, V122, P2449; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Onorati M, 2011, CELL MOL LIFE SCI, V68, P1769, DOI 10.1007/s00018-010-0548-7; Park CH, 2008, FEBS LETT, V582, P537, DOI 10.1016/j.febslet.2008.01.018; Perrone-Capano C, 2000, INT J DEV BIOL, V44, P679; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; Roy NS, 2000, J NEUROSCI RES, V59, P321, DOI 10.1002/(SICI)1097-4547(20000201)59:3<321::AID-JNR5>3.0.CO;2-9; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Shim JW, 2007, STEM CELLS, V25, P1252, DOI 10.1634/stemcells.2006-0274; Simon HH, 2001, J NEUROSCI, V21, P3126, DOI 10.1523/JNEUROSCI.21-09-03126.2001; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Sonntag KC, 2004, EUR J NEUROSCI, V19, P1141, DOI 10.1111/j.1460-9568.2004.03204.x; Thompson LH, 2006, EXP NEUROL, V198, P183, DOI 10.1016/j.expneurol.2005.11.025; Vallier L, 2004, STEM CELLS, V22, P2, DOI 10.1634/stemcells.22-1-2; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; Volpicelli F, 2007, J NEUROCHEM, V102, P441, DOI 10.1111/j.1471-4159.2007.04494.x; Volpicelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030661; Wallen A, 1999, EXP CELL RES, V253, P737, DOI 10.1006/excr.1999.4691; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	60	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51798	10.1371/journal.pone.0051798	http://dx.doi.org/10.1371/journal.pone.0051798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240065	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800101
J	Das, S; Czarnek, M; Bzowska, M; Mezyk-Kopec, R; Stalinska, K; Wyroba, B; Sroka, J; Jucha, J; Deneka, D; Stoklosa, P; Ogonek, J; Swartz, MA; Madeja, Z; Bereta, J				Das, Sudipta; Czarnek, Maria; Bzowska, Monika; Mezyk-Kopec, Renata; Stalinska, Krystyna; Wyroba, Barbara; Sroka, Jolanta; Jucha, Jaroslaw; Deneka, Dawid; Stoklosa, Paulina; Ogonek, Justyna; Swartz, Melody A.; Madeja, Zbigniew; Bereta, Joanna			ADAM17 Silencing in Mouse Colon Carcinoma Cells: The Effect on Tumoricidal Cytokines and Angiogenesis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ALPHA-CONVERTING ENZYME; GROWTH-FACTOR; BREAST-CANCER; PRESENILIN/GAMMA-SECRETASE; ENDOTHELIAL-CELLS; AUTONOMOUS GROWTH; REGULATES VEGF; OVARIAN-CANCER; EGFR	ADAM17 (a disintegrin and metalloprotease 17) is a major sheddase for numerous growth factors, cytokines, receptors, and cell adhesion molecules and is often overexpressed in malignant cells. It is generally accepted that ADAM17 promotes tumor development via activating growth factors from the EGF family, thus facilitating autocrine stimulation of tumor cell proliferation and migration. Here we show, using MC38CEA murine colon carcinoma model, that ADAM17 also regulates tumor angiogenesis and cytokine profile. When ADAM17 was silenced in MC38CEA cells, in vivo tumor growth and in vitro cell motility were significantly diminished, but no effect was seen on in vitro cell proliferation. ADAM17-silencing was accompanied by decreased in vitro expression of vascular endothelial growth factor-A and matrix metalloprotease-9, which was consistent with the limited angiogenesis and slower growth seen in ADAM17-silenced tumors. Among the growth factors susceptible to shedding by ADAM17, neuregulin-1 was the only candidate to mediate the effects of ADAM17 on MC38CEA motility and tumor angiogenesis. Concentrations of TNF and IFN gamma, cytokines that synergistically induced proapoptotic effects on MC38CEA cells, were significantly elevated in the lysates of ADAM17-silenced tumors compared to mock transfected controls, suggesting a possible role for ADAM17 in host immune suppression. These results introduce new, complex roles of ADAM17 in tumor progression, including its impact on the anti-tumor immune response.	[Das, Sudipta; Czarnek, Maria; Bzowska, Monika; Mezyk-Kopec, Renata; Stalinska, Krystyna; Wyroba, Barbara; Jucha, Jaroslaw; Deneka, Dawid; Stoklosa, Paulina; Ogonek, Justyna; Bereta, Joanna] Jagiellonian Univ, Dept Cell Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Sroka, Jolanta; Madeja, Zbigniew] Jagiellonian Univ, Dept Cell Biol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Swartz, Melody A.] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland; [Swartz, Melody A.] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland	Jagiellonian University; Jagiellonian University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Bereta, J (corresponding author), Jagiellonian Univ, Dept Cell Biochem, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	joanna.bereta@uj.edu.pl	Das, Sudipta/AAE-4236-2019	Madeja, Zbigniew/0000-0002-5523-1215; Sroka, Jolanta/0000-0003-3728-752X; Bereta, Joanna/0000-0001-7930-2770; Bzowska, Monika/0000-0003-1921-0334; Deneka, Dawid/0000-0001-9472-0663	Ministry of Science and Higher Education, Poland [3144/B/P01/2007/33]; New Member State of EU (Sciex NMS-CH) [10.085-2]; New Member State of Switzerland (Sciex NMS-CH) [10.085-2]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); New Member State of EU (Sciex NMS-CH); New Member State of Switzerland (Sciex NMS-CH)	This work was supported by grant 3144/B/P01/2007/33 from the Ministry of Science and Higher Education, Poland and the Scientific Exchange Program between the New Member States of the EU and Switzerland (Sciex NMS-CH; grant no. 10.085-2 to R.M-K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas J, 2009, CURR PHARM DESIGN, V15, P2319, DOI 10.2174/138161209788682398; Bagheri-Yarmand R, 2000, J BIOL CHEM, V275, P39451, DOI 10.1074/jbc.M006150200; Bereta M, 2007, VACCINE, V25, P4183, DOI 10.1016/j.vaccine.2007.03.008; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blanchot-Jossic F, 2005, J PATHOL, V207, P156, DOI 10.1002/path.1814; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Braun AH, 2005, CLIN CANCER RES, V11, P4639, DOI 10.1158/1078-0432.CCR-05-0973; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Cells J., 1998, CELL BIOL LAB HDB; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Coligan J.E., 1997, CURRENT PROTOCOLS PR; CORBETT TH, 1975, CANCER RES, V35, P2434; Dang M, 2011, J BIOL CHEM, V286, P17704, DOI 10.1074/jbc.M110.187823; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Eisenach PA, 2010, J CELL SCI, V123, P4182, DOI 10.1242/jcs.062711; Finigan JH, 2011, J BIOL CHEM, V286, P10660, DOI 10.1074/jbc.M110.208041; Franovic A, 2006, CANCER RES, V66, P8083, DOI 10.1158/0008-5472.CAN-06-1595; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Gonzalez-Perez RR, 2010, CELL SIGNAL, V22, P1350, DOI 10.1016/j.cellsig.2010.05.003; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Guan YQ, 2010, BIOMATERIALS, V31, P9074, DOI 10.1016/j.biomaterials.2010.08.044; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; HOFER DR, 1991, CANCER RES, V51, P2780; Hofman F., 2002, CURRENT PROTOCOLS IM; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Katakowski M, 2009, CANCER SCI, V100, P1597, DOI 10.1111/j.1349-7006.2009.01221.x; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Kornfeld JW, 2011, BRIT J CANCER, V104, P138, DOI 10.1038/sj.bjc.6606017; Luo XY, 2011, J BIOL CHEM, V286, P23967, DOI 10.1074/jbc.M111.251538; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; McGowan PM, 2007, CLIN CANCER RES, V13, P2335, DOI 10.1158/1078-0432.CCR-06-2092; Mocellin S, 2005, CYTOKINE GROWTH F R, V16, P35, DOI 10.1016/j.cytogfr.2004.11.001; Montero JC, 2000, MOL CELL NEUROSCI, V16, P631, DOI 10.1006/mcne.2000.0896; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Ringel J, 2006, CANCER RES, V66, P9045, DOI 10.1158/0008-5472.CAN-05-3287; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Sroka J, 2007, BIOL CELL, V99, P677, DOI 10.1042/BC20070024; Stamenkovic I, 2009, J INVEST DERMATOL, V129, P1321, DOI 10.1038/jid.2009.13; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Thathiah A, 2003, J BIOL CHEM, V278, P3386, DOI 10.1074/jbc.M208326200; Townsend PA, 2004, J BIOL CHEM, V279, P5811, DOI 10.1074/jbc.M302637200; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; WU JC, 1994, CANCER RES, V54, P5964; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006; Yokozeki T, 2007, GENES CELLS, V12, P329, DOI 10.1111/j.1365-2443.2007.01060.x; Yonezawa M, 2009, DIGESTION, V80, P215, DOI 10.1159/000229775; Zaidi MR, 2011, CLIN CANCER RES, V17, P6118, DOI 10.1158/1078-0432.CCR-11-0482; Zheng XG, 2012, MOL CARCINOGEN, V51, P150, DOI 10.1002/mc.20772; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	60	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50791	10.1371/journal.pone.0050791	http://dx.doi.org/10.1371/journal.pone.0050791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251384	Green Published, gold			2022-12-27	WOS:000312201900017
J	Lee, RE; Mama, SK; Adamus-Leach, HJ				Lee, Rebecca E.; Mama, Scherezade K.; Adamus-Leach, Heather J.			Neighborhood Street Scale Elements, Sedentary Time and Cardiometabolic Risk Factors in Inactive Ethnic Minority Women	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; PSYCHOSOCIAL STRESS; BUILT ENVIRONMENT; AFRICAN-AMERICAN; OBESITY; ADULTS; ASSOCIATIONS; ATTRIBUTES	Background: Cardiometabolic risk factors such as obesity, excess percent body fat, high blood pressure, elevated resting heart rate and sedentary behavior have increased in recent decades due to changes in the environment and lifestyle. Neighborhood micro-environmental, street scale elements may contribute to health above and beyond individual characteristics of residents. Purpose: To investigate the relationship between neighborhood street scale elements and cardiometabolic risk factors among inactive ethnic minority women. Method: Women (N = 410) completed measures of BMI, percent body fat, blood pressure, resting heart rate, sedentary behavior and demographics. Trained field assessors completed the Pedestrian Environment Data Scan in participants' neighborhoods. Data were collected from 2006-2008. Multiple regression models were conducted in 2011 to estimate the effect of environmental factors on cardiometabolic risk factors. Results: Adjusted regression models found an inverse association between sidewalk buffers and blood pressure, between traffic control devices and resting heart rate, and a positive association between presence of pedestrian crossing aids and BMI (ps<.05). Neighborhood attractiveness and safety for walking and cycling were related to more time spent in a motor vehicle (ps<.05). Conclusions: Findings suggest complex relationships among micro-environmental, street scale elements that may confer important cardiometabolic benefits and risks for residents. Living in the most attractive and safe neighborhoods for physical activity may be associated with longer times spent sitting in the car.	[Lee, Rebecca E.; Mama, Scherezade K.; Adamus-Leach, Heather J.] Univ Houston, Dept Hlth & Human Performance, Texas Obes Res Ctr, Houston, TX 77030 USA	University of Houston System; University of Houston	Lee, RE (corresponding author), Univ Houston, Dept Hlth & Human Performance, Texas Obes Res Ctr, Houston, TX 77030 USA.	releephd@yahoo.com	Leach, Heather J/F-9317-2017		National Institutes of Health's National Cancer Institute [1R01CA109403]; NATIONAL CANCER INSTITUTE [R01CA109403] Funding Source: NIH RePORTER	National Institutes of Health's National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by a research grant awarded to Dr. Rebecca E. Lee at the University of Houston by the National Institutes of Health's National Cancer Institute (1R01CA109403). The funders had no role in study design, data collection and analysis, decision to publish.	[Anonymous], 2011, REVERSING OBESOGENIC; Block JP, 2009, AM J EPIDEMIOL, V170, P181, DOI 10.1093/aje/kwp104; Booth M, 2000, Res Q Exerc Sport, V71 Suppl 2, P114, DOI 10.1080/02701367.2000.11082794; Brace N, 2009, SPSS PSYCHOL; Brownson RC, 2000, AM J PUBLIC HEALTH, V90, P264, DOI 10.2105/AJPH.90.2.264; Burdette HL, 2004, PREV MED, V38, P57, DOI 10.1016/j.ypmed.2003.09.029; California Department of Public Health, 2010, MAT INF HLTH ASS MIH; Centers for Disease Control and Prevention, 2011, PREGN RISK ASS MON S; Clifton KJ, 2007, LANDSCAPE URBAN PLAN, V80, P95, DOI 10.1016/j.landurbplan.2006.06.008; COOPER KH, 1976, JAMA-J AM MED ASSOC, V236, P166, DOI 10.1001/jama.236.2.166; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crawford D, 2010, INT J OBESITY, V34, P1177, DOI 10.1038/ijo.2010.57; Douglas MJ, 2011, J PUBLIC HEALTH-UK, V33, P160, DOI 10.1093/pubmed/fdr032; Frank LD, 2007, SOC SCI MED, V65, P1898, DOI 10.1016/j.socscimed.2007.05.053; Fung MM, 2011, HYPERTENSION, V58, P596, DOI 10.1161/HYPERTENSIONAHA.111.174409; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Gordon-Larsen P, 2009, ARCH INTERN MED, V169, P1216, DOI 10.1001/archinternmed.2009.163; Heinrich KM, 2008, AM J HEALTH PROMOT, V22, P187, DOI 10.4278/ajhp.22.3.187; Inagami S, 2009, J URBAN HEALTH, V86, P683, DOI 10.1007/s11524-009-9379-y; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Kozo J, 2012, HLTH PSYCHOL; Ledoux TA, 2012, J OBESITY IN PRESS; Lee RE, 2011, J COMMUNITY HLTH; Lee Rebecca E, 2005, Int J Behav Nutr Phys Act, V2, P13, DOI 10.1186/1479-5868-2-13; Lee RE, 2010, ENVIRON HEALTH INSIG, V4, P49; Lee RE, 2012, HEALTH PLACE, V18, P63, DOI 10.1016/j.healthplace.2011.08.013; Lee RE, 2011, J PHYS ACT HEALTH, V8, pS83, DOI 10.1123/jpah.8.s1.s83; Lee RE, 2009, EXERC SPORT SCI REV, V37, P10, DOI 10.1097/JES.0b013e318190eb2e; McAlexander KM, 2009, J URBAN HEALTH, V86, P696, DOI 10.1007/s11524-009-9385-0; McMillan TE, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-20; National Center forHealth Statistics, 2011, HLTH US 2010 SPEC FE; [National Centers for Chronic Disease Prevention and Health Promotion Translation DoD], 2011, PHYS IN EST; Parmenter B, 2008, J URBAN REG INF SYST, V20, P13; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Sarnoff R, 2005, MATERN CHILD HLTH J, V9, P343, DOI 10.1007/s10995-005-0023-5; Spence JC, 2003, PSYCHOL SPORT EXERC, V4, P7, DOI 10.1016/S1469-0292(02)00014-6; Spruill TM, 2010, CURR HYPERTENS REP, V12, P10, DOI 10.1007/s11906-009-0084-8; Ulijaszek SJ, 2005, ANN HUM BIOL, V32, P326, DOI 10.1080/03014460500087824; Van Dyck D, 2012, SOC SCI MED, V74, P1375, DOI 10.1016/j.socscimed.2012.01.018; Van Dyck D, 2010, AM J PREV MED, V39, P25, DOI 10.1016/j.amepre.2010.03.004; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x	43	20	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51081	10.1371/journal.pone.0051081	http://dx.doi.org/10.1371/journal.pone.0051081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	050OT	23236434	Green Published, gold			2022-12-27	WOS:000312064100063
J	Liu, ZH; Xiao, HM; Li, HP; Zhao, YH; Lai, SY; Yu, XL; Cai, T; Du, CG; Zhang, WG; Li, JQ				Liu, Zhihong; Xiao, Hongmei; Li, Huipeng; Zhao, Yanhong; Lai, Shuangying; Yu, Xinlei; Cai, Ting; Du, Chenguang; Zhang, Wenguang; Li, Jinquan			Identification of Conserved and Novel microRNAs in Cashmere Goat Skin by Deep Sequencing	PLOS ONE			English	Article							CELL DEVELOPMENT; RNAS; MORPHOGENESIS; BIOGENESIS; GENE	MicroRNAs (miRNAs) are a class of small RNAs that play significant roles in regulating the expression of the post-transcriptional skin and hair follicle gene. In recent years, extensive studies on these microRNAs have been carried out in mammals such as mice, rats, pigs and cattle. By comparison, the number of microRNAs that have been identified in goats is relatively low; and in particular, the miRNAs associated with the processes of skin and hair follicle development remain largely unknown. In this study, areas of skin where the cashmere grows in anagen were sampled. A total of 10,943,292 reads were obtained using Solexa sequencing, a high-throughput sequencing technology. From 10,644,467 reads, we identified 3,381 distinct reads and after applying the classification statistics we obtained 316 miRNAs. Among them, using conservative identification, we found that 68 miRNAs (55 of these are confirmed to match known sheep and goat miRNAs in miRBase) are conserved in goat and have been reported in NCBI; the remaining 248 miRNA were conserved in other species but have not been reported in goat. Furthermore, we identified 22 novel miRNAs. Both the known and novel miRNAs were confirmed by a second sequencing using the same method as was used in the first. This study confirmed the authenticity of 316 known miRNAs and the discovery of 22 novel miRNAs in goat. We found that the miRNAs that were co-expressed in goat and sheep were located in the same region of the respective chromosomes and may play an essential role in skin and follicle development. Identificaton of novel miRNAs resulted in significant enrichment of the repertoire of goat miRNAs.	[Liu, Zhihong; Zhao, Yanhong; Lai, Shuangying; Yu, Xinlei; Cai, Ting; Zhang, Wenguang; Li, Jinquan] Inner Mongolia Agr Univ, Dept Anim Sci, Inner Mongolia Key Lab Anim Genet Breeding & Repr, Hohhot, Inner Mongolia, Peoples R China; [Xiao, Hongmei; Li, Huipeng] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot, Inner Mongolia, Peoples R China; [Du, Chenguang] Inner Mongolia Agr Univ, Vocat & Tech Coll, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Agricultural University; Inner Mongolia Agricultural University; Inner Mongolia Agricultural University	Li, JQ (corresponding author), Inner Mongolia Agr Univ, Dept Anim Sci, Inner Mongolia Key Lab Anim Genet Breeding & Repr, Hohhot, Inner Mongolia, Peoples R China.	lijinquan_nd@126.com	zhao, yan/GWC-9174-2022		Natural Science Foundation of China [31072005]; earmarked fund for Modern Agro-industry Technology Research System, China [CARS-40-05]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for Modern Agro-industry Technology Research System, China	This work was supported by the Natural Science Foundation of China (Grant No. 31072005) and the earmarked fund for Modern Agro-industry Technology Research System, China (Grant No. CARS-40-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bashirullah A, 2003, DEV BIOL, V259, P1, DOI 10.1016/S0012-1606(03)00063-0; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Fan J-B, 2012, NEXT GENERATION MICR, Vxi; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Ford TD, 2009, NEW CANC RES DEV, Vxvi; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gomase Virendra S, 2009, Int J Bioinform Res Appl, V5, P479, DOI 10.1504/IJBRA.2009.028678; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Joyce CE, 2011, HUM MOL GENET; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lannuzzi L, 1997, CHROMOSOME RES, V5, P199, DOI 10.1023/A:1018451131929; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li SQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016956; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Mishima Y, 2007, CELL, V129, P247, DOI 10.1016/j.cell.2007.04.008; Pontarotti P, 2011, EVOLUTIONARY BIOL CO, Vxv; Ruvkun G, 2001, SCIENCE, V294, P797, DOI 10.1126/science.1066315; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shin KH, 2011, INT J ONCOL, V39, P1205, DOI 10.3892/ijo.2011.1111; Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yu Y, 2010, EPIGENETICS-US, V5, P124, DOI 10.4161/epi.5.2.11160; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006; Zhang WG, 2007, OMICS, V11, P385, DOI 10.1089/omi.2006.0031; Zhou B, 2011, IRISH J MED SCI, V180, P721, DOI 10.1007/s11845-010-0609-9	38	28	34	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50001	10.1371/journal.pone.0050001	http://dx.doi.org/10.1371/journal.pone.0050001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236360	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100010
J	Mao, XZ; Chen, X; Zhang, Y; Pangle, S; Xu, Y				Mao, Xizeng; Chen, Xin; Zhang, Yu; Pangle, Spencer; Xu, Ying			CINPER: An Interactive Web System for Pathway Prediction for Prokaryotes	PLOS ONE			English	Article							METABOLIC PATHWAYS; BIOCYC COLLECTION; COMPUTATIONAL PREDICTION; NITROGEN ASSIMILATION; BIOLOGICAL PATHWAYS; GENOME ANNOTATION; METACYC DATABASE; GENES; IRON; NETWORK	We present a web-based network-construction system, CINPER (CSBL INteractive Pathway BuildER), to assist a user to build a user-specified gene network for a prokaryotic organism in an intuitive manner. CINPER builds a network model based on different types of information provided by the user and stored in the system. CINPER's prediction process has four steps: (i) collection of template networks based on (partially) known pathways of related organism(s) from the SEED or BioCyc database and the published literature; (ii) construction of an initial network model based on the template networks using the P-Map program; (iii) expansion of the initial model, based on the association information derived from operons, protein-protein interactions, co-expression modules and phylogenetic profiles; and (iv) computational validation of the predicted models based on gene expression data. To facilitate easy applications, CINPER provides an interactive visualization environment for a user to enter, search and edit relevant data and for the system to display (partial) results and prompt for additional data. Evaluation of CINPER on 17 well-studied pathways in the MetaCyc database shows that the program achieves an average recall rate of 76% and an average precision rate of 90% on the initial models; and a higher average recall rate at 87% and an average precision rate at 28% on the final models. The reduced precision rate in the final models versus the initial models reflects the reality that the final models have large numbers of novel genes that have no experimental evidences and hence are not yet collected in the MetaCyc database. To demonstrate the usefulness of this server, we have predicted an iron homeostasis gene network of Synechocystis sp. PCC6803 using the server. The predicted models along with the server can be accessed at http://csbl.bmb.uga.edu/cinper/.	[Mao, Xizeng; Pangle, Spencer; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Mao, Xizeng; Pangle, Spencer; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Mao, Xizeng; Xu, Ying] Univ Georgia, BESC BioEnergy Sci Ctr, Athens, GA 30602 USA; [Chen, Xin; Zhang, Yu; Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Jilin, Peoples R China; [Chen, Xin; Zhang, Yu] Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Minist Educ, Changchun 130023, Jilin, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Jilin University; Jilin University	Xu, Y (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA.	xyn@bmb.uga.edu			National Science Foundation [DEB-0830024, DBI-0542119, MCB-0958172]; Chinese National Science Foundation [11001106]; DOE BioEnergy Science Center grant [DE-PS02-06ER64304]; Office of Biological and Environmental Research in the Department of Energy Office of Science	National Science Foundation(National Science Foundation (NSF)); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); DOE BioEnergy Science Center grant; Office of Biological and Environmental Research in the Department of Energy Office of Science	This work was supported in part by the National Science Foundation (DEB-0830024, DBI-0542119 and MCB-0958172), the Chinese National Science Foundation (11001106) and the DOE BioEnergy Science Center grant (DE-PS02-06ER64304), which is supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bader GD, 2006, NUCLEIC ACIDS RES, V34, pD504, DOI 10.1093/nar/gkj126; Brouwer RWW, 2008, BRIEF BIOINFORM, V9, P367, DOI 10.1093/bib/bbn019; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Chen LF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r17; Du QL, 2011, INT J BIOL SCI, V7, P41, DOI 10.7150/ijbs.7.41; Gillis J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002444; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; HANSSON M, 1994, J BACTERIOL, V176, P5962, DOI 10.1128/jb.176.19.5962-5970.1994; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Kharchenko P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-177; Kharchenko P, 2004, BIOINFORMATICS, V20, P178, DOI 10.1093/bioinformatics/bth930; Kobayashi M, 2004, PLANT CELL PHYSIOL, V45, P290, DOI 10.1093/pcp/pch034; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Mao FL, 2006, P NATL ACAD SCI USA, V103, P129, DOI 10.1073/pnas.0509737102; Mao XZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-291; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morrissey J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00043; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Orth JD, 2010, BIOTECHNOL BIOENG, V107, P403, DOI 10.1002/bit.22844; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Shcolnick S, 2009, PLANT PHYSIOL, V150, P2045, DOI 10.1104/pp.109.141853; Su ZC, 2006, NUCLEIC ACIDS RES, V34, P1050, DOI 10.1093/nar/gkj496; Su ZC, 2005, NUCLEIC ACIDS RES, V33, P5156, DOI 10.1093/nar/gki817; Su ZC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-156; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Yu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020092	39	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51252	10.1371/journal.pone.0051252	http://dx.doi.org/10.1371/journal.pone.0051252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236458	gold, Green Published			2022-12-27	WOS:000312064100083
J	Arnedo, M; Alonso, E; Eisenberg, N; Ibanez, L; Ferreyra, C; Jaen, A; Flevaud, L; Khamadi, S; Roddy, P; Gatell, JM; Dalmau, D				Arnedo, Mireia; Alonso, Elena; Eisenberg, Nell; Ibanez, Laura; Ferreyra, Cecilia; Jaen, Angels; Flevaud, Laurence; Khamadi, Samuel; Roddy, Paul; Maria Gatell, Jose; Dalmau, David		Busia O R Study Grp	Monitoring HIV Viral Load in Resource Limited Settings: Still a Matter of Debate?	PLOS ONE			English	Article							DRIED BLOOD SPOTS; IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; PLASMA PREPARATION TUBES; FIXED-DOSE COMBINATION; DRUG-RESISTANCE; HIV-1-INFECTED ADULTS; INFECTED PATIENTS; LAMIVUDINE; EFAVIRENZ	Introduction: Consequences of lack of viral monitoring in predicting the effects of development of HIV drug resistance mutations during HAART in resource-limited settings (RLS) is still a matter of debate. Design: To assess, among HIV+ patients receiving their first-line HAART, prevalence of virological failure and genotypic resistance mutations pattern in a Medecins Sans Frontieres/Ministry of Health programme in Busia District (Kenya). Methods: Patients with HAART treatment for >= 12 months were eligible for the study and those with HIV-RNA >= 5000 copies/ml underwent genotypic study. Total HIV-1 RNA from Dried Blood Spots was extracted using Nuclisens method. Results: 926 patients were included. Among 274 (29.6%) patients with detectable viral load, 55 (5.9%) experienced treatment failure (viral load >5.000 copies/ml); 61.8% were female and 10 (18.2%) had clinical failure. Median CD4 cell count was 116 cell/mm3 (IQR: 54-189). Median HIV-RNA was 32,000 copies/ml (IQR: 11000-68000). Eighteen out of 55 (33%) samples could be sequenced on PR and RT genes, with resistance associated mutations (RAMs) in 15 out of 18 samples (83%). Among patients carrying RAMs, 12/15 (81%) harboured RAMs associated to thymidine analogues (TAMs). All of them (100%) showed M184V resistance associated mutation to lamivudine as well as NNRTI's RAMS. Conclusions: Virological failure rate in resource-limited settings are similar to those observed in developed countries. Resistance mutation patterns were concordant with HAART received by failing patients. Long term detectable viral load confers greater probability of developing resistance and as a consequence, making difficult to find out a cost-effective subsequent treatment regimen. Citation: Arnedo M, Alonso E, Eisenberg N, Ibanez L, Ferreyra C, et al. (2012) Monitoring HIV Viral Load in Resource Limited Settings: Still a Matter of Debate? PLoS ONE 7(12): e47391. doi:10.1371/journal.pone.0047391	[Dalmau, David] Hosp Univ MutuaTerrassa, Dept Med, Terrassa, Spain; [Alonso, Elena; Eisenberg, Nell; Ferreyra, Cecilia; Flevaud, Laurence; Roddy, Paul] Med Sans Frontieres Operat Ctr Barcelona Athens, Barcelona, Spain; [Arnedo, Mireia; Maria Gatell, Jose] Hosp Clin Barcelona, IDIBAPS, Barcelona, Spain; [Ibanez, Laura; Jaen, Angels; Dalmau, David] Fundacio Docencia & Recerca MutuaTerrassa, Terrassa, Spain; [Khamadi, Samuel] Kenya Med Res Inst KEMRI, Nairobi, Kenya	Hospital Universitario Mutua Terrassa; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Kenya Medical Research Institute	Dalmau, D (corresponding author), Hosp Univ MutuaTerrassa, Dept Med, Terrassa, Spain.	ddalmau@mutuaterrassa.cat	Jaen, Angeles/J-9780-2013; Gatell, Jose M/ABC-3607-2020	Jaen, Angeles/0000-0002-6815-2022; FERREYRA, CECILIA/0000-0001-5480-7940; Ibanez, Laura/0000-0003-2381-7059	Roche; Boehringer Ingelheim; Abbott; BMS; GSK; Gilead, Janssen; Merck; Pfizer;  [MSF (Medecins Sans Frontieres)]	Roche(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); Abbott(Abbott Laboratories); BMS(Bristol-Myers Squibb); GSK(GlaxoSmithKline); Gilead, Janssen; Merck(Merck & Company); Pfizer(Pfizer); 	MSF (Medecins Sans Frontieres) are the sources of funding that have supported the work. There were no funding sources in the writing of the manuscript or the decision to submit it for publication neither to write this article by a pharmaceutical company or other agency. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; D Dalmau and JM Gatell have been a consultant on advisory boards, have participated in speakers' bureaus, have received research grants or have conducted clinical trials with Roche, Boehringer Ingelheim, Abbott, BMS, GSK, Gilead, Janssen, Merck and Pfizer. M. Arnedo, E. Alonso, N. Eisenberg, L. Ibanez, C. Ferreyra, A. Jaen, L. Flevaud, S. Khamadi, P. Roddy, J. Mashala, A. Alvarez and E. Velilla report no conflicts of interest relevant to this article. No other potential conflict of interest relevant to this article was reported. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2010, ANTIRETROVIRAL THERA; Bartlett JA, 2006, JAIDS-J ACQ IMM DEF, V41, P323; Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Bourgeois A, 2005, ANTIVIR THER, V10, P335; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; DART Virology Group and Trial Team, 2006, AIDS, V20, P1291; Elbeik T, 2005, J CLIN MICROBIOL, V43, P3769, DOI 10.1128/JCM.43.8.3769-3771.2005; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Garcia-Bujalance S, 2007, J MICROBIOL METH, V69, P384, DOI 10.1016/j.mimet.2007.01.018; Garcia-Lerma JG, 2009, J ANTIMICROB CHEMOTH, V64, P33, DOI 10.1093/jac/dkp150; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Laurent C, 2004, LANCET, V364, P29, DOI 10.1016/S0140-6736(04)16586-0; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; Margot NA, 2006, HIV MED, V7, P442, DOI 10.1111/j.1468-1293.2006.00404.x; Masciotra S, 2007, AIDS, V21, P2503, DOI 10.1097/QAD.0b013e3281c618db; McNulty A, 2007, J CLIN MICROBIOL, V45, P517, DOI 10.1128/JCM.02016-06; Monleau M, 2010, J ANTIMICROB CHEMOTH, V65, P1562, DOI 10.1093/jac/dkq205; Morison L, 2001, AIDS, V15, pS109, DOI 10.1097/00002030-200108004-00012; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Phillips A, 2010, 17 C RETR OPP INF FE; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Pieniazek D, 2010, 17 C RETR OPP INF FE; Saag M, 2012, 19 C RETR OPP INF MA; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Sow PS, 2007, JAIDS-J ACQ IMM DEF, V44, P262, DOI 10.1097/QAI.0b013e31802bf109; Squires K, 2004, JAIDS-J ACQ IMM DEF, V36, P1011, DOI 10.1097/00126334-200408150-00003; Stosor V, 2005, CLIN INFECT DIS, V41, P1671, DOI 10.1086/498025; Sung H, 2007, AIDS RES HUM RETROV, V23, P1223, DOI 10.1089/aid.2007.0008; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; World Health Organisation, 2007, PRIOR 2 LIN ANT DRUG; World Health Organization, 2009, ANT THER HIV INF AD; Youngpairoj AS, 2008, J ANTIMICROB CHEMOTH, V61, P1217, DOI 10.1093/jac/dkn100	38	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e47391	10.1371/journal.pone.0047391	http://dx.doi.org/10.1371/journal.pone.0047391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236346	gold, Green Published, Green Submitted			2022-12-27	WOS:000312589700003
J	Boije, H; Harun-Or-Rashid, M; Lee, YJ; Imsland, F; Bruneau, N; Vieaud, A; Gourichon, D; Tixier-Boichard, M; Bed'hom, B; Andersson, L; Hallbook, F				Boije, Henrik; Harun-Or-Rashid, Mohammad; Lee, Yu-Jen; Imsland, Freyja; Bruneau, Nicolas; Vieaud, Agathe; Gourichon, David; Tixier-Boichard, Michele; Bed'hom, Bertrand; Andersson, Leif; Hallbook, Finn			Sonic Hedgehog-Signalling Patterns the Developing Chicken Comb as Revealed by Exploration of the Pea-comb Mutation	PLOS ONE			English	Article							NEURAL CREST; OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; TRANSCRIPTION FACTORS; CANDIDATE GENE; EXPRESSION; ETS-1; FACE; SOX6; SPECIFICATION	The genetic basis and mechanisms behind the morphological variation observed throughout the animal kingdom is still relatively unknown. In the present work we have focused on the establishment of the chicken comb-morphology by exploring the Pea-comb mutant. The wild-type single-comb is reduced in size and distorted in the Pea-comb mutant. Pea-comb is formed by a lateral expansion of the central comb anlage into three ridges and is caused by a mutation in SOX5, which induces ectopic expression of the SOX5 transcription factor in mesenchyme under the developing comb. Analysis of differential gene expression identified decreased Sonic hedgehog (SHH) receptor expression in Pea-comb mesenchyme. By experimentally blocking SHH with cyclopamine, the wild-type single-comb was transformed into a Pea-comb-like phenotype. The results show that the patterning of the chicken comb is under the control of SHH and suggest that ectopic SOX5 expression in the Pea-comb change the response of mesenchyme to SHH signalling with altered comb morphogenesis as a result. A role for the mesenchyme during comb morphogenesis is further supported by the recent finding that another comb-mutant (Rose-comb), is caused by ectopic expression of a transcription factor in comb mesenchyme. The present study does not only give knowledge about how the chicken comb is formed, it also adds to our understanding how mutations or genetic polymorphisms may contribute to inherited variations in the human face.	[Boije, Henrik; Harun-Or-Rashid, Mohammad; Lee, Yu-Jen; Hallbook, Finn] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Imsland, Freyja; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Bruneau, Nicolas; Vieaud, Agathe; Tixier-Boichard, Michele; Bed'hom, Bertrand] AgroParisTech, INRA, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France; [Gourichon, David] INRA, Poultry Expt Platform Tours UE1295, F-37380 Nouzilly, France; [Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75007 Uppsala, Sweden	Uppsala University; Uppsala University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Swedish University of Agricultural Sciences	Hallbook, F (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	finn.hallbook@neuro.uu.se	Bed'Hom, Bertrand/G-7313-2011	Bed'Hom, Bertrand/0000-0002-0825-0886; Imsland, Freyja/0000-0002-9452-5566; Hallbook, Finn/0000-0001-7552-187X	Swedish Research Council [20859-01-3, 12187-15-3]; FORMAS; Barncancerfonden [PROJ09/038]; Ogonfonden and Kronprinsessan Margaretas arbetsnamnd for synskadade	Swedish Research Council(Swedish Research CouncilEuropean Commission); FORMAS(Swedish Research Council Formas); Barncancerfonden; Ogonfonden and Kronprinsessan Margaretas arbetsnamnd for synskadade	The PTCH1 vector was from Johan Ericson, Karolinska Institute. The work was supported by Swedish Research Council (20859-01-3, 12187-15-3), FORMAS, Barncancerfonden (PROJ09/038), Ogonfonden and Kronprinsessan Margaretas arbetsnamnd for synskadade. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateson W., 1902, REP EVOL COMM ROY SO, V1, P87; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Boije H, 2008, GENE EXPR PATTERNS, V8, P117, DOI 10.1016/j.modgep.2007.09.004; Brugmann SA, 2007, DEVELOPMENT, V134, P3283, DOI 10.1242/dev.005132; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Cordero D, 2004, J CLIN INVEST, V114, P485, DOI 10.1172/JCI200419596; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Goodnough LH, 2007, DEV DYNAM, V236, P1918, DOI 10.1002/dvdy.21195; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hu D, 1999, DEVELOPMENT, V126, P4873; Hu D, 2003, DEVELOPMENT, V130, P1749, DOI 10.1242/dev.00397; Hu D, 2012, DEV DYNAM, V241, P732, DOI 10.1002/dvdy.23764; Imsland F, 2012, PLOS GENET IN PRESS; Kaddatz K, 2010, J BIOL CHEM, V285, P29469, DOI 10.1074/jbc.M110.142018; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; LAWRENCE IE, 1968, J EXP ZOOL, V167, P263, DOI 10.1002/jez.1401670302; LAWRENCE IE, 1963, J EXP ZOOL, V152, P205, DOI 10.1002/jez.1401520209; LAWRENCE IE, 1971, J EXP ZOOL, V178, P195, DOI 10.1002/jez.1401780206; Lefebvre V, 2010, INT J BIOCHEM CELL B, V42, P429, DOI 10.1016/j.biocel.2009.07.016; Liu B, 2010, SEMIN CELL DEV BIOL, V21, P309, DOI 10.1016/j.semcdb.2009.09.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; Marigo V, 1996, DEVELOPMENT, V122, P1225; MAROULAKOU IG, 1994, ONCOGENE, V9, P1551; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakano T, 1996, J ANAT, V189, P643; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Perez-Alcala S, 2004, DEVELOPMENT, V131, P4455, DOI 10.1242/dev.01329; Pringle N, 2006, NONRADIOACTIVE SITU; Punnett RC, 1905, P CAMB PHILOS SOC, V13, P165; Raouf A, 2000, ONCOGENE, V19, P6455, DOI 10.1038/sj.onc.1204037; Remy P, 2000, ONCOGENE, V19, P6417, DOI 10.1038/sj.onc.1204044; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Sato S, 2010, ANIM GENET, V41, P659, DOI 10.1111/j.1365-2052.2010.02048.x; SAUNDERS JOHN WARREN, 1957, J MORPH, V101, P57, DOI 10.1002/jmor.1051010104; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Smits P, 2004, J CELL BIOL, V164, P747, DOI 10.1083/jcb.200312045; Smits P, 2003, DEVELOPMENT, V130, P1135, DOI 10.1242/dev.00331; Stephenson JC, 1915, WASHINGTON U STUDI 1, V2, P47; Tahtakran SA, 2003, GENE EXPR PATTERNS, V3, P455, DOI 10.1016/S1567-133X(03)00065-6; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Theveneau E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001142; Theveneau E, 2011, GENESIS, V49, P164, DOI 10.1002/dvg.20700; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; William CM, 2003, DEVELOPMENT, V130, P1523, DOI 10.1242/dev.00358; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200	50	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50890	10.1371/journal.pone.0050890	http://dx.doi.org/10.1371/journal.pone.0050890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227218	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200079
J	Byrne, AW; O'Keeffe, J; Green, S; Sleeman, DP; Corner, LAL; Gormley, E; Murphy, D; Martin, SW; Davenport, J				Byrne, Andrew W.; O'Keeffe, James; Green, Stuart; Sleeman, D. Paddy; Corner, Leigh A. L.; Gormley, Eamonn; Murphy, Denise; Martin, S. Wayne; Davenport, John			Population Estimation and Trappability of the European Badger (Meles meles): Implications for Tuberculosis Management	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS INFECTION; BRUSHTAIL POSSUMS; MARK-RECAPTURE; HERD-IMMUNITY; DYNAMICS; VACCINATION; WILDLIFE; DENSITY; OUTBREAK; DISEASES	Estimates of population size and trappability inform vaccine efficacy modelling and are required for adaptive management during prolonged wildlife vaccination campaigns. We present an analysis of mark-recapture data from a badger vaccine (Bacille Calmette-Guerin) study in Ireland. This study is the largest scale (755 km 2) mark-recapture study ever undertaken with this species. The study area was divided into three approximately equal-sized zones, each with similar survey and capture effort. A mean badger population size of 671 (SD: 76) was estimated using a closed-subpopulation model (CSpM) based on data from capturing sessions of the entire area and was consistent with a separate multiplicative model. Minimum number alive estimates calculated from the same data were on average 49-51% smaller than the CSpM estimates, but these are considered severely negatively biased when trappability is low. Population densities derived from the CSpM estimates were 0.82-1.06 badgers km 22, and broadly consistent with previous reports for an adjacent area. Mean trappability was estimated to be 34-35% per session across the population. By the fifth capture session, 79% of the adult badgers caught had been marked previously. Multivariable modelling suggested significant differences in badger trappability depending on zone, season and age-class. There were more putatively trap-wary badgers identified in the population than trap-happy badgers, but wariness was not related to individual's sex, zone or season of capture. Live-trapping efficacy can vary significantly amongst sites, seasons, age, or personality, hence monitoring of trappability is recommended as part of an adaptive management regime during large-scale wildlife vaccination programs to counter biases and to improve efficiencies. Citation: Byrne AW, O'Keeffe J, Green S, Sleeman DP, Corner LAL, et al. (2012) Population Estimation and Trappability of the European Badger (Meles meles): Implications for Tuberculosis Management. PLoS ONE 7(12): e50807. doi:10.1371/journal.pone.0050807	[Byrne, Andrew W.] TEAGASC, Athenry, County Galway, Ireland; [Byrne, Andrew W.; Sleeman, D. Paddy; Davenport, John] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci, Distillery Fields, Cork, Ireland; [O'Keeffe, James; Corner, Leigh A. L.; Gormley, Eamonn; Murphy, Denise] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [Green, Stuart] TEAGASC, Teagasc Rural Econ & Dev Programme Spatial Anal, Dublin, Ireland; [Martin, S. Wayne] Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada	Teagasc; University College Cork; University College Dublin; Teagasc; University of Guelph	Byrne, AW (corresponding author), TEAGASC, Mellows Campus, Athenry, County Galway, Ireland.	andrew.byrne@teagasc.ie	Gormley, Eamonn/AAU-6678-2020; Byrne, Andrew/N-3894-2015	Gormley, Eamonn/0000-0003-3900-0393; Byrne, Andrew/0000-0003-0296-4586	Teagasc; Agriculture and Food Development Authority through a Walsh Fellowship; Department of Agriculture, Food and the Marine (DAFM)	Teagasc; Agriculture and Food Development Authority through a Walsh Fellowship; Department of Agriculture, Food and the Marine (DAFM)	AWB was funded by Teagasc, the Agriculture and Food Development Authority (www.teagasc.ie), through a Walsh Fellowship. The vaccine trial was funded by the Department of Agriculture, Food and the Marine (DAFM; www.agriculture.gov.ie). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1985, PHILOS T R SOC B, V310, P327, DOI 10.1098/rstb.1985.0123; Aznar I, 2012, CENTRE FOR VETERINAR; Aznar I, 2011, VET MICROBIOL, V151, P104, DOI 10.1016/j.vetmic.2011.02.032; Blancou Jean, 2009, P97, DOI 10.1007/978-4-431-77134-0_6; Boyer N, 2010, J ANIM ECOL, V79, P538, DOI 10.1111/j.1365-2656.2010.01659.x; Byrne AW, 2013, PREV VET MED, V109, P128, DOI 10.1016/j.prevetmed.2012.08.016; Byrne AW, 2013, EUR J WILDLIFE RES, V59, P25, DOI 10.1007/s10344-012-0643-1; Byrne AW, 2012, BIOL ENVIRON, V112B, P105, DOI 10.3318/BIOE.2012.02; Caley P, 1999, NEW ZEAL VET J, V47, P133, DOI 10.1080/00480169.1999.36130; Cassidy A, 2012, SOCIOL RURALIS, V52, P192, DOI 10.1111/j.1467-9523.2012.00562.x; CHEESEMAN CL, 1981, J APPL ECOL, V18, P795, DOI 10.2307/2402370; Corner LAL, 2009, J WILDLIFE DIS, V45, P1042, DOI 10.7589/0090-3558-45.4.1042; Courtenay O, 2007, VET REC, V161, P817; Cresswell P, 1990, THE HISTORY DISTRIBU; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Delahay R, 2009, MANAGEMENT OF DISEAS; Do Linh San E, 2003, REV SUISSE ZOOL, V110, P565, DOI 10.5962/bhl.part.80199; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Feore SM, 1994, THESIS; Georgette NT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004168; Gormley E, 2011, VET J, V189, P239, DOI 10.1016/j.tvjl.2011.03.007; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Guerrero A, 1997, LANCET, V350, P1738, DOI 10.1016/S0140-6736(97)07567-3; Hardstaff JL, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-92; HILBORN R, 1976, CAN J ZOOL, V54, P1019, DOI 10.1139/z76-114; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; John TJ, 2000, EUR J EPIDEMIOL, V16, P601, DOI 10.1023/A:1007626510002; Knobel DL, 2008, J APPL ECOL, V45, P109, DOI 10.1111/j.1365-2664.2007.01387.x; KREBS CJ, 1984, CAN J ZOOL, V62, P2440, DOI 10.1139/z84-360; KREBS CJ, 1966, ECOL MONOGR, V36, P240, DOI 10.2307/1942418; Lachish S, 2010, CONSERV BIOL, V24, P841, DOI 10.1111/j.1523-1739.2009.01429.x; Macdonald DW, 2009, J MAMMAL, V90, P1392, DOI 10.1644/08-MAMM-A-356R1.1; Macdonald DW, 2002, J ZOOL, V256, P121, DOI 10.1017/S0952836902000158; Michel AL, 2006, VET MICROBIOL, V112, P91, DOI 10.1016/j.vetmic.2005.11.035; Munoz-Igualada J, 2008, J WILDLIFE MANAGE, V72, P830, DOI 10.2193/2007-198; Murphy D, 2010, RES VET SCI, V88, P1, DOI 10.1016/j.rvsc.2009.05.020; O'Brien DJ, 2011, VET MICROBIOL, V151, P179, DOI 10.1016/j.vetmic.2011.02.042; O'Corry-Crowe G., 1993, P35; OTIS DL, 1978, WILDLIFE MONOGR, P1; Palphramand KL, 2011, EUR J WILDLIFE RES, V57, P35, DOI 10.1007/s10344-010-0397-6; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; Ramsey DSL, 2010, J APPL ECOL, V47, P911, DOI 10.1111/j.1365-2664.2010.01839.x; Reid N, 2012, WILDLIFE BIOL, V18, P46, DOI 10.2981/11-016; Rogers LM, 1997, J ZOOL, V242, P705, DOI 10.1111/j.1469-7998.1997.tb05821.x; Sleeman DP, 2009, EUR J WILDLIFE RES, V55, P333, DOI 10.1007/s10344-008-0244-1; Sleeman DP, 1992, WILDLIFE TELEMETRY; Smal C, 1995, THE BADGER AND HABIT; Smith GC, 2007, VET REC, V160, P723, DOI 10.1136/vr.160.21.723; Trinkel M, 2011, J WILDLIFE DIS, V47, P494, DOI 10.7589/0090-3558-47.3.494; Tuyttens FAM, 2000, J ANIM ECOL, V69, P567, DOI 10.1046/j.1365-2656.2000.00419.x; Tuyttens FAM, 1999, J MAMMAL, V80, P950, DOI 10.2307/1383265; Tuyttens FAM, 1999, J APPL ECOL, V36, P1051, DOI 10.1046/j.1365-2664.1999.00462.x; Tuyttens FAM, 2000, CAN J ZOOL, V78, P320, DOI 10.1139/cjz-78-2-320; van Apeldoorn RC, 2006, MAMM BIOL, V71, P25, DOI 10.1016/j.mambio.2005.08.005; Wilkinson D, 2004, J APPL ECOL, V41, P492, DOI 10.1111/j.0021-8901.2004.00898.x	55	36	37	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50807	10.1371/journal.pone.0050807	http://dx.doi.org/10.1371/journal.pone.0050807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227211	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200071
J	Feng, FF; Wu, YM; Zhang, SF; Liu, Y; Qin, LJ; Wu, YJ; Yan, Z; Wu, WD				Feng, Feifei; Wu, Yiming; Zhang, Shaofeng; Liu, Yu; Qin, Lijuan; Wu, Yongjun; Yan, Zhen; Wu, Weidong			Macrophages Facilitate Coal Tar Pitch Extract-Induced Tumorigenic Transformation of Human Bronchial Epithelial Cells Mediated by NF-kappa B	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; LUNG-CANCER; BREAST-CANCER; COLON-CANCER; INFLAMMATION; CARCINOGENESIS; PROGRESSION; METASTASIS; MICROENVIRONMENT; LYMPHANGIOGENESIS	Objective: Chronic respiratory inflammation has been associated with lung cancer. Tumor-associated macrophages (TAMs) play a critical role in the formation of inflammation microenvironment. We sought to characterize the role of TAMs in coal tar pitch extract (CTPE)-induced tumorigenic transformation of human bronchial epithelial cells and the underlying mechanisms. Methods: The expression of TAMs-specific CD68 in lung cancer tissues and paired adjacent tissues from cancer patients was determined using immunostaining. Co-culture of human bronchial epithelial cells (BEAS-2B) and macrophage-like THP-1 cells were conducted to evaluate the promotive effect of macrophages on CTPE-induced tumorigenic transformation of BEAS-2B cells. BEAS-2B cells were first treated with 2.4 mu g/mL CTPE for 72 hours. After removal of CTPE, the cells were continuously cultured either with or without THP-1 cells and passaged using trypsin-EDTA. Alterations of cell cycle, karyotype, colony formation in soft agar and tumor xenograft growth in nude mice of BEAS-2B cells at passages 10, 20 and 30, indicative of tumorigenecity, were determined, respectively. In addition, mRNA and protein levels of NF-kappa B in BEAS-2B cells were measured with RT-PCR and western blot, respectively. B(a)P was used as the positive control. Results: The over-expression of TAMs-specific CD68 around lung tumor tissues was detected and associated with lung cancer progression. The tumorigenic alterations of BEAS-2B cells including increase in cell growth rate, number of cells with aneuploidy, clonogenicity in soft agar, and tumor size in nude mice in vivo occurred at passage 10, becoming significant at passages 20 and 30 of the co-culture following CTPE removal in compared to BEAS-2B cells alone. In addition, the expression levels of NF-kappa B in BEAS-2B cells were positively correlated to the malignancy of BEAS-2B cells under different conditions of treatment. Conclusion: The presence of macrophages facilitated CTPE-induced tumorigenic transformation of BEAS-2B cells, which may be mediated by NF-kappa B.	[Feng, Feifei; Wu, Yiming; Zhang, Shaofeng; Liu, Yu; Yan, Zhen] Zhengzhou Univ, Coll Publ Hlth, Dept Occupat & Environm Hlth, Zhengzhou, Henan, Peoples R China; [Qin, Lijuan; Wu, Yongjun] Zhengzhou Univ, Coll Publ Hlth, Dept Sanit Chem, Zhengzhou, Henan, Peoples R China; [Wu, Weidong] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC USA	Zhengzhou University; Zhengzhou University; University of North Carolina; University of North Carolina Chapel Hill	Feng, FF (corresponding author), Zhengzhou Univ, Coll Publ Hlth, Dept Occupat & Environm Hlth, Zhengzhou, Henan, Peoples R China.	feifeifeng9@gmail.com			Nature Science Foundation of China [81001240]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the grant from the Nature Science Foundation of China (NO.81001240) (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas I, 2011, J APPL TOXICOL; Azambuja D, 2012, ANN ONCOL, V23, P736, DOI 10.1093/annonc/mdr157; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Beresford MJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1618; Caillou B, 2011, PLOS ONE, P6; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; Cho WCS, 2011, EXPERT OPIN THER TAR, V15, P1127, DOI 10.1517/14728222.2011.599801; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Diaz-Rodriguez E, 2008, P NATL ACAD SCI USA, V105, P16719, DOI 10.1073/pnas.0803504105; Ding JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041942; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Erreni M, 2011, CANCER MICROENVIRON, V4, P141, DOI 10.1007/s12307-010-0052-5; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Gomperts BN, 2011, SEMIN RESP CRIT CARE, V32, P32, DOI 10.1055/s-0031-1272867; Gonda TA, 2009, CELL CYCLE, V8, P2005, DOI 10.4161/cc.8.13.8985; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Ju R, 2011, EUR J CANC; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; Kaler P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011700; Karabela SP, 2012, CARCINOGENESIS, V33, P859, DOI 10.1093/carcin/bgs024; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Koganti A, 2000, CARCINOGENESIS, V21, P1601, DOI 10.1093/carcin/21.8.1601; Kuramochi J, 2011, RESPIRATION, V82, P263, DOI 10.1159/000327738; Leinster DA, 2012, J PATHOL, V227, P136, DOI 10.1002/path.4002; Li ZT, 2011, J HAZARD MATER, V186, P1277, DOI 10.1016/j.jhazmat.2010.11.123; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Mizumoto Y, 2011, CLIN CANCER RES, V17, P1341, DOI 10.1158/1078-0432.CCR-10-2291; Mukhtar RA, 2011, EXPERT REV MOL DIAGN, V11, P91, DOI 10.1586/ERM.10.97; Munari F, 2011, BLOOD, V117, P6612, DOI 10.1182/blood-2010-06-293266; Muscat JE, 2003, CANCER, V97, P1732, DOI 10.1002/cncr.11242; O'Callaghan DS, 2010, J THORAC ONCOL, V5, P2024, DOI 10.1097/JTO.0b013e3181f387e4; Ohno S, 2004, ANTICANCER RES, V24, P3335; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rajagopalan H, 2004, CELL CYCLE, V3, P693; REDDEL RR, 1988, CANCER RES, V48, P1904; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Shukla R, 2011, CARCINOGENESIS, V32, P978, DOI 10.1093/carcin/bgr057; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Utrera-Barillas D, 2010, EXP MOL PATHOL, V89, P190, DOI 10.1016/j.yexmp.2010.06.002; Van Dyke AL, 2008, CANCER EPIDEM BIOMAR, V17, P148, DOI 10.1158/1055-9965.EPI-07-0517; Wang R, 2011, LUNG CANCER, V74, P188, DOI 10.1016/j.lungcan.2011.04.009; WEYAND EH, 1995, CHEM RES TOXICOL, V8, P949, DOI 10.1021/tx00049a008; Wu H, 2012, J SURG ONCOL, V106, P462, DOI 10.1002/jso.23110; Wu YM, 2000, J HENAN MED U, V35, P232; Young RP, 2011, RESPIROLOGY, V16, P1047, DOI 10.1111/j.1440-1843.2011.02019.x; Zhou Q, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-13	55	14	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51690	10.1371/journal.pone.0051690	http://dx.doi.org/10.1371/journal.pone.0051690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227270	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200129
J	Tong, XL; Lindemann, A; Monteiro, A				Tong, Xiaoling; Lindemann, Anna; Monteiro, Antonia			Differential Involvement of Hedgehog Signaling in Butterfly Wing and Eyespot Development	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PSEUDO-ACTIVE-SITE; SONIC HEDGEHOG; EVOLUTION; PROTEIN; ORTHODENTICLE; PROLIFERATION; LEPIDOPTERA; RECRUITMENT; ANTIBODIES	Butterfly eyespots may have evolved from the recruitment of pre-existent gene circuits or regulatory networks into novel locations on the wing. Gene expression data suggests one such circuit, the Hedgehog (Hh) signaling pathway and its target gene engrailed (en), was recruited from a role in patterning the anterior-posterior insect wing axis to a role patterning butterfly eyespots. However, while Junonia coenia expresses hh and en both in the posterior compartment of the wing and in eyespot centers, Bicyclus anynana lacks hh eyespot-specific expression. This suggests that Hh signaling may not be functioning in eyespot development in either species or that it functions in J. coenia but not in B. anynana. In order to test these hypotheses, we performed functional tests of Hh signaling in these species. We investigated the effects of Hh protein sequestration during the larval stage on en expression levels, and on wing size and eyespot size in adults. Hh sequestration led to significantly reduced en expression and to significantly smaller wings and eyespots in both species. But while eyespot size in B. anynana was reduced proportionately to wing size, in J. coenia, eyespots were reduced disproportionately, indicating an independent role of Hh signaling in eyespot development in J. coenia. We conclude that while Hh signaling retains a conserved role in promoting wing growth across nymphalid butterflies, it plays an additional role in eyespot development in some, but not all, lineages of nymphalid butterflies. We discuss our findings in the context of alternative evolutionary scenarios that led to the differential expression of hh and other Hh pathway signaling members across nymphalid species.	[Tong, Xiaoling; Lindemann, Anna; Monteiro, Antonia] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Tong, Xiaoling] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Yale University; Southwest University - China	Monteiro, A (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	antonia.monteiro@yale.edu	Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X; Tong, Xiaoling/0000-0002-2649-899X	REU [DO 1357]; National Science Foundation (NSF) [IOB-0653399, IOS 1146933]	REU; National Science Foundation (NSF)(National Science Foundation (NSF))	A.L. was supported by an REU DO 1357 supplement to National Science Foundation (NSF) award IOB-0653399 to AM and XT was partly supported by NSF award IOS 1146933 to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Aste-Amezaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009094; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Bejarano F, 2007, EMBO REP, V8, P778, DOI 10.1038/sj.embor.7401003; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Bossing T, 2006, DEVELOPMENT, V133, P1001, DOI 10.1242/dev.02288; Burglin TR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-241; De Rivoyre M, 2006, J BIOL CHEM, V281, P28584, DOI 10.1074/jbc.M512986200; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Fukasawa H, 2004, KIDNEY INT, V65, P63, DOI 10.1111/j.1523-1755.2004.00393.x; Hervold K, 2007, NUCLEIC ACIDS RES, V35, pD595, DOI 10.1093/nar/gkl1012; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Johnson RL, 1995, DEVELOPMENT, V121, P4161; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; Matson CK, 2012, NAT REV GENET, V13, P163, DOI 10.1038/nrg3161; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; McGregor AP, 2006, BIOESSAYS, V28, P683, DOI 10.1002/bies.20429; Monteiro A, 2001, MOL PHYLOGENET EVOL, V18, P264, DOI 10.1006/mpev.2000.0872; Nicholas K.B., 1997, EMBNETNEWS, V4, P1; Oliver JC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002893; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Saenko SV, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-9; Schroder R, 2003, NATURE, V422, P621, DOI 10.1038/nature01536; Shirai LT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-21; Stockwin LH, 2003, EXPERT OPIN BIOL TH, V3, P1133, DOI 10.1517/14712598.3.7.1133; Strigini M, 1997, DEVELOPMENT, V124, P4697; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; True JR, 2001, EVOL DEV, V3, P109, DOI 10.1046/j.1525-142x.2001.003002109.x; VISCHER NOE, 1994, BINARY BIOLINE, V6; Wang XY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001110; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	38	12	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51087	10.1371/journal.pone.0051087	http://dx.doi.org/10.1371/journal.pone.0051087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227236	Green Submitted, gold, Green Published			2022-12-27	WOS:000312588200096
J	Rodriguez, A; Negro, JJ; Mulero, M; Rodriguez, C; Hernandez-Pliego, J; Bustamante, J				Rodriguez, Airam; Negro, Juan J.; Mulero, Mara; Rodriguez, Carlos; Hernandez-Pliego, Jesus; Bustamante, Javier			The Eye in the Sky: Combined Use of Unmanned Aerial Systems and GPS Data Loggers for Ecological Research and Conservation of Small Birds	PLOS ONE			English	Article							KESTREL FALCO-NAUMANNI; LESSER KESTRELS; FORAGING HABITAT; BREEDING-SEASON; ATTRACTION; DIET	Technological advances for wildlife monitoring have expanded our ability to study behavior and space use of many species. But biotelemetry is limited by size, weight, data memory and battery power of the attached devices, especially in animals with light body masses, such as the majority of bird species. In this study, we describe the combined use of GPS data logger information obtained from free-ranging birds, and environmental information recorded by unmanned aerial systems (UASs). As a case study, we studied habitat selection of a small raptorial bird, the lesser kestrel Falco naumanni, foraging in a highly dynamic landscape. After downloading spatio-temporal information from data loggers attached to the birds, we programmed the UASs to fly and take imagery by means of an onboard digital camera documenting the flight paths of those same birds shortly after their recorded flights. This methodology permitted us to extract environmental information at quasi-real time. We demonstrate that UASs are a useful tool for a wide variety of wildlife studies.	[Rodriguez, Airam; Negro, Juan J.; Mulero, Mara] CSIC, Estn Biol Donana, Dept Evolutionary Ecol, E-41080 Seville, Spain; [Rodriguez, Carlos; Hernandez-Pliego, Jesus; Bustamante, Javier] CSIC, Estn Biol Donana, Dept Wetland Ecol, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Negro, JJ (corresponding author), CSIC, Estn Biol Donana, Dept Evolutionary Ecol, E-41080 Seville, Spain.	negro@ebd.csic.es	Bustamante, Javier/AAA-7273-2019; Bustamante, Javier/C-2735-2008; Negro, Juan Jose/I-2653-2015; Hernández-Pliego, Jesús/M-4067-2015; Rodríguez, Airam/D-5110-2011; Mulero-Pazmany, Margarita/M-5596-2013	Bustamante, Javier/0000-0001-7515-0677; Bustamante, Javier/0000-0001-7515-0677; Negro, Juan Jose/0000-0002-8697-5647; Hernández-Pliego, Jesús/0000-0002-7343-4518; Rodríguez, Airam/0000-0001-7882-135X; Mulero-Pazmany, Margarita/0000-0002-0303-9360	Junta de Andalucia (regional government) [P07-RNM-03246, P09-RNM-04588]; EC [257649]; EU	Junta de Andalucia (regional government)(Junta de Andalucia); EC(European CommissionEuropean Commission Joint Research Centre); EU(European Commission)	Financial support was obtained from the AEROMAB (reference: P07-RNM-03246) and HORUS projects (reference: P09-RNM-04588) funded by Junta de Andalucia (regional government) granted to JJN and JB, respectively, and from the PLANET project (reference: EC 7th FP Grant Agreement 257649) funded by the EU and granted to JJN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2010, CONSERV GENET, V11, P331, DOI 10.1007/s10592-009-9810-7; Bird Life International, 2011, SPEC FACTSH FALC NAU; BLACKBURN TM, 1994, OIKOS, V70, P127, DOI 10.2307/3545707; Bluff LA, 2008, BIOL LETTERS, V4, P319, DOI 10.1098/rsbl.2008.0075; Chabot D, 2012, WATERBIRDS, V35, P170, DOI 10.1675/063.035.0119; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cramp S., 1980, HDB BIRDS EUROPE MID, VII; DONAZAR JA, 1993, J APPL ECOL, V30, P515, DOI 10.2307/2404191; Duerr AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035548; Franco AMA, 2004, ANIM CONSERV, V7, P291, DOI 10.1017/S1367943004001465; Gremillet D, 2010, FRONT ECOL ENVIRON, V8, P401, DOI 10.1890/10.WB.020; Jones GP, 2006, WILDLIFE SOC B, V34, P750, DOI 10.2193/0091-7648(2006)34[750:AAOSUA]2.0.CO;2; Kenward RE., 2000, MANUAL WILDLIFE RADI; Millspaugh JJ, 2008, TRENDS ECOL EVOL, V23, P294, DOI 10.1016/j.tree.2008.03.002; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; Negro Juan J., 1997, BWP Update, V1, P49; Negro Juan Jose, 2007, P401; Perez-Granados C, 2010, ARDEOLA, V57, P443; Pomarol Manel, 1993, P24; Ribeiro EF, 2007, THESIS U AVEIRO AVEI; Rodriguez A, 2012, ANIM CONSERV, V15, P519, DOI 10.1111/j.1469-1795.2012.00544.x; Rodriguez A, 2009, DIVERS DISTRIB, V15, P1010, DOI 10.1111/j.1472-4642.2009.00600.x; Rodriguez A, 2009, IBIS, V151, P299, DOI 10.1111/j.1474-919X.2009.00925.x; Rodriguez C, 2009, AGR ECOSYST ENVIRON, V129, P361, DOI 10.1016/j.agee.2008.10.010; Rodriguez C, 2010, J RAPTOR RES, V44, P120, DOI 10.3356/JRR-09-34.1; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Rutz C, 2008, TRENDS ECOL EVOL, V23, P292, DOI 10.1016/j.tree.2008.01.011; Rutz C, 2007, SCIENCE, V318, P765, DOI 10.1126/science.1146788; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007322; Sarda-Palomera F, 2012, IBIS, V154, P177, DOI 10.1111/j.1474-919X.2011.01177.x; Shepard ELC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027375; Tella JL, 1998, CONSERV BIOL, V12, P593, DOI 10.1046/j.1523-1739.1998.96288.x; Ursua E, 2005, BIOL CONSERV, V122, P643, DOI 10.1016/j.biocon.2004.10.002; van Diermen Jan, 2009, Takkeling, V17, P109; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0; Watts AC, 2010, J WILDLIFE MANAGE, V74, P1614, DOI 10.2193/2009-425; Zavalaga CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019966	39	42	46	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50336	10.1371/journal.pone.0050336	http://dx.doi.org/10.1371/journal.pone.0050336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239979	Green Published, gold			2022-12-27	WOS:000312290800017
J	Gui, YX; Xu, ZP; Lv, W; Liu, HM; Zhao, JJ; Hu, XY				Gui, Ya-xing; Xu, Zhong-ping; Lv, Wen; Liu, Hong-mei; Zhao, Jin-Jia; Hu, Xing-Yue			Association of Mitochondrial DNA Polymerase gamma Gene POLG1 Polymorphisms with Parkinsonism in Chinese Populations	PLOS ONE			English	Article							IN-VITRO; DISEASE; MUTATION; VARIANTS; TRANSCRIPTION; FAMILY; TRACT; CELLS	Background: Mitochondrial DNA polymerase gamma (POLG1) mutations were associated with levodopa-responsive Parkinsonism. POLG1 gene contains a number of common nonsynonymous SNPs and intronic regulatory SNPs which may have functional consequences. It is of great interest to discover polymorphisms variants associated with Parkinson's disease (PD), both in isolation and in combination with specific SNPs. Materials and Methods: We conducted a case-control study and genotyped twenty SNPs and poly-Q polymorphisms of POLG1 gene including in 344 Chinese sporadic PD patients and 154 healthy controls. All the polymorphisms of POLG1 we found in this study were sequenced by PCR products with dye terminator methods using an ABI-3100 sequencer. Hardy-Weinberg equilibrium and linkage disequilibrium (LD) for association between twenty POLG1 SNPs and PD were calculated using the program Haploview. Principal Results: We provided evidence for strong association of four intronic SNPs of the POLG1 gene (new report: c. 2070-12T>A and rs2307439: c.2070-64G>A in intron 11, P = 0.00011, OR = 1.727; rs2302084: c. 3105-11T>C and rs2246900: c.3105-36A>G in intron 19, P = 0.00031, OR = 1.648) with PD. However, we did not identify any significant association between ten exonic SNPs of POLG1 and PD. Linkage disequilibrium analysis indicated that c.2070-12T>A and c.2070-64G>A could be parsed into one block as Haplotype 1 as well as c.3105-11T>C and c.3105-36A>G in Haplotype 2. In addition, case and control study on association of POLG1 CAG repeat (poly-Q) alleles with PD showed a significant association (P = 0.03, OR = 2.16) of the non-10/11Q variants with PD. Although intronic SNPs associated with PD didn't influence POLG1 mRNA alternative splicing, there was a strong association of c.2070-12T>A and c.2070-64G>A with decreased POLG1 mRNA level and protein levels. Conclusions: Our findings indicate that POLG1 may play a role in the pathogenesis of PD in Chinese populations.	[Gui, Ya-xing; Lv, Wen; Zhao, Jin-Jia; Hu, Xing-Yue] Zhejiang Univ, Dept Neurol, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Hong-mei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Xu, Zhong-ping] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Zhejiang University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chicago	Hu, XY (corresponding author), Zhejiang Univ, Dept Neurol, Sir Run Run Shaw Hosp, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	Huxingyue2003@163.com		GUI, YAXING/0000-0002-0466-3608				Anvret A, 2010, NEUROSCI LETT, V485, P117, DOI 10.1016/j.neulet.2010.08.082; Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153; Bereznai B, 2009, IDEGGYOGY SZEMLE, V62, P155; Bruggenwirth HT, 1997, AM J HUM GENET, V61, P1067, DOI 10.1086/301605; Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; de Almeida SF, 2012, TRENDS BIOCHEM SCI, V37, P248, DOI 10.1016/j.tibs.2012.02.002; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Di Fonzo A, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9203; Eerola J, 2010, NEUROSCI LETT, V477, P1, DOI 10.1016/j.neulet.2010.04.021; Fujimaru M, 1998, HUM GENET, V103, P462, DOI 10.1007/s004390050851; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Grzesiak JJ, 2005, ENDOCRINOLOGY, V146, P3567, DOI 10.1210/en.2005-0351; Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553; Hudson G, 2009, MOVEMENT DISORD, V24, P1092, DOI 10.1002/mds.22310; Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Montes M, 2012, GENE, V501, P104, DOI 10.1016/j.gene.2012.04.006; Moyer RA, 2011, NEUROPSYCHOPHARMACOL, V36, P753, DOI 10.1038/npp.2010.208; Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009; Rigo F, 2008, MOL CELL BIOL, V28, P849, DOI 10.1128/MCB.01410-07; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Wang D, 2011, PHARMACOGENOMICS J, V11, P274, DOI 10.1038/tpj.2010.28; Westerlund M, 2010, PROG NEUROBIOL, V90, P146, DOI 10.1016/j.pneurobio.2009.11.001; Yu CA, 2003, GENOMICS, V82, P575, DOI 10.1016/S0888-7543(03)00175-7	31	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50086	10.1371/journal.pone.0050086	http://dx.doi.org/10.1371/journal.pone.0050086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251356	Green Published, Green Submitted, gold			2022-12-27	WOS:000312201900005
J	Brody, MJ; Hacker, TA; Patel, JR; Feng, L; Sadoshima, J; Tevosian, SG; Balijepalli, RC; Moss, RL; Lee, Y				Brody, Matthew J.; Hacker, Timothy A.; Patel, Jitandrakumar R.; Feng, Li; Sadoshima, Junichi; Tevosian, Sergei G.; Balijepalli, Ravi C.; Moss, Richard L.; Lee, Youngsook			Ablation of the Cardiac-Specific Gene Leucine-Rich Repeat Containing 10 (Lrrc10) Results in Dilated Cardiomyopathy	PLOS ONE			English	Article							PROTEIN-KINASE-C; SIGNAL-TRANSDUCTION PATHWAYS; HEART-FAILURE; MUSCLE ACTIN; SEVERE FORM; IN-VIVO; EPSILON; EXPRESSION; MUTATIONS; HYPERTROPHY	Leucine-rich repeat containing 10 (LRRC10) is a cardiac-specific protein exclusively expressed in embryonic and adult cardiomyocytes. However, the role of LRRC10 in mammalian cardiac physiology remains unknown. To determine if LRRC10 is critical for cardiac function, Lrrc10-null (Lrrc10(-/-))mice were analyzed. Lrrc10(-/-) mice exhibit prenatal systolic dysfunction and dilated cardiomyopathy in postnatal life. Importantly, Lrrc10(-/-) mice have diminished cardiac performance in utero, prior to ventricular dilation observed in young adults. We demonstrate that LRRC10 endogenously interacts with alpha-actinin and alpha-actin in the heart and all actin isoforms in vitro. Gene expression profiling of embryonic Lrrc10(-/-) hearts identified pathways and transcripts involved in regulation of the actin cytoskeleton to be significantly upregulated, implicating dysregulation of the actin cytoskeleton as an early defective molecular signal in the absence of LRRC10. In contrast, microarray analyses of adult Lrrc10(-/-) hearts identified upregulation of oxidative phosphorylation and cardiac muscle contraction pathways during the progression of dilated cardiomyopathy. Analyses of hypertrophic signal transduction pathways indicate increased active forms of Akt and PKC epsilon in adult Lrrc10(-/-) hearts. Taken together, our data demonstrate that LRRC10 is essential for proper mammalian cardiac function. We identify Lrrc10 as a novel dilated cardiomyopathy candidate gene and the Lrrc10(-/-) mouse model as a unique system to investigate pediatric cardiomyopathy.	[Brody, Matthew J.; Patel, Jitandrakumar R.; Moss, Richard L.; Lee, Youngsook] Univ Wisconsin Madison, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Brody, Matthew J.; Lee, Youngsook] Univ Wisconsin Madison, Mol & Environm Toxicol Ctr, Madison, WI USA; [Hacker, Timothy A.; Feng, Li; Balijepalli, Ravi C.] Univ Wisconsin Madison, Dept Med, Madison, WI USA; [Sadoshima, Junichi] Univ Med & Dent New Jersey, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Tevosian, Sergei G.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Rutgers State University New Brunswick; Rutgers State University Medical Center; State University System of Florida; University of Florida	Lee, Y (corresponding author), Univ Wisconsin Madison, Dept Cell & Regenerat Biol, Madison, WI 53706 USA.	youngsooklee@wisc.edu		Brody, Matthew/0000-0003-4904-7670; Sadoshima, Junichi/0000-0003-3724-4132	National Institutes of Health [HL067050, HD042751, HL097127]; American Heart Association [11PRE5580012]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042751] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102738, R01HL112330, R01HL067050, R21HL097127, R01HL105713, R37HL082900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants HL067050 to YL and HD042751 and HL097127 to SGT. from the National Institutes of Health (http://www.nih.gov/) and predoctoral fellowship 11PRE5580012 to MJB from the American Heart Association (http://www.americanheart.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adameyko II, 2005, DEV DYNAM, V233, P540, DOI 10.1002/dvdy.20368; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Asakura M, 2009, CIRC J, V73, P1568, DOI 10.1253/circj.CJ-09-0465; Babbitt CJ, 2002, HISTOCHEM CELL BIOL, V118, P431, DOI 10.1007/s00418-002-0476-1; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; Barrans JD, 2002, AM J PATHOL, V160, P2035, DOI 10.1016/S0002-9440(10)61153-4; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; CHASE PB, 1994, BIOPHYS J, V67, P1994, DOI 10.1016/S0006-3495(94)80682-4; Cheng HQ, 2010, CIRC RES, V107, P348, DOI 10.1161/CIRCRESAHA.110.218735; Colak D, 2009, GENOMICS, V94, P20, DOI 10.1016/j.ygeno.2009.03.003; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Duboscq-Bidot L, 2008, CARDIOVASC RES, V77, P118, DOI 10.1093/cvr/cvm015; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Frank D, 2008, HYPERTENSION, V51, P309, DOI 10.1161/HYPERTENSIONAHA.107.098046; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Fujita M, 2012, DEV BIOL, V361, P79, DOI 10.1016/j.ydbio.2011.10.008; Goldspink PH, 2004, CIRC RES, V95, P424, DOI 10.1161/01.RES.0000138299.85648.92; Grzeskowiak R, 2003, CARDIOVASC RES, V59, P400, DOI 10.1016/S0008-6363(03)00426-7; GU X, 1994, CIRC RES, V75, P926, DOI 10.1161/01.RES.75.5.926; Hankiewicz JH, 2008, AM J PHYSIOL-HEART C, V294, pH330, DOI 10.1152/ajpheart.01109.2007; Haq S, 2001, CIRCULATION, V103, P670; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; Hassel D, 2009, NAT MED, V15, P1281, DOI 10.1038/nm.2037; Hoshijima M, 2006, AM J PHYSIOL-HEART C, V290, pH1313, DOI 10.1152/ajpheart.00816.2005; Huang XP, 1997, J CELL SCI, V110, P1625; Huang XP, 2004, J CELL SCI, V117, P1971, DOI 10.1242/jcs.01044; Iwata M, 2005, BIOCHEM BIOPH RES CO, V327, P1105, DOI 10.1016/j.bbrc.2004.12.128; Jung J, 2005, J BIOL CHEM, V280, P30916, DOI 10.1074/jbc.M414482200; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kehat I, 2011, CIRC RES, V108, P176, DOI 10.1161/CIRCRESAHA.110.231514; Kim KH, 2007, DEV DYNAM, V236, P2225, DOI 10.1002/dvdy.21225; Kim KH, 2007, DEV BIOL, V308, P494, DOI 10.1016/j.ydbio.2007.06.005; Kimura Akinori, 2008, Circ J, V72 Suppl A, pA38, DOI 10.1253/circj.CJ-08-0050; Knoll R, 2007, CIRCULATION, V116, P515, DOI 10.1161/CIRCULATIONAHA.107.689984; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; Li R, 2012, AM J PATHOL; Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715; Luther PK, 2009, J MUSCLE RES CELL M, V30, P171, DOI 10.1007/s10974-009-9189-6; Manuylov NL, 2008, GENESIS, V46, P441, DOI 10.1002/dvg.20422; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Miyamoto S, 2009, CARDIOVASC RES, V82, P272, DOI 10.1093/cvr/cvp087; Miyamoto T, 2004, BASIC RES CARDIOL, V99, P328, DOI 10.1007/s00395-004-0482-7; Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2; Molkentin JD, 2000, MOL CELL BIOL, V20, P5256, DOI 10.1128/MCB.20.14.5256-5260.2000; Mysliwiec MR, 2012, J BIOL CHEM, V287, P1235, DOI 10.1074/jbc.M111.315945; Mysliwiec MR, 2007, FEBS LETT, V581, P2633, DOI 10.1016/j.febslet.2007.05.006; Mysliwiec MR, 2011, J BIOL CHEM; Nakane T, 2004, BIOCHEM BIOPH RES CO, V314, P1086, DOI 10.1016/j.bbrc.2003.12.202; Nugent AW, 2003, NEW ENGL J MED, V348, P1639, DOI 10.1056/NEJMoa021737; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; Patel JR, 2001, AM J PHYSIOL-HEART C, V280, pH2732, DOI 10.1152/ajpheart.2001.280.6.H2732; Pepe M, 2010, CIRC RES, V106, P1893, DOI 10.1161/CIRCRESAHA.110.220855; Ping PP, 2001, CIRC RES, V88, P59, DOI 10.1161/01.RES.88.1.59; Polge C, 2011, FASEB J, V25, P3790, DOI 10.1096/fj.11-180968; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Robia SL, 2005, AM J PHYSIOL-HEART C, V289, pH1941, DOI 10.1152/ajpheart.01111.2004; Russell B, 2010, J MOL CELL CARDIOL, V48, P817, DOI 10.1016/j.yjmcc.2010.02.016; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; Sopko N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020184; Strait JB, 2001, AM J PHYSIOL-HEART C, V280, pH756, DOI 10.1152/ajpheart.2001.280.2.H756; Takeishi Y, 2000, CIRC RES, V86, P1218, DOI 10.1161/01.RES.86.12.1218; Toko H, 2010, CIRCULATION, V122, P891, DOI 10.1161/CIRCULATIONAHA.109.935296; Tsukada T, 2011, J BIOL CHEM, V286, P2194, DOI 10.1074/jbc.M110.186924; van der Meer DLM, 2006, DEV BIOL, V299, P356, DOI 10.1016/j.ydbio.2006.07.032; VANDEKERCKHOVE J, 1979, DIFFERENTIATION, V14, P123, DOI 10.1111/j.1432-0436.1979.tb01021.x; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Vollrath AL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-280; Wang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021767; Wang R, 2010, BIOL CELL, V102, P173, DOI 10.1042/BC20090091; Wang YY, 2010, CARDIOVASC RES, V87, P636, DOI 10.1093/cvr/cvq133; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Will RD, 2010, CIRC RES, V107, P1253, DOI 10.1161/CIRCRESAHA.110.222372; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Zheng M, 2009, HUM MOL GENET, V18, P701, DOI 10.1093/hmg/ddn400; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092; Zhou YQ, 2002, PHYSIOL GENOMICS, V10, P113, DOI 10.1152/physiolgenomics.00119.2001	88	24	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51621	10.1371/journal.pone.0051621	http://dx.doi.org/10.1371/journal.pone.0051621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236519	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100135
J	Cheraghi, Z; Poorolajal, J; Hashem, T; Esmailnasab, N; Irani, AD				Cheraghi, Zahra; Poorolajal, Jalal; Hashem, Tahereh; Esmailnasab, Nader; Irani, Amin Doosti			Effect of Body Mass Index on Breast Cancer during Premenopausal and Postmenopausal Periods: A Meta-Analysis	PLOS ONE			English	Review							PROGESTERONE-RECEPTOR STATUS; PHYSICAL-ACTIVITY; RISK-FACTORS; FAT DISTRIBUTION; HORMONE-THERAPY; ANTHROPOMETRIC MEASUREMENTS; MENOPAUSAL STATUS; WEIGHT-GAIN; SIZE; WOMEN	Objective: There is no universal consensus on the relationship between body mass index (BMI) and breast cancer. This meta-analysis was conducted to estimate the overall effect of overweight and obesity on breast cancer risk during pre- and post-menopausal period. Data Sources: All major electronic databases were searched until April 2012 including Web of Knowledge, Medline, Scopus, and ScienceDirect. Furthermore, the reference lists and related scientific conference databases were searched. Review Methods: All prospective cohort and case-control studies investigating the association between BMI and breast cancer were retrieved irrespective of publication date and language. Women were assessed irrespective of age, race and marital status. The exposure of interest was BMI. The primary outcome of interest was all kinds of breast cancers confirmed pathologically. Study quality was assessed using the checklist of STROBE. Study selection and data extraction were performed by two authors separately. The effect measure of choice was risk ratio (RRi) and rate ratio (RRa) for cohort studies and odds ratio (OR) in case-control studies. Results: Of 9163 retrieved studies, 50 studies were included in meta-analysis including 15 cohort studies involving 2,104,203 subjects and 3,414,806 person-years and 35 case-control studies involving 71,216 subjects. There was an inverse but non-significant correlation between BMI and breast cancer risk during premenopausal period: OR = 0.93 (95% CI 0.86, 1.02); RRi = 0.97 (95% CI 0.82, 1.16); and RRa = 0.99 (95% CI 0.94, 1.05), but a direct and significant correlation during postmenopausal period: OR = 1.15 (95% CI 1.07, 1.24); RRi = 1.16 (95% CI 1.08, 1.25); and RRa = 0.98 (95% CI 0.88, 1.09). Conclusion: The results of this meta-analysis showed that body mass index has no significant effect on the incidence of breast cancer during premenopausal period. On the other hand, overweight and obesity may have a minimal effect on breast cancer, although significant, but really small and not clinically so important.	[Poorolajal, Jalal] Hamadan Univ Med Sci, Sch Publ Hlth, Res Ctr Hlth Sci, Hamadan, Iran; [Cheraghi, Zahra; Poorolajal, Jalal; Irani, Amin Doosti] Hamadan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Hamadan, Iran; [Hashem, Tahereh] Hamadan Univ Med Sci, Fatemieh Hosp, Hamadan, Iran; [Esmailnasab, Nader] Kurdistan Univ Med Sci, Sch Med, Dept Community Med, Kurdistan, Iran	Kurdistan University of Medical Sciences	Poorolajal, J (corresponding author), Hamadan Univ Med Sci, Sch Publ Hlth, Res Ctr Hlth Sci, Hamadan, Iran.	poorolajal@umsha.ac.ir	Doosti-Irani, Amin/Q-1260-2016; Cheraghi, Zahra/AAF-6877-2019; Poorolajal, Jalal/D-3506-2013; Cheraghi, Zahra/H-6376-2013	Doosti-Irani, Amin/0000-0003-0623-7503; Cheraghi, Zahra/0000-0001-9041-559X; Cheraghi, Zahra/0000-0001-6076-4916	Research and Technology of Hamadan University of Medical Sciences	Research and Technology of Hamadan University of Medical Sciences	This study was funded by the Vice-Chancellor of Research and Technology of Hamadan University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebamowo CA, 2003, BREAST CANCER RES, V5, pR18, DOI 10.1186/bcr567; Barlow WE, 2006, JNCI-J NATL CANCER I, P98; Barnes BBE, 2011, CANCER EPIDEMIOL, V35, P345, DOI 10.1016/j.canep.2010.11.003; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berstad P, 2010, CANCER EPIDEM BIOMAR, V19, P1532, DOI 10.1158/1055-9965.EPI-10-0025; Brinton LA, 2008, CANCER EPIDEM BIOMAR, V17, P3150, DOI 10.1158/1055-9965.EPI-08-0435; Chow LWC, 2005, ASIAN J SURG, V28, P1791; Coates RJ, 1999, BRIT J CANCER, V81, P167, DOI 10.1038/sj.bjc.6690667; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Enger SM, 2000, CANCER EPIDEM BIOMAR, V9, P681; Friedenreich CM, 2002, INT J CANCER, V99, P445, DOI 10.1002/ijc.10389; Gordis L, 2008, EPIDEMIOLOGY; Hall IJ, 2000, AM J EPIDEMIOL, V151, P754, DOI 10.1093/oxfordjournals.aje.a010275; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hirose K, 2003, INT J CANCER, V107, P276, DOI 10.1002/ijc.11373; Hu YH, 1997, BREAST CANCER RES TR, V43, P65, DOI 10.1023/A:1005745824388; Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407; John EM, 2011, AM J EPIDEMIOL, V173, P201, DOI 10.1093/aje/kwq345; Jordan S, 2009, BREAST, V18, P299, DOI 10.1016/j.breast.2009.09.004; Kaaks R, 1998, INT J CANCER, V76, P647, DOI 10.1002/(SICI)1097-0215(19980529)76:5&lt;647::AID-IJC6&gt;3.0.CO;2-Q; Kerlikowske K, 2008, J NATL CANCER I, V100, P1724, DOI 10.1093/jnci/djn388; Kim Y, 2009, CANCER EPIDEM BIOMAR, V18, P508, DOI 10.1158/1055-9965.EPI-08-0133; Kruk J, 2003, CANCER DETECT PREV, V27, P187, DOI 10.1016/S0361-090X(03)00032-1; Kruk J, 2007, ASIAN PAC J CANCER P, V8, P513; Lacey JV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-84; LaVecchia C, 1997, BRIT J CANCER, V75, P441, DOI 10.1038/bjc.1997.73; Lee S, 2006, INT J CANCER, V118, P1285, DOI 10.1002/ijc.21481; Li CI, 2000, INT J EPIDEMIOL, V29, P208, DOI 10.1093/ije/29.2.208; Li CI, 2006, CANCER CAUSE CONTROL, V17, P695, DOI 10.1007/s10552-005-0001-7; Loi S, 2005, CANCER EPIDEM BIOMAR, V14, P1686, DOI 10.1158/1055-9965.EPI-05-0042; Magnusson C, 1998, INT J CANCER, V76, P29, DOI 10.1002/(SICI)1097-0215(19980330)76:1<29::AID-IJC6>3.3.CO;2-1; Magnusson CMK, 2005, BRIT J CANCER, V93, P817, DOI 10.1038/sj.bjc.6602758; Mathew A, 2008, BRIT J CANCER, V99, P207, DOI 10.1038/sj.bjc.6604423; McCredie MRE, 1998, CANCER CAUSE CONTROL, V9, P189, DOI 10.1023/A:1008886328352; Mezzetti M, 1998, J NATL CANCER I, V90, P389, DOI 10.1093/jnci/90.5.389; Michels KB, 2006, ARCH INTERN MED, V166, P2395, DOI 10.1001/archinte.166.21.2395; Montazeri A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-278; Palmer JR, 2007, CANCER EPIDEM BIOMAR, V16, P1795, DOI 10.1158/1055-9965.EPI-07-0336; Rev Man, 2008, REV MAN REVMAN COMP; Rosato V, 2011, ANN ONCOL, V22, P2687, DOI 10.1093/annonc/mdr025; Ryu SY, 2001, J KOREAN MED SCI, V16, P610, DOI 10.3346/jkms.2001.16.5.610; Sangaramoorthy M, 2011, CANCER EPIDEM BIOMAR, V20, P2572, DOI 10.1158/1055-9965.EPI-11-0848; Sellers TA, 2002, AM J EPIDEMIOL, V155, P225, DOI 10.1093/aje/155.3.225; Setiawan VW, 2009, AM J EPIDEMIOL, V169, P1251, DOI 10.1093/aje/kwp036; Shin A, 2009, BREAST CANCER RES TR, V113, P153, DOI 10.1007/s10549-008-9903-x; Shoff SM, 2000, CANCER EPIDEM BIOMAR, V9, P591; Shu XO, 2001, INT J CANCER, V94, P449, DOI 10.1002/ijc.1487; Sonnenschein E, 1999, INT J EPIDEMIOL, V28, P1026, DOI 10.1093/ije/28.6.1026; Suzuki R, 2009, INT J CANCER, V124, P698, DOI 10.1002/ijc.23943; Suzuki R, 2006, INT J CANCER, V119, P1683, DOI 10.1002/ijc.22034; Tehard B, 2006, INT J OBESITY, V30, P156, DOI 10.1038/sj.ijo.0803133; Tian YF, 2007, ENDOCR-RELAT CANCER, V14, P669, DOI 10.1677/ERC-06-0089; Titus-Ernstoff L, 1998, CANCER EPIDEM BIOMAR, V7, P783; TrenthamDietz A, 1997, AM J EPIDEMIOL, V145, P1011, DOI 10.1093/oxfordjournals.aje.a009057; Tung HT, 1999, JPN J CLIN ONCOL, V29, P137, DOI 10.1093/jjco/29.3.137; van de Water W, 2012, JAMA-J AM MED ASSOC, V307, P590, DOI 10.1001/jama.2012.84; vandenBrandt PA, 1997, CANCER CAUSE CONTROL, V8, P39, DOI 10.1023/A:1018479020716; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Verla-Tebit E, 2005, EUR J CANCER PREV, V14, P419, DOI 10.1097/00008469-200508000-00016; Weiderpass E, 2004, CANCER EPIDEM BIOMAR, V13, P1121; World Health Organization, 2006, EMRO TECHN PUBL SER; World Health Organization, 2012, 10 FACTS OB; World Health Organization (WHO), 2012, BREAST CANC PREV CON; Wrensch M, 2003, BREAST CANCER RES, V5, pR88, DOI 10.1186/bcr605	66	170	172	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51446	10.1371/journal.pone.0051446	http://dx.doi.org/10.1371/journal.pone.0051446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236502	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100120
J	Jin, JH; Zhang, B; Guo, HY; Cui, JY; Jiang, L; Song, SH; Sun, M; Ren, FZ				Jin, Junhua; Zhang, Bing; Guo, Huiyuan; Cui, Jianyun; Jiang, Lu; Song, Shuhui; Sun, Min; Ren, Fazheng			Mechanism Analysis of Acid Tolerance Response of Bifidobacterium longum subsp longum BBMN 68 by Gene Expression Profile Using RNA-Sequencing	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; STREPTOCOCCUS-MUTANS; ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; TRANSCRIPTIONAL ANALYSIS; STRESS RESPONSES; BREVE UCC-2003; IN-VIVO; LOW-PH; BACTERIA	To analyze the mechanism of the acid tolerance response (ATR) in Bifidobacterium longum subsp. longum BBMN68, we optimized the acid-adaptation condition to stimulate ATR effectively and analyzed the change of gene expression profile after acid-adaptation using high-throughput RNA-Seq. After acid-adaptation at pH 4.5 for 2 hours, the survival rate of BBMN68 at lethal pH 3.5 for 120 min was increased by 70 fold and the expression of 293 genes were upregulated by more than 2 fold, and 245 genes were downregulated by more than 2 fold. Gene expression profiling of ATR in BBMN68 suggested that, when the bacteria faced acid stress, the cells strengthened the integrity of cell wall and changed the permeability of membrane to keep the H+ from entering. Once the H+ entered the cytoplasm, the cells showed four main responses: First, the F0F1-ATPase system was initiated to discharge H+. Second, the ability to produce NH3 by cysteine-cystathionine-cycle was strengthened to neutralize excess H+. Third, the cells started NER-UVR and NER-VSR systems to minimize the damage to DNA and upregulated HtpX, IbpA, and gamma-glutamylcysteine production to protect proteins against damage. Fourth, the cells initiated global response signals ((p) ppGpp, polyP, and Sec-SRP) to bring the whole cell into a state of response to the stress. The cells also secreted the quorum sensing signal (AI-2) to communicate between intraspecies cells by the cellular signal system, such as two-component systems, to improve the overall survival rate. Besides, the cells varied the pathways of producing energy by shifting to BCAA metabolism and enhanced the ability to utilize sugar to supply sufficient energy for the operation of the mechanism mentioned above. Based on these reults, it was inferred that, during industrial applications, the acid resistance of bifidobacteria could be improved by adding BCAA, gamma-glutamylcysteine, cysteine, and cystathionine into the acid-stress environment.	[Jin, Junhua; Guo, Huiyuan; Cui, Jianyun; Jiang, Lu; Ren, Fazheng] China Agr Univ, Coll Food Sci & Nutr Engn, Key Lab Funct Dairy, Beijing 100094, Peoples R China; [Zhang, Bing; Song, Shuhui; Sun, Min] Chinese Acad Sci, Beijing Inst Genom, Core Genom Facil, Beijing, Peoples R China; [Guo, Huiyuan] Beijing Higher Inst, Engn Res Ctr Anim Prod, Beijing, Peoples R China; [Jiang, Lu; Ren, Fazheng] Beijing Key Lab Nutr Hlth & Food Safety, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Ren, FZ (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Key Lab Funct Dairy, Beijing 100094, Peoples R China.	renfazheng@263.net	song, shuhui/D-6015-2014	Zhao, Liang/0000-0001-9244-3121	Ministry of Science and Technology of China [2011AA100903, 2011BAD23B04]; Beijing Science and Technology Project [D101105046010001]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Beijing Science and Technology Project	1. The Ministry of Science and Technology of China (Grant NO. 2011AA100903, http://www.863.gov.cn/; 2011BAD23B04, http://kjzc.jhgl.org/); 2. The Beijing Science and Technology Project (Grant NO. D101105046010001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broadbent JR, 2010, J BACTERIOL, V192, P2445, DOI 10.1128/JB.01618-09; Brockmann-Gretza O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-230; Cappa F, 2005, RES MICROBIOL, V156, P1039, DOI 10.1016/j.resmic.2005.06.003; Champagne CP, 2005, CRIT REV FOOD SCI, V45, P61, DOI 10.1080/10408690590900144; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Cui P, 2010, GENOMICS, V96, P259, DOI 10.1016/j.ygeno.2010.07.010; De Angelis M, 2001, MICROBIOL-SGM, V147, P1863, DOI 10.1099/00221287-147-7-1863; Even S, 2002, MOL MICROBIOL, V45, P1143, DOI 10.1046/j.1365-2958.2002.03086.x; Gutierrez JA, 1999, MICROBIOL-UK, V145, P357, DOI 10.1099/13500872-145-2-357; HAMILTON IR, 1991, ORAL MICROBIOL IMMUN, V6, P65, DOI 10.1111/j.1399-302X.1991.tb00453.x; Hanna MN, 2001, J BACTERIOL, V183, P5964, DOI 10.1128/JB.183.20.5964-5973.2001; Hao YL, 2011, J BACTERIOL, V193, P787, DOI 10.1128/JB.01213-10; Jayaraman GC, 1997, MOL MICROBIOL, V25, P329, DOI 10.1046/j.1365-2958.1997.4671835.x; Jiang M, 2007, BIOCHEMISTRY-US, V46, P10979, DOI 10.1021/bi700810x; Jin JH, 2011, CURR MICROBIOL, V62, P612, DOI 10.1007/s00284-010-9751-x; Kim EK, 2008, BIOCHEM BIOPH RES CO, V369, P1047, DOI 10.1016/j.bbrc.2008.02.139; Kitagawa M, 2002, EUR J BIOCHEM, V269, P2907, DOI 10.1046/j.1432-1033.2002.02958.x; Kremer BHA, 2001, J BACTERIOL, V183, P2543, DOI 10.1128/JB.183.8.2543-2552.2001; Lee YJ, 2009, TETRAHEDRON, V65, P6310, DOI 10.1016/j.tet.2009.06.032; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Masco L, 2005, INT J FOOD MICROBIOL, V102, P221, DOI 10.1016/j.ijfoodmicro.2004.11.018; Matsui R, 2010, FUTURE MICROBIOL, V5, P403, DOI 10.2217/FMB.09.129; Matsumoto M, 2004, INT J FOOD MICROBIOL, V93, P109, DOI 10.1016/j.ijfoodmicro.2003.10.009; Matuszewska E, 2009, ACTA BIOCHIM POL, V56, P55; Maus JE, 2003, J APPL MICROBIOL, V95, P146, DOI 10.1046/j.1365-2672.2003.01954.x; Moslehi-Jenabian S, 2009, INT J FOOD MICROBIOL, V135, P295, DOI 10.1016/j.ijfoodmicro.2009.08.011; O'May GA, 2005, J CLIN MICROBIOL, V43, P3059, DOI 10.1128/JCM.43.7.3059-3065.2005; Parry-Hanson AA, 2010, MICROBIOL RES, V165, P546, DOI 10.1016/j.micres.2009.11.003; Peng L, 2012, FUTURE MICROBIOL, V7, P411, DOI [10.2217/FMB.12.3, 10.2217/fmb.12.3]; Qian YL, 2011, INT J FOOD MICROBIOL, V145, P320, DOI 10.1016/j.ijfoodmicro.2010.11.026; Rallu F, 1996, ANTON LEEUW INT J G, V70, P243, DOI 10.1007/BF00395935; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Saarela M, 2004, J APPL MICROBIOL, V96, P1205, DOI 10.1111/j.1365-2672.2004.02286.x; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Sanchez B, 2007, APPL ENVIRON MICROB, V73, P6450, DOI 10.1128/AEM.00886-07; Senadheera D, 2009, J BACTERIOL, V191, P6415, DOI 10.1128/JB.00793-09; Serrazanetti DI, 2011, APPL ENVIRON MICROB, V77, P2656, DOI 10.1128/AEM.01826-10; Shao HJ, 2010, PERIODONTOL 2000, V52, P53, DOI 10.1111/j.1600-0757.2009.00318.x; SVITIL AL, 1993, J BIOL CHEM, V268, P2307; Thi MHT, 2011, APPL ENVIRON MICROB, V77, P3327, DOI 10.1128/AEM.02518-10; Tonon T, 2000, J APPL MICROBIOL, V89, P526, DOI 10.1046/j.1365-2672.2000.01142.x; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; Vandecasteele SJ, 2002, BIOCHEM BIOPH RES CO, V291, P528, DOI 10.1006/bbrc.2002.6465; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Ventura M, 2005, J BACTERIOL, V187, P8411, DOI 10.1128/JB.187.24.8411-8426.2005; Ventura M, 2005, MICROBIOL-SGM, V151, P2861, DOI 10.1099/mic.0.28176-0; Ventura M, 2004, APPL ENVIRON MICROB, V70, P3110, DOI 10.1128/AEM.70.5.3110-3121.2004; Vercruysse M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r17; Waddington L, 2010, J APPL MICROBIOL, V108, P1408, DOI 10.1111/j.1365-2672.2009.04540.x; Wen ZT, 2004, J BACTERIOL, V186, P2682, DOI 10.1128/JB.186.9.2682-2691.2004; Wu CD, 2012, APPL MICROBIOL BIOT, V93, P707, DOI 10.1007/s00253-011-3757-6; Yang HY, 2009, NUTR RES, V29, P281, DOI 10.1016/j.nutres.2009.03.010; Yang HY, 2009, CURR MICROBIOL, V59, P439, DOI 10.1007/s00284-009-9457-0; Zhang J, 2007, APPL ENVIRON MICROB, V73, P5268, DOI 10.1128/AEM.02787-06; Zhao WM, 2011, BIOINFORMATICS, V27, P3076, DOI 10.1093/bioinformatics/btr504; Zuniga M, 1998, J BACTERIOL, V180, P4154	56	56	59	3	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50777	10.1371/journal.pone.0050777	http://dx.doi.org/10.1371/journal.pone.0050777			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236393	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100034
J	Lim, J; Clements, MA; Dobson, J				Lim, Jenson; Clements, Michael A.; Dobson, Jon			Delivery of Short Interfering Ribonucleic Acid-Complexed Magnetic Nanoparticles in an Oscillating Field Occurs via Caveolae-Mediated Endocytosis	PLOS ONE			English	Article							GENE-TRANSFER; CELL INVASION; ACTIN; INHIBITORS; CHOLESTEROL; DYNAMIN; RNA; INTERNALIZATION; TRANSFECTION; TRAFFICKING	Gene delivery technologies to introduce foreign genes into highly differentiated mammalian cells have improved significantly over the last few decades. Relatively new techniques such as magnetic nanoparticle-based gene transfection technology are showing great promise in terms of its high transfection efficiency and wide-ranging research applications. We have developed a novel gene delivery technique, which uses magnetic nanoparticles moving under the influence of an oscillating magnetic array. Herein we successfully introduced short interfering RNA (siRNA) against green fluorescent protein (GFP) or actin into stably-transfected GFP-HeLa cells or wild-type HeLa and rat aortic smooth muscle cells, respectively. This gene silencing technique occurred in a dose-and cell density-dependent manner, as reflected using fluorescence intensity and adhesion assays. Furthermore, using endocytosis inhibitors, we established that these magnetic nanoparticle-nucleic acid complexes, moving across the cell surface under the influence of an oscillating magnet array, enters into the cells via the caveolae-mediated endocytic pathway.	[Lim, Jenson; Clements, Michael A.] Keele Univ Sci & Business Pk, Med IC4, NanoTher Ltd, Newcastle Under Lyme, Staffs, England; [Lim, Jenson] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Dobson, Jon] Univ Florida, Dept Mat Sci & Engn, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA; [Dobson, Jon] Univ Florida, ICERM, Gainesville, FL 32611 USA; [Dobson, Jon] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England	University of Birmingham; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Keele University	Lim, J (corresponding author), Keele Univ Sci & Business Pk, Med IC4, NanoTher Ltd, Newcastle Under Lyme, Staffs, England.	jenson@nanotherics.com	Dobson, Jon P/C-8323-2009	Dobson, Jon P/0000-0002-8108-5362; Lim, Jenson/0000-0001-7417-356X	nanoTherics Limited	nanoTherics Limited	This research is wholly funded by nanoTherics Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonetta L, 2005, NAT METHODS, V2, P875, DOI 10.1038/nmeth1105-875; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Chen Y, 2011, BLOOD, V117, P6392, DOI 10.1182/blood-2010-12-322867; del Pino P, 2010, NANO LETT, V10, P3914, DOI 10.1021/nl102485v; Dormoy-Raclet V, 2007, MOL CELL BIOL, V27, P5365, DOI 10.1128/MCB.00113-07; Ensenauer R, 2011, BIOTECH HISTOCHEM, V86, P226, DOI 10.3109/10520291003675485; Fouriki A, 2012, J TISSUE EN IN PRESS; Govindan S, 2010, BRIT J PHARMACOL, V160, P1953, DOI 10.1111/j.1476-5381.2010.00763.x; Harborth J, 2001, J CELL SCI, V114, P4557; Huth S, 2004, J GENE MED, V6, P923, DOI 10.1002/jgm.577; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Jaumouille V, 2011, CURR OPIN CELL BIOL, V23, P22, DOI 10.1016/j.ceb.2010.10.006; Jenkins SI, 2011, ACS NANO, V5, P6527, DOI 10.1021/nn2018717; Kehn-Hall K, 2011, VIROLOGY, V415, P56, DOI 10.1016/j.virol.2011.03.025; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Lee S, 2011, NUCLEIC ACID THER, V21, P165, DOI 10.1089/nat.2010.0274; LIAO JF, 1993, MOL PHARMACOL, V44, P364; Lim J, 2012, J GENET, V91, P223, DOI 10.1007/s12041-012-0164-4; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; McBain SC, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/40/405102; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nankoe SR, 2006, TRENDS CELL BIOL, V16, P607, DOI 10.1016/j.tcb.2006.10.004; Neto H, 2011, BIOCHEM J, V437, P13, DOI 10.1042/BJ20110153; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pickard M, 2010, NANOMEDICINE-UK, V5, P217, DOI [10.2217/nnm.09.109, 10.2217/NNM.09.109]; Pickard MR, 2011, TISSUE ENG PART C-ME, V17, P89, DOI [10.1089/ten.tec.2010.0170, 10.1089/ten.TEC.2010.0170]; Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Uriarte SM, 2009, AM J PHYSIOL-CELL PH, V296, pC857, DOI 10.1152/ajpcell.00454.2008; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Visvikis O, 2011, TRAFFIC, V12, P579, DOI 10.1111/j.1600-0854.2011.01174.x; Wattiaux R, 2000, ADV DRUG DELIVER REV, V41, P201, DOI 10.1016/S0169-409X(99)00066-6	35	14	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51350	10.1371/journal.pone.0051350	http://dx.doi.org/10.1371/journal.pone.0051350			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236481	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000312064100102
J	McGinley, MP; Aschaffenburg, MD; Pettay, DT; Smith, RT; LaJeunesse, TC; Warner, ME				McGinley, Michael P.; Aschaffenburg, Matthew D.; Pettay, Daniel T.; Smith, Robin T.; LaJeunesse, Todd C.; Warner, Mark E.			Transcriptional Response of Two Core Photosystem Genes in Symbiodinium spp. Exposed to Thermal Stress	PLOS ONE			English	Article							REEF CORALS; CHLOROPLAST TRANSCRIPTS; OXIDATIVE STRESS; CLIMATE-CHANGE; HEAT-STRESS; PHOTOINHIBITION; EXPRESSION; PHOTOSYNTHESIS; DAMAGE; TEMPERATURE	Mutualistic symbioses between scleractinian corals and endosymbiotic dinoflagellates (Symbiodinium spp.) are the foundation of coral reef ecosystems. For many coral-algal symbioses, prolonged episodes of thermal stress damage the symbiont's photosynthetic capability, resulting in its expulsion from the host. Despite the link between photosynthetic competency and symbiont expulsion, little is known about the effect of thermal stress on the expression of photosystem genes in Symbiodinium. This study used real-time PCR to monitor the transcript abundance of two important photosynthetic reaction center genes, psbA (encoding the D1 protein of photosystem II) and psaA (encoding the P-700 protein of photosystem I), in four cultured isolates (representing ITS2-types A13, A20, B1, and F2) and two in hospite Symbiodinium spp. within the coral Pocillopora spp. (ITS2-types C1b-c and D1). Both cultured and in hospite Symbiodinium samples were exposed to elevated temperatures (32 degrees C) over a 7-day period and examined for changes in photochemistry and transcript abundance. Symbiodinium A13 and C1b-c (both thermally sensitive) demonstrated significant declines in both psbA and psaA during the thermal stress treatment, whereas the transcript levels of the other Symbiodinium types remained stable. The downregulation of both core photosystem genes could be the result of several different physiological mechanisms, but may ultimately limit repair rates of photosynthetic proteins, rendering some Symbiodinium spp. especially susceptible to thermal stress.	[McGinley, Michael P.; Aschaffenburg, Matthew D.; Pettay, Daniel T.; Warner, Mark E.] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA; [Smith, Robin T.] Florida Int Univ, Dept Biol, Miami, FL 33199 USA; [LaJeunesse, Todd C.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	University of Delaware; State University System of Florida; Florida International University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Warner, ME (corresponding author), Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA.	mwarner@udel.edu	Warner, Mark E/J-6241-2013; LaJeunesse, Todd/B-1720-2009	LaJeunesse, Todd/0000-0001-7607-9358; Warner, Mark/0000-0003-1015-9413	National Science Foundation [IOB 544765, OCE 0825413, IOB 544854]; Directorate For Geosciences [0825413] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by funding from the National Science Foundation (IOB 544765 and OCE 0825413 to MEW and IOB 544854 to TCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahles MD, 1967, THESIS, P158; Ambarsari I, 1997, MAR ECOL PROG SER, V159, P303, DOI 10.3354/meps159303; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; BAKER NR, 1991, PHYSIOL PLANTARUM, V81, P563, DOI 10.1111/j.1399-3054.1991.tb05101.x; Bellantuono AJ, 2012, P ROY SOC B-BIOL SCI, V279, P1100, DOI 10.1098/rspb.2011.1780; Bernhardt K, 1999, BBA-BIOENERGETICS, V1409, P125, DOI 10.1016/S0005-2728(98)00149-2; Boldt L., 2009, P 11 ICRS, P118; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Brown BE, 1999, CORAL REEFS, V18, P99; Buxton L, 2012, J PHYCOL, V48, P117, DOI 10.1111/j.1529-8817.2011.01099.x; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Dang Y, 2009, THESIS U BRIT COLUMB, P121; Dang YK, 2010, J BIOL CHEM, V285, P5196, DOI 10.1074/jbc.M109.058545; Diaz-Almeyda E, 2011, CORAL REEFS, V30, P217, DOI 10.1007/s00338-010-0691-5; Fagan T, 1999, BIOCHEMISTRY-US, V38, P7689, DOI 10.1021/bi9826005; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; FITT WK, 1993, CORAL REEFS, V12, P57, DOI 10.1007/BF00302102; Franklin DJ, 2004, MAR ECOL PROG SER, V272, P117, DOI 10.3354/meps272117; Gorbunov MY, 2001, LIMNOL OCEANOGR, V46, P75, DOI 10.4319/lo.2001.46.1.0075; Hackett JD, 2004, AM J BOT, V91, P1523, DOI 10.3732/ajb.91.10.1523; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAVAUX M, 1991, Z NATURFORSCH C, V46, P1038; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Hennige SJ, 2011, MAR BIOL, V158, P2515, DOI 10.1007/s00227-011-1752-1; Hill R, 2011, LIMNOL OCEANOGR, V56, P139, DOI 10.4319/lo.2011.56.1.0139; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoogenboom MO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030167; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Ivanov AG, 2012, BIOCHIM BIOPHYS ACTA, V1877, P1374; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; KUSNETSOV VV, 1993, FEBS LETT, V321, P189, DOI 10.1016/0014-5793(93)80105-4; LaJeunesse TC, 2008, LIMNOL OCEANOGR, V53, P719, DOI 10.4319/lo.2008.53.2.0719; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Leggat W, 2004, SYMBIOSIS, V37, P137; Leggat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026687; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Lidie KB, 2005, MAR BIOTECHNOL, V7, P481, DOI 10.1007/s10126-004-4110-6; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Moustafa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009688; Muscatine L., 1990, P75; Okamoto OK, 2003, GENE, V321, P73, DOI 10.1016/j.gene.2003.07.003; Okamoto OK, 2003, J PHYCOL, V39, P519, DOI 10.1046/j.1529-8817.2003.02170.x; Okamoto OK, 2001, J BIOL CHEM, V276, P19989, DOI 10.1074/jbc.M101169200; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; PORTER JW, 1982, P NATL ACAD SCI-BIOL, V79, P1678, DOI 10.1073/pnas.79.5.1678; Ragni M, 2010, MAR ECOL PROG SER, V406, P57, DOI 10.3354/meps08571; Robison JD, 2006, J PHYCOL, V42, P568, DOI 10.1111/j.1529-8817.2006.00232.x; Rosic NN, 2011, MAR BIOTECHNOL, V13, P355, DOI 10.1007/s10126-010-9308-9; Rosic NN, 2011, CELL STRESS CHAPERON, V16, P69, DOI 10.1007/s12192-010-0222-x; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Singh AK, 2001, PHOTOSYNTHETICA, V39, P353, DOI 10.1023/A:1015122124866; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takahashi S, 2008, P NATL ACAD SCI USA, V105, P4203, DOI 10.1073/pnas.0708554105; Takahashi S, 2009, P NATL ACAD SCI USA, V106, P3237, DOI 10.1073/pnas.0808363106; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; THOMAS EJ, 1995, PLANT MOL BIOL, V27, P317, DOI 10.1007/BF00020186; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjus SE, 1999, PHOTOSYNTH RES, V60, P75, DOI 10.1023/A:1006283618695; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warner ME, 2006, J EXP MAR BIOL ECOL, V339, P86, DOI 10.1016/j.jembe.2006.07.011; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Warner ME, 1996, PLANT CELL ENVIRON, V19, P291, DOI 10.1111/j.1365-3040.1996.tb00251.x	77	37	38	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50439	10.1371/journal.pone.0050439	http://dx.doi.org/10.1371/journal.pone.0050439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236373	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100016
J	Schneeweis, C; Schnackenburg, B; Stuber, M; Berger, A; Schneider, U; Yu, J; Gebker, R; Weiss, RG; Fleck, E; Kelle, S				Schneeweis, Christopher; Schnackenburg, Bernhard; Stuber, Matthias; Berger, Alexander; Schneider, Udo; Yu, Jing; Gebker, Rolf; Weiss, Robert G.; Fleck, Eckart; Kelle, Sebastian			Delayed Contrast-Enhanced MRI of the Coronary Artery Wall in Takayasu Arteritis	PLOS ONE			English	Article							NATURAL-HISTORY; DIAGNOSIS; DISEASE; CLASSIFICATION; INVOLVEMENT; MECHANISMS; CRITERIA	Background: Takayasu arteritis (TA) is a rare form of chronic inflammatory granulomatous arteritis of the aorta and its major branches. Late gadolinium enhancement (LGE) with magnetic resonance imaging (MRI) has demonstrated its value for the detection of vessel wall alterations in TA. The aim of this study was to assess LGE of the coronary artery wall in patients with TA compared to patients with stable CAD. Methods: We enrolled 9 patients (8 female, average age 46 +/- 13 years) with proven TA. In the CAD group 9 patients participated (8 male, average age 65 +/- 10 years). Studies were performed on a commercial 3T whole-body MR imaging system (Achieva; Philips, Best, The Netherlands) using a 3D inversion prepared navigator gated spoiled gradient-echo sequence, which was repeated 34-45 minutes after low-dose gadolinium administration. Results: No coronary vessel wall enhancement was observed prior to contrast in either group. Post contrast, coronary LGE on IR scans was detected in 28 of 50 segments (56%) seen on T2-Prep scans in TA and in 25 of 57 segments (44%) in CAD patients. LGE quantitative assessment of coronary artery vessel wall CNR post contrast revealed no significant differences between the two groups (CNR in TA: 6.0 +/- 2.4 and 7.3 +/- 2.5 in CAD; p = 0.474). Conclusion: Our findings suggest that LGE of the coronary artery wall seems to be common in patients with TA and similarly pronounced as in CAD patients. The observed coronary LGE seems to be rather unspecific, and differentiation between coronary vessel wall fibrosis and inflammation still remains unclear.	[Schneeweis, Christopher; Berger, Alexander; Gebker, Rolf; Fleck, Eckart; Kelle, Sebastian] Deutsch Herzzentrum Berlin, Dept Internal Med Cardiol, Berlin, Germany; [Schnackenburg, Bernhard] Philips Hlth Care, Hamburg, Germany; [Stuber, Matthias; Yu, Jing; Weiss, Robert G.] Johns Hopkins Univ, Dept Radiol, Div Magnet Resonance Res, Baltimore, MD USA; [Stuber, Matthias] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Stuber, Matthias] CHU Vaudois, Dept Radiol, Ctr Biomed Imaging CIBM, Lausanne, Switzerland; [Stuber, Matthias] Univ Lausanne, Lausanne, Switzerland; [Schneider, Udo] Charite, Dept Rheumatol, D-13353 Berlin, Germany; [Weiss, Robert G.] Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD USA	German Heart Center Berlin; Philips; Philips Healthcare; Johns Hopkins University; Johns Hopkins University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johns Hopkins University	Kelle, S (corresponding author), Deutsch Herzzentrum Berlin, Dept Internal Med Cardiol, Berlin, Germany.	kelle@dhzb.de	Kelle, Sebastian/ABH-7348-2020; Stuber, Matthias/B-2949-2010	Stuber, Matthias/0000-0001-9843-2028; Kelle, Sebastian/0000-0001-8105-6599	National Institutes of Health/National Heart, Lung, and Blood Institute [RO1HL084186, ARRA 3R01Hl084186 04S1]; Philips GmbH Healthcare, Clinical Science Hamburg, Germany; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084186] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Philips GmbH Healthcare, Clinical Science Hamburg, Germany; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health/National Heart, Lung, and Blood Institute research grants RO1HL084186 and ARRA 3R01Hl084186 04S1 and Philips GmbH Healthcare, Clinical Science Hamburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; Choe YH, 1998, INT J CARDIOL, V66, pS175; CIPRIANO PR, 1977, AM J CARDIOL, V39, P744, DOI 10.1016/S0002-9149(77)80139-2; Desai MY, 2005, AM J ROENTGENOL, V184, P1427, DOI 10.2214/ajr.184.5.01841427; Fischer SE, 1999, MAGN RESON MED, V42, P361, DOI 10.1002/(SICI)1522-2594(199908)42:2<361::AID-MRM18>3.0.CO;2-9; Flamm SD, 1998, INT J CARDIOL, V66, pS151, DOI 10.1016/S0167-5273(98)00163-6; Gerretsen SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012998; Goldschmidt-Clermont PJ, 2005, CIRCULATION, V112, P3348, DOI 10.1161/CIRCULATIONAHA.105.577460; Hamdan A, 2011, JACC-CARDIOVASC IMAG, V4, P50, DOI 10.1016/j.jcmg.2010.10.007; Hoffman GS, 1998, INT J CARDIOL, V66, pS191, DOI 10.1016/S0167-5273(98)00181-8; Ibrahim T, 2009, JACC-CARDIOVASC IMAG, V2, P580, DOI 10.1016/j.jcmg.2008.12.029; ISHIKAWA K, 1978, CIRCULATION, V57, P27, DOI 10.1161/01.CIR.57.1.27; Kelle S, 2010, CARDIOL RES PRACT, V2010, DOI 10.4061/2010/856418; Kelle S, 2009, MAGN RESON IMAGING C, V17, P145, DOI 10.1016/j.mric.2008.12.003; Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866; Maintz D, 2006, EUR HEART J, V27, P1732, DOI 10.1093/eurheartj/ehl102; Makowski MR, 2011, NAT MED, V17, P383, DOI 10.1038/nm.2310; Matsubara O, 1992, Heart Vessels Suppl, V7, P26, DOI 10.1007/BF01744540; Nagata S, 1990, MYAKKANGAKU, V30, P1303; Park MC, 2005, SCAND J RHEUMATOL, V34, P284, DOI 10.1080/03009740510026526; Rav-Acha M, 2007, AUTOIMMUN REV, V6, P566, DOI 10.1016/j.autrev.2007.04.001; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saadoun D, 2012, CIRCULATION; Schneeweis C, 2009, KARDIOLOGE, V3, P47, DOI 10.1007/s12181-008-0132-7; SUBRAMANYAN R, 1989, CIRCULATION, V80, P429, DOI 10.1161/01.CIR.80.3.429; Tacke CE, 2011, CIRC CARDIOVASC IMAG; TALWAR KK, 1988, INT J CARDIOL, V21, P323, DOI 10.1016/0167-5273(88)90109-X; Tso E, 2002, ARTHRITIS RHEUM-US, V46, P1634, DOI 10.1002/art.10251; Weyand CM, 2003, NEW ENGL J MED, V349, P160, DOI 10.1056/NEJMra022694; Yamada I, 2000, JMRI-J MAGN RESON IM, V11, P481, DOI 10.1002/(SICI)1522-2586(200005)11:5<481::AID-JMRI3>3.0.CO;2-4; Yeon SB, 2007, J AM COLL CARDIOL, V50, P441, DOI 10.1016/j.jacc.2007.03.052; Yu J, 2009, MAGN RESON MED, V62, P1211, DOI 10.1002/mrm.22114	32	21	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50655	10.1371/journal.pone.0050655	http://dx.doi.org/10.1371/journal.pone.0050655			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236382	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100024
J	Shea, FF; Rowell, JL; Li, YCW; Chang, TH; Alvarez, CE				Shea, Fortune F.; Rowell, Jennie L.; Li, Yechaowei; Chang, Tien-Hsien; Alvarez, Carlos E.			Mammalian Alpha Arrestins Link Activated Seven Transmembrane Receptors to Nedd4 Family E3 Ubiquitin Ligases and Interact with Beta Arrestins	PLOS ONE			English	Article							MEDIATE UBIQUITINATION; PROTEIN; THIOREDOXIN; TRAFFICKING; BINDING; CANCER; TXNIP; ADIPOGENESIS; ENDOCYTOSIS; GENE	The complement of fungal cell surface proteins is widely regulated by ubiquitination of membrane proteins, which results in their endocytosis and vacuolar degradation. For diverse fungal transporters, the specificity of ubiquitination is conferred by alpha arrestin adaptors, which recruit the Nedd4 family E3 ubiquitin ligase Rsp5. A recent study showed that one mammalian alpha arrestin also mediates ubiquitination and lysosomal trafficking of an activated plasma membrane receptor. Here we first screen all five widely-expressed human alpha arrestins for subcellular localization in ligand-stimulated and -unstimulated cells overexpressing the seven transmembrane receptor vasopressin 2. We then characterize the effects of alpha arrestins ARRDC3 and ARRDC4 upon activation of the seven transmembrane receptors vasopressin 2 and beta adrenergic 2. Using biochemical and imaging approaches, we show that ligand-activated receptors interact with alpha arrestins, and this results in recruitment of Nedd4 family E3 ubiquitin ligases and receptor ubiquitination - which are known to result in lysosomal trafficking. Our time course studies show these effects occur in the first 1-5 minutes after ligand activation, the same time that beta arrestins are known to have roles in receptor endocytic trafficking and kinase signaling. We tested the possibility that alpha and beta arrestins function coordinately and found co-immunoprecipitation and colocalization evidence to support this. Others recently reported that Arrdc3 knockout mice are lean and resistant to obesity. In the course of breeding our own Arrdc3-deficient mice, we observed two novel phenotypes in homozygotes: skin abnormalities, and embryonic lethality on normal chow diet, but not on high fat diet. Our findings suggest that alpha and beta arrestins function coordinately to maintain the optimal complement and function of cell surface proteins according to cellular physiological context and external signals. We discuss the implications of the alpha arrestin functions in fungi having evolved into coordinated alpha/beta arrestin functions in animals.	[Shea, Fortune F.; Rowell, Jennie L.; Li, Yechaowei; Alvarez, Carlos E.] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA; [Rowell, Jennie L.] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA; [Chang, Tien-Hsien] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Alvarez, Carlos E.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Alvarez, Carlos E.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Academia Sinica - Taiwan; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Alvarez, CE (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA.	alvarez.73@osu.edu			Research Institute at Nationwide Children's Hospital	Research Institute at Nationwide Children's Hospital(Ohio State University)	This work was supported by faculty start-up and bridge funds from The Research Institute at Nationwide Children's Hospital (to CEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Andoh T, 2002, FEBS LETT, V525, P131, DOI 10.1016/S0014-5793(02)03104-6; Becuwe M, 2012, J CELL BIOL; Becuwe M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/242764; Bedford MT, 2000, J BIOL CHEM, V275, P10359, DOI 10.1074/jbc.275.14.10359; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Boase NA, 2004, MOL MICROBIOL, V53, P929, DOI 10.1111/j.1365-2958.2004.04172.x; Chutkow WA, 2011, J BIOL CHEM, V286, P29139, DOI 10.1074/jbc.M111.267666; Chutkow WA, 2010, DIABETES, V59, P1424, DOI 10.2337/db09-1212; DeFea Kathryn Anne, 2008, Biochem J, V413, pe1, DOI 10.1042/BJ20081009; Draheim KM, 2010, ONCOGENE, V29, P5032, DOI 10.1038/onc.2010.250; Draheim KM, 2010, THESIS U MASSACHUSET; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Dupre DJ, 2003, J BIOL CHEM, V278, P48228, DOI 10.1074/jbc.M304082200; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Hislop JN, 2010, TRAFFIC; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang CN, 2011, ANN ONCOL; Jee C, 2012, J MOL BIOL, V417, P165, DOI 10.1016/j.jmb.2012.01.012; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; Kulman JD, 2007, P NATL ACAD SCI USA, V104, P8767, DOI 10.1073/pnas.0703195104; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Masutani H, 2012, J CLIN BIOCHEM NUTR, V50, P23, DOI 10.3164/jcbn.11-36SR; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nichols CD, 2004, J NEUROCHEM, V90, P576, DOI 10.1111/j.1471-4159.2004.02515.x; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; Oka S, 2006, ENDOCRINOLOGY, V147, P733, DOI 10.1210/en.2005-0679; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Patwari P, 2012, TRENDS ENDOCRIN MET, V23, P216, DOI 10.1016/j.tem.2012.03.003; Patwari P, 2011, CELL METAB, V14, P671, DOI 10.1016/j.cmet.2011.08.011; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Peterson CW, 2012, FRONT BIOSCI, V17, P2206; Polo S, 2008, CELL, V135, P590, DOI 10.1016/j.cell.2008.10.032; Rauch S, 2011, J VIROL, V85, P3546, DOI 10.1128/JVI.02045-10; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Sheth SS, 2006, ONCOGENE, V25, P3528, DOI 10.1038/sj.onc.1209394; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Xu JG, 2001, J BIOL CHEM, V276, P41310, DOI 10.1074/jbc.M107480200; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321; Zhou JBA, 2011, INT J BIOCHEM CELL B, V43, P1668, DOI 10.1016/j.biocel.2011.09.005; Zhuang LN, 2011, J BIOL CHEM, V286, P28403, DOI 10.1074/jbc.M111.256099; Zhuang LN, 2011, J BIOL CHEM, V286, P28396, DOI 10.1074/jbc.M111.223206	62	44	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50557	10.1371/journal.pone.0050557	http://dx.doi.org/10.1371/journal.pone.0050557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236378	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100020
J	Strauss, S; Dudziak, S; Hagemann, R; Barcikowski, S; Fliess, M; Israelowitz, M; Kracht, D; Kuhbier, JW; Radtke, C; Reimers, K; Vogt, PM				Strauss, Sarah; Dudziak, Sonja; Hagemann, Ronny; Barcikowski, Stephan; Fliess, Malte; Israelowitz, Meir; Kracht, Dietmar; Kuhbier, Joern W.; Radtke, Christine; Reimers, Kerstin; Vogt, Peter M.			Induction of Osteogenic Differentiation of Adipose Derived Stem Cells by Microstructured Nitinol Actuator-Mediated Mechanical Stress	PLOS ONE			English	Article							HUMAN BONE-MARROW; SHAPE-MEMORY; TISSUE; NICKEL; VASCULARIZATION; FABRICATION; INGROWTH; FRACTURE; FATIGUE; GROWTH	The development of large tissue engineered bone remains a challenge in vitro, therefore the use of hybrid-implants might offer a bridge between tissue engineering and dense metal or ceramic implants. Especially the combination of the pseudoelastic implant material Nitinol (NiTi) with adipose derived stem cells (ASCs) opens new opportunities, as ASCs are able to differentiate osteogenically and therefore enhance osseointegration of implants. Due to limited knowledge about the effects of NiTi-structures manufactured by selective laser melting (SLM) on ASCs the study started with an evaluation of cytocompatibility followed by the investigation of the use of SLM-generated 3-dimensional NiTi-structures preseeded with ASCs as osteoimplant model. In this study we could demonstrate for the first time that osteogenic differentiation of ASCs can be induced by implant-mediated mechanical stimulation without support of osteogenic cell culture media. By use of an innovative implant design and synthesis via SLM-technique we achieved high rates of vital cells, proper osteogenic differentiation and mechanically loadable NiTi-scaffolds could be achieved.	[Strauss, Sarah; Fliess, Malte; Kuhbier, Joern W.; Radtke, Christine; Reimers, Kerstin; Vogt, Peter M.] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany; [Dudziak, Sonja; Hagemann, Ronny; Barcikowski, Stephan; Kracht, Dietmar] Laser Zentrum Hannover eV, Hannover, Germany; [Barcikowski, Stephan] Univ Duisburg Essen, Ctr Nanointegrat, Essen, Germany; [Israelowitz, Meir] Biomimet Technol Inc, Toronto, ON, Canada	Hannover Medical School; University of Duisburg Essen	Strauss, S (corresponding author), Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany.	strauss.sarah@mh-hannover.de	Vogt, Peter M./AAL-1332-2020; Barcikowski, Stephan/I-4754-2012; Radtke, Christine/M-2927-2013; Radtke, Christine/B-8491-2018	Barcikowski, Stephan/0000-0002-9739-7272; Radtke, Christine/0000-0001-6877-5038; Israelowitz, Meir/0000-0003-3745-7955; Kracht, Dietmar/0000-0003-3473-4814	German Research Foundation within the Collaborative Research Centre [TransRegio 37]	German Research Foundation within the Collaborative Research Centre	German Research Foundation funded this work within the Collaborative Research Centre TransRegio 37 "Micro- and Nanosystems in Medicine - Reconstruction of biologic Functions". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assad M, 2003, J BIOMED MATER RES B, V64B, P107, DOI 10.1002/jbm.b.10530; Barcikowski S, 2010, J NANOPART RES, V12, P1733, DOI 10.1007/s11051-009-9834-4; Blackwood DJ, 2003, CORROS REV, V21, P97; BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79; Bram M, 2002, MAT SCI ENG A-STRUCT, V337, P254, DOI 10.1016/S0921-5093(02)00028-X; Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202; Council of the European Communities, 2008, OFF J EUR COMMUN, VL337, P41; Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X; Dudziak S, 2010, PHYSCS PROC, V5, P607, DOI 10.1016/j.phpro.2010.08.088; Dudziak S, 2012, BERICHTE LZH; FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745; Gebert A, 1998, J MICROSC-OXFORD, V191, P297, DOI 10.1046/j.1365-2818.1998.00380.x; Habijan T, 2009, IFMBE PROC, V22, P2165; Habijan T, 2011, ACTA BIOMATER, V7, P2733, DOI 10.1016/j.actbio.2011.02.022; Habijan T, 2009, THESIS RUHR U BOCHUM; Hahn A, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-011-0686-3; Heintz C, 2001, J ENDOVASC THER, V8, P248, DOI 10.1583/1545-1550(2001)008<0248:CNWIEA>2.0.CO;2; Hollander D, 2003, EUR J TRAUMA, V29, P228; Jeswani S, 2011, J NEUROINTERV SURG, V3, P2, DOI 10.1136/jnis.2010.003657; Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193; Kaveh K, 2011, J ANIM VET ADV, V10, P2317, DOI 10.3923/javaa.2011.2317.2330; Kloos K.-H., 2007, SCHRAUBENVERBINDUNGE; Kohl M, 2009, ADV ENG MATER, V11, P959, DOI 10.1002/adem.200900168; Kuhbier JW, 2010, CHIRURG, V81, P826, DOI 10.1007/s00104-010-1962-y; Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4; Lee KW, 2010, BIOMACROMOLECULES, V11, P682, DOI 10.1021/bm901260y; Lu ZF, 2012, NANOMED-NANOTECHNOL, V8, P507, DOI 10.1016/j.nano.2011.07.012; McKelvey AL, 2001, METALL MATER TRANS A, V32, P731, DOI 10.1007/s11661-001-1008-7; Mischen BT, 2008, PLAST RECONSTR SURG, V122, P725, DOI 10.1097/PRS.0b013e318180ec9f; Morgan NB, 2004, MAT SCI ENG A-STRUCT, V378, P16, DOI 10.1016/j.msea.2003.10.326; Nikanorov A, 2008, J VASC SURG, V48, P435, DOI 10.1016/j.jvs.2008.02.029; Papavasiliou G, 2010, J INVEST MED, V58, P838, DOI 10.231/JIM.0b013e3181f18e38; Peng B, 2005, INT ENDOD J, V38, P550, DOI 10.1111/j.1365-2591.2005.00991.x; Pfeiffer R, 2010, J MAT PROCESS TECH; Pu LLQ, 2012, J PLAST RECONSTR AES, V65, P413, DOI 10.1016/j.bjps.2011.09.033; Robertson SW, 2012, INT MATER REV, V57, P1, DOI 10.1179/1743280411Y.0000000009; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267; Shabalovskaya SA, 2001, INT MATER REV, V46, P233, DOI 10.1179/095066001771048745; Tjabringa GS, 2006, STEM CELLS, V24, P2262, DOI 10.1634/stemcells.2005-0625; Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032; van Griensven M, 2009, ADV BIOCHEM ENG BIOT, V112, P95, DOI [10.1007/10_2008_14, 10.1007/978-3-540-69357-4_5]; Verein Deutscher Ingeneure, 2003, 2230 VDI GES ENTW KO; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006; Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	48	23	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51264	10.1371/journal.pone.0051264	http://dx.doi.org/10.1371/journal.pone.0051264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236461	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100086
J	Tleyjeh, IM; Bin Abdulhak, AA; Riaz, M; Alasmari, FA; Garbati, MA; AlGhamdi, M; Khan, AR; Al Tannir, M; Erwin, PJ; Ibrahim, T; AlLehibi, A; Baddour, LM; Sutton, AJ				Tleyjeh, Imad M.; Bin Abdulhak, Aref A.; Riaz, Muhammad; Alasmari, Faisal A.; Garbati, Musa A.; AlGhamdi, Mushabab; Khan, Abdur Rahman; Al Tannir, Mohamad; Erwin, Patricia J.; Ibrahim, Talal; AlLehibi, Abed; Baddour, Larry M.; Sutton, Alex J.			Association between Proton Pump Inhibitor Therapy and Clostridium difficile Infection: A Contemporary Systematic Review and Meta-Analysis	PLOS ONE			English	Article							ACID-SUPPRESSIVE THERAPY; HOSPITALIZED-PATIENTS; BACTERIAL OVERGROWTH; PUBLICATION BIAS; UNITED-STATES; RISK; DISEASE; COHORT; OMEPRAZOLE; DIARRHEA	Introduction: Emerging epidemiological evidence suggests that proton pump inhibitor (PPI) acid-suppression therapy is associated with an increased risk of Clostridium difficile infection (CDI). Methods: Ovid MEDLINE, EMBASE, ISI Web of Science, and Scopus were searched from 1990 to January 2012 for analytical studies that reported an adjusted effect estimate of the association between PPI use and CDI. We performed random-effect meta-analyses. We used the GRADE framework to interpret the findings. Results: We identified 47 eligible citations (37 case-control and 14 cohort studies) with corresponding 51 effect estimates. The pooled OR was 1.65, 95% CI (1.47, 1.85), I-2 = 89.9%, with evidence of publication bias suggested by a contour funnel plot. A novel regression based method was used to adjust for publication bias and resulted in an adjusted pooled OR of 1.51 (95% CI, 1.26-1.83). In a speculative analysis that assumes that this association is based on causality, and based on published baseline CDI incidence, the risk of CDI would be very low in the general population taking PPIs with an estimated NNH of 3925 at 1 year. Conclusions: In this rigorously conducted systemic review and meta-analysis, we found very low quality evidence (GRADE class) for an association between PPI use and CDI that does not support a cause-effect relationship.	[Tleyjeh, Imad M.; Alasmari, Faisal A.; Garbati, Musa A.; AlGhamdi, Mushabab; AlLehibi, Abed] King Fahad Med City, Dept Med, Riyadh, Saudi Arabia; [Tleyjeh, Imad M.] AlFaisal Univ, Coll Med, Riyadh, Saudi Arabia; [Tleyjeh, Imad M.; Baddour, Larry M.] Mayo Clin, Div Infect Dis, Rochester, MN USA; [Tleyjeh, Imad M.] Mayo Clin, Div Epidemiol, Rochester, MN USA; [Bin Abdulhak, Aref A.] Univ Missouri, Dept Internal Med, Kansas City, MO 64110 USA; [Riaz, Muhammad; Al Tannir, Mohamad] King Fahad Med City, Res & Sci Publicat Ctr, Riyadh, Saudi Arabia; [Khan, Abdur Rahman] Univ Toledo, Med Ctr, Dept Internal Med, Toledo, OH 43606 USA; [Erwin, Patricia J.] Mayo Clin, Mayo Med Lib, Rochester, MN USA; [Ibrahim, Talal] Hamad Med Corp Doha, Dept Orthoped & Trauma Surg, Doha, Qatar; [Sutton, Alex J.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	King Fahad Medical City; Alfaisal University; Mayo Clinic; Mayo Clinic; University of Missouri System; University of Missouri Kansas City; King Fahad Medical City; University System of Ohio; University of Toledo; Mayo Clinic; Hamad Medical Corporation; University of Leicester	Tleyjeh, IM (corresponding author), King Fahad Med City, Dept Med, Riyadh, Saudi Arabia.	tleyjeh.imad@mayo.edu	Bin Abdulhak, Aref/AAK-4348-2020; Bin Abdulhak, Aref/AAM-9492-2020; Alasmari, Faisal/AGW-9536-2022; Al-Ghamdi, Mohammed Ibrahim/I-3651-2018; Riaz, Muhammad/AAA-5500-2021; alghamdi, Mushabab/AGR-6297-2022; Ibrahim, Talal/AAK-6433-2020	Bin Abdulhak, Aref/0000-0001-9988-8609; Al-Ghamdi, Mohammed Ibrahim/0000-0002-9794-554X; Riaz, Muhammad/0000-0002-5512-1745; Ibrahim, Talal/0000-0001-9192-1435; Al-Tannir, Mohamad/0000-0002-7739-8446; Sutton, Alexander/0000-0002-8934-9940; Tleyjeh, Imad/0000-0002-5551-0353; Garbati, Musa/0000-0003-3438-421X				Ahrens D, 2010, EUR J CLIN PHARMACOL, V66, P1265, DOI 10.1007/s00228-010-0871-9; Archibald LK, 2004, J INFECT DIS, V189, P1585, DOI 10.1086/383045; Bajaj JS, 2010, AM J GASTROENTEROL, V105, P106, DOI 10.1038/ajg.2009.615; Batuwitage BT, 2007, POSTGRAD MED J, V83, P66, DOI 10.1136/pgmj.2006.051151; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Boyce JM, 2002, INFECT CONT HOSP EP, V23, pS3, DOI 10.1086/503164; Cahir C, 2010, BRIT J CLIN PHARMACO, V69, P543, DOI 10.1111/j.1365-2125.2010.03628.x; Charlot M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2690; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deshpande A, 2012, CLIN GASTROENTEROL H, V10, P225, DOI 10.1016/j.cgh.2011.09.030; Dial MS, 2009, AM J GASTROENTEROL, V104, pS10, DOI 10.1038/ajg.2009.46; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eom CS, 2011, ANN FAM MED, V9, P257, DOI 10.1370/afm.1243; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Howell MD, 2010, ARCH INTERN MED, V170, P784, DOI 10.1001/archinternmed.2010.89; IMS Health, 2005, LEAD 20 THER CLASS U; Janarthanan S, 2012, AM J GASTROENTEROL, V107, P1001, DOI 10.1038/ajg.2012.179; Jarvis WR, 2009, AM J INFECT CONTROL, V37, P263, DOI 10.1016/j.ajic.2009.01.001; Jayatilaka S, 2007, ANN CLIN LAB SCI, V37, P241; Johnstone J, 2010, ALIMENT PHARM THER, V31, P1165, DOI 10.1111/j.1365-2036.2010.04284.x; Jump RLP, 2007, ANTIMICROB AGENTS CH, V51, P2883, DOI 10.1128/AAC.01443-06; Kutty PK, 2010, EMERG INFECT DIS, V16, P197, DOI 10.3201/eid1602.090953; Kwok CS, 2012, AM J GASTROENTEROL, V107, P1011, DOI 10.1038/ajg.2012.108; Leonard J, 2007, AM J GASTROENTEROL, V102, P2047, DOI 10.1111/j.1572-0241.2007.01275.x; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Linney Stephanie, 2010, Can J Hosp Pharm, V63, P31; Lowe DO, 2006, CLIN INFECT DIS, V43, P1272, DOI 10.1086/508453; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Nerandzic MM, 2009, ANTIMICROB AGENTS CH, V53, P4133, DOI 10.1128/AAC.00252-09; Niklasson A, 2003, RESP MED, V97, P1143, DOI 10.1016/S0954-6111(03)00187-2; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Saad AZM, 2005, INT J CLIN PRACT, V59, P31, DOI 10.1111/j.1368-5031.2004.00298.x; Scagliarini R, 2005, DIGEST DIS SCI, V50, P2307, DOI 10.1007/s10620-005-3052-4; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Sierra F, 2007, ALIMENT PHARM THER, V26, P545, DOI 10.1111/j.1365-2036.2007.03407.x; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Theisen J, 2000, J GASTROINTEST SURG, V4, P50, DOI 10.1016/S1091-255X(00)80032-3; Thorens J, 1996, GUT, V39, P54, DOI 10.1136/gut.39.1.54; US Food and Drug Administration, 2009, INF HEALTHC PROF UPD; Wells G.A., NEWCASTLE OTTAWA SCA; Wilcox CM, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-18; WILSON KH, 1983, J CLIN MICROBIOL, V18, P1017, DOI 10.1128/JCM.18.4.1017-1019.1983; Yachimski PS, 2010, ARCH INTERN MED, V170, P779, DOI 10.1001/archinternmed.2010.51; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	50	90	99	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50836	10.1371/journal.pone.0050836	http://dx.doi.org/10.1371/journal.pone.0050836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236397	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100037
J	Treutlein, G; Dorsch, R; Euler, KN; Hauck, SM; Amann, B; Hartmann, K; Deeg, CA				Treutlein, Gudrun; Dorsch, Roswitha; Euler, Kerstin N.; Hauck, Stefanie M.; Amann, Barbara; Hartmann, Katrin; Deeg, Cornelia A.			Novel Potential Interacting Partners of Fibronectin in Spontaneous Animal Model of Interstitial Cystitis	PLOS ONE			English	Article							ACID-BINDING-PROTEIN; IDIOPATHIC CYSTITIS; GENE-EXPRESSION; GROWTH-FACTORS; KAPPA-B; THIOREDOXIN; CELLS; CATS; COMPLEMENT; URINE	Feline idiopathic cystitis (FIC) is the only spontaneous animal model for human interstitial cystitis (IC), as both possess a distinctive chronical and relapsing character. Underlying pathomechanisms of both diseases are not clearly established yet. We recently detected increased urine fibronectin levels in FIC cases. The purpose of this study was to gain further insight into the pathogenesis by assessing interacting partners of fibronectin in urine of FIC affected cats. Several candidate proteins were identified via immunoprecipitation and mass spectrometry. Considerable changes in FIC conditions compared to physiological expression of co-purified proteins were detected by Western blot and immunohistochemistry. Compared to controls, complement C4a and thioredoxin were present in higher levels in urine of FIC patients whereas loss of signal intensity was detected in FIC affected tissue. Galectin-7 was exclusively detected in urine of FIC cats, pointing to an important role of this molecule in FIC pathogenesis. Moderate physiological signal intensity of galectin-7 in transitional epithelium shifted to distinct expression in transitional epithelium under pathophysiological conditions. I-FABP expression was reduced in urine and urinary bladder tissue of FIC cats. Additionally, transduction molecules of thioredoxin, NF-kappa B p65 and p38 MAPK, were examined. In FIC affected tissue, colocalization of thioredoxin and NF-kB p65 could be demonstrated compared to absent coexpression of thioredoxin and p38 MAPK. These considerable changes in expression level and pattern point to an important role for co-purified proteins of fibronectin and thioredoxin-regulated signal transduction pathways in FIC pathogenesis. These results could provide a promising starting point for novel therapeutic approaches in the future.	[Euler, Kerstin N.; Amann, Barbara; Deeg, Cornelia A.] Ludwig Maximilians Univ Munchen, Dept Vet Sci, Inst Anim Physiol, Munich, Germany; [Treutlein, Gudrun; Dorsch, Roswitha; Hartmann, Katrin] Ludwig Maximilians Univ Munchen, Ctr Clin Vet Med, Clin Small Anim Med, Munich, Germany; [Hauck, Stefanie M.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Prot Sci, Neuherberg, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Deeg, CA (corresponding author), Ludwig Maximilians Univ Munchen, Dept Vet Sci, Inst Anim Physiol, Munich, Germany.	deeg@tiph.vetmed.uni-muenchen.de	Deeg, Cornelia/U-4216-2019; Hauck, Stefanie/B-3300-2013; Deeg, Cornelia A/G-4940-2010	Hauck, Stefanie/0000-0002-1630-6827; Deeg, Cornelia A/0000-0003-0375-3190; Dorsch, Roswitha/0000-0002-7508-5411; Hartmann, Katrin/0000-0002-5256-863X	Deutsche Forschungsgemeinschaft (DFG) [SFB 571 A5 Deeg]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) SFB 571 A5 Deeg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mageed AB, 2003, UROL RES, V31, P300, DOI 10.1007/s00240-003-0339-9; Abdel-Mageed AB, 1998, J UROLOGY, V160, P2000, DOI 10.1016/S0022-5347(01)62224-9; Bjorling DE, 2011, NEUROUROL URODYNAM, V30, P673, DOI 10.1002/nau.21078; Buffington CAT, 2011, J VET INTERN MED, V25, P784, DOI 10.1111/j.1939-1676.2011.0732.x; Buffington CAT, 1999, J AM VET MED ASSOC, V215, P682; Cao ZY, 2003, ARCH OPHTHALMOL-CHIC, V121, P82; Clemens JQ, 2007, J UROLOGY, V177, P1390, DOI 10.1016/j.juro.2006.11.084; Dasgupta J, 2009, MATURITAS, V64, P212, DOI 10.1016/j.maturitas.2009.09.016; Dvorankova B, 2011, CELLS TISSUES ORGANS, V194, P469, DOI 10.1159/000324864; GOLLIN G, 1993, SURGERY, V113, P545; Gorreta F, 2005, CANCER BIOL THER, V4, P1079, DOI 10.4161/cbt.4.10.1987; Gunn-Moore DA, 2003, J FELINE MED SURG, V5, P133, DOI 10.1016/S1098-612X(02)00129-8; HALLDEN G, 1994, AM J PHYSIOL-GASTR L, V267, pG730, DOI 10.1152/ajpgi.1994.267.4.G730; Hanno P, 2009, NEUROUROL URODYNAM, V28, P274, DOI 10.1002/nau.20687; Hashimoto S, 1999, BIOCHEM BIOPH RES CO, V258, P443, DOI 10.1006/bbrc.1999.0658; HELIN H, 1987, CLIN IMMUNOL IMMUNOP, V43, P88, DOI 10.1016/0090-1229(87)90160-7; Ho CL, 2008, J UROLOGY, V179, P1155, DOI 10.1016/j.juro.2007.10.026; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; HORI K, 1994, BRAIN RES, V652, P304, DOI 10.1016/0006-8993(94)90241-0; Hotta M, 1998, J EXP MED, V188, P1445, DOI 10.1084/jem.188.8.1445; HUGLI TE, 1984, SPRINGER SEMIN IMMUN, V7, P193; Kasuno K, 2003, KIDNEY INT, V64, P1273, DOI 10.1046/j.1523-1755.2003.00224.x; Keay S, 1997, J UROLOGY, V158, P1983, DOI 10.1016/S0022-5347(01)64198-3; Kim HJ, 2005, J KOREAN MED SCI, V20, P1000, DOI 10.3346/jkms.2005.20.6.1000; Klima J, 2009, PHYSIOL RES, V58, P873, DOI 10.33549/physiolres.931624; Kruger JM, 2009, VET CLIN N AM-SMALL, V39, P15, DOI 10.1016/j.cvsm.2008.09.008; Kumar B, 2009, INT J ONCOL, V34, P1557, DOI 10.3892/ijo_00000285; Larson J, 2011, J VET INTERN MED, V25, P199, DOI 10.1111/j.1939-1676.2011.0685.x; Lavelle JP, 2000, AM J PHYSIOL-RENAL, V278, pF540, DOI 10.1152/ajprenal.2000.278.4.F540; Lemberger SIK, 2011, AM J VET RES, V72, P1407, DOI 10.2460/ajvr.72.10.1407; Lemberger SIK, 2011, BJU INT, V107, P670, DOI 10.1111/j.1464-410X.2010.09500.x; Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614; MATTILA J, 1983, EUR UROL, V9, P350; McCloskey KD, 2010, NEUROUROL URODYNAM, V29, P82, DOI 10.1002/nau.20739; Nordling J, 2011, WORLD J UROL; Ogawa T, 2010, J UROLOGY, V183, P1206, DOI 10.1016/j.juro.2009.11.007; Palma TF, 2011, ACTAS UROL ESP, V35, P253, DOI [10.1016/j.acuro.2010.05.018, 10.1016/j.acuroe.2011.06.006]; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; Rondanino C, 2011, AM J PHYSIOL-RENAL, V301, pF622, DOI 10.1152/ajprenal.00134.2011; Saban R, 2008, AM J PHYSIOL-RENAL, V295, pF1613, DOI 10.1152/ajprenal.90344.2008; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Saussez S, 2006, CELL MOL LIFE SCI, V63, P686, DOI 10.1007/s00018-005-5458-8; SCHULTZ G, 1994, EYE, V8, P184, DOI 10.1038/eye.1994.43; STEINERT BW, 1994, J UROLOGY, V151, P350, DOI 10.1016/S0022-5347(17)34946-7; Thuijls G, 2011, ANN SURG, V253, P303, DOI 10.1097/SLA.0b013e318207a767; Westropp JL, 2002, J UROLOGY, V167, P694, DOI 10.1016/S0022-5347(01)69129-8; Yoshioka J, 2006, ANTIOXID REDOX SIGN, V8, P2143, DOI 10.1089/ars.2006.8.2143; ZHANG K, 1994, AM J PATHOL, V145, P114; Zhou W, 2011, IMMUNOBIOLOGY	50	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51391	10.1371/journal.pone.0051391	http://dx.doi.org/10.1371/journal.pone.0051391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236492	gold, Green Published, Green Submitted			2022-12-27	WOS:000312064100111
J	Bedouch, P; Marra, CA; FitzGerald, JM; Lynd, LD; Sadatsafavi, M				Bedouch, Pierrick; Marra, Carlo A.; FitzGerald, J. Mark; Lynd, Larry D.; Sadatsafavi, Mohsen			Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study	PLOS ONE			English	Article							GLOBAL BURDEN; MANAGED-CARE; PREVALENCE; GUIDELINES; CHILDREN; VISITS; ADULTS	Background: Asthma-related health resource use and costs may be influenced by increasing asthma prevalence, changes to asthma management guidelines, and new medications over the last decade. The objective of this work was to analyze direct asthma-related medical costs, and trends in total and per-patient costs of hospitalizations, physician visits, and medications. Methods: A cohort of asthma patients from British Columbia (BC), Canada, was created. Asthma patients were identified using a validated case definition. Costs for hospitalizations, physician visits, and medications were calculated from billing records (in 2008 Canadian dollars). Trends in total and per-patient costs over the study period were analyzed using Generalized Linear Models. Results: 398,235 patients satisfied the asthma case definition (mid-point prevalence 8.0%). Patients consumed $315.9 million (M) in direct asthma-related health resources between 2002 and 2007. Hospitalizations, physician visits, and medication costs accounted for 16.0%, 15.7% and 68.2% of total costs, respectively. Cost of asthma increased from $49.4 M in 2002 to $54.7 M in 2007. Total annual costs attributable to hospitalizations and physician visits decreased (-39.8% and -25.5%, respectively; p<0.001), while medication costs increased (+38.7%; p<0.001). Interpretation: This population-based analysis shows that the total direct cost of asthma in BC has increased since 2002, mainly due to a rise in asthma prevalence and cost of medication. Combination therapy with inhaled corticosteroids/long-acting beta-agonists has become a significant component of the cost of asthma. Although billing records capture only a fraction of the true burden of asthma, the simultaneous increase in medication costs and reductions in hospitalization and physician visit costs provides valuable insight for policy makers into the shifts in asthma-related resource use.	[Bedouch, Pierrick; Marra, Carlo A.; Lynd, Larry D.; Sadatsafavi, Mohsen] Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver, BC, Canada; [FitzGerald, J. Mark; Sadatsafavi, Mohsen] Vancouver Coastal Hlth Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [FitzGerald, J. Mark; Sadatsafavi, Mohsen] Univ British Columbia, Fac Med, Div Resp Med, Vancouver, BC, Canada	University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia	Lynd, LD (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Collaborat Outcomes Res & Evaluat, Vancouver, BC, Canada.	larry.lynd@ubc.ca	Sadatsafayi, Mohsen/AAZ-1593-2020; Marra, Carlo/AAE-4904-2021; Bedouch, Pierrick/M-6169-2014	Sadatsafayi, Mohsen/0000-0002-0419-7862; Marra, Carlo/0000-0002-2625-2121; Bedouch, Pierrick/0000-0003-2245-0160; Lynd, Larry/0000-0002-7622-3919	AllerGen National Center of Excellence; Canada Research Chair in Pharmaceutical Outcomes; AllerGen-NCE grant; Sanofi-Aventis France; Grenoble University Hospital; CIHR fellowship award; Grenoble University Hospital, France; Canadian Institutes of Health Research fellowship award	AllerGen National Center of Excellence; Canada Research Chair in Pharmaceutical Outcomes(Canada Research Chairs); AllerGen-NCE grant; Sanofi-Aventis France(Sanofi-Aventis); Grenoble University Hospital; CIHR fellowship award(Canadian Institutes of Health Research (CIHR)); Grenoble University Hospital, France; Canadian Institutes of Health Research fellowship award(Canadian Institutes of Health Research (CIHR))	This study is part of the project "Platform for Outcomes Research and Translation in Asthma and Allergy (PORTAL)'' funded by AllerGen National Center of Excellence. Dr. Lynd is a Michael Smith Foundation for Health Research (MSFHR) Scholar and Canadian Institutes of Health Research (CIHR) New Investigator. Dr. Marra is funded by a Canada Research Chair in Pharmaceutical Outcomes. Dr. Bedouch is a Postdoctoral Fellow funded by an AllerGen-NCE grant, unrestricted grants from Sanofi-Aventis France and the Grenoble University Hospital, France. Dr. Sadatsafavi is a PhD candidate funded by a CIHR fellowship award. None of the sponsors played a role in the study design, data analysis, interpretation or publication of the results.; The content of this article is the sole responsibility of the authors. Dr. FitzGerald has served on advisory boards for GlaxoSmithKline, AstraZeneca, Novartis, Pfizer, Boehringer-Ingelheim, Altana, Merck and Topigen. He has also been a member of speakers' bureaus for Glaxo-SmithKline, AstraZeneca, Boehringer-Ingelheim, Pfizer and Merck. He has received research funding paid directly to the University of British Columbia from the Canadian Institutes of Health Research, AstraZeneca, Glaxo-SmithKline, Boehringer-Ingelheim, Merck, Wyeth, Schering, Genentech and Topigen. Dr. FitzGerald is a member of the Global Initiative for Asthma (GINA) and is chair of the GINA Science Committee. Dr. Bedouch has received financial support for research activities from drug companies including Actelion, Bioprojet, Glaxo-SmithKline. He has had access to unrestricted grants from Sanofi-Aventis France and the Grenoble University Hospital, France. He has also received fees from Actelion for participation in scientific advisory board. Dr. Sadatsafavi was funded by a Canadian Institutes of Health Research fellowship award. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aaron SD, 2008, CAN MED ASSOC J, V179, P1121, DOI 10.1503/cmaj.081332; Anderson HR, 2007, THORAX, V62, P85, DOI 10.1136/thx.2006.066407; Anis AH, 2001, CAN MED ASSOC J, V164, P625; [Anonymous], 2008, LATEST RELEASE CONSU; Armstrong EP, 2001, DIS MANAG HEALTH OUT, V9, P161, DOI 10.2165/00115677-200109030-00004; Awadh Behbehani N, 1999, Can Respir J, V6, P521; Bahadori Katayoun, 2009, BMC Pulm Med, V9, P24, DOI 10.1186/1471-2466-9-24; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; BC Ministry of Health (n.d.) Population Data BC, POP DAT BC; Becker A, 2005, CAN MED ASSOC J, V173, pS3; Boulet LP, 1999, CAN MED ASSOC J, V161, pS1; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Canadian Institute for Health Information (CIHI) (n.d.) Canadian MIS Database Hospital Financial Performance Indicators, 2008, CAN MIS DAT HOSP FIN; Chu C, 1994, Healthc Manage Forum, V7, P24; Finlayson G, 1999, HOSP CASE MIX COSTIN; Firoozi F, 2007, THORAX, V62, P581, DOI 10.1136/thx.2006.061572; FitzGerald J Mark, 2006, Can Respir J, V13, P253; Gendo K, 2003, ANN ALLERG ASTHMA IM, V91, P251, DOI 10.1016/S1081-1206(10)63526-0; Gershon AS, 2010, AM J EPIDEMIOL, V172, P728, DOI 10.1093/aje/kwq189; Gershon AS, 2010, THORAX, V65, P612, DOI 10.1136/thx.2009.131078; Barcala FJG, 2010, ALLERGOL IMMUNOPATH, V38, P254, DOI 10.1016/j.aller.2009.11.008; Government of Canada SC (n.d.) Population by sex and age group, POP SEX AG GROUP; Klomp H, 2008, CAN MED ASSOC J, V178, P1013, DOI 10.1503/cmaj.070426; Krahn MD, 1996, CAN MED ASSOC J, V154, P821; Lemiere Catherine, 2004, Can Respir J, V11 Suppl A, p9A; Li J, 1995, AM J MANAG CARE, V1, P137; Lougheed AD, 2006, CHEST, V129, P909, DOI 10.1378/chest.129.4.909; Lougheed MD, 2010, CAN RESPIR J, V17, P57, DOI 10.1155/2010/378289; Lougheed MD, 2010, CAN RESPIR J, V17, P15, DOI 10.1155/2010/827281; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Ministry of Health (n.d.) PharmaNet, PHARMANET; Piecoro LT, 2001, HEALTH SERV RES, V36, P357; Poole B, 1998, Healthc Manage Forum, V11, P22; Prosser RJ, 2008, HEALTH SERV RES, V43, P733, DOI 10.1111/j.1475-6773.2007.00775.x; Rowe BH, 2007, CAN RESPIR J, V14, P331, DOI 10.1155/2007/450489; Sapra S, 2005, J ASTHMA, V42, P469, DOI 10.1081/JAS-200067265; Stafford RS, 2003, J ALLERGY CLIN IMMUN, V111, P729, DOI 10.1067/mai.2003.177; Stock S, 2005, EUR RESPIR J, V25, P47, DOI 10.1183/09031936.04.00116203; Stow PJ, 2007, THORAX, V62, P842, DOI 10.1136/thx.2006.075317; Ungar WJ, 2001, PEDIATR PULM, V32, P101, DOI 10.1002/ppul.1095; Yuan Y., 2012, ANAL RISK FACTORS CH	41	54	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50949	10.1371/journal.pone.0050949	http://dx.doi.org/10.1371/journal.pone.0050949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227222	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200083
J	Nordberg, J; Mpindi, JP; Iljin, K; Pulliainen, AT; Kallajoki, M; Kallioniemi, O; Elenius, K; Elenius, V				Nordberg, Janne; Mpindi, John Patrick; Iljin, Kristiina; Pulliainen, Arto Tapio; Kallajoki, Markku; Kallioniemi, Olli; Elenius, Klaus; Elenius, Varpu			Systemic Analysis of Gene Expression Profiles Identifies ErbB3 as a Potential Drug Target in Pediatric Alveolar Rhabdomyosarcoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; REFRACTORY SOLID TUMORS; PRECLINICAL TESTING PROGRAM; KINASE INHIBITOR; CLINICAL-FEATURES; EWINGS-SARCOMA; EPH RECEPTORS; PHASE-II; CANCER; CHILDREN	Pediatric sarcomas, including rhabdomyosarcomas, Ewing's sarcoma, and osteosarcoma, are aggressive tumors with poor survival rates. To overcome problems associated with nonselectivity of the current therapeutic approaches, targeted therapeutics have been developed. Currently, an increasing number of such drugs are used for treating malignancies of adult patients but little is known about their effects in pediatric patients. We analyzed expression of 24 clinically approved target genes in a wide variety of pediatric normal and malignant tissues using a novel high-throughput systems biology approach. Analysis of the Genesapiens database of human transcriptomes demonstrated statistically significant upregulation of VEGFC and EPHA2 in Ewing's sarcoma, and ERBB3 in alveolar rhabdomyosarcomas. In silico data for ERBB3 was validated by demonstrating ErbB3 protein expression in pediatric rhabdomyosarcoma in vitro and in vivo. ERBB3 overexpression promoted whereas ERBB3-targeted siRNA suppressed rhabdomyosarcoma cell gowth, indicating a functional role for ErbB3 signaling in rhabdomyosarcoma. These data suggest that drugs targeting ErbB3, EphA2 or VEGF-C could be further tested as therapeutic targets for pediatric sarcomas. Citation: Nordberg J, Mpindi JP, Iljin K, Pulliainen AT, Kallajoki M, et al. (2012) Systemic Analysis of Gene Expression Profiles Identifies ErbB3 as a Potential Drug Target in Pediatric Alveolar Rhabdomyosarcoma. PLoS ONE 7(12): e50819. doi:10.1371/journal.pone.0050819	[Nordberg, Janne; Pulliainen, Arto Tapio; Elenius, Klaus; Elenius, Varpu] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Mpindi, John Patrick; Iljin, Kristiina; Kallioniemi, Olli] VTT Tech Res Ctr Finland, Turku, Finland; [Kallajoki, Markku] Turku Univ Hosp, Dept Pathol, FIN-20520 Turku, Finland; [Kallioniemi, Olli] Univ Helsinki, Inst Mol Med FIMM, Helsinki, Finland; [Elenius, Klaus] Univ Turku, Med Res Labs, Turku, Finland; [Elenius, Klaus] Turku Univ Hosp, Dept Oncol, FIN-20520 Turku, Finland; [Elenius, Varpu] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland	University of Turku; VTT Technical Research Center Finland; University of Turku; University of Helsinki; University of Turku; University of Turku; University of Turku	Elenius, V (corresponding author), Univ Turku, Dept Med Biochem & Genet, Turku, Finland.	varpu.elenius@utu.fi	Pulliainen, Arto/AAX-2052-2021; Kallioniemi, Olli P/H-5111-2011; Elenius, Klaus/AAI-7594-2021	Kallioniemi, Olli P/0000-0002-3231-0332; Elenius, Klaus/0000-0001-5700-0827; Nordberg, Janne/0000-0002-2917-4341; Iljin, Kristiina/0000-0002-5161-0584; Pulliainen, Arto Tapio/0000-0002-9361-8963	Academy of Finland; Finnish Medical Foundation	Academy of Finland(Academy of Finland); Finnish Medical Foundation	This work was supported by the Academy of Finland and the Finnish Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Campbell TN, 2008, CURR ISSUES MOL BIOL, V10, P61; Cho J, 2011, BLOOD, V117, P1156, DOI 10.1182/blood-2010-04-279349; Dalal S, 2005, CLIN CANCER RES, V11, P2364, DOI 10.1158/1078-0432.CCR-04-1201; Daw NC, 2005, J CLIN ONCOL, V23, P6172, DOI 10.1200/JCO.2005.11.429; DuBois S, 2007, CANCER-AM CANCER SOC, V109, P813, DOI 10.1002/cncr.22455; Edwards JR, 2008, HUM PATHOL, V39, P49, DOI 10.1016/j.humpath.2007.04.022; Fox E, 2010, J CLIN ONCOL, V28, P5174, DOI 10.1200/JCO.2010.30.9674; Fritsche-Guenther R, 2010, HISTOPATHOLOGY, V57, P836, DOI 10.1111/j.1365-2559.2010.03713.x; Funahashi Y, 2009, INT J UROL, V16, P769, DOI 10.1111/j.1442-2042.2009.02339.x; Furman WL, 2009, J CLIN ONCOL, V27, P4599, DOI 10.1200/JCO.2008.19.6642; Genander M, 2010, CURR OPIN CELL BIOL, V22, P611, DOI 10.1016/j.ceb.2010.08.005; Gerber HP, 2005, CANCER RES, V65, P671; Heckman CA, 2008, CANCER RES, V68, P4754, DOI 10.1158/0008-5472.CAN-07-5809; Hettmer S, 2010, NAT MED, V16, P171, DOI 10.1038/nm0210-171; Huang F, 2007, CANCER RES, V67, P2226, DOI 10.1158/0008-5472.CAN-06-3633; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jakacki RI, 2008, J CLIN ONCOL, V26, P4921, DOI 10.1200/JCO.2007.15.2306; Joensuu H, 2002, MED KLIN, V97, P28; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kolb EA, 2008, PEDIATR BLOOD CANCER, V50, P1198, DOI 10.1002/pbc.21368; Landier W, 2008, ONCOLOGIST, V13, P1181, DOI 10.1634/theoncologist.2008-0104; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Maki RG, 2009, J CLIN ONCOL, V27, P3133, DOI 10.1200/JCO.2008.20.4495; Maris JM, 2008, PEDIATR BLOOD CANCER, V50, P581, DOI 10.1002/pbc.21232; Messahel B, 2005, LANCET ONCOL, V6, P421, DOI 10.1016/S1470-2045(05)70209-6; Mpindi JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017259; Noguchi H, 1999, GASTROENTEROLOGY, V117, P1119, DOI 10.1016/S0016-5085(99)70397-5; Paolucci P, 2008, LANCET ONCOL, V9, P176, DOI 10.1016/S1470-2045(08)70030-5; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Sinha G, 2008, J NATL CANCER I, V100, P84, DOI 10.1093/jnci/djm317; Sleijfer S, 2009, J CLIN ONCOL, V27, P3126, DOI 10.1200/JCO.2008.21.3223; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Thompson PA, 2012, CURR ONCOL REP; Wachtel M, 2010, CANCER TREAT REV, V36, P318, DOI 10.1016/j.ctrv.2010.02.007; Watson Rory, 2005, BMJ, V330, P1348, DOI 10.1136/bmj.330.7504.1348-c; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	44	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50819	10.1371/journal.pone.0050819	http://dx.doi.org/10.1371/journal.pone.0050819			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227212	Green Submitted, Green Published, gold			2022-12-27	WOS:000312588200072
J	de Vries, SJ; Zacharias, M				de Vries, Sjoerd J.; Zacharias, Martin			ATTRACT-EM: A New Method for the Computational Assembly of Large Molecular Machines Using Cryo-EM Maps	PLOS ONE			English	Article							PROTEIN-PROTEIN DOCKING; GROEL-GROES COMPLEX; ATOMIC MODELS; CRYOELECTRON MICROSCOPY; CRYSTAL-STRUCTURE; ELECTRON; DENSITY; OPTIMIZATION; COMPONENTS; RIBOSOME	Many of the most important functions in the cell are carried out by proteins organized in large molecular machines. Cryoelectron microscopy (cryo-EM) is increasingly being used to obtain low resolution density maps of these large assemblies. A new method, ATTRACT-EM, for the computational assembly of molecular assemblies from their components has been developed. Based on concepts from the protein-protein docking field, it utilizes cryo-EM density maps to assemble molecular subunits at near atomic detail, starting from millions of initial subunit configurations. The search efficiency was further enhanced by recombining partial solutions, the inclusion of symmetry information, and refinement using a molecular force field. The approach was tested on the GroES-GroEL system, using an experimental cryo-EM map at 23.5 angstrom resolution, and on several smaller complexes. Inclusion of experimental information on the symmetry of the systems and the application of a new gradient vector matching algorithm allowed the efficient identification of docked assemblies in close agreement with experiment. Application to the GroES-GroEL complex resulted in a top ranked model with a deviation of 4.6 angstrom (and a 2.8 angstrom model within the top 10) from the GroES-GroEL crystal structure, a significant improvement over existing methods. Citation: de Vries SJ, Zacharias M (2012) ATTRACT-EM: A New Method for the Computational Assembly of Large Molecular Machines Using Cryo-EM Maps. PLoS ONE 7(12): e49733. doi:10.1371/journal.pone.0049733	[de Vries, Sjoerd J.; Zacharias, Martin] Tech Univ Munich, Phys Dept T38, D-8046 Garching, Germany	Technical University of Munich	de Vries, SJ (corresponding author), Tech Univ Munich, Phys Dept T38, D-8046 Garching, Germany.	sjoerd@tum.de			Marie Curie Intra-European Fellowship programme; FP7 of the European Commission [No 273003]	Marie Curie Intra-European Fellowship programme; FP7 of the European Commission	The presented work was made possible by the Marie Curie Intra-European Fellowship programme, financed by the FP7 of the European Commission (http://cordis.europa.eu/fp7) (contract-No 273003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Beck M, 2011, J STRUCT BIOL, V173, P483, DOI 10.1016/j.jsb.2010.11.011; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Birmanns S, 2011, J STRUCT BIOL, V173, P428, DOI 10.1016/j.jsb.2010.11.002; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Ceulemans H, 2004, J MOL BIOL, V338, P783, DOI 10.1016/j.jmb.2004.02.066; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chen DH, 2006, STRUCTURE, V14, P1711, DOI 10.1016/j.str.2006.09.010; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fabiola F, 2005, STRUCTURE, V13, P389, DOI 10.1016/j.str.2005.01.007; Fernandez-Recio J, 2003, PROTEINS, V52, P113, DOI 10.1002/prot.10383; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Fleishman SJ, 2011, J MOL BIOL, V414, P289, DOI 10.1016/j.jmb.2011.09.031; Garzon JI, 2007, BIOINFORMATICS, V23, P427, DOI 10.1093/bioinformatics/btl625; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Grubisic I, 2010, J STRUCT BIOL, V169, P95, DOI 10.1016/j.jsb.2009.09.010; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Henrick K, 2003, J STRUCT BIOL, V144, P228, DOI 10.1016/j.jsb.2003.09.009; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Jolley CC, 2008, BIOPHYS J, V94, P1613, DOI 10.1529/biophysj.107.115949; Kampmann M, 2009, NAT STRUCT MOL BIOL, V16, P782, DOI 10.1038/nsmb.1618; Kanno R, 2009, STRUCTURE, V17, P287, DOI 10.1016/j.str.2008.12.012; Kastritis PL, 2010, J PROTEOME RES, V9, P2216, DOI 10.1021/pr9009854; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kawabata T, 2008, BIOPHYS J, V95, P4643, DOI 10.1529/biophysj.108.137125; Kovacs JA, 2003, ACTA CRYSTALLOGR D, V59, P1371, DOI 10.1107/S0907444903011247; Kovacs JA, 2008, BIOPHYS J, V95, P3192, DOI 10.1529/biophysj.108.132357; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Lasker K, 2009, J MOL BIOL, V388, P180, DOI 10.1016/j.jmb.2009.02.031; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; Ludtke SJ, 2001, J MOL BIOL, V314, P253, DOI 10.1006/jmbi.2001.5133; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; May A, 2005, BBA-PROTEINS PROTEOM, V1754, P225, DOI 10.1016/j.bbapap.2005.07.045; Mendez R, 2005, PROTEINS, V60, P150, DOI 10.1002/prot.20551; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Quammen C., 2007, CLARITY C OPEN SOURC; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Roseman AM, 2000, ACTA CRYSTALLOGR D, V56, P1332, DOI 10.1107/S0907444900010908; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; Rossmann MG, 2000, ACTA CRYSTALLOGR D, V56, P1341, DOI 10.1107/S0907444900009562; Saha M, 2010, BIOINFORMATICS, V26, pi301, DOI 10.1093/bioinformatics/btq195; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Schueler-Furman O, 2005, PROTEINS, V60, P187, DOI 10.1002/prot.20556; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Stark H, 2006, ANNU REV BIOPH BIOM, V35, P435, DOI 10.1146/annurev.biophys.35.040405.101953; Suhre K, 2006, ACTA CRYSTALLOGR D, V62, P1098, DOI 10.1107/S090744490602244X; Tagari M, 2002, TRENDS BIOCHEM SCI, V27, P589, DOI 10.1016/S0968-0004(02)02176-X; Tama F, 2004, J STRUCT BIOL, V147, P315, DOI 10.1016/j.jsb.2004.03.002; Topf M, 2005, J STRUCT BIOL, V149, P191, DOI 10.1016/j.jsb.2004.11.004; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; Vasishtan D, 2011, J STRUCT BIOL, V174, P333, DOI 10.1016/j.jsb.2011.01.012; Velazquez-Muriel JA, 2007, J STRUCT BIOL, V158, P165, DOI 10.1016/j.jsb.2006.10.014; Velazquez-Muriel JA, 2006, STRUCTURE, V14, P1115, DOI 10.1016/j.str.2006.05.013; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Volkmann N, 2003, METHOD ENZYMOL, V374, P204, DOI 10.1016/S0076-6879(03)74010-5; Volkmann N, 1999, J STRUCT BIOL, V125, P176, DOI 10.1006/jsbi.1998.4074; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zacharias M, 2003, PROTEIN SCI, V12, P1271, DOI 10.1110/ps.0239303; Zhang SH, 2010, BIOINFORMATICS, V26, pi261, DOI 10.1093/bioinformatics/btq201	73	37	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e49733	10.1371/journal.pone.0049733	http://dx.doi.org/10.1371/journal.pone.0049733			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251350	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800009
J	Xu, J; Wen, ZR; Gong, ZJ; Zhang, M; Xie, P; Hansson, LA				Xu, Jun; Wen, Zhourui; Gong, Zhijun; Zhang, Min; Xie, Ping; Hansson, Lars-Anders			Seasonal Trophic Niche Shift and Cascading Effect of a Generalist Predator Fish	PLOS ONE			English	Article							STABLE-ISOTOPES; COMMUNITY STRUCTURE; ONTOGENIC NICHE; SHALLOW LAKES; BODY-SIZE; PREY; FOOD; POSITION; ZOOPLANKTON; ABUNDANCE	Few studies have examined how foraging niche shift of a predator over time cascade down to local prey communities. Here we examine patterns of temporal foraging niche shifts of a generalist predator (yellow catfish, Pelteobagrus fulvidraco) and the abundance of prey communities in a subtropical lake. We predicted that the nature of these interactions would have implications for patterns in diet shifts and growth of the predator. Our results show significant decreases in planktivory and benthivory from late spring to summer and autumn, whereas piscivory increased significantly from mid-summer until late autumn and also increased steadily with predator body length. The temporal dynamics in predator/prey ratios indicate that the predation pressure on zooplankton and zoobenthos decreased when the predation pressure on the prey fish and shrimps was high. Yellow catfish adjusted their foraging strategies to temporal changes in food availability, which is in agreement with optimal foraging theory. Meanwhile the decrease in planktivory and benthivory of yellow catfish enabled primary consumers, such as zooplankton and benthic invertebrates, to develop under low grazing pressure via trophic cascading effects in the local food web. Thus, yellow catfish shifts its foraging niche to intermediate consumers in the food web to benefit the energetic demand on growth and reproduction during summer, which in turn indirectly facilitate the primary consumers. In complex food webs, trophic interactions are usually expected to reduce the strength and penetrance of trophic cascades. However, our study demonstrates strong associations between foraging niche of piscivorous fish and abundance of prey. This relationship appeared to be an important factor in producing top-down effects on both benthic and planktonic food webs. Citation: Xu J, Wen Z, Gong Z, Zhang M, Xie P, et al. (2012) Seasonal Trophic Niche Shift and Cascading Effect of a Generalist Predator Fish. PLoS ONE 7(12): e49691. doi:10.1371/journal.pone.0049691	[Xu, Jun; Xie, Ping] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosyst, Wuhan, Hubei, Peoples R China; [Wen, Zhourui] Hubei Fishery Sci Inst, Wuhan, Hubei, Peoples R China; [Gong, Zhijun] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Nanjing, Jiangsu, Peoples R China; [Zhang, Min] Huazhong Agr Univ, Coll Fisheries, Wuhan, Hubei, Peoples R China; [Hansson, Lars-Anders] Lund Univ, Inst Biol Aquat Ecol, Lund, Sweden	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Huazhong Agricultural University; Lund University	Xu, J (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosyst, Wuhan, Hubei, Peoples R China.	xujun@ihb.ac.cn; xieping@ihb.ac.cn	Xie, Ping/AAL-7532-2020; Hansson, Lars-Anders/HCI-2735-2022	Hansson, Lars-Anders/0000-0002-3035-1317	National Natural Science Foundation of China [31170439]; National Basic Research Program of China [2008CB418001-1]; Ministry of Science and Technology of the People's Republic of China [2007BAC26B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This research was partially supported by the National Natural Science Foundation of China (Grant No. 31170439 to JX), the National Basic Research Program of China (2008CB418001-1), and the Ministry of Science and Technology of the People's Republic of China (Grant No. 2007BAC26B02). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adams R. A., 2000, ONTOGENY FUNCTIONAL; Akin S, 2008, ACTA OECOL, V33, P144, DOI 10.1016/j.actao.2007.08.002; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Boyd IL, 1996, ECOLOGY, V77, P426, DOI 10.2307/2265619; Cai YJ, 2011, ANN LIMNOL-INT J LIM, V47, P85, DOI 10.1051/limn/2010028; Carpenter S. R., 1996, TROPHIC CASCADE LAKE; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Eloranta AP, 2010, J FISH BIOL, V77, P80, DOI 10.1111/j.1095-8649.2010.02656.x; Ginter K, 2011, HYDROBIOLOGIA, V660, P79, DOI 10.1007/s10750-010-0393-6; Grey J, 2001, ECOL FRESHW FISH, V10, P168, DOI 10.1034/j.1600-0633.2001.100306.x; Hansson LA, 2013, NAT CLIM CHANGE, V3, P228, DOI 10.1038/NCLIMATE1689; Iglesias C, 2007, HYDROBIOLOGIA, V584, P179, DOI 10.1007/s10750-007-0599-4; Jennings S, 2003, ECOL LETT, V6, P971, DOI 10.1046/j.1461-0248.2003.00529.x; Jeppesen E, 1997, HYDROBIOLOGIA, V342, P151, DOI 10.1023/A:1017046130329; Jeppesen E, 2007, HYDROBIOLOGIA, V581, P269, DOI 10.1007/s10750-006-0507-3; Jeppesen E, 2010, HYDROBIOLOGIA, V646, P73, DOI 10.1007/s10750-010-0171-5; Kolasinski J, 2009, MAR ECOL PROG SER, V386, P181, DOI 10.3354/meps08081; Krivan V, 1996, THEOR POPUL BIOL, V49, P265, DOI 10.1006/tpbi.1996.0014; Layman CA, 2005, ECOLOGY, V86, P2530, DOI 10.1890/04-1098; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; Lopez-Bao JV, 2011, OIKOS, V120, P1489, DOI 10.1111/j.1600-0706.2011.19194.x; Meerhoff M, 2007, FRESHWATER BIOL, V52, P1009, DOI 10.1111/j.1365-2427.2007.01748.x; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PERSSON L, 1990, ECOLOGY, V71, P44, DOI 10.2307/1940246; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Core Team, 2020, R LANG ENV STAT COMP; RUSSELL RW, 1992, LANDSCAPE ECOL, V7, P195, DOI 10.1007/BF00133310; Scheffer M, 2007, HYDROBIOLOGIA, V584, P455, DOI 10.1007/s10750-007-0616-7; Schindler DE, 2002, OIKOS, V98, P177, DOI 10.1034/j.1600-0706.2002.980201.x; Stephens D., 2007, FORAGING BEHAV ECOLO; Stewart BD, 2001, MAR BIOL, V138, P383, DOI 10.1007/s002270000468; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Tan B, 1997, WATER RESOURCE FISHE, V5, P1; TISELIUS P, 1993, B MAR SCI, V53, P247; van Baalen M, 2001, AM NAT, V157, P512, DOI 10.1086/319933; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Xu J, 2008, HYDROBIOLOGIA, V605, P45, DOI 10.1007/s10750-008-9299-y; Xu J, 2007, ECOSCIENCE, V14, P170, DOI 10.2980/1195-6860(2007)14[170:SSIROB]2.0.CO;2; Xu J, 2011, LIMNOLOGY, V12, P107, DOI 10.1007/s10201-010-0327-z; Zimmerman MS, 2009, CAN J FISH AQUAT SCI, V66, P1007, DOI 10.1139/F09-060; Zou S, 1999, J HUBEI AGR COLL, V19, P240	44	8	9	3	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e49691	10.1371/journal.pone.0049691	http://dx.doi.org/10.1371/journal.pone.0049691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251347	gold, Green Published, Green Submitted			2022-12-27	WOS:000312386800006
J	Leger, PL; Bonnin, P; Nguyen, T; Renolleau, S; Baud, O; Charriaut-Marlangue, C				Leger, Pierre-Louis; Bonnin, Philippe; Thao Nguyen; Renolleau, Sylvain; Baud, Olivier; Charriaut-Marlangue, Christiane			Ischemic Postconditioning Fails to Protect against Neonatal Cerebral Stroke	PLOS ONE			English	Article							BLOOD-FLOW; ARTERY OCCLUSION; FOCAL ISCHEMIA; COLLATERAL CIRCULATION; CASPASE INHIBITOR; HYPOXIA-ISCHEMIA; BRAIN-DAMAGE; NITRIC-OXIDE; RATS; REPERFUSION	The lack of efficient neuroprotective strategies for neonatal stroke could be ascribed to pathogenic ischemic processes differentiating adults and neonates. We explored this hypothesis using a rat model of neonatal ischemia induced by permanent occlusion of the left distal middle cerebral artery combined with 50 min of occlusion of both common carotid arteries (CCA). Postconditioning was performed by repetitive brief release and occlusion (30 s, 1 and/or 5 min) of CCA after 50 min of CCA occlusion. Alternative reperfusion was generated by controlled release of the bilateral CCA occlusion. Blood-flow velocities in the left internal carotid artery were measured using color-coded pulsed Doppler ultrasound imaging. Cortical perfusion was measured using laser Doppler. Cerebrovascular vasoreactivity was evaluated after inhalation with the hypercapnic gas or inhaled nitric oxide (NO). Whatever the type of serial mechanical interruptions of blood flow at reperfusion, postconditioning did not reduce infarct volume after 72 hours. A gradual perfusion was found during early re-flow both in the left internal carotid artery and in the cortical penumbra. The absence of acute hyperemia during early CCA re-flow, and the lack of NO-dependent vasoreactivity in P7 rat brain could in part explain the inefficiency of ischemic postconditioning after ischemia-reperfusion.	[Leger, Pierre-Louis; Thao Nguyen; Baud, Olivier; Charriaut-Marlangue, Christiane] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, U676, Paris, France; [Bonnin, Philippe] Univ Paris Diderot, Hop Lariboisiere, AP HP, Sorbonne Paris Cite,Physiol Clin, Paris, France; [Bonnin, Philippe] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, U965, Paris, France; [Leger, Pierre-Louis; Renolleau, Sylvain] UPMC Paris6, Hop Armand Trousseau, AP HP, Serv Reanimat Pediat, Paris, France; [Baud, Olivier] Univ Paris Diderot, Hop Robert Debre, AP HP, Sorbonne Paris Cite,Serv Reanimat Neonatale & Ped, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Charriaut-Marlangue, C (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, INSERM, U676, Paris, France.	christiane.marlangue@gmail.com	, CHARRIAUT-MARLANGUE/H-3249-2019; Bonnin, Philippe/Y-5872-2019	Bonnin, Philippe/0000-0003-3184-3740	Fondation pour la Recherche Medicale	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	The "Fondation pour la Recherche Medicale" supported PL Leger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; Bonnin P, 2012, EXP NEUROL, V236, P50, DOI 10.1016/j.expneurol.2012.04.001; Bonnin P, 2011, J NEUROSCI METH, V198, P103, DOI 10.1016/j.jneumeth.2011.02.030; BONVENTO G, 1994, J CEREBR BLOOD F MET, V14, P699, DOI 10.1038/jcbfm.1994.90; Charriaut-Marlangue C, 2012, STROKE; Chauvier D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.87; Choy M, 2006, J CEREBR BLOOD F MET, V26, P1066, DOI 10.1038/sj.jcbfm.9600259; Ducrocq S, 2000, J NEUROCHEM, V74, P2504, DOI 10.1046/j.1471-4159.2000.0742504.x; Fabian RH, 2008, AM J PHYSIOL-HEART C, V295, pH1809, DOI 10.1152/ajpheart.00301.2007; Fisher M, 2008, CURR OPIN DRUG DISC, V11, P626; Gao XW, 2008, J NEUROSCI RES, V86, P2505, DOI 10.1002/jnr.21703; Golomb MR, 2008, J CHILD NEUROL, V23, P279, DOI 10.1177/0883073807309246; KIRSCH JR, 1990, AM J PHYSIOL, V259, pH1551; Liebeskind DS, 2009, NAT REV NEUROL, V5, P645, DOI 10.1038/nrneurol.2009.193; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MENZIES SA, 1992, NEUROSURGERY, V31, P100, DOI 10.1227/00006123-199207000-00014; Northington FJ, 2006, ILAR J, V47, P32, DOI 10.1093/ilar.47.1.32; Qiao M, 2004, MAGN RESON MATER PHY, V17, P117, DOI 10.1007/s10334-004-0058-4; Renolleau S, 1998, STROKE, V29, P1454, DOI 10.1161/01.STR.29.7.1454; Renolleau S, 2008, NEUROSCIENTIST, V14, P46, DOI 10.1177/1073858407308889; Renolleau S, 2007, J NEUROCHEM, V100, P1062, DOI 10.1111/j.1471-4159.2006.04269.x; Sutherland BA, 2011, J PHYSIOL-LONDON, V589, P4105, DOI 10.1113/jphysiol.2011.209601; van Laar PJ, 2007, RADIOLOGY, V242, P526, DOI 10.1148/radiol.2422060179; VANNUCCI RC, 1994, J CEREBR BLOOD F MET, V14, P279, DOI 10.1038/jcbfm.1994.35; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Wang JY, 2008, STROKE, V39, P983, DOI 10.1161/STROKEAHA.107.499079; Willis AP, 2001, AM J PHYSIOL-HEART C, V281, pH2366, DOI 10.1152/ajpheart.2001.281.6.H2366; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348	29	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49695	10.1371/journal.pone.0049695	http://dx.doi.org/10.1371/journal.pone.0049695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251348	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200019
J	Lin, WY; Pi-Sunyer, FX; Liu, CS; Li, CI; Davidson, LE; Li, TC; Lin, CC				Lin, Wen-Yuan; Pi-Sunyer, F. Xavier; Liu, Chiu-Shong; Li, Chia-Ing; Davidson, Lance E.; Li, Tsai-Chung; Lin, Cheng-Chieh			Central Obesity and Albuminuria: Both Cross-Sectional and Longitudinal Studies in Chinese	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ALL-CAUSE MORTALITY; METABOLIC SYNDROME; NONDIABETIC SUBJECTS; INSULIN-RESISTANCE; RENAL-DISEASE; MICROALBUMINURIA; IMPACT; HEALTH; ADIPONECTIN	Background: Albuminuria is recognized as a marker of vascular dysfunction. Central obesity increases the risk of cardiovascular disease. Little is known about the association between albuminuria and central obesity in Chinese. We aimed to assess the association between central obesity and prevalence and incidence of albuminuria in a middle-aged population-based cohort study. Methods: This is a cross-sectional and longitudinal cohort study. A total of 2350 subjects aged >= 40 years were recruited in 2004 in Taiwan for cross-sectional analysis. Longitudinal analysis included 1432 baseline normoalbuminuria subjects with a mean 2.8 years follow-up, 67 of whom exhibited incident albuminuria. Albuminuria was defined as urinary albumin-to-creatinine ratio >= 30 mg/g creatinine. Multiple logistic regression analyses were used to evaluate the relationship between central obesity and prevalence and incidence of albuminuria after adjustment for age, gender, body mass index, blood pressure, renal function, glucose, high sensitivity c-reactive protein, smoking, betel nut chewing, alcohol drinking, and physical activity. Results: At baseline, albuminuria is significantly associated with central obesity. The adjusted odds ratio of having albuminuria among subjects with central obesity was 1.73(95% confidence interval (CI): 1.04-2.85), compared to the subjects without central obesity. In multivariable models, participants with central obesity at baseline had a 112% increase in risk of incident albuminuria (adjusted incidence rate ratio (95% CI): 2.12(1.01-4.44)) compared with participants with non-central obesity. Conclusions: Abdominal adiposity was independently associated with increased prevalence and incidence of albuminuria in Chinese. The mechanisms linking adiposity and albuminuria need to be addressed.	[Lin, Wen-Yuan; Liu, Chiu-Shong; Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Lin, Wen-Yuan; Liu, Chiu-Shong; Li, Chia-Ing; Lin, Cheng-Chieh] China Med Univ, Sch Med, Taichung, Taiwan; [Lin, Wen-Yuan; Lin, Cheng-Chieh] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Grad Inst Biostat, Taichung, Taiwan; [Li, Tsai-Chung; Lin, Cheng-Chieh] Asia Univ, Coll Hlth Sci, Inst Hlth Care Adm, Taichung, Taiwan; [Pi-Sunyer, F. Xavier] Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp, New York Obes & Nutr Res Ctr, New York, NY 10032 USA; [Davidson, Lance E.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Utah System of Higher Education; University of Utah	Lin, CC (corresponding author), China Med Univ Hosp, Dept Family Med, Taichung, Taiwan.	cclin@mail.cmuh.org.tw	Li, Tsai-Chung/P-2052-2015; Lin, Cheng-Chieh/P-2564-2015; Davidson, Lance E./AAA-9689-2019; Stefanadis, Christodoulos/ABH-2232-2020	Li, Tsai-Chung/0000-0002-3346-7462; Lin, Cheng-Chieh/0000-0002-9625-6216; Davidson, Lance E./0000-0002-1383-0666; Stefanadis, Christodoulos/0000-0001-5974-6454	National Science Council of Taiwan [NSC93-2314-B-039-025, NSC94-2314-B-039-024, NSC96-2628-B-039-011-MY3]; China Medical University Hospital [DMR-99-110]; Taiwan Department of Health Clinical Trial and Research Center for Excellence [DOH101-TD-B-111-004]; US National Institutes of Health [DK 026687]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital; Taiwan Department of Health Clinical Trial and Research Center for Excellence; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by grants from National Science Council of Taiwan (NSC93-2314-B-039-025, NSC94-2314-B-039-024, NSC96-2628-B-039-011-MY3), from China Medical University Hospital (DMR-99-110), from Taiwan Department of Health Clinical Trial and Research Center for Excellence (DOH101-TD-B-111-004), and from the US National Institutes of Health (DK 026687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman RD, 2002, CURR OPIN NEPHROL HY, V11, P331, DOI 10.1097/00041552-200205000-00010; Bonnet F, 2006, J HYPERTENS, V24, P1157, DOI 10.1097/01.hjh.0000226206.03560.ac; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Calle EE, 2005, NEW ENGL J MED, V353, P2197, DOI 10.1056/NEJM200511173532020; Christopher JR, 2007, 13181 NBER; de Boer IH, 2007, J AM SOC NEPHROL, V18, P235, DOI 10.1681/ASN.2006040394; Deurenberg-Yap M, 1999, Asia Pac J Clin Nutr, V8, P177, DOI 10.1046/j.1440-6047.1999.00091.x; Dhaliwal SS, 2009, PREV MED, V49, P153, DOI 10.1016/j.ypmed.2009.07.019; Foster MC, 2011, OBESITY, V19, P1284, DOI 10.1038/oby.2010.308; Fujikawa R, 2001, DIABETES RES CLIN PR, V53, P99, DOI 10.1016/S0168-8227(01)00241-8; Gilardini L, 2010, INT J OBESITY, V34, P287, DOI 10.1038/ijo.2009.227; Hall JE, 2003, CURR HYPERTENS REP, V5, P386, DOI 10.1007/s11906-003-0084-z; Hall JE, 2002, AM J MED SCI, V324, P127, DOI 10.1097/00000441-200209000-00003; Hsu HS, 2011, EUR J CLIN INVEST, V41, P393, DOI 10.1111/j.1365-2362.2010.02421.x; Huang KC, 2002, INT J OBESITY, V26, P1060, DOI 10.1038/sj.ijo.0802047; Kadakia MB, 2011, HEART, V97, P1782, DOI 10.1136/heartjnl-2011-300231; KANNEL WB, 1991, J CLIN EPIDEMIOL, V44, P183, DOI 10.1016/0895-4356(91)90265-B; Khalili S, 2012, METABOLIC SYNDROME R; Klausen KP, 2009, CLIN ENDOCRINOL, V71, P40, DOI 10.1111/j.1365-2265.2008.03427.x; Kramer H, 2009, DIABETES CARE, V32, P851, DOI 10.2337/dc08-2059; Kuriyama S, 2006, J EPIDEMIOL, V16, P139, DOI 10.2188/jea.16.139; Lai MM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-429; Lin CC, 2007, EUR J CLIN INVEST, V37, P783, DOI 10.1111/j.1365-2362.2007.01865.x; Lin WY, 2006, OBESITY, V14, P1654, DOI 10.1038/oby.2006.190; Lin WY, 2009, J ATHEROSCLER THROMB, V16, P105, DOI 10.5551/jat.E603; Liu CS, 2010, ATHEROSCLEROSIS, V211, P315, DOI 10.1016/j.atherosclerosis.2010.02.015; Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010; Papafragkaki Dafni-Kalliopi, 2005, Hormones (Athens), V4, P90; Rutkowski P, 2006, J RENAL NUTR, V16, P216, DOI 10.1053/j.jrn.2006.04.017; Sarafidis PA, 2006, NEPHROL DIAL TRANSPL, V21, P2366, DOI 10.1093/ndt/gfl309; Sasson AN, 2012, WORLD J DIABETES, V3, P1, DOI 10.4239/wjd.v3.i1.1; Sharma K, 2008, J CLIN INVEST, V118, P1645, DOI 10.1172/JCI32691; Sharma K, 2009, KIDNEY INT, V76, P145, DOI 10.1038/ki.2009.137; Shaw PKC, 2007, DIABETES CARE, V30, P1840, DOI 10.2337/dc07-0028; Sochett EB, 2006, J AM SOC NEPHROL, V17, P1703, DOI 10.1681/ASN.2005080872; Sturm R, 2003, ARCH INTERN MED, V163, P2146, DOI 10.1001/archinte.163.18.2146; Sukhija R, 2006, AM J CARDIOL, V98, P279, DOI 10.1016/j.amjcard.2006.01.098; Sullivan JC, 2007, AM J PHYSIOL-REG I, V293, pR1573, DOI 10.1152/ajpregu.00429.2007; Thoenes M, 2009, VASC HEALTH RISK MAN, V5, P577; U.S. Renal Data System, 2011, USRDS 2011 ANN DAT R; Vedovato M, 2004, DIABETOLOGIA, V47, P300, DOI 10.1007/s00125-003-1303-5; Vlek ALM, 2008, J INTERN MED, V264, P351, DOI 10.1111/j.1365-2796.2008.01970.x; Wang YF, 2005, AM J CLIN NUTR, V81, P555; World Health Organization, 2021, OB OV FACT SHEETS; Yano Yuichiro, 2007, J Clin Hypertens (Greenwich), V9, P775, DOI 10.1111/j.1524-6175.2007.07321.x; Yeh CJ, 2011, ASIA PAC J CLIN NUTR, V20, P292; Yuyun MF, 2004, INT J EPIDEMIOL, V33, P189, DOI 10.1093/ije/dyh008	47	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e47960	10.1371/journal.pone.0047960	http://dx.doi.org/10.1371/journal.pone.0047960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251329	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200003
J	Nejadnik, H; Henning, TD; Do, T; Sutton, EJ; Baehner, F; Horvai, A; Sennino, B; McDonald, D; Meier, R; Misselwitz, B; Link, TM; Daldrup-Link, HE				Nejadnik, Hossein; Henning, Tobias D.; Thuy Do; Sutton, Elizabeth J.; Baehner, Frederick; Horvai, Andrew; Sennino, Barbara; McDonald, Donald; Meier, Reinhard; Misselwitz, Bernd; Link, Thomas M.; Daldrup-Link, Heike E.			MR Imaging Features of Gadofluorine-Labeled Matrix-Associated Stem Cell Implants in Cartilage Defects	PLOS ONE			English	Article							AUTOLOGOUS CHONDROCYTE IMPLANTATION; IN-VIVO; CONTRAST AGENTS; REPAIR; TRANSPLANTATION; KNEE; CHONDROGENESIS; FERUCARBOTRAN; REGENERATION; TRACKING	Objectives: The purpose of our study was to assess the chondrogenic potential and the MR signal effects of GadofluorineM-Cy labeled matrix associated stem cell implants (MASI) in pig knee specimen. Materials and Methods: Human mesenchymal stem cells (hMSCs) were labeled with the micelle-based contrast agent GadofluorineM-Cy. Ferucarbotran-labeled hMSCs, non-labeled hMSCs and scaffold only served as controls. Chondrogenic differentiation was induced and gene expression and histologic evaluation were performed. The proportions of spindle-shaped vs. round cells of chondrogenic pellets were compared between experimental groups using the Fisher's exact test. Labeled and unlabeled hMSCs and chondrocytes in scaffolds were implanted into cartilage defects of porcine femoral condyles and underwent MR imaging with T1- and T2-weighted SE and GE sequences. Contrast-to-noise ratios (CNR) between implants and adjacent cartilage were determined and analyzed for significant differences between different experimental groups using the Kruskal-Wallis test. Significance was assigned for p<0.017, considering a Bonferroni correction for multiple comparisons. Results: Collagen type II gene expression levels were not significantly different between different groups (p>0.017). However, hMSC differentiation into chondrocytes was superior for unlabeled and GadofluorineM-Cy-labeled cells compared with Ferucarbotran-labeled cells, as evidenced by a significantly higher proportion of spindle cells in chondrogenic pellets (p<0.05). GadofluorineM-Cy-labeled hMSCs and chondrocytes showed a positive signal effect on T1-weighted images and a negative signal effect on T2-weighted images while Ferucarbotran-labeled cells provided a negative signal effect on all sequences. CNR data for both GadofluorineM-Cy-labeled and Ferucarbotran-labeled hMSCs were significantly different compared to unlabeled control cells on T1-weighted SE and T2*-weighted MR images (p<0.017). Conclusion: hMSCs can be labeled by simple incubation with GadofluorineM-Cy. The labeled cells provide significant MR signal effects and less impaired chondrogenesis compared to Ferucarbotran-labeled hMSCs. Thus, GadoflurineM-Cy might represent an alternative MR cell marker to Ferucarbotran, which is not distributed any more in Europe or North America.	[Nejadnik, Hossein; Thuy Do; Daldrup-Link, Heike E.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Henning, Tobias D.; Meier, Reinhard] Univ Hosp Cologne, Dept Diagnost Radiol, Cologne, Germany; [Sutton, Elizabeth J.] Mt Auburn Hosp, Dept Radiol, Boston, MA USA; [Baehner, Frederick; Horvai, Andrew] Univ Calif San Francisco, Dept Pathol, UCSF Canc Ctr, San Francisco, CA 94140 USA; [Sennino, Barbara; McDonald, Donald] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Sennino, Barbara; McDonald, Donald] Univ Calif San Francisco, CVRI, San Francisco, CA 94143 USA; [Misselwitz, Bernd] Res Labs Bayer Schering Pharma AG, Berlin, Germany; [Link, Thomas M.] Univ Calif San Francisco, Dept Radiol, UCSF Med Ctr, San Francisco, CA USA	Stanford University; University of Cologne; Harvard University; Mount Auburn Hospital; University of California System; University of California San Francisco; UCSF Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center	Daldrup-Link, HE (corresponding author), Stanford Univ, Dept Radiol, Stanford, CA 94305 USA.	heiked@stanford.edu	Meier, Reinhard/B-2882-2014; Daldrup-Link, Heike E./D-9829-2012; Link, Thomas M. M/E-7522-2012; Nejadnik, Hossein/P-6214-2019	Meier, Reinhard/0000-0002-2169-4780; Daldrup-Link, Heike E./0000-0002-4929-819X; Sutton, Elizabeth/0000-0002-1407-7012	National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [2R01AR054458-05, NIH/NIAMS R21AR059861]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054458, R21AR059861] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors acknowledge support from the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) 2R01AR054458-05 and NIH/NIAMS R21AR059861 grants. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler ED, 2009, JACC-CARDIOVASC IMAG, V2, P1114, DOI 10.1016/j.jcmg.2009.04.015; Bendszus M, 2005, ANN NEUROL, V57, P388, DOI 10.1002/ana.20404; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Chu CR, 1999, CLIN ORTHOP RELAT R, P159; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Ding W, 2004, NUCL MED BIOL, V31, P719, DOI 10.1016/j.nucmedbio.2004.04.001; Gelse K, 2003, ARTHRITIS RHEUM-US, V48, P430, DOI 10.1002/art.10759; Giesel FL, 2006, INVEST RADIOL, V41, P868, DOI 10.1097/01.rli.0000246147.44835.4c; Henderson IJP, 2003, J BONE JOINT SURG BR, V85B, P1060, DOI 10.1302/0301-620X.85B7.13782; Henkel KO, 2005, J CRANIO MAXILL SURG, V33, P45, DOI 10.1016/j.jcms.2004.08.005; HENNING TD, 2008, J VIS EXP; Henning TD, 2007, EUR RADIOL, V17, P1226, DOI 10.1007/s00330-006-0522-9; Henning TD, 2009, CONTRAST MEDIA MOL I, V4, P165, DOI 10.1002/cmmi.276; Henning TD, 2009, MAGN RESON MED, V62, P325, DOI 10.1002/mrm.22011; Horas U, 2003, J BONE JOINT SURG AM, V85A, P185, DOI 10.2106/00004623-200302000-00001; Jaffer FA, 2005, JAMA-J AM MED ASSOC, V293, P855, DOI 10.1001/jama.293.7.855; Jorgensen C, 2004, CURR OPIN BIOTECH, V15, P406, DOI 10.1016/j.copbio.2004.08.003; Ko IK, 2007, ANN BIOMED ENG, V35, P101, DOI 10.1007/s10439-006-9204-7; Kostura L, 2004, NMR BIOMED, V17, P513, DOI 10.1002/nbm.925; Li X, 2009, CLIN RADIOL, V64, P1000, DOI 10.1016/j.crad.2009.07.008; Mao JJ, 2005, BIOL CELL, V97, P289, DOI 10.1042/BC20040100; Misselwitz B, 2004, RADIOLOGY, V231, P682, DOI 10.1148/radiol.2313021000; Nedopil A, 2010, INVEST RADIOL, V45, P634, DOI 10.1097/RLI.0b013e3181ed566c; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Roberts S, 2003, ARTHRITIS RES THER, V5, pR60, DOI 10.1186/ar613; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Simon GH, 2006, EUR RADIOL, V16, P738, DOI 10.1007/s00330-005-0031-2; Sirol M, 2004, CIRCULATION, V109, P2890, DOI 10.1161/01.CIR.0000129310.17277.E7; Tolar J, 2005, MOL THER, V12, P42, DOI 10.1016/j.ymthe.2005.02.023; Trattnig S, 2007, EUR RADIOL, V17, P103, DOI 10.1007/s00330-006-0333-z; Wada Yuichi, 2003, J Orthop Sci, V8, P514, DOI 10.1007/s00776-003-0677-z; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; Wolff SD, 1997, RADIOLOGY, V202, P25, DOI 10.1148/radiology.202.1.8988186	34	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49971	10.1371/journal.pone.0049971	http://dx.doi.org/10.1371/journal.pone.0049971			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251354	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200022
J	Couch, RB; Decker, WK; Utama, B; Atmar, RL; Nino, D; Feng, JQ; Halpert, MM; Air, GM				Couch, Robert B.; Decker, William K.; Utama, Budi; Atmar, Robert L.; Nino, Diane; Feng, Jing Qi; Halpert, Matthew M.; Air, Gillian M.			Evaluations for In Vitro Correlates of Immunogenicity of Inactivated Influenza A H5, H7 and H9 Vaccines in Humans	PLOS ONE			English	Article							PHASE-I; SUBUNIT VACCINES; A/H5N1 VACCINE; CLINICAL-TRIAL; SPLIT-VIRION; SAFETY; VIRUS; WHOLE; HEMAGGLUTININ; CANDIDATE	Background: Serum antibody responses in humans to inactivated influenza A (H5N1), (H9N2) and A (H7) vaccines have been varied but frequently low, particularly for subunit vaccines without adjuvant despite hemagglutinin (HA) concentrations expected to induce good responses. Design: To help understand the low responses to subunit vaccines, we evaluated influenza A (H5N1), (H9N2), (H7N7) vaccines and 2009 pandemic (H1N1) vaccines for antigen uptake, processing and presentation by dendritic cells to T cells, conformation of vaccine HA in antibody binding assays and gel analyses, HA titers with different red blood cells, and vaccine morphology in electron micrographs (EM). Results: Antigen uptake, processing and presentation of H5, H7, H9 and H1 vaccine preparations evaluated in humans appeared normal. No differences were detected in antibody interactions with vaccine and matched virus; although H7 trimer was not detected in western blots, no abnormalities in the conformation of the HA antigens were identified. The lowest HA titers for the vaccines were <1:4 for the H7 vaccine and 1: 661 for an H9 vaccine; these vaccines induced the fewest antibody responses. A (H1N1) vaccines were the most immunogenic in humans; intact virus and virus pieces were prominent in EM. A good immunogenic A (H9N2) vaccine contained primarily particles of viral membrane with external HA and NA. A (H5N1) vaccines intermediate in immunogenicity were mostly indistinct structural units with stellates; the least immunogenic A (H7N7) vaccine contained mostly small 5 to 20 nm structures. Summary: Antigen uptake, processing and presentation to human T cells and conformation of the HA appeared normal for each inactivated influenza A vaccine. Low HA titer was associated with low immunogenicity and presence of particles or split virus pieces was associated with higher immunogenicity. Citation: Couch RB, Decker WK, Utama B, Atmar RL, Nino D, et al. (2012) Evaluations for In Vitro Correlates of Immunogenicity of Inactivated Influenza A H5, H7 and H9 Vaccines in Humans. PLoS ONE 7(12): e50830. doi:10.1371/journal.pone.0050830	[Couch, Robert B.; Utama, Budi; Atmar, Robert L.; Nino, Diane] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Decker, William K.; Halpert, Matthew M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Atmar, Robert L.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Feng, Jing Qi; Air, Gillian M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Oklahoma System; University of Oklahoma Health Sciences Center	Couch, RB (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	rcouch@bcm.edu	Atmar, Robert/AFQ-5392-2022	Atmar, Robert/0000-0001-9989-6772; Air, Gillian/0000-0001-5724-3108	Public Health Service Contract from the National Institute of Allergy and Infectious Diseases [NO1 AI 30039]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030039, R01AI050933] Funding Source: NIH RePORTER	Public Health Service Contract from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research performed by the authors and summarized in this report was supported by Public Health Service Contract NO1 AI 30039 from the National Institute of Allergy and Infectious Diseases. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government. The funders did not participate in study design and had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Atmar RL, 2006, CLIN INFECT DIS, V43, P1135, DOI 10.1086/508174; Belshe RB, 2011, J INFECT DIS, V203, P666, DOI 10.1093/infdis/jiq093; Bernstein DI, 2008, J INFECT DIS, V197, P667, DOI 10.1086/527489; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Couch RB, 2012, PLOS ONE IN PRESS; Couch RB, 2008, VACCINE, V26, pD5, DOI 10.1016/j.vaccine.2008.05.076; Couch RB, 2011, BIRKHAUSER ADV INFEC, P359, DOI 10.1007/978-3-0346-0279-2_15; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; Decker WK, 2006, VACCINE, V24, P3203, DOI 10.1016/j.vaccine.2006.01.029; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Feng JQ, 2009, VACCINE, V27, P6358, DOI 10.1016/j.vaccine.2009.06.090; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; FRANK AL, 1981, J MED VIROL, V7, P135, DOI 10.1002/jmv.1890070207; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Gulati U, 2005, VACCINE, V23, P1414, DOI 10.1016/j.vaccine.2004.08.053; Hehme N, 2002, MED MICROBIOL IMMUN, V191, P203, DOI 10.1007/s00430-002-0147-9; HILLEMAN MR, 1958, JAMA-J AM MED ASSOC, V166, P1134, DOI 10.1001/jama.1958.02990100022005; Ikeno D, 2010, MICROBIOL IMMUNOL, V54, P81, DOI 10.1111/j.1348-0421.2009.00191.x; Jia N, 2008, J VIROL METHODS, V153, P43, DOI 10.1016/j.jviromet.2008.06.016; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Keitel W, 2010, VACCINE, V28, P840, DOI 10.1016/j.vaccine.2009.10.019; Keitel WA, 2008, J INFECT DIS, V198, P1309, DOI 10.1086/592172; Keitel WA, 2009, VACCINE, V27, P6642, DOI 10.1016/j.vaccine.2009.03.015; KNIGHT V, 1971, B WORLD HEALTH ORGAN, V45, P767; Langley JM, 2011, J INFECT DIS, V203, P1729, DOI 10.1093/infdis/jir172; Langley JM, 2010, J INFECT DIS, V201, P1644, DOI 10.1086/652701; LAVER WG, 1976, VIROLOGY, V69, P511, DOI 10.1016/0042-6822(76)90481-5; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Miller GL, 1944, J EXP MED, V79, P185, DOI 10.1084/jem.79.2.185; National Institutes of Health, 1977, J INFECT DIS S, V136, pS397; Nicholson KG, 2009, VACCINE, V28, P171, DOI 10.1016/j.vaccine.2009.09.103; Nolan T, 2008, VACCINE, V26, P6383, DOI 10.1016/j.vaccine.2008.08.046; Nolan TM, 2008, VACCINE, V26, P4160, DOI 10.1016/j.vaccine.2008.05.077; Patel SM, 2012, J INFECT DIS, V206, P1069, DOI 10.1093/infdis/jis402; Patel SM, 2010, VACCINE, V28, P3025, DOI 10.1016/j.vaccine.2009.10.152; Plennevaux E, 2011, VACCINE, V29, P1569, DOI 10.1016/j.vaccine.2010.12.116; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Qiu YZ, 2008, INFLUENZA OTHER RESP, V2, P237, DOI 10.1111/j.1750-2659.2008.00067.x; RENFREY S, 1994, VACCINE, V12, P747, DOI 10.1016/0264-410X(94)90227-5; Roman F, 2010, VACCINE, V28, P1740, DOI 10.1016/j.vaccine.2009.12.014; SCHILD GC, 1975, B WORLD HEALTH ORGAN, V52, P223; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Tada Y, 2008, INFLUENZA OTHER RESP, V2, P261, DOI 10.1111/j.1750-2659.2008.00066.x; Tambyah PA, 2012, VACCINE, V30, P329, DOI 10.1016/j.vaccine.2011.10.088; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Vajo Z, 2007, EMERG INFECT DIS, V13, P807, DOI 10.3201/eid1305.061248; WEBSTER RG, 1977, J IMMUNOL, V119, P2073; WEBSTER RG, 1976, J INFECT DIS, V134, P48, DOI 10.1093/infdis/134.1.48; WOOD JM, 1994, VACCINE, V12, P167, DOI 10.1016/0264-410X(94)90056-6; Wood JM, 2012, VACCINE, V30, P210, DOI 10.1016/j.vaccine.2011.11.019; Wu JA, 2010, VACCINE, V28, P6221, DOI 10.1016/j.vaccine.2010.07.008; Wu J, 2009, CLIN INFECT DIS, V48, P1087, DOI 10.1086/597401; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	56	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50830	10.1371/journal.pone.0050830	http://dx.doi.org/10.1371/journal.pone.0050830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239987	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800024
J	Porto, WF; Pires, AS; Franco, OL				Porto, William F.; Pires, Allan S.; Franco, Octavio L.			CS-AMPPred: An Updated SVM Model for Antimicrobial Activity Prediction in Cysteine-Stabilized Peptides	PLOS ONE			English	Article							RATIONAL DESIGN; IDENTIFICATION; PROTEIN; CYCLOTIDE; DISCOVERY; DEFENSIN; INSIGHTS; SEEDS	The antimicrobial peptides (AMP) have been proposed as an alternative to control resistant pathogens. However, due to multifunctional properties of several AMP classes, until now there has been no way to perform efficient AMP identification, except through in vitro and in vivo tests. Nevertheless, an indication of activity can be provided by prediction methods. In order to contribute to the AMP prediction field, the CS-AMPPred (Cysteine-Stabilized Antimicrobial Peptides Predictor) is presented here, consisting of an updated version of the Support Vector Machine (SVM) model for antimicrobial activity prediction in cysteine-stabilized peptides. The CS-AMPPred is based on five sequence descriptors: indexes of (i) a-helix and (ii) loop formation; and averages of (iii) net charge, (iv) hydrophobicity and (v) flexibility. CS-AMPPred was based on 310 cysteine-stabilized AMPs and 310 sequences extracted from PDB. The polynomial kernel achieves the best accuracy on 5-fold cross validation (85.81%), while the radial and linear kernels achieve 84.19%. Testing in a blind data set, the polynomial and radial kernels achieve an accuracy of 90.00%, while the linear model achieves 89.33%. The three models reach higher accuracies than previously described methods. A standalone version of CS-AMPPred is available for download at, <http://sourceforge.net/projects/csamppred/> and runs on any Linux machine.	[Porto, William F.; Pires, Allan S.; Franco, Octavio L.] Univ Catolica Brasilia, Ctr Anal Prote & Bioquim, Brasilia, DF, Brazil	Universidade Catolica de Brasilia	Franco, OL (corresponding author), Univ Catolica Brasilia, Ctr Anal Prote & Bioquim, Brasilia, DF, Brazil.	ocfranco@gmail.com	Franco, Octavio L/T-3020-2017	Porto, William/0000-0002-4739-8250; Franco, Octavio/0000-0001-9546-0525	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPDF (fundacao de Amparo a Pesquisa do Distrito Federal); UCB (Universidade Catolica de Brasilia)	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPDF (fundacao de Amparo a Pesquisa do Distrito Federal)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); UCB (Universidade Catolica de Brasilia)	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FAPDF (fundacao de Amparo a Pesquisa do Distrito Federal) and UCB (Universidade Catolica de Brasilia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHASKARAN R, 1988, INT J PEPT PROT RES, V32, P241; BROEKAERT WF, 1992, BIOCHEMISTRY-US, V31, P4308, DOI 10.1021/bi00132a023; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Candid  E.S., 2011, SCI MICROBIAL PATHOG, P951; Chen KC, 2002, BOT BULL ACAD SINICA, V43, P251; EISENBERG D, 1982, FARADAY SYMP CHEM S, P109, DOI 10.1039/fs9821700109; Fernandes FC, 2012, BIOPOLYMERS, V98, P280, DOI 10.1002/bip.22066; Fjell CD, 2009, J MED CHEM, V52, P2006, DOI 10.1021/jm8015365; Franco OL, 2011, FEBS LETT, V585, P995, DOI 10.1016/j.febslet.2011.03.008; Fujimura M, 2004, BIOSCI BIOTECH BIOCH, V68, P571, DOI 10.1271/bbb.68.571; Ishikawa C, 2010, J INNATE IMMUN, V2, P66, DOI 10.1159/000242114; Joachims T., 1999, MAKING LARGE SCALE S; Landon C, 1997, PROTEIN SCI, V6, P1878, DOI 10.1002/pro.5560060908; Landon C, 2008, PROTEINS, V72, P229, DOI 10.1002/prot.21912; Lata S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-263; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loose C, 2006, NATURE, V443, P867, DOI 10.1038/nature05233; Mandal SM, 2012, J CELL BIOCHEM, V113, P184, DOI 10.1002/jcb.23343; Mandal SM, 2009, PEPTIDES, V30, P633, DOI 10.1016/j.peptides.2008.12.001; Mulvenna JP, 2006, PLANT CELL, V18, P2134, DOI 10.1105/tpc.106.042812; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pelegrini PB, 2008, PEPTIDES, V29, P1271, DOI 10.1016/j.peptides.2008.03.013; Pinto MFS, 2012, J EVID-BASED INTEGR, V17, P40, DOI 10.1177/2156587211428077; Pinto MFS, 2012, J BIOL CHEM, V287, P134, DOI 10.1074/jbc.M111.294009; Porter EM, 1998, FEBS LETT, V434, P272, DOI 10.1016/S0014-5793(98)00994-6; Porto WF, 2012, PEPTIDES, V38, P127, DOI 10.1016/j.peptides.2012.07.025; Porto WF, 2010, LECT N BIOINFORMAT, V6268, P59, DOI 10.1007/978-3-642-15060-9_6; Romagnoli S, 2000, BIOCHEM J, V350, P569, DOI 10.1042/0264-6021:3500569; Silva O. N., 2012, PROTEIN STRUCTURE, P377; Silva ON, 2012, BIOPOLYMERS, V98, P322, DOI 10.1002/bip.22071; Silva ON, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00232; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tavares LS, 2012, PEPTIDES, V37, P294, DOI 10.1016/j.peptides.2012.07.017; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Torrent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016968; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Warren AS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-125; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354; Zhu SY, 2012, P NATL ACAD SCI USA, V109, P8495, DOI 10.1073/pnas.1201263109	43	60	62	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51444	10.1371/journal.pone.0051444	http://dx.doi.org/10.1371/journal.pone.0051444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240023	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800059
J	Singh, P; Agnihotri, SK; Tewari, MC; Kumar, S; Sachdev, M; Tripathi, RK				Singh, Poonam; Agnihotri, Saurabh Kumar; Tewari, Mahesh Chandra; Kumar, Sadan; Sachdev, Monika; Tripathi, Raj Kamal			HIV-1 Nef Breaches Placental Barrier in Rat Model	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BLOOD-BRAIN-BARRIER; VERTICAL TRANSMISSION; MOTHER; INFECTION; PREVENTION; PATHOGENICITY; DISRUPTION; MODULATION; EXPRESSION	The vertical transmission of HIV-1 from the mother to fetus is known, but the molecular mechanism regulating this transmission is not fully characterized. The fetus is highly protected by the placenta, which does not permit microbial pathogens to cross the placental barrier. In the present study, a rat model was established to observe the effect of HIV-1 protein Nef on placental barrier. Evans blue dye was used to assay permeability of placental barrier and fourteen day pregnant Sprague Dawley rats were injected intravenously with 2% Evans blue dye along with various concentrations of recombinant Nef. After an hour, animals were sacrificed and dye migration was observed through the assimilation of peripheral blood into fetus. Interestingly, traces of recombinant Nef protein were detected in the embryo as well as amniotic fluid and amniotic membrane along with placenta and uterus. Our study indicates that recombinant HIV-1-Nef protein breaches the placental barrier and allows the migration of Evans blue dye to the growing fetus. Further the concentration of Nef protein in blood is directly proportional to the intensity of dye migration and to the amount of Nef protein detected in uterus, placenta, amniotic membrane, amniotic fluid and embryo. Based on this study, it can be concluded that the HIV-1 Nef protein has a direct effect on breaching of the placental barrier in the model we have established in this study. Our observations will be helpful to understand the molecular mechanisms related to this breach of placental barrier by Nef in humans and may be helpful to identify specific Nef inhibitors. Citation: Singh P, Agnihotri SK, Tewari MC, Kumar S, Sachdev M, et al. (2012) HIV-1 Nef Breaches Placental Barrier in Rat Model. PLoS ONE 7(12): e51518. doi:10.1371/journal.pone.0051518	[Agnihotri, Saurabh Kumar; Tewari, Mahesh Chandra; Sachdev, Monika] Cent Drug Res Inst, Div Endocrinol, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India; [Singh, Poonam; Kumar, Sadan; Tripathi, Raj Kamal] Cent Drug Res Inst, Div Toxicol, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Sachdev, M (corresponding author), Cent Drug Res Inst, Div Endocrinol, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India.	smonika26@yahoo.com; rk_tripathi@cdri.res.in			Council of Scientific and Industrial Research, New Delhi; Ministry of Health and Alternative Animal Model [NWP034]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Health and Alternative Animal Model	The first author was supported by a fellowship from the Council of Scientific and Industrial Research, New Delhi. This manuscript is an outcome of the research funds provided by the Council of Scientific and Industrial Research, New Delhi, and grants from Ministry of Health and Alternative Animal Model (NWP034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheampong EA, 2009, J VIROL, V6, P10; Al-Husaini AM, 2009, J PERINATOL, V29, P331, DOI 10.1038/jp.2008.187; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P6; Bagasra O, 1995, NAT C HUM RETR REL I, V2, P136; Bai H, 2007, WORLD J GASTROENTERO, V13, P3625, DOI 10.3748/wjg.v13.i26.3625; Cao YZ, 1997, NAT MED, V3, P549, DOI 10.1038/nm0597-549; Cavarelli M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S10; CHANDWANI S, 1991, J INFECT DIS, V163, P1134, DOI 10.1093/infdis/163.5.1134; CHATURVEDI UC, 1991, J GEN VIROL, V72, P859, DOI 10.1099/0022-1317-72-4-859; D'costa Grace Francis, 2007, Indian J Pathol Microbiol, V50, P515; Dallasta LM, 1999, AM J PATHOL, V155, P1915, DOI 10.1016/S0002-9440(10)65511-3; Derrien M, 2005, J VIROL, V79, P12304, DOI 10.1128/JVI.79.19.12304-12310.2005; Diamond MS, 2004, NAT MED, V10, P1294, DOI 10.1038/nm1204-1294; Foster JL, 2008, RETROVIROL, P5; Frenkel LM, 1997, J INFECT DIS, V175, P971, DOI 10.1086/514003; Greenway AL, 2003, J BIO SCI, V28, P3; GREENWOOD J, 1991, NEURORADIOLOGY, V33, P95, DOI 10.1007/BF00588242; Hahn T, 2003, J BIOMED SCI, V10, P436, DOI 10.1159/000071163; Hanna Z, 2006, VIROLOGY, V346, P40, DOI 10.1016/j.virol.2005.10.010; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Husain M, 2001, AIDS RES HUM RETROV, V17, P765, DOI 10.1089/088922201750237040; Kwiek JJ, 2006, PLOS MED, V3, P70, DOI 10.1371/journal.pmed.0030010; Kwon BS, 1997, J BIOL CHEM, V272, P14272, DOI 10.1074/jbc.272.22.14272; LEWIS SH, 1990, LANCET, V335, P565, DOI 10.1016/0140-6736(90)90349-A; MATHUR A, 1992, INT J EXP PATHOL, V73, P603; MCGANN KA, 1994, J INFECT DIS, V169, P746, DOI 10.1093/infdis/169.4.746; Mishra MK, 2009, NEUROCHEM INT, V55, P717, DOI 10.1016/j.neuint.2009.07.006; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Mordelet E, 2004, FASEB J, V18, P1851, DOI 10.1096/fj.04-2308com; MULDERKAMPINGA GA, 1995, J VIROL, V69, P2285, DOI 10.1128/JVI.69.4.2285-2296.1995; Mullard A, 2008, NAT REV MICROBIOL, V6, P798, DOI 10.1038/nrmicro2025; Nazir A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015312; Patterson BK, 2001, J CLIN INVEST, V107, P287, DOI 10.1172/JCI11481; Pornprasert S, 2006, PLACENTA, V27, P989, DOI 10.1016/j.placenta.2005.10.010; Singh P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026629; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Sporer B, 2000, J NEUROIMMUNOL, V102, P125, DOI 10.1016/S0165-5728(99)00170-8; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Yedavalli VRK, 2001, AIDS RES HUM RETROV, V17, P911, DOI 10.1089/088922201750290032; Yedavalli VRK, 2001, AIDS RES HUM RETROV, V17, P1089, DOI 10.1089/088922201300343780	40	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51518	10.1371/journal.pone.0051518	http://dx.doi.org/10.1371/journal.pone.0051518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240037	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800073
J	Brisighelli, F; Alvarez-Iglesias, V; Fondevila, M; Blanco-Verea, A; Carracedo, A; Pascali, VL; Capelli, C; Salas, A				Brisighelli, Francesca; Alvarez-Iglesias, Vanesa; Fondevila, Manuel; Blanco-Verea, Alejandro; Carracedo, Angel; Pascali, Vincenzo L.; Capelli, Cristian; Salas, Antonio			Uniparental Markers of Contemporary Italian Population Reveals Details on Its Pre-Roman Heritage	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; MTDNA CONTROL REGION; HUMAN Y-CHROMOSOME; SEQUENCE DIVERSITY; GENETIC-STRUCTURE; MIGRATORY EVENTS; HAPLOGROUP-H; EUROPE; LINEAGES; HISTORY	Background: According to archaeological records and historical documentation, Italy has been a melting point for populations of different geographical and ethnic matrices. Although Italy has been a favorite subject for numerous population genetic studies, genetic patterns have never been analyzed comprehensively, including uniparental and autosomal markers throughout the country. Methods/Principal Findings: A total of 583 individuals were sampled from across the Italian Peninsula, from ten distant (if homogeneous by language) ethnic communities - and from two linguistic isolates (Ladins, Grecani Salentini). All samples were first typed for the mitochondrial DNA (mtDNA) control region and selected coding region SNPs (mtSNPs). This data was pooled for analysis with 3,778 mtDNA control-region profiles collected from the literature. Secondly, a set of Y-chromosome SNPs and STRs were also analyzed in 479 individuals together with a panel of autosomal ancestry informative markers (AIMs) from 441 samples. The resulting genetic record reveals clines of genetic frequencies laid according to the latitude slant along continental Italy - probably generated by demographical events dating back to the Neolithic. The Ladins showed distinctive, if more recent structure. The Neolithic contribution was estimated for the Y-chromosome as 14.5% and for mtDNA as 10.5%. Y-chromosome data showed larger differentiation between North, Center and South than mtDNA. AIMs detected a minor sub-Saharan component; this is however higher than for other European non-Mediterranean populations. The same signal of sub-Saharan heritage was also evident in uniparental markers. Conclusions/Significance: Italy shows patterns of molecular variation mirroring other European countries, although some heterogeneity exists based on different analysis and molecular markers. From North to South, Italy shows clinal patterns that were most likely modulated during Neolithic times.	[Brisighelli, Francesca; Alvarez-Iglesias, Vanesa; Fondevila, Manuel; Blanco-Verea, Alejandro; Carracedo, Angel; Salas, Antonio] Univ Santiago Compostela, Unidade Xenet, Fac Med, Inst Med, Galicia, Spain; [Brisighelli, Francesca; Pascali, Vincenzo L.] Univ Cattolica Sacro Cuore, Forens Genet Lab, Inst Legal Med, Rome, Italy; [Brisighelli, Francesca; Capelli, Cristian] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Carracedo, Angel] Fdn Publ Galega Med Xen FPGMX SERGAS, CIBER Enfermedades Raras, Santiago De Compostela, Galicia, Spain	Universidade de Santiago de Compostela; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Oxford; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Salas, A (corresponding author), Univ Santiago Compostela, Unidade Xenet, Fac Med, Inst Med, Galicia, Spain.	antonio.salas@usc.es	pascali, vincenzo lorenzo/AAC-8436-2022; Álvarez, María Sonia Fondevila/D-4385-2014; Salas, Antonio/E-3977-2012; Carracedo, Angel/D-4257-2012; Salas, Antonio/U-2029-2019	Salas, Antonio/0000-0002-2336-702X; Carracedo, Angel/0000-0003-1085-8986; Salas, Antonio/0000-0002-2336-702X; Brisighelli, Francesca/0000-0001-5469-4413; Capelli, Cristian/0000-0001-9348-9084	European Union [290344]; Ministerio de Ciencia e Innovacion [SAF2008-02971, SAF2011-26983]; British Academy	European Union(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); British Academy	The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/under REA grant agreement number 290344, and the Ministerio de Ciencia e Innovacion (SAF2008-02971 and SAF2011-26983)(AS). CC and FB were partially funded by the British Academy for the project "The Greeks in the West: the genetic legacy of the colonisation in South Italy and Sicily". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulafia D, 2001, GREAT SEA HUMAN HIST; Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Alonso S, 2005, EUR J HUM GENET, V13, P1293, DOI 10.1038/sj.ejhg.5201482; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Amigo J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-105; Amigo J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S3-S5; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Babalini C, 2005, EUR J HUM GENET, V13, P902, DOI 10.1038/sj.ejhg.5201439; Bandelt HJ, 2004, SCIENCE, V305, P1402; Bandelt HJ, 2004, INT J LEGAL MED, V118, P267, DOI 10.1007/s00414-004-0455-2; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Beleza S, 2006, ANN HUM GENET, V70, P181, DOI 10.1111/j.1529-8817.2005.00221.x; Bini C, 2003, FORENSIC SCI INT, V135, P48, DOI 10.1016/S0379-0738(03)00167-1; Bisol GD, 2008, J ANTHROPOL SCI, V86, P179; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Brigaglia M, 1989, STORIA SARDEGNA; Brion M, 2005, INT J LEGAL MED, V119, P10, DOI 10.1007/s00414-004-0439-2; Brisighelli F, 2012, FORENSIC SCI INT-GEN, V6, P834, DOI 10.1016/j.fsigen.2012.03.003; Brisighelli F, 2012, FORENSIC SC IN PRESS; Brisighelli F, 2009, EUR J HUM GENET, V17, P693, DOI 10.1038/ejhg.2008.224; Busby GBJ, 2012, P ROY SOC B-BIOL SCI, V279, P884, DOI 10.1098/rspb.2011.1044; Buti GG, 1974, PREISTORIA STORIA RE; Cali F, 2001, INT J LEGAL MED, V114, P229, DOI 10.1007/s004140000169; Capelli C, 2007, MOL PHYLOGENET EVOL, V44, P228, DOI 10.1016/j.ympev.2006.11.030; Capelli C, 2009, EUR J HUM GENET, V17, P848, DOI 10.1038/ejhg.2008.258; Carducci L, 1993, STORIA SALENTO TERRA; Castagnetti A, 2004, STORIA TRENTINO ETA, P2000; Cerezo M, 2012, GENOME RES IN PRESS; Cerezo M, 2012, GENOME RES, V22, P821, DOI 10.1101/gr.134452.111; CHILDE VG, 1934, NEW LIGHT MOST ANCIE; Coia V, 2012, J HUM GENET, V57, P254, DOI 10.1038/jhg.2012.14; Contu D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001430; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; Cunliffe B, 2001, OXFORD ILLUSTRATED H; De Concini W, 1997, GLI ALTRI ALPI MINOR; De Concini W, 2003, GLI ALTRI ITALIA MIN; Devoto G, 1977, GLI ANTICHI ITALICI; Di Gaetano C, 2009, EUR J HUM GENET, V17, P91, DOI 10.1038/ejhg.2008.120; Di Giacomo F, 2003, MOL PHYLOGENET EVOL, V28, P387, DOI 10.1016/S1055-7903(03)00016-2; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falchi A, 2006, J HUM GENET, V51, P9, DOI 10.1007/s10038-005-0324-y; Ferri G, 2009, FORENSIC SCI INT-GEN, V3, pE31, DOI 10.1016/j.fsigen.2008.05.004; Ferri G, 2008, FORENSIC SCI INT, V175, P250, DOI 10.1016/j.forsciint.2007.06.007; Flores C, 2003, ANN HUM GENET, V67, P138, DOI 10.1046/j.1469-1809.2003.00015.x; Forster P, 2002, INT J LEGAL MED, V116, P99, DOI 10.1007/s00414-001-0261-z; Francalacci P, 1996, AM J PHYS ANTHROPOL, V100, P443, DOI 10.1002/(SICI)1096-8644(199608)100:4<443::AID-AJPA1>3.0.CO;2-S; Francalacci P, 2008, J ANTHROPOL SCI, V86, P59; Gomez-Carballa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032851; Goncalves R, 2005, ANN HUM GENET, V69, P443, DOI 10.1111/j.1529-8817.2005.00161.x; Guidi A, 2005, ITALIA PREISTORICA; King R, 2002, ANTIQUITY, V76, P707, DOI 10.1017/S0003598X00091158; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Maca-Meyer N, 2003, ANN HUM GENET, V67, P329, DOI 10.1046/j.1469-1809.2003.00045.x; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Messina F, 2010, ANN HUM BIOL, V37, P385, DOI 10.3109/03014461003720304; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Montanini L, 2005, J NEURO-ONCOL, V74, P87, DOI 10.1007/s11060-004-4036-5; Nei N, 1987, MOL EVOLUTIONARY GEN; Norman D, 1975, ARABS MEDIEVAL EUROP; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Onofri V, 2007, INT J LEGAL MED, V121, P234, DOI 10.1007/s00414-007-0153-y; Ottoni C, 2009, ANN HUM BIOL, V36, P785, DOI 10.3109/03014460903198509; Ottoni C, 2009, ANN HUM GENET, V73, P438, DOI 10.1111/j.1469-1809.2009.00526.x; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Pallottino M, 1981, GENTI CULTURE ITALIA, V136; Pichler I, 2006, HUM BIOL, V78, P441, DOI 10.1353/hub.2006.0057; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rose G, 2008, EUR J NEUROL, V15, P1006, DOI 10.1111/j.1468-1331.2008.02222.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salas A, 2007, FORENSIC SCI INT, V168, P1, DOI 10.1016/j.forsciint.2006.05.037; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2005, FORENSIC SCI INT, V148, P191, DOI 10.1016/j.forsciint.2004.06.008; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Sanchez JJ, 2006, ELECTROPHORESIS, V27, P1713, DOI 10.1002/elps.200500671; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Stenico M, 1998, P ROY SOC B-BIOL SCI, V265, P555, DOI 10.1098/rspb.1998.0330; Stenico M, 1996, AM J HUM GENET, V59, P1363; Tagliabracci A, 2001, INT J LEGAL MED, V114, P224, DOI 10.1007/s004140000168; TAJIMA F, 1993, MOL BIOL EVOL, V10, P677; TAJIMA F, 1983, GENETICS, V105, P437; Thomas MG, 2008, EUR J HUM GENET, V16, P124, DOI 10.1038/sj.ejhg.5201906; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Trombetta B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016073; Turchi C, 2009, FORENSIC SCI INT-GEN, V3, P166, DOI 10.1016/j.fsigen.2009.01.014; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Verginelli F, 2003, J FORENSIC SCI, V48, P443; Vernesi C, 2002, HUM BIOL, V74, P725, DOI 10.1353/hub.2002.0060; Vona G, 2001, AM J HUM BIOL, V13, P576, DOI 10.1002/ajhb.1096; Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023	99	32	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50794	10.1371/journal.pone.0050794	http://dx.doi.org/10.1371/journal.pone.0050794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251386	Green Published, gold			2022-12-27	WOS:000312201900019
J	Guo, SL; Chen, PC; Chen, MS; Cheng, YC; Lin, JM; Lee, HC; Chen, CS				Guo, Shu-Lin; Chen, Po-Chung; Chen, Ming-Shuo; Cheng, Yu-Che; Lin, Jun-Mu; Lee, Hoong-Chien; Chen, Chien-Sheng			A Fast Universal Immobilization of Immunoglobulin G at 4 degrees C for the Development of Array-based Immunoassays	PLOS ONE			English	Article							ANTIBODY MICROARRAYS; ENZYME-IMMUNOASSAY; MASS-SPECTROMETRY; PROTEIN MICROARRAYS; SUBSTANCE-P; SERUM; TECHNOLOGY; PROTEOMICS; PAIN; STRATEGIES	To maintain the antibody activity and enhance performance of array-based immunoassays, protein G was used to allow a shorter duration of immunoglobulin G immobilization at 4 degrees C, with the antibody placed in the appropriate orientation. The multiplexed detection of six pain-related message molecules (PRMMs) was used as examples for the development of array-based immunoassays: substance P, calcitonin gene-related peptide, nerve growth factor, brain-derived neurotrophic factor, tumor necrosis factor-alpha, and beta-endorphin. Protein G- and non-protein G-coated slides were tested. Compared to non-protein G immunoassays, protein G shortened the antibody immobilization time at 4 degrees C from overnight to 2 hours. Only protein G- facilitated immunoassays succeeded in simultaneously detecting all six PRMMs with high specificity. Dose-response curves showed that the limits of detection of the protein G-multiplexed immunoassays for the PRMMs was approximately 164, 167, 120, 60, 80, and 92 pg/ml, respectively. Thus, protein G effectively shortens the duration of antibody immobilization at 4 degrees C, allowing the use of sensitive array-based immunoassays for the simultaneous detection of PRMMs. Citation: Guo S-L, Chen P-C, Chen M-S, Cheng Y-C, Lin J-M, et al. (2012) A Fast Universal Immobilization of Immunoglobulin G at 4 degrees C for the Development of Array-based Immunoassays. PLoS ONE 7(12): e51370. doi: 10.1371/journal.pone.0051370	[Guo, Shu-Lin; Chen, Po-Chung; Chen, Ming-Shuo; Lin, Jun-Mu; Lee, Hoong-Chien; Chen, Chien-Sheng] Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Guo, Shu-Lin] Cathay Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Cheng, Yu-Che] Cathay Gen Hosp, Dept Med Res, Taipei, Taiwan; [Cheng, Yu-Che] Natl Cent Univ, Inst Biomed Engn, Jhongli, Taiwan	National Central University; Cathay General Hospital; Cathay General Hospital; National Central University	Lee, HC (corresponding author), Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan.	hclee@sansan.phy.ncu.edu.tw; cchen103@gmail.com	Chen, Chien-Sheng/ACO-7414-2022	Cheng, Yu-Che/0000-0002-5346-3610	National Science Council, Taiwan [97-2311-B-019-001-MY2]; Veterans General Hospitals University System of Taiwan Joint Research Program [VGHUST99-G4-1]; National Central University; Landseed Hospital Program [NCU-LSH-100-A-012]; Cathay General Hospital [CGH-MR-9917, CGH-MR-10019, 99CGH-NCU-A2]; Taipei Medical University Hospital Program [100TMUH-NCU-005]; Center for Dynamical Biomarkers and Translational Medicine (CDBTM); Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Veterans General Hospitals University System of Taiwan Joint Research Program; National Central University; Landseed Hospital Program; Cathay General Hospital; Taipei Medical University Hospital Program; Center for Dynamical Biomarkers and Translational Medicine (CDBTM); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was partially supported by grants from the National Science Council, Taiwan (97-2311-B-019-001-MY2), Veterans General Hospitals University System of Taiwan Joint Research Program (VGHUST99-G4-1), the National Central University and Landseed Hospital Program (NCU-LSH-100-A-012), the Cathay General Hospital (CGH-MR-9917 and CGH-MR-10019), the joint grant from National Central University and Cathay General Hospital (99CGH-NCU-A2), and the National Central University and Taipei Medical University Hospital Program (100TMUH-NCU-005). The authors also thank the Center for Dynamical Biomarkers and Translational Medicine (CDBTM) and the Ministry of Education, Taiwan for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2001, CHEM REV, V101, P269, DOI 10.1021/cr990076h; AKERSTROM B, 1986, J BIOL CHEM, V261, P240; Blackstock WP, 1999, TRENDS BIOTECHNOL, V17, P121, DOI 10.1016/S0167-7799(98)01245-1; Capelle HH, 2009, CLIN J PAIN, V25, P729, DOI 10.1097/AJP.0b013e3181a776e4; Carlsson A, 2008, EUR J CANCER, V44, P472, DOI 10.1016/j.ejca.2007.11.025; Chen CS, 2006, BIOTECHNIQUES, V40, P423, DOI 10.2144/06404TE01; Chen MS, 2010, CHINESE J PAIN, V20, P18; Choi JW, 2008, ULTRAMICROSCOPY, V108, P1396, DOI 10.1016/j.ultramic.2008.04.050; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; Favre-Kontula L, 2006, J IMMUNOL METHODS, V317, P152, DOI 10.1016/j.jim.2006.10.001; Frobert Y, 1999, PEPTIDES, V20, P275, DOI 10.1016/S0196-9781(98)00172-7; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Hamelinck D, 2005, MOL CELL PROTEOMICS, V4, P773, DOI 10.1074/mcp.M400180-MCP200; Herrero M, 2008, ELECTROPHORESIS, V29, P2148, DOI 10.1002/elps.200700404; HOCHHAUS G, 1988, PHARM RES-DORDR, V5, P232, DOI 10.1023/A:1015993713471; Jonkheijm P, 2008, ANGEW CHEM INT EDIT, V47, P9618, DOI 10.1002/anie.200801711; Kim H, 2008, ULTRAMICROSCOPY, V108, P1152, DOI 10.1016/j.ultramic.2008.04.049; Klonisch T, 1996, IMMUNOLOGY, V89, P165, DOI 10.1046/j.1365-2567.1996.d01-722.x; Kusnezow W, 2002, BIOTECHNIQUES, P14; LIABAKK NB, 1990, J IMMUNOL METHODS, V134, P253, DOI 10.1016/0022-1759(90)90387-B; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; Mann M, 2001, ANNU REV BIOCHEM, V70, P437, DOI 10.1146/annurev.biochem.70.1.437; McMahon SB, 2005, EXP NEUROL, V192, P444, DOI 10.1016/j.expneurol.2004.11.001; McMahon SB, 2004, J NEUROBIOL, V61, P72, DOI 10.1002/neu.20093; Miller JC, 2003, PROTEOMICS, V3, P56, DOI 10.1002/pmic.200390009; NADERDJALAL N, 1995, ANESTH ANALG, V81, P591, DOI 10.1097/00000539-199509000-00030; NAWA H, 1995, EUR J NEUROSCI, V7, P1527, DOI 10.1111/j.1460-9568.1995.tb01148.x; Peluso P, 2003, ANAL BIOCHEM, V312, P113, DOI 10.1016/S0003-2697(02)00442-6; PRINCE WS, 1987, J PHARMACEUT BIOMED, V5, P793, DOI 10.1016/0731-7085(87)80097-3; Seurynck-Servoss SL, 2007, ANAL BIOCHEM, V371, P105, DOI 10.1016/j.ab.2007.07.010; TAKEYAMA M, 1990, CHEM PHARM BULL, V38, P3494, DOI 10.1248/cpb.38.3494; Tao SC, 2007, COMB CHEM HIGH T SCR, V10, P706, DOI 10.2174/138620707782507386; WESKAMP G, 1987, J NEUROCHEM, V48, P1779, DOI 10.1111/j.1471-4159.1987.tb05736.x; Wu WW, 2009, MOL CELL PROTEOMICS, V8, P245, DOI 10.1074/mcp.M800171-MCP200; Zheng JY, 2006, INT J PHARM, V308, P46, DOI 10.1016/j.ijpharm.2005.10.024; Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4	38	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51370	10.1371/journal.pone.0051370	http://dx.doi.org/10.1371/journal.pone.0051370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236488	gold, Green Published, Green Submitted			2022-12-27	WOS:000312064100107
J	Memminger, M; Keller, M; Lopuch, M; Pop, N; Bernhardt, G; von Angerer, E; Buschauer, A				Memminger, Martin; Keller, Max; Lopuch, Miroslaw; Pop, Nathalie; Bernhardt, Guenther; von Angerer, Erwin; Buschauer, Armin			The Neuropeptide Y Y-1 Receptor: A Diagnostic Marker? Expression in MCF-7 Breast Cancer Cells Is Down-Regulated by Antiestrogens In Vitro and in Xenografts	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; FUNCTIONAL EXPRESSION; PROGESTERONE-RECEPTOR; ADENYLATE-CYCLASE; ENDOCRINE THERAPY; HIGHLY POTENT; PEPTIDE-YY; ANTAGONIST; ALPHA; TARGETS	The neuropeptide Y (NPY) Y-1 receptor (Y1R) has been suggested as a tumor marker for in vivo imaging and as a therapeutic target. In view of the assumed link between estrogen receptor (ER) and Y1R in mammary carcinoma and with respect to the development of new diagnostic tools, we investigated the Y1R protein expression in human MCF-7 cell variants differing in ER content and sensitivity against antiestrogens. ER and Y1R expression were quantified by radioligand binding using [H-3]-17 beta-estradiol and the Y1R selective antagonist [H-3]-UR-MK114, respectively. The latter was used for cellular binding studies and for autoradiography of MCF-7 xenografts. The fluorescent ligands Cy5-pNPY (universal Y1R, Y2R and Y5R agonist) and UR-MK22 (selective Y1R antagonist), as well as the selective antagonists BIBP3226 (Y1R), BIIE0246 (Y2R) and CGP71683 (Y5R) were used to identify the NPY receptor subtype(s) by confocal microscopy. Y1R functionality was determined by mobilization of intracellular Ca2+. Sensitivity of MCF-7 cells against antiestrogen 4-hydroxytamoxifen correlated directly with the ER content. The exclusive expression of Y(1)Rs was confirmed by confocal microscopy. The Y1R protein was up-regulated (100%) by 17 beta-estradiol (EC50 20 pM) and the predominant role of ER alpha was demonstrated by using the ER alpha-selective agonist "propylpyrazole triol". 17 beta-Estradiol-induced over-expression of functional Y1R protein was reverted by the antiestrogen fulvestrant (IC50 5 nM) in vitro. Furthermore, tamoxifen treatment of nude mice resulted in an almost total loss of Y(1)Rs in MCF-7 xenografts. In conclusion, the value of the Y1R as a target for therapy and imaging in breast cancer patients may be compromised due to Y1R down-regulation induced by hormonal (antiestrogen) treatment.	[Memminger, Martin; Keller, Max; Lopuch, Miroslaw; Pop, Nathalie; Bernhardt, Guenther; von Angerer, Erwin; Buschauer, Armin] Univ Regensburg, Inst Pharm, Dept Pharmaceut Med Chem 2, D-8400 Regensburg, Germany	University of Regensburg	Buschauer, A (corresponding author), Univ Regensburg, Inst Pharm, Dept Pharmaceut Med Chem 2, D-8400 Regensburg, Germany.	armin.buschauer@chemie.uni-regensburg.de			Graduate Training Program (Graduiertenkolleg) of the German Research Foundation (DFG) [GRK760]; DFG	Graduate Training Program (Graduiertenkolleg) of the German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	Supported by the Graduate Training Program (Graduiertenkolleg) GRK760, "Medicinal Chemistry: Molecular Recognition - Ligand-Receptor Interactions" of the German Research Foundation (DFG) and by the DFG within the DFG funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAKERLUND L, 1990, FEBS LETT, V260, P73, DOI 10.1016/0014-5793(90)80069-U; Aiglstorfer I, 2000, BIOORG MED CHEM LETT, V10, P1597, DOI 10.1016/S0960-894X(00)00292-4; Allan GF, 2001, STEROIDS, V66, P663, DOI 10.1016/S0039-128X(01)00131-3; Amlal H, 2006, CANCER RES, V66, P3706, DOI 10.1158/0008-5472.CAN-05-2744; Barkhem T, 1998, MOL PHARMACOL, V54, P105, DOI 10.1124/mol.54.1.105; BERNHARDT G, 1992, J CANCER RES CLIN, V118, P35, DOI 10.1007/BF01192309; BERNHARDT G, 1992, CONTR ONCOL, V42, P128; BINDAL RD, 1988, J STEROID BIOCHEM, V31, P287, DOI 10.1016/0022-4731(88)90352-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chatenet D, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-21; Criscione L, 1998, J CLIN INVEST, V102, P2136, DOI 10.1172/JCI4188; Doods H, 1999, EUR J PHARMACOL, V384, pR3, DOI 10.1016/S0014-2999(99)00650-0; Driggers PH, 2002, TRENDS ENDOCRIN MET, V13, P422, DOI 10.1016/S1043-2760(02)00634-3; ENTZEROTH M, 1995, EUR J PHARMACOL, V278, P239, DOI 10.1016/0014-2999(95)00161-D; Fowler AM, 2012, J NUCL MED, V53, P1119, DOI 10.2967/jnumed.112.103465; Gilaberte Y, 2012, J AM ACAD DERMATOL, V66, pE201, DOI 10.1016/j.jaad.2011.02.015; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guerin B, 2010, B MENS SOC LINN LYON, P1; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; HORWITZ KB, 1978, J BIOL CHEM, V253, P2223; Keller M, 2008, J MED CHEM, V51, P8168, DOI 10.1021/jm801018u; Kempna P, 2010, MOL CELL ENDOCRINOL, V314, P101, DOI 10.1016/j.mce.2009.08.010; Khan IU, 2010, ANGEW CHEM INT EDIT, V49, P1155, DOI 10.1002/anie.200905008; Kitlinska J, 2005, CANCER RES, V65, P1719, DOI 10.1158/0008-5472.CAN-04-2192; Korner M, 2008, CLIN CANCER RES, V14, P5043, DOI 10.1158/1078-0432.CCR-07-4551; Korner M, 2008, J NEUROPATH EXP NEUR, V67, P741, DOI 10.1097/NEN.0b013e318180e618; Korner M, 2007, PEPTIDES, V28, P419, DOI 10.1016/j.peptides.2006.08.037; Kuang WW, 1998, NUCLEIC ACIDS RES, V26, P1116, DOI 10.1093/nar/26.4.1116; LARHAMMAR D, 1992, J BIOL CHEM, V267, P10935; Lu C, 2010, ONCOGENE, V29, P5630, DOI 10.1038/onc.2010.301; Magni P, 2001, ANN ONCOL, V12, pS27, DOI 10.1093/annonc/12.suppl_2.S27; Michel MC, 1998, PHARMACOL REV, V50, P143; Moser C, 2000, CAN J PHYSIOL PHARM, V78, P134, DOI 10.1139/cjpp-78-2-134; MOTULSKY HJ, 1988, AM J PHYSIOL, V255, pE880, DOI 10.1152/ajpendo.1988.255.6.E880; Muller M, 1997, ARCH PHARM, V330, P333, DOI 10.1002/ardp.19973301104; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; Reubi JC, 2003, ENDOCR REV, V24, P389, DOI 10.1210/er.2002-0007; Reubi JC, 2001, CANCER RES, V61, P4636; Reubi JC, 2008, J NUCL MED, V49, P1735, DOI 10.2967/jnumed.108.053041; Robertson JFR, 2001, BRIT J CANCER, V85, P11, DOI 10.1054/bjoc.2001.1982; RUDOLF K, 1994, EUR J PHARMACOL, V271, pR11, DOI 10.1016/0014-2999(94)90822-2; Schneider E, 2007, CHEMBIOCHEM, V8, P1981, DOI 10.1002/cbic.200700302; Schneider E, 2006, CHEMBIOCHEM, V7, P1400, DOI 10.1002/cbic.200600163; SCHOBERT R, 2007, CHEMMEDCHEM, V2, P333, DOI DOI 10.1002/CMDC.200600173; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200; Ziemek R, 2006, EUR J PHARMACOL, V551, P10, DOI 10.1016/j.ejphar.2006.08.075; Zimmermann J, 2005, J STEROID BIOCHEM, V94, P57, DOI 10.1016/j.bmcl.2004.10.040; Zwanziger D, 2008, CURR PHARM DESIGN, V14, P2385, DOI 10.2174/138161208785777397; Zwanziger D, 2008, BIOCONJUGATE CHEM, V19, P1430, DOI 10.1021/bc7004297	50	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51032	10.1371/journal.pone.0051032	http://dx.doi.org/10.1371/journal.pone.0051032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236424	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100055
J	Porco, TC; Gao, DZ; Scott, JC; Shim, E; Enanoria, WT; Galvani, AP; Lietman, TM				Porco, Travis C.; Gao, Daozhou; Scott, James C.; Shim, Eunha; Enanoria, Wayne T.; Galvani, Alison P.; Lietman, Thomas M.			When Does Overuse of Antibiotics Become a Tragedy of the Commons?	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; ANTIMICROBIAL RESISTANCE; ANTIRETROVIRAL THERAPY; COMPETITIVE-EXCLUSION; PENICILLIN RESISTANCE; SUSCEPTIBILITY TESTS; MULTIDRUG-RESISTANT; SELF-INTEREST; HIV; AZITHROMYCIN	Background: Over-prescribing of antibiotics is considered to result in increased morbidity and mortality from drug-resistant organisms. A resulting common wisdom is that it would be better for society if physicians would restrain their prescription of antibiotics. In this view, self-interest and societal interest are at odds, making antibiotic use a classic "tragedy of the commons". Methods and Findings: We developed two mathematical models of transmission of antibiotic resistance, featuring de novo development of resistance and transmission of resistant organisms. We analyzed the decision to prescribe antibiotics as a mathematical game, by analyzing individual incentives and community outcomes. Conclusions: A conflict of interest may indeed result, though not in all cases. Increased use of antibiotics by individuals benefits society under certain circumstances, despite the amplification of drug-resistant strains or organisms. In situations where increased use of antibiotics leads to less favorable outcomes for society, antibiotics may be harmful for the individual as well. For other scenarios, where a conflict between self-interest and society exists, restricting antibody use would benefit society. Thus, a case-by-case assessment of appropriate use of antibiotics may be warranted.	[Porco, Travis C.; Gao, Daozhou; Enanoria, Wayne T.; Lietman, Thomas M.] Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA; [Porco, Travis C.; Lietman, Thomas M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Porco, Travis C.; Enanoria, Wayne T.] Univ Calif Berkeley, Ctr Infect Dis & Emergency Readiness, Berkeley, CA 94720 USA; [Scott, James C.] Colby Coll, Dept Math & Stat, Waterville, ME 04901 USA; [Shim, Eunha] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Galvani, Alison P.] Yale Univ, Sch Med, New Haven, CT USA; [Porco, Travis C.; Lietman, Thomas M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Lietman, Thomas M.] Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Colby College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lietman, TM (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA.	tom.lietman@ucsf.edu	Gao, Daozhou/J-3157-2014	Gao, Daozhou/0000-0003-3991-569X	Research to Prevent Blindness and Modeling Infectious Disease Agent Study [NIH UO1 GM08778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087728] Funding Source: NIH RePORTER	Research to Prevent Blindness and Modeling Infectious Disease Agent Study; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work supported in part by Research to Prevent Blindness and Modeling Infectious Disease Agent Study (NIH UO1 GM08778) and the authors are grateful for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackleh AS, 2005, DISCRETE CONT DYN-B, V5, P175; Allen L.J.S., 2008, MATH EPIDEMIOLOGY; ANDERSON R M, 1991; ANDERSON RM, 1991, NATURE, V350, P356, DOI 10.1038/350356a0; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; [Anonymous], SAG MATH SOFTW VERS; Banerjee R, 2008, EXPERT REV ANTI-INFE, V6, P713, DOI 10.1586/14787210.6.5.713; Bangsberg DR, 2004, J INFECT DIS, V190, P162, DOI 10.1086/420790; Baquero F, 2003, Rev Esp Quimioter, V16, P11; Basar T., 1999, DYNAMIC NONCOOPERATI; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; Blower S, 1998, INNOV APPL MATH, P51; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Blower SM, 1998, NAT MED, V4, P673, DOI 10.1038/nm0698-673; Castillo-Chavez C, 1999, SIAM J APPL MATH, V59, P1790, DOI 10.1137/S0036139997325862; Chern KC, 1999, BRIT J OPHTHALMOL, V83, P1332, DOI 10.1136/bjo.83.12.1332; Cizman M, 2003, INT J ANTIMICROB AG, V21, P297, DOI 10.1016/S0924-8579(02)00394-1; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050; Conly J, 2010, B WORLD HEALTH ORGAN, V88, P805, DOI 10.2471/BLT.10.031110; Evans JR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001860.pub3; Foster KR, 2006, PLOS MED, V3, P177, DOI 10.1371/journal.pmed.0030029; Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414; Fudenberg D., 1991, GAME THEORY; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Garcia-Rey C, 2002, J CLIN MICROBIOL, V40, P159, DOI 10.1128/JCM.40.1.159-164.2002; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; GREENWOOD D, 1981, J INFECT DIS, V144, P380, DOI 10.1093/infdis/144.4.380; Handel A, 2007, PLOS COMPUT BIOL, V3, P2456, DOI 10.1371/journal.pcbi.0030240; Handel A, 2009, J THEOR BIOL, V256, P117, DOI 10.1016/j.jtbi.2008.09.021; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Lamport L, 1994, LATEX DOCUMENT PREPA; Leach AJ, 1997, CLIN INFECT DIS, V24, P356, DOI 10.1093/clinids/24.3.356; Levin BR, 2001, CLIN INFECT DIS, V33, pS161, DOI 10.1086/321843; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Lipsitch M, 2001, CLIN INFECT DIS, V32, P1044, DOI 10.1086/319604; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Livermore DM, 2005, LANCET INFECT DIS, V5, P450, DOI 10.1016/S1473-3099(05)70166-3; LORIAN V, 1990, J ANTIMICROB CHEMOTH, V25, P175, DOI 10.1093/jac/25.1.175; Maher MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029407; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Oldfield EC, 2001, GASTROENTEROL CLIN N, V30, P817, DOI 10.1016/S0889-8553(05)70212-0; Ostrom E., 1994, RULES GAMES COMMON P; PEARSON ML, 1992, ANN INTERN MED, V117, P191, DOI 10.7326/0003-4819-117-3-191; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; PINSKY P, 1990, MATH BIOSCI, V98, P103, DOI 10.1016/0025-5564(90)90013-O; Porco TC, 2005, J THEOR BIOL, V233, P91, DOI 10.1016/j.jtbi.2004.09.009; Porco TC, 2009, JAMA-J AM MED ASSOC, V302, P962, DOI 10.1001/jama.2009.1266; Reluga TC, 2011, MATH BIOSCI, V230, P67, DOI 10.1016/j.mbs.2011.01.003; Shim E, 2010, MED DECIS MAKING, V30, pE64, DOI 10.1177/0272989X10374112; Telalagic S, 2011, OPTIMAL TREATM UNPUB; Toman K, 2004, TOMANS TUBERCULOSIS, P193; TRAVIS J, 1994, SCIENCE, V264, P360, DOI 10.1126/science.8153615; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wainberg MA, 1998, JAMA-J AM MED ASSOC, V279, P1977, DOI 10.1001/jama.279.24.1977; Wright TL, 2006, AM J GASTROENTEROL, V101, pS32, DOI 10.1111/j.1572-0241.2006.00376.x	65	53	56	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e46505	10.1371/journal.pone.0046505	http://dx.doi.org/10.1371/journal.pone.0046505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236344	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100001
J	Shen, Y; Guo, YZ; Du, C; Wilczynska, M; Hellstrom, S; Ny, T				Shen, Yue; Guo, Yongzhi; Du, Chun; Wilczynska, Malgorzata; Hellstrom, Sten; Ny, Tor			Mice Deficient in Urokinase-Type Plasminogen Activator Have Delayed Healing of Tympanic Membrane Perforations	PLOS ONE			English	Article							RECEPTOR; UPA; KERATINOCYTES; SYSTEM; GENE; MODEL	Mice deficient in plasminogen, the precursor of plasmin, show completely arrested healing of tympanic membrane (TM) perforations, indicating that plasmin plays an essential role in TM healing. The activation of plasminogen to plasmin is performed by two plasminogen activators (PAs), urokinase-type PA (uPA) and tissue-type PA (tPA). To elucidate the functional roles of PAs in the healing of TM perforations, we investigated the phenotypes of single gene-deficient mice lacking uPA (uPA(-/-)) or tPA (tPA(-/-)) after TM perforation. Delayed healing of TM perforations was observed in uPA(-/-) mice but not tPA(-/-) mice. The migration of keratinocytes was clearly delayed and seemed to be misoriented in uPA(-/-) mice. Furthermore, fibrin deposition and the inflammatory response were persistent in these mice. Our findings demonstrate that uPA plays a role in the healing of TM perforations. The observed phenotypes in uPA(-/-) mice are most likely due to the reduced generation of plasmin.	[Shen, Yue; Guo, Yongzhi; Du, Chun; Wilczynska, Malgorzata; Ny, Tor] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Hellstrom, Sten] Karolinska Univ Hosp, Dept Audiol & Neurotol, Stockholm, Sweden	Umea University; Karolinska Institutet; Karolinska University Hospital	Ny, T (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	tor.ny@medchem.umu.se			Swedish Research Council [B0322301]; Lion's Cancer Research Foundation; Medical Faculty of Umea University; County Council of Vasterbotten	Swedish Research Council(Swedish Research CouncilEuropean Commission); Lion's Cancer Research Foundation; Medical Faculty of Umea University; County Council of Vasterbotten	This study was supported by the Swedish Research Council (grant B0322301) to T.N., Lion's Cancer Research Foundation and the Medical Faculty of Umea University and the County Council of Vasterbotten. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 1996, J CELL PHYSIOL, V167, P500, DOI 10.1002/(SICI)1097-4652(199606)167:3<500::AID-JCP14>3.0.CO;2-7; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Collen D, 2005, THROMB HAEMOSTASIS, V93, P627, DOI 10.1160/TH04-11-0724; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; Eriksson PO, 2006, INT J MED MICROBIOL, V296, P501, DOI 10.1016/j.ijmm.2006.04.002; Ghosh S, 2000, J BIOL CHEM, V275, P23869, DOI 10.1074/jbc.M000935200; GRONDAHLHANSEN J, 1988, J INVEST DERMATOL, V90, P790, DOI 10.1111/1523-1747.ep12461511; Guo YZ, 2008, ARTHRITIS RHEUM, V58, P764, DOI 10.1002/art.23263; Guo YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024774; Gyetko MR, 2000, J IMMUNOL, V165, P1513, DOI 10.4049/jimmunol.165.3.1513; Hellstrom S, 2003, OTOL NEUROTOL, V24, P494, DOI 10.1097/00129492-200305000-00024; Jogi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012746; Legrand C, 2001, EXP CELL RES, V264, P326, DOI 10.1006/excr.2000.5125; Li J, 2006, THROMB HAEMOSTASIS, V96, P512, DOI 10.1160/TH06-03-0168; Li WY, 2003, WOUND REPAIR REGEN, V11, P239, DOI 10.1046/j.1524-475X.2003.11402.x; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Lund LR, 1999, EMBO J, V18, P4645, DOI 10.1093/emboj/18.17.4645; Ma YX, 2002, ACTA OTO-LARYNGOL, V122, P586, DOI 10.1080/000164802320396259; Maria PLS, 2007, WOUND REPAIR REGEN, V15, P450, DOI 10.1111/j.1524-475X.2007.00251.x; Prestwich A, 2008, ACTA OTO-LARYNGOL, V128, P1294, DOI 10.1080/00016480701361996; Rahman A, 2005, OTOL NEUROTOL, V26, P1100, DOI 10.1097/01.mao.0000194886.59270.34; Rahman A, 2007, OTOL NEUROTOL, V28, P685; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; Shen Y, 2012, BLOOD, V119, P5879, DOI 10.1182/blood-2012-01-407825; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Stanley Zucker W-TC, 2003, CELL SURFACE PROTEAS; STENFORS LE, 1980, ACTA OTO-LARYNGOL, V90, P332, DOI 10.3109/00016488009131734; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Tchougounova E, 2001, FASEB J, V15, P2763, DOI 10.1096/fj.01-0486fje; Waisman D. M., 2003, PLASMINOGEN STRUCTUR	34	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51303	10.1371/journal.pone.0051303	http://dx.doi.org/10.1371/journal.pone.0051303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236466	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100090
J	Swadzba, ME; Hauck, SM; Naim, HY; Amann, B; Deeg, CA				Swadzba, Margarete E.; Hauck, Stefanie M.; Naim, Hassan Y.; Amann, Barbara; Deeg, Cornelia A.			Retinal Glycoprotein Enrichment by Concanavalin A Enabled Identification of Novel Membrane Autoantigen Synaptotagmin-1 in Equine Recurrent Uveitis	PLOS ONE			English	Article							EATON MYASTHENIC SYNDROME; NEUROMYELITIS-OPTICA; AQUAPORIN 4; S-ANTIGEN; EXPRESSION; PROTEIN; GLYCOSYLATION; MODEL; IMMUNOPATHOLOGY; AUTOANTIBODIES	Complete knowledge of autoantigen spectra is crucial for understanding pathomechanisms of autoimmune diseases like equine recurrent uveitis (ERU), a spontaneous model for human autoimmune uveitis. While several ERU autoantigens were identified previously, no membrane protein was found so far. As there is a great overlap between glycoproteins and membrane proteins, the aim of this study was to test whether pre-enrichment of retinal glycoproteins by ConA affinity is an effective tool to detect autoantigen candidates among membrane proteins. In 1D Western blots, the glycoprotein preparation allowed detection of IgG reactions to low abundant proteins in sera of ERU patients. Synaptotagmin-1, a Ca2+-sensing protein in synaptic vesicles, was identified as autoantigen candidate from the pre-enriched glycoprotein fraction by mass spectrometry and was validated as a highly prevalent autoantigen by enzyme-linked immunosorbent assay. Analysis of Syt1 expression in retinas of ERU cases showed a downregulation in the majority of ERU affected retinas to 24%. Results pointed to a dysregulation of retinal neurotransmitter release in ERU. Identification of synaptotagmin-1, the first cell membrane associated autoantigen in this spontaneous autoimmune disease, demonstrated that examination of tissue fractions can lead to the discovery of previously undetected novel autoantigens. Further experiments will address its role in ERU pathology.	[Swadzba, Margarete E.; Amann, Barbara; Deeg, Cornelia A.] Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany; [Hauck, Stefanie M.] German Res Ctr Environm Hlth GmbH, Res Unit Prot Sci, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Veterinary Medicine Hannover, Foundation	Deeg, CA (corresponding author), Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany.	deeg@tiph.vetmed.uni-muenchen.de	Deeg, Cornelia/U-4216-2019; Deeg, Cornelia A/G-4940-2010; Hauck, Stefanie/B-3300-2013	Deeg, Cornelia A/0000-0003-0375-3190; Hauck, Stefanie/0000-0002-1630-6827	Deutsche Forschungsgemeinschaft [SFB 571/3 A5 Deeg]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was financially supported by a grant from Deutsche Forschungsgemeinschaft, SFB 571/3 A5 Deeg, http://www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel P, 2012, PHYSIOLOGY, V27, P15, DOI 10.1152/physiol.00035.2011; BECKER JW, 1975, J BIOL CHEM, V250, P1513; Berntson AK, 2003, J VISION, V3, P274, DOI 10.1167/3.4.3; Bohm S, 2012, SEMIN IMMUNOPATHOL, V34, P443, DOI 10.1007/s00281-012-0308-x; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; COLLIN JP, 1986, NEUROSCIENCE, V19, P657, DOI 10.1016/0306-4522(86)90288-5; DAVID P, 1993, NEUROMUSCULAR DISORD, V3, P451, DOI 10.1016/0960-8966(93)90095-2; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Deeg CA, 2006, ANAT HISTOL EMBRYOL, V35, P412, DOI 10.1111/j.1439-0264.2006.00722.x; Deeg CA, 2002, EXP EYE RES, V75, P127, DOI 10.1006/exer.2002.2011; Deeg CA, 2001, INVEST OPHTH VIS SCI, V42, P393; Deeg CA, 2008, VET OPHTHALMOL, V11, P61, DOI 10.1111/j.1463-5224.2008.00625.x; Deeg CA, 2008, OPHTHAL RES, V40, P151, DOI 10.1159/000119867; Deeg CA, 2007, MOL IMMUNOL, V44, P3291, DOI 10.1016/j.molimm.2007.02.027; Deeg CA, 2007, PROTEOMICS, V7, P1540, DOI 10.1002/pmic.200600795; Deeg CA, 2006, MOL CELL PROTEOMICS, V5, P1462, DOI 10.1074/mcp.M500352-MCP200; Degroote RL, 2012, J PROTEOMICS, V75, P4536, DOI 10.1016/j.jprot.2012.01.023; Eberhardt C, 2011, GLIA, V59, P697, DOI 10.1002/glia.21139; Ehrenhofer MCA, 2002, VET OPHTHALMOL, V5, P39, DOI 10.1046/j.1463-5224.2002.00210.x; Gauba V, 2011, P NATL ACAD SCI USA, V108, P12821, DOI 10.1073/pnas.1110042108; Glavan G, 2009, ANAT REC, V292, P1849, DOI 10.1002/ar.21026; Greif KF, 2013, DEV NEUROBIOL, V73, P27, DOI 10.1002/dneu.22033; Han WP, 2004, NEURON, V41, P85, DOI 10.1016/S0896-6273(03)00820-1; Hauck SM, 2007, J PROTEOME RES, V6, P2121, DOI 10.1021/pr060668y; Hauck SM, 2010, MOL CELL PROTEOMICS, V9, P2292, DOI 10.1074/mcp.M110.001073; Josic D, 2007, PROTEOMICS, V7, P3010, DOI 10.1002/pmic.200700139; Kalsow CM, 1999, INVEST OPHTH VIS SCI, V40, P1611; Kiel C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.83; KOONTZ MA, 1993, SYNAPSE, V14, P268, DOI 10.1002/syn.890140405; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Levy RA, 2011, CLIN REV ALLERG IMMU, V41, P214, DOI 10.1007/s12016-011-8267-x; Lewis MJ, 2008, MOL IMMUNOL, V45, P818, DOI 10.1016/j.molimm.2007.06.158; Liu XQ, 2007, MOL VIS, V13, P309; Lux A, 2010, ANN RHEUM DIS, V69, P92, DOI 10.1136/ard.2009.117101; Marino K, 2010, NAT CHEM BIOL, V6, P713, DOI [10.1038/nchembio.437, 10.1038/NCHEMBIO.437]; MARTINMOUTOT N, 1993, J PHYSIOLOGY-PARIS, V87, P37, DOI 10.1016/0928-4257(93)90022-L; McNeil BD, 2009, NEURON, V63, P419, DOI 10.1016/j.neuron.2009.08.001; MIRSHAHI M, 1984, BIOL CELL, V52, P195; Morgans CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005230; NAIM HY, 1992, ARCH VIROL, V122, P45, DOI 10.1007/BF01321117; Papadopoulos MC, 2012, LANCET NEUROL, V11, P535, DOI 10.1016/S1474-4422(12)70133-3; Petersen J, 2009, J MOL MED, V87, P1045, DOI 10.1007/s00109-009-0526-4; Ratelade J, 2012, INT J BIOCHEM CELL B, V44, P1519, DOI 10.1016/j.biocel.2012.06.013; Redecker P, 1996, CELL TISSUE RES, V283, P443, DOI 10.1007/s004410050555; Schubert D, 2004, J IMMUNOL, V172, P4503, DOI 10.4049/jimmunol.172.7.4503; Shamsi KS, 2012, J GERONTOL A-BIOL, DOI [10.1093/gerona/glr1224, DOI 10.1093/GERONA/GLR1224]; Spiess B M, 2010, Equine Vet J Suppl, P50; Steck AK, 2011, DIABETES CARE, V34, P1397, DOI 10.2337/dc10-2088; Swadzba ME, 2012, INVEST OPHTH VIS SCI, V53, P294, DOI 10.1167/iovs.11-8734; Takamori M, 2000, AM J MED SCI, V319, P204, DOI 10.1097/00000441-200004000-00002; Takamori M, 2004, BIOCHEM BIOPH RES CO, V322, P1347, DOI 10.1016/j.bbrc.2004.08.040; TAKAMORI M, 1994, ANN NEUROL, V35, P74, DOI 10.1002/ana.410350112; Takamori M, 2008, J NEUROIMMUNOL, V201, P145, DOI 10.1016/j.jneuroim.2008.04.040; Troelsen LN, 2012, J RHEUMATOL, V39, P463, DOI 10.3899/jrheum.110584; Vennekate W, 2012, P NATL ACAD SCI USA, V109, P11037, DOI 10.1073/pnas.1116326109; Vrljic M, 2010, NAT STRUCT MOL BIOL, V17, P325, DOI 10.1038/nsmb.1764; Wang YF, 2008, J PROTEOME RES, V7, P4313, DOI 10.1021/pr8002547; WIGGERT B, 1986, INVEST OPHTH VIS SCI, V27, P1041; Zhao M, 2011, INVEST OPHTH VIS SCI, V52, P6340, DOI 10.1167/iovs.11-7675; Zipplies JK, 2012, VET OPHTHALMOL, V15, P57, DOI 10.1111/j.1463-5224.2012.01010.x	63	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50929	10.1371/journal.pone.0050929	http://dx.doi.org/10.1371/journal.pone.0050929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236410	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100046
J	Ameh, C; Msuya, S; Hofman, J; Raven, J; Mathai, M; van den Broek, N				Ameh, Charles; Msuya, Sia; Hofman, Jan; Raven, Joanna; Mathai, Matthews; van den Broek, Nynke			Status of Emergency Obstetric Care in Six Developing Countries Five Years before the MDG Targets for Maternal and Newborn Health	PLOS ONE			English	Article							CHILD HEALTH; SERVICES; AVAILABILITY; MORTALITY; QUALITY; IMPROVEMENT; ASSISTANCE; COUNTDOWN	Background: Ensuring women have access to good quality Emergency Obstetric Care (EOC) is a key strategy to reducing maternal and newborn deaths. Minimum coverage rates are expected to be 1 Comprehensive (CEOC) and 4 Basic EOC (BEOC) facilities per 500,000 population. Methods and Findings: A cross-sectional survey of 378 health facilities was conducted in Kenya, Malawi, Sierra Leone, Nigeria, Bangladesh and India between 2009 and 2011. This included 160 facilities designated to provide CEOC and 218 designated to provide BEOC. Fewer than 1 in 4 facilities aiming to provide CEOC were able to offer the nine required signal functions of CEOC (23.1%) and only 2.3% of health facilities expected to provide BEOC provided all seven signal functions. The two signal functions least likely to be provided included assisted delivery (17.5%) and manual vacuum aspiration (42.3%). Population indicators were assessed for 31 districts (total population = 15.7 million). The total number of available facilities (283) designated to provide EOC for this population exceeded the number required (158) a ratio of 1.8. However, none of the districts assessed met minimum UN coverage rates for EOC. The population based Caesarean Section rate was estimated to be <2%, the maternal Case Fatality Rate (CFR) for obstetric complications ranged from 2.0-9.3% and still birth (SB) rates ranged from 1.9-6.8%. Conclusions: Availability of EOC is well below minimum UN target coverage levels. Health facilities in the surveyed countries do not currently have the capacity to adequately respond to and manage women with obstetric complications. To achieve MDG 5 by 2015, there is a need to ensure that the full range of signal functions are available in health facilities designated to provide CEOC or BEOC and improve the quality of services provided so that CFR and SB rates decline. Citation: Ameh C, Msuya S, Hofman J, Raven J, Mathai M, et al. (2012) Status of Emergency Obstetric Care in Six Developing Countries Five Years before the MDG Targets for Maternal and Newborn Health. PLoS ONE 7(12): e49938. doi:10.1371/journal.pone.0049938	[Ameh, Charles; Msuya, Sia; Hofman, Jan; Raven, Joanna; van den Broek, Nynke] Univ Liverpool, Liverpool Sch Trop Med, Maternal & Newborn Hlth Unit, Liverpool L3 5QA, Merseyside, England; [Mathai, Matthews] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland	Liverpool School of Tropical Medicine; University of Liverpool; World Health Organization	Msuya, S (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Maternal & Newborn Hlth Unit, Liverpool L3 5QA, Merseyside, England.	cehercod@liv.ac.uk	Ameh, Charles Anawo/I-9872-2019	Ameh, Charles Anawo/0000-0002-2341-7605; Raven, Joanna/0000-0002-4112-6959; van den Broek, Nynke/0000-0001-8523-2684	DFID UK (Department of International Development), UNICEF Sierra Leone	DFID UK (Department of International Development), UNICEF Sierra Leone	The project is funded by DFID UK (Department of International Development), UNICEF Sierra Leone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegoke AA, 2009, BJOG-INT J OBSTET GY, V116, P33, DOI 10.1111/j.1471-0528.2009.02336.x; AMDD working group on indicators, 2002, INT J GYNECOL OBSTET, V78, P277; Bailey P, 2006, INT J GYNECOL OBSTET, V93, P285, DOI 10.1016/j.ijgo.2006.01.028; Bailey PE, 2002, INT J GYNECOL OBSTET, V77, P277; Bradley S, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-14; Cotter AM, 2001, COCHRANE DB SYST REV; Dumont A, 2006, B WORLD HEALTH ORGAN, V84, P218, DOI 10.2471/BLT.05.023903; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Government of India, 2010, FDN COURS REOR BAS E; Grady K, 2011, J OBSTET GYNAECOL, V31, P18, DOI 10.3109/01443615.2010.533218; Greco G, 2008, LANCET, V371, P1268, DOI 10.1016/S0140-6736(08)60561-9; Hussein J, 2001, INT J GYNECOL OBSTET, V75, P63, DOI 10.1016/S0020-7292(01)00474-X; Islam MT, 2005, INT J GYNECOL OBSTET, V91, P298, DOI 10.1016/j.ijgo.2005.06.029; Kongnyuy EJ, 2008, BRIT J OBSTET GYNAEC, V116, P7; Kongnyuy EJ, 2009, MATERN CHILD HLTH J, V13, P687, DOI 10.1007/s10995-008-0380-y; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Lehmann U, 2008, MIDLEVEL HLTH WORKER, P42; Leigh B, 2008, INT J GYNECOL OBSTET, V101, P107, DOI 10.1016/j.ijgo.2008.01.012; Mbonye AK, 2007, INT J GYNECOL OBSTET, V96, P220, DOI 10.1016/j.ijgo.2006.12.017; More NS, 2009, INT HEALTH, V1, P71, DOI 10.1016/j.inhe.2009.02.004; Oyerinde K, 2011, INT J GYNECOL OBSTET, V114, P168, DOI 10.1016/j.ijgo.2011.05.006; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Paxton A, 2006, INT J GYNECOL OBSTET, V95, P192, DOI 10.1016/j.ijgo.2006.08.009; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; Pearson L, 2005, INT J GYNECOL OBSTET, V88, P208, DOI 10.1016/j.ijgo.2004.09.027; Pereira C, 2011, INT J GYNECOL OBSTET, V114, P180, DOI 10.1016/j.ijgo.2011.05.004; Pitt C, 2010, LANCET, V376, P1485, DOI 10.1016/S0140-6736(10)61302-5; Raven J, 2011, INT J GYNECOL OBSTET, V114, P4, DOI 10.1016/j.ijgo.2011.02.007; Ronsmans C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S8; van den Akker T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020776; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; WHO UNFPA UNICEF, 2009, MON EM OBST CAR HDB; WHO UNICEF UNFPA & Bank T. W, 2010, TRENDS MAT MORT 1990; World Health Organization, 2011, WORLD HLTH STAT 2011; World Health Organization and UNICEF, 2010, COUNTD 2015 DEC REP; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]	37	89	89	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e49938	10.1371/journal.pone.0049938	http://dx.doi.org/10.1371/journal.pone.0049938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236357	Green Published, gold, Green Accepted			2022-12-27	WOS:000312589700006
J	Tyagi, RK; Sharma, YD				Tyagi, Rupesh Kumar; Sharma, Yagya Dutta			Erythrocyte Binding Activity Displayed by a Selective Group of Plasmodium vivax Tryptophan Rich Antigens Is Inhibited by Patients' Antibodies	PLOS ONE			English	Article							RESISTANCE-ASSOCIATED MUTATIONS; DIHYDROPTEROATE SYNTHASE; IMMUNOLOGICAL RESPONSES; DIHYDROFOLATE-REDUCTASE; MALARIA; FALCIPARUM; PROTEIN; IDENTIFICATION; INVASION; EXPRESSION	Plasmodium vivax is a very common but non-cultivable malaria parasite affecting large human population in tropical world. To develop therapeutic reagents for this malaria, the parasite molecules involved in host-parasite interaction need to be investigated as they form effective vaccine or drug targets. We have investigated here the erythrocyte binding activity of a group of 15 different Plasmodium vivax tryptophan rich antigens (PvTRAgs). Only six of them, named PvTRAg, PvTRAg38, PvTRAg33.5, PvTRAg35.2 PvTRAg69.4 and PvATRAg74, showed binding to host erythrocytes. That the PvTRAgs binding to host erythrocytes was specific was evident from the competitive inhibition and saturation kinetics results. The erythrocyte receptors for these six PvTRAgs were resistant to trypsin and neuraminidase. These receptors were also chymotrypsin resistant except the receptors for PvTRAg38 and PvATRAg74 which were partially sensitive to this enzyme. The cross-competition studies showed that the chymotrypsin resistant RBC receptor for each of these two proteins was different. Altogether, there seems to be three RBC receptors for these six PvTRAgs and each PvTRAg has two RBC receptors. Both RBC receptors for PvTRAg, PvTRAg69.4, PvTRAg33.5, and PvTRAg35.2 were common to all these four proteins. These four PvTRAgs also shared one of their RBC receptors with PvTRAg38 as well as with PvATRAg74. The erythrocyte binding activity of these six PvTRAgs was inhibited by the respective rabbit polyclonal antibodies as well as by the natural antibodies produced by the P. vivax exposed individuals. It is concluded that only selective few PvTRAgs show erythrocyte binding activity involving different receptor molecules which can be blocked by the natural antibodies. Further studies on these receptor and ligands may lead to the development of therapeutic reagents for P. vivax malaria. Citation: Tyagi RK, Sharma YD (2012) Erythrocyte Binding Activity Displayed by a Selective Group of Plasmodium vivax Tryptophan Rich Antigens Is Inhibited by Patients' Antibodies. PLoS ONE 7(12): e50754. doi:10.1371/journal.pone.0050754	[Tyagi, Rupesh Kumar; Sharma, Yagya Dutta] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Sharma, YD (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	ydsharma_aiims@yahoo.com		Tyagi, Rupesh/0000-0002-5095-8976	Department of Biotechnology [BT/PR9800/MED/29/44/2007]; Senior Research Fellowships of the Government of India	Department of Biotechnology; Senior Research Fellowships of the Government of India	This work was supported by the Department of Biotechnology (BT/PR9800/MED/29/44/2007 to Y.D.S. and Senior Research Fellowships to R.K.T.) of the Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MT, 2008, PARASITE IMMUNOL, V30, P379, DOI 10.1111/j.1365-3024.2008.01033.x; Alam MT, 2008, VACCINE, V26, P3787, DOI 10.1016/j.vaccine.2008.05.059; Alam MT, 2007, ANTIMICROB AGENTS CH, V51, P857, DOI 10.1128/AAC.01200-06; Barnadas C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-282; Bora H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016294; Burns JM, 2000, MOL BIOCHEM PARASIT, V110, P11, DOI 10.1016/S0166-6851(00)00252-8; Burns JM, 1999, INFECT IMMUN, V67, P675, DOI 10.1128/IAI.67.2.675-680.1999; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Chotivanich K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034509; Curtidor H, 2006, BIOCHEM BIOPH RES CO, V339, P888, DOI 10.1016/j.bbrc.2005.11.089; Curtidor H, 2004, VACCINE, V22, P1054, DOI 10.1016/j.vaccine.2003.07.019; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Garg S, 2008, MICROBES INFECT, V10, P1097, DOI 10.1016/j.micinf.2008.05.008; Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; HAYNES JD, 1988, J EXP MED, V167, P1873, DOI 10.1084/jem.167.6.1873; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Jalah R, 2005, MOL BIOCHEM PARASIT, V142, P158, DOI 10.1016/j.molbiopara.2005.01.020; Jasklewicz E, 2010, POSTEP HIG MED DOSW, V64, P617; Jovel IT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-376; Kitagawa Y, 2011, J VIROL, V85, P4606, DOI 10.1128/JVI.02012-10; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Kuesap J, 2011, MEM I OSWALDO CRUZ, V106, P130, DOI 10.1590/S0074-02762011000900017; Kute VB, 2012, EMERG INFECT DIS, V18, P842, DOI 10.3201/eid1805.111442; Li J, 2012, BIOCHEM BIOPH RES CO, V426, P1, DOI 10.1016/j.bbrc.2012.08.055; Lin CH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-85; Lu F, 2010, AM J TROP MED HYG, V83, P474, DOI 10.4269/ajtmh.2010.10-0004; Ma B, 2007, CURR TOP MED CHEM, V7, P999, DOI 10.2174/156802607780906717; Mendes C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001192; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; Mittra P, 2010, MICROBES INFECT, V12, P1019, DOI 10.1016/j.micinf.2010.07.004; Mulky A, 2005, J MOL BIOL, V349, P673, DOI 10.1016/j.jmb.2005.03.057; Ntumngia FB, 2004, MOL BIOCHEM PARASIT, V137, P349, DOI 10.1016/j.molbiopara.2004.06.008; Persson KEM, 2010, ACTA TROP, V114, P138, DOI 10.1016/j.actatropica.2009.05.017; Rodriguez-Morales AJ, 2006, AM J TROP MED HYG, V74, P755, DOI 10.4269/ajtmh.2006.74.755; Rogerson SJ, 2008, PLOS MED, V5, P875, DOI 10.1371/journal.pmed.0050136; Ryan JR, 2006, AM J TROP MED HYG, V75, P575, DOI 10.4269/ajtmh.2006.75.575; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sarin R, 2006, GENE, V376, P107, DOI 10.1016/j.gene.2006.02.012; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Siddiqui AA, 2008, INFECT IMMUN, V76, P2576, DOI 10.1128/IAI.00677-07; Siddiqui AA, 2007, VACCINE, V26, P96, DOI 10.1016/j.vaccine.2007.10.042; Singh Harpal, 2011, J Infect Public Health, V4, P91, DOI 10.1016/j.jiph.2011.03.002; Smith KJ, 1996, J BIOL CHEM, V271, P16703, DOI 10.1074/jbc.271.28.16703; Tanwar GS, 2011, ANN TROP PAEDIATR, V31, P351, DOI 10.1179/1465328111Y.0000000040; Tanwar GS, 2012, PLATELETS, V23, P211, DOI 10.3109/09537104.2011.607520; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Tran TM, 2005, CYTOM PART A, V63A, P59, DOI 10.1002/cyto.a.20098; Udomsangpetch R, 1995, T ROY SOC TROP MED H, V89, P635, DOI 10.1016/0035-9203(95)90422-0; Uhlemann AC, 2001, MOL BIOCHEM PARASIT, V118, P41, DOI 10.1016/S0166-6851(01)00370-X; Wickramarachchi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001732; Zeeshan M, 2012, J INFECT DIS	57	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50754	10.1371/journal.pone.0050754	http://dx.doi.org/10.1371/journal.pone.0050754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236392	Green Submitted, gold, Green Published			2022-12-27	WOS:000312589700017
J	Wang, ZF; Chen, ZW; Cheng, JP; Lai, YY; Wang, JF; Bao, YM; Huang, J; Zhang, HS				Wang, Zhoufei; Chen, Zhiwei; Cheng, Jinping; Lai, Yanyan; Wang, Jianfei; Bao, Yongmei; Huang, Ji; Zhang, Hongsheng			QTL Analysis of Na+ and K+ Concentrations in Roots and Shoots under Different Levels of NaCl Stress in Rice (Oryza sativa L.)	PLOS ONE			English	Article							SALT TOLERANCE; QUANTITATIVE TRAITS; SALINITY TOLERANCE; SODIUM; EPISTASIS; TRANSPORT; GENES; IDENTIFICATION; POTASSIUM; LINES	The key to plant survival under NaCl salt stress is maintaining a low Na+ level or Na+/K+ ratio in the cells. A population of recombinant inbred lines (RILs, F-2:9) derived from a cross between the salt-tolerant japonica rice variety Jiucaiqing and the salt-sensitive indica variety IR26, was used to determine Na+ and K+ concentrations in the roots and shoots under three different NaCl stress conditions (0, 100 and 120 mM NaCl). A total of nine additive QTLs were identified by QTL Cartographer program using single-environment phenotypic values, whereas eight additive QTLs were identified by QTL IciMapping program. Among these additive QTLs, five were identified by both programs. Epistatic QTLs and QTL-by-environment interactions were detected by QTLNetwork program in the joint analyses of multi-environment phenotypic values, and one additive QTL and nine epistatic QTLs were identified. There were three epistatic QTLs identified for Na+ in roots (RNC), three additive QTLs and two epistatic QTLs identified for Na+ in shoots (SNC), four additive QTLs identified for K+ in roots (RKC), four additive QTLs and three epistatic QTLs identified for K+ in shoots (SKC) and one additive QTL and one epistatic QTL for salt tolerance rating (STR). The phenotypic variation explained by each additive, epistatic QTL and QTLxenvironment interaction ranged from 8.5 to 18.9%, 0.5 to 5.3% and 0.7 to 7.5%, respectively. By comparing the chromosomal positions of these additive QTLs with those previously identified, five additive QTLs, qSNC9, qSKC1, qSKC9, qRKC4 and qSTR7, might represent novel salt tolerance loci. The identification of salt tolerance in selected RILs showed that a major QTL qSNC11 played a significant role in rice salt tolerance, and could be used to improve salt tolerance of commercial rice varieties with marker-assisted selection (MAS) approach. Citation: Wang Z, Chen Z, Cheng J, Lai Y, Wang J, et al. (2012) QTL Analysis of Na+ and K+ Concentrations in Roots and Shoots under Different Levels of NaCl Stress in Rice (Oryza sativa L.). PLoS ONE 7(12): e51202. doi:10.1371/journal.pone.0051202	[Wang, Zhoufei; Chen, Zhiwei; Cheng, Jinping; Lai, Yanyan; Wang, Jianfei; Bao, Yongmei; Huang, Ji; Zhang, Hongsheng] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Lab Seed Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Huang, J (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Lab Seed Sci & Technol, Nanjing, Jiangsu, Peoples R China.	huangji@njau.edu.cn; hszhang@njau.edu.cn	chen, zhiwei/G-1305-2013; chen, zhiwei/AAP-5465-2020; Huang, Ji/AAY-2852-2020	chen, zhiwei/0000-0002-0478-4880; Huang, Ji/0000-0002-9057-4299	National Natural Science Foundation of China [31000748, 31271806]; Special Fund for Agro-scientific Research in the Public Interest [201203052]; Fundamental Research Funds for the Central Universities [KYZ201202-9]; 111 Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (Grant No. 31000748; 31271806), the Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201203052), the Fundamental Research Funds for the Central Universities (Grant No. KYZ201202-9) and the 111 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi N, 2011, THEOR APPL GENET, V123, P881, DOI 10.1007/s00122-011-1634-4; Ammar MHM, 2009, J PLANT BIOCHEM BIOT, V18, P139, DOI 10.1007/BF03263312; Bonilla P, 2002, PHILIPP AGRIC SCI, V85, P68; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Chen X, 1997, GENOMICS, V1, P174; Cheng LR, 2012, GENOME, V55, P45, DOI [10.1139/G11-075, 10.1139/g11-075]; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Feki K, 2011, PLANT MOL BIOL, V76, P545, DOI 10.1007/s11103-011-9787-8; Garcia A, 1997, PLANT CELL ENVIRON, V20, P1167, DOI 10.1046/j.1365-3040.1997.d01-146.x; Garciadeblas B, 2003, PLANT J, V34, P788, DOI 10.1046/j.1365-313X.2003.01764.x; Gregorio GB, 2002, FIELD CROP RES, V76, P91, DOI 10.1016/S0378-4290(02)00031-X; Gregorio GB, 1995, P 2 ASIAN CROP SCI C; GULATI A, 1993, J PLANT PHYSIOL, V141, P120, DOI 10.1016/S0176-1617(11)80862-X; Ismail AM, 2007, PLANT MOL BIOL, V65, P547, DOI 10.1007/s11103-007-9215-2; Kader MA, 2006, J EXP BOT, V57, P4257, DOI 10.1093/jxb/erl199; Koyama ML, 2001, PLANT PHYSIOL, V125, P406, DOI 10.1104/pp.125.1.406; Lander ES, 1987, THEOR APPL GENET, V95, P553; Li HH, 2008, THEOR APPL GENET, V116, P243, DOI 10.1007/s00122-007-0663-5; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Lin HX, 2004, THEOR APPL GENET, V108, P253, DOI 10.1007/s00122-003-1421-y; Malmberg RL, 2005, GENETICS, V171, P2013, DOI 10.1534/genetics.105.046078; McCouch SR, 2008, RICE, V1, P72, DOI 10.1007/s12284-008-9004-9; Mohan A, 2009, EUPHYTICA, V168, P319, DOI 10.1007/s10681-009-9935-2; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pandit A, 2010, MOL GENET GENOMICS, V284, P121, DOI 10.1007/s00438-010-0551-6; Ravi K, 2011, THEOR APPL GENET, V122, P1119, DOI 10.1007/s00122-010-1517-0; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Rodriguez-Navarro A, 2006, J EXP BOT, V57, P1149, DOI 10.1093/jxb/erj068; Sahi Chandan, 2006, Functional & Integrative Genomics, V6, P263, DOI 10.1007/s10142-006-0032-5; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Shen XL, 2006, CROP SCI, V46, P61, DOI 10.2135/cropsci2005.0056; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Wang S, 2007, WINDOW QTL CARTOGRAP; Wang ZF, 2010, SEED SCI TECHNOL, V38, P104, DOI 10.15258/sst.2010.38.1.11; Wang ZF, 2012, THEOR APPL GENET, V125, P807, DOI 10.1007/s00122-012-1873-z; Wang ZF, 2011, EUPHYTICA, V178, P297, DOI 10.1007/s10681-010-0287-8; Wu YS, 2009, PLANT GROWTH REGUL, V57, P271, DOI 10.1007/s10725-008-9345-9; Wurschum T, 2011, THEOR APPL GENET, V123, P109, DOI 10.1007/s00122-011-1570-3; Yadav R, 1997, THEOR APPL GENET, V94, P619, DOI 10.1007/s001220050459; Yang J, 2005, QTLNETWORK 2 0; Yang XH, 2010, THEOR APPL GENET, V120, P665, DOI 10.1007/s00122-009-1184-1; YEO AR, 1982, PHYSIOL PLANTARUM, V56, P343, DOI 10.1111/j.1399-3054.1982.tb00350.x; Yoshida S., 1976, LAB MANUAL PHYSL STU	44	67	78	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51202	10.1371/journal.pone.0051202	http://dx.doi.org/10.1371/journal.pone.0051202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236455	Green Published, gold, Green Submitted			2022-12-27	WOS:000312589700032
J	Azoulay, L; Assimes, TL; Yin, H; Bartels, DB; Schiffrin, EL; Suissa, S				Azoulay, Laurent; Assimes, Themistocles L.; Yin, Hui; Bartels, Dorothee B.; Schiffrin, Ernesto L.; Suissa, Samy			Long-Term Use of Angiotensin Receptor Blockers and the Risk of Cancer	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; CONVERTING-ENZYME-INHIBITORS; CALCIUM-CHANNEL BLOCKERS; ANTIHYPERTENSIVE DRUGS; COHORT; METAANALYSIS; INFORMATION; VALIDATION	The association between angiotensin receptor blockers (ARBs) and cancer is controversial with meta-analyses of randomized controlled trials and observational studies reporting conflicting results. Thus, the objective of this study was to determine whether ARBs are associated with an overall increased risk of the four most common cancers, namely, lung, colorectal, breast and prostate cancers, and to explore these effects separately for each cancer type. We conducted a retrospective cohort study using a nested case-control analysis within the United Kingdom (UK) General Practice Research Database. We assembled a cohort of patients prescribed antihypertensive agents between 1995, the year the first ARB (losartan) entered the UK market, and 2008, with follow-up until December 31, 2010. Cases were patients newly-diagnosed with lung, colorectal, breast and prostate cancer during follow-up. We used conditional logistic regression to estimate adjusted rate ratios (RRs) and 95% confidence intervals (CIs) of cancer incidence, comparing ever use of ARBs with ever use of diuretics and/or beta-blockers. The cohort included 1,165,781 patients, during which 41,059 patients were diagnosed with one of the cancers under study (rate 554/100,000 person-years). When compared to diuretics and/or beta-blockers, ever use of ARBs was not associated with an increased rate of cancer overall (RR: 1.00; 95% CI: 0.96-1.03) or with each cancer site separately. The use of angiotensin-converting enzyme inhibitors and calcium channel blockers was associated with an increased rate of lung cancer (RR: 1.13; 95% CI: 1.06-1.20 and RR: 1.19; 95% CI: 1.12-1.27, respectively). This study provides additional evidence that the use of ARBs does not increase the risk of cancer overall or any of the four major cancer sites. Additional research is needed to further investigate a potentially increased risk of lung cancer with angiotensin-converting enzyme inhibitors and calcium channel blockers.	[Azoulay, Laurent; Yin, Hui; Suissa, Samy] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Azoulay, Laurent] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Assimes, Themistocles L.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Bartels, Dorothee B.] Boehringer Ingelheim GmbH & Co KG, Dept Global Epidemiol, Ingelheim, Germany; [Schiffrin, Ernesto L.] McGill Univ, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada; [Schiffrin, Ernesto L.] McGill Univ, Hypertens & Vasc Res Unit, Montreal, PQ H3T 1E2, Canada; [Suissa, Samy] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; Stanford University; Boehringer Ingelheim; McGill University; McGill University; McGill University	Azoulay, L (corresponding author), McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.	laurent.azoulay@mcgill.ca	Azoulay, Laurent/Z-4421-2019; Schiffrin, Ernesto L/AAB-9061-2019; Assimes, Themistocles Leonard/D-9696-2015	Schiffrin, Ernesto L/0000-0002-4502-2823; Assimes, Themistocles Leonard/0000-0003-2349-0009; Azoulay, Laurent/0000-0001-5162-3556	Canadian Institutes of Health Research (CIHR); Boehringer-Ingelheim; Canadian Foundation for Innovation (CFI)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Boehringer-Ingelheim(Boehringer Ingelheim); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This study was funded by grants from the Canadian Institutes of Health Research (CIHR), Boehringer-Ingelheim, and the Canadian Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FDA DRUG SAF COMM NO; Assimes TL, 2008, PHARMACOEPIDEM DR S, V17, P1039, DOI 10.1002/pds.1656; Assimes TL, 2011, AM J CARDIOL, V108, P902, DOI 10.1016/j.amjcard.2011.06.031; Assimes TL, 2009, CANCER CAUSE CONTROL, V20, P1811, DOI 10.1007/s10552-009-9374-3; Bangalore S, 2011, LANCET ONCOL, V12, P65, DOI 10.1016/S1470-2045(10)70260-6; Bhaskaran K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2697; Friis S, 2001, CANCER-AM CANCER SOC, V92, P2462, DOI 10.1002/1097-0142(20011101)92:9<2462::AID-CNCR1596>3.0.CO;2-L; Gonzalez-Perez A, 2005, CANCER CAUSE CONTROL, V16, P1055, DOI 10.1007/s10552-005-4705-5; Hall GC, 2005, DIABETES CARE, V28, P590, DOI 10.2337/diacare.28.3.590; Hallas J, 2012, BR J CLIN PHARM; Huang CC, 2011, AM J CARDIOL, V107, P1028, DOI 10.1016/j.amjcard.2010.11.026; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 1997, LANCET, V349, P525, DOI 10.1016/S0140-6736(97)80084-0; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Lawrenson R, 1999, J PUBLIC HEALTH MED, V21, P299, DOI 10.1093/pubmed/21.3.299; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Michels KB, 1998, CANCER, V83, P2003, DOI 10.1002/(SICI)1097-0142(19981101)83:9<2003::AID-CNCR17>3.3.CO;2-V; Pasternak B, 2011, CIRCULATION, V123, P1729, DOI 10.1161/CIRCULATIONAHA.110.007336; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Tenenbaum A, 2001, AM J MED, V110, P143, DOI 10.1016/S0002-9343(00)00674-4; van Staa TP, 2012, DIABETOLOGIA, V55, P654, DOI 10.1007/s00125-011-2390-3; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Yoon C, 2011, CAN MED ASSOC J, V183, pE1073, DOI 10.1503/cmaj.101497	25	68	70	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50893	10.1371/journal.pone.0050893	http://dx.doi.org/10.1371/journal.pone.0050893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251399	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200045
J	Friedman, A; Pizarro, O; Williams, SB; Johnson-Roberson, M				Friedman, Ariell; Pizarro, Oscar; Williams, Stefan B.; Johnson-Roberson, Matthew			Multi-Scale Measures of Rugosity, Slope and Aspect from Benthic Stereo Image Reconstructions	PLOS ONE			English	Article							BISCAYNE NATIONAL-PARK; SURFACE-TOPOGRAPHY; REEF; COMPLEXITY; MODELS; FLORIDA	This paper demonstrates how multi-scale measures of rugosity, slope and aspect can be derived from fine-scale bathymetric reconstructions created from geo-referenced stereo imagery. We generate three-dimensional reconstructions over large spatial scales using data collected by Autonomous Underwater Vehicles (AUVs), Remotely Operated Vehicles (ROVs), manned submersibles and diver-held imaging systems. We propose a new method for calculating rugosity in a Delaunay triangulated surface mesh by projecting areas onto the plane of best fit using Principal Component Analysis (PCA). Slope and aspect can be calculated with very little extra effort, and fitting a plane serves to decouple rugosity from slope. We compare the results of the virtual terrain complexity calculations with experimental results using conventional in-situ measurement methods. We show that performing calculations over a digital terrain reconstruction is more flexible, robust and easily repeatable. In addition, the method is non-contact and provides much less environmental impact compared to traditional survey techniques. For diver-based surveys, the time underwater needed to collect rugosity data is significantly reduced and, being a technique based on images, it is possible to use robotic platforms that can operate beyond diver depths. Measurements can be calculated exhaustively at multiple scales for surveys with tens of thousands of images covering thousands of square metres. The technique is demonstrated on data gathered by a diver-rig and an AUV, on small single-transect surveys and on a larger, dense survey that covers over 3,750m(2). Stereo images provide 3D structure as well as visual appearance, which could potentially feed into automated classification techniques. Our multi-scale rugosity, slope and aspect measures have already been adopted in a number of marine science studies. This paper presents a detailed description of the method and thoroughly validates it against traditional in-situ measurements.	[Friedman, Ariell; Pizarro, Oscar; Williams, Stefan B.; Johnson-Roberson, Matthew] Univ Sydney, Australian Ctr Field Robot, Sydney, NSW 2006, Australia	University of Sydney	Friedman, A (corresponding author), Univ Sydney, Australian Ctr Field Robot, Sydney, NSW 2006, Australia.	a.friedman@acfr.usyd.edu.au	Williams, Stefan/AAE-4376-2020	Williams, Stefan/0000-0001-9416-5639; Pizarro, Oscar/0000-0001-6612-2738	Australian Research Council (ARC) Centre of Excellence programme; ARC; New South Wales State Government; Integrated Marine Observing System through the DIISR National Collaborative Research Infrastructure Scheme	Australian Research Council (ARC) Centre of Excellence programme(Australian Research Council); ARC(Australian Research Council); New South Wales State Government; Integrated Marine Observing System through the DIISR National Collaborative Research Infrastructure Scheme	This work is supported by the Australian Research Council (ARC) Centre of Excellence programme, funded by the ARC and the New South Wales State Government and the Integrated Marine Observing System through the DIISR National Collaborative Research Infrastructure Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander TJ, 2009, MAR ECOL PROG SER, V389, P31, DOI 10.3354/meps08210; Bell KLC, 2011, NEW FRONTIERS OCEAN; Bishop C. M, 2006, PATTERN RECOGNITION; Bridge TCL, 2011, CORAL REEFS, V30, P143, DOI 10.1007/s00338-010-0677-3; Bridge TCL, 2011, MAR ECOL PROG SER, V428, P63, DOI 10.3354/meps09046; Brock JC, 2004, CORAL REEFS, V23, P48, DOI 10.1007/s00338-003-0365-7; Commito JA, 2000, J EXP MAR BIOL ECOL, V255, P133, DOI 10.1016/S0022-0981(00)00285-9; Curless B., 1996, ANN C SERIES ASS COM, V2006, P303, DOI DOI 10.1145/237170.237269; Dartnell P, 2004, PHOTOGRAMM ENG REM S, V70, P1081, DOI 10.14358/PERS.70.9.1081; Friedman AL, 2010, OCEANS 2010 SYDN; Friedman A, 2011, IEEE INT C INT ROBOT, P1533, DOI 10.1109/IROS.2011.6048779; Frost NJ, 2005, LIMNOL OCEANOGR-METH, V3, P203, DOI 10.4319/lom.2005.3.203; Hill J, 2004, TECHNICAL REPORT; Jenness JS, 2004, WILDLIFE SOC B, V32, P829, DOI 10.2193/0091-7648(2004)032[0829:CLSAFD]2.0.CO;2; Johnson-Roberson M, 2010, J FIELD ROBOT, V27, P21, DOI 10.1002/rob.20324; Knudby A, 2007, AM AC UND SCI 26 S D; Kuffner IB, 2007, ENVIRON BIOL FISH, V78, P71, DOI 10.1007/s10641-006-9078-4; LEE DT, 1980, INT J COMPUT INF SCI, V9, P219, DOI 10.1007/BF00977785; Mahon I, 2011, ROB AUT ICRA 2011 IE, P2315; Mahon I, 2008, IEEE T ROBOT, V24, P1002, DOI 10.1109/TRO.2008.2004888; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; Moustier CD, 1993, MAR GEOPHYS RES, V15, P27; Seiler J, CONTINENTAL IN PRESS; Sleeman JC, 2005, RESTOR ECOL, V13, P685, DOI 10.1111/j.1526-100X.2005.00087.x; Steinberg DM, 2010, IEEE INT C INT ROBOT, P4424, DOI 10.1109/IROS.2010.5652480; Williams SB, 2012, IEEE ROBOT AUTOM MAG, V19, P73, DOI 10.1109/MRA.2011.2181772	26	93	94	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50440	10.1371/journal.pone.0050440	http://dx.doi.org/10.1371/journal.pone.0050440			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251370	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200029
J	Venet, D; Detours, V; Bersini, H				Venet, David; Detours, Vincent; Bersini, Hugues			A Measure of the Signal-to-Noise Ratio of Microarray Samples and Studies Using Gene Correlations	PLOS ONE			English	Article							QUALITY-CONTROL; CELL-LINES; EXPRESSION; CANCER; ASSOCIATION; PHENOTYPE; SUBTYPES; DATABASE; MODELS; GRADE	Background: The quality of gene expression data can vary dramatically from platform to platform, study to study, and sample to sample. As reliable statistical analysis rests on reliable data, determining such quality is of the utmost importance. Quality measures to spot problematic samples exist, but they are platform-specific, and cannot be used to compare studies. Results: As a proxy for quality, we propose a signal-to-noise ratio for microarray data, the "Signal-to-Noise Applied to Gene Expression Experiments", or SNAGEE. SNAGEE is based on the consistency of gene-gene correlations. We applied SNAGEE to a compendium of 80 large datasets on 37 platforms, for a total of 24,380 samples, and assessed the signal-to-noise ratio of studies and samples. This allowed us to discover serious issues with three studies. We show that signal-to-noise ratios of both studies and samples are linked to the statistical significance of the biological results. Conclusions: We showed that SNAGEE is an effective way to measure data quality for most types of gene expression studies, and that it often outperforms existing techniques. Furthermore, SNAGEE is platform-independent and does not require raw data files. The SNAGEE R package is available in BioConductor.	[Venet, David; Bersini, Hugues] Univ Libre Bruxelles, IRIDIA, Brussels, Belgium; [Detours, Vincent] Univ Libre Bruxelles, IRIBHM, Brussels, Belgium; [Detours, Vincent] Univ Libre Bruxelles, WELBIO Walloon Excellence Lifesci & Biotechnol, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; WELBIO	Venet, D (corresponding author), Univ Libre Bruxelles, IRIDIA, Brussels, Belgium.	davenet@ulb.ac.be			ICT Impulse program, Brussels Capital Region, Belgium - project In Silico	ICT Impulse program, Brussels Capital Region, Belgium - project In Silico	This work was funded by the ICT Impulse program 2006, Brussels Capital Region, Belgium - project In Silico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez MJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r143; Asare AL, 2009, BIOINFORMATICS, V25, P48, DOI 10.1093/bioinformatics/btn591; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bolstad BM, 2004, INT REV NEUROBIOL, V60, P25; Chao A, 2008, RADIAT RES, V169, P76, DOI 10.1667/RR1045.1; Cope L., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1046, DOI 10.2202/1544-6115.1046]; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Freue GVC, 2007, BIOINFORMATICS, V23, P3162, DOI 10.1093/bioinformatics/btm487; GAYEN AK, 1951, BIOMETRIKA, V38, P219, DOI 10.1093/biomet/38.1-2.219; Hayashi T, 2006, PSYCHOTHER PSYCHOSOM, V75, P62, DOI 10.1159/000089228; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jumppanen M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1649; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; McCall MN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-137; Pierce A, 2008, J MOL BIOL, V382, P1195, DOI 10.1016/j.jmb.2008.07.088; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Savonet V, 1997, ANAL BIOCHEM, V247, P165, DOI 10.1006/abio.1997.2055; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; SPEARMAN C, 1987, AM J PSYCHOL, V100, P441, DOI 10.2307/1422689; van Staveren WCG, 2007, CANCER RES, V67, P8113, DOI 10.1158/0008-5472.CAN-06-4026; Wang JB, 2002, BIOINFORMATICS, V18, P1139, DOI 10.1093/bioinformatics/18.8.1139; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605	27	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e51013	10.1371/journal.pone.0051013	http://dx.doi.org/10.1371/journal.pone.0051013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251415	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200053
J	Weigel, S; Osterwalder, T; Tobler, U; Yao, L; Wiesli, M; Lehnert, T; Pandit, A; Bruinink, A				Weigel, Stefan; Osterwalder, Thomas; Tobler, Ursina; Yao, Li; Wiesli, Manuel; Lehnert, Thomas; Pandit, Abhay; Bruinink, Arie			Surface Microstructures on Planar Substrates and Textile Fibers Guide Neurite Outgrowth: A Scaffold Solution to Push Limits of Critical Nerve Defect Regeneration?	PLOS ONE			English	Article							PERIPHERAL-NERVE; GROWTH CONES; CONTACT GUIDANCE; IN-VITRO; TOPOGRAPHICAL CONTROL; AXONAL GROWTH; CELL BEHAVIOR; SCHWANN-CELLS; MIGRATION; NEURONS	The treatment of critical size peripheral nerve defects represents one of the most serious problems in neurosurgery. If the gap size exceeds a certain limit, healing can't be achieved. Connection mismatching may further reduce the clinical success. The present study investigates how far specific surface structures support neurite outgrowth and by that may represent one possibility to push distance limits that can be bridged. For this purpose, growth cone displacement of fluorescent embryonic chicken spinal cord neurons was monitored using time-lapse video. In a first series of experiments, parallel patterns of polyimide ridges of different geometry were created on planar silicon oxide surfaces. These channel-like structures were evaluated with and without amorphous hydrogenated carbon (a-C:H) coating. In a next step, structured and unstructured textile fibers were investigated. All planar surface materials (polyimide, silicon oxide and a-C:H) proved to be biocompatible, i.e. had no adverse effect on nerve cultures and supported neurite outgrowth. Mean growth cone migration velocity measured on 5 minute base was marginally affected by surface structuring. However, surface structure variability, i.e. ridge height, width and inter-ridge spacing, significantly enhanced the resulting net velocity by guiding the growth cone movement. Ridge height and inter-ridge distance affected the frequency of neurites crossing over ridges. Of the evaluated dimensions ridge height, width, and inter-ridge distance of respectively 3, 10, and 10 mu m maximally supported net axon growth. Comparable artificial grooves, fabricated onto the surface of PET fibers by using an excimer laser, showed similar positive effects. Our data may help to further optimize surface characteristics of artificial nerve conduits and bioelectronic interfaces.	[Weigel, Stefan; Osterwalder, Thomas; Tobler, Ursina; Wiesli, Manuel; Bruinink, Arie] EMPA Mat Sci & Technol, MaTisMed, Mat Biol Interact Lab, St Gallen, Switzerland; [Weigel, Stefan] Tech Univ Munich, Freising Weihenstephan, Germany; [Yao, Li; Pandit, Abhay] Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland; [Yao, Li] Wichita State Univ, Dept Biol Sci, Wichita, KS 67208 USA; [Lehnert, Thomas] Ecole Polytech Fed Lausanne, Lab Microsyst 2, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Technical University of Munich; Ollscoil na Gaillimhe-University of Galway; Wichita State University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Bruinink, A (corresponding author), EMPA Mat Sci & Technol, MaTisMed, Mat Biol Interact Lab, St Gallen, Switzerland.	arie.bruinink@empa.ch	Weigel, Stefan/AAG-4531-2021; Pandit, Abhay/B-6187-2008; Weigel, Stefan/AAV-7453-2021; Yao, Le/J-1372-2016	Pandit, Abhay/0000-0002-6292-4933; Weigel, Stefan/0000-0002-2463-816X; 	EMPA	EMPA	The study was supported by the EMPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075; Anderson M, 2006, HEARING RES, V215, P97, DOI 10.1016/j.heares.2006.03.014; Bernard A, 2001, NAT BIOTECHNOL, V19, P866, DOI 10.1038/nbt0901-866; Bilsland J, 1999, J NEUROSCI METH, V92, P75, DOI 10.1016/S0165-0270(99)00099-0; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; Bozkurt A, 2009, BIOMATERIALS, V30, P169, DOI 10.1016/j.biomaterials.2008.09.017; Brown MD, 2000, J NEUROBIOL, V43, P352, DOI 10.1002/1097-4695(20000615)43:4<352::AID-NEU4>3.0.CO;2-T; Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X; CLARK P, 1990, DEVELOPMENT, V108, P635; CLARK P, 1991, J CELL SCI, V99, P73; CLARK P, 1987, DEVELOPMENT, V99, P439; Corey JM, 1997, J NEUROSCI METH, V75, P91, DOI 10.1016/S0165-0270(97)00062-9; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Dowell-Mesfin NM, 2004, J NEURAL ENG, V1, P78, DOI 10.1088/1741-2560/1/2/003; Francz G, 1999, SURF INTERFACE ANAL, V28, P3, DOI 10.1002/(SICI)1096-9918(199908)28:1<3::AID-SIA609>3.3.CO;2-L; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HIRONO T, 1988, BRAIN RES, V446, P189, DOI 10.1016/0006-8993(88)91314-5; Ignatius MJ, 1998, J BIOMED MATER RES, V40, P264, DOI 10.1002/(SICI)1097-4636(199805)40:2<264::AID-JBM11>3.0.CO;2-M; Kaehr B, 2004, P NATL ACAD SCI USA, V101, P16104, DOI 10.1073/pnas.0407204101; Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002; KATZ MJ, 1985, J NEUROSCI, V5, P589; Kelly S, 2008, BIOMATERIALS, V29, P2573, DOI 10.1016/j.biomaterials.2008.03.001; Kim Y-H, 2005, J SEMICONDUCTOR TECH, V5, P11; Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042; Klinkhammer K, 2010, J MATER SCI-MATER M, V21, P2637, DOI 10.1007/s10856-010-4112-7; Kuhn TB, 2003, METHOD CELL BIOL, V71, P67, DOI 10.1016/S0091-679X(03)01005-7; Lee TH, 2010, NEUROMODULATION, V13, P299, DOI 10.1111/j.1525-1403.2010.00296.x; Lietz M, 2006, BIOMATERIALS, V27, P1425, DOI 10.1016/j.biomaterials.2005.08.007; Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073; Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015; Miller C, 2002, TISSUE ENG, V8, P367, DOI 10.1089/107632702760184646; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Morelli S, 2010, BIOMATERIALS, V31, P7000, DOI 10.1016/j.biomaterials.2010.05.079; NAGATA I, 1993, DEVELOPMENT, V117, P401; Odde DJ, 1996, BIOTECHNOL BIOENG, V50, P452, DOI 10.1002/(SICI)1097-0290(19960520)50:4<452::AID-BIT13>3.0.CO;2-L; Pekarik V, 2003, NAT BIOTECHNOL, V21, P93, DOI 10.1038/nbt770; Rajnicek AM, 1997, J CELL SCI, V110, P2905; Rajnicek AM, 1997, J CELL SCI, V110, P2915; Rajnicek AM, 2006, J CELL SCI, V119, P1723, DOI 10.1242/jcs.02896; Reich U, 2012, J BIOMED MATER RES B, V100B, P940, DOI 10.1002/jbm.b.32656; Schlosshauer B, 2003, BRAIN RES, V963, P321, DOI 10.1016/S0006-8993(02)03930-6; Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009; Schroeder A, 2000, BIOMATERIALS, V21, P449, DOI 10.1016/S0142-9612(99)00135-0; Shah A, 2004, J NEUROSCI METH, V136, P123, DOI 10.1016/j.jneumeth.2004.01.010; Smeal RM, 2005, ANN BIOMED ENG, V33, P376, DOI 10.1007/s10439-005-1740-z; SONDEREGGER P, 1985, EMBO J, V4, P1395, DOI 10.1002/j.1460-2075.1985.tb03792.x; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song M, 2007, ANN BIOMEDICAL ENG; Stepien E, 1999, CELL BIOL INT, V23, P105, DOI 10.1006/cbir.1998.0256; STIER H, 1995, DEVELOPMENT, V121, P1443; Sun M, 2010, J BIOMED MATER RES A, V93A, P1470, DOI 10.1002/jbm.a.32681; Tai HC, 1998, BIOTECHNOL PROGR, V14, P364, DOI 10.1021/bp980035r; TANAKA EM, 1991, J CELL BIOL, V115, P345, DOI 10.1083/jcb.115.2.345; Torigoe K, 1996, EXP NEUROL, V137, P301, DOI 10.1006/exnr.1996.0030; TORIMITSU K, 1990, DEV BRAIN RES, V51, P128, DOI 10.1016/0165-3806(90)90265-Z; Trumble TE, 2004, J AM SOC SURG HAND, V4, P134; Wagner F, 2000, APPL SURF SCI, V168, P158, DOI 10.1016/S0169-4332(00)00577-8; Wieringa PA, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016001; Yao L, 2009, ACTA BIOMATER, V5, P580, DOI 10.1016/j.actbio.2008.09.002; Yucel D, 2010, BIOMATERIALS, V31, P1596, DOI 10.1016/j.biomaterials.2009.11.013; Zhang Q, 2012, ACTA BIOMATER, V8, P11	62	11	11	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50714	10.1371/journal.pone.0050714	http://dx.doi.org/10.1371/journal.pone.0050714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251379	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200036
J	Wong, PY; Chang, CCR; Marx, CE; Caron, MG; Wetsel, WC; Zhang, XD				Wong, Peiyan; Chang, Cecilia Chin Roei; Marx, Christine E.; Caron, Marc G.; Wetsel, William C.; Zhang, Xiaodong			Pregnenolone Rescues Schizophrenia-Like Behavior in Dopamine Transporter Knockout Mice	PLOS ONE			English	Article							PREPULSE INHIBITION DEFICITS; CA1 HIPPOCAMPAL REGION; NEUROACTIVE STEROIDS; ALZHEIMERS-DISEASE; NEGATIVE SYMPTOMS; MAJOR DEPRESSION; NMDA ANTAGONIST; RAT HIPPOCAMPUS; OUT MICE; SULFATE	Pregnenolone belongs to a class of endogenous neurosteroids in the central nervous system (CNS), which has been suggested to enhance cognitive functions through GABA(A) receptor signaling by its metabolites. It has been shown that the level of pregnenolone is altered in certain brain areas of schizophrenic patients, and clozapine enhances pregnenolone in the CNS in rats, suggesting that pregnenolone could be used to treat certain symptoms of schizophrenia. In addition, early phase proof-of-concept clinical trials have indicated that pregnenolone is effective in reducing the negative symptoms and cognitive deficits of schizophrenia patients. Here, we evaluate the actions of pregnenolone on a mouse model for schizophrenia, the dopamine transporter knockout mouse (DAT KO). DAT KO mice mirror certain symptoms evident in patients with schizophrenia, such as the psychomotor agitation, stereotypy, deficits of prepulse inhibition and cognitive impairments. Following acute treatment, pregnenolone was found to reduce the hyperlocomotion, stereotypic bouts and pre-pulse inhibition (PPI) deficits in DAT KO mice in a dose-dependent manner. At 60 mg/kg of pregnenolone, there were no significant differences in locomotor activities and stereotypy between wild-type and DAT KO mice. Similarly, acute treatment of 60 mg/kg of pregnenolone fully rescued PPI deficits of DAT KO mice. Following chronic treatment with pregnenolone at 60 mg/kg, the cognitive deficits of DAT KO mice were rescued in the paradigms of novel object recognition test and social transmission of food preference test. Pregnenolone thus holds promise as a therapeutic candidate in schizophrenia.	[Wong, Peiyan; Chang, Cecilia Chin Roei; Zhang, Xiaodong] Duke NUS Grad Med Sch Singapore, Neurosci & Behav Disorders Program, Singapore, Singapore; [Marx, Christine E.] Durham VA Med Ctr, Dept Vet Affairs, Durham, NC USA; [Marx, Christine E.; Wetsel, William C.; Zhang, Xiaodong] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Caron, Marc G.; Wetsel, William C.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.; Wetsel, William C.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Zhang, Xiaodong] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore	National University of Singapore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University; Duke University; National University of Singapore	Zhang, XD (corresponding author), Duke NUS Grad Med Sch Singapore, Neurosci & Behav Disorders Program, Singapore, Singapore.	xiaodong.zhang@duke-nus.edu.sg		Wong, Peiyan/0000-0003-3734-2461	Singapore National Medical Research Council Translational and Clinical Research Program [NMRC/TCR/003-GMS/2008]; Singapore Biomedical Research Council [09-MayJGC-139]; Duke-NUS Block Funding	Singapore National Medical Research Council Translational and Clinical Research Program(National Medical Research Council, Singapore); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Duke-NUS Block Funding	This research was supported in part by grants from Singapore National Medical Research Council Translational and Clinical Research Program NMRC/TCR/003-GMS/2008 (X.Z., M.G.C., W.C.W.), Singapore Biomedical Research Council 09-MayJGC-139 (X.Z.), and Duke-NUS Block Funding (X.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akwa Y, 2001, P NATL ACAD SCI USA, V98, P14033, DOI 10.1073/pnas.241503698; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Bernardi F, 2000, EUR J ENDOCRINOL, V142, P466, DOI 10.1530/eje.0.1420466; Buchanan RW, 2006, AM J PSYCHIAT, V163, P1867, DOI 10.1176/appi.ajp.163.11.1867; Buchanan RW, 2005, AM J PSYCHIAT, V162, P124, DOI 10.1176/appi.ajp.162.1.124; Carlsson A, 2001, ANNU REV PHARMACOL, V41, P237, DOI 10.1146/annurev.pharmtox.41.1.237; Compagnone NA, 1998, P NATL ACAD SCI USA, V95, P4678, DOI 10.1073/pnas.95.8.4678; Darbra S, 2011, BEHAV BRAIN RES, V216, P705, DOI 10.1016/j.bbr.2010.09.018; Darnaudery M, 2000, BRAIN RES, V852, P173, DOI 10.1016/S0006-8993(99)01964-2; Dong E, 2001, P NATL ACAD SCI USA, V98, P2849, DOI 10.1073/pnas.051628598; Ducharme N, 2010, EUR J PHARMACOL, V641, P128, DOI 10.1016/j.ejphar.2010.05.033; Dzirasa K, 2009, J NEUROSCI, V29, P8215, DOI 10.1523/JNEUROSCI.1773-09.2009; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Eser D, 2008, CURR PHARM DESIGN, V14, P3525, DOI 10.2174/138161208786848838; FARR SA, 1995, PHYSIOL BEHAV, V58, P715, DOI 10.1016/0031-9384(95)00124-2; FLOOD DG, 1991, BRAIN RES, V540, P83, DOI 10.1016/0006-8993(91)90494-G; FLOOD JF, 1988, BRAIN RES, V447, P269, DOI 10.1016/0006-8993(88)91129-8; FLOOD JF, 1995, P NATL ACAD SCI USA, V92, P10806, DOI 10.1073/pnas.92.23.10806; FLOOD JF, 1992, P NATL ACAD SCI USA, V89, P1567, DOI 10.1073/pnas.89.5.1567; Frye CA, 2010, BEHAV BRAIN RES, V209, P59, DOI 10.1016/j.bbr.2010.01.015; Gainetdinov RR, 1999, BIOL PSYCHIAT, V46, P303, DOI 10.1016/S0006-3223(99)00122-5; Gainetdinov RR, 2001, P NATL ACAD SCI USA, V98, P11047, DOI 10.1073/pnas.191353298; Gainetdinov RR, 2001, TRENDS NEUROSCI, V24, P527, DOI 10.1016/S0166-2236(00)01886-5; GEORGE MS, 1994, BIOL PSYCHIAT, V35, P775, DOI 10.1016/0006-3223(94)91139-8; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gonzalez-Burgos G, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/723184; Green MF, 2006, J CLIN PSYCHIAT, V67, P3, DOI 10.4088/JCP.1006e12; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Harvey PD, 2004, J CLIN PSYCHIAT, V65, P361; Hashimoto K, 2012, PROG NEUROBIOL; Hashimoto K, 2007, NEUROPSYCHOPHARMACOL, V32, P514, DOI 10.1038/sj.npp.1301047; ISAACSON RL, 1994, BEHAV NEURAL BIOL, V61, P170, DOI 10.1016/S0163-1047(05)80071-8; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; Kirkpatrick B, 2006, SCHIZOPHRENIA BULL, V32, P246, DOI 10.1093/schbul/sbj054; Li BJ, 2010, EUR J PHARMACOL, V628, P104, DOI 10.1016/j.ejphar.2009.11.036; Marder Stephen R, 2006, J Clin Psychiatry, V67, pe03; Marx CE, 2011, NEUROSCIENCE, V191, P78, DOI 10.1016/j.neuroscience.2011.06.076; Marx CE, 2006, PHARMACOL BIOCHEM BE, V84, P598, DOI 10.1016/j.pbb.2006.07.026; Marx CE, 2006, PHARMACOL BIOCHEM BE, V84, P609, DOI 10.1016/j.pbb.2006.07.032; Marx CE, 2006, NEUROPSYCHOPHARMACOL, V31, P1249, DOI 10.1038/sj.npp.1300952; Marx CE, 2006, BIOL PSYCHIAT, V60, P1287, DOI 10.1016/j.biopsych.2006.06.017; Marx CE, 2009, NEUROPSYCHOPHARMACOL, V34, P1885, DOI 10.1038/npp.2009.26; MATHIS C, 1994, PSYCHOPHARMACOLOGY, V116, P201, DOI 10.1007/BF02245063; Mathis C, 1996, NEUROPHARMACOLOGY, V35, P1057, DOI 10.1016/S0028-3908(96)00041-X; Meyer DA, 2002, J BIOL CHEM, V277, P28725, DOI 10.1074/jbc.M202592200; Modol L, 2011, BEHAV BRAIN RES, V222, P223, DOI 10.1016/j.bbr.2011.03.058; Morice E, 2007, NEUROPSYCHOPHARMACOL, V32, P2108, DOI 10.1038/sj.npp.1301354; Moriguchi S, 2011, J NEUROCHEM, V117, P879, DOI 10.1111/j.1471-4159.2011.07256.x; MORLEY JE, 1984, PHYSIOL BEHAV, V33, P237, DOI 10.1016/0031-9384(84)90105-7; MORROW AL, 1987, EUR J PHARMACOL, V142, P483, DOI 10.1016/0014-2999(87)90094-X; Pillai-Nair N, 2005, J NEUROSCI, V25, P4659, DOI 10.1523/JNEUROSCI.0565-05.2005; Pogorelov VM, 2005, NEUROPSYCHOPHARMACOL, V30, P1818, DOI 10.1038/sj.npp.1300724; Porton B, 2010, GENES BRAIN BEHAV, V9, P257, DOI 10.1111/j.1601-183X.2009.00555.x; Powell SB, 2008, BEHAV PHARMACOL, V19, P562, DOI 10.1097/FBP.0b013e32830dc110; PURDY RH, 1990, J MED CHEM, V33, P1572, DOI 10.1021/jm00168a008; Ralph RJ, 2001, J NEUROSCI, V21, P305, DOI 10.1523/JNEUROSCI.21-01-00305.2001; Ritsner M, 2007, EUR NEUROPSYCHOPHARM, V17, P358, DOI 10.1016/j.euroneuro.2006.10.001; Ritsner MS, 2010, J CLIN PSYCHIAT, V71, P1351, DOI 10.4088/JCP.09m05031yel; Rodriguiz RM, 2008, GENES BRAIN BEHAV, V7, P418, DOI 10.1111/j.1601-183X.2007.00365.x; Rodriguiz RM, 2004, BEHAV BRAIN RES, V148, P185, DOI 10.1016/S0166-4328(03)00187-6; Romeo E, 1998, AM J PSYCHIAT, V155, P910, DOI 10.1176/ajp.155.7.910; ROMEO E, 1994, J PHARMACOL EXP THER, V270, P89; Sliwinski A, 2004, J NEUROSCI RES, V78, P691, DOI 10.1002/jnr.20332; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Uzunova V, 1998, P NATL ACAD SCI USA, V95, P3239, DOI 10.1073/pnas.95.6.3239; Vallee M, 2001, BRAIN RES REV, V37, P301, DOI 10.1016/S0165-0173(01)00135-7; Vallee M, 1997, P NATL ACAD SCI USA, V94, P14865, DOI 10.1073/pnas.94.26.14865; Weill-Engerer S, 2002, J CLIN ENDOCR METAB, V87, P5138, DOI 10.1210/jc.2002-020878; Whittaker MT, 2008, J NEUROCHEM, V107, P510, DOI 10.1111/j.1471-4159.2008.05627.x; Zheng P, 2009, PROG NEUROBIOL, V89, P134, DOI 10.1016/j.pneurobio.2009.07.001	70	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51455	10.1371/journal.pone.0051455	http://dx.doi.org/10.1371/journal.pone.0051455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240026	gold, Green Published, Green Submitted			2022-12-27	WOS:000312290800062
J	Zamora, E; Lupon, J; de Antonio, M; Vila, J; Galan, A; Gastelurrutia, P; Urrutia, A; Bayes-Genis, A				Zamora, Elisabet; Lupon, Josep; de Antonio, Marta; Vila, Joan; Galan, Amparo; Gastelurrutia, Paloma; Urrutia, Agustin; Bayes-Genis, Antoni			Limited Value of Cystatin-C over Estimated Glomerular Filtration Rate for Heart Failure Risk Stratification	PLOS ONE			English	Article							RENAL-FUNCTION; CARDIOVASCULAR EVENTS; DYSFUNCTION; PROGNOSIS; DEATH; INSUFFICIENCY; PREDICTION; CREATININE; MORTALITY; DISEASE	Background: To compare the prognostic value of estimated glomerular filtration rate, cystatin-C, an alternative renal biomarker, and their combination, in an outpatient population with heart failure. Estimated glomerular filtration rate is routinely used to assess renal function in heart failure patients. We recently demonstrated that the Cockroft-Gault formula is the best among the most commonly used estimated glomerular filtration rate formulas for predicting heart failure prognosis. Methodology/Principal Findings: A total of 879 consecutive patients (72% men, age 70.4 years [P25-75 60.5-77.2]) were studied. The etiology of heart failure was mainly ischemic heart disease (52.7%). The left ventricular ejection fraction was 34% (P25-75 26-43%). Most patients were New York Heart Association class II (65.8%) or III (25.9%). During a median follow-up of 3.46 years (P25-75 1.85-5.05), 312 deaths were recorded. In an adjusted model, estimated glomerular filtration rate and cystatin-C showed similar prognostic value according to the area under the curve (0.763 and 0.765, respectively). In Cox regression, the multivariable analysis hazard ratios were 0.99 (95% CI: 0.98-1, P=0.006) and 1.14 (95% CI: 1.02-1.28, P=0.02) for estimated glomerular filtration rate and cystatin-C, respectively. Reclassification, assessed by the integration discrimination improvement and the net reclassification improvement indices, was poorer with cystatin-C (-0.5 [-1.0; -0.1], P=0.024 and -4.9 [-8.8; -1.0], P=0.013, respectively). The value of cystatin-C over estimated glomerular filtration rate for risk-stratification only emerged in patients with moderate renal dysfunction (eGFR 30-60 ml/min/1.73 m(2), chi-square 12.9, P<0.001). Conclusions/Significance: Taken together, the results indicate that estimated glomerular filtration rate and cystatin-C have similar long-term predictive values in a real-life ambulatory heart failure population. Cystatin-C seems to offer improved prognostication in heart failure patients with moderate renal dysfunction.	[Zamora, Elisabet; Lupon, Josep; de Antonio, Marta; Gastelurrutia, Paloma; Urrutia, Agustin; Bayes-Genis, Antoni] Hosp Badalona Germans Trias & Pujol, Heart Failure Unit, Badalona, Spain; [Zamora, Elisabet; Lupon, Josep; de Antonio, Marta; Urrutia, Agustin; Bayes-Genis, Antoni] Autonomous Univ Barcelona, Dept Med, Barcelona, Spain; [Vila, Joan] IMIM Hosp Mar Res Inst, Inflammatory & Cardiovasc Dis Programme, Barcelona, Spain; [Vila, Joan] CIBER Epidemiol & Publ Hlth, Barcelona, Spain; [Galan, Amparo] Hosp Badalona Germans Trias & Pujol, Serv Biochem, Badalona, Spain	Hospital Germans Trias i Pujol; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Germans Trias i Pujol	Bayes-Genis, A (corresponding author), Hosp Badalona Germans Trias & Pujol, Heart Failure Unit, Badalona, Spain.	abayesgenis@gmail.com	de A F, Marta/AAL-3341-2020; Bayes-Genis, Antoni/C-4002-2015; Bayes-Genis, Antonio/AAV-9422-2021	de A F, Marta/0000-0002-4319-797X; Bayes-Genis, Antoni/0000-0002-3044-197X; Bayes-Genis, Antonio/0000-0002-3044-197X; Zamora, Elisabet/0000-0001-5317-7481; Vila-Domenech, Joan Salvador/0000-0002-0413-9291; Lupon, Josep/0000-0002-3981-3020; Lupon, Josep/0000-0002-5601-9611; Gastelurrutia, Paloma/0000-0001-6974-9210	Catalan Society of Cardiology (Barcelona, Spain)	Catalan Society of Cardiology (Barcelona, Spain)	Cystatin-C assays were provided by Radim Iberica (Barcelona, Spain) which had no role in the design of the study or the collection, management, analysis, interpretation or writing of the data. Dr. M. de Antonio received a competitive research grant from the Catalan Society of Cardiology (Barcelona, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto T, 2005, J CARD FAIL, V11, P595, DOI 10.1016/j.cardfail.2005.06.001; Bayes-Genis A, 2012, EUR J HEART FAIL, V14, P32, DOI 10.1093/eurjhf/hfr156; Cheng XW, 2006, HYPERTENSION, V48, P979, DOI 10.1161/01.HYP.0000242331.99369.2f; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coll E, 2000, AM J KIDNEY DIS, V36, P29, DOI 10.1053/ajkd.2000.8237; Damman K, 2012, HEART, V98, P319, DOI 10.1136/heartjnl-2011-300692; De Santo NG, 2005, SEMIN NEPHROL, V25, P404, DOI 10.1016/j.semnephrol.2005.05.010; de Silva R, 2006, EUR HEART J, V27, P569, DOI 10.1093/eurheartj/ehi696; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gao CL, 2011, ARCH CARDIOVASC DIS, V104, P565, DOI 10.1016/j.acvd.2011.08.003; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hoek FJ, 2003, NEPHROL DIAL TRANSPL, V18, P2024, DOI 10.1093/ndt/gfg349; Ix JH, 2007, CIRCULATION, V115, P173, DOI 10.1161/CIRCULATIONAHA.106.644286; Ix JH, 2006, J CARD FAIL, V12, P601, DOI 10.1016/j.cardfail.2006.07.005; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Lassus J, 2007, EUR HEART J, V28, P1841, DOI 10.1093/eurheartj/ehl507; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2000, J AM SOC NEPHROL, V11, p155A; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; McClellan WM, 2002, J AM SOC NEPHROL, V13, P1928, DOI 10.1097/01.ASN.0000018409.45834.FA; McMurray MD, 2009, CIRC-HEART FAIL, V2, P86, DOI 10.1161/CIRCHEARTFAILURE.109.856393; Naruse H, 2009, AM J MED, V122, P566, DOI 10.1016/j.amjmed.2008.10.042; O'Riordan SE, 2003, ANN CLIN BIOCHEM, V40, P648, DOI 10.1258/000456303770367243; Odden MC, 2010, NEPHROL DIAL TRANSPL, V25, P463, DOI 10.1093/ndt/gfp474; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Shlipak MG, 2005, J AM COLL CARDIOL, V45, P268, DOI 10.1016/j.jacc.2004.09.061; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Smith GL, 2006, J AM COLL CARDIOL, V47, P1987, DOI 10.1016/j.jacc.2005.11.084; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; Waheed S, 2012, AM J KIDNEY DIS, V24; Zamora E, 2012, J AM COLL CARDIOL, V59, P1709, DOI 10.1016/j.jacc.2011.11.066	32	9	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51234	10.1371/journal.pone.0051234	http://dx.doi.org/10.1371/journal.pone.0051234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240006	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800042
J	Sun, DF; Sun, GL				Sun, Dongfa; Sun, Genlou			Untangling Nucleotide Diversity and Evolution of the H Genome in Polyploid Hordeum and Elymus Species Based on the Single Copy of Nuclear Gene DMC1	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; RECURRENT FORMATION; RPB2 GENE; ADH LOCI; ORIGIN; POACEAE; WHEAT; DIFFERENTIATION; INTROGRESSION; POLYMORPHISM	Numerous hybrid and polypoid species are found within the Triticeae. It has been suggested that the H subgenome of allopolyploid Elymus (wheatgrass) species originated from diploid Hordeum (barley) species, but the role of hybridization between polyploid Elymus and Hordeum has not been studied. It is not clear whether gene flow across polyploid Hordeum and Elymus species has occurred following polyploid speciation. Answering these questions will provide new insights into the formation of these polyploid species, and the potential role of gene flow among polyploid species during polyploid evolution. In order to address these questions, disrupted meiotic cDNA1 (DMC1) data from the allopolyploid StH Elymus are analyzed together with diploid and polyploid Hordeum species. Phylogenetic analysis revealed that the H copies of DMC1 sequence in some Elymus are very close to the H copies of DMC1 sequence in some polyploid Hordeum species, indicating either that the H genome in theses Elymus and polyploid Hordeum species originated from same diploid donor or that gene flow has occurred among them. Our analysis also suggested that the H genomes in Elymus species originated from limited gene pool, while H genomes in Hordeum polyploids have originated from broad gene pools. Nucleotide diversity (pi) of the DMC1 sequences on H genome from polyploid species (pi = 0.02083 in Elymus, pi = 0.01680 in polyploid Hordeum) is higher than that in diploid Hordeum (pi = 0.01488). The estimates of Tajima's D were significantly departure from the equilibrium neutral model at this locus in diploid Hordeum species (P<0.05), suggesting an excess of rare variants in diploid species which may not contribute to the origination of polyploids. Nucleotide diversity (pi) of the DMC1 sequences in Elymus polyploid species (pi = 0.02083) is higher than that in polyploid Hordeum (pi = 0.01680), suggesting that the degree of relationships between two parents of a polyploid might be a factor affecting nucleotide diversity in allopolyploids.	[Sun, Dongfa; Sun, Genlou] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Huazhong Agricultural University; Saint Marys University - Canada	Sun, GL (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	genlou.sun@smu.ca			Natural Sciences and Engineering Research Council of Canada [238425]; Canadian Foundation for Innovation; Saint Mary's University; earmarked fund for China Agriculture Research System	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Saint Mary's University; earmarked fund for China Agriculture Research System	This research was supported by a discovery grant (238425) from Natural Sciences and Engineering Research Council of Canada, Canadian Foundation for Innovation, and a Senate research grant at Saint Mary's University to GS, and the earmarked fund for China Agriculture Research System to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Barrier M, 2001, P NATL ACAD SCI USA, V98, P10208, DOI 10.1073/pnas.181257698; BAUM BR, 1991, CAN J BOT, V69, P2421, DOI 10.1139/b91-300; Blattner FR, 2004, MOL PHYLOGENET EVOL, V33, P289, DOI 10.1016/j.ympev.2004.05.012; Bothmer R. von, 1986, Canadian Journal of Genetics and Cytology, V28, P525; Bothmer von R, 1987, EVOL TREND PLANT, V1, P42; BROCHMANN C, 1992, PLANT SYST EVOL, V182, P35, DOI 10.1007/BF00941414; Caldwell KS, 2004, GENETICS, V167, P941, DOI 10.1534/genetics.103.016303; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; DEWEY D R, 1984, P209; DOEBLEY J, 1992, AM J BOT, V79, P576, DOI 10.2307/2444870; Dvorak J, 2006, MOL BIOL EVOL, V23, P1386, DOI 10.1093/molbev/msl004; Espinoza NR, 2002, J HERED, V93, P81, DOI 10.1093/jhered/93.2.81; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FU YX, 1993, GENETICS, V133, P693; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; JAASKA V, 1992, HEREDITAS, V117, P11, DOI 10.1111/j.1601-5223.1992.tb00002.x; JORGENSEN RB, 1986, HEREDITAS, V104, P273, DOI 10.1111/j.1601-5223.1986.tb00541.x; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lawton-Rauh A, 2003, MOL ECOL, V12, P1301, DOI 10.1046/j.1365-294X.2003.01814.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lihova J, 2006, MOL PHYLOGENET EVOL, V39, P759, DOI 10.1016/j.ympev.2006.01.027; LINDELAURSEN I, 1994, PLANT SYST EVOL, V192, P165, DOI 10.1007/BF00986250; Love A., 1984, Feddes Repertorium, V95, P425; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; Mahelka V, 2010, MOL BIOL EVOL, V27, P1370, DOI 10.1093/molbev/msq021; Mason-Gamer RJ, 2004, SYST BIOL, V53, P25, DOI 10.1080/10635150490424402; Mason-Gamer RJ, 2008, MOL PHYLOGENET EVOL, V47, P598, DOI 10.1016/j.ympev.2008.02.008; Mason-Gamer RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010989; Nishikawa T, 2002, GENOME, V45, P1157, DOI [10.1139/g02-088, 10.1139/G02-088]; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Petersen G, 2000, MOL BIOL EVOL, V17, P1589, DOI 10.1093/oxfordjournals.molbev.a026258; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Petersen G, 2004, SYST BOT, V29, P862, DOI 10.1600/0363644042451080; Petersen G, 2003, SYST BOT, V28, P293; RAJHATHY T, 1966, CAN J BOTANY, V44, P1224, DOI 10.1139/b66-135; Sha LN, 2010, MOL PHYLOGENET EVOL, V54, P327, DOI 10.1016/j.ympev.2009.05.005; Slotte T, 2008, MOL BIOL EVOL, V25, P1472, DOI 10.1093/molbev/msn092; Small RL, 1999, MOL BIOL EVOL, V16, P491, DOI 10.1093/oxfordjournals.molbev.a026131; Small RL, 2002, MOL BIOL EVOL, V19, P597, DOI 10.1093/oxfordjournals.molbev.a004119; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; SOLTIS DE, 1993, CRIT REV PLANT SCI, V12, P243, DOI 10.1080/713608048; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Sun GL, 2008, MOL PHYLOGENET EVOL, V46, P897, DOI 10.1016/j.ympev.2007.12.024; Sun GL, 2007, PLANT MOL BIOL, V64, P645, DOI 10.1007/s11103-007-9183-6; Sun GL, 2011, GENOME, V54, P655, DOI [10.1139/G11-036, 10.1139/g11-036]; Sun G, 2010, MOL PHYLOGENET EVOL, V56, P727, DOI 10.1016/j.ympev.2010.03.037; Sun G, 2009, BREEDING SCI, V59, P487, DOI 10.1270/jsbbs.59.487; Sun GL, 1997, GENOME, V40, P806, DOI 10.1139/g97-804; SVITASHEV S, 1994, THEOR APPL GENET, V89, P801, DOI 10.1007/BF00224500; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Symonds VV, 2010, EVOLUTION, V64, P1984, DOI [10.1111/j.1558-5646.2010.00978-x, 10.1111/j.1558-5646.2010.00978.x]; TAJIMA F, 1989, GENETICS, V123, P585; Taketa S, 2005, ANN BOT-LONDON, V96, P23, DOI 10.1093/aob/mci147; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trewick SA, 2002, MOL ECOL, V11, P2003, DOI 10.1046/j.1365-294X.2002.01583.x; Vanichanon A, 2003, THEOR APPL GENET, V106, P804, DOI 10.1007/s00122-002-1092-0; von Bothmer R., 1994, P 2 INT TRIT S UT ST, P1; Wang H, 2011, BOTANY, V89, P405, DOI [10.1139/B11-030, 10.1139/b11-030]; WANG RRC, 1986, CAN J GENET CYTOL, V28, P947, DOI 10.1139/g86-132; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Zwickl D. J, 2006, GENETIC ALGORITHM AP	65	9	10	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50369	10.1371/journal.pone.0050369	http://dx.doi.org/10.1371/journal.pone.0050369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251367	Green Submitted, Green Published, gold			2022-12-27	WOS:000312201900011
J	Thelen, K; Jaehrling, S; Spatz, JP; Pollerberg, GE				Thelen, Karsten; Jaehrling, Steffen; Spatz, Joachim P.; Pollerberg, G. Elisabeth			Depending on Its Nano-Spacing, ALCAM Promotes Cell Attachment and Axon Growth	PLOS ONE			English	Article							MOLECULE DM-GRASP; ADHESION MOLECULE; IMMUNOGLOBULIN SUPERFAMILY; GANGLION-CELLS; MESSENGER-RNA; PROTEIN; EXPRESSION; NEURONS; BEN; NANOPATTERNS	ALCAM is a member of the cell adhesion molecule (CAM) family which plays an important role during nervous system formation. We here show that the two neuron populations of developing dorsal root ganglia (DRG) display ALCAM transiently on centrally and peripherally projecting axons during the two phases of axon outgrowth. To analyze the impact of ALCAM on cell adhesion and axon growth, DRG single cells were cultured on ALCAM-coated coverslips or on nanopatterns where ALCAM is presented in physiological amino-carboxyl terminal orientation at highly defined distances (29, 54, 70, 86, and 137 nm) and where the interspaces are passivated to prevent unspecific protein deposition. Some axonal features (branching, lateral deviation) showed density dependence whereas others (number of axons per neuron, various axon growth parameters) turned out to be an all-or-nothing reaction. Time-lapse analyses revealed that ALCAM density has an impact on axon velocity and advance efficiency. The behavior of the sensory axon tip, the growth cone, partially depended on ALCAM density in a dose-response fashion (shape, dynamics, detachment) while other features did not (size, complexity). Whereas axon growth was equally promoted whether ALCAM was presented at high (29 nm) or low densities (86 nm), the attachment of non-neuronal cells depended on high ALCAM densities. The attachment of non-neuronal cells to the rather unspecific standard proteins presented by conventional implants designed to enhance axonal regeneration is a severe problem. Our findings point to ALCAM, presented as 86 nm pattern, for a promising candidate for the improvement of such implants since this pattern drives axon growth to its full extent while at the same time non-neuronal cell attachment is clearly reduced.	[Thelen, Karsten; Jaehrling, Steffen; Pollerberg, G. Elisabeth] Heidelberg Univ, Dept Dev Neurobiol, Ctr Organismal Studies, Heidelberg, Germany; [Spatz, Joachim P.] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Spatz, Joachim P.] Heidelberg Univ, Dept Biophys Chem, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Ruprecht Karls University Heidelberg	Pollerberg, GE (corresponding author), Heidelberg Univ, Dept Dev Neurobiol, Ctr Organismal Studies, Heidelberg, Germany.	G.E.Pollerberg@cos.uni-heidelberg.de	Spatz, Joachim P/A-1107-2017	Spatz, Joachim P/0000-0003-3419-9807	German Research Council (DFG) [GK791, PO289, SFB488]	German Research Council (DFG)(German Research Foundation (DFG))	The project is funded by the German Research Council (DFG; GK791, PO289 and SFB488). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Avci HX, 2004, DEV BIOL, V271, P291, DOI 10.1016/j.ydbio.2004.03.035; Blummel J, 2007, BIOMATERIALS, V28, P4739, DOI 10.1016/j.biomaterials.2007.07.038; Buhusi M, 2009, J NEUROSCI, V29, P15630, DOI 10.1523/JNEUROSCI.2215-09.2009; BURNS FR, 1991, NEURON, V7, P209, DOI 10.1016/0896-6273(91)90259-3; Chedotal A, 1996, J NEUROSCI, V16, P3296; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; De Jonge F, 2004, AM J PHYSIOL-GASTR L, V287, pG178, DOI 10.1152/ajpgi.00528.2003; DEBERNARDO AP, 1995, DEV BIOL, V169, P65, DOI 10.1006/dbio.1995.1127; DeBernardo AP, 1996, J CELL BIOL, V133, P657, DOI 10.1083/jcb.133.3.657; ELDEEB S, 1992, DEV BIOL, V149, P213, DOI 10.1016/0012-1606(92)90278-O; Franze K, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/9/094601; Glass R, 2003, NANOTECHNOLOGY, V14, P1153, DOI 10.1088/0957-4484/14/10/314; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; He Y, 2003, METHOD CELL BIOL, V71, P17, DOI 10.1016/S0091-679X(03)01002-1; Heffron DS, 2000, J NEUROSCI, V20, P2287; Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b; HYNES RO, 1986, SCI AM, V254, P42, DOI 10.1038/scientificamerican0686-42; Jaehrling S, 2009, NANO LETT, V9, P4115, DOI 10.1021/nl9023325; KAYYEM JF, 1992, J CELL BIOL, V118, P1259, DOI 10.1083/jcb.118.5.1259; Koester MP, 2007, J NEUROSCI, V27, P12590, DOI 10.1523/JNEUROSCI.2250-07.2007; Mack TGA, 2000, MOL CELL NEUROSCI, V15, P51, DOI 10.1006/mcne.1999.0802; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Panicker AK, 2003, FRONT BIOSCI, V8, pD900, DOI 10.2741/1014; POLLERBERG GE, 1994, DEV BIOL, V165, P670, DOI 10.1006/dbio.1994.1284; POLLERBERG GE, 1986, NATURE, V324, P462, DOI 10.1038/324462a0; POLLERBERG GE, 1993, DEV BIOL, V156, P324, DOI 10.1006/dbio.1993.1081; POURQUIE O, 1990, DEVELOPMENT, V109, P743; POURQUIE O, 1992, J NEUROSCI, V12, P1548; SARTHY PV, 1990, J CELL BIOL, V110, P2099, DOI 10.1083/jcb.110.6.2099; SENIOR PV, 1988, DEVELOPMENT, V104, P431; Stephan JP, 1999, DEV BIOL, V212, P264, DOI 10.1006/dbio.1999.9348; STOECKLI ET, 1989, EUR J BIOCHEM, V180, P249, DOI 10.1111/j.1432-1033.1989.tb14640.x; Swart GWM, 2002, EUR J CELL BIOL, V81, P313, DOI 10.1078/0171-9335-00256; TANAKA H, 1991, NEURON, V7, P535, DOI 10.1016/0896-6273(91)90366-8; Thelen K, 2007, SOFT MATTER, V3, P1486, DOI 10.1039/b707250c; Tinazli A, 2005, CHEM-EUR J, V11, P5249, DOI 10.1002/chem.200500154; van Kempen LCLT, 2001, J BIOL CHEM, V276, P25783, DOI 10.1074/jbc.M011272200; Wolfram T, 2007, BIOINTERPHASES, V2, P44, DOI 10.1116/1.2713991; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; Zelina P, 2005, DEVELOPMENT, V132, P3609, DOI 10.1242/dev.01934	42	14	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e40493	10.1371/journal.pone.0040493	http://dx.doi.org/10.1371/journal.pone.0040493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251325	gold, Green Submitted, Green Published			2022-12-27	WOS:000312201900001
J	Braithwaite, JE; Meeuwig, JJ; Jenner, KCS				Braithwaite, Janelle E.; Meeuwig, Jessica J.; Jenner, K. Curt S.			Estimating Cetacean Carrying Capacity Based on Spacing Behaviour	PLOS ONE			English	Article							ABUNDANCE-OCCUPANCY RELATIONSHIPS; HUMPBACK WHALES; DENSITY; RANGE; SIZE; AGGRESSION; MIGRATION; SUMMER; BIRDS	Conservation of large ocean wildlife requires an understanding of how they use space. In Western Australia, the humpback whale (Megaptera novaeangliae) population is growing at a minimum rate of 10% per year. An important consideration for conservation based management in space-limited environments, such as coastal resting areas, is the potential expansion in area use by humpback whales if the carrying capacity of existing areas is exceeded. Here we determined the theoretical carrying capacity of a known humpback resting area based on the spacing behaviour of pods, where a resting area is defined as a sheltered embayment along the coast. Two separate approaches were taken to estimate this distance. The first used the median nearest neighbour distance between pods in relatively dense areas, giving a spacing distance of 2.16 km (60.94). The second estimated the spacing distance as the radius at which 50% of the population included no other pods, and was calculated as 1.93 km (range: 1.62-2.50 km). Using these values, the maximum number of pods able to fit into the resting area was 698 and 872 pods, respectively. Given an average observed pod size of 1.7 whales, this equates to a carrying capacity estimate of between 1187 and 1482 whales at any given point in time. This study demonstrates that whale pods do maintain a distance from each other, which may determine the number of animals that can occupy aggregation areas where space is limited. This requirement for space has implications when considering boundaries for protected areas or competition for space with the fishing and resources sectors.	[Braithwaite, Janelle E.; Meeuwig, Jessica J.] Univ Western Australia, Fac Nat & Agr Sci, Ctr Marine Futures, UWA Oceans Inst, Perth, WA 6009, Australia; [Jenner, K. Curt S.] Ctr Whale Res, Fremantle, WA, Australia; [Braithwaite, Janelle E.; Meeuwig, Jessica J.] Univ Western Australia, Fac Nat & Agr Sci, Sch Anim Biol, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia	Braithwaite, JE (corresponding author), Univ Western Australia, Fac Nat & Agr Sci, Ctr Marine Futures, UWA Oceans Inst, Perth, WA 6009, Australia.	janelle.braithwaite@uwa.edu.au		Meeuwig, Jessica/0000-0003-1169-8785	Straits Resources grant	Straits Resources grant	Funding for data collection was provided for by a Straits Resources grant awarded to the Centre for Whale Research, WA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO JC, 1994, J APPL ECOL, V31, P212, DOI 10.2307/2404537; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; Armstrong JD, 2001, J FISH BIOL, V58, P1524, DOI 10.1006/jfbi.2001.1554; BAKER CS, 1985, MAR MAMMAL SCI, V1, P304, DOI 10.1111/j.1748-7692.1985.tb00018.x; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Beck JL, 2006, J WILDLIFE MANAGE, V70, P283, DOI 10.2193/0022-541X(2006)70[283:EOESRN]2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Buckland S.T., 2001, pi; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Chittleborough R. G., 1953, Australian Journal of Marine and Freshwater Research, V4, P219; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Clubb R, 2007, APPL ANIM BEHAV SCI, V102, P303, DOI 10.1016/j.applanim.2006.05.033; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Cowlishaw G, 1999, BEHAV ECOL SOCIOBIOL, V45, P67, DOI 10.1007/s002650050540; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Dawbin W.H., 1966, WHALES DOLPHINS PORP, P145; DAWKINS MS, 1989, BRIT POULTRY SCI, V30, P413, DOI 10.1080/00071668908417163; Dunlop RA, 2010, P ROY SOC B-BIOL SCI, V277, P2521, DOI 10.1098/rspb.2009.2319; Fisher JAD, 2004, MAR ECOL PROG SER, V279, P201, DOI 10.3354/meps279201; Frost MT, 2004, ECOGRAPHY, V27, P643; Gaston KJ, 1997, ECOGRAPHY, V20, P569, DOI 10.1111/j.1600-0587.1997.tb00425.x; Gaston KJ, 1996, OIKOS, V76, P211, DOI 10.2307/3546192; Goss-Custard JD, 2002, BIOL CONSERV, V105, P27, DOI 10.1016/S0006-3207(01)00175-6; Goss-Custard JD, 2003, J APPL ECOL, V40, P176, DOI 10.1046/j.1365-2664.2003.00785.x; Hall K, 2010, J MAR BIOL ASSOC UK, V90, P1571, DOI 10.1017/S0025315410000263; Hedley SL, 2009, SC61SH23 INT WHAL CO; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; HOLM JC, 1990, AQUACULTURE, V89, P225, DOI 10.1016/0044-8486(90)90128-A; Jenner K.C.S., 2001, APPEA J, V38, p692?707, DOI DOI 10.1071/aj00044; Jenner KCS, 2010, EFFECTIVE MITIGATION; Jensen MB, 1998, APPL ANIM BEHAV SCI, V56, P97, DOI 10.1016/S0168-1591(97)00106-8; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Kent Chandra Salgado, 2012, Journal of Cetacean Research and Management, V12, P29; Krause J, 2002, LIVING GROUPS; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Leopold A., 1933, GAME MANAGEMENT; Li CW, 2007, GEN COMP ENDOCR, V151, P202, DOI 10.1016/j.ygcen.2007.01.014; McCauley R.D., 2000, APPEA J, V40, P692, DOI DOI 10.1071/AJ99048; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; Nicol C, 2007, J VET BEHAV, V2, P188, DOI 10.1016/j.jveb.2007.10.002; Noad MJ, 2005, ABSOLUTE RELATIVE AB; Petherick JC, 2009, APPL ANIM BEHAV SCI, V117, P1, DOI 10.1016/j.applanim.2008.09.008; Petherick JC, 2007, J VET BEHAV, V2, P197, DOI 10.1016/j.jveb.2007.10.001; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Redfern JV, 2006, MAR ECOL PROG SER, V310, P271, DOI 10.3354/meps310271; SILBER GK, 1986, CAN J ZOOL, V64, P2075, DOI 10.1139/z86-316; Steinhaus H., 1999, MATH SNAPSHOTS; TARRANT PV, 1988, MEAT SCI, V24, P209, DOI 10.1016/0309-1740(88)90079-4; Thomas L., 2009, DISTANCE 6 0 RELEASE; Tilman D., 1982, Monographs in Population Biology, pi; Tiwari M, 2010, MAR ECOL PROG SER, V419, P289, DOI 10.3354/meps08833; TRIPPEL EA, 1991, CAN J FISH AQUAT SCI, V48, P1446, DOI 10.1139/f91-172; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; Wedemeyer G.A., 1996, PHYSL FISH INTENSIVE; WEIL CS, 1952, BIOMETRICS, V8, P249, DOI 10.2307/3001557; Western D., 1975, E AFR WILDL J, V13, P265, DOI DOI 10.1111/J.1365-2028.1975.TB00139.X; Zerbini AN, 2010, MAR BIOL, V157, P1225, DOI 10.1007/s00227-010-1403-y	60	12	13	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51347	10.1371/journal.pone.0051347	http://dx.doi.org/10.1371/journal.pone.0051347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236479	gold, Green Published, Green Submitted			2022-12-27	WOS:000312064100101
J	Kaiser, DM; Acharya, M; Leighton, PLA; Wang, H; Daude, N; Wohlgemuth, S; Shi, BP; Allison, WT				Kaiser, Darcy M.; Acharya, Moulinath; Leighton, Patricia L. A.; Wang, Hao; Daude, Nathalie; Wohlgemuth, Serene; Shi, Beipei; Allison, W. Ted			Amyloid Beta Precursor Protein and Prion Protein Have a Conserved Interaction Affecting Cell Adhesion and CNS Development	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; A-BETA; EXPRESSION PATTERNS; SECRETASE CLEAVAGE; ZEBRAFISH; BINDING; GENES; APP; RNA; IDENTIFICATION	Genetic and biochemical mechanisms linking onset or progression of Alzheimer Disease and prion diseases have been lacking and/or controversial, and their etiologies are often considered independent. Here we document a novel, conserved and specific genetic interaction between the proteins that underlie these diseases, amyloid-beta precursor protein and prion protein, APP and PRP, respectively. Knockdown of APP and/or PRNP homologs in the zebrafish (appa, appb, prp1, and prp2) produces a dose-dependent phenotype characterized by systemic morphological defects, reduced cell adhesion and CNS cell death. This genetic interaction is surprisingly exclusive in that prp1 genetically interacts with zebrafish appa, but not with appb, and the zebrafish paralog prp2 fails to interact with appa. Intriguingly, appa & appb are largely redundant in early zebrafish development yet their abilities to rescue CNS cell death are differentially contingent on prp1 abundance. Delivery of human APP or mouse Prnp mRNAs rescue the phenotypes observed in app-prp-depleted zebrafish, highlighting the conserved nature of this interaction. Immunoprecipitation revealed that human APP and PrPC proteins can have a physical interaction. Our study reports a unique in vivo interdependence between APP and PRP loss-of-function, detailing a biochemical interaction that considerably expands the hypothesized roles of PRP in Alzheimer Disease.	[Kaiser, Darcy M.; Acharya, Moulinath; Leighton, Patricia L. A.; Daude, Nathalie; Wohlgemuth, Serene; Shi, Beipei; Allison, W. Ted] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Kaiser, Darcy M.; Acharya, Moulinath; Leighton, Patricia L. A.; Wang, Hao; Allison, W. Ted] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Allison, W. Ted] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Allison, WT (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.	ted.allison@ualberta.ca	Allison, W. Ted/A-2612-2014; Allison, W. Ted/K-5228-2012	Allison, W. Ted/0000-0002-8461-4864; Acharya, Moulinath/0000-0001-8013-7426; Wohlgemuth, Serene/0000-0001-7287-0935	Alberta Innovates Health Solutions; Canadian Institutes for Health Research; Alzheimer Society of Canada; Canadian Foundation for Innovation	Alberta Innovates Health Solutions; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Canada; Canadian Foundation for Innovation(Canada Foundation for Innovation)	Alberta Innovates Health Solutions (www.aihealthsolutions.ca) Studentships to DMK and PLAL, Canadian Institutes for Health Research (www.cihr-irsc.gc.ca) Studentship to DMK, and Annie Dakens Research Fund Doctoral Award from the Alzheimer Society of Canada (www.alzheimer.ca) to PLAL. Canadian Foundation for Innovation (www.innovation.ca) NIF grant to WTA and others (D. Westaway Principal Applicant) and LOF grant to WTA. Alzheimer Society of Canada (www.alzheimer.ca) "Great-West Life, London Life & Canada Life Young Investigators Award" to WTA, PrioNet Canada (www.prionetcanada.ca), a Networks of Centres of Excellence (www.nce-rce.gc.ca), and Alberta Prion Research Institute (www.prioninstitute.ca) to WTA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamar E, 2008, DEV BIOL, V318, P335, DOI 10.1016/j.ydbio.2008.03.040; Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Alier K, 2011, J NEUROSCI, V31, P16292, DOI 10.1523/JNEUROSCI.4367-11.2011; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Bertram L, 2008, CELL, V135, P993, DOI 10.1016/j.cell.2008.11.030; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Broytman O, 2009, NEUROBIOL AGING, V30, P1962, DOI 10.1016/j.neurobiolaging.2008.02.011; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Corley SM, 2008, BIOINFORM BIOL INSIG, V2, P383; Cotto E, 2005, FEBS J, V272, P500, DOI 10.1111/j.1742-4658.2004.04492.x; Dermaut B, 2003, ANN NEUROL, V53, P409, DOI 10.1002/ana.10507; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fleisch VC, 2011, BBA-MOL BASIS DIS, V1812, P364, DOI 10.1016/j.bbadis.2010.10.012; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Goggin K, 2008, BBA-MOL CELL RES, V1783, P479, DOI 10.1016/j.bbamcr.2007.10.008; Goguel V, 2011, J NEUROSCI, V31, P1032, DOI 10.1523/JNEUROSCI.2896-10.2011; Golanska E, 2009, J ALZHEIMERS DIS, V17, P359, DOI 10.3233/JAD-2009-1055; Gomes MPB, 2012, WIRES RNA, V3, P415, DOI 10.1002/wrna.118; Ravetti MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010153; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Griffiths HH, 2012, PRION, V6, P217, DOI 10.4161/pri.18988; Gunther EC, 2010, J MOL MED, V88, P331, DOI 10.1007/s00109-009-0568-7; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jellinger KA, 2009, J NEURAL TRANSM, V116, P1111, DOI 10.1007/s00702-009-0240-y; Joshi P, 2009, DEV BIOL, V335, P1, DOI 10.1016/j.ydbio.2009.07.041; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; King OD, 2012, BRAIN RES; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lewis V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031754; Liao HK, 2012, DEV DYNAM, V241, P415, DOI 10.1002/dvdy.23725; Malaga-Trillo E, 2009, PRION, V3, P129, DOI 10.4161/pri.3.3.9651; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Mange A, 2002, FEBS LETT, V514, P159, DOI 10.1016/S0014-5793(02)02338-4; Martins VR, 2010, CURR ISSUES MOL BIOL, V12, P63; Medina S, 2009, J TOXICOL ENV HEAL A, V72, P1075, DOI 10.1080/15287390903084561; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Musa A, 2001, DEV GENES EVOL, V211, P563, DOI 10.1007/s00427-001-0189-9; NARINDRASORASAK S, 1992, LAB INVEST, V67, P643; Neve RL, 2000, BRAIN RES, V886, P54, DOI 10.1016/S0006-8993(00)02869-9; Nicolas O, 2009, BRAIN RES REV, V61, P170, DOI 10.1016/j.brainresrev.2009.06.002; Nik SHM, 2012, J ALZHEIMERS DIS, V28, P515, DOI 10.3233/JAD-2011-110533; Nourizadeh-Lillabadi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013573; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Parkin ET, 2000, METH MOLEC MED, V32, P345, DOI 10.1385/1-59259-195-7:345; Perreau VM, 2010, PROTEOMICS, V10, P2377, DOI 10.1002/pmic.200900773; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Reiniger L, 2011, ACTA NEUROPATHOL, V121, P5, DOI 10.1007/s00401-010-0691-0; Riemenschneider M, 2004, NEUROBIOL AGING, V25, P1305, DOI 10.1016/j.neurobiolaging.2004.01.001; Robakis NK, 2011, NEUROBIOL AGING, V32, P372, DOI 10.1016/j.neurobiolaging.2010.05.022; Roucou X, 2009, FRONT BIOSCI-LANDMRK, V14, P5157, DOI 10.2741/3592; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Schwarze-Eicker KA, 2005, NEUROBIOL AGING, V26, P1177, DOI 10.1016/j.neurobiolaging.2004.10.004; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; Stevens JC, 2011, J NEUROL NEUROSUR PS, V82, P1054, DOI 10.1136/jnnp.2009.199653; Tamayev R, 2012, J NEUROSCI, V32, P5481, DOI 10.1523/JNEUROSCI.5193-11.2012; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Webb TEF, 2008, J NEUROPATH EXP NEUR, V67, P838, DOI 10.1097/NEN.0b013e318182f36e; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Yehiely F, 1997, NEUROBIOL DIS, V3, P339, DOI 10.1006/nbdi.1997.0130; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109	82	42	42	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51305	10.1371/journal.pone.0051305	http://dx.doi.org/10.1371/journal.pone.0051305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236467	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100091
J	Aravena, C; Beltran, AR; Cornejo, M; Torres, V; Diaz, ES; Guzman-Gutierrez, E; Pardo, F; Leiva, A; Sobrevia, L; Ramirez, MA				Aravena, Carmen; Beltran, Ana R.; Cornejo, Marcelo; Torres, Viviana; Diaz, Emilce S.; Guzman-Gutierrez, Enrique; Pardo, Fabian; Leiva, Andrea; Sobrevia, Luis; Ramirez, Marco A.			Potential Role of Sodium-Proton Exchangers in the Low Concentration Arsenic Trioxide-Increased Intracellular pH and Cell Proliferation	PLOS ONE			English	Article							EPITHELIAL DOME FORMATION; VEIN ENDOTHELIAL-CELLS; PROTEIN-KINASE-C; NA+/H+ EXCHANGER; CANCER CELLS; NHE3 EXPRESSION; DRINKING-WATER; SMOOTH-MUSCLE; DNA-SYNTHESIS; NITRIC-OXIDE	Arsenic main inorganic compound is arsenic trioxide (ATO) presented in solution mainly as arsenite. ATO increases intracellular pH (pHi), cell proliferation and tumor growth. Sodium-proton exchangers (NHEs) modulate the pHi, with NHE1 playing significant roles. Whether ATO-increased cell proliferation results from altered NHEs expression and activity is unknown. We hypothesize that ATO increases cell proliferation by altering pHi due to increased NHEs-like transport activity. Madin-Darby canine kidney (MDCK) cells grown in 5 mmol/L D-glucose-containing DMEM were exposed to ATO (0.05, 0.5 or 5 mu mol/L, 0-48 hours) in the absence or presence of 5-N, N-hexamethylene amiloride (HMA, 5-100 mu mol/L, NHEs inhibitor), PD-98059 (30 mu mol/L, MAPK1/2 inhibitor), Go6976 (10 mu mol/L, PKC alpha, beta I and mu inhibitor), or Schering 28080 (10 mu mol/L, H+/K(+)ATPase inhibitor) plus concanamycin (0.1 mu mol/L, V type ATPases inhibitor). Incorporation of [H-3]thymidine was used to estimate cell proliferation, and counting cells with a hemocytometer to determine the cell number. The pHi was measured by fluorometry in 2,7-bicarboxyethyl-5,6-carboxyfluorescein loaded cells. The Na+-dependent HMA-sensitive NHEs-like mediated proton transport kinetics, NHE1 protein abundance in the total, cytoplasm and plasma membrane protein fractions, and phosphorylated and total p42/44 mitogen-activated protein kinases (p42/44(mapk)) were also determined. Lowest ATO (0.05 mu mol/L, similar to 0.01 ppm) used in this study increased cell proliferation, pHi, NHEs-like transport and plasma membrane NHE1 protein abundance, effects blocked by HMA, PD-98059 or Go6976. Cell-buffering capacity did not change by ATO. The results show that a low ATO concentration increases MDCK cells proliferation by NHEs (probably NHE1)-like transport dependent-increased pHi requiring p42/44(mapk) and PKC alpha, beta I and/or mu activity. This finding could be crucial in diseases where uncontrolled cell growth occurs, such as tumor growth, and in circumstances where ATO, likely arsenite, is available at the drinking-water at these levels. Citation: Aravena C, Beltran AR, Cornejo M, Torres V, Diaz ES, et al. (2012) Potential Role of Sodium-Proton Exchangers in the Low Concentration Arsenic Trioxide-Increased Intracellular pH and Cell Proliferation. PLoS ONE 7(12): e51451. doi:10.1371/journal.pone.0051451	[Guzman-Gutierrez, Enrique; Pardo, Fabian; Leiva, Andrea; Sobrevia, Luis; Ramirez, Marco A.] Pontificia Univ Catolica Chile, Fac Med, Div Obstet & Gynecol, CMPL,Sch Med, Santiago, Chile; [Aravena, Carmen; Beltran, Ana R.; Cornejo, Marcelo; Diaz, Emilce S.; Ramirez, Marco A.] Univ Antofagasta, Fac Hlth Sci, Biomed Dept, Cellular Physiol Lab, Antofagasta, Chile; [Beltran, Ana R.] Univ Antofagasta, Dept Educ, Fac Educ, Antofagasta, Chile; [Torres, Viviana] Univ Concepcion, Fac Biol Sci, Adv Microscopy Ctr CMA Bio Bio, Concepcion, Chile	Pontificia Universidad Catolica de Chile; Universidad de Antofagasta; Universidad de Antofagasta; Universidad de Concepcion	Sobrevia, L (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Div Obstet & Gynecol, CMPL,Sch Med, Alameda 340, Santiago, Chile.	sobrevia@med.puc.cl; biomarco@uantof.cl	Sobrevia, Luis/H-9608-2016; Torres, Viviana/AAC-3329-2019; Cornejo Alaniz, Marcelo Alejandro/AGD-4851-2022; Guzman-Gutierrez, Enrique/H-3536-2016	Cornejo Alaniz, Marcelo Alejandro/0000-0002-1377-0149; Guzman-Gutierrez, Enrique/0000-0001-6589-5667; Sobrevia, Luis/0000-0001-5802-2243; Beltran Gonzalez, Ana Rosa/0000-0001-5068-2132	Direccion de Investigacion [DI-1339-07]; Vicerrectoria Academica, Universidad de Antofagasta (Chile); Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1110977, 11110059, 3130583]; Programa de Investigacion Interdisciplinario (PIA) from Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT) (Chile) [Anillos ACT-73]; CONICYT Ayuda de Tesis [CONICYT AT-24120944]	Direccion de Investigacion; Vicerrectoria Academica, Universidad de Antofagasta (Chile); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa de Investigacion Interdisciplinario (PIA) from Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT) (Chile); CONICYT Ayuda de Tesis	This research was supported by Direccion de Investigacion [DI-1339-07] and Vicerrectoria Academica, Universidad de Antofagasta (Chile), Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1110977, 11110059, 3130583], Programa de Investigacion Interdisciplinario (PIA) from Comision Nacional de Investigacion en Ciencia y Tecnologia (CONICYT) [Anillos ACT-73] (Chile) and CONICYT Ayuda de Tesis [CONICYT AT-24120944]. CA and EG-G hold CONICYT-PhD (Chile) fellowships. FP was the recipient of a postdoctoral position (CONICYT PIA Anillos ACT-73 postdoctoral research associate at CMPL, Pontificia Universidad Catolica de Chile). MC is a PhD student at Universidad de Antofagasta (Chile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RT, 2011, BIOCHEM CELL BIOL, V89, P85, DOI [10.1139/O10-159, 10.1139/o10-159]; Beltran AR, 2008, PFLUG ARCH EUR J PHY, V455, P799, DOI 10.1007/s00424-007-0333-0; Calvino E, 2011, BIOCHEM PHARMACOL, V82, P1619, DOI 10.1016/j.bcp.2011.08.017; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Cheung WMW, 2007, CANCER LETT, V246, P122, DOI 10.1016/j.canlet.2006.02.009; Chowdhury R, 2010, TOXICOL LETT, V198, P263, DOI 10.1016/j.toxlet.2010.07.006; Czepan M, 2012, PFLUG ARCH EUR J PHY, V463, P459, DOI 10.1007/s00424-011-1059-6; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Farias M, 2010, CARDIOVASC RES, V86, P45, DOI 10.1093/cvr/cvp410; Fernandez R, 1998, J MEMBRANE BIOL, V163, P137, DOI 10.1007/s002329900378; Gonzalez M, 2004, PFLUG ARCH EUR J PHY, V448, P383; Gumz ML, 2010, AM J PHYSIOL-RENAL, V298, pF12, DOI 10.1152/ajprenal.90723.2008; Harguindey S, 2005, BBA-REV CANCER, V1756, P1, DOI 10.1016/j.bbcan.2005.06.004; Hodges K, 2006, AM J PHYSIOL-GASTR L, V291, pG959, DOI 10.1152/ajpgi.00274.2005; Huang CY, 2011, J UROLOGY, V185, P2040, DOI 10.1016/j.juro.2011.01.079; Instituto Nacional de Normalizacion Gobierno de Chile, 1984, 4091OF84 I NAC NORM; Kang YH, 2008, J CELL PHYSIOL, V217, P23, DOI 10.1002/jcp.21470; Karki P, 2011, J BIOL CHEM, V286, P13096, DOI 10.1074/jbc.M110.165134; KEIZER HG, 1989, J NATL CANCER I, V81, P706, DOI 10.1093/jnci/81.9.706; Lagana A, 2000, J CELL SCI, V113, P3649; Lau ATY, 2004, CARCINOGENESIS, V25, P21, DOI 10.1093/carcin/bgg179; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Liu YH, 2010, J CELL BIOCHEM, V111, P1546, DOI 10.1002/jcb.22886; Malo ME, 2006, CAN J PHYSIOL PHARM, V84, P1081, DOI 10.1139/Y06-065; Marshall G, 2007, JNCI-J NATL CANCER I, V99, P920, DOI 10.1093/jnci/djm004; Ministerio de Salud Gobierno de Chile, 2012, PRIM INF REG POBL CA; Pan XY, 2006, BRIT J HAEMATOL, V134, P491, DOI 10.1111/j.1365-2141.2006.06224.x; Rich IN, 2000, BLOOD, V95, P1427, DOI 10.1182/blood.V95.4.1427.004k48_1427_1434; Rigor RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029210; Rios EJ, 2005, AM J PHYSIOL-LUNG C, V289, pL867, DOI 10.1152/ajplung.00455.2004; Rojas S, 2003, EXP PHYSIOL, V88, P209, DOI 10.1113/eph8802515; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Soucy NV, 2003, TOXICOL SCI, V76, P271, DOI 10.1093/toxsci/kfg231; Su HW, 2007, J BIOL CHEM, V282, P9883, DOI 10.1074/jbc.M606754200; Su HW, 2009, AM J PHYSIOL-CELL PH, V296, pC13, DOI 10.1152/ajpcell.00263.2008; Turturro F, 2004, CLIN CANCER RES, V10, P7022, DOI 10.1158/1078-0432.CCR-04-0879; Walker AM, 2010, INT J ENV RES PUB HE, V7, P1996, DOI 10.3390/ijerph7051996; Wang Y, 2009, UROL INT, V82, P214, DOI 10.1159/000200803; WHO, 2011, GUID DRINK WAT QUAL; Wu SJ, 2008, BIOCHEM BIOPH RES CO, V375, P384, DOI 10.1016/j.bbrc.2008.08.008; Xiao YF, 2007, WORLD J GASTROENTERO, V13, P6498, DOI 10.3748/wjg.13.6498; Yang GF, 2010, CHINESE MED J-PEKING, V123, P1768, DOI 10.3760/cma.j.issn.0366-6999.2010.13.028; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238; Zhang XY, 2012, CANCER LETT, V318, P93, DOI 10.1016/j.canlet.2011.12.005	45	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51451	10.1371/journal.pone.0051451	http://dx.doi.org/10.1371/journal.pone.0051451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236503	Green Published, Green Submitted, gold			2022-12-27	WOS:000312589700041
J	Mancini, G; D'Annessa, I; Coletta, A; Chillemi, G; Pommier, Y; Cushman, M; Desideri, A				Mancini, Giordano; D'Annessa, Ilda; Coletta, Andrea; Chillemi, Giovanni; Pommier, Yves; Cushman, Mark; Desideri, Alessandro			Binding of an Indenoisoquinoline to the Topoisomerase-DNA Complex Induces Reduction of Linker Mobility and Strengthening of Protein-DNA Interaction	PLOS ONE			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; CATALYTIC MECHANISM; CLEAVAGE COMPLEXES; COVALENT COMPLEX; I INHIBITORS; CAMPTOTHECIN; SIMULATIONS; RESISTANCE; IDENTIFICATION	Long-duration comparative molecular dynamics simulations of the DNA-topoisomerase binary and DNA-topoisomerase-indenoisoquinoline ternary complexes have been carried out. The analyses demonstrated the role of the drug in conformationally stabilizing the protein-DNA interaction. In detail, the protein lips, clamping the DNA substrate, interact more tightly in the ternary complex than in the binary one. The drug also reduces the conformational space sampled by the protein linker domain through an increased interaction with the helix bundle proximal to the active site. A similar alteration of linker domain dynamics has been observed in a precedent work for topotecan but the molecular mechanisms were different if compared to those described in this work. Finally, the indenoisoquinoline keeps Lys532 far from the DNA, making it unable to participate in the religation reaction, indicating that both short- and long-range interactions contribute to the drug poisoning effect. Citation: Mancini G, D'Annessa I, Coletta A, Chillemi G, Pommier Y, et al. (2012) Binding of an Indenoisoquinoline to the Topoisomerase-DNA Complex Induces Reduction of Linker Mobility and Strengthening of Protein-DNA Interaction. PLoS ONE 7(12): e51354. doi:10.1371/journal.pone.0051354	[D'Annessa, Ilda; Coletta, Andrea; Desideri, Alessandro] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [D'Annessa, Ilda; Coletta, Andrea; Desideri, Alessandro] Univ Roma Tor Vergata, Ctr Bioinformat & Biostat, I-00173 Rome, Italy; [Mancini, Giordano; Chillemi, Giovanni] CASPUR Interuniv Consortium Applicat Super Comp U, Rome, Italy; [Pommier, Yves] NCI, Mol Pharmacol Lab, Bethesda, MD 20892 USA; [Cushman, Mark] Purdue Univ, Dept Med Chem & Mol Pharmacol, Coll Pharm, W Lafayette, IN 47907 USA; [Cushman, Mark] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA	University of Rome Tor Vergata; University of Rome Tor Vergata; CINECA, Italy; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Desideri, A (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci, I-00173 Rome, Italy.	desideri@uniroma2.it	Coletta, Andrea/H-9856-2012; Chillemi, Giovanni/O-2825-2019; Chillemi, Giovanni/E-5201-2010; Coletta, Andrea/GXF-2972-2022	Coletta, Andrea/0000-0003-4032-394X; Chillemi, Giovanni/0000-0003-3901-6926; Chillemi, Giovanni/0000-0003-3901-6926; D'Annessa, Ilda/0000-0002-6174-6899; desideri, alessandro/0000-0003-1541-4217	Associazione Italiana Ricerca Cancro AIRC [10121]; NATIONAL CANCER INSTITUTE [ZIABC006161] Funding Source: NIH RePORTER	Associazione Italiana Ricerca Cancro AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	AD thanks the Associazione Italiana Ricerca Cancro AIRC (www.airc.it), which supported the work with project number 10121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony S, 2003, CANCER RES, V63, P7428; Antony S, 2007, CANCER RES, V67, P10397, DOI 10.1158/0008-5472.CAN-07-0938; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Champoux JJ, 2000, ANN NY ACAD SCI, V922, P56; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; CUSHMAN M, 1978, J ORG CHEM, V43, P3781, DOI 10.1021/jo00413a036; DAnnessa I, 2012, J AMINO ACIDS, V2012; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fiorani P, 2003, J BIOL CHEM, V278, P43268, DOI 10.1074/jbc.M303899200; Gongora C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-64; Hess B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031910; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HSIANG YH, 1988, CANCER RES, V48, P1722; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Interthal H, 2004, J BIOL CHEM, V279, P2984, DOI 10.1074/jbc.M309959200; Ioanoviciu A, 2005, J MED CHEM, V48, P4803, DOI 10.1021/jm050076b; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kohlhagen G, 1998, MOL PHARMACOL, V54, P50, DOI 10.1124/mol.54.1.50; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; Liao Z, 2008, MOL PHARMACOL, V73, P490, DOI 10.1124/mol.107.041178; Mancini G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010934; Marchand C, 2006, MOL CANCER THER, V5, P287, DOI 10.1158/1535-7163.MCT-05-0456; Meng LH, 2003, CURR TOP MED CHEM, V3, P305; Nagarajan M, 2006, J MED CHEM, V49, P6283, DOI 10.1021/jm060564z; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Scaldaferro S, 2001, CHEM BIOL, V8, P871, DOI 10.1016/S1074-5521(01)00059-X; SHUMAN S, 1987, P NATL ACAD SCI USA, V84, P7478, DOI 10.1073/pnas.84.21.7478; Soret J, 2003, CANCER RES, V63, P8203; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Staker BL, 2005, J MED CHEM, V48, P2336, DOI 10.1021/jm049146p; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1999, J BIOL CHEM, V274, P32950, DOI 10.1074/jbc.274.46.32950; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stewart L, 1996, J BIOL CHEM, V271, P7602, DOI 10.1074/jbc.271.13.7602; Strumberg D, 1999, J MED CHEM, V42, P446, DOI 10.1021/jm9803323; Taniguchi K, 1996, CANCER RES, V56, P2348; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223	44	13	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51354	10.1371/journal.pone.0051354	http://dx.doi.org/10.1371/journal.pone.0051354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236483	gold, Green Published, Green Submitted			2022-12-27	WOS:000312589700038
J	Harari, O; Wang, JC; Bucholz, K; Edenberg, HJ; Heath, A; Martin, NG; Pergadia, ML; Montgomery, G; Schrage, A; Bierut, LJ; Madden, PF; Goate, AM				Harari, Oscar; Wang, Jen-Chyong; Bucholz, Kathleen; Edenberg, Howard J.; Heath, Andrew; Martin, Nicholas G.; Pergadia, Michele L.; Montgomery, Grant; Schrage, Andrew; Bierut, Laura J.; Madden, Pamela F.; Goate, Alison M.			Pathway Analysis of Smoking Quantity in Multiple GWAS Identifies Cholinergic and Sensory Pathways	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NICOTINE DEPENDENCE; HEAVY-SMOKING; EUROPEAN-AMERICANS; GENETIC-LINKAGE; VARIANTS; BEHAVIOR; RISK; HERITABILITY; ALLELES	Cigarette smoking is a common addiction that increases the risk for many diseases, including lung cancer and chronic obstructive pulmonary disease. Genome-wide association studies (GWAS) have successfully identified and validated several susceptibility loci for nicotine consumption and dependence. However, the trait variance explained by these genes is only a small fraction of the estimated genetic risk. Pathway analysis complements single marker methods by including biological knowledge into the evaluation of GWAS, under the assumption that causal variants lie in functionally related genes, enabling the evaluation of a broad range of signals. Our approach to the identification of pathways enriched for multiple genes associated with smoking quantity includes the analysis of two studies and the replication of common findings in a third dataset. This study identified pathways for the cholinergic receptors, which included SNPs known to be genome-wide significant; as well as novel pathways, such as genes involved in the sensory perception of smell, that do not contain any single SNP that achieves that stringent threshold.	[Harari, Oscar; Wang, Jen-Chyong; Bucholz, Kathleen; Heath, Andrew; Pergadia, Michele L.; Schrage, Andrew; Bierut, Laura J.; Madden, Pamela F.; Goate, Alison M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Edenberg, Howard J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Martin, Nicholas G.; Montgomery, Grant] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	Washington University (WUSTL); Indiana University System; Indiana University-Purdue University Indianapolis; QIMR Berghofer Medical Research Institute	Goate, AM (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	goatea@psychiatry.wustl.edu	Martin, Nicholas/R-9235-2019; Bierut, Laura Jean/W-6806-2019	Martin, Nicholas/0000-0003-4069-8020; Bierut, Laura Jean/0000-0002-9952-4810; Edenberg, Howard/0000-0003-0344-9690; Goate, Alison/0000-0002-0576-2472	National Institute of Drug Abuse [DA027995]; Barnes-Jewish Hospital Foundation; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004438, U01HG004422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013320, R37AA007728, K05AA017688, R01AA007728, R01AA013321, P60AA011998, R01AA014041, P50AA011998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019963, R01DA013423, R01DA012854, K08DA019951, R25DA027995, R56DA012854] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Barnes-Jewish Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	O.H is supported by the National Institute of Drug Abuse (DA027995) and the Barnes-Jewish Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bloom J, 2011, PHARMACOGENET GENOM, V21, P403, DOI 10.1097/FPC.0b013e328346e8c0; Broms U, 2006, TWIN RES HUM GENET, V9, P64, DOI 10.1375/183242706776403046; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gui Hongsheng, 2011, BMC Res Notes, V4, P386, DOI 10.1186/1756-0500-4-386; Haller G, 2012, HUM MOL GENET, V21, P647, DOI 10.1093/hmg/ddr498; Heath AC, 2011, BIOL PSYCHIAT, V70, P513, DOI 10.1016/j.biopsych.2011.02.028; Hinrichs AL, 2011, PHARMACOGENET GENOM, V21, P397, DOI 10.1097/FPC.0b013e328346886f; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Jones L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013950; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kuehl GE, 2003, DRUG METAB DISPOS, V31, P1361, DOI 10.1124/dmd.31.11.1361; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Liu QR, 2006, AM J MED GENET B, V141B, P918, DOI 10.1002/ajmg.b.30436; Malaiyandi V, 2006, MOL PSYCHIATR, V11, P400, DOI 10.1038/sj.mp.4001794; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; Osanai M, 2011, CANCER SCI, V102, P1158, DOI 10.1111/j.1349-7006.2011.01920.x; Pergadia ML, 2011, AM J PSYCHIAT, V168, P848, DOI 10.1176/appi.ajp.2011.10091319; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rasmussen-Torvik LJ, 2010, GENET EPIDEMIOL, V34, P665, DOI 10.1002/gepi.20525; Reed DR, 2010, HUM MOL GENET, V19, P4278, DOI 10.1093/hmg/ddq324; Saccone NL, 2010, GENES BRAIN BEHAV, V9, P741, DOI 10.1111/j.1601-183X.2010.00608.x; Saccone SF, 2007, AM J HUM GENET, V80, P856, DOI 10.1086/513703; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Sharrett A R, 1992, Ann Epidemiol, V2, P467; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Uhl GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-10; Vink J, 2005, BEHAV GENET, V35, P397, DOI 10.1007/s10519-004-1327-8; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	44	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50913	10.1371/journal.pone.0050913	http://dx.doi.org/10.1371/journal.pone.0050913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227220	Green Published, gold			2022-12-27	WOS:000312588200081
J	Daliento, L; Dal Bianco, L; Bagato, F; Secco, E; Sarubbi, B; Mazzotti, E; Bauce, B; Rizzoli, G				Daliento, Luciano; Dal Bianco, Lucia; Bagato, Francesco; Secco, Eleonora; Sarubbi, Berardo; Mazzotti, Elisa; Bauce, Barbara; Rizzoli, Giulio			Gender Differences and Role of Pregnancy in the History of Post-Surgical Women Affected by Tetralogy of Fallot	PLOS ONE			English	Article							REPAIR	Background: The aim of this study was to describe gender differences in patients operated on for TOF and to define the impact of pregnancy in late post-surgical follow-up in women. Methods: In this research, we studied 145 patients after correction of TOF: 66 male, 79 women, 41 of which reported history of 68 pregnancies, means age 37 +/- 10 years, age at operation 7 +/- 8 years, mean duration of post-surgical follow-up 30 +/- 7 years. Selected variables were compared according to sex and according to history of pregnancy with statistical tests. Results: Men had more severe hemodynamic impairment and a higher number of cardiac reoperations than females. 41% of patients had at least one complication during pregnancy; there were 16 (67%) abortions and 39 (74%) Caesarian delivers; the recurrence of congenital heart defect was 10%. After pregnancy, there was a shift from first to second functional class: unique pregnancy determined no differences in term of morpho-functional ventricular features compared to nulliparous, but they complained fatigue and palpitation and echocardiographyc dysfunction. Left ventricular dysfunction and QRS duration at ECG were independent predictors of ventricular arrhythmias in all patients. Conclusions: There were no gender-specific differences in patients operated on for TOF using ventriculotomy. Pregnancy is an event in these patients at risk for the newborn, in terms of miscarriage, prematurity, and recurrence of birth defects, and for the mother in terms of ventricular dysfunction and electrical instability. At least a single pregnancy does not appear to significantly modify the natural history of post-surgical patients operated on for TOF.	[Daliento, Luciano; Dal Bianco, Lucia; Bagato, Francesco; Secco, Eleonora; Mazzotti, Elisa; Bauce, Barbara] Univ Padua, Sch Med, Dept Cardiac Thorac & Vasc Surg, Cardiol Unit, Padua, Italy; [Sarubbi, Berardo] Univ Naples Federico II, Sch Med, Cardiol Unit, Naples, Italy; [Rizzoli, Giulio] Univ Padua, Sch Med, Dept Cardiac Thorac & Vasc Surg, Adult Cardiac Surg Unit, Padua, Italy	University of Padua; University of Naples Federico II; University of Padua	Dal Bianco, L (corresponding author), Univ Padua, Sch Med, Dept Cardiac Thorac & Vasc Surg, Cardiol Unit, Padua, Italy.	lucia_db@libero.it	Sarubbi, Berardo/AAL-1439-2021	Sarubbi, Berardo/0000-0001-9941-8500				Balci A, 2011, AM HEART J, V161, P307, DOI 10.1016/j.ahj.2010.10.027; Broberg CS, 2011, AM J CARDIOL, V107, P1215, DOI 10.1016/j.amjcard.2010.12.026; Daliento L, 2005, HEART, V91, P213, DOI 10.1136/hrt.2003.029280; Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LILLEHEI CW, 1955, ANN SURG, V142, P418, DOI 10.1097/00000658-195509000-00010; Naguib MA, 2010, INT J OBSTET ANESTH, V19, P306, DOI 10.1016/j.ijoa.2009.10.009; Nollert G, 1997, J AM COLL CARDIOL, V30, P1374, DOI 10.1016/S0735-1097(97)00318-5; Sarikouch S, 2011, CIRC CARDIOVASC IMAG, DOI CIRCIMAGING.111.963637; Shinebourne EA., 2002, PAEDIAT CARDIOLOGY, P1213; Somerville J, 1998, EUR HEART J, V19, P1766, DOI 10.1053/euhj.1998.1204; STATA, 2009, STATA STAT CORP 2009; Uebing A, 2010, INT J CARDIOL, V139, P50, DOI 10.1016/j.ijcard.2008.09.001; UNGER RK, 1979, AM PSYCHOL, V34, P1085, DOI 10.1037/0003-066X.34.11.1085; Veldtman GR, 2004, J AM COLL CARDIOL, V44, P174, DOI 10.1016/j.jacc.2003.11.067; Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4	16	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49729	10.1371/journal.pone.0049729	http://dx.doi.org/10.1371/journal.pone.0049729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239969	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800007
J	Mellert, DJ; Robinett, CC; Baker, BS				Mellert, David J.; Robinett, Carmen C.; Baker, Bruce S.			doublesex Functions Early and Late in Gustatory Sense Organ Development	PLOS ONE			English	Article							MALE COURTSHIP BEHAVIOR; SOMATIC SEXUAL-DIFFERENTIATION; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; PERIPHERAL NEUROGENESIS; DETERMINATION PATHWAY; NEURAL PRECURSORS; FEMALE PHEROMONES; SEGMENT NUMBER; POX-NEURO	Somatic sexual dimorphisms outside of the nervous system in Drosophila melanogaster are largely controlled by the male- and female-specific Doublesex transcription factors (DSXM and DSXF, respectively). The DSX proteins must act at the right times and places in development to regulate the diverse array of genes that sculpt male and female characteristics across a variety of tissues. To explore how cellular and developmental contexts integrate with doublesex (dsx) gene function, we focused on the sexually dimorphic number of gustatory sense organs (GSOs) in the foreleg. We show that DSXM and DSXF promote and repress GSO formation, respectively, and that their relative contribution to this dimorphism varies along the proximodistal axis of the foreleg. Our results suggest that the DSX proteins impact specification of the gustatory sensory organ precursors (SOPs). DSXF then acts later in the foreleg to regulate gustatory receptor neuron axon guidance. These results suggest that the foreleg provides a unique opportunity for examining the context-dependent functions of DSX.	[Mellert, David J.; Robinett, Carmen C.; Baker, Bruce S.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Mellert, David J.; Baker, Bruce S.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Robinett, CC (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	robinettc@janelia.hhmi.org	Robinett, Carmen/AAH-3177-2019	Mellert, David/0000-0001-6606-0274	National Institutes of Health; Howard Hughes Medical Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was funded by the National Institutes of Health and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN WQ, 1995, GENE DEV, V9, P256, DOI 10.1101/gad.9.2.256; Arbeitman MN, 2004, DEVELOPMENT, V131, P2007, DOI 10.1242/dev.01077; Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; Awasaki T, 2001, DEV GENES EVOL, V211, P20, DOI 10.1007/s004270000119; BAKER BS, 1980, GENETICS, V94, P383; Barmina O, 2005, DEV BIOL, V288, P528, DOI 10.1016/j.ydbio.2005.09.052; BELOTE JM, 1982, P NATL ACAD SCI-BIOL, V79, P1568, DOI 10.1073/pnas.79.5.1568; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; BOULIANNE GL, 1991, EMBO J, V10, P2975, DOI 10.1002/j.1460-2075.1991.tb07848.x; BOWNES M, 1994, BIOESSAYS, V16, P745, DOI 10.1002/bies.950161009; BOWNES M, 1981, MOL GEN GENET, V182, P222, DOI 10.1007/BF00269661; BRAND M, 1993, DEVELOPMENT, V119, P1; BURTIS KC, 1991, EMBO J, V10, P2577, DOI 10.1002/j.1460-2075.1991.tb07798.x; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Calleja M, 2002, GENE, V292, P1, DOI 10.1016/S0378-1119(02)00628-5; Camara N, 2008, CURR TOP DEV BIOL, V83, P65, DOI 10.1016/S0070-2153(08)00403-1; Campuzano S, 2001, ONCOGENE, V20, P8299, DOI 10.1038/sj.onc.1205162; Chatterjee SS, 2011, DEVELOPMENT, V138, P1099, DOI 10.1242/dev.055731; Christiansen AE, 2002, TRENDS GENET, V18, P510, DOI 10.1016/S0168-9525(02)02769-5; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; COSCHIGANO KT, 1993, GENE DEV, V7, P42, DOI 10.1101/gad.7.1.42; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; Culi J, 2001, DEVELOPMENT, V128, P299; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Erdman SE, 1996, GENETICS, V144, P1639; ERDMAN SE, 1993, EMBO J, V12, P527, DOI 10.1002/j.1460-2075.1993.tb05684.x; Fujii S, 2002, EMBO J, V21, P5353, DOI 10.1093/emboj/cdf556; Furman DP, 2008, CURR GENOMICS, V9, P312, DOI 10.2174/138920208785133271; Gehring WJ, 1996, GENES CELLS, V1, P11, DOI 10.1046/j.1365-2443.1996.11011.x; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; Goldman TD, 2007, PLOS GENET, V3, P2278, DOI 10.1371/journal.pgen.0030216; Gomez-Skarmeta J, 2003, NAT REV NEUROSCI, V4, P587, DOI 10.1038/nrn1142; GRABOWSKI CT, 1954, J MORPHOL, V94, P1, DOI 10.1002/jmor.1050940102; HANNAH-ALAVA ALOHA, 1958, J MORPH, V103, P281, DOI 10.1002/jmor.1051030205; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Hempel LU, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-113; HILDRETH PE, 1965, GENETICS, V51, P659; HUANG F, 1991, DEVELOPMENT, V111, P1087; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; JALLON JM, 1988, GENET RES, V51, P17, DOI 10.1017/S0016672300023892; JARMAN AP, 1993, DEVELOPMENT, V119, P19; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Lai EC, 2004, DEV BIOL, V269, P1, DOI 10.1016/j.ydbio.2004.01.032; Lebo MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-80; Lin HP, 2005, P NATL ACAD SCI USA, V102, P12831, DOI 10.1073/pnas.0506420102; Luo SZD, 2011, DEVELOPMENT, V138, P2761, DOI 10.1242/dev.065227; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Mellert DJ, 2010, DEVELOPMENT, V137, P323, DOI 10.1242/dev.045047; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; Miller A., 1950, BIOL DROSOPHILA, P420; NAGOSHI RN, 1990, GENE DEV, V4, P89, DOI 10.1101/gad.4.1.89; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; NOTTEBOHM E, 1994, J PHYSIOL-PARIS, V88, P141, DOI 10.1016/0928-4257(94)90024-8; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; ORENIC TV, 1993, DEVELOPMENT, V118, P9; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; POSSIDENTE DR, 1989, DEV BIOL, V132, P448, DOI 10.1016/0012-1606(89)90241-8; RAY K, 1993, DEV BIOL, V155, P26, DOI 10.1006/dbio.1993.1003; Rideout EJ, 2007, CURR BIOL, V17, P1473, DOI 10.1016/j.cub.2007.07.047; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; Robinett CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000365; Sanchez L, 2001, BIOESSAYS, V23, P698, DOI 10.1002/bies.1099; Sanders LE, 2008, DEV BIOL, V320, P378, DOI 10.1016/j.ydbio.2008.05.543; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Shirangi TR, 2007, DEV BIOL, V306, P10, DOI 10.1016/j.ydbio.2007.03.022; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Simpson P, 1999, DEVELOPMENT, V126, P1349; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; Starostina E, 2012, J NEUROSCI, V32, P4665, DOI 10.1523/JNEUROSCI.6178-11.2012; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tanaka K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001131; TAYLOR BJ, 1992, DEVELOPMENT, V114, P625; TAYLOR BJ, 1994, DEV GENET, V15, P275, DOI 10.1002/dvg.1020150309; Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371; Venard R, 1989, DROSOPHILA CHEMORECE; Wang W, 2011, P NATL ACAD SCI USA, V108, P11139, DOI 10.1073/pnas.1108431108; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Yamamoto D, 2007, ADV GENET, V59, P39, DOI 10.1016/S0065-2660(07)59002-4	82	23	23	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51489	10.1371/journal.pone.0051489	http://dx.doi.org/10.1371/journal.pone.0051489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240029	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800065
J	Xu, W; Wang, HS; Cheng, WQ; Fu, D; Xia, T; Kibbe, WA; Lin, SM				Xu, Wei; Wang, Huisong; Cheng, Wenqing; Fu, Dong; Xia, Tian; Kibbe, Warren A.; Lin, Simon M.			A Framework for Annotating Human Genome in Disease Context	PLOS ONE			English	Article							GENE ONTOLOGY	Identification of gene-disease association is crucial to understanding disease mechanism. A rapid increase in biomedical literatures, led by advances of genome-scale technologies, poses challenge for manually-curated-based annotation databases to characterize gene-disease associations effectively and timely. We propose an automatic method-The Disease Ontology Annotation Framework (DOAF) to provide a comprehensive annotation of the human genome using the computable Disease Ontology (DO), the NCBO Annotator service and NCBI Gene Reference Into Function (GeneRIF). DOAF can keep the resulting knowledgebase current by periodically executing automatic pipeline to re-annotate the human genome using the latest DO and GeneRIF releases at any frequency such as daily or monthly. Further, DOAF provides a computable and programmable environment which enables large-scale and integrative analysis by working with external analytic software or online service platforms. A user-friendly web interface (doa.nubic.northwestern.edu) is implemented to allow users to efficiently query, download, and view disease annotations and the underlying evidences.	[Xu, Wei; Wang, Huisong; Cheng, Wenqing; Xia, Tian] Huazhong Univ Sci & Technol, Dept Elect & Informat Engn, Wuhan 430074, Hubei, Peoples R China; [Fu, Dong; Xia, Tian; Kibbe, Warren A.; Lin, Simon M.] Northwestern Univ, Biomed Informat Ctr NUBIC, NUCATS, Feinberg Sch Med, Chicago, IL 60611 USA; [Fu, Dong; Xia, Tian; Kibbe, Warren A.; Lin, Simon M.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Lin, Simon M.] Marshfield Ctr, Biomed Informat Res Ctr, Marshfield, WI USA	Huazhong University of Science & Technology; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Xia, T (corresponding author), Huazhong Univ Sci & Technol, Dept Elect & Informat Engn, Wuhan 430074, Hubei, Peoples R China.	tianxia@northwestern.edu; wakibbe@northwestern.edu; LINMD.SIMON@mcrf.mfldclin.edu	Kibbe, Warren/B-2106-2010	Kibbe, Warren/0000-0001-5622-7659	American Recovery and Reinvestment Act through National Institutes of Health, National Center for Research Resources [1R01RR025342]; CTSA Clinical and Translational Science award [UL1RR025741]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741, R01RR025342] Funding Source: NIH RePORTER	American Recovery and Reinvestment Act through National Institutes of Health, National Center for Research Resources; CTSA Clinical and Translational Science award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project has been funded under the American Recovery and Reinvestment Act of 2009 through National Institutes of Health, National Center for Research Resources award 1R01RR025342 and the CTSA Clinical and Translational Science award UL1RR025741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P109, DOI 10.1109/CSB.2002.1039334; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bundschus M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-207; Gobeill J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S9; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Humphreys BL, 1998, J AM MED INFORM ASSN, V5, P1; Jonquet Clement, 2009, Summit Transl Bioinform, V2009, P56; Kann MG, 2010, BRIEF BIOINFORM, V11, P96, DOI 10.1093/bib/bbp048; Lu ZY, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P269; Lu ZY, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq036; McGowan PM, 2007, CLIN CANCER RES, V13, P2335, DOI 10.1158/1078-0432.CCR-06-2092; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Rath A, 2012, HUM MUTAT, V33, P803, DOI 10.1002/humu.22078; Rubinstein R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-12; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Shatkay H, 2003, J COMPUT BIOL, V10, P821, DOI 10.1089/106652703322756104; Sintchenko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009535; Spackman KA, 1997, J AM MED INFORM ASSN, P640; Zaremba S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-177	21	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e49686	10.1371/journal.pone.0049686	http://dx.doi.org/10.1371/journal.pone.0049686			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251346	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900003
J	Benyo, M; Flasko, T; Molnar, Z; Kerenyi, A; Batta, Z; Jozsa, T; Harsfalvi, J				Benyo, Matyas; Flasko, Tibor; Molnar, Zsuzsanna; Kerenyi, Adrienne; Batta, Zoltan; Jozsa, Tamas; Harsfalvi, Jolan			Follow-Up of Thrombin Generation after Prostate Cancer Surgery: Global Test for Increased Hypercoagulability	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; PROCOAGULANT ACTIVITY; PLASMA; RISK	Recent studies provided evidence that evaluation of thrombin generation identifies patients at thrombotic risk. Thrombin generation has a central role in hemorrhage control and vascular occlusion and its measurement provides new metrics of these processes providing sufficient evaluation of an individual's hemostatic competence and response to anticoagulant therapy. The objective of the study is to assess a new measure of hypercoagulability that predisposes to venous thromboembolism in the postoperative period after radical prostatectomy. Pre- (day-1) and postoperative (hour 1, day 6, month 1 and 10) blood samples of 24 patients were tested for plasma thrombin generation (peak thrombin), routine hematology and hemostasis. Patients received low molecular weight heparin for thromboprophylaxis. Peak thrombin levels were higher in patients compared to controls at baseline (p<0.001), and elevated further in the early postoperative period (p<0.001). Longer general anesthesia and high body mass index were associated with increased thrombin generation after surgery (p = 0.024 and p = 0.040). D dimer and fibrinogen levels were higher after radical prostatectomy (p = 0.001 and p<0.001). Conventional clotting tests remained within the reference range. Our study contributed to the cognition of the hypercoagulable state in cancer patients undergoing pelvic surgery and revealed the course of thrombin generation after radical prostatectomy. Whilst it is unsurprising that thrombin generation increases after tissue trauma, further evaluation of this condition during the postoperative period would lead urologists to an international and well-supported consensus regarding thromboprophylaxis in order to provide better clinical outcome. Considering the routine evaluation of procoagulant activity and extending prophylactic anticoagulant therapy accordingly may potentially prevent late thrombotic events.	[Batta, Zoltan; Harsfalvi, Jolan] Univ Debrecen, Clin Res Ctr, Med & Hlth Sci Ctr, Debrecen, Hungary; [Benyo, Matyas; Flasko, Tibor; Molnar, Zsuzsanna; Jozsa, Tamas] Univ Debrecen, Med & Hlth Sci Ctr, Dept Urol, Debrecen, Hungary; [Kerenyi, Adrienne] Univ Debrecen, Med & Hlth Sci Ctr, Dept Lab Med, Debrecen, Hungary; [Jozsa, Tamas] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Dept Paediat Surg, Div Urol, Stockholm, Sweden	University of Debrecen; University of Debrecen; University of Debrecen; Karolinska Institutet; Karolinska University Hospital	Harsfalvi, J (corresponding author), Univ Debrecen, Clin Res Ctr, Med & Hlth Sci Ctr, Debrecen, Hungary.	harsfalv@med.unideb.hu	Harsfalvi, Jolan/F-2572-2010	Harsfalvi, Jolan/0000-0001-9940-4846	OTKA [K62317]; OTKA-NKTH [NI 69238]; Hungarian Association of Urology; Janos Bolyai Research Scholarship of the Hungarian Academy of Science	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); OTKA-NKTH(National Office for Research and TechnologyOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Association of Urology; Janos Bolyai Research Scholarship of the Hungarian Academy of Science(Hungarian Academy of Sciences)	This work was supported by OTKA K62317, OTKA-NKTH NI 69238 (http://www.otka.hu/index.php?akt_menu=991&set_lang=991), and by the Hungarian Association of Urology (http://esru.uroweb.org/countries-pages/hungary/). Kerenyi's work is supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Science (http://mta.hu/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli G, 2006, ANN SURG, V243, P89, DOI 10.1097/01.sla.0000193959.44677.48; Al Dieri R, 2012, BLOOD REV, V26, P197, DOI 10.1016/j.blre.2012.06.001; Aleman MM, 2011, J THROMB HAEMOST; AUA, 2008, BEST PRACT POL STAT, V29; Ay C, 2011, J CLIN ONCOL, V29, P2099, DOI 10.1200/JCO.2010.32.8294; Beijers HJBH, 2010, ARTERIOSCL THROM VAS, V30, P2639, DOI 10.1161/ATVBAHA.110.211946; Bell CRW, 1999, BJU INT, V83, P984; Bounameaux H, 2006, HEMOSTASIS THROMBOSI, P1827; Butenas S, 1999, BLOOD, V94, P2169, DOI 10.1182/blood.V94.7.2169.419k22_2169_2178; Chandler WL, 2010, AM J CLIN PATHOL, V134, P90, DOI 10.1309/AJCP3WPOYSKK6BFE; Chandler WL, 2009, AM J CLIN PATHOL, V132, P169, DOI 10.1309/AJCP6AY4HTRAAJFQ; Debaugnies F, 2010, THROMB RES, V126, P531, DOI 10.1016/j.thromres.2010.09.002; Galvin DJ, 2004, PROSTATE, V60, P338, DOI 10.1002/pros.20063; Haubold K, 2009, THROMB HAEMOSTASIS, V101, P1147, DOI 10.1160/TH08-10-0654; Hron G, 2006, JAMA-J AM MED ASSOC, V296, P397, DOI 10.1001/jama.296.4.397; Langer F, 2007, THROMB HAEMOSTASIS, V97, P464, DOI 10.1160/TH06-09-0523; Lutsey PL, 2009, J THROMB HAEMOST, V7, P1639, DOI 10.1111/j.1538-7836.2009.03561.x; Mann KG, 2011, CIRCULATION, V124, P225, DOI 10.1161/CIRCULATIONAHA.110.952648; Orfeo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027852; Phillips J, 2010, BJU INT, V106, P1110, DOI 10.1111/j.1464-410X.2010.09639.x; Thachil J, 2008, BRIT J SURG, V95, P1437, DOI 10.1002/bjs.6381	21	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51299	10.1371/journal.pone.0051299	http://dx.doi.org/10.1371/journal.pone.0051299			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236465	gold, Green Submitted, Green Published			2022-12-27	WOS:000312064100089
J	Crane, BT				Crane, Benjamin T.			Direction Specific Biases in Human Visual and Vestibular Heading Perception	PLOS ONE			English	Article							SELF-MOTION; OPTIC FLOW; PERIPHERAL-VISION; VERTICAL AXIS; MST NEURONS; ROTATION; THRESHOLDS; MONKEY; SENSITIVITY; INTEGRATION	Heading direction is determined from visual and vestibular cues. Both sensory modalities have been shown to have better direction discrimination for headings near straight ahead. Previous studies of visual heading estimation have not used the full range of stimuli, and vestibular heading estimation has not previously been reported. The current experiments measure human heading estimation in the horizontal plane to vestibular, visual, and spoken stimuli. The vestibular and visual tasks involved 16 cm of platform or visual motion. The spoken stimulus was a voice command speaking a heading angle. All conditions demonstrated direction dependent biases in perceived headings such that biases increased with headings further from the fore-aft axis. The bias was larger with the visual stimulus when compared with the vestibular stimulus in all 10 subjects. For the visual and vestibular tasks precision was best for headings near fore-aft. The spoken headings had the least bias, and the variation in precision was less dependent on direction. In a separate experiment when headings were limited to +/- 45 degrees, the biases were much less, demonstrating the range of headings influences perception. There was a strong and highly significant correlation between the bias curves for visual and spoken stimuli in every subject. The correlation between visual-vestibular and vestibular-spoken biases were weaker but remained significant. The observed biases in both visual and vestibular heading perception qualitatively resembled predictions of a recent population vector decoder model (Gu et al., 2010) based on the known distribution of neuronal sensitivities. Citation: Crane BT (2012) Direction Specific Biases in Human Visual and Vestibular Heading Perception. PLoS ONE 7(12): e51383. doi: 10.1371/journal.pone.0051383	[Crane, Benjamin T.] Univ Rochester, Dept Otolaryngol, Rochester, NY 14627 USA; [Crane, Benjamin T.] Univ Rochester, Dept Neurobiol & Anat, Rochester, NY USA; [Crane, Benjamin T.] Univ Rochester, Dept Bioengn, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester	Crane, BT (corresponding author), Univ Rochester, Dept Otolaryngol, Rochester, NY 14627 USA.	craneb@gmail.com			NIDCD [K23 DC011298]; Triological Society; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC011298, P30DC005409] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Triological Society; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The research was supported by NIDCD K23 DC011298 and a career scientist award from the Triological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; Bardy BG, 1999, PERCEPT PSYCHOPHYS, V61, P1356, DOI 10.3758/BF03206186; BENSON AJ, 1989, AVIAT SPACE ENVIR MD, V60, P629; BENSON AJ, 1989, AVIAT SPACE ENVIR MD, V60, P205; Britten KH, 2008, ANNU REV NEUROSCI, V31, P389, DOI 10.1146/annurev.neuro.29.051605.112953; Britten KH, 1998, NAT NEUROSCI, V1, P59, DOI 10.1038/259; Carriot J, 2011, EXP BRAIN RES, V209, P415, DOI 10.1007/s00221-011-2567-5; Chowdhury SA, 2009, J NEUROSCI, V29, P12020, DOI 10.1523/JNEUROSCI.0004-09.2009; CLARK B, 1968, PERCEPT PSYCHOPHYS, V3, P253, DOI 10.3758/BF03212740; CROWELL JA, 1993, PERCEPT PSYCHOPHYS, V53, P325, DOI 10.3758/BF03205187; Crowell JA, 1996, VISION RES, V36, P471, DOI 10.1016/0042-6989(95)00121-2; DAvossa G, 1996, VISION RES, V36, P2915, DOI 10.1016/0042-6989(96)00010-7; DOCKSTADER SL, 1971, PERCEPT PSYCHOPHYS, V9, P299, DOI 10.3758/BF03212653; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; Fetsch CR, 2007, J NEUROSCI, V27, P700, DOI 10.1523/JNEUROSCI.3553-06.2007; Fetsch CR, 2012, NAT NEUROSCI, V15, P146, DOI 10.1038/nn.2983; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gibson JJ, 1950, PERCEPTION VISUAL WO; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Grabherr L, 2008, EXP BRAIN RES, V186, P677, DOI 10.1007/s00221-008-1350-8; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; HUANG J, 1981, EXP BRAIN RES, V41, P172; Ivanenko YP, 1997, COGNITIVE BRAIN RES, V5, P323, DOI 10.1016/S0926-6410(97)00011-6; JOHNSTON IR, 1973, AM J PSYCHOL, V86, P311, DOI 10.2307/1421439; KOENDERINK JJ, 1987, BIOL CYBERN, V56, P247, DOI 10.1007/BF00365219; Lappe M, 1996, J NEUROSCI, V16, P6265; Li L, 2002, OPTOMETRY VISION SCI, V79, P581, DOI 10.1097/00006324-200209000-00009; Li L, 2006, J VISION, V6, P874, DOI 10.1167/6.9.2; LLEWELLYN KR, 1971, J EXP PSYCHOL, V91, P245, DOI 10.1037/h0031788; MacNeilage PR, 2010, J NEUROSCI, V30, P9084, DOI 10.1523/JNEUROSCI.1304-10.2010; NIJHOFF P, 1956, Acta Otolaryngol, V46, P533; Page WK, 2003, J NEUROPHYSIOL, V89, P1994, DOI 10.1152/jn.00493.2002; Roditi RE, 2012, JARO-J ASSOC RES OTO, V13, P381, DOI 10.1007/s10162-012-0318-3; Roditi RE, 2011, 34 ANN M BALT MD, P1006; ROSENHALL U, 1972, ANN OTO RHINOL LARYN, V81, P339, DOI 10.1177/000348947208100305; ROSENHALL U, 1974, ACTA OTO-LARYNGOL, P3; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Telford L, 1996, PERCEPT PSYCHOPHYS, V58, P283, DOI 10.3758/BF03211881; WARREN R, 1976, J EXP PSYCHOL HUMAN, V2, P448, DOI 10.1037/0096-1523.2.3.448; WARREN WH, 1988, J EXP PSYCHOL HUMAN, V14, P646, DOI 10.1037/0096-1523.14.4.646; WARREN WH, 1992, PERCEPT PSYCHOPHYS, V51, P443, DOI 10.3758/BF03211640; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	52	35	35	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51383	10.1371/journal.pone.0051383	http://dx.doi.org/10.1371/journal.pone.0051383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236490	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100109
J	Dawson, LF; Valiente, E; Faulds-Pain, A; Donahue, EH; Wren, BW				Dawson, Lisa F.; Valiente, Esmeralda; Faulds-Pain, Alexandra; Donahue, Elizabeth H.; Wren, Brendan W.			Characterisation of Clostridium difficile Biofilm Formation, a Role for Spo0A	PLOS ONE			English	Article							BACILLUS-SUBTILIS; MICROBIAL BIOFILMS; MASTER REGULATOR; EPIDEMIOLOGY; BACTERIA; INCREASE; GENOME; MATRIX	Clostridium difficile is a Gram-positive anaerobic, spore-forming bacillus that is the leading cause of nosocomial diarrhoea worldwide. We demonstrate that C. difficile aggregates and forms biofilms in vitro on abiotic surfaces. These polymicrobial aggregates are attached to each other and to an abiotic surface by an extracellular polymeric substance (EPS). The EPS matrix provides the scaffold bonding together vegetative cells and spores, as well as forming a protective barrier for vegetative cells against oxygen stress. The master regulator of sporulation, Spo0A, may play a key role in biofilm formation, as genetic inactivation of spo0A in strain R20291 exhibits decreased biofilm formation. Our findings highlight an important attribute of C. difficile pathogenesis, which may have significant implications for infection, treatment and relapse.	[Dawson, Lisa F.; Valiente, Esmeralda; Faulds-Pain, Alexandra; Donahue, Elizabeth H.; Wren, Brendan W.] Univ London London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Wren, BW (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Keppel St, London WC1E 7HT, England.	Brendan.wren@lshtm.ac.uk			Wellcome Trust [086418/Z/]; MRC [94717]; Marie Curie Intra-European Fellowship [PIEF-GA-2009-252207]; Medical Research Council [G1000214] Funding Source: researchfish; MRC [G1000214] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Intra-European Fellowship(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Wellcome Trust grant number 086418/Z/and MRC grant number 94717. A Marie Curie Intra-European Fellowship (PIEF-GA-2009-252207) also provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Julio Carlos, 2010, P1; Barbut F, 2000, J CLIN MICROBIOL, V38, P2386; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Borriello SP, 1998, J ANTIMICROB CHEMOTH, V41, P13, DOI 10.1093/jac/41.suppl_3.13; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Colledge VL, 2011, J MOL BIOL, V411, P597, DOI 10.1016/j.jmb.2011.06.004; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Dawson LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025754; Dawson LF, 2009, INFECT GENET EVOL, V9, P1410, DOI 10.1016/j.meegid.2009.06.005; Deakin LJ, 2012, INFECT IMMU IN PRESS; Donelli G, 2012, FEMS IMMUNOL MED MIC, V65, P318, DOI 10.1111/j.1574-695X.2012.00962.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fujita M, 2005, GENE DEV, V19, P2236, DOI 10.1101/gad.1335705; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; Goorhuis A, 2007, CLIN INFECT DIS, V45, P695, DOI 10.1086/520984; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Kuijper EJ, 2007, CURR OPIN INFECT DIS, V20, P376; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Lopez D, 2009, MOL MICROBIOL, V74, P609, DOI 10.1111/j.1365-2958.2009.06882.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Purcell EB, 2012, J BACTERIOL, V194, P3307, DOI 10.1128/JB.00100-12; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Schneider EE, 2011, WATER SCI TECHNOL, V63, P143, DOI 10.2166/wst.2011.024; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Worthington RJ, 2012, ORG BIOMOL CHEM; Yu J, 2010, WATER SCI TECHNOL, V61, P163, DOI 10.2166/wst.2010.813; Zandri G, 2012, CLIN MICROBIOL INFEC, V18, pE259, DOI 10.1111/j.1469-0691.2012.03893.x; ZOTTOLA EA, 1994, INT J FOOD MICROBIOL, V23, P125, DOI 10.1016/0168-1605(94)90047-7	39	81	83	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50527	10.1371/journal.pone.0050527	http://dx.doi.org/10.1371/journal.pone.0050527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236376	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000312064100018
J	Griese, M; Heinrich, S; Ratjen, F; Kabesch, M; Paul, K; Ballmann, M; Rietschel, E; Kappler, M				Griese, Matthias; Heinrich, Stephanie; Ratjen, Felix; Kabesch, Michael; Paul, Karl; Ballmann, Manfred; Rietschel, Ernst; Kappler, Matthias			Surfactant Protein A in Cystic Fibrosis: Supratrimeric Structure and Pulmonary Outcome	PLOS ONE			English	Article							AIRWAY INFLAMMATION; PSEUDOMONAS-AERUGINOSA; YOUNG-CHILDREN; LUNG-FUNCTION; HOST-DEFENSE; DISEASE; OLIGOMERIZATION; PHAGOCYTOSIS; BINDING; SP-A1	Background: The state of oligomerization of surfactant associated protein-A (SP-A) monomers differs between individuals. This likely affects SP-A's functional properties and could thereby influence clinical status in patients with lung diseases. In this study we focus on SP-A structure in cystic fibrosis (CF) compared to both healthy subjects and disease controls. Methods: SP-A composition and function were assessed in both bronchoalveolar lavage (BAL) fluid and serum of 46 CF patients with mild disease, 25 patients with chronic bronchitis and 22 healthy subjects by gel chromatography and a functional agglutination assay. Relation of SP-A agglutination ability to disease severity of the subjects was explored. Results: SP-A was present in seven major oligomeric forms with the majority of SP-A being structurally organized as complex oligomeric forms. More complex oligomeric forms were associated with better SP-A function with regard to its agglutination ability. These forms were more frequently observed in BAL than in serum, but there were no differences between disease groups. In CF patients, more complex forms of SP-A were associated with better lung function. Conclusions: Organizational structure of SP-A affects its functional activity and is linked to disease severity in CF.	[Griese, Matthias; Heinrich, Stephanie; Kappler, Matthias] Univ Munich, Dr von Haunersches Kinderspital, Munich, Germany; [Ratjen, Felix] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Kabesch, Michael] Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, D-3000 Hannover, Germany; [Paul, Karl] Lungenpraxis, Berlin, Germany; [Ballmann, Manfred] St Josefs Hosp, Klin Kinder & Jugendmed, Bochum, Germany; [Rietschel, Ernst] Univ Cologne, Klin & Poliklin Kinder & Jugendmed, D-50931 Cologne, Germany	University of Munich; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Hannover Medical School; Ruhr University Bochum; University of Cologne	Griese, M (corresponding author), Univ Munich, Dr von Haunersches Kinderspital, Munich, Germany.	Matthias.griese@med.uni-muenchen.de	Kabesch, Michael/GZM-1583-2022; Ballmann, Manfred/AAE-3730-2019; Kabesch, Michael/AAB-5701-2020	Ratjen, Felix/0000-0003-4057-6592	Mukoviszidose e.V.; Vaincre la Mucoviscidose	Mukoviszidose e.V.; Vaincre la Mucoviscidose	This work was supported by a grant from the Mukoviszidose e.V. and Vaincre la Mucoviscidose. Dr. von Haunersches Kinderspital, University of Munich, Munich, Germany is a Member of the German Center for Lung Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bufler P, 2004, EXP LUNG RES, V30, P163, DOI 10.1080/01902140490276294; Bufler P, 2003, AM J RESP CELL MOL, V28, P249, DOI 10.1165/rcmb.4896; Crouch EC, 1998, AM J RESP CELL MOL, V19, P177, DOI 10.1165/ajrcmb.19.2.140; Dobbie JW, 1996, PERITON DIALYSIS INT, V16, P574; Floros J, 2009, CRIT REV EUKAR GENE, V19, P125, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.30; GEERTSMA MF, 1994, AM J PHYSIOL-LUNG C, V267, pL578, DOI 10.1152/ajplung.1994.267.5.L578; Giannoni E, 2006, AM J RESP CELL MOL, V34, P704, DOI 10.1165/rcmb.2005-0461OC; Griese M, 2008, EUR RESPIR J, V32, P783, DOI 10.1183/09031936.00146807; Griese M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-133; Griese M, 2007, EUR RESPIR J, V29, P240, DOI 10.1183/09031936.00047306; Griese M, 2004, AM J RESP CRIT CARE, V170, P1000, DOI 10.1164/rccm.200405-575oc; Griese M, 2002, AM J RESP CRIT CARE, V165, P1546, DOI 10.1164/rccm.2107147; Griese M, 1997, EUR RESPIR J, V10, P1983, DOI 10.1183/09031936.97.10091983; Griese M, 2001, ELECTROPHORESIS, V22, P165, DOI 10.1002/1522-2683(200101)22:1<165::AID-ELPS165>3.0.CO;2-H; Heinrich S, 2006, CURR MED CHEM, V13, P3239, DOI 10.2174/092986706778773112; Heinrich SM, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-59; Hickling TP, 1998, MOL MED, V4, P266, DOI 10.1007/BF03401923; Hull J, 1997, AM J RESP CRIT CARE, V156, P161, DOI 10.1164/ajrccm.156.1.9609090; Khubchandani KR, 2001, PEDIATR PATHOL MOL M, V20, P349, DOI 10.1080/15513810109168620; Madan T, 1997, INFECT IMMUN, V65, P3171, DOI 10.1128/IAI.65.8.3171-3179.1997; Meyer KC, 2000, CHEST, V118, P164, DOI 10.1378/chest.118.1.164; Noah TL, 2003, AM J RESP CRIT CARE, V168, P685, DOI 10.1164/rccm.200301-005OC; Paul K, 2004, AM J RESP CRIT CARE, V169, P719, DOI 10.1164/rccm.200307-959OC; Peterson-Carmichael SL, 2009, PEDIATR PULM, V44, P503, DOI 10.1002/ppul.21044; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Sanchez-Barbero F, 2007, BIOCHEM J, V406, P479, DOI 10.1042/BJ20070275; Schluchter MD, 2006, AM J RESP CRIT CARE, V174, P780, DOI 10.1164/rccm.200512-1919OC; Uemura T, 2006, BIOCHEMISTRY-US, V45, P14543, DOI 10.1021/bi061338u; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200	30	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51050	10.1371/journal.pone.0051050	http://dx.doi.org/10.1371/journal.pone.0051050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236429	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100059
J	Oikawa, D; Kitamura, A; Kinjo, M; Iwawaki, T				Oikawa, Daisuke; Kitamura, Akira; Kinjo, Masataka; Iwawaki, Takao			Direct Association of Unfolded Proteins with Mammalian ER Stress Sensor, IRE1 beta	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MESSENGER-RNA; TRANSCRIPTIONAL INDUCTION; TRANSMEMBRANE PROTEIN; IRE1; IRE1-ALPHA; BIP; ACTIVATION; DISSOCIATION; SIGNALS	IRE1, an ER-localized transmembrane protein, plays a central role in the unfolded protein response (UPR). IRE1 senses the accumulation of unfolded proteins in its luminal domain and transmits a signal to the cytosolic side through its kinase and RNase domains. Although the downstream pathways mediated by two mammalian IRE1s, IRE1 alpha and IRE1 beta, are well documented, their luminal events have not been fully elucidated. In particular, there have been no reports on how IRE1 beta senses the unfolded proteins. In this study, we performed a comparative analysis to clarify the luminal event mediated by the mammalian IRE1s. Confocal fluorescent microscopy using GFP-fused IRE1s revealed that IRE1 beta clustered into discrete foci upon ER stress. Also, fluorescence correlation spectroscopy (FCS) analysis in living cells indicated that the size of the IRE1 beta complex is robustly increased upon ER stress. Moreover, unlike IRE1 alpha, the luminal domain of IRE1 beta showed antiaggregation activity in vitro, and IRE1 beta was coprecipitated with the model unfolded proteins in cells. Strikingly, association with BiP was drastically reduced in IRE1 beta, while IRE1 alpha was associated with BiP and dissociated upon ER stress. This is the first report indicating that, differently from IRE1 alpha, the luminal event mediated by IRE1 beta involves direct interaction with unfolded proteins rather than association/dissociation with BiP, implying an intrinsic diversity in the sensing mechanism of mammalian sensors.	[Oikawa, Daisuke; Iwawaki, Takao] Gunma Univ, Adv Sci Res Leaders Dev Unit, Iwawaki Lab, Maebashi, Gunma 371, Japan; [Oikawa, Daisuke] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Oikawa, Daisuke; Iwawaki, Takao] RIKEN, Adv Sci Inst, Iwawaki Initiat Res Unit, Wako, Saitama, Japan; [Kitamura, Akira; Kinjo, Masataka] Hokkaido Univ, Fac Adv Life Sci, Lab Mol Cell Dynam, Kita Ku, Sapporo, Hokkaido, Japan; [Iwawaki, Takao] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Gunma University; Japan Society for the Promotion of Science; RIKEN; Hokkaido University; Japan Science & Technology Agency (JST)	Oikawa, D (corresponding author), Gunma Univ, Adv Sci Res Leaders Dev Unit, Iwawaki Lab, Maebashi, Gunma 371, Japan.	oikawa@gunma-u.ac.jp; iwawaki@gunma-u.ac.jp	Kinjo, Masataka/F-5267-2011	Kinjo, Masataka/0000-0001-8889-8369	RIKEN, JST (Japan Science and Technology Agency); MEXT (Ministry of Education, Culture, Sports, Science and Technology) [22113524, 24113702]; JSPS (Japan Society for the Promotion of Science)	RIKEN, JST (Japan Science and Technology Agency); MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from RIKEN, JST (Japan Science and Technology Agency) and MEXT (Ministry of Education, Culture, Sports, Science and Technology: No. 22113524, No. 24113702) to TI, and from JSPS (Japan Society for the Promotion of Science) to DO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dai KZ, 2010, ARTERIOSCL THROM VAS, V30, P568, DOI 10.1161/ATVBAHA.109.198135; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hosoda A, 2010, BIOCHEM J, V425, P117, DOI 10.1042/BJ20091269; Imagawa Y, 2008, FEBS LETT, V582, P656, DOI 10.1016/j.febslet.2008.01.038; Iqbal J, 2008, CELL METAB, V7, P445, DOI 10.1016/j.cmet.2008.03.005; Iqbal J, 2012, CIRC RES, V110, P1575, DOI 10.1161/CIRCRESAHA.112.264283; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Iwawaki T, 2006, BIOCHEM BIOPH RES CO, V350, P709, DOI 10.1016/j.bbrc.2006.09.100; Kimata Y, 2004, J CELL BIOL, V167, P445, DOI 10.1083/jcb.200405153; Kimata Y, 2003, MOL BIOL CELL, V14, P2559, DOI 10.1091/mbc.E02-11-0708; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lai CW, 2010, MOL BIOL CELL, V21, P1909, DOI 10.1091/mbc.E09-12-1066; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Liu CY, 2003, J BIOL CHEM, V278, P17680, DOI 10.1074/jbc.M300418200; Liu CY, 2002, J BIOL CHEM, V277, P18346, DOI 10.1074/jbc.M112454200; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; MORI K, 1993, CELL, V74, P743; Nakamura D, 2011, FEBS LETT, V585, P133, DOI 10.1016/j.febslet.2010.12.002; Oikawa D, 2005, BIOCHEM J, V391, P135, DOI 10.1042/BJ20050640; Oikawa D, 2007, J CELL SCI, V120, P1681, DOI 10.1242/jcs.002808; Oikawa D, 2010, NUCLEIC ACIDS RES, V38, P6265, DOI 10.1093/nar/gkq452; Oikawa D, 2009, EXP CELL RES, V315, P2496, DOI 10.1016/j.yexcr.2009.06.009; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	50	43	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51290	10.1371/journal.pone.0051290	http://dx.doi.org/10.1371/journal.pone.0051290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236464	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100088
J	Song, XJ; Jin, P; Qin, S; Chen, LM; Ma, F				Song, Xiaojun; Jin, Ping; Qin, Sheng; Chen, Liming; Ma, Fei			The Evolution and Origin of Animal Toll-Like Receptor Signaling Pathway Revealed by Network-Level Molecular Evolutionary Analyses	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN LENGTH; GENOME; DROSOPHILA; RATES; REPERTOIRE; CENTRALITY; PATTERNS; HISTORY; MUSCLE	Genes carry out their biological functions through pathways in complex networks consisting of many interacting molecules. Studies on the effect of network architecture on the evolution of individual proteins will provide valuable information for understanding the origin and evolution as well as functional conservation of signaling pathways. However, the relationship between the network architecture and the individual protein sequence evolution is yet little known. In current study, we carried out network-level molecular evolution analysis on TLR (Toll-like receptor) signaling pathway, which plays an important role in innate immunity in insects and mammals, and we found that: 1) The selection constraint of genes was negatively correlated with its position along TLR signaling pathway; 2) all genes in TLR signaling pathway were highly conserved and underwent strong purifying selection; 3) the distribution of selective pressure along the pathway was driven by differential nonsynonymous substitution levels; 4) The TLR signaling pathway might present in a common ancestor of sponges and eumetazoa, and evolve via the TLR, IKK, I kappa B and NF-kappa B genes underwent duplication events as well as adaptor molecular enlargement, and gene structure and conservation motif of NF-kappa B genes shifted in their evolutionary history. Our results will improve our understanding on the evolutionary history of animal TLR signaling pathway as well as the relationship between the network architecture and the sequences evolution of individual protein.	[Song, Xiaojun; Jin, Ping; Qin, Sheng; Ma, Fei] Nanjing Normal Univ, Coll Life Sci, Lab Comparat Genom & Bioinformat, Nanjing, Jiangsu, Peoples R China; [Song, Xiaojun; Jin, Ping; Qin, Sheng; Ma, Fei] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Chen, Liming] Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Normal University; Southeast University - China	Ma, F (corresponding author), Nanjing Normal Univ, Coll Life Sci, Lab Comparat Genom & Bioinformat, Nanjing, Jiangsu, Peoples R China.	mafei01@tsinghua.org.cn	Qin, Sheng/HCH-0856-2022		National Natural Science Foundation of China [30970348]; Major Program of Natural Science Research of Jiangsu Higher Education Institutions [12KJA180005]; Ph.D. Programs Foundation of Ministry of Education of China [20113207110009]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of Natural Science Research of Jiangsu Higher Education Institutions; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was jointly supported by grants from the National Natural Science Foundation of China (30970348), the Major Program of Natural Science Research of Jiangsu Higher Education Institutions (12KJA180005), the Ph.D. Programs Foundation of Ministry of Education of China (20113207110009) and a grant from Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ponce D, 2011, GENOME BIOL EVOL, V3, P87, DOI 10.1093/gbe/evq084; Alvarez-Ponce D, 2009, GENOME RES, V19, P234, DOI 10.1101/gr.084038.108; Ball EE, 2004, NAT REV GENET, V5, P567, DOI 10.1038/nrg1402; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Cui QH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-21; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gauthier MEA, 2010, EVOL DEV, V12, P519, DOI 10.1111/j.1525-142X.2010.00436.x; Gerdol M, 2011, DEV COMP IMMUNOL, V35, P635, DOI 10.1016/j.dci.2011.01.018; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Hilman D, 2011, MOL BIOL EVOL, V28, P2403, DOI 10.1093/molbev/msr065; Hishiya A, 2006, EMBO J, V25, P554, DOI 10.1038/sj.emboj.7600945; Huang J, 2004, J BIOL CHEM, V279, P16847, DOI 10.1074/jbc.M309491200; Ingvarsson PK, 2007, MOL BIOL EVOL, V24, P836, DOI 10.1093/molbev/msl212; Jovelin R, 2011, GENOME BIOL EVOL, V3, P715, DOI 10.1093/gbe/evr071; Jovelin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r35; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Livingstone K, 2009, J HERED, V100, P754, DOI 10.1093/jhered/esp026; Lu CQ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-407; Lu YQ, 2003, MOL BIOL EVOL, V20, P1844, DOI 10.1093/molbev/msg197; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Montanucci L, 2011, MOL BIOL EVOL, V28, P813, DOI 10.1093/molbev/msq259; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Pal C, 2001, GENETICS, V158, P927; Pincus D, 2008, P NATL ACAD SCI USA, V105, P9680, DOI 10.1073/pnas.0803161105; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ramsay H, 2009, MOL BIOL EVOL, V26, P1045, DOI 10.1093/molbev/msp021; Rausher MD, 2008, J MOL EVOL, V67, P137, DOI 10.1007/s00239-008-9105-5; Rausher MD, 1999, MOL BIOL EVOL, V16, P266, DOI 10.1093/oxfordjournals.molbev.a026108; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sebe-Pedros A, 2011, MOL BIOL EVOL, V28, P1241, DOI 10.1093/molbev/msq309; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Song XJ, 2012, GENOMICS, V99, P361, DOI 10.1016/j.ygeno.2012.03.002; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; Vij S, 2008, FUNCT INTEGR GENOMIC, V8, P301, DOI 10.1007/s10142-008-0078-7; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; Wang YQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007456; Wiens M, 2007, MOL BIOL EVOL, V24, P792, DOI 10.1093/molbev/msl208; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Wu XC, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-46; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu HS, 2011, MOL BIOL EVOL, V28, P1785, DOI 10.1093/molbev/msr002	56	37	38	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51657	10.1371/journal.pone.0051657	http://dx.doi.org/10.1371/journal.pone.0051657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236523	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100139
J	Kim, J; Keay, SK; You, S; Loda, M; Freeman, MR				Kim, Jayoung; Keay, Susan K.; You, Sungyong; Loda, Massimo; Freeman, Michael R.			A Synthetic Form of Frizzled 8-Associated Antiproliferative Factor Enhances p53 Stability through USP2a and MDM2	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; BLADDER EPITHELIAL-CELLS; INTERSTITIAL-CYSTITIS; TUMOR-SUPPRESSOR; URINE MARKERS; CYCLIN D1; PATHWAY; EXPRESSION; PROLIFERATION; CKAP4/P63	Frizzled 8-associated Antiproliferative Factor (APF) is a sialoglycopeptide urinary biomarker of interstitial cystitis/painful bladder syndrome (IC/PBS), a chronic condition of unknown etiology with variable symptoms that generally include pelvic and/or perineal pain, urinary frequency, and urgency. We previously reported that native human APF suppresses the proliferation of normal bladder epithelial cells through a mechanism that involves increased levels of p53. The goal of this study was to delineate the regulatory mechanism whereby p53 expression is regulated by APF. Two APF-responsive cell lines (T24 bladder carcinoma cells and the immortalized human bladder epithelial cell line, TRT-HU1) were treated with asialo-APF (as-APF), a chemically synthesized form of APF. Biochemical analysis revealed that as-APF increased p53 levels in two ways: by decreasing ubiquitin specific protease 2a (USP2a) expression leading to enhanced ubiquitination of murine double minute 2 E3 ubiquitin ligase (MDM2), and by suppressing association of p53 with MDM2, thus impairing p53 ubiquitination. Biological responses to as-APF were suppressed by increased expression of wild type, but not mutant USP2a, which enhanced cell growth via upregulation of a cell cycle mediator, cyclin D1, at both transcription and protein levels. Consistent with this, gene silencing of USP2a with siRNA arrested cell proliferation. Our findings suggest that APF upregulates cellular p53 levels via functional attenuation of the USP2a-MDM2 pathway, resulting in p53 accumulation and growth arrest. These data also imply that targeting USP2a, MDM2, p53 and/or complex formation by these molecules may be relevant in the development of novel therapeutic approaches to IC/PBS. Citation: Kim J, Keay SK, You S, Loda M, Freeman MR (2012) A Synthetic Form of Frizzled 8-Associated Antiproliferative Factor Enhances p53 Stability through USP2a and MDM2. PLoS ONE 7(12): e50392. doi:10.1371/journal.pone.0050392	[Kim, Jayoung; You, Sungyong; Freeman, Michael R.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Surg, Div Canc Biol & Therapeut, Los Angeles, CA 90048 USA; [Kim, Jayoung; You, Sungyong; Freeman, Michael R.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Kim, Jayoung; Freeman, Michael R.] Childrens Hosp, Urol Dis Res Ctr, Boston, MA 02115 USA; [Kim, Jayoung; Freeman, Michael R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Kim, Jayoung; Freeman, Michael R.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Keay, Susan K.] Univ Maryland, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21201 USA; [Keay, Susan K.] VA Maryland Hlth Care Ctr, Baltimore, MD USA; [Loda, Massimo] Harvard Univ, Sch Med, Dept Med Oncol, Boston, MA USA; [Loda, Massimo] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Loda, Massimo] Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University System of Maryland; University of Maryland Baltimore; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kim, J (corresponding author), Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Surg, Div Canc Biol & Therapeut, Los Angeles, CA 90048 USA.	Jayoung.Kim@cshs.org	You, Sungyong/AAJ-7372-2020	You, Sungyong/0000-0003-3513-1783	NIH [R37 DK47556, R01 DK57691, P50 DK65298, R01 CA131945, R01 DK52596]; Fishbein Family IC Research Foundation/Interstitial Cystitis Association; New York Academy of Medicine; Children's Hospital Boston Faculty Development; NATIONAL CANCER INSTITUTE [R01CA131945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087806, R37DK047556, R01DK052596, P50DK065298, R01DK057691] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fishbein Family IC Research Foundation/Interstitial Cystitis Association; New York Academy of Medicine; Children's Hospital Boston Faculty Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by: NIH grants R37 DK47556, R01 DK57691, P50 DK65298 (to MRF); R01 CA131945 (to ML); R01 DK52596 (to SKK); and the Fishbein Family IC Research Foundation/Interstitial Cystitis Association; New York Academy of Medicine; and Children's Hospital Boston Faculty Development (to JK); JK is an American Urological Association Foundation Research Scholar and an Eleanor and Miles Shore Scholar of Harvard Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Benassi B, 2012, CANCER DISCOV, V2, P236, DOI 10.1158/2159-8290.CD-11-0219; Bogart LM, 2007, J UROLOGY, V177, P450, DOI 10.1016/j.juro.2006.09.032; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chai TC, 2000, J UROLOGY, V163, P1440, DOI 10.1016/S0022-5347(05)67638-0; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Clemens JQ, 2009, NEUROUROL URODYNAM, V28, P907; Conrads TP, 2006, J BIOL CHEM, V281, P37836, DOI 10.1074/jbc.M604581200; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Deb SP, 2002, FRONT BIOSCI, V7, pD235, DOI 10.2741/deb; Erickson DR, 2002, J UROLOGY, V167, P2461, DOI 10.1016/S0022-5347(05)65005-7; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; HANNO P, 1990, J UROLOGY, V143, P278, DOI 10.1016/S0022-5347(17)39933-0; Hanno Philip, 2005, Int Urogynecol J Pelvic Floor Dysfunct, V16 Suppl 1, pS2, DOI 10.1007/s00192-005-1301-x; Hanno PM, 2011, J UROLOGY, V185, P2162, DOI 10.1016/j.juro.2011.03.064; Hanno PM, 1997, UROLOGY, V49, P93, DOI 10.1016/S0090-4295(97)00179-9; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Keay S, 2000, J UROLOGY, V164, P2112, DOI 10.1016/S0022-5347(05)66980-7; Keay S, 2001, Urology, V57, P104, DOI 10.1016/S0090-4295(01)01028-7; Keay S, 1998, UROLOGY, V52, P974, DOI 10.1016/S0090-4295(98)00488-9; Keay S, 2003, UROLOGY, V61, P1278, DOI 10.1016/S0090-4295(03)00005-0; Keay SK, 2004, P NATL ACAD SCI USA, V101, P11803, DOI 10.1073/pnas.0404509101; Keay SK, 2001, UROLOGY, V57, P9, DOI 10.1016/S0090-4295(01)01127-X; Keay S, 2011, CHEM BIOL DRUG DES, V77, P421, DOI 10.1111/j.1747-0285.2011.01108.x; Keay S, 2008, CELL SIGNAL, V20, P2174, DOI 10.1016/j.cellsig.2008.06.004; Kim J, 2007, FEBS LETT, V581, P3795, DOI 10.1016/j.febslet.2007.06.058; Kim J, 2011, IN VITRO CELL DEV-AN, V47, P2, DOI 10.1007/s11626-010-9350-y; Kim JY, 2009, BJU INT, V103, P541, DOI 10.1111/j.1464-410X.2008.08097.x; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lane DP, 2005, COLD SH Q B, V70, P489, DOI 10.1101/sqb.2005.70.049; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Moutzouris DA, 2009, CLIN J AM SOC NEPHRO, V4, P1844, DOI 10.2215/CJN.02000309; Ness TJ, 2005, J UROLOGY, V173, P1983, DOI 10.1097/01.ju.0000158452.15915.e2; Nordling J, 2004, EUR UROL, V45, P662, DOI 10.1016/j.eururo.2003.11.021; Persu C, 2010, J Med Life, V3, P167; Phatak S, 2006, NAT CLIN PRACT UROL, V3, P45, DOI 10.1038/ncpuro0385; Planey SL, 2009, MOL BIOL CELL, V20, P1454, DOI 10.1091/mbc.E08-08-0849; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Sant GR, 2001, UROLOGY, V57, P82, DOI 10.1016/S0090-4295(01)01131-1; Shahjee HM, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-160; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Shi Y, 2011, J BIOL CHEM; Slobodov G, 2004, J UROLOGY, V171, P1554, DOI 10.1097/01.ju.0000118938.09119.a5; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Warren John W, 2002, Curr Opin Urol, V12, P69, DOI 10.1097/00042307-200201000-00013; Yang W, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007492; Zhang CO, 2005, J UROLOGY, V174, P2382, DOI 10.1097/01.ju.0000180417.11976.99; Zhang J, 2008, MOL CELL PROTEOMICS, V7, P1378, DOI 10.1074/mcp.M800069-MCP200	54	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50392	10.1371/journal.pone.0050392	http://dx.doi.org/10.1371/journal.pone.0050392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236372	Green Published, Green Submitted, gold			2022-12-27	WOS:000312589700014
J	Lukats, O; Vizkelety, T; Markella, Z; Maka, E; Kiss, M; Dobai, A; Bujtar, P; Szucs, A; Barabas, J				Lukats, Olga; Vizkelety, Tamas; Markella, Zsolt; Maka, Erika; Kiss, Maria; Dobai, Adrienn; Bujtar, Peter; Szucs, Attila; Barabas, Jozsef			Measurement of Orbital Volume after Enucleation and Orbital Implantation	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY	Introduction: This article reports experience relating to the measurement of orbital volume by means of cone beam computed tomography (CBCT) and Cranioviewer program software in patients who have undergone enucleation and orbital implantation. Patients and Methods: CBCT scans were made in 30 cases, 10 of which were later excluded because of various technical problems. The study group therefore consisted of 20 patients (8 men and 12 women). The longest follow-up time was 7 years, and the shortest was 1 year. In all 20 cases, the orbital volume was measured with Cranioviewer orbital program software. Slices were made in the ventrodorsal direction at 4.8 mm intervals in the frontal plane, in both bony orbits (both that containing the orbital implant and the healthy one). Similar measurements were made in 20 patients with various dental problems. CBCT scans were recorded for the facial region of the skull, containing the orbital region. The Cranioviewer program can colour the area of the slices red, and it automatically measures the area in mm. Results: In 5 of the 20 cases, the first 4 or all 5 slices revealed that the volume of the operated orbit was significantly smaller than that of the healthy orbit, in 12 cases only from 1 to 3 of the slices indicated such a significant difference, and in 3 cases no differences were observed between the orbits. In the control group of patients with various dental problems, there was no significant difference between the two healthy orbits. The accuracy of the volume measurements was assessed statistically by means of the paired samples t-test. Summary: To date, no appropriate method is avaliable for exact measurement of the bony orbital volume, which would be of particular importance in orbital injury reconstruction. However, the use of CBCT scans and Cranioviewer orbital program software appears to offer a reliable method for the measurement of changes in orbital volume. Citation: Lukats O, Vizkelety T, Markella Z, Maka E, Kiss M, et al. (2012) Measurement of Orbital Volume after Enucleation and Orbital Implantation. PLoS ONE 7(12): e50333. doi:10.1371/journal.pone.0050333	[Lukats, Olga; Maka, Erika] Semmelweis Univ, Fac Med, Dept Opthalmol, Budapest, Hungary; [Vizkelety, Tamas; Dobai, Adrienn; Szucs, Attila; Barabas, Jozsef] Semmelweis Univ, Fac Dent, Dept Oral & Maxillofacial Surg & Dent, Budapest, Hungary; [Markella, Zsolt] Obuda Univ, Kalman Kando Fac Elect Engn, Budapest, Hungary; [Kiss, Maria] Dunaujvaros Coll, Dunaujvaros, Hungary; [Bujtar, Peter] Univ Hosp, Dept Oral & Maxillofacial Surg, Leicester, Leics, England	Semmelweis University; Semmelweis University; Obuda University; University Hospitals of Leicester NHS Trust	Lukats, O (corresponding author), Semmelweis Univ, Fac Med, Dept Opthalmol, Budapest, Hungary.	lukatsolga@gmail.com			scientific application TAMOP (Tarsadalmi Megujulas Operativ Program) [4.2.1./B-09/1KMR 2010-001]	scientific application TAMOP (Tarsadalmi Megujulas Operativ Program)	The authors' work was part of a study which was supported by a scientific application TAMOP (Tarsadalmi Megujulas Operativ Program) 4.2.1./B-09/1KMR 2010-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv RI, 2005, CLIN RADIOL, V60, P279, DOI 10.1016/j.crad.2004.05.017; Bryant JA, 2008, DENTOMAXILLOFAC RAD, V37, P365, DOI 10.1259/dmfr/13227258; De Vos W, 2009, INT J ORAL MAX SURG, V38, P609, DOI 10.1016/j.ijom.2009.02.028; FORBES G, 1985, AM J ROENTGENOL, V145, P149, DOI 10.2214/ajr.145.1.149; Hintschich C, 2001, BRIT J OPHTHALMOL, V85, P205, DOI 10.1136/bjo.85.2.205; Hintschich C, 2001, OPER TECH OCULOPLAST, V4, P3; HOWARD GM, 1965, ARCH OPHTHALMOL-CHIC, V73, P80; Ji YR, 2010, J ANAT, V217, P501, DOI 10.1111/j.1469-7580.2010.01286.x; Koppel DA, 2003, J CRANIO MAXILL SURG, V31, P88, DOI 10.1016/S1010-5182(02)00170-1; Kwon J, 2010, OPHTHAL PLAST RECONS, V26, P26, DOI 10.1097/IOP.0b013e3181b80c6a; Kwon J, 2009, ARCH FACIAL PLAST S, V11, P395, DOI 10.1001/archfacial.2009.77; Nout E, 2012, J CRANIO MAXILL SURG, V40, P223, DOI 10.1016/j.jcms.2011.04.005; O'Connor EJF, 2009, PLAST RECONSTR SURG, V123, P1570, DOI 10.1097/PRS.0b013e3181a07625	13	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50333	10.1371/journal.pone.0050333	http://dx.doi.org/10.1371/journal.pone.0050333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236368	Green Published, gold, Green Submitted			2022-12-27	WOS:000312589700011
J	Posel, C; Moller, K; Frohlich, W; Schulz, I; Boltze, J; Wagner, DC				Poesel, Claudia; Moeller, Karoline; Froehlich, Wenke; Schulz, Isabell; Boltze, Johannes; Wagner, Daniel-Christoph			Density Gradient Centrifugation Compromises Bone Marrow Mononuclear Cell Yield	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; FICOLL-HYPAQUE SEPARATION; BLOOD LYSIS TECHNIQUE; STEM-CELLS; PROGENITOR CELLS; THERAPEUTIC ANGIOGENESIS; VENTRICULAR-FUNCTION; FLOW-CYTOMETRY; NORMAL ADULTS; TRANSPLANTATION	Bone marrow mononuclear cells (BMNCs) are widely used in regenerative medicine, but recent data suggests that the isolation of BMNCs by commonly used Ficoll-Paque density gradient centrifugation (DGC) causes significant cell loss and influences graft function. The objective of this study was to determine in an animal study whether and how Ficoll-Paque DGC affects the yield and composition of BMNCs compared to alternative isolation methods such as adjusted Percoll DGC or immunomagnetic separation of polymorphonuclear cells (PMNs). Each isolation procedure was confounded by a significant loss of BMNCs that was maximal after Ficoll-Paque DGC, moderate after adjusted Percoll DGC and least after immunomagnetic PMN depletion (25.6 +/- 5.8%, 51.5 +/- 2.3 and 72.3 +/- 6.7% recovery of total BMNCs in lysed bone marrow). Interestingly, proportions of BMNC subpopulations resembled those of lysed bone marrow indicating symmetric BMNC loss independent from the isolation protocol. Hematopoietic stem cell (HSC) content, determined by colony-forming units for granulocytes-macrophages (CFU-GM), was significantly reduced after Ficoll-Paque DGC compared to Percoll DGC and immunomagnetic PMN depletion. Finally, in a proof-of-concept study, we successfully applied the protocol for BMNC isolation by immunodepletion to fresh human bone marrow aspirates. Our findings indicate that the common method to isolate BMNCs in both preclinical and clinical research can be considerably improved by replacing Ficoll-Paque DGC with adapted Percoll DGC, or particularly by immunodepletion of PMNs. Citation: Posel C, Moller K, Frohlich W, Schulz I, Boltze J, et al. (2012) Density Gradient Centrifugation Compromises Bone Marrow Mononuclear Cell Yield. PLoS ONE 7(12): e50293. doi:10.1371/journal.pone.0050293	[Poesel, Claudia; Moeller, Karoline; Froehlich, Wenke; Schulz, Isabell; Boltze, Johannes; Wagner, Daniel-Christoph] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany; [Froehlich, Wenke; Boltze, Johannes; Wagner, Daniel-Christoph] Translat Ctr Regenerat Med, Leipzig, Germany	Fraunhofer Gesellschaft	Posel, C (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany.	claudia.poesel@izi.fraunhofer.de		Boltze, Johannes/0000-0003-3956-4164	German Federal Ministry of Education and Research (BMBF) [01GN0981]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF), http://www.bmbf.de/en/index.php, grant number 01GN0981. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Ahmadbeigi N, 2012, CYTOTHERAPY, V14, P917, DOI 10.3109/14653249.2012.689426; Aktas M, 2008, CYTOTHERAPY, V10, P203, DOI 10.1080/14653240701851324; Assmus B, 2010, J AM COLL CARDIOL, V55, P1385, DOI 10.1016/j.jacc.2009.10.059; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Bhartiya D, 2012, STEM CELLS DEV, V21, P1, DOI 10.1089/scd.2011.0311; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Federmann B, 2012, HAEMATOL-HEMATOL J, V97, P1523, DOI 10.3324/haematol.2011.059378; Friedrich MAG, 2012, CELL TRANSPLANT, V21, pS13, DOI 10.3727/096368912X612512; Ghodsizad A, 2004, CYTOTHERAPY, V6, P523, DOI 10.1080/14653240410005014; Goodchild TT, 2009, JACC-CARDIOVASC INTE, V2, P1005, DOI 10.1016/j.jcin.2009.08.010; Jaatinen Taina, 2007, Curr Protoc Stem Cell Biol, VChapter 2, DOI [10.1002/9780470151808.sc02a02s1, 10.1002/9780470151808.sc02a01s1]; Korf-Klingebiel M, 2008, EUR HEART J, V29, P2851, DOI 10.1093/eurheartj/ehn456; Koskenvuo JW, 2012, ANN MED; Lachtermacher S, 2012, STEM CELL REV REP, V8, P251, DOI 10.1007/s12015-011-9282-2; Lannert H, 2008, BONE MARROW TRANSPL, V42, P443, DOI 10.1038/bmt.2008.196; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Luttmann W, 2006, IMMUNOLOGY; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; Matoba S, 2008, AM HEART J, V156, P1010, DOI 10.1016/j.ahj.2008.06.025; Medina RJ, 2006, INT J MOL MED, V17, P721; Mouquet F, 2011, CELL TRANSPLANT, V20, P1087, DOI 10.3727/096368910X544924; Naranbhai V, 2011, J IMMUNOL METHODS, V366, P28, DOI 10.1016/j.jim.2011.01.001; Nieto JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031297; Preobrazhensky SN, 2009, CRYOBIOLOGY, V59, P366, DOI 10.1016/j.cryobiol.2009.09.008; RENZI P, 1987, J IMMUNOL METHODS, V98, P53, DOI 10.1016/0022-1759(87)90434-0; ROMEU MA, 1992, J IMMUNOL METHODS, V154, P7; Rosca AM, 2010, BIOTECHNOL APPL BIOC, V55, P199, DOI 10.1042/BA20090356; Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172; Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Seeger FH, 2007, EUR HEART J, V28, P766, DOI 10.1093/eurheartj/ehl509; Stelzer GT, 1997, CYTOMETRY, V30, P214, DOI 10.1002/(SICI)1097-0320(19971015)30:5<214::AID-CYTO2>3.0.CO;2-H; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Tendera M, 2009, EUR HEART J, V30, P1313, DOI 10.1093/eurheartj/ehp073; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; van Beem Rachel T, 2008, EuroIntervention, V4, P133; Yerebakan C, 2011, J THORAC CARDIOV SUR, V142, P1530, DOI 10.1016/j.jtcvs.2011.05.002	41	84	88	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50293	10.1371/journal.pone.0050293	http://dx.doi.org/10.1371/journal.pone.0050293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236366	gold, Green Submitted, Green Published			2022-12-27	WOS:000312589700010
J	Zahn, R; Gillisen, G; Roos, A; Koning, M; van der Helm, E; Spek, D; Weijtens, M; Pau, MG; Radosevic, K; Weverling, GJ; Custers, J; Vellinga, J; Schuitemaker, H; Goudsmit, J; Rodriguez, A				Zahn, Roland; Gillisen, Gert; Roos, Anna; Koning, Marina; van der Helm, Esmeralda; Spek, Dirk; Weijtens, Mo; Pau, Maria Grazia; Radosevic, Katarina; Weverling, Gerrit Jan; Custers, Jerome; Vellinga, Jort; Schuitemaker, Hanneke; Goudsmit, Jaap; Rodriguez, Ariane			Ad35 and Ad26 Vaccine Vectors Induce Potent and Cross-Reactive Antibody and T-Cell Responses to Multiple Filovirus Species	PLOS ONE			English	Article							PROTECTS NONHUMAN-PRIMATES; ATTENUATED RECOMBINANT VACCINE; EBOLA-VIRUS INFECTION; HEMORRHAGIC-FEVER; MARBURG VIRUS; ADENOVIRUS VECTORS; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSES; RHESUS-MONKEYS; POPULATIONS	Filoviruses cause sporadic but highly lethal outbreaks of hemorrhagic fever in Africa in the human population. Currently, no drug or vaccine is available for treatment or prevention. A previous study with a vaccine candidate based on the low seroprevalent adenoviruses 26 and 35 (Ad26 and Ad35) was shown to provide protection against homologous Ebola Zaire challenge in non human primates (NHP) if applied in a prime-boost regimen. Here we have aimed to expand this principle to construct and evaluate Ad26 and Ad35 vectors for development of a vaccine to provide universal filovirus protection against all highly lethal strains that have caused major outbreaks in the past. We have therefore performed a phylogenetic analysis of filovirus glycoproteins to select the glycoproteins from two Ebola species (Ebola Zaire and Ebola Sudan/Gulu,), two Marburg strains (Marburg Angola and Marburg Ravn) and added the more distant non-lethal Ebola Ivory Coast species for broadest coverage. Ad26 and Ad35 vectors expressing these five filovirus glycoproteins were evaluated to induce a potent cellular and humoral immune response in mice. All adenoviral vectors induced a humoral immune response after single vaccination in a dose dependent manner that was cross-reactive within the Ebola and Marburg lineages. In addition, both strain-specific as well as cross-reactive T cell responses could be detected. A heterologous Ad26-Ad35 prime-boost regime enhanced mainly the humoral and to a lower extend the cellular immune response against the transgene. Combination of the five selected filovirus glycoproteins in one multivalent vaccine potentially elicits protective immunity in man against all major filovirus strains that have caused lethal outbreaks in the last 20 years. Citation: Zahn R, Gillisen G, Roos A, Koning M, van der Helm E, et al. (2012) Ad35 and Ad26 Vaccine Vectors Induce Potent and Cross-Reactive Antibody and T-Cell Responses to Multiple Filovirus Species. PLoS ONE 7(12): e44115. doi:10.1371/journal.pone.0044115	[Zahn, Roland; Gillisen, Gert; Roos, Anna; Koning, Marina; van der Helm, Esmeralda; Spek, Dirk; Weijtens, Mo; Pau, Maria Grazia; Radosevic, Katarina; Weverling, Gerrit Jan; Custers, Jerome; Vellinga, Jort; Schuitemaker, Hanneke; Goudsmit, Jaap; Rodriguez, Ariane] Crucell Holland BV, Leiden, Netherlands	Johnson & Johnson	Rodriguez, A (corresponding author), Crucell Holland BV, Leiden, Netherlands.	Ariane.Rodriquez@crucell.com			Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200800056C]	Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services	This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200800056C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Alazard-Dany N, 2006, J GEN VIROL, V87, P1247, DOI 10.1099/vir.0.81361-0; Bannister B, 2010, BRIT MED BULL, V95, P193, DOI 10.1093/bmb/ldq022; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Becquart P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009126; Bradfute SB, 2011, HUM VACCINES, V7, P701, DOI 10.4161/hv.7.6.15398; Busico KM, 1999, J INFECT DIS, V179, pS102, DOI 10.1086/514309; Daddario-DiCaprio KM, 2006, J VIROL, V80, P9659, DOI 10.1128/JVI.00959-06; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ersching J, 2010, VIROLOGY, V407, P1, DOI 10.1016/j.virol.2010.07.043; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Francois Jerome, 2010, Proceedings 2010 IEEE International Workshop on Information Forensics and Security (WIFS 2010), DOI 10.1109/WIFS.2010.5711450; Geisbert TW, 2011, J VIROL, V85, P4222, DOI 10.1128/JVI.02407-10; Geisbert TW, 2010, REV MED VIROL, V20, P344, DOI 10.1002/rmv.661; Geisbert TW, 2010, J VIROL, V84, P10386, DOI 10.1128/JVI.00594-10; Geisbert TW, 2009, J VIROL, V83, P7296, DOI 10.1128/JVI.00561-09; Gonzalez JP, 2000, MICROBES INFECT, V2, P39, DOI 10.1016/S1286-4579(00)00287-2; GONZALEZ JP, 1989, RES VIROLOGY, V140, P319, DOI 10.1016/S0923-2516(89)80112-8; Groseth A, 2007, TRENDS MICROBIOL, V15, P408, DOI 10.1016/j.tim.2007.08.001; Havenga M, 2006, J GEN VIROL, V87, P2135, DOI 10.1099/vir.0.81956-0; Hayman DTS, 2010, PLOS ONE, V5; Hensley LE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000904; Holmes EC, 2009, EVOLUTION EMERGENCE, P254; Honeyman MC, 1998, NAT BIOTECHNOL, V16, P966, DOI 10.1038/nbt1098-966; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Jahrling PB, 1996, ARCH VIROL, P135; Jahrling PB, 2007, J INFECT DIS, V196, pS400, DOI 10.1086/520587; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kotturi MF, 2008, J IMMUNOL, V181, P2124, DOI 10.4049/jimmunol.181.3.2124; Kuhn JH, 2010, ARCH VIROLOGY; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Leroy EM, 2002, J GEN VIROL, V83, P67, DOI 10.1099/0022-1317-83-1-67; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Olinger GG, 2005, J VIROL, V79, P14189, DOI 10.1128/JVI.79.22.14189-14196.2005; Ophorst OJAE, 2007, VACCINE, V25, P6501, DOI 10.1016/j.vaccine.2007.06.019; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Pratt WD, 2010, CLIN VACCINE IMMUNOL, V17, P572, DOI 10.1128/CVI.00467-09; Qiu XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005547; Radosevic K, 2010, CLIN VACCINE IMMUNOL, V17, P1687, DOI 10.1128/CVI.00311-10; Radosevic K, 2009, EXPERT REV VACCINES, V8, P577, DOI 10.1586/ERV.09.14; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reed DS, 2007, VACCINE, V25, P1923, DOI 10.1016/j.vaccine.2006.11.037; Rhee EG, 2010, J VIROL, V84, P10413, DOI 10.1128/JVI.00928-10; Rodriguez A, 2009, VACCINE, V27, P6226, DOI 10.1016/j.vaccine.2009.07.106; Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Shott JP, 2008, VACCINE, V26, P2818, DOI 10.1016/j.vaccine.2008.03.080; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Sullivan NJ, 2011, NATURE MED; Swenson DL, 2008, CLIN VACCINE IMMUNOL, V15, P460, DOI 10.1128/CVI.00431-07; Swenson DL, 2008, EXPERT REV VACCINES, V7, P417, DOI 10.1586/14760584.7.4.417; Towner JS, 2007, J INFECT DIS, V196, pS205, DOI 10.1086/520601; Towner JS, 2006, J VIROL, V80, P6497, DOI 10.1128/JVI.00069-06; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536	66	43	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e44115	10.1371/journal.pone.0044115	http://dx.doi.org/10.1371/journal.pone.0044115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236343	Green Published, gold, Green Submitted			2022-12-27	WOS:000312589700001
J	Bonilla, C; Lawlor, DA; Taylor, AE; Gunnell, DJ; Ben-Shlomo, Y; Ness, AR; Timpson, NJ; St Pourcain, B; Ring, SM; Emmett, PM; Smith, AD; Refsum, H; Pennell, CE; Brion, MJ; Smith, GD; Lewis, SJ				Bonilla, Carolina; Lawlor, Debbie A.; Taylor, Amy E.; Gunnell, David J.; Ben-Shlomo, Yoav; Ness, Andrew R.; Timpson, Nicholas J.; St Pourcain, Beate; Ring, Susan M.; Emmett, Pauline M.; Smith, A. David; Refsum, Helga; Pennell, Craig E.; Brion, Marie-Jo; Smith, George Davey; Lewis, Sarah J.			Vitamin B-12 Status during Pregnancy and Child's IQ at Age 8: A Mendelian Randomization Study in the Avon Longitudinal Study of Parents and Children	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COGNITIVE FUNCTION; COBALAMIN STATUS; GENETIC EPIDEMIOLOGY; TRANSCOBALAMIN GENE; HOMOCYSTEINE; POLYMORPHISM; PLASMA; POPULATION; FOLATE	Vitamin B-12 is essential for the development and maintenance of a healthy nervous system. Brain development occurs primarily in utero and early infancy, but the role of maternal vitamin B-12 status during pregnancy on offspring cognitive function is unclear. In this study we assessed the effect of vitamin B-12 status in well-nourished pregnant women on the cognitive ability of their offspring in a UK birth cohort (ALSPAC). We then examined the association of SNPs in maternal genes FUT2 (rs492602) and TCN2 (rs1801198, rs9606756) that are related to plasma vitamin B-12, with offspring IQ. Observationally, there was a positive association between maternal vitamin B-12 intake and child's IQ that was markedly attenuated after adjustment for potential confounders (mean difference in offspring IQ score per doubling of maternal B-12 intake, before adjustment: 2.0 (95% CI 1.3, 2.8); after adjustment: 0.7 (95% CI -0.04, 1.4)). Maternal FUT2 was weakly associated with offspring IQ: mean difference in IQ per allele was 0.9 (95% CI 0.1, 1.6). The expected effect of maternal vitamin B-12 on offspring IQ, given the relationships between SNPs and vitamin B-12, and SNPs and IQ was consistent with the observational result. Our findings suggest that maternal vitamin B-12 may not have an important effect on offspring cognitive ability. However, further examination of this issue is warranted.	[Bonilla, Carolina; Lawlor, Debbie A.; Taylor, Amy E.; Timpson, Nicholas J.; Brion, Marie-Jo; Smith, George Davey] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Ness, Andrew R.] Univ Bristol, Sch Oral & Dent Sci, Bristol, Avon, England; [Smith, A. David; Refsum, Helga] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Refsum, Helga] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Pennell, Craig E.; Brion, Marie-Jo] Univ Western Australia, Sch Womens & Infants Hlth, Nedlands, WA 6009, Australia	University of Bristol; University of Bristol; University of Oxford; University of Oslo; University of Western Australia	Bonilla, C (corresponding author), Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England.	C.Bonilla@bristol.ac.uk	Refsum, Helga/A-4073-2010; Davey Smith, George/A-7407-2013; Berryman, Katie/J-4236-2014; Fox, Laura J/C-6249-2016; Timpson, Nicholas John/O-7548-2015; Attrill, Lauren/V-1688-2018; Ness, Andy R/M-7612-2013; Gunnell, David/ABE-6653-2020; Bonilla, Carolina/U-9263-2018; Brion, Marie-Jo A/O-6825-2014; Study, Raine/G-9547-2015; Smith, Anthony D./A-4233-2010; Pennell, Craig/ABD-6902-2020; Emmett, Pauline/AAL-6815-2021; Ben-Shlomo, Yoav/ABD-2004-2021	Davey Smith, George/0000-0002-1407-8314; Timpson, Nicholas John/0000-0002-7141-9189; Ness, Andy R/0000-0003-3548-9523; Gunnell, David/0000-0002-0829-6470; Bonilla, Carolina/0000-0002-9972-6383; Brion, Marie-Jo A/0000-0002-9030-2103; Smith, Anthony D./0000-0002-1095-6722; Pennell, Craig/0000-0002-0937-6165; Ben-Shlomo, Yoav/0000-0001-6648-3007; St Pourcain, Beate/0000-0002-4680-3517; Lewis, Sarah/0000-0003-4311-6890; s, hema/0000-0002-3440-9475; Lawlor, Debbie A/0000-0002-6793-2262; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Emmett, Pauline/0000-0003-1076-4779	Wellcome Trust [WT084668MA, 076467]; UK Medical Research Council [G0600705, 74882]; University of Bristol; MRC (Medical Research Council); Arthritic Association; Sir Henry Wellcome Postdoctoral Fellowship [085515]; University of Western Australia (UWA); Telethon Institute for Child Health Research; Raine Medical Research Foundation; UWA Faculty of Medicine, Dentistry and Health Sciences; Women and Infants Research Foundation; Australian National Health and Medical Research Council; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705, G9815508] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritic Association; Sir Henry Wellcome Postdoctoral Fellowship; University of Western Australia (UWA); Telethon Institute for Child Health Research; Raine Medical Research Foundation; UWA Faculty of Medicine, Dentistry and Health Sciences; Women and Infants Research Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by a Wellcome Trust grant (grant ref: WT084668MA), which funds CB. AET is funded by a Wellcome Trust PhD studentship and DAL, NJT and GDS work in an MRC Centre that is supported by the UK Medical Research Council (G0600705) and the University of Bristol; the MRC (Medical Research Council) contribution to this centre funds NJT's salary. DJG is an NIHR Senior Investigator (National Institute for Health Research), the work of PME is partly supported by the Arthritic Association. The UK Medical Research Council (grant ref: 74882), the Wellcome Trust (grant ref: 076467) and the University of Bristol provide core support for ALSPAC. MJB is funded by a Sir Henry Wellcome Postdoctoral Fellowship (grant ref: 085515). Core management for the Raine study is funded by The University of Western Australia (UWA), Telethon Institute for Child Health Research, Raine Medical Research Foundation, UWA Faculty of Medicine, Dentistry and Health Sciences and the Women and Infants Research Foundation. Collection, extraction and genotyping of maternal and child DNA in Raine was funded by the Australian National Health and Medical Research Council and the Women and Infants Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afman LA, 2002, EUR J HUM GENET, V10, P433, DOI 10.1038/sj.ejhg.5200830; Akcam M, 2010, INDIAN PEDIATR, V47, P119, DOI 10.1007/s13312-010-0017-2; Benton D, 2008, EUR J NUTR, V47, P38, DOI 10.1007/s00394-008-3004-9; Bhate V, 2008, FOOD NUTR BULL, V29, P249, DOI 10.1177/156482650802900401; Black MM, 2008, FOOD NUTR BULL, V29, pS126, DOI 10.1177/15648265080292S117; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Castro R, 2010, CLIN BIOCHEM, V43, P645, DOI 10.1016/j.clinbiochem.2010.01.015; Davey Smith G, PLOS MED, V4, pe352; Garcia CD, 2009, NUTR NEUROSCI, V12, P13, DOI 10.1179/147683009X388913; Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6; Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Hay G, 2010, J NUTR, V140, P557, DOI 10.3945/jn.109.117424; Hazra A, 2008, NAT GENET, V40, P1160, DOI 10.1038/ng.210; Holland B., 1991, MCCANCE WIDDOWSONS C, V5; Joinson C, 2007, PEDIATRICS, V120, pE308, DOI 10.1542/peds.2006-2891; Jones RW, 2000, EUR J HUM GENET, V8, P653, DOI 10.1038/sj.ejhg.5200502; KELLEHER BP, 1987, CLIN CHEM, V33, P52; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lievers KJA, 2002, CLIN CHEM, V48, P1383; Louwman MWJ, 2000, AM J CLIN NUTR, V72, P762; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Morkbak AL, 2007, HAEMATOLOGICA, V92, P1711, DOI 10.3324/haematol.11636; Murphy MM, 2007, J NUTR, V137, P1863, DOI 10.1093/jn/137.8.1863; Namour F, 2001, BLOOD, V97, P1092, DOI 10.1182/blood.V97.4.1092; Obeid R, 2005, CLIN CHEM LAB MED, V43, P1052, DOI 10.1515/CCLM.2005.184; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Refsum H, 2006, CLIN CHEM, V52, P129, DOI 10.1373/clinchem.2005.054619; Riedel BM, 2011, J NUTR, V141, P1784, DOI 10.3945/jn.111.141960; Rogers I, 1998, EUR J CLIN NUTR, V52, P246, DOI 10.1038/sj.ejcn.1600543; Silla Y, 2011, BIOCHEMISTRY-US, V50, P1396, DOI 10.1021/bi101095g; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Tanaka T, 2009, AM J HUM GENET, V84, P477, DOI 10.1016/j.ajhg.2009.02.011; Veena SR, 2010, J NUTR, V140, P1014, DOI 10.3945/jn.109.118075; Verduijn M, 2010, NEPHROL DIAL TRANSPL, V25, P1394, DOI 10.1093/ndt/gfq098; Vogiatzoglou A, 2009, AM J CLIN NUTR, V89, P1078, DOI 10.3945/ajcn.2008.26598; von Castel-Dunwoody KM, 2005, AM J CLIN NUTR, V81, P1436; vonSchenck U, 1997, ARCH DIS CHILD, V77, P137, DOI 10.1136/adc.77.2.137; Wechsler D., 1991, MANUAL WECHSLER INTE	41	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51084	10.1371/journal.pone.0051084	http://dx.doi.org/10.1371/journal.pone.0051084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227234	gold, Green Published, Green Submitted			2022-12-27	WOS:000312588200094
J	Gray, SM; Akob, DM; Green, SJ; Kostka, JE				Gray, Sarah M.; Akob, Denise M.; Green, Stefan J.; Kostka, Joel E.			The Bacterial Composition within the Sarracenia purpurea Model System: Local Scale Differences and the Relationship with the Other Members of the Food Web	PLOS ONE			English	Article							PITCHER-PLANT; COMMUNITY STRUCTURE; DIVERSITY; RICHNESS; DISTINCT	The leaves of the carnivorous pitcher plant, Sarracenia purpurea, contain a microscopic aquatic food web that is considered a model system in ecological research. The species identity of the intermediate and top trophic level of this food web, as well the detritivore midge, are highly similar across the native geographic range of S. purpurea and, in some cases, appear to have co-evolved with the plant. However, until recently, the identity, geographic variation, and diversity of the bacteria in the bottom trophic level of this food web have remained largely unknown. This study investigated bacterial community composition inside the leaves of S. purpurea to address: 1) variation in bacterial communities at the beginning of succession at the local scale in different areas of the plant's native geographic range (southern and mid-regional sites) and 2) the impacts of bacterial consumers and other members of the aquatic food web (i. e., insects) on bacterial community structure. Communities from six leaves (one leaf per plant) from New York and Florida study sites were analyzed using 16S ribosomal RNA gene cloning. Each pitcher within each site had a distinct community; however, there was more overlap in bacterial composition within each site than when communities were compared across sites. In contrast, the identity of protozoans and metazoans in this community were similar in species identity both within a site and between the two sites, but abundances differed. Our results indicate that, at least during the beginning of succession, there is no strong selection for bacterial taxa and that there is no core group of bacteria required by the plant to start the decomposition of trapped insects. Co-evolution between the plant and bacteria appears to not have occurred as it has for other members of this community.	[Gray, Sarah M.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Gray, Sarah M.] Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland; [Akob, Denise M.] Univ Jena, Inst Ecol, Jena, Germany; [Green, Stefan J.] Univ Illinois, Res Resources Ctr, DNA Serv Facil, Chicago, IL USA; [Green, Stefan J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Kostka, Joel E.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kostka, Joel E.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Fribourg; Friedrich Schiller University of Jena; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Gray, SM (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	sarahmarie.gray@unifr.ch	Akob, Denise/D-9478-2013	Akob, Denise/0000-0003-1534-3025; Green, Stefan/0000-0003-2781-359X	United States Department of Energy [ER65245]; United States National Institutes of Health [GM060731]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060731] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Office of Biological and Environmental Research, Terrestrial Ecosystem Science (TES) Program, under the United States Department of Energy contract #ER65245 (J. Kostka as PI) and by United States National Institutes of Health Grant # GM060731 (D. Dykuizen as PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT JF, 1974, ECOLOGY, V55, P475, DOI 10.2307/1935141; Akob DM, 2007, FEMS MICROBIOL ECOL, V59, P95, DOI 10.1111/j.1574-6941.2006.00203.x; BRADSHAW WE, 1984, AM MIDL NAT, V112, P294, DOI 10.2307/2425436; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Buckley HL, 2010, GLOBAL ECOL BIOGEOGR, V19, P711, DOI 10.1111/j.1466-8238.2010.00554.x; Buckley HL, 2003, ECOL LETT, V6, P825, DOI 10.1046/j.1461-0248.2003.00504.x; Cochran-Stafira DL, 1998, ECOLOGY, V79, P880, DOI 10.1890/0012-9658(1998)079[0880:IBIFWS]2.0.CO;2; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Gallie DR, 1997, PLANT PHYSIOL, V115, P1461, DOI 10.1104/pp.115.4.1461; Godt MJW, 1998, SYST BOT, V23, P427, DOI 10.2307/2419375; Gray SM, 2006, HYDROBIOLOGIA, V573, P173, DOI 10.1007/s10750-006-0265-2; Gray SM, 2012, AQUAT ECOL, V46, P487, DOI 10.1007/s10452-012-9417-9; Gray SM, 2011, THESIS STONY BROOK U; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; HEARD SB, 1994, ECOLOGY, V75, P1647, DOI 10.2307/1939625; Hegner RW, 1926, BIOL BULL-US, V50, P271, DOI 10.2307/1536674; Johnson John L., 1994, P683; Juniper B. E., 1989, CARNIVOROUS PLANTS; Kneitel JM, 2002, ECOLOGY, V83, P680, DOI 10.1890/0012-9658(2002)083[0680:RATPRI]2.0.CO;2; Koopman MM, 2011, MICROB ECOL, V61, P750, DOI 10.1007/s00248-011-9832-9; Koopman MM, 2010, APPL ENVIRON MICROB, V76, P1851, DOI 10.1128/AEM.02440-09; Krieger JR, 2012, FEMS MICROBIOL ECOL, V79, P555, DOI 10.1111/j.1574-6941.2011.01240.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Ludwig W., 2001, BERGEYS MANUAL SYSTE, P49; Miller TE, 2002, ECOLOGY, V83, P898, DOI 10.1890/0012-9658(2002)083[0898:EOCSOI]2.0.CO;2; Miller TE, 2012, OECOLOGIA, V170, P243, DOI 10.1007/s00442-012-2292-1; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Peterson CN, 2008, ENVIRON MICROBIOL, V10, P2257, DOI 10.1111/j.1462-2920.2008.01648.x; Schnell D.E., 2002, CARNIVOROUS PLANTS U; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990	33	20	20	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50969	10.1371/journal.pone.0050969	http://dx.doi.org/10.1371/journal.pone.0050969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227224	Green Published, gold			2022-12-27	WOS:000312588200085
J	Zhang, L; Ye, R; Yu, FQ; Cao, ZL; Zhu, CY; Cai, Z; Hu, PP; Pu, H; Wang, K				Zhang, Lei; Ye, Rong; Yu, Fengqiong; Cao, Zhaolun; Zhu, Chunyan; Cai, Zhu; Hu, Panpan; Pu, Hui; Wang, Kai			How Does Emotional Context Modulate Response Inhibition in Alexithymia: Electrophysiological Evidence from an ERP Study	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; EVENT-RELATED POTENTIALS; SCALE; CONFLICT; TASK; ASSOCIATION; PREVALENCE; ACTIVATION; STABILITY; PARADIGM	Background: Alexithymia, characterized by difficulties in identifying and describing feelings, is highly indicative of a broad range of psychiatric disorders. Several studies have also discovered the response inhibition ability impairment in alexithymia. However, few studies on alexithymic individuals have specifically examined how emotional context modulates response inhibition procedure. In order to investigate emotion cognition interaction in alexithymia, we analyzed the spatiao-temporal features of such emotional response inhibition by the approaches of event-related potentials and neural source-localization. Method: The study participants included 15 subjects with high alexithymia scores on the 20-item Toronto Alexithymia Scale (alexithymic group) and 15 matched subjects with low alexithymia scores (control group). Subjects were instructed to perform a modified emotional Go/Nogo task while their continuous electroencephalography activities were synchronously recorded. The task includes 3 categories of emotional contexts (positive, negative and neutral) and 2 letters ("M'' and "W'') centered in the screen. Participants were told to complete go and nogo actions based on the letters. We tested the influence of alexithymia in this emotional Go/Nogo task both in behavioral level and related neural activities of N2 and P3 ERP components. Results: We found that negatively valenced context elicited larger central P3 amplitudes of the Nogo-Go difference wave in the alexithymic group than in the control group. Furthermore, source-localization analyses implicated the anterior cingulate cortex (ACC) as the neural generator of the Nogo-P3. Conclusion: These findings suggest that difficulties in identifying feelings, particularly in negative emotions, is a major feature of alexithymia, and the ACC plays a critical role in emotion-modulated response inhibition related to alexithymia.	[Zhang, Lei; Ye, Rong; Yu, Fengqiong; Cao, Zhaolun; Zhu, Chunyan; Cai, Zhu; Wang, Kai] Anhui Med Univ, Lab Cognit Neuropsychol, Dept Med Psychol, Hefei, Anhui, Peoples R China; [Hu, Panpan; Pu, Hui; Wang, Kai] Anhui Med Univ, Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Wang, K (corresponding author), Anhui Med Univ, Lab Cognit Neuropsychol, Dept Med Psychol, Hefei, Anhui, Peoples R China.	wangkai1964@126.com	hu, panpan/ABD-5695-2021	Ye, Rong/0000-0003-2529-7755	Natural Science Foundation of China [81171273, 31100812, 31000503]; Special Research Fund for Doctoral Program of Higher Education [20113420110001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Research Fund for Doctoral Program of Higher Education	This research was supported by the Natural Science Foundation of China (81171273, 31100812, and 31000503), Special Research Fund for Doctoral Program of Higher Education (20113420110001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2010, NEUROIMAGE, V49, P914, DOI 10.1016/j.neuroimage.2009.08.045; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Berthoz S, 2002, AM J PSYCHIAT, V159, P961, DOI 10.1176/appi.ajp.159.6.961; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chiu PH, 2008, NEUROIMAGE, V42, P988, DOI 10.1016/j.neuroimage.2008.04.248; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delplanque S, 2004, NEUROSCI LETT, V356, P1, DOI 10.1016/j.neulet.2003.10.014; Delplanque S, 2007, J NEUROSCI METH, V165, P144, DOI 10.1016/j.jneumeth.2007.05.030; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Fallgatter AJ, 2002, J NEURAL TRANSM, V109, P977, DOI 10.1007/s007020200080; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; Fredrickson BL, 2004, PHILOS T R SOC B, V359, P1367, DOI 10.1098/rstb.2004.1512; Freitas AL, 2009, PSYCHOPHYSIOLOGY, V46, P1226, DOI 10.1111/j.1469-8986.2009.00864.x; GLENN SW, 1993, ALCOHOL, V10, P89, DOI 10.1016/0741-8329(93)90086-4; Goldstein M, 2007, NEUROIMAGE, V36, P1026, DOI 10.1016/j.neuroimage.2007.01.056; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; JODO E, 1990, ELECTROEN CLIN NEURO, V76, P249, DOI 10.1016/0013-4694(90)90019-G; Joukamaa M, 2007, J PSYCHOSOM RES, V63, P373, DOI 10.1016/j.jpsychores.2007.01.018; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Kamarajan C, 2005, CLIN NEUROPHYSIOL, V116, P1049, DOI 10.1016/j.clinph.2004.12.015; Karlsson H, 2008, BRIT J PSYCHIAT, V192, P32, DOI 10.1192/bjp.bp.106.034728; Kugel H, 2008, NEUROSCI LETT, V435, P40, DOI 10.1016/j.neulet.2008.02.005; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Lemogne C, 2012, J AFFECT DISORDERS, V136, pE1, DOI 10.1016/j.jad.2010.11.034; Loas G, 2001, J PSYCHOSOM RES, V50, P255, DOI 10.1016/S0022-3999(01)00197-0; Luminet O, 2007, J PSYCHOSOM RES, V62, P641, DOI 10.1016/j.jpsychores.2007.01.003; Machin GC, 2009, PERS INDIV DIFFER, V46, P412, DOI 10.1016/j.paid.2008.11.010; Moriguchi Y, 2007, CEREB CORTEX, V17, P2223, DOI 10.1093/cercor/bhl130; Nemiah J.C., 1976, MODERN TRENDS PSYCHO, P430, DOI DOI 10.1016/J.IJNURSTU.2009.03.014; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Salminen JK, 1999, J PSYCHOSOM RES, V46, P75, DOI 10.1016/S0022-3999(98)00053-1; Shafritz KM, 2006, NEUROIMAGE, V31, P468, DOI 10.1016/j.neuroimage.2005.11.053; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Smith JL, 2008, CLIN NEUROPHYSIOL, V119, P704, DOI 10.1016/j.clinph.2007.11.042; Smith JL, 2006, INT J PSYCHOPHYSIOL, V61, P121, DOI 10.1016/j.ijpsycho.2005.07.013; Stadler C, 2007, J PSYCHIATR RES, V41, P410, DOI 10.1016/j.jpsychires.2006.01.006; Swick D, 2002, NEUROPSYCHOLOGIA, V40, P1240, DOI 10.1016/S0028-3932(01)00226-3; TAYLOR GJ, 1991, PSYCHOSOMATICS, V32, P153, DOI 10.1016/S0033-3182(91)72086-0; TAYLOR GJ, 1988, PSYCHIAT CLIN N AM, V11, P351; Tolmunen T, 2011, COMPR PSYCHIAT, V52, P536, DOI 10.1016/j.comppsych.2010.09.007; WISE TN, 1995, PSYCHOPATHOLOGY, V28, P173, DOI 10.1159/000284919; [蚁金瑶 Yi Jinyao], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P763; Zech E, 1999, EUR J PERSONALITY, V13, P511; Zhang L, 2008, CHIN J NERV MENT DIS, V2, P103; Zhang L, 2011, NEUROSCI LETT, V504, P261, DOI 10.1016/j.neulet.2011.09.043	52	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51110	10.1371/journal.pone.0051110	http://dx.doi.org/10.1371/journal.pone.0051110			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057TZ	23227242	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200101
J	Chao, CT; Hou, CC; Wu, VC; Lu, HM; Wang, CY; Chen, L; Kao, TW				Chao, Chia-Ter; Hou, Chun-Cheng; Wu, Vin-Cent; Lu, Hsin-Ming; Wang, Cheng-Yi; Chen, Likwang; Kao, Tze-Wah			The Impact of Dialysis-Requiring Acute Kidney Injury on Long-Term Prognosis of Patients Requiring Prolonged Mechanical Ventilation: Nationwide Population-Based Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; REPLACEMENT THERAPY; RESOURCE UTILIZATION; RISK-FACTORS; MORTALITY; OUTCOMES; DEATH; DISEASE	Background: Prolonged mechanical ventilation (PMV) is increasingly common worldwide, consuming enormous healthcare resources. Factors that modify PMV outcome are still obscure. Methods: We selected patients without preceding mechanical ventilation within the one past year and who developed PMV during index admission in Taiwan's National Health Insurance (NHI) system during 1998-2007 for comparison of mortality and resource use. They were divided into three groups: (1) patients with end-stage renal diseases (ESRD) before the index admission for PMV onset; (2) patients with dialysis-requiring acute kidney injury (AKI-dialysis) during the hospitalization course; and (3) patients without AKI or with non dialysis-requiring AKI during the hospitalization course (non-AKI). We used a random-effects logistic regression model to identify factors associated with mortality. Results: Compared with the other two groups, patients with AKI-dialysis had significantly longer mechanical ventilation, more frequent use of vasopressors, longer intensive care unit/hospital stay and higher inpatient expenditures during the index admission. Relative to non-AKI patients, patients with AKI-dialysis had an elevated mortality hazard; the adjusted relative risk ratios were 1.51 (95% confidence interval [CI]:1.46-1.56), 1.27 (95% CI: 1.23-1.32), and 1.10 (95% CI: 1.08-1.12) for mortality rates at discharge, 3 months, and 4 years after PMV, respectively. Patients with AKI-dialysis also consumed significantly higher total in-patient expenditure than the other two patient groups (p < 0.001). Conclusions: Among patients that need PMV care during an admission, the presence of de novo AKI requiring dialysis significantly increased short and long term mortality, and demand for health care resources.	[Chao, Chia-Ter; Wu, Vin-Cent; Kao, Tze-Wah] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan; [Hou, Chun-Cheng] Min Sheng Gen Hosp, Dept Internal Med, Tao Yuan, Taiwan; [Lu, Hsin-Ming; Chen, Likwang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Wang, Cheng-Yi] Cardinal Tien Hosp, Dept Internal Med, Xindian, Taiwan; [Hou, Chun-Cheng] Taipei Med Univ, Sch Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Health Research Institutes - Taiwan; Taipei Medical University	Chen, L (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan.	likwang@nhri.org.tw; twkao2@ntuh.gov.tw	Chen, Li-Kwang/E-3934-2010; Chao, Chia-Ter/H-7994-2019	Chao, Chia-Ter/0000-0003-2892-7986; WU, VIN-CENT/0000-0001-7935-0991	Taiwan's National Health Research Institutes [PH-100-PP-19, PH-101-PP-16]; National Taiwan University Hospital	Taiwan's National Health Research Institutes; National Taiwan University Hospital(National Taiwan University)	This study was financially supported by Taiwan's National Health Research Institutes, through grants PH-100-PP-19 and PH-101-PP-16; and by intramural funding from National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu U, 2011, CONTRIB NEPHROL, V174, P119, DOI 10.1159/000329249; Alkandari O, 2011, CRIT CARE, V15, DOI 10.1186/cc10269; Bruetto RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035496; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Carson SS, 2008, CRIT CARE MED, V36, P2061, DOI 10.1097/CCM.0b013e31817b8925; Carson SS, 2006, CURR OPIN CRIT CARE, V12, P405, DOI 10.1097/01.ccx.0000244118.08753.dc; Carson SS, 2012, CRIT CARE MED, V40, P1171, DOI 10.1097/CCM.0b013e3182387d43; Carson SS, 2001, CHEST, V120, P928, DOI 10.1378/chest.120.3.928; Chelluri L, 2004, CRIT CARE MED, V32, P61, DOI 10.1097/01.CCM.0000098029.65347.F9; Clermont G, 2002, KIDNEY INT, V62, P986, DOI 10.1046/j.1523-1755.2002.00509.x; Cox CE, 2007, CRIT CARE MED, V35, P1918, DOI 10.1097/01.CCM.0000275391.35834.10; Cox CE, 2007, CRIT CARE, V11, DOI 10.1186/cc5667; Flori HR, 2011, CRIT CARE RES PRACT, V2011, DOI 10.1155/2011/854142; Ho J, 2012, AM J KIDNEY DIS, V59, P196, DOI 10.1053/j.ajkd.2011.08.023; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Hung MC, 2011, CRIT CARE, V15, DOI 10.1186/cc10128; Hutchison CA, 2007, CRIT CARE, V11, DOI 10.1186/cc5785; Jassal SV, 2011, NEPHRON CLIN PRACT, V119, pC5, DOI 10.1159/000328017; Kao KC, 2011, J CRIT CARE, V26, P600, DOI 10.1016/j.jcrc.2011.03.005; Kojicic M, 2011, RESP CARE, V56, P1765, DOI 10.4187/respcare.01096; Kong WY, 2012, NEPHROLOGY, V17, P445, DOI 10.1111/j.1440-1797.2012.01593.x; Liano F, 1998, KIDNEY INT, V53, pS16; Lien YC, 2009, ANN THORAC SURG, V88, P1124, DOI 10.1016/j.athoracsur.2009.06.002; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Lone NI, 2011, CRIT CARE, V15, DOI 10.1186/cc10117; Lu HM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-100; MacIntyre NR, 2005, CHEST, V128, P3937, DOI 10.1378/chest.128.6.3937; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Metnitz PGH, 2002, CRIT CARE MED, V30, P2051, DOI 10.1097/00003246-200209000-00016; Needham DM, 2004, CRIT CARE MED, V32, P1504, DOI 10.1097/01.CCM.0000129972.31533.37; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Nierman DM, 2002, CRIT CARE CLIN, V18, P477, DOI 10.1016/S0749-0704(02)00010-6; Nin N, 2010, SHOCK, V34, P109, DOI 10.1097/SHK.0b013e3181d671a6; Ostermann M, 2008, CRIT CARE, V12, DOI 10.1186/cc7085; Pan SW, 2011, J CRIT CARE, V26, P586, DOI 10.1016/j.jcrc.2011.04.009; Ricci Z, 2011, NAT REV NEPHROL, V7, P201, DOI 10.1038/nrneph.2011.14; Rocha E, 2009, NEPHROL DIAL TRANSPL, V24, P1925, DOI 10.1093/ndt/gfn750; Scheinhorn DJ, 1998, CRIT CARE CLIN, V14, P819, DOI 10.1016/S0749-0704(05)70032-4; Seferian EG, 2008, CRIT CARE MED, V36, P2779, DOI 10.1097/CCM.0b013e318186ab1b; Sood MM, 2011, NEPHROL DIAL TRANSPL, V26, P2965, DOI 10.1093/ndt/gfq835; Strijack B, 2009, J AM SOC NEPHROL, V20, P2441, DOI 10.1681/ASN.2009040366; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Uchino S, 2003, BLOOD PURIFICAT, V21, P170, DOI 10.1159/000069156; Unroe M, 2010, ANN INTERN MED, V153, P167, DOI 10.7326/0003-4819-153-3-201008030-00007; Vieira JM, 2007, CRIT CARE MED, V35, P184, DOI 10.1097/01.CCM.0000249828.81705.65; Wald R, 2012, AM J MED, V125, P585, DOI 10.1016/j.amjmed.2012.01.016; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wi J, 2011, HEART, V97, P1753, DOI 10.1136/hrt.2010.218677; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	49	37	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50675	10.1371/journal.pone.0050675	http://dx.doi.org/10.1371/journal.pone.0050675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251377	gold, Green Submitted, Green Published			2022-12-27	WOS:000313236200034
J	Xiong, F; Liu, Y				Xiong, Fei; Liu, Yun			Empirical Analysis and Modeling of Users' Topic Interests in Online Forums	PLOS ONE			English	Article							NETWORKS; DYNAMICS	Bulletin Board Systems (BBSs) have demonstrated their usefulness in spreading information. In BBS forums, a few posts that address currently popular social topics attract a lot of attention, and different users are interested in many different discussion topics. We investigate topic cluster features and user interests of an actual BBS forum, analyzing user posting and replying behavior. According to the growing process of BBS, we suggest a network model in which each agent only replies to the posts that belong to its specific topics of interest. A post that is replied to will be immediately assigned the highest priority on the post list. Simulation results show that characteristics of our model are similar to those of the real BBS. The model with heterogeneous user interests promotes the occurrence of popular posts, and the user relationship network possesses a large clustering coefficient. Bursts and long waiting time exist in user replying behavior, leading to non-Poisson user activity pattern. In addition, the model produces an analogous evolving trend of Gini coefficients for posts' and clusters' participants as BBS forums.	[Xiong, Fei; Liu, Yun] Beijing Jiaotong Univ, Sch Elect & Informat Engn, Beijing, Peoples R China; [Xiong, Fei; Liu, Yun] Beijing Jiaotong Univ, Key Lab Commun & Informat Syst, Beijing Municipal Commiss Educ, Beijing, Peoples R China	Beijing Jiaotong University; Beijing Jiaotong University; Beijing Municipal Commission of Education	Liu, Y (corresponding author), Beijing Jiaotong Univ, Sch Elect & Informat Engn, Beijing, Peoples R China.	liuyun@bjtu.edu.cn			State Natural Sciences Fund [61172072, 61271308]; Beijing Natural Science Foundation [4112045]; Beijing Science and Technology Program [Z121100000312024]; Academic Discipline and Postgraduate Education Project of Beijing Municipal Commission of Education	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Science and Technology Program; Academic Discipline and Postgraduate Education Project of Beijing Municipal Commission of Education	This work has been supported by the State Natural Sciences Fund under Grants 61172072, 61271308, the Beijing Natural Science Foundation under Grant 4112045, the Beijing Science and Technology Program under Grant Z121100000312024, the Academic Discipline and Postgraduate Education Project of Beijing Municipal Commission of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2000, SCIENCE, V287, DOI 10.1126/science.287.5461.2115a; Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Ben-Naim E, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48003; Cai KQ, 2012, CHINESE PHYS B, V21, DOI 10.1088/1674-1056/21/2/028903; CAN F, 1990, ACM T DATABASE SYST, V15, P483, DOI 10.1145/99935.99938; Chmiel A, 2011, PHYSICA A, V390, P2936, DOI 10.1016/j.physa.2011.03.040; DAGUM C, 1980, ECON APPL, V33, P327; Di Mare A, 2007, INT J MOD PHYS C, V18, P1377, DOI 10.1142/S012918310701139X; Dietz H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.098101; Ding F, 2010, EUR PHYS J B, V78, P245, DOI 10.1140/epjb/e2010-10453-9; Ding F, 2010, 2ND IEEE INTERNATIONAL CONFERENCE ON ADVANCED COMPUTER CONTROL (ICACC 2010), VOL. 4, P571, DOI 10.1109/ICACC.2010.5486884; Fu F, 2008, PHYSICA A, V387, P675, DOI 10.1016/j.physa.2007.10.006; Goh KI, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066123; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Juanico B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.238104; Kleinberg J, 2001, SCIENCE, V294, P1849, DOI 10.1126/science.1067014; Lv L, 2011, PLOS ONE, V6; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Osinski S, 2005, IEEE INTELL SYST, V20, P48, DOI 10.1109/MIS.2005.38; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Si XM, 2011, ACTA PHYS SIN-CH ED, V60, DOI 10.7498/aps.60.078903; Wang P, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18005; Wang WX, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046109; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu Y, 2007, ACTA PHYS SIN-CH ED, V56, P2037, DOI 10.7498/aps.56.2037; Xie YB, 2008, PHYSICA A, V387, P1683, DOI 10.1016/j.physa.2007.11.005; Xiong F, 2011, EUR PHYS J B, V84, P115, DOI 10.1140/epjb/e2011-20286-7; Yu JF, 2010, PHYSICA A, V389, P3267, DOI 10.1016/j.physa.2010.03.043; Zhang H.P., 2003, P 2 SIGHAN WORKSH CH, P184, DOI [10.3115/1119250.1119280, DOI 10.3115/1119250.1119280]	33	5	7	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50912	10.1371/journal.pone.0050912	http://dx.doi.org/10.1371/journal.pone.0050912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251401	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200048
J	An, XH; Xiong, W; Yang, Y; Li, FH; Zhou, XF; Wang, ZJ; Deng, ZX; Liang, JD				An, Xianhui; Xiong, Wei; Yang, Yan; Li, Fuhou; Zhou, Xiufen; Wang, Zhijun; Deng, Zixin; Liang, Jingdan			A Novel Target of IscS in Escherichia coli: Participating in DNA Phosphorothioation	PLOS ONE			English	Article							STREPTOMYCES-LIVIDANS; SELENOCYSTEINE LYASE; S-MODIFICATION; GENE CLONING; TRANSFER-RNA; SULFUR; PURIFICATION; BACTERIA; BACKBONE; SEQUENCE	Many bacterial species modify their DNA with the addition of sulfur to phosphate groups, a modification known as DNA phosphorothioation. DndA is known to act as a cysteine desulfurase, catalyzing a key biochemical step in phosphorothioation. However, bioinformatic analysis revealed that 19 out of the 31 known dnd gene clusters, contain only four genes (dndB-E), lacking a key cysteine desulfurase corresponding gene. There are multiple cysteine desulfurase genes in Escherichia coli, but which one of them participates into DNA phosphorothioation is unknown. Here, by employing heterologous expression of the Salmonella enterica dnd gene cluster named dptBCDE in three E. coli mutants, each of which lacked a different cysteine desulfurase gene, we show that IscS is the only cysteine desulfurase that collaborates with dptB-E, resulting in DNA phosphorothioation. Using a bacterial two-hybrid system, protein interactions between IscS and DptC, and IscS and DptE were identified. Our findings revealed IscS as a key participant in DNA phosphorothioation and lay the basis for in-depth analysis of the DNA phosphorothioation biochemical pathway.	[An, Xianhui; Xiong, Wei; Yang, Yan; Li, Fuhou; Zhou, Xiufen; Wang, Zhijun; Deng, Zixin; Liang, Jingdan] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [An, Xianhui; Xiong, Wei; Yang, Yan; Li, Fuhou; Zhou, Xiufen; Wang, Zhijun; Deng, Zixin; Liang, Jingdan] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [An, Xianhui; Li, Fuhou] Ocean Coll, HuaiHai Inst Technol, Lianyungang, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Jiangsu Ocean University	Deng, ZX (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	zxdeng@sjtu.edu.cn; jdliang@sjtu.edu.cn	Yang, Sophie/GQB-2082-2022		National Science Foundation of China; Ministry of Science and Technology (973 program); Ministry of Science and Technology (863 program); Ministry of Education of China; Shanghai Municipal Council of Science and Technology and Shanghai Leading Academic Discipline Project [B203]; State Key Laboratory of Bio-Organic and Natural Products Chemistry (CAS); National Program of Development of Transgenic New Species of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (973 program)(National Basic Research Program of China); Ministry of Science and Technology (863 program); Ministry of Education of China(Ministry of Education, China); Shanghai Municipal Council of Science and Technology and Shanghai Leading Academic Discipline Project; State Key Laboratory of Bio-Organic and Natural Products Chemistry (CAS)(Chinese Academy of Sciences); National Program of Development of Transgenic New Species of China	The authors wish to thank the National Science Foundation of China, the Ministry of Science and Technology (973 and 863 programs), the Ministry of Education of China, the Shanghai Municipal Council of Science and Technology and Shanghai Leading Academic Discipline Project B203, the State Key Laboratory of Bio-Organic and Natural Products Chemistry (CAS) and the National Program of Development of Transgenic New Species of China for research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BJORK GR, 1995, PROG NUCLEIC ACID RE, V50, P263, DOI 10.1016/S0079-6603(08)60817-X; BJORK GR, 1987, ANNU REV BIOCHEM, V56, P263, DOI 10.1146/annurev.bi.56.070187.001403; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; He X, 2007, MOL MICROBIOL, V65, P1034, DOI 10.1111/j.1365-2958.2007.05846.x; Liang JD, 2007, NUCLEIC ACIDS RES, V35, P2944, DOI 10.1093/nar/gkm176; Mihara H, 1997, J BIOL CHEM, V272, P22417, DOI 10.1074/jbc.272.36.22417; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Ou HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005132; Ray T, 1992, FEDERATION EUROPEAN, V96, P6; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Stratagene, 2008, BACTERIOMATCH 2 2 HY; Wang LR, 2007, NAT CHEM BIOL, V3, P709, DOI 10.1038/nchembio.2007.39; Xu TG, 2010, NUCLEIC ACIDS RES, V38, P7133, DOI 10.1093/nar/gkq610; Xu TG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-41; You DL, 2007, BIOCHEMISTRY-US, V46, P6126, DOI 10.1021/bi602615k; Zhang WJ, 2010, J BIOL CHEM, V285, P2302, DOI 10.1074/jbc.M109.082172; Zhou XF, 2005, MOL MICROBIOL, V57, P1428, DOI 10.1111/j.1365-2958.2005.04764.x	19	35	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51265	10.1371/journal.pone.0051265	http://dx.doi.org/10.1371/journal.pone.0051265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240007	gold, Green Published, Green Submitted			2022-12-27	WOS:000312290800043
J	Millen, AM; Horvath, P; Boyaval, P; Romero, DA				Millen, Anne M.; Horvath, Philippe; Boyaval, Patrick; Romero, Dennis A.			Mobile CRISPR/Cas-Mediated Bacteriophage Resistance in Lactococcus lactis	PLOS ONE			English	Article							SHORT PALINDROMIC REPEATS; STREPTOCOCCUS-LACTIS; ESCHERICHIA-COLI; IMMUNE-SYSTEM; SEQUENCE-ANALYSIS; CONJUGAL TRANSFER; CELL-AGGREGATION; GENOME ANALYSIS; SEED SEQUENCE; DNA ELEMENTS	Lactococcus lactis is a biotechnological workhorse for food fermentations and potentially therapeutic products and is therefore widely consumed by humans. It is predominantly used as a starter microbe for fermented dairy products, and specialized strains have adapted from a plant environment through reductive evolution and horizontal gene transfer as evidenced by the association of adventitious traits with mobile elements. Specifically, L. lactis has armed itself with a myriad of plasmid-encoded bacteriophage defensive systems to protect against viral predation. This known arsenal had not included CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins), which forms a remarkable microbial immunity system against invading DNA. Although CRISPR/Cas systems are common in the genomes of closely related lactic acid bacteria (LAB), none was identified within the eight published lactococcal genomes. Furthermore, a PCR-based search of the common LAB CRISPR/Cas systems (Types I and II) in 383 industrial L. lactis strains proved unsuccessful. Here we describe a novel, Type III, self-transmissible, plasmid-encoded, phage-interfering CRISPR/Cas discovered in L. lactis. The native CRISPR spacers confer resistance based on sequence identity to corresponding lactococcal phage. The interference is directed at phages problematic to the dairy industry, indicative of a responsive system. Moreover, targeting could be modified by engineering the spacer content. The 62.8-kb plasmid was shown to be conjugally transferrable to various strains. Its mobility should facilitate dissemination within microbial communities and provide a readily applicable system to naturally introduce CRISPR/Cas to industrially relevant strains for enhanced phage resistance and prevention against acquisition of undesirable genes.	[Millen, Anne M.; Romero, Dennis A.] DuPont Nutr & Hlth, Madison, WI 55431 USA; [Horvath, Philippe; Boyaval, Patrick] DuPont Nutr & Hlth, Dange St Romain, France	DuPont	Romero, DA (corresponding author), DuPont Nutr & Hlth, Madison, WI 55431 USA.	dennis.romero@dupont.com	HORVATH, Philippe/K-5266-2015	HORVATH, Philippe/0000-0003-2015-8123				Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; ANDERSON DG, 1984, J BACTERIOL, V158, P954, DOI 10.1128/JB.158.3.954-962.1984; ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; CHOPIN A, 1984, PLASMID, V11, P260, DOI 10.1016/0147-619X(84)90033-7; Coffey A, 2002, ANTON LEEUW INT J G, V82, P303, DOI 10.1023/A:1020639717181; Crutz-Le Coq AM, 2002, MICROBIOL-SGM, V148, P985, DOI 10.1099/00221287-148-4-985; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dougherty BA, 1998, MOL MICROBIOL, V29, P1029, DOI 10.1046/j.1365-2958.1998.00988.x; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Garrett RA, 2011, TRENDS MICROBIOL, V19, P549, DOI 10.1016/j.tim.2011.08.002; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Hayes F, 1998, J BACTERIOL, V180, P6415; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kelly WJ, 2010, GENOME BIOL EVOL, V2, P729, DOI 10.1093/gbe/evq056; KOK J, 1984, APPL ENVIRON MICROB, V48, P726, DOI 10.1128/AEM.48.4.726-731.1984; Labrie SJ, 2008, APPL ENVIRON MICROB, V74, P4636, DOI 10.1128/AEM.00118-08; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Mahanivong C, 2001, APPL ENVIRON MICROB, V67, P3564, DOI 10.1128/AEM.67.8.3564-3576.2001; Mahony J, 2006, FEMS MICROBIOL LETT, V261, P253, DOI 10.1111/j.1574-6968.2006.00372.x; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; MCKAY LL, 1980, APPL ENVIRON MICROB, V40, P84, DOI 10.1128/AEM.40.1.84-91.1980; MCKAY LL, 1972, APPL MICROBIOL, V23, P1090, DOI 10.1128/AEM.23.6.1090-1096.1972; Mills S, 2006, FEMS MICROBIOL REV, V30, P243, DOI 10.1111/j.1574-6976.2005.00011.x; Samson JE, 2010, APPL ENVIRON MICROB, V76, P6843, DOI 10.1128/AEM.00796-10; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; SCHOULER C, 1994, MICROBIOL-UK, V140, P3061, DOI 10.1099/13500872-140-11-3061; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shah SA, 2011, RES MICROBIOL, V162, P27, DOI 10.1016/j.resmic.2010.09.001; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Trotter M, 2006, GENE, V366, P189, DOI 10.1016/j.gene.2005.09.022; WALSH PM, 1981, J BACTERIOL, V146, P937, DOI 10.1128/JB.146.3.937-944.1981; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	48	54	59	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51663	10.1371/journal.pone.0051663	http://dx.doi.org/10.1371/journal.pone.0051663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240053	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800089
J	Rather, GM; Mukherjee, J; Halling, PJ; Gupta, MN				Rather, Gulam Mohmad; Mukherjee, Joyeeta; Halling, Peter James; Gupta, Munishwar Nath			Activation of Alpha Chymotrypsin by Three Phase Partitioning Is Accompanied by Aggregation	PLOS ONE			English	Article							BACTERIAL INCLUSION-BODIES; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; ORGANIC-SOLVENTS; PROTEIN; PURIFICATION; FLUORESCENCE; ENZYMES; HYDROPHOBICITY; SUBTILISIN	Precipitation of alpha chymotrypsin in the simultaneous presence of ammonium sulphate and t-butanol (three phase partitioning) resulted in preparations which showed self aggregation of the enzyme molecules. Precipitation with increasing amounts of ammonium sulphate led to increasing size of aggregates. While light scattering estimated the hydrodynamic diameter of these aggregates in the range of 242-1124 nm; Nanoparticle tracking analysis (NTA) gave the value as 130-462 nm. Scanning electron microscopy and gel filtration on Sephadex G-200 showed extensive aggregation in these preparations. Transmission electron microscopy showed that the aggregates had irregular shapes. All the aggregates had about 3 x higher catalytic activity than the native enzyme. These aggregates did not differ in lambda(max) of fluorescence emission which was around 340 nm. However, all the aggregates showed higher fluorescence emission intensity. Far-UV and near-UV circular dichroism also showed no significant structural changes as compared to the native molecule. Interestingly, HPLC gel filtration (on a hydroxylated silica column) gave 14 nm as the diameter for all preparations. Light scattering of preparations in the presence of 10% ethylene glycol also dissociated the aggregates to monomers of 14 nm. Both these results indicated that hydrophobic interactions were the driving force behind this aggregation. These results indicate: (1) Even without any major structural change, three phase partitioning led to protein molecules becoming highly prone to aggregation. (2) Different methods gave widely different estimates of sizes of aggregates. It was however possible to reconcile the data obtained with various approaches. (3) The nature of the gel filtration column is crucial and use of this technique for refolding and studying aggregation needs a rethink. Citation: Rather GM, Mukherjee J, Halling PJ, Gupta MN (2012) Activation of Alpha Chymotrypsin by Three Phase Partitioning Is Accompanied by Aggregation. PLoS ONE 7(12): e49241. doi: 10.1371/journal.pone.0049241	[Rather, Gulam Mohmad; Mukherjee, Joyeeta; Gupta, Munishwar Nath] Indian Inst Technol Delhi, Dept Chem, New Delhi, India; [Halling, Peter James] Univ Strathclyde, Dept Pure & Appl Chem, Glasgow, Lanark, Scotland	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; University of Strathclyde	Gupta, MN (corresponding author), Indian Inst Technol Delhi, Dept Chem, New Delhi, India.	appliedbiocat@yahoo.co.in			Department of Science and Technology (DST) core group, Government of India; Department of Biotechnology (DBT), Government of India; United Kingdom India Education and Research Initiative (UKIERI); University Grants Commission (UGC); Council of Scientific and Industrial Research (CSIR)	Department of Science and Technology (DST) core group, Government of India; Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); United Kingdom India Education and Research Initiative (UKIERI); University Grants Commission (UGC)(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	Partial financial support was provided by the Department of Science and Technology (DST) core group funding for "applied biocatalysis" and Department of Biotechnology (DBT), both Government of India organizations. Support was also provided by the United Kingdom India Education and Research Initiative (UKIERI) for funding the collaboration between MNG and PJH. Financial support was provided by University Grants Commission (UGC) to GMR and Council of Scientific and Industrial Research (CSIR) to JM, in the form of Senior and Junior Research Fellowships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERCREUTZ P, 1990, ANN NY ACAD SCI, V613, P517, DOI 10.1111/j.1749-6632.1990.tb18211.x; Bemporad F, 2009, FEBS LETT, V583, P2630, DOI 10.1016/j.febslet.2009.07.013; Celej MS, 2004, BIOCHEM J, V378, P1059, DOI 10.1042/BJ20031536; CHAUDHURI TK, 1993, J BIOCHEM, V113, P729, DOI 10.1093/oxfordjournals.jbchem.a124111; Clark DS, 2004, PHILOS T ROY SOC B, V359, P1299, DOI 10.1098/rstb.2004.1506; De Diego T, 2004, BIOTECHNOL BIOENG, V88, P916, DOI 10.1002/bit.20330; Dennison C, 1997, PROTEIN EXPRES PURIF, V11, P149, DOI 10.1006/prep.1997.0779; DESIE G, 1986, BIOCHEMISTRY-US, V25, P8301, DOI 10.1021/bi00373a026; Desnuelle P, 1960, 118, P93; Elshereef R, 2006, BIOTECHNOL BIOENG, V95, P863, DOI 10.1002/bit.21039; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Flores-Fernandez GM, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-57; Freydell EJ, 2010, J CHROMATOGR A, V1217, P7723, DOI 10.1016/j.chroma.2010.10.038; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27; Garcia-Fruitos E, 2012, TRENDS BIOTECHNOL, V30, P65, DOI 10.1016/j.tibtech.2011.09.003; Ghaouar N, 2010, INT J BIOL MACROMOL, V47, P425, DOI 10.1016/j.ijbiomac.2010.08.001; Hames BD, 1986, GEL ELECTROPHORESIS, P1; HAYNES CA, 1992, J PHYS CHEM-US, V96, P905, DOI 10.1021/j100181a069; HEINITZ ML, 1988, J CHROMATOGR, V443, P173, DOI 10.1016/S0021-9673(00)94791-5; Jain S, 2004, J CHROMATOGR A, V1035, P83, DOI 10.1016/j.chroma.2004.01.007; KATO A, 1980, BIOCHIM BIOPHYS ACTA, V624, P13, DOI 10.1016/0005-2795(80)90220-2; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kobayashi T, 2007, APPL MICROBIOL BIOT, V75, P71, DOI 10.1007/s00253-006-0800-0; Lovrein R., 1987, PROTEIN PURIFICATION, P131; Lovrein R.E., 1995, PROTEIN SOLVENT INTE, P521; Marcon G, 2006, METHOD ENZYMOL, V413, P75, DOI 10.1016/S0076-6879(06)13004-9; Pallares I, 2004, J MOL BIOL, V342, P321, DOI 10.1016/j.jmb.2004.06.089; Petsko G., 2004, PROTEIN STRUCTURE FU; PIKE RN, 1989, BIOTECHNOL BIOENG, V33, P221, DOI 10.1002/bit.260330213; PORATH J, 1973, NATURE, V245, P465, DOI 10.1038/245465a0; Przybycien TM, 2004, CURR OPIN BIOTECH, V15, P469, DOI 10.1016/j.copbio.2004.08.008; Raghava S, 2008, PROTEIN SCI, V17, P1987, DOI 10.1110/ps.036939.108; RAJPUT YS, 1987, ENZYME MICROB TECH, V9, P161, DOI 10.1016/0141-0229(87)90071-8; Rezaei-Ghaleh N, 2008, BIOPHYS J, V95, P4139, DOI 10.1529/biophysj.108.132407; Roy I, 2005, ENZYME MICROB TECH, V37, P113, DOI 10.1016/j.enzmictec.2005.02.007; Roy I, 2004, BIOCATAL BIOTRANSFOR, V22, P261, DOI 10.1080/10242420400010523; Shah S, 2007, BBA-GEN SUBJECTS, V1770, P94, DOI 10.1016/j.bbagen.2006.10.004; Sharma S, 2001, PROTEIN EXPRES PURIF, V21, P310, DOI 10.1006/prep.2000.1357; Singh N, 2005, FEBS J, V272, P562, DOI 10.1111/j.1742-4658.2004.04499.x; Singh RK, 2001, PROTEIN ENG, V14, P307, DOI 10.1093/protein/14.5.307; Solanki K, 2012, BIORESOURCE TECHNOL, V115, P147, DOI 10.1016/j.biortech.2011.12.066; Vallejo LF, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-11	43	13	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49241	10.1371/journal.pone.0049241	http://dx.doi.org/10.1371/journal.pone.0049241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239966	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800004
J	Shringi, S; Schmidt, C; Katherine, K; Brayton, KA; Hancock, DD; Besser, TE				Shringi, Smriti; Schmidt, Carrie; Katherine, Kaya; Brayton, Kelly A.; Hancock, Dale D.; Besser, Thomas E.			Carriage of stx2a Differentiates Clinical and Bovine-Biased Strains of Escherichia coli O157	PLOS ONE			English	Article							SHIGA TOXIN; NUCLEOTIDE-SEQUENCE; VIRULENCE FACTORS; GENETIC-STRUCTURE; INTEGRATION SITE; GENOME; PHAGE; IDENTIFICATION; GENOTYPES; VARIANTS	Background: Shiga toxin (Stx) are cardinal virulence factors of enterohemorrhagic E. coli O157:H7 (EHEC O157). The gene content and genomic insertion sites of Stx-associated bacteriophages differentiate clinical genotypes of EHEC O157 (CG, typical of clinical isolates) from bovine-biased genotypes (BBG, rarely identified among clinical isolates). This project was designed to identify bacteriophage-mediated differences that may affect the virulence of CG and BBG. Methods: Stx-associated bacteriophage differences were identified by whole genome optical scans and characterized among >400 EHEC O157 clinical and cattle isolates by PCR. Results: Optical restriction maps of BBG strains consistently differed from those of CG strains only in the chromosomal insertion sites of Stx2-associated bacteriophages. Multiplex PCRs (stx1, stx2a, and stx2c as well as Stx-associated bacteriophage - chromosomal insertion site junctions) revealed four CG and three BBG that accounted for >90% of isolates. All BBG contained stx2c and Stx2c-associated bacteriophage - sbcB junctions. All CG contained stx2a and Stx2a-associated bacteriophage junctions in wrbA or argW. Conclusions: Presence or absence of stx2a (or another product encoded by the Stx2a-associated bacteriophage) is a parsimonious explanation for differential virulence of BBG and CG, as reflected in the distributions of these genotypes in humans and in the cattle reservoir.	[Shringi, Smriti; Schmidt, Carrie; Katherine, Kaya; Brayton, Kelly A.; Besser, Thomas E.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Hancock, Dale D.] Washington State Univ, Dept Vet Clin Sci, Pullman, WA 99164 USA	Washington State University; Washington State University	Besser, TE (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	tbesser@vetmed.wsu.edu	Shringi, Smriti/AAC-9789-2020	Shringi, Smriti/0000-0001-9212-9175	National Institute of Allergy and Infectious Diseases, National Institutes of Health [N01-AI-30055]; United States Department of Agriculture, Agriculture and Food Research Initiative [2009-04248]; Poncin fellowship Fund; Agricultural Animal Health Program, Washington State University College of Veterinary Medicine, Pullman, WA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Department of Agriculture, Agriculture and Food Research Initiative(United States Department of Agriculture (USDA)); Poncin fellowship Fund; Agricultural Animal Health Program, Washington State University College of Veterinary Medicine, Pullman, WA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institute of Allergy and Infectious Diseases, National Institutes of Health [contract N01-AI-30055]; United States Department of Agriculture, Agriculture and Food Research Initiative [grant 2009-04248]; Poncin fellowship Fund and the Agricultural Animal Health Program, Washington State University College of Veterinary Medicine, Pullman, WA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Besser RE, 1999, ANNU REV MED, V50, P355, DOI 10.1146/annurev.med.50.1.355; Besser TE, 2007, APPL ENVIRON MICROB, V73, P671, DOI 10.1128/AEM.01035-06; Bono JL, 2012, MOL BIOL EVOL, V29, P2047, DOI 10.1093/molbev/mss072; BORCZYK AA, 1987, LANCET, V1, P98; Cobbold RN, 2007, APPL ENVIRON MICROB, V73, P1563, DOI 10.1128/AEM.01742-06; Creuzburg K, 2005, MICROBIOL-SGM, V151, P941, DOI 10.1099/mic.0.27632-0; Eklund M, 2002, J CLIN MICROBIOL, V40, P4585, DOI 10.1128/JCM.40.12.4585-4593.2002; Fogg PCM, 2007, MICROBIOL-SGM, V153, P4098, DOI 10.1099/mic.0.2007/011205-0; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Gannon VPJ, 1997, J CLIN MICROBIOL, V35, P656, DOI 10.1128/JCM.35.3.656-662.1997; Jelacic JK, 2003, J INFECT DIS, V188, P719, DOI 10.1086/376999; Kawano K, 2008, EUR J CLIN MICROBIOL, V27, P227, DOI 10.1007/s10096-007-0420-3; Kawano K, 2012, EUR J CLIN MICROBIOL, V31, P119, DOI 10.1007/s10096-011-1283-1; Kim J, 1999, P NATL ACAD SCI USA, V96, P13288, DOI 10.1073/pnas.96.23.13288; Kim JY, 2001, J BACTERIOL, V183, P6885, DOI 10.1128/JB.183.23.6885-6897.2001; Koch C, 2003, J BACTERIOL, V185, P6463, DOI 10.1128/JB.185.21.6463-6466.2003; Kotewicz ML, 2007, MICROBIOL-SGM, V153, P1720, DOI 10.1099/mic.0.2006/004507-0; Kotewicz ML, 2008, MICROBIOL-SGM, V154, P3518, DOI 10.1099/mic.0.2008/019026-0; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Laing CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-287; Law D, 2000, J APPL MICROBIOL, V88, P729, DOI 10.1046/j.1365-2672.2000.01031.x; Lee K, 2012, APPL ENVIRON MICROB, V78, P3361, DOI 10.1128/AEM.06646-11; Lee K, 2011, J CLIN MICROBIOL, V49, P1495, DOI 10.1128/JCM.02640-10; Lefebvre B, 2009, FOODBORNE PATHOG DIS, V6, P357, DOI 10.1089/fpd.2008.0188; Makino K, 1999, GENES GENET SYST, V74, P227, DOI 10.1266/ggs.74.227; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Nakamura H, 2008, JPN J INFECT DIS, V61, P251; Nishikawa Y, 2000, J CLIN MICROBIOL, V38, P2440; Ohnishi M, 2002, P NATL ACAD SCI USA, V99, P17043, DOI 10.1073/pnas.262441699; OLSVIK O, 1991, MOL CELL PROBE, V5, P429, DOI 10.1016/S0890-8508(05)80014-3; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Plunkett G, 1999, J BACTERIOL, V181, P1767, DOI 10.1128/JB.181.6.1767-1778.1999; Recktenwald J, 2002, INFECT IMMUN, V70, P1896, DOI 10.1128/IAI.70.4.1896-1908.2002; Rivas M, 2008, EMERG INFECT DIS, V14, P763, DOI 10.3201/eid1405.071050; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Shaikh N, 2003, J BACTERIOL, V185, P3596, DOI 10.1128/JB.185.12.3596-3605.2003; Shringi S, 2012, INFECT IMMUN, V80, P369, DOI 10.1128/IAI.05470-11; Strauch E, 2008, INFECT IMMUN, V76, P5466, DOI 10.1128/IAI.00875-08; Vanaja SK, 2010, APPL ENVIRON MICROB, V76, P60, DOI 10.1128/AEM.01666-09; Whitworth J, 2010, APPL ENVIRON MICROB, V76, P361, DOI 10.1128/AEM.01761-09; Whitworth JH, 2008, APPL ENVIRON MICROB, V74, P7447, DOI 10.1128/AEM.01190-08; Wick LM, 2005, J BACTERIOL, V187, P1783, DOI 10.1128/JB.187.5.1783-1791.2005; Yang Z, 2004, APPL ENVIRON MICROB, V70, P6846, DOI 10.1128/AEM.70.11.6846-6854.2004; Zhang YX, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-121; Zhang YX, 2010, APPL ENVIRON MICROB, V76, P474, DOI 10.1128/AEM.01288-09; Zhou S, 2004, J BACTERIOL, V186, P7773, DOI 10.1128/JB.186.22.7773-7782.2004; Ziebell K, 2008, APPL ENVIRON MICROB, V74, P4314, DOI 10.1128/AEM.02821-07	50	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51572	10.1371/journal.pone.0051572	http://dx.doi.org/10.1371/journal.pone.0051572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240045	Green Submitted, gold, Green Published			2022-12-27	WOS:000312290800081
J	Heni, M; Hennenlotter, J; Scharpf, M; Lutz, SZ; Schwentner, C; Todenhofer, T; Schilling, D; Kuhs, U; Gerber, V; Machicao, F; Staiger, H; Haring, HU; Stenzl, A				Heni, Martin; Hennenlotter, Joerg; Scharpf, Marcus; Lutz, Stefan Z.; Schwentner, Christian; Todenhoefer, Tilman; Schilling, David; Kuehs, Ursula; Gerber, Valentina; Machicao, Fausto; Staiger, Harald; Haering, Hans-Ulrich; Stenzl, Arnulf			Insulin Receptor Isoforms A and B as well as Insulin Receptor Substrates-1 and-2 Are Differentially Expressed in Prostate Cancer	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; GROWTH-FACTOR RECEPTOR; TISSUE ADJACENT; IRS PROTEINS; RISK; METASTASIS; CONSENSUS; STRATEGY; PATHWAY; DISEASE	Aims/Hypothesis: In different cancers types, insulin receptor isoform composition or insulin receptor substrate (IRS) isoforms are different to healthy tissue. This may be a molecular link to increased cancer risk in diabetes and obesity. Since this is yet unclear for prostate cancer, we investigated IR isoform composition and IRS balance in prostate cancer compared to benign and tumor adjacent benign prostate tissue and brought this into relation to cell proliferation. Methods: We studied 23 benign prostate samples from radical cystectomy or benign prostatic hyperplasia surgery, 30 samples from benign tissue directly adjacent to prostate cancer foci and 35 cancer samples from different patients. RNA expression levels for insulin receptor isoforms A and B, IRS-1, IRS-2, and IGF-1 receptor were assessed by quantitative real-time RT-PCR. In addition, RNA-and protein expression of the cell cycle regulator p27(Kip1) was quantified by real-time RT-PCR and immunohistochemistry. Results: Insulin receptor isoform A to B ratio was significantly higher in cancer as well as in tumor adjacent benign prostate tissue compared to purely benign prostates (p<0.05). IRS-1 to IRS-2 ratios were lower in malignant than in benign prostatic tissue (p<0.05). These altered ratios both in cancer and adjacent tissue were significantly associated with reduced p27(Kip1) content (p<0.02). Interestingly, IGF-1 receptor levels were significantly lower in patients with type 2 diabetes (p = 0.0019). Conclusions/Interpretation: We found significant differences in the insulin signaling cascade between benign prostate tissue and prostate cancer. Histological benign tissue adjacent to cancer showed expression patterns similar to the malignancies. Our findings suggest a role of the insulin signaling pathway in prostate cancer and surrounding tissue and can hence be relevant for both novel diagnostic and therapeutic approaches in this malignancy.	[Heni, Martin; Lutz, Stefan Z.; Machicao, Fausto; Staiger, Harald; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany; [Hennenlotter, Joerg; Schwentner, Christian; Todenhoefer, Tilman; Schilling, David; Kuehs, Ursula; Gerber, Valentina; Stenzl, Arnulf] Univ Tubingen, Dept Urol, D-7400 Tubingen, Germany; [Scharpf, Marcus] Univ Tubingen, Inst Pathol, D-7400 Tubingen, Germany; [Machicao, Fausto; Staiger, Harald; Haering, Hans-Ulrich] Univ Tubingen, Inst Diabet Res & Metab Dis, Helmholtz Ctr Munich, German Ctr Diabet Res DZD, D-7400 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Haring, HU (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014	Heni, Martin/0000-0002-8462-3832; Staiger, Harald/0000-0002-9507-5333	German Federal Ministry of Education and Research (BMBF) [01GI0925]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was supported by a grant (01GI0925) from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Chandran UR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-45; Cox ME, 2009, PROSTATE, V69, P33, DOI 10.1002/pros.20852; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; Gallagher EJ, 2010, TRENDS ENDOCRIN MET, V21, P610, DOI 10.1016/j.tem.2010.06.007; Gibson SL, 2007, CELL CYCLE, V6, P631, DOI 10.4161/cc.6.6.3987; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Grossmann M, 2011, J CLIN ENDOCR METAB, V96, P2341, DOI 10.1210/jc.2011-0118; Hellawell GO, 2002, CANCER RES, V62, P2942; Heni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021594; Hribal ML, 2003, FASEB J, V17, P1340, DOI 10.1096/fj.02-0685fje; Kasper JS, 2008, CANCER CAUSE CONTROL, V19, P703, DOI 10.1007/s10552-008-9133-x; Ma ZF, 2006, MOL CELL BIOL, V26, P9338, DOI 10.1128/MCB.01032-06; Macri E, 1998, CANCER METAST REV, V17, P337, DOI 10.1023/A:1006133620914; Merseburger AS, 2006, ONCOL REP, V16, P79; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Mussig K, 2011, DIABETIC MED, V28, P276, DOI 10.1111/j.1464-5491.2010.03132.x; Renehan A, 2010, LANCET, V375, P2201, DOI 10.1016/S0140-6736(10)60706-4; Sesti G, 2001, DIABETES-METAB RES, V17, P363, DOI 10.1002/dmrr.225; Shaw LM, 2011, CELL CYCLE, V10, P1750, DOI 10.4161/cc.10.11.15824; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Theodorescu D, 1997, J UROLOGY, V158, P131, DOI 10.1097/00005392-199707000-00040; Waalkes S, 2010, ONCOL REP, V23, P1257, DOI 10.3892/or_00000758; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Wu C, 2011, PROSTATE CANCER P D, V14, P326, DOI 10.1038/pcan.2011.28; Yan PS, 2006, CLIN CANCER RES, V12, P6626, DOI 10.1158/1078-0432.CCR-06-0467	27	46	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50953	10.1371/journal.pone.0050953	http://dx.doi.org/10.1371/journal.pone.0050953			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251408	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900029
J	aan den Toorn, M; Huijbers, MME; de Vries, SC; van Mierlo, CPM				aan den Toorn, Marije; Huijbers, Mieke M. E.; de Vries, Sacco C.; van Mierlo, Carlo P. M.			The Arabidopsis thaliana SERK1 Kinase Domain Spontaneously Refolds to an Active State In Vitro	PLOS ONE			English	Article							INTRINSICALLY DISORDERED PROTEINS; RECEPTOR-LIKE KINASES; TO-ORDER TRANSITION; STRUCTURAL BASIS; ACTIVATION LOOP; GRAS PROTEINS; PHOSPHORYLATION; COMPLEX; PERCEPTION; PREDICTION	Auto-phosphorylating kinase activity of plant leucine-rich-repeat receptor-like kinases (LRR-RLK's) needs to be under tight negative control to avoid unscheduled activation. One way to achieve this would be to keep these kinase domains as intrinsically disordered protein (IDP) during synthesis and transport to its final location. Subsequent folding, which may depend on chaperone activity or presence of interaction partners, is then required for full activation of the kinase domain. Bacterially produced SERK1 kinase domain was previously shown to be an active Ser/Thr kinase. SERK1 is predicted to contain a disordered region in kinase domains X and XI. Here, we show that loss of structure of the SERK1 kinase domain during unfolding is intimately linked to loss of activity. Phosphorylation of the SERK1 kinase domain neither changes its structure nor its stability. Unfolded SERK1 kinase has no autophosphorylation activity and upon removal of denaturant about one half of the protein population spontaneously refolds to an active protein in vitro. Thus, neither chaperones nor interaction partners are required during folding of this protein to its catalytically active state.	[aan den Toorn, Marije; Huijbers, Mieke M. E.; de Vries, Sacco C.; van Mierlo, Carlo P. M.] Wageningen Univ, Biochem Lab, Wageningen, Netherlands; [aan den Toorn, Marije] Ctr Biosyst Gen, Wageningen, Netherlands	Wageningen University & Research; Centre for BioSystems Genomics	aan den Toorn, M (corresponding author), Wageningen Univ, Biochem Lab, Wageningen, Netherlands.	marije.aandentoorn@wur.nl	vanMierlo, Carlo p/B-4491-2016	vanMierlo, Carlo p/0000-0002-5358-8392	Centre for BioSystems Genomics (CBSG), which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research	Centre for BioSystems Genomics (CBSG), which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This project was (co)financed by the Centre for BioSystems Genomics (CBSG), which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.1	Albrecht C, 2005, PLANT CELL, V17, P3337, DOI 10.1105/tpc.105.036814; Albrecht C, 2008, PLANT PHYSIOL, V148, P611, DOI 10.1104/pp.108.123216; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bublil EM, 2010, FASEB J, V24, P4744, DOI 10.1096/fj.10-166199; Cheng W, 2011, CELL HOST MICROBE, V10, P616, DOI 10.1016/j.chom.2011.10.013; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Espinoza-Fonseca LM, 2007, BIOPHYS J, V93, P2083, DOI 10.1529/biophysj.106.095802; Espinoza-Fonseca LM, 2008, J AM CHEM SOC, V130, P12208, DOI 10.1021/ja803143g; Fong JH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000316; Ganguly D, 2009, J AM CHEM SOC, V131, P5214, DOI 10.1021/ja808999m; Garza AMS, 2010, MOL CELL BIOL, V30, P220, DOI 10.1128/MCB.00552-09; Gershenson A, 2011, CURR OPIN STRUC BIOL, V21, P32, DOI 10.1016/j.sbi.2010.11.001; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gou XP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002452; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Hink MA, 2008, BIOPHYS J, V94, P1052, DOI 10.1529/biophysj.107.112003; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Karlova R, 2009, PROTEOMICS, V9, P368, DOI 10.1002/pmic.200701059; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Kwaaitaal MACJ, 2005, PROTOPLASMA, V226, P55, DOI 10.1007/s00709-005-0111-9; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Marin M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00086; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Nabuurs SM, 2009, J AM CHEM SOC, V131, P8290, DOI 10.1021/ja9014309; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oh MH, 2012, P NATL ACAD SCI USA, V109, P327, DOI 10.1073/pnas.1108321109; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Rey O, 2004, J BIOL CHEM, V279, P34361, DOI 10.1074/jbc.M403265200; Rienties IM, 2005, PLANTA, V221, P394, DOI 10.1007/s00425-004-1447-7; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schmid FX., 1989, SPECTRAL METHODS CHA, P251; Shah K, 2002, GENE DEV, V16, P1707, DOI 10.1101/gad.220402; Shah K, 2001, J BIOL CHEM, V276, P41263, DOI 10.1074/jbc.M102381200; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Su W, 2011, P NATL ACAD SCI USA, V108, P870, DOI 10.1073/pnas.1013251108; Sun XL, 2012, BIOCHEM J, V442, P1, DOI 10.1042/BJ20111766; Sun XL, 2011, PLANT MOL BIOL, V77, P205, DOI 10.1007/s11103-011-9803-z; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang ZL, 2006, STRUCTURE, V14, P1835, DOI 10.1016/j.str.2006.11.001; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu G, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001258; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	64	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50907	10.1371/journal.pone.0050907	http://dx.doi.org/10.1371/journal.pone.0050907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236403	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100041
J	Dorion, C; Hunter, PR; Van den Bergh, R; Roure, C; Delchevalerie, P; Reid, T; Maes, P				Dorion, Claire; Hunter, Paul R.; Van den Bergh, Rafael; Roure, Carme; Delchevalerie, Pascale; Reid, Tony; Maes, Peter			Does Village Water Supply Affect Children's Length of Stay in a Therapeutic Feeding Program in Niger? Lessons from a Medecins Sans Frontieres Program	PLOS ONE			English	Article							INFECTION; MALNUTRITION	Objective: With an increasing move towards outpatient therapeutic feeding for moderately and severely malnourished children, the home environment has become an increasingly important factor in achieving good program outcomes. Infections, including those water-borne, may significantly delay weight gain in a therapeutic feeding program. This study examined the relationship between adequacy of water supply and children's length of stay in a therapeutic feeding program in Niger. Methods: The length of stay in a therapeutic feeding program of Medecins Sans Frontieres in Niger was registered for 1518 children from 20 villages in the region. In parallel, the quality and quantity of the water source in each village were documented, and the association between adequacy of the water supply and length of stay in the program was assessed through Generalized Estimating Equation analysis. Results: 36% of the children presented with a secondary infection, 69% of which were water-related. When stratified by the adequacy of the quantity and/or quality of the water supply in their village of origin, non-adequacy of the water supply was clearly associated with a higher prevalence of secondary water-related infections and with much longer lengths of stay of malnourished children in the therapeutic feeding program. Conclusion: This study suggests that therapeutic feeding programs using an outpatient model should routinely evaluate the water supply in their target children's villages if they are to provide optimal care.	[Van den Bergh, Rafael; Delchevalerie, Pascale; Reid, Tony; Maes, Peter] Med Sans Frontieres, Operat Ctr Brussels, Brussels, Belgium; [Dorion, Claire; Roure, Carme] Med Sans Frontieres, Operat Ctr Barcelona, Barcelona, Spain; [Hunter, Paul R.] Univ E Anglia, Norwich Sch Med, Norwich NR4 7TJ, Norfolk, England	Doctors Without Borders; Doctors Without Borders; University of East Anglia	Maes, P (corresponding author), Med Sans Frontieres, Operat Ctr Brussels, Brussels, Belgium.	peter.maes@brussels.msf.org	Hunter, Paul/A-7172-2008; Hunter, Paul/N-9021-2019	Hunter, Paul/0000-0002-5608-6144; Hunter, Paul/0000-0002-5608-6144; Van den Bergh, Rafael/0000-0001-6277-8713				Braghetta A, 2006, J AM WATER WORKS ASS, V98, P97; CAIRNCROSS AM, 1990, J INST WATER ENV MAN, V4, P571; Cairncross S., 1993, ENV HLTH ENG TROPICS, V2nd; Chen LC, 1983, DIARRHEA MALNUTRITIO; Dewey KG, 2011, MATERN CHILD NUTR, V7, P129, DOI 10.1111/j.1740-8709.2011.00357.x; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Faim ACL, 2005, HERMANN EDITEURS CHA, P3; Hunter PR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000361; KEUSCH GT, 1986, REV INFECT DIS, V8, P273; Khara T, 2004, COMMUNITY BASED THER; Lutter Chessa K., 1992, Food and Nutrition Bulletin, V14, P36; MARTORELL R, 1980, AM J CLIN NUTR, V33, P345, DOI 10.1093/ajcn/33.2.345; PELLETIER DL, 1994, NUTR REV, V52, P409, DOI 10.1111/j.1753-4887.1994.tb01376.x; Rudert C, 2007, PLUMPYNUT MALNOURISH; Scrimshaw N S, 1968, Monogr Ser World Health Organ, V57, P3; SINNOTT RW, 1984, SKY TELESCOPE, V68, P159; WHO (World Health Organization), 2002, JOINT MON PROGR WAT	18	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50982	10.1371/journal.pone.0050982	http://dx.doi.org/10.1371/journal.pone.0050982			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236416	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100049
J	Yang, XY; Forier, K; Steukers, L; Van Vlierberghe, S; Dubruel, P; Braeckmans, K; Glorieux, S; Nauwynck, HJ				Yang, Xiaoyun; Forier, Katrien; Steukers, Lennert; Van Vlierberghe, Sandra; Dubruel, Peter; Braeckmans, Kevin; Glorieux, Sarah; Nauwynck, Hans J.			Immobilization of Pseudorabies Virus in Porcine Tracheal Respiratory Mucus Revealed by Single Particle Tracking	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; CYSTIC-FIBROSIS SPUTUM; BASEMENT-MEMBRANE; DIFFUSION; SULFATE; TRANSLOCATION; INFECTIONS; PEGYLATION; INVASION; PIGS	Pseudorabies virus (PRV) initially replicates in the porcine upper respiratory tract. It easily invades the mucosae and submucosae for subsequent spread throughout the body via blood vessels and nervous system. In this context, PRV developed ingenious processes to overcome different barriers such as epithelial cells and the basement membrane. Another important but often overlooked barrier is the substantial mucus layer which coats the mucosae. However, little is known about how PRV particles interact with porcine respiratory mucus. We therefore measured the barrier properties of porcine tracheal respiratory mucus, and investigated the mobility of nanoparticles including PRV in this mucus. We developed an in vitro model utilizing single particle tracking microscopy. Firstly, the mucus pore size was evaluated with polyethylene glycol coupled (PEGylated) nanoparticles and atomic force microscope. Secondly, the mobility of PRV in porcine tracheal respiratory mucus was examined and compared with that of negative, positive and PEGylated nanoparticles. The pore size of porcine tracheal respiratory mucus ranged from 80 to 1500 nm, with an average diameter of 455 +/- 240 nm. PRV (zeta potential: -31.8 +/- 1.5 mV) experienced a severe obstruction in porcine tracheal respiratory mucus, diffusing 59-fold more slowly than in water. Similarly, the highly negatively (-49.8 +/- 0.6 mV) and positively (36.7 +/- 1.1 mV) charged nanoparticles were significantly trapped. In contrast, the nearly neutral, hydrophilic PEGylated nanoparticles (-9.6 +/- 0.8 mV) diffused rapidly, with the majority of particles moving 50-fold faster than PRV. The mobility of the particles measured was found to be related but not correlated to their surface charge. Furthermore, PEGylated PRV (-13.8 +/- 0.9 mV) was observed to diffuse 13-fold faster than native PRV. These findings clearly show that the mobility of PRV was significantly hindered in porcine tracheal respiratory mucus, and that the obstruction of PRV was due to complex mucoadhesive interactions including charge interactions rather than size exclusion.	[Yang, Xiaoyun; Steukers, Lennert; Glorieux, Sarah; Nauwynck, Hans J.] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Virol Lab, Merelbeke, Belgium; [Forier, Katrien; Braeckmans, Kevin] Univ Ghent, Lab Gen Biochem & Phys Pharm, B-9000 Ghent, Belgium; [Forier, Katrien; Braeckmans, Kevin] Univ Ghent, Ctr Nano & Biophoton, B-9000 Ghent, Belgium; [Van Vlierberghe, Sandra; Dubruel, Peter] Polymer Chem & Biomat Grp, Ghent, Belgium	Ghent University; Ghent University; Ghent University	Nauwynck, HJ (corresponding author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Virol Lab, Salisburylaan, Merelbeke, Belgium.	hans.nauwynck@ugent.be	Van Vlierberghe, Sandra./AAN-7863-2021; Braeckmans, Kevin/HCH-3119-2022	Braeckmans, Kevin/0000-0002-7993-6295; Nauwynck, Hans/0000-0001-5470-0713; Forier, Katrien/0000-0002-7003-3612; Van Vlierberghe, Sandra/0000-0001-7688-1682; Dubruel, Peter/0000-0002-5928-7726	Ghent University	Ghent University(Ghent University)	This work was supported by Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GA, 2000, CORNEA, V19, P57, DOI 10.1097/00003226-200001000-00012; AGARWAL M, 1994, BIORHEOLOGY, V31, P11; Braeckmans K, 2010, NANOSCOPY AND MULTIDIMENSIONAL OPTICAL FLUORESCENCE MICROSCOPY; Broughton-Head VJ, 2007, PULM PHARMACOL THER, V20, P708, DOI 10.1016/j.pupt.2006.08.008; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Croyle MA, 2004, J VIROL, V78, P912, DOI 10.1128/JVI.78.2.912-921.2004; Croyle MA, 2000, HUM GENE THER, V11, P1713, DOI 10.1089/10430340050111368; EMERY N, 1995, AM J RESP CELL MOL, V12, P130, DOI 10.1165/ajrcmb.12.2.7865212; Forier K, 2012, NANOMEDICIN IN PRESS; Gadegaard N, 2006, BIOTECH HISTOCHEM, V81, P87, DOI 10.1080/10520290600783143; GIBSON JS, 1992, ARCH VIROL, V123, P351, DOI 10.1007/BF01317269; Glorieux S, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-58; Glorieux S, 2009, VET MICROBIOL, V136, P341, DOI 10.1016/j.vetmic.2008.11.005; HAMPSON IN, 1984, BIOCHIM BIOPHYS ACTA, V801, P306, DOI 10.1016/0304-4165(84)90081-3; Hida K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019919; Khutoryanskiy VV, 2011, MACROMOL BIOSCI, V11, P748, DOI 10.1002/mabi.201000388; KING M, 1980, FED PROC, V39, P3080; Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107; Lai SK, 2009, J VIROL, V83, P11196, DOI 10.1128/JVI.01899-08; Lai SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004294; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Lieleg O, 2010, BIOPHYS J, V98, P1782, DOI 10.1016/j.bpj.2010.01.012; Lieleg O, 2009, BIOPHYS J, V97, P1569, DOI 10.1016/j.bpj.2009.07.009; Maeda K, 1998, J VET MED SCI, V60, P881, DOI 10.1292/jvms.60.881; Manzenreiter R, 2012, J CYST FIBROS, V11, P84, DOI 10.1016/j.jcf.2011.09.008; McGrane SJ, 2004, STARCH-STARKE, V56, P122, DOI 10.1002/star.200300242; MORTAZAVI SA, 1995, INT J PHARM, V124, P173, DOI 10.1016/0378-5173(95)00073-R; Murphy JA, 2003, J VIROL, V77, P9337, DOI 10.1128/JVI.77.17.9337-9345.2003; Nauwynck H, 2007, VET RES, V38, P229, DOI 10.1051/vetres:200661; Nauwynck HJ, 1997, VET MICROBIOL, V55, P3, DOI 10.1016/S0378-1135(96)01299-0; Norris DA, 1997, J APPL POLYM SCI, V63, P1481, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1481::AID-APP10>3.0.CO;2-5; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Ramachandran S, 2011, WIRES SYST BIOL MED, V3, P702, DOI 10.1002/wsbm.154; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Sims DE, 1997, AM J PHYSIOL-LUNG C, V273, pL1036; Steukers L, 2012, TRENDS MICROBIOL, V20, P147, DOI 10.1016/j.tim.2012.01.001; Steukers L, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-33; Suh J, 2005, ADV DRUG DELIVER REV, V57, P1551, DOI 10.1016/j.addr.2005.05.003; Symens N, 2011, MOL PHARMACEUT, V8, P1757, DOI 10.1021/mp200120v; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Trybala E, 1998, J BIOL CHEM, V273, P5047, DOI 10.1074/jbc.273.9.5047; Trybala E, 1996, VIROLOGY, V218, P35, DOI 10.1006/viro.1996.0163; Vandekerckhove AP, 2010, J GEN VIROL, V91, P2019, DOI 10.1099/vir.0.019257-0; Varum FJO, 2012, J PHARM PHARMACOL, V64, P218, DOI 10.1111/j.2042-7158.2011.01399.x; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; WITTMANN G, 1980, ARCH VIROL, V66, P227, DOI 10.1007/BF01314736; Xie H, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/21/215301	49	27	27	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51054	10.1371/journal.pone.0051054	http://dx.doi.org/10.1371/journal.pone.0051054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236432	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100061
J	Zhang, Q; Chen, XG; Zang, YJ; Zhang, L; Chen, H; Wang, LT; Niu, YJ; Ren, XY; Shen, ZY; Shang, L				Zhang, Qing; Chen, Xinguo; Zang, Yunjin; Zhang, Li; Chen, Hong; Wang, Letian; Niu, Yujian; Ren, Xiuyun; Shen, Zhongyang; Shang, Lei			RETRACTED: The Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection and Cirrhosis (Retracted article. See vol. 14, 2019)	PLOS ONE			English	Article; Retracted Publication							TUMOR SIZE; RESECTION; RECURRENCE; UNIVARIATE; EXPERIENCE; PROGNOSIS; EVOLUTION; RISK	Background: A precise predictive survival model of liver transplantation (LT) with antiviral prophylaxis for hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC) and cirrhosis has not been established. The aim of our study was to identify predictors of outcome after LT in these patients based on tumor staging systems, antitumor therapy pre-LT, and antiviral prophylaxis in patients considered to be unfit by Milan or UCSF criteria. Methods: From 2002 to 2008, 917 LTs with antiviral prophylaxis were performed on patients with HBV-cirrhosis, and 313 had concurrent HCC. Results: Stratified univariate and multivariate analyses demonstrated that independent predictors for poor survival were tumor size >7.5 cm (P = 0.001), tumor number >1 (P = 0.005), vascular invasion (P = 0.001), pre-LT serum alpha-fetoprotein (AFP) level >= 1000 ng/ml (P = 0.009), and pre-LT aspartate aminotransferase (AST) level >= 120 IU/L (P = 0.044). Pre-LT therapy for HCC was an independent predictor of better survival (P = 0.028). Based on CLIP and TNM tumor staging systems, HCC patients with HBV-cirrhosis who met the following criteria: solitary tumor <= 7.5 cm, or <= 4 multifocal nodules, the largest lesion <= 5 cm and total tumor diameter <= 10 cm, or more nodules with the largest lesion <= 3 cm, and pre-LT serum AFP level <1000 mg/L and AST level <120 IU/L without vascular invasion and lymph node metastasis who were unfit for UCSF, had survival rates of 89% at 5 years. There was a 47% 5-year survival rate for patients with HCC exceeding the revised criteria. Conclusions: The current criteria for LT based on tumor size, number and levels of AFP and AST may be modestly expanded while still preserving excellent survival after LT. The expanded criteria combined with antiviral prophylaxis and pre-LT adjuvant therapy for HCC may be a rational strategy to prolong survival after LT for HCC patients with HBV-associated cirrhosis.	[Zhang, Qing; Chen, Xinguo; Zang, Yunjin; Chen, Hong; Wang, Letian; Niu, Yujian; Ren, Xiuyun; Shen, Zhongyang] Gen Hosp Chinese Peoples Armed Police Force, Inst Liver Transplantat, Beijing, Peoples R China; [Shang, Lei] Fourth Mil Med Univ, Fac Prevent Med, Dept Hlth Stat, Xian 710032, Peoples R China; [Zhang, Li] Shaanxi Prov Corps Hosp Chinese Peoples Armed Pol, Dept Surg 1, Xian, Peoples R China	Air Force Military Medical University	Shen, ZY (corresponding author), Gen Hosp Chinese Peoples Armed Police Force, Inst Liver Transplantat, Beijing, Peoples R China.	zqy47@sina.com; shanglei@fmmu.edu.cn						Adam R, 2003, ANN SURG, V238, P508, DOI 10.1097/01.sla.0000090449.87109.44; Bechstein W O, 1994, Transpl Int, V7 Suppl 1, pS238; BISMUTH H, 1993, ANN SURG, V218, P145, DOI 10.1097/00000658-199308000-00005; Cescon M, 2010, J TRANSPLANT, V2010, P9041; Cescon M, 2009, ARCH SURG-CHICAGO, V144, P906, DOI 10.1001/archsurg.2009.99; Chen MF, 2003, WORLD J SURG, V27, P443, DOI 10.1007/s00268-002-6708-7; Chu F, 2006, EJSO-EUR J SURG ONC, V32, P568, DOI 10.1016/j.ejso.2006.02.005; Cillo U, 2010, DIGEST LIVER DIS, V42, P642, DOI 10.1016/j.dld.2010.02.010; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Dan YY, 2006, LIVER TRANSPLANT, V12, P736, DOI 10.1002/lt.20685; DuBay D, 2011, ANN SURG, V253, P166, DOI 10.1097/SLA.0b013e31820508f1; Ercolani G, 2003, ANN SURG, V237, P536, DOI 10.1097/00000658-200304000-00016; Figueras J, 1997, HEPATOLOGY, V25, P1485, DOI 10.1002/hep.510250629; Forman LM, 2001, HEPATOLOGY, V33, P473, DOI 10.1053/jhep.2001.22481; Gondolesi GE, 2004, ANN SURG, V239, P142, DOI 10.1097/01.sla.0000109022.32391.eb; Hemming AW, 2001, ANN SURG, V233, P652, DOI 10.1097/00000658-200105000-00009; Hertl M, 2005, ONCOLOGIST, V10, P269, DOI 10.1634/theoncologist.10-4-269; Huitzil-Melendez FD, 2010, J CLIN ONCOL, V28, P2889, DOI 10.1200/JCO.2009.25.9895; Ishizaki Y, 2008, J GASTROENTEROL, V43, P18, DOI 10.1007/s00535-007-2141-x; IWATSUKI S, 1991, ANN SURG, V214, P221, DOI 10.1097/00000658-199109000-00005; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Llovet JM, 1998, HEPATOLOGY, V27, P1572, DOI 10.1002/hep.510270616; Marsh JW, 2000, TRANSPLANTATION, V69, pS139; Marsh JW, 1997, HEPATOLOGY, V26, P444, DOI 10.1002/hep.510260227; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; MCPEAKE JR, 1993, J HEPATOL, V18, P226, DOI 10.1016/S0168-8278(05)80250-8; Otto G, 1998, ANN SURG, V227, P424, DOI 10.1097/00000658-199803000-00015; Park Ui Jun, 2008, Korean J Hepatol, V14, P371, DOI 10.3350/kjhep.2008.14.3.371; Poon RTP, 2002, ANN SURG, V235, P373, DOI 10.1097/00000658-200203000-00009; ROMANI F, 1994, J AM COLL SURGEONS, V178, P379; Saab S, 2009, LIVER TRANSPLANT, V15, P1525, DOI 10.1002/lt.21882; Steinmuller T, 2002, HEPATOLOGY, V35, P1528, DOI 10.1053/jhep.2002.33681; Sutcliffe R, 2006, BRIT J SURG, V93, P11, DOI 10.1002/bjs.5198; TAN KC, 1995, BRIT J SURG, V82, P253, DOI 10.1002/bjs.1800820239; Wong SN, 2007, LIVER TRANSPLANT, V13, P334, DOI 10.1002/lt.20959; Workman P, 2002, TRENDS MOL MED, V8, pS1, DOI 10.1016/S1471-4914(02)02319-5; World Health Organization, 2009, HEP B SURV CONTR; Xu J, 2009, J DIGEST DIS, V10, P138, DOI 10.1111/j.1751-2980.2009.00376.x; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563; Yao FY, 2001, HEPATOLOGY, V34, P411, DOI 10.1053/jhep.2001.26512; Yao FY, 2002, LIVER TRANSPLANT, V8, P765, DOI 10.1053/jlts.2002.34892; Yoo HY, 2003, J CLIN ONCOL, V21, P4329, DOI 10.1200/JCO.2003.11.137; Zimmerman MA, 2007, TRANSPL P, V39, P3276, DOI 10.1016/j.transproceed.2007.07.085	45	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50919	10.1371/journal.pone.0050919	http://dx.doi.org/10.1371/journal.pone.0050919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236406	gold, Green Published, Green Submitted			2022-12-27	WOS:000312064100043
J	Cuthbertson, DJ; Irwin, A; Gardner, CJ; Daousi, C; Purewal, T; Furlong, N; Goenka, N; Thomas, EL; Adams, VL; Pushpakom, SP; Pirmohamed, M; Kemp, GJ				Cuthbertson, Daniel J.; Irwin, Andrew; Gardner, Chris J.; Daousi, Christina; Purewal, Tej; Furlong, Niall; Goenka, Niru; Thomas, E. Louise; Adams, Valerie L.; Pushpakom, Sudeep P.; Pirmohamed, Munir; Kemp, Graham J.			Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists	PLOS ONE			English	Article							HEPATIC INSULIN-RESISTANCE; MAGNETIC-RESONANCE-SPECTROSCOPY; NONALCOHOLIC STEATOHEPATITIS; CARDIOVASCULAR-DISEASE; INCREASED PREVALENCE; TRIGLYCERIDE CONTENT; PLASMA ADIPONECTIN; CONTROLLED-TRIAL; ADIPOSE-TISSUE; OPEN-LABEL	Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are effective for obese patients with type 2 diabetes mellitus (T2DM) because they concomitantly target obesity and dysglycaemia. Considering the high prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with T2DM, we determined the impact of 6 months' GLP-1 RA therapy on intrahepatic lipid (IHL) in obese, T2DM patients with hepatic steatosis, and evaluated the inter-relationship between changes in IHL with those in glycosylated haemoglobin (HbA(1)c), body weight, and volume of abdominal visceral and subcutaneous adipose tissue (VAT and SAT). We prospectively studied 25 (12 male) patients, age 50 +/- 10 years, BMI 38.4 +/- 5.6 kg/m(2) (mean +/- SD) with baseline IHL of 28.2% (16.5 to 43.1%) and HbA(1)c of 9.6% (7.9 to 10.7%) (median and interquartile range). Patients treated with metformin and sulphonylureas/DPP-IV inhibitors were given 6 months GLP-1 RA (exenatide, n = 19; liraglutide, n = 6). IHL was quantified by liver proton magnetic resonance spectroscopy (H-1 MRS) and VAT and SAT by whole body magnetic resonance imaging (MRI). Treatment was associated with mean weight loss of 5.0 kg (95% CI 3.5,6.5 kg), mean HbA(1c) reduction of 1.6% (17 mmol/mol) (0.8, 2.4%) and a 42% relative reduction in IHL (-59.3, -16.5%). The relative reduction in IHL correlated with that in HbA(1)c (rho = 0.49; p = 0.01) but was not significantly correlated with that in total body weight, VAT or SAT. The greatest IHL reduction occurred in individuals with highest pre-treatment levels. Mechanistic studies are needed to determine potential direct effects of GLP-1 RA on human liver lipid metabolism. Citation: Cuthbertson DJ, Irwin A, Gardner CJ, Daousi C, Purewal T, et al. (2012) Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists. PLoS ONE 7(12): e50117. doi:10.1371/journal.pone.0050117	[Cuthbertson, Daniel J.; Irwin, Andrew; Gardner, Chris J.; Daousi, Christina] Aintree Univ Hosp NHS Fdn Trust, Dept Obes & Endocrinol, Liverpool L9 7AL, Merseyside, England; [Cuthbertson, Daniel J.; Daousi, Christina] Univ Liverpool, Inst Ageing & Chron Dis, Dept Obes & Endocrinol, Liverpool L69 3BX, Merseyside, England; [Purewal, Tej] Royal Liverpool Univ Hosp, Dept Endocrinol & Diabet, Liverpool, Merseyside, England; [Furlong, Niall] St Helens & Knowsley, Dept Endocrinol & Diabet, Whiston, Merseyside, England; [Goenka, Niru] Countess Chester Hosp, Dept Endocrinol & Diabet, Chester, Cheshire, England; [Thomas, E. Louise] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Metab & Mol Imaging Grp, London, England; [Adams, Valerie L.; Kemp, Graham J.] Univ Liverpool, Magnet Resonance & Image Anal Res Ctr, Liverpool L69 3BX, Merseyside, England; [Pushpakom, Sudeep P.; Pirmohamed, Munir] Univ Liverpool, Wolfson Ctr Personalised Med, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Kemp, Graham J.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England	Aintree University Hospitals NHS Foundation Trust; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Imperial College London; University of Liverpool; University of Liverpool; University of Liverpool	Cuthbertson, DJ (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Dept Obes & Endocrinol, Liverpool L9 7AL, Merseyside, England.	daniel.cuthbertson@liverpool.ac.uk	Thomas, Elizabeth Louise/AIF-0055-2022; Pirmohamed, Munir/H-6004-2011; Pushpakom, Sudeep/AAK-3281-2020; Kemp, Graham J/A-7540-2008	Pirmohamed, Munir/0000-0002-7534-7266; Kemp, Graham J/0000-0002-8324-9666; Thomas, Elizabeth/0000-0003-4235-4694; Cuthbertson, Daniel/0000-0002-6128-0822	medical charity Weight Matters; European Federation for the Study of Diabetes (EFSD)	medical charity Weight Matters; European Federation for the Study of Diabetes (EFSD)	Funding from medical charity Weight Matters was for 2500 pound. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Please note this charity is a local charity set up by the investigators and the volunteers within the authors' hospital and they contributed 2500 pound towards cost of MRI scanning.; We would like to acknowledge the support of the European Federation for the Study of Diabetes (EFSD) in establishing the magnetic resonance spectroscopy methodologies. We would also like to thank Dan Lythgoe, Department of Molecular and Clinical Cancer Medicine, University of Liverpool for his help with the statistical analysis.	Bajaj M, 2004, J CLIN ENDOCR METAB, V89, P200, DOI 10.1210/jc.2003-031315; Bajaj M, 2003, DIABETES, V52, P1364, DOI 10.2337/diabetes.52.6.1364; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Bugianesi E, 2005, AM J GASTROENTEROL, V100, P1082, DOI 10.1111/j.1572-0241.2005.41583.x; Bugianesi E, 2005, J CLIN ENDOCR METAB, V90, P3498, DOI 10.1210/jc.2004-2240; Bunck MC, 2010, DIABETES CARE, V33, P1734, DOI 10.2337/dc09-2361; Buse JB, 2007, CLIN THER, V29, P139, DOI 10.1016/j.clinthera.2007.01.015; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Centre for Clinical Practice at NICE (UK), 2009, TYP 2 DIAB NEW AG BL; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; de Marco R, 1999, DIABETES CARE, V22, P756, DOI 10.2337/diacare.22.5.756; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Gardner CJ, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c7199; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Harrison SA, 2007, GUT, V56, P1760, DOI 10.1136/gut.2006.112094; Hattersley JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039029; Jendle J, 2009, DIABETES OBES METAB, V11, P1163, DOI 10.1111/j.1463-1326.2009.01158.x; Kenny PR, 2010, AM J GASTROENTEROL, V105, P2707, DOI 10.1038/ajg.2010.363; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Kotronen A, 2008, DIABETES CARE, V31, P165, DOI 10.2337/dc07-1463; Lazo M, 2010, DIABETES CARE, V33, P2156, DOI 10.2337/dc10-0856; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Ratziu V, 2010, HEPATOLOGY, V52, P2206, DOI 10.1002/hep.24042; Sathyanarayana P, 2011, OBESITY SILVER SPRIN; Shlomo SB, 2010, J HEPATOL; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Targher G, 2008, DIABETOLOGIA, V51, P1947, DOI 10.1007/s00125-008-1135-4; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Targher G, 2006, DIABETIC MED, V23, P403, DOI 10.1111/j.1464-5491.2006.01817.x; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Thomas EL, 2005, GUT, V54, P122, DOI 10.1136/gut.2003.036566; Tiikkainen M, 2004, DIABETES, V53, P2169, DOI 10.2337/diabetes.53.8.2169; Tushuizen ME, 2006, LIVER INT, V26, P1015, DOI 10.1111/j.1478-3231.2006.01315.x; Williamson RM, 2011, DIABETES CARE, V34, P1139, DOI 10.2337/dc10-2229	38	166	181	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50117	10.1371/journal.pone.0050117	http://dx.doi.org/10.1371/journal.pone.0050117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236362	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000312589700008
J	Jaeschke, A; Bittner, T; Jentsch, A; Reineking, B; Schlumprecht, H; Beierkuhnlein, C				Jaeschke, Anja; Bittner, Torsten; Jentsch, Anke; Reineking, Bjoern; Schlumprecht, Helmut; Beierkuhnlein, Carl			Biotic Interactions in the Face of Climate Change: A Comparison of Three Modelling Approaches	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; DRAGONFLY AESHNA-VIRIDIS; STRATIOTES-ALOIDES; HABITAT MODELS; THRESHOLD CRITERIA; RANGE EXPANSION; DISTRIBUTIONS; SHIFTS; BIODIVERSITY; PREDICTION	Climate change is expected to alter biotic interactions, and may lead to temporal and spatial mismatches of interacting species. Although the importance of interactions for climate change risk assessments is increasingly acknowledged in observational and experimental studies, biotic interactions are still rarely incorporated in species distribution models. We assessed the potential impacts of climate change on the obligate interaction between Aeshna viridis and its egg-laying plant Stratiotes aloides in Europe, based on an ensemble modelling technique. We compared three different approaches for incorporating biotic interactions in distribution models: (1) We separately modelled each species based on climatic information, and intersected the future range overlap ('overlap approach'). (2) We modelled the potential future distribution of A. viridis with the projected occurrence probability of S. aloides as further predictor in addition to climate ('explanatory variable approach'). (3) We calibrated the model of A. viridis in the current range of S. aloides and multiplied the future occurrence probabilities of both species ('reference area approach'). Subsequently, all approaches were compared to a single species model of A. viridis without interactions. All approaches projected a range expansion for A. viridis. Model performance on test data and amount of range gain differed depending on the biotic interaction approach. All interaction approaches yielded lower range gains (up to 667% lower) than the model without interaction. Regarding the contribution of algorithm and approach to the overall uncertainty, the main part of explained variation stems from the modelling algorithm, and only a small part is attributed to the modelling approach. The comparison of the no-interaction model with the three interaction approaches emphasizes the importance of including obligate biotic interactions in projective species distribution modelling. We recommend the use of the 'reference area approach' as this method allows a separation of the effect of climate and occurrence of host plant. Citation: Jaeschke A, Bittner T, Jentsch A, Reineking B, Schlumprecht H, et al. (2012) Biotic Interactions in the Face of Climate Change: A Comparison of Three Modelling Approaches. PLoS ONE 7(12): e51472. doi:10.1371/journal.pone.0051472	[Jaeschke, Anja; Beierkuhnlein, Carl] Univ Bayreuth, BayCEER, Dept Biogeog, Bayreuth, Germany; [Bittner, Torsten] LUBW Landesanstalt Umwelt Messungen & Nat Schutz, Karlsruhe, Germany; [Jentsch, Anke] Univ Bayreuth, BayCEER, Dept Disturbance Ecol, Bayreuth, Germany; [Schlumprecht, Helmut] Buro Okol Studien, Bayreuth, Germany	University of Bayreuth; University of Bayreuth	Jaeschke, A (corresponding author), Univ Bayreuth, BayCEER, Dept Biogeog, Bayreuth, Germany.	anja.jaeschke@uni-bayreuth.de	Beierkuhnlein, Carl/ABF-8797-2021; Beierkuhnlein, Carl/ABF-9693-2021	Beierkuhnlein, Carl/0000-0002-6456-4628; Reineking, Bjorn/0000-0001-5277-9181	Federal Agency for Nature Conservation Germany [FKZ 3508 85 0600]; German Research Foundation; Federal Agency for Nature Conservation Germany for the coordination of the project "Impacts of climate change on fauna, flora and habitats as well as adaptation strategies of nature conservation'' [FKZ 3508 85 0600]	Federal Agency for Nature Conservation Germany; German Research Foundation(German Research Foundation (DFG)); Federal Agency for Nature Conservation Germany for the coordination of the project "Impacts of climate change on fauna, flora and habitats as well as adaptation strategies of nature conservation''	The work was funded by the Federal Agency for Nature Conservation Germany (FKZ 3508 85 0600) (www.bfn.de). This publication was funded by the German Research Foundation (www.dfg.de) and the University of Bayreuth (www.uni-bayreuth.de) in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Federal Agency for Nature Conservation Germany for the coordination of the project "Impacts of climate change on fauna, flora and habitats as well as adaptation strategies of nature conservation'' (FKZ 3508 85 0600). Further, we thank two anonymous reviewers for their helpful comments on an earlier version of this manuscript.	Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681; [Anonymous], 2010, R LANG ENV STAT COMP; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; Bittner T, 2011, J VEG SCI, V22, P699, DOI 10.1111/j.1654-1103.2011.01266.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Dijkstra K.-D.B., 2006, FIELD GUIDE DRAGONFL; Dormann CF, 2008, ECOLOGY, V89, P3371, DOI 10.1890/07-1772.1; EIONET, 2009, CENTR DAT REP CDR; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hassall C, 2008, INT J ODONATOL, V11, P131, DOI 10.1080/13887890.2008.9748319; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hickling R, 2005, GLOBAL CHANGE BIOL, V11, P502, DOI 10.1111/j.1365-2486.2005.00904.x; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Jump AS, 2009, TRENDS PLANT SCI, V14, P51, DOI 10.1016/j.tplants.2008.10.002; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Liu YZ, 2011, ECOLOGY, V92, P1201, DOI 10.1890/10-2060.1; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Menendez R, 2008, ECOL ENTOMOL, V33, P413, DOI 10.1111/j.1365-2311.2008.00985.x; Mitchell T. D., 2004, TYNDALL CTR CLIMATE, V55, P25; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Pagel J, 2012, GLOBAL ECOL BIOGEOGR, V21, P293, DOI 10.1111/j.1466-8238.2011.00663.x; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pateman RM, 2012, SCIENCE, V336, P1028, DOI 10.1126/science.1216980; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Preston CD, 1997, AQUATIC PLANTS BRIT; Preston K, 2008, GLOBAL CHANGE BIOL, V14, P2501, DOI 10.1111/j.1365-2486.2008.01671.x; Rantala MJ, 2004, AQUAT ECOL, V38, P77; Reineking B, 2006, ECOL MODEL, V193, P675, DOI 10.1016/j.ecolmodel.2005.10.003; Ruete A, 2012, P ROY SOC B-BIOL SCI, V279, P3098, DOI 10.1098/rspb.2012.0428; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Settele J, 2005, GAIA, V14, P69, DOI 10.14512/gaia.14.1.20; Smolders AJP, 1996, ARCH HYDROBIOL, V136, P327; Spangenberg JH, 2007, SUSTAIN DEV, V15, P343, DOI 10.1002/sd.320; Sugier P, 2010, HYDROBIOLOGIA, V656, P43, DOI 10.1007/s10750-010-0433-2; Suutari E, 2004, OECOLOGIA, V140, P135, DOI 10.1007/s00442-004-1559-6; Suutari E, 2009, J INSECT CONSERV, V13, P413, DOI 10.1007/s10841-008-9188-8; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W., 2009, BIOMOD SPECIES CLIMA; Thuiller W., 2010, BIOMOD SPECIES CLIMA; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Walsh C., 2008, HIER PART HIERARCHIC	59	20	20	4	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51472	10.1371/journal.pone.0051472	http://dx.doi.org/10.1371/journal.pone.0051472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236505	Green Submitted, gold, Green Published			2022-12-27	WOS:000312589700042
J	Mbuagbaw, L; Thabane, L; Ongolo-Zogo, P; Lester, RT; Mills, EJ; Smieja, M; Dolovich, L; Kouanfack, C				Mbuagbaw, Lawrence; Thabane, Lehana; Ongolo-Zogo, Pierre; Lester, Richard T.; Mills, Edward J.; Smieja, Marek; Dolovich, Lisa; Kouanfack, Charles			The Cameroon Mobile Phone SMS (CAMPS) Trial: A Randomized Trial of Text Messaging versus Usual Care for Adherence to Antiretroviral Therapy	PLOS ONE			English	Article							HEALTH; HIV/AIDS	Background: Mobile phone technology is a novel way of delivering health care and improving health outcomes. This trial investigates the use of motivational mobile phone text messages (SMS) to improve adherence to antiretroviral therapy (ART) over six months. Methodology/Principal Findings: CAMPS was a single-site randomized two-arm parallel design trial in Yaounde, Cameroon. We enrolled and randomized HIV-positive adults on ART, aged 21 years and above to receive a weekly standardized motivational text message versus usual care alone. The primary outcome was adherence measured using a visual analogue scale (VAS), number of doses missed (in the week preceding the interview) and pharmacy refill data. Outcomes were measured at 3 and 6 months. Service providers and outcome assessors were blinded to allocation. Analysis was by intention-to-treat. Between November and December 2010, 200 participants were randomized, with 101 in the intervention group and 99 in the control group. At 6 months, overall retention was 81.5%. We found no significant effect on adherence by VAS>95% (risk ratio [RR] 1.06, 95% confidence interval [CI] 0.89, 1.29; p = 0.542; reported missed doses (RR 1.01, 95% CI 0.87, 1.16; p>.999) or number of pharmacy refills (mean difference [ MD] 0.1, 95% CI: 0.23, 0.43; p = 0.617. One participant in the intervention arm reported a possible disclosure of status. Conclusions/Significance: Standardized motivational mobile phone text messages did not significantly improve adherence to ART in this study. Other types of messaging or longer term studies are recommended.	[Mbuagbaw, Lawrence; Ongolo-Zogo, Pierre] Yaounde Cent Hosp, CDBPH, Yaounde, Centre, Cameroon; [Mbuagbaw, Lawrence; Thabane, Lehana; Smieja, Marek] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Thabane, Lehana] St Josephs Healthcare, Father Sean OSullivan Res Ctr, Biostat Unit, Hamilton, ON, Canada; [Lester, Richard T.] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC, Canada; [Lester, Richard T.] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Smieja, Marek] St Josephs Healthcare Hamilton, Hamilton, ON, Canada; [Dolovich, Lisa] McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada; [Kouanfack, Charles] Yaounde Cent Hosp, Accredited Treatment Ctr, Yaounde, Centre, Cameroon	McMaster University; University of British Columbia; University of Ottawa; McMaster University; McMaster University	Mbuagbaw, L (corresponding author), Yaounde Cent Hosp, CDBPH, Yaounde, Centre, Cameroon.	mbuagblc@mcmaster.ca	Mbuagbaw, Lawrence/D-9381-2015	Mbuagbaw, Lawrence/0000-0001-5855-5461; Dolovich, Lisa/0000-0002-0061-6783	CIHR Canadian HIV Trials Network (CTN); Centre for the Development of Best Practices in Health (CDBPH); Yaounde Central Hospital Accredited Treatment Centre (YCH ATC)	CIHR Canadian HIV Trials Network (CTN)(Canadian Institutes of Health Research (CIHR)); Centre for the Development of Best Practices in Health (CDBPH); Yaounde Central Hospital Accredited Treatment Centre (YCH ATC)	This study was funded in part by the CIHR Canadian HIV Trials Network (CTN). http://www.hivnet.ubc.ca/2011/04/camps-trial/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; We acknowledge the support of the CIHR Canadian HIV Trials Network (CTN) the Centre for the Development of Best Practices in Health (CDBPH) and the Yaounde Central Hospital Accredited Treatment Centre (YCH ATC).	Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6; Bahadur KCM, 2010, STUD HEALTH TECHNOL, V160, P530, DOI 10.3233/978-1-60750-588-4-530; Boyer S, 2011, SOC SCI MED, V72, P1383, DOI 10.1016/j.socscimed.2011.02.030; CRAMER JA, 1990, ARCH INTERN MED, V150, P1509, DOI 10.1001/archinte.150.7.1509; Gillwald A, GENDER ASSESSMENT IC; Hardy H, 2011, AIDS PATIENT CARE ST, V25, P153, DOI 10.1089/apc.2010.0006; Horvath T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009756; Kaplan WA, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-9; Keutchankeu RT, 2005, AFRICAN E INDEX ICT; Kouanfack C, 2008, JAIDS-J ACQ IMM DEF, V48, P216, DOI 10.1097/QAI.0b013e3181743955; Lester RT, 2006, AIDS, V20, P2242, DOI 10.1097/QAD.0b013e3280108508; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Little R. J. A., 1987, STAT ANAL MISSING DA; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; MAIMAN LA, 1974, HEALTH EDUC QUART, V2, P336, DOI 10.1177/109019817400200404; Martin S, 2009, AIDS PATIENT CARE ST, V23, P593, DOI 10.1089/apc.2009.0021; Mbuagbaw L, 2012, HIV AIDS-RES PALLIAT, V4, P45, DOI 10.2147/HIV.S29954; Mbuagbaw L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-5; Perrine R, 2011, JAIDS-J ACQ IMM DEF, V57, pS40, DOI 10.1097/QAI.0b013e318222b5c2; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; SabatU E., 2003, ADHERENCE LONG TERM; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; SF Tools, 2010, SF TOOLS SF 12 EV SH; Shet A, 2010, AIDS BEHAV, V14, P716, DOI 10.1007/s10461-009-9658-3; Sinha SR, 2011, NEW ENGL J MED, V365, P779, DOI 10.1056/NEJMp1108040; Strandbygaard U, 2010, RESP MED, V104, P166, DOI 10.1016/j.rmed.2009.10.003; Thirumurthy H, 2012, B WORLD HEALTH ORGAN, V90, P390, DOI 10.2471/BLT.11.099317; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; UNICEF, 2010, CAM STAT; WHO, 2010, PAT SAF YAOUND; [WHO UNAIDS], 2005, RES NEEDS EXP RESP A	31	152	156	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e46909	10.1371/journal.pone.0046909	http://dx.doi.org/10.1371/journal.pone.0046909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057UO	23236345	Green Submitted, Green Published, gold			2022-12-27	WOS:000312589700002
J	Oxaran, V; Ledue-Clier, F; Dieye, Y; Herry, JM; Pechoux, C; Meylheuc, T; Briandet, R; Juillard, V; Piard, JC				Oxaran, Virginie; Ledue-Clier, Florence; Dieye, Yakhya; Herry, Jean-Marie; Pechoux, Christine; Meylheuc, Thierry; Briandet, Romain; Juillard, Vincent; Piard, Jean-Christophe			Pilus Biogenesis in Lactococcus lactis: Molecular Characterization and Role in Aggregation and Biofilm Formation	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; LACTOBACILLUS-RHAMNOSUS GG; STAPHYLOCOCCUS-AUREUS SORTASE; GROUP-B STREPTOCOCCUS; CELL-WALL ANCHOR; SURFACE-PROTEINS; ACTINOMYCES-NAESLUNDII; GENE INACTIVATION; ACID BACTERIA; CORYNEBACTERIUM-DIPHTHERIAE	The genome of Lactococcus lactis strain IL1403 harbors a putative pilus biogenesis cluster consisting of a sortase C gene flanked by 3 LPxTG protein encoding genes (yhgD, yhgE, and yhhB), called here pil. However, pili were not detected under standard growth conditions. Over-expression of the pil operon resulted in production and display of pili on the surface of lactococci. Functional analysis of the pilus biogenesis machinery indicated that the pilus shaft is formed by oligomers of the YhgE pilin, that the pilus cap is formed by the YhgD pilin and that YhhB is the basal pilin allowing the tethering of the pilus fibers to the cell wall. Oligomerization of pilin subunits was catalyzed by sortase C while anchoring of pili to the cell wall was mediated by sortase A. Piliated L. lactis cells exhibited an auto-aggregation phenotype in liquid cultures, which was attributed to the polymerization of major pilin, YhgE. The piliated lactococci formed thicker, more aerial biofilms compared to those produced by non-piliated bacteria. This phenotype was attributed to oligomers of YhgE. This study provides the first dissection of the pilus biogenesis machinery in a non-pathogenic Gram-positive bacterium. Analysis of natural lactococci isolates from clinical and vegetal environments showed pili production under standard growth conditions. The identification of functional pili in lactococci suggests that the changes they promote in aggregation and biofilm formation may be important for the natural lifestyle as well as for applications in which these bacteria are used. Citation: Oxaran V, Ledue-Clier F, Dieye Y, Herry J-M, Pechoux C, et al. (2012) Pilus Biogenesis in Lactococcus lactis: Molecular Characterization and Role in Aggregation and Biofilm Formation. PLoS ONE 7(12): e50989. doi:10.1371/journal.pone.0050989	[Oxaran, Virginie; Ledue-Clier, Florence; Dieye, Yakhya; Herry, Jean-Marie; Meylheuc, Thierry; Briandet, Romain; Juillard, Vincent; Piard, Jean-Christophe] INRA, Micalis UMR1319, Jouy En Josas, France; [Oxaran, Virginie; Ledue-Clier, Florence; Dieye, Yakhya; Herry, Jean-Marie; Meylheuc, Thierry; Briandet, Romain; Juillard, Vincent; Piard, Jean-Christophe] Agro ParisTech, Micalis UMR1319, Jouy En Josas, France; [Pechoux, Christine] INRA, GPL UR1196, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Piard, JC (corresponding author), INRA, Micalis UMR1319, Jouy En Josas, France.	jean-christophe.piard@jouy.inra.fr	Briandet, Romain/AAD-2102-2020; Dieye, Yakhya/P-9086-2019; Dieye, Yakhya/A-5175-2012	Briandet, Romain/0000-0002-8123-3492; Dieye, Yakhya/0000-0003-2461-6558; Oxaran, Virginie/0000-0001-6766-6497; HERRY, Jean-Marie/0000-0001-8627-9994	French government through the doctoral school ABIES; INRA; Fondation pour la Recherche Medicale	French government through the doctoral school ABIES; INRA; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	V.O. was the recipient of a doctoral grant from the French government through the doctoral school ABIES (http://www.agroparistech.fr/abies/) and INRA (http://www.inra.fr/); Y.D. was the recipient of a joint grant from INRA and Fondation pour la Recherche Medicale (http://www.frm.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett TC, 2002, J BACTERIOL, V184, P2181, DOI 10.1128/JB.184.8.2181-2191.2002; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Becherelli M, 2012, MOL MICROBIOL, V83, P1035, DOI 10.1111/j.1365-2958.2012.07987.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bermudez-Humaran LG, 2005, J IMMUNOL, V175, P7297, DOI 10.4049/jimmunol.175.11.7297; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; Boekhorst J, 2005, J BACTERIOL, V187, P4928, DOI 10.1128/JB.187.14.4928-4934.2005; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Bridier A, 2010, J MICROBIOL METH, V82, P64, DOI 10.1016/j.mimet.2010.04.006; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Budzik JM, 2008, J BIOL CHEM, V283, P36676, DOI 10.1074/jbc.M806796200; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; CHOPIN A, 1984, PLASMID, V11, P260, DOI 10.1016/0147-619X(84)90033-7; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Cossart P, 2000, P NATL ACAD SCI USA, V97, P5013, DOI 10.1073/pnas.97.10.5013; DeDent AC, 2007, J BACTERIOL, V189, P4473, DOI 10.1128/JB.00227-07; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Delcour J, 1999, ANTON LEEUW INT J G, V76, P159, DOI 10.1023/A:1002089722581; DELORME C, 1993, J BACTERIOL, V175, P4391, DOI 10.1128/JB.175.14.4391-4399.1993; deRuyter PGGA, 1997, NAT BIOTECHNOL, V15, P976, DOI 10.1038/nbt1097-976; Dieye Y, 2003, APPL ENVIRON MICROB, V69, P7281, DOI 10.1128/AEM.69.12.7281-7288.2003; Dieye Y, 2010, APPL ENVIRON MICROB, V76, P7332, DOI 10.1128/AEM.00928-10; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; ELLIOTT JA, 1991, J CLIN MICROBIOL, V29, P2731, DOI 10.1128/JCM.29.12.2731-2734.1991; Falker S, 2008, MOL MICROBIOL, V70, P595, DOI 10.1111/j.1365-2958.2008.06396.x; Fittipaldi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008426; Foroni E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S16; Gaeng S, 2000, APPL ENVIRON MICROB, V66, P2951, DOI 10.1128/AEM.66.7.2951-2958.2000; Garandeau C, 2002, INFECT IMMUN, V70, P1382, DOI 10.1128/IAI.70.3.1382-1390.2002; Gilad O, 2011, PROTEOMICS, V11, P2503, DOI 10.1002/pmic.201000716; GODON JJ, 1993, J BACTERIOL, V175, P4383, DOI 10.1128/JB.175.14.4383-4390.1993; Habimana O, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-36; Habimana O, 2009, APPL ENVIRON MICROB, V75, P7814, DOI 10.1128/AEM.01333-09; Hanniffy SB, 2007, J INFECT DIS, V195, P185, DOI 10.1086/509807; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hugenholtz J, 2002, ANTON LEEUW INT J G, V82, P217, DOI 10.1023/A:1020608304886; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Igarashi T, 2003, ORAL MICROBIOL IMMUN, V18, P266, DOI 10.1034/j.1399-302X.2003.00076.x; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kelly WJ, 1998, INT J FOOD MICROBIOL, V45, P85, DOI 10.1016/S0168-1605(98)00135-4; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Kline KA, 2010, TRENDS MICROBIOL, V18, P224, DOI 10.1016/j.tim.2010.03.002; Kline KA, 2009, J BACTERIOL, V191, P3237, DOI 10.1128/JB.01837-08; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; LANGELLA P, 1993, J BACTERIOL, V175, P5806, DOI 10.1128/JB.175.18.5806-5813.1993; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Manchester KL, 1996, BIOTECHNIQUES, V20, P968; Mandlik A, 2008, P NATL ACAD SCI US; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2006, MOL MICROBIOL, V62, P1402, DOI 10.1111/j.1365-2958.2006.05469.x; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mercenier A, 2000, Curr Issues Mol Biol, V2, P17; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Nelson AL, 2007, MOL MICROBIOL; Nobbs AH, 2007, MICROBIOL-SGM, V153, P4088, DOI 10.1099/mic.0.2007/007252-0; O'Callaghan J, 2012, APPL ENVIRON MICROB, V78, P5196, DOI 10.1128/AEM.00507-12; Osaki M, 2002, J BACTERIOL, V184, P971, DOI 10.1128/jb.184.4.971-982.2002; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Piard JC, 1997, J BACTERIOL, V179, P3068, DOI 10.1128/jb.179.9.3068-3072.1997; Ping H, 2008, ARCH ORAL BIOL, V53, P150; Price CE, 2012, FEMS MICROBIOL REV, V36, P949, DOI 10.1111/j.1574-6976.2011.00323.x; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Quigley BR, 2010, INFECT IMMUN, V78, P1294, DOI 10.1128/IAI.01037-09; Raz A, 2008, P NATL ACAD SCI US; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Rosch JW, 2005, MOL MICROBIOL, V58, P959, DOI 10.1111/j.1365-2958.2005.04887.x; Ross RP, 1999, ANTON LEEUW INT J G, V76, P337, DOI 10.1023/A:1002069416067; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanders JW, 1998, MOL MICROBIOL, V27, P299, DOI 10.1046/j.1365-2958.1998.00676.x; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; Siciliano RA, 2012, CURR OPIN M IN PRESS; Sillapaa J, 2008, MICROBIOL-SGM, V154, P3199, DOI 10.1099/mic.0.2008/017319-0; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stentz R, 2004, MICROBIOL-SGM, V150, P2503, DOI 10.1099/mic.0.27149-0; Sulavik MC, 1996, J BACTERIOL, V178, P5826, DOI 10.1128/jb.178.19.5826-5830.1996; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; VANDERVOSSEN JMBM, 1987, APPL ENVIRON MICROB, V53, P2452, DOI 10.1128/AEM.53.10.2452-2457.1987; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Yeung MK, 1998, INFECT IMMUN, V66, P1482, DOI 10.1128/IAI.66.4.1482-1491.1998; Yeung MK, 1997, INFECT IMMUN, V65, P2629, DOI 10.1128/IAI.65.7.2629-2639.1997; Zhou M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-173; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200	112	47	47	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50989	10.1371/journal.pone.0050989	http://dx.doi.org/10.1371/journal.pone.0050989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236417	Green Submitted, gold, Green Published			2022-12-27	WOS:000312589700026
J	Aikio, M; Alahuhta, I; Nurmenniemi, S; Suojanen, J; Palovuori, R; Teppo, S; Sorsa, T; Lopez-Otin, C; Pihlajaniemi, T; Salo, T; Heljasvaara, R; Nyberg, P				Aikio, Mari; Alahuhta, Ilkka; Nurmenniemi, Sini; Suojanen, Juho; Palovuori, Riitta; Teppo, Susanna; Sorsa, Timo; Lopez-Otin, Carlos; Pihlajaniemi, Taina; Salo, Tuula; Heljasvaara, Ritva; Nyberg, Pia			Arresten, a Collagen-Derived Angiogenesis Inhibitor, Suppresses Invasion of Squamous Cell Carcinoma	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; IV COLLAGEN; E-CADHERIN; IN-VIVO; TUMOR MICROENVIRONMENT; BASEMENT-MEMBRANE; ALPHA-1-BETA-1 INTEGRIN; ALPHA-3 CHAIN; CANCER CELLS; NC1 DOMAIN	The turnover of extracellular matrix liberates various cryptic molecules with novel biological activity. Among these are the collagen-derived anti-angiogenic fragments, some of which are suggested to affect carcinoma cells also directly. Arresten is an endogenous angiogenesis inhibitor that is derived from the non-collagenous domain of the basement membrane collagen IV alpha 1 chain. As the mere prevention of tumor angiogenesis leads to hypoxia that can result in selection of more aggressive cell types and reduces the efficacy of chemotherapy, we aimed here to elucidate how arresten influences the aggressive human carcinoma cells. Arresten efficiently inhibited migration and invasion of HSC-3 tongue carcinoma cells in culture and in an organotypic model. Subcutaneous Arr-HSC xenografts grew markedly more slowly in nude mice and showed reduced tumor cell proliferation, vessel density and local invasiveness. In the organotypic assay, HSC-3 cells overproducing arresten (Arr-HSC) showed induction of cell death. In monolayer culture the Arr-HSC cells grew in aggregated cobblestone-like clusters and, relative to the control cells, showed increased expression and localization of epithelial marker E-cadherin in cell-cell contacts. Application of electric cell-substrate impedance sensing (ECIS) further supported our observations on altered morphology and motility of the Arr-HSC cells. Administration of a function-blocking alpha 1 integrin antibody abolished the impedance difference between the Arr-HSC and control cells suggesting that the effect of arresten on promotion of HSC-3 cell-cell contacts and cell spreading is at least partly mediated by alpha 1 beta 1 integrin. Collectively, our data suggest novel roles for arresten in the regulation of oral squamous carcinoma cell proliferation, survival, motility and invasion through the modulation of cell differentiation state and integrin signaling.	[Aikio, Mari; Alahuhta, Ilkka; Nurmenniemi, Sini; Palovuori, Riitta; Teppo, Susanna; Pihlajaniemi, Taina; Salo, Tuula; Heljasvaara, Ritva; Nyberg, Pia] Univ Oulu, Oulu Ctr Cell Matrix Res, Oulu, Finland; [Aikio, Mari; Palovuori, Riitta; Pihlajaniemi, Taina; Heljasvaara, Ritva] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Aikio, Mari; Palovuori, Riitta; Pihlajaniemi, Taina; Heljasvaara, Ritva] Univ Oulu, Dept Med Biochem & Mol Biol, Oulu, Finland; [Alahuhta, Ilkka; Nurmenniemi, Sini; Teppo, Susanna; Salo, Tuula; Nyberg, Pia] Univ Oulu, Inst Dent, Dept Diagnost & Oral Med, Oulu, Finland; [Suojanen, Juho; Sorsa, Timo] Univ Helsinki, Inst Dent, Helsinki, Finland; [Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, Oviedo, Spain; [Salo, Tuula; Nyberg, Pia] Oulu Univ Hosp, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Helsinki; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oulu	Nyberg, P (corresponding author), Univ Oulu, Oulu Ctr Cell Matrix Res, Oulu, Finland.	pia.nyberg@oulu.fi	, tuula/ABG-2051-2021; Suojanen, Juho/D-5448-2013; López-Otín, Carlos/AAB-2106-2020	López-Otín, Carlos/0000-0001-6964-1904; Suojanen, Juho/0000-0002-2361-5134; Salo, Tuula/0000-0001-6039-0088; Pihlajaniemi, Taina/0000-0002-1664-9045; Heljasvaara, Ritva/0000-0003-4763-3844	Academy of Finland [1126783, 1130140, 115256, 128259, 132051, 138866]; Centre of Excellence of Academy of Finland [251314]; Finnish Cancer Organizations; Cancer Foundation of Northern Finland; Sigrid Juselius Foundation; Oulu and Helsinki University Hospital KEVO-support; Oulu University Scholarship Foundation; Finnish Dental Society Apollonia; Cancer Foundation Finland sr [110111, 100130] Funding Source: researchfish	Academy of Finland(Academy of Finland); Centre of Excellence of Academy of Finland; Finnish Cancer Organizations; Cancer Foundation of Northern Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Oulu and Helsinki University Hospital KEVO-support; Oulu University Scholarship Foundation; Finnish Dental Society Apollonia; Cancer Foundation Finland sr	This study was financially supported by Academy of Finland (1126783, 1130140, 115256, 128259, 132051, 138866), Centre of Excellence of Academy of Finland Grant 2012-2017 (251314, Finnish Cancer Organizations, Cancer Foundation of Northern Finland, Sigrid Juselius Foundation, Oulu and Helsinki University Hospital KEVO-support, Oulu University Scholarship Foundation, and Finnish Dental Society Apollonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assadian S, 2012, CANCER RES, V72, P1270, DOI 10.1158/0008-5472.CAN-11-2348; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Boosani CS, 2009, INVEST OPHTH VIS SCI, V50, P4567, DOI 10.1167/iovs.09-3473; Boosani CS, 2006, PROTEIN EXPRES PURIF, V49, P211, DOI 10.1016/j.pep.2006.03.007; Brassart-Pasco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029587; Brideau G, 2007, CANCER RES, V67, P11528, DOI 10.1158/0008-5472.CAN-07-1458; Calabrese EJ, 2005, CRIT REV TOXICOL, V35, P463, DOI 10.1080/10408440591034502; Canel M, 2010, CANCER RES, V70, P9413, DOI 10.1158/0008-5472.CAN-10-1454; Celik I, 2005, CANCER RES, V65, P11044, DOI 10.1158/0008-5472.CAN-05-2617; Colorado PC, 2000, CANCER RES, V60, P2520; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Giehl K, 2008, FRONT BIOSCI-LANDMRK, V13, P3975, DOI 10.2741/2985; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Kylmaniemi M, 1996, J DENT RES, V75, P919, DOI 10.1177/00220345960750030901; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Maeshima Y, 2001, J BIOL CHEM, V276, P31959, DOI 10.1074/jbc.M103024200; Magnon C, 2005, CANCER RES, V65, P4353, DOI 10.1158/0008-5472.CAN-04-3536; Medici D, 2010, MATRIX BIOL, V29, P161, DOI 10.1016/j.matbio.2009.12.003; Mundel TM, 2008, INT J CANCER, V122, P1738, DOI 10.1002/ijc.23269; Nurmenniemi S, 2009, AM J PATHOL, V175, P1281, DOI 10.2353/ajpath.2009.081110; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Nyberg P, 2008, EXP CELL RES, V314, P3292, DOI 10.1016/j.yexcr.2008.08.011; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; Pasco S, 2000, J BIOL CHEM, V275, P32999, DOI 10.1074/jbc.M005235200; Pasco S, 2004, EXP CELL RES, V301, P251, DOI 10.1016/j.yexcr.2004.07.036; Pedchenko V, 2004, J BIOL CHEM, V279, P2772, DOI 10.1074/jbc.M311901200; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; Ramazani M, 2011, EUR J VASC ENDOVASC, V42, P484, DOI 10.1016/j.ejvs.2011.05.021; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; Schuh JoAnn C L, 2004, Toxicol Pathol, V32 Suppl 1, P53, DOI 10.1080/01926230490424770; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Sudhakar A, 2005, J CLIN INVEST, V115, P2801, DOI 10.1172/JCI24813; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Talbot Lindsay J, 2012, Int J Biochem Mol Biol, V3, P117; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Wang XQ, 1999, J CELL BIOL, V147, P389, DOI 10.1083/jcb.147.2.389; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wells A, 2011, FRONT BIOSCI-LANDMRK, V16, P815, DOI 10.2741/3722; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7; Zhang WT, 2006, J CELL SCI, V119, P283, DOI 10.1242/jcs.02738	57	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51044	10.1371/journal.pone.0051044	http://dx.doi.org/10.1371/journal.pone.0051044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227231	gold, Green Submitted, Green Published			2022-12-27	WOS:000312588200091
J	Parlee, SD; McNeil, JO; Muruganandan, S; Sinal, CJ; Goralski, KB				Parlee, Sebastian D.; McNeil, Jenna O.; Muruganandan, Shanmugam; Sinal, Christopher J.; Goralski, Kerry B.			Elastase and Tryptase Govern TNF alpha-Mediated Production of Active Chemerin by Adipocytes	PLOS ONE			English	Article							EPICARDIAL ADIPOSE-TISSUE; CORONARY-ARTERY-DISEASE; NECROSIS-FACTOR-ALPHA; METABOLIC SYNDROME; CATHEPSIN-S; SERINE PROTEASES; DENDRITIC CELLS; INFLAMMATION; EXPRESSION; RECEPTOR	Chemerin is a leukocyte chemoattractant and adipokine with important immune and metabolic roles. Chemerin, secreted in an inactive form prochemerin, undergoes C-terminal proteolytic cleavage to generate active chemerin, a ligand for the chemokine-like receptor-1 (CMKLR1). We previously identified that adipocytes secrete and activate chemerin. Following treatment with the obesity-associated inflammatory mediator TNF alpha, unknown adipocyte mechanisms are altered resulting in an increased ratio of active to total chemerin production. Based on these findings we hypothesized adipocytes produce proteases capable of modifying chemerin and its ability to activate CMKRL1. 3T3-L1 adipocytes expressed mRNA of immunocyte and fibrinolytic proteases known to activate chemerin in vitro. Following treatment with a general protease inhibitor cocktail (PIC), the TNF alpha-stimulated increase in apparent active chemerin concentration in adipocyte media was amplified 10-fold, as measured by CMKLR1 activation. When the components of the PIC were investigated individually, aprotinin, a serine protease inhibitor, blocked 90% of the TNF alpha-associated increase in active chemerin. The serine proteases, elastase and tryptase were elevated in adipocyte media following treatment with TNF alpha and their targeted neutralization recapitulated the aprotinin-mediated effects. In contrast, bestatin, an aminopeptidase inhibitor, further elevated the TNF alpha-associated increase in active chemerin. Our results support that adipocytes regulate chemerin by serine protease-mediated activation pathways and aminopeptidase deactivation pathways. Following TNF alpha treatment, increased elastase and tryptase modify the balance between activation and deactivation, elevating active chemerin concentration in adipocyte media and subsequent CMKLR1 activation.	[McNeil, Jenna O.; Goralski, Kerry B.] Dalhousie Univ, Coll Pharm, Halifax, NS B3H 3J5, Canada; [Parlee, Sebastian D.; Muruganandan, Shanmugam; Sinal, Christopher J.; Goralski, Kerry B.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University	Goralski, KB (corresponding author), Dalhousie Univ, Coll Pharm, Halifax, NS B3H 3J5, Canada.	kerry.goralski@dal.ca	Muruganandan, Shanmugam/H-5673-2019	Goralski, Kerry/0000-0003-0040-5879; Shanmugam, Muruganandan/0000-0001-9552-2175; Sinal, Christopher/0000-0001-8301-3349	Canadian Foundation for Innovation; Canadian Institutes of Health Research; Nova Scotia Health Research Foundation; Dalhousie Pharmacy Endowment; Dalhousie Medical Research Foundation	Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation; Dalhousie Pharmacy Endowment; Dalhousie Medical Research Foundation	The research project was funded by grants from the Canadian Foundation for Innovation (to KBG), the Canadian Institutes of Health Research (to KBG and CJS), the Nova Scotia Health Research Foundation (to KBG), the Dalhousie Pharmacy Endowment (to KBG) and the Dalhousie Medical Research Foundation (to KBG). SDP received scholarship support from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; Bonnart C, 2010, J CLIN INVEST, V120, P871, DOI 10.1172/JCI41440; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Buxbaum E, 2007, FUNDAMENTALS PROTEIN, Vxi; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; CATALAN V, 2011, SURG OBES RELAT DIS; Chakaroun R, 2011, METABOLISM; CSERNOK E, 1994, CLIN EXP IMMUNOL, V95, P244; Dong BK, 2011, INTERNAL MED, V50, P1093, DOI 10.2169/internalmedicine.50.5025; Du XY, 2009, ACTA BIOCH BIOPH SIN, V41, P973, DOI 10.1093/abbs/gmp091; Du XY, 2009, J BIOL CHEM, V284, P751, DOI 10.1074/jbc.M805000200; El-Mesallamy HO, 2011, DIABET MED; Ernst MC, 2010, ENDOCRINOLOGY, V151, P1998, DOI 10.1210/en.2009-1098; FRITZ H, 1983, ARZNEIMITTELFORSCH, V33-1, P479; Gao XY, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-87; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Guillabert A, 2008, J LEUKOCYTE BIOL, V84, P1530, DOI 10.1189/jlb.0508322; Hah YJ, 2011, DIABETES METAB J, V35, P248, DOI 10.4093/dmj.2011.35.3.248; HEYMANN E, 1986, BIOMED BIOCHIM ACTA, V45, P575; Hou WS, 2002, ARTHRITIS RHEUM, V46, P663, DOI 10.1002/art.10114; HUET G, 1993, ARTHRITIS RHEUM-US, V36, P772, DOI 10.1002/art.1780360606; HUI KS, 1983, BIOCHEMISTRY-US, V22, P1062, DOI 10.1021/bi00274a010; Issa ME, 2012, AM J PHYSL CELL PHYS; John H, 2007, ANAL BIOCHEM, V362, P117, DOI 10.1016/j.ab.2006.12.001; KANAYAMA N, 1995, J LEUKOCYTE BIOL, V57, P129, DOI 10.1002/jlb.57.1.129; Kulig P, 2011, J IMMUNOL, V187, P1403, DOI 10.4049/jimmunol.1002352; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Le QT, 2011, J IMMUNOL, V186, P7136, DOI 10.4049/jimmunol.1001804; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Lehr S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010504; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; Lemaire R, 1997, BRIT J RHEUMATOL, V36, P735; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Mikhail N, 2011, CURR DRUG SAF, V6, P304, DOI 10.2174/157488611798918700; Mussig K, 2009, METABOLISM, V58, P519, DOI 10.1016/j.metabol.2008.11.011; Muruganandan S, 2011, J BIOL CHEM, V286, P23982, DOI 10.1074/jbc.M111.220491; Muruganandan S, 2010, J BONE MINER RES, V25, P222, DOI 10.1359/jbmr.091106; Nagpal S, 1997, J INVEST DERMATOL, V109, P91, DOI 10.1111/1523-1747.ep12276660; Naour N, 2010, J CLIN ENDOCR METAB, V95, P1861, DOI 10.1210/jc.2009-1894; Parlee SD, 2010, ENDOCRINOLOGY, V151, P2590, DOI 10.1210/en.2009-0794; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Ramirez M, 2008, HEART FAIL REV, V13, P339, DOI 10.1007/s10741-007-9066-6; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Ress C, 2010, EUR J CLIN INVEST, V40, P277, DOI 10.1111/j.1365-2362.2010.02255.x; Seki T, 2001, J CELL PHYSIOL, V189, P72, DOI 10.1002/jcp.1140; Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; Song SH, 2010, DOMEST ANIM ENDOCRIN, V39, P97, DOI 10.1016/j.domaniend.2010.02.007; Spiroglou SG, 2010, J ATHEROSCLER THROMB, V17, P115; Stejskal D, 2008, BIOMED PAP, V152, P217, DOI 10.5507/bp.2008.033; Taggart C, 2000, AM J PHYSIOL-LUNG C, V278, pL33, DOI 10.1152/ajplung.2000.278.1.L33; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Taleb S, 2005, FASEB J, V19, P1540, DOI 10.1096/fj.05-3673fje; Taleb S, 2006, ENDOCRINOLOGY, V147, P4950, DOI 10.1210/en.2006-0386; Tan BK, 2009, DIABETES, V58, P1971, DOI 10.2337/db08-1528; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; Tetley TD, 2002, CHEST, V121, p156S, DOI 10.1378/chest.121.5_suppl.156S; Tonjes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013911; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yan Q, 2012, ENDOCRINE, V41, P281, DOI 10.1007/s12020-011-9550-6; Yang ML, 2010, J INVEST MED, V58, P883, DOI 10.231/JIM.0b013e3181ec5db2; Yoo HJ, 2012, J ATHEROSCLER THROMB, V19, P59, DOI 10.5551/jat.9647; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zhao L, 2011, J BIOL CHEM, V286, P39520, DOI 10.1074/jbc.M111.258954; Zollner H., 1993, HDB ENZYME INHIBITOR, P1065	77	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51072	10.1371/journal.pone.0051072	http://dx.doi.org/10.1371/journal.pone.0051072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227233	gold, Green Published, Green Submitted			2022-12-27	WOS:000312588200093
J	Yokoya, M; Shimizu, H; Higuchi, Y				Yokoya, Masana; Shimizu, Hideyasu; Higuchi, Yukito			Geographical Distribution of Adolescent Body Height with Respect to Effective Day Length in Japan: An Ecological Analysis	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; LUTEINIZING-HORMONE; SEASONAL-VARIATION; HUMAN ILLUMINATION; CIRCADIAN-RHYTHMS; SOLAR-RADIATION; ACTION SPECTRUM; SECULAR TRENDS; MELATONIN; SLEEP	The height of Japanese youth raised in the northern region tends to be greater than that of youth raised in the southern region; therefore, a geographical gradient in youth body height exists. Although this gradient has existed for about 100 years, the reasons for it remain unclear. Consideration of the nutritional improvement, economic growth, and intense migration that has occurred in this period indicates that it is probably the result of environmental rather than nutritional or genetic factors. To identify possible environmental factors, ecological analysis of prefecture-level data on the body size of 8-to 17-year-old youth averaged over a 13-year period (1996 to 2008) and Japanese mesh climatic data on the climatic variables of temperature, solar radiation, and effective day length (duration of photoperiod exceeding the threshold of light intensity) was performed. The geographical distribution of the standardized height of Japanese adolescents was found to be inversely correlated to a great extent with the distribution of effective day length at a light intensity greater than 4000 lx. The results of multiple regression analysis of effective day length, temperature, and weight (as an index of food intake) indicated that a combination of effective day length and weight was statistically significant as predictors of height in early adolescence; however, only effective day length was statistically significant as a predictor of height in late adolescence. Day length may affect height by affecting the secretion of melatonin, a hormone that inhibits sexual and skeletal maturation, which in turn induces increases in height. By affecting melatonin production, regional differences in the duration of the photoperiod may lead to regional differences in height. Exposure to light intensity greater than 4000 lx appears to be the threshold at which light intensity begins to affect the melatonin secretion of humans who spend much of their time indoors. Citation: Yokoya M, Shimizu H, Higuchi Y (2012) Geographical Distribution of Adolescent Body Height with Respect to Effective Day Length in Japan: An Ecological Analysis. PLoS ONE 7(12): e50994. doi:10.1371/journal.pone.0050994	[Yokoya, Masana] Shimonoseki Jr Coll, Shimonoseki, Yamaguchi, Japan; [Shimizu, Hideyasu] Toshiwa Kai Hosp, Naka Ku, Nagoya, Aichi, Japan; [Higuchi, Yukito] Kyushu Kyoritsu Univ, Yahatanishi Ku, Kitakyushu, Fukuoka, Japan		Yokoya, M (corresponding author), Shimonoseki Jr Coll, 1-1 Sakurayama Cho, Shimonoseki, Yamaguchi, Japan.	m.yokoya@shimonoseki-jc.ac.jp		Yokoya, Masana/0000-0002-1122-9500				Agyemang C, 2005, J HYPERTENS, V23, P913, DOI 10.1097/01.hjh.0000166827.94699.f9; Alfonzo-Gonzalez G, 2004, EUR J CLIN NUTR, V58, P1125, DOI 10.1038/sj.ejcn.1601940; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; [Anonymous], TRANSF US GUID REF M; Arble DM, 2010, BEST PRACT RES CL EN, V24, P785, DOI 10.1016/j.beem.2010.08.003; Arendt J, 2005, SLEEP MED REV, V9, P25, DOI 10.1016/j.smrv.2004.05.002; Baggs JE, 2010, CURR OPIN GENET DEV, V20, P581, DOI 10.1016/j.gde.2010.08.009; Blanckenhorn WU, 2006, EVOLUTION, V60, P2004, DOI 10.1111/j.0014-3820.2006.tb01838.x; Boivin DB, 1996, NATURE, V379, P540, DOI 10.1038/379540a0; BOJLEN K, 1964, Bibl Laeger, V156, P109; Brainard GC, 2001, J NEUROSCI, V21, P6405; Bray MS, 2007, OBES REV, V8, P169, DOI 10.1111/j.1467-789X.2006.00277.x; Case A, 2008, AM ECON REV, V98, P463, DOI 10.1257/aer.98.2.463; Central Intelligence Agency, 2008, CIA WORLD FACT BOOK; Cole RJ, 1995, J BIOL RHYTHM, V10, P324, DOI 10.1177/074873049501000406; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; ENDO A, 1993, AM J PHYS ANTHROPOL, V91, P299, DOI 10.1002/ajpa.1330910305; ESQUIFINO AI, 1987, J STEROID BIOCHEM, V27, P1089; GEIST V, 1987, CAN J ZOOL, V65, P1035, DOI 10.1139/z87-164; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; Golub MS, 2008, PEDIATRICS, V121, pS218, DOI 10.1542/peds.2007-1813G; Gooley JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000741; Grivas TB, 2006, SCOLIOSIS SPINAL DIS, V1, DOI 10.1186/1748-7161-1-9; Hebert M, 1998, CHRONOBIOL INT, V15, P59; Hermanussen M, 2007, ANTHROPOL ANZ, V65, P275, DOI 10.1127/anthranz/65/2007/275; Higuchi S, 2007, AM J PHYSIOL-REG I, V292, pR2352, DOI 10.1152/ajpregu.00355.2006; HONMA KI, 1992, AM J PHYSIOL, V262, pR885, DOI 10.1152/ajpregu.1992.262.5.R885; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Japan Meteorological Agency, AMEDAS DAT; Japan Meteorological Agency, 2000, EXPL MESH CLIM DAT 2; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; Kouchi M, 1983, B U MUSEUM U TOKYO, V22, P1; Lesgards JF, 2002, ENVIRON HEALTH PERSP, V110, P479, DOI 10.1289/ehp.02110479; LINCOLN GA, 1982, J ENDOCRINOL, V92, P237, DOI 10.1677/joe.0.0920237; MCNAB BK, 1971, ECOLOGY, V52, P845, DOI 10.2307/1936032; Ministry of Education Culture Sports Science and Technology, 2010, SCH HLTH EX SURV REP; Ministry of Health and Welfare, 2006, INF NUTR SURV 2006; Ministry of Health and Welfare, 2011, REP NAT NUTR SURV 20; Ministry of Health and Welfare, 2010, DIET REF INT JAP 201; Ministry of Internal Affairs and Communications, 2010, FIN REP 2005 POP CEN; Nole Gregory, 2004, Dermatol Ther, V17 Suppl 1, P57, DOI 10.1111/j.1396-0296.2004.04S1007.x; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Parker JE, 2002, AM J VET RES, V63, P948, DOI 10.2460/ajvr.2002.63.948; Reiter RJ, 2009, BIOL REPROD, V81, P445, DOI 10.1095/biolreprod.108.075655; Roberts DF, 1953, AM J PHYS ANTHROP-NE, V11, P533, DOI 10.1002/ajpa.1330110404; Rogol AD, 2000, AM J CLIN NUTR, V72, p521S, DOI 10.1093/ajcn/72.2.521S; Rozman B, 2003, COLLEGIUM ANTROPOL, V27, P285; Sack RL, 2007, SLEEP, V30, P1460, DOI 10.1093/sleep/30.11.1460; Smith MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006014; Steckel RH, 1995, J ECON LIT, V33, P1903; Steegmann AT, 2007, AM J HUM BIOL, V19, P218, DOI 10.1002/ajhb.20614; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Thornthwaite C. W., 1957, DREXEL I TECHNOLOGY, V10, P185, DOI DOI 10.1007/S10584-011-0148-Z; TOUITOU Y, 1981, J ENDOCRINOL, V91, P467, DOI 10.1677/joe.0.0910467; Tsutsui K, 2010, FRONT NEUROENDOCRIN, V31, P284, DOI 10.1016/j.yfrne.2010.03.001; Ubuka T, 2005, P NATL ACAD SCI USA, V102, P3052, DOI 10.1073/pnas.0403840102; Van Cauter E, 1998, HORM RES, V49, P147, DOI 10.1159/000023162; Wehr TA, 1997, J BIOL RHYTHM, V12, P518, DOI 10.1177/074873049701200605; Yokoya M., 2010, Japanese Journal of Nutrition and Dietetics, V68, P263, DOI 10.5264/eiyogakuzashi.68.263; Yokoya M, 2011, INT J ENV RES PUB HE, V8, P4272, DOI 10.3390/ijerph8114272; YOUNG IM, 1988, J PINEAL RES, V5, P71, DOI 10.1111/j.1600-079X.1988.tb00770.x; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x	64	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50994	10.1371/journal.pone.0050994	http://dx.doi.org/10.1371/journal.pone.0050994			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227226	gold, Green Published, Green Submitted			2022-12-27	WOS:000312588200087
J	Yuji, K; Imoto, S; Yamaguchi, R; Matsumura, T; Murashige, N; Kodama, Y; Minayo, S; Imai, K; Kami, M				Yuji, Koichiro; Imoto, Seiya; Yamaguchi, Rui; Matsumura, Tomoko; Murashige, Naoko; Kodama, Yuko; Minayo, Satoru; Imai, Kohzoh; Kami, Masahiro			Forecasting Japan's Physician Shortage in 2035 as the First Full-Fledged Aged Society	PLOS ONE			English	Article							WORKFORCE; DOCTORS; HOSPITALS; IMPACT	Introduction: Japan is rapidly becoming a full-fledged aged society, and physician shortage is a significant concern. The Japanese government has increased the number of medical school enrollments since 2008, but some researchers warn that this increase could lead to physician surplus in the future. It is unknown how many physicians will be required to accommodate future healthcare needs. Materials and Methods: We simulated changes in age/sex composition of the population, fatalities (the number of fatalities for the consecutive five years), and number of physicians from 2010 to 2035. Two indicators were defined: fatalities per physician and fatalities by physician working hour, based on the data of the working hours of physicians for each tuple of sex and age groups. We estimated the necessary number of physicians in 2035 and the number of new physicians to maintain the indicator levels in 2010. Results: The number of physicians per 1,000 population is predicted to rise from 2.00 in 2010 to 3.14 in 2035. The number of physicians aged 60 years or older is expected to increase from 55,375 (20% of physicians) to 141,711 (36%). In 2010 and 2035, fatalities per physician were 23.1 and 24.0 for the total population, and 13.9 and 19.2 for 75 years or older, respectively. Fatalities per physician working hour are predicted to rise from 0.128 to 0.138. If working hours are limited to 48 hours per week in 2035, the number of fatalities per physician working hour is expected to be 0.196, and the number of new physicians must be increased by 53% over the current pace. Discussion: The number of physicians per population continues to rise, but the estimated supply will not fulfill the demand for healthcare in the aging society. Strategies to increase the number of physicians and improve working conditions are urgently needed. Citation: Yuji K, Imoto S, Yamaguchi R, Matsumura T, Murashige N, et al. (2012) Forecasting Japan's Physician Shortage in 2035 as the First Full-Fledged Aged Society. PLoS ONE 7(11): e50410. doi:10.1371/journal.pone.0050410	[Yuji, Koichiro; Imai, Kohzoh] Univ Tokyo, Res Hosp, Inst Med Sci, Dept Internal Med,Minato Ku, Tokyo, Japan; [Imoto, Seiya; Yamaguchi, Rui; Minayo, Satoru] Univ Tokyo, Lab DNA Informat Anal, Ctr Human Genome, Inst Med Sci,Minato Ku, Tokyo, Japan; [Imoto, Seiya; Yamaguchi, Rui; Minayo, Satoru] Univ Tokyo, Lab Sequence Anal, Ctr Human Genome, Inst Med Sci,Minato Ku, Tokyo, Japan; [Matsumura, Tomoko; Murashige, Naoko; Kodama, Yuko; Kami, Masahiro] Univ Tokyo, Div Social Commun Syst Adv Clin Res, Inst Med Sci, Minato Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Yuji, K (corresponding author), Univ Tokyo, Res Hosp, Inst Med Sci, Dept Internal Med,Minato Ku, Tokyo, Japan.	yuji-tky@umin.ac.jp						[Anonymous], 2011, JAPAN TIMES     1128; [Anonymous], 2008, AGENCE FRANCE P 0315; [Anonymous], 2007, JAPAN TIMES     1001; [Anonymous], 2001, CONDITION NEED LONG, P30; [Anonymous], 2008, JAPAN TIMES     0412; [Anonymous], 2009, JAPAN TIMES     0423; [Anonymous], 2006, JAPAN TIMES     0412; Campbell JL, 2004, OXFORD TXB PRIMARY M, P65; Charles J, 2004, MED J AUSTRALIA, V181, P85, DOI 10.5694/j.1326-5377.2004.tb06181.x; Gray S, 2005, BRIT MED J, V331, P696, DOI 10.1136/bmj.331.7518.696; Hiyama T, 2008, OCCUP ENVIRON MED, V65, P428, DOI 10.1136/oem.2007.037473; Horev T, 2004, HEALTH POLICY, V68, P223, DOI 10.1016/j.healthpol.2003.09.011; Izumi M, 2008, IGAKU KYOIKU, V39, pS15; Jackson DB, 2011, NAT REV CLIN ONCOL, V8, P735, DOI 10.1038/nrclinonc.2011.151; Kaneto C, 2009, HEALTH POLICY, V89, P115, DOI 10.1016/j.healthpol.2008.05.010; KOBAYASHI Y, 1992, LANCET, V340, P1391, DOI 10.1016/0140-6736(92)92569-2; Koike S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-180; Koike S, 2009, HEALTH POLICY, V92, P244, DOI 10.1016/j.healthpol.2009.04.005; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Matsumoto K., 2010, J JAPAN SOC HLTH CAR, V10, P575; Matsumoto M, 2010, HEALTH POLICY, V95, P129, DOI 10.1016/j.healthpol.2009.11.012; McMurray Julia E, 2002, J Am Med Womens Assoc (1972), V57, P185; Ministry of Health Labor and Welfare, 2009, VIT STAT JAP; Ministry of Health Labor and Welfare, 2009, ANN REG NUMB TABL GU; Ministry of Health Labour and Welfare Japan, 2008, SURV MED CAR ACT PUB; Moonesinghe SR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1580; Moore W, 2002, BRIT MED J, V324, P754; Nagamatsu S, 2009, CURR OPIN ANESTHESIO, V22, P199, DOI 10.1097/ACO.0b013e328323f7aa; National Institute of Population and Social Security, 2011, POP PROJ JAP 2001 20; Organization for Economic Co-operation and Development, 2010, PRACT PHYS PER 1000; Prunier-Poulmaire S, 2001, J Hum Ergol (Tokyo), V30, P41; Takata H, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-14; The Association of American Medical Colleges, 2012, 2011 STAT PHYS WORKF; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Whitcomb ME, 2010, NEW ENGL J MED, V362, P1255, DOI 10.1056/NEJMp0912179; Working Group on the new post-graduate clinical training system Ministry of Health Labor and Welfare, 2012, REG IMP INTR NEW POS; World Health Organization, 2010, HLTH LIF EXP HALE BI; Yazaki Y, 2006, REPORT STUDY GROUP P	38	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e50410	10.1371/journal.pone.0050410	http://dx.doi.org/10.1371/journal.pone.0050410			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054WM	23233868	Green Published, Green Submitted, gold			2022-12-27	WOS:000312376100090
J	Carter, SP; Chambers, MA; Rushton, SP; Shirley, MDF; Schuchert, P; Pietravalle, S; Murray, A; Rogers, F; Gettinby, G; Smith, GC; Delahay, RJ; Hewinson, RG; McDonald, RA				Carter, Stephen P.; Chambers, Mark A.; Rushton, Stephen P.; Shirley, Mark D. F.; Schuchert, Pia; Pietravalle, Stephane; Murray, Alistair; Rogers, Fiona; Gettinby, George; Smith, Graham C.; Delahay, Richard J.; Hewinson, R. Glyn; McDonald, Robbie A.			BCG Vaccination Reduces Risk of Tuberculosis Infection in Vaccinated Badgers and Unvaccinated Badger Cubs	PLOS ONE			English	Article							MELES-MELES; BOVINE TUBERCULOSIS; CATTLE TUBERCULOSIS; IMPACT; ORGANIZATION; ERADICATION; POPULATION; CESSATION; SEVERITY; MOVEMENT	Wildlife is a global source of endemic and emerging infectious diseases. The control of tuberculosis (TB) in cattle in Britain and Ireland is hindered by persistent infection in wild badgers (Meles meles). Vaccination with Bacillus Calmette-Guerin (BCG) has been shown to reduce the severity and progression of experimentally induced TB in captive badgers. Analysis of data from a four-year clinical field study, conducted at the social group level, suggested a similar, direct protective effect of BCG in a wild badger population. Here we present new evidence from the same study identifying both a direct beneficial effect of vaccination in individual badgers and an indirect protective effect in unvaccinated cubs. We show that intramuscular injection of BCG reduced by 76% (Odds ratio = 0.24, 95% confidence interval (CI) 0.11-0.52) the risk of free-living vaccinated individuals testing positive to a diagnostic test combination to detect progressive infection. A more sensitive panel of tests for the detection of infection per se identified a reduction of 54% (Odds ratio = 0.46, 95% CI 0.26-0.88) in the risk of a positive result following vaccination. In addition, we show the risk of unvaccinated badger cubs, but not adults, testing positive to an even more sensitive panel of diagnostic tests decreased significantly as the proportion of vaccinated individuals in their social group increased (Odds ratio = 0.08, 95% CI 0.01-0.76; P = 0.03). When more than a third of their social group had been vaccinated, the risk to unvaccinated cubs was reduced by 79% (Odds ratio = 0.21, 95% CI 0.05-0.81; P = 0.02).	[Carter, Stephen P.; Pietravalle, Stephane; Murray, Alistair; Rogers, Fiona; Smith, Graham C.; Delahay, Richard J.] Food & Environm Res Agcy, York, N Yorkshire, England; [Chambers, Mark A.; Hewinson, R. Glyn] Anim Hlth & Vet Labs Agcy, Dept Bacteriol, Addlestone, Surrey, England; [Rushton, Stephen P.; Shirley, Mark D. F.; Schuchert, Pia] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gettinby, George] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [McDonald, Robbie A.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	Food & Environment Research Agency; Veterinary Laboratories Agency; Newcastle University - UK; University of Strathclyde; University of Exeter	Carter, SP (corresponding author), Food & Environm Res Agcy, York, N Yorkshire, England.	steve.carter@fera.gsi.gov.uk	Chambers, Mark A/C-9470-2009; Delahay, Richard/J-2261-2014; Chambers, Mark/M-6189-2019; Carter, Steve P/J-1686-2014; McDonald, Robbie A/A-2931-2012; Hewinson, Glyn/AAA-2364-2019; Smith, Graham C/J-2593-2013; Delahay, Richard/GSI-4663-2022; McDonald, Robbie/AAK-2718-2020; Hewinson, Glyn/J-1902-2014	Chambers, Mark A/0000-0002-8073-8069; Chambers, Mark/0000-0002-8073-8069; Carter, Steve P/0000-0002-9487-7377; McDonald, Robbie A/0000-0002-6922-3195; Smith, Graham C/0000-0002-9897-6794; McDonald, Robbie/0000-0002-6922-3195; Shirley, Mark/0000-0002-6220-2578; Hewinson, Glyn/0000-0002-5517-4281	Department for Environment, Food and Rural Affairs [SE3254]	Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department for Environment, Food and Rural Affairs (Defra project number SE3254, http://www.defra.gov.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript but provided helpful comments to earlier versions of the manuscript.	ANDERSON RM, 1986, NATURE, V322, P304, DOI 10.1038/322304a0; ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; [Anonymous], 2011, VET REC, V169, P425, DOI 10.1136/vr.d6781; [Anonymous], 2011, BOV TB ER PROGR ENGL; [Anonymous], 2010, FIELD TRIAL ASSESS S; Bishop P, 2012, J ENVIRON LAW, V24, P145, DOI 10.1093/jel/eqs001; Blancou Jean, 2009, P97, DOI 10.1007/978-4-431-77134-0_6; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BROCHIER B, 1991, NATURE, V354, P520, DOI 10.1038/354520a0; Brostrom G, 2011, GEN LINEAR MODELS CL; Brostrom G., 2011, GLMMML GEN LINEAR MO; Carter SP, 2007, P ROY SOC B-BIOL SCI, V274, P2769, DOI 10.1098/rspb.2007.0998; Chambers MA, 2008, J CLIN MICROBIOL, V46, P1498, DOI 10.1128/JCM.02117-07; Chambers MA, 2011, P ROY SOC B-BIOL SCI, V278, P1913, DOI 10.1098/rspb.2010.1953; Chambers MA, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-42; CLIFTONHADLEY RS, 1995, EPIDEMIOL INFECT, V114, P179, DOI 10.1017/S0950268800052031; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Leeuw ANS, 2004, VET J, V167, P186, DOI 10.1016/S1090-0233(03)00113-8; Delahay RJ, 2011, J ZOOL, V284, P183, DOI 10.1111/j.1469-7998.2011.00796.x; Delahay RJ, 2000, MAMMAL REV, V30, P73, DOI 10.1046/j.1365-2907.2000.00058.x; Delahay RJ, 2000, J ANIM ECOL, V69, P428, DOI 10.1046/j.1365-2656.2000.00406.x; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Donnelly CA, 2007, INT J INFECT DIS, V11, P300, DOI 10.1016/j.ijid.2007.04.001; Donnelly CA, 2012, NATURE, V485, P582, DOI 10.1038/485582a; Eves JA, 1999, IRISH VET J, V52, P199; Farr W, 1840, 2 ANN REPORT REGISTR; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; GALLAGHER J, 1977, J HYG-CAMBRIDGE, V79, P155, DOI 10.1017/S0022172400052943; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Henschel V, 2009, INTCOX COMPENDIUM AP; Jenkins HE, 2008, INT J INFECT DIS, V12, P457, DOI 10.1016/j.ijid.2008.04.001; Jenkins HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009090; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kaden V, 2003, BERL MUNCH TIERARZTL, V116, P362; Krebs J. (Chairman), 1997, Bovine tuberculosis in cattle and badgers.; Lesellier S, 2011, VACCINE, V29, P3782, DOI 10.1016/j.vaccine.2011.03.028; Neal E., 1996, BADGERS; O Mairtin D, 1998, PREV VET MED, V34, P47, DOI 10.1016/S0167-5877(97)00067-6; Rogers LM, 1998, P ROY SOC B-BIOL SCI, V265, P1269, DOI 10.1098/rspb.1998.0429; Rogers LM, 1997, J ZOOL, V242, P705, DOI 10.1111/j.1469-7998.1997.tb05821.x; Rushton SP, 2009, EPIDEMIOL INFECT, V137, P1099, DOI 10.1017/S095026880800188X; Sheridan M, 2011, VET MICROBIOL, V151, P160, DOI 10.1016/j.vetmic.2011.02.040; Slate D, 2005, VIRUS RES, V111, P68, DOI 10.1016/j.virusres.2005.03.012; Therneau T. M., 2013, MODELING SURVIVAL DA, DOI 10.1007/978-1-4757-3294-8; Tomlinson A, 2012, VET IMMUNOL IN PRESS; Topley WWC, 1923, J HYG-CAMBRIDGE, V21, P243, DOI 10.1017/S0022172400031478; Vicente J, 2007, J ANIM ECOL, V76, P348, DOI 10.1111/j.1365-2656.2006.01199.x; von Ruden S, 2008, VET MICROBIOL, V132, P29, DOI 10.1016/j.vetmic.2008.04.022	50	59	59	1	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49833	10.1371/journal.pone.0049833	http://dx.doi.org/10.1371/journal.pone.0049833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251352	Green Published, Green Accepted, gold			2022-12-27	WOS:000313236200020
J	Graves, TA; Royle, JA; Kendall, KC; Beier, P; Stetz, JB; Macleod, AC				Graves, Tabitha A.; Royle, J. Andrew; Kendall, Katherine C.; Beier, Paul; Stetz, Jeffrey B.; Macleod, Amy C.			Balancing Precision and Risk: Should Multiple Detection Methods Be Analyzed Separately in N-Mixture Models?	PLOS ONE			English	Article							ESTIMATING ABUNDANCE; COUNTS	Using multiple detection methods can increase the number, kind, and distribution of individuals sampled, which may increase accuracy and precision and reduce cost of population abundance estimates. However, when variables influencing abundance are of interest, if individuals detected via different methods are influenced by the landscape differently, separate analysis of multiple detection methods may be more appropriate. We evaluated the effects of combining two detection methods on the identification of variables important to local abundance using detections of grizzly bears with hair traps (systematic) and bear rubs (opportunistic). We used hierarchical abundance models (N-mixture models) with separate model components for each detection method. If both methods sample the same population, the use of either data set alone should (1) lead to the selection of the same variables as important and (2) provide similar estimates of relative local abundance. We hypothesized that the inclusion of 2 detection methods versus either method alone should (3) yield more support for variables identified in single method analyses (i.e. fewer variables and models with greater weight), and (4) improve precision of covariate estimates for variables selected in both separate and combined analyses because sample size is larger. As expected, joint analysis of both methods increased precision as well as certainty in variable and model selection. However, the single-method analyses identified different variables and the resulting predicted abundances had different spatial distributions. We recommend comparing single-method and jointly modeled results to identify the presence of individual heterogeneity between detection methods in N-mixture models, along with consideration of detection probabilities, correlations among variables, and tolerance to risk of failing to identify variables important to a subset of the population. The benefits of increased precision should be weighed against those risks. The analysis framework presented here will be useful for other species exhibiting heterogeneity by detection method.	[Graves, Tabitha A.; Beier, Paul] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; [Royle, J. Andrew] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA; [Kendall, Katherine C.] US Geol Survey, No Rocky Mt Sci Ctr, Glacier Field Stn, Glacier Natl Pk, MT USA; [Stetz, Jeffrey B.] Univ Montana, Montana Cooperat Wildlife Res Unit, Missoula, MT 59812 USA; [Macleod, Amy C.] Univ Montana, Glacier Field Stn, Cooperat Ecosyst Studies Unit, Glacier Natl Pk, MT USA	Northern Arizona University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of Montana System; University of Montana; University of Montana System; University of Montana	Graves, TA (corresponding author), No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA.	Tabitha.Graves@colostate.edu	Beier, Paul/K-9294-2013; MACLEOD, AMY C/A-5724-2009	Beier, Paul/0000-0002-4297-4343; MACLEOD, AMY C/0000-0002-6966-2278; Royle, Jeffrey/0000-0003-3135-2167	NSF-IGERT; NAU School of Forestry; Hafen Scholarship; Prather Scholarship; David-German Scholarship; P.E.O. Scholar Award; AAUW American Fellowship; David H. Smith Conservation Research Fellowship	NSF-IGERT(National Science Foundation (NSF)); NAU School of Forestry; Hafen Scholarship; Prather Scholarship; David-German Scholarship; P.E.O. Scholar Award; AAUW American Fellowship; David H. Smith Conservation Research Fellowship	Tabitha was supported by NSF-IGERT, NAU School of Forestry, the Hafen, Prather, and David-German Scholarships, the P.E.O. Scholar Award, the AAUW American Fellowship, and the David H. Smith Conservation Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Boulanger J, 2004, J MAMMAL, V85, P618, DOI 10.1644/BRB-134; Boulanger J, 2008, ECOL APPL, V18, P577, DOI 10.1890/06-1941.1; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Conway CJ, 2005, AUK, V122, P26, DOI 10.1642/0004-8038(2005)122[0026:EOCSFM]2.0.CO;2; Dreher BP, 2007, J WILDLIFE MANAGE, V71, P2684, DOI 10.2193/2006-398; Field SA, 2005, J WILDLIFE MANAGE, V69, P473, DOI 10.2193/0022-541X(2005)069[0473:OAOMEU]2.0.CO;2; Graves TA, 2011, ANIM CONSERV, V14, P652, DOI 10.1111/j.1469-1795.2011.00471.x; Kendall KC, 2008, J WILDLIFE MANAGE, V72, P1693, DOI 10.2193/2008-007; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kery M, 2005, ECOL APPL, V15, P1450, DOI 10.1890/04-1120; Kery M, 2008, AUK, V125, P336, DOI 10.1525/auk.2008.06185; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacKenzie DI, 2005, ECOLOGY, V86, P1101, DOI 10.1890/04-1060; Martin J, 2011, METHODS ECOL EVOL, V2, P595, DOI 10.1111/j.2041-210X.2011.00113.x; Meyer CFJ, 2010, BIOL CONSERV, V143, P2797, DOI 10.1016/j.biocon.2010.07.029; Nichols JD, 2008, J APPL ECOL, V45, P1321, DOI 10.1111/j.1365-2664.2008.01509.x; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robert C.P., 2000, TECHNOMETRICS, V42, P430, DOI [10.2307/1270959, DOI 10.2307/1270959]; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Williams B. K., 2002, ANAL MANAGEMENT ANIM; [No title captured]	24	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49410	10.1371/journal.pone.0049410	http://dx.doi.org/10.1371/journal.pone.0049410			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251342	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200015
J	Baumstarck, K; Reuter, F; Boucekine, M; Aghababian, V; Klemina, I; Loundou, A; Pelletier, J; Auquier, P				Baumstarck, Karine; Reuter, Francoise; Boucekine, Mohamed; Aghababian, Valerie; Klemina, Irina; Loundou, Anderson; Pelletier, Jean; Auquier, Pascal			Relevance of Quality of Life Assessment for Multiple Sclerosis Patients with Memory Impairment	PLOS ONE			English	Article							NOTTINGHAM HEALTH PROFILE; COGNITIVE IMPAIRMENT; VALIDITY; RELIABILITY; VALIDATION; ACQUISITION; DEMENTIA; STORAGE	Background: Memory disturbances, in particular episodic verbal memory dysfunction, are the most frequent cognitive impairment observed in multiple sclerosis (MS) patients. The use of self-reported outcomes for evaluating treatment and managing care of these subjects has been questioned. The aim of this study was to provide new evidence about the suitability of self-reported outcomes for use in this impaired population by exploring the internal structure, reliability and external validity of a specific quality of life (QoL) instrument, the Multiple Sclerosis International Quality of Life questionnaire (MusiQoL). Methods: Design: cross-sectional study. Inclusion criteria: MS patients of any disease subtype. Data collection: sociodemographic (age, gender, marital status, education level, and occupational activity) and clinical data (MS subtype, Expanded Disability Status Scale, disease duration); QoL (MusiQoL and SF36); and memory performance (Grober and Buschke test). In accordance with the French norms of the memory test, non-impaired and impaired populations were defined for short- and long-delay free composites and for short- and long-delay total composites. For the 8 populations, psychometric properties were compared to those reported from the reference population assessed in the validation study. Principal Findings: One hundred and twenty-four consecutive patients were enrolled. The analysis performed in the impaired populations showed that the questionnaire structure adequately matched the initial structure of the MusiQoL. The unidimensionality of the dimensions was preserved, and the internal/external validity indices were close to those of the reference population. Conclusions/Significance: Our study suggests that memory dysfunction did not compromise the reliability or validity of the self-reported QoL questionnaires. Citation: Baumstarck K, Reuter F, Boucekine M, Aghababian V, Klemina I, et al. (2012) Relevance of Quality of Life Assessment for Multiple Sclerosis Patients with Memory Impairment. PLoS ONE 7(12): e50056. doi:10.1371/journal.pone.0050056	[Baumstarck, Karine; Boucekine, Mohamed; Loundou, Anderson; Auquier, Pascal] Timone Univ, APHM, Self Perceived Hlth Assessment Res Unit EA3279, Dept Publ Hlth, Marseille, France; [Reuter, Francoise; Klemina, Irina; Pelletier, Jean] Timone Univ Hosp, APHM, Dept Neurol, Marseille, France; [Reuter, Francoise; Klemina, Irina; Pelletier, Jean] Timone Univ Hosp, APHM, CRMBM CNRS6612, Marseille, France; [Aghababian, Valerie] Aix Marseille Univ, Dept Psychol, Psychol Cognit Language & Emot Res Ctr EA 3273, Aix En Provence, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Baumstarck, K (corresponding author), Timone Univ, APHM, Self Perceived Hlth Assessment Res Unit EA3279, Dept Publ Hlth, Marseille, France.	karine.baumstarck@univmed.fr		Baumstarck, Karine/0000-0003-3602-6766	French Programme Hospitalier Recherche Clinique; French Institut de Recherche en Sante Publique (CUD-QV, Concepts, Usages et Determinants en Qualite de Vie); Assistance Publique, Hopitaux de Marseille (Marseille, France)	French Programme Hospitalier Recherche Clinique; French Institut de Recherche en Sante Publique (CUD-QV, Concepts, Usages et Determinants en Qualite de Vie); Assistance Publique, Hopitaux de Marseille (Marseille, France)	This work was supported by institutional grants from the French 2004 Programme Hospitalier Recherche Clinique and the French 2009 Institut de Recherche en Sante Publique (CUD-QV, Concepts, Usages et Determinants en Qualite de Vie). The sponsor was represented by Assistance Publique, Hopitaux de Marseille (Marseille, France). The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation.	Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Amato MP, 2004, J NEUROL, V251, P1472, DOI 10.1007/s00415-004-0567-0; Auquier P, 2003, SCHIZOPHR RES, V63, P137, DOI 10.1016/S0920-9964(02)00355-9; Baro E, 2006, QUAL LIFE RES, V15, P575, DOI 10.1007/s11136-005-3691-0; Baumstarck K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030627; Baumstarck-Barrau K, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-17; Benedict RHB, 2009, J NEUROL NEUROSUR PS, V80, P201, DOI 10.1136/jnnp.2008.148403; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Benedict RHB, 2004, MULT SCLER J, V10, P675, DOI 10.1191/1352458504ms1098oa; Benito-Leon J, 2002, EUR J NEUROL, V9, P497, DOI 10.1046/j.1468-1331.2002.00450.x; Bureau-Chalot F, 2002, GERONTOLOGY, V48, P220, DOI 10.1159/000058354; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; DeLuca J, 1998, J CLIN EXP NEUROPSYC, V20, P376, DOI 10.1076/jcen.20.3.376.819; DELUCA J, 1994, J CLIN EXP NEUROPSYC, V16, P183, DOI 10.1080/01688639408402629; FEINSTEIN A, 1992, J NEUROL NEUROSUR PS, V55, P869, DOI 10.1136/jnnp.55.10.869; Feuillet L, 2007, MULT SCLER, V13, P124, DOI 10.1177/1352458506071196; Gold SM, 2003, MULT SCLER J, V9, P404, DOI 10.1191/1352458503ms927oa; Goverover Y, 2005, MULT SCLER J, V11, P203, DOI 10.1191/1352458505ms1153oa; GRAFMAN J, 1991, ARCH NEUROL-CHICAGO, V48, P1072, DOI 10.1001/archneur.1991.00530220094025; GRANT I, 1984, J NEUROL NEUROSUR PS, V47, P250, DOI 10.1136/jnnp.47.3.250; Hoe J, 2005, AGE AGEING, V34, P130, DOI 10.1093/ageing/afi030; Juniper E.F., 1996, QUAL LIFE PHARAMACOE, P49; Leplege A, 1998, J CLIN EPIDEMIOL, V51, P1013, DOI 10.1016/S0895-4356(98)00093-6; Marrie RA, 2007, MULT SCLER J, V13, P1176, DOI 10.1177/1352458507078388; Marrie RA, 2003, MULT SCLER, V9, P621, DOI 10.1191/1352458503ms971oa; Nishiyama T, 2010, QUAL LIFE RES, V19, P25, DOI 10.1007/s11136-009-9556-1; Nunnaly JC, 1994, PSYCHOMETRIC THEORY; Orley J, 1998, BRIT J PSYCHIAT, V172, P291, DOI 10.1192/bjp.172.4.291; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Polman CH, 2005, MULT SCLER, V11, P5, DOI 10.1191/1352458505ms1135oa; RAO SM, 1995, CURR OPIN NEUROL, V8, P216, DOI 10.1097/00019052-199506000-00010; Rectem D, 2004, EVALUATION TROUBLES; Riemsma R P, 2001, Health Technol Assess, V5, P1; Simeoni MC, 2008, MULT SCLER J, V14, P219, DOI 10.1177/1352458507080733; Van der Linden M, 2004, EVALUATION TROUBLES, P25; Ware J. E., 1997, MAP R WINDOWS MULTIT; Wong JGWS, 2005, QUAL LIFE RES, V14, P687, DOI 10.1007/s11136-004-1215-y; Wright BD, 1979, BEST TEST DESIGN RAS	41	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50056	10.1371/journal.pone.0050056	http://dx.doi.org/10.1371/journal.pone.0050056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053RN	23239975	Green Published, gold			2022-12-27	WOS:000312290800013
J	Couch, RB; Patel, SM; Wade-Bowers, CL; Nino, D				Couch, Robert B.; Patel, Shital M.; Wade-Bowers, Chianti L.; Nino, Diane			A Randomized Clinical Trial of an Inactivated Avian Influenza A (H7N7) Vaccine	PLOS ONE			English	Article							SINGLE-RADIAL-IMMUNODIFFUSION; HUMAN INFECTION; H5N1 VIRUS; PANDEMIC INFLUENZA; BRITISH-COLUMBIA; CANDIDATE; OUTBREAK; ANTIBODY; ASSAY; H9N2	Background: Concern for a pandemic caused by a newly emerged avian influenza A virus has led to clinical trials with candidate vaccines as preparation for such an event. Most trials have involved vaccines for influenza A (H5N1), A (H7N7) or A (H9N2). Objective: To evaluate dosage-related safety and immunogenicity of an inactivated influenza A (H7N7) vaccine in humans. Design: One hundred twenty-five healthy young adults were randomized to receive two doses intramuscularly of placebo or 7.5, 15, 45 or 90 mu g of HA of an inactivated subunit influenza A (H7N7) vaccine (25 per group), four weeks apart. Reactogenicity was evaluated closely for one week and for any adverse effect for six months after each dose. Serum hemagglutination-inhibiting and neutralizing antibody responses were determined four weeks after each dose and at six months. Results: Reactogenicity evaluations indicated the vaccinations were well tolerated. Only one subject developed a >= 4-fold serum hemagglutination-inhibition (HAI) antibody response and a final titer of >= 1:40 four weeks after dose two and only five subjects developed a neutralizing antibody rise and a final titer of >= 1:40 in tests performed at a central laboratory. Four of the five were given the 45 or 90 mu g HA dosage. A more sensitive HAI assay at the study site revealed a dose-response with increasing HA dosage but only 36% in the 90 mu g HA group developed a >= 4-fold rise in antibody in this test and only one of these achieved a titer of >= 1:32. Conclusion: This inactivated subunit influenza A (H7N7) vaccine was safe but poorly immunogenic in humans.	[Couch, Robert B.; Wade-Bowers, Chianti L.; Nino, Diane] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Patel, Shital M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Couch, RB (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	rcouch@bcm.edu			Public Health Service from National Institute of Allergy and Infectious Diseases [NO1 AI 30039]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI030039] Funding Source: NIH RePORTER	Public Health Service from National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research performed by the authors and summarized in this report was supported by Public Health Service Contract NO1 AI 30039 from the National Institute of Allergy and Infectious Diseases. The funders participated in study design but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Couch RB, 2007, VACCINE, V25, P7656, DOI 10.1016/j.vaccine.2007.08.042; Cox RJ, 2009, VACCINE, V27, P1889, DOI 10.1016/j.vaccine.2009.01.116; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Itoh Y, 2010, VACCINE, V28, P780, DOI 10.1016/j.vaccine.2009.10.067; Jadhao SJ, 2008, VACCINE, V26, P1742, DOI 10.1016/j.vaccine.2008.01.036; Keitel WA, 2009, CURR TOP MICROBIOL, V333, P431, DOI 10.1007/978-3-540-92165-3_21; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Min JY, 2010, J VIROL, V84, P11950, DOI 10.1128/JVI.01305-10; Pappas C, 2007, CLIN VACCINE IMMUNOL, V14, P1425, DOI 10.1128/CVI.00174-07; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Talaat KR, 2009, VACCINE, V27, P3744, DOI 10.1016/j.vaccine.2009.03.082; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WILLIAMS MS, 1993, VET MICROBIOL, V37, P253, DOI 10.1016/0378-1135(93)90027-5; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; 2008, N ENGL J MED, V358, P261	27	98	101	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49704	10.1371/journal.pone.0049704	http://dx.doi.org/10.1371/journal.pone.0049704			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239968	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800006
J	Giesecke, T; Wolters, S; Jahns, S; Brande, A				Giesecke, Thomas; Wolters, Steffen; Jahns, Susanne; Brande, Arthur			Exploring Holocene Changes in Palynological Richness in Northern Europe - Did Postglacial Immigration Matter?	PLOS ONE			English	Article							LATE-QUATERNARY VEGETATION; CLIMATE-CHANGE; PLANT DIVERSITY; FOSSIL POLLEN; DISPERSAL; TIME; DYNAMICS; HISTORY; FOREST; RANGE	In mid to high latitudes glacial and interglacial cycles have repeatedly changed the area available for plant growth. The speed at which plants are able to colonize areas at the onset of an interglacial is hypothesized to limit their distribution ranges even today (migrational lag). If the spread of plants would have been generally slow then plant diversity in previously glaciated areas would be expected to increase over time. We explore this hypothesis using results from six palynological investigations from two previously glaciated regions: central Sweden and north-eastern Germany. Rarefaction, slope of rank order abundance, and taxa accumulation plots were used to evaluate richness and evenness in pollen data in an attempt to separate richness from evenness. These analyses show little change in palynological richness for the northern sites throughout the Holocene. In contrast, the southern sites show an increase in richness and evenness during the early Holocene; this may be explained by the different initial conditions at the onset of the Holocene. A strong rise in palynological richness around 6000 and 1000 years ago at the southern sites can be attributed to the regional initiation of agriculture and major opening of the forest, respectively. For the northern sites there is no evidence for increased taxonomic diversity through time that could be due to delayed immigration of species.	[Giesecke, Thomas] Univ Gottingen, Dept Palynol & Climate Dynam, Albrecht von Haller Inst Plant Sci, Gottingen, Germany; [Wolters, Steffen] Lower Saxony Inst Hist Coastal Res, Wilhelmshaven, Germany; [Jahns, Susanne] Brandenburg Dept Cultural Heritage, Zossen, Germany; [Jahns, Susanne] Archaeol State Museum, Zossen, Germany; [Brande, Arthur] Tech Univ Berlin, Dept Ecol, Berlin, Germany	University of Gottingen; Technical University of Berlin	Giesecke, T (corresponding author), Univ Gottingen, Dept Palynol & Climate Dynam, Albrecht von Haller Inst Plant Sci, Gottingen, Germany.	thomas.giesecke@biologie.uni-goettingen.de	Giesecke, Thomas/A-2450-2013; Giesecke, Thomas/N-6395-2019	Giesecke, Thomas/0000-0002-5132-1061; Giesecke, Thomas/0000-0002-5132-1061; Wolters, Steffen/0000-0003-3727-1982	German Research Foundation (DFG) [GI 732/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded by the the German Research Foundation (DFG), project GI 732/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2003, ECOL LETT, V6, P749, DOI 10.1046/j.1461-0248.2003.00497.x; [Anonymous], PALAEOECOLOGICAL EVE; Berglund BE, 2008, QUATERN INT, V184, P187, DOI 10.1016/j.quaint.2007.09.018; Beug H.J, 2004, LEITFADEN POLLENBEST; Birks HJB, 2008, HOLOCENE, V18, P19, DOI 10.1177/0959683607085572; Birks HJB, 1992, HOLOCENE, V2, P1, DOI 10.1177/095968369200200101; Birks H.J.B., 1973, PRESENT VEGETATION I; BIRKS HJB, 1988, CULTURAL LANDSCAPE P, P229; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Brochmann C, 2003, TAXON, V52, P417, DOI 10.2307/3647444; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Davis M., 1976, GEOSCIENCE MAN, V13, P13; DAVIS MB, 1986, VEGETATIO, V67, P93, DOI 10.1007/BF00037360; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Firbas F., 1949, SPAT NACHEISZEITLICH; Giesecke T, 2005, HOLOCENE, V15, P858, DOI 10.1191/0959683605hl859ra; Giesecke T, 2005, VEG HIST ARCHAEOBOT, V14, P133, DOI 10.1007/s00334-005-0070-2; Giesecke T, 2007, J BIOGEOGR, V34, P118, DOI 10.1111/j.1365-2699.2006.01580.x; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; HUNTLEY B, 1993, J BIOGEOGR, V20, P163, DOI 10.2307/2845669; Huntley B., 1983, ATLAS PRESENT POLLEN; Iversen J., 1973, Danmarks geol Unders (Raekke 5), VNo. 7C, P1; Jahns S, 2000, VEG HIST ARCHAEOBOT, V9, P111, DOI 10.1007/BF01300061; Jaramillo C, 2010, SCIENCE, V330, P957, DOI 10.1126/science.1193833; Lachmuth S, 2010, MOL ECOL, V19, P3952, DOI 10.1111/j.1365-294X.2010.04797.x; Lisitsyna OV, 2011, REV PALAEOBOT PALYNO, V166, P311, DOI 10.1016/j.revpalbo.2011.06.004; McKinney ML, 1999, EVOL ECOL RES, V1, P641; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; Nielsen AB, 2012, QUATERNARY SCI REV, V47, P131, DOI 10.1016/j.quascirev.2012.05.011; Normand S, 2011, P ROY SOC B-BIOL SCI, V278, P3644, DOI 10.1098/rspb.2010.2769; Odgaard B.V, 1994, OPERA BOT, V123, P3; Odgaard B.V, 2008, TERRA NOSTRA, V2, P209; Odgaard Bent Vad, 2001, Diversity and Distributions, V7, P197, DOI 10.1111/j.1472-4642.2001.00110.x; Odgaard BV, 1999, J BIOGEOGR, V26, P7, DOI 10.1046/j.1365-2699.1999.00280.x; Oksanen J., 2016, R PACKAG; Peros MC, 2008, J PALEOLIMNOL, V40, P357, DOI 10.1007/s10933-007-9166-2; Poska A, 2002, VEG HIST ARCHAEOBOT, V11, P191, DOI 10.1007/s003340200022; PRENTICE IC, 1991, ECOLOGY, V72, P2038, DOI 10.2307/1941558; PRESTON FW, 1960, ECOLOGY, V41, P611, DOI 10.2307/1931793; R Development Core Team, 2012, R LANG ENV STAT COMP; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rull V, 1987, POLLEN SPORES, V29, P471; Seppa H, 1998, HOLOCENE, V8, P43, DOI 10.1191/095968398674096317; Seppa H, 2009, J ECOL, V97, P629, DOI 10.1111/j.1365-2745.2009.01505.x; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; SOBERON J, 1993, CONSERV BIOL, V7, P480, DOI 10.1046/j.1523-1739.1993.07030480.x; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Svenning JC, 2008, ECOGRAPHY, V31, P316, DOI 10.1111/j.0906-7590.2008.05206.x; Theuerkauf M, 2012, BOREAS, V41, P391, DOI 10.1111/j.1502-3885.2011.00240.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; van der Knaap WO, 2009, HOLOCENE, V19, P159, DOI 10.1177/0959683608098962; WEBB T, 1986, VEGETATIO, V67, P75, DOI 10.1007/BF00037359; Weng CY, 2006, DIVERS DISTRIB, V12, P310, DOI 10.1111/j.1366-9516.2006.00230.x; White EP, 2006, OIKOS, V112, P185; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045; Williams JW, 2001, ECOLOGY, V82, P3346; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Wolters S., 2002, DISSERTATIONES BOT, V366, P1; Zerbe S, 2003, PHYTOCOENOLOGIA, V33, P683, DOI 10.1127/0340-269X/2003/0033-0683	64	40	43	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51624	10.1371/journal.pone.0051624	http://dx.doi.org/10.1371/journal.pone.0051624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240048	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800084
J	Lopez-Alvarez, D; Lopez-Herranz, ML; Betekhtin, A; Catalan, P				Lopez-Alvarez, Diana; Luisa Lopez-Herranz, Maria; Betekhtin, Alexander; Catalan, Pilar			A DNA Barcoding Method to Discriminate between the Model Plant Brachypodium distachyon and Its Close Relatives B. stacei and B. hybridum (Poaceae)	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; GENETIC DIVERSITY; GRASS; MARKERS; IDENTIFICATION; PHYLOGENETICS; EVOLUTIONARY; POPULATIONS; GENOMES	Background: Brachypodium distachyon s. l. has been widely investigated across the world as a model plant for temperate cereals and biofuel grasses. However, this annual plant shows three cytotypes that have been recently recognized as three independent species, the diploids B. distachyon (2n = 10) and B. stacei (2n = 20) and their derived allotetraploid B. hybridum (2n = 30). Methodology/Principal Findings: We propose a DNA barcoding approach that consists of a rapid, accurate and automatable species identification method using the standard DNA sequences of complementary plastid (trnLF) and nuclear (ITS, GI) loci. The highly homogenous but largely divergent B. distachyon and B. stacei diploids could be easily distinguished (100% identification success) using direct trnLF (2.4%), ITS (5.5%) or GI (3.8%) sequence divergence. By contrast, B. hybridum could only be unambiguously identified through the use of combined trnLF+ITS sequences (90% of identification success) or by cloned GI sequences (96.7%) that showed 5.4% (ITS) and 4% (GI) rate divergence between the two parental sequences found in the allopolyploid. Conclusion/Significance: Our data provide an unbiased and effective barcode to differentiate these three closely-related species from one another. This procedure overcomes the taxonomic uncertainty generated from methods based on morphology or flow cytometry identifications that have resulted in some misclassifications of the model plant and its allies. Our study also demonstrates that the allotetraploid B. hybridum has resulted from bi-directional crosses of B. distachyon and B. stacei plants acting either as maternal or paternal parents. Citation: Lopez-Alvarez D, Lopez-Herranz ML, Betekhtin A, Catalan P (2012) A DNA Barcoding Method to Discriminate between the Model Plant Brachypodium distachyon and Its Close Relatives B. stacei and B. hybridum (Poaceae). PLoS ONE 7(12): e51058. doi:10.1371/journal.pone.0051058	[Lopez-Alvarez, Diana; Luisa Lopez-Herranz, Maria; Betekhtin, Alexander; Catalan, Pilar] Univ Zaragoza, Dept Agr & Environm Sci, Huesca, Spain; [Betekhtin, Alexander] Univ Silesia, Dept Plant Anat & Cytol, Katowice, Poland	University of Zaragoza; University of Silesia in Katowice	Catalan, P (corresponding author), Univ Zaragoza, Dept Agr & Environm Sci, Huesca, Spain.	pcatalan@unizar.es	Betekhtin, Alexander/O-4619-2018; Catalan, Pilar/N-7641-2014; López-Alvarez, Diana Carolina/AAW-5358-2021; Catalan, Pilar/AAL-8833-2020	Betekhtin, Alexander/0000-0001-6146-1669; López-Alvarez, Diana Carolina/0000-0002-7734-8481; Catalan Rodriguez, Maria Pilar/0000-0001-7793-5259	Spanish Ministry of Science and Innovation grant [CGL2009-12955-C02-01]; Bioflora research grant; Spanish Aragon government; European Social Fund; Spanish Ministry of Science and Innovation PhD FPI grant; European Erasmus; UPGOW project	Spanish Ministry of Science and Innovation grant(Spanish Government); Bioflora research grant; Spanish Aragon government(Gobierno de Aragon); European Social Fund(European Social Fund (ESF)); Spanish Ministry of Science and Innovation PhD FPI grant; European Erasmus; UPGOW project	This work was financed by the Spanish Ministry of Science and Innovation grant project CGL2009-12955-C02-01 and partially supported by the Bioflora research grant co-funded by the Spanish Aragon government and the European Social Fund. DL-A was funded by a Spanish Ministry of Science and Innovation PhD FPI grant. AB was funded by a European Erasmus visiting stay grant at the University of Zaragoza and by the UPGOW project co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arca M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034089; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Casiraghi M, 2011, BIOINFORM, V4, P440; Catalan P, 2000, PLANT SYST EVOL, V220, P1, DOI 10.1007/BF00985367; Catalan P, 2012, ANN BOT-LONDON, V109, P385, DOI 10.1093/aob/mcr294; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dentinger BTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025081; Doyle J. J., 1987, PHYTOCHEM B, P11; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Ennos RA, 2005, TRENDS ECOL EVOL, V20, P164, DOI 10.1016/j.tree.2005.01.012; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Filiz E, 2009, GENOME, V52, P876, DOI [10.1139/G09-062, 10.1139/g09-062]; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Giraldo P, 2012, GENOME, V55, P523, DOI [10.1139/g2012-039, 10.1139/G2012-039]; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Griffin PC, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-19; Hammami R, 2011, PLANT SYST EVOL, V297, P99, DOI 10.1007/s00606-011-0502-7; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hasterok R, 2004, CHROMOSOME RES, V12, P397, DOI 10.1023/B:CHRO.0000034130.35983.99; Hasterok R, 2006, GENETICS, V173, P349, DOI 10.1534/genetics.105.049726; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hong SY, 2010, PLANT MOL BIOL, V72, P485, DOI 10.1007/s11103-009-9586-7; HSIAO C, 1995, GENOME, V38, P211, DOI 10.1139/g95-026; Idziak D, 2008, GENOME, V51, P387, DOI 10.1139/G08-017; Idziak D, 2011, CHROMOSOMA, V120, P469, DOI 10.1007/s00412-011-0326-9; Jenkins G, 2003, BUILDING MOL INFRAST; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li MG, 2008, CLADISTICS, V24, P727, DOI 10.1111/j.1096-0031.2008.00207.x; Madisson WP, 2000, ANAL PHYLOGENY CHARA; Manzaneda AJ, 2012, NEW PHYTOL, V193, P797, DOI 10.1111/j.1469-8137.2011.03988.x; Mur LAJ, 2011, NEW PHYTOL, V191, P334, DOI 10.1111/j.1469-8137.2011.03748.x; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Opanowicz M, 2008, TRENDS PLANT SCI, V13, P172, DOI 10.1016/j.tplants.2008.01.007; Paun O, 2009, NEW PHYTOL, V182, P507, DOI 10.1111/j.1469-8137.2009.02767.x; Ramsey J, 2011, P NATL ACAD SCI USA, V108, P7096, DOI 10.1073/pnas.1016631108; ROBERTSON IH, 1981, GENETICA, V56, P55, DOI 10.1007/BF00126930; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Soltis DE, 2004, BIOL J LINN SOC, V82, P485, DOI 10.1111/j.1095-8312.2004.00335.x; Soltis DE, 2010, TAXON, V59, P1387, DOI 10.1002/tax.595006; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Steele PR, 2011, AM J BOT, V98, P415, DOI 10.3732/ajb.1000296; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vain P, 2011, J CEREAL SCI, V54, P1, DOI 10.1016/j.jcs.2011.04.002; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Vanhaecke D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032939; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; Wang Q, 2011, J SYST EVOL, V49, P182, DOI 10.1111/j.1759-6831.2011.00135.x; Wolny E, 2011, CHROMOSOMA, V120, P199, DOI 10.1007/s00412-010-0303-8; Wolny E, 2009, ANN BOT-LONDON, V104, P873, DOI 10.1093/aob/mcp179; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455	62	47	50	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51058	10.1371/journal.pone.0051058	http://dx.doi.org/10.1371/journal.pone.0051058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240000	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800036
J	Penas-Steinhardt, A; Barcos, LS; Belforte, FS; de Sereday, M; Vilarino, J; Gonzalez, CD; Martinez-Larrad, MT; Tellechea, ML; Serrano-Rios, M; Poskus, E; Frechtel, GD; Leskow, FC				Penas-Steinhardt, Alberto; Soledad Barcos, Lucia; Sabrina Belforte, Fiorella; de Sereday, Martha; Vilarino, Jorge; Daniel Gonzalez, Claudio; Teresa Martinez-Larrad, Maria; Lorena Tellechea, Mariana; Serrano-Rios, Manuel; Poskus, Edgardo; Daniel Frechtel, Gustavo; Coluccio Leskow, Federico			Functional Characterization of TLR4+3725 G/C Polymorphism and Association with Protection against Overweight	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; SYSTEMIC INFLAMMATION; METABOLIC SYNDROME; DIABETES-MELLITUS; OBESITY; TOLL-LIKE-RECEPTOR-4; SMOKING; POPULATION; ACTIVATION	Subclinical low-grade systemic inflammation has been associated with obesity, insulin resistance and metabolic syndrome (MS). Recent studies have highlighted the role of gut microbiota in these disorders. The toll-like receptor 4 (TLR4) plays a key role in the innate immune response activation. We studied two polymorphisms (+3725G/C and 11350G/C) in the 3' untranslated region (3'UTR) of the TLR4 gene that may alter its expression and their association with metabolic disorders related to systemic inflammation. We cloned the 3'UTR into a luciferase reporter system and compared wild-type 3'UTR (WT) and +3725C variant (MUT) constructs luciferase activities. MUT construct reduced the reporter gene activity by 30% compared to WT (P = 0.0001). To evaluate the association between these polymorphisms with biochemical and clinical overweight related variables, we conducted a population cross-sectional study in 966 men of Argentine general population. Considering smoking as a confounding variable that causes systemic inflammation, we studied these possible effects in both, smokers and nonsmokers. The 11350G/C polymorphism was not detected in our sample whereas the CC genotype of +3725 polymorphism was associated with lean subjects (p = 0.011) and higher Adiponectin levels (p = 0.021). Subjects without any NCEP/ATP III MS component were associated with this genotype as well (p = 0.001). These results were strengthened in nonsmokers, in which CC genotype was associated with lean subjects (p = 0.003) and compared with G carriers showed significantly lower BMI (25.53 vs. 28.60 kg/m2; p = 0.023) and waist circumference (89.27 vs. 97.51 cm; p = 0.025). None of these associations were found in smokers. These results showed that +3725C variant has a functional effect down-regulating gene expression and it could be considered as a predictive factor against overweight, particularly in nonsmokers. Considering the role of TLR4 in inflammation, these findings would suggest that the presence of +3725C variant could predict a lower prevalence of chronic metabolic disorders.	[Penas-Steinhardt, Alberto; Lorena Tellechea, Mariana; Poskus, Edgardo] Univ Buenos Aires, CONICET, Inst Estudios Inmunidad Humoral IDEHU, Buenos Aires, DF, Argentina; [Penas-Steinhardt, Alberto; Lorena Tellechea, Mariana; Poskus, Edgardo] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Inmunol, RA-1113 Buenos Aires, DF, Argentina; [Penas-Steinhardt, Alberto] Univ Buenos Aires, Hosp Clin, Div Endocrinol, Buenos Aires, DF, Argentina; [Soledad Barcos, Lucia; Coluccio Leskow, Federico] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, Dept Quim Biol,IQUIBICEN, Buenos Aires, DF, Argentina; [Soledad Barcos, Lucia; Coluccio Leskow, Federico] Univ Nacl Lujan, Dept Ciencias Basicas, Buenos Aires, DF, Argentina; [Sabrina Belforte, Fiorella] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Genet & Biol Mol, Mol Biol Lab, RA-1113 Buenos Aires, DF, Argentina; [de Sereday, Martha] Hosp Fiorito, Serv Endocrinol, Buenos Aires, DF, Argentina; [Vilarino, Jorge] Inst FLENI, Cardiol Clin, Buenos Aires, DF, Argentina; [Daniel Gonzalez, Claudio] Univ Buenos Aires, Fac Med, Dept Farmacol, Buenos Aires, DF, Argentina; [Teresa Martinez-Larrad, Maria; Serrano-Rios, Manuel] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain; [Daniel Frechtel, Gustavo] Univ Buenos Aires, Hosp Clin, Div Genet, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidad Nacional de Lujan; University of Buenos Aires; University of Buenos Aires; Hospital Clinico San Carlos; University of Buenos Aires	Penas-Steinhardt, A (corresponding author), Univ Buenos Aires, CONICET, Inst Estudios Inmunidad Humoral IDEHU, Buenos Aires, DF, Argentina.	pufetin@gmail.com	TELLECHEA, MARIANA L/AAM-6673-2021	TELLECHEA, MARIANA L/0000-0002-1194-8433; Penas-Steinhardt, Alberto/0000-0002-6164-8842; Gonzalez, Claudio/0000-0002-3772-8850; Belforte, Fiorella S./0000-0002-3437-1454	ANCyP-Argentina [PICT 38343, PICT-2008-260]; UBACyT [B118 - B104, 20020090200714]; CONICET-Argentina [PIP 0697]; Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III-RETIC, Madrid, Spain [RD06/0015/0012]	ANCyP-Argentina; UBACyT; CONICET-Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III-RETIC, Madrid, Spain(Instituto de Salud Carlos III)	This work was supported by the following grants: PICT 38343 and PICT-2008-260 (ANCyP-Argentina, http://www.agencia.mincyt.gov.ar/), UBACyT B118 - B104 and 20020090200714 (UBA-Argentina, http://www.uba.ar/), PIP 0697 (CONICET-Argentina, http://www.conicet.gov.ar/), and by a grant from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III-RETIC http://www.isciii.es/(RD06/0015/0012), Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ANDERSON KV, 1985, CELL, V42, P791, DOI 10.1016/0092-8674(85)90275-2; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Cornier M-A, ENDOCRINE REV, V29, P777; Duncan BB, 2006, DIABETES TECHNOL THE, V8, P7, DOI 10.1089/dia.2006.8.7; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Frohlich M, 2003, EUR HEART J, V24, P1365, DOI 10.1016/S0195-668X(03)00260-4; Fukusaki T, 2007, J PERIODONTAL RES, V42, P541, DOI 10.1111/j.1600-0765.2007.00979.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Grundy SM, CRITICAL PATHWAYS CA, V4, P198; Hishida A, 2009, HELICOBACTER, V14, P47, DOI 10.1111/j.1523-5378.2009.00659.x; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ikonomidis I, 2005, AM HEART J, V149, P832, DOI 10.1016/j.ahj.2004.08.030; JOHNSON GB, 2004, FASEB J, V4, P1; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kissebah AH, 1997, DIABETES REV, V5, P8; Kolek MJ, 2004, AM HEART J, V148, P1034, DOI 10.1016/j.ahj.2004.05.049; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Liu PY, 2007, ATHEROSCLEROSIS, V195, P199, DOI 10.1016/j.atherosclerosis.2006.11.001; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; NEEL JV, 1962, AM J HUM GENET, V14, P353; Steinhardt AP, 2010, METABOLISM, V59, P711, DOI 10.1016/j.metabol.2009.09.015; Pesole G, 1999, TRENDS GENET, V15, P378, DOI 10.1016/S0168-9525(99)01795-3; Petruzzelli M, 2010, CELL METAB, V11, P345, DOI 10.1016/j.cmet.2010.04.012; Sam S, 2009, DIABETES CARE, V32, P1916, DOI 10.2337/dc09-0412; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Song C, 2006, CANCER BIOL THER, V5, P1285, DOI 10.4161/cbt.5.10.3304; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI [10.1042/BST0331078, 10.1042/BST20051078]; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	39	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50992	10.1371/journal.pone.0050992	http://dx.doi.org/10.1371/journal.pone.0050992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239997	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800033
J	You, S; Cho, CS; Lee, I; Hood, L; Hwang, D; Kim, WU				You, Sungyong; Cho, Chul-Soo; Lee, Inyoul; Hood, Leroy; Hwang, Daehee; Kim, Wan-Uk			A Systems Approach to Rheumatoid Arthritis	PLOS ONE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; TUMOR-SUPPRESSOR GENE; SYNOVIAL TISSUE HETEROGENEITY; TRANSCRIPTION FACTOR; T-CELLS; SOMATIC MUTATIONS; TARGET GENES; DATABASE; EXPRESSION; DISEASE	Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily attacks synovial joints. Despite the advances in diagnosis and treatment of RA, novel molecular targets are still needed to improve the accuracy of diagnosis and the therapeutic outcomes. Here, we present a systems approach that can effectively 1) identify core RA-associated genes (RAGs), 2) reconstruct RA-perturbed networks, and 3) select potential targets for diagnosis and treatments of RA. By integrating multiple gene expression datasets previously reported, we first identified 983 core RAGs that show RA dominant differential expression, compared to osteoarthritis (OA), in the multiple datasets. Using the core RAGs, we then reconstructed RA-perturbed networks that delineate key RA associated cellular processes and transcriptional regulation. The networks revealed that synovial fibroblasts play major roles in defining RA-perturbed processes, anti-TNF-alpha therapy restored many RA-perturbed processes, and 19 transcription factors (TFs) have major contribution to deregulation of the core RAGs in the RA-perturbed networks. Finally, we selected a list of potential molecular targets that can act as metrics or modulators of the RA-perturbed networks. Therefore, these network models identify a panel of potential targets that will serve as an important resource for the discovery of therapeutic targets and diagnostic markers, as well as providing novel insights into RA pathogenesis.	[You, Sungyong; Hwang, Daehee] POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Cho, Chul-Soo; Kim, Wan-Uk] Catholic Res Inst Med Sci, Res Inst Immunobiol, Seoul, South Korea; [Cho, Chul-Soo; Kim, Wan-Uk] Catholic Univ Korea, Dept Internal Med, Seoul, South Korea; [Lee, Inyoul; Hood, Leroy] Inst Syst Biol, Seattle, WA USA; [Hwang, Daehee] POSTECH, Dept Chem Engn, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Catholic University of Korea; Catholic University of Korea; Institute for Systems Biology (ISB); Pohang University of Science & Technology (POSTECH)	Hwang, D (corresponding author), POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea.	dhhwang@postech.ac.kr; wan725@catholic.ac.kr	Kim, Wan-Uk/AAO-8502-2020; You, Sungyong/AAJ-7372-2020	You, Sungyong/0000-0003-3513-1783; Kim, Wan-Uk/0000-0001-8224-8496	Korean MEST from the Global Frontier Project [NRF-M1AXA002-2011-0028392]; WCU program [R31-2008-000-10105-0]; Converging Research Center Program [2011K000896]; National Research Foundation of Korea [R31-2008-000-10105-0, 20090080087]; ISB-University of Luxembourg program [NS41997]	Korean MEST from the Global Frontier Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); WCU program; Converging Research Center Program; National Research Foundation of Korea(National Research Foundation of Korea); ISB-University of Luxembourg program	This study was supported by Korean MEST grants from the Global Frontier Project grant (NRF-M1AXA002-2011-0028392), WCU program (R31-2008-000-10105-0), the Converging Research Center Program (2011K000896 to D. Hwang), National Research Foundation of Korea (R31-2008-000-10105-0 and 20090080087), and ISB-University of Luxembourg program (NS41997). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buch MH, 2004, ARTHRITIS RHEUM-US, V50, P725, DOI 10.1002/art.20115; CASH JM, 1994, NEW ENGL J MED, V330, P1368; Cui J, 2010, ARTHRITIS RHEUM-US, V62, P1849, DOI 10.1002/art.27457; FARAHAT MN, 1993, ANN RHEUM DIS, V52, P870, DOI 10.1136/ard.52.12.870; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; Firestein GS, 1997, ARTHRITIS RHEUM, V40, P255; Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P; Han ZN, 1998, AUTOIMMUNITY, V28, P197, DOI 10.3109/08916939808995367; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2485; Imamura F, 1998, ARTHRITIS RHEUM, V41, P1979; Inazuka M, 2000, RHEUMATOLOGY, V39, P262, DOI 10.1093/rheumatology/39.3.262; JANOSSY G, 1981, LANCET, V2, P839; Jeon KI, 2000, J IMMUNOL, V164, P5981, DOI 10.4049/jimmunol.164.11.5981; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kasperkovitz PV, 2005, ARTHRITIS RHEUM-US, V52, P430, DOI 10.1002/art.20811; Keystone E, 2009, ANN RHEUM DIS, V68, P216, DOI 10.1136/ard.2007.085787; Keystone E, 2008, ARTHRIT RHEUM-ARTHR, V59, P785, DOI 10.1002/art.23715; Kim Y, 2011, BIOINFORMATICS, V27, P391, DOI 10.1093/bioinformatics/btq670; KINNE RW, 1995, SCAND J RHEUMATOL, P121; Koch AE, 1998, ARTHRITIS RHEUM-US, V41, P951, DOI 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Kraan TCTMV, 2003, ARTHRITIS RHEUM-US, V48, P2132, DOI 10.1002/art.11096; Kremer JM, 2006, ANN RHEUM DIS, V65, P326; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McInnes IB, 2005, NAT CLIN PRACT RHEUM, V1, P31, DOI 10.1038/ncprheum0020; Meyer LH, 2006, BEST PRACT RES CL RH, V20, P969, DOI 10.1016/j.berh.2006.06.005; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Nakazato T, 2009, NUCLEIC ACIDS RES, V37, pW166, DOI 10.1093/nar/gkp483; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Reme T, 1998, CLIN EXP IMMUNOL, V111, P353; Ryu T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-136; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Sanders M, 2000, J RHEUMATOL, V27, P523; Severin J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r39; Shiozawa S, 1997, J CLIN INVEST, V99, P1210, DOI 10.1172/JCI119277; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tak PP, 2001, ARTHRITIS RHEUM, V44, P1897, DOI 10.1002/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4; Tamamura H, 2007, CURR MED CHEM, V14, P93, DOI 10.2174/092986707779313499; Tedder TF, 2009, NAT REV RHEUMATOL, V5, P572, DOI 10.1038/nrrheum.2009.184; Tolboom TCA, 2006, CLIN EXP RHEUMATOL, V24, P142; Ungethuem U, 2010, PHYSIOL GENOMICS, V42A, P267, DOI 10.1152/physiolgenomics.00004.2010; van Baarsen LGM, 2010, ARTHRITIS RHEUM-US, V62, P1602, DOI 10.1002/art.27415; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yamanishi Y, 2002, P NATL ACAD SCI USA, V99, P10025, DOI 10.1073/pnas.152333199; Yoon HJ, 2011, ARTHRITIS RHEUM-US, V63, P1843, DOI 10.1002/art.30229; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	57	21	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51508	10.1371/journal.pone.0051508	http://dx.doi.org/10.1371/journal.pone.0051508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240033	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800069
J	Liu, CQ; Desikan, R; Ying, ZK; Gushchina, L; Kampfrath, T; Deiuliis, J; Wang, AX; Xu, XH; Zhong, JX; Rao, XQ; Sun, QH; Maiseyeu, A; Parthasarathy, S; Rajagopalan, S				Liu, Cuiqing; Desikan, Rajagopal; Ying, Zhekang; Gushchina, Liubov; Kampfrath, Thomas; Deiuliis, Jeffrey; Wang, Aixia; Xu, Xiaohua; Zhong, Jixin; Rao, Xiaoquan; Sun, Qinghua; Maiseyeu, Andrei; Parthasarathy, Sampath; Rajagopalan, Sanjay			Effects of a Novel Pharmacologic Inhibitor of Myeloperoxidase in a Mouse Atherosclerosis Model	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; AIR-POLLUTION EXPOSURE; APOLIPOPROTEIN-A-I; MICE; ACTIVATION; NITRATION; OXIDANTS; DISEASE; CHLORINATION; OBESITY	Inflammation and oxidative stress play fundamental roles in the pathogenesis of atherosclerosis. Myeloperoxidase has been extensively implicated as a key mediator of inflammatory and redox-dependent processes in atherosclerosis. However, the effect of synthetic myeloperoxidase inhibitors on atherosclerosis has been insufficiently studied. In this study, ApoE (-/-) mice were randomized to low-and high-dose INV-315 groups for 16 weeks on high-fat diet. INV-315 resulted in reduced plaque burden and improved endothelial function in response to acetylcholine. These effects occurred without adverse events or changes in body weight or blood pressure. INV-315 treatment resulted in a decrease in iNOS gene expression, superoxide production and nitrotyrosine content in the aorta. Circulating IL-6 and inflammatory CD11b(+)/Ly6G(low)/7/4(hi) monocytes were significantly decreased in response to INV-315 treatment. Acute pretreatment with INV-315 blocked TNF alpha-mediated leukocyte adhesion in cremasteric venules and inhibited myeloperoxidase activity. Cholesterol efflux was significantly increased by high-dose INV-315 via ex-vivo reverse cholesterol transport assays. Our results suggest that myeloperoxidase inhibition may exert anti-atherosclerotic effects via inhibition of oxidative stress and enhancement of cholesterol efflux. These findings demonstrate a role for pharmacologic modulation of myeloperoxidase in atherosclerosis.	[Liu, Cuiqing; Ying, Zhekang; Gushchina, Liubov; Kampfrath, Thomas; Deiuliis, Jeffrey; Wang, Aixia; Xu, Xiaohua; Zhong, Jixin; Rao, Xiaoquan; Sun, Qinghua; Maiseyeu, Andrei; Parthasarathy, Sampath; Rajagopalan, Sanjay] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Liu, Cuiqing] Hangzhou Normal Univ, Dept Physiol, Hangzhou, Zhejiang, Peoples R China; [Desikan, Rajagopal] InVasc Therapeut, Tucker, GA USA	University System of Ohio; Ohio State University; Hangzhou Normal University	Rajagopalan, S (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	sanjay.rajagopalan@osumc.edu	Parthasarathy, Sampath/AAP-3361-2020; Gushchina, Liubov/AAN-1037-2021; Zhong, Jixin/ABE-3768-2020	Maiseyeu, Andrei/0000-0001-8830-1809; Liu, Cuiqing/0000-0002-0393-7806; Rao, Xiaoquan/0000-0001-7316-4530; Deiuliis, Jeffrey/0000-0002-5665-8894; Zhong, Jixin/0000-0002-3534-7480	National Institutes of Health (NIH) [R01ES017290, R21 DK088522, R01AT004106]; NIH SBIR [R43HL103269-01]; American Heart Association [10POST4150090, 11POST7640030]; NRSA [F32-DK083903]; National Institutes of Health SBIR [R43HL103269]; OSU; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004106] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL103269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK088522, F32DK083903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017290] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH SBIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health SBIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OSU; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study is partially supported by National Institutes of Health (NIH) grants R01ES017290 and R21 DK088522 (SR) R01AT004106 (SP) and NIH SBIR (R43HL103269-01) to InVasc Therapeutics (subcontract to OSU). Dr. Maiseyeu and Dr. Ying are supported by American Heart Association Great Rivers Affiliate Postdoctoral Fellowship Program (10POST4150090, 11POST7640030); Dr. Deiuliis is supported by NRSA grant (F32-DK083903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge that this work was made possible via a collaborative effort between InVasc Therapeutics and Ohio State University. InVasc Therapeutics is a non-publicly traded private company based in Columbus, OH. Dr. Rajagopal Desiakan, one of the co-authors, was fully employed by InVasc Therapeutics at the time of this work. Cuiqing Liu was a co-founder of the company along with Sampath Parthasarathy and have patents on INV315 and related myeloperoxidase inhibitors that are currently pending approval at the US Patent and Trade office. The molecules that were investigated in this work were licensed for use by InVasc Therapeutics. Funding for this work was through a National Institutes of Health SBIR grant (R43HL103269) awarded to InVasc Therapeutics with OSU as a subcontractor. Neither Dr. Parthasarathy nor Cuiqing Liu are employees of InVasc but do function in an advisory role to the company. The authors declare that the relationship with InVasc does not alter their adherence to all of the PLOS ONE policies on sharing data and materials.	Bachoual R, 2011, FOOD CHEM TOXICOL, V49, P1224, DOI 10.1016/j.fct.2011.02.024; Bergt C, 2004, J BIOL CHEM, V279, P7856, DOI 10.1074/jbc.M309046200; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; Castellani LW, 2006, J LIPID RES, V47, P1366, DOI 10.1194/jlr.M600005-JLR200; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Hazen SL, 1999, CIRC RES, V85, P950; Hochholzer W, 2010, AM HEART J, V160, P583, DOI 10.1016/j.ahj.2010.06.010; Kampfrath T, 2011, CIRC RES, V108, P716, DOI 10.1161/CIRCRESAHA.110.237560; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; KOEFFLER HP, 1985, BLOOD, V65, P484; Lau D, 2006, PHARMACOL THERAPEUT, V111, P16, DOI 10.1016/j.pharmthera.2005.06.023; Liu CQ, 2009, BIOCHEM PHARMACOL, V78, P374, DOI 10.1016/j.bcp.2009.04.022; Nestel P, 2011, INT J OBES LOND; Nguyen AB, 2011, ARTERIOSCL THROM VAS, V31, P2136, DOI 10.1161/ATVBAHA.111.228692; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Rodrigues MR, 2002, BIOCHEM BIOPH RES CO, V292, P869, DOI 10.1006/bbrc.2002.6724; Sampson JB, 1998, ARCH BIOCHEM BIOPHYS, V356, P207, DOI 10.1006/abbi.1998.0772; Schindhelm RK, 2009, CLIN CHEM, V55, P1462, DOI 10.1373/clinchem.2009.126029; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Sun QH, 2008, ARTERIOSCL THROM VAS, V28, P1760, DOI 10.1161/ATVBAHA.108.166967; Wang X, 2007, CIRC RES, V100, P1008, DOI 10.1161/01.RES.0000263011.34709.c5; Xu XH, 2010, ARTERIOSCL THROM VAS, V30, P2518, DOI 10.1161/ATVBAHA.110.215350	29	31	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50767	10.1371/journal.pone.0050767	http://dx.doi.org/10.1371/journal.pone.0050767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251382	gold, Green Published, Green Submitted			2022-12-27	WOS:000312201900016
J	Hwang, E; Kim, S; Han, K; Choi, JH				Hwang, Eunjin; Kim, Seunghwan; Han, Kyungreem; Choi, Jee Hyun			Characterization of Phase Transition in the Thalamocortical System during Anesthesia-Induced Loss of Consciousness	PLOS ONE			English	Article							CORTICAL EFFECTIVE CONNECTIVITY; GENERAL-ANESTHESIA; SPECTRAL EDGE; BREAKDOWN; PROPOFOL; BRAIN; STATE	The thalamocortical system plays a key role in the breakdown or emergence of consciousness, providing bottom-up information delivery from sensory afferents and integrating top-down intracortical and thalamocortical reciprocal signaling. A fundamental and so far unanswered question for cognitive neuroscience remains whether the thalamocortical switch for consciousness works in a discontinuous manner or not. To unveil the nature of thalamocortical system phase transition in conjunction with consciousness transition, ketamine/xylazine was administered unobtrusively to ten mice under a forced working test with motion tracker, and field potentials in the sensory and motor-related cortex and thalamic nuclei were concomitantly collected. Sensory and motor-related thalamocortical networks were found to behave continuously at anesthesia induction and emergence, as evidenced by a sigmoidal response function with respect to anesthetic concentration. Hyperpolarizing and depolarizing susceptibility diverged, and a non-discrete change of transitional probability occurred at transitional regimes, which are hallmarks of continuous phase transition. The hyperpolarization curve as a function of anesthetic concentration demonstrated a hysteresis loop, with a significantly higher anesthetic level for transition to the down state compared to transition to the up state. Together, our findings concerning the nature of phase transition in the thalamocortical system during consciousness transition further elucidate the underlying basis for the ambiguous borderlines between conscious and unconscious brains. Moreover, our novel analysis method can be applied to systematic and quantitative handling of subjective concepts in cognitive neuroscience.	[Hwang, Eunjin; Choi, Jee Hyun] Korea Inst Sci & Technol, Ctr Neurosci, Seoul, South Korea; [Hwang, Eunjin; Kim, Seunghwan] Pohang Univ Sci & Technol, Dept Phys, Nonlinear Complex Syst Lab, Pohang, South Korea; [Han, Kyungreem] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Choi, Jee Hyun] Univ Sci & Technol, Dept Neurosci, Taejon, South Korea; [Hwang, Eunjin; Kim, Seunghwan] Pohang Univ Sci & Technol, Asia Pacific Ctr Theoret Phys, Pohang, South Korea	Korea Institute of Science & Technology (KIST); Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Asia Pacific Center for Theoretical Physics; Pohang University of Science & Technology (POSTECH)	Choi, JH (corresponding author), Korea Inst Sci & Technol, Ctr Neurosci, Seoul, South Korea.	jeechoi@kist.re.kr		Ward, Lawrence/0000-0003-4431-5015; KIM, Seunghwan/0000-0002-0563-3902	National Research Foundation; Ministry of Education, Science and Technology of South Korea [2012-0001414, 2012-0005805]	National Research Foundation; Ministry of Education, Science and Technology of South Korea	This research was supported by the Brain Research Program and Basic Science Research Program through the National Research Foundation funded by the Ministry of Education, Science and Technology of South Korea (2012-0001414; 2012-0005805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alkire MT, 2010, SUPPRESSING THE MIND: ANESTHETIC MODULATION OF MEMORY AND CONSCIOUSNESS, P127, DOI 10.1007/978-1-60761-462-3_6; Billard V, 1997, CLIN PHARMACOL THER, V61, P45, DOI 10.1016/S0009-9236(97)90181-8; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Edelman GM, 2003, P NATL ACAD SCI USA, V100, P5520, DOI 10.1073/pnas.0931349100; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; FOSSE RT, 1987, AM J VET RES, V48, P211; Friedman EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011903; Gandomani MJ, 2011, VET SCAN, V6, P81; Hudetz A., 2006, SEMIN ANESTH PERIO M, V25, P196, DOI [DOI 10.1053/j.sane.2006.09.003, 10.1053/j.sane.2006.09.003]; Hwang E, 2010, J NEUROSCI METH, V188, P14, DOI 10.1016/j.jneumeth.2010.01.028; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Liley DTJ, 2005, J CLIN NEUROPHYSIOL, V22, P300; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Molaee-Ardekani B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041911; Paxinos G., 2001, MOUSE BRAIN STEREOTA; SCHUTTLER J, 1987, J PHARMACOKINET BIOP, V15, P241, DOI 10.1007/BF01066320; Schwender D, 1996, BRIT J ANAESTH, V77, P179, DOI 10.1093/bja/77.2.179; Sleigh J, 2010, SUPPRESSING THE MIND: ANESTHETIC MODULATION OF MEMORY AND CONSCIOUSNESS, P139, DOI 10.1007/978-1-60761-462-3_7; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steyn-Ross ML, 2004, PROG BIOPHYS MOL BIO, V85, P369, DOI 10.1016/j.pbiomolbio.2004.02.001	22	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50580	10.1371/journal.pone.0050580	http://dx.doi.org/10.1371/journal.pone.0050580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236379	gold, Green Submitted, Green Published			2022-12-27	WOS:000312064100021
J	Park, CH; Jeong, YH; Jeong, YI; Lee, SY; Jeong, YW; Shin, T; Kim, NH; Jeung, EB; Hyun, SH; Lee, CK; Lee, E; Hwang, WS				Park, Chi-Hun; Jeong, Young Hee; Jeong, Yeun-Ik; Lee, Se-Yeong; Jeong, Yeon-Woo; Shin, Taeyoung; Kim, Nam-Hyung; Jeung, Eui-Bae; Hyun, Sang-Hwan; Lee, Chang-Kyu; Lee, Eunsong; Hwang, Woo Suk			X-Linked Gene Transcription Patterns in Female and Male In Vivo, In Vitro and Cloned Porcine Individual Blastocysts	PLOS ONE			English	Article							PREIMPLANTATION DEVELOPMENT; CHROMOSOME INACTIVATION; XIST EXPRESSION; METHYLATION STATUS; SEX; EMBRYOS; PIG; PLACENTA; REGIONS; HEALTH	To determine the presence of sexual dimorphic transcription and how in vitro culture environments influence X-linked gene transcription patterns in preimplantation embryos, we analyzed mRNA expression levels in in vivo-derived, in vitro-fertilized (IVF), and cloned porcine blastocysts. Our results clearly show that sex-biased expression occurred between female and male in vivo blastocysts in X-linked genes. The expression levels of XIST, G6PD, HPRT1, PGK1, and BEX1 were significantly higher in female than in male blastocysts, but ZXDA displayed higher levels in male than in female blastocysts. Although we found aberrant expression patterns for several genes in IVF and cloned blastocysts, similar sex-biased expression patterns (on average) were observed between the sexes. The transcript levels of BEX1 and XIST were upregulated and PGK1 was downregulated in both IVF and cloned blastocysts compared with in vivo counterparts. Moreover, a remarkable degree of expression heterogeneity was observed among individual cloned embryos (the level of heterogeneity was similar in both sexes) but only a small proportion of female IVF embryos exhibited variability, indicating that this phenomenon may be primarily caused by faulty reprogramming by the somatic cell nuclear transfer (SCNT) process rather than in vitro conditions. Aberrant expression patterns in cloned embryos of both sexes were not ameliorated by treatment with Scriptaid as a potent HDACi, although the blastocyst rate increased remarkably after this treatment. Taken together, these results indicate that female and male porcine blastocysts produced in vivo and in vitro transcriptional sexual dimorphisms in the selected X-linked genes and compensation of X-linked gene dosage may not occur at the blastocyst stage. Moreover, altered X-linked gene expression frequently occurred in porcine IVF and cloned embryos, indicating that X-linked gene regulation is susceptible to in vitro culture and the SCNT process, which may eventually lead to problems with embryonic or placental defects.	[Park, Chi-Hun; Jeong, Young Hee; Jeong, Yeun-Ik; Lee, Se-Yeong; Jeong, Yeon-Woo; Shin, Taeyoung; Hwang, Woo Suk] Sooam Biotech Res Fdn, Seoul, South Korea; [Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea; [Jeung, Eui-Bae; Hyun, Sang-Hwan] Chungbuk Natl Univ, Coll Vet Med, Cheongju, South Korea; [Lee, Chang-Kyu] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Lee, Chang-Kyu] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Lee, Eunsong] Kangwon Natl Univ, Coll Vet Med, Chunchon, South Korea; [Lee, Eunsong] Kangwon Natl Univ, Inst Vet Sci, Chunchon, South Korea	Chungbuk National University; Chungbuk National University; Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Kangwon National University	Hwang, WS (corresponding author), Sooam Biotech Res Fdn, Seoul, South Korea.	hwangws@sooam.org	Park, Chi-Hun/J-1258-2019; Lee, Eunsong/AAJ-3848-2020	Park, Chi-Hun/0000-0002-7618-9028; Lee, Eunsong/0000-0001-9654-7788	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ008054, PJ00832303]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by the grants of Next-Generation BioGreen 21 Program (No. PJ008054 and No. PJ00832303), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kandari W, 2007, J MOL BIOL, V369, P1175, DOI 10.1016/j.jmb.2007.04.033; Bermejo-Alvarez P, 2008, PHYSIOL GENOMICS, V32, P264, DOI 10.1152/physiolgenomics.00234.2007; Bermejo-Alvarez P, 2011, REPRODUCTION, V141, P563, DOI 10.1530/REP-10-0482; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Brown AL, 1999, HUM MOL GENET, V8, P611, DOI 10.1093/hmg/8.4.611; Bui HT, 2011, BIOL REPROD, V83, P454; Cibelli JB, 2002, NAT BIOTECHNOL, V20, P13, DOI 10.1038/nbt0102-13; De La Fuente R, 1999, BIOL REPROD, V60, P769, DOI 10.1095/biolreprod60.3.769; Deng XX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000751; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Fukuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011274; Gardner DK, 2010, MOL HUM REPROD, V16, P539, DOI 10.1093/molehr/gaq042; Gutierrez-Adan A, 2000, MOL REPROD DEV, V55, P146, DOI 10.1002/(SICI)1098-2795(200002)55:2&lt;146::AID-MRD3&gt;3.0.CO;2-F; Hemberger M, 2002, CYTOGENET GENOME RES, V99, P210, DOI 10.1159/000071595; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Jiang L, 2008, MOL REPROD DEV, V75, P265, DOI 10.1002/mrd.20758; Kaminski MA, 1996, J REPROD FERTIL, V106, P107, DOI 10.1530/jrf.0.1060107; Kobayashi S, 2006, CURR BIOL, V16, P166, DOI 10.1016/j.cub.2005.11.071; Kohda T, 2005, BIOL REPROD, V73, P1302, DOI 10.1095/biolreprod.105.044958; Latham KE, 2005, TRENDS GENET, V21, P120, DOI 10.1016/j.tig.2004.12.003; Latham KE, 2002, BIOL REPROD, V67, P386, DOI 10.1095/biolreprod67.2.386; Latham KE, 2000, BIOL REPROD, V63, P64, DOI 10.1095/biolreprod63.1.64; Mann MRW, 2004, DEVELOPMENT, V131, P3727, DOI 10.1242/dev.01241; Mao J, 2010, P NATL ACAD SCI USA, V107, P5557, DOI 10.1073/pnas.1000440107; Matoba S, 2011, P NATL ACAD SCI USA, V108, P20621, DOI 10.1073/pnas.1112664108; Niemann H, 2008, REPRODUCTION, V135, P151, DOI 10.1530/REP-07-0397; Niemann H, 2010, CELL REPROGRAM, V12, P33, DOI 10.1089/cell.2009.0063; Nino-Soto MI, 2007, MOL REPROD DEV, V74, P144, DOI 10.1002/mrd.20575; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Park CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022216; Park CH, 2009, ANIM REPROD SCI, V115, P169, DOI 10.1016/j.anireprosci.2008.12.004; Park CH, 2009, GENOMICS, V93, P179, DOI 10.1016/j.ygeno.2008.10.002; Peippo JP, 2002, MOL HUM REPROD, V8, P923, DOI 10.1093/molehr/8.10.923; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Ray PF, 1997, HUM MOL GENET, V6, P1323, DOI 10.1093/hmg/6.8.1323; Rosenfeld CS, 2010, BIOL REPROD, V82, P473, DOI 10.1095/biolreprod.109.080952; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Song K, 2009, MOL REPROD DEV, V76, P611, DOI 10.1002/mrd.20989; Taylor DM, 2001, MOL HUM REPROD, V7, P147, DOI 10.1093/molehr/7.2.147; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017; Wei YC, 2010, CELL REPROGRAM, V12, P213, DOI 10.1089/cell.2009.0090; Whitworth KM, 2011, CELL REPROGRAM, V13, P191, DOI 10.1089/cell.2010.0087; Wrenzycki C, 2002, BIOL REPROD, V66, P127, DOI 10.1095/biolreprod66.1.127; Xue F, 2002, NAT GENET, V31, P216, DOI 10.1038/ng900; Zhao JG, 2009, BIOL REPROD, V81, P525, DOI 10.1095/biolreprod.109.077016	45	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51398	10.1371/journal.pone.0051398	http://dx.doi.org/10.1371/journal.pone.0051398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236494	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100113
J	Ren, XW; Liu, T; Dong, J; Sun, LL; Yang, J; Zhu, YF; Jin, Q				Ren, Xianwen; Liu, Tao; Dong, Jie; Sun, Lilian; Yang, Jian; Zhu, Yafang; Jin, Qi			Evaluating de Bruijn Graph Assemblers on 454 Transcriptomic Data	PLOS ONE			English	Article							RNA-SEQ ANALYSIS; NOVO ASSEMBLER; SINGLE-CELL; GENERATION; GENOME; IDBA	Next generation sequencing (NGS) technologies have greatly changed the landscape of transcriptomic studies of non-model organisms. Since there is no reference genome available, de novo assembly methods play key roles in the analysis of these data sets. Because of the huge amount of data generated by NGS technologies for each run, many assemblers, e. g., ABySS, Velvet and Trinity, are developed based on a de Bruijn graph due to its time-and space-efficiency. However, most of these assemblers were developed initially for the Illumina/Solexa platform. The performance of these assemblers on 454 transcriptomic data is unknown. In this study, we evaluated and compared the relative performance of these de Bruijn graph based assemblers on both simulated and real 454 transcriptomic data. The results suggest that Trinity, the Illumina/Solexa-specialized transcriptomic assembler, performs the best among the multiple de Bruijn graph assemblers, comparable to or even outperforming the standard 454 assembler Newbler which is based on the overlap-layout-consensus algorithm. Our evaluation is expected to provide helpful guidance for researchers to choose assemblers when analyzing 454 transcriptomic data.	[Jin, Qi] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jin, Q (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	zdsys@vip.sina.com			Eleven-Fifth Mega-Scientific Project on infectious diseases, China [2008ZX10401-3, 2009ZX10004-303]; National Nature Science Foundation of China [30870104]	Eleven-Fifth Mega-Scientific Project on infectious diseases, China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Eleven-Fifth Mega-Scientific Project on infectious diseases, China (grant nos. 2008ZX10401-3 and 2009ZX10004-303) and the National Nature Science Foundation of China (grant no. 30870104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Costa Milce, 2002, Rev. Soc. Bras. Med. Trop., V35, P19, DOI 10.1590/S0037-86822002000100004; De Bruijn NG, 1946, KONINKLIJKE NEDERLAN, V46, P7; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Iyer MK, 2011, NAT BIOTECHNOL, V29, P599, DOI 10.1038/nbt.1915; Jennings MB, 2002, J AM PODIAT MED ASSN, V92, P327, DOI 10.7547/87507315-92-6-327; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Monod M, 2002, DERMATOLOGY, V205, P201, DOI 10.1159/000063913; Mortazavi A, 2010, GENOME RES, V20, P1740, DOI 10.1101/gr.111021.110; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Peng Y, 2011, BIOINFORMATICS, V27, pI94, DOI 10.1093/bioinformatics/btr216; Peng Y, 2011, LECT N BIOINFORMAT, V6577, P337, DOI 10.1007/978-3-642-20036-6_31; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vezzi F, 2012, PLOS ONE, V7; Wilhelm BT, 2011, BLOOD, V117, pE27, DOI 10.1182/blood-2010-07-293332; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang W, 2011, PLOS ONE, V6; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	36	19	20	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51188	10.1371/journal.pone.0051188	http://dx.doi.org/10.1371/journal.pone.0051188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236450	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100078
J	Rostovskaya, M; Anastassiadis, K				Rostovskaya, Maria; Anastassiadis, Konstantinos			Differential Expression of Surface Markers in Mouse Bone Marrow Mesenchymal Stromal Cell Subpopulations with Distinct Lineage Commitment	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; OSTEOGENESIS IMPERFECTA; CLONAL HETEROGENEITY; FIBROUS DYSPLASIA; IN-VITRO; MSCS; GENE; IDENTIFICATION; PROLIFERATION; MAINTENANCE	Bone marrow mesenchymal stromal cells (BM MSCs) represent a heterogeneous population of progenitors with potential for generation of skeletal tissues. However the identity of BM MSC subpopulations is poorly defined mainly due to the absence of specific markers allowing in situ localization of those cells and isolation of pure cell types. Here, we aimed at characterization of surface markers in mouse BM MSCs and in their subsets with distinct differentiation potential. Using conditionally immortalized BM MSCs we performed a screening with 176 antibodies and high-throughput flow cytometry, and found 33 markers expressed in MSCs, and among them 3 were novel for MSCs and 13 have not been reported for MSCs from mice. Furthermore, we obtained clonally derived MSC subpopulations and identified bipotential progenitors capable for osteo-and adipogenic differentiation, as well as monopotential osteogenic and adipogenic clones, and thus confirmed heterogeneity of MSCs. We found that expression of CD200 was characteristic for the clones with osteogenic potential, whereas SSEA4 marked adipogenic progenitors lacking osteogenic capacity, and CD140a was expressed in adipogenic cells independently of their efficiency for osteogenesis. We confirmed our observations in cell sorting experiments and further investigated the expression of those markers during the course of differentiation. Thus, our findings provide to our knowledge the most comprehensive characterization of surface antigens expression in mouse BM MSCs to date, and suggest CD200, SSEA4 and CD140a as markers differentially expressed in distinct types of MSC progenitors.	[Rostovskaya, Maria; Anastassiadis, Konstantinos] Tech Univ Dresden, BIOTEC, D-01062 Dresden, Germany	Technische Universitat Dresden	Anastassiadis, K (corresponding author), Tech Univ Dresden, BIOTEC, D-01062 Dresden, Germany.	konstantinos.anastassiadis@biotec.tu-dresden.de	Anastassiadis, Konstantinos/A-8944-2010	Anastassiadis, Konstantinos/0000-0002-9814-0559	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft grant Collaborative Research Center 655 "Cells into tissues: Stem cell and progenitor commitment and interactions during tissue formation" (Project B1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis K, 2002, GENE, V298, P159, DOI 10.1016/S0378-1119(02)00979-4; Anastassiadis K, 2010, GENESIS, V48, P220, DOI 10.1002/dvg.20605; Artemenko Y, 2005, J CELL PHYSIOL, V204, P646, DOI 10.1002/jcp.20314; Arthur A, 2009, J CELL PHYSIOL, V218, P237, DOI 10.1002/jcp.21592; Baer PC, 2012, STEM CELLS DEV; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Bianco P, 2000, J BONE MINER RES, V15, P120, DOI 10.1359/jbmr.2000.15.1.120; Bianco P, 1998, J CLIN INVEST, V101, P1737, DOI 10.1172/JCI2361; Buhring HJ, 2009, ANN NY ACAD SCI, V1176, P124, DOI 10.1111/j.1749-6632.2009.04564.x; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Delorme B, 2008, BLOOD, V111, P2631, DOI 10.1182/blood-2007-07-099622; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Fitter S, 2012, J MOL ENDOCRINOL, V48, P229, DOI 10.1530/JME-12-0003; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; Fukiage K, 2008, BIOCHEM BIOPH RES CO, V365, P406, DOI 10.1016/j.bbrc.2007.10.149; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Gioia R, 2012, STEM CELLS, V30, P1465, DOI 10.1002/stem.1107; Gorczynski R, 2004, J IMMUNOL, V172, P7744, DOI 10.4049/jimmunol.172.12.7744; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Kaltz N, 2010, EXP CELL RES, V316, P2609, DOI 10.1016/j.yexcr.2010.06.002; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401; Lee L, 2006, IMMUNOL LETT, V105, P150, DOI 10.1016/j.imlet.2006.02.002; Lin Y, 2011, ADV HEMATOL, V2011, DOI DOI 10.1155/2011/427863; Mareddy S, 2009, J CELL BIOCHEM, V106, P776, DOI 10.1002/jcb.22088; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Muraglia A, 2000, J CELL SCI, V113, P1161; Niehage C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020399; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pelekanos RA, 2012, STEM CELL RES, V8, P58, DOI 10.1016/j.scr.2011.08.003; Pochampally RR, 2005, GENE THER, V12, P1119, DOI 10.1038/sj.gt.3302514; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Rosu-Myles M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038954; Russell KC, 2010, STEM CELLS, V28, P788, DOI 10.1002/stem.312; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; TAVASSOLI M, 1968, SCIENCE, V161, P54, DOI 10.1126/science.161.3836.54; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; van den Berk LCJ, 2010, J LEUKOCYTE BIOL, V87, P283, DOI 10.1189/jlb.0709467; Vinatier C, 2009, CURR STEM CELL RES T, V4, P318, DOI 10.2174/157488809789649205; Vogel W, 2003, HAEMATOLOGICA, V88, P126; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wu Y, 2008, CELL BIOL INT, V32, P748, DOI 10.1016/j.cellbi.2008.02.006; Yanagisawa M, 2011, NEUROCHEM RES, V36, P1623, DOI 10.1007/s11064-010-0358-1	56	46	47	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51221	10.1371/journal.pone.0051221	http://dx.doi.org/10.1371/journal.pone.0051221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236457	Green Published, gold			2022-12-27	WOS:000312064100082
J	Wibom, C; Ghasimi, S; Van Loo, P; Brannstrom, T; Trygg, J; Lau, C; Henriksson, R; Bergenheim, T; Andersson, U; Ryden, P; Melin, B				Wibom, Carl; Ghasimi, Soma; Van Loo, Peter; Brannstrom, Thomas; Trygg, Johan; Lau, Ching; Henriksson, Roger; Bergenheim, Tommy; Andersson, Ulrika; Ryden, Patrik; Melin, Beatrice			EGFR Gene Variants Are Associated with Specific Somatic Aberrations in Glioma	PLOS ONE			English	Article							GENOMIC STABILITY; RISK; GLIOBLASTOMA; RECEPTOR; SUSCEPTIBILITY; MUTATIONS; PATHWAYS	A number of gene variants have been associated with an increased risk of developing glioma. We hypothesized that the reported risk variants may be associated with tumor genomic instability. To explore potential correlations between germline risk variants and somatic genetic events, we analyzed matched tumor and blood samples from 95 glioma patients by means of SNP genotyping. The generated genotype data was used to calculate genome-wide allele-specific copy number profiles of the tumor samples. We compared the copy number profiles across samples and found two EGFR gene variants (rs17172430 and rs11979158) that were associated with homozygous deletion at the CDKN2A/B locus. One of the EGFR variants (rs17172430) was also associated with loss of heterozygosity at the EGFR locus. Our findings were confirmed in a separate dataset consisting of matched blood and tumor samples from 300 glioblastoma patients, compiled from publically available TCGA data. These results imply there is a functional effect of germline EGFR variants on tumor progression.	[Wibom, Carl] Umea Univ, Computat Life Sci Cluster CLiC, Dept Radiat Sci, Umea, Sweden; [Ghasimi, Soma; Andersson, Ulrika; Melin, Beatrice] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Van Loo, Peter] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, Cambs, England; [Brannstrom, Thomas] Umea Univ, Dept Med Biosci, Umea, Sweden; [Trygg, Johan] Umea Univ, Computat Life Sci Cluster CLiC, Dept Chem, Umea, Sweden; [Lau, Ching] Baylor Coll Med, Dept Pediat & Hematol, Houston, TX 77030 USA; [Henriksson, Roger] Karolinska Inst, Dept Oncol, Umea, Sweden; [Ryden, Patrik] Umea Univ, Computat Life Sci Cluster CLiC, Dept Math & Math Stat, Umea, Sweden; [Van Loo, Peter] VIB, Dept Human Genet, Louvain, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Louvain, Belgium	Umea University; Umea University; Wellcome Trust Sanger Institute; Umea University; Umea University; Baylor College of Medicine; Karolinska Institutet; Umea University; Flanders Institute for Biotechnology (VIB); KU Leuven	Wibom, C (corresponding author), Umea Univ, Computat Life Sci Cluster CLiC, Dept Radiat Sci, Umea, Sweden.	carl.wibom@onkologi.umu.se	Henriksson, Roger/AAI-8608-2020	Van Loo, Peter/0000-0003-0292-1949	Umea University Hospital Cutting Edge Grant; Umea University; Acta Oncologica through the Royal Swedish Academy of Science; Swedish Cancer Foundation; Swedish Research Council; Northern Sweden Research Foundation; FWO	Umea University Hospital Cutting Edge Grant; Umea University; Acta Oncologica through the Royal Swedish Academy of Science; Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Northern Sweden Research Foundation; FWO(FWO)	The study was supported by the following grants; Umea University Hospital Cutting Edge Grant, Young Investigator Award by Umea University, Acta Oncologica through the Royal Swedish Academy of Science, The Swedish Cancer Foundation, The Swedish Research Council, and the Northern Sweden Research Foundation. PVL is a postdoctoral researcher of the Research Foundation - Flanders (FWO) and is as a visiting scientist at the Wellcome Trust Sanger Institute supported by a travel grant from the FWO. The SNP&SEQ Technology Platform is part of Science for Life Laboratory at Uppsala University and supported as a national infrastructure by the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2010, ACTA ONCOL, V49, P767, DOI 10.3109/0284186X.2010.480980; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Barbashina V, 2005, CLIN CANCER RES, V11, P1119; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cymer F, 2010, CELL ADHES MIGR, V4, P299, DOI 10.4161/cam.4.2.11191; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; EKSTRAND AJ, 1994, ONCOGENE, V9, P2313; Feng JJ, 2012, CANCER-AM CANCER SOC, V118, P232, DOI 10.1002/cncr.26250; Jenkins RB, 2011, CANCER GENET-NY, V204, P13, DOI 10.1016/j.cancergencyto.2010.10.002; Lystig TC, 2003, GENETICS, V164, P1683; Melin B, 2011, CURR OPIN ONCOL, V23, P643, DOI 10.1097/CCO.0b013e32834a6f61; Saavedra HI, 1999, J BIOL CHEM, V274, P38083, DOI 10.1074/jbc.274.53.38083; Sanson M, 2011, HUM MOL GENET, V20, P2897, DOI 10.1093/hmg/ddr192; Schwartzbaum JA, 2010, CARCINOGENESIS, V31, P1770, DOI 10.1093/carcin/bgq152; Sharma GG, 2003, ONCOGENE, V22, P131, DOI 10.1038/sj.onc.1206063; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Simon M, 2010, CLIN CANCER RES, V16, P5252, DOI 10.1158/1078-0432.CCR-10-1502; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	22	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e47929	10.1371/journal.pone.0047929	http://dx.doi.org/10.1371/journal.pone.0047929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236348	gold, Green Published, Green Submitted			2022-12-27	WOS:000312064100003
J	Zhang, XF; Sobue, T; Isshiki, M; Makino, S; Inoue, M; Kato, K; Shioda, T; Ohashi, T; Sato, H; Komano, J; Hanabusa, H; Shida, H				Zhang, Xianfeng; Sobue, Tomoyoshi; Isshiki, Mao; Makino, Shun-ichi; Inoue, Makoto; Kato, Kazunori; Shioda, Tatsuo; Ohashi, Takashi; Sato, Hirotaka; Komano, Jun; Hanabusa, Hideji; Shida, Hisatoshi			Elicitation of Both Anti HIV-1 Env Humoral and Cellular Immunities by Replicating Vaccinia Prime Sendai Virus Boost Regimen and Boosting by CD40Lm	PLOS ONE			English	Article							IMMUNE-RESPONSES; GENE-TRANSFER; DNA VACCINE; T-CELLS; INFECTION; TYPE-1; CD154; GAG; ANTIBODIES; LIGAND	For protection from HIV-1 infection, a vaccine should elicit both humoral and cell-mediated immune responses. A novel vaccine regimen and adjuvant that induce high levels of HIV-1 Env-specific T cell and antibody (Ab) responses was developed in this study. The prime-boost regimen that used combinations of replication-competent vaccinia LC16m8 Delta (m8 Delta) and Sendai virus (SeV) vectors expressing HIV-1 Env efficiently produced both Env-specific CD8(+) T cells and anti-Env antibodies, including neutralizing antibodies (nAbs). These results sharply contrast with vaccine regimens that prime with an Env expressing plasmid and boost with the m8 Delta or SeV vector that mainly elicited cellular immunities. Moreover, co-priming with combinations of m8 Delta s expressing Env or a membrane-bound human CD40 ligand mutant (CD40Lm) enhanced Env-specific CD8(+) T cell production, but not anti-Env antibody production. In contrast, priming with an m8 Delta that coexpresses CD40Lm and Env elicited more anti-Env Abs with higher avidity, but did not promote T cell responses. These results suggest that the m8 Delta prime/SeV boost regimen in conjunction with CD40Lm expression could be used as an immunization platform for driving both potent cellular and humoral immunities against pathogens such as HIV-1.	[Zhang, Xianfeng; Sobue, Tomoyoshi; Isshiki, Mao; Makino, Shun-ichi; Ohashi, Takashi; Sato, Hirotaka; Shida, Hisatoshi] Hokkaido Univ, Inst Med Genet, Kita Ku, Sapporo, Hokkaido, Japan; [Inoue, Makoto] DNAVEC Corp, Tsukuba, Ibaraki, Japan; [Kato, Kazunori] Toyo Univ, Dept BioMed Engn, Kawagoe, Saitama, Japan; [Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka, Japan; [Komano, Jun] Osaka Prefectural Inst Publ Hlth, Div Virol, Dept Infect Dis, Nakamichi Higashinari Ku, Osaka 537, Japan; [Hanabusa, Hideji] Ogikubo Hosp, Tokyo, Tokyo, Japan	Hokkaido University; DNAVEC Corporation; Toyo University; Osaka University; Osaka Prefectural Institute of Public Health	Shida, H (corresponding author), Hokkaido Univ, Inst Med Genet, Kita Ku, Sapporo, Hokkaido, Japan.	hshida@igm.hokudai.ac.jp	Ohashi, Takashi/C-4671-2012; zhang, xian/GYA-0290-2022	Ohashi, Takashi/0000-0002-3769-4224; Inoue, Makoto/0000-0003-0804-7439; Sato, Hirotaka/0000-0002-8321-9731	Ministry of Sports and Culture (Japan) [21390135]; Ministry of Health and Welfare (Japan); Health Science Foundation; Ministry of Education, Culture, Sports, Science and Technology [21390135]; Human Health Foundation [SAB4861]; Grants-in-Aid for Scientific Research [22390118] Funding Source: KAKEN	Ministry of Sports and Culture (Japan); Ministry of Health and Welfare (Japan)(Ministry of Health, Labour and Welfare, Japan); Health Science Foundation; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Health Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Sports and Culture (Japan) (21390135), the Ministry of Health and Welfare (Japan), and the Health Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare one author, M. Inoue, has an affiliation in DNAVEC Corporation. Although DNAVEC, a profit company, has developed and is preparing for marketing the Sendai Virus Vector (SeV Vector), it has not financially supported this study at all. This study has been exclusively supported by the grants (No: 21390135) of Ministry of Education, Culture, Sports, Science and Technology and that (No: SAB4861) of Human Health Foundation. Thus, participation of Makoto Inoue, a member of DNAVEC, does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Asmuth DM, 2010, J INFECT DIS, V201, P132, DOI 10.1086/648591; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Brown SA, 2010, VIRUSES-BASEL, V2, P435, DOI 10.3390/v2020435; Carter D, 2010, CURR OPIN HIV AIDS, V5, P409, DOI 10.1097/COH.0b013e32833d2cdb; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Cox KS, 2008, J VIROL, V82, P8161, DOI 10.1128/JVI.00620-08; Evans TG, 2001, VACCINE, V19, P2080, DOI 10.1016/S0264-410X(00)00415-1; Garcin D, 1995, EMBO J, V14, P6087, DOI 10.1002/j.1460-2075.1995.tb00299.x; Gares SL, 2006, CLIN VACCINE IMMUNOL, V13, P958, DOI 10.1128/CVI.00080-06; GAUCHAT JF, 1994, RES IMMUNOL, V145, P240, DOI 10.1016/S0923-2494(94)80191-6; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Gordon SN, 2011, J INFECT DIS, V203, P1043, DOI 10.1093/infdis/jiq162; Gurunathan S, 1998, J IMMUNOL, V161, P4563; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Hashizume S, 1985, VACCINIA VIRUSES VEC, P421; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; JIN NY, 1994, ARCH VIROL, V138, P315, DOI 10.1007/BF01379134; Kato A, 1996, GENES CELLS, V1, P569, DOI 10.1046/j.1365-2443.1996.d01-261.x; Kato A, 1997, J VIROL, V71, P7266, DOI 10.1128/JVI.71.10.7266-7272.1997; Kawada M, 2006, J VIROL, V80, P1949, DOI 10.1128/JVI.80.4.1949-1958.2006; Kawada M, 2008, J VIROL, V82, P10199, DOI 10.1128/JVI.01103-08; Kidokoro M, 2005, P NATL ACAD SCI USA, V102, P4152, DOI 10.1073/pnas.0406671102; Li HO, 2000, J VIROL, V74, P6564, DOI 10.1128/JVI.74.14.6564-6569.2000; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liu J, 2008, VACCINE, V26, P4062, DOI 10.1016/j.vaccine.2008.05.018; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; MACKETT M, 1982, P NATL ACAD SCI-BIOL, V79, P7415, DOI 10.1073/pnas.79.23.7415; Manoj S, 2003, J IMMUNOL, V170, P989, DOI 10.4049/jimmunol.170.2.989; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Masuta Y, 2007, J IMMUNOTHER, V30, P694, DOI 10.1097/CJI.0b013e31811a5c51; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McElrath MJ, 1995, SEMIN CANCER BIOL, V6, P375, DOI 10.1016/1044-579X(95)90007-1; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mendoza RB, 1997, J IMMUNOL, V159, P5777; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Saito T, 2009, JAMA-J AM MED ASSOC, V301, P1025, DOI 10.1001/jama.2009.289; Sakurai A, 2004, MICROBES INFECT, V6, P150, DOI 10.1016/j.micinf.2003.10.011; SHIDA H, 1983, CELL, V33, P423, DOI 10.1016/0092-8674(83)90424-5; SHIDA H, 1987, EMBO J, V6, P3379, DOI 10.1002/j.1460-2075.1987.tb02660.x; SHIDA H, 1986, VIROLOGY, V150, P451, DOI 10.1016/0042-6822(86)90309-0; Slobod KS, 2004, VACCINE, V22, P3182, DOI 10.1016/j.vaccine.2004.01.053; Suzuki Hajime, 2009, Vaccine, V27, P966, DOI 10.1016/j.vaccine.2008.12.015; Tokui M, 1997, BIOCHEM BIOPH RES CO, V233, P527, DOI 10.1006/bbrc.1997.6485; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vogel TU, 2003, J VIROL, V77, P13348, DOI 10.1128/JVI.77.24.13348-13360.2003; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yu SQ, 2008, VACCINE, V26, P6124, DOI 10.1016/j.vaccine.2008.09.017	59	8	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51633	10.1371/journal.pone.0051633	http://dx.doi.org/10.1371/journal.pone.0051633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236521	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100137
J	Aurich, MK; Thiele, I				Aurich, Maike K.; Thiele, Ines			Contextualization Procedure and Modeling of Monocyte Specific TLR Signaling	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NOD-LIKE RECEPTOR; NF-KAPPA-B; GENE-EXPRESSION; BINDING-PROTEIN; MESSENGER-RNAS; NETWORK; ACTIVATION; CELL; INTEGRATION	Innate immunity is the first line of defense against invasion of pathogens. Toll-like receptor (TLR) signaling is involved in a variety of human diseases extending far beyond immune system-related diseases, affecting a number of different tissues and cell-types. Computational models often do not account for cell-type specific differences in signaling networks. Investigation of these differences and its phenotypic implications could increase understanding of cell signaling and processes such as inflammation. The wealth of knowledge for TLR signaling has been recently summarized in a stoichiometric signaling network applicable for constraint-based modeling and analysis (COBRA). COBRA methods have been applied to investigate tissue-specific metabolism using omics data integration. Comparable approaches have not been conducted using signaling networks. In this study, we present ihsTLRv2, an updated TLR signaling network accounting for the association of 314 genes with 558 network reactions. We present a mapping procedure for transcriptomic data onto signaling networks and demonstrate the generation of a monocyte-specific TLR network. The generated monocyte network is characterized through expression of a specific set of isozymes rather than reduction of pathway contents. While further tailoring the network to a specific stimulation condition, we observed that the quantitative changes in gene expression due to LPS stimulation affected the tightly connected set of genes. Differential expression influenced about one third of the entire TLR signaling network, in particular, NF-kappa B activation. Thus, a cell-type and condition-specific signaling network can provide functional insight into signaling cascades. Furthermore, we demonstrate the energy dependence of TLR signaling pathways in monocytes. Citation: Aurich MK, Thiele I (2012) Contextualization Procedure and Modeling of Monocyte Specific TLR Signaling. PLoS ONE 7(12): e49978. doi:10.1371/journal.pone.0049978	[Aurich, Maike K.; Thiele, Ines] Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland; [Thiele, Ines] Univ Iceland, Fac Ind Engn Mech Engn & Comp Sci, Reykjavik, Iceland	University of Iceland; University of Iceland	Thiele, I (corresponding author), Univ Iceland, Ctr Syst Biol, Reykjavik, Iceland.	ines.thiele@gmail.com	Thiele, Ines/A-7629-2014	Thiele, Ines/0000-0002-8071-7110	European Research Council Advanced Grant [N 232816]; Marie Curie International Reintegration Grant within the 7th European Community Framework Program [N 249261]	European Research Council Advanced Grant(European Research Council (ERC)); Marie Curie International Reintegration Grant within the 7th European Community Framework Program	This work was supported by a European Research Council Advanced Grant (N 232816), and by a Marie Curie International Reintegration Grant awarded to IT (N 249261) within the 7th European Community Framework Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bajikar SS, 2012, ANN BIOMEDICAL ENG; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Blazier AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00299; Cachia O, 1998, J BIOL CHEM, V273, P32801, DOI 10.1074/jbc.273.49.32801; COHN ZA, 1965, J EXP MED, V121, P153, DOI 10.1084/jem.121.1.153; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Covert MW, 2008, BIOINFORMATICS, V24, P2044, DOI 10.1093/bioinformatics/btn352; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Dasika MS, 2006, BIOPHYS J, V91, P382, DOI 10.1529/biophysj.105.069724; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dower K, 2008, J IMMUNOL, V180, P3520, DOI 10.4049/jimmunol.180.5.3520; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Dunne A, 2011, CURR OPIN PHARMACOL, V11, P404, DOI 10.1016/j.coph.2011.03.004; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Farina C, 2004, INT IMMUNOL, V16, P799, DOI 10.1093/intimm/dxh083; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gianchandani EP, 2006, PLOS COMPUT BIOL, V2, P902, DOI 10.1371/journal.pcbi.0020101; Gianchandani EP, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000403; GRUBE BJ, 1994, J BIOL CHEM, V269, P8477; Gudmundsson S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-489; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Jensen PA, 2011, BIOINFORMATICS, V27, P541, DOI 10.1093/bioinformatics/btq702; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; KAVITA U, 1995, J BIOL CHEM, V270, P27758, DOI 10.1074/jbc.270.46.27758; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kostromins A, 2012, BIOSYSTEMS, V109, P233, DOI 10.1016/j.biosystems.2012.03.002; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lech M, 2010, INT IMMUNOL, V22, P717, DOI 10.1093/intimm/dxq058; Lee JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000086; Li F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000292; MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Moynagh PN, 2009, TRENDS IMMUNOL, V30, P33, DOI 10.1016/j.it.2008.10.001; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Ospelt C, 2010, INT J BIOCHEM CELL B, V42, P495, DOI 10.1016/j.biocel.2009.10.010; Palsson B, 2006, SYSTEMS BIOL PROPERT, pxii; Papin JA, 2004, BIOPHYS J, V87, P37, DOI 10.1529/biophysj.103.029884; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; Richard G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031341; Richard G, 2011, IEEE DECIS CONTR P, P2227, DOI 10.1109/CDC.2011.6160954; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Tannahill GM, 2011, FEBS LETT, V585, P1568, DOI 10.1016/j.febslet.2011.05.008; Thiele I, 2012, PLOS ONE IN PRESS; Thiele I, 2010, BIOPHYS J, V98, P2072, DOI 10.1016/j.bpj.2010.01.060; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thiele I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000312; Thomas CJ, 2002, FEBS LETT, V531, P184, DOI 10.1016/S0014-5793(02)03499-3; Thorleifsson SG, 2011, BIOINFORMATICS, V27, P2009, DOI 10.1093/bioinformatics/btr308; Vardi L, 2012, J COMPUT BIOL, V19, P232, DOI 10.1089/cmb.2011.0277; Warren P, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P108; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	66	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e49978	10.1371/journal.pone.0049978	http://dx.doi.org/10.1371/journal.pone.0049978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236359	Green Published, Green Submitted, gold			2022-12-27	WOS:000312589700007
J	Kaur, H; Mao, SH; Li, QW; Sameni, M; Krawetz, SA; Sloane, BF; Mattingly, RR				Kaur, Hitchintan; Mao, Shihong; Li, Quanwen; Sameni, Mansoureh; Krawetz, Stephen A.; Sloane, Bonnie F.; Mattingly, Raymond R.			RNA-Seq of Human Breast Ductal Carcinoma In Situ Models Reveals Aldehyde Dehydrogenase Isoform 5A1 as a Novel Potential Target	PLOS ONE			English	Article							CANCER CELL-LINES; GENE-EXPRESSION; HISTONE DEACETYLASE; LOCAL RECURRENCE; GASTRIC-CANCER; VALPROIC ACID; TUMOR-CELLS; MCF10 MODEL; PROGRESSION; INHIBITORS	Breast ductal carcinoma in situ (DCIS) is being found in great numbers of women due to the widespread use of mammography. To increase knowledge of DCIS, we determined the expression changes that are common among three DCIS models (MCF10.DCIS, SUM102 and SUM225) compared to the MCF10A model of non-tumorigenic mammary epithelial cells in three dimensional (3D) overlay culture with reconstituted basement membrane (rBM). Extracted mRNA was subjected to 76 cycles of deep sequencing (RNA-Seq) using Illumina Genome Analyzer GAIIx. Analysis of RNA-Seq results showed 295 consistently differentially expressed transcripts in the DCIS models. These differentially expressed genes encode proteins that are associated with a number of signaling pathways such as integrin, fibroblast growth factor and TGF beta signaling, show association with cell-cell signaling, cell-cell adhesion and cell proliferation, and have a notable bias toward localization in the extracellular and plasma membrane compartments. RNA-Seq data was validated by quantitative real-time PCR of selected differentially expressed genes. Aldehyde dehydrogenase 5A1 (ALDH5A1) which is an enzyme that is involved in mitochondrial glutamate metabolism, was over-expressed in all three DCIS models at both the mRNA and protein levels. Disulfiram and valproic acid are known to inhibit ALDH5A1 and are safe for chronic use in humans for other disorders. Both of these drugs significantly inhibited net proliferation of the DCIS 3D rBM overlay models, but had minimal effect on MCF10A 3D rBM overlay models. These results suggest that ALDH5A1 may play an important role in DCIS and potentially serve as a novel molecular therapeutic target. Citation: Kaur H, Mao S, Li Q, Sameni M, Krawetz SA, et al. (2012) RNA-Seq of Human Breast Ductal Carcinoma In Situ Models Reveals Aldehyde Dehydrogenase Isoform 5A1 as a Novel Potential Target. PLoS ONE 7(12): e50249. doi:10.1371/journal.pone.0050249	[Kaur, Hitchintan; Li, Quanwen; Sameni, Mansoureh; Sloane, Bonnie F.; Mattingly, Raymond R.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Mao, Shihong; Krawetz, Stephen A.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Li, Quanwen; Krawetz, Stephen A.; Sloane, Bonnie F.; Mattingly, Raymond R.] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Mattingly, RR (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	r.mattingly@wayne.edu	krawetz, stephen/GQQ-3308-2022		National Institute of Health [R01 CA131990]; The Genomics and Microscopic Imaging and Cytometry Resources Cores [NIH P30 CA22453]; NATIONAL CANCER INSTITUTE [P30CA022453, R01CA131990] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Genomics and Microscopic Imaging and Cytometry Resources Cores; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institute of Health R01 CA131990 (BFS and RRM). The Genomics and Microscopic Imaging and Cytometry Resources Cores are supported by NIH P30 CA22453. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2004, BREAST CANCER RES, V6, pR499, DOI 10.1186/bcr899; Adeyinka A, 2002, CLIN CANCER RES, V8, P3788; Allred DC, 2012, J CLIN ONCOL, V30, P1268, DOI 10.1200/JCO.2010.34.0141; ALLRED DC, 1992, HUM PATHOL, V23, P974, DOI 10.1016/0046-8177(92)90257-4; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barnes NLP, 2005, BRIT J SURG, V92, P429, DOI 10.1002/bjs.4878; Barraclough DL, 2009, AM J PATHOL, V175, P1848, DOI 10.2353/ajpath.2009.090246; Calaf GM, 2008, INT J MOL MED, V21, P561; Cardiff RD, 2010, TOXICOL PATHOL, V38, P171, DOI 10.1177/0192623309356447; Castellana B, 2012, J CANCER, V3, P175, DOI 10.7150/jca.4120; Castro NP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2157; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Chen JL, 2010, WORLD J GASTROENTERO, V16, P5874, DOI 10.3748/wjg.v16.i46.5874; Clark SE, 2011, BRIT J CANCER, V104, P120, DOI 10.1038/sj.bjc.6606021; Claus EB, 2001, EXP MOL PATHOL, V70, P303, DOI 10.1006/exmp.2001.2366; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DeCensi A, 2011, CANCER PREV RES, V4, P1181, DOI 10.1158/1940-6207.CAPR-10-0337; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; Emery LA, 2009, AM J PATHOL, V175, P1292, DOI 10.2353/ajpath.2009.090115; Eyal S, 2004, EPILEPSIA, V45, P737, DOI 10.1111/j.0013-9580.2004.00104.x; Gao J, 2009, GLIA, V57, P989, DOI 10.1002/glia.20823; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Griffith OL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2923; Han K, 2012, CLIN ONCOL-UK, V24, P183, DOI 10.1016/j.clon.2011.09.008; Hannemann J, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1613; Hebner C, 2008, ANNU REV PATHOL-MECH, V3, P313, DOI 10.1146/annurev.pathmechdis.3.121806.151526; Heiser LM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r31; HELLSTROM E, 1982, BIOCHEM PHARMACOL, V31, P3899, DOI 10.1016/0006-2952(82)90308-2; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Howe LR, 2011, CANCER PREV RES, V4, P1149, DOI 10.1158/1940-6207.CAPR-11-0334; Hrstka R, 2010, ONCOGENE, V29, P4838, DOI 10.1038/onc.2010.228; Jedeszko C, 2009, CANCER RES, V69, P9148, DOI 10.1158/0008-5472.CAN-09-1043; Jeevan R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4505; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kerlikowske K, 2010, JNCI-J NATL CANCER I, V102, P627, DOI 10.1093/jnci/djq101; Koike H, 2011, INT J CANC; Kuerer HM, 2009, J CLIN ONCOL, V27, P279, DOI 10.1200/JCO.2008.18.3103; Kulka J, 2009, PATHOL ONCOL RES, V15, P59, DOI 10.1007/s12253-008-9089-x; Kumar AS, 2005, BREAST CANCER RES, V7, P271, DOI 10.1186/bcr1346; Lari SA, 2011, J CANCER, V2, P232, DOI 10.7150/jca.2.232; Lee LY, 2008, HISTOL HISTOPATHOL, V23, P515, DOI 10.14670/HH-23.515; Lee SH, 2012, CURR CANCER RES, P45, DOI 10.1007/978-1-4614-0016-5_3; Li QW, 2008, NEOPLASIA, V10, P314, DOI 10.1593/neo.07970; Li QW, 2010, J PHARMACOL EXP THER, V332, P821, DOI 10.1124/jpet.109.160390; Li XR, 2009, BIOCHEMISTRY-MOSCOW+, V74, P979, DOI 10.1134/S0006297909090053; Lucas B, 2005, ONCOGENE, V24, P6418, DOI 10.1038/sj.onc.1208794; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Moreb JS, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-87; Muggerud AA, 2010, MOL ONCOL, V4, P357, DOI 10.1016/j.molonc.2010.06.007; Muzio G, 2012, FREE RADICAL BIO MED, V52, P735, DOI 10.1016/j.freeradbiomed.2011.11.033; Nan HM, 2011, HUM MOL GENET, V20, P2673, DOI 10.1093/hmg/ddr154; Pearce DJ, 2005, STEM CELLS, V23, P752, DOI 10.1634/stemcells.2004-0292; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Pleijhuis RG, 2009, ANN SURG ONCOL, V16, P2717, DOI 10.1245/s10434-009-0609-z; Porter D, 2003, MOL CANCER RES, V1, P362; Provenzano E, 2003, EUR J CANCER, V39, P622, DOI 10.1016/S0959-8049(02)00666-4; Raveh S, 2009, J CELL BIOCHEM, V108, P326, DOI 10.1002/jcb.22258; Rhee DK, 2008, GENOMICS, V92, P419, DOI 10.1016/j.ygeno.2008.08.005; Ringberg A, 2001, EUR J CANCER, V37, P1514, DOI 10.1016/S0959-8049(01)00165-4; Sakorafas GH, 2008, CANCER TREAT REV, V34, P483, DOI 10.1016/j.ctrv.2008.03.001; Sameni M, 2009, CLIN EXP METASTAS, V26, P299, DOI 10.1007/s10585-008-9218-7; Sartor CI, 1997, CANCER RES, V57, P978; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Seth A, 2003, ANTICANCER RES, V23, P2043; Ulazzi L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-17; VANDERLAAN JW, 1979, J NEUROCHEM, V32, P1769, DOI 10.1111/j.1471-4159.1979.tb02290.x; Vargas AC, 2012, BREAST CANC RES TREA; Vincent-Salomon A, 2008, CLIN CANCER RES, V14, P1956, DOI 10.1158/1078-0432.CCR-07-1465; Virnig Beth A., 2010, Journal of the National Cancer Institute Monographs, P113, DOI 10.1093/jncimonographs/lgq024; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039446; Wen GY, 2011, CANCER LETT, V308, P23, DOI 10.1016/j.canlet.2011.04.010; WHITTLE SR, 1981, BIOCHIM BIOPHYS ACTA, V657, P94, DOI 10.1016/0005-2744(81)90133-9; Wickstrom M, 2007, BIOCHEM PHARMACOL, V73, P25, DOI 10.1016/j.bcp.2006.08.016; Worsham MJ, 2006, BREAST CANCER RES TR, V96, P177, DOI 10.1007/s10549-005-9077-8; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Yang ZQ, 2004, CANCER GENET CYTOGEN, V155, P57, DOI 10.1016/j.cancergencyto.2004.03.013	80	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50249	10.1371/journal.pone.0050249	http://dx.doi.org/10.1371/journal.pone.0050249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236365	Green Published, gold, Green Submitted			2022-12-27	WOS:000312589700009
J	Koishi, AC; Zanello, PR; Bianco, EM; Bordignon, J; dos Santos, CND				Koishi, Andrea Cristine; Zanello, Paula Rodrigues; Bianco, Everson Miguel; Bordignon, Juliano; Duarte dos Santos, Claudia Nunes			Screening of Dengue Virus Antiviral Activity of Marine Seaweeds by an In Situ Enzyme-Linked Immunosorbent Assay	PLOS ONE			English	Article							MOSQUITO CELLS; NEUTRAL RED; BROWN-ALGAE; OPTIMIZATION; IMMUNOASSAY; INHIBITION; VALIDATION; MONOLAYERS	Dengue is a significant public health problem worldwide. Despite the important social and clinical impact, there is no vaccine or specific antiviral therapy for prevention and treatment of dengue virus (DENV) infection. Considering the above, drug discovery research for dengue is of utmost importance; in addition natural marine products provide diverse and novel chemical structures with potent biological activities that must be evaluated. In this study we propose a target-free approach for dengue drug discovery based on a novel, rapid, and economic in situ enzyme-linked immunosorbent assay and the screening of a panel of marine seaweed extracts. The in situ ELISA was standardized and validated for Huh7.5 cell line infected with all four serotypes of DENV, among them clinical isolates and a laboratory strain. Statistical analysis showed an average S/B of 7.2 and Z-factor of 0.62, demonstrating assay consistency and reliability. A panel of fifteen seaweed extracts was then screened at the maximum non-toxic dose previously determined by the MTT and Neutral Red cytotoxic assays. Eight seaweed extracts were able to reduce DENV infection of at least one serotype tested. Four extracts (Phaeophyta: Canistrocarpus cervicornis, Padina gymnospora; Rhodophyta: Palisada perforate; Chlorophyta: Caulerpa racemosa) were chosen for further evaluation, and time of addition studies point that they might act at an early stage of the viral infection cycle, such as binding or internalization.	[Koishi, Andrea Cristine; Zanello, Paula Rodrigues; Bordignon, Juliano; Duarte dos Santos, Claudia Nunes] Inst Carlos Chagas ICC FIOCRUZ PR, Mol Virol Lab, Curitiba, Parana, Brazil; [Koishi, Andrea Cristine] Univ Fed Parana UFPR, Programa Posgrad Biol Celular & Mol, Curitiba, Parana, Brazil; [Bianco, Everson Miguel] Univ Fed Pernambuco UFPE, Programa Posgrad Quim, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Parana; Universidade Federal de Pernambuco	Bordignon, J (corresponding author), Inst Carlos Chagas ICC FIOCRUZ PR, Mol Virol Lab, Curitiba, Parana, Brazil.	jbordig@tecpar.br; clsantos@tecpar.br	dos Santos, Claudia Nunes Duarte/E-1857-2018; Bordignon, Juliano/Z-6268-2019; dos Santos, Claudia Duarte/P-4868-2019; P, CM/B-1358-2013; Koishi, Andrea/N-2484-2013; Publica, Inct Saude/J-9544-2013	dos Santos, Claudia Nunes Duarte/0000-0001-8707-6638; Bordignon, Juliano/0000-0002-1965-6152; dos Santos, Claudia Duarte/0000-0001-8707-6638; Koishi, Andrea/0000-0002-3542-1353; 	CNPq; Fundacao Araucaria; Fiocruz EMB; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Fiocruz EMB; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by CNPq, Fundacao Araucaria and Fiocruz EMB (post-doctoral fellowship PRODOC/DQF/UFPE jan2009-april2010) and PRZ are supported by fellowships from CAPES. ACK and CNDS are CNPq fellowship recipients. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliya R, 2003, PAKISTAN J BOT, V35, P659; BERKOWITZ FE, 1985, ANTIMICROB AGENTS CH, V28, P207, DOI 10.1128/AAC.28.2.207; BIO Ventures for Global Health, 2007, DENGUE FEVER; BORENFREUND E, 1988, TOXICOL IN VITRO, V2, P1, DOI 10.1016/0887-2333(88)90030-6; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Che PL, 2009, INT J CLIN EXP MED, V2, P363; Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P3255, DOI 10.1128/AAC.00397-10; Chen YL, 2010, ANTIMICROB AGENTS CH, V54, P2932, DOI 10.1128/AAC.00140-10; Chiba K, 1998, TOXICOL IN VITRO, V12, P251, DOI 10.1016/S0887-2333(97)00107-0; Clercq ED, 2009, MED RES REV, V29; Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7; De Burghgraeve T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037244; de Oliveira AS, 2008, NAT PROD COMMUN, V3, P1469; DESPRES P, 1993, VIROLOGY, V196, P209, DOI 10.1006/viro.1993.1469; Ferreira LD, 2012, INT J ANAL CHEM, V2012, DOI 10.1155/2012/431954; FIGUEIREDO LTM, 1989, T ROY SOC TROP MED H, V83, P702, DOI 10.1016/0035-9203(89)90403-3; FIGUEIREDO LTM, 1987, J VIROL METHODS, V17, P191, DOI 10.1016/0166-0934(87)90129-7; Fujii MT, 2011, REV BRAS FARMACOGN, V21, P268, DOI 10.1590/S0102-695X2011005000064; Guha-Sapir D, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-1; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Harden EA, 2009, ANTIVIR RES, V83, P282, DOI 10.1016/j.antiviral.2009.06.007; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Hidari KIPJ, 2008, BIOCHEM BIOPH RES CO, V376, P91, DOI 10.1016/j.bbrc.2008.08.100; Hong JY, 2011, CURR OPIN CHEM BIOL, V15, P350, DOI 10.1016/j.cbpa.2011.03.004; Jamur MC, 2010, METHODS MOL BIOL, V588, P55, DOI 10.1007/978-1-59745-324-0_8; Khanavi M, 2010, BIOL RES, V43, P31, DOI [10.4067/S0716-97602010000100005, /S0716-97602010000100005]; Kim EJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-96; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001; Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638; Marques CT, 2012, REV BRAS FARMACOGN, V22, P115, DOI 10.1590/S0102-695X2011005000206; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Myc A, 1999, J VIROL METHODS, V77, P165, DOI 10.1016/S0166-0934(98)00150-5; Nielsen DG, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-211; Qing M, 2010, ANTIVIR RES, V86, P163, DOI 10.1016/j.antiviral.2010.02.313; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656; Sayce AC, 2010, TRENDS MICROBIOL, V18, P323, DOI 10.1016/j.tim.2010.04.003; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Shum D, 2010, ASSAY DRUG DEV TECHN, V8, P553, DOI 10.1089/adt.2010.0321; Stahle EL, 1998, ANTIVIR RES, V40, P105; Stengel DB, 2011, BIOTECHNOL ADV, V29, P483, DOI 10.1016/j.biotechadv.2011.05.016; Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001; Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08; WHO, 2009, DENGUE GUIDELINES FO; Yasuhara-Bell J, 2010, ANTIVIR RES, V86, P231, DOI 10.1016/j.antiviral.2010.03.009; Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang XCG, 2009, ANTIVIR RES, V83, P21, DOI 10.1016/j.antiviral.2009.02.204	51	26	30	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51089	10.1371/journal.pone.0051089	http://dx.doi.org/10.1371/journal.pone.0051089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227238	Green Published, gold, Green Submitted			2022-12-27	WOS:000312588200098
J	Yu, PL; Wild, DJ				Yu, Pulan; Wild, David J.			Discovering Associations in Biomedical Datasets by Link-based Associative Classifier (LAC)	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; GENE-EXPRESSION DATA; STOCHASTIC APPROACH; RULES; PAGERANK; SALSA; INHIBITOR; DATABASES; CELLS; AKT	Associative classification mining (ACM) can be used to provide predictive models with high accuracy as well as interpretability. However, traditional ACM ignores the difference of significances among the features used for mining. Although weighted associative classification mining (WACM) addresses this issue by assigning different weights to features, most implementations can only be utilized when pre-assigned weights are available. In this paper, we propose a link-based approach to automatically derive weight information from a dataset using link-based models which treat the dataset as a bipartite model. By combining this link-based feature weighting method with a traditional ACM method-classification based on associations (CBA), a Link-based Associative Classifier (LAC) is developed. We then demonstrate the application of LAC to biomedical datasets for association discovery between chemical compounds and bioactivities or diseases. The results indicate that the novel link-based weighting method is comparable to support vector machine (SVM) and RELIEF method, and is capable of capturing significant features. Additionally, LAC is shown to produce models with high accuracies and discover interesting associations which may otherwise remain unrevealed by traditional ACM. Citation: Yu P, Wild DJ (2012) Discovering Associations in Biomedical Datasets by Link-based Associative Classifier (LAC). PLoS ONE 7(12): e51018. doi:10.1371/journal.pone.0051018	[Yu, Pulan; Wild, David J.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Wild, DJ (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.	djwild@indiana.edu						Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Bauckhage C, 2008, LECT NOTES COMPUT SC, V5096, P426, DOI 10.1007/978-3-540-69321-5_43; Becquet C, 2002, GENOME BIOL, V3; Bingzheng Wang, 2011, 2011 IEEE 3rd International Conference on Communication Software and Networks (ICCSN 2011), P145, DOI 10.1109/ICCSN.2011.6014692; Bouzouita I, 2006, LECT NOTES COMPUT SC, V4081, P554; Cai CH, 1998, IDEAS 98 - INTERNATIONAL DATABASE ENGINEERING AND APPLICATIONS SYMPOSIUM, PROCEEDINGS, P68, DOI 10.1109/IDEAS.1998.694360; Carmona-Saez P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-54; Chen Z, 2002, WISE 2002: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON WEB INFORMATION SYSTEMS ENGINEERING, P63, DOI 10.1109/WISE.2002.1181644; Cheng TJ, 2011, J CHEM INF MODEL, V51, P2440, DOI 10.1021/ci200192v; Cheng TJ, 2011, J CHEM INF MODEL, V51, P229, DOI 10.1021/ci100364a; Creighton C, 2003, BIOINFORMATICS, V19, P79, DOI 10.1093/bioinformatics/19.1.79; Ding C., 2002, Proceedings of SIGIR 2002. Twenty-Fifth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P353; Evangelisti C, 2011, J CELL PHYSIOL, V226, P822, DOI 10.1002/jcp.22407; Farahat A, 2006, SIAM J SCI COMPUT, V27, P1181, DOI 10.1137/S1064827502412875; Fliri AF, 2005, J MED CHEM, V48, P6918, DOI 10.1021/jm050494g; Fliri AF, 2005, P NATL ACAD SCI USA, V102, P261, DOI 10.1073/pnas.0407790101; Garrett CR, 2011, INVEST NEW DRUG, V29, P1381, DOI 10.1007/s10637-010-9479-2; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hansen K, 2009, J CHEM INF MODEL, V49, P2077, DOI 10.1021/ci900161g; Jankowski N, 2011, LECT NOTES COMPUT SC, V7063, P238, DOI 10.1007/978-3-642-24958-7_28; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kazius J, 2005, J MED CHEM, V48, P312, DOI 10.1021/jm040835a; Khan MS, 2008, LECT NOTES ARTIF INT, V5077, P200, DOI 10.1007/978-3-540-70720-2_16; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Kumar P, 2010, INT CONF COMPUT AUTO, P718, DOI 10.1109/ICCAE.2010.5451339; Lempel R, 2001, ACM T INFORM SYST, V19, P131, DOI 10.1145/382979.383041; Lempel R, 2000, COMPUT NETW, V33, P387, DOI 10.1016/S1389-1286(00)00034-7; Leung KS, 2010, NUCLEIC ACIDS RES, V38, P6324, DOI 10.1093/nar/gkq500; Li GJ, 2011, INFORMATION SCIENCE AND TECHNOLOGY IN CHINA: A ROADMAP TO 2050, P1; Li WM, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P369, DOI 10.1109/ICDM.2001.989541; Liu B, 1998, KNOWLEDGE DISCOVERY, P80, DOI DOI 10.5555/3000292.3000305; MacDonald NJ, 2010, BIOINFORMATICS, V26, P1834, DOI 10.1093/bioinformatics/btq305; Martinez R, 2008, BIOINFORMATICS, V24, P2643, DOI 10.1093/bioinformatics/btn490; Marx KA, 2003, J CHEM INF COMP SCI, V43, P1652, DOI 10.1021/ci034050+; Meghabghab G, 2008, STUD COMPUT INTELL, V99, P69; Muyeba M, 2009, LECT NOTES ARTIF INT, V5433, P49; Page Lawrence, 1999, 199966 STANF INFOLAB; Park SH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-36; Qian-Cheng Wang, 2010, 2010 International Conference on Machine Learning and Cybernetics (ICMLC 2010), P220, DOI 10.1109/ICMLC.2010.5581062; Ramkumar G.D., 1998, P 4 ACM INT C KNOWL; Ross DD, 2000, BLOOD, V96, P365, DOI 10.1182/blood.V96.1.365.013k46_365_368; Soni S, 2009, NAT BIOL INSP COMP 2, P1492; Soni S, 2011, PERFORM EVALUATION, P224; Sun K, 2008, IEEE T KNOWL DATA EN, V20, P489, DOI 10.1109/TKDE.2007.190723; Tao F., 2003, P 9 ACM SIGKDD INT C, P661, DOI DOI 10.1145/956750.956836; Thabtah F.A., 2005, P 3 ACSIEEE INT C CO, P127; Thabtah F, 2007, KNOWL ENG REV, V22, P37, DOI 10.1017/S0269888907001026; Tseng VS, 2010, KDD, P253; van der Kolk DM, 2002, BLOOD, V99, P3763, DOI 10.1182/blood.V99.10.3763; Wang W, 2004, KNOWL INF SYST, V6, P203, DOI 10.1007/s10115-003-0108-7; Weill N, 2009, J CHEM INF MODEL, V49, P1049, DOI 10.1021/ci800447g; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yin XX, 2003, SIAM PROC S, P331; Yu P, 2013, J CHEMINFOR IN PRESS; Zuo J, 2002, MINING PREDICATE ASS, P281	55	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51018	10.1371/journal.pone.0051018	http://dx.doi.org/10.1371/journal.pone.0051018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227228	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200089
J	Murnane, PM; Hughes, JP; Celum, C; Lingappa, JR; Mugo, N; Farquhar, C; Kiarie, J; Wald, A; Baeten, JM				Murnane, Pamela M.; Hughes, James P.; Celum, Connie; Lingappa, Jairam R.; Mugo, Nelly; Farquhar, Carey; Kiarie, James; Wald, Anna; Baeten, Jared M.		Partners Prevention HSV HIV	Using Plasma Viral Load to Guide Antiretroviral Therapy Initiation to Prevent HIV-1 Transmission	PLOS ONE			English	Article							COITAL-ACT; COUPLES	Background: Current WHO guidelines recommend antiretroviral therapy (ART) initiation at CD4 counts <= 350 cells/mu L. Increasing this threshold has been proposed, with a primary goal of reducing HIV-1 infectiousness. Because the quantity of HIV-1 in plasma is the primary predictor of HIV-1 transmission, consideration of plasma viral load in ART initiation guidelines is warranted. Methods: Using per-sex-act infectivity estimates and cross-sectional sexual behavior data from 2,484 HIV-1 infected persons with CD4 counts >350 enrolled in a study of African heterosexual HIV-1 serodiscordant couples, we calculated the number of transmissions expected and the number potentially averted under selected scenarios for ART initiation: i) CD4 count <500 cells/mu L, ii) viral load >= 10,000 or >= 50,000 copies/mL and iii) universal treatment. For each scenario, we estimated the proportion of expected infections that could be averted, the proportion of infected persons initiating treatment, and the ratio of these proportions. Results: Initiating treatment at viral load >= 50,000 copies/mL would require treating 19.8% of infected persons with CD4 counts >350 while averting 40.5% of expected transmissions (ratio 2.0); treating at viral load >= 10,0000 copies/mL had a ratio of 1.5. In contrast, initiation at CD4 count <500 would require treating 41.8%, while averting 48.4% (ratio 1.1). Conclusion: Inclusion of viral load in ART initiation guidelines could permit targeting ART resources to HIV-1 infected persons who have a higher risk of transmitting HIV-1. Further work is needed to estimate costs and feasibility.	[Murnane, Pamela M.; Celum, Connie; Farquhar, Carey; Wald, Anna; Baeten, Jared M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Murnane, Pamela M.; Celum, Connie; Lingappa, Jairam R.; Mugo, Nelly; Farquhar, Carey; Kiarie, James] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Hughes, James P.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Celum, Connie; Lingappa, Jairam R.; Farquhar, Carey; Baeten, Jared M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Lingappa, Jairam R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Mugo, Nelly; Kiarie, James] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya; [Mugo, Nelly; Kiarie, James] Kenyatta Natl Hosp, Dept Obstet & Gynaecol, Nairobi, Kenya; [Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Wald, Anna] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA USA; [Wald, Anna] FHCRC, Div Publ Hlth Sci, Seattle, WA USA; [Wald, Anna] FHCRC, Div Clin Res, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; Kenyatta National Hospital; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Murnane, PM (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	pmurnane@uw.edu	Lingappa, Jairam/N-7760-2017; Wald, Anna/B-6272-2012	Wald, Anna/0000-0003-3486-6438; Rees, Helen/0000-0003-1442-6734; de Bruyn, Guy/0000-0002-8028-4474; kiarie, james/0000-0003-4180-7858; Were, Edwin/0000-0002-4783-0795; Ronald, Allan/0000-0002-5746-3490; Kapiga, Saidi/0000-0003-1753-4060; John-Stewart, Grace/0000-0002-4301-1573	National Institutes of Health [R01 MH095507, R01 AI083034]; Bill and Melinda Gates Foundation [26469]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (R01 MH095507 and R01 AI083034) and the Bill and Melinda Gates Foundation (grant 26469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglemyer A., 2011, COCHRANE DATABASE SY; Brown MS, 2000, J BIOSOC SCI, V32, P145, DOI 10.1017/S0021932000001450; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Cohen MS, 2011, N ENGL J MED; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; European AIDS Clinical Society, 2011, GUID VERS 6; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Lingappa JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012598; Novitsky V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010148; Okui L, 2012, 19 C RETR OPP INF SE; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Wang SQ, 2010, BIOTECHNOL ADV, V28, P770, DOI 10.1016/j.biotechadv.2010.06.004; WHO, 2010, ANT THER HIV INF AD	16	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2012	7	11							e51192	10.1371/journal.pone.0051192	http://dx.doi.org/10.1371/journal.pone.0051192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054WM	23250272	Green Submitted, Green Published, gold			2022-12-27	WOS:000312376100299
J	Yang, S; Hwang, JS; Park, HK; Lee, HS; Kim, HS; Kim, EY; Lim, JS				Yang, Seung; Hwang, Jin Soon; Park, Hong Kyu; Lee, Hae Sang; Kim, Hae Soon; Kim, Eun Young; Lim, Jung Sub			Serum Lipid Concentrations, Prevalence of Dyslipidemia, and Percentage Eligible for Pharmacological Treatment of Korean Children and Adolescents; Data from the Korea National Health and Nutrition Examination Survey IV (2007-2009)	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK-FACTORS; DENSITY-LIPOPROTEIN CHOLESTEROL; UNITED-STATES; JAPANESE CHILDREN; CHILDHOOD; TRENDS; ADULTS; ATHEROSCLEROSIS; ASSOCIATION	Objectives: Dyslipidemia is one of the important modifiable risk factors for cardiovascular disease. Thus, to know the prevalence of dyslipidemia is the 1st step to make guidelines of screening and management plan. Although, American Academy of Pediatrics updated the guidelines for lipid in childhood, Asian study is rare. Methods: The authors aimed to make a reference of each serum lipid level of Korean children and adolescents (2,363 subjects aged 10 to 18 years) from the data of Korea National Health and Nutrition Examination Survey IV (2007-2009). Results: The mean serum concentrations for total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C) were 158 mg/dL, 90 mg/dL, 90 mg/dL, and 49 mg/dL, respectively. The 95th percentile values for TC, LDL-C, and TG were 203 mg/dL, 129 mg/dL, and 185 mg/dL, respectively. The 5th percentile value for HDL-C was 36 mg/dL. The prevalence of hypercholesterolemia, high LDL-C, high TG, and low HDL-C was 6.5%, 4.7%, 10.1%, and 7.1%, respectively. Considering the risk factors such as obesity, hypertension, smoking, and diabetes, approximately 0.41% of the subjects were potentially eligible for pharmacological treatment. Conclusions: This information may be useful in not only Korean but also Asian planning programs for the prevention of cardiovascular disease through lipid control from childhood. Citation: Yang S, Hwang JS, Park HK, Lee HS, Kim HS, et al. (2012) Serum Lipid Concentrations, Prevalence of Dyslipidemia, and Percentage Eligible for Pharmacological Treatment of Korean Children and Adolescents; Data from the Korea National Health and Nutrition Examination Survey IV (2007-2009). PLoS ONE 7(12): e49253. doi: 10.1371/journal.pone.0049253	[Lim, Jung Sub] Korea Canc Ctr Hosp, Dept Pediat, Seoul, South Korea; [Yang, Seung; Park, Hong Kyu] Hallym Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Hwang, Jin Soon; Lee, Hae Sang] Ajou Univ, Ajou Univ Hosp, Sch Med, Dept Pediat, Suwon 441749, South Korea; [Kim, Hae Soon] Ewha Womans Univ, Sch Med, Dept Pediat, Seoul, South Korea; [Kim, Eun Young] Chosun Univ, Coll Med, Dept Pediat, Kwangju, South Korea	National Cancer Center - Korea (NCC); Hallym University; Ajou University; Ajou University Hospital; Ewha Womans University; Chosun University	Lim, JS (corresponding author), Korea Canc Ctr Hosp, Dept Pediat, Seoul, South Korea.	limjs@kcch.re.kr	lee, haesang/AAG-6951-2022; LIM, JUNG SUB/GLU-0130-2022; lee, Hae Sang/AFL-6833-2022	lee, Hae Sang/0000-0002-9684-4042				American Academy of Pediatrics, 1992, PEDIATRICS, V89, P525; Azizi F, 2001, EUR J EPIDEMIOL, V17, P281, DOI 10.1023/A:1017932212350; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Committee for Establishing Treatment Instruction for Dyslipidemia of the Korean Society of Lipidology and Atherosclerosis, 2009, GUID MAN DYSL; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Ford ES, 2009, CIRCULATION, V119, P1108, DOI 10.1161/CIRCULATIONAHA.108.816769; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goff DC, 2006, CIRCULATION, V113, P647, DOI 10.1161/CIRCULATIONAHA.105.552737; Goldbourt U, 1997, ARTERIOSCL THROM VAS, V17, P107, DOI 10.1161/01.ATV.17.1.107; Hickman TB, 1998, PREV MED, V27, P879, DOI 10.1006/pmed.1998.0376; Kavey REW, 2003, CIRCULATION, V107, P1562, DOI 10.1161/01.CIR.0000061521.15730.6E; Kim DJ, 2011, DIABETES METAB J, V35, P303, DOI 10.4093/dmj.2011.35.4.303; Kim HM, 2006, AM J EPIDEMIOL, V164, P787, DOI 10.1093/aje/kwj251; Kim S, 2000, AM J CLIN NUTR, V71, P44; Ko MJ, 2006, INT J CARDIOL, V110, P184, DOI 10.1016/j.ijcard.2005.07.030; Korea National Statistical Office, 2010, ANN REP CAUS DEATH S; Kouda K, 2004, J EPIDEMIOL, V14, P78, DOI 10.2188/jea.14.78; LAUER RM, 1988, PEDIATRICS, V82, P309; Lee CG, 2011, KOREAN J PEDIAT, V51, P463; Lee Hyung Min, 2011, J Prev Med Public Health, V44, P74, DOI 10.3961/jpmph.2011.44.2.74; Liao Y, 2008, ACTA PAEDIATR, V97, P1449, DOI 10.1111/j.1651-2227.2008.00946.x; Liu LL, 2009, DIABETES CARE, V32, pS133, DOI 10.2337/dc09-S205; May A. L., 2010, Morbidity and Mortality Weekly Report, V59, P29; McGill HC, 2001, CIRCULATION, V103, P1546; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Mirzaei M, 2009, HEART, V95, P740, DOI 10.1136/hrt.2008.154856; Moon Jin Soo, 2011, Korean J Pediatr, V54, P436, DOI 10.3345/kjp.2011.54.11.436; Okada T, 2002, PEDIATR INT, V44, P596, DOI 10.1046/j.1442-200X.2002.01634.x; PARK C B, 1955, Bull World Health Organ, V13, P69; Park SH, 2010, INT J CARDIOL, V139, P234, DOI 10.1016/j.ijcard.2008.10.011; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Sone H, 2011, J CLIN ENDOCR METAB, V96, P3448, DOI 10.1210/jc.2011-0622; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Wang S, 2011, PLOS ONE, V6; World Health Organization (WHO), 2004, GLOB BURD DIS 2004; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	39	38	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e49253	10.1371/journal.pone.0049253	http://dx.doi.org/10.1371/journal.pone.0049253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251338	Green Published, gold, Green Submitted			2022-12-27	WOS:000312386800005
J	Marioni, RE; Valenzuela, MJ; van den Hout, A; Brayne, C; Matthews, FE				Marioni, Riccardo E.; Valenzuela, Michael J.; van den Hout, Ardo; Brayne, Carol; Matthews, Fiona E.		MRC Cognitive Function Ageing Stud	Active Cognitive Lifestyle Is Associated with Positive Cognitive Health Transitions and Compression of Morbidity from Age Sixty-Five	PLOS ONE			English	Article							BRAIN RESERVE; DEMENTIA; RISK; POPULATION; IMPAIRMENT; DECLINE	Background: Three factors commonly used as measures of cognitive lifestyle are education, occupation, and social engagement. This study determined the relative importance of each variable to long term cognitive health in those with and without severe cognitive impairment. Methods: Data came from 12,470 participants from a multi-centre population-based cohort (Medical Research Council Cognitive Function and Ageing Study). Respondents were aged 65 years and over and were followed-up over 16 years. Cognitive states of no impairment, slight impairment, and moderate/severe impairment were defined, based on scores from the Mini-Mental State Examination. Multi-state modelling was used to investigate links between component cognitive lifestyle variables, cognitive state transitions over time, and death. Results: Higher educational attainment and a more complex mid-life occupation were associated with a lower risk of moving from a non-impaired to a slightly impaired state (hazard ratios 0.5 and 0.8), but with increased mortality from a severely impaired state (1.3 and 1.1). More socially engaged individuals had a decreased risk of moving from a slightly impaired state to a moderately/severely impaired state (0.7). All three cognitive lifestyle variables were linked to an increased chance of cognitive recovery back to the non-impaired state. Conclusions: In those without severe cognitive impairment, different aspects of cognitive lifestyle predict positive cognitive transitions over time, and in those with severe cognitive impairment, a reduced life-expectancy. An active cognitive lifestyle is therefore linked to compression of cognitive morbidity in late life.	[Marioni, Riccardo E.; Brayne, Carol] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Valenzuela, Michael J.] Univ Sydney, Regenerat Neurosci Grp, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [van den Hout, Ardo] UCL, Dept Stat Sci, London, England; [Matthews, Fiona E.] MRC, Biostat Unit, Cambridge CB2 2BW, England	University of Cambridge; University of Sydney; University of London; University College London; MRC Biostatistics Unit	Marioni, RE (corresponding author), Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland.	riccardo.marioni@ed.ac.uk	Matthews, Fiona/O-6932-2015; Brayne, Carol/AAA-4285-2020	Matthews, Fiona/0000-0002-1728-2388; Brayne, Carol/0000-0001-5307-663X; Valenzuela, Michael/0000-0001-7162-6607; Marioni, Riccardo/0000-0003-4430-4260	Medical Research Council [MRC G9901400]; MRC [UC_US_A030_0031]; National Health and Medical Research Council of Australia (NHMRC) [630551]; NHMRC Clinical Career Development Award [ID1004156]; MRC [G9901400] Funding Source: UKRI; Alzheimers Research UK [ART-RF2010-2] Funding Source: researchfish; Medical Research Council [G9901400] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Clinical Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a Medical Research Council project grant (MRC G9901400). Fiona Matthews and Ardo van den Hout are funded under MRC programme grant UC_US_A030_0031. Riccardo Marioni is an Alzheimer's Research United Kingdom Fellow (ART-RF2010-2). Michael Valenzuela is supported by National Health and Medical Research Council of Australia (NHMRC) project grant (ID 630551) and is funded by a NHMRC Clinical Career Development Award (ID1004156). The study is part of the Cambridge and Peterborough CLAHRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Access Economics Pty Limited for Alzheimer's Australia, 2009, KEEP DEM FRONT MIND; Alzheimers Assoc, 2011, ALZHEIMERS DEMENT, V7, P208, DOI 10.1016/j.jalz.2011.02.004; [Anonymous], 2010, R LANG ENV STAT COMP; Brayne C, 1998, PSYCHOL MED, V28, P319; Brayne C, 2010, BRAIN, V133, P2210, DOI 10.1093/brain/awq185; Deary IJ, 2012, NATURE, V482, P212, DOI 10.1038/nature10781; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Health Economics Research Centre (University of Oxford for the Alzheimer's Research Trust), 2010, DEM 2010; Jackson CH, 2011, J STAT SOFTW, V38, P1; Marioni RE, 2012, J ALZHEIMERS DIS, V28, P223, DOI 10.3233/JAD-2011-110377; Prince M, 2009, WORLD ALZHEIMER REPO; Reuser M, 2011, EUR J EPIDEMIOL, V26, P395, DOI 10.1007/s10654-011-9553-x; Rohwedder S, 2010, J ECON PERSPECT, V24, P119, DOI 10.1257/jep.24.1.119; Scarmeas Nikolaos, 2004, Curr Neurol Neurosci Rep, V4, P374, DOI 10.1007/s11910-004-0084-7; Sharp ES, 2011, ALZ DIS ASSOC DIS, V25, P289, DOI 10.1097/WAD.0b013e318211c83c; Stephan BCM, 2010, AM J GERIAT PSYCHIAT, V18, P662, DOI 10.1097/JGP.0b013e3181e0450d; STERN Y, 1995, ANN NEUROL, V37, P590, DOI 10.1002/ana.410370508; The Hon. Wayne Swan MP Treasurer of the Commonwealth of Australia, 2010, INTERGENERATIONAL RE; Valenzuela M, 2011, AM J EPIDEMIOL, V173, P1004, DOI 10.1093/aje/kwq476; Valenzuela MJ, 2006, PSYCHOL MED, V36, P1065, DOI 10.1017/S0033291706007744; Valenzuela MJ, 2012, BIOL PSYCHIAT, V71, P783, DOI 10.1016/j.biopsych.2011.07.036; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; van den Hout A, 2010, J R STAT SOC A STAT, V173, P331, DOI 10.1111/j.1467-985X.2009.00610.x	25	44	46	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50940	10.1371/journal.pone.0050940	http://dx.doi.org/10.1371/journal.pone.0050940			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251404	gold, Green Published, Green Submitted			2022-12-27	WOS:000313236200049
J	Ohkura, M; Sasaki, T; Sadakari, J; Gengyo-Ando, K; Kagawa-Nagamura, Y; Kobayashi, C; Ikegaya, Y; Nakai, J				Ohkura, Masamichi; Sasaki, Takuya; Sadakari, Junko; Gengyo-Ando, Keiko; Kagawa-Nagamura, Yuko; Kobayashi, Chiaki; Ikegaya, Yuji; Nakai, Junichi			Genetically Encoded Green Fluorescent Ca2+ Indicators with Improved Detectability for Neuronal Ca2+ Signals	PLOS ONE			English	Article							GCAMP CALCIUM INDICATOR; IN-VIVO; NEURAL ACTIVITY; ELECTROPORATION; ACTIVATION; REPORTER; SPINES; MOUSE	Imaging the activities of individual neurons with genetically encoded Ca2+ indicators (GECIs) is a promising method for understanding neuronal network functions. Here, we report GECIs with improved neuronal Ca2+ signal detectability, termed G-CaMP6 and G-CaMP8. Compared to a series of existing G-CaMPs, G-CaMP6 showed fairly high sensitivity and rapid kinetics, both of which are suitable properties for detecting subtle and fast neuronal activities. G-CaMP8 showed a greater signal (F-max/F-min = 38) than G-CaMP6 and demonstrated kinetics similar to those of G-CaMP6. Both GECIs could detect individual spikes from pyramidal neurons of cultured hippocampal slices or acute cortical slices with 100% detection rates, demonstrating their superior performance to existing GECIs. Because G-CaMP6 showed a higher sensitivity and brighter baseline fluorescence than G-CaMP8 in a cellular environment, we applied G-CaMP6 for Ca2+ imaging of dendritic spines, the putative postsynaptic sites. By expressing a G-CaMP6-actin fusion protein for the spines in hippocampal CA3 pyramidal neurons and electrically stimulating the granule cells of the dentate gyrus, which innervate CA3 pyramidal neurons, we found that sub-threshold stimulation triggered small Ca2+ responses in a limited number of spines with a low response rate in active spines, whereas supra-threshold stimulation triggered large fluorescence responses in virtually all of the spines with a 100% activity rate.	[Ohkura, Masamichi; Sasaki, Takuya; Sadakari, Junko; Gengyo-Ando, Keiko; Kagawa-Nagamura, Yuko; Nakai, Junichi] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan; [Kobayashi, Chiaki; Ikegaya, Yuji] Univ Tokyo, Chem Pharmacol Lab, Grad Sch Pharmaceut Sci, Tokyo, Japan	Saitama University; University of Tokyo	Ohkura, M (corresponding author), Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan.	mohkura@mail.saitama-u.ac.jp; ikegaya@mol.f.u-tokyo.ac.jp; jnakai@mail.saitama-u.ac.jp	Sasaki, Takuya/J-3283-2015; Ohkura, Masamichi/J-6976-2012; Nakai, Junichi/GQZ-6415-2022; Gengyo-Ando, Keiko/AAC-4504-2019	Ohkura, Masamichi/0000-0002-3659-7780; Ikegaya, Yuji/0000-0003-2260-8191	Regional Innovation Cluster Program (City Area Type, Central Saitama Area); Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22500285, 24111509, 10J05408, 22500353, 21500379]	Regional Innovation Cluster Program (City Area Type, Central Saitama Area); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by the Regional Innovation Cluster Program (City Area Type, Central Saitama Area) and by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to M.O. (nos. 22500285 and 24111509), T.S. (no. 10J05408), K.G.-A. (no. 22500353) and J.N. (no. 21500379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; BRENNER S, 1974, GENETICS, V77, P71; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Edwards RA, 1998, BIOCHEM J, V331, P149, DOI 10.1042/bj3310149; Fisher AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002351; Gengyo-Ando K, 2006, BIOCHEM BIOPH RES CO, V349, P1345, DOI 10.1016/j.bbrc.2006.08.183; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Judkewitz B, 2009, NAT PROTOC, V4, P862, DOI 10.1038/nprot.2009.56; Kotlikoff MI, 2007, J PHYSIOL-LONDON, V578, P55, DOI 10.1113/jphysiol.2006.120212; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Koyama R, 2007, J PHARMACOL SCI, V104, P191, DOI 10.1254/jphs.SC0070119; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mittmann W, 2011, NAT NEUROSCI, V14, P1089, DOI 10.1038/nn.2879; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039933; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Peled ES, 2011, NAT NEUROSCI, V14, P519, DOI 10.1038/nn.2767; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wallace DJ, 2008, NAT METHODS, V5, P797, DOI 10.1038/NMETH.1242; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Yamada Y, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00018; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	33	136	141	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51286	10.1371/journal.pone.0051286	http://dx.doi.org/10.1371/journal.pone.0051286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240011	gold, Green Submitted, Green Published			2022-12-27	WOS:000312290800047
J	Sullivan, C; Liu, YH; Shen, JJ; Curtis, A; Newman, C; Hock, JM; Li, X				Sullivan, Con; Liu, Youhong; Shen, Jingjing; Curtis, Adam; Newman, Christina; Hock, Janet M.; Li, Xiong			Novel Interactions between FOXM1 and CDC25A Regulate the Cell Cycle	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; G(1)/S TRANSITION; TYROSINE PHOSPHATASE; MITOTIC PROGRESSION; ACTIVATES P34CDC2; FORKHEAD; CANCER; EXPRESSION; BINDING; MITOSIS	FOXM1 is a critical regulator of the G1/S and G2/M cell cycle transitions, as well as of the mitotic spindle assembly. Previous studies have suggested that FOXM1 regulates CDC25A gene transcription, but the mechanism remains unknown. Here, we provide evidence that FOXM1 directly regulates CDC25A gene transcription via direct promoter binding and indirect activation of E2F-dependent pathways. Prior literature reported that CDC25B and CDC25C activate CDK1/cyclinB complexes in order to enable phosphorylation of FOXM1. It was unknown if CDC25A functions in a similar manner. We report that FOXM1 transcriptional activity is synergistically enhanced when co-expressed with CDC25A. The increase is dependent upon CDK1 phosphorylation of FOXM1 at T600, T611 and T620 residues. We also report a novel protein interaction between FOXM1 and CDC25A via the C-terminus of FOXM1. We demonstrate that the phosphorylation of Thr 600 and Thr 611 residues of FOXM1 enhanced this interaction, and that the interaction is dependent upon CDC25A phosphatase activity. Our work provides novel insight into the underlying mechanisms by which FOXM1 controls the cell cycle through its association with CDC25A.	[Sullivan, Con; Liu, Youhong; Shen, Jingjing; Curtis, Adam; Newman, Christina; Hock, Janet M.; Li, Xiong] Maine Inst Human Genet & Hlth, Brewer, ME 04412 USA; [Liu, Youhong; Li, Xiong] Cent S Univ, Xiangya Hosp, Ctr Mol Med, Changsha, Hunan, Peoples R China; [Sullivan, Con] Univ Maine, Orono, ME USA	Central South University; University of Maine System; University of Maine Orono	Li, X (corresponding author), Maine Inst Human Genet & Hlth, Brewer, ME 04412 USA.	xiolijob@gmail.com		Hock, Janet/0000-0001-8873-2545	United States Army Medical Research and Materiel Command [USAMRMC 617 0704400]; Maine Institute for Human Genetics and Health, United States of America; "Shenghua Scholar Professorship", Central South University, People's Republic of China	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Maine Institute for Human Genetics and Health, United States of America; "Shenghua Scholar Professorship", Central South University, People's Republic of China	This work was supported by United States Army Medical Research and Materiel Command (USAMRMC 617 0704400), the Maine Institute for Human Genetics and Health, United States of America, and the "Shenghua Scholar Professorship", Central South University, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir T, 2005, NAT CELL BIOL, V7, P779, DOI 10.1038/ncb0805-779; Blomberg I, 1999, MOL CELL BIOL, V19, P6183; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Chen X, 1999, MOL CELL BIOL, V19, P4695; Chen YJ, 2009, J BIOL CHEM, V284, P30695, DOI 10.1074/jbc.M109.007997; Costa RH, 2005, CURR OPIN GENET DEV, V15, P42, DOI 10.1016/j.gde.2004.12.007; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2003, J BIOL CHEM, V278, P37888, DOI 10.1074/jbc.M305555200; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; LEE MS, 1992, MOL BIOL CELL, V3, P73, DOI 10.1091/mbc.3.1.73; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Li X, 2005, CANCER RES, V65, P1941, DOI 10.1158/0008-5472.CAN-04-3666; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Liu YH, 2010, J CELL BIOCHEM, V111, P1546, DOI 10.1002/jcb.22886; Loffler H, 2003, ONCOGENE, V22, P8063, DOI 10.1038/sj.onc.1206976; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Manning ET, 2001, MOL CELL BIOL, V21, P3876, DOI 10.1128/MCB.21.12.3876-3887.2001; McCain DF, 2002, J BIOL CHEM, V277, P11190, DOI 10.1074/jbc.M109636200; MILLAR JBA, 1991, EMBO J, V10, P4301, DOI 10.1002/j.1460-2075.1991.tb05008.x; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Rudolph J, 2007, NAT REV CANCER, V7, P202, DOI 10.1038/nrc2087; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sullivan C, 2007, J IMMUNOL, V178, P4517, DOI 10.4049/jimmunol.178.7.4517; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang ZW, 2010, PHARM RES-DORDR, V27, P1159, DOI 10.1007/s11095-010-0106-x; Wierstra I, 2006, BIOCHEM BIOPH RES CO, V348, P99, DOI 10.1016/j.bbrc.2006.07.008; Wierstra I, 2006, BIOL CHEM, V387, P949, DOI 10.1515/BC.2006.119; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Xu X, 1996, J BIOL CHEM, V271, P5118; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827	50	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51277	10.1371/journal.pone.0051277	http://dx.doi.org/10.1371/journal.pone.0051277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240008	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800044
J	Wootton, EC; Woolmer, AP; Vogan, CL; Pope, EC; Hamilton, KM; Rowley, AF				Wootton, Emma C.; Woolmer, Andrew P.; Vogan, Claire L.; Pope, Edward C.; Hamilton, Kristina M.; Rowley, Andrew F.			Increased Disease Calls for a Cost-Benefits Review of Marine Reserves	PLOS ONE			English	Article							PROTECTED AREAS; SHELL DISEASE; ECOLOGICAL CONSEQUENCES; DECAPOD CRUSTACEANS; HOMARUS-AMERICANUS; TROPHIC CASCADES; LOBSTER; POPULATION; ABUNDANCE; RECOGNITION	Marine reserves (or No-Take Zones) are implemented to protect species and habitats, with the aim of restoring a balanced ecosystem. Although the benefits of marine reserves are commonly monitored, there is a lack of insight into the potential detriments of such highly protected waters. High population densities attained within reserves may induce negative impacts such as unfavourable trophic cascades and disease outbreaks. Hence, we investigated the health of lobster populations in the UK's Marine Conservation Zone (MCZ) at Lundy Island. Comparisons were made between the fished, Refuge Zone (RZ) and the un-fished, No-Take Zone (NTZ; marine reserve). We show ostensibly positive effects such as increased lobster abundance and size within the NTZ; however, we also demonstrate apparent negative effects such as increased injury and shell disease. Our findings suggest that robust cost-benefit analyses of marine reserves could improve marine reserve efficacy and subsequent management strategies.	[Wootton, Emma C.; Pope, Edward C.; Hamilton, Kristina M.; Rowley, Andrew F.] Swansea Univ, Dept Biosci, Swansea, W Glam, Wales; [Woolmer, Andrew P.] Salacia Marine, Swansea, W Glam, Wales; [Vogan, Claire L.] Swansea Univ, Coll Med, Swansea, W Glam, Wales	Swansea University; Swansea University	Rowley, AF (corresponding author), Swansea Univ, Dept Biosci, Swansea, W Glam, Wales.	a.f.rowley@swansea.ac.uk	Pope, Edward/G-5665-2011	Pope, Edward/0000-0001-5781-5575	Interreg 4A Ireland-Wales 2007-3013 Programme	Interreg 4A Ireland-Wales 2007-3013 Programme	This work was funded by Interreg 4A Ireland-Wales 2007-3013 Programme (Grant entitled SUSFISH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Agardy T, 2011, UNEP REGIONAL SEAS R; ANDERSON RM, 1986, PHILOS T ROY SOC B, V314, P533, DOI 10.1098/rstb.1986.0072; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Beamish RJ, 2006, PROG OCEANOGR, V68, P289, DOI 10.1016/j.pocean.2006.02.005; Beukers-Stewart BD, 2005, MAR ECOL PROG SER, V298, P189, DOI 10.3354/meps298189; Caveen AJ, 2013, MAR POLICY, V37, P3, DOI 10.1016/j.marpol.2012.04.005; Cawthorn RJ, 2011, J INVERTEBR PATHOL, V106, P71, DOI 10.1016/j.jip.2010.09.010; Childress Michael J., 2006, P78, DOI 10.1002/9780470995969.ch3; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Debuse VJ, 1999, ANIM BEHAV, V58, P973, DOI 10.1006/anbe.1999.1213; DOBSON AP, 1987, INT J PARASITOL, V17, P363, DOI 10.1016/0020-7519(87)90111-1; Ehler C., 2009, IOC MANUAL GUIDES, V53; Freeman DJ, 2009, MAR FRESHWATER RES, V60, P140, DOI 10.1071/MF08091; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; GETCHELL R G, 1989, Journal of Shellfish Research, V8, P1; Goni R, 2010, MAR ECOL PROG SER, V400, P233, DOI 10.3354/meps08419; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; Hoskin MG, 2011, CAN J FISH AQUAT SCI, V68, P185, DOI 10.1139/F10-143; Juanes F, 1995, J EXP MAR BIOL ECOL, V193, P197, DOI 10.1016/0022-0981(95)00118-2; Jury SH, 2001, MAR FRESHWATER RES, V52, P1125, DOI 10.1071/MF01096; Karavanich C, 1998, ANIM BEHAV, V56, P1553, DOI 10.1006/anbe.1998.0914; Kelly S, 2002, COAST MANAGE, V30, P153, DOI 10.1080/089207502753504689; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Lafferty KD, 2002, CONSERV BIOL, V16, P593, DOI 10.1046/j.1523-1739.2002.00446.x; Lebarbenchon C, 2006, ECOHEALTH, V3, P303, DOI 10.1007/s10393-006-0067-z; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lubchenco J, 2003, ECOL APPL, V13, pS3; McCallum H, 2005, J APPL ECOL, V42, P688, DOI 10.1111/j.1365-2664.2005.01043.x; Moland E, 2010, MAR ECOL PROG SER, V400, P165, DOI 10.3354/meps08397; O'Sullivan D, 2011, MAR ECOL PROG SER, V440, P115, DOI 10.3354/meps09294; Page CA, 2009, DIS AQUAT ORGAN, V87, P135, DOI 10.3354/dao02112; Pande A, 2008, MAR ECOL PROG SER, V366, P147, DOI 10.3354/meps07494; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Rowe S, 2002, FISH RES, V56, P167, DOI 10.1016/S0165-7836(01)00321-6; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sasal P, 2004, J FISH BIOL, V64, P370, DOI 10.1111/j.0022-1112.2004.00297.x; Skog M, 2009, BEHAVIOUR, V146, P1071, DOI 10.1163/156853909X406437; SMOLOWITZ RM, 1992, BIOL BULL, V183, P99, DOI 10.2307/1542411; Stokesbury KDE, 2007, MAR ECOL PROG SER, V349, P151, DOI 10.3354/meps07113; Vogan CL, 2001, DIS AQUAT ORGAN, V47, P209, DOI 10.3354/dao047209; Vogan CL, 2008, ENVIRON MICROBIOL, V10, P826, DOI 10.1111/j.1462-2920.2007.01514.x	51	25	26	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51615	10.1371/journal.pone.0051615	http://dx.doi.org/10.1371/journal.pone.0051615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240047	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800083
J	Buyantuyev, A; Xu, PY; Wu, JG; Piao, SJ; Wang, DC				Buyantuyev, Alexander; Xu, Pengyan; Wu, Jianguo; Piao, Shunji; Wang, Dachuan			A Space-For-Time (SFT) Substitution Approach to Studying Historical Phenological Changes in Urban Environment	PLOS ONE			English	Article							CLIMATE-CHANGE; BUD BURST; FLOWERING TIMES; TREE PHENOLOGY; GROWING-SEASON; TEMPERATURE; RESPONSES; SERIES; VARIABILITY; GREENUP	Plant phenological records are crucial for predicting plant responses to global warming. However, many historical records are either short or replete with data gaps, which pose limitations and may lead to erroneous conclusions about the direction and magnitude of change. In addition to uninterrupted monitoring, missing observations may be substituted via modeling, experimentation, or gradient analysis. Here we have developed a space-for-time (SFT) substitution method that uses spatial phenology and temperature data to fill gaps in historical records. To do this, we combined historical data for several tree species from a single location with spatial data for the same species and used linear regression and Analysis of Covariance (ANCOVA) to build complementary spring phenology models and assess improvements achieved by the approach. SFT substitution allowed increasing the sample size and developing more robust phenology models for some of the species studied. Testing models with reduced historical data size revealed thresholds at which SFT improved historical trend estimation. We conclude that under certain circumstances both the robustness of models and accuracy of phenological trends can be enhanced although some limitations and assumptions still need to be resolved. There is considerable potential for exploring SFT analyses in phenology studies, especially those conducted in urban environments and those dealing with non-linearities in phenology modeling.	[Buyantuyev, Alexander; Wu, Jianguo] Inner Mongolia Univ, Sino US Ctr Conservat Energy & Sustainabil Sci, Hohhot, Peoples R China; [Buyantuyev, Alexander; Xu, Pengyan; Piao, Shunji; Wang, Dachuan] Inner Mongolia Univ, Sch Life Sci, Hohhot, Peoples R China; [Wu, Jianguo] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Wu, Jianguo] Arizona State Univ, Global Inst Sustainabil, Tempe, AZ USA	Inner Mongolia University; Inner Mongolia University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Buyantuyev, A (corresponding author), Inner Mongolia Univ, Sino US Ctr Conservat Energy & Sustainabil Sci, Hohhot, Peoples R China.	abuyantu@gmail.com	Wu, Jianguo/G-6267-2010; Buyantuev, Alexander/L-9887-2013	Wu, Jianguo/0000-0002-1182-3024; Buyantuev, Alexander/0000-0003-1670-0741	Natural Science Foundation of China [30970504]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is funded by the Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm) under Grant No. 30970504. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badeck FW, 2004, NEW PHYTOL, V162, P295, DOI 10.1111/j.1469-8137.2004.01059.x; Bertin RI, 2008, J TORREY BOT SOC, V135, P126, DOI 10.3159/07-RP-035R.1; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Chen XQ, 2012, INT J BIOMETEOROL, V56, P695, DOI 10.1007/s00484-011-0471-0; Chen XQ, 2003, TASK VEG SC, V39, P11; Chmielewski FM, 2002, CLIMATE RES, V19, P257, DOI 10.3354/cr019257; Chmielewski FM, 2001, AGR FOREST METEOROL, V108, P101, DOI 10.1016/S0168-1923(01)00233-7; Chuine I, 1999, PLANT CELL ENVIRON, V22, P1, DOI 10.1046/j.1365-3040.1999.00395.x; Chuine I, 2003, PHENOLOGY INTEGRATIV, P11; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dunne JA, 2004, ECOLOGY, V85, P904, DOI 10.1890/03-8003; Fisher JI, 2007, GLOBAL CHANGE BIOL, V13, P707, DOI 10.1111/j.1365-2486.2006.01311.x; FITTER AH, 1995, FUNCT ECOL, V9, P55, DOI 10.2307/2390090; Forrest J, 2010, PHILOS T R SOC B, V365, P3101, DOI 10.1098/rstb.2010.0145; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Gazal R, 2008, GLOBAL CHANGE BIOL, V14, P1568, DOI 10.1111/j.1365-2486.2008.01602.x; Gotelli NJ, 2013, ECOSIMR 1 00; HAKKINEN R, 1995, TREE PHYSIOL, V15, P721, DOI 10.1093/treephys/15.11.721; Heide OM, 2003, TREE PHYSIOL, V23, P931, DOI 10.1093/treephys/23.13.931; Hudson IL, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P209, DOI 10.1007/978-90-481-3335-2_10; Jochner S, 2011, INT J BIOMETEOROL, P1; Kelly N, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P271, DOI 10.1007/978-90-481-3335-2_13; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; KRAMER K, 1995, PLANT CELL ENVIRON, V18, P93, DOI 10.1111/j.1365-3040.1995.tb00356.x; Linkosalo T, 1996, TREE PHYSIOL, V16, P661; Little R. J. A., 1987, STAT ANAL MISSING DA; Matsumoto K, 2003, GLOBAL CHANGE BIOL, V9, P1634, DOI 10.1046/j.1365-2486.2003.00688.x; Menzel A, 2003, TASK VEG SC, V39, P319; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Miller-Rushing AJ, 2008, ECOLOGY, V89, P332, DOI 10.1890/07-0068.1; Miller-Rushing AJ, 2006, AM J BOT, V93, P1667, DOI 10.3732/ajb.93.11.1667; Mimet A, 2009, INT J BIOMETEOROL, V53, P287, DOI 10.1007/s00484-009-0214-7; Morin X, 2010, NEW PHYTOL, V186, P900, DOI 10.1111/j.1469-8137.2010.03252.x; Morisette JT, 2009, FRONT ECOL ENVIRON, V7, P253, DOI 10.1890/070217; Neil KL, 2010, J ARID ENVIRON, V74, P440, DOI 10.1016/j.jaridenv.2009.10.010; Neter J., 1996, APPL LINEAR STAT MOD; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pau S, 2011, GLOBAL CHANGE BIOL, V17, P3633, DOI 10.1111/j.1365-2486.2011.02515.x; PICKETT S T A, 1989, P110; Polgar CA, 2011, NEW PHYTOL, V191, P926, DOI 10.1111/j.1469-8137.2011.03803.x; Post ES, 2008, ECOLOGY, V89, P363, DOI 10.1890/06-2138.1; Primack RB, 2009, BIOL CONSERV, V142, P2569, DOI 10.1016/j.biocon.2009.06.003; Roberts AMI, 2008, INT J BIOMETEOROL, V52, P463, DOI 10.1007/s00484-007-0141-4; Rotzer T, 2004, INT J BIOMETEOROL, V48, P109, DOI 10.1007/s00484-003-0191-1; Schaber J, 2002, TREE PHYSIOL, V22, P973, DOI 10.1093/treephys/22.14.973; Schaber J, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P147, DOI 10.1007/978-90-481-3335-2_7; Schleip C, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P229, DOI 10.1007/978-90-481-3335-2_11; Schwartz M.D., 2003, PHENOLOGY INTEGRATIV; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Shustack DP, 2009, BIOL INVASIONS, V11, P1357, DOI 10.1007/s10530-008-9343-x; Sparks TH, 2005, INT J CLIMATOL, V25, P271, DOI 10.1002/joc.1136; Sparks TH, 2000, INT J BIOMETEOROL, V44, P82, DOI 10.1007/s004840000049; Thompson R, 2006, INT J BIOMETEOROL, V50, P312, DOI 10.1007/s00484-005-0017-4; VITOUSEK PM, 1991, COMPARATIVE ANALYSES OF ECOSYSTEMS, P287; Wielgolaski FE, 1999, INT J BIOMETEOROL, V42, P158, DOI 10.1007/s004840050100; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Ziska LH, 2003, J ALLERGY CLIN IMMUN, V111, P290, DOI 10.1067/mai.2003.53	57	18	18	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51260	10.1371/journal.pone.0051260	http://dx.doi.org/10.1371/journal.pone.0051260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236460	Green Published, gold			2022-12-27	WOS:000312064100085
J	Long, GW; Wang, F; Duan, QL; Yang, SL; Chen, FQ; Gong, W; Yang, X; Wang, Y; Chen, C; Wang, DW				Long, Guangwen; Wang, Feng; Duan, Quanlu; Yang, Shenglan; Chen, Fuqiong; Gong, Wei; Yang, Xu; Wang, Yan; Chen, Chen; Wang, Dao Wen			Circulating miR-30a, miR-195 and let-7b Associated with Acute Myocardial Infarction	PLOS ONE			English	Article							DOWN-REGULATION; HEART-FAILURE; MICRORNAS; BIOGENESIS; DISEASE; ANGIOGENESIS; EXPRESSION; BIOMARKERS; APOPTOSIS; PATHWAY	Background: MicroRNAs (miRNAs) play key roles in diverse biological and pathological processes, including the regulation of proliferation, apoptosis, angiogenesis and cellular differentiation. Recently, circulating miRNAs have been reported as potential biomarkers for various pathologic conditions. This study investigated miR-30a, miR-195 and let-7b as potential of biomarker for acute myocardial infarction (AMI). Methods and Results: Plasma samples from 18 patients with AMI and 30 healthy adults were collected. Total RNA was extracted from plasma with TRIzol LS Reagent. MiRNA levels and plasma cardiac troponin I (cTnI) concentrations were measured by quantitative real-time PCR and ELISA assay, respectively. Results showed that circulating miR-30a in AMI patients was highly expressed at 4 h, 8 h and 12 h after onset of AMI, and miR-195 was highly expressed at 8 h and 12 h. However, let-7b was lower in AMI patients than in controls throughout the whole time points. Interestingly, in these patients, circulating miR-30a, miR-195 and let-7b all reached their expression peak at 8 h. By the receiver operating characteristic (ROC) curve analyses, these plasma miRNAs were of significant diagnostic value for AMI. The combined ROC analysis revealed the an AUC value of 0.93 with 94% sensitivity and 90% specificity at 8 h after onset, and an AUC value of 0.92 with 90% sensitivity and 90% specificity at 12 h after onset, in discriminating the AMI patients from healthy controls. Conclusions: Our results imply that the plasma concentration of miR-30a, miR-195 and let-7b can be potential indicators for AMI.	[Chen, Chen] Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; Huazhong Univ Sci & Technol, Inst Hypertens, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, C (corresponding author), Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	chenchen@tjh.tjmu.edu.cn	, Chen/R-4321-2019	, Chen/0000-0001-5080-9383	National Natural Science Foundation of China [30770882, 81070236, 31200594]; Ministry of Health of the People's Republic of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health of the People's Republic of China	This work was supported by grant from the National Natural Science Foundation of China (No. 30770882, 81070236 and 31200594) and Key Project of Ministry of Health of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Barringhaus KG, 2009, CIRCULATION, V119, P2217, DOI 10.1161/CIRCULATIONAHA.107.715839; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Condorelli G, 2010, EUR HEART J, V31, P649, DOI 10.1093/eurheartj/ehp573; Cordes KR, 2010, PEDIATR CARDIOL, V31, P349, DOI 10.1007/s00246-010-9639-3; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Fu J, 2012, ENVIRON TOXICOL PHAR, V33, P312, DOI 10.1016/j.etap.2011.12.023; Fukushima Y, 2011, CIRC J, V75, P336, DOI 10.1253/circj.CJ-10-0457; Goren Y, 2012, EUR J HEART FAIL, V14, P147, DOI 10.1093/eurjhf/hfr155; Guo R, 2012, AUTOPHAGY, P8; Ha Tai-You, 2011, Immune Netw, V11, P227, DOI 10.4110/in.2011.11.5.227; He JF, 2011, J BIOCHEM MOL TOXIC, V25, P404, DOI 10.1002/jbt.20396; Kim CW, 2012, NUCLEIC ACIDS RES, V40, P3856, DOI 10.1093/nar/gkr1302; Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morrow David A, 2007, Circulation, V115, pe356; Oglesby IK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-148; Olivieri F., 2012, INT J CARDIOL; Qin SS, 2011, J CARDIOVASC PHARM, V57, P8, DOI 10.1097/FJC.0b013e318203759b; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi B, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-11; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wittmann J, 2010, BBA-REV CANCER, V1806, P200, DOI 10.1016/j.bbcan.2010.07.002; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yang YF, 2011, CIRC RES, V108, P305, DOI 10.1161/CIRCRESAHA.110.228437; Yasui N, 2007, HYPERTENS RES, V30, P185, DOI 10.1291/hypres.30.185; Yu ML, 2011, CIRC J, V75, P703, DOI 10.1253/circj.CJ-10-0393; Zhu HQ, 2011, CARDIOVASC RES, V92, P75, DOI 10.1093/cvr/cvr145	36	106	118	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50926	10.1371/journal.pone.0050926	http://dx.doi.org/10.1371/journal.pone.0050926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236408	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100045
J	Pin, C; Hansen, T; Munoz-Cuevas, M; de Jonge, R; Rosenkrantz, JT; Lofstrom, C; Aarts, H; Olsen, JE				Pin, Carmen; Hansen, Trine; Munoz-Cuevas, Marina; de Jonge, Rob; Rosenkrantz, Jesper T.; Lofstrom, Charlotta; Aarts, Henk; Olsen, John E.			The Transcriptional Heat Shock Response of Salmonella Typhimurium Shows Hysteresis and Heated Cells Show Increased Resistance to Heat and Acid Stress	PLOS ONE			English	Article							ESCHERICHIA-COLI; LISTERIA-MONOCYTOGENES; EXPONENTIAL-GROWTH; OSMOTIC SHIFTS; GENE NETWORKS; SINGLE-CELL; BISTABILITY; PHASE; FOOD; BOUNDARIES	We investigated if the transcriptional response of Salmonella Typhimurium to temperature and acid variations was hysteretic, i.e. whether the transcriptional regulation caused by environmental stimuli showed memory and remained after the stimuli ceased. The transcriptional activity of non-replicating stationary phase cells of S. Typhimurium caused by the exposure to 45 degrees C and to pH 5 for 30 min was monitored by microarray hybridizations at the end of the treatment period as well as immediately and 30 minutes after conditions were set back to their initial values, 25 degrees C and pH 7. One hundred and two out of 120 up-regulated genes during the heat shock remained up-regulated 30 minutes after the temperature was set back to 25 degrees C, while only 86 out of 293 down regulated genes remained down regulated 30 minutes after the heat shock ceased. Thus, the majority of the induced genes exhibited hysteresis, i.e., they remained up-regulated after the environmental stress ceased. At 25 degrees C the transcriptional regulation of genes encoding for heat shock proteins was determined by the previous environment. Gene networks constructed with up-regulated genes were significantly more modular than those of down-regulated genes, implying that down-regulation was significantly less synchronized than up-regulation. The hysteretic transcriptional response to heat shock was accompanied by higher resistance to inactivation at 50 degrees C as well as cross-resistance to inactivation at pH 3; however, growth rates and lag times at 43 degrees C and at pH 4.5 were not affected. The exposure to pH 5 only caused up-regulation of 12 genes and this response was neither hysteretic nor accompanied of increased resistance to inactivation conditions. Cellular memory at the transcriptional level may represent a mechanism of adaptation to the environment and a deterministic source of variability in gene regulation.	[Pin, Carmen; Munoz-Cuevas, Marina] AFRC, Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Hansen, Trine; Lofstrom, Charlotta] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [de Jonge, Rob; Aarts, Henk] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Rosenkrantz, Jesper T.; Olsen, John E.] Univ Copenhagen, Dept Vet Dis Biol, Copenhagen, Denmark	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Quadram Institute; University of East Anglia; Technical University of Denmark; Netherlands National Institute for Public Health & the Environment; University of Copenhagen	Pin, C (corresponding author), AFRC, Inst Food Res, Colney Lane, Norwich NR4 7UA, Norfolk, England.	carmen.pin@bbsrc.ac.uk	Olsen, John Elmerdahl/N-9271-2019; Löfström, Charlotta/F-2217-2011; pin, carmen/C-8959-2014	Löfström, Charlotta/0000-0001-6492-1245; Olsen, John Elmerdahl/0000-0001-6225-6587	European Union [FP6-2006-FOOD-036272]; BBSRC [BBS/E/F/00044406] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044406] Funding Source: researchfish	European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work has been supported by the European Union integrated project BIOTRACER (FP6-2006-FOOD-036272) under the 6th RTD Framework (http://cordis.europa.eu/fp6/dc/index.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ordonez A, 2009, FOODBORNE PATHOG DIS, V6, P1147, DOI 10.1089/fpd.2009.0313; Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; ANDERSON KL, 2009, INT J MICROBIOL; BARANYI J, 1994, INT J FOOD MICROBIOL, V23, P277, DOI 10.1016/0168-1605(94)90157-0; Baranyi J, 2004, J FOOD PROTECT, V67, P1967, DOI 10.4315/0362-028X-67.9.1967; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Belessi CIA, 2011, J FOOD PROTECT, V74, P78, DOI 10.4315/0362-028X.JFP-10-117; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hoorfar J, 2011, INT J FOOD MICROBIOL, V145, pS1, DOI 10.1016/j.ijfoodmicro.2010.04.028; Jovanovic G, 2006, J BIOL CHEM, V281, P21147, DOI 10.1074/jbc.M602323200; Laurent M, 2005, CELL MOL BIOL, V51, P583, DOI 10.1170/T667; Le Marc Y, 2010, APPL ENVIRON MICROB, V76, P6555, DOI 10.1128/AEM.00847-10; MACKEY BM, 1990, J APPL BACTERIOL, V69, P373, DOI 10.1111/j.1365-2672.1990.tb01527.x; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Munoz-Cuevas M, 2010, APPL ENVIRON MICROB, V76, P2908, DOI 10.1128/AEM.02572-09; Ou KL, 2005, J BACTERIOL, V187, P4276, DOI 10.1128/JB.187.12.4276-4285.2005; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Pin C, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-108; Pin C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-455; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rychlik I, 2006, VET MICROBIOL, V112, P1, DOI 10.1016/j.vetmic.2005.10.030; Samelis J, 2003, J APPL MICROBIOL, V95, P563, DOI 10.1046/j.1365-2672.2003.02013.x; SELKOV E, 1975, EUR J BIOCHEM, V59, P151, DOI 10.1111/j.1432-1033.1975.tb02436.x; Shachrai I, 2010, MOL CELL, V38, P758, DOI 10.1016/j.molcel.2010.04.015; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Zhang DL, 2010, INT J FOOD MICROBIOL, V141, P177, DOI 10.1016/j.ijfoodmicro.2010.05.015	32	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51196	10.1371/journal.pone.0051196	http://dx.doi.org/10.1371/journal.pone.0051196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236453	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100081
J	Scheibner, KA; Teaboldt, B; Hauer, MC; Chen, XC; Cherukuri, S; Guo, Y; Kelley, SM; Liu, ZQ; Baer, MR; Heimfeld, S; Civin, CI				Scheibner, Kara A.; Teaboldt, Brianne; Hauer, Mary Claire; Chen, Xiaochun; Cherukuri, Srujana; Guo, Yin; Kelley, Shannon M.; Liu, Zhenqiu; Baer, Maria R.; Heimfeld, Shelly; Civin, Curt I.			MiR-27a Functions as a Tumor Suppressor in Acute Leukemia by Regulating 14-3-3 theta	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; STEM-CELL DIFFERENTIATION; C-MYC; MIR-23A-SIMILAR-TO-27A-SIMILAR-TO-24-2 CLUSTER; MICRORNA EXPRESSION; APOPTOSIS; REPRESSION; MIRNAS; CANCER	MicroRNAs (miRs) play major roles in normal hematopoietic differentiation and hematopoietic malignancies. In this work, we report that miR-27a, and its coordinately expressed cluster (miR-23a similar to miR-27a similar to miR-24-2), was down-regulated in acute leukemia cell lines and primary samples compared to hematopoietic stem-progenitor cells (HSPCs). Decreased miR-23a cluster expression in some acute leukemia cell lines was mediated by c-MYC. Replacement of miR-27a in acute leukemia cell lines inhibited cell growth due, at least in part, to increased cellular apoptosis. We identified a member of the anti-apoptotic 14-3-3 family of proteins, which support cell survival by interacting with and negatively regulating pro-apoptotic proteins such as Bax and Bad, as a target of miR-27a. Specifically, miR-27a regulated 14-3-3 theta at both the mRNA and protein levels. These data indicate that miR-27a contributes a tumor suppressor-like activity in acute leukemia cells via regulation of apoptosis, and that miR-27a and 14-3-3 theta may be potential therapeutic targets.	[Scheibner, Kara A.; Teaboldt, Brianne; Hauer, Mary Claire; Chen, Xiaochun; Cherukuri, Srujana; Guo, Yin; Kelley, Shannon M.; Civin, Curt I.] Univ Maryland, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA; [Scheibner, Kara A.; Chen, Xiaochun; Cherukuri, Srujana; Civin, Curt I.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Liu, Zhenqiu] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Baer, Maria R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Heimfeld, Shelly] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Fred Hutchinson Cancer Center	Scheibner, KA (corresponding author), Univ Maryland, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA.	KScheibner@som.umaryland.edu			National Foundation for Cancer Research; National Institutes of Health [PO1CA70970, RO1DK080750]; Maryland Stem Cell Research Foundation/TEDCO [2007-MSCRFII-0114, 2008-MSCRF-303524, 2010-MSCRFII-0065-00, 2010-MSCRFE-0067-00]; NATIONAL CANCER INSTITUTE [P01CA070970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080750, P30DK056465] Funding Source: NIH RePORTER	National Foundation for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Foundation/TEDCO; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Foundation for Cancer Research, the National Institutes of Health (PO1CA70970 and RO1DK080750) (http://www.nih.gov/) and the Maryland Stem Cell Research Foundation/TEDCO (2007-MSCRFII-0114, 2008-MSCRF-303524, 2010-MSCRFII-0065-00, and 2010-MSCRFE-0067-00) (http://www.mscrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjappala BS, 2009, J IMMUNOL, V182, P1050, DOI 10.4049/jimmunol.182.2.1050; AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Ami O, 2009, P NATL ACAD SCI USA, V106, P238, DOI 10.1073/pnas.0811466106; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhatia S, 2010, MOL CELL BIOCHEM, V340, P97, DOI 10.1007/s11010-010-0406-9; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dick JE, 2005, ANN NY ACAD SCI, V1044, P1, DOI 10.1196/annals.1349.001; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Feng DD, 2011, J CELL MOL MED, V15, P2164, DOI 10.1111/j.1582-4934.2010.01213.x; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Gomez-Curet I, 2006, J PEDIATR SURG, V41, P207, DOI 10.1016/j.jpedsurg.2005.10.025; Han BW, 2011, HUM MOL GENET, V20, P4903, DOI 10.1093/hmg/ddr428; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jordan CT, 2002, LEUKEMIA, V16, P559, DOI 10.1038/sj.leu.2402446; Kong KY, 2010, EXP HEMATOL, V38, P629, DOI 10.1016/j.exphem.2010.04.004; Kong Y, 2008, LEUKEMIA, V22, P1207, DOI 10.1038/leu.2008.83; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuzelova K, 2009, J CELL BIOCHEM, V106, P673, DOI 10.1002/jcb.22061; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Merkel O, 2010, CELL CYCLE, V9, P2764, DOI 10.4161/cc.9.14.12267; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morisot S, 2010, LEUKEMIA, V24, P1859, DOI 10.1038/leu.2010.184; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Sakamaki J, 2011, P NATL ACAD SCI USA, V108, P6085, DOI 10.1073/pnas.1015328108; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Saumet A, 2009, BLOOD, V113, P412, DOI 10.1182/blood-2008-05-158139; Singh R, 2012, J CELL SCI, V125, P1568, DOI 10.1242/jcs.095976; Srivastava N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2861; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Yu XB, 2003, MOL THER, V7, P827, DOI 10.1016/S1525-0016(03)00104-7; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007826; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006849	55	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50895	10.1371/journal.pone.0050895	http://dx.doi.org/10.1371/journal.pone.0050895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236401	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100039
J	Sol, EM; Wagner, SA; Weinert, BT; Kumar, A; Kim, HS; Deng, CX; Choudhary, C				Sol, Eri Maria; Wagner, Sebastian A.; Weinert, Brian T.; Kumar, Amit; Kim, Hyun-Seok; Deng, Chu-Xia; Choudhary, Chunaram			Proteomic Investigations of Lysine Acetylation Identify Diverse Substrates of Mitochondrial Deacetylase Sirt3	PLOS ONE			English	Article							FATTY-ACID OXIDATION; MASS SPECTROMETRY; FRACTIONATION; PHOSPHORYLATION; IDENTIFICATION; METABOLISM; PHYSIOLOGY; EFFICIENT; DISEASE	Lysine acetylation is a posttranslational modification that is dynamically regulated by the activity of acetyltransferases and deacetylases. The human and mouse genomes encode 18 different lysine deacetylases (KDACs) which are key regulators of many cellular processes. Identifying substrates of KDACs and pinpointing the regulated acetylation sites on target proteins may provide important information about the molecular basis of their functions. Here we apply quantitative proteomics to identify endogenous substrates of the mitochondrial deacetylase Sirtuin 3 (Sirt3) by comparing site-specific acetylation in wild-type murine embryonic fibroblasts to Sirt3 knockout cells. We confirm Sirt3-regulated acetylation of several mitochondrial proteins in human cells by comparing acetylation in U2OS cells overexpressing Sirt3 to U2OS cells in which Sirt3 expression was reduced by shRNA. Our data demonstrate that ablation of Sirt3 significantly increases acetylation at dozens of sites on mitochondrial proteins. Substrates of Sirt3 are implicated in various metabolic pathways, including fatty acid metabolism and the tricarboxylic acid cycle. These results imply broader regulatory roles of Sirt3 in the mitochondria by modulating acetylation on diverse substrates. The experimental strategy described here is generic and can be applied to identify endogenous substrates of other lysine deacetylases.	[Sol, Eri Maria; Wagner, Sebastian A.; Weinert, Brian T.; Kumar, Amit; Choudhary, Chunaram] Univ Copenhagen, Dept Prote, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth Sci, Copenhagen, Denmark; [Kim, Hyun-Seok; Deng, Chu-Xia] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD USA; [Kim, Hyun-Seok] Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Coll Nat Sci, Seoul, South Korea	University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Ewha Womans University	Choudhary, C (corresponding author), Univ Copenhagen, Dept Prote, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth Sci, Copenhagen, Denmark.	chuna.choudhary@cpr.ku.dk	deng, chuxia/N-6713-2016; choudhary, chunaram/ABE-6634-2020; Imhof, Axel/O-8905-2018	choudhary, chunaram/0000-0002-9863-433X; Weinert, Brian/0000-0002-1335-9915; Imhof, Axel/0000-0003-2993-8249	European Commission [INFRASTRUCTURES-F7-2010-262067/PRIME-XS]; Lundbeck Foundation [R48-A4649]; Novo Nordisk Foundation; Swedish Research Council [20097387]; Danish Council for Independent Research [FSS: 10-085134]	European Commission(European CommissionEuropean Commission Joint Research Centre); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Research Council(Swedish Research CouncilEuropean Commission); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work is supported in part by the European Commission's 7th Framework Programme grant Proteomics Research Infrastructure Maximising knowledge EXchange and access (XS) (INFRASTRUCTURES-F7-2010-262067/PRIME-XS), and the Lundbeck Foundation (R48-A4649). The Center for Protein Research is funded by a generous grant from the Novo Nordisk Foundation. EMS is supported by a postdoctoral fellowship from Swedish Research Council (20097387). SAW is supported by a postdoctoral grant from Danish Council for Independent Research (FSS: 10-085134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Gnad F, 2010, MOL CELL PROTEOMICS, V9, P2642, DOI 10.1074/mcp.M110.001594; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Horth P, 2006, MOL CELL PROTEOMICS, V5, P1968, DOI 10.1074/mcp.T600037-MCP200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Hubner NC, 2008, PROTEOMICS, V8, P4862, DOI 10.1002/pmic.200800351; Kelstrup C. D, 2012, J PROTEOME RES; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim JY, 2002, ANAL CHEM, V74, P5443, DOI 10.1021/ac0256080; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	51	112	114	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50545	10.1371/journal.pone.0050545	http://dx.doi.org/10.1371/journal.pone.0050545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236377	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100019
J	Sjastad, HN; Grawe, RW; Egeland, J				Sjastad, Hege Nordem; Grawe, Rolf W.; Egeland, Jens			Affective Disorders among Patients with Borderline Personality Disorder	PLOS ONE			English	Article							AXIS-II; BIPOLAR SPECTRUM; AFFECTIVE INSTABILITY; MAJOR DEPRESSION; COMMUNITY SAMPLE; MOOD DISORDERS; CO-MORBIDITY; FOLLOW-UP; COMORBIDITY; PREVALENCE	Background: The high co-occurrence between borderline personality disorder and affective disorders has led many to believe that borderline personality disorder should be considered as part of an affective spectrum. The aim of the present study was to examine whether the prevalence of affective disorders are higher for patients with borderline personality disorder than for patients with other personality disorders. Methods: In a national cross-sectional study of patients receiving mental health treatment in Norway (N = 36 773), we determined whether psychiatric outpatients with borderline personality disorder (N = 1 043) had a higher prevalence of affective disorder in general, and whether they had an increased prevalence of depression, bipolar disorder or dysthymia specifically. They were compared to patients with paranoid, schizoid, dissocial, histrionic, obsessive-compulsive, avoidant, dependent, or unspecified personality disorder, as well as an aggregated group of patients with personality disorders other than the borderline type (N = 2 636). Odds ratios were computed for the borderline personality disorder group comparing it to the mixed sample of other personality disorders. Diagnostic assessments were conducted in routine clinical practice. Results: More subjects with borderline personality disorder suffered from unipolar than bipolar disorders. Nevertheless, borderline personality disorder had a lower rate of depression and dysthymia than several other personality disorder groups, whereas the rate of bipolar disorder tended to be higher. Odds ratios showed 34% lower risk for unipolar depression, 70% lower risk for dysthymia and 66% higher risk for bipolar disorder in patients with borderline personality disorder compared to the aggregated group of other personality disorders. Conclusions: The results suggest that borderline personality disorder has a stronger association with affective disorders in the bipolar spectrum than disorders in the unipolar spectrum. This association may reflect an etiological relationship or diagnostic overlapping criteria. Citation: Sjastad HN, Grawe RW, Egeland J (2012) Affective Disorders among Patients with Borderline Personality Disorder. PLoS ONE 7(12): e50930. doi:10.1371/journal.pone.0050930	[Sjastad, Hege Nordem; Egeland, Jens] Vestfold Hosp Trust, Div Mental Hlth & Addict, Tonsberg, Norway; [Grawe, Rolf W.] Alcohol & Drug Treatment Hlth Trust Cent Norway, Dept Res & Dev, Trondheim, Norway		Sjastad, HN (corresponding author), Vestfold Hosp Trust, Div Mental Hlth & Addict, Tonsberg, Norway.	hege.nordem.sjastad@siv.no			Vestfold Mental Health Care Trust	Vestfold Mental Health Care Trust	Vestfold Mental Health Care Trust has supported the work with a research grant for the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiskal HS, 2004, ACTA PSYCHIAT SCAND, V110, P401, DOI 10.1111/j.1600-0447.2004.00461.x; Baumeister H, 2007, SOC PSYCH PSYCH EPID, V42, P537, DOI 10.1007/s00127-007-0204-1; Benazzi F, 2006, PROG NEURO-PSYCHOPH, V30, P68, DOI 10.1016/j.pnpbp.2005.06.010; BENJAMIN LS, 1994, J ABNORM PSYCHOL, V103, P610, DOI 10.1037/0021-843X.103.4.610; Brieger P, 2003, COMPR PSYCHIAT, V44, P28, DOI 10.1053/comp.2003.50009; Coulston CM, 2012, AUST NZ J PSYCHIAT, V46, P506, DOI 10.1177/0004867412445528; Deltito J, 2001, J AFFECT DISORDERS, V67, P221, DOI 10.1016/S0165-0327(01)00436-0; Devanand DP, 2000, AM J GERIAT PSYCHIAT, V8, P188, DOI 10.1176/appi.ajgp.8.3.188; FABREGA H, 1993, HOSP COMMUNITY PSYCH, V44, P159; Fava M, 1996, AM J PSYCHIAT, V153, P1308; Foti ME, 2011, PSYCHIAT QUART, V82, P95, DOI 10.1007/s11126-010-9154-y; FYER MR, 1988, ARCH GEN PSYCHIAT, V45, P348; Gunderson JG, 2004, J CLIN PSYCHIAT, V65, P1049; GUNDERSON JG, 1991, AM J PSYCHIAT, V148, P967; Gunderson JG, 2011, ARCH GEN PSYCHIAT, V68, P827, DOI 10.1001/archgenpsychiatry.2011.37; Gunderson JG, 2009, AM J PSYCHIAT, V166, P530, DOI 10.1176/appi.ajp.2009.08121825; Henry C, 2001, J PSYCHIATR RES, V35, P307, DOI 10.1016/S0022-3956(01)00038-3; HIRSCHFELD RMA, 1982, ARCH GEN PSYCHIAT, V39, P35; Janzing JGE, 2009, SOC PSYCH PSYCH EPID, V44, P1067, DOI 10.1007/s00127-009-0026-4; KERNBERG O, 1967, J AM PSYCHOANAL ASS, V15, P641, DOI 10.1177/000306516701500309; Koenigsberg HW, 2010, J PERS DISORD, V24, P60, DOI 10.1521/pedi.2010.24.1.60; Lewis M, 2009, EUR PSYCHIAT, V24, P464, DOI 10.1016/j.eurpsy.2009.03.004; Lilleng S, 2009, 309 SINTEF TECHN SOC; McGlashan TH, 2000, ACTA PSYCHIAT SCAND, V102, P256, DOI 10.1034/j.1600-0447.2000.102004256.x; OLDHAM JM, 1995, AM J PSYCHIAT, V152, P571; OLDHAM JM, 1991, HOSP COMMUNITY PSYCH, V42, P481; Paris J, 2005, CAN J PSYCHIAT, V50, P435, DOI 10.1177/070674370505000802; Paris J, 2012, AM J PSYCHIAT, V169, P445, DOI 10.1176/appi.ajp.2012.12010092; Paris J, 2010, J PERS DISORD, V24, P3, DOI 10.1521/pedi.2010.24.1.3; Paris Joel, 2007, Psychiatry (Edgmont), V4, P35; PEPPER CM, 1995, AM J PSYCHIAT, V152, P239; PERRY JC, 1988, J PERSONALITY DISORD, V2, P49, DOI DOI 10.1521/PEDI.1988.2.1.49; ROGERS JH, 1995, AM J PSYCHIAT, V152, P268; Samuels J, 2002, BRIT J PSYCHIAT, V180, P536, DOI 10.1192/bjp.180.6.536; Shea MT, 2004, J ABNORM PSYCHOL, V113, P499, DOI 10.1037/0021-843X.113.4.499; Silk KR, 2010, J PERS DISORD, V24, P25, DOI 10.1521/pedi.2010.24.1.25; Torgersen S, 2001, ARCH GEN PSYCHIAT, V58, P590, DOI 10.1001/archpsyc.58.6.590; Tyrer P, 2009, PERSONAL MENT HEALTH, V3, P86, DOI 10.1002/pmh.78; Westen D, 1997, AM J PSYCHIAT, V154, P895; Wilson ST, 2007, J CLIN PSYCHIAT, V68, P1533, DOI 10.4088/JCP.v68n1010; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Zanarini MC, 2012, AM J PSYCHIAT, V169, P476, DOI 10.1176/appi.ajp.2011.11101550; Zanarini MC, 2004, AM J PSYCHIAT, V161, P2108, DOI 10.1176/appi.ajp.161.11.2108; ZIMMERMAN M, 1989, ARCH GEN PSYCHIAT, V46, P682	44	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50930	10.1371/journal.pone.0050930	http://dx.doi.org/10.1371/journal.pone.0050930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057UO	23236411	Green Published, Green Submitted, gold			2022-12-27	WOS:000312589700023
J	Strand, LB; Laugsand, LE; Skaug, EA; Ellingsen, O; Madssen, E; Wisloff, U; Vatten, L; Janszky, I				Strand, Linn B.; Laugsand, Lars E.; Skaug, Eli-Anne; Ellingsen, Oyvind; Madssen, Erik; Wisloff, Ulrik; Vatten, Lars; Janszky, Imre			Insomnia and Endothelial Function - The HUNT 3 Fitness Study	PLOS ONE			English	Article							SHORT-SLEEP DURATION; ACUTE MYOCARDIAL-INFARCTION; FLOW-MEDIATED DILATION; BRACHIAL-ARTERY; HOSPITAL ANXIETY; RISK; DYSFUNCTION; DEPRESSION; DEPRIVATION; DISTURBANCE	Background: Insomnia is associated with increased risk of coronary heart disease (CHD), but the underlying mechanisms are not understood. To our knowledge, no previous studies have examined insomnia in relation to endothelial function, an indicator of preclinical atherosclerosis. Our aim was to assess the association of insomnia with endothelial function in a large population based study of healthy individuals. Methods: A total of 4 739 participants free from known cardiovascular or pulmonary diseases, cancer, and sarcoidosis, and who were not using antihypertensive medication were included in the study. They reported how often they had experienced difficulties falling asleep at night, repeated awakenings during the night, early awakenings without being able to go back to sleep, and daytime sleepiness. Endothelial function was measured by flow mediated dilation (FMD) derived from the brachial artery. Results: We found no consistent association between the insomnia symptoms and endothelial function in multiadjusted models, but individual insomnia symptoms may be related to endothelial function. Among women who reported early awakenings, endothelial function may be lower than in women without this symptom (p = 0.03). Conclusions: This study provided no evidence that endothelial function, an early indicator of atherosclerosis, is an important linking factor between insomnia and CHD. Further studies are needed to explore the complex interrelation between sleep and cardiovascular pathology. Citation: Strand LB, Laugsand LE, Skaug E-A, Ellingsen O, Madssen E, et al. (2012) Insomnia and Endothelial Function - The HUNT 3 Fitness Study. PLoS ONE 7(12): e50933. doi:10.1371/journal.pone.0050933	[Strand, Linn B.; Laugsand, Lars E.; Vatten, Lars; Janszky, Imre] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Skaug, Eli-Anne; Ellingsen, Oyvind; Madssen, Erik; Wisloff, Ulrik] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway; [Janszky, Imre] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Ellingsen, Oyvind; Madssen, Erik] St Olavs Hosp, Dept Cardiol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Karolinska Institutet; Norwegian University of Science & Technology (NTNU)	Strand, LB (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.	linn.b.strand@ntnu.no	Wisloff, Ulrik/K-2899-2012; Vatten, Lars/AFK-2073-2022; Vatten, Lars/AAF-9380-2022	Wisloff, Ulrik/0000-0002-7211-3587; Skaug, Eli-Anne/0000-0001-8472-3916	Liaison Committee between the Central Norway Regional Health Authority; Norwegian University of Science and Technology; Swedish Research Council; Swedish Council of Working Life and Social Research; Norwegian Council on Cardiovascular Disease; Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated; Norwegian Research Council Grant for Outstanding Young Investigators; K.G. Jebsen Foundation; Norwegian Council of Cardiovascular Disease	Liaison Committee between the Central Norway Regional Health Authority; Norwegian University of Science and Technology; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council of Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Norwegian Council on Cardiovascular Disease; Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated; Norwegian Research Council Grant for Outstanding Young Investigators; K.G. Jebsen Foundation; Norwegian Council of Cardiovascular Disease	This work was supported by the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (LBS, IJ, LEL), the Swedish Research Council and by the Swedish Council of Working Life and Social Research (IJ). FMD-data was collected in the Fitness - study and this work was supported by grants from the Norwegian Council on Cardiovascular Disease, the Foundation for Cardiovascular Research at St. Olav's Hospital; the Norwegian State Railways; and Roche Norway Incorporated, and a Norwegian Research Council Grant for Outstanding Young Investigators (UW) and the K.G. Jebsen Foundation, Norwegian Council of Cardiovascular Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Amir O, 2004, AM J CARDIOL, V93, P947, DOI 10.1016/j.amjcard.2003.12.032; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; Behrendt D, 2002, AM J CARDIOL, V90, p40L, DOI 10.1016/S0002-9149(02)02963-6; BENOIT O, 1981, CHRONOBIOLOGIA, V8, P341; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Carney CE, 2010, SER ANXIETY RELAT DI, P1, DOI 10.1007/978-1-4419-1434-7; Chandola T, 2010, SLEEP, V33, P739, DOI 10.1093/sleep/33.6.739; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Drexler H, 1997, PROG CARDIOVASC DIS, V39, P287, DOI 10.1016/S0033-0620(97)80030-8; Egashira K, 2002, CIRC J, V66, P529, DOI 10.1253/circj.66.529; Elwood P, 2006, J EPIDEMIOL COMMUN H, V60, P69, DOI 10.1136/jech.2005.039057; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Hattori M, 2001, J Hum Ergol (Tokyo), V30, P321; Irwin MR, 2008, BIOL PSYCHIAT, V64, P538, DOI 10.1016/j.biopsych.2008.05.004; Janszky I, 2010, EUR J EPIDEMIOL, V25, P361, DOI 10.1007/s10654-010-9462-4; Janszky I, 2010, J AM COLL CARDIOL, V56, P31, DOI 10.1016/j.jacc.2010.03.033; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; Kuvin JT, 2001, J AM COLL CARDIOL, V38, P1843, DOI 10.1016/S0735-1097(01)01657-6; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Littner M, 2003, SLEEP, V26, P754, DOI 10.1093/sleep/26.6.754; Liu Y, 2002, OCCUP ENVIRON MED, V59, P447, DOI 10.1136/oem.59.7.447; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Miller MA, 2010, ARTERIOSCL THROM VAS, V30, P2032, DOI 10.1161/ATVBAHA.110.206987; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Peretz Alon, 2007, BMC Cardiovasc Disord, V7, P11, DOI 10.1186/1471-2261-7-11; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Sauvet F, 2010, J APPL PHYSIOL, V108, P68, DOI 10.1152/japplphysiol.00851.2009; Schillaci G, 2001, AM J CARDIOL, V87, P1323, DOI 10.1016/S0002-9149(01)01535-1; Skaug E-A, 2012, EUROPEAN J PREVENTIV; Spiegelhalder K, 2010, NAT SCI SLEEP, V2, P71; Takase B, 2004, CLIN CARDIOL, V27, P223, DOI 10.1002/clc.4960270411; Taylor DJ, 2008, SLEEP, V31, P447, DOI 10.1093/sleep/31.4.447; TOFLER GH, 1987, NEW ENGL J MED, V316, P1514, DOI 10.1056/NEJM198706113162405; Van Dongen HPA, 2005, SLEEP, V28, P479, DOI 10.1093/sleep/28.4.479; Vgontzas AN, 2009, SLEEP, V32, P491, DOI 10.1093/sleep/32.4.491; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Weil BR, 2010, CAN J PHYSIOL PHARM, V88, P777, DOI 10.1139/Y10-046; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276; ZEIHER AM, 1991, CIRCULATION, V83, P391, DOI 10.1161/01.CIR.83.2.391; Zigmond A. S., 1994, HADS HOSP ANXIETY DE	46	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e50933	10.1371/journal.pone.0050933	http://dx.doi.org/10.1371/journal.pone.0050933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236412	Green Published, gold			2022-12-27	WOS:000312589700024
J	Heise, CE; Murray, J; Augustyn, KE; Bravo, B; Chugha, P; Cohen, F; Giannetti, AM; Gibbons, P; Hannoush, RN; Hearn, BR; Jaishankar, P; Ly, CQ; Shah, K; Stanger, K; Steffek, M; Tang, YY; Zhao, XR; Lewcock, JW; Renslo, AR; Flygare, J; Arkin, MR				Heise, Christopher E.; Murray, Jeremy; Augustyn, Katherine E.; Bravo, Brandon; Chugha, Preeti; Cohen, Frederick; Giannetti, Anthony M.; Gibbons, Paul; Hannoush, Rami N.; Hearn, Brian R.; Jaishankar, Priyadarshini; Ly, Cuong Q.; Shah, Kinjalkumar; Stanger, Karen; Steffek, Micah; Tang, Yinyan; Zhao, Xianrui; Lewcock, Joseph W.; Renslo, Adam R.; Flygare, John; Arkin, Michelle R.			Mechanistic and Structural Understanding of Uncompetitive Inhibitors of Caspase-6	PLOS ONE			English	Article							SUBSTRATE RECOGNITION; PROTEOLYTIC CLEAVAGE; ALLOSTERIC SITE; ACTIVATION; PROTEIN; IDENTIFICATION; BINDING; DEHYDROGENASE; RESVERATROL; SPECIFICITY	Inhibition of caspase-6 is a potential therapeutic strategy for some neurodegenerative diseases, but it has been difficult to develop selective inhibitors against caspases. We report the discovery and characterization of a potent inhibitor of caspase-6 that acts by an uncompetitive binding mode that is an unprecedented mechanism of inhibition against this target class. Biochemical assays demonstrate that, while exquisitely selective for caspase-6 over caspase-3 and -7, the compound's inhibitory activity is also dependent on the amino acid sequence and P1' character of the peptide substrate. The crystal structure of the ternary complex of caspase-6, substrate-mimetic and an 11 nM inhibitor reveals the molecular basis of inhibition. The general strategy to develop uncompetitive inhibitors together with the unique mechanism described herein provides a rationale for engineering caspase selectivity.	[Heise, Christopher E.; Bravo, Brandon; Giannetti, Anthony M.; Shah, Kinjalkumar] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Murray, Jeremy; Steffek, Micah] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Augustyn, Katherine E.; Chugha, Preeti; Hearn, Brian R.; Jaishankar, Priyadarshini; Tang, Yinyan; Renslo, Adam R.; Arkin, Michelle R.] Univ Calif San Francisco, Small Mol Discovery Ctr, San Francisco, CA 94143 USA; [Cohen, Frederick; Gibbons, Paul; Ly, Cuong Q.; Zhao, Xianrui; Flygare, John] Genentech Inc, Dept Discovery Chem, San Francisco, CA 94080 USA; [Hannoush, Rami N.; Stanger, Karen] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Lewcock, Joseph W.] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; University of California System; University of California San Francisco; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Heise, CE (corresponding author), Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA.	heise.christopher@gene.com; michelle.arkin@ucsf.edu	arkin, michelle/AAN-4298-2021; Arkin, Michelle/AAO-2009-2021	arkin, michelle/0000-0002-9366-6770; Renslo, Adam/0000-0002-1240-2846; Hearn, Brian/0000-0002-2078-5728				Abad-Zapatero C, 2005, DRUG DISCOV TODAY, V10, P464, DOI 10.1016/S1359-6446(05)03386-6; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Giannetti AM, 2011, METHOD ENZYMOL, V493, P169, DOI 10.1016/B978-0-12-381274-2.00008-X; Graham RK, 2011, TRENDS NEUROSCI; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Groebe DR, 2009, DRUG DISCOV TODAY, V14, P41, DOI 10.1016/j.drudis.2008.09.011; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; HEDSTROM L, 1990, BIOCHEMISTRY-US, V29, P849, DOI 10.1021/bi00456a001; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Leyva MJ, 2010, CHEM BIOL, V17, P1189, DOI 10.1016/j.chembiol.2010.08.014; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Mintzer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030376; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Panigrahi SK, 2007, PROTEINS, V67, P128, DOI 10.1002/prot.21253; Pereira NA, 2008, BIOCHEM BIOPH RES CO, V377, P873, DOI 10.1016/j.bbrc.2008.10.101; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Schmidt MF, 2009, ANGEW CHEM INT EDIT, V48, P6346, DOI 10.1002/anie.200901647; Schneck JL, 2008, BIOCHEMISTRY-US, V47, P8697, DOI 10.1021/bi8007627; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Sintchak MD, 1996, CELL, V85, P921, DOI 10.1016/S0092-8674(00)81275-1; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Tang YY, 2011, J BIOL CHEM, V286, P34147, DOI 10.1074/jbc.M111.247627; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; VanScyoc WS, 2008, BIOCHEMISTRY-US, V47, P5017, DOI 10.1021/bi701811x; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141	40	31	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50864	10.1371/journal.pone.0050864	http://dx.doi.org/10.1371/journal.pone.0050864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227217	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200078
J	Kundu, D; Kumar, AMV; Satyanarayana, S; Dewan, PK; Nair, SA; Khaparde, K; Nayak, P; Van den Bergh, R; Manzi, M; Enarson, DA; Deshpande, MR; Chandraker, S				Kundu, Debashish; Kumar, Ajay M. V.; Satyanarayana, Srinath; Dewan, Puneet Kumar; Nair, Sreenivas Achuthan; Khaparde, Kshitij; Nayak, Priyakanta; Van den Bergh, Rafael; Manzi, Marcel; Enarson, Donald A.; Deshpande, Madhav Rao; Chandraker, Sachin			Can Follow-Up Examination of Tuberculosis Patients Be Simplified? A Study in Chhattisgarh, India	PLOS ONE			English	Article								Background: Each follow-up during the course of tuberculosis treatment currently requires two sputum examinations. However, the incremental yield of the second sputum sample during follow-up of different types of tuberculosis patients has never been determined precisely. Objectives: To assess the incremental yield of the second sputum sample in the follow-up of tuberculosis patients under the Revised National Tuberculosis Control Programme (RNTCP) in Chhattisgarh, India. Methodology: A record review of tuberculosis (TB) patients registered in 2009 using a structured proforma from two sources, Tuberculosis and Laboratory Register, was undertaken in the six districts of Chhattisgarh, India. Results: In smear positive cases, of 10,048 follow-up examinations, 45 (0.5%) were found to be smear positive only on the second sputum when the result of the first sample was negative. In smear negative pulmonary and extra pulmonary TB patients, of 6,206 follow-up smear examinations, 11(0.2%) were found to be smear positive. Conclusions: The incremental yield of a second smear examination was very low, indicating that examination of one sputum sample is enough during follow-up among TB patients. There is insufficient yield to support sputum smear microscopy for monitoring smear negative pulmonary TB and extra pulmonary TB patients. These results indicate that the follow-up smear microscopy can be substantially simplified with favourable resource implications.	[Kundu, Debashish; Dewan, Puneet Kumar; Nair, Sreenivas Achuthan; Khaparde, Kshitij; Nayak, Priyakanta] WHO Country Off, Off World Hlth Org WHO Representat India, New Delhi, India; [Kumar, Ajay M. V.; Satyanarayana, Srinath; Enarson, Donald A.] South East Asia Off, Int Union TB & Lung Dis Union, New Delhi, India; [Kumar, Ajay M. V.; Satyanarayana, Srinath; Enarson, Donald A.] South East Asia Off, Int Union TB & Lung Dis Union, Paris, France; [Van den Bergh, Rafael; Manzi, Marcel] OCB, Luxembourg, Luxembourg; [Deshpande, Madhav Rao] Directorate Hlth Serv, Raipur, Chhattisgarh, India; [Chandraker, Sachin] Intermediate Reference Lab, Raipur, Chhattisgarh, India	World Health Organization	Kundu, D (corresponding author), WHO Country Off, Off World Hlth Org WHO Representat India, New Delhi, India.	debashishkundu@yahoo.com		Nair, Sreenivas/0000-0002-2586-6797; Van den Bergh, Rafael/0000-0001-6277-8713; Satyanarayana, Srinath/0000-0002-5420-2551	Department for International Development, United Kingdom; Operational Research Unit, Medecins Sans Frontieres, Brussels-Luxembourg	Department for International Development, United Kingdom; Operational Research Unit, Medecins Sans Frontieres, Brussels-Luxembourg	This research was supported through an operational research course, which was jointly developed and run by the Center for Operational Research, International Union Against Tuberculosis and Lung Disease, France, and the Operational Research Unit, Medecins Sans Frontieres, Brussels-Luxembourg. Funding for the course was from an anonymous donor and the Department for International Development, United Kingdom. Additional support for running the course was provided by the Center for International Health, University of Bergen, Norway. This study itself was not funded. However, the publication fee is being funded by the Operational Research Unit, Medecins Sans Frontieres, Brussels-Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central TB Division, 2011, MAN RNTCP YOUR AR TR; Nataraj Gita, 2011, Indian J Tuberc, V58, P60; Shivakumar M, 2006, INT J TUBERC LUNG D, V10, P1296; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1	4	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51038	10.1371/journal.pone.0051038	http://dx.doi.org/10.1371/journal.pone.0051038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201YT	23227230	gold, Green Published, Green Submitted			2022-12-27	WOS:000323179700002
J	Liu, P; Xia, JH; Lin, G; Sun, F; Liu, F; Lim, HS; Pang, HY; Yue, GH				Liu, Peng; Xia, Jun Hong; Lin, Grace; Sun, Fei; Liu, Feng; Lim, Huan Sein; Pang, Hong Yan; Yue, Gen Hua			Molecular Parentage Analysis Is Essential in Breeding Asian Seabass	PLOS ONE			English	Article							BARRAMUNDI LATES-CALCARIFER; GROWTH-RELATED TRAITS; LINKAGE MAP; MICROSATELLITE MARKERS; SPERM COMPETITION; DNA MARKER; HERITABILITY; AQUACULTURE; GENETICS; PROGRAM	In aquaculture species, maintaining pedigree information and genetic variation in each generation is essential, but very difficult. In this study, we used nine microsatellites to genotype 2,520 offspring from four independent full-factorial crosses (10 males x 10 females) of Asian seabass to reconstruct pedigree and monitor the change of genetic variations. In all four crosses, over 96.8% of the offspring could be assigned to their parents, indicating the high power of the nine microsatellites for parentage assignment. This study revealed several interesting results: (1). In all four crosses, the contribution of parents to offspring was significantly uneven, and some dominant breeding fishes (i.e. brooders) were found; (2). In two mass crosses where the brooders were carefully checked for reproductive status, a majority (>= 90%) of brooders contributed to offspring, whereas in another two crosses, where the brooders were randomly picked without checking reproductive status, only a few brooders (40.0-45.0%) produced offspring; (3). Females had more problems in successful spawning compared to males; and (4). In the two crosses where a few brooders produced offspring, there was a substantial loss in allelic (24.1-34.3%) and gene (20.5-25.7%) diversities in offspring, while in the other two crosses, the majority of allelic (96.8-97.0%) and gene diversities (94.8-97.1%) were maintained. These observations suggest that a routine molecular parentage analysis is required to maintain both allelic and gene diversity in breeding Asian seabass.	[Liu, Peng; Xia, Jun Hong; Lin, Grace; Sun, Fei; Liu, Feng; Pang, Hong Yan; Yue, Gen Hua] Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, Singapore 117548, Singapore; [Lim, Huan Sein] Agri Food & Vet Author Singapore, Marine Aquaculture Ctr, Singapore, Singapore	National University of Singapore	Yue, GH (corresponding author), Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, Singapore 117548, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015	Yue, GH/0000-0002-3537-2248	AVA, Singapore	AVA, Singapore	This study is part of the project "To ensure self-sufficiency of safe seafood for Singapore through the development of aquaculture genomic tools for marker-assisted selective breeding of tropical marine foodfish'' funded by AVA, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Duchesne P, 2002, MOL ECOL NOTES, V2, P191, DOI 10.1046/j.1471-8286.2002.00164.x; *FAO, 2008, FOOD AGR ORG UN STAT; Frost LA, 2006, AQUACULTURE, V261, P1056, DOI 10.1016/j.aquaculture.2006.09.004; GARCIA LMB, 1990, AQUACULTURE, V86, P333, DOI 10.1016/0044-8486(90)90124-6; Gjedrem T, 2009, REV-METHODS TECHNOL, V10, P1, DOI 10.1007/978-90-481-2773-3_1; Gjedrem T, 2010, REV AQUACULT, V2, P2, DOI 10.1111/j.1753-5131.2010.01011.x; Hara M, 2003, AQUACULTURE, V217, P107, DOI 10.1016/S0044-8486(02)00069-8; Herbinger CM, 1995, AQUACULTURE, V137, P245, DOI 10.1016/0044-8486(95)01109-9; Jerry DR, 2006, AQUACULTURE, V254, P171, DOI 10.1016/j.aquaculture.2005.10.035; Jerry DR, 2004, AQUACULTURE, V235, P237, DOI 10.1016/j.aquaculture.2004.01.019; Lewis PO, 2000, GENETIC DATA ANAL; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Norris AT, 2000, AQUACULTURE, V182, P73, DOI 10.1016/S0044-8486(99)00247-1; PALMER PJ, 1993, REPROD FERT DEVELOP, V5, P285, DOI 10.1071/RD9930285; Parker GA, 1996, P ROY SOC B-BIOL SCI, V263, P1291, DOI 10.1098/rspb.1996.0189; Schuster SC, 2008, NATURE, V5, P15; Taborsky M, 1998, TRENDS ECOL EVOL, V13, P222, DOI 10.1016/S0169-5347(97)01318-9; Vandeputte M, 2004, AQUACULTURE, V235, P223, DOI 10.1016/j.aquaculture.2003.12.019; Wang CM, 2008, ANIM GENET, V39, P34, DOI 10.1111/j.1365-2052.2007.01672.x; Wang CM, 2008, AQUAC RES, V39, P1612, DOI 10.1111/j.1365-2109.2008.02034.x; Wang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-274; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; Wang CM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-174; Wang CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-139; Xia JH, 2011, DNA RES, V18, P513, DOI 10.1093/dnares/dsr036; Xia JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011974; Xu YX, 2006, ANIM GENET, V37, P266, DOI 10.1111/j.1365-2052.2006.01423.x; Yue GH, 2009, AQUACULTURE, V293, P22, DOI 10.1016/j.aquaculture.2009.03.053; Yue GH, 2005, ELECTROPHORESIS, V26, P3081, DOI 10.1002/elps.200410411; Yue GH, 2002, MAR BIOTECHNOL, V4, P503, DOI 10.1007/s10126-002-0037-6; Zhu ZY, 2010, ANIM GENET, V41, P208, DOI 10.1111/j.1365-2052.2009.01973.x; Zhu ZY, 2006, AQUACULTURE, V256, P167, DOI 10.1016/j.aquaculture.2006.02.033	34	22	22	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51142	10.1371/journal.pone.0051142	http://dx.doi.org/10.1371/journal.pone.0051142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227245	Green Submitted, gold, Green Published			2022-12-27	WOS:000312588200104
J	Mologni, L; Brussolo, S; Ceccon, M; Gambacorti-Passerini, C				Mologni, Luca; Brussolo, Stefania; Ceccon, Monica; Gambacorti-Passerini, Carlo			Synergistic Effects of Combined Wnt/KRAS Inhibition in Colorectal Cancer Cells	PLOS ONE			English	Article							PANCREATIC TUMOR-GROWTH; BETA-CATENIN; K-RAS; COLON-CANCER; PYRVINIUM PAMOATE; CARCINOMA-CELLS; IN-VITRO; FARNESYLTHIOSALICYLIC ACID; PROMOTES APOPTOSIS; THYROID CARCINOMAS	Activation of Wnt signalling due to inability to degrade beta-catenin is found in >85% of colorectal cancers. Approximately half of colon cancers express a constitutively active KRAS protein. A significant fraction of patients show both abnormalities. We previously reported that simultaneous down-regulation of both beta-catenin and KRAS was necessary to induce significant cell death and tumor growth inhibition of colorectal cancer cells. Although attractive, an RNAi-based therapeutic approach is still far from being employed in the clinical setting. Therefore, we sought to recapitulate our previous findings by the use of small-molecule inhibitors of beta-catenin and KRAS. We show here that the beta-catenin inhibitors PKF115-584 and pyrvinium pamoate block beta-catenin-dependent transcriptional activity and synergize with the KRAS inhibitor S-trans, transfarnesylthiosalicylic acid (FTS, salirasib) in colon cancer cells driven by Wnt and KRAS oncogenic signals, but not in cells carrying BRAF mutations. The combined use of these compounds was superior to the use of any drug alone in inducing cell growth arrest, cell death, MYC and survivin down-modulation, and inhibition of anchorage-independent growth. Expression analysis of selected cancer-relevant genes revealed down-regulation of CD44 as a common response to the combined treatments. These data provide a proof of principle for a combination therapeutic strategy in colorectal cancer.	[Mologni, Luca; Ceccon, Monica; Gambacorti-Passerini, Carlo] Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy; [Brussolo, Stefania] Univ Ca Foscari, Dept Environm Sci, Venice, Italy	University of Milano-Bicocca; Universita Ca Foscari Venezia	Mologni, L (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, Monza, Italy.	luca.mologni@unimib.it	Mologni, Luca/AAC-1065-2022	Mologni, Luca/0000-0002-6365-5149; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X	Italian Association for Cancer Research (AIRC), Cariplo Foundation; Italian Ministry of Health and Lombardy Regional Government	Italian Association for Cancer Research (AIRC), Cariplo Foundation(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health and Lombardy Regional Government	This work was supported by the Italian Association for Cancer Research (AIRC), Cariplo Foundation, the Italian Ministry of Health and Lombardy Regional Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist T, 2008, NEOPLASIA, V10, P680, DOI 10.1593/neo.08312; Balmanno K, 2009, INT J CANCER, V125, P2332, DOI 10.1002/ijc.24604; Biankin AV, 2011, HUM GENET, V130, P79, DOI 10.1007/s00439-011-1010-0; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Doghman M, 2008, J CLIN ENDOCR METAB, V93, P3222, DOI 10.1210/jc.2008-0247; Downey AS, 2008, ANTIMICROB AGENTS CH, V52, P3106, DOI 10.1128/AAC.00207-08; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Elad G, 1999, BBA-MOL CELL RES, V1452, P228, DOI 10.1016/S0167-4889(99)00144-5; Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x; FABIEN N, 1992, BRIT J CANCER, V66, P1094, DOI 10.1038/bjc.1992.416; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Frattini M, 2004, CLIN CANCER RES, V10, P4015, DOI 10.1158/1078-0432.CCR-04-0031; Friday BB, 2005, BBA-REV CANCER, V1756, P127, DOI 10.1016/j.bbcan.2005.08.001; Gandhirajan RK, 2010, NEOPLASIA, V12, P326, DOI 10.1593/neo.91972; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; Gerstung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027136; Gorospe M, 1996, MOL CELL BIOL, V16, P6654; Haklai R, 2008, CANCER CHEMOTH PHARM, V61, P89, DOI 10.1007/s00280-007-0451-6; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Kaneko R, 2007, J BIOL CHEM, V282, P19273, DOI 10.1074/jbc.M610350200; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kohler EM, 2009, HUM MOL GENET, V18, P213, DOI 10.1093/hmg/ddn338; Kucherlapati R, 2012, AACR ANN M; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Levy R, 2010, MOL CANCER THER, V9, P2208, DOI 10.1158/1535-7163.MCT-10-0262; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; MARCIANO D, 1995, J MED CHEM, V38, P1267, DOI 10.1021/jm00008a004; Mariadason JM, 2001, CANCER RES, V61, P3465; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Migliardi G, 2012, CLIN CANCER RES, V2012, P12; Misra S, 1944, FEBS J, V278, P1429; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Mologni L, 2010, CANCER RES, V70, P7253, DOI 10.1158/0008-5472.CAN-10-1108; Mologni L, 2009, INT J CANCER, V124, P1990, DOI 10.1002/ijc.24158; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Oxnard GR, 2010, ONCOLOGY-NY, V24, P392; Poluha W, 1996, MOL CELL BIOL, V16, P1335; Rotblat B, 2008, METHOD ENZYMOL, V439, P467, DOI 10.1016/S0076-6879(07)00432-6; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Sarthy AV, 2007, MOL CANCER THER, V6, P269, DOI 10.1158/1535-7163.MCT-06-0560; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smakman N, 2006, CANCER RES, V66, P5403, DOI 10.1158/0008-5472.CAN-05-4108; SMITH TC, 1976, CLIN PHARMACOL THER, V19, P802; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Tan YH, 2008, PATHOLOGY, V40, P295, DOI 10.1080/00313020801911512; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Vasovcak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024114; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Weis B, 1999, ONCOGENE, V18, P2579, DOI 10.1038/sj.onc.1202602; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Yu DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003951; Zhang T, 2001, CANCER RES, V61, P8664; Zundelevich A, 2007, MOL CANCER THER, V6, P1765, DOI 10.1158/1535-7163.MCT-06-0706	63	35	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e51449	10.1371/journal.pone.0051449	http://dx.doi.org/10.1371/journal.pone.0051449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227266	gold, Green Published, Green Submitted			2022-12-27	WOS:000312588200125
J	Andresen, V; Pollok, K; Rinnenthal, JL; Oehme, L; Gunther, R; Spiecker, H; Radbruch, H; Gerhard, J; Sporbert, A; Cseresnyes, Z; Hauser, AE; Niesner, R				Andresen, Volker; Pollok, Karolin; Rinnenthal, Jan-Leo; Oehme, Laura; Guenther, Robert; Spiecker, Heinrich; Radbruch, Helena; Gerhard, Jenny; Sporbert, Anje; Cseresnyes, Zoltan; Hauser, Anja E.; Niesner, Raluca			High-Resolution Intravital Microscopy	PLOS ONE			English	Article							2-PHOTON MICROSCOPY; DEEP TISSUE; CELLS; SINGLE; NANOSCOPY; SYSTEM; LIVE	Cellular communication constitutes a fundamental mechanism of life, for instance by permitting transfer of information through synapses in the nervous system and by leading to activation of cells during the course of immune responses. Monitoring cell-cell interactions within living adult organisms is crucial in order to draw conclusions on their behavior with respect to the fate of cells, tissues and organs. Until now, there is no technology available that enables dynamic imaging deep within the tissue of living adult organisms at sub-cellular resolution, i.e. detection at the level of few protein molecules. Here we present a novel approach called multi-beam striped- illumination which applies for the first time the principle and advantages of structured-illumination, spatial modulation of the excitation pattern, to laser-scanning-microscopy. We use this approach in two-photon-microscopy - the most adequate optical deep-tissue imaging-technique. As compared to standard two-photon-microscopy, it achieves significant contrast enhancement and up to 3-fold improved axial resolution (optical sectioning) while photobleaching, photodamage and acquisition speed are similar. Its imaging depth is comparable to multifocal two-photon-microscopy and only slightly less than in standard single-beam two-photon-microscopy. Precisely, our studies within mouse lymph nodes demonstrated 216% improved axial and 23% improved lateral resolutions at a depth of 80 mm below the surface. Thus, we are for the first time able to visualize the dynamic interactions between B cells and immune complex deposits on follicular dendritic cells within germinal centers (GCs) of live mice. These interactions play a decisive role in the process of clonal selection, leading to affinity maturation of the humoral immune response. This novel high-resolution intravital microscopy method has a huge potential for numerous applications in neurosciences, immunology, cancer research and developmental biology. Moreover, our striped- illumination approach is able to improve the resolution of any laser-scanning-microscope, including confocal microscopes, by simply choosing an appropriate detector. Citation: Andresen V, Pollok K, Rinnenthal J-L, Oehme L, Gunther R, et al. (2012) High-Resolution Intravital Microscopy. PLoS ONE 7(12): e50915. doi:10.1371/journal.pone. 0050915	[Pollok, Karolin; Rinnenthal, Jan-Leo; Oehme, Laura; Guenther, Robert; Radbruch, Helena; Gerhard, Jenny; Hauser, Anja E.; Niesner, Raluca] German Rheumatism Res Ctr, Berlin, Germany; [Andresen, Volker; Spiecker, Heinrich] LaVis Biotec GmbH, Bielefeld, Germany; [Pollok, Karolin; Rinnenthal, Jan-Leo; Radbruch, Helena; Gerhard, Jenny; Niesner, Raluca] Charite, D-13353 Berlin, Germany; [Sporbert, Anje; Cseresnyes, Zoltan] Max Delbruck Ctr Mol Med, Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Niesner, R (corresponding author), German Rheumatism Res Ctr, Berlin, Germany.	niesner@drfz.de	Cseresnyes, Zoltan/AAG-4266-2020	Andresen, Volker/0000-0002-8960-6599; Cseresnyes, Zoltan/0000-0002-6574-2588; Hauser, Anja Erika/0000-0002-7725-9526; Radbruch, Helena/0000-0001-6941-3397	Deutsche Forschungs-gemeinschaft [NI1167/2-1, HA5354/4-1, SFB633, A15]; Charite under grant Rahel-Hirsch Fellowship; MAMOCELL EU FP6	Deutsche Forschungs-gemeinschaft(German Research Foundation (DFG)); Charite under grant Rahel-Hirsch Fellowship; MAMOCELL EU FP6	The authors acknowledge the Deutsche Forschungs-gemeinschaft under grant NI1167/2-1 (to RN), HA5354/4-1 and SFB633, project A15 (to AEH), the Charite under grant Rahel-Hirsch Fellowship (to RN) and MAMOCELL EU FP6 (to AEH) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie SG, 2012, P NATL ACAD SCI USA, V109, P7175, DOI 10.1073/pnas.1121193109; Andresen V, 2001, OPT LETT, V26, P75, DOI 10.1364/OL.26.000075; [Anonymous], [No title captured]; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Berning S, 2012, SCIENCE, V335, P551, DOI 10.1126/science.1215369; Bianchini P, 2012, P NATL ACAD SCI USA, V109, P6390, DOI 10.1073/pnas.1119129109; Caccia M, 2008, EUR BIOPHYS J BIOPHY, V37, P979, DOI 10.1007/s00249-008-0323-y; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Centonze VE, 1998, BIOPHYS J, V75, P2015, DOI 10.1016/S0006-3495(98)77643-X; de Gauw CJ, 1999, APPL OPTICS, V38, P5995; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Ding JB, 2009, NEURON, V63, P429, DOI 10.1016/j.neuron.2009.07.011; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Eisenhoffer GT, 2011, J VIS EXP, V2689; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Hell SW, 2009, NATURE, V461, P1069, DOI 10.1038/4611069a; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Herz J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-131; Herz J, 2010, BIOPHYS J, V98, P715, DOI 10.1016/j.bpj.2009.10.035; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Klein T, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7b; Lu J, 2009, NANO LETT, V9, P3883, DOI 10.1021/nl902087d; Mertz J, 2011, NAT METHODS, V8, P811, DOI 10.1038/nmeth.1709; Moneron G, 2009, OPT EXPRESS, V17, P14567, DOI 10.1364/OE.17.014567; Niesner R, 2007, BIOPHYS J, V93, P2519, DOI 10.1529/biophysj.106.102459; Niesner RA, 2011, CYTOM PART A, V79A, P789, DOI 10.1002/cyto.a.21140; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Speier S, 2008, NAT MED, V14, P574, DOI 10.1038/nm1701; Tang JY, 2012, P NATL ACAD SCI USA, V109, P8434, DOI 10.1073/pnas.1119590109; Wang E, 2005, J MICROSC-OXFORD, V218, P148, DOI 10.1111/j.1365-2818.2005.01473.x; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; York AG, 2012, NAT METHODS, V9, P749, DOI [10.1038/nmeth.2025, 10.1038/NMETH.2025]; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	41	28	28	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2012	7	12							e50915	10.1371/journal.pone.0050915	http://dx.doi.org/10.1371/journal.pone.0050915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AJ	23251402	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000312386800021
J	Graham, J; Nosek, BA; Haidt, J				Graham, Jesse; Nosek, Brian A.; Haidt, Jonathan			The Moral Stereotypes of Liberals and Conservatives: Exaggeration of Differences across the Political Spectrum	PLOS ONE			English	Article							IN-GROUP; MISPERCEPTIONS; CONFLICT; ACCURACY; PARTY	We investigated the moral stereotypes political liberals and conservatives have of themselves and each other. In reality, liberals endorse the individual-focused moral concerns of compassion and fairness more than conservatives do, and conservatives endorse the group-focused moral concerns of ingroup loyalty, respect for authorities and traditions, and physical/spiritual purity more than liberals do. 2,212 U.S. participants filled out the Moral Foundations Questionnaire with their own answers, or as a typical liberal or conservative would answer. Across the political spectrum, moral stereotypes about "typical" liberals and conservatives correctly reflected the direction of actual differences in foundation endorsement but exaggerated the magnitude of these differences. Contrary to common theories of stereotyping, the moral stereotypes were not simple underestimations of the political outgroup's morality. Both liberals and conservatives exaggerated the ideological extremity of moral concerns for the ingroup as well as the outgroup. Liberals were least accurate about both groups.	[Graham, Jesse] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Nosek, Brian A.] Univ Virginia, Psychol Depatment, Charlottesville, VA USA; [Haidt, Jonathan] NYU, Stern Sch Business, New York, NY USA	University of Southern California; University of Virginia; New York University	Graham, J (corresponding author), Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA.	jesse.graham@usc.edu	Haidt, Jonathan/B-2835-2013	Graham, Jesse/0000-0001-8863-7978; Nosek, Brian/0000-0001-6797-5476	Project Implicit	Project Implicit	This work was supported by Project Implicit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport G. W., 1954, NATURE PREJUDICE; Cannon PR, 2011, SOC PSYCHOL PERS SCI, V2, P325, DOI 10.1177/1948550610390525; Carter JD, 2006, J RES PERS, V40, P1103, DOI 10.1016/j.jrp.2005.11.005; Chambers JR, 2006, PERS SOC PSYCHOL B, V32, P1295, DOI 10.1177/0146167206289979; Chambers JR, 2006, PSYCHOL SCI, V17, P38, DOI 10.1111/j.1467-9280.2005.01662.x; Cohen GL, 2003, J PERS SOC PSYCHOL, V85, P808, DOI 10.1037/0022-3514.85.5.808; DAWES RM, 1972, J PERS SOC PSYCHOL, V21, P281, DOI 10.1037/h0032322; Farah J, 2003, WORLD NET DAILY 1120; Feingold M, 2004, VILLAGE VOICE   0121; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Graham Jesse, 2011, SOCIAL PSYCHOL MORAL; Graham JW, 2006, PSYCHOL METHODS, V11, P323, DOI 10.1037/1082-989X.11.4.323; Greenberg J, 2003, PSYCHOL BULL, V129, P376, DOI 10.1037/0033-2909.129.3.376; Greene S, 2004, SOC SCI QUART, V85, P136, DOI 10.1111/j.0038-4941.2004.08501010.x; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Iyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042366; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Judd CM, 2005, ON THE NATURE OF PREJUDICE: FIFTY YEARS AFTER ALLPORT, P123; JUDD CM, 1993, PSYCHOL REV, V100, P109, DOI 10.1037/0033-295X.100.1.109; Jussim L., 2005, INTERACTION STUDIES, V6, P85, DOI [10.1075/is.6.1.07jus, DOI 10.1075/IS.6.1.07JUS]; Krugman Paul, 2007, CONSCIENCE LIBERAL; Leo J, 2002, ETHICS ARE MADE EASY; Lindner NM, 2009, POLIT PSYCHOL, V30, P67, DOI 10.1111/j.1467-9221.2008.00681.x; LINVILLE PW, 1989, J PERS SOC PSYCHOL, V57, P165, DOI 10.1037/0022-3514.57.2.165; McAdams DP, 2008, J PERS SOC PSYCHOL, V95, P978, DOI 10.1037/a0012650; MCCAULEY C, 1978, J PERS SOC PSYCHOL, V36, P929, DOI 10.1037/0022-3514.36.9.929; McCauley CR., 1995, STEREOTYPE ACCURACY, P215, DOI [DOI 10.1037/10495-009, 10.1037/10495-009]; Nosek BA, 2009, SOCIAL PSYCHOL BASES, P480, DOI [10.1093/acprof:oso/9780195320916.003.020, DOI 10.1093/ACPROF:OSO/9780195320916.003.020]; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; ROBINSON RJ, 1995, J PERS SOC PSYCHOL, V68, P404, DOI 10.1037/0022-3514.68.3.404; ROKEACH M, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093727; Ryan C. S., 2002, EUROPEAN REV SOCIAL, V13, P75; Ryan CS, 1996, PERS SOC PSYCHOL B, V22, P1114, DOI 10.1177/01461672962211003; Sibley CG, 2008, PERS SOC PSYCHOL REV, V12, P248, DOI 10.1177/1088868308319226; Smith C, 2009, CHARITABLE GIV UNPUB; Smith CT, 2012, SOC COGNITION, V30, P199, DOI 10.1521/soco.2012.30.2.199; Tajfel H, 1986, PSYCHOL INTERGROUP R; TETLOCK PE, 1984, J PERS SOC PSYCHOL, V46, P365, DOI 10.1037/0022-3514.46.2.365; van Leeuwen F, 2009, PERS INDIV DIFFER, V47, P169, DOI 10.1016/j.paid.2009.02.017	40	101	103	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50092	10.1371/journal.pone.0050092	http://dx.doi.org/10.1371/journal.pone.0050092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251357	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200024
J	Kador, PF; Zhang, P; Makita, J; Zhang, ZF; Guo, CM; Randazzo, J; Kawada, H; Haider, N; Blessing, K				Kador, Peter F.; Zhang, Peng; Makita, Jun; Zhang, Zifeng; Guo, Changmei; Randazzo, James; Kawada, Hiroyoshi; Haider, Neena; Blessing, Karen			Novel Diabetic Mouse Models as Tools for Investigating Diabetic Retinopathy	PLOS ONE			English	Article							GALACTOSE-FED DOGS; ALDOSE REDUCTASE INHIBITOR; ENDOTHELIAL GROWTH-FACTOR; RETINAL VESSEL CHANGES; PIGMENT EPITHELIAL-CELLS; CAPILLARY PERICYTES; AQUEOUS-HUMOR; BARRIER BREAKDOWN; VASCULAR PATTERNS; POLYOL FORMATION	Objective: Mouse models possessing green fluorescent protein (GFP) and/or human aldose reductase (hAR) in vascular tissues have been established and crossed with naturally diabetic Akita mice to produce new diabetic mouse models. Research Design and Methods: Colonies of transgenic C57BL mice expressing GFP (SMAA-GFP), hAR (SMAA-hAR) or both (SMAA-GFP-hAR) in vascular tissues expressing smooth muscle actin were established and crossbred with C57BL/6-Ins2(Akita)/J (AK) mice to produce naturally diabetic offspring AK-SMAA-GFP and AK-SMAA-GFP-hAR. Aldose reductase inhibitor AL1576 (ARI) was administered in chow. Retinal and lenticular sorbitol levels were determined by HPLC. Retinal functions were evaluated by electroretinography (ERGs). Growth factor and signaling changes were determined by Western Blots using commercially available antibodies. Retinal vasculatures were isolated from the neural retina by enzymatic digestion. Flat mounts were stained with PAS-hematoxylin and analyzed. Results: Akita transgenics developed DM by 8 weeks of age with blood glucose levels higher in males than females. Sorbitol levels were higher in neural retinas of AK-SMAA-GFP-hAR compared to AK-SMAA-GFP mice. AK-SMAA-GFP-hAR mice also had higher VEGF levels and reduced ERG scotopic b-wave function, both of which were normalized by AL1576. AK-SMAA-GFP-hAR mice showed induction of the retinal growth factors bFGF, IGF-1, and TGF beta, as well as signaling changes in P-Akt, P-SAPK/JNK and P-44/42 MAPK that were also reduced by ARI treatment. Quantitative analysis of flat mounts in 18 week AK-SMAA-GFP-hAR mice revealed increased loss of nuclei/capillary length and a significant increase in the percentage of acellular capillaries present which was not seen in AK-SMAA-GFP-hAR treated with ARI. Conclusions/Significance: These new mouse models of early onset diabetes may be valuable tools for assessing both the role of hyperglycemia and AR in the development of retinal lesions associated with diabetic retinopathy.	[Kador, Peter F.; Zhang, Peng; Makita, Jun; Zhang, Zifeng; Guo, Changmei; Randazzo, James; Kawada, Hiroyoshi; Blessing, Karen] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE USA; [Kador, Peter F.; Haider, Neena] Univ Nebraska Med Ctr, Coll Med, Dept Ophthalmol, Omaha, NE USA; [Haider, Neena] Univ Nebraska Med Ctr, Coll Med, Dept Genet Cell Biol & Anat, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Kador, PF (corresponding author), Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE USA.	pkador@unmc.edu			National Institutes of Health [EY016730]; NATIONAL EYE INSTITUTE [R01EY016730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grant EY016730. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI Y, 1986, CURR EYE RES, V5, P883, DOI 10.3109/02713688609029241; AKAGI Y, 1984, DIABETES, V33, P562, DOI 10.2337/diabetes.33.6.562; AKAGI Y, 1983, INVEST OPHTH VIS SCI, V24, P1516; Amano S, 2002, BIOCHEM BIOPH RES CO, V299, P183, DOI 10.1016/S0006-291X(02)02584-6; ANTONELLIORLIDGE A, 1989, AM REV RESPIR DIS, V140, P1129, DOI 10.1164/ajrccm/140.4.1129; ANTONELLIORLIDGE A, 1989, P NATL ACAD SCI USA, V86, P4544, DOI 10.1073/pnas.86.12.4544; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Beck SC, 2010, INVEST OPHTH VIS SCI, V51, P493, DOI 10.1167/iovs.09-4003; Betsholtz C, 2005, EXP SUPPL, V94, P115; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai J, 2002, EYE, V16, P242, DOI 10.1038/sj.eye.6700133; CHAN LS, 1986, EXP EYE RES, V43, P41, DOI 10.1016/S0014-4835(86)80044-6; Chen Y, 2009, OCUL SURF, V7, P176, DOI 10.1016/S1542-0124(12)70185-4; Cheung AKH, 2005, DIABETES, V54, P3119, DOI 10.2337/diabetes.54.11.3119; COGAN DG, 1961, ARCH OPHTHALMOL-CHIC, V66, P366, DOI 10.1001/archopht.1961.00960010368014; CUTHBERTSON RA, 1987, TRANSPLANT P, V19, P2919; CUTHBERTSON RA, 1986, INVEST OPHTH VIS SCI, V27, P1659; Deeds MC, 2011, LAB ANIM-UK, V45, P131, DOI 10.1258/la.2010.010090; Dreixler JC, 2011, EXP EYE RES, V93, P340, DOI 10.1016/j.exer.2010.10.011; DRENCKHAHN D, 1977, CELL TISSUE RES, V181, P493; Frank RN, 1997, ARCH OPHTHALMOL-CHIC, V115, P1036, DOI 10.1001/archopht.1997.01100160206011; FRANK RN, 1983, INVEST OPHTH VIS SCI, V24, P1519; Henry DN, 2000, INVEST OPHTH VIS SCI, V41, P1554; Hickman F., 2002, INVEST OPHTH VIS SCI, V43, P742; Ho TC, 2006, APOPTOSIS, V11, P1899, DOI 10.1007/s10495-006-9403-6; HOTTA N, 1995, EXP PHYSIOL, V80, P981, DOI 10.1113/expphysiol.1995.sp003909; Hotta N, 1995, EUR J CLIN INVEST, V25, P948, DOI 10.1111/j.1365-2362.1995.tb01972.x; Iyengar L, 2006, EXP EYE RES, V83, P667, DOI 10.1016/j.exer.2006.03.008; Joussen AM, 2009, MOL VIS, V15, P1418; Kador PF, 2009, J OCUL PHARMACOL TH, V25, P299, DOI 10.1089/jop.2008.0070; KADOR PF, 1988, ARCH OPHTHALMOL-CHIC, V106, P1099, DOI 10.1001/archopht.1988.01060140255036; KADOR PF, 1990, ARCH OPHTHALMOL-CHIC, V108, P1301, DOI 10.1001/archopht.1990.01070110117035; Kador PF, 2002, INVEST OPHTH VIS SCI, V43, P1916; KADOR PF, 1995, ARCH OPHTHALMOL-CHIC, V113, P352, DOI 10.1001/archopht.1995.01100030108031; Kivela T, 1998, PROG RETIN EYE RES, V17, P385, DOI 10.1016/S1350-9462(98)00001-9; KUWABARA T, 1961, ARCH OPHTHALMOL-CHIC, V65, P708, DOI 10.1001/archopht.1961.01840020710019; Mochizuki M, 2000, CORNEA, V19, pS24, DOI 10.1097/00003226-200005001-00006; Murata M, 2002, J DIABETES COMPLICAT, V16, P363, DOI 10.1016/S1056-8727(01)00171-4; Neuenschwander H, 1997, J OCUL PHARMACOL TH, V13, P517, DOI 10.1089/jop.1997.13.517; Nystuen AM, 2008, MAMM GENOME, V19, P623, DOI 10.1007/s00335-008-9138-5; Obrosova IG, 2006, DIABETOLOGIA, V49, P2525, DOI 10.1007/s00125-006-0356-7; Obrosova IG, 2003, DIABETES, V52, P864, DOI 10.2337/diabetes.52.3.864; Ozawa Y, 2011, EXP DIABETES RES, DOI 10.1155/2011/108328; Pfister F, 2008, DIABETES, V57, pA234, DOI 10.2337/db08-0325; ROBINSON WG, 1991, CURR EYE RES, V10, P339, DOI 10.3109/02713689108996340; ROBISON WG, 1983, SCIENCE, V221, P1177, DOI 10.1126/science.6612330; Robison WG, 1995, ROLE ALDOSE REDUCTAS, P593; Robison WG, 2000, GALACTOSEMIC ANIMAL, P273; Sato S, 1999, INVEST OPHTH VIS SCI, V40, P697; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; STAVRI GT, 1995, CIRCULATION, V92, P11, DOI 10.1161/01.CIR.92.1.11; Sun W, 2006, DIABETES, V55, P2757, DOI 10.2337/db06-0138; TAKAHASHI Y, 1993, J OCUL PHARMACOL, V9, P257, DOI 10.1089/jop.1993.9.257; TAKAHASHI Y, 1992, ARCH OPHTHALMOL-CHIC, V110, P1295, DOI 10.1001/archopht.1992.01080210113037; TILTON RG, 1986, INVEST OPHTH VIS SCI, V27, P716; TILTON RG, 1985, INVEST OPHTH VIS SCI, V26, P68; Tsai J, 2002, INVEST OPHTH VIS SCI, V43, P192; Tsai J-Y, 2001, INVEST OPHTH VIS SCI, V42, P2001; Van Geest RJ, 2010, INVEST OPHTH VIS SCI, V51, P1857, DOI 10.1167/iovs.09-4181; VINORES SA, 1993, EXP EYE RES, V57, P723, DOI 10.1006/exer.1993.1180; Wang JW, 1997, J CLIN INVEST, V100, P1425, DOI 10.1172/JCI119663; Welge-Lussen U, 2001, CURR OPIN OPHTHALMOL, V12, P94, DOI 10.1097/00055735-200104000-00003; WILSON GL, 1990, CURR TOP MICROBIOL, V156, P27; YAMAOKA T, 1995, DIABETOLOGIA, V38, P255, DOI 10.1007/s001250050278; Yokota T, 2006, STEM CELLS, V24, P13, DOI 10.1634/stemcells.2004-0346; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zong H, 2010, DIABETOLOGIA, V53, P2656, DOI 10.1007/s00125-010-1900-z	69	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49422	10.1371/journal.pone.0049422	http://dx.doi.org/10.1371/journal.pone.0049422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251343	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200016
J	Pace, E; Di Sano, C; La Grutta, S; Ferraro, M; Albeggiani, G; Liotta, G; Di Vincenzo, S; Uasuf, CG; Bousquet, J; Gjomarkaj, M				Pace, Elisabetta; Di Sano, Caterina; La Grutta, Stefania; Ferraro, Maria; Albeggiani, Giuseppe; Liotta, Giuseppe; Di Vincenzo, Serena; Uasuf, Carina Gabriela; Bousquet, Jean; Gjomarkaj, Mark			Multiple In Vitro and In Vivo Regulatory Effects of Budesonide in CD4+T Lymphocyte Subpopulations of Allergic Asthmatics	PLOS ONE			English	Article							T-CELLS; GLUCOCORTICOID ACTION; APOPTOSIS; ICOS; EXPRESSION; EOSINOPHILS; GENERATION; RESISTANCE; INDUCTION; TOLERANCE	Background: Increased activation and increased survival of T lymphocytes characterise bronchial asthma. Objectives: In this study the effect of budesonide on T cell survival, on inducible co-stimulator T cells (ICOS), on Foxp3 and on IL-10 molecules in T lymphocyte sub-populations was assessed. Methods: Cell survival (by annexin V binding) and ICOS in total lymphocytes, in CD4+/CD25+ and in CD4+/CD25-and Foxp3 and IL-10 in CD4+/CD25+ and in CD4+/CD25-cells was evaluated, by cytofluorimetric analysis, in mild intermittent asthmatics (n = 19) and in controls (n = 15). Allergen induced T lymphocyte proliferation and the in vivo effects of budesonide in mild persistent asthmatics (n = 6) were also explored. Results: Foxp3 was reduced in CD4+/CD25- and in CD4+/CD25+ cells and ICOS was reduced in CD4+/CD25+ cells but it was increased in CD4+ CD25-in asthmatics when compared to controls. In asthmatics, in vitro, budesonide was able to: 1) increase annexin V binding and to reduce ICOS in total lymphocytes; 2) increase annexin V binding and Foxp3 and to reduce ICOS in CD4+/CD25-cells; 3) reduce annexin V binding and to increase IL-10 and ICOS in CD4+/CD25+ cells; 4) reduce cell allergen induced proliferation. In vivo, budesonide increased ICOS in CD4+/CD25+ while it increased Foxp3 and IL-10 in CD4+/CD25+ and in CD4+/CD25- cells. Conclusions: Budesonide modulates T cell survival, ICOS, Foxp3 and IL-10 molecules differently in T lymphocyte sub-populations. The findings provided shed light on new mechanisms by which corticosteroids, drugs widely used for the clinical management of bronchial asthma, control T lymphocyte activation.	[Pace, Elisabetta; Di Sano, Caterina; La Grutta, Stefania; Ferraro, Maria; Albeggiani, Giuseppe; Liotta, Giuseppe; Di Vincenzo, Serena; Uasuf, Carina Gabriela; Gjomarkaj, Mark] CNR, Ist Biomed & Immunol Mol, Unita Immunopatol & Farmacol Clin & Sperimentale, Palermo, Italy; [La Grutta, Stefania] ARPA, Palermo, Italy; [Bousquet, Jean] Univ Hosp, Montpellier, France	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Regional Environmental Protection Agency - Italy; Universite de Montpellier; CHU de Montpellier	Pace, E (corresponding author), CNR, Ist Biomed & Immunol Mol, Unita Immunopatol & Farmacol Clin & Sperimentale, Palermo, Italy.	pace@ibim.cnr.it	DI SANO, CATERINA/AAX-7536-2020; Bousquet, Jean/O-4221-2019; Ferraro, Maria/AAX-8156-2020; Uasuf, Carina Gabriela/AAG-9329-2019; La Grutta, Stefania/N-3615-2014; Pace, Elisabetta/AAL-2537-2020; Di Vincenzo, Serena/Q-7852-2019; Di Vincenzo, Serena/K-3330-2018	Uasuf, Carina Gabriela/0000-0003-4158-8333; La Grutta, Stefania/0000-0001-8026-0715; Pace, Elisabetta/0000-0003-1141-9010; Di Vincenzo, Serena/0000-0003-1695-9307; FERRARO, MARIA/0000-0003-2533-7446; DI SANO, CATERINA/0000-0003-3904-3465	Italian National Research Council; Italchimici	Italian National Research Council(Consiglio Nazionale delle Ricerche (CNR)); Italchimici	This work was funded by the Italian National Research Council and by Italchimici. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bateman ED, 2002, EUR RESPIR J, V20, P588, DOI 10.1183/09031936.02.00294702; Bentley AM, 1996, AM J RESP CRIT CARE, V153, P551, DOI 10.1164/ajrccm.153.2.8564096; Bousquet J, 2000, CLIN EXP ALLERGY, V30, P2; Busse M, 2012, J IMMUNOL, V189, P1975, DOI 10.4049/jimmunol.1103581; Chen YQ, 2006, ALLERGY, V61, P15, DOI 10.1111/j.1398-9995.2006.01008.x; Deng JM, 2005, CLIN IMMUNOL, V115, P178, DOI 10.1016/j.clim.2005.01.002; Duperrier K, 2005, MOL IMMUNOL, V42, P1531, DOI 10.1016/j.molimm.2005.01.006; Gonzalo JA, 2001, NAT IMMUNOL, V2, P597, DOI 10.1038/89739; Gregori S, 2009, HUM IMMUNOL, V70, P966, DOI 10.1016/j.humimm.2009.07.022; Grimm LM, 1996, EMBO J, V15, P3835, DOI 10.1002/j.1460-2075.1996.tb00757.x; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Hawrylowicz CM, 2005, J EXP MED, V202, P1459, DOI 10.1084/jem.20052211; Ho CY, 2002, CHEST, V122, P1751, DOI 10.1378/chest.122.5.1751; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Kim BS, 2010, P NATL ACAD SCI USA, V107, P8742, DOI 10.1073/pnas.0911756107; Kroczek R, 2005, J ALLERGY CLIN IMMUN, V116, P906, DOI 10.1016/j.jaci.2005.07.005; Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V125, pS95, DOI 10.1016/j.jaci.2009.10.047; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P3, DOI 10.1067/mai.2003.97; Ma JX, 2011, J ALLERGY CLIN IMMUN, V127, P1447, DOI 10.1016/j.jaci.2011.01.032; Mayer E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029355; Mcgee HS, 2009, AM J RESP CRIT CARE, V180, P211, DOI 10.1164/rccm.200809-1505OC; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Melis M, 2002, EUR RESPIR J, V19, P257, DOI 10.1183/09031936.02.00239202; Oneda K, 1999, Arerugi, V48, P13; Pace E, 2004, J ALLERGY CLIN IMMUN, V114, P1216, DOI 10.1016/j.jaci.2004.07.052; Pace E, 2010, ALLERGY, V65, P1495, DOI 10.1111/j.1398-9995.2010.02403.x; Palomares O, 2012, J ALLERGY CLIN IMMUN, V129, P510, DOI 10.1016/j.jaci.2011.09.031; Pochard P, 2010, J ALLERGY CLIN IMMUN, V126, P92, DOI 10.1016/j.jaci.2010.04.003; Prado C, 2011, IMMUNOBIOLOGY, V216, P386, DOI 10.1016/j.imbio.2010.06.013; Robinson DS, 2009, CLIN EXP ALLERGY, V39, P1314, DOI 10.1111/j.1365-2222.2009.03301.x; Strauss L, 2008, J IMMUNOL, V180, P2967, DOI 10.4049/jimmunol.180.5.2967; Taylor A, 2007, J ALLERGY CLIN IMMUN, V120, P76, DOI 10.1016/j.jaci.2007.04.004; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Vignola AM, 1999, J ALLERGY CLIN IMMUN, V103, P563, DOI 10.1016/S0091-6749(99)70225-3; Whitehead GS, 2012, J ALLERGY CLIN IMMUN, V129, P207, DOI 10.1016/j.jaci.2011.08.009; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zhan YF, 2008, J IMMUNOL, V181, P5405, DOI 10.4049/jimmunol.181.8.5405	40	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48816	10.1371/journal.pone.0048816	http://dx.doi.org/10.1371/journal.pone.0048816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251336	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200010
J	Ibitokou, S; Oesterholt, M; Brutus, L; Borgella, S; Agbowai, C; Ezinmegnon, S; Lusingu, J; Schmiegelow, C; Massougbodji, A; Deloron, P; Troye-Blomberg, M; Varani, S; Luty, AJF; Fievet, N				Ibitokou, Samad; Oesterholt, Mayke; Brutus, Laurent; Borgella, Sophie; Agbowai, Carine; Ezinmegnon, Sem; Lusingu, John; Schmiegelow, Christentze; Massougbodji, Achille; Deloron, Philippe; Troye-Blomberg, Marita; Varani, Stefania; Luty, Adrian J. F.; Fievet, Nadine			Peripheral Blood Cell Signatures of Plasmodium falciparum Infection during Pregnancy	PLOS ONE			English	Article							REGULATORY T-CELLS; PLASMACYTOID DENDRITIC CELLS; PLACENTAL MALARIA; INTERVILLOUS BLOOD; UP-REGULATION; CC-CHEMOKINE; ACTIVATION; IMMUNITY; CHILDREN; PATHOGENESIS	Sequestration of Plasmodium falciparum-infected erythrocytes in placental intervillous spaces causes inflammation and pathology. Knowledge of the profiles of immune cells associated with the physiopathology of pregnancy-associated malaria (PAM) is scarce. We conducted a longitudinal, prospective study, both in Benin and Tanzania, including similar to 1000 pregnant women in each site with systematic follow-up at scheduled antenatal visits until delivery. We used ex vivo flow cytometry to identify peripheral blood mononuclear cell (PBMC) profiles that are associated with PAM and anaemia, determining the phenotypic composition and activation status of PBMC in selected sub-groups with and without PAM both at inclusion and at delivery in a total of 302 women. Both at inclusion and at delivery PAM was associated with significantly increased frequencies both of B cells overall and of activated B cells. Infection-related profiles were otherwise quite distinct at the two different time-points. At inclusion, PAM was associated with anaemia, with an increased frequency of immature monocytes and with a decreased frequency of regulatory T cells (Treg). At delivery, infected women presented with significantly fewer plasmacytoid dendritic cells (DC), more myeloid DC expressing low levels of HLA-DR, and more effector T cells (Teff) compared to uninfected women. Independent associations with an increased risk of anaemia were found for altered antigen-presenting cell frequencies at inclusion, but for an increased frequency of Teff at delivery. Our findings emphasize the prominent role played by B cells during PAM whenever it arises during pregnancy, whilst also revealing signature changes in other circulating cell types that, we conclude, primarily reflect the relative duration of the infections. Thus, the acute, recently-acquired infections present at delivery were marked by changes in DC and Teff frequencies, contrasting with infections at inclusion, considered chronic in nature, that were characterized by an abundance of immature monocytes and a paucity of Treg in PBMC. Citation: Ibitokou S, Oesterholt M, Brutus L, Borgella S, Agbowai C, et al. (2012) Peripheral Blood Cell Signatures of Plasmodium falciparum Infection during Pregnancy. PLoS ONE 7(12): e49621. doi: 10.1371/journal.pone.0049621	[Ibitokou, Samad; Brutus, Laurent; Deloron, Philippe; Luty, Adrian J. F.; Fievet, Nadine] Inst Rech Dev, UMR 216, Paris, France; [Ibitokou, Samad; Borgella, Sophie; Agbowai, Carine; Ezinmegnon, Sem; Massougbodji, Achille] Univ Abomey Calavi, Fac Sci Sante, Ctr Etud & Rech Paludisme Associe Grossesse & Enf, Cotonou, Benin; [Ibitokou, Samad; Brutus, Laurent; Deloron, Philippe; Luty, Adrian J. F.; Fievet, Nadine] Univ Paris 05, Fac Pharm, PRES Sorbonne Paris Cite, Paris, France; [Oesterholt, Mayke; Luty, Adrian J. F.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Lusingu, John] Natl Inst Med Res, Tanga, Tanzania; [Schmiegelow, Christentze] Univ Copenhagen, Ctr Med Parasitol, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Schmiegelow, Christentze] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Troye-Blomberg, Marita] Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden; [Varani, Stefania] Univ Bologna, Dept Hematol & Oncol, Microbiol Unit, Bologna, Italy	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi; UDICE-French Research Universities; Universite Paris Cite; Radboud University Nijmegen; University of Copenhagen; University of Copenhagen; Stockholm University; University of Bologna	Luty, AJF (corresponding author), Inst Rech Dev, UMR 216, Paris, France.	adrian.luty@ird.fr	Lusingu, John P. A./GSJ-3228-2022; Troye-Blomberg, Marita/B-9210-2016; Brutus, Laurent/A-7430-2011; Deloron, Philippe/G-6305-2010; Varani, Stefania/AAZ-1856-2021; Luty, Adrian/CAH-2547-2022	Troye-Blomberg, Marita/0000-0002-2804-0325; Brutus, Laurent/0000-0002-9967-0666; Deloron, Philippe/0000-0003-4705-2484; Luty, Adrian John Frederick/0000-0001-8830-3425; shmiegelow, christentze/0000-0002-9360-9741; Lusingu, John P. A./0000-0002-9407-0602; VARANI, STEFANIA/0000-0003-0862-4937; Fievet, Nadine/0000-0003-2272-9794	European Union Framework 7 [200889]; AIRD-DPF	European Union Framework 7; AIRD-DPF	This work was supported by the European Union Framework 7 contract number 200889, and by a PhD scholarship awarded by AIRD-DPF to S. Ibitokou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Asito AS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-238; Bachy V, 2008, J REPROD IMMUNOL, V78, P11, DOI 10.1016/j.jri.2007.09.004; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Beeson JG, 2005, CURR TOP MICROBIOL, V297, P187; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Bouyou-Akotet MK, 2004, CLIN INFECT DIS, V38, P342, DOI 10.1086/380646; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Chaisavaneeyakorn S, 2003, CLIN DIAGN LAB IMMUN, V10, P631, DOI 10.1128/CDLI.10.4.631-636.2003; Chaisavaneeyakorn S, 2002, J INFECT DIS, V186, P1371, DOI 10.1086/344322; Chaisavaneeyakorn S, 2002, J INFECT DIS, V185, P127, DOI 10.1086/338013; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Darmochwal-Kolarz D, 2003, J REPROD IMMUNOL, V59, P193, DOI 10.1016/S0165-0378(03)00047-0; Della Bella S, 2011, CLIN EXP IMMUNOL, V164, P180, DOI 10.1111/j.1365-2249.2011.04330.x; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Diallo M, 2008, INT J PARASITOL, V38, P1557, DOI 10.1016/j.ijpara.2008.04.013; Diouf I, 2004, J INFECT DIS, V189, P2235, DOI 10.1086/420791; Diouf I, 2007, J REPROD IMMUNOL, V74, P152, DOI 10.1016/j.jri.2006.10.001; Donati D, 2006, J IMMUNOL, V177, P3035, DOI 10.4049/jimmunol.177.5.3035; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Heikkinen J, 2004, CLIN EXP IMMUNOL, V136, P373, DOI 10.1111/j.1365-2249.2004.02441.x; Holloway JA, 2009, PEDIAT ALLERG IMM-UK, V20, P119, DOI 10.1111/j.1399-3038.2008.00771.x; Hviid L, 2007, PARASITOLOGY, V134, P1871, DOI 10.1017/S0031182007000121; Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Kolte L, 2011, BLOOD, V117, P1861, DOI 10.1182/blood-2010-07-298992; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; Leber A, 2010, AM J REPROD IMMUNOL, V63, P445, DOI 10.1111/j.1600-0897.2010.00821.x; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Morva A, 2012, BLOOD, V119, P106, DOI 10.1182/blood-2011-06-360768; Muehlenbachs A, 2007, J IMMUNOL, V179, P557, DOI 10.4049/jimmunol.179.1.557; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; Nduati E, 2011, J INFECT DIS, V204, P962, DOI 10.1093/infdis/jir438; Ordi J, 2001, J INFECT DIS, V183, P1100, DOI 10.1086/319295; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Sato K, 1999, J IMMUNOL, V162, P3865; Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Tkachuk AN, 2001, J INFECT DIS, V183, P967, DOI 10.1086/319248; Urban BC, 2001, BLOOD, V98, P2859, DOI 10.1182/blood.V98.9.2859; Urban BC, 2006, INFECT IMMUN, V74, P6700, DOI 10.1128/IAI.00861-06; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Wykes MN, 2012, TRENDS PARASITOL, V28, P182, DOI 10.1016/j.pt.2012.01.007	50	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49621	10.1371/journal.pone.0049621	http://dx.doi.org/10.1371/journal.pone.0049621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239967	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800005
J	Gomez-Abellan, P; Diez-Noguera, A; Madrid, JA; Lujan, JA; Ordovas, JM; Garaulet, M				Gomez-Abellan, Purificacion; Diez-Noguera, Antoni; Madrid, Juan A.; Lujan, Juan A.; Ordovas, Jose M.; Garaulet, Marta			Glucocorticoids Affect 24 h Clock Genes Expression in Human Adipose Tissue Explant Cultures	PLOS ONE			English	Article							METABOLIC SYNDROME; CIRCADIAN EXPRESSION; OBESITY; MONONUCLEAR; ASSOCIATION; PATTERNS	Aims: to examine firstly whether CLOCK exhibits a circadian expression in human visceral (V) and subcutaneous (S) adipose tissue (AT) in vitro as compared with BMAL1 and PER2, and secondly to investigate the possible effect of the glucocorticoid analogue dexamethasone (DEX) on positive and negative clock genes expression. Subjects and Methods: VAT and SAT biopsies were obtained from morbid obese women (body mass index >= 40 kg/m(2)) (n = 6). In order to investigate rhythmic expression pattern of clock genes and the effect of DEX on CLOCK, PER2 and BMAL1 expression, control AT (without DEX) and AT explants treated with DEX (2 hours) were cultured during 24 h and gene expression was analyzed at the following times: 10:00 h, 14:00 h, 18:00 h, 22:00 h, 02:00 h and 06:00 h, using qRT-PCR. Results: CLOCK, BMAL1 and PER2 expression exhibited circadian patterns in both VAT and SAT explants that were adjusted to a typical 24 h sinusoidal curve. PER2 expression (negative element) was in antiphase with respect to CLOCK and in phase with BMAL1 expression (both positive elements) in the SAT (situation not present in VAT). A marked effect of DEX exposure on both positive and negative clock genes expression patterns was observed. Indeed, DEX treatment modified the rhythmicity pattern towards altered patterns with a period lower than 24 hours in all genes and in both tissues. Conclusions: 24 h patterns in CLOCK and BMAL1 (positive clock elements) and PER2 (negative element) mRNA levels were observed in human adipose explants. These patterns were altered by dexamethasone exposure.	[Gomez-Abellan, Purificacion; Madrid, Juan A.; Garaulet, Marta] Univ Murcia, Dept Physiol, Fac Biol, Murcia, Spain; [Diez-Noguera, Antoni] Univ Barcelona, Dept Physiol, Fac Pharm, Barcelona, Spain; [Lujan, Juan A.] Univ Hosp Virgen de la Arrixaca, Gen Surg Serv, Murcia, Spain; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, Jean Mayer USDA, Human Nutr Res Ctr, Boston, MA 02111 USA; [Ordovas, Jose M.] Ctr Nacl Invest Cardiovasc CNIC, Dept Epidemiol, Madrid, Spain; [Ordovas, Jose M.] Inst Madrileno Estudios Avanzados Alimentac IMDEA, Madrid, Spain	University of Murcia; University of Barcelona; Hospital Clinico Universitario Virgen de la Arrixaca; Tufts University; United States Department of Agriculture (USDA); Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Garaulet, M (corresponding author), Univ Murcia, Dept Physiol, Fac Biol, Murcia, Spain.	garaulet@um.es	Garaulet, Marta/K-6625-2014; Ordovas, Jose/B-8727-2013	Garaulet, Marta/0000-0002-4066-3509; Ordovas, Jose/0000-0002-7581-5680; Lujan Mompean, Juan Antonio/0000-0003-4987-7578; Madrid, Juan Antonio/0000-0002-9286-1371	Tomas Pascual Foundation; Pilar Gomez-Cuetara Foundation; Spanish Government of Science and Innovation [BFU2011-24720]; Seneca Foundation from the Government of Murcia [15123/PI/10]; National Heart, Lung, and Blood Institute [HL-54776]; National Institute of Diabetes and Digestive and Kidney Diseases [DK075030]; United States Department of Agriculture Research [53-K06-5-10, 58-1950-9-001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054776] Funding Source: NIH RePORTER	Tomas Pascual Foundation; Pilar Gomez-Cuetara Foundation; Spanish Government of Science and Innovation(Spanish Government); Seneca Foundation from the Government of Murcia(Fundacion Seneca); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); United States Department of Agriculture Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from Tomas Pascual and Pilar Gomez-Cuetara Foundations, Spanish Government of Science and Innovation (BFU2011-24720), Seneca Foundation from the Government of Murcia (15123/PI/10), National Heart, Lung, and Blood Institute grants HL-54776, National Institute of Diabetes and Digestive and Kidney Diseases, grant number DK075030 and by contracts 53-K06-5-10 and 58-1950-9-001 from the United States Department of Agriculture Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Batschelet E, 1981, CIRCULAR STAT BIOL; Bjarnason GA, 2001, AM J PATHOL, V158, P1793, DOI 10.1016/S0002-9440(10)64135-1; Boivin DB, 2003, BLOOD, V102, P4143, DOI 10.1182/blood-2003-03-0779; Burioka N, 2010, ADV DRUG DELIVER REV, V62, P946, DOI 10.1016/j.addr.2010.03.012; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Garaulet M, 2010, INT J OBESITY, V34, P516, DOI 10.1038/ijo.2009.255; Garaulet M, 2006, OBESITY, V14, P1181, DOI 10.1038/oby.2006.135; Garaulet M, 2009, AM J CLIN NUTR, V90, P1466, DOI 10.3945/ajcn.2009.27536; Abellan PG, 2011, NUTR HOSP, V26, P1394, DOI [10.3305/nh.2011.26.6.5305, 10.1590/S0212-16112011000600029]; Gomez-Abellan P, 2010, ENDOCRINOLOGY, V151, P115, DOI 10.1210/en.2009-0647; Gomez-Santos C, 2009, OBESITY, V17, P1481, DOI 10.1038/oby.2009.164; Granda TG, 2004, FASEB J, V18, P304, DOI 10.1096/fj.04-2665fje; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Hernandez-Morante JJ, 2009, INT J OBESITY, V33, P473, DOI 10.1038/ijo.2009.4; Kusanagi H, 2004, NEUROSCI LETT, V365, P124, DOI 10.1016/j.neulet.2004.04.065; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee MJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE571, DOI 10.1152/ajpendo.00231.2010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loboda A, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-7; Nebzydoski SJ, 2010, VET IMMUNOL IMMUNOP, V138, P183, DOI 10.1016/j.vetimm.2010.07.017; Otway DT, 2011, DIABETES, V60, P1577, DOI 10.2337/db10-1098; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2011, FEBS LETT, V585, P1384, DOI 10.1016/j.febslet.2011.02.027; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Sookoian S, 2008, AM J CLIN NUTR, V87, P1606, DOI 10.1093/ajcn/87.6.1606; Tanaka K, 2007, HEART VESSELS, V22, P254, DOI 10.1007/s00380-006-0968-3; Teboul M, 2005, J MOL MED, V83, P693, DOI 10.1007/s00109-005-0697-6; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Veilleux A, 2010, J STEROID BIOCHEM, V122, P28, DOI 10.1016/j.jsbmb.2010.02.024; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wu XY, 2007, OBESITY, V15, P2560, DOI 10.1038/oby.2007.308	34	39	39	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50435	10.1371/journal.pone.0050435	http://dx.doi.org/10.1371/journal.pone.0050435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251369	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900012
J	Liu, J; Eischeid, AN; Chen, XM				Liu, Jun; Eischeid, Alex N.; Chen, Xian-Ming			Col1A1 Production and Apoptotic Resistance in TGF-beta 1-Induced Epithelial-to-Mesenchymal Transition-Like Phenotype of 603B Cells	PLOS ONE			English	Article							BILE-DUCT LIGATION; LIVER FIBROSIS; TGF-BETA; TRANSCRIPTION FACTORS; HEPATIC FIBROGENESIS; BILIARY FIBROSIS; HEPATOCYTES; CHOLANGIOCYTES; DISEASE; MICE	Recent studies have suggested that proliferating cholangiocytes have an important role in the induction of fibrosis, either directly via epithelial-to-mesenchymal transition (EMT), or indirectly via activation of other liver cell types. Transforming growth factor beta 1 (TGF-beta 1), a critical fibrotic cytokine for hepatic fibrosis, is a potent EMT inducer. This study aimed to clarify the potential contributions of TGF-beta 1-induced EMT-like cholangiocyte phenotype to collagen production and cell survival of cholangiocytes in vitro. Mouse cholangiocytes (603B cells) were treated with TGF-beta 1 and EMT-like phenotype alterations were monitored by morphological changes and expression of EMT-associated genes. Alterations in Col1A1 gene, Col1A1-associated miR-29s, and pro-apoptotic genes were measured in TGF-beta 1-treated 603B cells. Snail1 knockdown was achieved using shRNA to evaluate the contribution of EMT-associated changes to Col1A1 production and cell survival. We found TGF-beta 1 treatment induced partial EMT-like phenotype transition in 603B cells in a Snail1-dependent manner. TGF-beta 1 also stimulated collagen alpha 1(I) expression in 603B cells. However, this induction was not parallel to the EMT-like alterations and independent of Snail1 or miR-29 expression. Cells undergoing EMT-like changes showed a modest down-regulation of multiple pro-apoptotic genes and displayed resistance to TNF-alpha-induced apoptosis. TGF-beta 1-induced apoptosis resistance was attenuated in Snail1 knockdown 603B cells. TGF-beta 1-induced Col1A1 production seems to be independent of EMT-like transition and miR-29 expression. Nevertheless, TGF-beta 1-induced EMT may contribute to the increased survival capacity of cholangiocytes via modulating the expression of pro-apoptotic genes. Citation: Liu J, Eischeid AN, Chen X-M (2012) Col1A1 Production and Apoptotic Resistance in TGF-beta 1-Induced Epithelial-to-Mesenchymal Transition-Like Phenotype of 603B Cells. PLoS ONE 7(12): e51371. doi: 10.1371/journal.pone.0051371	[Liu, Jun; Eischeid, Alex N.; Chen, Xian-Ming] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68102 USA	Creighton University	Chen, XM (corresponding author), Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE 68102 USA.	xianmingchen@creighton.edu			Nebraska Tobacco Settlement Biomedical Research Program [LB506, LB692, LB595]	Nebraska Tobacco Settlement Biomedical Research Program	This study was supported by the Nebraska Tobacco Settlement Biomedical Research Program (LB506, LB692 and LB595) (to X-MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Beaussier M, 2007, LAB INVEST, V87, P292, DOI 10.1038/labinvest.3700513; Chu AS, 2011, HEPATOLOGY, V53, P1685, DOI 10.1002/hep.24206; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Decker P, 2000, J BIOL CHEM, V275, P9043, DOI 10.1074/jbc.275.12.9043; Escriva M, 2008, MOL CELL BIOL, V28, P1528, DOI 10.1128/MCB.02061-07; Franco DL, 2010, J CELL SCI, V123, P3467, DOI 10.1242/jcs.068692; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Glaser SS, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000994; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Hanada S, 2003, LIVER INT, V23, P3; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Jung Y, 2008, GASTROENTEROLOGY, V134, P1532, DOI 10.1053/j.gastro.2008.02.022; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Omenetti A, 2007, LAB INVEST, V87, P499, DOI 10.1038/labinvest.3700537; Patsenker E, 2008, GASTROENTEROLOGY, V135, P660, DOI 10.1053/j.gastro.2008.04.009; Popov Y, 2010, GASTROENTEROLOGY, V139, P722, DOI 10.1053/j.gastro.2010.07.015; Priester Sally, 2010, World J Gastrointest Pathophysiol, V1, P30, DOI 10.4291/wjgp.v1.i2.30; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704; Sato Y, 2007, AM J PATHOL, V171, P1859, DOI 10.2353/ajpath.2007.070337; Scholten D, 2010, GASTROENTEROLOGY, V139, P987, DOI 10.1053/j.gastro.2010.05.005; Song JG, 2007, CELL RES, V17, P289, DOI 10.1038/cr.2007.25; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Valdes F, 2004, EXP CELL RES, V292, P209, DOI 10.1016/j.yexcr.2003.08.015; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wells RG, 2008, CLIN LIVER DIS, V12, P759, DOI 10.1016/j.cld.2008.07.008; Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	38	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51371	10.1371/journal.pone.0051371	http://dx.doi.org/10.1371/journal.pone.0051371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236489	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100108
J	Roszczynska-Kurasinska, M; Nowak, A; Kamieniarz, D; Solomon, S; Andersen, JV				Roszczynska-Kurasinska, Magda; Nowak, Andrzej; Kamieniarz, Daniel; Solomon, Sorin; Andersen, Jorgen Vitting			Short and Long Term Investor Synchronization Caused by Decoupling	PLOS ONE			English	Article							FINANCIAL-MARKETS; BUBBLES; EXPECTATIONS; PRICES	The dynamics of collective decision making is not yet well understood. Its practical relevance however can be of utmost importance, as experienced by people who lost their fortunes in turbulent moments of financial markets. In this paper we show how spontaneous collective "moods'' or "biases'' emerge dynamically among human participants playing a trading game in a simple model of the stock market. Applying theory and computer simulations to the experimental data generated by humans, we are able to predict the onset of such moments before they actually happen. Citation: Roszczynska-Kurasinska M, Nowak A, Kamieniarz D, Solomon S, Andersen JV (2012) Short and Long Term Investor Synchronization Caused by Decoupling. PLoS ONE 7(12): e50700. doi:10.1371/journal.pone.0050700	[Roszczynska-Kurasinska, Magda; Kamieniarz, Daniel] Univ Warsaw, Robert B Zajonc Inst Social Studies, Warsaw, Poland; [Nowak, Andrzej] Univ Social Sci & Humanities, Warsaw, Poland; [Nowak, Andrzej] Florida Atlantic Univ, Dept Psychol, Boca Raton, FL 33431 USA; [Solomon, Sorin] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Andersen, Jorgen Vitting] Univ Paris 01, CNRS, Ctr Econ Sorbonne, F-75231 Paris 05, France	University of Warsaw; SWPS University of Social Sciences & Humanities; State University System of Florida; Florida Atlantic University; Hebrew University of Jerusalem; Centre National de la Recherche Scientifique (CNRS); heSam Universite; Universite Pantheon-Sorbonne	Roszczynska-Kurasinska, M (corresponding author), Univ Warsaw, Robert B Zajonc Inst Social Studies, Warsaw, Poland.	magda.roszczynska@gmail.com	Nowak, Andrzej/ABC-5414-2020	Nowak, Andrzej K/0000-0001-9965-0684	EU grant CO3 - Common Complex Collective Phenomena in Statistical Mechanics, Society, Economics, and Biology [12410]; NESS - Non-Equilibrium Social Science [296777]; Polish grant [BW 1770 40]	EU grant CO3 - Common Complex Collective Phenomena in Statistical Mechanics, Society, Economics, and Biology; NESS - Non-Equilibrium Social Science; Polish grant	This work was supported by EU grant CO3 - Common Complex Collective Phenomena in Statistical Mechanics, Society, Economics, and Biology, (Project Reference:12410; http://cordis.europa.eu/search/index.cfm? fuseaction = proj.document&PJ_RCN = 7888888), NESS - Non-Equilibrium Social Science (project number: 296777; http://www.nessnet.eu/) and Polish grant BW 1770 40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlof George, 2009, ANIMAL SPIRITS HUMAN; Andersen JV, 2005, INT J THEOR APPL FIN, V8, P509, DOI 10.1142/S021902490500313X; Andersen JV, 2010, J BEHAV FINANC, V11, P129, DOI 10.1080/15427560.2010.483186; Andersen JV, 2005, EUROPHYS LETT, V70, P697, DOI 10.1209/epl/i2005-10033-3; Andersen JV, 2003, EUR PHYS J B, V31, P141, DOI 10.1140/epjb/e2003-00017-7; Barberis N, 1998, J FINANC ECON, V49, P307, DOI 10.1016/S0304-405X(98)00027-0; Berstein P.L., 1996, GODS REMARKABLE STOR; Challet D., 2004, MINORITY GAMES INTER; Daniel K, 1997, J FINANC, V52, P1, DOI 10.2307/2329554; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Holt CA, 2004, P NATL ACAD SCI USA, V101, P3999, DOI 10.1073/pnas.0308738101; Hommes C, 2008, J ECON BEHAV ORGAN, V67, P116, DOI 10.1016/j.jebo.2007.06.006; Hommes CH, 2007, TECHNICAL REPORT; JEGADEESH N, 1995, J FINANC INTERMED, V4, P116, DOI 10.1006/jfin.1995.1006; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; LAKONISHOK J, 1994, J FINANC, V49, P1541, DOI 10.2307/2329262; Lei V, 2001, ECONOMETRICA, V69, P831, DOI 10.1111/1468-0262.00222; MANDELBROT B, 1966, J BUS, V39, P242, DOI 10.1086/294850; Murstein BI, 2003, J BEHAV FINANC, V4, P234, DOI DOI 10.1207/S15427579JPFM0404_6; PYLYSHYN ZW, 1973, PSYCHOL BULL, V80, P1, DOI 10.1037/h0034650; SAMUELSON PA, 1965, IMR-IND MANAG REV, V6, P41; Shefrin, 2002, GREED FEAR UNDERSTAN; Shleifer A., 2000, INEFFICIENT MARKETS; SMITH VL, 1988, ECONOMETRICA, V56, P1119, DOI 10.2307/1911361; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wohlmuth J, 2006, PHYSICA A, V363, P459, DOI 10.1016/j.physa.2005.08.067	26	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50700	10.1371/journal.pone.0050700	http://dx.doi.org/10.1371/journal.pone.0050700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	050OT	23236385	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100027
J	Singh, G; Dal Grande, F; Cornejo, C; Schmitt, I; Scheidegger, C				Singh, Garima; Dal Grande, Francesco; Cornejo, Carolina; Schmitt, Imke; Scheidegger, Christoph			Genetic Basis of Self-Incompatibility in the Lichen-Forming Fungus Lobaria pulmonaria and Skewed Frequency Distribution of Mating-Type Idiomorphs: Implications for Conservation	PLOS ONE			English	Article							EPIPHYTIC LICHEN; MICROSATELLITE MARKERS; GENUS XANTHORIA; POPULATION; SEX; RECOMBINATION; SYSTEMS; DISPERSAL; PCR; AMPLIFICATION	Fungal populations that reproduce sexually are likely to be genetically more diverse and have a higher adaptive potential than asexually reproducing populations. Mating systems of fungal species can be self-incompatible, requiring the presence of isolates of different mating-type genes for sexual reproduction to occur, or self-compatible, requiring only one. Understanding the distribution of mating-type genes in populations can help to assess the potential of self-incompatible species to reproduce sexually. In the locally threatened epiphytic lichen-forming fungus Lobaria pulmonaria (L.) Hoffm., low frequency of sexual reproduction is likely to limit the potential of populations to adapt to changing environmental conditions. Our study provides direct evidence of self-incompatibility (heterothallism) in L. pulmonaria. It can thus be hypothesized that sexual reproduction in small populations might be limited by an unbalanced distribution of mating-type genes. We therefore assessed neutral genetic diversity (using microsatellites) and mating-type ratio in 27 lichen populations (933 individuals). We found significant differences in the frequency of the two mating types in 13 populations, indicating a lower likelihood of sexual reproduction in these populations. This suggests that conservation translocation activities aiming at maximizing genetic heterogeneity in threatened and declining populations should take into account not only presence of fruiting bodies in transplanted individuals, but also the identity and balanced representation of mating-type genes.	[Singh, Garima; Dal Grande, Francesco; Cornejo, Carolina; Scheidegger, Christoph] WSL Swiss Fed Res Inst, Birmensdorf, Switzerland; [Dal Grande, Francesco; Schmitt, Imke] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Schmitt, Imke] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Frankfurt, Germany	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt	Singh, G (corresponding author), WSL Swiss Fed Res Inst, Birmensdorf, Switzerland.	garima.singh@stud.uni-frankfurt.de	Dal Grande, Francesco/K-1914-2016; Scheidegger, Christoph/C-6547-2011; Singh, Garima/ABF-5659-2021; Singh, Garima/P-1518-2017; Cornejo, Carolina/ADX-6219-2022	Dal Grande, Francesco/0000-0002-1865-6281; Scheidegger, Christoph/0000-0003-3713-5331; Singh, Garima/0000-0003-3753-5431; Singh, Garima/0000-0003-3753-5431; 	Swiss National Science Foundation [31003A-105830, 31003A-127346]; 'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts	This study was supported by the Swiss National Science Foundation (projects 31003A-105830 and 31003A-127346 to CS), and by 'LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz' of Hesse's Ministry of Higher Education, Research, and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alby K, 2009, NATURE, V460, P890, DOI 10.1038/nature08252; AnalystSoft Inc, STATPLUS MAC STAT AN; Arie T, 2000, MOL PLANT MICROBE IN, V13, P1330, DOI 10.1094/MPMI.2000.13.12.1330; Arie T, 1997, FUNGAL GENET BIOL, V21, P118, DOI 10.1006/fgbi.1997.0961; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bell G, 1982, MASTERPIECE NATURE E; Brown Dennis H., 1992, P259; Budel B, 2008, LICHEN BIOLOGY, 2ND EDITION, P40, DOI 10.1017/CBO9780511790478.005; CHARLESWORTH B, 1980, J THEOR BIOL, V84, P655, DOI 10.1016/S0022-5193(80)80026-9; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; Consolo VF, 2005, MYCOPATHOLOGIA, V160, P285, DOI 10.1007/s11046-005-4333-3; Coppin E, 1997, MICROBIOL MOL BIOL R, V61, P411, DOI 10.1128/.61.4.411-428.1997; Dal Grande F, 2012, MOL ECOL, V21, P3159, DOI 10.1111/j.1365-294X.2012.05482.x; Dal Grande F, 2011, THESIS U BERN BERN; Dal Grande F, 2010, CONSERV GENET, V11, P1147, DOI 10.1007/s10592-009-9904-2; Denison WC, 2003, MYCOLOGIA, V95, P513, DOI 10.2307/3761894; Dyer PS, 2005, MED MYCOL, V43, pS7, DOI 10.1080/13693780400029015; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foster SJ, 2003, CURR GENET, V44, P277, DOI 10.1007/s00294-003-0445-9; Gauslaa Y, 2009, NEW PHYTOL, V181, P683, DOI 10.1111/j.1469-8137.2008.02690.x; Genkai-Kato M, 1999, THEOR POPUL BIOL, V55, P309, DOI 10.1006/tpbi.1998.1407; Grube M, 2012, MOL ECOL, V21, P3098, DOI 10.1111/j.1365-294X.2012.05647.x; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hawksworth D., 1990, EARTH TRANSITION PAT, P45; Hawksworth D.L., 1973, AIR POLLUTION LICHEN, P330; Heitman J., 2007, SEX FUNGI MOL DETERM; Hilmo O, 2012, MOL ECOL, V21, P3250, DOI 10.1111/j.1365-294X.2012.05605.x; Hoistad F, 2011, LICHENOLOGIST, V43, P495, DOI 10.1017/S0024282911000429; Honegger R, 2004, MYCOL RES, V108, P480, DOI 10.1017/s0953756204009682; Honegger R, 2008, LICHEN BIOLOGY, 2ND EDITION, P27, DOI 10.1017/CBO9780511790478.004; Honegger R, 2008, LICHEN BIOLOGY, 2ND EDITION, P94, DOI 10.1017/CBO9780511790478.007; Honegger R, 2007, MYCOL RES, V111, P424, DOI 10.1016/j.mycres.2007.02.005; KOELLA JC, 1988, J EVOLUTION BIOL, V1, P95, DOI 10.1046/j.1420-9101.1988.1020095.x; Kronstad JW, 1997, ANNU REV GENET, V31, P245, DOI 10.1146/annurev.genet.31.1.245; Kueck Ulrich, 2009, Fungal Biology Reviews, V23, P86, DOI 10.1016/j.fbr.2009.10.004; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Martin T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015199; Mikryukov VS, 2011, THESIS RUSSIAN ACAD; Murtagh GJ, 2000, NATURE, V404, P564, DOI 10.1038/35007142; Nelson MA, 1996, TRENDS GENET, V12, P69, DOI 10.1016/0168-9525(96)81403-X; OCHMAN H, 1988, GENETICS, V120, P621; Olarte RA, 2012, MOL ECOL, V21, P1453, DOI 10.1111/j.1365-294X.2011.05398.x; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Pentecost A, 2011, ROYAL IRISH ACAD, V111, P1; Pringle A, 2003, BRYOLOGIST, V106, P221, DOI 10.1639/0007-2745(2003)106[0221:SFICTS]2.0.CO;2; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rydholm C, 2007, EUKARYOT CELL, V6, P868, DOI 10.1128/EC.00319-06; Saleh D, 2012, MOL ECOL, V21, P1330, DOI 10.1111/j.1365-294X.2012.05469.x; Scarascia-Mugnozza G. T., 2002, P1, DOI 10.1079/9780851995229.0001; Schei FH, 2012, J VEG SCI, V23, P459, DOI 10.1111/j.1654-1103.2011.01368.x; Scheidegger C, 2002, NATO SCI S SS IV EAR, V7, P163; SCHEIDEGGER C, 1995, LICHENOLOGIST, V27, P361, DOI 10.1017/S0024282995000478; Scheidegger C., 1995, MITTEILUNGEN EIDGEN, V70, P41; Scheidegger C, 2012, ECOL EVOL, V2, P2223, DOI 10.1002/ece3.341; Scheidegger Christoph, 2009, Fungal Biology Reviews, V23, P55, DOI 10.1016/j.fbr.2009.10.003; Scherrer S, 2005, FUNGAL GENET BIOL, V42, P976, DOI 10.1016/j.fgb.2005.09.002; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Seymour FA, 2005, FUNGAL GENET BIOL, V42, P554, DOI 10.1016/j.fgb.2005.03.006; Singer T, 2003, METH MOL B, V236, P241; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stofer S, 2006, LICHENOLOGIST, V38, P331, DOI 10.1017/S0024282906006207; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tomiuk J, 1998, GENETICA, V102-3, P545, DOI 10.1023/A:1017080119277; TURGEON BG, 1993, MOL GEN GENET, V238, P270; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Walser JC, 2004, HEREDITY, V93, P322, DOI 10.1038/sj.hdy.6800505; Walser JC, 2004, AM J BOT, V91, P1273, DOI 10.3732/ajb.91.8.1273; Walser JC, 2003, FUNGAL GENET BIOL, V40, P72, DOI 10.1016/S1087-1845(03)00080-X; Wang LQ, 2011, FUNGAL GENET BIOL, V48, P651, DOI 10.1016/j.fgb.2011.02.001; Werth S, 2007, MOL ECOL, V16, P2807, DOI 10.1111/j.1365-294X.2007.03344.x; Werth S, 2006, ECOLOGY, V87, P2037, DOI 10.1890/0012-9658(2006)87[2037:QDAELI]2.0.CO;2; Whittle CA, 2011, FUNGAL GENET BIOL, V48, P661, DOI 10.1016/j.fgb.2011.02.005; Widmer I, 2012, MOL ECOL, V21, P5827, DOI 10.1111/mec.12051; Widmer I, 2010, FUNGAL BIOL-UK, V114, P538, DOI 10.1016/j.funbio.2010.04.003; Wirth V., 1996, SCHRIFTENREIHE VEGET, V28, P307; Zoller S, 1999, MOL ECOL, V8, P2049, DOI 10.1046/j.1365-294x.1999.00820.x	80	25	25	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51402	10.1371/journal.pone.0051402	http://dx.doi.org/10.1371/journal.pone.0051402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236495	Green Published, gold			2022-12-27	WOS:000312064100114
J	Vogt, L; Grobe, P; Quast, B; Bartolomaeus, T				Vogt, Lars; Grobe, Peter; Quast, Bjoern; Bartolomaeus, Thomas			Fiat or Bona Fide Boundary-A Matter of Granular Perspective	PLOS ONE			English	Article							EVOLUTION; HOMOLOGY	Background: Distinguishing bona fide (i.e. natural) and fiat (i.e. artificial) physical boundaries plays a key role for distinguishing natural from artificial material entities and is thus relevant to any scientific formal foundational top-level ontology, as for instance the Basic Formal Ontology (BFO). In BFO, the distinction is essential for demarcating two foundational categories of material entity: object and fiat object part. The commonly used basis for demarcating bona fide from fiat boundary refers to two criteria: (i) intrinsic qualities of the boundary bearers (i.e. spatial/physical discontinuity, qualitative heterogeneity) and (ii) mind-independent existence of the boundary. The resulting distinction of bona fide and fiat boundaries is considered to be categorial and exhaustive. Methodology/Principal Findings: By referring to various examples from biology, we demonstrate that the hitherto used distinction of boundaries is not categorial: (i) spatial/physical discontinuity is a matter of scale and the differentiation of bona fide and fiat boundaries is thus granularity-dependent, and (ii) this differentiation is not absolute, but comes in degrees. By reducing the demarcation criteria to mind-independence and by also considering dispositions and historical relations of the bearers of boundaries, instead of only considering their spatio-structural properties, we demonstrate with various examples that spatio-structurally fiat boundaries can nevertheless be mind-independent and in this sense bona fide. Conclusions/Significance: We argue that the ontological status of a given boundary is perspective-dependent and that the strictly spatio-structural demarcation criteria follow a static perspective that is ignorant of causality and the dynamics of reality. Based on a distinction of several ontologically independent perspectives, we suggest different types of boundaries and corresponding material entities, including boundaries based on function (locomotion, physiology, ecology, development, reproduction) and common history (development, heredity, evolution). We argue that for each perspective one can differentiate respective bona fide from fiat boundaries.	[Vogt, Lars; Quast, Bjoern; Bartolomaeus, Thomas] Univ Bonn, Inst Evolut Biol & Onkol, Bonn, Germany; [Grobe, Peter] Forsch Museum Alexander Koenig Bonn, Bonn, Germany	University of Bonn; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Vogt, L (corresponding author), Univ Bonn, Inst Evolut Biol & Onkol, Bonn, Germany.	lars.m.vogt@gmail.com	Vogt, Lars/K-4166-2012	Vogt, Lars/0000-0002-8280-0487; Quast, Bjorn/0000-0002-3760-5834				Amundson R, 1998, BIOL PHILOS, V13, P153, DOI 10.1023/A:1006599002775; Appel T.A., 1987, CUVIER GEOFFREY DEBA; Arendt D, 2009, PHILOS T R SOC B, V364, P2809, DOI 10.1098/rstb.2009.0104; Bittner T., 2001, Formal Ontology in Information Systems. Collected Papers from the Second International Conference, P309, DOI 10.1145/505168.505197; Bittner T, 2003, FDN GEOGRAPHIC INFOR, P117, DOI DOI 10.1201/9780203009543.CH7; Brentano F, 1988, PHILOS INVESTIGATION; Brinkley James F, 2006, AMIA Annu Symp Proc, P96; Brogaard Berit, 2000, LOG ANAL, V43, P49; Cohn AG, 1994, TOPOLOGICAL FDN COGN, P131; GHISELIN MT, 1974, SYST ZOOL, V23, P536, DOI 10.2307/2412471; Johansson I, 2005, ACTA BIOTHEOR, V53, P153, DOI 10.1007/s10441-005-2525-3; Keet CM, 2008, KRDB DISSERTATION SE; Laubichler MD, 2000, AM ZOOL, V40, P777, DOI 10.1668/0003-1569(2000)040[0777:HIDATD]2.0.CO;2; LEWIS D, 1983, AUSTRALAS J PHILOS, V61, P343, DOI 10.1080/00048408312341131; Mejino Jr J. L. V., 2004, P KR 2004 WORKSH FOR, P48; Mitchell SD, 2006, BIOL THEORY, V1, P98, DOI [10.1162/biot.2006.1.1.98, DOI 10.1162/BIOT.2006.1.1.98]; Rosse Cornelius, 2005, AMIA Annu Symp Proc, P639; Russell ES., 1916, FORM FUNCTION CONTRI; Schulz S, 2009, METHOD INFORM MED, V48, P184, DOI 10.3414/ME9221; Schulz S, 2007, MONIST, V90, P499, DOI 10.5840/monist200790434; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Smith B, 2005, LECT NOTES COMPUT SC, V3693, P149; Smith B, 2004, STUD HEALTH TECHNOL, V102, P39; Smith B, 2001, TOPOI-INT REV PHILOS, V20, P131, DOI 10.1023/A:1017948522031; Smith B, 1999, LECT NOTES COMPUT SC, V1661, P267; Smith B, 1995, LECT NOTES COMPUT SC, V988, P475; Smith B, 1997, LECT NOTES COMPUT SC, V1329, P103; Smith B, 2000, PHILOS PHENOMEN RES, V60, P401, DOI 10.2307/2653492; Smith B., 1997, ELECT J ANAL PHILOS, V5; Smith B., 1994, PARTS WHOLES CONCEPT, P15; Smith B, 2005, J INFORM SYSTEMS, P1; Smith B, 2004, CATEGORIES HIST SYST, P225; Smith Barry, 2006, STUDIES HLTH TECHNOL, V2006, P57; Sorensen R.A., 1988, BLINDSPOTS; Spear AD, 2006, SCIENCE, P1; TYE M, 1990, MIND, V99, P535; Unger P., 1980, MIDWEST STUDIES PHIL, V5, P411, DOI [DOI 10.1111/J.1475-4975.1980.TB00416.X, 10.1111/j.1475-4975.1980.tb00416.x]; Varzi A, 2008, STANFORD ENCY PHILOS; Vogt L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030004; Vogt L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018794; Vogt L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-289; Vogt L, 2010, CLADISTICS, V26, P301, DOI 10.1111/j.1096-0031.2009.00286.x; Wagner GP, 1996, AM ZOOL, V36, P36; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Williamson Timothy., 1994, VAGUENESS	45	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e48603	10.1371/journal.pone.0048603	http://dx.doi.org/10.1371/journal.pone.0048603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251333	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200006
J	Agha, R				Agha, Riaz			Towards National Surgical Surveillance in the UK - A Pilot Study	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSM; HOSPITAL VOLUME; CARDIAC-SURGERY; MORTALITY DATA; METAANALYSIS; ENGLAND; RATES; CARE; OUTCOMES; CENTERS	Objective: The Bristol heart inquiry in the United Kingdom (UK) highlighted the lack of standards for evaluating surgical performance and quality. In 2009, the World Health Organisation (WHO) proposed six standardised metrics for surgical surveillance. This is the first study to collect and analyse such metrics from a cohort of National Health Service (NHS) Trusts in England, helping to determine their feasibility and utility in measuring surgical performance, its impact on public health and mortality, and for tracking surgical trends over time. Methods: Freedom of Information Act 2000 (FOI) requests for WHO standardised surgical metrics were made to 36 NHS Trusts in England during July to November 2010. Additional data on Hospital Standardised Mortality Ratio (HSMR), Patient Safety Score and Abdominal Aortic Aneurysm (AAA) volume and mortality was obtained from Dr Foster Health and The Guardian Newspaper. Analysis was performed using mixed-effect logistic regression. Results: 30/36 trusts responded (83%). During 2005-9, 5.4 million operations were performed with a 24.2% increase in annual number of operations. This rising volume within hospitals was associated with lower mortality ratios. A 10% increase in operative volume was associated with a lower day of surgery death rate (DDR OR = 0.94, p = 0.056) and post-operative inpatient 30-day mortality (PDR30 OR = 0.93, p = 0.001). For every 10,000 more operations that an NHS Trust does, a 4% drop in PDR30 mortality was achieved. A 10% increase in the volume of elective AAAs was associated with lower elective AAA (OR = 0.96, p = 0.032) and emergency AAA (OR = 0.95, p = 0.009) PDR30 mortality. Lower DDR mortality was noted for emergency AAA mortality (OR = 0.95, p = 0.025) but not elective AAAs (OR = 0.97, p = 0.116). Conclusion: Standarised surgical metrics can provide policy makers and commissioners with valuable summary data on surgical performance allowing for statistical process control of a complex intervention. This study has shown their collection is feasible albeit using FOI and the first to show a statistically significant volume-outcome relationship for surgery as a whole within hospitals. It adds weight to the argument that patients are safer in larger hospitals or those that become larger by growing their patient base. Together with other measures, such metrics can help build a picture of surgical surveillance in the UK and potentially lead us to safer surgery. Citation: Agha R (2012) Towards National Surgical Surveillance in the UK - A Pilot Study. PLoS ONE 7(12): e47969. doi: 10.1371/journal.pone.0047969	[Agha, Riaz] Natl Inst Hlth & Clin Excellence Scholar, London, England; [Agha, Riaz] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England	National Institute for Health & Care Excellence; University of Cambridge	Agha, R (corresponding author), Natl Inst Hlth & Clin Excellence Scholar, London, England.	mail@riazagha.com		Agha, Riaz/0000-0002-9348-0095	NICE	NICE	No funding was sought or obtained. The study was supported by NICE as part of their scholarship programme. NICE helped provide links with data providers and general support/mentorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, 6 SHIPM INQ; [Anonymous], GUARDIAN NEWSPAPER; Awopetu AI, 2010, BRIT J SURG, V97, P797, DOI 10.1002/bjs.7089; Aylin P, 2003, LANCET, V362, P485, DOI 10.1016/S0140-6736(03)14077-9; Boseley S, 2010, GUARDIAN NEWSPA 0613; Bridgewater B, 2005, BMJ-BRIT MED J, V330, P506, DOI 10.1136/bmj.330.7490.506; Bridgewater B, 2007, HEART, V93, P744, DOI 10.1136/hrt.2006.106393; Care Quality Commission, CQC TELLS BAS THURR; Department of Health, POL IMPL PROTH PIP S; Department of Health, 2012, NEW OBJ SET RED MRSA; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Ettinger WH, 2008, AM J MED QUAL, V23, P90, DOI 10.1177/1062860607313141; Foster Dr, 2009, DOCTOR FOSTER HOSP G; Foster Dr, 2011, HOSP GUIDE 2011; Foster Dr, QUALITY ACCOUNTS MET; Foster Dr, INSIDE YOUR HOSP FOS; Head RF, 2008, HEALTH SERV MANAG RE, V21, P178, DOI 10.1258/hsmr.2007.007017; Holt PJE, 2007, EUR J VASC ENDOVASC, V34, P646, DOI 10.1016/j.ejvs.2007.07.021; Holt PJE, 2007, EUR J VASC ENDOVASC, V33, P645, DOI 10.1016/j.ejvs.2007.01.014; Holt PJE, 2007, BRIT J SURG, V94, P441, DOI 10.1002/bjs.5725; Holt PJE, 2010, BRIT J SURG, V97, P496, DOI 10.1002/bjs.6911; Holt PJE, 2008, BRIT J SURG, V95, P1469, DOI 10.1002/bjs.6433; Holt PJE, 2008, BMJ-BRIT MED J, V336, P900, DOI 10.1136/bmj.39545.504792.80; Holt PJE, 2009, CIRC-CARDIOVASC QUAL, V2, P624, DOI 10.1161/CIRCOUTCOMES.109.848465; Kang W. L., 2006, SMJ Singapore Medical Journal, V47, P614; Karthikesalingam A, 2010, VASC ENDOVASC SURG, V44, P556, DOI 10.1177/1538574410375130; Kennedy I, 2001, LEARNING BRISTOL REP; Keogh B, 2010, BASIS BUILD SAF IMPR; Lee P., MANY SURG PROCEDURES; NHS Choices, NHS; NHS Institute for Innovation and Improvement, PROD OP THEATR; Patrick H, 2012, J PUBLIC HLTH OXF; Poloniecki J, 2004, BRIT MED J, V328, P375, DOI 10.1136/bmj.37956.520567.44; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Royal College of Surgeons of England Department of Health, HIGH RISK GEN SURG P; Scott IA, 2011, MED J AUSTRALIA, V194, P645, DOI 10.5694/j.1326-5377.2011.tb03150.x; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Stoddard GJ, BIOSTATISTICS EPIDEM; Thompson M, 2011, EUR J VASC ENDOVASC, V42, P411, DOI 10.1016/j.ejvs.2011.07.025; Thompson M, 2011, J VASC SURG, V54, P1208, DOI 10.1016/j.jvs.2011.07.064; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Weiser TG, 2009, LANCET, V374, P1113, DOI 10.1016/S0140-6736(09)61161-2; Young EL, 2007, J VASC SURG, V46, P1287, DOI 10.1016/j.jvs.2007.06.038	43	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e47969	10.1371/journal.pone.0047969	http://dx.doi.org/10.1371/journal.pone.0047969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239962	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800001
J	Kost, A; Laderach, P; Fisher, M; Cook, S; Gomez, L				Kost, Andre; Laederach, Peter; Fisher, Myles; Cook, Simon; Gomez, Lorena			Improving Index-Based Drought Insurance in Varying Topography: Evaluating Basis Risk Based on Perceptions of Nicaraguan Hillside Farmers	PLOS ONE			English	Article							WEATHER GENERATORS; AGRICULTURE; VARIABILITY; INNOVATIONS; AMERICA; AFRICA; AREAS; MODEL	This paper discusses a methodology to model precipitation indices and premium prices for index-based drought insurance for smallholders. Spatial basis risk, which is borne by the insured, is a problem, especially in variable topography. Also, site-specific drought risk needs to be estimated accurately in order to offer effective insurance cover and ensure financial sustainability of the insurance scheme. We explore farmers' perceptions on drought and spatial climate variability and draw conclusions concerning basis risk with regards to the proposed methodology. There are technically many options to represent natural heterogeneity in index insurance contracts while serving the customer adequately and keeping transaction costs low.	[Kost, Andre] Univ Bonn, Dept Geog, Bonn, Germany; [Laederach, Peter; Gomez, Lorena] Ctr Int Agr Trop, Managua, Nicaragua; [Fisher, Myles] Ctr Int Agr Trop, Cali, Colombia; [Cook, Simon] Int Water Management Inst, Pelawatte, Battaramulla, Sri Lanka	University of Bonn; Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; International Water Management Institute (IWMI)	Kost, A (corresponding author), Univ Bonn, Dept Geog, Bonn, Germany.	andre.kost@arcor.de	; Cook, Simon/R-7762-2017	Laderach, Peter/0000-0001-8708-6318; Cook, Simon/0000-0003-0902-1476	Gesellschaft fur Internationale Zusammenarbeit; Deutsche Gesellschaft fur Internationale Zusammenarbeit, Beratungsgruppe Entwicklungsorientierte Agrarforschung (GIZ-BEAF); Nicaraguan Ministerio Agropecuario y Forestal (MAGFOR); Instituto Nicaraguense de Technologia Agropecuaria (INTA)	Gesellschaft fur Internationale Zusammenarbeit; Deutsche Gesellschaft fur Internationale Zusammenarbeit, Beratungsgruppe Entwicklungsorientierte Agrarforschung (GIZ-BEAF); Nicaraguan Ministerio Agropecuario y Forestal (MAGFOR); Instituto Nicaraguense de Technologia Agropecuaria (INTA)	Research was partially financed by Gesellschaft fur Internationale Zusammenarbeit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; This research was conducted under the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS) with additional funding from Deutsche Gesellschaft fur Internationale Zusammenarbeit, Beratungsgruppe Entwicklungsorientierte Agrarforschung (GIZ-BEAF). Many thanks also to Lesbia Rizo, Dr. Carlos Zelaya, Narisoki Castro and Armando Martinez from CIAT as well as to the Nicaraguan Ministerio Agropecuario y Forestal (MAGFOR) and the Instituto Nicaraguense de Technologia Agropecuaria (INTA), for supporting this study.	Anderson JR, 2003, AGR SYST, V75, P161, DOI 10.1016/S0308-521X(02)00064-1; [Anonymous], 2007, AGR DEV; [Anonymous], 2009, LA PRENSA; [Anonymous], 2004, COPING RISK AGR; Baethgen W, 2008, CONTRIBUTIONS AGR SY; Balzer N, 2010, POTENTIAL SCALE SUST; Barnett BJ, 2007, AM J AGR ECON, V89, P1241, DOI 10.1111/j.1467-8276.2007.01091.x; Barrett C.B., 2007, POVERTY TRAPS CLIMAT; Carter M.R., 2008, INSURING NEVER INSUR; Churchill C, 2006, PROTECTING POOR MICR, P13; Dercon S, 2004, J DEV ECON, V74, P309, DOI 10.1016/j.jdeveco.2004.01.001; DEWALT BR, 1994, HUM ORGAN, V53, P123, DOI 10.17730/humo.53.2.ku60563817m03n73; Diaz Nieto J, 2006, SYSTEM DROUGHT INSUR; Diaz Nieto J, 2004, 11 CIAT; Diaz Nieto J, 2004, 4 CIAT; El Nuevo Diario, 2010, AMPL COB SEG AGR; El Nuevo Diario, 2009, LAF LANZ SEG AGR ANT; Ericksen PJ, 2003, GEODERMA, V111, P233, DOI 10.1016/S0016-7061(02)00266-5; FAO, 2011, PROM GROWTH DEV SMAL; FUJISAKA S, 1994, AGR SYST, V46, P409, DOI 10.1016/0308-521X(94)90104-N; Gabler Wirtschaftslexikon, 2011, BAS; Giannini A, 2009, 0901 IRI; Gine X., 2010, 5459 WORLD BANK; Gold J. R, 1980, INTRO BEHAV GEOGRAPH; Golledge RG., 1997, SPATIAL BEHAV GEOGRA; GUDGER M, 1991, RISK IN AGRICULTURE, P143; Hartkamp AD, 2003, AGR SYST, V76, P539, DOI 10.1016/S0308-521X(01)00108-1; Hellmuth ME, 2009, INDEX INSURANCE CLIM, V2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ingram KT, 2002, AGR SYST, V74, P331, DOI 10.1016/S0308-521X(02)00044-6; Instituto Nicaragu ense de Estudios Territoriales (INETER), 2005, CAR CLIM NIC MAN ATL; Instituto Nicaraguense de Estudios Territoriales (INETER), 2010, BOL CLIM MENS; Instituto Nicaraguense de Estudios Territoriales (INETER), 2005, FEN NIN; Instituto Nicaraguense de Tecnologia Agropecuaria (INTA), 2004, CULT FRIJ CON MEN RI; JASANOFF S, 1993, RISK ANAL, V13, P123, DOI 10.1111/j.1539-6924.1993.tb01057.x; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; Jones P. G., 2002, MARKSIM COMPUTER TOO; JONES PG, 1993, AGR FOREST METEOROL, V63, P1, DOI 10.1016/0168-1923(93)90019-E; Jones PG, 1997, AGR FOREST METEOROL, V86, P127, DOI 10.1016/S0168-1923(96)02399-4; Jones PG, 2000, AGRON J, V92, P445, DOI 10.2134/agronj2000.923445x; Kitchin R., 2002, COGNITION GEOGRAPHIC; Kluge S., 2010, EINZELFALL TYPUS FAL; Magana V, 1999, J CLIMATE, V12, P1577, DOI 10.1175/1520-0442(1999)012<1577:TMDOMA>2.0.CO;2; Mavromatis T, 2001, AGR FOREST METEOROL, V109, P283, DOI 10.1016/S0168-1923(01)00272-6; Mayring P., 2021, QUALITATIVE CONTENT; Miranda M, 2001, AM J AGR ECON, V83, P650, DOI 10.1111/0002-9092.00185; MIRANDA MJ, 1991, AM J AGR ECON, V73, P233, DOI 10.2307/1242708; Nieto JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038281; Nieto JD, 2010, CLIM DEV, V2, P233, DOI 10.3763/cdev.2010.0050; NIEUWOLT S, 1982, AGR ENVIRON, V7, P135, DOI 10.1016/0304-1131(82)90003-0; Osgood DE, 2007, 0702 IRI WORLD BANK; Renn O., 2017, RISK GOVERNANCE COPI; Skees J, 1999, IFPRI DISCUSSION PAP; Skees J. R., 2008, Agricultural and Resource Economics Review, V37, P1; The World Bank, 2005, MAN AGR PROD RISK IN; Wilhite D. A., 1985, Water International, V10, P111, DOI 10.1080/02508068508686328; Witzel A., 2000, FORUM QUALITATIVE SO, V1, P26	57	6	6	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51412	10.1371/journal.pone.0051412	http://dx.doi.org/10.1371/journal.pone.0051412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053RN	23240020	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800056
J	Kuo, SY; Tu, CH; Hsu, YT; Wang, HD; Wen, RK; Lin, CT; Wu, CL; Huang, YT; Huang, GS; Lan, TH; Fu, TF				Kuo, Shu-Yun; Tu, Chiao-Hui; Hsu, Ya-Ting; Wang, Horng-Dar; Wen, Rong-Kun; Lin, Chen-Ta; Wu, Chia-Lin; Huang, Yu-Ting; Huang, Guan-Shieng; Lan, Tsuo-Hung; Fu, Tsai-Feng			A Hormone Receptor-Based Transactivator Bridges Different Binary Systems to Precisely Control Spatial-Temporal Gene Expression in Drosophila	PLOS ONE			English	Article							TRANSGENE EXPRESSION; DISRUPTION PROJECT; LIFE-SPAN; TEMPERATURE; LONGEVITY; SLEEP; ENTRAINMENT; RESISTANCE; NEURONS; RESCUE	The GAL4/UAS gene expression system is a precise means of targeted gene expression employed to study biological phenomena in Drosophila. A modified GAL4/UAS system can be conditionally regulated using a temporal and regional gene expression targeting (TARGET) system that responds to heat shock induction. However heat shock-related temperature shifts sometimes cause unexpected physiological responses that confound behavioral analyses. We describe here the construction of a drug-inducible version of this system that takes advantage of tissue-specific GAL4 driver lines to yield either RU486-activated LexA-progesterone receptor chimeras (LexPR) or beta-estradiol-activated LexA-estrogen receptor chimeras (XVE). Upon induction, these chimeras bind to a LexA operator (LexAop) and activate transgene expression. Using GFP expression as a marker for induction in fly brain cells, both approaches are capable of tightly and precisely modulating transgene expression in a temporal and dosage-dependent manner. Additionally, tissue-specific GAL4 drivers resulted in target gene expression that was restricted to those specific tissues. Constitutive expression of the active PKA catalytic subunit using these systems altered the sleep pattern of flies, demonstrating that both systems can regulate transgene expression that precisely mimics regulation that was previously engineered using the GeneSwitch/UAS system. Unlike the limited number of GeneSwitch drivers, this approach allows for the usage of the multitudinous, tissue-specific GAL4 lines for studying temporal gene regulation and tissue-specific gene expression. Together, these new inducible systems provide additional, highly valuable tools available to study gene function in Drosophila.	[Kuo, Shu-Yun; Hsu, Ya-Ting; Lin, Chen-Ta; Fu, Tsai-Feng] Natl Chi Nan Univ, Grad Inst Biomed & Biomed Technol, Nantou, Taiwan; [Kuo, Shu-Yun; Tu, Chiao-Hui; Wen, Rong-Kun; Lin, Chen-Ta; Huang, Yu-Ting; Fu, Tsai-Feng] Natl Chi Nan Univ, Dept Appl Chem, Nantou, Taiwan; [Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Wang, Horng-Dar] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Wu, Chia-Lin] Chang Gung Univ, Coll Med, Dept Biochem, Tao Yuan, Taiwan; [Wu, Chia-Lin] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Huang, Guan-Shieng] Natl Chi Nan Univ, Dept Comp Sci & Informat Engn, Nantou, Taiwan; [Lan, Tsuo-Hung] Natl Yang Ming Univ, Sch Med, Dept Psychiat, Taipei 112, Taiwan; [Lan, Tsuo-Hung] Taichung Vet Gen Hosp, Dept Psychiat, Taichung, Taiwan	National Chi Nan University; National Chi Nan University; National Tsing Hua University; National Tsing Hua University; Chang Gung University; Chang Gung University; National Chi Nan University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital	Fu, TF (corresponding author), Natl Chi Nan Univ, Grad Inst Biomed & Biomed Technol, Nantou, Taiwan.	tffu@ncnu.edu.tw		Wu, Chia-Lin/0000-0002-7906-2364; Wang, Horng-Dar/0000-0001-9570-3611; Lan, Tsuo-Hung/0000-0002-2796-1026; Fu, Tsai-Feng/0000-0002-0343-3018	National Science Council [101-2311-B-260-002, 101-2627-M-260-001-, 98-2311-B-260-001-MY3]; Taichung Veterans General Hospital/National Chi Nan University Joint Research Program [TCVGH-NCNU1017904]	National Science Council(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital/National Chi Nan University Joint Research Program	This work was supported by National Science Council Grant 101-2311-B-260-002, 101-2627-M-260-001- and 98-2311-B-260-001-MY3 (to T.-F. F.) and a grant from the Taichung Veterans General Hospital/National Chi Nan University Joint Research Program TCVGH-NCNU1017904 (also to T.-F. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; Bello B, 1998, DEVELOPMENT, V125, P2193; Bieschke ET, 1998, MOL GEN GENET, V258, P571, DOI 10.1007/s004380050770; Boothroyd CE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030054; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bubliy OA, 2005, J EVOLUTION BIOL, V18, P789, DOI 10.1111/j.1420-9101.2005.00928.x; Burcin Mark M., 1998, Frontiers in Bioscience, V3, pC1; Busza A, 2007, J NEUROSCI, V27, P10722, DOI 10.1523/JNEUROSCI.2479-07.2007; Emelyanov A, 2008, DEV BIOL, V320, P113, DOI 10.1016/j.ydbio.2008.04.042; Folguera G, 2010, J INSECT PHYSIOL, V56, P1679, DOI 10.1016/j.jinsphys.2010.06.015; Ford D, 2007, EXP GERONTOL, V42, P483, DOI 10.1016/j.exger.2007.01.004; Garcia AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000950; Han DD, 2000, DEVELOPMENT, V127, P573; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Howlader G, 2006, J BIOL RHYTHM, V21, P13, DOI 10.1177/0748730405282882; Huckesfeld S, 2011, J INSECT PHYSIOL, V57, P136, DOI 10.1016/j.jinsphys.2010.10.002; Ito C, 2011, J BIOL RHYTHM, V26, P14, DOI 10.1177/0748730410391640; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Le Bourg E, 2007, BIOGERONTOLOGY, V8, P431, DOI 10.1007/s10522-007-9086-6; Madalan A, 2012, LEARN MEMORY, V19, P26, DOI 10.1101/lm.024802.111; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Marshall KE, 2010, P ROY SOC B-BIOL SCI, V277, P963, DOI 10.1098/rspb.2009.1807; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2004, SCI STKE, P16, DOI DOI 10.1126/28822202004P16; Mizuguchi H, 2002, J GENE MED, V4, P240, DOI 10.1002/jgm.261; Munch SB, 2009, P NATL ACAD SCI USA, V106, P13860, DOI 10.1073/pnas.0900300106; Nicholson L, 2008, GENETICS, V178, P215, DOI 10.1534/genetics.107.081968; Ohlmeyer JT, 1997, GENE DEV, V11, P2250, DOI 10.1101/gad.11.17.2250; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Peng IF, 2007, J NEUROSCI, V27, P12611, DOI 10.1523/JNEUROSCI.2179-07.2007; Riveron J, 2009, J INSECT PHYSIOL, V55, P943, DOI 10.1016/j.jinsphys.2009.06.009; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Shih CT, 2011, COMPUT PHYS COMMUN, V182, P195, DOI 10.1016/j.cpc.2010.07.021; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Stebbins MJ, 2001, P NATL ACAD SCI USA, V98, P10775, DOI 10.1073/pnas.121186498; Stebbins MJ, 2001, GENE, V270, P103, DOI 10.1016/S0378-1119(01)00447-4; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Viktorinova I, 2007, INSECT BIOCHEM MOLEC, V37, P246, DOI 10.1016/j.ibmb.2006.11.010; Wang HD, 2004, P NATL ACAD SCI USA, V101, P12610, DOI 10.1073/pnas.0404648101; Wang X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001125; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Zars M, 2006, J COMP PHYSIOL A, V192, P727, DOI 10.1007/s00359-006-0109-6; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	46	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50855	10.1371/journal.pone.0050855	http://dx.doi.org/10.1371/journal.pone.0050855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239992	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800028
J	Walkey, CJ; Luo, ZL; Madilao, LL; van Vuuren, HJJ				Walkey, Christopher J.; Luo, Zongli; Madilao, Lufiani L.; van Vuuren, Hennie J. J.			The Fermentation Stress Response Protein Aaf1p/Yml081Wp Regulates Acetate Production in Saccharomyces cerevisiae	PLOS ONE			English	Article							ACETALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASES; GENE DISRUPTION; BUDDING YEAST; ALD3 GENES; GLUCOSE; CASSETTE; GROWTH; ENZYME; WINE	The production of acetic acid during wine fermentation is a critical issue for wineries since the sensory quality of a wine can be affected by the amount of acetic acid it contains. We found that the C2H2-type zinc-finger transcription factor YML081Wp regulated the mRNA levels of ALD4 and ALD6, which encode a cytosolic acetaldehyde dehydrogenase (ACDH) and a mitochondrial ACDH, respectively. These enzymes produce acetate from acetaldehyde as part of the pyruvate dehydrogenase bypass. This regulation was also reflected in the protein levels of Ald4p and Ald6p, as well as total ACDH activity. In the absence of ALD6, YML081W had no effect on acetic acid levels, suggesting that this transcription factor's effects are mediated primarily through this gene. lacZ reporter assays revealed that Yml081wp stimulates ALD6 transcription, in large part from a GAGGGG element 590 base pairs upstream of the translation start site. The non-annotated ORF YML081W therefore encodes a transcription factor that regulates acetate production in Saccharomyces cerevisiae. We propose AAF1 as a gene name for the YML081W ORF.	[Walkey, Christopher J.; Luo, Zongli; Madilao, Lufiani L.; van Vuuren, Hennie J. J.] Univ British Columbia, Wine Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	van Vuuren, HJJ (corresponding author), Univ British Columbia, Wine Res Ctr, Vancouver, BC V5Z 1M9, Canada.	hjjvv@mail.ubc.ca			Genome Canada/Genome BC [WIN151]; NSERC [217271-09]	Genome Canada/Genome BC(Genome Canada); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by Genome Canada/Genome BC grant WIN151 and NSERC grant 217271-09 to HJJvV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C, 2010, AM J ENOL VITICULT, V61, P125; Deed NK, 2011, APPL MICROBIOL BIOT, V89, P1537, DOI 10.1007/s00253-011-3084-y; Flikweert MT, 1996, YEAST, V12, P247, DOI 10.1002/(SICI)1097-0061(19960315)12:3<247::AID-YEA911>3.0.CO;2-I; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grabowska D, 2003, J BIOL CHEM, V278, P13984, DOI 10.1074/jbc.M210076200; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Hansen J, 2003, FEMS YEAST RES, V4, P323, DOI 10.1016/S1567-1356(03)00178-8; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; KISPAL G, 1991, BIOCHIM BIOPHYS ACTA, V1085, P217, DOI 10.1016/0005-2760(91)90097-2; Kurita O, 1999, FEMS MICROBIOL LETT, V181, P281, DOI 10.1111/j.1574-6968.1999.tb08856.x; Marks VD, 2008, FEMS YEAST RES, V8, P35, DOI 10.1111/j.1567-1364.2007.00338.x; Meaden PG, 1997, YEAST, V13, P1319, DOI 10.1002/(SICI)1097-0061(199711)13:14<1319::AID-YEA183>3.0.CO;2-T; Melcher K, 2000, GENE, V247, P53, DOI 10.1016/S0378-1119(00)00124-4; Navarro-Avino JP, 1999, YEAST, V15, P829, DOI 10.1002/(SICI)1097-0061(199907)15:10A<829::AID-YEA423>3.0.CO;2-9; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; Reid RJD, 2011, GENOME RES, V21, P477, DOI 10.1101/gr.109033.110; Remize F, 2000, APPL ENVIRON MICROB, V66, P3151, DOI 10.1128/AEM.66.8.3151-3159.2000; Richards KD, 2009, ANTON LEEUW INT J G, V96, P355, DOI 10.1007/s10482-009-9346-3; Saint-Prix F, 2004, MICROBIOL-SGM, V150, P2209, DOI 10.1099/mic.0.26999-0; SEEGMILLER JE, 1953, J BIOL CHEM, V201, P629; Tessier WD, 1998, FEMS MICROBIOL LETT, V164, P29, DOI 10.1111/j.1574-6968.1998.tb13063.x; Volschenk H, 1997, NAT BIOTECHNOL, V15, P253, DOI 10.1038/nbt0397-253; Walkey CJ, 2011, FEMS YEAST RES, V11, P499, DOI 10.1111/j.1567-1364.2011.00740.x; White WH, 2003, GENETICS, V163, P69; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893	27	18	20	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51551	10.1371/journal.pone.0051551	http://dx.doi.org/10.1371/journal.pone.0051551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240040	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800076
J	Burgos-Rivera, B; Dawe, RK				Burgos-Rivera, Brunilis; Dawe, R. Kelly			An Arabidopsis Tissue-Specific RNAi Method for Studying Genes Essential to Mitosis	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; CENP-C; INNER KINETOCHORE; MAIZE HOMOLOG; THALIANA; CENTROMERE; PLANTS; TRANSFORMATION; TRANSCRIPTION; ORGANIZATION	A large fraction of the genes in plants can be considered essential in the sense that when absent the plant fails to develop past the first few cell divisions. The fact that angiosperms pass through a haploid gametophyte stage can make it challenging to propagate such mutants even in the heterozygous condition. Here we describe a tissue-specific RNAi method that allows us to visualize cell division phenotypes in petals, which are large dispensable organs. Portions of the APETALA (AP3) and PISTILLATA (PI) promoters confer early petal-specific expression. We show that when either promoter is used to drive the expression of a beta-glucuronidase (GUS) RNAi transgene in plants uniformly expressing GUS, GUS expression is knocked down specifically in petals. We further tested the system by targeting the essential kinetochore protein CENPC and two different components of the Spindle Assembly Checkpoint (MAD2 and BUBR1). Plant lines expressing petal-specific RNAi hairpins targeting these genes exhibited an array of petal phenotypes. Cytological analyses of the affected flower buds confirmed that CENPC knockdown causes cell cycle arrest but provided no evidence that either MAD2 or BUBR1 are required for mitosis (although both genes are required for petal growth by this assay). A key benefit of the petal-specific RNAi method is that the phenotypes are not expressed in the lineages leading to germ cells, and the phenotypes are faithfully transmitted for at least four generations despite their pronounced effects on growth. Citation: Burgos-Rivera B, Dawe RK (2012) An Arabidopsis Tissue-Specific RNAi Method for Studying Genes Essential to Mitosis. PLoS ONE 7(12): e51388. doi: 10.1371/journal.pone.0051388	[Burgos-Rivera, Brunilis; Dawe, R. Kelly] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Dawe, R. Kelly] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Dawe, RK (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	kelly@plantbio.uga.edu			National Science Foundation grant [0922703]; SREB-State Doctoral Scholars Program; National Institutes of Health training grant; Direct For Biological Sciences [0922703] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007103] Funding Source: NIH RePORTER	National Science Foundation grant(National Science Foundation (NSF)); SREB-State Doctoral Scholars Program; National Institutes of Health training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation grant 0922703, a fellowship from the SREB-State Doctoral Scholars Program, and funds from an National Institutes of Health training grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Byzova M, 2004, PLANTA, V218, P379, DOI 10.1007/s00425-003-1117-1; Caillaud MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006757; CASTLE LA, 1993, MOL GEN GENET, V241, P504, DOI 10.1007/BF00279892; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Dawe RK, 1999, PLANT CELL, V11, P1227, DOI 10.1105/tpc.11.7.1227; Ding DF, 2012, PLANT MOL BIOL, V79, P203, DOI 10.1007/s11103-012-9903-4; Du YQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000835; ERRAMPALLI D, 1991, PLANT CELL, V3, P149, DOI 10.1105/tpc.3.2.149; Fukagawa T, 1999, EMBO J, V18, P4196, DOI 10.1093/emboj/18.15.4196; Fukagawa T, 1997, HUM MOL GENET, V6, P2301, DOI 10.1093/hmg/6.13.2301; Hill TA, 1998, DEVELOPMENT, V125, P1711; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Honma T, 2000, DEVELOPMENT, V127, P2021; JEFFERSON RA, 1987, EMBO J, V6, P3901; JURGENS G, 1991, DEVELOPMENT, P27; Kalantidis K, 2008, BIOL CELL, V100, P13, DOI 10.1042/BC20070079; Kimbara J, 2004, CHROMOSOME RES, V12, P703, DOI 10.1023/B:CHRO.0000045760.42880.8c; Krizek BA, 1996, DEVELOPMENT, V122, P11; Kwon MS, 2007, MOL BIOL CELL, V18, P2155, DOI 10.1091/mbc.E07-01-0045; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; MAYER U, 1991, NATURE, V353, P402, DOI 10.1038/353402a0; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; Meinke David W., 1994, V27, P253; Milks KJ, 2009, MOL BIOL CELL, V20, P4246, DOI 10.1091/mbc.E09-05-0378; Moore I, 2006, PLANT J, V45, P651, DOI 10.1111/j.1365-313X.2006.02660.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Ogura Y, 2004, GENES GENET SYST, V79, P139, DOI 10.1266/ggs.79.139; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Rao MK, 2006, NAT PROTOC, V1, P1494, DOI 10.1038/nprot.2006.260; Round EK, 1997, GENOME RES, V7, P1045, DOI 10.1101/gr.7.11.1045; Ruzicka DR, 2007, PLANT J, V52, P460, DOI 10.1111/j.1365-313X.2007.03257.x; SAITOH H, 1992, CELL, V70, P115, DOI 10.1016/0092-8674(92)90538-N; Salinas J, 2006, ARABIDOPSIS PROTOCOL; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sung DY, 2003, TRENDS PLANT SCI, V8, P179, DOI 10.1016/S1360-1385(03)00047-5; TOMKIEL J, 1994, J CELL BIOL, V125, P531, DOI 10.1083/jcb.125.3.531; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Yu HG, 1999, J CELL BIOL, V145, P425, DOI 10.1083/jcb.145.3.425; Yu HG, 2000, J CELL BIOL, V151, P131, DOI 10.1083/jcb.151.1.131	47	10	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51388	10.1371/journal.pone.0051388	http://dx.doi.org/10.1371/journal.pone.0051388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236491	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100110
J	Coisel, Y; Bousbia, S; Forel, JM; Hraiech, S; Lascola, B; Roch, A; Zandotti, C; Million, M; Jaber, S; Raoult, D; Papazian, L				Coisel, Yannael; Bousbia, Sabri; Forel, Jean-Marie; Hraiech, Sami; Lascola, Bernard; Roch, Antoine; Zandotti, Christine; Million, Matthieu; Jaber, Samir; Raoult, Didier; Papazian, Laurent			Cytomegalovirus and Herpes Simplex Virus Effect on the Prognosis of Mechanically Ventilated Patients Suspected to Have Ventilator-Associated Pneumonia	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; RESPIRATORY-DISTRESS-SYNDROME; SURGICAL-PATIENTS; NONIMMUNOSUPPRESSED PATIENTS; SEVERE SEPSIS; INFECTION; REACTIVATION; MORTALITY; SCORE	Objective: Cytomegalovirus (CMV) and herpes simplex virus (HSV) are common viruses that can affect critically ill patients who are not immunocompromised. The aim of this study was to determine whether the identification of CMV and/or HSV in mechanically ventilated critically ill patients suspected of having pneumonia was associated with an increased mortality. Design: Prospective epidemiological study. Setting: Medical intensive care unit of a tertiary medical center. Patients: Ninety-three patients with suspected pneumonia. Interventions: Patients with suspected pneumonia had bronchoalveolar lavage and blood samples taken to confirm the diagnosis. Antigenemia was used to detect CMV in the blood. Bronchoalveolar lavage samples were submitted to testing using quantitative real-time Polymerase Chain Reaction. Measurements and Main Results: We identified 22 patients with a CMV infection, 26 patients with an HSV infection and 45 patients without CMV or HSV infection (control group). Mortality at day 60 was higher in patients with a CMV infection than in patients from the control group (55% vs. 20%, P<0.01). Mortality at day 60 was not significantly increased in the group with HSV infection. Duration of ICU stay and ICU mortality were significantly higher in patients with CMV infections when compared to patients from the control group, whereas ventilator free days were significantly lower in patients with CMV infections when compared to patients from the control group. Conclusions: In critically ill patients, a CMV infection is associated with an increased mortality. Further interventional studies are needed to evaluate whether treatment could improve the prognosis.	[Coisel, Yannael; Jaber, Samir] Ctr Hosp Univ, Serv Anesthesie Reanimat St Eloi, Montpellier, France; [Coisel, Yannael; Jaber, Samir] Univ Montpellier I, INSERM, U1046, Montpellier, France; [Bousbia, Sabri; Forel, Jean-Marie; Hraiech, Sami; Lascola, Bernard; Roch, Antoine; Zandotti, Christine; Million, Matthieu; Raoult, Didier; Papazian, Laurent] Univ Aix Marseille, UMR CNRS 7278, Marseille, France; [Forel, Jean-Marie; Hraiech, Sami; Roch, Antoine; Papazian, Laurent] Hop Nord Marseille, Assistance Publ Hop Marseille, Marseille, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Coisel, Y (corresponding author), Ctr Hosp Univ, Serv Anesthesie Reanimat St Eloi, Montpellier, France.	y-coisel@chu-montpellier.fr	LA SCOLA, Bernard/P-6477-2016; RAOULT, Didier/A-8434-2008; Million, Matthieu/F-7693-2011	LA SCOLA, Bernard/0000-0001-8006-7704; RAOULT, Didier/0000-0002-0633-5974; Million, Matthieu/0000-0002-5556-6947	Programme Hospitalier de Recherche Clinique	Programme Hospitalier de Recherche Clinique	This work was supported by a grant from the Programme Hospitalier de Recherche Clinique 2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bousbia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011298; Bouza E, 2011, J CRIT CARE, V432, pe431; Bruynseels P, 2003, LANCET, V362, P1536, DOI 10.1016/S0140-6736(03)14740-X; Chiche L, 2011, CURR OPIN INFECT DIS, V24, P152, DOI 10.1097/QCO.0b013e328343b6e4; Chiche L, 2009, CRIT CARE MED, V37, P1850, DOI 10.1097/CCM.0b013e31819ffea6; Chilet M, 2010, J MED VIROL, V82, P1384, DOI 10.1002/jmv.21825; Cook CH, 1998, AM J SURG, V176, P357, DOI 10.1016/S0002-9610(98)00205-0; Cook CH, 2006, CRIT CARE MED, V34, P842, DOI 10.1097/01.CCM.0000201876.11059.05; Cook CH, 2003, CRIT CARE MED, V31, P1923, DOI 10.1097/01.CCM.0000070222.11325.C4; Daubin C, 2005, INTENS CARE MED, V31, P1116, DOI 10.1007/s00134-005-2706-1; De Vos N, 2009, CLIN MICROBIOL INFEC, V15, P358, DOI 10.1111/j.1469-0691.2009.02704.x; Deback C, 2010, J CLIN VIROL, V47, P313, DOI 10.1016/j.jcv.2010.01.019; Desachy A, 2001, CLIN INFECT DIS, V32, P197, DOI 10.1086/318474; DOMART Y, 1990, CHEST, V97, P18, DOI 10.1378/chest.97.1.18; Drew WL, 2007, CURR OPIN INFECT DIS, V20, P408, DOI 10.1097/QCO.0b013e32821f6010; Engelmann I, 2007, CRIT CARE, V11, DOI 10.1186/cc6175; Fielding K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025571; Heininger A, 2006, CRIT CARE MED, V34, P929, DOI 10.1097/01.CCM.0000202442.33792.04; Heininger A, 2000, CRIT CARE MED, V28, P563, DOI 10.1097/00003246-200002000-00046; Heininger A, 2001, CRIT CARE MED, V29, P541, DOI 10.1097/00003246-200103000-00012; Heininger A, 2011, CRIT CARE, V15, DOI 10.1186/cc10069; Jaber S, 2005, CHEST, V127, P233, DOI 10.1378/chest.127.1.233; Jung B, 2010, INTENS CARE MED, V36, P790, DOI 10.1007/s00134-010-1833-5; Kalil AC, 2010, CRIT CARE MED, V38, pS663, DOI 10.1097/CCM.0b013e3181f20319; Kalil AC, 2008, CRIT CARE MED, V36, P3261, DOI 10.1097/CCM.0b013e31818f24c3; Kalil AC, 2009, CRIT CARE MED, V37, P2350, DOI 10.1097/CCM.0b013e3181a3aa43; Kutza AST, 1998, CLIN INFECT DIS, V26, P1076, DOI 10.1086/520307; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Limaye AP, 2010, REV MED VIROL, V20, P372, DOI 10.1002/rmv.664; Linssen CFM, 2008, INTENS CARE MED, V34, P2202, DOI 10.1007/s00134-008-1231-4; Luna CM, 2003, CRIT CARE MED, V31, P676, DOI 10.1097/01.CCM.0000055380.86458.1E; Luyt CE, 2007, AM J RESP CRIT CARE, V175, P935, DOI 10.1164/rccm.200609-1322OC; Miggins M, PLOS ONE, V6; Ong GM, 2004, J MED VIROL, V72, P121, DOI 10.1002/jmv.10524; Papazian L, 1998, ANESTHESIOLOGY, V88, P935, DOI 10.1097/00000542-199804000-00013; Papazian L, 1996, ANESTHESIOLOGY, V84, P280, DOI 10.1097/00000542-199602000-00005; Piipairnen H, 2005, J MED VIROL, V76, P367, DOI 10.1002/jmv.20367; PORTEOUS C, 1984, CRIT CARE MED, V12, P626, DOI 10.1097/00003246-198408000-00003; Sanadgol N, 2011, NEW MICROBIOL, V34, P263; Scheithauer S, 2010, INFECTION, V38, P401, DOI 10.1007/s15010-010-0036-x; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Smith CA, 2010, J MED VIROL, V82, P1406, DOI 10.1002/jmv.21794; Stephan F, 1996, INTENS CARE MED, V22, P1244, DOI 10.1007/s001340050245; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; von Muller L, 2006, EMERG INFECT DIS, V12, P1517, DOI 10.3201/eid1210.060411; Ziemann M, 2008, CRIT CARE MED, V36, P3145, DOI 10.1097/CCM.0b013e31818f3fc4	48	70	72	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51340	10.1371/journal.pone.0051340	http://dx.doi.org/10.1371/journal.pone.0051340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236477	Green Published, gold			2022-12-27	WOS:000312064100099
J	Margine, I; Martinez-Gil, L; Chou, YY; Krammer, F				Margine, Irina; Martinez-Gil, Luis; Chou, Yi-ying; Krammer, Florian			Residual Baculovirus in Insect Cell-Derived Influenza Virus-Like Particle Preparations Enhances Immunogenicity	PLOS ONE			English	Article							IMMUNE-RESPONSES; HETEROLOGOUS STRAINS; PROTECTIVE IMMUNITY; M1 PROTEINS; H5N1; ANTIBODY; HEMAGGLUTININ; VACCINE; EFFICACY; NEUTRALIZATION	Influenza virus-like particles are currently evaluated in clinical trials as vaccine candidates for influenza viruses. Most commonly they are produced in baculovirus- or mammalian-expression systems. Here we used different vaccination schemes in order to systematically compare virus-like particle preparations generated in the two systems. Our work shows significant differences in immunogenicity between the two, and indicates superior and broader immune responses induced by the baculovirus- derived constructs. We demonstrate that these differences critically influence protection and survival in a mouse model of influenza virus infection. Finally, we show that the enhanced immunogenicity of the baculovirus- derived virus-like particles is caused by contamination with residual baculovirus which activates the innate immune response at the site of inoculation.	[Margine, Irina; Martinez-Gil, Luis; Chou, Yi-ying; Krammer, Florian] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Margine, Irina; Chou, Yi-ying] Mt Sinai Sch Med, Grad Sch Biol Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Krammer, F (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	florian.krammer@mssm.edu	Krammer, Florian/H-3237-2019; Martinez-Gil, Luis/M-7422-2014	Krammer, Florian/0000-0003-4121-776X; Martinez-Gil, Luis/0000-0002-9076-7760	PATH; CEIRS (Centers for Excellence for Influenza Research and Surveillance) [HHSN26620070010C]	PATH; CEIRS (Centers for Excellence for Influenza Research and Surveillance)	This work was partially supported by PATH and CEIRS (Centers for Excellence for Influenza Research and Surveillance, HHSN26620070010C) grants to Dr. Peter Palese. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2005, J VIROL, V79, P2847, DOI 10.1128/JVI.79.5.2847-2858.2005; Abe T, 2003, J IMMUNOL, V171, P1133, DOI 10.4049/jimmunol.171.3.1133; Abe T, 2010, CURR GENE THER, V10, P226, DOI 10.2174/156652310791321279; Abe T, 2009, J VIROL, V83, P7629, DOI 10.1128/JVI.00679-09; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; Dinca Luminita, 1993, Viral Immunology, V6, P75, DOI 10.1089/vim.1993.6.75; Easterbrook JD, 2012, VIROLOGY, V432, P39, DOI 10.1016/j.virol.2012.06.003; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Giles BM, 2012, CLIN VACCINE IMMUNOL, V19, P128, DOI 10.1128/CVI.05533-11; Guarino L, 2001, BACULOVIRUSES; Hai R, 2008, J VIROL, V82, P10580, DOI 10.1128/JVI.01213-08; Haynes JR, 2009, VACCINE, V27, P530, DOI 10.1016/j.vaccine.2008.11.011; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; Hervas-Stubbs S, 2007, J IMMUNOL, V178, P2361, DOI 10.4049/jimmunol.178.4.2361; Hu YC, 2008, CURR GENE THER, V8, P54, DOI 10.2174/156652308783688509; Kang SM, 2011, J VIROL, V85, P11391, DOI 10.1128/JVI.00080-11; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Khurana S, 2011, J VIROL; Krammer F., 2012, J VIROL; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; Krammer F, 2010, TRENDS MOL MED, V16, P313, DOI 10.1016/j.molmed.2010.05.002; Krammer F, 2010, MOL BIOTECHNOL, V45, P226, DOI 10.1007/s12033-010-9268-3; Krammer F, 2010, BIOTECHNOL J, V5, P17, DOI 10.1002/biot.200900267; Latham T, 2001, J VIROL, V75, P6154, DOI 10.1128/JVI.75.13.6154-6165.2001; Lopez-Macias C, 2011, VACCINE, V29, P7826, DOI 10.1016/j.vaccine.2011.07.099; Lopez-Macias G, 2012, HUM VACC IMMUNOTHER, P8; Lowen AC, 2009, J VIROL, V83, P2803, DOI 10.1128/JVI.02424-08; Nichol KL, 2008, VACCINE, V26, pD17, DOI 10.1016/j.vaccine.2008.07.048; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Palese P, 2006, EMERG INFECT DIS, V12, P61, DOI 10.3201/eid1201.051043; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Pushko P, 2005, VACCINE, V23, P5751, DOI 10.1016/j.vaccine.2005.07.098; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Song JM, 2011, J PROTEOME RES, V10, P3450, DOI 10.1021/pr200086v; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Szecsi J, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-70; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; Tao P, 2009, VIRAL IMMUNOL, V22, P273, DOI 10.1089/vim.2009.0017; Toporovski R, 2010, EXPERT OPIN BIOL TH, V10, P1489, DOI 10.1517/14712598.2010.521495; Tosh PK, 2010, MAYO CLIN PROC, V85, P257, DOI 10.4065/mcp.2009.0615; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Wang TT, 2011, SCIENCE, V333, P834, DOI 10.1126/science.1210724; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; WICKHAM TJ, 1991, BIOTECHNOL LETT, V13, P483, DOI 10.1007/BF01049204; Wu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009784	49	44	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51559	10.1371/journal.pone.0051559	http://dx.doi.org/10.1371/journal.pone.0051559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236516	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100132
J	Narasimhan, M; Patel, D; Vedpathak, D; Rathinam, M; Henderson, G; Mahimainathan, L				Narasimhan, Madhusudhanan; Patel, Dhyanesh; Vedpathak, Dhanashree; Rathinam, Marylatha; Henderson, George; Mahimainathan, Lenin			Identification of Novel microRNAs in Post-Transcriptional Control of Nrf2 Expression and Redox Homeostasis in Neuronal, SH-SY5Y Cells	PLOS ONE			English	Article							ANTIOXIDANT RESPONSE ELEMENT; MESSENGER-RNA DEGRADATION; CUL3-BASED E3 LIGASE; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; NEUROBLASTOMA-CELLS; SIGNALING PATHWAY; GENE-EXPRESSION; NEURODEGENERATIVE DISEASES; NF-E2-RELATED FACTOR-2	Nuclear factor-erythroid 2-related factor 2 (Nrf2/NFE2L2), a redox-sensitive transcription factor plays a critical role in adaptation to cellular stress and affords cellular defense by initiating transcription of antioxidative and detoxification genes. While a protein can be regulated at multiple levels, control of Nrf2 has been largely studied at post-translational regulation points by Keap1. Importantly, post-transcriptional/translational based regulation of Nrf2 is less understood and to date there are no reports on such mechanisms in neuronal systems. In this context, studies involving the role of microRNAs (miRs) which are normally considered as fine tuning regulators of protein production through translation repression and/or post-transcriptional alterations, are in place. In the current study, based on in-silico analysis followed by immunoblotting and real time analysis, we have identified and validated for the first time that human NFE2L2 could be targeted by miR153/miR27a/miR142-5p/miR144 in neuronal, SH-SY5Y cells. Co-transfection studies with individual miR mimics along with either WT 3' UTR of human Nrf2 or mutated miRNA targeting seed sequence within Nrf2 3' UTR, demonstrated that Nrf2 is a direct regulatory target of these miRs. In addition, ectopic expression of miR153/miR27a/miR142-5p/miR144 affected Nrf2 mRNA abundance and nucleo-cytoplasmic concentration of Nrf2 in a Keap1 independent manner resulting in inefficient transactivating ability of Nrf2. Furthermore, forced expression of miRs diminished GCLC and GSR expression resulting in alteration of Nrf2 dependent redox homeostasis. Finally, bioinformatics based miRNA-disease network analysis (MDN) along with extended computational network analysis of Nrf2 associated pathologic processes suggests that if in a particular cellular scenario where any of these miR153/miR27a/miR142-5p/miR144 either individually or as a group is altered, it could affect Nrf2 thus triggering and/or determining the fate of wide range of disease outcomes.	[Narasimhan, Madhusudhanan; Patel, Dhyanesh; Vedpathak, Dhanashree; Rathinam, Marylatha; Henderson, George; Mahimainathan, Lenin] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Narasimhan, Madhusudhanan; Henderson, George; Mahimainathan, Lenin] Texas Tech Univ, Hlth Sci Ctr, S Plains Alcohol & Addict Res Ctr, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Narasimhan, M (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA.	madhu.narasimhan@ttuhsc.edu; lenin.mahimainathan@ttuhsc.edu		/0000-0001-5077-3552	National Institutes of Health Research Project Grant Program [RO1 AA010114]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010114] Funding Source: NIH RePORTER	National Institutes of Health Research Project Grant Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by RO1 AA010114 (National Institutes of Health Research Project Grant Program) to George I. Henderson. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Aleksunes LM, 2012, DRUG METABOLISM DISP; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Bartuma H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-36; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Bignami F, 2012, BLOOD, V119, P6259, DOI 10.1182/blood-2011-09-379503; Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Burton NC, 2006, NEUROTOXICOLOGY, V27, P1094, DOI 10.1016/j.neuro.2006.07.019; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Chumanov RS, 2010, PROTEIN EXPRES PURIF, V74, P280, DOI 10.1016/j.pep.2010.06.017; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Dunckley T, 2006, BRAIN RES, V1116, P39, DOI 10.1016/j.brainres.2006.07.111; Fujimori K, 2012, J NEUROCHEM, V120, P279, DOI 10.1111/j.1471-4159.2011.07570.x; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grudt TJ, 1996, MOL BRAIN RES, V36, P93, DOI 10.1016/0169-328X(95)00248-Q; Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040; Ho PWL, 2006, J NEUROSCI RES, V84, P1358, DOI 10.1002/jnr.21034; Hota KB, 2012, J CEREBRAL BLOOD FLO; Im JY, 2012, HUMAN MOL GENETICS; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Janssen HL, 2011, HEPATOLOGY, V54, p1430A; Kang KW, 2002, MOL PHARMACOL, V62, P1001, DOI 10.1124/mol.62.5.1001; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kocerha J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-527; Kokot A, 2009, ENDOCRINOLOGY, V150, P3197, DOI 10.1210/en.2008-1315; Lau A, 2012, ANTIOXIDANT IN PRESS; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Li N, 2011, MECH AGEING DEV, V132, P75, DOI 10.1016/j.mad.2010.12.004; Li WG, 2010, NUCLEIC ACIDS RES, V38, P778, DOI 10.1093/nar/gkp1048; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; McGinnis KM, 1999, J NEUROCHEM, V72, P1853, DOI 10.1046/j.1471-4159.1999.0721853.x; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Narasimhan M, 2011, MOL PHARMACOL, V80, P988, DOI 10.1124/mol.111.073262; Nath R, 1997, BIOCHEM MOL BIOL INT, V43, P197; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Nguyen HN, 2002, BRAIN RES, V924, P159, DOI 10.1016/S0006-8993(01)03229-2; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Ragusa M, 2010, MOL CANCER THER, V9, P3396, DOI 10.1158/1535-7163.MCT-10-0137; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; Sangokoya C, 2010, BLOOD, V116, P4338, DOI 10.1182/blood-2009-04-214817; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shin JH, 2012, NEUROCHEMISTRY INT; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Silveira LR, 2003, FREE RADICAL BIO MED, V35, P455, DOI 10.1016/S0891-5849(03)00271-5; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Vo NK, 2010, P NATL ACAD SCI USA, V107, P19231, DOI 10.1073/pnas.1013162107; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Yang MH, 2011, BREAST CANCER RES TR, V129, P983, DOI 10.1007/s10549-011-1604-1; Yeang HXA, 2012, J BIOL CHEM, V287, P10556, DOI 10.1074/jbc.M111.322420; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	70	145	154	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51111	10.1371/journal.pone.0051111	http://dx.doi.org/10.1371/journal.pone.0051111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236440	gold, Green Submitted, Green Published			2022-12-27	WOS:000312064100069
J	Odunsi, K; Mhawech-Fauceglia, P; Andrews, C; Beck, A; Amuwo, O; Lele, S; Black, JD; Huang, RY				Odunsi, Kunle; Mhawech-Fauceglia, Paulette; Andrews, Christopher; Beck, Amy; Amuwo, Olajumoke; Lele, Shashikant; Black, Jennifer D.; Huang, Ruea-Yea			Elevated Expression of the Serine-Arginine Protein Kinase 1 Gene in Ovarian Cancer and Its Role in Cisplatin Cytotoxicity In Vitro	PLOS ONE			English	Article							SPLICING FACTORS; SACCHAROMYCES-CEREVISIAE; SR PROTEINS; CELL-CYCLE; NUCLEAR; INACTIVATION; RESISTANCE; DEPHOSPHORYLATION; PHOSPHORYLATION; VARIANTS	Alternatively spliced variants of several oncogenes and tumor suppressors have been shown to be important for their tumorigenicity. In the present study we have tested whether serine-arginine protein kinase 1 (SRPK1), a major regulator of splicing factors, is involved in ovarian cancer progression and plays a role in chemo-sensitivity. By Western blot analyses, SRPK1 protein was found to be overexpressed in 4 out of 6 ovarian cancer cell lines as compared with an immortalized ovarian surface epithelial cell line; and in 55% of ovarian tumor samples as compared with non-neoplastic ovarian tissue samples. Reduction of SRPK1 expression using small interfering RNA (siRNA) encoding small hairpin RNA in ovarian cancer cells led to (i) reduced cell proliferation rate, slower cell cycle progression and compromised anchorage-independent growth and migration ability in vitro, (ii) decreased level of phosphorylation of multiple serine-arginine proteins, and P44/42MAPK and AKT proteins, and (iii) enhanced sensitivity to cisplatin. Together, these results suggest that elevated SRPK1 expression may play a role in ovarian tumorigenesis and SRPK1 may be a potential target for ovarian cancer therapy.	[Odunsi, Kunle; Amuwo, Olajumoke; Lele, Shashikant; Huang, Ruea-Yea] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Mhawech-Fauceglia, Paulette] Roswell Pk Canc Inst, Dept Pathol & Lab Med, Buffalo, NY 14263 USA; [Andrews, Christopher] SUNY Buffalo, Dept Biostatist, Buffalo, NY 14260 USA; [Black, Jennifer D.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Odunsi, Kunle; Beck, Amy] Roswell Pk Canc Inst, Ctr Immunotherapy, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Huang, RY (corresponding author), Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA.	raya.huang@roswellpark.org		Andrews, Chris/0000-0001-5130-6374	National Institutes of Health [CA 107303]; Gynecologic Cancer Foundation [DK60632, CA16056]; Cancer Research Institute/Ludwig Institute for Cancer Research Cancer Vaccine Collaborative Grant; Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA016056, R21CA107303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK060632, R01DK060632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gynecologic Cancer Foundation; Cancer Research Institute/Ludwig Institute for Cancer Research Cancer Vaccine Collaborative Grant; Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants CA 107303 (RH), Gynecologic Cancer Foundation (RH), DK60632 (JDB), and CA16056 (RPCI Core Grant); Cancer Research Institute/Ludwig Institute for Cancer Research Cancer Vaccine Collaborative Grant (KO); and Hilton-Ludwig Cancer Metastasis Grant of the Ludwig Institute for Cancer Research (KO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn EY, 2011, MOL CELL, V42, P185, DOI 10.1016/j.molcel.2011.03.014; ANDREWS PA, 1985, CANCER RES, V45, P6250; ANDREWS PA, 1990, CANCER CELL-MON REV, V2, P35; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; AUERSPERG N, 1994, LAB INVEST, V71, P510; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Cao WH, 1997, RNA, V3, P1456; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; FU XD, 1995, RNA, V1, P663; Ghigna C, 1998, CANCER RES, V58, P5818; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Hayes GM, 2006, CANCER RES, V66, P3819, DOI 10.1158/0008-5472.CAN-05-4065; Hayes GM, 2007, CANCER RES, V67, P2072, DOI 10.1158/0008-5472.CAN-06-2969; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; He X, 2007, ONCOGENE; He XL, 2004, CLIN CANCER RES, V10, P4652, DOI 10.1158/1078-0432.CCR-03-0439; Hishizawa M, 2005, BRIT J HAEMATOL, V130, P382, DOI 10.1111/j.1365-2141.2005.05619.x; Huang RY, 1996, NUCLEIC ACIDS RES, V24, P816, DOI 10.1093/nar/24.5.816; Huang RY, 2005, CANCER RES, V65, P5890, DOI 10.1158/0008-5472.CAN-04-4093; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Krishnakumar S, 2008, PEDIATR BLOOD CANCER, V50, P402, DOI 10.1002/pbc.21088; Lin SR, 2005, MOL CELL, V20, P413, DOI 10.1016/j.molcel.2005.09.015; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; MERMOUD JE, 1994, EMBO J, V13, P5679, DOI 10.1002/j.1460-2075.1994.tb06906.x; Mhawech P, 2005, MODERN PATHOL, V18, P340, DOI 10.1038/modpathol.3800240; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Papoutsopoulou S, 1999, NUCLEIC ACIDS RES, V27, P2972, DOI 10.1093/nar/27.14.2972; Pelisch F, 2005, J BIOL CHEM, V280, P25461, DOI 10.1074/jbc.M412007200; Plasencia C, 2006, INT J ONCOL, V29, P225; ROTH MB, 1991, J CELL BIOL, V115, P587, DOI 10.1083/jcb.115.3.587; Salesse S, 2004, LEUKEMIA, V18, P727, DOI 10.1038/sj.leu.2403310; Schenk PW, 2002, MOL PHARMACOL, V61, P659, DOI 10.1124/mol.61.3.659; Schenk PW, 2001, CANCER RES, V61, P6982; Thorsen K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002998; Tockman MS, 1997, CLIN CANCER RES, V3, P2237; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang ZN, 2003, CANCER RES, V63, P655; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I	43	39	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51030	10.1371/journal.pone.0051030	http://dx.doi.org/10.1371/journal.pone.0051030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236423	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100054
J	Preissner, S; Dunkel, M; Hoffmann, MF; Preissner, SC; Genov, N; Rong, WW; Preissner, R; Seeger, K				Preissner, Saskia; Dunkel, Mathias; Hoffmann, Michael F.; Preissner, Sarah C.; Genov, Nikolai; Rong, Wen Wei; Preissner, Robert; Seeger, Karlheinz			Drug Cocktail Optimization in Chemotherapy of Cancer	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HUMAN LIVER-MICROSOMES; HUMAN HEPATOCYTES; IFOSFAMIDE ACTIVATION; METABOLIZING-ENZYMES; HEPG2 CELLS; IN-VITRO; CYTOCHROME-P450; DEXAMETHASONE; CYCLOPHOSPHAMIDE	Background: In general, drug metabolism has to be considered to avoid adverse effects and ineffective therapy. In particular, chemotherapeutic drug cocktails strain drug metabolizing enzymes especially the cytochrome P450 family (CYP). Furthermore, a number of important chemotherapeutic drugs such as cyclophosphamide, ifosfamide, tamoxifen or procarbazine are administered as prodrugs and have to be activated by CYP. Therefore, the genetic variability of these enzymes should be taken into account to design appropriate therapeutic regimens to avoid inadequate drug administration, toxicity and inefficiency. Objective: The aim of this work was to find drug interactions and to avoid side effects or ineffective therapy in chemotherapy. Data sources and methods: Information on drug administration in the therapy of leukemia and their drug metabolism was collected from scientific literature and various web resources. We carried out an automated textmining approach. Abstracts of PubMed were filtered for relevant articles using specific keywords. Abstracts were automatically screened for antineoplastic drugs and their synonyms in combination with a set of human CYPs in title or abstract. Results: We present a comprehensive analysis of over 100 common cancer treatment regimens regarding drug-drug interactions and present alternatives avoiding CYP overload. Typical concomitant medication, e. g. antiemetics or antibiotics is a preferred subject to improvement. A webtool, which allows drug cocktail optimization was developed and is publicly available on http://bioinformatics.charite.de/chemotherapy.	[Seeger, Karlheinz] Charite Univ Med Berlin, Dept Pediat, Div Hematol & Oncol, CC17, Berlin, Germany; [Preissner, Saskia] Charite Univ Med Berlin, Dept Operat & Prevent Dent, CC3, Berlin, Germany; [Dunkel, Mathias; Hoffmann, Michael F.; Preissner, Sarah C.; Genov, Nikolai; Rong, Wen Wei; Preissner, Robert] Charite Univ Med Berlin, Inst Physiol, CC2, Struct Bioinformat Grp, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Seeger, K (corresponding author), Charite Univ Med Berlin, Dept Pediat, Div Hematol & Oncol, CC17, Berlin, Germany.	karl.seeger@charite.de	Genov, Nikolai/F-1197-2017	Genov, Nikolai/0000-0002-0443-9841; Dunkel, Mathias/0000-0002-6642-483X; preissner, robert/0000-0002-2407-1087	Berliner Krebsgeselleschaft; DFG Graduate School 1776; BMBF MedSys; EU SynSys	Berliner Krebsgeselleschaft; DFG Graduate School 1776; BMBF MedSys(Federal Ministry of Education & Research (BMBF)); EU SynSys	This work was supported by Berliner Krebsgeselleschaft, DFG Graduate School 1776, BMBF MedSys, EU SynSys. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angalakuditi M, 2011, CLINICOECONOMIC OUTC, V3, P105, DOI 10.2147/CEOR.S21789; Araya Z, 2003, BIOCHEM J, V372, P529, DOI 10.1042/BJ20021651; Bates S, 2010, DRUG DISCOV TODAY, V15, P115, DOI 10.1016/j.drudis.2009.11.001; Baumhakel M, 2001, INT J CLIN PHARM TH, V39, P517; Bazargan A, 2012, EXPERT REV ANTICANC, V12, P393, DOI [10.1586/era.12.2, 10.1586/ERA.12.2]; Bell EC, 2007, ANN PHARMACOTHER, V41, P1819, DOI 10.1345/aph.1K316; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berners-Lee T, 2001, NATURE, V410, P1023, DOI 10.1038/35074206; Berners-Lee T, 2006, SCIENCE, V313, P769, DOI 10.1126/science.1126902; Bosch TM, 2006, CLIN PHARMACOKINET, V45, P253, DOI 10.2165/00003088-200645030-00003; CHANG TKH, 1993, CANCER RES, V53, P5629; Chang TKH, 1997, CANCER RES, V57, P1946; Colburn Dawn E, 2004, Hematology, V9, P217, DOI 10.1080/10245330410001701585; Davidsen ML, 2008, J PEDIAT HEMATOL ONC, V30, P831, DOI 10.1097/MPH.0b013e3181868570; Dennison JB, 2006, DRUG METAB DISPOS, V34, P1317, DOI 10.1124/dmd.106.009902; Egbelakin A, 2011, PEDIATR BLOOD CANCER, V56, P361, DOI 10.1002/pbc.22845; Engelhardt MB, 2008, BLAUE BUCH; Ferron GM, 1999, J PHARMACOKINET BIOP, V27, P1, DOI 10.1023/A:1020626611479; Flockhart DA., 2007, DRUG INTERACTIONS CY; Gardiner SJ, 2006, PHARMACOL REV, V58, P521, DOI 10.1124/pr.58.3.6; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Gentile DM, 1996, J PHARMACOL EXP THER, V277, P105; Gerbal-Chaloin S, 2001, DRUG METAB DISPOS, V29, P242; Gor PP, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2570; Grishanova A. Y., 2003, Biomeditsinskaya Khimiya, V49, P27; Hukkanen J, 2000, AM J RESP CELL MOL, V22, P360, DOI 10.1165/ajrcmb.22.3.3845; Ingelman-Sundberg Magnus, 2005, Toxicol Appl Pharmacol, V207, P52; Kanou M, 2004, MOL BIOL REP, V31, P151, DOI 10.1023/B:MOLE.0000043582.35335.ff; Krusekopf S, 2003, EUR J PHARMACOL, V466, P7, DOI 10.1016/S0014-2999(03)01481-X; Lampen A, 1995, DRUG METAB DISPOS, V23, P1315; Lindley C, 2002, DRUG METAB DISPOS, V30, P814, DOI 10.1124/dmd.30.7.814; Lund B, 2011, PEDIATR BLOOD CANCER, V56, P551, DOI 10.1002/pbc.22719; May-Manke A, 1999, CANCER CHEMOTH PHARM, V44, P327, DOI 10.1007/s002800050985; Mehta PA, 2004, CURR OPIN HEMATOL, V11, P434, DOI 10.1097/01.moh.0000145671.04385.4f; Miranda SR, 2007, FOOD CHEM TOXICOL, V45, P871, DOI 10.1016/j.fct.2006.11.011; Morrow PK, 2011, CANCER; Nelson David R, 2006, Methods Mol Biol, V320, P1; Niwa T, 2011, CURR DRUG METAB, V12, P549; OERTLE M, 1993, MOL CELL ENDOCRINOL, V91, P201, DOI 10.1016/0303-7207(93)90273-M; Patterson LH, 2002, CURR PHARM DESIGN, V8, P1335, DOI 10.2174/1381612023394502; Potter GA, 2002, BRIT J CANCER, V86, P774, DOI 10.1038/sj.bjc.6600197; Roy P, 1999, DRUG METAB DISPOS, V27, P655; Savas U, 2003, ARCH BIOCHEM BIOPHYS, V409, P212, DOI 10.1016/S0003-9861(02)00499-X; TRZECIAK WH, 1993, MOL ENDOCRINOL, V7, P206, DOI 10.1210/me.7.2.206; Usui T, 2003, BIOL PHARM BULL, V26, P510; Villikka K, 1999, CLIN PHARMACOL THER, V66, P589, DOI 10.1016/S0009-9236(99)90067-X; Vrzal R, 2009, CHEM-BIOL INTERACT, V179, P288, DOI 10.1016/j.cbi.2008.10.035; Xia XY, 2002, ACTA PHARMACOL SIN, V23, P471; ZHOU XJ, 1993, BIOCHEM PHARMACOL, V45, P853, DOI 10.1016/0006-2952(93)90169-W; ZHOUPAN XR, 1993, CANCER RES, V53, P5121	50	10	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51020	10.1371/journal.pone.0051020	http://dx.doi.org/10.1371/journal.pone.0051020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236419	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100051
J	Lauxmann, MA; Brun, B; Borsani, J; Bustamante, CA; Budde, CO; Lara, MV; Drincovich, MF				Lauxmann, Martin A.; Brun, Bianca; Borsani, Julia; Bustamante, Claudia A.; Budde, Claudio O.; Lara, Maria V.; Drincovich, Maria F.			Transcriptomic Profiling during the Post-Harvest of Heat-Treated Dixiland Prunus persica Fruits: Common and Distinct Response to Heat and Cold	PLOS ONE			English	Article							PEACH FRUIT; CHILLING INJURY; SHOCK PROTEINS; PROTEOMIC ANALYSIS; GENES; ACID; EXPRESSION; IDENTIFICATION; ACCUMULATION; WOOLLINESS	Cold storage is extensively used to slow the rapid deterioration of peach (Prunus persica L. Batsch) fruit after harvest. However, peach fruit subjected to long periods of cold storage develop chilling injury (CI) symptoms. Post-harvest heat treatment (HT) of peach fruit prior to cold storage is effective in reducing some CI symptoms, maintaining fruit quality, preventing softening and controlling post-harvest diseases. To identify the molecular changes induced by HT, which may be associated to CI protection, the differential transcriptome of peach fruit subjected to HT was characterized by the differential display technique. A total of 127 differentially expressed unigenes (DEUs), with a presence-absence pattern, were identified comparing peach fruit ripening at 20 degrees C with those exposed to a 39 degrees C-HT for 3 days. The 127 DEUs were divided into four expression profile clusters, among which the heat-induced (47%) and heat-repressed (36%) groups resulted the most represented, including genes with unknown function, or involved in protein modification, transcription or RNA metabolism. Considering the CI-protection induced by HT, 23-heat-responsive genes were selected and analyzed during and after short-term cold storage of peach fruit. More than 90% of the genes selected resulted modified by cold, from which nearly 60% followed the same and nearly 40% opposite response to heat and cold. Moreover, by using available Arabidopsis microarray data, it was found that nearly 70% of the peach-heat responsive genes also respond to cold in Arabidopsis, either following the same trend or showing an opposite response. Overall, the high number of common responsive genes to heat and cold identified in the present work indicates that HT of peach fruit after harvest induces a cold response involving complex cellular processes; identifying genes that are involved in the better preparation of peach fruit for cold-storage and unraveling the basis for the CI protection induced by HT. Citation: Lauxmann MA, Brun B, Borsani J, Bustamante CA, Budde CO, et al. (2012) Transcriptomic Profiling during the Post-Harvest of Heat-Treated Dixiland Prunus persica Fruits: Common and Distinct Response to Heat and Cold. PLoS ONE 7(12): e51052. doi:10.1371/journal.pone.0051052	[Lauxmann, Martin A.; Brun, Bianca; Borsani, Julia; Bustamante, Claudia A.; Lara, Maria V.; Drincovich, Maria F.] Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim CEFOBI, RA-2000 Rosario, Santa Fe, Argentina; [Budde, Claudio O.] INTA, Estn Expt San Pedro, San Pedro, Argentina	National University of Rosario; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Drincovich, MF (corresponding author), Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim CEFOBI, RA-2000 Rosario, Santa Fe, Argentina.	drincovich@cefobi-conicet.gov.ar	Drincovich, Maria F/Q-4195-2019; Drincovich, Maria F/F-3902-2017	Drincovich, Maria F/0000-0003-4897-3285; Drincovich, Maria F/0000-0003-4897-3285; Bustamante, Claudia/0000-0003-4113-4219; Lauxmann, Martin Alexander/0000-0003-1162-4858	Agencia Nacional de Promocion de Actividades Cientificas y Tecnicas (Argentina); CONICET (Argentina) [PIP 0679]	Agencia Nacional de Promocion de Actividades Cientificas y Tecnicas (Argentina); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Agencia Nacional de Promocion de Actividades Cientificas y Tecnicas (Argentina) and by CONICET (PIP 0679; Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borsani J, 2009, J EXP BOT, V60, P1823, DOI 10.1093/jxb/erp055; Brummell DA, 2004, J EXP BOT, V55, P2041, DOI 10.1093/jxb/erh228; Cao SF, 2010, POSTHARVEST BIOL TEC, V58, P93, DOI 10.1016/j.postharvbio.2010.05.010; Childs KL, 2007, NUCLEIC ACIDS RES, V35, pD846, DOI 10.1093/nar/gkl785; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dagar A, 2013, TREE GENET GENOMES, V9, P223, DOI 10.1007/s11295-012-0549-9; Dagar A, 2011, POSTHARVEST BIOL TEC, V60, P1, DOI 10.1016/j.postharvbio.2010.11.002; Dagar A, 2010, POSTHARVEST BIOL TEC, V57, P77, DOI 10.1016/j.postharvbio.2010.03.009; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Falara V, 2011, FUNCT INTEGR GENOMIC, V11, P357, DOI 10.1007/s10142-010-0204-1; Ferguson IB, 2000, POSTHARVEST BIOL TEC, V21, P1, DOI 10.1016/S0925-5214(00)00160-5; Gonzalez-Aguero M, 2008, J EXP BOT, V59, P1973, DOI 10.1093/jxb/em69; Jin P, 2009, POSTHARVEST BIOL TEC, V52, P24, DOI 10.1016/j.postharvbio.2008.09.011; Jung S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-81; Lara MV, 2011, PLANT CELL PHYSIOL, V52, P392, DOI 10.1093/pcp/pcq200; Lara MV, 2009, J EXP BOT, V60, P4315, DOI 10.1093/jxb/erp267; Lazzari B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S9; Liang P, 1998, MOL BIOTECHNOL, V10, P261, DOI 10.1007/BF02740847; Liu J, 2012, POSTHARVEST BIOL TEC, V65, P61, DOI 10.1016/j.postharvbio.2011.11.002; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lurie S, 2006, ACTA HORTIC, P165, DOI 10.17660/ActaHortic.2006.712.16; Lurie S, 2005, POSTHARVEST BIOL TEC, V37, P195, DOI 10.1016/j.postharvbio.2005.04.012; Lurie S, 1998, POSTHARVEST BIOL TEC, V14, P257, DOI 10.1016/S0925-5214(98)00045-3; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; Nilo R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-43; Ogundiwin EA, 2008, PLANT MOL BIOL, V68, P379, DOI 10.1007/s11103-008-9378-5; Paull RE, 2000, POSTHARVEST BIOL TEC, V21, P21, DOI 10.1016/S0925-5214(00)00162-9; Pegoraro C, 2011, PLANT GROWTH REGUL, V65, P231, DOI 10.1007/s10725-011-9591-0; Pegoraro C, 2010, POSTHARVEST BIOL TEC, V57, P19, DOI 10.1016/j.postharvbio.2010.02.003; Polenta GA, 2007, FEBS J, V274, P6447, DOI 10.1111/j.1742-4658.2007.06162.x; Rugkong A, 2011, POSTHARVEST BIOL TEC, V61, P1, DOI 10.1016/j.postharvbio.2011.02.009; Sabehat A, 1996, PLANT PHYSIOL, V110, P531, DOI 10.1104/pp.110.2.531; Sabehat A, 1998, PLANT PHYSIOL, V117, P651, DOI 10.1104/pp.117.2.651; Sanchez-Ballesta MT, 2003, PLANTA, V218, P65, DOI 10.1007/s00425-003-1086-4; Sapitnitskaya M, 2006, J EXP BOT, V57, P2943, DOI 10.1093/jxb/erl055; Tittarelli A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-121; Trainotti L, 2007, J EXP BOT, V58, P3299, DOI 10.1093/jxb/erm178; Vizoso P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-423; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wang LJ, 2006, POSTHARVEST BIOL TEC, V41, P244, DOI 10.1016/j.postharvbio.2006.04.010; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yang AP, 2011, FOOD CHEM, V129, P1619, DOI 10.1016/j.foodchem.2011.06.018; Yang ZF, 2012, J AGR FOOD CHEM, V60, P1209, DOI 10.1021/jf2041164; Zhang CF, 2010, AMINO ACIDS, V39, P181, DOI 10.1007/s00726-009-0397-6; Zhang CF, 2010, FOOD CHEM, V120, P864, DOI 10.1016/j.foodchem.2009.11.029; Zhang CF, 2009, FOOD CHEM, V115, P405, DOI 10.1016/j.foodchem.2008.12.021; Zhang L, 2011, J PROTEOMICS, V74, P1135, DOI 10.1016/j.jprot.2011.04.012	50	29	29	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51052	10.1371/journal.pone.0051052	http://dx.doi.org/10.1371/journal.pone.0051052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236430	Green Published, gold, Green Submitted			2022-12-27	WOS:000312589700029
J	Mura, M; Cappato, S; Giacopelli, F; Ravazzolo, R; Bocciardi, R				Mura, Marzia; Cappato, Serena; Giacopelli, Francesca; Ravazzolo, Roberto; Bocciardi, Renata			The Role of the 3 ' UTR Region in the Regulation of the ACVR1/Alk-2 Gene Expression	PLOS ONE			English	Article							MESSENGER-RNA; UP-REGULATION; ALK2; MICRORNAS; DIFFERENTIATION; MIR-365; GROWTH; CELLS; REPRESSION; RECEPTORS	Background: The ACVR1/Alk-2 gene, encoding a BMP type I receptor, is mutated in Fibrodysplasia Ossificans Progressiva, a severe form of heterotopic ossification. Regulation of ACVR1/Alk-2 expression, still poorly understood, is likely to be controlled by transcriptional and post-transcriptional mechanisms. In our work, we focused on the functional role of the 3'UTR region of the gene and on microRNAs as possible modulators of the ACVR1/Alk-2 expression. Results: The ACVR1/Alk-2 3'UTR region consists of a 1.1 kb sequence harboring several putative, well-conserved binding sites for miRNAs in its proximal half, and AU-rich elements in the distal one, as assessed by bioinformatic analysis. The functional role of this region was tested in presence of transcription inhibitors and in transfection experiments in different cell lines, with a ACVR1/Alk-2-3'UTR reporter construct. By this transfection-based approach, we have also verified that three microRNAs, among those predicted to target ACVR1/Alk-2 gene by in silico analysis, can bind its 3'UTR sequence thereby modulating its expression. Conclusion: In this work we demonstrated that the ACVR1/Alk-2 transcript is unstable in presence of inhibitors of transcription. Functional analysis of the 3'UTR region by Luciferase reporter assays showed that it plays an inhibitory role on ACVR1/Alk-2 gene expression. Moreover, we found that specific miRNAs are involved in modulating ACVR1/Alk-2 gene expression as suggested by binding sites prediction in its 3'UTR sequence. In particular, we found that mir148b and mir365 were able to down-regulate ACVR1/Alk-2 expression, whereas mir26a showed a positive effect on its mRNA. Our data contribute to elucidate some of the mechanisms intervening in the modulation of ACVR1/Alk-2 expression. Considering that no specific and effective treatment of FOP is available, clarifying the basic mechanisms of the ACVR1/Alk-2 gene biology may provide means to develop innovative therapeutics approaches.	[Mura, Marzia; Ravazzolo, Roberto; Bocciardi, Renata] G Gaslini Inst Children, Mol Genet Lab, Genoa, Italy; [Cappato, Serena; Giacopelli, Francesca; Ravazzolo, Roberto; Bocciardi, Renata] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy; [Cappato, Serena; Giacopelli, Francesca; Ravazzolo, Roberto; Bocciardi, Renata] CEBR, Genoa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa	Bocciardi, R (corresponding author), G Gaslini Inst Children, Mol Genet Lab, Genoa, Italy.	bocciardi@unige.it	Cappato, Serena/J-8605-2016; Cappato, Serena/AAB-3972-2021; Bocciardi, Renata/J-8577-2016	Cappato, Serena/0000-0002-1745-5410; Cappato, Serena/0000-0002-1745-5410; Bocciardi, Renata/0000-0001-8415-3802	FOP Italia Association; Italian Ministry of Health [RFPS-2007-4-631972]	FOP Italia Association; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by FOP Italia Association and by the Strategic grant RFPS-2007-4-631972 of the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTUS MS, 1991, J BIOL CHEM, V266, P21190; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Chen LZ, 2011, MOL THER, V19, P1521, DOI 10.1038/mt.2011.64; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Guan YJ, 2011, FASEB J, V25, P4457, DOI 10.1096/fj.11-185132; Harradine KA, 2006, ANN MED, V38, P403, DOI 10.1080/07853890600919911; Herrera B, 2009, CANCER RES, V69, P9254, DOI 10.1158/0008-5472.CAN-09-2912; Kaartinen V, 2004, DEVELOPMENT, V131, P3481, DOI 10.1242/dev.01214; Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868; Karbiener M, 2011, RNA BIOL, V1; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Qin B, 2011, BIOCHEM BIOPH RES CO, V410, P127, DOI 10.1016/j.bbrc.2011.05.118; Romero D, 2010, CARCINOGENESIS, V31, P359, DOI 10.1093/carcin/bgp217; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605; Shore EM, 2010, NAT REV RHEUMATOL, V6, P518, DOI 10.1038/nrrheum.2010.122; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Song YX, 2012, INT J CANCER, V131, P1042, DOI 10.1002/ijc.26485; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Wang J, 2011, BIRTH DEFECTS RES A, V91, P441, DOI 10.1002/bdra.20785; Witwer KW, 2010, J IMMUNOL, V184, P2369, DOI 10.4049/jimmunol.0902712; Xu Z, 2011, J BIOL CHEM, V286, P21401, DOI 10.1074/jbc.M110.198630; Yamazaki S, 2008, BBA-GENE REGUL MECH, V1779, P108, DOI 10.1016/j.bbagmi.2007.11.001; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209	36	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50958	10.1371/journal.pone.0050958	http://dx.doi.org/10.1371/journal.pone.0050958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227223	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200084
J	Fausto, S; Machado, FA; Bento, LFJ; Iamarino, A; Nahas, TR; Munger, DS				Fausto, Sibele; Machado, Fabio A.; Bento, Luiz Fernando J.; Iamarino, Atila; Nahas, Tatiana R.; Munger, David S.			Research Blogging: Indexing and Registering the Change in Science 2.0	PLOS ONE			English	Article							BLOGS	Increasing public interest in science information in a digital and 2.0 science era promotes a dramatically, rapid and deep change in science itself. The emergence and expansion of new technologies and internet-based tools is leading to new means to improve scientific methodology and communication, assessment, promotion and certification. It allows methods of acquisition, manipulation and storage, generating vast quantities of data that can further facilitate the research process. It also improves access to scientific results through information sharing and discussion. Content previously restricted only to specialists is now available to a wider audience. This context requires new management systems to make scientific knowledge more accessible and useable, including new measures to evaluate the reach of scientific information. The new science and research quality measures are strongly related to the new online technologies and services based in social media. Tools such as blogs, social bookmarks and online reference managers, Twitter and others offer alternative, transparent and more comprehensive information about the active interest, usage and reach of scientific publications. Another of these new filters is the Research Blogging platform, which was created in 2007 and now has over 1,230 active blogs, with over 26,960 entries posted about peer-reviewed research on subjects ranging from Anthropology to Zoology. This study takes a closer look at RB, in order to get insights into its contribution to the rapidly changing landscape of scientific communication.	[Fausto, Sibele] Univ Sao Paulo, Escola Comunicacoes & Artes, Sao Paulo, Brazil; [Machado, Fabio A.] Univ Sao Paulo, Inst Biociencias, Sao Paulo, Brazil; [Bento, Luiz Fernando J.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Iamarino, Atila] Univ Sao Paulo, Inst Ciencias Biomed, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Fausto, S (corresponding author), Univ Sao Paulo, Escola Comunicacoes & Artes, Sao Paulo, Brazil.	sifausto@usp.br		Machado, Fabio/0000-0002-0215-9926; Iamarino, Atila/0000-0003-3904-0248	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2011/21674-4, 2008/58559-5]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	FAM and AI are supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), grant numbers 2011/21674-4 and 2008/58559-5, respectively.	AKST J, 2010, PUBLISH POST SCI BLO, DOI DOI 10.1371/JOURNAL.PBIO.0060240; Anderson K, 2009, IMPACT FACTOR TOOL B; [Anonymous], 2011, GOBBLEDYGOOK    1220; [Anonymous], 2012, SCI ONL 2012 C; [Anonymous], GUARDIAN; Arbesman S, 2012, NEW WAYS MEASURE SCI; Bar-Ilan J, 2009, PRO INT CONF SCI INF, V1, P1; Batts SA, 2008, PLOS BIOL, V6, P1837, DOI 10.1371/journal.pbio.0060240; Beltrao P, 2006, PUBLIC RAMBLING 1121; Bogers T, 2008, RECSYS'08: PROCEEDINGS OF THE 2008 ACM CONFERENCE ON RECOMMENDER SYSTEMS, P287; Bollen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006022; Bonetta L, 2007, CELL, V129, P443, DOI 10.1016/j.cell.2007.04.032; Bonetta L, 2009, CELL, V139, P452, DOI 10.1016/j.cell.2009.10.017; De Moya-Anegon F, 2007, SCIENTOMETRICS, V73, P53, DOI 10.1007/s11192-007-1681-4; Deitering AM, 2011, PORTAL-LIBR ACAD, V11, P489; *ED, 2009, NATURE, V457, P1058, DOI DOI 10.1038/4571058A; Eisen MB, 2012, ECONOMIST; Evans Perry, 2011, AMIA Annu Symp Proc, V2011, P374; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1923; Fausto S, 2011, EARTH, V2, P957; Groth P, 2010, P WEBSCI10 RAL NC US; Gu F, 2011, ELECTRON LIBR, V29, P762, DOI 10.1108/02640471111187999; HARNAD S, 1991, PUBLIC ACCESS COMPUT, V2, P39; Haustein S, 2011, J INFORMETR, V5, P446, DOI 10.1016/j.joi.2011.04.002; Kouper I, 2010, JCOM-J SCI COMMUN, V9; Kowalczyk S, 2011, ANNU REV INFORM SCI, V45, P247, DOI 10.1002/aris.2011.1440450113; Kwak H., 2010, INT WORLD WID WEB C; Kwak H, 2010, HYDROLOGIC      0623, DOI 10.1145/1772690.1772751; Lane J, 2010, NATURE, V464, P488, DOI 10.1038/464488a; Li XM, 2012, SCIENTOMETRICS, V91, P461, DOI 10.1007/s11192-011-0580-x; MacRoberts MH, 2010, J AM SOC INF SCI TEC, V61, P1, DOI 10.1002/asi.21228; Molloy JC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001195; Moya-Anegon F, 2007, P 13 INT SOC SCI INF, V73, P53, DOI 10.1007/s11192-007-1681-4; Neylon C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000242; Powell DA, 2012, INNOV HIGH EDUC, V37, P271, DOI 10.1007/s10755-011-9207-7; Priem J., 2010, 1 MONDAY, V15, DOI DOI 10.5210/FM.V15I7.2874; Priem J., 2010, ALTMETRICS MANIFESTO; Priem J., 2012, ARXIV12034745; R Development Core Team, 2012, R LANG ENV STAT COMP; Rossner M, 2007, J CELL BIOL, V179, P1091, DOI 10.1083/jcb.200711140; Schofield PN, 2009, NATURE, V461, P171, DOI 10.1038/461171a; Shema H, 2012, SEED MAGAZINE   0922, V7, DOI 10.1371/journal.-pone.0035869; Shema H, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035869, 10.4161/psb.19467]; Taylor M, 2012, NY TIMES; The price of information, 2012, SCI BLOGGING    1123; Wikipedia. Philosophical Transactions of the Royal Society, PHILOS T ROYAL SOC; Yan KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019917	47	54	54	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50109	10.1371/journal.pone.0050109	http://dx.doi.org/10.1371/journal.pone.0050109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251358	gold, Green Submitted, Green Published			2022-12-27	WOS:000313236200025
J	Reitz, C; Tosto, G; Mayeux, R; Luchsinger, JA				Reitz, Christiane; Tosto, Giuseppe; Mayeux, Richard; Luchsinger, Jose A.		NIA-LOAD NCRAD Family Study Grp; Alzheimer's Dis Neuroimaging Initi	Genetic Variants in the Fat and Obesity Associated (FTO) Gene and Risk of Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FALSE DISCOVERY RATE; IDENTIFIES VARIANTS; COMMON VARIANTS; BLOOD-PRESSURE; DEMENTIA; ADIPOSITY; LOCI; CLU; HYPERINSULINEMIA	Background: Recent studies showed that polymorphisms in the Fat and Obesity-Associated (FTO) gene have robust effects on obesity, obesity-related traits and endophenotypes associated with Alzheimer's disease (AD). Methods: We used 1,877 Caucasian cases and controls from the NIA-LOAD study and 1,093 Caribbean Hispanics to further explore the association of FTO with AD. Using logistic regression, we assessed 42 SNPs in introns 1 and 2, the region previously reported to be associated with AD endophenotypes, which had been derived by genome-wide screenings. In addition, we performed gene expression analyses of neuropathologically confirmed AD cases and controls of two independent datasets (19 AD cases, 10 controls; 176 AD cases, 188 controls) using within-and between-group factors ANOVA of log(10) transformed rank invariant normalized expression data. Results: In the NIALOAD study, one SNP was significantly associated with AD and three additional markers were close to significance (rs6499640, rs10852521, rs16945088, rs8044769, FDR p-value: 0.05<p<0.09). Two of the SNPs are in strong LD (D'>0.9) with the previously reported SNPs. In the Caribbean Hispanic dataset, we identified three SNPs (rs17219084, rs11075996, rs11075997, FDR p-value: 0.009<p<0.01) that were associated with AD. These results were confirmed by haplotype analyses and in a metaanalysis in which we included the ADNI dataset. FTO had a significantly lower expresssion in AD cases compared to controls in two independent datasets derived from human cortex and amygdala tissue, respectively (p = 2.18x10-5 and p<0.0001). Conclusions: Our data support the notion that genetic variation in Introns 1 and 2 of the FTO gene may contribute to AD risk.	[Reitz, Christiane; Tosto, Giuseppe; Mayeux, Richard] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Reitz, Christiane; Mayeux, Richard] Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY 10027 USA; [Reitz, Christiane; Mayeux, Richard] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY USA; [Mayeux, Richard] Columbia Univ, Dept Psychiat, Coll Phys & Surg, New York, NY USA; [Mayeux, Richard; Luchsinger, Jose A.] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Mayeux, R (corresponding author), Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	rpm2@columbia.edu	Preda, Adrian/K-8889-2013; Mayeux, Richard/E-9788-2013; Hsiung, Robin/AAT-1661-2021; Levey, Allan/F-2104-2011; Reitz, Christiane/GNP-0257-2022	Preda, Adrian/0000-0003-3373-2438; Mayeux, Richard/0000-0001-6519-9696; Hsiung, Robin/0000-0002-8017-0856; Levey, Allan/0000-0002-3153-502X; Luchsinger, Jose/0000-0002-5886-3648	National Institutes of Health (NIH); National Institute on Aging [R37-AG15473, P01-AG07232]; Blanchett Hooker Rockefeller Foundation; Paul B. Beeson Career Development Award [K23AG034550]; National Institute on Aging - Late Onset Alzheimer's Disease Family Study [U24AG026390]; National Cell Repository for Alzheimer's Disease (NCRAD) [U24 AG21886]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Northern California Institute for Research and Education; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; National Institute on Aging (NIA); Abbott; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; Takeda Pharmaceutical Company; NATIONAL INSTITUTE ON AGING [U24AG021886, R37AG015473, U01AG024904, P30AG010129, P30AG013846, K23AG034550, P01AG007232, P30AG019610, R01AG041797, U19AG010483, R01AG026390, K01AG030514, P50AG008702, R01AG037212] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Blanchett Hooker Rockefeller Foundation; Paul B. Beeson Career Development Award; National Institute on Aging - Late Onset Alzheimer's Disease Family Study; National Cell Repository for Alzheimer's Disease (NCRAD); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Northern California Institute for Research and Education; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Abbott(Abbott Laboratories); Amorfix Life Sciences Ltd.; AstraZeneca(AstraZeneca); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); BioClinica, Inc.; Biogen Idec Inc.(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals Inc.; Eli Lilly and Company(Eli Lilly); F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); GE Healthcare(General ElectricGE Healthcare); Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Medpace, Inc.; Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Servier(Servier); Synarc Inc.; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (NIH) and the National Institute on Aging: R37-AG15473, P01-AG07232, The Blanchett Hooker Rockefeller Foundation, The Charles S. Robertson Gift from the Banbury Fund, and The Merrill Lynch Foundation. Dr. Reitz was further supported by a Paul B. Beeson Career Development Award (K23AG034550). Data and samples from the National Institute on Aging - Late Onset Alzheimer's Disease Family Study, which receives government support under a cooperative agreement grant (U24AG026390), were also used in this study. Samples from the National Cell Repository for Alzheimer's Disease (NCRAD), which receives government support under a cooperative agreement grant (U24 AG21886) awarded by the National Institute on Aging (NIA), were used in this study. Data collection and sharing for the ADNI project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N. V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ADNI is partly funded through generous contributions from the following: Abbott; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 1976, GERIATRIC PSYCHIAT; [Anonymous], 1981, WAIS R MANUAL; Benedict C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.02.006; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Benton A., 1955, BENTON VISUAL RETENT; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Chen JJ, 2010, CANCER CONTROL, V17, P58, DOI 10.1177/107327481001700108; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Goodglass H., 1983, BOSTON NAMING TEST; Goodglass H., 1983, ASSESSMENT APHASIA R, V2nd; Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hertel JK, 2011, DIABETES, V60, P1637, DOI 10.2337/db10-1340; Ho AJ, 2010, P NATL ACAD SCI USA, V107, P8404, DOI 10.1073/pnas.0910878107; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hotta K, 2011, J HUM GENET; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Keller L, 2011, J ALZHEIMERS DIS, V23, P461, DOI 10.3233/JAD-2010-101068; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee JH, 2008, ARCH NEUROL-CHICAGO, V65, P1518, DOI 10.1001/archneur.65.11.1518; Lee JH, 2011, ARCH NEUROL-CHICAGO, V68, P320, DOI 10.1001/archneurol.2010.292; Lewandowski NM, 2005, J NEUROSCI, V25, P10341, DOI 10.1523/JNEUROSCI.4006-05.2005; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P392, DOI 10.1001/archneur.64.3.392; Luchsinger JA, 2008, EUR J PHARMACOL, V585, P119, DOI 10.1016/j.ejphar.2008.02.048; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nourhashemi F, 2003, NEUROLOGY, V60, P117, DOI 10.1212/01.WNL.0000038910.46217.AA; Pausova Z, 2009, CIRC-CARDIOVASC GENE, V2, P260, DOI 10.1161/CIRCGENETICS.109.857359; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Rosen W., 1981, ROSEN DRAWING TEST; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; STERN Y, 1992, ARCH NEUROL-CHICAGO, V49, P453, DOI 10.1001/archneur.1992.00530290035009; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; van Boxtel MPJ, 2006, J HUM HYPERTENS, V20, P5, DOI 10.1038/sj.jhh.1001934; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018939; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Yu YH, 2005, CIRC RES, V96, P1042, DOI 10.1161/01.RES.0000165803.47776.38; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010375	54	66	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50354	10.1371/journal.pone.0050354	http://dx.doi.org/10.1371/journal.pone.0050354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251365	Green Published, gold			2022-12-27	WOS:000313236200027
J	Schneider, A; David, VA; Johnson, WE; O'Brien, SJ; Barsh, GS; Menotti-Raymond, M; Eizirik, E				Schneider, Alexsandra; David, Victor A.; Johnson, Warren E.; O'Brien, Stephen J.; Barsh, Gregory S.; Menotti-Raymond, Marilyn; Eizirik, Eduardo			How the Leopard Hides Its Spots: ASIP Mutations and Melanism in Wild Cats	PLOS ONE			English	Article							AGOUTI SIGNALING PROTEIN; COAT-COLOR; GENETICS; PIGMENTATION; EVOLUTION; INHERITANCE; EXTENSION; PATTERNS; RECEPTOR; GENES	The occurrence of melanism (darkening of the background coloration) is documented in 13 felid species, in some cases reaching high frequencies at the population level. Recent analyses have indicated that it arose multiple times in the Felidae, with three different species exhibiting unique mutations associated with this trait. The causative mutations in the remaining species have so far not been identified, precluding a broader assessment of the evolutionary dynamics of melanism in the Felidae. Among these, the leopard (Panthera pardus) is a particularly important target for research, given the iconic status of the 'black panther' and the extremely high frequency of melanism observed in some Asian populations. Another felid species from the same region, the Asian golden cat (Pardofelis temminckii), also exhibits frequent records of melanism in some areas. We have sequenced the coding region of the Agouti Signaling Protein (ASIP) gene in multiple leopard and Asian golden cat individuals, and identified distinct mutations strongly associated with melanism in each of them. The single nucleotide polymorphism (SNP) detected among the P. pardus individuals was caused by a nonsense mutation predicted to completely ablate ASIP function. A different SNP was identified in P. temminckii, causing a predicted amino acid change that should also induce loss of function. Our results reveal two additional cases of species-specific mutations implicated in melanism in the Felidae, and indicate that ASIP mutations may play an important role in naturally-occurring coloration polymorphism.	[Schneider, Alexsandra; Eizirik, Eduardo] Pontificia Univ Catolica Rio Grande Sul PUCRS, Lab Biol Genom & Mol, Fac Biociencias, Porto Alegre, RS, Brazil; [David, Victor A.; Johnson, Warren E.; O'Brien, Stephen J.; Menotti-Raymond, Marilyn] Frederick Natl Lab Canc Res, Lab Genom Div, Frederick, MD USA; [O'Brien, Stephen J.] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Informat, St Petersburg, Russia; [Barsh, Gregory S.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Eizirik, Eduardo] Inst Procarnivoros, Sao Paulo, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Saint Petersburg State University; HudsonAlpha Institute for Biotechnology	Schneider, A (corresponding author), Pontificia Univ Catolica Rio Grande Sul PUCRS, Lab Biol Genom & Mol, Fac Biociencias, Porto Alegre, RS, Brazil.	ale-schneider@live.com; eduardo.eizirik@pucrs.br	OBRIEN, STEPHEN/ABD-1346-2020; Johnson, Warren/D-4149-2016; David, Victor A/I-9330-2012; Eizirik, Eduardo/K-8034-2012	Johnson, Warren/0000-0002-5954-186X; Eizirik, Eduardo/0000-0002-9658-0999; OBRIEN, STEPHEN/0000-0001-7857-0757; O'Brien, Stephen J./0000-0001-7353-8301	Brazilian National Research Council/CNPq; CAPES/Brazil; USA federal funds from the National Cancer Institute, National Institutes of Health [HHSN26120080001E]	Brazilian National Research Council/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); USA federal funds from the National Cancer Institute, National Institutes of Health	This work was funded by the Brazilian National Research Council/CNPq (www.cnpq.br), CAPES/Brazil (www.capes.gov.br), and USA federal funds from the National Cancer Institute, National Institutes of Health (www.nih.gov), under contract HHSN26120080001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does its mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angwin D, 1975, B E AFR NAT HIST SOC, V3; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Barsh GS, 2006, PIGMENTARY SYSTEM, P395, DOI DOI 10.1002/9780470987100.CH19; Burton RG, 1928, FIELD, V152, P656; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Coleman L.E., 1974, Carnivore Genet Newsl, V2, P209; Dinulescu DM, 2000, J BIOL CHEM, V275, P6695, DOI 10.1074/jbc.275.10.6695; Dittrich L., 1979, Zoologische Garten, V49, P417; Dunstone N, 1998, CAT NEWS, V29, P18; Eizirik E, 2003, CURR BIOL, V13, P448, DOI 10.1016/S0960-9822(03)00128-3; Eizirik E, 2010, GENETICS, V184, P267, DOI 10.1534/genetics.109.109629; Gibson-Hill CA, 1950, J BOMBAY NAT HIST SO, V19, P375; Hillis David M., 1996, P321; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; Junge C, 1975, INT ZOO NEWS, V21, P38; Kaelin C, 2010, PIGM CELL MELANOMA R, V23, P514, DOI 10.1111/j.1755-148X.2010.00723.x; Kaelin CB, 2012, SCIENCE, V337, P1536, DOI 10.1126/science.1220893; Kawanishi K, 2010, J ZOOL, V282, P201, DOI 10.1111/j.1469-7998.2010.00731.x; Kerns JA, 2004, MAMM GENOME, V15, P798, DOI 10.1007/s00335-004-2377-1; Kingsley EP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006435; KLUNGLAND H, 1995, MAMM GENOME, V6, P636, DOI 10.1007/BF00352371; Lamotte Maxime, 1942, MAMMALIA, V6, P114, DOI 10.1515/mamm.1942.6.3.114; Lonnberg E., 1898, ZOOL JB, V10, P569; MacDougall-Shackleton EA, 2003, MOL BIOL EVOL, V20, P1675, DOI 10.1093/molbev/msg186; Majerus MEN, 2003, TRENDS GENET, V19, P585, DOI 10.1016/j.tig.2003.09.003; McNulty JC, 2005, J MOL BIOL, V346, P1059, DOI 10.1016/j.jmb.2004.12.030; Miltenberger RJ, 2002, GENETICS, V160, P659; Mundy NI, 2006, MAMM GENOME, V17, P1205, DOI 10.1007/s00335-006-0056-0; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Palumbi Stephen R., 1996, P205; Perry WL, 1996, GENETICS, V144, P255; Rieder S, 2001, MAMM GENOME, V12, P450, DOI 10.1007/s003350020017; ROBINSON R, 1970, GENETICA, V41, P190, DOI 10.1007/BF00958904; Robinson R., 1959, Bibliographia Genetica, V18, P273; ROBINSON R, 1976, GENETICA, V46, P1; ROBINSON R, 1969, Journal of the Bombay Natural History Society, V66, P423; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Searle A.G., 1968, COMP GENETICS COAT C; Sunquist ME, 2002, WILD CATS WORLD; Sunquist Mel, 1998, Cat News, V28, P17; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; ULMER FRED A., 1941, JOUR MAMMAL, V22, P285, DOI 10.2307/1374954; Vage DI, 1997, NAT GENET, V15, P311, DOI 10.1038/ng0397-311; Weigel I., 1961, Saugetierkundliche Mitteilungen, V9, P1; Whiting PW, 1918, J EXP ZOOL, V25, P539, DOI 10.1002/jez.1400250207; Wibisono Hariyo T., 2010, Cat News, V52, P9; Wrogemann N., 1975, CHEETAH SUN; Young SP., 1946, PUMA MYSTERIOUS AM C	50	25	30	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50386	10.1371/journal.pone.0050386	http://dx.doi.org/10.1371/journal.pone.0050386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251368	Green Submitted, Green Published, gold			2022-12-27	WOS:000313236200028
J	Yin, XX; Tu, XC; Tong, YQ; Yang, R; Wang, YX; Cao, SY; Fan, H; Wang, F; Gong, YH; Yin, P; Lu, ZX				Yin, Xiaoxv; Tu, Xiaochen; Tong, Yeqing; Yang, Rui; Wang, Yunxia; Cao, Shiyi; Fan, Hong; Wang, Feng; Gong, Yanhong; Yin, Ping; Lu, Zuxun			Development and Validation of a Tuberculosis Medication Adherence Scale	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PATIENT ADHERENCE; VALIDITY; RATES; CHINA; DOTS	Background: Medication adherence is critical in Tuberculosis (TB) treatment success, but existing tools are inadequate in identifying non-adherents, reasons for non-adherence or interventions to improve adherence. This study intended to fill the gap by developing and validating a TB medication adherence scale (TBMAS). Methods: An initial 41-item TBMAS was designed through review of literature, consultation from an 8-member clinical expert panel and a 15-patient focus group, and pilot-testing in 25 TB patients. The questionnaire was validated in 438 patients who visited 23 community health centers for TB treatment in Wuhan from September 1, 2010, to August 31, 2011, using pharmacy refill records in a 15-week period as external criteria for medication adherence. After removing redundant and cross-loading items, the internal consistency, reliability and validity of TBMAS in identifying non-adherents were examined. Results: The final TBMAS included 30 items scored on a 5-point Likert scale, and these items were loaded in nine distinct factors that explained 65% of cumulative variance among respondents. Cronbach's alpha, test-retest reliability and split-half reliability were 0.87, 0.83, and 0.85, respectively. Convergent validity was supported by statistically significant associations between TBMAS scores and adherence measured by pharmacy refill records. Receiver Operating Characteristics curve analysis suggested a cut-off point at 113, with which TBMAS showed a positive predictive value of 65.5% and sensitivity of 82.9% in identifying non-adherents. Conclusion: TBMAS demonstrated satisfactory internal consistency, reliability and validity in identifying TB patients with poor adherence and potential causes for non-adherence.	[Yin, Xiaoxv; Tu, Xiaochen; Yang, Rui; Wang, Yunxia; Cao, Shiyi; Gong, Yanhong; Lu, Zuxun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Tong, Yeqing] Hubei Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Fan, Hong] Nanjing Med Univ, Dept Social Med & Educ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Wang, Feng] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Yin, Ping] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Nanjing Medical University; Chinese University of Hong Kong; Huazhong University of Science & Technology	Yin, P (corresponding author), Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China.	ping_y2000@163.com; zuxunlu@yahoo.com		Wang, Feng/0000-0003-2618-201X	National Natural Science Foundation of China [70973041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by National Natural Science Foundation of China (70973041). Available: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, GLOB TUB CONTR SURV; Cao S, 2011, CHINESE J SOCAIL MED, V28, P125; Coly A, 2004, INT J TUBERC LUNG D, V8, P703; Garfield S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-149; Hahn SR, 2008, CURR MED RES OPIN, V24, P2127, DOI [10.1185/03007990802174769, 10.1185/03007990802174769 ]; Hu D, 2008, HEALTH POLICY PLANN, V23, P43, DOI 10.1093/heapol/czm038; Khan MA, 2005, HEALTH POLICY PLANN, V20, P354, DOI 10.1093/heapol/czi047; Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; MORISKY DE, 1990, HEALTH EDUC QUART, V17, P253, DOI 10.1177/109019819001700303; Obermeyer Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001721; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Sun Q, 2008, INT J TUBERC LUNG D, V12, P625; Svarstad BL, 1999, PATIENT EDUC COUNS, V37, P113, DOI 10.1016/S0738-3991(98)00107-4; Thompson K, 2000, SCHIZOPHR RES, V42, P241, DOI 10.1016/S0920-9964(99)00130-9; Volmink J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000010; Volmink J, 2000, LANCET, V355, P1345, DOI 10.1016/S0140-6736(00)02124-3; Walley JD, 2001, LANCET, V357, P664, DOI 10.1016/S0140-6736(00)04129-5; Wang JM, 2009, SCAND J PUBLIC HEALT, V37, P304, DOI 10.1177/1403494809103907; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; WHO, 2011, WORLD MALARIA REPORT 2011, P1; World Health Organization, 2002, EXP DOTS FRAM EFF TB; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; Xie X, 2005, CHINA PHARM, V16, P1311; Xu WG, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-169; Zwarenstein M, 1998, LANCET, V352, P1340, DOI 10.1016/S0140-6736(98)04022-7	26	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50328	10.1371/journal.pone.0050328	http://dx.doi.org/10.1371/journal.pone.0050328			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066QV	23251363	Green Published, Green Submitted, gold			2022-12-27	WOS:000313236200026
J	Higueruelo, AP; Schreyer, A; Bickerton, GRJ; Blundell, TL; Pitt, WR				Higueruelo, Alicia P.; Schreyer, Adrian; Bickerton, G. Richard J.; Blundell, Tom L.; Pitt, Will R.			What Can We Learn from the Evolution of Protein-Ligand Interactions to Aid the Design of New Therapeutics?	PLOS ONE			English	Article							X-RAY CRYSTALLOGRAPHY; DRUG DISCOVERY; BINDING; DATABASE; ANTAGONISTS; DOMAIN; ALPHA; P53; THERMODYNAMICS; CLASSIFICATION	Efforts to increase affinity in the design of new therapeutic molecules have tended to lead to greater lipophilicity, a factor that is generally agreed to be contributing to the low success rate of new drug candidates. Our aim is to provide a structural perspective to the study of lipophilic efficiency and to compare molecular interactions created over evolutionary time with those designed by humans. We show that natural complexes typically engage in more polar contacts than synthetic molecules bound to proteins. The synthetic molecules also have a higher proportion of unmatched heteroatoms at the interface than the natural sets. These observations suggest that there are lessons to be learnt from Nature, which could help us to improve the characteristics of man-made molecules. In particular, it is possible to increase the density of polar contacts without increasing lipophilicity and this is best achieved early in discovery while molecules remain relatively small.	[Higueruelo, Alicia P.; Schreyer, Adrian; Bickerton, G. Richard J.; Blundell, Tom L.; Pitt, Will R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Pitt, Will R.] UCB Pharma, Slough, Berks, England	University of Cambridge; UCB Pharma SA	Higueruelo, AP (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	alicia@cryst.bioc.cam.ac.uk		Schreyer, Adrian/0000-0001-5270-3742; Pitt, William/0000-0001-8164-4550; Higueruelo, Alicia/0000-0001-5616-6593; /0000-0001-6426-0598	BBSRC; Wellcome Trust; UCB Pharma; University of Cambridge	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); UCB Pharma(UCB Pharma SA); University of Cambridge(University of Cambridge)	Funding was provided by the BBSRC, Wellcome Trust, UCB Pharma, and the University of Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bickerton GR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-313; Charpentier TH, 2009, BIOCHEMISTRY-US, V48, P6202, DOI 10.1021/bi9005754; Cochran AG, 2000, CHEM BIOL, V7, pR85, DOI 10.1016/S1074-5521(00)00106-X; Congreve M, 2008, J MED CHEM, V51, P3661, DOI 10.1021/jm8000373; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Deu E, 2012, NAT STRUCT MOL BIOL, V19, P9, DOI 10.1038/nsmb.2203; Dobson PD, 2008, NAT REV DRUG DISCOV, V7, P205, DOI 10.1038/nrd2438; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Ferenczy GG, 2010, DRUG DISCOV TODAY, V15, P919, DOI 10.1016/j.drudis.2010.08.013; Garnier JP, 2008, HARVARD BUS REV, V86, P68; Gleeson MP, 2011, NAT REV DRUG DISCOV, V10, P197, DOI 10.1038/nrd3367; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Hann MM, 2011, MEDCHEMCOMM, V2, P349, DOI 10.1039/c1md00017a; Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Higueruelo AP, 2009, CHEM BIOL DRUG DES, V74, P457, DOI 10.1111/j.1747-0285.2009.00889.x; Kahraman A, 2007, J MOL BIOL, V368, P283, DOI 10.1016/j.jmb.2007.01.086; Keseru GM, 2009, NAT REV DRUG DISCOV, V8, P203, DOI 10.1038/nrd2796; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Leeson PD, 2011, NAT REV DRUG DISCOV, V10, P749, DOI 10.1038/nrd3552; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Olsson TSG, 2008, J MOL BIOL, V384, P1002, DOI 10.1016/j.jmb.2008.09.073; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; Rush TS, 2005, J MED CHEM, V48, P1489, DOI 10.1021/jm040163o; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Schreyer A, 2009, CHEM BIOL DRUG DES, V73, P157, DOI 10.1111/j.1747-0285.2008.00762.x; Sugano K, 2010, NAT REV DRUG DISCOV, V9, P597, DOI 10.1038/nrd3187; Thanos CD, 2003, J AM CHEM SOC, V125, P15280, DOI 10.1021/ja0382617; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Wang RX, 2004, J MED CHEM, V47, P2977, DOI 10.1021/jm030580l; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526	39	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51742	10.1371/journal.pone.0051742	http://dx.doi.org/10.1371/journal.pone.0051742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240060	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800096
J	Jin, Q; He, LJ; Zhang, AB				Jin, Qian; He, Li-Jun; Zhang, Ai-Bing			A Simple 2D Non-Parametric Resampling Statistical Approach to Assess Confidence in Species Identification in DNA Barcoding-An Alternative to Likelihood and Bayesian Approaches	PLOS ONE			English	Article							HYBRIDIZATION; TAXONOMY; LIFE; LEPIDOPTERA; SEQUENCES; DIPTERA	In the recent worldwide campaign for the global biodiversity inventory via DNA barcoding, a simple and easily used measure of confidence for assigning sequences to species in DNA barcoding has not been established so far, although the likelihood ratio test and the Bayesian approach had been proposed to address this issue from a statistical point of view. The TDR ( Two Dimensional non-parametric Resampling) measure newly proposed in this study offers users a simple and easy approach to evaluate the confidence of species membership in DNA barcoding projects. We assessed the validity and robustness of the TDR approach using datasets simulated under coalescent models, and an empirical dataset, and found that TDR measure is very robust in assessing species membership of DNA barcoding. In contrast to the likelihood ratio test and Bayesian approach, the TDR method stands out due to simplicity in both concepts and calculations, with little in the way of restrictive population genetic assumptions. To implement this approach we have developed a computer program package (TDR1.0beta) freely available from ftp://202.204.209.200/education/video/TDR1.0beta.rar. Citation: Jin Q, He L-J, Zhang A-B (2012) A Simple 2D Non-Parametric Resampling Statistical Approach to Assess Confidence in Species Identification in DNA Barcoding-An Alternative to Likelihood and Bayesian Approaches. PLoS ONE 7(12): e50831. doi:10.1371/journal.pone.0050831	[Jin, Qian; Zhang, Ai-Bing] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [He, Li-Jun] E China Normal Univ, State Key Lab Estuarine & Coastal Res, Shanghai 200062, Peoples R China	Capital Normal University; East China Normal University	Zhang, AB (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	zhangab2008@mail.cnu.edu.cn	He, Lijun/I-4996-2013	He, Lijun/0000-0002-8792-6409; ZHANG, Ai-bing/0000-0003-3450-5421; zhang, ai bing/0000-0002-6580-5462	Beijing Municipal Natural Science Foundation Key Projects [KZ201010028028]; Natural Science Foundation of China [31071963]; Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality [PHR201107120]; Research Fund for the Doctoral Program of Higher Education [20101108120002]	Beijing Municipal Natural Science Foundation Key Projects; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This study was supported by Beijing Municipal Natural Science Foundation Key Projects (No. KZ201010028028 to Zhang) and by the Natural Science Foundation of China (to Zhang, Grant No. 31071963), by the Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality (to Zhang, Grant No. PHR201107120), and by The Research Fund for the Doctoral Program of Higher Education (to Zhang, Grant No. 20101108120002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bloomquist EW, 2010, SYST BIOL, V59, P27, DOI 10.1093/sysbio/syp076; Brower AVZ, 2006, SYST BIODIVERS, V4, P127, DOI 10.1017/S147720000500191X; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Gregory TR, 2005, NATURE, V434, P1067, DOI 10.1038/4341067b; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hesterberg T, 2006, INTRO PRACTICE STAT; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Holland BR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-202; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Lou M, 2010, MOL PHYLOGENET EVOL, V56, P187, DOI 10.1016/j.ympev.2010.01.002; Blanco-Pastor JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039089; MADDISON WP, 2006, MESQUITE MODULAR SYS; Marshall E, 2005, SCIENCE, V307, P1037, DOI 10.1126/science.307.5712.1037; Matz MV, 2005, PHILOS T R SOC B, V360, P1969, DOI 10.1098/rstb.2005.1728; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meng C, 2009, THEOR POPUL BIOL, V75, P35, DOI 10.1016/j.tpb.2008.10.004; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Silva-Brandao KL, 2009, NEOTROP ENTOMOL, V38, P441, DOI 10.1590/S1519-566X2009000400001; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; van Velzen R, 2007, P NETH ENT SOC M, V18, P95103; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Yu Y, 2011, SYST BIOL, V60, P138, DOI 10.1093/sysbio/syq084; Zhang AB, 2008, SYST BIOL, V57, P202, DOI 10.1080/10635150802032982; Zhang AB, 2007, MOL PHYLOGENET EVOL, V45, P534, DOI 10.1016/j.ympev.2007.07.003	45	6	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50831	10.1371/journal.pone.0050831	http://dx.doi.org/10.1371/journal.pone.0050831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239988	gold, Green Submitted, Green Published			2022-12-27	WOS:000312290800025
J	Li, DS; Dong, BL; Tong, ZS; Wang, QN; Liu, WH; Wang, Y; Liu, W; Chen, JB; Xu, L; Chen, LQ; Duan, YQ				Li, Dongsheng; Dong, Bilin; Tong, Zhongsheng; Wang, Qinning; Liu, Weihuang; Wang, Yan; Liu, Wei; Chen, Jinbo; Xu, Li; Chen, Liuqing; Duan, Yiqun			MBL-Mediated Opsonophagocytosis of Candida albicans by Human Neutrophils Is Coupled with Intracellular Dectin-1-Triggered ROS Production	PLOS ONE			English	Article							BINDING LECTIN MBL; DECTIN-1; RECOGNITION; RECEPTOR; MANNOSE; ACTIVATION; YEAST	Mannan-binding lectin (MBL), a lectin homologous to C1q, greatly facilitates C3/C4-mediated opsonophagocytosis of Candida albicans (C. albicans) by human neutrophils, and has the capacity to bind to CR1 (CD35) expressed on circulating neutrophils. The intracellular pool of neutrophil Dectin-1 plays a critical role in stimulating the reactive oxygen species (ROS) generation through recognition of beta-1,3-glucan component of phagocytized zymosan or yeasts. However, little is known about whether MBL can mediate the opsonophagocytosis of Candida albicans by neutrophils independent of complement activation, and whether MBL-mediated opsonophagocytosis influence the intracellular expression of Dectin-1 and ROS production. Here we showed that the inhibited phagocytic efficiency of neutrophils as a result of blockage of Dectin-1 was compensated by exogenous MBL alone in a dose-dependent manner. Furthermore, the expressions of Dectin-1 at mRNA and intracellular protein levels were significantly up-regulated in neutrophils stimulated by MBL-pre-incubated C. albicans, while the expression of surface Dectin-1 remained almost unchanged. Nevertheless, the stimulated ROS production in neutrophils was partly and irreversibly inhibited by blockage of Dectin-1 in the presence of exogenous MBL. Confocal microscopy examination showed that intracellular Dectin-1 was recruited and co-distributed with ROS on the surface of some phagocytized yeasts. The beta-1,3-glucanase digestion test further suggested that the specific recognition and binding site of human Dectin-1 is just the beta-1,3-glucan moiety on the cell wall of C. albicans. These data demonstrate that MBL has an ability to mediate the opsonophagocytosis of Candida albicans by human neutrophils independent of complement activation, which is coupled with intracellular Dectin-1-triggered ROS production.	[Li, Dongsheng; Dong, Bilin; Tong, Zhongsheng; Chen, Jinbo; Xu, Li; Chen, Liuqing; Duan, Yiqun] 1 Hosp Wuhan, Dept Dermatol, Ctr Infect Skin Dis, Wuhan, Peoples R China; [Wang, Qinning] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW 2145, Australia; [Liu, Weihuang] Wuhan Univ, Med Res Ctr, Wuhan 430072, Peoples R China; [Wang, Yan; Liu, Wei] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China	University of Sydney; Wuhan University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Chen, LQ (corresponding author), 1 Hosp Wuhan, Dept Dermatol, Ctr Infect Skin Dis, Wuhan, Peoples R China.	chlq35@yahoo.com.cn; augustusdong@126.com		Chen, Jinbo/0000-0002-9665-8506	Wuhan Health Bureau [[2011] 99]; Hubei Health Department, China [JX3A25]	Wuhan Health Bureau; Hubei Health Department, China	This study is supported by the grants from Wuhan Health Bureau (NO: [2011] 99) and Hubei Health Department (NO: JX3A25), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alangaden GJ, 2011, INFECT DIS CLIN N AM, V25, P201, DOI 10.1016/j.idc.2010.11.003; Brouwer N, 2008, J IMMUNOL, V180, P4124, DOI 10.4049/jimmunol.180.6.4124; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chen LY, 2011, J HOSP INFECT, V78, P50, DOI 10.1016/j.jhin.2010.12.007; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Ghiran I, 2000, J EXP MED, V192, P1797, DOI 10.1084/jem.192.12.1797; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; Han X, 2011, PLOS ONE; Kennedy AD, 2007, EUR J IMMUNOL, V37, P467, DOI 10.1002/eji.200636653; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Lillegard JB, 2006, J INFECT DIS, V193, P1589, DOI 10.1086/503804; Linden JR, 2010, MED MYCOL, V48, P355, DOI [10.1080/13693780903164566, 10.3109/13693780903164566]; McGreal E, 2002, BIOCHEM SOC T, V30, P1010, DOI 10.1042/BST0301010; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Sealy PI, 2008, MED MYCOL, V46, P531, DOI 10.1080/13693780801961329; Skrzypek F, 2009, MICROBES INFECT, V11, P661, DOI 10.1016/j.micinf.2009.03.010; Van Asbeck EC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-229; Yang Z, 2009, ZYMOSAN TREATMENT MO	19	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e50589	10.1371/journal.pone.0050589	http://dx.doi.org/10.1371/journal.pone.0050589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239982	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800020
J	Olsson, J; Drott, JB; Laurantzon, L; Laurantzon, O; Bergh, A; Elgh, F				Olsson, Jan; Drott, Johanna Bergh; Laurantzon, Lovisa; Laurantzon, Oscar; Bergh, Anders; Elgh, Fredrik			Chronic Prostatic Infection and Inflammation by Propionibacterium acnes in a Rat Prostate Infection Model	PLOS ONE			English	Article							BACTERIAL INFLAMMATION; MOUSE PROSTATE; CANCER; HYPERPLASIA; CARCINOGENESIS; PATHOGENESIS; CASTRATION; SPECIMENS; PROTEINS; CELLS	Chronic inflammation in the prostate, seen as infiltration of inflammatory cells into the prostate gland in histological samples, affects approximately half the male population without indication of prostate disease, and is almost ubiquitous in patients diagnosed with benign prostate hyperplasia and cancer. Several studies have demonstrated the Gram-positive bacterium Propionibacterium acnes to be frequently present in prostate tissue from men suffering from prostate disease. P. acnes has been shown to be associated with histological inflammation in human prostatectomy specimens, and also to induce strong inflammatory response in prostate-derived tissue culture models. The present paper describes a rat model for assessment of the pathogenic potential of P. acnes in prostate. Prostate glands of Sprague Dawley rats (n = 98) were exposed via an abdominal incision and live P. acnes or, in control rats, saline were injected into the ventral and dorso-lateral lobes. Rats were sacrificed 5 days, 3 weeks, 3 months and 6 months post infection, and prostate tissue was analyzed for bacterial content and histological inflammation. Rat sera were assessed for levels of CRP and anti-P. acnes IgG. Live P. acnes could be recovered from the dorso-lateral lobes up to 3 months post infection, while the ventral lobes were cleared from bacteria at that time. In samples up to 3 months post infection, the dorso-lateral lobes exhibited intense focal inflammation. CRP and IgG levels were elevated throughout the span of the experiment, and reached maximum levels 3 weeks and 3 months post infection, respectively. We show that P. acnes have the potential to cause chronic infection in previously healthy prostate, and that the infection has potential to cause chronic histological inflammation in the infected tissue. The high prevalence of P. acnes in human prostate tissue calls for resolution of pathogenic details. The present rat model suggests that complications such as chronic inflammation may be induced by P. acnes infection.	[Olsson, Jan; Drott, Johanna Bergh; Laurantzon, Lovisa; Laurantzon, Oscar; Elgh, Fredrik] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Bergh, Anders] Umea Univ, Dept Med Biosci, Umea, Sweden	Umea University; Umea University	Olsson, J (corresponding author), Umea Univ, Dept Clin Microbiol, Umea, Sweden.	jan.olsson@climi.umu.se		Olsson, Jan/0000-0001-9094-319X	County Council of Vasterbotten (ALF); Medical Faculty of Umea University; Lions Cancer Research Foundation; Cancerforskningsfonden Norrland; Percy Falks Stiftelse for forskning betraffande prostatacancer och brostcancer; Svenska Lakaresallskapet [SLS-173871, SLS-248771]	County Council of Vasterbotten (ALF); Medical Faculty of Umea University; Lions Cancer Research Foundation; Cancerforskningsfonden Norrland; Percy Falks Stiftelse for forskning betraffande prostatacancer och brostcancer; Svenska Lakaresallskapet	This study was funded by grants from the County Council of Vasterbotten (ALF), (FE), the Medical Faculty of Umea University (FE), the Lions Cancer Research Foundation and Cancerforskningsfonden Norrland (JO, FE), Percy Falks Stiftelse for forskning betraffande prostatacancer och brostcancer (JO), and Svenska Lakaresallskapet (SLS-173871, SLS-248771) (JO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev O, 2006, CANCER CAUSE CONTROL, V17, P1127, DOI 10.1007/s10552-006-0054-2; Boehm BJ, 2012, PROSTATE, V72, P307, DOI 10.1002/pros.21433; Cheng I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008736; Cohen RJ, 2005, J UROLOGY, V173, P1969, DOI 10.1097/01.ju.0000158161.15277.78; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; DEBEER FC, 1982, IMMUNOLOGY, V45, P55; Delongchamps NB, 2008, J UROLOGY, V179, P1736, DOI 10.1016/j.juro.2008.01.034; Drott JB, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-126; Elkahwaji JE, 2009, BRIT J CANCER, V101, P1740, DOI 10.1038/sj.bjc.6605370; Elkahwaji JE, 2005, UROLOGY, V66, P883, DOI 10.1016/j.urology.2005.04.013; Fassi Fehri L, 2010, INT J MED MICROBIOL; Goldschmidt P, 2009, BRIT J OPHTHALMOL, V93, P258, DOI 10.1136/bjo.2008.146639; Good PI, 2005, PERMUTATION PARAMETR, Vxix; Halin S, 2007, PROSTATE, V67, P370, DOI 10.1002/pros.20473; Hochreiter WW, 2000, J UROLOGY, V163, P127, DOI 10.1016/S0022-5347(05)67987-6; KAPLAN L, 1983, PROSTATE, V4, P625, DOI 10.1002/pros.2990040608; Khalili M, 2010, AM J PATHOL; Kramer G, 2007, EUR UROL, V51, P1202, DOI 10.1016/j.eururo.2006.12.011; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; NASLUND MJ, 1988, J UROLOGY, V140, P1049, DOI 10.1016/S0022-5347(17)41924-0; Nickel JC, 2008, J UROLOGY, V179, P1391, DOI 10.1016/j.juro.2007.11.081; Nickel JC, 2008, UROL CLIN N AM, V35, P109, DOI 10.1016/j.ucl.2007.09.012; Olsson J, 2012, APMIS, V120, P778, DOI 10.1111/j.1600-0463.2012.02905.x; Palapattu GS, 2005, CARCINOGENESIS, V26, P1170, DOI 10.1093/carcin/bgh317; Sfanos KS, 2008, PROSTATE, V68, P306, DOI 10.1002/pros.20680; Sfanos KS, 2009, P NATL ACAD SCI USA, V106, P3443, DOI 10.1073/pnas.0810473106; Shannon BA, 2008, BJU INT, V101, P429, DOI 10.1111/j.1464-410X.2007.07214.x; SHARMA OP, 1992, J STEROID BIOCHEM, V43, P557, DOI 10.1016/0960-0760(92)90244-D; Sutcliffe Siobhan, 2008, Curr Urol Rep, V9, P243, DOI 10.1007/s11934-008-0042-z; Yanamandra K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005562	32	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51434	10.1371/journal.pone.0051434	http://dx.doi.org/10.1371/journal.pone.0051434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240022	Green Published, gold			2022-12-27	WOS:000312290800058
J	Pine, MK; Jeffs, AG; Radford, CA				Pine, Matthew K.; Jeffs, Andrew G.; Radford, Craig A.			Turbine Sound May Influence the Metamorphosis Behaviour of Estuarine Crab Megalopae	PLOS ONE			English	Article							MUD CRAB; CHASMAGNATHUS-GRANULATA; DELAYED METAMORPHOSIS; SWIMMING BEHAVIOR; CLIMATE-CHANGE; HELICE-CRASSA; REEF SOUND; CUES; INDUCTION; LARVAE	It is now widely accepted that a shift towards renewable energy production is needed in order to avoid further anthropogenically induced climate change. The ocean provides a largely untapped source of renewable energy. As a result, harvesting electrical power from the wind and tides has sparked immense government and commercial interest but with relatively little detailed understanding of the potential environmental impacts. This study investigated how the sound emitted from an underwater tidal turbine and an offshore wind turbine would influence the settlement and metamorphosis of the pelagic larvae of estuarine brachyuran crabs which are ubiquitous in most coastal habitats. In a laboratory experiment the median time to metamorphosis (TTM) for the megalopae of the crabs Austrohelice crassa and Hemigrapsus crenulatus was significantly increased by at least 18 h when exposed to either tidal turbine or sea-based wind turbine sound, compared to silent control treatments. Contrastingly, when either species were subjected to natural habitat sound, observed median TTM decreased by approximately 21-31% compared to silent control treatments, 38-47% compared to tidal turbine sound treatments, and 46-60% compared to wind turbine sound treatments. A lack of difference in median TTM in A. crassa between two different source levels of tidal turbine sound suggests the frequency composition of turbine sound is more relevant in explaining such responses rather than sound intensity. These results show that estuarine mudflat sound mediates natural metamorphosis behaviour in two common species of estuarine crabs, and that exposure to continuous turbine sound interferes with this natural process. These results raise concerns about the potential ecological impacts of sound generated by renewable energy generation systems placed in the nearshore environment.	[Pine, Matthew K.; Jeffs, Andrew G.; Radford, Craig A.] Univ Auckland, Leigh Marine Lab, Auckland 1, New Zealand	University of Auckland	Pine, MK (corresponding author), Univ Auckland, Leigh Marine Lab, Auckland 1, New Zealand.	matt.pine@auckland.ac.nz	Jeffs, Andrew G/D-9474-2012	Jeffs, Andrew/0000-0002-8504-1949; Radford, Craig/0000-0001-7949-9497	Marsden Fast-Start Grant; University of Auckland, Faculty of Science, Research and Development Fund	Marsden Fast-Start Grant(Royal Society of New ZealandMarsden Fund (NZ)); University of Auckland, Faculty of Science, Research and Development Fund	This research was funded by a Marsden Fast-Start Grant to CAR, and the University of Auckland, Faculty of Science, Research and Development Fund to CAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cada G, 2007, FISHERIES, V32, P174, DOI 10.1577/1548-8446(2007)32[174:PIOHAW]2.0.CO;2; Ferro B.D., 2006, REFOCUS, V7, P46, DOI [10.1016/S1471-0846(06)70574-1, DOI 10.1016/S1471-0846(06)70574-1]; Forward RB, 2001, AM ZOOL, V41, P1108, DOI 10.1668/0003-1569(2001)041[1108:CFMOBC]2.0.CO;2; Forward RB, 2000, J EXP MAR BIOL ECOL, V245, P277, DOI 10.1016/S0022-0981(99)00169-0; Forward RB, 1996, MAR ECOL PROG SER, V131, P165, DOI 10.3354/meps131165; Gebauer P, 2004, J EXP MAR BIOL ECOL, V311, P25, DOI 10.1016/j.jembe.2004.04.014; Gebauer P, 1999, J EXP MAR BIOL ECOL, V238, P271, DOI 10.1016/S0022-0981(98)00219-6; Gunson D, 1993, GUIDE NZ SEASHORE; Herbert GMJ, 2007, RENEW SUST ENERG REV, V11, P1117, DOI 10.1016/j.rser.2005.08.004; Inger R, 2009, J APPL ECOL, V46, P1145, DOI 10.1111/j.1365-2664.2009.01697.x; Jeffs AG, 2000, CRUSTACEANA, V73, P847, DOI 10.1163/156854000504859; JONES MB, 1983, B MAR SCI, V33, P656; King DA, 2004, SCIENCE, V303, P176, DOI 10.1126/science.1094329; Lloyd TP, 2011, MODELLING TECHNIQUES, P777; Mann DA, 2007, MAR ECOL PROG SER, V338, P307, DOI 10.3354/meps338307; Medina JM, 2010, CURR ZOOL, V56, P618, DOI 10.1093/czoolo/56.5.618; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; Morrisey DJ, 1999, MAR ECOL PROG SER, V182, P231, DOI 10.3354/meps182231; O'Connor NJ, 1998, J CRUSTACEAN BIOL, V18, P700, DOI 10.2307/1549146; OCONNOR NJ, 1991, MAR ECOL PROG SER, V68, P243; Parvin S, 2005, ASSESSMENT TIDAL CUR; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; PECHENIK JA, 1990, OPHELIA, V32, P63, DOI 10.1080/00785236.1990.10422025; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Radford CA, 2008, OECOLOGIA, V156, P921, DOI 10.1007/s00442-008-1041-y; Radford CA, 2007, B MAR SCI, V80, P369; Richards S, 2007, UNDERWATER NOISE STU; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Simpson SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016625; Sivaguru K, 2000, THESIS U AUCKLAND; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Stanley JA, 2012, P ROY SOC B-BIOL SCI, V279, P3622, DOI 10.1098/rspb.2012.0697; Stanley JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028572; Stanley JA, 2010, BEHAV ECOL, V21, P113, DOI 10.1093/beheco/arp159; Steinberg MK, 2008, ESTUAR COAST, V31, P738, DOI 10.1007/s12237-008-9063-6; Thomas G, 2009, OVERVIEW IMPACTS ANT; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010660; Wahlberg M, 2005, MAR ECOL PROG SER, V288, P295, DOI 10.3354/meps288295; Weber JC, 1996, MAR BIOL, V126, P655, DOI 10.1007/BF00351332; Wilkens SL, 2012, BIOFOULING, V28, P65, DOI 10.1080/08927014.2011.651717; Wright A. J, 2008, INT WORKSH SHIPP NOI, V15	42	34	35	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51790	10.1371/journal.pone.0051790	http://dx.doi.org/10.1371/journal.pone.0051790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240063	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800099
J	Witty, CF; Foster, TC; Semple-Rowland, SL; Daniel, JM				Witty, Christine F.; Foster, Thomas C.; Semple-Rowland, Susan L.; Daniel, Jill M.			Increasing Hippocampal Estrogen Receptor Alpha Levels via Viral Vectors Increases MAP Kinase Activation and Enhances Memory in Aging Rats in the Absence of Ovarian Estrogens	PLOS ONE			English	Article							MIDDLE-AGED RATS; ESTRADIOL REPLACEMENT; WORKING-MEMORY; REPRODUCTIVE EXPERIENCE; SYNAPTIC PLASTICITY; LENTIVIRAL VECTORS; PREFRONTAL CORTEX; PROTEIN-LEVELS; BETA; PERFORMANCE	We previously demonstrated that aged ovariectomized rats that had received prior estradiol treatment in middle-age exhibited increased levels of estrogen receptor alpha (ER alpha) in the hippocampus as well as enhanced hippocampal dependent memory as compared to aged rats that had not received mid-life estradiol treatment. These effects persisted long after the estradiol treatment had been terminated. The goal of the current experiment was to determine if increased expression of ER alpha in the hippocampus, in the absence of exogenously administered estrogens, can impact the hippocampus and cognitive function in aging ovariectomized rats. Middle-aged rats were trained for 24 days on an eightarm radial maze spatial memory task. All rats were then ovariectomized. Forty days later, rats received either lentiviral delivery to the hippocampus of the gene encoding ER alpha (lenti-ER alpha) or a control virus. Rats were tested on delay trials in the radial-maze in which delays of varying lengths were imposed between the fourth and fifth arm choices. Following behavior testing, hippocampi were immunostained using western blotting for ER alpha, the ER alpha-regulated protein choline acetyltransferase, and phosphorylation of the ER alpha-regulated kinases, ERK/MAPK and Akt. Results revealed that aging ovariectomized rats that received delivery of lenti-ER alpha to the hippocampus exhibited enhanced spatial memory as indicated by increased arm-choice accuracy across delays as compared to ovariectomized rats that received control virus. Western blot data revealed that lenti-ER alpha delivery significantly increased levels of ER alpha and phosphorylated ERK/MAPK and had no impact on levels of ChAT or phosphorylation of Akt. Results indicate that increasing hippocampal levels of ER alpha in aging females in the absence of ovarian or exogenously administered estrogens leads to increases in phosphorylation of ERK/MAPK as well as in enhanced memory.	[Witty, Christine F.; Daniel, Jill M.] Tulane Univ, Neurosci Program, New Orleans, LA 70118 USA; [Foster, Thomas C.; Semple-Rowland, Susan L.] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Daniel, Jill M.] Tulane Univ, Dept Psychol, New Orleans, LA 70118 USA	Tulane University; State University System of Florida; University of Florida; Tulane University	Daniel, JM (corresponding author), Tulane Univ, Neurosci Program, New Orleans, LA 70118 USA.	jmdaniel@tulane.edu		Daniel, Jill/0000-0002-0383-2414	National Science Foundation [0951008]; National Institute of Aging [R01AG041374, AG014979, AG037984, AG036800]; Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE ON AGING [R01AG037984, P30AG028740, R01AG014979, R56AG037984, R37AG036800, R01AG041374] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0951008] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Evelyn F. McKnight Brain Research Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant 0951008 and National Institute of Aging Grant R01AG041374 to JMD and National Institute of Aging Grants AG014979, AG037984, AG036800, and the Evelyn F. McKnight Brain Research Foundation to TCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2002, J NEUROSCI, V22, P3608; Bimonte HA, 1999, PSYCHONEUROENDOCRINO, V24, P161, DOI 10.1016/S0306-4530(98)00068-7; Bimonte-Nelson HA, 2010, MOLECULES, V15, P6050, DOI 10.3390/molecules15096050; Bohacek J, 2008, J NEUROENDOCRINOL, V20, P1023, DOI 10.1111/j.1365-2826.2008.01752.x; Bohacek J, 2009, J NEUROENDOCRINOL, V21, P640, DOI 10.1111/j.1365-2826.2009.01882.x; Bohacek J, 2010, PSYCHONEUROENDOCRINO, V35, P694, DOI 10.1016/j.psyneuen.2009.10.010; Bora SH, 2005, EXP NEUROL, V194, P506, DOI 10.1016/j.expneurol.2005.03.015; CHROBAK JJ, 1995, BEHAV NEUROSCI, V109, P241; Coleman JE, 2003, PHYSIOL GENOMICS, V12, P221, DOI 10.1152/physiolgenomics.00135.2002; Daniel JM, 2006, J NEUROENDOCRINOL, V18, P787, DOI 10.1111/j.1365-2826.2006.01471.x; Daniel JM, 2010, BBA-GEN SUBJECTS, V1800, P1068, DOI 10.1016/j.bbagen.2010.01.007; Daniel JM, 2006, ENDOCRINOLOGY, V147, P607, DOI 10.1210/en.2005-0998; Daniel JM, 2001, J NEUROSCI, V21, P6949, DOI 10.1523/JNEUROSCI.21-17-06949.2001; Dohanich G, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P539; Fan L, 2010, J NEUROSCI, V30, P4390, DOI 10.1523/JNEUROSCI.4333-09.2010; Foster TC, 2003, NEUROBIOL AGING, V24, P839, DOI 10.1016/S0197-4580(03)00014-9; FOSTER TC, 2011, HIPPOCAMPUS, DOI DOI 10.1002/HIPO.20935; Foster TC, 2008, MOL THER, V16, P1587, DOI 10.1038/mt.2008.140; Ghosh S, 2009, NEUROSCI LETT, V464, P218, DOI 10.1016/j.neulet.2009.08.054; Gibbs RB, 2009, HORM BEHAV, V56, P73, DOI 10.1016/j.yhbeh.2009.03.003; Gibbs RB, 2000, NEUROBIOL AGING, V21, P107, DOI 10.1016/S0197-4580(00)00103-2; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hyder SM, 1999, BIOCHEM PHARMACOL, V57, P597, DOI 10.1016/S0006-2952(98)00355-4; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kelly JF, 2008, CURR ALZHEIMER RES, V5, P45, DOI 10.2174/156720508783884611; Korol DL, 2004, NEUROBIOL LEARN MEM, V82, P309, DOI 10.1016/j.nlm.2004.07.006; Kretz O, 2004, J NEUROSCI, V24, P5913, DOI 10.1523/JNEUROSCI.5186-03.2004; Luine VN, 2008, J NEUROENDOCRINOL, V20, P866, DOI 10.1111/j.1365-2826.2008.01710.x; Luine VN, 1998, HORM BEHAV, V34, P149, DOI 10.1006/hbeh.1998.1473; Maki PM, 2011, BRAIN RES, V1379, P232, DOI 10.1016/j.brainres.2010.11.030; Matthews J, 2006, MOL ENDOCRINOL, V20, P534, DOI 10.1210/me.2005-0140; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Mehra RD, 2005, BRAIN RES, V1056, P22, DOI 10.1016/j.brainres.2005.06.073; Miller NR, 2005, ENDOCRINOLOGY, V146, P3070, DOI 10.1210/en.2004-1515; Mukai H, 2010, BBA-GEN SUBJECTS, V1800, P1030, DOI 10.1016/j.bbagen.2009.11.002; Ogiue-Ikeda M, 2008, BRAIN RES REV, V57, P363, DOI 10.1016/j.brainresrev.2007.06.010; OOISHI Y, 2011, J STEROID BIOCHEM, DOI DOI 10.1016/J.JSBMB.2011.10.004; Pawluski JL, 2006, HORM BEHAV, V49, P143, DOI 10.1016/j.yhbeh.2005.05.016; Pawluski JL, 2006, J NEUROBIOL, V66, P71, DOI 10.1002/neu.20194; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PAXINOS G, 1995, RAT NERVOUS SYSTEM, DOI DOI 10.1016/J.BRAINRESREV.2007.06.010; Perez SE, 2003, DEV BRAIN RES, V145, P117, DOI 10.1016/S0165-3806(03)00223-2; Resnick SM, 2002, JAMA-J AM MED ASSOC, V288, P2170, DOI 10.1001/jama.288.17.2170; Rodgers SP, 2010, ENDOCRINOLOGY, V151, P1194, DOI 10.1210/en.2009-1245; Semple-Rowland SL, 2010, MOL VIS, V16, P916; Smith CC, 2010, P NATL ACAD SCI USA, V107, P19543, DOI 10.1073/pnas.1009307107; Smith CL, 1998, BIOL REPROD, V58, P627, DOI 10.1095/biolreprod58.3.627; Spencer-Segal JL, 2012, NEUROSCIENCE, V202, P131, DOI 10.1016/j.neuroscience.2011.11.035; Towart LA, 2003, J COMP NEUROL, V463, P390, DOI 10.1002/cne.10753; Waters EM, 2011, BRAIN RES, V1379, P86, DOI 10.1016/j.brainres.2010.09.069; Wu TW, 2011, BRAIN RES, V1379, P34, DOI 10.1016/j.brainres.2011.01.034; Yaffe K, 2002, BIOL PSYCHIAT, V51, P677, DOI 10.1016/S0006-3223(01)01289-6; Yaffe K, 2009, NEUROBIOL AGING, V30, P607, DOI 10.1016/j.neurobiolaging.2007.08.003; Zhang QG, 2011, P NATL ACAD SCI USA, V108, pE617, DOI 10.1073/pnas.1104391108; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092; Zhou LP, 2007, EXP NEUROL, V203, P72, DOI 10.1016/j.expneurol.2006.07.020	58	43	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51385	10.1371/journal.pone.0051385	http://dx.doi.org/10.1371/journal.pone.0051385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240018	Green Submitted, Green Published, gold			2022-12-27	WOS:000312290800054
J	Zhang, SJ; Li, GQ; Zhao, YF; Liu, GZ; Wang, Y; Ma, XX; Li, DX; Wu, Y; Lu, JF				Zhang, Shuijun; Li, Gongquan; Zhao, Yongfu; Liu, Guangzhi; Wang, Yu; Ma, Xiuxian; Li, Dexu; Wu, Yang; Lu, Jianfeng			Smac Mimetic SM-164 Potentiates APO2L/TRAIL- and Doxorubicin-Mediated Anticancer Activity in Human Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							X-LINKED-INHIBITOR; NF-KAPPA-B; CASPASE ACTIVATION; APOPTOSIS-PROTEIN; CANCER-CELLS; TRAIL; IAPS; CHEMOTHERAPY; EXPRESSION; DESIGN	Background: The members of inhibitor of apoptosis proteins (IAPs) family are key negative regulators of apoptosis. Overexpression of IAPs are found in hepatocellular carcinoma (HCC), and can contribute to chemotherapy resistance and recurrence of HCC. Small-molecule Second mitochondria-derived activator of caspases (Smac) mimetics have recently emerged as novel anticancer drugs through targeting IAPs. The specific aims of this study were to 1) examine the anticancer activity of Smac mimetics as a single agent and in combination with chemotherapy in HCC cells, and 2) investigate the mechanism of anticancer action of Smac mimetics. Methods: Four HCC cell lines, including SMMC-7721, BEL-7402, HepG2 and Hep3B, and 12 primary HCC cells were used in this study. Smac mimetic SM-164 was used to treat HCC cells. Cell viability, cell death induction and clonal formation assays were used to evaluate the anticancer activity. Western blotting analysis and a pancaspase inhibitor were used to investigate the mechanisms. Results: Although SM-164 induced complete cIAP-1 degradation, it displayed weak inhibitory effects on the viability of HCC cells. Nevertheless, SM-164 considerably potentiated Apo2 ligand or TNF-related apoptosis-inducing ligand (APO2L/TRAIL)-and Doxorubicin-mediated anticancer activity in HCC cells. Mechanistic studies demonstrated that SM-164 in combination with chemotherapeutic agents resulted in enhanced activation of caspases-9, -3 and cleavage of poly ADP-ribose polymerase (PARP), and also led to decreased AKT activation. Conclusions: Smac mimetics can enhance chemotherapeutic-mediated anticancer activity by enhancing apoptosis signaling and suppressing survival signaling in HCC cells. This study suggests Smac mimetics are potential therapeutic agents for HCC.	[Zhang, Shuijun; Li, Gongquan; Zhao, Yongfu; Ma, Xiuxian; Li, Dexu; Wu, Yang; Lu, Jianfeng] Zhengzhou Univ, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Zhengzhou, Henan, Peoples R China; [Zhang, Shuijun; Li, Gongquan; Zhao, Yongfu; Ma, Xiuxian; Li, Dexu; Wu, Yang] Key Lab Hepatobiliary & Pancreat Surg & Digest Or, Wuhan, Henan, Peoples R China; [Liu, Guangzhi; Wang, Yu] Zhengzhou Univ, Henan Prov Hosp, Dept Obstet & Gynecol, Zhengzhou, Henan, Peoples R China; [Lu, Jianfeng] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	Zhengzhou University; Zhengzhou University; University of Michigan System; University of Michigan	Zhang, SJ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Zhengzhou, Henan, Peoples R China.	zhangshuijun@zzu.edu.cn; jialu@umich.edu		Liu, Guangzhi/0000-0002-4973-7113				Asghar U, 2012, J HEPATOL, V56, P686, DOI 10.1016/j.jhep.2011.07.031; Augello C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-125; Bauer JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001313; Bockbrader KM, 2005, ONCOGENE, V24, P7381, DOI 10.1038/sj.onc.1208888; Brechot C, 2000, SEMIN CANCER BIOL, V10, P211, DOI 10.1006/scbi.2000.0321; Cheung HH, 2009, CANCER RES, V69, P7729, DOI 10.1158/0008-5472.CAN-09-1794; Dineen SP, 2010, CANCER RES, V70, P2852, DOI 10.1158/0008-5472.CAN-09-3892; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Fakler M, 2009, BLOOD, V113, P1710, DOI 10.1182/blood-2007-09-114314; Fandy TE, 2005, NEOPLASIA, V7, P646, DOI 10.1593/neo.04655; Greer RM, 2011, CANCER RES, V71, P7640, DOI 10.1158/0008-5472.CAN-10-3947; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lee TKW, 2011, HEPATOLOGY, V53, P160, DOI 10.1002/hep.24000; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Lu JF, 2011, MOL CANCER THER, V10, P902, DOI 10.1158/1535-7163.MCT-10-0864; Lu Xuanyong, 2005, Int J Med Sci, V2, P30; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Omar HA, 2006, MOL PHARM, V76, P957; Pan QW, 2008, ACTA ONCOL, V47, P135, DOI 10.1080/02841860701403053; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Probst BL, 2010, CELL DEATH DIFFER, V17, P1645, DOI 10.1038/cdd.2010.44; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shi YH, 2008, HEPATOLOGY, V48, P497, DOI 10.1002/hep.22393; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun HY, 2007, J AM CHEM SOC, V129, P15279, DOI 10.1021/ja074725f; Sun HY, 2004, J MED CHEM, V47, P4147, DOI 10.1021/jm0499108; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Weisberg E, 2007, MOL CANCER THER, V6, P1951, DOI 10.1158/1535-7163.MCT-06-0810; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yamaguchi Y, 2005, ONCOL REP, V14, P1311; Yang TS, 2002, ANN ONCOL, V13, P1771, DOI 10.1093/annonc/mdf303; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	39	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51461	10.1371/journal.pone.0051461	http://dx.doi.org/10.1371/journal.pone.0051461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240027	Green Published, Green Submitted, gold			2022-12-27	WOS:000312290800063
J	Mostafa, SA; Davies, MJ; Morris, DH; Yates, T; Srinivasan, BT; Webb, D; Brady, E; Khunti, K				Mostafa, Samiul A.; Davies, Melanie J.; Morris, Danielle H.; Yates, Tom; Srinivasan, Balasubramanian Thiagarajan; Webb, David; Brady, Emer; Khunti, Kamlesh			The Association of the Triglyceride-to-HDL Cholesterol Ratio with Insulin Resistance in White European and South Asian Men and Women	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOMETABOLIC RISK-FACTORS; GLYCATED HEMOGLOBIN; POTENTIAL IMPACT; GLUCOSE; SENSITIVITY; DISEASE; MARKERS; INDEX	Introduction: There is recent interest surrounding the use of the triglyceride-to-HDL cholesterol ratio as a surrogate marker of insulin resistance in clinical practice, as it may identify people at high risk of developing diabetes or its complications. However, it has been suggested using this lipid ratio may not be appropriate for measuring insulin resistance in African-Americans, particularly women. We investigated if this inconsistency extended to South Asian women in a UK multi-ethnic cohort of White Europeans and South Asians. Methods: Cross-sectional analysis was done of 729 participants from the ADDITION-Leicester study from 2005 to 2009. The association between tertiles of triglyceride-to-HDL cholesterol ratio to fasting insulin, homeostatic model of assessment for insulin resistance (HOMA1-IR), quantitative insulin sensitivity check index (QUICKI) and glucose: insulin ratio was examined with adjustment for confounding variables. Results: Incremental tertiles of the triglyceride-to-HDL cholesterol ratio demonstrated a significant positive association with levels of fasting insulin, HOMA1-IR, glucose: insulin ratio and a negative association with QUICKI in White European men (n = 255) and women (n = 250) and South Asian men (n = 124) (all p<0.05), but not South Asian women (n = 100). A significant interaction was demonstrated between sex and triglyceride-to-HDL cholesterol ratio tertiles in South Asians only (p<0.05). The area under the receiver operating characteristic curve for triglyceride-to-HDL cholesterol ratio to detect insulin resistance, defined as the cohort HOMA1-IR >= 75th percentile (3.08), was 0.74 (0.67 to 0.81), 0.72 (0.65 to 0.79), 0.75 (0.66 to 0.85) and 0.67 (0.56 to 0.78) in White European men and women, South Asian men and women respectively. The optimal cut-points for detecting insulin resistance were 0.9-1.7 in mmol/l (2.0-3.8 in mg/dl) for the triglyceride-to-HDL ratio. Conclusion: In South Asian women the triglyceride-to-HDL cholesterol ratio was not associated with insulin resistance; therefore there may be limitations in its use as a surrogate marker in this group.	[Mostafa, Samiul A.; Davies, Melanie J.; Morris, Danielle H.; Yates, Tom; Srinivasan, Balasubramanian Thiagarajan; Webb, David; Brady, Emer] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Khunti, Kamlesh] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of Leicester; University of Leicester	Mostafa, SA (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	samiul.mostafa@uhl-tr.nhs.uk	/ABC-9527-2021	Webb, David/0000-0002-3932-3339; Davies, Melanie/0000-0002-9987-9371; Khunti, Kamlesh/0000-0003-2343-7099; Mostafa, Samiul/0000-0002-0415-7908	United Kingdom NHS Department of Health; Lilly; Sanofi Aventis; MSD; Novo Nordisk; BMS; BI; Roche; Astra Zeneca; Novartis; Pfizer; Servier; Novo Nordisk UK research foundation; NIHR LNR CLAHRC; NIHR Leicester-Loughborough Diet, Lifestyle and physical activity Biomedical Research Unit; National Institute for Health Research [RP-DG-1210-10183, RP-PG-0606-1272] Funding Source: researchfish	United Kingdom NHS Department of Health; Lilly(Eli Lilly); Sanofi Aventis(Sanofi-Aventis); MSD; Novo Nordisk(Novo Nordisk); BMS(Bristol-Myers Squibb); BI; Roche(Roche Holding); Astra Zeneca(AstraZeneca); Novartis(Novartis); Pfizer(Pfizer); Servier(Servier); Novo Nordisk UK research foundation; NIHR LNR CLAHRC; NIHR Leicester-Loughborough Diet, Lifestyle and physical activity Biomedical Research Unit; National Institute for Health Research(National Institute for Health Research (NIHR))	ADDITION-Leicester study was originally funded for support and treatment costs by United Kingdom NHS Department of Health (ClinicalTrials.gov Registration number: NCT00318032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KK (Chair) and MJD are members of the National Institute for Health and Clinical Excellence Public Health Guidance on prevention of Type 2 diabetes among people with prediabetes. MJD and KK are advisors to the UK Department Health for the NHS Health Checks Programme. MJD has received funds for research, honoraria for speaking at meetings and has served on Advisory Boards for Lilly, Sanofi Aventis, MSD, Novo Nordisk, BMS, BI and Roche. KK has received funds for research, honoraria for speaking at meetings and or served on Advisory Boards for Astra Zeneca, Lilly, Novartis, Pfizer, Servier, Sanofi Aventis, MSD and Novo Nordisk. SAM and DW have received fellowships from Novo Nordisk UK research foundation.; All members of the ADDITION-Leicester team and the participants for their contributions, as well as support from NIHR LNR CLAHRC and NIHR Leicester-Loughborough Diet, Lifestyle and physical activity Biomedical Research Unit.	[Anonymous], UK ETHNICITY NATL ST; Balkau B, 1999, DIABETIC MED, V16, P442; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bhalodkar NC, 2004, AM J CARDIOL, V94, P1561, DOI 10.1016/j.amjcard.2004.08.040; Bittner V, 2009, AM HEART J, V157, P548, DOI 10.1016/j.ahj.2008.11.014; Bovet P, 2006, ARCH INTERN MED, V166, P1236, DOI 10.1001/archinte.166.11.1236-b; Communities and Local Government, 2007, ENGL IND DEPR 2004; Cordero A, 2008, AM J CARDIOL, V102, P424, DOI 10.1016/j.amjcard.2008.03.079; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Despres JP, 2000, ARTERIOSCL THROM VAS, V20, P1932, DOI 10.1161/01.ATV.20.8.1932; Di Bonito P, 2012, DIABETES CARE, V35, P158, DOI 10.2337/dc11-1456; Fan XD, 2011, J CLIN PSYCHIAT, V72, P806, DOI 10.4088/JCP.09m05107yel; Gasevic D, 2012, METABOLISM, V61, P583, DOI 10.1016/j.metabol.2011.09.009; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gaziano JM, 1997, CIRCULATION, V96, P2520, DOI 10.1161/01.CIR.96.8.2520; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Hall LML, 2008, FUTURE LIPIDOL, V3, P411, DOI 10.2217/17460875.3.4.411; He S, 2012, METABOLISM, V61, P30, DOI 10.1016/j.metabol.2011.05.007; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kim-Dorner SJ, 2010, METABOLISM, V59, P299, DOI 10.1016/j.metabol.2009.07.027; Legro RS, 1998, J CLIN ENDOCR METAB, V83, P2694, DOI 10.1210/jc.83.8.2694; Li CY, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-4; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; Millan J, 2009, VASC HEALTH RISK MAN, V5, P757; Mostafa SA, 2010, DIABETIC MED, V27, P762, DOI 10.1111/j.1464-5491.2010.03015.x; Mostafa SA, 2010, DIABETES RES CLIN PR, V90, P100, DOI 10.1016/j.diabres.2010.06.008; Musso C, 2011, PEDIATR DIABETES, V12, P229, DOI 10.1111/j.1399-5448.2010.00710.x; Perkins NJ, 2005, BIOMETRICAL J, V47, P428, DOI 10.1002/bimj.200410133; Population estimates by Ethnic group, 2011, METH PAP OFF NAT STA; Quijada Z, 2008, PEDIATR DIABETES, V9, P464, DOI 10.1111/j.1399-5448.2008.00406.x; Report of a WHO Expert Consultation, 2008, REP WHO EXP CONS; Robbins DC, 1996, DIABETES, V45, P242, DOI 10.2337/diabetes.45.2.242; Sumner AE, 2005, ARCH INTERN MED, V165, P1395, DOI 10.1001/archinte.165.12.1395; Sumner AE, 2010, METAB SYNDR RELAT D, V8, P511, DOI 10.1089/met.2010.0028; The IDF consensus worldwide definition of the metabolic syndrome, 2006, IDF CONS WORLDW DEF; United States Census Bureau, PROF GEN POP HOUS CH; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Webb DR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-16; Zoppini G, 2012, METABOLISM, V61, P22, DOI 10.1016/j.metabol.2011.05.004	42	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2012	7	12							e50931	10.1371/journal.pone.0050931	http://dx.doi.org/10.1371/journal.pone.0050931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052ML	23251403	Green Published, gold, Green Submitted			2022-12-27	WOS:000312201900026
J	Brauer, A; Kurz, A; Stockwell, T; Baden-Tillson, H; Heidler, J; Wittig, I; Kauferstein, S; Mebs, D; Stocklin, R; Remm, M				Brauer, Age; Kurz, Alexander; Stockwell, Tim; Baden-Tillson, Holly; Heidler, Juliana; Wittig, Ilka; Kauferstein, Silke; Mebs, Dietrich; Stoecklin, Reto; Remm, Maido			The Mitochondrial Genome of the Venomous Cone Snail Conus consors	PLOS ONE			English	Article							TRANSFER-RNA GENES; DNA CONTROL REGION; COMPLETE SEQUENCE; NUCLEOTIDE-SEQUENCES; EVOLUTION; ORGANIZATION; GASTROPOD; REARRANGEMENT; TEREBRIDAE; PHYLOGENY	Cone snails are venomous predatory marine neogastropods that belong to the species-rich superfamily of the Conoidea. So far, the mitochondrial genomes of two cone snail species (Conus textile and Conus borgesi) have been described, and these feed on snails and worms, respectively. Here, we report the mitochondrial genome sequence of the fish-hunting cone snail Conus consors and describe a novel putative control region (CR) which seems to be absent in the mitochondrial DNA (mtDNA) of other cone snail species. This possible CR spans about 700 base pairs (bp) and is located between the genes encoding the transfer RNA for phenylalanine (tRNA-Phe, trnF) and cytochrome c oxidase subunit III (cox3). The novel putative CR contains several sequence motifs that suggest a role in mitochondrial replication and transcription.	[Brauer, Age; Remm, Maido] Estonian Bioctr, Tartu, Estonia; [Brauer, Age; Remm, Maido] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Kurz, Alexander; Kauferstein, Silke; Mebs, Dietrich] Goethe Univ Frankfurt, Sch Med, Inst Forens Med, Frankfurt, Germany; [Stockwell, Tim; Baden-Tillson, Holly] J Craig Venter Inst, Rockville, MD USA; [Heidler, Juliana] Goethe Univ Frankfurt, Sch Med, Dept Mol Hematol, Frankfurt, Germany; [Wittig, Ilka] Goethe Univ Frankfurt, Sch Med, Mol Bioenerget Grp, Frankfurt, Germany; [Mebs, Dietrich] Toxin Fdn, Geneva, Switzerland; [Stoecklin, Reto] Atheris Labs, Geneva, Switzerland	Estonian Biocentre; University of Tartu; Goethe University Frankfurt; J. Craig Venter Institute; Goethe University Frankfurt; Goethe University Frankfurt	Brauer, A (corresponding author), Estonian Bioctr, Tartu, Estonia.	age.brauer@ut.ee	Kauferstein, Silke/AFK-4350-2022; Brauer, Age/ABI-7540-2020; Brauer, Age/AAO-6064-2021; Remm, Maido/L-9072-2019; Kauferstein, Silke/AAG-3102-2022	Brauer, Age/0000-0003-4779-2458; Remm, Maido/0000-0003-3966-8422; Stockwell, Timothy/0000-0002-3595-4539	European Commission [037592]; Estonian Ministry of Education and Research [SF0180026s09]; European Union European Regional Development Fund through the Estonian Centre of Excellence in Genomics; German Network for Mitochondrial Disorders mitoNET of the Bundesministerium fur Bildung und Forschung [01GM1113B]	European Commission(European CommissionEuropean Commission Joint Research Centre); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Union European Regional Development Fund through the Estonian Centre of Excellence in Genomics; German Network for Mitochondrial Disorders mitoNET of the Bundesministerium fur Bildung und Forschung	This study has been performed as part of the CONCO cone snail genome project for health (www.conco.eu) funded by the European Commission within the 6th Framework Program (LIFESCIHEALTH-6 Integrated Project LSHB-CT-2007, contract number 037592) with Dr Torbjorn Ingemansson as scientific officer. AB and MR were partially supported by SF0180026s09 from the Estonian Ministry of Education and Research and by the European Union European Regional Development Fund through the Estonian Centre of Excellence in Genomics. IW was supported by the German Network for Mitochondrial Disorders mitoNET 01GM1113B of the Bundesministerium fur Bildung und Forschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQUADRO CF, 1983, GENETICS, V103, P287; Arndt A, 1998, MOL BIOL EVOL, V15, P1009, DOI 10.1093/oxfordjournals.molbev.a025999; Bandyopadhyay PK, 2008, MOL PHYLOGENET EVOL, V46, P215, DOI 10.1016/j.ympev.2007.08.002; Bandyopadhyay PK, 2006, TOXICON, V48, P29, DOI 10.1016/j.toxicon.2006.04.013; BERNARDI G, 1965, NATURE, V206, P779, DOI 10.1038/206779a0; Boore JL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-182; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2004, MOL BIOL EVOL, V21, P1492, DOI 10.1093/molbev/msh090; BOORE JL, 1994, GENETICS, V138, P423; Brehm A, 2003, J MOL EVOL, V56, P46, DOI 10.1007/s00239-002-2379-0; CANN RL, 1984, GENETICS, V106, P479; Cao LQ, 2004, GENETICS, V167, P835, DOI 10.1534/genetics.103.026187; Castelin M, 2012, MOL PHYLOGENET EVOL, V64, P21, DOI 10.1016/j.ympev.2012.03.001; Cunha RL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-210; DeGiorgi C, 1996, MOL PHYLOGENET EVOL, V5, P323, DOI 10.1006/mpev.1996.0027; DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fernandez-Silva P, 2001, NUCLEIC ACIDS RES, V29, P4736, DOI 10.1093/nar/29.22.4736; GJETVAJ B, 1992, MOL BIOL EVOL, V9, P106; Grande C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-61; HIXSON JE, 1986, J BIOL CHEM, V261, P2384; Holford M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007667; Hu H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-60; Jiang L, 1995, MOL MAR BIOL BIOTECH, V4, P353; Kurabayashi A, 2000, MOL BIOL EVOL, V17, P266, DOI 10.1093/oxfordjournals.molbev.a026306; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Machida RJ, 2004, MAR BIOTECHNOL, V6, P238, DOI 10.1007/s10126-003-0016-6; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maynard BT, 2005, MAR BIOTECHNOL, V7, P645, DOI 10.1007/s10126-005-0013-z; McComish BJ, 2010, GENOME BIOL EVOL, V2, P410, DOI 10.1093/gbe/evq029; Menez A, 2006, TOXICON, V47, P255, DOI 10.1016/j.toxicon.2005.12.010; Milbury CA, 2005, MAR BIOTECHNOL, V7, P697, DOI 10.1007/s10126-005-0004-0; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mueller RL, 2005, MOL BIOL EVOL, V22, P2104, DOI 10.1093/molbev/msi204; Oliveira MT, 2007, J MOL EVOL, V64, P519, DOI 10.1007/s00239-006-0099-6; Randi E, 1998, J MOL EVOL, V47, P449, DOI 10.1007/PL00006402; Roberti M, 1999, CURR GENET, V34, P449, DOI 10.1007/s002940050419; Sambrook J., 2002, MOL CLONING LAB MANU; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Simison WB, 2006, MOL PHYLOGENET EVOL, V39, P562, DOI 10.1016/j.ympev.2005.11.006; SNYDER M, 1987, P NATL ACAD SCI USA, V84, P7595, DOI 10.1073/pnas.84.21.7595; Stockwell T, 2010, ADV NEW TECHNOLOGIES, P11; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yuan Y, 2012, MOL BIOL REP, V39, P1287, DOI 10.1007/s11033-011-0861-8; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	14	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51528	10.1371/journal.pone.0051528	http://dx.doi.org/10.1371/journal.pone.0051528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236512	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100128
J	Chamontin, C; Yu, B; Racine, PJ; Darlix, JL; Mougel, M				Chamontin, Celia; Yu, Bing; Racine, Pierre-Jean; Darlix, Jena-Luc; Mougel, Marylene			MoMuLV and HIV-1 Nucleocapsid Proteins Have a Common Role in Genomic RNA Packaging but Different in Late Reverse Transcription	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; ZINC-FINGER; HUMAN-IMMUNODEFICIENCY; VIRAL-RNA; BASIC RESIDUES; GAG; MUTATIONS; VIRIONS; ENCAPSIDATION; REPLICATION	Retroviral nucleocapsid proteins harbor nucleic acid chaperoning activities that mostly rely on the N-terminal basic residues and the CCHC zinc finger motif. Such chaperoning is essential for virus replication, notably for genomic RNA selection and packaging in virions, and for reverse transcription of genomic RNA into DNA. Recent data revealed that HIV-1 nucleocapsid restricts reverse transcription during virus assembly - a process called late reverse transcription - suggesting a regulation between RNA packaging and late reverse transcription. Indeed, mutating the HIV-1 nucleocapsid basic residues or the two zinc fingers caused a reduction in RNA incorporated and an increase in newly made viral DNA in the mutant virions. MoMuLV nucleocapsid has an N-terminal basic region similar to HIV-1 nucleocapsid but a unique zinc finger. This prompted us to investigate whether the N-terminal basic residues and the zinc finger of MoMuLV and HIV-1 nucleocapsids play a similar role in genomic RNA packaging and late reverse transcription. To this end, we analyzed the genomic RNA and viral DNA contents of virions produced by cells transfected with MoMuLV molecular clones where the zinc finger was mutated or completely deleted or with a deletion of the N-terminal basic residues of nucleocapsid. All mutant virions showed a strong defect in genomic RNA content indicating that the basic residues and zinc finger are important for genomic RNA packaging. In contrast to HIV-1 nucleocapsid-mutants, the level of viral DNA in mutant MoMuLV virions was only slightly increased. These results confirm that the N-terminal basic residues and zinc finger of MoMuLV nucleocapsid are critical for genomic RNA packaging but, in contrast to HIV-1 nucleocapsid, they most probably do not play a role in the control of late reverse transcription. In addition, these results suggest that virus formation and late reverse transcription proceed according to distinct mechanisms for MuLV and HIV-1.	[Chamontin, Celia; Yu, Bing; Racine, Pierre-Jean; Mougel, Marylene] UM2, UM1, CNRS UMR5236, CPBS, Montpellier, France; [Darlix, Jena-Luc] Fac Pharm, UMR CNRS 7213, Lab Biophoton & Pharmacol, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mougel, M (corresponding author), UM2, UM1, CNRS UMR5236, CPBS, Montpellier, France.	marylene.mougel@cpbs.cnrs.fr	LUC, DARLIX JEAN/AAE-9268-2020; Mougel, Marylene/K-7958-2013	Mougel, Marylene/0000-0002-0345-1427; CHAMONTIN, CELIA/0000-0001-7760-373X; RACINE, pierre-jean/0000-0003-1747-6737	Infectiopole Sud; ANRS; UMI; CNRS;  [ANRS2009-2]	Infectiopole Sud; ANRS(ANRSFrench National Research Agency (ANR)); UMI; CNRS(Centre National de la Recherche Scientifique (CNRS)); 	YB was supported by Infectiopole Sud, PJR by ANRS, CC by UMI and MM by CNRS. YB was supported by Infectiopole Sud and PJR by ANRS2009-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKOWITZ RD, 1995, J VIROL, V69, P6445, DOI 10.1128/JVI.69.10.6445-6456.1995; Bowzard JB, 1998, J VIROL, V72, P9034, DOI 10.1128/JVI.72.11.9034-9044.1998; D'Souza V, 2005, NAT REV MICROBIOL, V3, P643, DOI 10.1038/nrmicro1210; D'Souza V, 2004, NATURE, V431, P586, DOI 10.1038/nature02944; Darlix J L, 2000, Adv Pharmacol, V48, P345; Darlix JL, 2007, ADV PHARMACOL, V55, P299, DOI 10.1016/S1054-3589(07)55009-X; Darlix JL, 2011, J MOL BIOL, V410, P565, DOI 10.1016/j.jmb.2011.03.037; DARLIX JL, 1977, J VIROL, V22, P118, DOI 10.1128/JVI.22.1.118-129.1977; DARLIX JL, 1995, J MOL BIOL, V254, P523, DOI 10.1006/jmbi.1995.0635; Datta SAK, 2011, J VIROL, V85, P12733, DOI 10.1128/JVI.05889-11; DEROCQUIGNY H, 1993, NUCLEIC ACIDS RES, V21, P823; Dey A, 2005, BIOCHEMISTRY-US, V44, P3735, DOI 10.1021/bi047639q; Didierlaurent L, 2011, NUCL ACIDS RES; Didierlaurent L, 2008, NUCLEIC ACIDS RES, V36, P4745, DOI 10.1093/nar/gkn474; FU W, 1993, J VIROL, V67, P5443, DOI 10.1128/JVI.67.9.5443-5449.1993; GORELICK RJ, 1988, P NATL ACAD SCI USA, V85, P8420, DOI 10.1073/pnas.85.22.8420; Grigorov B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-54; Grohmann D, 2008, BIOCHEMISTRY-US, V47, P12230, DOI 10.1021/bi801386r; Heldsinger A, 2001, ARCH VIROL, V146, P2385, DOI 10.1007/s007050170010; HOUSSET V, 1993, J VIROL, V67, P2537, DOI 10.1128/JVI.67.5.2537-2545.1993; Housset V, 1996, CR ACAD SCI III-VIE, V319, P81; Houzet L, 2003, EMBO J, V22, P4866, DOI 10.1093/emboj/cdg450; Houzet L, 2008, NUCLEIC ACIDS RES, V36, P2311, DOI 10.1093/nar/gkn069; Houzet L, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-30; Houzet L, 2007, NUCLEIC ACIDS RES, V35, P2695, DOI 10.1093/nar/gkm153; Jouvenet N, 2011, RNA BIOL, V8, P572, DOI 10.4161/rna.8.4.16030; Lener D, 1998, J BIOL CHEM, V273, P33781, DOI 10.1074/jbc.273.50.33781; Levin JG, 2010, RNA BIOL, V7, P754, DOI 10.4161/rna.7.6.14115; LORI F, 1992, J VIROL, V66, P5067, DOI 10.1128/JVI.66.8.5067-5074.1992; Lu K, 2011, SCIENCE, V334, P242, DOI 10.1126/science.1210460; MELY Y, 1991, BIOPOLYMERS, V31, P899, DOI 10.1002/bip.360310709; MERIC C, 1989, J VIROL, V63, P1558; Mirambeau G, 2010, RNA BIOL, V7, P724, DOI 10.4161/rna.7.6.13777; Mougel M, 1996, J VIROL, V70, P5043, DOI 10.1128/JVI.70.8.5043-5050.1996; Mougel M, 2010, VIRUSES-BASEL, V2, P939, DOI 10.3390/v2040939; Mougel M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-24; Muriaux D, 2004, J VIROL, V78, P12378, DOI 10.1128/JVI.78.22.12378-12385.2004; Muriaux D, 2002, J VIROL, V76, P11405, DOI 10.1128/JVI.76.22.11405-11413.2002; Muriaux D, 2010, RNA BIOL, V7, P744, DOI 10.4161/rna.7.6.14065; Ott DE, 1998, VIROLOGY, V243, P283, DOI 10.1006/viro.1998.9062; PRATS AC, 1988, EMBO J, V7, P1777, DOI 10.1002/j.1460-2075.1988.tb03008.x; REIN A, 1994, J VIROL, V68, P6124, DOI 10.1128/JVI.68.9.6124-6129.1994; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Rein Alan, 1997, Leukemia (Basingstoke), V11, P106; Roda RH, 2003, J BIOL CHEM, V278, P31536, DOI 10.1074/jbc.M304608200; Smagulova F, 2005, J MOL BIOL, V354, P1118, DOI 10.1016/j.jmb.2005.10.021; Stewart-Maynard KM, 2008, J VIROL, V82, P10129, DOI 10.1128/JVI.01169-08; Still A, 2011, VIRUS RES, V155, P181, DOI 10.1016/j.virusres.2010.10.001; Swanstrom R., 1997, P263; Thomas JA, 2008, J VIROL, V82, P9318, DOI 10.1128/JVI.00583-08; TOUNEKTI N, 1992, J MOL BIOL, V223, P205, DOI 10.1016/0022-2836(92)90726-Z; TRONO D, 1992, J VIROL, V66, P4893, DOI 10.1128/JVI.66.8.4893-4900.1992; Yu QA, 1996, J VIROL, V70, P5791, DOI 10.1128/JVI.70.9.5791-5798.1996; ZHANG H, 1993, AIDS RES HUM RETROV, V9, P1287, DOI 10.1089/aid.1993.9.1287; Zhang WH, 2002, J VIROL, V76, P7473, DOI 10.1128/JVI.76.15.7473-7484.2002; ZHANG YQ, 1995, J VIROL, V69, P5716, DOI 10.1128/JVI.69.9.5716-5722.1995	56	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51534	10.1371/journal.pone.0051534	http://dx.doi.org/10.1371/journal.pone.0051534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236513	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100129
J	Conner, OL; Siegle, GJ; McFarland, AM; Silk, JS; Ladouceur, CD; Dahl, RE; Coan, JA; Ryan, ND				Conner, Olivia L.; Siegle, Greg J.; McFarland, Ashley M.; Silk, Jennifer S.; Ladouceur, Cecile D.; Dahl, Ronald E.; Coan, James A.; Ryan, Neal D.			Mom-It Helps When You're Right Here! Attenuation of Neural Stress Markers in Anxious Youths Whose Caregivers Are Present during fMRI	PLOS ONE			English	Article							PREFRONTAL CORTEX ACTIVATION; EMOTIONAL INFORMATION; ATTENTIONAL BIAS; ANGRY FACES; ANXIETY; ADOLESCENTS; AMYGDALA; CHILDREN	Close proximity to an attachment figure, such as a caregiver, has been shown to attenuate threat-related activity in limbic regions such as the hypothalamus in healthy individuals. We hypothesized that such features might be similarly attenuated by proximity during a potentially stressful situation in a clinically anxious population of youths. Confirmation of this hypothesis could support the role of attachment figures in the management of anxiety among children and adolescents. Three groups were analyzed: anxious children and adolescents who requested that their caregiver accompany them in the scanner room, anxious children and adolescents without their caregiver in the scanner room and healthy controls (each of N = 10). The groups were matched for age and, among the two anxious groups, for diagnosis (mean age 9.5). The children and adolescents were exposed to physical threat words during an fMRI assessment. Results indicate that activity in the hypothalamus, ventromedial, and ventrolateral prefrontal cortex were significantly reduced in anxious children and adolescents who requested that their caregiver accompany them in the scanner room compared to those without their caregiver in the scanner room. Mean activity in these regions in anxious children and adolescents with their caregiver in the scanner room was comparable to that of healthy controls. These data suggest links between social contact and neural mechanisms of emotional reactivity; specifically, presence of caregivers moderates the increase in anxiety seen with stressful stimuli. Capitalizing on the ability of anxious youths to manifest low levels of anxiety-like information processing in the presence of a caregiver could help in modeling adaptive function in behavioral treatments.	[Conner, Olivia L.; McFarland, Ashley M.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; [Siegle, Greg J.; Silk, Jennifer S.; Ladouceur, Cecile D.; Ryan, Neal D.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Dahl, Ronald E.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Coan, James A.] Univ Virginia, Charlottesville, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Berkeley; University of Virginia	Conner, OL (corresponding author), Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA.	connerol@upmc.edu	Dahl, Ronald/AAW-8714-2021; Ladouceur, Cecile D/H-3124-2016	Silk, Jennifer/0000-0002-8638-4337; dahl, ronald/0000-0002-1794-7132	National Institutes of Health [P50 MH080215, MH082998, MH083001]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH080215, K02MH082998, K01MH083001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by P50 MH080215, the National Institutes of Health MH082998 and MH083001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, DIAGN STAT MAN DIS; Barrett PM, 1996, J CONSULT CLIN PSYCH, V64, P333, DOI 10.1037/0022-006X.64.2.333; Beckes L, 2011, SOC PERSONAL PSYCHOL, V5, P976, DOI 10.1111/j.1751-9004.2011.00400.x; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Bowlby J., 1982, ATTACHMENT LOSS, V2nd; Cacioppo JT, 1999, CURR DIR PSYCHOL SCI, V8, P133, DOI 10.1111/1467-8721.00031; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Kemeny ME, 2003, CURR DIR PSYCHOL SCI, V12, P124, DOI 10.1111/1467-8721.01246; MACLEOD C, 1992, BEHAV RES THER, V30, P479, DOI 10.1016/0005-7967(92)90032-C; Monk CS, 2008, ARCH GEN PSYCHIAT, V65, P568, DOI 10.1001/archpsyc.65.5.568; Monk CS, 2006, AM J PSYCHIAT, V163, P1091, DOI 10.1176/appi.ajp.163.6.1091; Neshat-Doost HT, 2000, J CHILD PSYCHOL PSYC, V41, P363, DOI 10.1111/1469-7610.00620; Riddle MA, 2002, J AM ACAD CHILD PSY, V41, P1061, DOI 10.1097/01.CHI.0000020259.43550.F4; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET, V3rd ed.; Silk JS, 2007, AM J PSYCHIAT, V164, P1873, DOI 10.1176/appi.ajp.2007.06111816; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Wechsler D., 2011, WASI 2 WECHSLER ABBR; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024	20	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50680	10.1371/journal.pone.0050680	http://dx.doi.org/10.1371/journal.pone.0050680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236383	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100025
J	Pan, XB; Han, JC; Cong, X; Wei, L				Pan, Xiao-Ben; Han, Jin-Chao; Cong, Xu; Wei, Lai			BST2/Tetherin Inhibits Dengue Virus Release from Human Hepatoma Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; WEST NILE VIRUS; INTERFERON-ALPHA; INFECTION; TETHERIN; PROTEIN; INNATE; IDENTIFICATION; LOCALIZATION; REPLICATION	Type I interferons (IFN) have been shown to play an important role for inhibiting Dengue virus (DENV) infection. Identifying IFN-induced cellular proteins are essential for understanding its mechanisms against DENV. Here we established stable Huh7-derived cell lines expressing the IFN-induced cell membrane protein BST2 (Huh7-BST2) or its variant bearing a V5 tag at the C-terminal (Huh7-BST5CV5). These cell lines were infected with DENV to determine proteins modulating their anti-DENV response. We found that expression of BST2 did not affect the efficiency of DENV infection and intracellular replication. Rather, it significantly reduced the virion yield of the infected cells, particularly at low MOI infection. In addition, BST2 also decreased the foci formation and the size of infectious foci in cultured Huh7 monolayers with media containing methocellulose. The addition of the V5 tag at C-terminal inhibited the GPI modification of BST2 and blocked its shift from endoplasm to cytoplastic membrane. BST2CV5 did not affect DENV infection and foci formation in Huh7 cells but reduced virion yield by 1 log at low MOI infection. Interestingly, intracellular BST2CV5 expression was reduced by high level of DENV production. Conclusion: Our results imply that BST2 is a functional mediator of the IFN response against DENV infection. BST2 inhibits the release of DENV virions from Huh7 cells and limits viral cell-to-cell transmission. BST2CV5 variant is unable to inhibit DENV release but impairs viral infection in cells.	[Pan, Xiao-Ben; Han, Jin-Chao; Cong, Xu; Wei, Lai] Peking Univ, Peoples Hosp, Inst Hepatol, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100871, Peoples R China; [Wei, Lai] Peking Univ, Peoples Hosp, Dept Infect Dis, Beijing 100871, Peoples R China	Peking University; Peking University	Pan, XB (corresponding author), Peking Univ, Peoples Hosp, Inst Hepatol, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100871, Peoples R China.	Panxiaoben@pkuph.edu.cn; weilai@pkuph.edu.cn		Pan, Xiao-Ben/0000-0002-7795-8159	National Natural Science Foundation of China [30972605, 30700697]; Program for New Century Excellent Talents in University (NCET) [BMU20110272]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (NCET)(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Natural Science Foundation of China (30972605 and 30700697) and Program for New Century Excellent Talents in University (NCET, BMU20110272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-24; Barrett BS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002596; Beatty M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001450; Becquart P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-356; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Dafa-Berger A, 2012, VIROLOGY, V428, P98, DOI 10.1016/j.virol.2012.03.011; Dai JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-468; de-Oliveira-Pinto LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038527; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; GOTO T, 1994, BLOOD, V84, P1922; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hammonds J, 2012, J VIROL, V86, P2259, DOI 10.1128/JVI.05906-11; Hinz A, 2010, CELL HOST MICROBE, V7, P314, DOI 10.1016/j.chom.2010.03.005; Janvier K, 2012, CURR HIV RES, V10, P315, DOI 10.2174/157016212800792414; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Jolly C, 2010, J VIROL, V84, P12185, DOI 10.1128/JVI.01447-10; Jones PH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-10; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kuhl BD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-115; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Le Tortorec A, 2011, VIRUSES-BASEL, V3, P520, DOI 10.3390/v3050520; Liang ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023346; Lu MY, 2011, CELL DEATH DIFFER, V18, P925, DOI 10.1038/cdd.2010.160; Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847; Modhiran N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000924; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Panchal RG, 2003, P NATL ACAD SCI USA, V100, P15936, DOI 10.1073/pnas.2533915100; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Perry ST, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001297; Perry ST, 2009, J VIROL, V83, P8276, DOI 10.1128/JVI.00365-09; Pichyangkul S, 2003, J IMMUNOL, V171, P5571, DOI 10.4049/jimmunol.171.10.5571; Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; Ruiz A, 2010, VIROLOGY, V406, P312, DOI 10.1016/j.virol.2010.07.021; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310; St John AL, 2011, P NATL ACAD SCI USA, V108, P9190, DOI 10.1073/pnas.1105079108; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Thomas SJ, 2011, HUM VACCINES, V7, P674, DOI 10.4161/hv.7.6.14985; Viswanathan K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002332; Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10	50	36	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51033	10.1371/journal.pone.0051033	http://dx.doi.org/10.1371/journal.pone.0051033			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236425	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100056
J	Siwy, J; Zoja, C; Klein, J; Benigni, A; Mullen, W; Mayer, B; Mischak, H; Jankowski, J; Stevens, R; Vlahou, A; Kossida, S; Perco, P; Bahlmann, FH				Siwy, Justyna; Zoja, Carlamaria; Klein, Julie; Benigni, Ariela; Mullen, Wiliam; Mayer, Bernd; Mischak, Harald; Jankowski, Joachim; Stevens, Robert; Vlahou, Antonia; Kossida, Sophia; Perco, Paul; Bahlmann, Ferdinand H.			Evaluation of the Zucker Diabetic Fatty (ZDF) Rat as a Model for Human Disease Based on Urinary Peptidomic Profiles	PLOS ONE			English	Article							FANCONI-SYNDROME; DISCOVERY; PROTEOME; COMPLICATIONS; ACCUMULATION; DYSFUNCTION; PROGRESSION; VALIDATION; BIOMARKERS; PATTERNS	Representative animal models for diabetes-associated vascular complications are extremely relevant in assessing potential therapeutic drugs. While several rodent models for type 2 diabetes (T2D) are available, their relevance in recapitulating renal and cardiovascular features of diabetes in man is not entirely clear. Here we evaluate at the molecular level the similarity between Zucker diabetic fatty (ZDF) rats, as a model of T2D-associated vascular complications, and human disease by urinary proteome analysis. Urine analysis of ZDF rats at early and late stages of disease compared to age-matched LEAN rats identified 180 peptides as potentially associated with diabetes complications. Overlaps with human chronic kidney disease (CKD) and cardiovascular disease (CVD) biomarkers were observed, corresponding to proteins marking kidney damage (eg albumin, alpha-1 antitrypsin) or related to disease development (collagen). Concordance in regulation of these peptides in rats versus humans was more pronounced in the CVD compared to the CKD panels. In addition, disease-associated predicted protease activities in ZDF rats showed higher similarities to the predicted activities in human CVD. Based on urinary peptidomic analysis, the ZDF rat model displays similarity to human CVD but might not be the most appropriate model to display human CKD on a molecular level.	[Bahlmann, Ferdinand H.] Saarland Univ Hosp, Dept Internal Med, Homburg, Germany; [Siwy, Justyna; Jankowski, Joachim] Charite Univ Med Berlin, Berlin, Germany; [Zoja, Carlamaria; Benigni, Ariela] Ctr Anna Maria Astori, Mario Negri Inst Pharmacol Res, Bergamo, Italy; [Klein, Julie; Stevens, Robert] Univ Manchester, Sch Comp Sci, Manchester M13 9PL, Lancs, England; [Mullen, Wiliam; Mischak, Harald] Univ Glasgow, e BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8QQ, Lanark, Scotland; [Mayer, Bernd; Perco, Paul] Emergentec Biodev GmbH, Vienna, Austria; [Vlahou, Antonia; Kossida, Sophia] Acad Athens, Biomed Res Fdn, Athens, Greece; [Siwy, Justyna; Mischak, Harald] Mosa Diagnost, Hannover, Germany	Universitatsklinikum des Saarlandes; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Manchester; University of Glasgow; Emergentec Biodevelopment GmbH; Academy of Athens	Bahlmann, FH (corresponding author), Saarland Univ Hosp, Dept Internal Med, Homburg, Germany.	ferdinandbahlmann@web.de	Kossida, Sofia/ABG-3526-2020; zoja, carlamaria/ABF-5896-2020; Perco, Paul/U-2489-2019; Klein, Julie/M-7088-2017; Klein, Julie/ABE-2622-2020; Ariela, Benigni/ABH-3492-2020	zoja, carlamaria/0000-0003-2507-8894; Perco, Paul/0000-0003-2087-5691; Klein, Julie/0000-0002-3279-0559; Klein, Julie/0000-0002-3279-0559; Ariela, Benigni/0000-0002-4721-5485; Mischak, Harald/0000-0003-0323-0306; Vlahou, Antonia/0000-0003-3284-5713; Siwy, Justyna/0000-0003-1407-2534	EuroKUP COST Action [BM0702]; EU through SysKID [HEALTH-F2-2009-241544]; European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) [ALTF 82-2011]	EuroKUP COST Action(European Cooperation in Science and Technology (COST)); EU through SysKID; European Renal Association-European Dialysis and Transplant Association (ERA-EDTA)	This work was supported in part by the EuroKUP COST Action (BM0702), and by EU funding through SysKID (HEALTH-F2-2009-241544). JK was supported by the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA, ALTF 82-2011). No additional external funding was received or needed for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Andersen S, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-29; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cutillas PR, 2004, AM J PHYSIOL-RENAL, V287, pF353, DOI 10.1152/ajprenal.00018.2004; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; Delles C, 2010, J HYPERTENS, V28, P2316, DOI 10.1097/HJH.0b013e32833d81b7; Drube J, 2009, NEPHROL DIAL TRANSPL, V24, P2161, DOI 10.1093/ndt/gfp063; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Good DM, 2010, MOL CELL PROTEOMICS; Hashemi M, 2007, DIABETES RES CLIN PR, V75, P246, DOI 10.1016/j.diabres.2006.06.020; Haubitz M, 2005, KIDNEY INT, V67, P2313, DOI 10.1111/j.1523-1755.2005.00335.x; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Jonsson B, 2002, DIABETOLOGIA, V45, pS5, DOI 10.1007/s00125-002-0858-x; KURTZ TW, 1989, HYPERTENSION, V13, P896, DOI 10.1161/01.HYP.13.6.896; Maahs DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013051; Mischak H, 2009, PROTEOM CLIN APPL, V3, P1062, DOI 10.1002/prca.200900030; Mischak H, 2009, MASS SPECTROM REV, V28, P703, DOI 10.1002/mas.20205; Nakagawa T, 2011, NAT REV NEPHROL, V7, P36, DOI 10.1038/nrneph.2010.152; Oltman CL, 2006, AM J PHYSIOL-HEART C, V291, pH1780, DOI 10.1152/ajpheart.01297.2005; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rouse R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034606; Talmud PJ, 2003, ARTERIOSCL THROM VAS, V23, P644, DOI 10.1161/01.ATV.0000065196.61663.8D; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Toblli JE, 2010, J HYPERTENS, V28, P1007, DOI 10.1097/HJH.0b013e328337598c; Varghese SA, 2007, J AM SOC NEPHROL, V18, P913, DOI 10.1681/ASN.2006070767; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Voros K, 2011, EUR J CLIN INVEST, V41, P703, DOI 10.1111/j.1365-2362.2010.02456.x; Wenger CD, 2011, PROTEOMICS, V11, P1064, DOI 10.1002/pmic.201000616; Westenfeld R, 2009, J AM SOC NEPHROL; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zoja C, 2011, AM J PHYSIOL-RENAL, V301, pF1114, DOI 10.1152/ajprenal.00122.2011; Zuerbig P, 2012, DIABETES; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	34	47	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51334	10.1371/journal.pone.0051334	http://dx.doi.org/10.1371/journal.pone.0051334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236474	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000312064100097
J	Stewart, P; Campbell, L; Skogtvedt, S; Griffin, KA; Arnemo, JM; Tryland, M; Girling, S; Miller, MW; Tranulis, MA; Goldmann, W				Stewart, Paula; Campbell, Lauren; Skogtvedt, Susan; Griffin, Karen A.; Arnemo, Jon M.; Tryland, Morten; Girling, Simon; Miller, Michael W.; Tranulis, Michael A.; Goldmann, Wilfred			Genetic Predictions of Prion Disease Susceptibility in Carnivore Species Based on Variability of the Prion Gene Coding Region	PLOS ONE			English	Article							FELINE SPONGIFORM ENCEPHALOPATHY; CHRONIC WASTING DISEASE; TRANSMISSIBLE MINK ENCEPHALOPATHY; PROTEIN GENE; SCRAPIE; PRP; SHEEP; CATS; MICE; CONSERVATION	Mammalian species vary widely in their apparent susceptibility to prion diseases. For example, several felid species developed prion disease (feline spongiform encephalopathy or FSE) during the bovine spongiform encephalopathy (BSE) epidemic in the United Kingdom, whereas no canine BSE cases were detected. Whether either of these or other groups of carnivore species can contract other prion diseases (e. g. chronic wasting disease or CWD) remains an open question. Variation in the host-encoded prion protein (PrP C) largely explains observed disease susceptibility patterns within ruminant species, and may explain interspecies differences in susceptibility as well. We sequenced and compared the open reading frame of the PRNP gene encoding PrP C protein from 609 animal samples comprising 29 species from 22 genera of the Order Carnivora; amongst these samples were 15 FSE cases. Our analysis revealed that FSE cases did not encode an identifiable disease-associated PrP polymorphism. However, all canid PrPs contained aspartic acid or glutamic acid at codon 163 which we propose provides a genetic basis for observed susceptibility differences between canids and felids. Among other carnivores studied, wolverine (Gulo gulo) and pine marten (Martes martes) were the only non-canid species to also express PrP-Asp163, which may impact on their prion diseases susceptibility. Populations of black bear (Ursus americanus) and mountain lion (Puma concolor) from Colorado showed little genetic variation in the PrP protein and no variants likely to be highly resistant to prions in general, suggesting that strain differences between BSE and CWD prions also may contribute to the limited apparent host range of the latter.	[Stewart, Paula; Campbell, Lauren; Goldmann, Wilfred] Univ Edinburgh, Roslin Inst, Div Neurobiol, Roslin, Midlothian, Scotland; [Skogtvedt, Susan; Tranulis, Michael A.] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [Griffin, Karen A.; Miller, Michael W.] Colorado Div Pk & Wildlife, Wildlife Res Ctr, Ft Collins, CO USA; [Arnemo, Jon M.] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Dept Forestry & Wildlife Management, Elverum, Norway; [Arnemo, Jon M.] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Fac Forest Sci, S-90183 Umea, Sweden; [Tryland, Morten] Norwegian Sch Vet Sci, Sect Arctic Vet Med, Tromso, Norway; [Tryland, Morten] GenOk Ctr Biosafety, Tromso, Norway; [Girling, Simon] Royal Zool Soc Scotland, Edinburgh Zoo, Edinburgh, Midlothian, Scotland; [Stewart, Paula; Campbell, Lauren; Goldmann, Wilfred] Univ Edinburgh, R D SVS, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Norwegian University of Life Sciences; Inland Norway University of Applied Sciences; Swedish University of Agricultural Sciences; Norwegian University of Life Sciences; University of Edinburgh	Goldmann, W (corresponding author), Univ Edinburgh, Roslin Inst, Div Neurobiol, Roslin, Midlothian, Scotland.	wilfred.goldmann@roslin.ed.ac.uk		Tryland, Morten/0000-0001-5394-5196; Girling, Simon/0000-0001-9927-9491	Roslin Institute; Biotechnology and Biological Sciences Research Council, United Kingdom; BBSRC [BBS/E/D/20251967, BBS/E/D/20251968, BBS/E/D/05241340, BBS/E/A/00001652] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251968, BBS/E/D/20251967, BBS/E/D/05241340, BBS/E/A/00001652] Funding Source: researchfish	Roslin Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	PS, LC and WG were supported by Roslin Institute Strategic Grant funding from the Biotechnology and Biological Sciences Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; B-Rao C, 2001, HUM HERED, V52, P191, DOI 10.1159/000053376; Baron T, 1997, VET REC, V141, P270, DOI 10.1136/vr.141.11.270; Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Bartz JC, 1998, VIROLOGY, V251, P297, DOI 10.1006/viro.1998.9427; Bencsik A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006929; BRATBERG B, 1995, VET REC, V136, P444, DOI 10.1136/vr.136.17.444; Brun A, 2004, NEUROSCI RES, V48, P75, DOI 10.1016/j.neures.2003.09.004; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chase-Topping ME, 2005, J GEN VIROL, V86, P1229, DOI 10.1099/vir.0.80277-0; Eiden M, 2010, J GEN VIROL, V91, P2874, DOI 10.1099/vir.0.022103-0; Fernandez-Borges N, 2012, PRION S, V6, P47; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Goldmann W, 1998, J GEN VIROL, V79, P3173, DOI 10.1099/0022-1317-79-12-3173; Goldmann W, 2008, VET RES, V39, DOI 10.1051/vetres:2008010; Hamir AN, 2005, VET PATHOL, V42, P844, DOI 10.1354/vp.42-6-844; Hamir AN, 2004, J VET DIAGN INVEST, V16, P57, DOI 10.1177/104063870401600110; Harrington RD, 2008, J GEN VIROL, V89, P1086, DOI 10.1099/vir.0.83422-0; Heisey DM, 2010, J VIROL, V84, P210, DOI 10.1128/JVI.00560-09; Hewicker-Trautwein M, 2007, PRIONS IN HUMANS AND ANIMALS, P271; Hilbe MM, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-11; Iulini B, 2008, VET PATHOL, V45, P626, DOI 10.1354/vp.45-5-626; Jennelle CS, 2009, J TOXICOL ENV HEAL A, V72, P1018, DOI 10.1080/15287390903084249; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kirkwood JK, 2007, PRIONS IN HUMANS AND ANIMALS, P250; Krumm CE, 2010, BIOL LETTERS, V6, P209, DOI 10.1098/rsbl.2009.0742; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Laffont-Proust I, 2005, FEBS LETT, V579, P6333, DOI 10.1016/j.febslet.2005.10.013; LEGGETT MM, 1990, VET REC, V127, P586; Lezmi S, 2003, HISTOCHEM CELL BIOL, V119, P415, DOI 10.1007/s00418-003-0524-5; Liberski PP, 2009, FOLIA NEUROPATHOL, V47, P195; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; Lysek DA, 2004, GENE, V341, P249, DOI 10.1016/j.gene.2004.07.002; Maj A, 2008, VIRUS GENES, V36, P433, DOI 10.1007/s11262-008-0208-2; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; MENOTTIRAYMOND MA, 1995, J HERED, V86, P319, DOI 10.1093/oxfordjournals.jhered.a111594; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Nalls AH, 2011, PRION, V5, P1; O'Brien SJ, 2005, ANNU REV GENOM HUM G, V6, P407, DOI 10.1146/annurev.genom.6.080604.162151; PEARSON GR, 1991, VET REC, V128, P532, DOI 10.1136/vr.128.22.532-b; Peletto S, 2009, J VET SCI, V10, P115, DOI 10.4142/jvs.2009.10.2.115; Plinston C, 2011, J VIROL, V85, P1174, DOI 10.1128/JVI.01578-10; Polymenidou M, 2008, VACCINE, V26, P2601, DOI 10.1016/j.vaccine.2008.03.035; Robinson PJ, 2009, BIOCHEMISTRY-US, V48, P8551, DOI 10.1021/bi901070t; Schatzl HM, 1997, J MOL BIOL, V265, P257, DOI 10.1006/jmbi.1996.0791; Sigurdson CJ, 2008, J COMP PATHOL, V138, P189, DOI 10.1016/j.jcpa.2008.01.004; Slate J, 2005, P ROY SOC B-BIOL SCI, V272, P2371, DOI 10.1098/rspb.2005.3259; Sweeting B, 2010, BIOCHEM CELL BIOL, V88, P195, DOI [10.1139/o09-172, 10.1139/O09-172]; Vorberg I, 1999, VIROLOGY, V255, P26, DOI 10.1006/viro.1998.9561; Wan JY, 2009, MOL BIOL REP, V36, P1299, DOI 10.1007/s11033-008-9312-6; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Wik L, 2012, PRION, V6, P1; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Young S, 2003, AUST VET J, V81, P295, DOI 10.1111/j.1751-0813.2003.tb12579.x	57	26	28	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50623	10.1371/journal.pone.0050623	http://dx.doi.org/10.1371/journal.pone.0050623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236380	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100022
J	Tennant, BR; Islam, R; Kramer, MM; Merkulova, Y; Kiang, RL; Whiting, CJ; Hoffman, BG				Tennant, Bryan R.; Islam, Ratib; Kramer, Marabeth M.; Merkulova, Yulia; Kiang, Roger L.; Whiting, Cheryl J.; Hoffman, Brad G.			The Transcription Factor Myt3 Acts as a Pro-Survival Factor in beta-cells	PLOS ONE			English	Article							INSULIN GENE-EXPRESSION; ZINC-FINGER; OLIGODENDROCYTE LINEAGE; MAFA EXPRESSION; DIFFERENTIATION; FAMILY; ENHANCERS; APOPTOSIS; IDENTIFICATION; MUTATION	Aims/Hypothesis: We previously identified the transcription factor Myt3 as specifically expressed in pancreatic islets. Here, we sought to determine the expression and regulation of Myt3 in islets and to determine its significance in regulating islet function and survival. Methods: Myt3 expression was determined in embryonic pancreas and adult islets by qPCR and immunohistochemistry. ChIP-seq, ChIP-qPCR and luciferase assays were used to evaluate regulation of Myt3 expression. Suppression of Myt3 was used to evaluate gene expression, insulin secretion and apoptosis in islets. Results: We show that Myt3 is the most abundant MYT family member in adult islets and that it is expressed in all the major endocrine cell types in the pancreas after E18.5. We demonstrate that Myt3 expression is directly regulated by Foxa2, Pdx1, and Neurod1, which are critical to normal beta-cell development and function, and that Ngn3 induces Myt3 expression through alterations in the Myt3 promoter chromatin state. Further, we show that Myt3 expression is sensitive to both glucose and cytokine exposure. Of specific interest, suppressing Myt3 expression reduces insulin content and increases beta-cell apoptosis, at least in part, due to reduced Pdx1, Mafa, Il-6, Bcl-xl, c-Iap2 and Igfr1 levels, while over-expression of Myt3 protects islets from cytokine induced apoptosis. Conclusion/Interpretation: We have identified Myt3 as a novel transcriptional regulator with a critical role in beta-cell survival. These data are an important step in clarifying the regulatory networks responsible for beta-cell survival, and point to Myt3 as a potential therapeutic target for improving functional beta-cell mass.	[Tennant, Bryan R.; Islam, Ratib; Kramer, Marabeth M.; Merkulova, Yulia; Kiang, Roger L.; Whiting, Cheryl J.; Hoffman, Brad G.] British Columbia Childrens Hosp, Child & Family Res Inst, Vancouver, BC V6H 3V4, Canada; [Tennant, Bryan R.; Islam, Ratib; Kramer, Marabeth M.; Merkulova, Yulia; Kiang, Roger L.; Whiting, Cheryl J.; Hoffman, Brad G.] Sunny Hill Hlth Ctr, Vancouver, BC, Canada; [Hoffman, Brad G.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	BC Childrens Hospital; Child & Family Research Institute; University of British Columbia; University of British Columbia	Hoffman, BG (corresponding author), British Columbia Childrens Hosp, Child & Family Res Inst, Vancouver, BC V6H 3V4, Canada.	brad.hoffman@ubc.ca			Child and Family Research Institute (CFRI); Canadian Institutes for Health Research (CIHR); BC Knowledge Development fund	Child and Family Research Institute (CFRI); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); BC Knowledge Development fund(General Electric)	Funding was provided by the Child and Family Research Institute (CFRI, www.cfri.ca) and the Canadian Institutes for Health Research (CIHR, www.cihr.ca). Infrastructure support was provided by the Canadian Foundation for Innovation (www.innovation.ca), the BC Knowledge Development fund (www.jti.gov.bc.ca/researchandinnovation/Funding/BCKDF/index.htm), Commonwealth Insurance (http://www.nbfc.com), and the CFRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Andersson AK, 2005, MOL CELL ENDOCRINOL, V240, P50, DOI 10.1016/j.mce.2005.06.001; Andrali SS, 2008, BIOCHEM J, V415, P1, DOI 10.1042/BJ20081029; Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Aramata S, 2005, BBA-GENE STRUCT EXPR, V1730, P41, DOI 10.1016/j.bbaexp.2005.05.009; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; Bernardo AS, 2008, MOL CELL ENDOCRINOL, V294, P1, DOI 10.1016/j.mce.2008.07.006; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Cai T, 2011, ENDOCRINOLOGY, V152, P1961, DOI 10.1210/en.2010-1065; Carbone I, 2002, DIABETOLOGIA, V45, P153; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Cardozo AK, 2001, DIABETES, V50, P909, DOI 10.2337/diabetes.50.5.909; Carrington EM, 2009, DIABETES, V58, P2316, DOI 10.2337/db08-1602; Choi SE, 2004, TRANSPL IMMUNOL, V13, P43, DOI 10.1016/j.trim.2004.04.001; Cockburn B N, 2005, Hum Genet, V116, P538; Cornu M, 2009, ISLETS, V1, P280, DOI 10.4161/isl.1.3.9932; Cunha DA, 2009, DIABETES, V58, P2851, DOI 10.2337/db09-0685; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Ehses Jan A., 2009, Archives of Physiology and Biochemistry, V115, P240, DOI 10.1080/13813450903025879; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Furuta H, 1997, DIABETES, V46, P1652, DOI 10.2337/diabetes.46.10.1652; Gamsjaeger R, 2008, J BIOL CHEM, V283, P5158, DOI 10.1074/jbc.M703772200; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Gasa R, 2008, DIFFERENTIATION, V76, P381, DOI 10.1111/j.1432-0436.2007.00228.x; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu C, CELL METAB, V11, P298; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hoffman BG, 2010, GENOME RES, V20, P1037, DOI 10.1101/gr.104356.109; Hoffman BG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r99; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; Jiang YH, 1996, J BIOL CHEM, V271, P10723, DOI 10.1074/jbc.271.18.10723; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kim JG, 1997, J NEUROSCI RES, V50, P272, DOI 10.1002/(SICI)1097-4547(19971015)50:2<272::AID-JNR16>3.0.CO;2-A; Klusmann JH, GENES DEV, V24, P478; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Lawrence MC, 2011, J BIOL CHEM, V286, P1025, DOI 10.1074/jbc.M110.158675; Leibiger B, 2000, J BIOL CHEM, V275, P30153, DOI 10.1074/jbc.M005216200; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Liu LM, 2007, MOL CELL BIOCHEM, V303, P115, DOI 10.1007/s11010-007-9463-0; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; Macfarlane WM, 2000, J BIOL CHEM, V275, P15330, DOI 10.1074/jbc.M908045199; Matsushita F, 2002, MECH DEVELOP, V118, P209, DOI 10.1016/S0925-4773(02)00250-2; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Nielsen JA, 2004, MOL CELL NEUROSCI, V25, P111, DOI 10.1016/j.mcn.2003.10.001; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Prado CL, 2004, P NATL ACAD SCI USA, V101, P2924, DOI 10.1073/pnas.0308604100; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; van Belle TL, PHYSL REV, V91, P79; Vanderford NL, 2007, J BIOL CHEM, V282, P1577, DOI 10.1074/jbc.M605064200; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang S, 2008, DEV BIOL, V317, P531, DOI 10.1016/j.ydbio.2008.02.052; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Yang JL, 2008, FASEB J, V22, P3956, DOI 10.1096/fj.08-111013; Yee KSY, 1998, J BIOL CHEM, V273, P5366, DOI 10.1074/jbc.273.9.5366; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005	73	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51501	10.1371/journal.pone.0051501	http://dx.doi.org/10.1371/journal.pone.0051501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236509	Green Submitted, Green Published, gold			2022-12-27	WOS:000312064100125
J	Todoli, F; Rodriguez-Cortes, A; Nunez, MD; Laurenti, MD; Gomez-Sebastian, S; Rodriguez, F; Perez-Martin, E; Escribano, JM; Alberola, J				Todoli, Felicitat; Rodriguez-Cortes, Alheli; del Carmen Nunez, Maria; Laurenti, Marcia D.; Gomez-Sebastian, Silvia; Rodriguez, Fernando; Perez-Martin, Eva; Escribano, Jose M.; Alberola, Jordi			Head-to-Head Comparison of Three Vaccination Strategies Based on DNA and Raw Insect-Derived Recombinant Proteins against Leishmania	PLOS ONE			English	Article							CANINE VISCERAL LEISHMANIASIS; PRIME-BOOST VACCINATION; TRICHOPLUSIA-NI-LARVAE; CONFERS PROTECTIVE IMMUNITY; BLOOD MONONUCLEAR-CELLS; NITRIC-OXIDE; BALB/C MICE; ANTIGEN PROTECTS; MAJOR INFECTION; HAMSTER MODEL	Parasitic diseases plague billions of people among the poorest, killing millions annually, and causing additional millions of disability-adjusted life years lost. Leishmaniases affect more than 12 million people, with over 350 million people at risk. There is an urgent need for efficacious and cheap vaccines and treatments against visceral leishmaniasis (VL), its most severe form. Several vaccination strategies have been proposed but to date no head-to-head comparison was undertaken to assess which is the best in a clinical model of the disease. We simultaneously assayed three vaccination strategies against VL in the hamster model, using KMPII, TRYP, LACK, and PAPLE22 vaccine candidate antigens. Four groups of hamsters were immunized using the following approaches: 1) raw extracts of baculovirus-infected Trichoplusia ni larvae expressing individually one of the four recombinant proteins (PROT); 2) naked pVAX1 plasmids carrying the four genes individually (DNA); 3) a heterologous prime-boost (HPB) strategy involving DNA followed by PROT (DNA-PROT); and 4) a Control including empty pVAX1 plasmid followed by raw extract of wild-type baculovirus-infected T. ni larvae. Hamsters were challenged with L. infantum promastigotes and maintained for 20 weeks. While PROT vaccine was not protective, DNA vaccination achieved protection in spleen. Only DNA-PROT vaccination induced significant NO production by macrophages, accompanied by a significant parasitological protection in spleen and blood. Thus, the DNA-PROT strategy elicits strong immune responses and high parasitological protection in the clinical model of VL, better than its corresponding naked DNA or protein versions. Furthermore, we show that naked DNA coupled with raw recombinant proteins produced in insect larvae biofactories -the cheapest way of producing DNA-PROT vaccines-is a practical and cost-effective way for potential "off the shelf" supplying vaccines at very low prices for the protection against leishmaniases, and possibly against other parasitic diseases affecting the poorest of the poor.	[Todoli, Felicitat; Rodriguez-Cortes, Alheli; Alberola, Jordi] Univ Autonoma Barcelona, LeishLAB Serv Anal Farm, Dept Farmacol Terapeut & Toxicol, E-08193 Barcelona, Spain; [del Carmen Nunez, Maria; Gomez-Sebastian, Silvia] Univ Politecn Madrid, Alternat Gene Express SL, Ctr Empresarial Parque Cient & Tecnol, Madrid, Spain; [Laurenti, Marcia D.] Univ Sao Paulo, Fac Med, Lab Patol Molestias Infecciosas, Sao Paulo, Brazil; [Rodriguez, Fernando; Perez-Martin, Eva] UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain; [Escribano, Jose M.] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotecnol, Madrid, Spain	Autonomous University of Barcelona; Universidad Politecnica de Madrid; Universidade de Sao Paulo; IRTA; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Alberola, J (corresponding author), Univ Autonoma Barcelona, LeishLAB Serv Anal Farm, Dept Farmacol Terapeut & Toxicol, Edifici 5, E-08193 Barcelona, Spain.	Jordi.Alberola@uab.cat	Laurenti, Marcia Dalastra/C-4734-2012; Alberola, Jordi/N-9695-2013; Gómez-Sebastián, Silvia/ABC-5878-2020; Rodriguez, Fernando/GLN-3947-2022; Gomez-Sebastian, Silvia/AAA-4441-2019; Perez-MArtin, Eva/AFP-6433-2022	Alberola, Jordi/0000-0002-1033-6339; Gómez-Sebastián, Silvia/0000-0002-7326-3181; Rodriguez, Fernando/0000-0001-7361-8408; RODRIGUEZ-CORTES, Alheli/0000-0003-3617-0119; Perez-Martin, Eva/0000-0002-4355-4367; Laurenti, Marcia Dalastra/0000-0002-1080-2440	Spanish Government [AGL2008-00748, AGL2010-16678-GAN]; Generalitat de Catalunya [2005 FI 01116]	Spanish Government(Spanish GovernmentEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by Projects AGL2008-00748 and AGL2010-16678-GAN, from the Spanish Government, for Jordi Alberola; and Grant 2005 FI 01116, from Generalitat de Catalunya, for Felicitat Todoli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2005, J VIROL, V79, P2847, DOI 10.1128/JVI.79.5.2847-2858.2005; Abe T, 2003, J IMMUNOL, V171, P1133, DOI 10.4049/jimmunol.171.3.1133; Ahmed SBH, 2009, VACCINE, V27, P99, DOI 10.1016/j.vaccine.2008.10.013; Alberola J, 2004, ANTIMICROB AGENTS CH, V48, P641, DOI 10.1128/AAC.48.2.641-643.2004; Alonso-Padilla J, 2011, VACCINE, V29, P1830, DOI 10.1016/j.vaccine.2010.12.081; Banks R E, 1995, Contemp Top Lab Anim Sci, V34, P50; Barderas MG, 2000, J VIROL METHODS, V89, P129, DOI 10.1016/S0166-0934(00)00209-3; Barderas MG, 2001, ARCH VIROL, V146, P1681, DOI 10.1007/s007050170056; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Bogdan C, 1998, INT J PARASITOL, V28, P121, DOI 10.1016/S0020-7519(97)00169-0; Borj-Cabrera GP, 2002, VACCINE, V20, P3277, DOI 10.1016/S0264-410X(02)00294-3; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Carvalho LP, 2005, SCAND J IMMUNOL, V61, P337, DOI 10.1111/j.1365-3083.2005.01581.x; Coler RN, 2009, PARASITE IMMUNOL, V31, P520, DOI 10.1111/j.1365-3024.2009.01142.x; Coler RN, 2007, INFECT IMMUN, V75, P4648, DOI 10.1128/IAI.00394-07; Coler RN, 2005, TRENDS PARASITOL, V21, P244, DOI 10.1016/j.pt.2005.03.006; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; de Carvalho LP, 2003, MICROBES INFECT, V5, P7, DOI 10.1016/S1286-4579(02)00051-5; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dondji B, 2005, INFECT IMMUN, V73, P5286, DOI 10.1128/IAI.73.8.5286-5289.2005; Duthie MS, 2012, VACCINE, V30, P134, DOI 10.1016/j.vaccine.2011.11.005; Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125; Evans KJ, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/892817; Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095; Millan AFS, 2010, PROTEIN EXPRES PURIF, V74, P1, DOI 10.1016/j.pep.2010.06.009; Ferrer E, 2007, PARASITOL RES, V101, P517, DOI 10.1007/s00436-007-0507-x; Fragaki K, 2001, VACCINE, V19, P1701, DOI 10.1016/S0264-410X(00)00398-4; Francino O, 2006, VET PARASITOL, V137, P214, DOI 10.1016/j.vetpar.2006.01.011; Giunchetti RC, 2008, RES VET SCI, V84, P269, DOI 10.1016/j.rvsc.2007.04.020; Gomes R, 2008, P NATL ACAD SCI USA, V105, P7845, DOI 10.1073/pnas.0712153105; Gomez-Casado E, 2011, PROTEIN EXPRES PURIF, V79, P35, DOI 10.1016/j.pep.2011.03.007; Gomez-Ochoa P, 2009, VET J, V179, P259, DOI 10.1016/j.tvjl.2007.09.014; Gomez-Sebastian S, 2008, J VIROL METHODS, V153, P29, DOI 10.1016/j.jviromet.2008.06.017; Gonzalo RM, 2002, VACCINE, V20, P1226, DOI 10.1016/S0264-410X(01)00427-3; Goto Y, 2007, VACCINE, V25, P7450, DOI 10.1016/j.vaccine.2007.08.001; Hervas-Stubbs S, 2007, J IMMUNOL, V178, P2361, DOI 10.4049/jimmunol.178.4.2361; Holzmuller P, 2006, PARASITOLOGY, V132, pS19, DOI 10.1017/S0031182006000837; Huygen K, 2005, MICROBES INFECT, V7, P932, DOI 10.1016/j.micinf.2005.03.010; de Oya NJ, 2009, J CLIN MICROBIOL, V47, P3276, DOI 10.1128/JCM.00750-09; Kaye PM, 2011, CLIN MICROBIOL INFEC, V17, P1462, DOI 10.1111/j.1469-0691.2011.03610.x; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Kedzierski L, 2006, PARASITOLOGY, V133, pS87, DOI 10.1017/S0031182006001831; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Lange UG, 2004, INFECT IMMUN, V72, P4924, DOI 10.1128/IAI.72.8.4924-4928.2004; Lee BY, 2012, AM J TROP MED HYG, V86, P417, DOI 10.4269/ajtmh.2012.10-0415; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madhan S, 2010, CURR GENE THER, V10, P201, DOI 10.2174/156652310791321233; Mazumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014644; Melby PC, 1998, INFECT IMMUN, V66, P2135, DOI 10.1128/IAI.66.5.2135-2142.1998; Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001; Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912; Molinari P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024108; Palatnik-de-Sousa CB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00069; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Perez LE, 2006, J IMMUNOL, V176, P5519, DOI 10.4049/jimmunol.176.9.5519; Perez-Filgueira DA, 2006, J CLIN MICROBIOL, V44, P3114, DOI 10.1128/JCM.00406-06; Perez-Filgueira DM, 2007, VIROLOGY, V364, P422, DOI 10.1016/j.virol.2007.03.016; Perez-Martin E, 2008, J VIROL METHODS, V154, P167, DOI 10.1016/j.jviromet.2008.07.034; Perez-Martin E, 2010, VACCINE, V28, P2340, DOI 10.1016/j.vaccine.2009.12.061; Rafati S, 2006, VACCINE, V24, P3290, DOI 10.1016/j.vaccine.2006.01.030; Rafati S, 2006, VACCINE, V24, P2169, DOI 10.1016/j.vaccine.2005.11.011; Rafati S, 2005, VACCINE, V23, P3716, DOI 10.1016/j.vaccine.2005.02.009; Ramiro MJ, 2003, VACCINE, V21, P2474, DOI 10.1016/S0264-410X(03)00032-X; Ramos I, 2008, VACCINE, V26, P333, DOI 10.1016/j.vaccine.2007.11.021; Ramos I, 2009, VACCINE, V27, P6695, DOI 10.1016/j.vaccine.2009.08.091; Requena JM, 2000, VET IMMUNOL IMMUNOP, V76, P269, DOI 10.1016/S0165-2427(00)00221-X; Rica-Capela MJ, 2003, PARASITOL RES, V89, P163, DOI 10.1007/s00436-002-0738-9; Riera C, 1999, VET PARASITOL, V84, P33, DOI 10.1016/S0304-4017(99)00084-9; Robertson DG, 2008, CHEM RES TOXICOL, V21, P1917, DOI 10.1021/tx800204g; Rodriguez-Cortees A, 2007, VACCINE, V25, P7962, DOI 10.1016/j.vaccine.2007.08.023; Russell WMS., 1959, MED J AUSTRALIA; Suffia I, 2000, INFECT IMMUN, V68, P630, DOI 10.1128/IAI.68.2.630-636.2000; Tewary P, 2005, J INFECT DIS, V191, P2130, DOI 10.1086/430348; Todoli F, 2010, AM J TROP M IN PRESS; Todoli F, 2009, VET PARASITOL, V164, P154, DOI 10.1016/j.vetpar.2009.05.032; Ulmer JB, 2006, TRENDS MOL MED, V12, P216, DOI 10.1016/j.molmed.2006.03.007; WHO, 2012, IN VACC RES IVR; WHO, 1997, GUID EV PLASM FALC V; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; Yerushalmi R, 2012, ANN ONCOL, V23, P338, DOI 10.1093/annonc/mdr154; Zivcec M, 2011, J IMMUNOL METHODS, V368, P24, DOI 10.1016/j.jim.2011.02.004	83	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51181	10.1371/journal.pone.0051181	http://dx.doi.org/10.1371/journal.pone.0051181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236448	Green Published, gold, Green Submitted			2022-12-27	WOS:000312064100076
J	Van Landeghem, L; Blue, RE; Dehmer, JJ; Henning, SJ; Helmrath, MA; Lund, PK				Van Landeghem, Laurianne; Blue, Randall Eric; Dehmer, Jeffrey J.; Henning, Susan J.; Helmrath, Michael A.; Lund, Pauline Kay			Localized Intestinal Radiation and Liquid Diet Enhance Survival and Permit Evaluation of Long-Term Intestinal Responses to High Dose Radiation in Mice	PLOS ONE			English	Article							STEM-CELL POPULATIONS; GASTROINTESTINAL SYNDROME; GROWTH-FACTOR; REGENERATION; IRRADIATION; PREVENTION; FIBROSIS; MARKER; CRYPTS; DEATH	Background: In vivo studies of high dose radiation-induced crypt and intestinal stem cell (ISC) loss and subsequent regeneration are typically restricted to 5-8 days after radiation due to high mortality and immune failure. This study aimed to develop murine radiation models of complete crypt loss that permit longer-term studies of ISC and crypt regeneration, repair and normalization of the intestinal epithelium. Methods: In C57Bl/6J mice, a predetermined small intestinal segment was exteriorized and exposed to 14Gy-radiation, while a lead shield protected the rest of the body from radiation. Sham controls had segment exteriorization but no radiation. Results were compared to C57Bl/6J mice given 14 Gy-abdominal radiation. Effects of elemental liquid diet feeding from the day prior to radiation until day 7 post-radiation were assessed in both models. Body weight and a custom-developed health score was assessed every day until day 21 post-radiation. Intestine was assessed histologically. Results: At day 3 after segment radiation, complete loss of crypts occurred in the targeted segment, while adjacent and remaining intestine in segment-radiated mice, and entire intestine of sham controls, showed no detectable epithelial damage. Liquid diet feeding was required for survival of mice after segment radiation. Liquid diet significantly improved survival, body weight recovery and normalization of intestinal epithelium after abdominal radiation. Mice given segment radiation combined with liquid diet feeding showed minimal body weight loss, increased food intake and enhanced health score. Conclusions: The segment radiation method provides a useful model to study ISC/crypt loss and long-term crypt regeneration and epithelial repair, and may be valuable for future application to ISC transplantation or to genetic mutants that would not otherwise survive radiation doses that lead to complete crypt loss. Liquid diet is a simple intervention that improves survival and facilitates long-term studies of intestine in mice after high dose abdominal or segment radiation.	[Van Landeghem, Laurianne; Blue, Randall Eric; Lund, Pauline Kay] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Dehmer, Jeffrey J.] Univ N Carolina, Dept Surg, Chapel Hill, NC USA; [Henning, Susan J.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Helmrath, Michael A.] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; University of Cincinnati	Lund, PK (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA.	empk@med.unc.edu	, Histology Research Core Facility/ABF-6317-2021; Van Landeghem, Laurianne/K-2430-2015; Van+Landeghem, Laurianne/AAG-7334-2019	Van+Landeghem, Laurianne/0000-0001-7408-3521; Blue, Eric/0000-0002-9774-6778	National Institutes of Health (NIH), Intestinal Stem Cell Consortium [U01-DK085547]; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; NIH [R01-DK040247-20]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083325, R01DK040247, P30DK034987, U01DK085547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health (NIH), Intestinal Stem Cell Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (NIH) Grant U01-DK085547, which is part of the Intestinal Stem Cell Consortium, a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Allergy and Infectious Diseases. The study also received support from NIH grant R01-DK040247-20. The work was assisted by services from the UNC Animal Clinical Chemistry and Gene Expression Laboratories, and the Histology Research Core Facilities of the Center for Gastrointestinal Biology and Disease (P30-DK034987) and the Department of Cell and Molecular Physiology (UNC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN MK, 1956, RADIAT RES, V5, P303, DOI 10.2307/3570411; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bhanja P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008014; Booth D, 2001, J Natl Cancer Inst Monogr, P16; FROELEN H, 1961, RADIAT RES, V14, P381, DOI 10.2307/3570987; GOEPP RA, 1963, RADIAT RES, V19, P670, DOI 10.2307/3571488; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; GRAHN D, 1958, GENETICS, V43, P835; GRAHN D, 1957, GENETICS, V42, P189; Helmrath MA, 1996, J AM COLL SURGEONS, V183, P441; HENDRY JH, 1992, RADIAT RES, V132, P115, DOI 10.2307/3578342; KOHN HI, 1956, RADIAT RES, V5, P309, DOI 10.2307/3570420; Martin K, 1998, J CELL SCI, V111, P2297; MASON KA, 1989, RADIAT RES, V117, P480, DOI 10.2307/3577353; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Otterson MF, 2007, WORLD J GASTROENTERO, V13, P2684, DOI 10.3748/wjg.v13.i19.2684; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Polistena Andrea, 2008, BMC Surg, V8, P1, DOI 10.1186/1471-2482-8-1; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Rigby RJ, 2009, GUT, V58, P1104, DOI 10.1136/gut.2008.157636; Rotolo JA, 2009, INT J RADIAT ONCOL, V73, P6, DOI 10.1016/j.ijrobp.2008.09.009; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Somosy Z, 2002, MICRON, V33, P167, DOI 10.1016/S0968-4328(01)00013-0; SUMMERS RW, 1987, DIGEST DIS SCI, V32, P1402, DOI 10.1007/BF01296667; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; TERRY NHA, 1989, INT J RADIAT ONCOL, V17, P569, DOI 10.1016/0360-3016(89)90108-9; Theis VS, 2010, CLIN ONCOL-UK, V22, P70, DOI 10.1016/j.clon.2009.10.003; Theiss AL, 2005, GASTROENTEROLOGY, V129, P204, DOI 10.1053/j.gastro.2005.05.019; Tustison KS, 2000, METH MOLEC MED, V50, P267; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011; von Furstenberg RJ, 2011, AM J PHYSIOL-GASTR L, V300, pG409, DOI 10.1152/ajpgi.00453.2010; WALBURG HE, 1966, RADIAT RES, V27, P616, DOI 10.2307/3571845; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291; Yamamoto T, 2010, J RADIAT RES, V51, P145, DOI 10.1269/jrr.09078; Zheng H, 2000, GASTROENTEROLOGY, V119, P1286, DOI 10.1053/gast.2000.19282; Zimmerer T, 2008, Z GASTROENTEROL, V46, P441, DOI 10.1055/s-2008-1027150	38	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e51310	10.1371/journal.pone.0051310	http://dx.doi.org/10.1371/journal.pone.0051310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	23236468	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100092
J	Mracek, P; Santoriello, C; Idda, ML; Pagano, C; Ben-Moshe, Z; Gothilf, Y; Vallone, D; Foulkes, NS				Mracek, Philipp; Santoriello, Cristina; Idda, M. Laura; Pagano, Cristina; Ben-Moshe, Zohar; Gothilf, Yoav; Vallone, Daniela; Foulkes, Nicholas S.			Regulation of per and cry Genes Reveals a Central Role for the D-Box Enhancer in Light-Dependent Gene Expression	PLOS ONE			English	Article							CIRCADIAN CLOCK; TRANSCRIPTION; INDUCTION; SYSTEM; AP-1; JUN	Light serves as a key environmental signal for synchronizing the circadian clock with the day night cycle. The zebrafish represents an attractive model for exploring how light influences the vertebrate clock mechanism. Direct illumination of most fish tissues and cell lines induces expression of a broad range of genes including DNA repair, stress response and key clock genes. We have previously identified D- and E-box elements within the promoter of the zebrafish per2 gene that together direct light-induced gene expression. However, is the combined regulation by E- and D-boxes a general feature for all light-induced gene expression? We have tackled this question by examining the regulation of additional light-inducible genes. Our results demonstrate that with the exception of per2, all other genes tested are not induced by light upon blocking of de novo protein synthesis. We reveal that a single D-box serves as the principal light responsive element within the cry1a promoter. Furthermore, upon inhibition of protein synthesis D-box mediated gene expression is abolished while the E-box confers light driven activation as observed in the per2 gene. Given the existence of different photoreceptors in fish cells, our results implicate the D-box enhancer as a general convergence point for light driven signaling. Citation: Mracek P, Santoriello C, Idda ML, Pagano C, Ben-Moshe Z, et al. (2012) Regulation of per and cry Genes Reveals a Central Role for the D- Box Enhancer in Light-Dependent Gene Expression. PLoS ONE 7(12): e51278. doi:10.1371/journal.pone.0051278	[Mracek, Philipp; Idda, M. Laura; Pagano, Cristina; Vallone, Daniela; Foulkes, Nicholas S.] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany; [Santoriello, Cristina] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Ben-Moshe, Zohar; Gothilf, Yoav] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel	Helmholtz Association; Karlsruhe Institute of Technology; Harvard University; Tel Aviv University	Vallone, D (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany.	Daniela.Vallone@kit.edu; nicholas.foulkes@kit.edu	Foulkes, Nicholas S/K-7003-2013; Vallone, Daniela/S-2244-2019	Foulkes, Nicholas S/0000-0002-1794-9891; Pagano, Cristina/0000-0002-9181-6595; Gothilf, Yoav/0000-0002-6054-4128	Max-Planck-Institute for Developmental Biology, Tubingen; BioInterfaces programme of Karlsruhe Institute of Technology (KIT, Germany); CNRS (France)	Max-Planck-Institute for Developmental Biology, Tubingen; BioInterfaces programme of Karlsruhe Institute of Technology (KIT, Germany); CNRS (France)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by funding from the Max-Planck-Institute for Developmental Biology, Tubingen, the BioInterfaces programme of Karlsruhe Institute of Technology (KIT, Germany) and the CNRS (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bailes HJ, 2010, CELL MOL LIFE SCI, V67, P99, DOI 10.1007/s00018-009-0155-7; Ben-Moshe Z, 2010, CHRONOBIOL INT, V27, P1509, DOI 10.3109/07420528.2010.510229; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Cermakian N, 2002, CURR BIOL, V12, P844, DOI 10.1016/S0960-9822(02)00835-7; Gachon F, 2007, ANN MED, V39, P562, DOI 10.1080/07853890701491034; Gavriouchkina D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012542; Hirayama J, 2005, P NATL ACAD SCI USA, V102, P10194, DOI 10.1073/pnas.0502610102; Hirayama J, 2007, P NATL ACAD SCI USA, V104, P15747, DOI 10.1073/pnas.0705614104; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LIN S, 1994, SCIENCE, V265, P666, DOI 10.1126/science.8036514; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Pando MP, 2001, P NATL ACAD SCI USA, V98, P10178, DOI 10.1073/pnas.181228598; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Roenneberg T, 2003, J BIOL RHYTHM, V18, P183, DOI 10.1177/0748730403018003001; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Uchida Y, 2010, BIOL PHARM BULL, V33, P535, DOI 10.1248/bpb.33.535; Vallone D, 2004, P NATL ACAD SCI USA, V101, P4106, DOI 10.1073/pnas.0305436101; Vallone Daniela, 2007, Methods Mol Biol, V362, P429; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	33	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2012	7	12							e51278	10.1371/journal.pone.0051278	http://dx.doi.org/10.1371/journal.pone.0051278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057UO	23236462	gold, Green Published, Green Submitted			2022-12-27	WOS:000312589700034
J	Chen, J; Wang, LL; Li, Y; Cai, B; Fu, Y; Liao, Y; Zhang, JL				Chen, Jie; Wang, Lanlan; Li, Yi; Cai, Bei; Fu, Yang; Liao, Yun; Zhang, Junlong			Association Analysis between SNPs in IL-28B Gene and the Progress of Hepatitis B Infection in Han Chinese	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; VIRUS; PROMOTER	Objective: As a candidate gene association study, we investigated the genetic association of SNPs in IL-28B genes with different outcomes of HBV infection, including LC and HCC occurrence. Methods: Chinese Han subjects were categorized into two groups: 406 LC caused by CHB and 406 HCC caused by CHB. Genomic DNA was isolated from whole blood samples, SNPs were detected using high resolution melting curve (HRM) method. PCR amplification was carried out under the same conditions in a 96-well plate in Real-Time PCR System. Then 341 LC and 356 HCC patients caused by HBV infection were analyzed as a verification by independent sample. 393 CHB patients and 244 health subjects were included as control. Results: CHB patients who progress to LC or HCC showed a significant different frequency in rs12979860 (p = 0.046). Patients with HCC carried more frequently the T alleles in rs12979860 comparison to LC. Same results were found in the independent sample. Conclusion: IL-28B rs12979860 C/T polymorphism T allele appears to be more prevalent in patients with HCC than in LC. Carriage of this allele seems to enhance the risk for developing HCC. Gene polymorphism of IL-28B may confer symptomatic specificity in progress and extent of hepatitis B infection.	[Chen, Jie; Wang, Lanlan; Li, Yi; Cai, Bei; Fu, Yang; Liao, Yun; Zhang, Junlong] Sichuan Univ, W China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China	Sichuan University	Wang, LL (corresponding author), Sichuan Univ, W China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China.	wangll1019@163.com						Chui SH, 2011, BRIT J BIOMED SCI, V68, P143; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Domagalski K, 2010, POSTEP HIG MED DOSW, V64, P522; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Fabris C, 2011, J HEPATOL, V54, P716, DOI 10.1016/j.jhep.2010.07.019; Kim BK, 2011, ANTIVIR THER, V16, P1169, DOI 10.3851/IMP1982; Martin MP, 2010, J INFECT DIS, V202, P1749, DOI 10.1086/657146; Michielsen P, 2011, ACTA GASTRO-ENT BELG, V74, P4; Migita K, 2009, TRANSL RES, V153, P91, DOI 10.1016/j.trsl.2008.11.008; Pearlman Brian L, 2011, Curr Gastroenterol Rep, V13, P78, DOI 10.1007/s11894-010-0161-9; Ren S, 2012, CANCER IMMUNOL IMMUN, V61, P1433, DOI 10.1007/s00262-012-1203-y; Ruiz-Extremera A, 2011, HEPATOLOGY, V53, P1830, DOI 10.1002/hep.24298; Shimomura S, 2012, HEPATOL RES, V42, P22, DOI 10.1111/j.1872-034X.2011.00889.x; Thursz M, 2011, SEMIN LIVER DIS, V31, P115, DOI 10.1055/s-0031-1276642; Yan J, 2011, HEPAT MON, V11, P358	15	16	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50787	10.1371/journal.pone.0050787	http://dx.doi.org/10.1371/journal.pone.0050787			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	23227209	Green Submitted, gold, Green Published			2022-12-27	WOS:000312588200069
J	Ma, WN; Lu, S; Pan, P; Sadatmousavi, P; Yuan, YF; Chen, P				Ma, Weina; Lu, Sheng; Pan, Pei; Sadatmousavi, Parisa; Yuan, Yongfang; Chen, P.			Pharmacokinetics of Peptide Mediated Delivery of Anticancer Drug Ellipticine	PLOS ONE			English	Article							INDUCED APOPTOSIS; CANCER-CELLS	The amino acid pairing peptide EAK16-II (EAK) has shown the ability to stabilize the hydrophobic anticancer agent ellipticine (EPT) in aqueous solution. In this study, we investigate pharmacokinetics of the formulation of EAK-EPT complexes in vivo. The developed formulation can achieve a sufficiently high drug concentration required in vivo animal models. The nanostructure and surface properties of EAK-EPT complexes or nanoparticle were characterized by transmission electron microscopy (TEM) and zeta potential measurements, respectively. 12 healthy male SD rats were divided into EPT group and EAK-EPT group randomly. Rats in EPT group were tail intravenously injected with the EPT (20 mg/kg); rats in EAK-EPT group were injected with EAK-EPT complexes (EPT's concentration is 20 mg/kg). EPT was extracted from rat plasma with dexamethasone sodium phosphate as internal standards (IS). The pharmacokinetic parameters were obtained using high pressure liquid chromatography (HPLC). Significant differences in main pharmacokinetic parameters between EPT and EAK-EPT complexes were observed, demonstrating that the complexation with EAK prolongs the residence time of the drug and enlarges the area under the concentration-time curve (AUC). This means that EAK can serve as a suitable carrier to increase the bioavailability of EPT.	[Ma, Weina; Pan, Pei; Yuan, Yongfang] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 3, Dept Pharm, Shanghai 200030, Peoples R China; [Lu, Sheng; Sadatmousavi, Parisa; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	Shanghai Jiao Tong University; University of Waterloo	Ma, WN (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 3, Dept Pharm, Shanghai 200030, Peoples R China.	nmxyyf@yahoo.cn			Shanghai Committee of Science and Technology, China [10410711300]; Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; Canada Research Chairs Program	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chairs Program(Canada Research Chairs)	This project was supported by the Shanghai Committee of Science and Technology, China (Grant No. 10410711300). This research was financially supported by the Natural Sciences and Engineering Research Council of Canada, Canadian Foundation for Innovation and the Canada Research Chairs Program for one of the co-authors (PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bawa R, 2011, NANOMEDICIN IN PRESS; Fang K, 2009, LUNG CANCER, V63, P227, DOI 10.1016/j.lungcan.2008.05.026; Fung SY, 2006, J PHYS CHEM A, V110, P11446, DOI 10.1021/jp062778y; Fung SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001956; Fung SY, 2011, BIOMATERIALS, V32, P4000, DOI 10.1016/j.biomaterials.2011.02.005; FUNG SY, 2005, HDB NANOSTRUCTURED B, P1; Garbett Nichola C., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P149, DOI 10.2174/1568011043482070; Kuo PL, 2005, CANCER LETT, V223, P293, DOI 10.1016/j.canlet.2004.09.046; Kuo YC, 2006, LIFE SCI, V78, P2550, DOI 10.1016/j.lfs.2005.10.041; Peng YH, 2003, ONCOGENE, V22, P4478, DOI 10.1038/sj.onc.1206777; Stiborova M, 2006, GEN PHYSIOL BIOPHYS, V25, P245; Stiborova Marie, 2006, Biomedical Papers (Olomouc), V150, P13; SUREAU F, 1993, BIOPHYS J, V65, P1767, DOI 10.1016/S0006-3495(93)81273-6; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	14	44	44	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2012	7	8							e43684	10.1371/journal.pone.0043684	http://dx.doi.org/10.1371/journal.pone.0043684			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998EY	23236514	Green Published, gold, Green Submitted			2022-12-27	WOS:000308221300022
J	Buga, AM; Vintilescu, R; Balseanu, AT; Pop, OT; Streba, C; Toescu, E; Popa-Wagner, A				Buga, Ana-Maria; Vintilescu, Raluca; Balseanu, Adrian Tudor; Pop, Oltin Tiberiu; Streba, Costin; Toescu, Emil; Popa-Wagner, Aurel			Repeated PTZ Treatment at 25-Day Intervals Leads to a Highly Efficient Accumulation of Doublecortin in the Dorsal Hippocampus of Rats	PLOS ONE			English	Article							ENHANCED SYNAPTIC PLASTICITY; GENERATED GRANULE CELLS; ADULT DENTATE GYRUS; NITRIC-OXIDE; NEURONAL DIFFERENTIATION; SUBVENTRICULAR ZONE; PROGENITOR CELLS; CRITICAL PERIOD; SPATIAL MEMORY; DOWN-SYNDROME	Background: Neurogenesis persists throughout life in the adult mammalian brain. Because neurogenesis can only be assessed in postmortem tissue, its functional significance remains undetermined, and identifying an in vivo correlate of neurogenesis has become an important goal. By studying pentylenetetrazole-induced brain stimulation in a rat model of kindling we accidentally discovered that 25+/-1 days periodic stimulation of Sprague-Dawley rats led to a highly efficient increase in seizure susceptibility. Methodology/Principal Findings: By EEG, RT-PCR, western blotting and immunohistochemistry, we show that repeated convulsive seizures with a periodicity of 25+/-1 days led to an enrichment of newly generated neurons, that were BrdU-positive in the dentate gyrus at day 25+/-1 post-seizure. At the same time, there was a massive increase in the number of neurons expressing the migratory marker, doublecortin, at the boundary between the granule cell layer and the polymorphic layer in the dorsal hippocampus. Some of these migrating neurons were also positive for NeuN, a marker for adult neurons. Conclusion/Significance: Our results suggest that the increased susceptibility to seizure at day 25+/-1 post-treatment is coincident with a critical time required for newborn neurons to differentiate and integrate into the existing hippocampal network, and outlines the importance of the dorsal hippocampus for seizure-related neurogenesis. This model can be used as an in vivo correlate of neurogenesis to study basic questions related to neurogenesis and to the neurogenic mechanisms that contribute to the development of epilepsy.	[Buga, Ana-Maria; Balseanu, Adrian Tudor; Popa-Wagner, Aurel] Univ Rostock, Sch Med, Dept Psychiat, Rostock, Germany; [Buga, Ana-Maria; Vintilescu, Raluca; Balseanu, Adrian Tudor; Pop, Oltin Tiberiu; Streba, Costin; Popa-Wagner, Aurel] Univ Med & Pharm, Dept Funct Sci, Craiova, Romania; [Toescu, Emil] Univ Birmingham Edgbaston, Coll Med & Dent Sci, Dept Clin & Expt Med, Birmingham, W Midlands, England	University of Rostock; University of Medicine & Pharmacy of Craiova; University of Birmingham	Buga, AM (corresponding author), Univ Rostock, Sch Med, Dept Psychiat, Rostock, Germany.	aurel.popa-wagner@med.uni-rostock.de	Alexandru, Dragos Ovidiu/AAM-8276-2020; Popa-Wagner, Aurel/E-2541-2013; Scholz, Claus Jürgen/H-3202-2019; Balseanu, Tudor Adrian/O-2289-2018; Buga, Ana-Maria I/P-1478-2014; Buga, Ana Maria/ABA-8108-2021; Streba, Costin Teodor T/C-4196-2011; Popa-Wagner, Aurel/I-2581-2019; Vintilescu, Raluca/A-9499-2018; Dandekar, Thomas/A-4431-2017; Balseanu, Tudor Adrian/T-8118-2019	Alexandru, Dragos Ovidiu/0000-0001-7578-8048; Scholz, Claus Jürgen/0000-0002-6406-7859; Balseanu, Tudor Adrian/0000-0002-0047-3436; Streba, Costin Teodor T/0000-0001-9590-3197; Dandekar, Thomas/0000-0003-1886-7625; Balseanu, Tudor Adrian/0000-0002-0047-3436; Sivanesan, Senthilkumar/0000-0001-5133-7090	Ministry of Research and Education of Germany [0314107]; National Council for Scientific Research of Romania [PN-II-ID-PCE-2011-3-0848]; European project ERA-NET FLARE2 of United Kingdom; Executive Unit for Funding Higher Education, Scientific Research, Development and Innovation (UEFISCDI) of Romania [8555/2011]; CNCS-UEFISCDI [PN-II-ID-PCE-2011-3-0848]; ERA-NET FLARE2/UEFISCDI [8555/2011]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Ministry of Research and Education of Germany; National Council for Scientific Research of Romania(Consiliul National al Cercetarii Stiintifice (CNCS)); European project ERA-NET FLARE2 of United Kingdom; Executive Unit for Funding Higher Education, Scientific Research, Development and Innovation (UEFISCDI) of Romania(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); CNCS-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); ERA-NET FLARE2/UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the Ministry of Research and Education of Germany (No 0314107) and from National Council for Scientific Research of Romania (No PN-II-ID-PCE-2011-3-0848). Dr. Ana-Maria Buga and Dr. Toescu were supported by a grant from the European project ERA-NET FLARE2 of United Kingdom and the Executive Unit for Funding Higher Education, Scientific Research, Development and Innovation (UEFISCDI) of Romania (No 8555/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Popa-Wagner was supported by a grant from CNCS-UEFISCDI, project No PN-II-ID-PCE-2011-3-0848. Dr. Ana-Maria Buga was supported by a grant from ERA-NET FLARE2/UEFISCDI, project No 8555/2011. We also acknowledge the critical reading of the manuscript by Lary Walker.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Babb T L, 1986, Adv Neurol, V44, P949; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Buckmaster PS, 2002, J NEUROSCI, V22, P6650; Dashtipour K, 2001, BRAIN RES, V890, P261, DOI 10.1016/S0006-8993(00)03119-X; Detour J, 2005, EPILEPSIA, V46, P499, DOI 10.1111/j.0013-9580.2005.38704.x; Devinsky Orrin, 2004, Rev Neurol Dis, V1, P2; ENGEL J, 1993, ELECTROEN CLIN NEURO, V87, P437, DOI 10.1016/0013-4694(93)90158-R; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ferland RJ, 2002, NEUROSCI LETT, V332, P131, DOI 10.1016/S0304-3940(02)00808-X; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Geoghegan D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-2; Hosseini M, 2009, SEIZURE-EUR J EPILEP, V18, P695, DOI 10.1016/j.seizure.2009.09.008; Huttmann K, 2003, EUR J NEUROSCI, V18, P2769, DOI 10.1111/j.1460-9568.2003.03002.x; Junker H, 2005, EPILEPSIA, V46, P339, DOI 10.1111/j.0013-9580.2005.46904.x; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kheirbek MA, 2011, NEUROPSYCHOPHARMACOL, V36, P373, DOI 10.1038/npp.2010.148; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Kohler SJ, 2011, P NATL ACAD SCI USA, V108, P10326, DOI 10.1073/pnas.1017099108; Kron MM, 2010, J NEUROSCI, V30, P2051, DOI 10.1523/JNEUROSCI.5655-09.2010; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Parent JM, 1997, J NEUROSCI, V17, P3727; Piatti VC, 2011, J NEUROSCI, V31, P7715, DOI 10.1523/JNEUROSCI.1380-11.2011; Pinnock SB, 2007, NEUROPSYCHOPHARMACOL, V32, P493, DOI 10.1038/sj.npp.1301245; Popa-Wagner A, 2007, CURR NEUROVASC RES, V4, P216; PopaWagner A, 1997, EXP NEUROL, V148, P73, DOI 10.1006/exnr.1997.6652; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rueda N, 2008, NEUROSCI LETT, V433, P22, DOI 10.1016/j.neulet.2007.12.039; Scharfman HE, 2004, ADV EXP MED BIOL, V548, P192; Scharfman Helen E., 2002, Epilepsy Curr, V2, P63, DOI 10.1046/j.1535-7597.2002.00023.x; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schmoll H, 2003, AM J PATHOL, V162, P1027, DOI 10.1016/S0002-9440(10)63897-7; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	42	71	73	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39302	10.1371/journal.pone.0039302	http://dx.doi.org/10.1371/journal.pone.0039302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	22768071	gold, Green Published, Green Submitted			2022-12-27	WOS:000305892100042
J	Liu, ZY; Owen, T; Fang, J; Zuo, J				Liu, Zhiyong; Owen, Thomas; Fang, Jie; Zuo, Jian			Overactivation of Notch1 Signaling Induces Ectopic Hair Cells in the Mouse Inner Ear in an Age-Dependent Manner	PLOS ONE			English	Article							OTIC PLACODE; SUPPORTING CELLS; REGULATES DEVELOPMENT; FATE SPECIFICATION; PROSENSORY PATCHES; SENSORY EPITHELIA; MAMMALIAN COCHLEA; EXPRESSION; MATH1; FGF	Background: During mouse inner ear development, Notch1 signaling first specifies sensory progenitors, and subsequently controls progenitors to further differentiate into either hair cells (HCs) or supporting cells (SCs). Overactivation of NICD (Notch1 intracellular domain) at early embryonic stages leads to ectopic HC formation. However, it remains unclear whether such an effect can be elicited at later embryonic or postnatal stages, which has important implications in mouse HC regeneration by reactivation of Notch1 signaling. Methodology/Principal Findings: We performed comprehensive in vivo inducible overactivation of NICD at various developmental stages. In CAG(CreER+); Rosa26-NICDloxp/+ mice, tamoxifen treatment at embryonic day 10.5 (E10.5) generated ectopic HCs in the non-sensory regions in both utricle and cochlea, whereas ectopic HCs only appeared in the utricle when tamoxifen was given at E13. When tamoxifen was injected at postnatal day 0 (P0) and P1, no ectopic HCs were observed in either utricle or cochlea. Interestingly, Notch1 signaling induced new HCs in a non-cell-autonomous manner, because the new HCs did not express NICD. Adjacent to the new HCs were cells expressing the SC marker Sox10 (either NICD+ or NICD-negative). Conclusions/Significance: Our data demonstrate that the developmental stage determines responsiveness of embryonic otic precursors and neonatal non-sensory epithelial cells to NICD overactivation, and that Notch 1 signaling in the wild type, postnatal inner ear is not sufficient for generating new HCs. Thus, our genetic mouse model is suitable to test additional pathways that could synergistically interact with Notch1 pathway to produce HCs at postnatal ages.	[Liu, Zhiyong; Owen, Thomas; Fang, Jie; Zuo, Jian] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Liu, Zhiyong] Univ Tennessee, Ctr Hlth Sci, Integrated Program Biomed Sci, Memphis, TN 38163 USA; [Owen, Thomas] Univ Bath, Bath BA2 7AY, Avon, England	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Bath	Liu, ZY (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jian.zuo@stjude.org			National Institutes of Health [DC06471, DC05168, DC008800, CA21765]; Office of Naval Research [N000140911014]; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; Hartwell Individual Biomedical Research Award; NOHR; St. Jude Children's Research Hospital; University of Tennessee Health Science Center; Society of Developmental Biology; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006471, R21DC005168, R21DC008800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Hartwell Individual Biomedical Research Award; NOHR; St. Jude Children's Research Hospital; University of Tennessee Health Science Center; Society of Developmental Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding was provided by the National Institutes of Health (DC06471, DC05168, DC008800 and CA21765), the Office of Naval Research (N000140911014), the American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital, The Hartwell Individual Biomedical Research Award, NOHR, Travel Awards from Academic Programs of St. Jude Children's Research Hospital, the University of Tennessee Health Science Center, and the Society of Developmental Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basch ML, 2011, J NEUROSCI, V31, P8046, DOI 10.1523/JNEUROSCI.6671-10.2011; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bok J, 2007, DEVELOPMENT, V134, P1713, DOI 10.1242/dev.000760; Breuskin I, 2009, DEV BIOL, V335, P327, DOI 10.1016/j.ydbio.2009.09.007; Brigande JV, 2009, NAT NEUROSCI, V12, P679, DOI 10.1038/nn.2311; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Burns J, 2008, J COMP NEUROL, V511, P396, DOI 10.1002/cne.21849; Chen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023376; Chen P, 2002, DEVELOPMENT, V129, P2495; Collado MS, 2008, CURR OPIN OTOLARYNGO, V16, P465, DOI 10.1097/MOO.0b013e32830f4ab5; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Driver EC, 2008, J NEUROSCI, V28, P7350, DOI 10.1523/JNEUROSCI.0312-08.2008; Eddison M, 2000, P NATL ACAD SCI USA, V97, P11692, DOI 10.1073/pnas.97.22.11692; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Fekete DM, 1998, J NEUROSCI, V18, P7811; Fekete DM, 2002, CURR OPIN NEUROBIOL, V12, P35, DOI 10.1016/S0959-4388(02)00287-8; Freyer L, 2010, DEV DYNAM, V239, P1708, DOI 10.1002/dvdy.22308; Groves AK, 2000, DEVELOPMENT, V127, P3489; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Hackney CM, 2005, J NEUROSCI, V25, P7867, DOI 10.1523/JNEUROSCI.1196-05.2005; Hartman BH, 2010, P NATL ACAD SCI USA, V107, P15792, DOI 10.1073/pnas.1002827107; Hatch EP, 2007, DEVELOPMENT, V134, P3615, DOI 10.1242/dev.006627; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hayashi T, 2008, J NEUROSCI, V28, P5991, DOI 10.1523/JNEUROSCI.1690-08.2008; Hayashi T, 2008, DEV BIOL, V316, P87, DOI 10.1016/j.ydbio.2008.01.006; Huh SH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001231; Hwang CH, 2010, DEV DYNAM, V239, P505, DOI 10.1002/dvdy.22200; Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103; Jahan I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011661; Jayasena CS, 2008, DEVELOPMENT, V135, P2251, DOI 10.1242/dev.017905; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kelly MC, 2009, CURR OPIN NEUROBIOL, V19, P395, DOI 10.1016/j.conb.2009.07.010; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Kwan T, 2009, ANN NY ACAD SCI, V1170, P28, DOI 10.1111/j.1749-6632.2009.04484.x; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Li HW, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-16; Liu ZY, 2010, DEV DYNAM, V239, P1674, DOI 10.1002/dvdy.22302; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Morrison A, 1999, MECH DEVELOP, V84, P169, DOI 10.1016/S0925-4773(99)00066-0; Morsli H, 1998, J NEUROSCI, V18, P3327; Murata J, 2006, J COMP NEUROL, V497, P502, DOI 10.1002/cne.20997; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Mustapha M, 2009, J NEUROSCI, V29, P1212, DOI 10.1523/JNEUROSCI.4957-08.2009; Neves J, 2011, DEVELOPMENT, V138, P735, DOI 10.1242/dev.060657; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Ohyama T, 2007, INT J DEV BIOL, V51, P463, DOI 10.1387/ijdb.072320to; Ohyama T, 2010, J NEUROSCI, V30, P15044, DOI 10.1523/JNEUROSCI.3547-10.2010; Pan W, 2010, P NATL ACAD SCI USA, V107, P15798, DOI 10.1073/pnas.1003089107; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Riccomagno MM, 2002, GENE DEV, V16, P2365, DOI 10.1101/gad.1013302; Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js; Sweet EM, 2011, DEV BIOL, V358, P113, DOI 10.1016/j.ydbio.2011.07.019; Takebayashi S, 2007, DEV BIOL, V307, P165, DOI 10.1016/j.ydbio.2007.04.035; Tsai H, 2001, HUM MOL GENET, V10, P507, DOI 10.1093/hmg/10.5.507; Urness LD, 2010, DEV BIOL, V340, P595, DOI 10.1016/j.ydbio.2010.02.016; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Wright TJ, 2003, CURR TOP DEV BIOL, V57, P225, DOI 10.1016/S0070-2153(03)57008-9; Yamamoto N, 2006, J MOL MED, V84, P37, DOI 10.1007/s00109-005-0706-9; Yamamoto N, 2011, DEV BIOL, V353, P367, DOI 10.1016/j.ydbio.2011.03.016; Yu YL, 2010, J NEUROSCI, V30, P5927, DOI 10.1523/JNEUROSCI.5989-09.2010; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753	72	41	44	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2012	7	3							e34123	10.1371/journal.pone.0034123	http://dx.doi.org/10.1371/journal.pone.0034123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YB	23251366	Green Published, Green Submitted, gold			2022-12-27	WOS:000303855700080
J	IJssennagger, N; de Wit, N; Muller, M; van der Meer, R				IJssennagger, Noortje; de Wit, Nicole; Muller, Michael; van der Meer, Roelof			Dietary Heme-Mediated PPAR alpha Activation Does Not Affect the Heme-Induced Epithelial Hyperproliferation and Hyperplasia in Mouse Colon	PLOS ONE			English	Article							ACID-BINDING PROTEIN; RED MEAT; OXIDATIVE STRESS; CANCER; GENE; MICE; CARCINOGENESIS; EXPRESSION; RISK; NRF1	Red meat consumption is associated with an increased colon cancer risk. Heme, present in red meat, injures the colon surface epithelium by luminal cytotoxicity and reactive oxygen species. This surface injury is overcompensated by hyperproliferation and hyperplasia of crypt cells. Transcriptome analysis of mucosa of heme-fed mice showed, besides stress-and proliferation-related genes, many upregulated lipid metabolism-related PPAR alpha target genes. The aim of this study was to investigate the role of PPAR alpha in heme-induced hyperproliferation and hyperplasia. Male PPAR alpha KO and WT mice received a purified diet with or without heme. As PPAR alpha is proposed to protect against oxidative stress and lipid peroxidation, we hypothesized that the absence of PPAR alpha leads to more surface injury and crypt hyperproliferation in the colon upon heme-feeding. Heme induced luminal cytotoxicity and lipid peroxidation and colonic hyperproliferation and hyperplasia to the same extent in WT and KO mice. Transcriptome analysis of colonic mucosa confirmed similar heme-induced hyperproliferation in WT and KO mice. Stainings for alkaline phosphatase activity and expression levels of Vanin-1 and Nrf2-targets indicated a compromised antioxidant defense in heme-fed KO mice. Our results suggest that the protective role of PPAR alpha in antioxidant defense involves the Nrf2-inhibitor Fosl1, which is upregulated by heme in PPAR alpha KO mice. We conclude that PPAR alpha plays a protective role in colon against oxidative stress, but PPAR alpha does not mediate heme-induced hyperproliferation. This implies that oxidative stress of surface cells is not the main determinant of heme-induced hyperproliferation and hyperplasia.	[IJssennagger, Noortje; de Wit, Nicole; Muller, Michael; van der Meer, Roelof] Top Inst Food & Nutr, Wageningen, Netherlands; [IJssennagger, Noortje; Muller, Michael; van der Meer, Roelof] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands; [de Wit, Nicole; Muller, Michael] Netherlands Nutrigen Ctr, Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research	IJssennagger, N (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	noortje.ijssennagger@wur.nl	Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008; Kleerebezem, Michiel/AAT-2078-2021; Derrien, Muriel/AAS-6845-2021	Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Derrien, Muriel/0000-0001-8841-9153; Kleerebezem, Michiel/0000-0001-8552-2235	program council of TIFN [A-1001]	program council of TIFN	This study was funded by the program council of TIFN (grant A-1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmegeed MA, 2009, FREE RADICAL BIO MED, V47, P767, DOI 10.1016/j.freeradbiomed.2009.06.017; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Anton PM, 2002, DIGEST DIS SCI, V47, P1308, DOI 10.1023/A:1015322514547; Bastide NM, 2011, CANCER PREV RES, V4, P177, DOI 10.1158/1940-6207.CAPR-10-0113; Berruyer C, 2004, MOL CELL BIOL, V24, P7214, DOI 10.1128/MCB.24.16.7214-7224.2004; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Vogel J, 2005, CARCINOGENESIS, V26, P387, DOI 10.1093/carcin/bgh331; de Vogel J, 2008, CARCINOGENESIS, V29, P398, DOI 10.1093/carcin/bgm278; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; Harada T, 2003, AM J PHYSIOL-GASTR L, V284, pG255, DOI 10.1152/ajpgi.00244.2002; IJssennagger N, 2012, GUT, V61, P1041, DOI 10.1136/gutjnl-2011-300239; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Larsson SC, 2005, INT J CANCER, V113, P829, DOI 10.1002/ijc.20658; Lee SJ, 2010, TOXICOL APPL PHARM, V242, P191, DOI 10.1016/j.taap.2009.10.007; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Pialoux V, 2009, FREE RADICAL BIO MED, V46, P321, DOI 10.1016/j.freeradbiomed.2008.10.047; Pierre F, 2003, CARCINOGENESIS, V24, P1683, DOI 10.1093/carcin/bgg130; Pouyet L, 2010, INFLAMM BOWEL DIS, V16, P96, DOI 10.1002/ibd.21031; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Reddy SPM, 2002, AM J PHYSIOL-LUNG C, V283, pL1161, DOI 10.1152/ajplung.00140.2002; Sesink ALA, 1999, CANCER RES, V59, P5704; Thompson J, 1999, MOL CELL BIOCHEM, V192, P9, DOI 10.1023/A:1006806616963; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang GQ, 2005, HEPATOLOGY, V42, P871, DOI 10.1002/hep.20857; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yamamoto T, 2007, J AM SOC NEPHROL, V18, P2894, DOI 10.1681/ASN.2007010097; Yang HP, 2005, MOL CELL BIOL, V25, P5933, DOI 10.1128/MCB.25.14.5933-5946.2005; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007	38	74	75	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2012	7	8							e43260	10.1371/journal.pone.0043260	http://dx.doi.org/10.1371/journal.pone.0043260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OQ	23239972	gold, Green Submitted, Green Published			2022-12-27	WOS:000307500800068
J	Borges, JC; Seraphim, TV; Mokry, DZ; Almeida, FCL; Cyr, DM; Ramos, CHI				Borges, Julio C.; Seraphim, Thiago V.; Mokry, David Z.; Almeida, Fabio C. L.; Cyr, Douglas M.; Ramos, Carlos H. I.			Identification of Regions Involved in Substrate Binding and Dimer Stabilization within the Central Domains of Yeast Hsp40 Sis1	PLOS ONE			English	Article							MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; DNAK CHAPERONE; HSP70; PROTEIN; YDJ1; ULTRACENTRIFUGATION; SPECTROSCOPY; AGGREGATION; SPECIFICITY	Protein folding, refolding and degradation are essential for cellular life and are regulated by protein homeostatic processes such those that involve the molecular chaperone DnaK/Hsp70 and its co-chaperone DnaJ. Hsp70 action is initiated when proteins from the DnaJ family bind an unfolded protein for delivery purposes. In eukaryotes, the DnaJ family can be divided into two main groups, Type I and Type II, represented by yeast cytosolic Ydj1 and Sis1, respectively. Although sharing some unique features both members of the DnaJ family, Ydj1 and Sis1 are structurally and functionally distinct as deemed by previous studies, including the observation that their central domains carry the structural and functional information even in switched chimeras. In this study, we combined several biophysical tools for evaluating the stability of Sis1 and mutants that had the central domains (named Gly/Met rich domain and C-terminal Domain I) deleted or switched to those of Ydj1 to gain insight into the role of these regions in the structure and function of Sis1. The mutants retained some functions similar to full length wild-type Sis1, however they were defective in others. We found that: 1) Sis1 unfolds in at least two steps as follows: folded dimer to partially folded monomer and then to an unfolded monomer. 2) The Gly/Met rich domain had intrinsically disordered characteristics and its deletion had no effect on the conformational stability of the protein. 3) The deletion of the C-terminal Domain I perturbed the stability of the dimer. 4) Exchanging the central domains perturbed the conformational stability of the protein. Altogether, our results suggest the existence of two similar subdomains in the C-terminal domain of DnaJ that could be important for stabilizing each other in order to maintain a folded substrate-binding site as well as the dimeric state of the protein.	[Seraphim, Thiago V.; Mokry, David Z.; Ramos, Carlos H. I.] Univ Campinas UNICAMP, Inst Chem, Sao Paulo, Brazil; [Borges, Julio C.; Seraphim, Thiago V.] Univ Sao Paulo, Inst Chem Sao Carlos, Sao Paulo, Brazil; [Seraphim, Thiago V.] Univ Campinas UNICAMP, Inst Biol, Sao Paulo, Brazil; [Almeida, Fabio C. L.] Natl Ctr Nucl Magnet Resonance Macromol UFRJ, Inst Med Biochem, Rio De Janeiro, Brazil; [Almeida, Fabio C. L.] Natl Inst Sci & Technol Struct Biol & Bioimaging, Rio De Janeiro, Brazil; [Cyr, Douglas M.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; University of North Carolina; University of North Carolina Chapel Hill	Ramos, CHI (corresponding author), Univ Campinas UNICAMP, Inst Chem, Sao Paulo, Brazil.	cramos@iqm.unicamp.br	Ramos, CH/C-1571-2012; Almeida, Fabio/O-4989-2018; Borges, Julio C/C-6160-2008; Seraphim, Thiago V/J-9949-2013; Portes Santos, Claudia/D-5093-2009	Ramos, CH/0000-0002-7246-9081; Almeida, Fabio/0000-0001-6046-7006; Borges, Julio C/0000-0003-4856-748X; Santos, Helena/0000-0002-5240-5662; Monteiro-Neto, Cassiano/0000-0001-9342-8089; Cyr, Douglas/0000-0002-4928-3414; Vargas Seraphim, Thiago/0000-0002-8682-8962; Portes Santos, Claudia/0000-0001-5165-0853	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Ministerio da Ciencia e Tecnologia/Conselho Nacional de Pesquisa e Desenvolvimento (MCT/CNPq); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056981, R01GM067785] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministerio da Ciencia e Tecnologia/Conselho Nacional de Pesquisa e Desenvolvimento (MCT/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the agencies that funded this work through grants, namely, the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - www.fapesp.br) and Ministerio da Ciencia e Tecnologia/Conselho Nacional de Pesquisa e Desenvolvimento (MCT/CNPq - www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borges JC, 2011, CURR MED CHEM, V18, P1276; Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; da Silva KP, 2011, PROTEIN PEPTIDE LETT, V18, P132; Fan CY, 2004, MOL BIOL CELL, V15, P761, DOI 10.1091/mbc.E03-03-0146; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Li JZ, 2009, PROTEIN PEPTIDE LETT, V16, P606, DOI 10.2174/092986609788490159; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Pierpaoli EV, 1998, J BIOL CHEM, V273, P6643, DOI 10.1074/jbc.273.12.6643; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Ramos CHI, 2005, PROTEIN PEPTIDE LETT, V12, P213, DOI 10.2174/0929866053587156; Ramos CHI, 1999, BIOCHEMISTRY-US, V38, P9783, DOI 10.1021/bi9828627; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Silva JC, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-40; Summers DW, 2009, TRENDS BIOCHEM SCI, V34, P230, DOI 10.1016/j.tibs.2008.12.009; SZYPERSKI T, 1994, P NATL ACAD SCI USA, V91, P11343, DOI 10.1073/pnas.91.24.11343; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]	31	41	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2012	7	12							e50927	10.1371/journal.pone.0050927	http://dx.doi.org/10.1371/journal.pone.0050927			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057TZ	22792329	Green Published, Green Submitted, gold			2022-12-27	WOS:000312588200082
J	McCann, FJ; Chapman, SJ; Yu, WC; Maskell, NA; Davies, RJO; Lee, YCG				McCann, Fiona J.; Chapman, Stephen J.; Yu, Wai Cho; Maskell, Nick A.; Davies, Robert J. O.; Lee, Y. C. Gary			Ability of Procalcitonin to Discriminate Infection from Non-Infective Inflammation Using Two Pleural Disease Settings	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; FLUID PROCALCITONIN; SEPSIS; DIAGNOSIS; PLEURODESIS; BIOMARKERS; ADULTS; SERUM	Procalcitonin has been shown to be useful in separating infection from non-infective disorders. However, infection is often paralleled by tissue inflammation. Most studies supporting the use of procalcitonin were confounded by more significant inflammation in the infection group. Few studies have examined the usefulness of procalcitonin when adjusted for inflammation. Pleural inflammation underlies the development of most exudative effusions including pleural infection and malignancy. Pleurodesis, often used to treat effusions, involves provocation of intense aseptic pleural inflammation. We conducted a two-part proof-of-concept study to test the specificity of procalcitonin in differentiating infection using cohorts of patients with pleural effusions of infective and non-infective etiologies, as well as subjects undergoing pleurodesis. Methods: We measured the blood procalcitonin level (i) in 248 patients with pleural infection or with non-infective pleural inflammation, matched for severity of systemic inflammation by C-reactive protein (CRP), age and gender; and (ii) in patients before and 24-48 hours after induction of non-infective pleural inflammation (from talc pleurodesis). Results: 1) Procalcitonin was significantly higher in patients with pleural infection compared with controls with noninfective effusions (n = 32 each group) that were case-matched for systemic inflammation as measured by CRP [median (25-75% IQR): 0.58 (0.35-1.50) vs 0.34 (0.31-0.42) mu g/L respectively, p = 0.003]. 2) Talc pleurodesis provoked intense systemic inflammation, and raised serum CRP by 360% over baseline. However procalcitonin remained relatively unaffected (21% rise). 3) Procalcitonin and CRP levels did not correlate. In 214 patients with pleural infection, procalcitonin levels did not predict the survival or need for surgical intervention. Conclusion: Using a pleural model, this proof-of-principle study confirmed that procalcitonin is a biomarker specific for infection and is not affected by non-infective inflammation. Procalcitonin is superior to CRP in distinguishing infection from non-infective pleural diseases, even when controlled for the level of systemic inflammation.	[McCann, Fiona J.; Chapman, Stephen J.; Davies, Robert J. O.; Lee, Y. C. Gary] Oxford Ctr Resp Med, Oxford, England; [McCann, Fiona J.; Chapman, Stephen J.; Davies, Robert J. O.; Lee, Y. C. Gary] Univ Oxford, Oxford, England; [Lee, Y. C. Gary] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Yu, Wai Cho] Princess Margaret Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Maskell, Nick A.] Southmead Hosp, N Bristol Lung Ctr, Bristol, Avon, England	University of Oxford; University of Western Australia; Southmead Hospital	Lee, YCG (corresponding author), Oxford Ctr Resp Med, Oxford, England.	gary.lee@uwa.edu.au	Lee, Y C Gary/H-5264-2014	Ming, Zhangyin/0000-0002-8773-3930; Lee, Yun Chor Gary/0000-0002-0036-511X; maskell, nick/0000-0002-1276-6500	Oxford Health and Research Committee; NIHR Oxford Biomedical Research Centre, Medical Research Council Project Grant; United Kingdom and National Health & Medical Research Council (Australia) Project Grant; Western Australia; Higher Education Funding Council for England Clinical Senior Lecturer Awards, United Kingdom; MRC [G1001712] Funding Source: UKRI; Medical Research Council [G1001712] Funding Source: researchfish; National Institute for Health Research [CL-2006-13-003] Funding Source: researchfish	Oxford Health and Research Committee; NIHR Oxford Biomedical Research Centre, Medical Research Council Project Grant; United Kingdom and National Health & Medical Research Council (Australia) Project Grant; Western Australia; Higher Education Funding Council for England Clinical Senior Lecturer Awards, United Kingdom; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the Oxford Health and Research Committee research grant (FJMcC, SJC, RJOD & YCGL). NIHR Oxford Biomedical Research Centre (RJOD), Medical Research Council Project Grant, United Kingdom and National Health & Medical Research Council (Australia) Project Grant, Westcare Grant of Western Australia (YCGL) & Higher Education Funding Council for England Clinical Senior Lecturer Awards, United Kingdom (NAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, CLIN INFECT DIS, V53, P379, DOI 10.1093/cid/cir408; Albert SS, 2008, CLIN RESP MED, P853; Becker KL, 2008, CRIT CARE MED, V36, P941, DOI 10.1097/CCM.0B013E318165BABB; Brims FJH, 2010, EUR RESPIR REV, V19, P220, DOI 10.1183/09059180.00005610; Brunkhorst FM, 1999, CRIT CARE MED, V27, P2172, DOI 10.1097/00003246-199910000-00016; Cuquemelle E, 2011, INTENS CARE MED, V37, P796, DOI 10.1007/s00134-011-2189-1; de Kruif MD, 2008, INTENS CARE MED, V34, P518, DOI 10.1007/s00134-007-0955-x; San Jose ME, 2010, J INVEST MED, V58, P971, DOI 10.231/JIM.0b013e3181f88648; Hooper C, 2010, THORAX, V65, P4, DOI 10.1136/thx.2010.136978; Jereb M, 2001, INFECTION, V29, P209, DOI 10.1007/s15010-001-1165-z; Ko YC, 2009, J KOREAN MED SCI, V24, P398, DOI 10.3346/jkms.2009.24.3.398; Lee YCG, 2004, RESPIROLOGY, V9, P148, DOI 10.1111/j.1440-1843.2004.00566.x; Lin MC, 2009, CHEST, V136, P205, DOI 10.1378/chest.08-1134; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; Maskell NA, 2004, CHEST, V126, P2022, DOI 10.1378/chest.126.6.2022; Maskell NA, 2004, AM J RESP CRIT CARE, V170, P377, DOI 10.1164/rccm.200311-1579OC; Muller F, 2010, CHEST, V138, P121, DOI 10.1378/chest.09-2920; Muller B, 2002, J LEUKOCYTE BIOL, V72, P643; Olah A, 2005, HEPATO-GASTROENTEROL, V52, P243; Papassotiriou I, 2008, EUR J CLIN INVEST, V38, P276, DOI 10.1111/j.1365-2362.2008.01935.x; Porcel JM, 2009, EUR RESP J IN PRESS; Rahman NM, 2011, NEW ENGL J MED, V365, P518, DOI 10.1056/NEJMoa1012740; RAHMAN NM, 2008, TXB PLEURAL DIS, P341; Reinhart K, 2011, CRIT CARE CLIN, V27, P253, DOI 10.1016/j.ccc.2011.01.002; Russwurm S, 1999, CLIN CHEM LAB MED, V37, P789, DOI 10.1515/CCLM.1999.119; Sahn SA, 2008, TXB PLEURAL DIS, P209; Schuetz P, 2012, CHEST, V141, P1063, DOI 10.1378/chest.11-2430; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Tobin CL, 2012, CURR OPIN PULM MED, V18, P321, DOI 10.1097/MCP.0b013e328352c673; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Wang CY, 2011, EUR J CLIN MICROBIOL, V30, P313, DOI 10.1007/s10096-010-1082-0; West SD, 2004, CURR OPIN PULM MED, V10, P305, DOI 10.1097/01.mcp.0000129756.87090.55	32	137	142	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e49894	10.1371/journal.pone.0049894	http://dx.doi.org/10.1371/journal.pone.0049894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	23251674	Green Published, gold, Green Submitted			2022-12-27	WOS:000313236200021
J	Bourgeois, FT; Murthy, S; Mandl, KD				Bourgeois, Florence T.; Murthy, Srinivas; Mandl, Kenneth D.			Comparative Effectiveness Research: An Empirical Study of Trials Registered in ClinicalTrials.gov	PLOS ONE			English	Article							CLINICAL-TRIALS; COMPARATIVE EFFICACY; COST-EFFECTIVENESS; HEALTH; INFORMATION; COMPANIES; BRITAIN; SERVICE; CANADA; NICE	Background: The $1.1 billion investment in comparative effectiveness research will reshape the evidence-base supporting decisions about treatment effectiveness, safety, and cost. Defining the current prevalence and characteristics of comparative effectiveness (CE) research will enable future assessments of the impact of this program. Methods: We conducted an observational study of clinical trials addressing priority research topics defined by the Institute of Medicine and conducted in the US between 2007 and 2010. Trials were identified in ClinicalTrials.gov. Main outcome measures were the prevalence of comparative effectiveness research, nature of comparators selected, funding sources, and impact of these factors on results. Results: 231 (22.3%; 95% CI 19.8%-24.9%) studies were CE studies and 804 (77.7%; 95% CI, 75.1%-80.2%) were non-CE studies, with 379 (36.6%; 95% CI, 33.7%-39.6%) employing a placebo control and 425 (41.1%; 95% CI, 38.1%-44.1%) no control. The most common treatments examined in CE studies were drug interventions (37.2%), behavioral interventions (28.6%), and procedures (15.6%). Study findings were favorable for the experimental treatment in 34.8% of CE studies and greater than twice as many (78.6%) non-CE studies (P < 0.001). CE studies were more likely to receive government funding (P = 0.003) and less likely to receive industry funding (P = 0.01), with 71.8% of CE studies primarily funded by a noncommercial source. The types of interventions studied differed based on funding source, with 95.4% of industry trials studying a drug or device. In addition, industry-funded CE studies were associated with the fewest pediatric subjects (P < 0.001), the largest anticipated sample size (P < 0.001), and the shortest study duration (P < 0.001). Conclusions: In this sample of studies examining high priority areas for CE research, less than a quarter are CE studies and the majority is supported by government and nonprofits. The low prevalence of CE research exists across CE studies with a broad array of interventions and characteristics.	[Bourgeois, Florence T.; Mandl, Kenneth D.] Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Bourgeois, Florence T.; Mandl, Kenneth D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Murthy, Srinivas] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Mandl, Kenneth D.] Childrens Hosp, Harvard MIT Div Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Boston Children's Hospital	Bourgeois, FT (corresponding author), Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	florence.bourgeois@childrens.harvard.edu	Bourgeois, Florence/H-6710-2016; Murthy, Srinivas/AAS-7243-2020; BERTRAND, Joris/C-1812-2014; Mila, Borja/L-4867-2014; Bourgeois, Yann/D-9938-2012	Bourgeois, Florence/0000-0001-7798-4560; BERTRAND, Joris/0000-0002-3379-1019; Mila, Borja/0000-0002-6446-0079; Bourgeois, Yann/0000-0002-1809-387X; Murthy, Srinivas/0000-0002-9476-839X; Thebaud, Christophe/0000-0002-8586-1234	National Institute of Child Health and Human Development [5T32HD040128]; National Library of Medicine, National Institutes of Health [5G08LM009778]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040128] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [G08LM009778] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Dr. Bourgeois was supported by a training grant (5T32HD040128) from the National Institute of Child Health and Human Development, and Dr. Mandl by a grant from the National Library of Medicine (5G08LM009778), National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GC, 2009, JAMA-J AM MED ASSOC, V301, P2488, DOI 10.1001/jama.2009.851; Baicker K, 2004, HLTH AFF MILLWOOD S, pVAR33; Berger E, 2008, ANN EMERG MED, V52, P137, DOI 10.1016/j.annemergmed.2008.06.009; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; De Angelis C, 2004, MED J AUSTRALIA, V181, P293, DOI 10.5694/j.1326-5377.2004.tb06290.x; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Federal Coordinating Council for Comparative Effectiveness Research, 2009, REP PRES C; Henry DA, 2005, JAMA-J AM MED ASSOC, V294, P2630, DOI 10.1001/jama.294.20.2630; Hochman M, 2010, JAMA-J AM MED ASSOC, V303, P951, DOI 10.1001/jama.2010.240; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Kirschner N, 2008, ANN INTERN MED, V148, P956, DOI 10.7326/0003-4819-148-12-200806170-00222; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Luce BR, 2009, ANN INTERN MED, V151, P206, DOI 10.7326/0003-4819-151-3-200908040-00126; Mittler JN, 2010, HEALTH SERV RES, V45, P647, DOI 10.1111/j.1475-6773.2010.01108.x; O'Connor AB, 2010, JAMA-J AM MED ASSOC, V303, P979, DOI 10.1001/jama.2010.257; Rawlins MD, 2004, NEW ENGL J MED, V351, P1383, DOI 10.1056/NEJMp048221; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Smith R, 2005, PLOS MED, V2, P364, DOI 10.1371/journal.pmed.0020138.g001; Sorenson C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4849; Sox HC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000269; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; Steinbrook R, 2008, NEW ENGL J MED, V359, P1977, DOI 10.1056/NEJMp0806862; Tierney M, 2008, CAN MED ASSOC J, V178, P432, DOI 10.1503/cmaj.070713; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Weinstein MC, 2010, NEW ENGL J MED, V362, P460, DOI 10.1056/NEJMsb0911104; Zarin DA, 2008, SCIENCE, V319, P1340, DOI 10.1126/science.1153632	30	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2012	7	1							e28820	10.1371/journal.pone.0028820	http://dx.doi.org/10.1371/journal.pone.0028820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906NN	22253698	gold, Green Submitted, Green Published			2022-12-27	WOS:000301352400001
J	Buga, AM; Scholz, CJ; Kumar, S; Herndon, JG; Alexandru, D; Cojocaru, GR; Dandekar, T; Popa-Wagner, A				Buga, Ana-Maria; Scholz, Claus Juergen; Kumar, Senthil; Herndon, James G.; Alexandru, Dragos; Cojocaru, Gabriel Radu; Dandekar, Thomas; Popa-Wagner, Aurel			Identification of New Therapeutic Targets by Genome-Wide Analysis of Gene Expression in the Ipsilateral Cortex of Aged Rats after Stroke	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; COLONY-STIMULATING FACTOR; CEREBRAL-ISCHEMIA; RECEPTOR; BRAIN; PROTEIN; INHIBITOR; MOUSE; GAMMA; DIFFERENTIATION	Background: Because most human stroke victims are elderly, studies of experimental stroke in the aged rather than the young rat model may be optimal for identifying clinically relevant cellular responses, as well for pinpointing beneficial interventions. Methodology/Principal Findings: We employed the Affymetrix platform to analyze the whole-gene transcriptome following temporary ligation of the middle cerebral artery in aged and young rats. The correspondence, heat map, and dendrogram analyses independently suggest a differential, age-group-specific behaviour of major gene clusters after stroke. Overall, the pattern of gene expression strongly suggests that the response of the aged rat brain is qualitatively rather than quantitatively different from the young, i.e. the total number of regulated genes is comparable in the two age groups, but the aged rats had great difficulty in mounting a timely response to stroke. Our study indicates that four genes related to neuropathic syndrome, stress, anxiety disorders and depression (Acvr1c, Cort, Htr2b and Pnoc) may have impaired response to stroke in aged rats. New therapeutic options in aged rats may also include Calcrl, Cyp11b1, Prcp, Cebpa, Cfd, Gpnmb, Fcgr2b, Fcgr3a, Tnfrsf26, Adam 17 and Mmp14. An unexpected target is the enzyme 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 in aged rats, a key enzyme in the cholesterol synthesis pathway. Post-stroke axonal growth was compromised in both age groups. Conclusion/Significance: We suggest that a multi-stage, multimodal treatment in aged animals may be more likely to produce positive results. Such a therapeutic approach should be focused on tissue restoration but should also address other aspects of patient post-stroke therapy such as neuropathic syndrome, stress, anxiety disorders, depression, neurotransmission and blood pressure.	[Buga, Ana-Maria; Popa-Wagner, Aurel] Univ Med, Dept Psychiat, Rostock, Germany; [Buga, Ana-Maria; Alexandru, Dragos; Cojocaru, Gabriel Radu] Univ Med, Dept Funct Sci, Craiova, Romania; [Scholz, Claus Juergen] Univ Wurzburg, Lab Microarray Applicat, Interdisciplinary Ctr Clin Res, D-97070 Wurzburg, Germany; [Kumar, Senthil] Iowa State Univ Sci & Technol, Coll Vet Med, Dept Biomed Sci, Ames, IA 50011 USA; [Herndon, James G.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Dandekar, Thomas] Bioctr Hubland, Dept Bioinformat, Wurzburg, Germany	University of Medicine & Pharmacy of Craiova; University of Wurzburg; Iowa State University; Emory University	Popa-Wagner, A (corresponding author), Univ Med, Dept Psychiat, Rostock, Germany.	aurel.popa-wagner@med.uni-rostock.de	Alexandru, Dragos Ovidiu/AAM-8276-2020; Popa-Wagner, Aurel/E-2541-2013; Scholz, Claus Jürgen/H-3202-2019; Balseanu, Tudor Adrian/O-2289-2018; Buga, Ana-Maria I/P-1478-2014; Buga, Ana Maria/ABA-8108-2021; Streba, Costin Teodor T/C-4196-2011; Popa-Wagner, Aurel/I-2581-2019; Vintilescu, Raluca/A-9499-2018; Dandekar, Thomas/A-4431-2017; Balseanu, Tudor Adrian/T-8118-2019	Alexandru, Dragos Ovidiu/0000-0001-7578-8048; Scholz, Claus Jürgen/0000-0002-6406-7859; Balseanu, Tudor Adrian/0000-0002-0047-3436; Streba, Costin Teodor T/0000-0001-9590-3197; Dandekar, Thomas/0000-0003-1886-7625; Balseanu, Tudor Adrian/0000-0002-0047-3436; Sivanesan, Senthilkumar/0000-0001-5133-7090	Federal Ministry of Education and Research [01GN0982]; CNCS-UEFISCDI [PN-II-ID-PCE-2011-3-0848]; NIH [OD P51OD11132]; ERA-NET FLARE2/UEFISCDI [8555/2011]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); CNCS-UEFISCDI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERA-NET FLARE2/UEFISCDI; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported financially by the Federal Ministry of Education and Research (Grant No 01GN0982) and by a grant from CNCS-UEFISCDI, project No PN-II-ID-PCE-2011-3-0848 to A. P. W. and by NIH grant OD P51OD11132 to the Yerkes National Primate Research Center. Dr. Ana-Maria Buga was supported by a grant from ERA-NET FLARE2/UEFISCDI, project No 8555/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer HL, 2006, AM J MED GENET A, V140A, P691, DOI 10.1002/ajmg.a.31133; Badan I, 2004, EUR J NEUROSCI, V19, P2270, DOI 10.1111/j.0953-816X.2004.03323.x; Badan I, 2003, GERONTOLOGY, V49, P356, DOI 10.1159/000073763; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borday C, 2004, PROG BIOPHYS MOL BIO, V84, P89, DOI 10.1016/j.pbiomolbio.2003.11.002; Buga AM, 2008, J CELL MOL MED, V12, P2731, DOI 10.1111/j.1582-4934.2008.00252.x; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Chae JI, 2009, PROTEOMICS, V9, P1128, DOI 10.1002/pmic.200800234; Chiou LC, 2007, CURR DRUG TARGETS, V8, P117, DOI 10.2174/138945007779315605; Chnari E, 2006, BIOMACROMOLECULES, V7, P1796, DOI 10.1021/bm0600872; Cruz C, 2010, P NATL ACAD SCI USA, V107, P3564, DOI 10.1073/pnas.1000389107; Deshmukh HS, 2009, AM J RESP CRIT CARE, V180, P834, DOI 10.1164/rccm.200903-0328OC; Deussing JM, 2007, J CEREBR BLOOD F MET, V27, P1476, DOI 10.1038/sj.jcbfm.9600451; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Fischer T, 2011, DEV BIOL, V350, P496, DOI 10.1016/j.ydbio.2010.12.017; Gavioli EC, 2008, PEPTIDES, V29, P1404, DOI 10.1016/j.peptides.2008.04.004; Ghzili H, 2006, REGUL PEPTIDES, V137, P89, DOI 10.1016/j.regpep.2006.06.015; Gierten J, 2008, BRIT J PHARMACOL, V154, P1680, DOI 10.1038/bjp.2008.213; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Hemley CF, 2007, CURR DRUG TARGETS, V8, P105, DOI 10.2174/138945007779315542; Huang JJ, 2012, BRAIN BEHAV, V2, P85, DOI 10.1002/brb3.39; Irizarry RA, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1002; Islam O, 2009, MOL BIOL CELL, V20, P188, DOI 10.1091/mbc.E08-05-0463; Jackson AC, 2011, J NEUROSCI, V31, P3939, DOI 10.1523/JNEUROSCI.5134-10.2011; Jang JE, 2012, CIRC RES, V110, P1057, DOI 10.1161/CIRCRESAHA.112.266411; Kagerer SM, 2011, PEPTIDES, V32, P839, DOI 10.1016/j.peptides.2011.01.004; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Kennett GA, 1998, NEUROPHARMACOLOGY, V37, P1603, DOI 10.1016/S0028-3908(98)00115-4; Kirton JP, 2006, CIRC RES, V98, P1264, DOI 10.1161/01.RES.0000223056.68892.8b; Kurnellas MP, 2004, FASEB J, V18, P298, DOI 10.1096/fj.04-2549fje; Leitch B, 2009, J COMP NEUROL, V512, P52, DOI 10.1002/cne.21890; Lewis J, 2010, NEURON, V68, P601, DOI 10.1016/j.neuron.2010.11.014; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Lin SY, 2011, J NEUROSCI, V31, P1410, DOI 10.1523/JNEUROSCI.4682-10.2011; Lindner MD, 2003, J NEUROSCI, V23, P10913; Little GE, 2009, PLOS BIOL, V7, P756, DOI 10.1371/journal.pbio.1000098; Liu RZ, 2004, EUR J BIOCHEM, V271, P339, DOI 10.1046/j.1432-1033.2003.03932.x; Liu YL, 2008, BIOL PSYCHIAT, V64, P789, DOI 10.1016/j.biopsych.2008.04.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Markus TM, 2005, ANN NEUROL, V58, P950, DOI 10.1002/ana.20676; Martinez-Ferrer M, 2010, AM J PATHOL, V176, P98, DOI 10.2353/ajpath.2010.090283; Martinowich K, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-11; Matsuo R, 2001, BIOCHEM BIOPH RES CO, V289, P479, DOI 10.1006/bbrc.2001.5975; Mertsch S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-302; Moore EL, 2010, BIOCHEM BIOPH RES CO, V394, P141, DOI 10.1016/j.bbrc.2010.02.131; Morikis D, 2002, BIOCHEM SOC T, V30, P1026, DOI 10.1042/BST0301026; Na IK, 2009, J IMMUNOTHER, V32, P907, DOI 10.1097/CJI.0b013e3181b7be60; Papac-Milicevic N, 2012, CIRC RES, V110, pE50, DOI 10.1161/CIRCRESAHA.111.258814; Popa-Wagner A, 1999, J CEREBR BLOOD F MET, V19, P425, DOI 10.1097/00004647-199904000-00008; Popa-Wagner A, 2011, AGEING RES REV, V10, P71, DOI 10.1016/j.arr.2009.10.008; Popa-Wagner A, 2010, STROKE, V41, P1027, DOI 10.1161/STROKEAHA.109.575621; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Saleh S, 2005, J PHYSIOL-LONDON, V568, P155, DOI 10.1113/jphysiol.2005.090951; Schmidt-Kastner R, 2002, MOL BRAIN RES, V108, P81, DOI 10.1016/S0169-328X(02)00516-8; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shariat-Madar Z, 2002, J BIOL CHEM, V277, P17962, DOI 10.1074/jbc.M106101200; Siehler S, 2008, MOL CELL ENDOCRINOL, V286, P26, DOI 10.1016/j.mce.2007.12.007; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Tanaka M, 2009, J IMMUNOL, V183, P2349, DOI 10.4049/jimmunol.0801683; Tanji K, 2010, NEUROBIOL DIS, V38, P210, DOI 10.1016/j.nbd.2010.01.007; Teronen O, 1997, J DENT RES, V76, P1529, DOI 10.1177/00220345970760090401; Trumbach D, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-159; Tseveleki V, 2010, GENOMICS, V96, P82, DOI 10.1016/j.ygeno.2010.04.004; Tuomi JM, 2010, AM J PHYSIOL-HEART C, V298, pH554, DOI 10.1152/ajpheart.00779.2009; Wang QF, 2002, BLOOD, V99, P2776, DOI 10.1182/blood.V99.8.2776; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Wunder F, 2008, MOL PHARMACOL, V73, P1235, DOI 10.1124/mol.107.042283; Yamada Y, 2011, EUR J PHARMACOL, V667, P113, DOI 10.1016/j.ejphar.2011.05.072; Zarrabi K, 2011, J BIOL CHEM, V286, P33167, DOI 10.1074/jbc.M111.256644; Zhang GX, 2010, HYPERTENS RES, V33, P478, DOI 10.1038/hr.2010.21; Zhou CY, 2010, J MED CHEM, V53, P7251, DOI 10.1021/jm101013m; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	78	71	73	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2012	7	12							e50985	10.1371/journal.pone.0050985	http://dx.doi.org/10.1371/journal.pone.0050985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066QV	22768071	Green Published, gold			2022-12-27	WOS:000313236200051
J	Li, XB; Yan, WG; Agrama, H; Jia, LM; Jackson, A; Moldenhauer, K; Yeater, K; McClung, A; Wu, DX				Li, Xiaobai; Yan, Wengui; Agrama, Hesham; Jia, Limeng; Jackson, Aaron; Moldenhauer, Karen; Yeater, Kathleen; McClung, Anna; Wu, Dianxing			Unraveling the Complex Trait of Harvest Index with Association Mapping in Rice (Oryza sativa L.)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; YIELD-RELATED TRAITS; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; QUANTITATIVE TRAITS; GENETIC DIVERSITY; GRAIN-YIELD; CORE SUBSET; QUALITY; MODEL	Harvest index is a measure of success in partitioning assimilated photosynthate. An improvement of harvest index means an increase in the economic portion of the plant. Our objective was to identify genetic markers associated with harvest index traits using 203 O. sativa accessions. The phenotyping for 14 traits was conducted in both temperate (Arkansas) and subtropical (Texas) climates and the genotyping used 154 SSRs and an indel marker. Heading, plant height and weight, and panicle length had negative correlations, while seed set and grain weight/panicle had positive correlations with harvest index across both locations. Subsequent genetic diversity and population structure analyses identified five groups in this collection, which corresponded to their geographic origins. Model comparisons revealed that different dimensions of principal components analysis (PCA) affected harvest index traits for mapping accuracy, and kinship did not help. In total, 36 markers in Arkansas and 28 markers in Texas were identified to be significantly associated with harvest index traits. Seven and two markers were consistently associated with two or more harvest index correlated traits in Arkansas and Texas, respectively. Additionally, four markers were constitutively identified at both locations, while 32 and 24 markers were identified specifically in Arkansas and Texas, respectively. Allelic analysis of four constitutive markers demonstrated that allele 253 bp of RM431 had significantly greater effect on decreasing plant height, and 390 bp of RM24011 had the greatest effect on decreasing panicle length across both locations. Many of these identified markers are located either nearby or flanking the regions where the QTLs for harvest index have been reported. Thus, the results from this association mapping study complement and enrich the information from linkage-based QTL studies and will be the basis for improving harvest index directly and indirectly in rice.	[Li, Xiaobai; Jia, Limeng; Wu, Dianxing] Zhejiang Univ, State Key Lab Rice Biol, Int Atom Energy Agcy, Collaborating Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Yan, Wengui; Jia, Limeng; Jackson, Aaron; McClung, Anna] ARS, USDA, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR USA; [Li, Xiaobai] Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China; [Agrama, Hesham; Jia, Limeng; Moldenhauer, Karen] Univ Arkansas, Rice Res & Extens Ctr, Stuttgart, AR USA; [Yeater, Kathleen] ARS, USDA, So Plains Area, College Stn, TX USA	Zhejiang University; United States Department of Agriculture (USDA); Zhejiang Academy of Agricultural Sciences; University of Arkansas System; University of Arkansas Fayetteville; United States Department of Agriculture (USDA)	Li, XB (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Int Atom Energy Agcy, Collaborating Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	Wengui.Yan@ars.usda.gov; dxwu@zju.edu.cn	Li, Xiaobai/AAB-7604-2021; Yin, Minghao/E-9611-2015	Li, Xiaobai/0000-0001-9615-3543; Jackson, Aaron/0000-0002-5540-9255; Yin, Minghao/0000-0002-6226-2394	United States Department of Agriculture-Agricultural Research Service	United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding was provided by the United States Department of Agriculture-Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2008, EUPHYTICA, V160, P339, DOI 10.1007/s10681-007-9535-y; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Agrama HA, 2009, CROP SCI, V49, P1336, DOI 10.2135/cropsci2008.06.0551; Ando T, 2008, THEOR APPL GENET, V116, P881, DOI 10.1007/s00122-008-0722-6; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; BORBA TCO, 2005, CROP BREED APPL BIOT, V2, P157; Breseghello F, 2006, CROP SCI, V46, P1323, DOI 10.2135/cropsci2005.09-0305; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Brondani C, 2006, GENET MOL BIOL, V29, P676, DOI 10.1590/S1415-47572006000400017; Can N. D., 1999, Plant Production Science, V2, P67; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Dalling M. J., 1985, EXPLOITATION PHYSL G, P55; Borba TCD, 2009, GENETICA, V137, P293, DOI 10.1007/s10709-009-9380-0; Din K., 2005, SAIC NEWSLETTER, V15, P4; Din RU, 2010, WHEAT PAK J BOT, V42, P899; DONALD CM, 1976, ADV AGRON, V28, P361, DOI 10.1016/S0065-2113(08)60559-3; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Franco J, 2006, CROP SCI, V46, P854, DOI 10.2135/cropsci2005.07-0201; Fu Q, 2010, J GENET GENOMICS, V37, P147, DOI 10.1016/S1673-8527(09)60033-3; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Gepts P., 2004, Plant Breeding Reviews, V24, P1, DOI 10.1002/9780470650288.ch1; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Hao ZF, 2010, EUPHYTICA, V174, P165, DOI 10.1007/s10681-009-0091-5; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HAY RKM, 1995, ANN APPL BIOL, V126, P197, DOI 10.1111/j.1744-7348.1995.tb05015.x; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Hemamalini GS, 2000, EUPHYTICA, V112, P69, DOI 10.1023/A:1003854224905; Hittalmani S, 2003, THEOR APPL GENET, V107, P679, DOI 10.1007/s00122-003-1269-1; Homma K, 2004, FIELD CROP RES, V88, P11, DOI 10.1016/j.fcr.2003.08.010; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jain S, 2004, THEOR APPL GENET, V109, P965, DOI 10.1007/s00122-004-1700-2; Jun F, 1997, CROP RES, V2, P1; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kim S, 2006, GENETICS, V173, P1125, DOI 10.1534/genetics.105.052720; Koutroubas SD, 2003, FIELD CROP RES, V83, P251, DOI 10.1016/S0378-4290(03)00067-4; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; Li Xiaobai, 2010, Genetica, V138, P1221, DOI 10.1007/s10709-010-9521-5; Li XB, 2011, PLANTA, V234, P347, DOI 10.1007/s00425-011-1405-0; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mao Bei-Bei, 2003, Acta Genetica Sinica, V30, P1118; Marri PR, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-33; Matsumoto TK, 2006, HORTSCIENCE, V41, P131, DOI 10.21273/HORTSCI.41.1.131; MOHAMMAD D, 1993, INDIAN J AGR SCI, V63, P92; Nei M., 1983, P 5 WORLD C GEN APPL, V21, P405; Parisseaux B, 2004, THEOR APPL GENET, V109, P508, DOI 10.1007/S00122-004-1666-0; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Raes D, 2009, AGRON J, V101, P438, DOI 10.2134/agronj2008.0140s; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rohlf F, 2000, FNTSYS PC NUMERICAL; Rong J, 2007, GENETICS, V176, P2577, DOI 10.1534/genetics.107.074518; Sabouri H, 2009, AUST J CROP SCI, V3, P155; Saxton AM, 1998, PROCEEDINGS OF THE TWENTY-THIRD ANNUAL SAS USERS GROUP INTERNATIONAL CONFERENCE, P1243; Shao YF, 2011, THEOR APPL GENET, V122, P1005, DOI 10.1007/s00122-010-1505-4; SHPILER L, 1990, EUPHYTICA, V51, P257, DOI 10.1007/BF00039727; Shrotria PK, 1988, SORGHUM NEWSLETTER U, V31, P4; Sial MA, 2005, PAKISTAN J BOT, V37, P575; Sinclair TR, 1998, CROP SCI, V38, P638, DOI 10.2135/cropsci1998.0011183X003800030002x; Soltani A., 2001, Journal of Science and Technology of Agriculture and Natural Resources, V5, P127; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang T, 2006, PLOS GENET, V2, P1824, DOI 10.1371/journal.pgen.0020199; Terao T, 2010, THEOR APPL GENET, V120, P875, DOI 10.1007/s00122-009-1218-8; Thomson MJ, 2007, THEOR APPL GENET, V114, P559, DOI 10.1007/s00122-006-0457-1; Thomson MJ, 2009, RICE, V2, P80, DOI 10.1007/s12284-009-9023-1; Tyagi AK, 2004, J GENET, V83, P79, DOI 10.1007/BF02715832; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; Wang LQ, 2007, THEOR APPL GENET, V115, P463, DOI 10.1007/s00122-007-0580-7; Wang ML, 2009, THEOR APPL GENET, V120, P13, DOI 10.1007/s00122-009-1155-6; Xin ZG, 2003, BIOTECHNIQUES, V34, P820, DOI 10.2144/03344rr04; Xu YB, 2004, CROP SCI, V44, P1947, DOI 10.2135/cropsci2004.1947; XUE W, 2008, NAT GENET, V143, P1; Yan W, 2007, CROP SCI, V47, P869, DOI 10.2135/cropsci2006.07.0444; Yan WG, 2005, U AR AGRI EXP STA RE, P63; Yang XC, 2008, HEREDITY, V101, P396, DOI 10.1038/hdy.2008.90; Yoshida S., 1981, Fundamentals of rice crop science.; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang YM, 2005, GENETICS, V169, P2267, DOI 10.1534/genetics.104.033217; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhu CS, 2009, GENETICS, V182, P875, DOI 10.1534/genetics.108.098863; Zou JiangShi, 2003, Acta Agronomica Sinica, V29, P652	84	189	201	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29350	10.1371/journal.pone.0029350	http://dx.doi.org/10.1371/journal.pone.0029350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	23240004	Green Published, gold			2022-12-27	WOS:000301570600005
J	Yang, HS; Fu, DZ; Shao, H; Kong, XF; Wang, W; Yang, XJ; Nyachoti, CM; Yin, YL				Yang, Huansheng; Fu, Dezhi; Shao, Hua; Kong, Xiangfeng; Wang, Wence; Yang, Xiaojian; Nyachoti, Charles M.; Yin, Yulong			Impacts of Birth Weight on Plasma, Liver and Skeletal Muscle Neutral Amino Acid Profiles and Intestinal Amino Acid Transporters in Suckling Huanjiang Mini-Piglets	PLOS ONE			English	Article							ULTRA-FINE POWDER; GROWTH-PERFORMANCE; ADIPOSE-TISSUE; SUPPLEMENTATION; DIGESTIBILITY; METABOLISM; CAPACITY; ILEAL; GAIN; PIGS	Genetic selection strategies towards increased prolificacy have resulted in more and more increased littler size and incidences of impaired fetal development. Low birth weight (LBW) piglets, with long-term alterations in structure, physiology and metabolism, have lower survival rates and poor growth performance. The aim of the study was to compare the plasma, liver and skeletal muscle contents of neutral amino acids (NAA) and the intestinal expression of NAA transporters between LBW and high birth weight (HBW) suckling Huanjiang mini-piglets. Forty piglets with either LBW or HBW (20 piglets per group) were sampled on day 0, 7, 14 and 21 of age to give 5 observations per day per group. The contents of NAA in plasma, liver and skeletal muscle were measured, and jejunal expression of transporters for NAA, including Slc6a19 (B(0)AT1) and Slc1a5 (ASCT2), were determined by real-time RT-PCR and Western Blot, respectively. Results showed that the suckling piglets with LBW had higher contents of Thr, Ser, Gly, Ala, Val, Met, Ile, Leu, Tyr, Phe and Pro in liver, and Gly in skeletal muscle, whereas lower contents of Met, Ser and Ala in plasma when compared with the HBW littermates. Consistent with the content differences in plasma NAA, the jejunal expression profiles of both Slc6a19 (B(0)AT1) and Slc1a5 (ASCT2) in the LBW piglets were lower in compared with the HBW littermates during the early suckling period. These findings suggested that intestinal dysfunction in the LBW piglets may be one of the reasons in altered physiology and metabolism states of other organs, which result in lower survival and growth rate.	[Yang, Huansheng; Fu, Dezhi; Shao, Hua; Kong, Xiangfeng; Wang, Wence; Yin, Yulong] Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China; [Yang, Huansheng; Fu, Dezhi; Shao, Hua; Kong, Xiangfeng; Wang, Wence; Yin, Yulong] Chinese Acad Sci, Res Ctr Hlth Breeding Livestock & Poultry, Inst Subtrop Agr, Changsha, Hunan, Peoples R China; [Kong, Xiangfeng] Chinese Acad Sci, Huanjiang Observat & Res Stn Karst Ecosyst, Huanjiang, Guangxi, Peoples R China; [Yang, Xiaojian] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Nyachoti, Charles M.] Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada; [Shao, Hua] Univ Ottawa, Res Inst, Ottawa Hosp, Ottawa, ON, Canada; [Yang, Huansheng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Sciences; University of Guelph; University of Manitoba; University of Ottawa; Ottawa Hospital Research Institute; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Kong, XF (corresponding author), Chinese Acad Sci, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China.	nnkxf@isa.ac.cn; yinyulong@isa.ac.cn	Wentzensen, Nicolas/AAG-8522-2019; Yang, Huansheng/AAA-1380-2020; Schiffman, Mark/B-9766-2015	WANG, SOPHIA/0000-0003-2597-9393	National Basic Research Program of China [2012CB124704]; National Natural Science Foundation of China [31110103909, 30901040, 30928018, 31101729]; National Scientific and Technology Support Project [2011BAD26B002-5]; Chinese Academy of Sciences [2011T2S15]; NATIONAL CANCER INSTITUTE [ZIACP010124] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Scientific and Technology Support Project; Chinese Academy of Sciences(Chinese Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was jointly supported by the National Basic Research Program of China (2012CB124704), National Natural Science Foundation of China (No. 31110103909, 30901040, 30928018, and 31101729), National Scientific and Technology Support Project (2011BAD26B002-5) and Chinese Academy of Sciences Visiting Professorship for Senior International Scientists Grant No. 2011T2S15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Bauer R, 1998, EXP TOXICOL PATHOL, V50, P59, DOI 10.1016/S0940-2993(98)80071-7; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Deng D, 2009, J NUTR BIOCHEM, V20, P544, DOI 10.1016/j.jnutbio.2008.05.014; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Gondret F, 2005, LIVEST PROD SCI, V93, P137, DOI 10.1016/j.livprodsci.2004.09.009; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HAUSSINGER D, 1992, ENZYME, V46, P72; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Kong XF, 2007, LIVEST SCI, V108, P272, DOI 10.1016/j.livsci.2007.01.079; Kong XF, 2007, LIVEST SCI, V108, P94, DOI 10.1016/j.livsci.2007.01.002; Kong XF, 2009, LIVEST SCI, V123, P261, DOI 10.1016/j.livsci.2008.11.015; Kong XF, 2009, AMINO ACIDS, V37, P573, DOI 10.1007/s00726-008-0176-9; Milligan BN, 2002, PREV VET MED, V56, P119, DOI 10.1016/S0167-5877(02)00157-5; Milligan BN, 2002, LIVEST PROD SCI, V76, P181, DOI 10.1016/S0301-6226(02)00012-X; Morise A, 2008, ANIMAL, V2, P73, DOI 10.1017/S175173110700095X; Quiniou N, 2002, LIVEST PROD SCI, V78, P63, DOI 10.1016/S0301-6226(02)00181-1; Rehfeldt C, 2008, MEAT SCI, V78, P170, DOI 10.1016/j.meatsci.2007.05.029; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Ritacco G, 1997, J ANIM SCI, V75, P1237; Sangild PT, 2002, BIOL GROW ANIM, V1, P111, DOI 10.1016/S1877-1823(09)70119-5; Selak MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE130, DOI 10.1152/ajpendo.00322.2002; Tan B, 2011, J NUTR BIOCHEM, V22, P441, DOI 10.1016/j.jnutbio.2010.03.012; Thorn SR, 2009, ENDOCRINOLOGY, V150, P3021, DOI 10.1210/en.2008-1789; THORNBURY JC, 1993, PEDIATR PATHOL, V13, P59, DOI 10.3109/15513819309048193; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; XU RJ, 1994, J PEDIATR GASTR NUTR, V18, P231, DOI 10.1097/00005176-199402000-00018; Yin FG, 2010, BRIT J NUTR, V103, P1404, DOI 10.1017/S0007114509993321; Yin YL, 2000, LIVEST PROD SCI, V62, P119, DOI 10.1016/S0301-6226(99)00129-3; Zhang M, 1996, SWINE PROD, V2, P30; Zhao DS, 2008, LIVEST POULTRY HUSBA, V3, P16	31	72	78	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2012	7	12							e50921	10.1371/journal.pone.0050921	http://dx.doi.org/10.1371/journal.pone.0050921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050OT	22253702	Green Published, Green Submitted, gold			2022-12-27	WOS:000312064100044
J	Yu, Q; Wu, HH; He, NP; Lu, XT; Wang, ZP; Elser, JJ; Wu, JG; Han, XG				Yu, Qiang; Wu, Honghui; He, Nianpeng; Lue, Xiaotao; Wang, Zhiping; Elser, James J.; Wu, Jianguo; Han, Xingguo			Testing the Growth Rate Hypothesis in Vascular Plants with Above- and Below-Ground Biomass	PLOS ONE			English	Article							N-P STOICHIOMETRY; BIOLOGICAL STOICHIOMETRY; LEAF NITROGEN; NUTRIENT LIMITATION; MINERAL-NUTRITION; PHOSPHORUS; RATIOS; RNA; HOMEOSTASIS; AUTOTROPHS	The growth rate hypothesis (GRH) proposes that higher growth rate (the rate of change in biomass per unit biomass, mu) is associated with higher P concentration and lower C: P and N:P ratios. However, the applicability of the GRH to vascular plants is not well-studied and few studies have been done on belowground biomass. Here we showed that, for aboveground, belowground and total biomass of three study species, mu was positively correlated with N: C under N limitation and positively correlated with P: C under P limitation. However, the N: P ratio was a unimodal function of mu, increasing for small values of mu, reaching a maximum, and then decreasing. The range of variations in mu was positively correlated with variation in C: N: P stoichiometry. Furthermore, mu and C: N: P ranges for aboveground biomass were negatively correlated with those for belowground. Our results confirm the well-known association of growth rate with tissue concentration of the limiting nutrient and provide empirical support for recent theoretical formulations.	[Yu, Qiang; Wu, Honghui; Lue, Xiaotao; Han, Xingguo] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Yu, Qiang; Wu, Honghui; Lue, Xiaotao; Wang, Zhiping; Han, Xingguo] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [He, Nianpeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Elser, James J.; Wu, Jianguo] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Wu, Jianguo] Inner Mongolia Univ, SUCCESS, Hohhot, Inner Mongolia, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Arizona State University; Arizona State University-Tempe; Inner Mongolia University	Yu, Q (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China.	turfyu@gmail.com; xghan@ibcas.ac.cn	Elser, James/A-7082-2008; Han, Xingguo/K-7552-2016; Wu, Jianguo/G-6267-2010; Yu, Qiang/E-2097-2011; Lu (ü), Xiao-Tao/B-3905-2008; Elser, James J/AAL-6199-2020; Wu, Honghui/AAF-5696-2019	Elser, James/0000-0002-1460-2155; Han, Xingguo/0000-0002-1836-975X; Wu, Jianguo/0000-0002-1182-3024; Yu, Qiang/0000-0002-5480-0623; Lu (ü), Xiao-Tao/0000-0001-5571-1895; Elser, James J/0000-0002-1460-2155; he, nianpeng/0000-0002-0458-5953	National Natural Science Foundation of China (NSFC) [31170434]; NSFC [30830026]; Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering [K0802]; National Science Foundation [DEB-0618193]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering; National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Natural Science Foundation of China (NSFC, 31170434) and the Key Project of NSFC (30830026). N. He acknowledges support from the Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering (K0802). J. Elser and J. Wu acknowledge support from the National Science Foundation (DEB-0618193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya K, 2004, LIMNOL OCEANOGR, V49, P656, DOI 10.4319/lo.2004.49.3.0656; Agren GI, 2004, ECOL LETT, V7, P185, DOI 10.1111/j.1461-0248.2004.00567.x; Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Cernusak LA, 2010, NEW PHYTOL, V185, P770, DOI 10.1111/j.1469-8137.2009.03106.x; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; ELRIFI IR, 1985, J PHYCOL, V21, P592, DOI 10.1111/j.0022-3646.1985.00592.x; Elser JJ, 2006, FUNCT ECOL, V20, P846, DOI 10.1111/j.1365-2435.2006.01165.x; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Elser JJ, 1998, ECOSYSTEMS, V1, P120, DOI 10.1007/s100219900009; ERICSSON T, 1995, PLANT SOIL, V168, P205, DOI 10.1007/BF00029330; Gorokhova E, 2002, P ROY SOC B-BIOL SCI, V269, P2373, DOI 10.1098/rspb.2002.2145; Gusewell S, 2009, FUNCT ECOL, V23, P211, DOI 10.1111/j.1365-2435.2008.01478.x; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hessen DO, 2007, FUNCT ECOL, V21, P956, DOI 10.1111/j.1365-2435.2007.01306.x; Hessen DO, 2004, ECOLOGY, V85, P1179, DOI 10.1890/02-0251; Hoagland R, 347 U CAL COLL AGR C; INGESTAD T, 1982, PLANT CELL ENVIRON, V5, P443, DOI 10.1111/1365-3040.ep11611714; Ingestad T, 1986, SCAND J FOREST RES, V1, P439, DOI 10.1080/02827588609382436; Jensen M. H., 1985, Horticultural Reviews, V7, P483, DOI 10.1002/9781118060735.ch10; Johnson NC, 2008, ECOLOGY, V89, P2868, DOI 10.1890/07-1394.1; Kerkhoff AJ, 2006, ECOL LETT, V9, P419, DOI 10.1111/j.1461-0248.2006.00888.x; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Limpens J, 2003, NEW PHYTOL, V157, P339, DOI 10.1046/j.1469-8137.2003.00667.x; Loladze I, 2000, B MATH BIOL, V62, P1137, DOI 10.1006/bulm.2000.0201; Makino W, 2003, FUNCT ECOL, V17, P121, DOI 10.1046/j.1365-2435.2003.00712.x; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; Matzek V, 2009, ECOL LETT, V12, P765, DOI 10.1111/j.1461-0248.2009.01310.x; MCJANNET CL, 1995, FUNCT ECOL, V9, P231, DOI 10.2307/2390569; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Niklas KJ, 2006, ANN BOT-LONDON, V97, P155, DOI 10.1093/aob/mcj021; Niklas KJ, 2005, ECOL LETT, V8, P636, DOI 10.1111/j.1461-0248.2005.00759.x; Persson J, 2010, OIKOS, V119, P741, DOI 10.1111/j.1600-0706.2009.18545.x; POORTER H, 1992, PLANT CELL ENVIRON, V15, P221, DOI 10.1111/j.1365-3040.1992.tb01476.x; Reich PB, 2010, P ROY SOC B-BIOL SCI, V277, P877, DOI 10.1098/rspb.2009.1818; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; STERNER RW, 1994, ANNU REV ECOL SYST, V25, P1, DOI 10.1146/annurev.es.25.110194.000245; STERNER RW, 1992, BIOGEOCHEMISTRY, V17, P49; TILMAN D, 1988; Tomassen HBM, 2004, J APPL ECOL, V41, P139, DOI 10.1111/j.1365-2664.2004.00870.x; Venterink HO, 2010, FUNCT ECOL, V24, P877, DOI 10.1111/j.1365-2435.2010.01692.x; Watts T, 2006, J INSECT PHYSIOL, V52, P187, DOI 10.1016/j.jinsphys.2005.09.012; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Yu QA, 2011, OECOLOGIA, V166, P1, DOI 10.1007/s00442-010-1902-z; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x	52	52	78	8	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2012	7	3							e32162	10.1371/journal.pone.0032162	http://dx.doi.org/10.1371/journal.pone.0032162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930IA	22427823	Green Published, gold			2022-12-27	WOS:000303129700007
J	Yang, HP; Zuna, RE; Schiffman, M; Walker, JL; Sherman, ME; Landrum, LM; Moxley, K; Gold, MA; Dunn, ST; Allen, RA; Zhang, R; Long, R; Wang, SS; Wentzensen, N				Yang, Hannah P.; Zuna, Rosemary E.; Schiffman, Mark; Walker, Joan L.; Sherman, Mark E.; Landrum, Lisa M.; Moxley, Katherine; Gold, Michael A.; Dunn, S. Terence; Allen, Richard A.; Zhang, Roy; Long, Rodney; Wang, Sophia S.; Wentzensen, Nicolas			Clinical and Pathological Heterogeneity of Cervical Intraepithelial Neoplasia Grade 3	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; EARLY END-POINTS; NATURAL-HISTORY; LOOP EXCISION; CANCER; LESIONS; WOMEN; DETERMINANTS; METAANALYSIS; PROGRESSION	Objective: Cervical intraepithelial neoplasia grade 3 (CIN3), the immediate cervical cancer precursor, is a target of cervical cancer prevention. However, less than half of CIN3s will progress to cancer. Routine treatment of all CIN3s and the majority of CIN2s may lead to overtreatment of many lesions that would not progress. To improve our understanding of CIN3 natural history, we performed a detailed characterization of CIN3 heterogeneity in a large referral population in the US. Methods: We examined 309 CIN3 cases in the SUCCEED, a large population-based study of women with abnormal cervical cancer screening results. Histology information for 12 individual loop electrosurgical excision procedure (LEEP) segments was evaluated for each woman. We performed case-case comparisons of CIN3s to analyze determinants of heterogeneity and screening test performance. Results: CIN3 cases varied substantially by size (1-10 LEEP segments) and by presentation with concomitant CIN2 and CIN1. All grades of CINs were equally distributed over the cervical surface. In half of the women, CIN3 lesions were found as multiple distinct lesions on the cervix. Women with large and solitary CIN3 lesions were more likely to be older, have longer sexual activity span, and have fewer multiple high risk HPV infections. Screening frequency, but not HPV16 positivity, was an important predictor of CIN3 size. Large CIN3 lesions were also characterized by high-grade clinical test results. Conclusions: We demonstrate substantial heterogeneity in clinical and pathological presentation of CIN3 in a US population. Time since sexual debut and participation in screening were predictors of CIN3 size. We did not observe a preferential site of CIN3 on the cervical surface that could serve as a target for cervical biopsy. Cervical cancer screening procedures were more likely to detect larger CIN3s, suggesting that CIN3s detected by multiple independent diagnostic tests may represent cases with increased risk of invasion.	[Yang, Hannah P.; Schiffman, Mark; Sherman, Mark E.; Wentzensen, Nicolas] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Zuna, Rosemary E.; Dunn, S. Terence; Allen, Richard A.; Zhang, Roy] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Walker, Joan L.; Landrum, Lisa M.; Moxley, Katherine] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA; [Gold, Michael A.] Vanderbilt Univ, Dept Obstet & Gynecol, Nashville, TN USA; [Long, Rodney] Natl Lib Med, Bethesda, MD USA; [Wang, Sophia S.] City Hope Natl Med Ctr, Beckman Res Inst, Div Canc Etiol, Duarte, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); City of Hope; Beckman Research Institute of City of Hope	Yang, HP (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.	yanghan@mail.nih.gov	Wentzensen, Nicolas/AAG-8522-2019; Yang, Huansheng/AAA-1380-2020; Schiffman, Mark/B-9766-2015	WANG, SOPHIA/0000-0003-2597-9393	US National Cancer Institute, Division of Cancer Epidemiology and Genetics in the Hormonal and Reproductive Epidemiology Branch; NATIONAL CANCER INSTITUTE [ZIACP010124] Funding Source: NIH RePORTER	US National Cancer Institute, Division of Cancer Epidemiology and Genetics in the Hormonal and Reproductive Epidemiology Branch(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural research program at the US National Cancer Institute, Division of Cancer Epidemiology and Genetics in the Hormonal and Reproductive Epidemiology Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard Jay E, 2005, J Low Genit Tract Dis, V9, P36, DOI 10.1097/00128360-200501000-00008; Cardenas-Turanzas M, 2005, LANCET ONCOL, V6, P43; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Guido RS, 2005, AM J OBSTET GYNECOL, V193, P1331, DOI 10.1016/j.ajog.2005.05.008; HEATLEY M, 1995, J CLIN PATHOL, V48, P323, DOI 10.1136/jcp.48.4.323; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lurie S, 2007, AM J OBSTET GYNECOL, V125, pe121; Massad LS, 1996, GYNECOL ONCOL, V60, P400, DOI 10.1006/gyno.1996.0062; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Mitchell M F, 1996, J Natl Cancer Inst Monogr, P17; Porras C, 2009, CANCER EPIDEM BIOMAR, V18, P863, DOI 10.1158/1055-9965.EPI-08-0951; Pretorius Robert G, 2006, J Low Genit Tract Dis, V10, P45, DOI 10.1097/01.lgt.0000192697.31291.42; RICHART RM, 1965, CANCER, V18, P950, DOI 10.1002/1097-0142(196508)18:8<950::AID-CNCR2820180805>3.0.CO;2-T; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schiffman M, 2010, OBSTET GYNECOL, V116, P177, DOI 10.1097/AOG.0b013e3181e4629f; Sherman ME, 2003, CANCER EPIDEM BIOMAR, V12, P372; Shiffman M, 2008, LANCET ONCOL, V9, P404, DOI 10.1016/S1470-2045(08)70110-4; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Szurkus DC, 2003, AM J OBSTET GYNECOL, V188, P1180, DOI 10.1067/mob.2003.282; TIDBURY P, 1992, BRIT J OBSTET GYNAEC, V99, P583, DOI 10.1111/j.1471-0528.1992.tb13825.x; Vinokurova S, 2008, CANCER RES, V68, P307, DOI 10.1158/0008-5472.CAN-07-2754; Wang SS, 2009, CANCER EPIDEM BIOMAR, V18, P113, DOI 10.1158/1055-9965.EPI-08-0591; Wentzensen N, 2009, INT J CANCER, V125, P2151, DOI 10.1002/ijc.24528; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510; Wheeler CM, 2008, OBSTET GYN CLIN N AM, V35, P519, DOI 10.1016/j.ogc.2008.09.006; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P340, DOI 10.1016/j.ajog.2007.07.050	27	72	78	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2012	7	1							e29051	10.1371/journal.pone.0029051	http://dx.doi.org/10.1371/journal.pone.0029051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906QI	22253702	gold, Green Published, Green Submitted			2022-12-27	WOS:000301361500005
J	IJssennagger, N; Derrien, M; van Doorn, GM; Rijnierse, A; van den Bogert, B; Muller, M; Dekker, J; Kleerebezem, M; van der Meer, R				IJssennagger, Noortje; Derrien, Muriel; van Doorn, Gerdien M.; Rijnierse, Anneke; van den Bogert, Bartholomeus; Muller, Michael; Dekker, Jan; Kleerebezem, Michiel; van der Meer, Roelof			Dietary Heme Alters Microbiota and Mucosa of Mouse Colon without Functional Changes in Host-Microbe Cross-Talk	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; RED MEAT; COLORECTAL-CANCER; HYDROGEN-SULFIDE; RISK; GUT; INHIBITOR; SHOCK; CONSUMPTION; MODULATION	Colon cancer is a major cause of cancer deaths in Western countries and is associated with diets high in red meat. Heme, the iron-porphyrin pigment of red meat, induces cytotoxicity of gut contents which injures surface cells leading to compensatory hyperproliferation of crypt cells. This hyperproliferation results in epithelial hyperplasia which increases the risk of colon cancer. In humans, a high red-meat diet increases Bacteroides spp in feces. Therefore, we simultaneously investigated the effects of dietary heme on colonic microbiota and on the host mucosa of mice. Whole genome microarrays showed that heme injured the colonic surface epithelium and induced hyperproliferation by changing the surface to crypt signaling. Using 16S rRNA phylogenetic microarrays, we investigated whether bacteria play a role in this changed signaling. Heme increased Bacteroidetes and decreased Firmicutes in colonic contents. This shift was most likely caused by a selective susceptibility of Gram-positive bacteria to heme cytotoxic fecal water, which is not observed for Gram-negative bacteria, allowing expansion of the Gram-negative community. The increased amount of Gram-negative bacteria most probably increased LPS exposure to colonocytes, however, there is no appreciable immune response detected in the heme-fed mice. There was no functional change in the sensing of the bacteria by the mucosa, as changes in inflammation pathways and Toll-like receptor signaling were not detected. This unaltered host-microbe cross-talk indicates that the changes in microbiota did not play a causal role in the observed hyperproliferation and hyperplasia.	[IJssennagger, Noortje; Derrien, Muriel; van Doorn, Gerdien M.; Rijnierse, Anneke; van den Bogert, Bartholomeus; Muller, Michael; Dekker, Jan; Kleerebezem, Michiel; van der Meer, Roelof] Top Inst Food & Nutr, Wageningen, Netherlands; [IJssennagger, Noortje; Rijnierse, Anneke; Muller, Michael; van der Meer, Roelof] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Derrien, Muriel; van Doorn, Gerdien M.; van den Bogert, Bartholomeus; Kleerebezem, Michiel] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Wageningen University & Research; NIZO Food Research	Muller, M (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	michiel.kleerebezem@nizo.nl	Muller, Michael/M-5724-2019; Muller, Michael/B-5795-2008; Kleerebezem, Michiel/AAT-2078-2021; Derrien, Muriel/AAS-6845-2021	Muller, Michael/0000-0002-5930-9905; Muller, Michael/0000-0002-5930-9905; Derrien, Muriel/0000-0001-8841-9153; Kleerebezem, Michiel/0000-0001-8552-2235	program council of Top Institute Food and Nutrition (TIFN), Wageningen, the Netherlands [A-1001]	program council of Top Institute Food and Nutrition (TIFN), Wageningen, the Netherlands	This study was funded only by the program council of Top Institute Food and Nutrition (TIFN), Wageningen, the Netherlands (grant A-1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; ALJALILI TAR, 1988, CURR MICROBIOL, V17, P13, DOI 10.1007/BF01568812; Attene-Ramos MS, 2010, ENVIRON MOL MUTAGEN, V51, P304, DOI 10.1002/em.20546; Balder HF, 2006, CANCER EPIDEM BIOMAR, V15, P717, DOI 10.1158/1055-9965.EPI-05-0772; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Bovee-Oudenhoven IM, 1999, J NUTR, V129, P607, DOI 10.1093/jn/129.3.607; CARTER RL, 1989, PSYCHOMETRIKA, V54, P9, DOI 10.1007/BF02294446; Collins D, 2011, LANCET ONCOL, V12, P504, DOI 10.1016/S1470-2045(10)70186-8; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Vogel J, 2005, CARCINOGENESIS, V26, P387, DOI 10.1093/carcin/bgh331; de Vogel J, 2008, CARCINOGENESIS, V29, P398, DOI 10.1093/carcin/bgm278; Fund WCR Research AIfC, 2007, FOOD NUTR PHYS ACT P, V1; Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; Harada T, 2003, AM J PHYSIOL-GASTR L, V284, pG255, DOI 10.1152/ajpgi.00244.2002; Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702; IJssennagger N, 2011, GUT; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; LAPRE JA, 1992, AM J PHYSIOL, V263, pG333, DOI 10.1152/ajpgi.1992.263.3.G333; Larsson SC, 2005, INT J CANCER, V113, P829, DOI 10.1002/ijc.20658; Lee DH, 2004, JNCI-J NATL CANCER I, V96, P403, DOI 10.1093/jnci/djh047; Levitt MD, 1999, J CLIN INVEST, V104, P1107, DOI 10.1172/JCI7712; Lewin MH, 2006, CANCER RES, V66, P1859, DOI 10.1158/0008-5472.CAN-05-2237; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; MAIER BR, 1974, AM J CLIN NUTR, V27, P1470, DOI 10.1093/ajcn/27.12.1470; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Meijerink M, 2010, BENEF MICROBES, V1, P317, DOI 10.3920/BM2010.0029; Nakamura A, 2003, J EXP MED, V197, P669, DOI 10.1084/jem.20021824; NITZAN Y, 1994, CURR MICROBIOL, V29, P125, DOI 10.1007/BF01570752; Nobles CL, 2011, METALLOMICS, V3, P788, DOI 10.1039/c1mt00047k; O'Keefe SJD, 2008, CURR OPIN GASTROEN, V24, P51, DOI 10.1097/MOG.0b013e3282f323f3; Parham NJ, 2000, FEMS MICROBIOL ECOL, V31, P21, DOI 10.1111/j.1574-6941.2000.tb00667.x; Pierre F, 2003, CARCINOGENESIS, V24, P1683, DOI 10.1093/carcin/bgg130; Poelstra K, 1997, AM J PATHOL, V151, P1163; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schepens MAA, 2011, NUTRITION, V27, P590, DOI 10.1016/j.nut.2010.05.002; SCHWARTZ S, 1985, GASTROENTEROLOGY, V89, P19, DOI 10.1016/0016-5085(85)90740-1; Sesink ALA, 1999, CANCER RES, V59, P5704; Si-Tahar M, 2000, GASTROENTEROLOGY, V118, P1061, DOI 10.1016/S0016-5085(00)70359-3; Vaishnava S, 2007, CELL HOST MICROBE, V2, P365, DOI 10.1016/j.chom.2007.11.004; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Williams SE, 2006, CLIN SCI, V110, P21, DOI 10.1042/CS20050115; Xu WF, 2007, NAT IMMUNOL, V8, P294, DOI 10.1038/ni1434; YOUNG GP, 1989, J GASTROEN HEPATOL, V4, P537, DOI 10.1111/j.1440-1746.1989.tb00858.x; Zhang XH, 2011, CANCER CAUSE CONTROL, V22, P1627, DOI 10.1007/s10552-011-9839-z; Zimmer J, 2012, EUR J CLIN NUTR, V66, P53, DOI 10.1038/ejcn.2011.141	57	74	75	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e49868	10.1371/journal.pone.0049868	http://dx.doi.org/10.1371/journal.pone.0049868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23239972	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800010
J	Wang, GY; Zhang, JW; Liu, LY; Sharma, S; Dong, QH				Wang, Guanyu; Zhang, Jiawei; Liu, Luying; Sharma, Sherven; Dong, Qinghua			Quercetin Potentiates Doxorubicin Mediated Antitumor Effects against Liver Cancer through p53/Bcl-xl	PLOS ONE			English	Article							INDUCED APOPTOSIS; P-GLYCOPROTEIN; HEPATOCELLULAR-CARCINOMA; CELLS; EXPRESSION; FLAVONOIDS; CARDIOTOXICITY; MITOCHONDRIA; ADRIAMYCIN; TOXICITY	Background: The dose-dependent toxicities of doxorubicin (DOX) limit its clinical applications, particularly in drug-resistant cancers, such as liver cancer. In this study, we investigated the role of quercetin on the antitumor effects of DOX on liver cancer cells and its ability to provide protection against DOX-mediated liver damage in mice. Methodology and Results: The MTT and Annexin V/PI staining assay demonstrated that quercetin selectively sensitized DOX-induced cytotoxicity against liver cancer cells while protecting normal liver cells. The increase in DOX-mediated apoptosis in hepatoma cells by quercetin was p53-dependent and occurred by downregulating Bcl-xl expression. Z-VAD-fmk (caspase inhibitor), pifithrin-alpha (p53 inhibitor), or overexpressed Bcl-xl decreased the effects of quercetin on DOX-mediated apoptosis. The combined treatment of quercetin and DOX significantly reduced the growth of liver cancer xenografts in mice. Moreover, quercetin decreased the serum levels of alanine aminotransferase and aspartate aminotransferase that were increased in DOX-treated mice. Quercetin also reversed the DOX-induced pathological changes in mice livers. Conclusion and Significance: These results indicate that quercetin potentiated the antitumor effects of DOX on liver cancer cells while protecting normal liver cells. Therefore, the development of quercetin may be beneficial in a combined treatment with DOX for increased therapeutic efficacy against liver cancer.	[Dong, Qinghua] Zhejiang Univ, Sch Med, Biomed Res Ctr, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Guanyu] Zhejiang Univ, Sch Med, Dept Gen Surg, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Jiawei] Zhejiang Univ, Inst Canc, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Luying] Zhejiang Canc Hosp, Dept Radiotherapy, Hangzhou, Zhejiang, Peoples R China; [Sharma, Sherven] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Sharma, Sherven] W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA; [Dong, Qinghua] China Natl Minist Educ, Key Lab Canc Prevent & Intervent, Key Lab Canc Biotherapy Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang Cancer Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Dong, QH (corresponding author), Zhejiang Univ, Sch Med, Biomed Res Ctr, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	dongqinghua@zju.edu.cn	Wang, Ge/AAH-8592-2020; Vannier, Michael W/AAI-6951-2021; Yu, Hengyong/AAH-5726-2019	Wang, Ge/0000-0002-2656-7705; Yu, Hengyong/0000-0002-5852-0813; Vannier, Michael/0000-0001-9898-384X	National Natural Science Foundation of China [30400521]; Science Technology Department of Zhejiang Province [2012R10047, 2012C33116]; Education Department of Zhejiang Province [Y201224108]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011785] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Department of Zhejiang Province; Education Department of Zhejiang Province; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Natural Science Foundation of China (No.: 30400521), the Science Technology Department of Zhejiang Province (No.: 2012R10047 to QD and No.: 2012C33116 to GW) and the Education Department of Zhejiang Province (No.: Y201224108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshabanah OA, 2010, OXID MED CELL LONGEV, V3, P428, DOI 10.4161/oxim.3.6.14416; BENJAMIN RS, 1974, CANCER, V33, P19, DOI 10.1002/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO;2-M; Bulucu F, 2009, BIOL TRACE ELEM RES, V132, P184, DOI 10.1007/s12011-009-8377-y; Chipuk JE, 2009, CELL CYCLE, V8, P2692, DOI 10.4161/cc.8.17.9412; Choi KC, 2010, FOOD CHEM TOXICOL, V48, P2747, DOI 10.1016/j.fct.2010.07.001; de David C, 2011, TOXICOL PATHOL, V39, P949, DOI 10.1177/0192623311418680; Donmez Y, 2011, CANCER CHEMOTH PHARM, V67, P823, DOI 10.1007/s00280-010-1385-y; Du GJ, 2010, INT IMMUNOPHARMACOL, V10, P819, DOI 10.1016/j.intimp.2010.04.018; Du GJ, 2010, CANCER CHEMOTH PHARM, V65, P277, DOI 10.1007/s00280-009-1032-7; Dudka J, 2005, BASIC CLIN PHARMACOL, V97, P74, DOI 10.1111/j.1742-7843.2005.pto_98.x; Duraj J, 2005, NEOPLASMA, V52, P273; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fotsis T, 1997, CANCER RES, V57, P2916; Gibellini L, 2011, EVID BASED COMPLEMEN; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Hovorka O, 2010, EUR J PHARM BIOPHARM, V76, P514, DOI 10.1016/j.ejpb.2010.07.008; Jing S, 2008, INT J HYPERTHER, V24, P151, DOI 10.1080/02656730701843109; Kahraman A, 2012, MOL BIOL REP, V39, P2789, DOI 10.1007/s11033-011-1037-2; Kaiserova H, 2007, BBA-MOL BASIS DIS, V1772, P1065, DOI 10.1016/j.bbadis.2007.05.002; Kawaii S, 1999, BIOSCI BIOTECH BIOCH, V63, P896, DOI 10.1271/bbb.63.896; Kebieche M, 2009, EXP TOXICOL PATHOL, V61, P161, DOI 10.1016/j.etp.2008.06.002; King PD, 2001, ONCOLOGIST, V6, P162, DOI 10.1634/theoncologist.6-2-162; Krizkova Jitka, 2009, Interdiscip Toxicol, V2, P201, DOI 10.2478/v10102-009-0018-y; Li L, 2006, BIOCHEM PHARMACOL, V71, P584, DOI 10.1016/j.bcp.2005.11.026; Limtrakul P, 2005, J CHEMOTHERAPY, V17, P86, DOI 10.1179/joc.2005.17.1.86; Llambi F, 2011, CURR OPIN GENET DEV, V21, P12, DOI 10.1016/j.gde.2010.12.001; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; Mukhopadhyay P, 2009, AM J PHYSIOL-HEART C, V296, pH1466, DOI 10.1152/ajpheart.00795.2008; Nessa MU, 2011, ANTICANCER RES, V31, P3789; Nowak AK, 2004, EUR J CANCER, V40, P1474, DOI 10.1016/j.ejca.2004.02.027; Odbayar TO, 2009, MOL CELL BIOCHEM, V325, P121, DOI 10.1007/s11010-009-0026-4; Park MH, 2011, BIOCHEM BIOPH RES CO, V412, P710, DOI 10.1016/j.bbrc.2011.08.037; Pei Tian-xian, 2007, Yaoxue Xuebao, V42, P1029; Riad A, 2009, CANCER RES, V69, P695, DOI 10.1158/0008-5472.CAN-08-3076; SCAMBIA G, 1994, CANCER CHEMOTH PHARM, V34, P459, DOI 10.1007/BF00685655; SILBER JH, 1995, NEW ENGL J MED, V333, P1359; Staedler D, 2011, CANCER CHEMOTH PHARM, V68, P1161, DOI 10.1007/s00280-011-1596-x; Suematsu N, 2011, NEUROSCI LETT, V504, P223, DOI 10.1016/j.neulet.2011.09.028; Szanto M, 2011, CARDIOVASC RES, V92, P430, DOI 10.1093/cvr/cvr246; Tiong KH, 2010, XENOBIOTICA, V40, P458, DOI 10.3109/00498251003786749; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Walia V, 2011, FRONT BIOSCI-LANDMRK, V16, P749, DOI 10.2741/3717; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wang YA, 2008, INT J CANCER, V123, P1536, DOI 10.1002/ijc.23671; Wiegand H, 2009, NUTR CANCER, V61, P717, DOI 10.1080/01635580902825621; Yague E, 2003, J BIOL CHEM, V278, P10344, DOI 10.1074/jbc.M211093200; Zordoky BNM, 2011, DRUG METAB DISPOS, V39, P1440, DOI 10.1124/dmd.111.039123	50	211	237	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2012	7	12							e51764	10.1371/journal.pone.0051764	http://dx.doi.org/10.1371/journal.pone.0051764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053RN	23240061	Green Published, gold, Green Submitted			2022-12-27	WOS:000312290800097
J	Wang, G; Zhang, J; Gao, H; Weir, V; Yu, HY; Cong, WX; Xu, XC; Shen, HO; Bennett, J; Furth, M; Wang, Y; Vannier, M				Wang, Ge; Zhang, Jie; Gao, Hao; Weir, Victor; Yu, Hengyong; Cong, Wenxiang; Xu, Xiaochen; Shen, Haiou; Bennett, James; Furth, Mark; Wang, Yue; Vannier, Michael			Towards Omni-Tomography-Grand Fusion of Multiple Modalities for Simultaneous Interior Tomography	PLOS ONE			English	Article							NANOPARTICLE-LOADED OBJECTS; LINEAR INVERSE PROBLEMS; COMPUTED-TOMOGRAPHY; PHYSIOME PROJECT; PET/CT; SPECT/CT; RECONSTRUCTION; MRI; INTEGRATION; PROTEINS	We recently elevated interior tomography from its origin in computed tomography (CT) to a general tomographic principle, and proved its validity for other tomographic modalities including SPECT, MRI, and others. Here we propose "omni-tomography", a novel concept for the grand fusion of multiple tomographic modalities for simultaneous data acquisition in a region of interest (ROI). Omni-tomography can be instrumental when physiological processes under investigation are multi-dimensional, multi-scale, multi-temporal and multi-parametric. Both preclinical and clinical studies now depend on in vivo tomography, often requiring separate evaluations by different imaging modalities. Over the past decade, two approaches have been used for multimodality fusion: Software based image registration and hybrid scanners such as PET-CT, PET-MRI, and SPECT-CT among others. While there are intrinsic limitations with both approaches, the main obstacle to the seamless fusion of multiple imaging modalities has been the bulkiness of each individual imager and the conflict of their physical (especially spatial) requirements. To address this challenge, omni-tomography is now unveiled as an emerging direction for biomedical imaging and systems biomedicine.	[Wang, Ge; Cong, Wenxiang; Shen, Haiou; Bennett, James] Virginia Tech, VT WFU Sch Biomed Engn & Sci, Biomed Imaging Div, Blacksburg, VA 24061 USA; [Zhang, Jie] Univ Kentucky, Dept Radiol, Lexington, KY USA; [Gao, Hao] Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90024 USA; [Weir, Victor] Baylor Hlth Care Syst, Dept Med Phys & Radiat Safety, Dallas, TX USA; [Wang, Ge; Yu, Hengyong] Wake Forest Univ Hlth Sci, VT WFU Sch Biomed Engn & Sci, Biomed Imaging Div, Winston Salem, NC USA; [Xu, Xiaochen] Texas Instruments Inc, Med Business Unit, Dallas, TX USA; [Furth, Mark] Wake Forest Univ Hlth Sci, Ctr Comprehens Canc, Winston Salem, NC USA; [Wang, Yue] Virginia Tech, Dept Elect & Comp Engn, Blacksburg, VA USA; [Vannier, Michael] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	Virginia Polytechnic Institute & State University; University of Kentucky; University of California System; University of California Los Angeles; Baylor Health Care System; Wake Forest University; Wake Forest University School of Medicine; Texas Instruments; Wake Forest University; Wake Forest University School of Medicine; Virginia Polytechnic Institute & State University; University of Chicago	Wang, G (corresponding author), Virginia Tech, VT WFU Sch Biomed Engn & Sci, Biomed Imaging Div, Blacksburg, VA 24061 USA.	ge-wang@ieee.org	Wang, Ge/AAH-8592-2020; Vannier, Michael W/AAI-6951-2021; Yu, Hengyong/AAH-5726-2019	Wang, Ge/0000-0002-2656-7705; Yu, Hengyong/0000-0002-5852-0813; Vannier, Michael/0000-0001-9898-384X	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB) [EB011785]; National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NIH/NHLBI) [HL098912]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011785] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NIH/NHLBI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported by National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering (NIH/NIBIB) grant EB011785 and National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NIH/NHLBI) grant HL098912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahn PH, 2008, SEMIN NUCL MED, V38, P141, DOI 10.1053/j.semnuclmed.2007.11.002; Annie M, 2007, 29 ANN INT C IEEE EN; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Bieri O, 2005, MAGNET RESON MED, V54, P129, DOI 10.1002/mrm.20527; Bockisch A, 2009, SEMIN NUCL MED, V39, P276, DOI 10.1053/j.semnuclmed.2009.03.003; Boles CD, 1998, IEEE J SOLID-ST CIRC, V33, P733, DOI 10.1109/4.668988; Boss A, 2011, EUR RADIOL, V21, P1439, DOI 10.1007/s00330-011-2072-z; Boss A, 2010, J NUCL MED, V51, P1198, DOI 10.2967/jnumed.110.074773; Chen XY, 2011, NANOPLATFORM-BASED MOLECULAR IMAGING, pIX; Cheong SK, 2010, PHYS MED BIOL, V55, P647, DOI 10.1088/0031-9155/55/3/007; Cherry SR, 2009, SEMIN NUCL MED, V39, P348, DOI 10.1053/j.semnuclmed.2009.03.001; Cong WX, 2012, PHYS MED BIOL, V57, P2905, DOI 10.1088/0031-9155/57/10/2905; Cong WX, 2012, J OPTICAL S IN PRESS; Courdurier M, 2008, INVERSE PROBL, V24, DOI 10.1088/0266-5611/24/6/065001; Daubechies I, 2008, J FOURIER ANAL APPL, V14, P764, DOI 10.1007/s00041-008-9039-8; Delbeke D, 2009, SEMIN NUCL MED, V39, P308, DOI 10.1053/j.semnuclmed.2009.03.002; Even-Sapir E, 2009, SEMIN NUCL MED, V39, P264, DOI 10.1053/j.semnuclmed.2009.03.004; Fessler JA, 2010, IEEE SIGNAL PROC MAG, V27, P81, DOI 10.1109/MSP.2010.936726; Gao H, 2011, INVERSE PROBL, V27, DOI 10.1088/0266-5611/27/11/115012; Gao H, 2011, PHYS MED BIOL, V56, P3181, DOI 10.1088/0031-9155/56/11/002; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Han WM, 2009, INT J BIOMED IMAGING, V2009, DOI 10.1155/2009/125871; Hunter P, 2005, MECH AGEING DEV, V126, P187, DOI 10.1016/j.mad.2004.09.025; Hunter P, 2002, PFLUG ARCH EUR J PHY, V445, P1, DOI 10.1007/s00424-002-0890-1; Hunter PJ, 2003, NAT REV MOL CELL BIO, V4, P237, DOI 10.1038/nrm1054; Jin YD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1042; Jones BL, 2011, PHYS MED BIOL, V56, P3719, DOI 10.1088/0031-9155/56/12/017; Katsevich E, 2012, INVERSE PRO IN PRESS; Kaufmann PA, 2009, SEMIN NUCL MED, V39, P341, DOI 10.1053/j.semnuclmed.2009.03.007; Kudo H, 2008, PHYS MED BIOL, V53, P2207, DOI 10.1088/0031-9155/53/9/001; Laskaris ET, 1995, OPEN MRI MAGNET WTH; Mah D, 2008, SEMIN NUCL MED, V38, P114, DOI 10.1053/j.semnuclmed.2007.11.003; Moon CH, 2000, MEAS SCI TECHNOL, V11, pN89, DOI 10.1088/0957-0233/11/8/401; Patton JA, 2009, SEMIN NUCL MED, V39, P247, DOI 10.1053/j.semnuclmed.2009.03.005; Pichler BJ, 2008, SEMIN NUCL MED, V38, P199, DOI 10.1053/j.semnuclmed.2008.02.001; Rutman AM, 2009, EUR J RADIOL, V70, P232, DOI 10.1016/j.ejrad.2009.01.050; Tumer TO, 2006, IEEE NUCL SCI CONF R, P384, DOI 10.1109/NSSMIC.2006.356181; van Houten VMM, 2000, CLIN CANCER RES, V6, P3803; Wang G, 2011, ARXIV11062124PHYSICS; Wang G, 2010, P NATL ACAD SCI USA, V107, pE92, DOI 10.1073/pnas.1002473107; Wang G, 2009, MED PHYS, V36, P3575, DOI 10.1118/1.3157103; While PT, 2010, J MAGN RESON, V207, P124, DOI 10.1016/j.jmr.2010.08.017; Xu Q, 2012, IEEE T BIOM IN PRESS; Yang J., 2011, INVERSE PROBL, V28; Yang JS, 2010, INVERSE PROBL, V26, DOI 10.1088/0266-5611/26/3/035013; Ye YB, 2007, INT J BIOMED IMAGING, V2007, DOI 10.1155/2007/63634; Yu HY, 2011, J COMPUT ASSIST TOMO, V35, P762, DOI 10.1097/RCT.0b013e318231c578; Yu HY, 2009, PHYS MED BIOL, V54, pN425, DOI 10.1088/0031-9155/54/18/N04; Yu HY, 2009, COMMUN NUMER METH EN, V25, P693, DOI 10.1002/cnm.1206; Yu HY, 2008, J X-RAY SCI TECHNOL, V16, P243; Yu HY, 2009, PHYS MED BIOL, V54, P2791, DOI 10.1088/0031-9155/54/9/014; Yu HY, 2012, J XRAY SCI TECHNOLOG	52	211	237	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39700	10.1371/journal.pone.0039700	http://dx.doi.org/10.1371/journal.pone.0039700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	23240061	Green Published, gold, Green Submitted			2022-12-27	WOS:000305892100078
J	Wang, G; Li, CX; Guo, XX; Xing, D; Dong, YD; Wang, ZM; Zhang, YM; Liu, MD; Zheng, Z; Zhang, HD; Zhu, XJ; Wu, ZM; Zhao, TY				Wang, Gang; Li, Chunxiao; Guo, Xiaoxia; Xing, Dan; Dong, Yande; Wang, Zhongming; Zhang, Yingmei; Liu, Meide; Zheng, Zhong; Zhang, Hengduan; Zhu, Xiaojuan; Wu, Zhiming; Zhao, Tongyan			Identifying the Main Mosquito Species in China Based on DNA Barcoding	PLOS ONE			English	Article							CODON USAGE; SPARIDAE; TAXONOMY; DIPTERA	Mosquitoes are insects of the Diptera, Nematocera, and Culicidae families, some species of which are important disease vectors. Identifying mosquito species based on morphological characteristics is difficult, particularly the identification of specimens collected in the field as part of disease surveillance programs. Because of this difficulty, we constructed DNA barcodes of the cytochrome c oxidase subunit 1, the COI gene, for the more common mosquito species in China, including the major disease vectors. A total of 404 mosquito specimens were collected and assigned to 15 genera and 122 species and subspecies on the basis of morphological characteristics. Individuals of the same species grouped closely together in a Neighborhood- Joining tree based on COI sequence similarity, regardless of collection site. COI gene sequence divergence was approximately 30 times higher for species in the same genus than for members of the same species. Divergence in over 98% of congeneric species ranged from 2.3% to 21.8%, whereas divergence in conspecific individuals ranged from 0% to 1.67%. Cryptic species may be common and a few pseudogenes were detected.	[Wang, Gang; Li, Chunxiao; Guo, Xiaoxia; Xing, Dan; Dong, Yande; Wang, Zhongming; Zhang, Yingmei; Liu, Meide; Zheng, Zhong; Zhang, Hengduan; Zhu, Xiaojuan; Wu, Zhiming; Zhao, Tongyan] Acad Mil Med Sci, Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Zheng, Zhong] Mil Area Command, Ctr Dis Control & Prevent, Xinjiang, Peoples R China	Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention	Zhao, TY (corresponding author), Acad Mil Med Sci, Inst Microbiol & Epidemiol, Beijing, Peoples R China.	aedes@263.net	Wang, Ge/AAH-8592-2020; Vannier, Michael W/AAI-6951-2021; Yu, Hengyong/AAH-5726-2019	Wang, Ge/0000-0002-2656-7705; Yu, Hengyong/0000-0002-5852-0813; Vannier, Michael/0000-0001-9898-384X	Infective Diseases Prevention and Cure Project of China [2008ZX10402, 2012ZX10004219]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011785] Funding Source: NIH RePORTER	Infective Diseases Prevention and Cure Project of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Infective Diseases Prevention and Cure Project of China (NO: 2008ZX10402) and (NO: 2012ZX10004219).	AKASHI H, 1994, GENETICS, V136, P927; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Baolin L, 1997, FAUNA SINICA INSECTA, V9; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Brown JW, 2003, P ENTOMOL SOC WASH, V105, P1043; Burns JM, 2007, PNAS, V105, p6 350; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; De la Herran R, 2001, HEREDITY, V87, P691, DOI 10.1046/j.1365-2540.2001.00967.x; Edwards FW, 1932, GENERA INSECTORUM DI; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FENG Lan-chou, 1938, Peking Natural History Bulletin, V12, P285; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gao Q, 2004, J MED ENTOMOL, V41, P5, DOI 10.1603/0022-2585-41.1.5; Hanel R, 2000, J MOL EVOL, V50, P276, DOI 10.1007/s002399910032; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; LI WH, 1981, NATURE, V292, P237, DOI 10.1038/292237a0; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Marko PB, 2002, EVOLUTION, V56, P1303; Moftah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027001; Monaghan M, 2005, PHIL TRAMS R SOCB, V360; Moriyama EN, 1997, J MOL EVOL, V45, P514, DOI 10.1007/PL00006256; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Phuc HK, 2003, MED VET ENTOMOL, V17, P423, DOI 10.1111/j.1365-2915.2003.00462.x; Remigio EA, 2003, MOL PHYLOGENET EVOL, V29, P641, DOI 10.1016/S1055-7903(03)00140-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sirivanakarn S., 1976, Contributions Am ent Inst, V12, P1; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716	35	211	237	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e47051	10.1371/journal.pone.0047051	http://dx.doi.org/10.1371/journal.pone.0047051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23240061	Green Submitted, gold, Green Published			2022-12-27	WOS:000312385200072
J	Ferreira, CM; Chen, JL; Li, JR; Shimomura, K; Yang, XN; Lussier, YA; Pinto, LH; Solway, J				Ferreira, Caroline M.; Chen, James L.; Li, Jianrong; Shimomura, Kazuhiro; Yang, Xinan; Lussier, Yves A.; Pinto, Lawrence H.; Solway, Julian			Genetic Interactions between Chromosomes 11 and 18 Contribute to Airway Hyperresponsiveness in Mice	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; SMOOTH-MUSCLE; CHOLESTEROL; ASTHMA; TRAIT; MOUSE; C1; RESPONSIVENESS; ATHEROSCLEROSIS; HYPERREACTIVITY	We used two-dimensional quantitative trait locus analysis to identify interacting genetic loci that contribute to the native airway constrictor hyperresponsiveness to methacholine that characterizes A/J mice, relative to C57BL/6J mice. We quantified airway responsiveness to intravenous methacholine boluses in eighty-eight (C57BL/6J X A/J) F-2 and twenty-seven (A/J X C57BL/6J) F2 mice as well as ten A/J mice and six C57BL/6J mice; all studies were performed in male mice. Mice were genotyped at 384 SNP markers, and from these data two-QTL analyses disclosed one pair of interacting loci on chromosomes 11 and 18; the homozygous A/J genotype at each locus constituted the genetic interaction linked to the hyperresponsive A/J phenotype. Bioinformatic network analysis of potential interactions among proteins encoded by genes in the linked regions disclosed two high priority subnetworks - Myl7, Rock1, Limk2; and Npc1, Npc1/1. Evidence in the literature supports the possibility that either or both networks could contribute to the regulation of airway constrictor responsiveness. Together, these results should stimulate evaluation of the genetic contribution of these networks in the regulation of airway responsiveness in humans.	[Ferreira, Caroline M.; Chen, James L.; Li, Jianrong; Yang, Xinan; Lussier, Yves A.; Solway, Julian] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ferreira, Caroline M.; Shimomura, Kazuhiro; Pinto, Lawrence H.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	University of Chicago; Northwestern University	Ferreira, CM (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jsolway@medicine.bsd.uchicago.edu	Gentile, Agustina/G-7174-2012; Ferreira, Caroline M/D-3949-2012; Lussier, Yves/N-4891-2017; Menossi, Marcelo/C-6305-2014; Menossi, Marcelo/A-4364-2012; Costa, Gustavo/HFZ-9405-2022; Endres, Lauricio/G-8650-2012; Vidal, Nicole/L-4130-2017; Costa, Gustavo Gilson Lacerda/B-6312-2009; Delaporte, Eric/J-5397-2018; Chen, James/A-9964-2016	Lussier, Yves/0000-0001-9854-1005; Menossi, Marcelo/0000-0002-9211-3787; Menossi, Marcelo/0000-0002-9211-3787; Endres, Lauricio/0000-0003-1215-4456; Vidal, Nicole/0000-0001-7022-2643; Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X; Chen, James/0000-0002-4095-5202	CNPq (National Council for Scientific and Technological Development) [UL1RR024999-04]; National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT) [U54CA121852-5, K22LM008308, R01HL079398]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079398] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by CNPq (National Council for Scientific and Technological Development), UL1RR024999-04, National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT; U54CA121852-5), K22LM008308, R01HL079398. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ackerman KG, 2005, PHYSIOL GENOMICS, V21, P105, DOI 10.1152/physiolgenomics.00267.2004; Al-Shawwa B, 2006, J ASTHMA, V43, P231, DOI 10.1080/02770900600567056; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Buchele G, 2010, PEDIATR PULM, V45, P796, DOI 10.1002/ppul.21259; Camateros P, 2010, MAMM GENOME, V21, P28, DOI 10.1007/s00335-009-9236-z; Chen BH, 2006, J APPL PHYSIOL, V101, P249, DOI 10.1152/japplphysiol.01010.2004; Chen J, 2010, J BIOMED INFORM, V43, P385, DOI 10.1016/j.jbi.2010.03.009; Chiba Yoshihiko, 2004, Journal of Smooth Muscle Research, V40, P155, DOI 10.1540/jsmr.40.155; Davis HR, 2008, ATHEROSCLEROSIS SUPP, V9, P77, DOI 10.1016/j.atherosclerosissup.2008.05.008; Davis HR, 2007, ARTERIOSCL THROM VAS, V27, P841, DOI 10.1161/01.ATV.0000257627.40486.46; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Davis HR, 2001, ARTERIOSCL THROM VAS, V21, P2032, DOI 10.1161/hq1201.100260; De Sanctis GT, 1999, AM J PHYSIOL-LUNG C, V277, pL1118, DOI 10.1152/ajplung.1999.277.6.L1118; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; Dowell ML, 2010, EUR RESPIR J, V36, P630, DOI 10.1183/09031936.00160209; Dowell ML, 2005, J APPL PHYSIOL, V98, P489, DOI 10.1152/japplphysiol.01378.2003; Ewart SL, 1996, AM J RESP CELL MOL, V14, P487, DOI 10.1165/ajrcmb.14.5.8624254; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Gunst SJ, 2000, EUR RESPIR J, V15, P600, DOI 10.1034/j.1399-3003.2000.15.29.x; Hoffjan S, 2002, CURR OPIN IMMUNOL, V14, P709, DOI 10.1016/S0952-7915(02)00393-X; Iyer SPN, 2005, BBA-GEN SUBJECTS, V1722, P282, DOI 10.1016/j.bbagen.2004.12.021; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kovesi TA, 1996, J INHERIT METAB DIS, V19, P792, DOI 10.1007/BF01799175; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leme AS, 2010, MOL GENET GENOMICS, V283, P317, DOI 10.1007/s00438-010-0515-x; LEVITT RC, 1989, J APPL PHYSIOL, V67, P1125, DOI 10.1152/jappl.1989.67.3.1125; LEVITT RC, 1988, FASEB J, V2, P2605, DOI 10.1096/fasebj.2.10.3384240; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Nicholson AG, 2006, HISTOPATHOLOGY, V48, P596, DOI 10.1111/j.1365-2559.2006.02355.x; Nicolae D, 2005, AM J HUM GENET, V76, P349, DOI 10.1086/427763; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Otera H, 2009, AM J PHYSIOL-LUNG C, V296, pL594, DOI 10.1152/ajplung.90530.2008; Palmeri S, 2005, NEUROL SCI, V26, P171, DOI 10.1007/s10072-005-0456-z; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Schlenz H, 2010, AM J PHYSIOL-LUNG C, V298, pL626, DOI 10.1152/ajplung.00261.2009; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sommer B, 2009, CAN J PHYSIOL PHARM, V87, P180, DOI [10.1139/Y08-114, 10.1139/y08-114]; Tossa P, 2010, AM J RESP CRIT CARE, V182, P738, DOI 10.1164/rccm.200903-0415OC; Wang WL, 2010, J LIPID RES, V51, P2560, DOI 10.1194/jlr.M004549; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weiss LA, 2005, AM J RESP CRIT CARE, V172, P67, DOI 10.1164/rccm.200411-1555OC; Woolcock AJ, 1997, ASTHMA, P27; Yao XL, 2011, J IMMUNOL, V186, P576, DOI 10.4049/jimmunol.1001534; Yao XL, 2010, AM J RESP CRIT CARE, V182, P1228, DOI 10.1164/rccm.201002-0308OC; Yeh YF, 2004, J BIOMED SCI, V11, P599, DOI 10.1007/BF02256124	49	247	260	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					100	106	e29579	10.1371/journal.pone.0029579	http://dx.doi.org/10.1371/journal.pone.0029579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	23071617	Green Published, Green Submitted, gold			2022-12-27	WOS:000301353900011
J	Chen, S; Cai, WP; He, JY; Vidal, N; Lai, CH; Guo, WZ; He, HL; Chen, XJ; Fu, LS; Peeters, M; Delaporte, E; Andrieu, JM; Lu, W				Chen, Song; Cai, Weiping; He, Jingyang; Vidal, Nicole; Lai, Chunhui; Guo, Weizhong; He, Haolan; Chen, Xiejie; Fu, Linsheng; Peeters, Martine; Delaporte, Eric; Andrieu, Jean-Marie; Lu, Wei			Molecular Epidemiology of Human Immunodeficiency Virus Type 1 in Guangdong Province of Southern China	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; DRUG-RESISTANCE; SUBTYPE C; HIV-1; TRANSMISSION; RISK; DIVERSITY	Background: Although the outbreak of human immunodeficiency virus type 1 (HIV-1) in Guangdong has been documented for more than a decade, the molecular characteristics of such a regional HIV-1 epidemic remained unknown. Methodology/Principal Findings: By sequencing of HIV-1 pol/env genes and phylogenetic analysis, we performed a molecular epidemiologic study in a representative subset (n = 200) of the 508 HIV-1-seropositive individuals followed up at the center for HIV/AIDS care and treatment of Guangzhou Hospital of Infectious Diseases. Of 157 samples (54.1% heterosexual acquired adults, 20.4% needle-sharing drug users, 5.7% receivers of blood transfusion, 1.3% men who have sex with men, and 18.5% remained unknown) with successful sequencing for both pol and env genes, 105 (66.9%) HIV-1 subtype CRF01_AE and 24 (15.3%) CRF07_BC, 9 (5.7%) B', 5 (3.2%) CRF08_BC, 5 (3.2%) B, 1 (0.6%) C, 3 (1.9%) CRF02_AG, and 5 (3.2%) inter-region recombinants were identified within pol/env sequences. Thirteen (8.3%) samples (3 naives, 6 and 5 received with antiretroviral treatment [ART] 1-21 weeks and >= 24 weeks respectively) showed mutations conferring resistance to nucleoside/nonnucleoside reverse transcriptase inhibitors or protease inhibitors. Among 63 ART-naive patients, 3 (4.8%) showed single or multiple drug resistant mutations. Phylogenetic analysis showed 8 small clusters (2-3 sequences/cluster) with only 17 (10.8%) sequences involved. Conclusion/Significance: This study confirms that sexual transmission with dominant CRF01_AE strain is a major risk for current HIV-1 outbreak in the Guangdong's general population. The transmission with drug-resistant variants is starting to emerge in this region.	[Chen, Song; He, Jingyang; Lai, Chunhui; Guo, Weizhong; Fu, Linsheng; Lu, Wei] Guangzhou Univ Chinese Med, Sinofrench Collaborat Lab, Inst Trop Med, Guangzhou, Guangdong, Peoples R China; [Chen, Song; Andrieu, Jean-Marie] Univ Paris 05, Lab Oncol & Virol Mol, Paris, France; [Cai, Weiping; He, Haolan; Chen, Xiejie] Guangzhou Hosp Infect Dis, Guangzhou, Guangdong, Peoples R China; [Vidal, Nicole; Peeters, Martine; Delaporte, Eric; Lu, Wei] Inst Rech Dev, UMI 233, Montpellier, France; [Vidal, Nicole; Peeters, Martine; Delaporte, Eric; Lu, Wei] Univ Monpellier 1, Montpellier, France	Guangzhou University of Chinese Medicine; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Lu, W (corresponding author), Guangzhou Univ Chinese Med, Sinofrench Collaborat Lab, Inst Trop Med, Guangzhou, Guangdong, Peoples R China.	louis.luwei@ird.fr	Gentile, Agustina/G-7174-2012; Ferreira, Caroline M/D-3949-2012; Lussier, Yves/N-4891-2017; Menossi, Marcelo/C-6305-2014; Menossi, Marcelo/A-4364-2012; Costa, Gustavo/HFZ-9405-2022; Endres, Lauricio/G-8650-2012; Vidal, Nicole/L-4130-2017; Costa, Gustavo Gilson Lacerda/B-6312-2009; Delaporte, Eric/J-5397-2018; Chen, James/A-9964-2016	Lussier, Yves/0000-0001-9854-1005; Menossi, Marcelo/0000-0002-9211-3787; Menossi, Marcelo/0000-0002-9211-3787; Endres, Lauricio/0000-0003-1215-4456; Vidal, Nicole/0000-0001-7022-2643; Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X; Chen, James/0000-0002-4095-5202	Institut de Recherche pour le Developpement (IRD); Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS); Universite Paris Descartes; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079398] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	Institut de Recherche pour le Developpement (IRD); Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS); Universite Paris Descartes; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Institut de Recherche pour le Developpement (IRD) and the Institut de Recherche sur les Vaccins et l'Immunotherapie des Cancers et du Sida (IRVICS). S. C. was supported by a fellowship from Universite Paris Descartes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao LL, 2008, AIDS RES HUM RETROV, V24, P733, DOI 10.1089/aid.2007.0269; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Deeks SG, 2004, J INFECT DIS, V189, P312, DOI 10.1086/380098; Deng W, 2009, AIDS, V23, P977, DOI 10.1097/QAD.0b013e328329217d; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fischetti L, 2004, J MED VIROL, V73, P158, DOI 10.1002/jmv.20070; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Jia ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025671; Li Y, 2010, VIROLOGY, V402, P223, DOI 10.1016/j.virol.2010.03.048; Lin P, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P194; Lin P., 2009, Morbidity and Mortality Weekly Report, V58, P396; Liu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023347; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McCutchan FE, 2002, AIDS RES HUM RETROV, V18, P1135, DOI 10.1089/088922202320567879; Meyerhans A, 2003, SWISS MED WKLY, V133, P451; Mild M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022741; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Pang W, 2012, AIDS, V26, P1121, DOI 10.1097/QAD.0b013e3283522c97; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Sun XH, 2007, AIDS, V21, pS33, DOI 10.1097/01.aids.0000304694.54884.06; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94; Vidal N, 2007, AIDS RES HUM RETROV, V23, P175, DOI 10.1089/aid.2006.0126; Wang XQ, 2007, AIDS, V21, pS149, DOI 10.1097/01.aids.0000304711.87164.99; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang KL, 2002, BMJ-BRIT MED J, V324, P803, DOI 10.1136/bmj.324.7341.803; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196	33	247	260	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48747	10.1371/journal.pone.0048747	http://dx.doi.org/10.1371/journal.pone.0048747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23071617	gold, Green Submitted, Green Published			2022-12-27	WOS:000311935800118
J	Ferreira, TH; Gentile, A; Vilela, RD; Costa, GGL; Dias, LI; Endres, L; Menossi, M				Ferreira, Thais Helena; Gentile, Agustina; Vilela, Romel Duarte; Lacerda Costa, Gustavo Gilson; Dias, Lara Isys; Endres, Lauricio; Menossi, Marcelo			microRNAs Associated with Drought Response in the Bioenergy Crop Sugarcane (Saccharum spp.)	PLOS ONE			English	Article							STRESS-REGULATED MICRORNAS; SMALL RNAS; TRANSCRIPTION FACTORS; SOYBEAN MICRORNAS; GENE-EXPRESSION; DOWN-REGULATION; SALT TOLERANCE; ORYZA-SATIVA; ARABIDOPSIS; IDENTIFICATION	Sugarcane (Saccharum spp.) is one of the most important crops in the world. Drought stress is a major abiotic stress factor that significantly reduces sugarcane yields. However the gene network that mediates plant responses to water stress remains largely unknown in several crop species. Although several microRNAs that mediate post-transcriptional regulation during water stress have been described in other species, the role of the sugarcane microRNAs during drought stress has not been studied. The objective of this work was to identify sugarcane miRNAs that are differentially expressed under drought stress and to correlate this expression with the behavior of two sugarcane cultivars with different drought tolerances. The sugarcane cultivars RB867515 (higher drought tolerance) and RB855536 (lower drought tolerance) were cultivated in a greenhouse for three months and then subjected to drought for 2, 4, 6 or 8 days. By deep sequencing of small RNAs, we were able to identify 18 miRNA families. Among all of the miRNAs thus identified, seven were differentially expressed during drought. Six of these miRNAs were differentially expressed at two days of stress, and five miRNAs were differentially expressed at four days. The expression levels of five miRNAs (ssp-miR164, ssp-miR394, ssp-miR397, ssp-miR399-seq 1 and miR528) were validated by RT-qPCR (quantitative reverse transcriptase PCR). Six precursors and the targets of the differentially expressed miRNA were predicted using an in silico approach and validated by RT-qPCR; many of these targets may play important roles in drought tolerance. These findings constitute a significant increase in the number of identified miRNAs in sugarcane and contribute to the elucidation of the complex regulatory network that is activated by drought stress.	[Ferreira, Thais Helena; Gentile, Agustina; Dias, Lara Isys; Menossi, Marcelo] Univ Estadual Campinas, Inst Biol, Lab Genoma Func, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil; [Vilela, Romel Duarte; Endres, Lauricio] Univ Fed Alagoas, Ctr Ciencias Agr, Rio Largo, Alagoas, Brazil; [Lacerda Costa, Gustavo Gilson] Univ Estadual Campinas, Lab Cent Tecnol Alto Desempenho, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Alagoas; Universidade Estadual de Campinas	Menossi, M (corresponding author), Univ Estadual Campinas, Inst Biol, Lab Genoma Func, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil.	menossi@unicamp.br	Gentile, Agustina/G-7174-2012; Ferreira, Caroline M/D-3949-2012; Lussier, Yves/N-4891-2017; Menossi, Marcelo/C-6305-2014; Menossi, Marcelo/A-4364-2012; Costa, Gustavo/HFZ-9405-2022; Endres, Lauricio/G-8650-2012; Vidal, Nicole/L-4130-2017; Costa, Gustavo Gilson Lacerda/B-6312-2009; Delaporte, Eric/J-5397-2018; Chen, James/A-9964-2016	Lussier, Yves/0000-0001-9854-1005; Menossi, Marcelo/0000-0002-9211-3787; Menossi, Marcelo/0000-0002-9211-3787; Endres, Lauricio/0000-0003-1215-4456; Vidal, Nicole/0000-0001-7022-2643; Delaporte, Eric/0000-0002-1822-9853; CHEN, Song/0000-0003-2521-717X; Chen, James/0000-0002-4095-5202	FINEP (The Financiadora de Estudos e Projetos); FAPESP (Sao Paulo Research Foundation); CNPq (The National Council for Scientific and Technological Development); CAPES (Co-ordination of Improvement of Higher Education Personnel); NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079398] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	FINEP (The Financiadora de Estudos e Projetos); FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (The National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Co-ordination of Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by the following Brazilian funding institutions: FINEP (The Financiadora de Estudos e Projetos), FAPESP (Sao Paulo Research Foundation), CNPq (The National Council for Scientific and Technological Development) and CAPES (Co-ordination of Improvement of Higher Education Personnel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berger Y, 2009, DEVELOPMENT, V136, P823, DOI 10.1242/dev.031625; CACHORRO P, 1993, PHYTON-ANN REI BOT A, V33, P33; Calvino M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-356; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dillon SL, 2007, ANN BOT-LONDON, V100, P975, DOI 10.1093/aob/mcm192; Ditt RF, 2011, SCI AGR, V68, P454, DOI 10.1590/S0103-90162011000400010; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Giordani T, 2011, THEOR APPL GENET, V122, P1039, DOI 10.1007/s00122-010-1509-0; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hegedus D, 2003, PLANT MOL BIOL, V53, P383, DOI 10.1023/B:PLAN.0000006944.61384.11; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hoopes JT, 2004, PLANT PHYSIOL BIOCH, V42, P27, DOI 10.1016/j.plaphy.2003.10.011; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Inman-Bamber NG, 2005, FIELD CROP RES, V92, P185, DOI 10.1016/j.fcr.2005.01.023; Islam MS, 2010, HORTIC ENVIRON BIOTE, V51, P556; Jannoo N, 2007, PLANT J, V50, P574, DOI 10.1111/j.1365-313X.2007.03082.x; Jeong MJ, 2000, BIOCHEM BIOPH RES CO, V278, P192, DOI 10.1006/bbrc.2000.3732; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kikuchi K, 2000, MOL GEN GENET, V262, P1047, DOI 10.1007/PL00008647; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liang MX, 2006, PLANT CELL ENVIRON, V29, P746, DOI 10.1111/j.1365-3040.2005.01435.x; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu QL, 2011, BIOTECHNOL LETT, V33, P2073, DOI 10.1007/s10529-011-0659-8; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; NEUMANN PM, 1994, PLANT CELL ENVIRON, V17, P303, DOI 10.1111/j.1365-3040.1994.tb00296.x; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Papini-Terzi FS, 2005, DNA RES, V12, P27, DOI 10.1093/dnares/12.1.27; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Paro S, 2007, J BIOL CHEM, V282, P5217, DOI 10.1074/jbc.M609042200; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Pillai MA, 2002, THEOR APPL GENET, V105, P34, DOI 10.1007/s00122-001-0833-9; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Raman S, 2008, PLANT J, V55, P65, DOI 10.1111/j.1365-313X.2008.03483.x; Rancour DM, 2004, J BIOL CHEM, V279, P54264, DOI 10.1074/jbc.M405498200; Ranocha P, 2002, PLANT PHYSIOL, V129, P145, DOI 10.1104/pp.010988; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vaseva I, 2011, SCI HORTIC-AMSTERDAM, V130, P653, DOI 10.1016/j.scienta.2011.08.021; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wei JZ, 2000, PLANT SCI, V159, P135, DOI 10.1016/S0168-9452(00)00344-7; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777; Yang O, 2009, GENE, V436, P45, DOI 10.1016/j.gene.2009.02.010; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Yang XZ, 2011, GENOMICS, V98, P40, DOI 10.1016/j.ygeno.2011.03.011; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zanca AS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-260; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang H, 2011, PLANT SIGNAL BEHAV, V6, P861, DOI 10.4161/psb.6.6.15223; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhao FY, 2006, MOL BREEDING, V17, P341, DOI 10.1007/s11032-006-9005-6; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	81	247	260	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e46703	10.1371/journal.pone.0046703	http://dx.doi.org/10.1371/journal.pone.0046703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23071617	gold, Green Published, Green Submitted			2022-12-27	WOS:000309807700025
